<SEC-DOCUMENT>0001493152-24-012368.txt : 20240401
<SEC-HEADER>0001493152-24-012368.hdr.sgml : 20240401
<ACCEPTANCE-DATETIME>20240401161437
ACCESSION NUMBER:		0001493152-24-012368
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		150
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240401
DATE AS OF CHANGE:		20240401

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arena Group Holdings, Inc.
		CENTRAL INDEX KEY:			0000894871
		STANDARD INDUSTRIAL CLASSIFICATION:	CABLE & OTHER PAY TELEVISION SERVICES [4841]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				680232575
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12471
		FILM NUMBER:		24809415

	BUSINESS ADDRESS:	
		STREET 1:		200 VESEY STREET
		STREET 2:		24TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10281
		BUSINESS PHONE:		212 321 5002

	MAIL ADDRESS:	
		STREET 1:		200 VESEY STREET
		STREET 2:		24TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10281

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	theMaven, Inc.
		DATE OF NAME CHANGE:	20161228

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	THEMAVEN, INC.
		DATE OF NAME CHANGE:	20161209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTEGRATED SURGICAL SYSTEMS INC
		DATE OF NAME CHANGE:	19960725
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>form10-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:AREN="http://thearenagroup.net/20231231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_076_XDX_form10%2Dk.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_AREN_thearenagroup.net_20231231 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20230101_20231231 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0000894871 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_Segment_0_Segment -->
<!-- Field: Set; Name: xdx; ID: xdx_064_Integer_5_Integer -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000004" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000005" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000006" name="dei:EntityCentralIndexKey">0000894871</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:RestrictedCashCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl0060" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl0124" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl0141" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:LiquidatingDamagesPayableNonCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl0144" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-12-31" id="xdx2ixbrl0156" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2022-12-31" id="xdx2ixbrl0157" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember" id="xdx2ixbrl0195" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:CommonStockToBeIssuedDuringPeriod" contextRef="AsOf2023-12-31" id="xdx2ixbrl0251" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:CommonStockToBeIssuedDuringPeriod" contextRef="AsOf2022-12-31" id="xdx2ixbrl0252" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:LossOnSaleOfAssets" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0295" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0307" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0327" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0342" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0344" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0367" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0377" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0379" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0385" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0387" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne" contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0393" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0395" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0400" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0401" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0403" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0408" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0409" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0411" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0415" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0417" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0418" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0423" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0425" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0430" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0431" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0432" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0433" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0434" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0438" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0439" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0440" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0441" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0442" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0448" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0449" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0451" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0454" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0455" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0457" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0460" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0461" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0463" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0466" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0467" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0468" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0473" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0483" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0493" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0505" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0511" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0513" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0518" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger" contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0519" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0520" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0521" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0522" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0528" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0529" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0531" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0537" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0539" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0544" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0545" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0547" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0551" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0553" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0559" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0561" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0562" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0567" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0569" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0574" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0575" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0576" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0577" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0578" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0583" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0585" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0590" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0591" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0593" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0596" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0597" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0598" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0603" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_CommonStockToBeIssuedMember" id="xdx2ixbrl0613" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:LossOnSaleOfAssets" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0647" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0650" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherOperatingActivitiesCashFlowStatement" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0664" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidRoyalties" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0676" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0709" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0716" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0718" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0733" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0746" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0748" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:PaymentOfRestrictedStockLiabilities" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0757" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RestrictedCash" contextRef="AsOf2023-12-31" id="xdx2ixbrl0778" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0791" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:ReclassificationToLiabilityUponCommonStockModification" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0818" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RestrictedCashCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl0929" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RestrictedCashCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl0935" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0954" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31_us-gaap_SeriesHPreferredStockMember" id="xdx2ixbrl1043" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31_custom_FinancingWarrantsMember" id="xdx2ixbrl1047" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31_custom_RestrictedStockAwardsMember" id="xdx2ixbrl1063" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="AREN:EmployeeRetentionCredits" contextRef="AsOf2022-12-31" id="xdx2ixbrl1358" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl1455" unitRef="USD" xs:nil="true"/>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl1529" name="us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">http://fasb.org/us-gaap/2023#AssetImpairmentCharges</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-12-31_custom_DevelopedTechnologyMember" id="xdx2ixbrl1541" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2022-12-31" id="xdx2ixbrl1681" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2023-01-012023-12-31_custom_ParadeMember" id="xdx2ixbrl1699" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2022-01-012022-12-31_custom_FexyStudiosMember" id="xdx2ixbrl1706" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl1708" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1709" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl1714" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1716" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl1742" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:LeaseDepositLiability" contextRef="AsOf2022-12-31" id="xdx2ixbrl1748" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:PublicInformationFailureDamages" contextRef="AsOf2023-12-31_custom_MDBCommonStockToBeIssuedMember" id="xdx2ixbrl1803" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2023-12-31_custom_MDBCommonStockToBeIssuedMember" id="xdx2ixbrl1805" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:RegistrationRightsDamages" contextRef="AsOf2023-12-31_custom_ConvertibleDebenturesMember" id="xdx2ixbrl1817" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:PublicInformationFailureDamages" contextRef="AsOf2022-12-31_custom_MDBCommonStockToBeIssuedMember" id="xdx2ixbrl1870" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2022-12-31_custom_MDBCommonStockToBeIssuedMember" id="xdx2ixbrl1872" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:RegistrationRightsDamages" contextRef="AsOf2022-12-31_custom_ConvertibleDebenturesMember" id="xdx2ixbrl1884" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:LeaseTerminationLiabilityNonCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl1928" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="AsOf2023-12-31_custom_ContingentConsiderationMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1956" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_custom_ContingentConsiderationMember" id="xdx2ixbrl1960" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1965" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1969" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="xdx2ixbrl2120" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="xdx2ixbrl2122" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="xdx2ixbrl2124" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="xdx2ixbrl2148" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyThreeNotesMember" id="xdx2ixbrl2163" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2022-01-012022-12-31_custom_SeniorSecuredNotesMember" id="xdx2ixbrl2166" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2022-01-012022-12-31_custom_DelayedDrawTermNoteMember" id="xdx2ixbrl2169" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="xdx2ixbrl2172" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2022-01-012022-12-31_custom_LineOfCreditTerminationFeeMember" id="xdx2ixbrl2175" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2023-01-012023-12-31_custom_ParadeMember66267484" id="xdx2ixbrl2177" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyThreeNotesMember" id="xdx2ixbrl2193" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="xdx2ixbrl2202" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2211" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2023-12-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl2408" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2023-12-31_custom_CommonStockFinancingWarrantMember" id="xdx2ixbrl2424" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber" contextRef="AsOf2023-12-31_custom_CommonStockFinancingWarrantMember" id="xdx2ixbrl2426" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber" contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember66276312" id="xdx2ixbrl2731" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber" contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember66276312" id="xdx2ixbrl2733" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-12-31_custom_NewPublisherPartnerWarrantMember" id="xdx2ixbrl2769" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" contextRef="AsOf2022-12-31_custom_NewPublisherPartnerWarrantMember" id="xdx2ixbrl2771" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeOneMember" id="xdx2ixbrl2802" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember" id="xdx2ixbrl2828" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DevelopmentCosts" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember" id="xdx2ixbrl2848" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DevelopmentCosts" contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember" id="xdx2ixbrl2852" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-01-012022-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember" id="xdx2ixbrl2868" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-01-012022-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember" id="xdx2ixbrl2876" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DevelopmentCosts" contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember" id="xdx2ixbrl2896" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DevelopmentCosts" contextRef="From2022-01-012022-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember" id="xdx2ixbrl2900" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl2946" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2947" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="AREN:EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl3078" unitRef="USD" xs:nil="true"/>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="aren-20231231.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-01-01to2023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesGRedeemableAndConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesGRedeemableAndConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SeriesHConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesHRedeemableAndConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesHRedeemableAndConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CommonStockToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:CommonStockToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:CommonStockToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CommonStockToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:CommonStockToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CommonStockToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:CommonStockToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:CommonStockToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-082022-02-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-08</xbrli:startDate>
        <xbrli:endDate>2022-02-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-01_custom_BRileyFBRIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:BRileyFBRIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_DigitalAndPrintSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalAndPrintSubscriptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AREN:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AREN:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AREN:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AREN:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_SellingAndMarketingExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_SellingAndMarketingExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_DigitalAdvertisingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalAdvertisingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_DigitalAdvertisingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalAdvertisingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_DigitalSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalSubscriptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_DigitalSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalSubscriptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_LicensingAndSyndicationRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:LicensingAndSyndicationRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_LicensingAndSyndicationRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:LicensingAndSyndicationRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_ProductAndServiceOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_ProductAndServiceOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_DigitalRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_DigitalRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_PrintAdvertisingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:PrintAdvertisingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_PrintAdvertisingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:PrintAdvertisingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_PrintSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:PrintSubscriptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_PrintSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:PrintSubscriptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_PrintRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:PrintRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_PrintRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:PrintRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">AREN:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">AREN:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_TransferredAtPointInTimeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_TransferredAtPointInTimeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_TransferredOverTimeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_TransferredOverTimeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_DigitalRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_DigitalRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PrintRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:PrintRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PrintRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:PrintRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OfficeEquipmentAndComputersMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:OfficeEquipmentAndComputersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OfficeEquipmentAndComputersMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:OfficeEquipmentAndComputersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SeriesGConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SeriesGConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_SeriesHPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_SeriesHPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_FinancingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:FinancingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_FinancingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:FinancingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ABGWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ABGWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AllHipHopWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:AllHipHopWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AllHipHopWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:AllHipHopWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_PublisherPartnerWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:PublisherPartnerWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_PublisherPartnerWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:PublisherPartnerWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RestrictedStockAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:RestrictedStockAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_RestrictedStockAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:RestrictedStockAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CommonStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:CommonStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_CommonStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:CommonStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ParadePrintMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">AREN:ParadePrintMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-11</xbrli:startDate>
        <xbrli:endDate>2023-01-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012023-03-01_custom_TeneologyIncMember_custom_FexyStudiosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2023-03-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-04-01_custom_TeneologyIncMember_custom_FexyStudiosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-04-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-05-01_custom_TeneologyIncMember_custom_FexyStudiosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-05-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AdvertiserRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">AREN:AdvertiserRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">AREN:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TeneologyIncMember_custom_FexyStudiosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-11-172023-11-17_custom_Disposition2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">AREN:Disposition2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-17</xbrli:startDate>
        <xbrli:endDate>2023-11-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_Disposition2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">AREN:Disposition2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_Disposition2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">AREN:Disposition2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-01_custom_AthlonHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-01_custom_AthlonHoldingsIncMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_AthlonHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember_custom_DigitalContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">AREN:DigitalContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember_custom_AdvertiserRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">AREN:AdvertiserRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember_us-gaap_TradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-272022-09-27_custom_BuffaloGroupeLLCMember_custom_IntellectualPropertiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:BuffaloGroupeLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:IntellectualPropertiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-27</xbrli:startDate>
        <xbrli:endDate>2022-09-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-12-152022-12-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-15</xbrli:startDate>
        <xbrli:endDate>2022-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-12-072022-12-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-07</xbrli:startDate>
        <xbrli:endDate>2022-12-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_MensJournalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:MensJournalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_A360MediaLLCMember_custom_AdvertiserRelationshipMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:A360MediaLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:AdvertiserRelationshipMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_A360MediaLLCMember_custom_BrandNameMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:A360MediaLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BrandNameMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_FexyStudiosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AthlonHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember_custom_AdvertiserRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">AREN:AdvertiserRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember_custom_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">AREN:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember_us-gaap_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ParadeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:ParadeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ArenaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:ArenaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AdjustmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AdjustmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_AthlonHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OfficeEquipmentAndComputersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:OfficeEquipmentAndComputersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_OfficeEquipmentAndComputersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:OfficeEquipmentAndComputersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SubleaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SubleaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-012021-09-30_custom_LeaseArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:LeaseArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OctoberOneTwoThousandAndTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">AREN:OctoberOneTwoThousandAndTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_OctoberOneTwoThousandAndTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">AREN:OctoberOneTwoThousandAndTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_BusinessMembershipAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:BusinessMembershipAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_BusinessMembershipAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:BusinessMembershipAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_MonthToMonthLeaseArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:MonthToMonthLeaseArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_MonthToMonthLeaseArrangementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:MonthToMonthLeaseArrangementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PlatformDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:PlatformDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PlatformDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:PlatformDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PlatformDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:PlatformDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_PlatformDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:PlatformDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_PlatformDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:PlatformDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_DevelopedTechnologyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:DevelopedTechnologyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_DevelopedTechnologyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:DevelopedTechnologyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_TradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_TradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SubscriberRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:SubscriberRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SubscriberRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:SubscriberRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_AdvertiserRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:AdvertiserRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_AdvertiserRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:AdvertiserRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_DatabasesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_DatabasesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_DigitalContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:DigitalContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_DigitalContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:DigitalContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_DevelopedTechnologyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:DevelopedTechnologyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_DevelopedTechnologyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:DevelopedTechnologyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_FiniteLivedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_FiniteLivedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ParadeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:ParadeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_MensJournalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:MensJournalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_FexyStudiosMember66260062">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_FexyStudiosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-12-152022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-15</xbrli:startDate>
        <xbrli:endDate>2022-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-12-152022-12-15_custom_SLRDigitalFinanceLLCMember_custom_FinancingAndSecurityAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-15</xbrli:startDate>
        <xbrli:endDate>2022-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember_custom_TwoThousandTwentyThreeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember_custom_SeriesLPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:SeriesLPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_MDBCommonStockToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:MDBCommonStockToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ConvertibleDebenturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:ConvertibleDebenturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SeriesJPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesJPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SeriesKPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesKPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_MDBCommonStockToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:MDBCommonStockToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ConvertibleDebenturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:ConvertibleDebenturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SeriesJPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesJPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SeriesKPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesKPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-082023-02-08_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-08</xbrli:startDate>
        <xbrli:endDate>2023-02-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-08_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-012023-12-01_custom_BRileyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-01</xbrli:startDate>
        <xbrli:endDate>2023-12-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_BRileyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_FlexyStudiosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:FlexyStudiosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_PutOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_FexyStudiosAcquistionMember_us-gaap_PutOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosAcquistionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ContingentConsiderationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">AREN:ContingentConsiderationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ContingentConsiderationMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">AREN:ContingentConsiderationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ContingentConsiderationMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">AREN:ContingentConsiderationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_custom_ContingentConsiderationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">AREN:ContingentConsiderationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SeniorSecuredNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">AREN:SeniorSecuredNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SeniorSecuredNoteMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">AREN:SeniorSecuredNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SeniorSecuredNoteMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">AREN:SeniorSecuredNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SeniorSecuredNoteMember_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">AREN:SeniorSecuredNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31_custom_TwoThousandTwentyThreeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-312023-08-31_custom_TwoThousandTwentyThreeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-31</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-292023-09-29_custom_TwoThousandTwentyThreeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-29</xbrli:startDate>
        <xbrli:endDate>2023-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-27_custom_TwoThousandTwentyThreeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-29_custom_TwoThousandTwentyThreeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_BridgeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:BridgeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwoThousandTwentyThreeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_BridgeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:BridgeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-15_custom_TwoThousandTwentyTwoBridgeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-12-152022-12-15_custom_TwoThousandTwentyTwoBridgeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-15</xbrli:startDate>
        <xbrli:endDate>2022-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SeniorSecuredNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:SeniorSecuredNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SLRDigitalFinanceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_DelayedDrawTermNotesMember_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">AREN:DelayedDrawTermNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_DelayedDrawTermNotesMember_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">AREN:DelayedDrawTermNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012023-03-01_custom_TwoThousandTwentyTwoBridgeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2023-03-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-05-01_custom_TwoThousandTwentyTwoBridgeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-05-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-07-01_custom_TwoThousandTwentyTwoBridgeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-07-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-12-312022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-31</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-12-312022-12-31_custom_BRileyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-31</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SeniorSecuredNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:SeniorSecuredNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SeniorSecuredNoteMember66266859">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:SeniorSecuredNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_DelayedDrawTermNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:DelayedDrawTermNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_DelayedDrawTermNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:DelayedDrawTermNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_DelayedDrawTermNoteMember66267140">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">AREN:DelayedDrawTermNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_DelayedDrawTermNoteMember66267140">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">AREN:DelayedDrawTermNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember66267156">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember66267156">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_LineOfCreditMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_LineOfCreditMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SeniorSecuredNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:SeniorSecuredNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SeniorSecuredNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:SeniorSecuredNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_DelayedDrawTermNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:DelayedDrawTermNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_DelayedDrawTermNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:DelayedDrawTermNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TwoThousandTwentyThreeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_LineOfCreditTerminationFeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:LineOfCreditTerminationFeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_LineOfCreditTerminationFeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:LineOfCreditTerminationFeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ParadeMember66267484">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:ParadeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ParadeMember66267484">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:ParadeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_OtherAccruedInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:OtherAccruedInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_OtherAccruedInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:OtherAccruedInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_OtherMember66267546">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_OtherMember66267562">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SeriesGConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_SeriesHPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_SeriesGPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_SeriesGPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2000-05-302000-05-30_us-gaap_SeriesGPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2000-05-30</xbrli:startDate>
        <xbrli:endDate>2000-05-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2000-05-30_us-gaap_SeriesGPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2000-05-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OriginalInvestorMember_us-gaap_SeriesGPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:OriginalInvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-10_custom_SeriesHConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-302023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:PurchasersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-30</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:PurchasersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SeriesHConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SeriesHConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-102023-01-11_custom_FexyStudiosAcquisitionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:FexyStudiosAcquisitionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-10</xbrli:startDate>
        <xbrli:endDate>2023-01-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-01_custom_AssetPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:AssetPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-282022-04-02_custom_ParadeStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:ParadeStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-28</xbrli:startDate>
        <xbrli:endDate>2022-04-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-09_custom_AssetPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:AssetPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SeveralStockPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:SeveralInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SeveralStockPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:SeveralInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SeveralStockPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:SeveralInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_CommonStockMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_CommonStockMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_CommonStockMember_custom_RestrictedCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:RestrictedCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_CommonStockMember_custom_RestrictedCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:RestrictedCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ExerciseOfStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ExerciseOfStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ExerciseOfStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ExerciseOfStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-202022-01-21_custom_ServicesAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ServicesAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-20</xbrli:startDate>
        <xbrli:endDate>2022-01-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-112022-01-12_custom_ServicesAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ServicesAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-11</xbrli:startDate>
        <xbrli:endDate>2022-01-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-12_custom_ServicesAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ServicesAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-26_custom_ServicesAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ServicesAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ServicesAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ServicesAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-112022-03-11_custom_UnderwritingPublicOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">AREN:UnderwritingPublicOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-11</xbrli:startDate>
        <xbrli:endDate>2022-03-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-152022-02-15_custom_UnderwritingPublicOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">AREN:UnderwritingPublicOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-15</xbrli:startDate>
        <xbrli:endDate>2022-02-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-152022-02-15_custom_UnderwritingOverallotmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">AREN:UnderwritingOverallotmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-15</xbrli:startDate>
        <xbrli:endDate>2022-02-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-112022-03-11_custom_UnderwritingOverallotmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">AREN:UnderwritingOverallotmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-11</xbrli:startDate>
        <xbrli:endDate>2022-03-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_BRileyMember66269906">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">AREN:BRileyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_UnderwritingPublicOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">AREN:UnderwritingPublicOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-032018-01-04_custom_MDBCapitalGroupLLCMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:MDBCapitalGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-03</xbrli:startDate>
        <xbrli:endDate>2018-01-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-26_custom_AllHipHopWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:AllHipHopWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-26_custom_PublisherPartnerWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:PublisherPartnerWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-14_custom_ABGWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-06-132019-06-14_custom_ABGWarransMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:ABGWarransMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-06-13</xbrli:startDate>
        <xbrli:endDate>2019-06-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ABGTimeBasedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:ABGTimeBasedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ABGPerformanceBasedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:ABGPerformanceBasedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-20_custom_PublisherPartnerWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:PublisherPartnerWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-11-02_custom_NewPublisherPartnerWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:NewPublisherPartnerWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-11-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CommonStockFinancingWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:CommonStockFinancingWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CommonStockFinancingWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:CommonStockFinancingWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CommonStockFinancingWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:CommonStockFinancingWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-02_custom_TwoThousandTwentyTwoPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-272023-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-27</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-292023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-29</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-11-202022-11-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-11-20</xbrli:startDate>
        <xbrli:endDate>2022-11-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember66271921">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember66271937">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TwoThousandTwentyTwoPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-282023-02-28_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-28</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-282023-02-28_custom_CommonStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-28</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-282023-02-28_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-28</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_CommonStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CommonStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-06-30_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-06-30_custom_CommonStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_CommonStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-292023-06-30_custom_CommonStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-29</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-11-012023-11-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-01</xbrli:startDate>
        <xbrli:endDate>2023-11-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-152022-03-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-15</xbrli:startDate>
        <xbrli:endDate>2022-03-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SportsIllustratedLicensingAgreementMember_custom_ABGWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SportsIllustratedLicensingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SportsIllustratedLicensingAgreementMember_custom_ABGWarrantsMember66272984">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SportsIllustratedLicensingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PublisherPartnerWarrantProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:PublisherPartnerWarrantProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:NewPublisherPartnerWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CommonEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CommonStockAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ABGWarrantsMember66273406">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_NewPublisherPartnerWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:NewPublisherPartnerWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:UpListMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:UpListMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:NoUpListMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:UpListMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:UpListMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:NoUpListMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:NoUpListMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ABGWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:NewPublisherPartnerWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:NewPublisherPartnerWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:NewPublisherPartnerWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:NewPublisherPartnerWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ABGWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ABGWarrantsMember66276281">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ABGWarrantsMember66276312">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_NewPublisherPartnerWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:NewPublisherPartnerWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_StockBasedCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_StockBasedCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_StockBasedCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_StateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">AREN:StateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_LocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">AREN:LocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_USFederalTaxMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">AREN:USFederalTaxMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_StateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">AREN:StateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_LocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">AREN:LocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-012023-12-01_custom_BRileyFBRIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:BRileyFBRIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-01</xbrli:startDate>
        <xbrli:endDate>2023-12-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_BRileyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-312023-03-31_custom_BRileyMember_us-gaap_CommonStockMember_custom_DirectOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">AREN:DirectOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-31</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_DirectOfferingMember_custom_BRileyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">AREN:DirectOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-10_custom_BRileyMember_custom_SeriesHConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31_custom_BRileyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-29_custom_BRileyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-27_custom_BRileyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_BRileyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_BRileyFinancialIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:BRileyFinancialIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_BRileyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:PurchasersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-31</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-31</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_HHuntAllredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:HHuntAllredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-31</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_AllredTrustHHAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:AllredTrustHHAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-31</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_AllredTrustNLAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:AllredTrustNLAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-31</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_OneEightyDegreeCapitalCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:OneEightyDegreeCapitalCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-31</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_DanielShribmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:DanielShribmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-31</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_RossLevinsohnMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:RossLevinsohnMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-31</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_PaulEdmonsonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:PaulEdmonsonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-31</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-142020-12-15_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-14</xbrli:startDate>
        <xbrli:endDate>2020-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-15_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_MrEdmonsonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:MrEdmonsonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ABGSILLCMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:ABGSILLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-01-05_custom_ArenaLoanAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ArenaLoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-01-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ArenaLoanAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ArenaLoanAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-01-02_custom_LicensingAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:LicensingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-022024-01-02_us-gaap_SubsequentEventMember_custom_ABGWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-02</xbrli:startDate>
        <xbrli:endDate>2024-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_custom_TransactionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:TransactionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-09</xbrli:startDate>
        <xbrli:endDate>2024-02-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_TransactionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:TransactionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_custom_TransactionAgreementMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:TransactionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-09</xbrli:startDate>
        <xbrli:endDate>2024-02-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-092024-02-09_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-09</xbrli:startDate>
        <xbrli:endDate>2024-02-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-09_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-09</xbrli:startDate>
        <xbrli:endDate>2024-02-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-09</xbrli:startDate>
        <xbrli:endDate>2024-02-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-142024-02-14_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SubscriptionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SubscriptionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-14</xbrli:startDate>
        <xbrli:endDate>2024-02-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-14_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SubscriptionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SubscriptionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_SubscriptionAgreementMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SubscriptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-152024-02-15_us-gaap_SubsequentEventMember_custom_FexyStudiosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-15</xbrli:startDate>
        <xbrli:endDate>2024-02-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-132024-03-14_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-13</xbrli:startDate>
        <xbrli:endDate>2024-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-13_us-gaap_SubsequentEventMember_custom_SimplyfyLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">AREN:SimplyfyLoanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-13_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-212024-03-21_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-21</xbrli:startDate>
        <xbrli:endDate>2024-03-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-01-01_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-01-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-01-01_us-gaap_SubsequentEventMember_custom_MembersOfBoardMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:MembersOfBoardMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-01-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-01-01_us-gaap_SubsequentEventMember_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-01-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-01-01_us-gaap_SubsequentEventMember_custom_FormerEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:FormerEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-01-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-14_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-14_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894871</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Segment">
      <xbrli:measure>AREN:Segment</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Integer">
      <xbrli:measure>AREN:Integer</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact001405" toRefs="Footnote001420"/>
  <ix:relationship fromRefs="Fact001407" toRefs="Footnote001420"/>
  <ix:relationship fromRefs="Fact001427" toRefs="Footnote001435"/>
  <ix:relationship fromRefs="Fact001428" toRefs="Footnote001435"/>
  <ix:relationship fromRefs="Fact001801" toRefs="Footnote001848"/>
  <ix:relationship fromRefs="xdx2ixbrl1803" toRefs="Footnote001848"/>
  <ix:relationship fromRefs="xdx2ixbrl1805" toRefs="Footnote001848"/>
  <ix:relationship fromRefs="Fact001807" toRefs="Footnote001848"/>
  <ix:relationship fromRefs="xdx2ixbrl1817" toRefs="Footnote001849"/>
  <ix:relationship fromRefs="Fact001819" toRefs="Footnote001849"/>
  <ix:relationship fromRefs="Fact001821" toRefs="Footnote001849"/>
  <ix:relationship fromRefs="Fact001823" toRefs="Footnote001849"/>
  <ix:relationship fromRefs="Fact001825" toRefs="Footnote001849"/>
  <ix:relationship fromRefs="Fact001827" toRefs="Footnote001849"/>
  <ix:relationship fromRefs="Fact001829" toRefs="Footnote001849"/>
  <ix:relationship fromRefs="Fact001831" toRefs="Footnote001849"/>
  <ix:relationship fromRefs="Fact001833" toRefs="Footnote001849"/>
  <ix:relationship fromRefs="Fact001835" toRefs="Footnote001849"/>
  <ix:relationship fromRefs="Fact001837" toRefs="Footnote001849"/>
  <ix:relationship fromRefs="Fact001839" toRefs="Footnote001849"/>
  <ix:relationship fromRefs="Fact001868" toRefs="Footnote001915"/>
  <ix:relationship fromRefs="xdx2ixbrl1870" toRefs="Footnote001915"/>
  <ix:relationship fromRefs="xdx2ixbrl1872" toRefs="Footnote001915"/>
  <ix:relationship fromRefs="Fact001874" toRefs="Footnote001915"/>
  <ix:relationship fromRefs="xdx2ixbrl1884" toRefs="Footnote001916"/>
  <ix:relationship fromRefs="Fact001886" toRefs="Footnote001916"/>
  <ix:relationship fromRefs="Fact001888" toRefs="Footnote001916"/>
  <ix:relationship fromRefs="Fact001890" toRefs="Footnote001916"/>
  <ix:relationship fromRefs="Fact001892" toRefs="Footnote001916"/>
  <ix:relationship fromRefs="Fact001894" toRefs="Footnote001916"/>
  <ix:relationship fromRefs="Fact001896" toRefs="Footnote001916"/>
  <ix:relationship fromRefs="Fact001898" toRefs="Footnote001916"/>
  <ix:relationship fromRefs="Fact001900" toRefs="Footnote001916"/>
  <ix:relationship fromRefs="Fact001902" toRefs="Footnote001916"/>
  <ix:relationship fromRefs="Fact001904" toRefs="Footnote001916"/>
  <ix:relationship fromRefs="Fact001906" toRefs="Footnote001916"/>
  <ix:relationship fromRefs="Fact002210" toRefs="Footnote002215"/>
  <ix:relationship fromRefs="xdx2ixbrl2211" toRefs="Footnote002215"/>
  <ix:relationship fromRefs="Fact002572" toRefs="Footnote002573"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span style="text-decoration: underline">FORM
<span id="xdx_90F_edei--DocumentType_c20230101__20231231_znt2nJe5KT33"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000014" name="dei:DocumentType">10-K</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--DocumentAnnualReport_c20230101__20231231_zZEq79NDeFP"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleantrue" id="Fact000015" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span>
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">For
the fiscal year ended <span id="xdx_907_edei--DocumentPeriodEndDate_c20230101__20231231_zKTzJQc3iGGa"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:datemonthdayyearen" id="Fact000016" name="dei:DocumentPeriodEndDate"><span id="xdx_909_edei--CurrentFiscalYearEndDate_c20230101__20231231_zx4GTRn5zwa5"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:datemonthdayen" id="Fact000017" name="dei:CurrentFiscalYearEndDate">December 31</ix:nonNumeric></span>, <span id="xdx_905_edei--DocumentFiscalYearFocus_c20230101__20231231_z19jZmQJug2a"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000018" name="dei:DocumentFiscalYearFocus">2023</ix:nonNumeric></span></ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--DocumentTransitionReport_c20230101__20231231_zg9wXPGFk9w2"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleanfalse" id="Fact000019" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the transition period from __________ to __________</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Commission
file number <span id="xdx_905_edei--EntityFileNumber_c20230101__20231231_z9jjrwMXEKTk"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000020" name="dei:EntityFileNumber">001-12471</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_901_edei--EntityRegistrantName_c20230101__20231231_zlnuXjDounr4"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000021" name="dei:EntityRegistrantName">THE
ARENA GROUP HOLDINGS, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(formerly
known as theMaven, Inc.)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20230101__20231231_zGGH612PrE0e"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt-sec:stateprovnameen" id="Fact000022" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20230101__20231231_zR0ClEcrFEt6"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000023" name="dei:EntityTaxIdentificationNumber">68-0232575</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction of</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
    or organization)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityAddressAddressLine1_c20230101__20231231_zNB86PpJdd19"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000024" name="dei:EntityAddressAddressLine1">200
                                            Vesey Street</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_909_edei--EntityAddressAddressLine2_c20230101__20231231_zsbgikvtJOCd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000025" name="dei:EntityAddressAddressLine2">24<sup>th
    </sup>Floor</ix:nonNumeric></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressCityOrTown_c20230101__20231231_zLwhxe0bNBYd"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000026" name="dei:EntityAddressCityOrTown">New
    York</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressStateOrProvince_c20230101__20231231_zfid9644cvuf"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt-sec:stateprovnameen" id="Fact000027" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressPostalZipCode_c20230101__20231231_z48OEhRC0t8a"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000028" name="dei:EntityAddressPostalZipCode">10281</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--CityAreaCode_c20230101__20231231_zqYhW5CEUoo3"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000029" name="dei:CityAreaCode">(212)</ix:nonNumeric></span>
<span id="xdx_907_edei--LocalPhoneNumber_c20230101__20231231_ztu1eOfQXY0g"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000030" name="dei:LocalPhoneNumber">321-5002</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 42%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--Security12bTitle_c20230101__20231231_zxvGZ7G6Woo5"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000031" name="dei:Security12bTitle">Common
    Stock, $0.01 par value</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--TradingSymbol_c20230101__20231231_zUBKGAZuqyw1"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000032" name="dei:TradingSymbol">AREN</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--SecurityExchangeName_c20230101__20231231_zKKjh7BpYeL3"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt-sec:exchnameen" id="Fact000033" name="dei:SecurityExchangeName">NYSE
    American</ix:nonNumeric></span> </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(g) of the Act: <b>None</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744; <span id="xdx_90D_edei--EntityWellKnownSeasonedIssuer_c20230101__20231231_ztkBtXwMX6t"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000034" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes &#9744; <span id="xdx_906_edei--EntityVoluntaryFilers_c20230101__20231231_z0RsX34gZkVe"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000035" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. <span id="xdx_902_edei--EntityCurrentReportingStatus_c20230101__20231231_z4SqKzKZckB6"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000036" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). <span id="xdx_905_edei--EntityInteractiveDataCurrent_c20230101__20231231_zBdWlAKtNCck"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000037" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer &#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer &#9744;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--EntityFilerCategory_c20230101__20231231_zK1KFbaZvHY4"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt-sec:entityfilercategoryen" id="Fact000038" name="dei:EntityFilerCategory">Non-accelerated
    filer</ix:nonNumeric></span> &#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company <span id="xdx_903_edei--EntitySmallBusiness_dbT_c20230101__20231231_zpwJBSYoAkj9"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleantrue" id="Fact000039" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company <span id="xdx_90C_edei--EntityEmergingGrowthCompany_dbF_c20230101__20231231_zAEQapm2cjVc"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleanfalse" id="Fact000040" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
emerging growth company, indicated by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. <span id="xdx_900_edei--IcfrAuditorAttestationFlag_dbF_c20230101__20231231_z3fzc5lCaOZh"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleanfalse" id="Fact000041" name="dei:IcfrAuditorAttestationFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. <span id="xdx_90E_edei--DocumentFinStmtErrorCorrectionFlag_dbF_c20230101__20231231_zondTcGsoYIb"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleanfalse" id="Fact000042" name="dei:DocumentFinStmtErrorCorrectionFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes &#9744; or No <span id="xdx_90E_edei--EntityShellCompany_dbF_c20230101__20231231_zNXGlCzE8vsi"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleanfalse" id="Fact000043" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023, which was the last business day of the registrant&#8217;s most recently completed second fiscal quarter for fiscal
2023, the aggregate market value of the common stock held by non-affiliates was $<span id="xdx_909_edei--EntityPublicFloat_iI_pid_c20230630_z2UbHPbZVEo2"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2023-06-30" id="Fact000044" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">57,218,045</ix:nonFraction></span>. This calculation is based upon the closing
price of the common stock of $4.58 per share on that date, as reported by the NYSE American.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 28, 2024, the Registrant had <span id="xdx_902_edei--EntityCommonStockSharesOutstanding_iI_pid_c20240328_zWIwOnLYpcvi"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2024-03-28" id="Fact000045" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,770,553</ix:nonFraction></span> shares of common stock outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DOCUMENTS
INCORPORATED BY REFERENCE</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--DocumentsIncorporatedByReferenceTextBlock_c20230101__20231231_zWDiOb3zSLui"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000046" name="dei:DocumentsIncorporatedByReferenceTextBlock">Portions
of the registrant&#8217;s definitive proxy statement for its 2024 Annual Meeting of Stockholders, or Proxy Statement, to be filed within
120 days after the end of the fiscal year covered by this Annual Report on Form 10-K, are incorporated by reference in Part III. Except
with respect to information specifically incorporated by reference in this Annual Report, the Proxy Statement shall not be deemed to
be filed as part hereof.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Form
10-K</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table
of Contents</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><b>Page</b></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><a href="#Su_001">Part I.</a></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">4</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Su_002">Business</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">4</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Su_003">Risk Factors</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">11</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Su_004">Unresolved Staff Comments</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">24</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Su_005">Cybersecurity</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">24</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Su_006">Properties</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">25</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Su_007">Legal Proceedings</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">25</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Su_008">Mine Safety Disclosure</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">25</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><a href="#Su_009">Part II.</a></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">26</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Su_010">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">26</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Su_011">[Reserved]</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">26</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    7.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Su_012">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">26</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    7A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#K_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quantitative and Qualitative Disclosures About Market Risk</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">41</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    8.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#K_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Statements and Supplementary Data</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">42</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#K_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">42</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#K_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Controls and Procedures</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">42</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#K_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Information</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">43</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#K_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">43</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#K_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Part III.</span></b></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">43</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    10.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#K_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors, Executive Officers and Corporate Governance</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">43</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    11.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#K_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Compensation</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">43</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    12.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#K_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">43</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    13.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#K_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Relationships and Related Transactions, and Director Independence</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">44</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    14.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#K_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Accountant Fees and Services</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">44</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#K_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Part IV.</span></b></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">44</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    15.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#K_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits and Financial Statement Schedules</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">44</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    16.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#K_022"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form 10-K Summary</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">51</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_001">Signatures</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">52</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cautionary
Statement Regarding Forward-Looking Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
statements and information in this Annual Report on Form 10-K may constitute &#8220;forward-looking statements&#8221; within the meaning
of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange
Act of 1934, as amended (&#8220;Exchange Act&#8221;). Forward-looking statements relate to future events or future performance and include,
without limitation, statements concerning our business strategy, future revenues, market growth, capital requirements, product introductions,
the timing, outcome or financial impacts of the planned Business Combination (as defined below) and related transactions, and expansion
plans and the adequacy of our funding. Other statements contained in this Annual Report on Form 10-K that are not historical facts are
also forward-looking statements. We have tried, wherever possible, to identify forward-looking statements by terminology such as &#8220;may,&#8221;
&#8220;will,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221;
&#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; and other comparable terminology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements in this Annual Report on Form 10-K, for example, statements about:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to achieve and maintain profitability in the future;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to maintain an effective system of internal control over financial reporting;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to attract new subscribers and to persuade existing subscribers to renew their subscriptions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    success of strategic relationships with third parties;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to recruit and retain qualified personnel;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to manage our growth effectively, including through strategic acquisitions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to attract, develop, and retain capable Publisher Partners (as described below) and expert contributors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to attract new advertisers and to persuade existing advertisers to continue to advertise on the Platform (as described below);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to grow market share in our existing markets or any new markets we may enter;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to respond to general economic conditions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact of the novel coronavirus (&#8220;COVID-19&#8221;) pandemic;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to continue to satisfy NYSE American listing rules;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    estimates of the sufficiency of our existing capital resources combined with future anticipated cash flows to finance our operating
    requirements; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    factors detailed under the section entitled &#8220;<a href="#Su_003">Risk Factors</a>.&#8221;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
caution investors that any forward-looking statements presented in this Annual Report on Form 10-K, or that we may make orally or in
writing from time to time, are based on the beliefs of, assumptions made by, and information currently available to, us. Such statements
are based on assumptions, and the actual outcome will be affected by known and unknown risks, trends, uncertainties, and factors that
are beyond our control or ability to predict. Although we believe that our assumptions are reasonable, they are not guarantees of future
performance, and some will inevitably prove to be incorrect. As a result, our actual future results can be expected to differ from our
expectations, and those differences may be material. Accordingly, investors should use caution in relying on forward-looking statements,
which are based only on known results and trends at the time they are made, to anticipate future results or trends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
risks are discussed in this Annual Report on Form 10-K and also from time to time in our other filings with the U.S. Securities and Exchange
Commission (the &#8220;SEC&#8221; or &#8220;Commission&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annual Report on Form 10-K and all subsequent written and oral forward-looking statements attributable to us or any person acting on
our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. We do not
undertake any obligation to release publicly any revisions to our forward-looking statements to reflect events or circumstances after
the date of this Annual Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Su_001"></span>Part
I</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Su_002"></span>Item
1. Business</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Arena Group Holdings, Inc. (the &#8220;Company,&#8221; &#8220;Arena Group,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;),
is a media company that leverages technology to build deep content verticals powered by anchor brands and a best-in-class digital media
platform (the &#8220;Platform&#8221;) empowering publishers who impact, inform, educate, and entertain. Our strategy is to focus on key
subject matter verticals where audiences are passionate about a topic category (e.g., sports and finance) where we can leverage the strength
of our core brands to grow our audience and increase monetization both within our core brands as well as for our media publisher partners
(each, a &#8220;Publisher Partner&#8221;). Our focus is on leveraging our Platform and brands in targeted verticals to maximize audience
reach, enhance engagement, and optimize monetization of digital publishing assets for the benefit of our users, our advertiser clients,
and our greater than 40 owned and operated properties as well as properties we run on behalf of independent Publisher Partners. We own
and operate TheStreet, The Spun, Parade, and Men&#8217;s Journal and power more than 320 independent Publisher Partners, including the
many sports team sites that comprise FanNation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Publisher Partner joins the Platform by invitation only with the objective of improving our position in key verticals while optimizing
the performance of the Publisher Partner. Publisher Partners incur the costs in content creation on their respective channels and receive
a share of the revenue associated with their content. Because of the state-of-the-art technology and large scale of the Platform and
our expertise in search engine optimization, social media, ad monetization and subscription marketing, Publisher Partners continually
benefit from our ongoing technological advances and audience development expertise. Additionally, we believe the lead brands within our
verticals, create a halo benefit for all Publisher Partners while each of them adds to the breadth and quality of content.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Platform</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
developed the Platform, a proprietary online publishing platform that provides our owned and operated media businesses, Publisher Partners
(who are third parties producing and publishing content on their own domains), and individual creators contributing content to our owned
and operated sites (&#8220;Expert Contributors&#8221;), the ability to produce and manage editorially focused content through tools and
services provided by us. We have also developed proprietary advertising technology, techniques and relationships that allow us, our Publisher
Partners, and our Expert Contributors to monetize editorially focused online content through various display and video advertisements
and tools and services for driving a subscription or membership based business and other monetization services (the &#8220;Monetization
Solutions&#8221; and, together with the Platform, the &#8220;Platform Services&#8221;). Our Platform offers audiences bespoke content
with optimized design and page construction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Platform comprises state-of-the-art publishing tools, video platforms, social distribution channels, newsletter technology, machine learning
content recommendations, notifications, and other technology that deliver a complete set of features to drive a digital media business
in an entirely cloud-based suite of services. Our software engineering and product development teams are experienced at delivering these
services at scale. We continue to develop the Platform software by combining proprietary code with components from the open-source community,
plus select commercial services as well as identifying, acquiring, and integrating other platform technologies where we see unique long-term
benefits to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Platform Services include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Content
                                            management, machine learning driven content recommendations, traffic redistribution, hosting
                                            and bandwidth;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Video
                                            publishing, hosting, and player solution via an integrated set of third party providers;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dashboards
                                            for our Publisher Partners as well as integration with leading analytics services like Google
                                            Analytics;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">User
                                            account management;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">User
                                            account migration to our Platform, including emails and membership data;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Technical
                                            support team to support our Publisher Partners and staff (if applicable) on the Platform;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising
                                            serving, trafficking/insertion orders, yield management, reporting and collection;</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Various
                                            integrations to enable the syndication of content (e.g., Apple News, Facebook Instant Articles,
                                            Google AMP, Google news and RSS feeds); and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                            features, as they may be added to the Platform from time to time.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Publisher Partners use the Platform Services to produce, manage, host and monetize their content in accordance with the terms and
conditions of partner agreements between each of our Publisher Partners and us (the &#8220;Partner Agreements&#8221;). Our Publisher
Partners incur the costs with respect to creating their content; thus, not requiring capital investment by us. Pursuant to the
Partner Agreements, we and our Publisher Partners split revenue generated from the Platform Services used in connection with the
Publisher Partner&#8217;s content based on certain criteria. Criteria include whether the revenue was from direct or programmatic
advertising sales, was generated by our Publisher Partner or us, was generated in connection with a subscription or a membership,
was generated from syndicating or third party licensing, or whether the revenue was derived from affiliate links.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms and conditions of each Partner Agreement and in exchange for the Platform Services, our Publisher Partners grant us, for
so long as our Publisher Partner&#8217;s assets are hosted on the Platform, (i) the right to use, host, store, cache, reproduce, publish,
publicly display, distribute, transmit, modify, adapt and create derivative works of the content provided by the Publisher Partner to
provide, maintain and improve the Platform Services; (ii) use, publicly display, distribute and transmit the name, logo, and trademarks
of the Publisher Partner to identify them as users of the Platform Services; (iii) exclusive control of ads.txt with respect to our Publisher
Partner&#8217;s domains; and (iv) the exclusive right to include our Publisher Partner&#8217;s website domains and related URLs in a
consolidated listing assembled by third party measurement companies such as comScore, Nielsen or other similar measuring services selected
by us. As such, the Platform serves as the primary digital media and social platform with respect to each of our Publisher Partners&#8217;
website domains during the applicable term of each Partner Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Brands and Growth Strategy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business model is to grow our Platform audience while striving to diversify revenue and drive gross margin through traditional media
brands as well as new digital-first brands. We believe our vertical model allows us and our Publisher Partners to leverage audience growth,
technological efficiencies and cost savings across all of our brands. Our vertical model consists of (i) acquiring or partnering with
powerful brands that can offer our audience custom content and domain authority, (ii) forming key strategic partnerships with like-minded
partners of high-quality content, (iii) partnering with entrepreneurial publishers to drive local content at variable cost tied to performance,
and (iv) growing our Publisher Partners on our network to expand our content offerings and add scale to the ecosystem.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
growth strategy is to continue adding new Publisher Partners in key verticals that management believes will expand the scale of
unique users interacting on the Platform. In each vertical, we seek to build around leading brands, such as FanNation, Athlon Sports
or The Spun (for sports), TheStreet (for finance) and Parade and Men&#8217;s Journal (for lifestyle), surround them with subcategory
specialists, and further enhance coverage with individual Expert Contributors. The primary means of expansion is adding independent
Publisher Partners or acquiring publishers that have premium branded content and can broaden the reach and impact of the Platform.
Specifically, our growth initiatives include: (i) increasing syndication of the content on our Platform through the re-publishing
the content on third party websites, (ii) offering of podcasts and e-commerce through our Platform, (iii) acquiring or developing
new verticals for our users, and (iv) continuing to identify and partner with new Publisher Partners.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><span style="text-decoration: underline">Sports Vertical</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2019, we launched our sports vertical by entering into a Licensing Agreement (as described below) with Authentic Brands Group
(&#8220;ABG&#8221;), pursuant to which we were granted the exclusive right and license in the United States, Canada, Mexico, the
United Kingdom, Republic of Ireland, Australia, and New Zealand to operate the Sports Illustrated print and digital media business
under the Sports Illustrated brand. While continuing to evolve and expand the sports business and leverage the Sports Illustrated
brand, in October 2020 we launched FanNation, a curated collection of independent sports journalists, each focused on a single
professional or leading collegiate sports team. FanNation and other sports Publisher Partners helped to more than triple pageviews
in our sports vertical from 2020 to 2023. In 2023 our sports Publisher Partners represented more than double the traffic of Sports
Illustrated internet domains. Also driving the expansion in the sports vertical was the addition of The Spun and Athlon Sports.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Spun founded in September 2012, and acquired by us in June 2021, is an online independent sports publication that brings readers the
most interesting athletic stories of the day. The Spun focuses on the social media aspect of the industry. Athlon Sports was acquired by us as part of the Parade acquisition in April 2022. It had been a print-only property
publishing newsstand magazines covering the various drafts and both professional and collegiate sports. We leveraged its expertise and
appeal on-line as part of our sports vertical and today it is a significant part of our digital sports presence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
further described in the section titled &#8220;Risk Factors&#8221; and elsewhere in this Annual Report on Form 10-K, in connection
with our failure to make a quarterly payment due ABG pursuant to the Licensing Agreement for the Sports Illustrated media business,
of approximately $3,750,000, on January 18, 2024, ABG notified the Company of its intention to terminate our Licensing Agreement,
effective immediately, for the Sports Illustrated media business, dated June 14, 2019, by and between us and ABG (as amended to
date, the &#8220;Licensing Agreement&#8221;). Upon such termination, a fee of $45.0 million became immediately due and payable by us
to ABG pursuant to the terms and conditions of the Licensing Agreement. In addition, upon termination of the Licensing Agreement,
all outstanding and unvested warrants to purchase shares of our common stock issued to ABG in connection with the Licensing
Agreement became immediately vested and exercisable. On March 18, 2024, ABG announced it had reached an agreement in principle with
a third party that will become the new operator of the Sports Illustrated media business. We are engaging in continuing discussions
with ABG and the third party regarding the timing and terms of the transition of the Sports Illustrated component of the business to
the aforementioned third party. We will continue to operate our sports vertical led by FanNation, The Spun, Athlon Sports, and the other sports
Publisher Partners.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">TheStreet</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TheStreet
is a leading financial news and information provider to investors and institutions worldwide and produces business news and market analysis
for individual investors. TheStreet has a strong editorial tradition, a subscription platform, and valuable membership base to us,
and benefits from our mobile-friendly Content Management System, social, video, and monetization technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Parade</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
acquired Parade, a premium-branded company in April 2022 which helped to expand our digital audience reach. Parade has become the anchor
of our new lifestyle vertical, and Athlon Sports, one of Parade&#8217;s premium-brands, has expanded our sports vertical. In the fourth
quarter of 2022, we discontinued the Parade print business, including the print operations of Parade, and the Relish and Spry Living print
products that were acquired as part of the Parade acquisition. See Note 3, <i>Discontinued Operations</i> in our accompanying consolidated
financial statements for additional information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Men&#8217;s
Journal</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
acquired the digital assets of Men&#8217;s Journal from Weider Publications, a subsidiary of A360 Media, LLC in December 2022 to supplement
our growing lifestyle vertical. This suite of digital assets provides our audience with access to premium active lifestyle brands including
Men&#8217;s Journal, Men&#8217;s Fitness, Surfer, Powder, Bike, SKATEboarding, Snowboarder and NewSchoolers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">HubPages</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HubPages
enhances the user&#8217;s experience by including content from individual creators to the HubPages network of premium content channels
that are owned and operated by Arena. These channels, such as PetHelpful, dengarden and Fashionista, act as an open community for writers,
explorers, knowledge seekers, and conversation starters to connect in an interactive and informative online space.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Corporate
History</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were originally incorporated in Delaware as Integrated Surgical Systems, Inc. (&#8220;Integrated&#8221;) in 1990. On October 11, 2016,
Integrated and TheMaven Network, Inc. (&#8220;Maven Network&#8221;) entered into a share exchange agreement (the &#8220;Share Exchange
Agreement&#8221;), whereby the stockholders of Maven Network agreed to exchange all of the then-issued and outstanding shares of common
stock of Maven Network for shares of common stock of Integrated. On November 4, 2016, the parties consummated a re-capitalization pursuant
to the Share Exchange Agreement and, as a result, Maven Network became a wholly owned subsidiary of Integrated. Integrated changed its
name to theMaven, Inc. on December 2, 2016.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On
September 20, 2021, we re-branded to &#8220;The Arena Group.&#8221; Effective on February 8, 2022, we changed our legal name to The
Arena Group Holdings, Inc. in conjunction with filing a Certificate of Amendment and Certificate of Corrections with the State of
Delaware. On February 9, 2022, our common stock began trading on the NYSE American under the trading symbol &#8220;AREN&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intellectual
Property</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
use proprietary technology to operate our business, and our success depends, in part, on our ability to protect our technology and intellectual
property. We rely on a combination of patent, copyright, trademark and trade secret laws, as well as contractual restrictions, to establish
and protect our intellectual property. We maintain a policy requiring our employees, contractors, consultants and other third parties
to enter into confidentiality and proprietary rights agreements to control access to our proprietary information. These laws, procedures
and restrictions provide only limited protection and any of our intellectual property rights may be challenged, invalidated, circumvented,
infringed or misappropriated. Further, the laws of certain countries do not protect proprietary rights to the same extent as the laws
of the United States and, therefore, in certain jurisdictions, we may be unable to protect our proprietary technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, we had seven issued patents in the United States, all expiring by 2033.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, we also owned approximately 1,300 U.S. copyright registrations and had unregistered copyrights in our software
documentation, software code, marketing materials, and website content that we developed, and owned over 1,600 registered domain names.
As of December 31, 2023, we also owned approximately 160 U.S. trademark registrations, 29 pending U.S. trademark applications, and 89 issued foreign
trademark registrations and 16 pending foreign trademark applications in over 30 countries, and a number of unregistered marks that we
use in the United States and other countries to promote our brands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
registered trademarks are all subject to maintenance or renewal at various times through 2033.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will continue to file updated trademark applications in the United States and abroad to reflect our branding evolution and to continue
strengthening our trademark portfolio as financial resources permit. From time to time, we also expect to file additional patents and
copyrights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Publisher Partners and Licensing</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with our Partner Agreements and any other applicable agreements between us and our Publisher Partners, (i) we and our affiliates
own and retain (a) all right, title, and interest in and to the Platform, other Monetization Solutions and data collected by us, and
(b) we and our licensors&#8217; trademarks and branding and all software and technology we use to provide and operate the Platform and
Monetization Solutions, and (ii) each Publisher Partner owns and retains (a) all right, title, and interest in and to the Publisher Partner&#8217;s
assets, content, and data collected by Publisher Partner and (b) each Publisher Partner&#8217;s trademarks and branding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Human
Capital Resources</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
total number of employees as of December 31, 2023 was 448, of which 441 were full-time employees and seven were part-time employees.
As of December 31, 2023 approximately 18% of our workforce, or 82 employees, is represented by a union named The NewsGuild of New York,
CWA Local 31003 (the &#8220;Guild&#8221;) pursuant to a binding Memorandum of Agreement executed by and between the Guild and The
Arena Media Brands, LLC (&#8220;Arena Media&#8221;) on December 31, 2021 (the &#8220;MOA&#8221;), which covers Sports Illustrated
editorial staff. The MOA addresses the terms of employment for covered employees and non-employees regarding, among other things,
wages, raises, bonuses, severances, benefits, discipline and the like. We incorporated the terms of the MOA into our fiscal 2023
employment practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2024, we announced a reduction to our workforce of approximately one-third of our employees in order to reduce costs and achieve
profitability. This included all 82 employees represented by the Guild.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Corporate
Culture</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
like to say that The Arena Group is where the action is - where passion drives each of us. The things we love are what keep us coming
back to read, watch and experience the best in sports, finance, and entertainment &#8211; brought to you by the iconic brands you admire
most. We are building out the pathways to passion &#8211; your ticket to continuous excitement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are working to build and sustain a company culture that enables our employees to show up as their best, whole selves; to communicate,
collaborate, and innovate with their colleagues, no matter where they are located; and to learn, grow, and belong.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Diversity,
Equity, and Inclusion</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that a workforce rich in diversity of thought, background, and experience helps us build a company and community where we can
all succeed. In December 2022, we launched our first company-wide Diversity, Equity, and Inclusion (&#8220;DEI&#8221;) Council &#8211;
comprised of 18 employees with a variety of identities and backgrounds that also represented as wide a selection as possible across brands,
functions, and tenures at Arena, and most importantly, represented a clear commitment to diversity and inclusion at our company. In 2023,
the Council met monthly to share employee experiences, identify opportunities to improve our culture, and advise senior leadership on
how to direct an annual DEI budget. As a result of feedback from the Council, a sample of outcomes include attendance at multiple conferences
led by diverse journalism organizations, hosted panels internally ranging from celebration of identities to supporting mental health,
and the creation of the framework for our 2024 monthly DEI learning and discovery series.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Seasonality</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
experience seasonality as a result of advertising seasonality, sports seasons and major sporting events. Advertising typically peaks
in the fourth quarter of our fiscal year as advertisers tend to concentrate their budgets during the holiday season. This trend is magnified
by professional sports and college football seasons, which account for a significant portion of our advertising revenue during that period
of the year. Other sporting events such as the Super Bowl, the Winter and Summer Olympics, soccer&#8217;s World Cup, and major golf,
tennis and cycling events create increased traffic at the time of these respective events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Competition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
we believe that there are many competitors delivering media content in the verticals that we serve on the web and on mobile devices
and an even broader array of general media companies and major media brands that compete for the attention of users overall and the
advertisers who desire to reach them. We have developed a playbook that leverages our Platform to optimize the performance of both
our owned and operated and our Publisher Partners&#8217; properties. The playbook is a set of processes, procedures and tactics that
help improve the consumer experience, develop a greater organic audience reach, apply data management and artificial intelligence
tools, optimize monetization and leverage content through syndication and improve distribution. The iconic brands leading each of
our verticals, such as Athlon Sports, FanNation, The Spun, TheStreet and Men&#8217;s Journal, leverage this playbook to deliver a highly engaging and
effective experience for our users, advertisers and subscribers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Internet allows theoretically unlimited market access for niche or general media companies resulting in a large number and variety of
participants competing directly for audiences, ad spend and membership revenues. The general business of online media, combined with
some level or method of leveraging community attracts many potential entrants, and in the future, there may be strong competitors that
will compete with us in general or in selected markets. These and other companies may be better financed and be able to develop their
markets more quickly and penetrate those markets more effectively. The following is a list of possible competitors and their respective
categories:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice,
                                            Buzzfeed, Business Insider, et al., producers of niche content, leveraging social media,
                                            mobile, and video to compete for ad dollars;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fortune,
                                            CNN, ESPN, Yahoo!, Google, et al., major media companies and producers of general content
                                            which compete for ad dollars;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WordPress,
                                            Medium, RebelMouse, Arc, content management software providers, open to all including experts
                                            and professionals, which compete for publishers;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leaf
                                            Group Ltd. And Future PLC, which compete for partners and ad dollars;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">YouTube,
                                            Twitter, Facebook, Reddit, social media platforms open to all creators and which also compete for ad dollars;
                                            and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affiliate
                                            networks such as Liberty Alliance, which compete for ad dollars.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we view Nexstar Media Group, Inc. and Ziff Davis as peer companies for purposes of performance comparisons even though we do
not consider them direct competitors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our technology, our substantial scale in traffic, the ease of use of our Platform, our well-known lead media brands, and
the continuing development and evolution of our Platform and an acquisition program provides us with a basis to compete effectively for
market share in terms of ad spend and membership revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Government
Regulations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations are subject to many United States federal and state laws and regulations that involve data privacy, data protection,
rights of publicity, content regulation, intellectual property, or other subjects. The application and interpretation of these laws and
regulations often are uncertain and the impact of regulatory changes cannot be predicted with certainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Several
government authorities, both in the United States and abroad are increasing their focus on privacy issues and the use of personal information.
All U.S. states have enacted some form of data security legislation and there are several federal laws governing data privacy. A growing
number of U.S. states have enacted laws regarding the collection, use and disclosure of personal information such as the California Consumer
Privacy Act of 2018 (the &#8220;CCPA&#8221;), which was amended by the California Privacy Rights Act (the &#8220;CPRA&#8221;) which went
into effect January 1, 2020. As more states consider or enact laws about information security, companies may be required to adopt written
information security policies consistent with state laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the U.S. federal the Federal Trade Commission (&#8220;FTC&#8221;) and state attorneys general have oversight of business operations concerning
the use of personal information and breaches of the privacy laws and may examine privacy policies to ensure that a company discloses
all material practices and fully complies with representations in the policies regarding the use of personal information and the failure
to do so could give rise to penalties under state or federal unfair competition or consumer protection laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
review our privacy policies and overall operations on a regular basis to ensure compliance with applicable United States federal and
state laws, and to the extent applicable, any foreign laws. We launched a CCPA compliance program in January 2020, and have expedited
it to cover CPRA as well. On an annual basis we review the program and adjust our privacy notice and compliance program practices to
account for our evolving practices and the CCPA/CPRA regulations, which were first promulgated in July 2020 and continue to be subject
to ongoing rulemaking. There are conflicting interpretations of adopted law in the digital media industry, and given the lack of guidance
to date on many of these issues, our compliance posture on some issues might not be accepted by the State of California.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the laws of the United States, we may be subject to foreign laws regulating web sites and online services that in some jurisdictions
are stricter than the laws in the United States. For example, the General Data Protection Regulation (the &#8220;GDPR&#8221;) includes
operational requirements for companies that receive or process personal data of residents of the European Union (&#8220;EU&#8221;). Some
EU countries are considering or have passed legislation implementing additional data protection requirements that could increase the
cost and complexity of delivering our services. The GDPR also includes certain requirements regarding notification of data processing
obligations or security incidents to appropriate data protection authorities. How the GDPR will be fully applied to online services,
including cookies and digital advertising, is still being determined through ongoing rulemaking and evolving interpretation by applicable
authorities. On June 16, 2020, the Court of Justice of the European Union (&#8220;CJEU&#8221;), declared the E.U.-U.S. Privacy Shield
framework (&#8220;Privacy Shield&#8221;) to be invalid. As a result, Privacy Shield is no longer a valid mechanism for transferring personal
data from the European Economic Area to the United States. We are addressing this issue, for instance, by including standard contractual
clauses as part of our Data Processing Agreements; however, it is uncertain whether the standard contractual clauses will also be invalidated
by the European courts or legislature. GDPR also convers a private right of action to lodge complaints with supervisory authorities to
seek judicial remedies and obtain compensation for damages for violations of the GDPR. GDPR imposes substantial fines for breaches and
violations (up to the greater of &#8364;20 million or 4% of our consolidated annual worldwide gross revenue).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Social
networking websites are also under increasing scrutiny. Legislation has been introduced on the state and federal level that could regulate
social networking websites. Any such regulation would likely be an impediment to our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FTC regularly considers issues relating to online behavioral advertising (a/k/a interest-based advertising), which is a significant revenue
source for us, and Congress and state legislatures are frequently asked to regulate this type of advertising, including requiring consumers
to provide express consent for tracking purposes, so that advertisers may know their interests and are, therefore, able to serve them
more relevant, targeted ads. Targeted ads generate higher per impression fees than non-targeted ads. New laws, or new interpretations
of existing laws, could potentially place restrictions on our ability to utilize our database and other marketing data (e.g., from third
parties) on our own behalf and on behalf of our advertising clients, which may adversely affect our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legislation
concerning the above-described online activities could affect our ability to make our websites available in certain countries as future
legislation is made effective. It is possible that state and foreign governments might also attempt to regulate our transmissions of
content on our website or prosecute us for violations of their laws. United States law offers limited safe harbors and immunities to
publishers for certain liability arising out of user-posted content, but other countries do not. Further, legislative proposals in the
United States and internationally could impose new obligations in areas affecting our business, such as liability for copyright infringement
by third parties and liability for defamation or other claims arising out of user-posted content. Our business could be negatively impacted
if applicable laws subject us to greater regulation or risk of liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business could also be adversely affected if regulatory enforcement authorities, such as the California Attorney General or EU/EEA data
protection authorities, take issue with any of our approaches to compliance, or if new laws, regulations or decisions regarding the collection,
storage, transmission, use or disclosure of personal information are implemented in such ways that impose new or additional technological
requirements on us, limit our ability to collect, transmit, store and use or disclose the information, or if government authorities or
private parties challenge our data privacy or security practices that result in liability to, or restrictions on us, or we experience
a significant data or information breach which would require public disclosure under existing notification laws and for which we may
be liable for damages or penalties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
governments of applicable jurisdictions might attempt to regulate our transmissions or levy sales or other taxes relating to our activities
even though we do not have a physical presence or operate in those jurisdictions. As our platforms, products and advertising activities
are available over the Internet anywhere in the world, multiple jurisdictions may claim that we are required to qualify to do business
as a foreign corporation in each of those jurisdictions and pay various taxes in those jurisdictions. We address state and local jurisdictions
where we believe we have nexus, however, there can be no assurance that we have complied with all jurisdictions that may assert that
we owe taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
we carry cybersecurity and business interruption coverage to mitigate certain potential losses, but this insurance is limited in amount
and may not be sufficient in type or amount to cover us against claims related to a cybersecurity breach and related business and system
disruptions. We cannot be certain that such potential losses will not exceed our policy limits, insurance will continue to be available
to us on economically reasonable terms, or at all, or any insurer will not deny coverage as to any future claim. In addition, we may
be subject to changes in our insurance policies, including premium increases or the imposition of large deductible or co-insurance requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Available
Information</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file our annual, periodic and current reports, and other required information, electronically with the SEC. The SEC maintains a website
at www.sec.gov that contains reports, proxy and information statements and other information that we file with the SEC electronically.
We also make available on our website at www.thearenagroup.net, free of charge, copies of these reports and other information as soon
as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
use our website, blog, press releases, public conference calls and public webcasts as means of disclosing material non-public information
and for complying with our disclosure obligations under Regulation FD. The information disclosed by the foregoing channels could be deemed
to be material information. As such, we encourage investors, the media, and others to follow the channels listed above and to review
the information disclosed through such channels. The contents of the websites referred to above are not incorporated into this filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Su_003"></span>Item
1A. Risk Factors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
in our common stock involves a high degree of risk. Listed below is a summary of the principal risks that could adversely affect our
business, operations and financial results. There are numerous factors that affect our business, operations and financial results, many
of which are beyond our control. The risks described below are not the only risks we face. Additional risks and uncertainties not presently
known to us or that we currently deem immaterial may also affect our business operations. If any of the following risks actually occur,
our business, financial condition, results of operations, cash flows, or our ability to pay our debts and other liabilities could suffer.
As a result, the trading price and liquidity of our securities could decline, perhaps significantly, and you could lose all or part of
your investment. The risks discussed below also include forward-looking statements and our actual results may differ substantially from
those discussed in these forward-looking statements. See the section entitled &#8220;Cautionary Statement Regarding Forward-Looking Statements.&#8221;
All dollar figures are presented in thousands unless otherwise stated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATED TO OUR BUSINESS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt TimesNewRoman\,BoldItalic; margin: 0; text-align: justify"><b><i>If we fail to retain current users or add new users,
or if our users decrease their level of engagement with the Platform, our business would be seriously harmed.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
success of our business and our ability to attract and retain advertisers heavily depends on the size of our user base and the level
of engagement of our users. Several factors could negatively affect user retention, growth, and engagement, including if:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            users increasingly engage with competing platforms instead of the Platform;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            fail to introduce new and exciting products and services, or such products and services do
                                            not achieve a high level of market acceptance;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            fail to accurately anticipate user needs, or we fail to innovate and develop new software
                                            and products that meet these needs;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            fail to price our products competitively;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            do not provide a compelling user experience because of the decisions we make regarding the
                                            type and frequency of advertisements that we display;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            are unable to combat spam, bugs, malwares, viruses, hacking, or other hostile or inappropriate
                                            usage of our products or the Platform (as defined below);</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
                                            are changes in user sentiment about the quality or usefulness of our existing products in
                                            the short-term, long-term, or both;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
                                            are increased user concerns related to privacy and information sharing, safety, or security
                                            on the Platform;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
                                            are adverse changes in our products or services that are mandated by legislation, regulatory
                                            authorities, or legal proceedings;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">technical
                                            or other problems frustrate the user experience, particularly if those problems prevent us
                                            from delivering our products in a fast and reliable manner;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we,
                                            our Publisher Partners, or other companies in our industry are the subject of adverse media
                                            reports or other negative publicity, some of which may be inaccurate or include confidential
                                            information that we are unable to correct or retract; or</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            fail to maintain our brand image or our reputation is damaged.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
license agreement to operate the Sports Illustrated media business was terminated by the licensor, which may materially harm our
business, operating results and financial condition.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with our failure to make a quarterly payment due to ABG pursuant to the Licensing Agreement of approximately $3,750,000, on
January 18, 2024, ABG notified us of the termination of the Licensing Agreement, effective immediately, in accordance with its rights
under the Licensing Agreement. Upon such termination, a fee of $45.0 million became immediately due and payable by us to ABG pursuant
to the terms and conditions of the Licensing Agreement. In addition, upon termination of the Licensing Agreement, all outstanding and
unvested warrants to purchase shares of Arena common stock issued to ABG in connection with the Licensing Agreement became immediately
vested and exercisable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 18, 2024, ABG announced it had reached an agreement in principle with a third party to become the new operator of the Sports
Illustrated media business. We are engaging in discussions with ABG and the third party regarding the timing and terms of
the transition of the Sports Illustrated media business to the aforementioned third party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
loss of the rights to operate the Sports Illustrated media business, in addition to termination payments that are due following termination
of the Licensing Agreement, could harm our competitiveness in our industry, damage any goodwill we may have generated, and otherwise
have a material adverse effect on our business, operating results and financial condition. Any subsequent rebranding efforts we may undertake
may require significant resources and expenses and may affect our ability to attract and retain customers, all of which may have a material
adverse effect on our business, contracts, financial condition, operating results, liquidity and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
defaulted on certain covenants included in our debt agreements that could result in the acceleration of the related debt or the
exercise of other remedies.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, we failed to make the interest payment due pursuant to the Third A&amp;R NPA (as defined in
&#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations &#8211; Liquidity and Capital
Resources &#8211; Senior Secured Notes&#8221;) in the amount of approximately $2.8 million, resulting in an event of default under
the Arena Notes (as described below) (the &#8220;Arena Notes Default&#8221;). On January 5, 2024, we entered into a forbearance
agreement (the &#8220;Forbearance Agreement&#8221;) with Renew Group Private Limited (&#8220;Renew&#8221;), the lender under the
Third A&amp;R NPA, pursuant to which Renew agreed to a forbearance period through March 29, 2024, while reserving its rights and
remedies. The forbearance period is subject to us retaining a chief restructuring officer acceptable to Renew. Also on January 5,
2024, the Company&#8217;s board of directors finalized an engagement with FTI Consulting Inc. (&#8220;FTI&#8221;), a global business
advisory firm, to assist the Company with its turnaround plans and forge an expedited path to sustainable positive cash flow and
earnings to create shareholder value (the &#8220;FTI Engagement&#8221;). As part of the FTI Engagement, Jason Frankl, a senior managing director of FTI, was appointed as the Company&#8217;s Chief Business
Transformation Officer. Jason Frankl is a chief restructuring officer
acceptable to Renew. On March 27, 2024, the forbearance period was extended through the earlier of the following: (a) April 30,
2024<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #393A39; line-height: 115%">; </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%">(b)
the occurrence of the closing of the Business Combination and (c) the termination of the Business Combination prior to closing. </span>
The outstanding principal on the Arena Notes was approximately $110.7 million as of December 31, 2023. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Arena Notes Default, as well as the Company&#8217;s failure to make a quarterly payment due to ABG pursuant to the Licensing
Agreement, resulted in an Event of Default under its credit and security agreement dated February 2020 (as amended, the &#8220;Arena
Credit Agreement&#8221;) with SLR Digital Finance LLC (&#8220;SLR&#8221;). On March 13, 2024 the Company entered into a loan
agreement (the &#8220;Arena Loan Agreement&#8221;), by and between the Company and Simplify Inventions, LLC (&#8220;Simplify&#8221;
and in reference to the loan agreement, the &#8220;Simplify Loan&#8221;), which provides for up to $25 million of borrowings to be
used for working capital and general corporate purposes. Upon the closing, the Company borrowed approximately $7.7 million, of which
approximately $3.4 million was used to repay the outstanding loan balance, accrued interest, certain fees and contingency reserves
under its Arena Credit Agreement. The indirect owner of Renew also has an indirect non-controlling interest in Simplify.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings
under the Arena Loan Agreement are secured by substantially all of our assets. Upon the termination of the forbearance period under the Forbearance Agreement, Renew can declare
all outstanding borrowings under the Arena Notes, together with accrued and unpaid interest and fees, to be immediately due and
payable. In addition, Simplify could declare all outstanding borrowings under the Arena Loan Agreement together with accrued and
unpaid interest and fees, to be immediately due and payable and, subject to the terms of the intercreditor agreement between Renew
and Simplify, foreclose on our assets. Any of these actions would have a material adverse effect on our business, financial
condition, or results of operations and could lead to selling assets, cutting costs, reducing cash requirements, filing bankruptcy
or ceasing operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
market in which we participate is intensely competitive, and if we do not compete effectively, our operating results could be harmed.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
digital media industry is fragmented and highly competitive. There are many players in the digital media market, many with greater name
recognition and financial resources, which may give them a competitive advantage. The general business of online media, combined with
some level or method of leveraging community attracts many potential entrants, and in the future, there may be strong competitors that
will compete with us in general or in selected markets. These and other companies may be better financed and be able to develop their
markets more quickly and penetrate those markets more effectively. We expect competition to intensify in the future. All of this could
adversely affect our revenues and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
sales and payment cycle for online advertising is long, and such sales may not occur when anticipated or at all, all of which could adversely
affect our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
decision process is typically lengthy for brand advertisers and sponsors to commit to online campaigns and subject to delays which may
be beyond our control. In addition, some advertisers and sponsors take months after the campaign runs to pay, and some may not pay at
all, or require partial &#8220;make-goods&#8221; based on performance. This could have a material adverse effect on our business, financial
condition, or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are dependent on the continued services and on the performance of key third party content contributors, the loss of which could adversely
affect our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on content contributed by third party providers to attract users that drive advertising and subscription revenue. The loss of the
services of any of such key contributors could have a material adverse effect on our business, operating results, and financial condition.
Competition for such contributors is intense, and there can be no assurance that we will be able to successfully attract, assimilate,
or retain them which could have a material adverse effect on our business, financial condition, or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
revenues could decrease if the Platform does not continue to operate as intended.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Platform performs complex functions and is vulnerable to undetected errors or unforeseen defects that could result in a failure to operate
or inefficiency. The occurrence of errors and defects could result in loss of or delay in revenue, loss of market share, increased development
costs, diversion of development resources and injury to our reputation or damage to our efforts to expand brand awareness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
growing percentage of users whose computers, tablets, or phones do not support identification through third party cookies, mobile
identifiers, or other tracking technologies could adversely affect our business, results of operations, and financial
conditions.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely heavily on our ability to collect and disclose data and metrics in order to attract new advertisers and retain existing advertisers.
Any restriction, whether by law, regulation, policy, or other reason, on our ability to collect and disclose data that our advertisers
find useful would impede our ability to attract and retain advertisers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
use &#8220;cookies,&#8221; or small text files placed on user devices when an Internet browser is used, as well as mobile device identifiers,
to connect users&#8217; computers anonymously to information that we gather, enabling the Platform to demonstrate to advertisers its
efficacy. More and more devices have offered functionalities that block such anonymized identifiers and some prominent technology companies
have announced intentions to discontinue the use of cookies entirely. Although we believe the Platform is well-positioned to continue
to provide key data insights to advertisers without cookies, actions by advertisers to buy advertising based on alternative identifiers
could lead to changes in purchase behavior of such advertisers, thereby possibly impacting our operations, and our financial condition
could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Publisher Partners may engage in intentional or negligent misconduct or other improper activities on the Platform or otherwise misuse
the Platform, which may damage our brand image, our business and our results of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Platform provides our owned and operated media businesses, Publisher Partners, and individual creators contributing content the ability
to produce and manage editorially focused content through tools and services provided by us. We might not be able to monitor or edit
a significant portion of the content, such as advertising content, that appears on the Platform. If misconduct and misuse of the Platform
for inappropriate or illegal purposes occurs, user experience on the Platform may suffer, and claims may be brought against us. Our business
and public perception of our brands may be materially and adversely affected if we face any related lawsuits or other liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Platform and our technology systems contain open-source software, which may pose particular risk to our proprietary software, features
and functionalities in a manner that negatively affect our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
use open-source software in the Platform and our technology systems and will continue to use open-source software in the future. We have
set up an internal system to monitor the open-source software we use in our operation and its functionality, and to manage the risk it
poses to our business. We may face claims from third parties claiming ownership of, or demanding release of, the open-source software
or derivative works that we developed using such software. These claims could result in litigation and could require us to make our software
source code freely available, purchase a costly license or cease offering the implicated services unless and until we can re-engineer
them to avoid infringement. This could require significant additional technology and development resources, and we may not be able to
complete such re-engineering successfully.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ECONOMIC
AND OPERATIONAL RISKS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may have difficulty managing our growth.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have added, and expect to continue to add, Publisher Partner and end-user support capabilities, continue software development activities,
and expand our administrative capabilities. In the past two years, we have entered into multiple strategic transactions which have significantly
expanded our business and placed significant strain on our resources. To manage any further growth, we will be required to improve existing,
and implement new, operational and financial systems and properly manage our employee base. If we are unable to manage growth effectively,
our business could be harmed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
strategic relationships that we may be able to develop and on which we may come to rely may not be successful.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will seek to develop strategic relationships with advertising, media, technology, and other companies to enhance our market penetration,
business development, and advertising sales revenues. There can be no assurance that these relationships will develop and mature, or
that potential competitors will not develop more substantial relationships with the same or more attractive partners. Our inability to
successfully implement our strategy of building valuable strategic relationships could harm our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A
significant portion of our revenues is derived from a single customer. If we were to lose this customer, our revenues could decrease
significantly.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2023, approximately 10% of our revenue was derived from sales to a single customer. The loss of this customer,
or a significant reduction in sales to such customer, could adversely affect our financial condition and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interruptions
or performance problems associated with our technology and infrastructure may adversely affect our business and operating results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
growth will depend in part on the ability of our users, customers, and Publisher Partners to access the Platform at any time and within
an acceptable amount of time. We may experience performance problems due to a variety of factors, including infrastructure changes, introductions
of new functionality, human or software errors, capacity constraints due to an overwhelming number of users accessing the Platform software
simultaneously, denial of service attacks, or other security related incidents. If the Platform software is unavailable or if our users
are unable to access it within a reasonable amount of time or at all, our business would be negatively affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
the Partner Agreements with our Publisher Partners include service level standards that obligate us to provide credits or termination
rights in the event of a significant disruption of the Platform, which may adversely affect our business and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
operate our exclusive coalition of professional-managed online media channels on third party cloud platforms and data center hosting
facilities.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on software and services licensed from, and cloud platforms provided by, third parties to offer our digital media services. Any
errors or defects in third party software or cloud platforms could result in errors in, or a failure of, our digital media services,
which could harm our reputation, our business and force us to seek more expensive alternatives. Failure of these third party systems
could cause us to render credits or pay penalties or cause our Publisher Partners to terminate their contractual arrangements with
us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to certain standard terms and conditions with Amazon Web Services and Google Cloud, companies which have broad discretion
to change their terms of service and other policies with respect to us, and those changes may be unfavorable to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Real
or perceived errors, failures, or &#8220;bugs&#8221; in the Platform could adversely affect our operating results and growth prospects.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
the Platform is complex, undetected errors, failures, vulnerabilities, or bugs may occur despite prior testing, especially when updates
are deployed. Real or perceived errors, failures, or bugs in our software could result in negative publicity, loss of or delay in market
acceptance of the Platform, loss of competitive position, or claims by our Publisher Partners or our users for losses sustained by them.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Malware,
viruses, hacking attacks, and improper or illegal use of the Platform could harm our business and results of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Malware,
viruses, and hacking attacks have become more prevalent in our industry and have occurred on our systems and may occur in the future.
Any security breach caused by hacking, which involves efforts to gain unauthorized access to information or systems, or to cause intentional
malfunctions or loss or corruption of data, software, hardware, or other computer equipment, and the inadvertent transmission of computer
viruses could harm our business, financial condition and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to protect our intellectual property rights, our business could suffer.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success significantly depends on our proprietary technology. We rely on a combination of copyright, trademark and trade secret laws,
employee and third party non-disclosure and invention assignment agreements and other methods to protect our proprietary technology.
Our business, profitability and growth prospects could be adversely affected if we fail to receive adequate protection of our
proprietary rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
could be required to cease certain activities or incur substantial costs due to claims of infringement of another party&#8217;s intellectual
property rights.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of our competitors and other third parties may own technology patents, copyrights, trademarks, trade secrets and website content which
they may use to assert claims against us. We cannot assure you that we will not become subject to claims that we have misappropriated
or misused other parties&#8217; intellectual property rights. Any claim or litigation alleging that we have infringed or otherwise violated
intellectual property or other rights of third parties, with or without merit, whether or not settled out of court or determined in our
favor, could be time-consuming and costly to address and resolve, and could divert the time and attention of our management and technical
personnel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are required to make substantial payments, cease using the challenged intellectual property, obtain a license or redesign existing
technology due to any intellectual property infringement claims against us, such payments or actions could have a material adverse effect
upon our business and financial results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to many laws and regulations in the United States and abroad that are constantly evolving and involve matters central
to our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject or will be subject in the future to myriad constantly evolving laws, statutes and regulations in the United States as well
as in other countries where we may do business. These include, among others, privacy, data protection, and personal information, rights
of publicity, content, intellectual property, advertising, marketing, distribution, data security, data retention and deletion, personal
information, electronic contracts and other communications, competition, protection of minors, consumer protection, telecommunications,
employee classification, product liability, taxation, economic or other trade prohibitions or sanctions, securities law compliance, and
online payment services, and the related compliance costs. Our failure to comply with these laws and regulations could adversely affect
our business and cause significant penalties to be imposed on us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
particular, the growth and development of Internet content, commerce and communities may prompt more stringent consumer protection, privacy,
and data protection laws, both in the United States and abroad, as well as new laws governing their taxation. Compliance with any newly
adopted laws may prove difficult and costly for us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
services involve the storage and transmission of digital information; therefore, cybersecurity incidents, including those caused by unintentional
errors and those intentionally caused by third parties, may expose us to a risk of loss, unauthorized disclosure or other misuse of this
information, litigation liability, regulatory exposure, reputational harm and increased security costs.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
and our third party service providers experience attempted cyber-attacks of varying degrees on a regular basis, one of which
infiltrated our systems and accessed a limited amount of our non-financial and encrypted data. We expect to incur significant,
increasing costs in ongoing efforts to detect and prevent cybersecurity-related incidents. We cannot ensure that our efforts to
prevent cyber security incidents will succeed. While we purchase liability coverage for certain of these types of
matters, a significant cybersecurity incident could subject us to reputational harm, loss of revenue, financial liability and other
damage that may exceed our insurance coverage and preclude us from obtaining adequate insurance levels in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Existing
or future strategic alliances, long-term investments and acquisitions may have a material and adverse effect on our business, reputation,
and results of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may enter strategic business relationships with third parties to further our business purpose from time to time. These alliances could subject us
to risks, including risks associated with sharing proprietary information, non-performance by the third party and increased expenses
in establishing new strategic alliances, any of which may materially and adversely affect our business. We may have limited ability to
monitor or control the actions of these third parties and, to the extent any of these strategic third parties suffer negative publicity
or harm to their reputation from events relating to their business, we may also suffer negative publicity or harm to our reputation by
virtue of our association.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
acquisitions and the subsequent integration of new assets and businesses into our own will require significant attention from our management
and could result in a diversion of resources from our existing business, which in turn could have an adverse effect on our business operations.
Acquisitions may not achieve our goals and could be viewed negatively by users, business partners or investors, use substantial amounts
of cash, cause potentially dilutive issuances of equity securities, require significant goodwill impairment charges or amortization expenses
for other intangible assets and expose us to unknown liabilities of the acquired business. Moreover, the costs of identifying and consummating
acquisitions may be significant. In addition to, in some cases, having to obtain shareholders&#8217; approval, we may also have to obtain approvals and licenses
from relevant authorities for the acquisitions, which could result in increased delay and costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
products may require availability of components or known technology from third parties and their non-availability can impede our growth.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
license/buy certain technology integral to our products from third parties, including open-source and commercially available
software. Our inability to acquire and maintain any third party product licenses or integrate the related third party products into
our products in compliance with license arrangements, could result in delays in product development until equivalent products can be
identified, licensed and integrated. We also expect to require new licenses in the future as our business grows and technology
evolves. We cannot provide assurance that these licenses will continue to be available to us on commercially reasonable terms, if at
all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business is subject to the risk of catastrophic events such as pandemics, earthquakes, flooding, fire, and power outages, and to interruption
by man-made acts, such as war and terrorism.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is vulnerable to damage or interruption from pandemics, earthquakes, flooding, fire, power outages, telecommunications
failures, terrorist attacks, acts of war, human errors, break-ins, and similar events. A significant natural disaster could have a
material adverse effect on our business, results of operations, and financial condition, and our insurance coverage may be
insufficient to compensate us for losses that may occur. Furthermore, acts of terrorism, which may be targeted at metropolitan areas
that have higher population density than rural areas, could cause disruptions in our or our Publisher Partners&#8217; businesses or
the U.S. economy as a whole. Our technology infrastructure may also be vulnerable to computer viruses, break-ins, denial-of-service
attacks, and similar disruptions from unauthorized tampering with our computer systems, which could lead to interruptions, delays
and loss of critical data. We may not have sufficient protection or recovery plans in some circumstances. As we rely heavily on our
computer and communications systems and the Internet to conduct our business and provide high-quality user and customer service,
these disruptions could negatively impact our ability to run our business and either directly or indirectly disrupt our Publisher
Partners&#8217; businesses, which could adversely affect our business, results of operations, and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compliance
with the reporting obligations under the United States securities laws and Section 404 of Sarbanes-Oxley requires expenditure of capital and other resources and may divert management&#8217;s attention. If we fail to comply with these reporting
obligations or to maintain adequate internal controls our operations, and investors&#8217; confidence in us, could be materially and
adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public company, we are required to comply with the periodic reporting obligations of the Exchange Act, Sarbanes-Oxley and other applicable
securities rules and regulations, including the preparation of annual reports, quarterly reports, and current reports. Complying with
these rules and regulations have caused us and will continue to cause us to incur additional legal and financial compliance costs and
make some activities more difficult, time-consuming and costly. Further, by complying with public disclosure requirements, our business
and financial condition are more visible, which may result in increased threatened or actual litigation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
preparing our financial statements for the year ended December 31, 2022, we identified material weaknesses in our internal control over
financial reporting, which were remediated in 2023 with the implementation of additional controls and procedures. However, we
may in the future discover material weaknesses in other areas of our internal control over financial reporting that require remediation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
failure to maintain internal control over financial reporting could severely inhibit our ability to accurately report our financial condition
or results of operations, cause us to lose investor confidence, prevent us from obtaining capital on favorable terms or at all, and subject
us to sanctions or investigations by the SEC, the NYSE American or other regulatory authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we fail to timely meet our reporting obligations under the Exchange Act, Sarbanes-Oxley and other applicable securities rules and regulations
in their entirety, we could be subject to penalties under federal securities laws and regulations of the NYSE American and face lawsuits,
and we will not be able to obtain independent accountant certifications required for public companies under Sarbanes-Oxley.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Unfavorable
economic and market conditions could adversely affect our business, reputation, and results of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
services, products, properties, and our ability to access the capital markets on terms acceptable or at all may be adversely impacted
by uncertain economic conditions, including but not limited to, regional conflicts, pandemics, adverse changes in interest rates, foreign
currency exchange rates, tax laws or tax rates, inflation, economic downturns, recessions, contraction in the availability of credit,
and the effects of government initiatives to manage economic conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ongoing cash management strategy is to maintain diversity in our deposit accounts across financial institutions to manage risks from
potential instability in the banking system, but deposits in these institutions may exceed the amount of insurance provided on such deposits
and there can be no assurance that this strategy will be successful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict how future economic conditions will affect our users and Publisher Partners and any negative impact on our users or Publisher
Partners may also have an adverse impact on our own results of operations or financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATED TO OUR INDEBTEDNESS, FINANCIAL CONDITION, AND INTERNAL CONTROL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>As
the general economic and market conditions present uncertainty as to our ability to secure additional capital, there can be no assurances
that we will be able to secure additional financing on acceptable terms, or at all, as and when necessary to continue to conduct operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future liquidity and capital requirements will depend upon numerous factors, including the success of the Platform, our offerings, competing
technological developments, and general economic and market conditions, which have presented substantial uncertainty in recent months.
We may need to raise funds through public or private financings, strategic relationships, or other arrangements. There can be no assurance
that such funding will be available on terms acceptable to us, or at all. Furthermore, any equity financing will be dilutive to existing
stockholders, and debt financing, if available, may involve restrictive covenants that may limit our operating flexibility with respect
to certain business matters. Strategic arrangements may require us to relinquish our rights or grant licenses to some or substantial
parts of our intellectual property. If funds are raised through the issuance of equity securities, the percentage ownership of our stockholders
will be reduced, stockholders may experience additional dilution in net book value per share, and such equity securities may have rights,
preferences, or privileges senior to those of the holders of our existing capital stock. If adequate funds are not available on acceptable
terms, we may not be able to continue operating, develop or enhance products, take advantage of future opportunities or respond to competitive
pressures, any of which could have a material adverse effect on our business, operating results, and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have a history of losses.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the year ended December 31, 2023, we had net loss of approximately $193.8 million compared to approximately $135.0 million for the year
ended December 31, 2022. Our accumulated deficit as of December 31, 2023 was approximately $373.1 million. In fiscal 2023, we had net
loss of approximately $55.6 million compared to approximately $70.9 million in fiscal 2022. Our accumulated deficit as of December 31,
2022 was approximately $378.7 million. We may continue to incur losses in the future if we do not achieve sufficient revenue or adequately
reduce costs to achieve and maintain profitability. There is no assurance that our operations will generate sufficient cash flows to
support our continued operations in the future without needing to seek additional capital funding or borrowings. We can provide no assurance
that if we need to seek such additional outside capital that it will be available on favorable terms or at all. Any failure to achieve
and maintain profitability could have a materially adverse effect on our ability to implement our business plan, our results and operations,
and our financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><b><i>Our financial
conditions raise substantial doubt about our ability to continue as a &#8220;going concern&#8221; through one year from the date of the
financial statements contained herein if the Business Combination is not consummated and we are unable to refinance or modify the terms
of the Third A&amp;R NPA and the underlying debt with Renew.</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2023, Arena incurred a net loss of $55.6 million. For year ended December 31, 2023 and year ended December
31, 2022, our cash on hand of $9.3 million and $13.9 million and a working capital deficit of $63.3 million and $137.7 million,
respectively. Arena&#8217;s net loss and working capital deficit have been evaluated by management to determine if the significance of
those conditions or events would limit its ability to meet its obligations when due.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, management determined there is substantial doubt about Arena&#8217;s ability to continue as a going concern for a one-year
period following the financial statement issuance date, unless (i) Arena closes the transactions contemplated by the <span style="line-height: 115%">business
combination agreement by and among the Company, Simplify, Bridge Media Networks, LLC (&#8220;Bridge Media&#8221;), New Arena Holdco,
Inc (&#8220;New Arena&#8221;) and the other parties dated November 5, 2023, as amended on December 1, 2023 (the &#8220;Business
Combination&#8221;) and (ii) Arena is able to refinance or modify the terms of the Third A&amp;R NPA and the underlying debt with
Renew, which is subject to a forbearance period through the earlier of the following: (a) April 30, 2024, (b) the closing of the
Business Combination, and (c) the termination of the Business Combination, and establishes debt payments that are serviceable by the
Company&#8217;s cash flow. </span>If we are unable to raise additional capital, we may be required to take additional measures to
conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a
potential transaction and reducing overhead expenses. We cannot provide any assurance that financing sources will be available to us
on commercially acceptable terms or if at all, that our plans to consummate the Business Combination will be successful or the
Company will be able to refinance or modify the terms of the Third A&amp;R NPA and the underlying debt with Renew<span style="background-color: white">.</span>
The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
results of operations may fluctuate significantly and may not meet our expectations or those of securities analysts and investors.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate in an evolving industry, and as a result, our business has evolved over time such that our operating history makes it difficult
to evaluate our business and future prospects. Our results of operations have fluctuated in the past, and future results of operations
are likely to fluctuate as well. Although we have experienced substantial revenue growth, we may not be able to sustain this growth rate
or current revenue levels or achieve profitability. In addition, because our business is evolving, our historical results of operations
may be of limited utility in assessing our future prospects. We expect to face challenges, risks, and difficulties frequently experienced
by growing companies in rapidly developing industries, including those relating to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in demand and pricing for our products, services and the Platform;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">developing,
                                            maintaining, and expanding relationships with Publisher Partners and advertisers;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">innovating
                                            and developing new solutions that are adopted by and meet the needs of Publisher Partners
                                            and advertisers;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">competing
                                            against companies with a larger user and customer base or greater financial or technical
                                            resources;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in the pricing policies of Publisher Partners, advertisers and competitors;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in our access to valuable user data;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs
                                            to develop and upgrade the Platform to incorporate new technologies;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs
                                            related to the acquisition of businesses, talent, technologies, or intellectual property,
                                            including potentially significant amortization costs and possible write-downs;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">seasonality
                                            in our business;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            length and complexity of our sales cycles;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            timing of stock-based compensation expense;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                            costs to attract, onboard, retain and motivate qualified personnel;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">responding
                                            to evolving industry standards and government regulations that impact our business, particularly
                                            in the areas of data protection and consumer privacy;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in demand as a result of changes in the macroeconomic environment, as a result of inflation,
                                            changes in interest rates or foreign exchange rates, or otherwise; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">further
                                            expanding our business in other markets.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
one or more of the factors above may result in significant fluctuations in our results of operations. You should not rely on our past
results as an indicator of our future performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
many of our expenses are based upon forecast demand and may be difficult to reduce in the short term, volatility in quarterly revenue
could cause significant variations in quarterly results of operations. We may not forecast our revenue or expenses accurately, which
may cause our results of operations to diverge from our estimates or the expectations of securities analysts, and investors. If we fail
to meet or exceed such expectations for these or any other reasons, the trading price of our common stock could fall, and we could face
costly litigation, including securities class action lawsuits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Any
future litigation against us could be costly and time-consuming to defend.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have in the past and may in the future become subject to legal proceedings and claims or regulatory inquiries or proceedings that arise
in the ordinary course of business, such as claims brought by our customers and partners in connection with commercial disputes, employment
claims made by our current or former employees, or claims for reimbursement following misappropriation of customer data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
example, we could face claims relating to information published or made available on the Platform. In particular, the nature of our
business exposes us to claims related to defamation, intellectual property rights and rights of publicity and privacy. We might not
be able to monitor or edit a significant portion of the content that appears on the Platform. This risk is enhanced in certain
jurisdictions outside the United States where our protection from liability for third party actions may be unclear and where we may
be less protected under local laws than we are in the United States. We could also face fines or orders restricting or blocking our
services in particular geographies as a result of content hosted on our services. If any of these events occur, our business could
be seriously harmed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
employees are highly experienced, having worked in our industry for many years and prior employers may try to assert that our
employees are breaching restrictive covenants and other limitations imposed by past employment arrangements. We believe that all of
our employees are free to work for us in their various capacities and have not breached past employment arrangements.
Notwithstanding our care in our employment practices, a prior employer may assert a claim against us. Such claims can be costly to
contest, disruptive to our work environment, and may be detrimental to our operations and financial results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
insurance may not cover any such claims that rise in the ordinary course of business, may not provide sufficient payments to cover
all the costs to resolve one or more such claims, and may not continue to be available on terms acceptable to us. A claim brought against
us that is uninsured or underinsured could result in unanticipated costs, thereby reducing our results of operations and leading analysts
or potential investors to reduce their expectations of our performance, which could reduce the trading price of our common stock. Litigation
may result in substantial costs and may divert management&#8217;s attention and resources, which could adversely affect our business,
financial condition, results of operations, and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
ability to utilize our net operating loss carryforwards may be limited.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, we had federal net operating loss carryforwards, or NOLs, due to prior period losses of $193.8 million, and certain
NOLs could expire before we generate sufficient taxable income to make use of our NOLs. Subject to certain limitations, NOLs can be used
to offset taxable income for U.S. federal income tax purposes. However, Section 382 of the Internal Revenue Code of 1986, as amended,
may limit certain NOLs we may use in any year for U.S. federal income tax purposes in the event of certain changes in ownership of our
Company. If an &#8220;ownership change&#8221; occurs, Section 382 would impose an annual limit on certain pre-ownership NOLs and other
tax attributes we can use to reduce our taxable income, potentially increasing and accelerating our liability for income taxes, and also
potentially causing those tax attributes to expire unused. In addition, our ability to use our net operating losses is dependent on our
ability to generate taxable income, and certain net operating losses could expire before we generate sufficient taxable income to make
use of our net operating losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATED TO GOVERNANCE AND COMMON STOCK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are dependent on the continued services and on the performance of our key executive officers, management team, and other key personnel,
the loss of which could adversely affect our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are dependent on the continued services and on the performance of our key executive officers, management team, and other key
personnel. We also depend on our ability to identify, attract, hire, train, retain, and motivate other highly skilled technical,
managerial, sales, operational, business development, and customer service personnel. Competition for such personnel is intense, and
there can be no assurance that we will be able to successfully attract, assimilate, or retain sufficiently qualified personnel. The
loss or limitation of the services of any of our executive officers, members of our management team, or other key personnel or the
inability to attract and retain additional qualified key personnel, could have a material adverse effect on our business, financial
condition, or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
elimination of monetary liability against our directors, officers, and employees under Delaware law and the existence of indemnification
rights for our obligations to our directors, officers, and employees may result in substantial expenditures by us and may discourage
lawsuits against our directors, officers, and employees.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Amended and Restated Certificate of Incorporation, as amended (our &#8220;Certificate of Incorporation&#8221;), and our Second Amended
and Restated Bylaws (our &#8220;Bylaws&#8221;) contain provisions permitting us to eliminate the personal liability of our directors
and officers to us and our stockholders for damages for the breach of a fiduciary duty as a director or officer to the extent provided
by Delaware law. We may also have contractual indemnification obligations under any future employment agreements with our officers. The
foregoing indemnification obligations could result in us incurring substantial expenditures to cover the cost of settlement or damage
awards against directors and officers, which we may be unable to recoup. These provisions and the resulting costs may also discourage
us from bringing a lawsuit against directors and officers for breaches of their fiduciary duties, and may similarly discourage the filing
of derivative litigation by our stockholders against our directors and officers even through such actions, if successful, might otherwise
benefit us and our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Because
we are a &#8220;smaller reporting company,&#8221; we will not be required to comply with certain disclosure requirements that are applicable
to other public companies, and we cannot be certain if the reduced disclosure requirements applicable to smaller reporting companies
will make our common stock less attractive to investors.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the consummation of the Business Combination, we will be a &#8220;smaller reporting company,&#8221; as defined in Item 10(f)(1) of Regulation
S-K. As a smaller reporting company, we are eligible for exemptions from various reporting requirements applicable to other public companies
that are not smaller reporting companies, including, but not limited to reduced disclosure obligations, including with respect to executive
compensation, in our periodic reports, proxy statements, and registration statements. We will continue to be a smaller reporting company
if either (i) the market value of our stock held by non-affiliates is less than $250 million as of the prior June 30, or (ii) our
annual revenue is less than $100 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates
is less than $700 million as of the prior June 30. We cannot predict if investors will find our common stock less attractive because
we may rely on these exemptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Provisions
in our Certificate of Incorporation and Bylaws and Delaware law may discourage a takeover attempt even if a takeover might be beneficial
to our stockholders and limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors,
officers and employees.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions
contained in our Certificate of Incorporation and Bylaws could make it more difficult for a third party to acquire us. Provisions in
our Certificate of Incorporation and Bylaws impose various procedural and other requirements, which could make it more difficult for
stockholders to affect certain corporate actions. For example, our Certificate of Incorporation authorizes our Board to determine the
rights, preferences, privileges, and restrictions of unissued series of our Preferred Stock without any vote or action by our stockholders.
Thus, our Board can authorize and issue shares of our Preferred Stock with voting or conversion rights that could dilute the voting power
of holders of other series of our capital stock. These rights may have the effect of delaying or deterring a change of control of us.
Additionally, our Certificate of Incorporation or Bylaws establish limitations on the removal of directors and include advance notice
requirements for nominations for election to our Board and for proposing matters that can be acted upon at stockholder meetings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our Certificate of Incorporation provides that a state or federal court located within the state of Delaware will be the exclusive
forum for: any derivative action or proceeding brought on our behalf; any action asserting a breach of fiduciary duty; any action asserting
a claim against us arising pursuant to the DGCL, our Certificate of Incorporation, or our Bylaws; any action to interpret, apply, enforce,
or determine the validity of our Certificate of Incorporation or our Bylaws; or any action asserting a claim against us that is governed
by the internal affairs doctrine. This choice of forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial
forum that it finds favorable for disputes with us or any of our directors, officers, or other employees, which may discourage lawsuits
with respect to such claims. Alternatively, if a court were to find the choice of forum provision contained in our restated certificate
of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action
in other jurisdictions, which could harm our business, operating results, and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law (&#8220;DGCL&#8221;),
which prohibits an &#8220;interested stockholder&#8221; owning in excess of 15% of our outstanding voting stock from merging or combining
with us for a period of three years after the date of the transaction in which such stockholder acquired in excess of 15% of our outstanding
voting stock, unless the merger or combination is approved in a prescribed manner. These provisions could limit the price that certain
investors might be willing to pay in the future for shares of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Claims
for indemnification by our directors and officers may reduce our available funds to satisfy successful third party claims against us
and may reduce the amount of money available to us.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation provides that we will indemnify our directors and officers, in each case, to the fullest extent permitted
by Delaware law. In addition, Section 145 of the DGCL or our Certificate of Incorporation provides that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We indemnify our directors and officers for serving us in those capacities or for serving
                                            other business enterprises at our request, to the fullest extent permitted by Delaware law.
                                            Delaware law provides that a corporation may indemnify such person if such person acted in
                                            good faith and in a manner such person reasonably believed to be in or not opposed to the
                                            best interests of the corporation and, with respect to any criminal action or proceeding,
                                            had no reasonable cause to believe such person&#8217;s conduct was unlawful.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may, in our discretion, indemnify employees and agents in those circumstances where indemnification
                                            is permitted by applicable law.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are required to advance expenses, as incurred, to our directors and officers in connection
                                            with defending a legal proceeding, except that such directors or officers shall undertake to repay
                                            such advances if it is ultimately determined that such person is not entitled to indemnification.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            rights conferred in our Certificate of Incorporation are not exclusive, and we are authorized
                                            to enter into indemnification agreements with our directors, officers, employees, and agents
                                            and to obtain insurance to indemnify such persons.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may not retroactively amend our Certificate of Incorporation or indemnification agreement,
                                            if any, to reduce our indemnification obligations to directors, officers, employees, and
                                            agents.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
trading price of the shares of our common stock has been and may continue to be volatile and could subject us to litigation.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stocks
of companies in the media and technology industries have historically experienced high levels of volatility. The trading price of our
common stock has fluctuated substantially and may continue to do so. These fluctuations could cause you to incur substantial losses,
including all of your investment in our common stock. Factors that could cause fluctuations in the trading price of our common stock,
some of which are beyond our control and may not be related to our operational or financial performance, include, among others, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">price
                                            and volume fluctuations in the overall stock market from time to time;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                            of new products, solutions or technologies, commercial relationships, acquisitions, or other
                                            events by us or our competitors;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            public&#8217;s reaction to our press releases, other public announcements, and filings with
                                            the SEC;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuations
                                            in the trading volume of our shares or the size of our public float, including in connection
                                            with an acquisition;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
                                            of large blocks of our common stock;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
                                            or anticipated changes or fluctuations in our results of operations or financial projections;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            of securities analysts to initiate or maintain coverage of us, changes in financial estimates
                                            by any securities analysts who follow our company, or our failure to meet these estimates
                                            or the expectations of investors;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recruitment
                                            or departures of key personnel;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">governmental
                                            or regulatory developments or actions, or litigation involving us, our industry, or both</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                                            economic conditions and trends, including inflation and fluctuating interest rates;</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                                            political conditions and trends, political instability and acts of war or terrorism, including
                                            the ongoing conflict between Russia and Ukraine, as well as in the Middle East;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">public
                                            health crises and related measures to protect the public health (such as the COVID-19 pandemic);</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">major
                                            catastrophic events in our domestic and foreign markets;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in accounting standards, policies, guidelines, interpretations, or principles; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;flash
                                            crashes,&#8221; &#8220;freeze flashes,&#8221; or other glitches that disrupt trading on the
                                            securities exchange on which we are listed.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if the market for stock of media and technology companies or the stock market, in general, experiences a loss of investor confidence,
the trading price of our common stock could decline for reasons unrelated to our business, results of operations, or financial condition.
The trading price of our common stock might also decline in reaction to events that affect other companies in the media and technology
industries even if these events do not directly affect us. In the past, following periods of volatility in the market price of a company&#8217;s
securities, securities class action litigation has often been brought against that company. If litigation is instituted against us, it
could subject us to substantial costs, divert management&#8217;s attention and resources, and adversely affect our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Board is authorized to issue additional shares of our common stock that would dilute existing stockholders and sales, distribution or
issuance of substantial amounts of our common stock could cause the market price of our common stock to decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has the authority to issue any or all authorized but unissued shares of our common stock at any price and, with regard to our preferred
stock, at any price and with any attributes our Board considers appropriate, absent stockholder approval. The issuance of additional
shares of our common stock in the future will reduce the proportionate ownership and voting power of current stockholders and may negatively
impact the market price of our common stock. Moreover, the sale or distribution of a substantial number of shares of our common stock,
particularly sales by us or our directors, executive officers, and principal stockholders, or the perception that these sales or distributions
might occur in large quantities, could cause the market price of our common stock to decline. In addition, shares subject to outstanding
warrants as well as the shares of common stock subject to outstanding options and restricted stock unit awards under our equity incentive
plans, and the shares reserved for future issuance under our equity incentive plans, will become eligible for sale in the public market
upon issuance, subject to compliance with applicable securities laws. Further, we also may issue our capital stock or securities convertible
into our capital stock, from time to time in connection with financing, an acquisition, investments, or otherwise. Any of the aforementioned
activity, could result in substantial dilution to our existing stockholders and cause the market price of common stock to decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may issue additional securities with rights superior to those of our common stock, which could materially limit the ownership rights
of our stockholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may offer additional debt or equity securities in private or public offerings in order to raise working capital or to refinance our debt.
Our Board has the right to determine the terms and rights of any debt securities and preferred stock without obtaining the approval of
our stockholders. It is possible that any debt securities or preferred stock that we sell would have terms and rights superior to those
of our common stock and may be convertible into shares of our common stock. Any sale of securities could adversely affect the interests
or voting rights of the holders of our common stock, result in substantial dilution to existing stockholders, or adversely affect the
market price of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cyber-attacks
and other security threats and disruptions could have a material adverse </b></span><b>effect on our business.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a tech-powered media company, we face cybersecurity threats, such as ransomware and denial-of-service, and attacks on technical infrastructure.
Our customers and suppliers face similar cybersecurity threats, and a cybersecurity incident impacting us or any of these entities could
materially adversely affect our operations, performance and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sophistication of threats continues to evolve and grow, including the risk associated with the use of emerging technologies, such as
artificial intelligence and quantum computing, for nefarious purposes. In addition to cybersecurity threats, we face threats to the security
of our systems and employees from terrorist acts, sabotage or other disruptions, any of which could adversely affect our business. The
improper conduct of our employees or others working on behalf of us who have access to confidential or sensitive information could also
adversely affect our business and reputation. Our customers (including sites that we operate for our customers) and suppliers experience
similar security threats.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to protect sensitive information, including complying with evolving information security, data protection and privacy
regulations, our customers or governmental authorities could investigate the adequacy of our threat mitigation and detection
processes and procedures; and could bring actions against us for noncompliance with applicable laws and regulations. Moreover,
depending on the severity of an incident, our customers&#8217; data, our employees&#8217; data, our intellectual property (including
trade secrets and research, development and engineering know-how), and other third party data (such as suppliers) could be
compromised, which could adversely affect our business. Products and services we provide to customers also carry cybersecurity
risks, including risks that they could be breached or fail to detect, prevent or combat attacks, which could result in losses to our
customers and claims against us, and could harm our relationships with our customers and financial results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
the persistence, sophistication, volume and novelty of threats we face, we may not be successful in preventing or mitigating an attack
that could have a material adverse effect on us and the costs related to cyber or other security threats or disruptions may not be fully
insured or indemnified by other means.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Our
suppliers face similar security threats and an incident at one of these entities could adversely impact our business. These entities
are typically outside our control and may have access to our information with varying levels of security and cybersecurity resources,
expertise, safeguards and capabilities. Adversaries actively seek to exploit security and cybersecurity weaknesses in our supply chain.
Breaches in our supply chain could in the future compromise our data and adversely affect customer deliverables. We also must rely on
our supply chain for adequately detecting and reporting cyber incidents, which could affect our ability to report or respond to cybersecurity
incidents effectively or in a timely manner. Failures by our suppliers could result in damages to you and have an adverse effect on our business and operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Su_004"></span>Item
1B. Unresolved Staff Comments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
Applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Su_005"></span>Item
1C. Cybersecurity</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a tech-powered media company, we face cybersecurity threats, such as ransomware and denial-of-service, and attacks on technical infrastructure.
Our customers and suppliers face similar cybersecurity threats, and a cybersecurity incident impacting us or any of these entities could
materially adversely affect our operations, performance and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We maintain a cyber risk management program designed to identify, assess, manage, mitigate, and respond to cybersecurity threats.
This program addresses cybersecurity risks to the corporate information technology (&#8220;IT&#8221;) environment including systems,
hardware, software, data, people, and processes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee of the Board of Directors oversees management&#8217;s processes for identifying and mitigating risks, including cybersecurity
risks. Our VP of Information Security regularly briefs senior leadership on our cybersecurity and information security posture including
on the prevention, detection, mitigation, and remediation of cybersecurity incidents, and senior leadership will then brief the Audit
Committee. In the event of an incident, we intend to follow our incident response playbook, which outlines our planned response from
incident detection to mitigation, recovery and notification, including notifying functional areas (e.g. legal), as well as senior leadership
and the Board, as appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
security team is responsible for our overall information security strategy, including policy, security engineering, operations and cyber
threat detection and response. Our security team has extensive experience selecting, deploying, and overseeing cybersecurity technologies,
initiatives, and processes. Employees outside of our security team also have a role in our cybersecurity defenses, and they are given
training which we believe improves our cybersecurity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third
parties also play a role in our cybersecurity risk management strategy. We engage third parties to conduct risk assessments and
evaluations of our security controls. Such risk assessment and evaluations identify, quantify, and categorize any cyber risks. In
addition, we, along with third party cyber risk management specialists, develops a risk mitigation plan to address such risks, and
where necessary, remediate potential vulnerabilities identified through the assessment and evaluation process. Third party
cybersecurity risk management engagement also includes activities such as penetration testing, independent audits or consulting on
best practices to address new challenges. We include security and privacy addendums to our contracts where applicable. We have also
commenced third party risk management assessments to help manage the risks associated with reliance on vendors, critical service </span>providers,
and other third-parties that may lead to a service disruption or an adverse cybersecurity incident.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
VP of Information Security and cybersecurity stakeholders regularly brief the senior leadership team on cyber vulnerabilities identified
through the risk management process, the effectiveness of our cyber risk management program, the emerging threat landscape,
and new cyber risks on at least an annual basis. This includes updates on our processes to prevent, detect, and mitigate
cybersecurity incidents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the approach we take to cybersecurity, we may not be successful in preventing or mitigating a cybersecurity incident that could have
a material adverse effect on us. While we maintain cybersecurity insurance, the costs related to cybersecurity threats or
disruptions may not be fully insured. We have not identified any risks from known cybersecurity threats, including as a result of
any prior cybersecurity incidents, that have materially affected or are reasonably likely to materially affect our operations,
business strategy, regulatory compliance, results of operations, or financial condition. The Company
proactively seeks to detect and investigate unauthorized attempts and attacks against Company IT assets, data, and services, and to
prevent their occurrence and recurrence where practicable through changes or updates to internal processes and tools and changes or
updates to Company service delivery; however, potential vulnerabilities to known or unknown threats will still remain. See Item 1A.
&#8220;Risk Factors&#8221; for a discussion of cybersecurity risks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Su_006"></span>Item
2. Properties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, we had two leases in California. In Santa Monica, California we have a leased space which we sublet that
terminates in November 2024. In Carlsbad, California we have a lease for office space that is partially sublet. We do not occupy the
balance of the space. The Carlsbad lease terminates in March 2025. As we operate our business principally in a virtual environment,
these two leased spaces are not utilized in our operations. To the extent we need to lease physical properties in the future, we
believe we would be able to find suitable properties at market rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Su_007"></span>Item
3. Legal Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we may be subject to claims and litigation arising in the ordinary course of business. Except as described in Note 27, <i>Commitments
and Contingencies</i> to our accompanying consolidated financial statements under Item 8 of this Annual Report, as of the date of
this Annual Report, we are not currently subject to any pending or threatened legal proceedings that we believe would reasonably be
expected to have a material adverse effect on our business, financial condition, results of operations or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 30, 2024, our former President&#160;of
Media filed an action against us and Manoj Bhargava, alleging claims for breach of contract, failure to pay wages and defamation, among
other things, in the United States District Court of the Southern District of New York, and seeking&#160;damages in an unspecified amount.
We believe that we have strong defenses to these claims and intend to vigorously defend ourselves and the allegations made
in this lawsuit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 21, 2024, our former CEO and Chairman of
the Board filed an action against us, members of the Board of directors and Simplify, alleging claims for retaliation, breach of contract,
wrongful termination and age discrimination, among other things, in the Superior Court of the State of California seeking damages in an
amount of $20 million. We believe that we have strong defenses to these claims and intend to vigorously defend ourselves and
the allegations made in this lawsuit.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Su_008"></span>Item
4. Mine Safety Disclosure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Su_009"></span>Part
II.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Su_010"></span>Item
5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock began trading on the NYSE American on February 9, 2022 under the symbol &#8220;AREN.&#8221; Before then, from September
21, 2021 until February 8, 2022, our common stock was quoted on the OTCM&#8217;s OTCQX trading under the symbol &#8220;MVEN.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Holders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 28, 2024, there were approximately 162 holders of record of our common stock. Since many of our shares of common stock are held
by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by
these record holders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never paid cash dividends on our common stock, and our present policy is to retain any future earnings to support our operations
and finance the growth and development of our business. We do not intend to pay cash dividends on our common stock for the foreseeable
future. Any future determination related to our dividend policy will be made at the discretion of our Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purchases
of Equity Securities by the Issuer and Affiliated Purchasers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Sales of Unregistered Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
of Proceeds</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Su_011"></span>Item
6. [Reserved]</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Su_012"></span>Item
7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion should be read in conjunction with the consolidated financial statements and the notes to those statements that
are included elsewhere in this Annual Report. Our discussion includes forward-looking statements based upon current expectations that
involve risks and uncertainties, such as our plans, objectives, expectations, and intentions. Actual results and the timing of events
could differ materially from those anticipated in these forward-looking statements as a result of a number of factors. We use words such
as &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;continuing,&#8221; &#8220;ongoing,&#8221;
&#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221;
and similar expressions to identify forward-looking statements. All dollar figures are presented in thousands unless otherwise stated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
an overview of the Company, see the information above presented under the section labeled &#8220;Item 1. Business,&#8221; which is in
&#8220;Part I&#8221; of this Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key
Operating Metrics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
key operating metrics are:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
                                            per page view (&#8220;RPM&#8221;) &#8211; represents the advertising revenue earned per 1,000
                                            pageviews. It is calculated as our advertising revenue during a period divided by our total
                                            page views during that period and multiplied by $1,000; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monthly
                                            average pageviews &#8211; represents the total number of pageviews in a given month or the
                                            average of each month&#8217;s pageviews in a fiscal quarter or year, which is calculated
                                            as the total number of page views recorded in a quarter or year divided by three months or
                                            12 months, respectively.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
monitor and review our key operating metrics as we believe that these metrics are relevant for our industry and specifically to us and
to understanding our business. Moreover, they form the basis for trends informing certain predictions related to our financial condition.
Our key operating metrics focus primarily on our digital advertising revenue, which has experienced significant growth in recent periods
as indicated in the <i>Results of Operations</i> section below. Management monitors and reviews these metrics because such metrics are
readily measurable in real time and can provide valuable insight into the performance of and trends related to our digital advertising
revenue and our overall business. We consider only those key operating metrics described here to be material to our financial condition,
results of operations and future prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
pricing indicators, we focus on RPM as it is the pricing metric most closely aligned with monthly average pageviews. RPM is an indicator
of yield and pricing driven by both advertising density and demand from our advertisers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monthly
average pageviews are measured across all properties hosted on the Platform and provide us with insight into volume, engagement and
effective page management and are therefore our primary measure of traffic. We utilize a third party source, Google Analytics, to
confirm this traffic data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described above, these key operating metrics are critical for management as they provide insights into our digital advertising revenue
generation and overall business performance. This information also provides feedback on the content on our website and its ability to
attract and engage users, which allows us to make strategic business decisions designed to drive more users to read or view more of our
content and generate higher advertising revenue across all properties hosted on the Platform.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2023 and 2022 our RPM was $23.95 and $18.17, respectively. The 32% increase in RPM reflects a
significant increase in video advertising as a percentage of total digital advertising as digital video advertising is sold at a
significantly higher price than digital display advertising. For the years ended December 31, 2023 and 2022 our monthly average
pageviews were 464,261,595 and 489,659,595, respectively. The 5% decrease in monthly average pageviews reflects algorithmic changes
at Google, Facebook and other platforms which subdued user click-throughs to the original content.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impact
of Macroeconomic Conditions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Uncertainty
in the global economy presents significant risks to our business. Increases in inflation, rising interest rates, instability in the global
banking system, geopolitical factors, including the ongoing conflicts in Ukraine and Israel and the responses thereto, and the remaining
effects of the COVID-19 pandemic may have an adverse effect on our business. While we are closely monitoring the impact of the current
macroeconomic conditions on all aspects of our business, the ultimate extent of the impact on our business remains highly uncertain and
will depend on future developments and factors that continue to evolve. Most of these developments and factors are outside of our control
and could exist for an extended period of time. As a result, we are subject to continuing risks and uncertainties. For more information regarding these
risks and uncertainties, see the section titled &#8220;Risk Factors&#8221; in Part 1, Item 1A of this Annual Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash
and Working Capital Facility</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, our principal sources of liquidity consisted of cash of $9,284 and accounts receivable, net of our advances under
the Arena Credit Agreement of $25,202. As of December 31, 2023, the outstanding balance of the Arena Credit Agreement was $19,609. On
March 13, 2024 the Arena Credit Agreement was refinanced with the Simplify Loan. As of the issuance date of our accompanying consolidated
financial statements our cash balance is $4,151 and the balance outstanding under the Simplify Loan is $7,748, with the additional availability of $17,252.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
accompanying consolidated financial statements have been presented on the basis that we are a going concern, which contemplates the realization
of assets and satisfaction of liabilities in the normal course of business. We had revenues of $244,203 during fiscal 2023 and have experienced
recurring net losses from operations and negative operating cash flows. Consequently, we were dependent upon continued access to funding
and capital resources from both new investors and related parties. If continued funding and capital resources are unavailable at reasonable
terms, we may not be able to implement our growth plan and plan of operations. These financings may include terms that may be highly
dilutive to existing stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
continue to be focused on growing our existing operations and seeking accretive and complementary strategic acquisitions as part of our
growth strategy. We believe, that with additional sources of liquidity and the ability to raise additional capital or incur additional
indebtedness to supplement our internal projections, we will be able to execute our growth plan and finance our working capital requirements
both in the short-term and long-term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going
Concern</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
performed an annual reporting period going concern assessment. We are required to assess our ability to continue as a going concern.
Our accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates
the realization of assets and the liquidation of liabilities in the normal course of business. Our accompanying consolidated financial
statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
recently, for the year ended December 31, 2023, we incurred a net loss from continuing operations of $55,582, had cash on hand of
$9,284 and a working capital deficit of $145,622. Our net loss from continuing operations and working capital deficit have been
evaluated by management to determine if the significance of those conditions or events would limit our ability to meet our
obligations when due. Also, since our 2023 Notes, Senior Secured Notes, Delayed Draw Term Notes and 2022 Bridge Notes (as further
described below) (collectively &#8220;our current debt&#8221;) are subject to a forbearance period through the earlier of the following: (a) April 30, 2024, (b) the closing of the
Business Combination, and (c) the termination of the Business Combination (see Note 28, <i>Subsequent Events</i>,
in our accompanying consolidated financial statements), unless we are able to refinance or modify the terms of our current debt we run the risk that our
 debt could be called, therefore, we may not be able to meet our obligations when due.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
our evaluation, management determined there is substantial doubt about our ability to continue as a going concern for a one-year period
following the financial statement issuance date, unless we are able to refinance or modify our current debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to refinance or modify the maturities of our current debt and complete the Business Combination to alleviate the conditions
that raise substantial doubt about our ability to continue as a going concern, however, there can be no assurance that we will be able to refinance or modify our current debt and complete the
Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Debt
Financings and Obligations</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
proceeds from our debt financings consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Arena
Credit Agreement</span>. We were party to a financing and security agreement with SLR (the &#8220;Arena Credit Agreement&#8221;), as amended on December 15, 2022 and August 31,
2023, pursuant to which SLR extended a $40,000 line of credit for working capital purposes secured by a first lien on all our cash
and accounts receivable and a second lien on all other assets. Borrowings under the facility bore interest at the prime rate plus 4%
per annum of the amount advanced and had a maturity date of December 31, 2025. The aggregate principal amount outstanding, plus
accrued and unpaid interest as of December 31, 2023 was $19,609. On March 13, 2024, the Arena Credit Agreement was refinanced by
the Simplify Loan, which bears interest at 10% per annum of the amount advanced and has a maturity date of March 13, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">2023
Notes</span>. Pursuant to the Third A&amp;R NPA (as defined below)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">,</span>
on August 31, 2023, we issued $5,000 aggregate principal amount of notes with additional borrowings of $1,000 on September 29, 2023
and $2,000 on November 23, 2023 (the &#8220;2023 Notes&#8221;). On December 1, 2023, <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Renew,
an affiliated entity of Simplify, in its capacity as agent for the purchasers and as purchaser, purchased the 2023 Notes from BRF
Finance Co., LLC (&#8220;BRF Finance&#8221;), an affiliated entity of B. Riley</span> Financial, Inc. (&#8220;B. Riley&#8221;).
Borrowings under the 2023 Notes bore interest at 10% per annum. <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">On
December 29, 2023, we failed to make the interest payment </span>due on the 2023 <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Notes
resulting in an event of default with</span> subsequent agreement to a forbearance period through the earlier of the following: (a)
April 30, 2024; (b) the occurrence of the closing of the Business Combination and (c) the termination of the Business Combination
prior to closing <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">(further details are
provided under the heading <i>Arena Loan Agreement</i> in Note 28, <i>Subsequent Events </i>in</span> our accompanying consolidated
financial statements). The balance outstanding under our 2023 Notes as of December 31, 2023 was $8,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Bridge
Notes</span>. Pursuant to the Third A&amp;R NPA (as defined below), on December 15, 2022, we issued $36,000 aggregate principal amount
of senior secured notes (the &#8220;Bridge Notes&#8221;). <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">On
December 1, 2023, Renew,</span> an affiliated entity of Simplify, in its capacity as agent for the purchasers and as purchaser,
purchased the Bridge Notes from BRF Finance. We received net proceeds of $34,728, after the payment of $1,000 to B. Riley for an
advisory fee and $272 for other legal costs, from the issuance of the Bridge Notes. Interest on the Bridge Notes was payable in cash
at a rate of 10% per annum as amended on August 31, 2023, from 12% per annum quarterly, with an increase in the interest rate by
1.5% per annum on March 1, 2023, May 1, 2023 and July 1, 2023. <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">On December 29, 2023,
we failed to make the interest payment due on the Bridge Notes resulting in an event of default with subsequent agreement to a forbearance
period <span style="color: #181717">through the earlier of the following: (a) April 30, 2024</span><span style="color: #393A39">; </span><span style="color: #181717">(b)
the occurrence of the closing of the Business Combination and (c) the termination of the Business Combination prior to closing </span>(further
details are provided under the heading <i>Arena Loan Agreement</i> in Note 28, <i>Subsequent Events </i>in our accompanying consolidated
financial statements).</span> The Bridge Notes are subject to certain mandatory prepayment requirements,
including, but not limited to, a requirement that we apply the net proceeds from certain debt incurrences or equity offerings to
repay the Bridge Notes. We may elect to prepay the Bridge Notes, at any time, at our option at 100% of the principal amount. The
Bridge Notes are secured by liens on the same collateral that secures indebtedness under our outstanding Senior Secured Notes (as
defined below) and are guaranteed by our subsidiaries that guarantee the Third A&amp;R NPA. The Note Purchase Agreement contains
covenants and events of default substantially similar to those contained in the note purchase agreement that governed the Third
A&amp;R NPA. The proceeds received were used for the acquisition of Men&#8217;s Journal and to repay $5,928 of our existing Delayed
Draw Term Notes (as defined below). The balance outstanding under our Bridge Notes as of December 31, 2023 was $36,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Senior
Secured Notes</span>. We are party to a third amended and restated note purchase agreement (the &#8220;Third A&amp;R NPA&#8221;), with
Renew, an affiliated entity of <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Simplify,
where we issued senior secured notes (the &#8220;Senior Secured Notes&#8221;).</span> On December 1, 2023, Renew purchased the
Senior Secured Notes from BRF Finance. The Senior Secured Notes bear interest at a rate of 10% per annum. Interest payments are
payable at Renew&#8217;s discretion either in cash quarterly in arrears on the last day of each quarter or by adding the interest to
the outstanding principal amount. On December 29, 2023, we failed to make the interest payment due on the Senior Secured Notes resulting in an event of default with subsequent agreement to a forbearance period <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%">through
the earlier of the following: (a) April 30, 2024</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #393A39; line-height: 115%">;
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%">(b) the occurrence
of the closing of the Business Combination and (c) the termination of the Business Combination prior to closing </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">(further
details are provided under the heading <i>Arena Loan Agreement</i> in Note 28, <i>Subsequent Events </i>in</span> our accompanying consolidated financial statements). The balance
outstanding under our Senior Secured Notes as of December 31, 2023 was $62,691, which included outstanding principal of $48,791 and
payment of in-kind interest of $13,900 that we were permitted to add to the aggregate outstanding principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Delayed
Draw Term Notes</span>. Pursuant to the Third A&amp;R NPA, we agreed to issue delayed draw term notes (the &#8220;Delayed Draw Term
Notes&#8221;). On December 1, 2023, Renew, an affiliated entity of Simplify, in its capacity as agent for the purchasers and as
purchaser, purchased the Delayed Draw Term Notes from BRF Finance. The Delayed Draw Term Notes bear interest at a rate of 10% per
annum. Interest payments are payable, at Renew&#8217;s discretion, either in cash quarterly in arrears on the last day of each
fiscal quarter or in kind in arrears on the last day of each fiscal quarter. On December 29, 2023, we failed to make the interest
payment due on the Delayed Draw Term Notes resulting in an event of default with subsequent agreement to a forbearance period <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%">through
the earlier of the following: (a) April 30, 2024</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #393A39; line-height: 115%">;
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%">(b) the occurrence
of the closing of the Business Combination and (c) the termination of the Business Combination prior to closing </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">(further
details are provided under the heading <i>Arena Loan Agreement</i> in Note 28, <i>Subsequent Events </i>in</span> our accompanying
consolidated financial statements). We paid $5,928 in principal on December 31, 2022. The Delayed Draw Term Notes have a maturity
date of December 31, 2026. The balance outstanding under the Delayed Draw Term Notes as of December 31, 2023 was <span style="background-color: white">$4,000.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Acquisition</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
January 11, 2023, we entered into an asset purchase agreement with Teneology, Inc., pursuant to which we acquired certain assets (consisting
of the RoadFood media business, including digital and television assets; the Moveable Feast media business, including digital and television
assets; the Fexy-branded content studio business; and the MonkeySee YouTube Channel media business, collectively &#8220;Fexy Studios&#8221;),
for a purchase price of $3,307. The purchase price consisted of the following: (1) $500 cash paid at closing; (2) $75 cash payments due
in three equal installments of $25 on March 1, 2023 (paid), April 1, 2023 (paid) and May 1, 2023 (paid); (3) $200 deferred cash payment
due on the first anniversary of the closing date, subject to certain indemnity provisions; and (4) the issuance of 274,692 shares of
our common stock, subject to certain lock-up provisions, on the closing date with a fair value of $2,000 (fair value was determined based
on an independent appraisal); and which is subject to a put option under certain conditions. The number of shares of the Company&#8217;s common
stock issued was determined based on a $2,225 value using the common stock trading price on the day immediately preceding the January
11, 2023 closing date (on the closing date the common stock trading price was $7.94 per share).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Off-Balance
Sheet Arrangements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Material
Contractual Obligations</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have material contractual obligations that arise in the normal course of business primarily consisting of employment contracts,
consulting agreements, leases, liquidated damages, debt and related interest payments. Purchase obligations consist of contracts
primarily related to merchandise, equipment, and third party services, the majority of which are due in the next 12 months. See Note
7, <i>Leases</i>, Note 15, <i>Liquidated Damages Payable</i>, Note 18, <i>Bridge Notes</i>, and Note 19, <i>Long-term Debt</i>, in
our accompanying consolidated financial statements for amounts outstanding as of December 31, 2023, related to leases, liquidated
damages, bridge financing and long-term debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2022, we assumed the lease from Men&#8217;s Journal for office space in Carlsbad, California, that expires in March 2025, and as of December
31, 2023 we remain responsible for $1,439 over the remaining lease term. The lease provides for fixed payments of $89 for three months,
$92 for twelve months and $94 for twelve months, with an estimate of common expenses per month of $25 through the end of the lease term.
Pursuant to two subleases entered into during 2023, the sublessees will pay us an aggregate of $312, net of security deposits, through
March 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We also subleased our office space in Santa Monica, California in November 2021 and remain responsible to the original
lessor for $373 through October 2024. Pursuant to the sublease, the sublessee will pay us an aggregate of $225 through October 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2021, we entered into a termination agreement of our sublease agreement for a property located in New York, New York and remain responsible
for $4,000 in cash payments to the sublandlord through October 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Working
Capital Deficit</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have financed our working capital requirements since inception through issuances of equity securities and various debt financings. Our
working capital deficit as of December 31, 2023 and 2022 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Current assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">90,399</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">78,695</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(236,021</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(216,364</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Working capital deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(145,622</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(137,669</td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, we had a working capital deficit of $145,622, as compared to $137,669 as of December 31, 2022, consisting of $90,399
in total current assets and $236,021 in total current liabilities. As of December 31, 2022, our working capital deficit consisted of
$78,695 in total current assets and $216,364 in total current liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
cash flows during the years ended December 31, 2023 and 2022 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Net cash used in operating activities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(24,772</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(11,304</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,212</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(38,590</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Net cash provided by financing activities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">22,895</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">54,416</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Net (decrease) increase in cash, cash equivalents, and restricted cash</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(5,089</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,522</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Cash, cash equivalents, and restricted cash, end of year</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,284</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,373</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2023, net cash used in operating activities was $24,772, consisting primarily of $239,737 of cash paid to
employees, Publisher Partners, Expert Contributors, suppliers, and vendors, and for revenue share arrangements and professional services,
and $12,101 of cash paid for interest, offset by $227,066 of cash received from customers. For the year ended December 31, 2022, net
cash used in operating activities was $11,304, consisting primarily of $219,282 of cash paid to employees, Publisher Partners, Expert
Contributors, suppliers, and vendors, and for revenue share arrangements, advance of royalty fees and professional services, and $9,528
of cash paid for interest, offset by $219,407 of cash received from customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2023, net cash used in investing activities was $3,212, consisting primarily of $3,773 for capitalized costs
for our Platform and $500 for the acquisition of a business, offset by $1,061 from sale of assets. For the year ended December 31, 2022,
net cash used in investing activities was $38,590, consisting primarily of $35,331 for the acquisition of a business, $5,179 for capitalized
costs for our Platform, and $530 for property and equipment, offset by $2,450 from the sale of an equity investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2023, net cash provided by financing activities was $22,895, consisting primarily of $11,333 (excluding accrued
offering costs of $167) in net proceeds from the public offering of common stock, $5,517 from borrowings under our Arena Credit Agreement,
$7,543 (excluding debt issuance costs of $457) in net proceeds from issuance of our 2023 Notes; offset by $1,423 tax payments relating to
the withholding of shares of common stock for certain employees, and $75 payment of deferred cash payments for an acquisition. For the
year ended December 31, 2022, net cash provided by financing activities was $54,416, consisting primarily of $30,490 (net of issuance
costs paid of $1,568) in net proceeds from a public offering of common stock, $28,800 (net of issuance costs paid of $1,272 and payments
of $5,928) in proceeds from long term-debt, $2,104 from advancements of our Arena Credit Agreement, and $95 from exercises of common
stock options, offset by $4,468 for tax payments relating to the withholding of shares of common stock for certain employees, $2,152
related to payments of restricted stock liabilities, and $453 related to deferred cash payments for an acquisition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Comparison
of Fiscal 2023 to Fiscal 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023 versus 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$ Change</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% Change</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%"><b>Revenue</b></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">244,203</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">220,935</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">23,268</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">10.5</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Cost of revenue</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">142,240</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">132,923</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,317</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross profit</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">101,963</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">88,012</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,951</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><b>Operating expenses</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Selling and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74,245</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72,489</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,756</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53,499</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,347</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-17.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,924</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,650</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,274</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Loss on impairment of assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">119</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">257</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(138</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-53.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Loss on sale of assets</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">325</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">325</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">100.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0pt">Total operating expenses</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">137,765</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">143,895</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,130</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-4.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Loss from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(35,802</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(55,883</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,081</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-35.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0pt">Total other expenses</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(19,558</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,568</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,990</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">55.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(55,360</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(68,451</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,091</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-19.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0pt">Income tax benefit</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(222</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,063</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,285</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-120.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Net loss from continuing operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(55,582</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(67,388</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,806</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-17.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0pt">Net loss from discontinued operations, net of tax</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,470</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,470</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-100.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net loss</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(55,582</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(70,858</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,276</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-21.6</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2023, the loss from operations improved $20,081 to $35,802 as compared to $55,883 during the year ended
December 31, 2022 due to a $23,268 increase in revenue, with a $6,130 decrease in operating expenses. For the year ended December
31, 2023, the net loss was $55,582, a decrease of $15,276 as compared to a net loss of $70,858 for the year ended December 31, 2022
as the improvement in the loss from operations was partially offset by an increase in interest expense of $6,537 included in other
expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth revenue, cost of revenue, and gross profit from continuing operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023 versus 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$ Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">244,203</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">220,935</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">23,268</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">10.5</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">142,240</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">132,923</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,317</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Gross profit</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">101,963</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">88,012</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,951</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">15.9</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2023 we had gross profit of $101,963, as compared to $88,012 for the year ended December 31, 2022, an increase
of $13,951. Gross profit percentage for the year ended December 31, 2023 was 41.8%, as compared to 39.8% for the year ended December
31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The improvement in gross profit percentage was driven by an increase
in total revenue of $23,268, or 10.5%, primarily as a result of increased digital advertising due to improved programmatic video inventory
monetization. This increase is partially offset by an increase in cost of revenue of $9,317, or 7%, resulting from higher publisher partner
revenue share along with increased technology, Platform and software licensing costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth revenue from continuing operations by category:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023 versus 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$ Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Digital revenue:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%; text-align: left; padding-left: 10pt">Digital advertising</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">135,376</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">109,317</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">26,059</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">23.8</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Digital subscriptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,764</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,156</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,392</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-39.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Licensing and syndication revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,173</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">309</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other digital revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,384</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,166</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,218</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">361.7</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Total digital revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">172,006</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">149,812</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">22,194</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14.8</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Print revenue:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Print advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,881</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,214</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(333</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-3.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Print subscriptions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">62,316</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">60,909</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,407</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.3</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Total print revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">72,197</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">71,123</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,074</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.5</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">244,203</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">220,935</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">23,268</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">10.5</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2023, total revenue increased $23,268 to $244,203 from $220,935 for the year ended December 31, 2022. The
primary sources of revenue for the year ended December 31, 2023 were as follows: (i) digital advertising of $135,376, (ii) digital subscriptions
of $12,764, (iii) licensing and syndication revenue and other digital revenue of $23,866, (iv) print advertising of $9,881 and (v) print
subscriptions of $62,316</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary driver of the increase in our total revenue is derived from digital advertising revenue which benefited from a 32% rise in RPMs
due to the higher mix of higher priced digital video advertising in the year ended December 31, 2023 versus the prior year. Other digital
revenue, which was mostly e-commerce revenue, increased by $4,218 to $5,384. These improvements were partially offset by a decrease in
digital subscriptions of $8,392, resulting in a $22,194, or 14.8%, increase in total digital revenue for the year ended December 31, 2023
as compared to the prior year period. In addition, total print revenue increased by $1,074 as print advertising decreased by $333 and
print subscriptions grew by $1,407.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
of Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth cost of revenue from continuing operations by category:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023 versus 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$ Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Publisher Partner revenue share payments</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">27,174</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">20,108</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">7,066</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">35.1</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Technology, Platform and software licensing fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,990</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,294</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,696</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Royalty fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Content and editorial expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,669</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,581</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Printing, distribution and fulfillment costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,391</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,835</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">556</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amortization of developed technology and platform development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,782</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,459</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(677</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-7.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,562</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,235</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,673</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-35.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other cost of revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">91</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">323</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(232</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-71.8</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total cost of revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">142,240</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">132,923</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,317</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">7.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2023, we recognized cost of revenue of $142,240, as compared to $132,923 for the year ended December 31,
2022, representing an increase of $9,317. Cost of revenue for the year ended December 31, 2023 was impacted by increases in (i) Publisher
Partner revenue share payments of $7,066, (ii) technology, Platform and software licensing fees of $2,696, (iii) content and editorial
expenses of $3,581, and (iv) printing, distribution and fulfillment costs of $556; partially offset by a decrease in stock-based compensation
of $3,673.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Selling
and Marketing</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth selling and marketing expenses from continuing operations by category:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023 versus 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$ Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Payroll and employee benefits of selling and marketing account management support teams</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">19,106</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">14,467</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,639</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">32.1</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,659</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,772</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,113</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-40.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Professional marketing services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,406</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,528</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,122</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-24.8</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Circulation costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,257</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,006</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">251</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Subscription acquisition costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38,112</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,190</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">922</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Advertising costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,372</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,987</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,615</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-27.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other selling and marketing expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,333</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,539</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(206</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-8.1</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total selling and marketing</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">74,245</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">72,489</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,756</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.4</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2023, we incurred selling and marketing costs of $74,245 as compared to $72,489 for the year ended December
31, 2022. The increase in selling and marketing costs of $1,756 is primarily related to increases in (i) payroll and employee benefits
of $4,639, (ii) circulation costs of $251, and (iii) subscription acquisition costs of $922; partially offset by decreases in (i) professional
marketing services costs of $1,122, (ii) advertising costs of $1,615 and (iii) stock-based compensation costs of $1,113.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General
and Administrative</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth general and administrative expenses from continuing operations by category:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023 versus 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$ Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Payroll and related expenses for executive and administrative personnel</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">14,337</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">15,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,463</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">-9.3</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,839</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,338</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,499</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-40.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Professional services, including accounting, legal and insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,229</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,364</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,135</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-8.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other general and administrative expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,747</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,997</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12.5</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total general and administrative</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">44,152</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">53,499</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(9,347</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-17.5</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2023, we incurred general and administrative costs of $44,152 as compared to $53,499 for the year ended December
31, 2022. The $9,347 decrease in general and administrative expenses is primarily due to decreases in stock-based compensation of $7,499,
payroll and related expenses of $1,463 and professional services of $1,135.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth other expenses:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023 versus 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$ Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Change in fair value of contingent consideration</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,010</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,010</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">100.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest expense, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(17,965</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,428</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,537</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Liquidated damages</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(583</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,140</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">557</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-48.9</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total other expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(19,558</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(12,568</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(6,990</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">55.6</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Change
in Fair Value of Contingent Consideration</span>. The change in fair value of contingent consideration of $1,010 for the year ended December
31, 2023 represents the change in the put option on our common stock in connection with the acquisition of Fexy Studios. As part of that
acquisition consideration, we issued 274,692 shares of our common stock, which was subject to a put option under certain conditions (as
further described in Note 17, <i>Fair Value Measurement</i> in our accompanying consolidated financial statements).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Interest
Expense</span>. We incurred interest expense, net of $17,965 for the year ended December 31, 2023, as compared to $11,428 for the year ended
December 31, 2022. The increase in interest expense of $6,537 was primarily from additional interest from our debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Liquidated
Damages</span>. We recorded liquidated damages of $583 for the year ended December 31, 2023, as compared to $1,140 for the year ended December
31, 2022. The decrease of $557 in liquidated damages recorded for the year ended December 31, 2023, is primarily because in 2022 we had
an assessment under certain agreements as a result of filing a registration statement outside of the agreed upon filing deadline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Income
Taxes</span>. For the year ended December 31, 2023, we recorded an income tax provision of $222 primarily related to tax deductible goodwill. For the year ended December 31, 2022, we recorded
an income tax benefit of $1,063 primarily from our acquired deferred tax liabilities from an acquisition during the year and change
in valuation allowance as of year-end that was, in part, offset by certain previous acquisitions related to tax deductible
goodwill.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
further details refer to Note 24, <i>Income Taxes</i>, in our accompanying consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of Non-GAAP Financial Measures</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
report our financial results in accordance with generally accepted accounting principles in the United States of America
(&#8220;GAAP&#8221;); however, management believes that certain non-GAAP financial measures provide users of our financial
information with useful supplemental information that enables a better comparison of our performance across periods. We believe
Adjusted EBITDA provides visibility to the underlying continuing operating performance by excluding the impact of certain items that
are noncash in nature or not related to our core business operations. We calculate Adjusted EBITDA as net loss as adjusted for loss
from discontinued operations, with additional adjustments for (i) interest expense (net), (ii) income taxes, (iii) depreciation and
amortization, (iv) stock-based compensation, (v) change in valuation of contingent consideration, (vi) liquidated damages, (vii)
loss on impairment of assets, (viii) loss on sale of assets; (ix) employee retention credit, (x) employee restructuring payments;
and (xi) professional and vendor fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
non-GAAP Adjusted EBITDA may not be comparable to a similarly titled measure used by other companies, has limitations as an analytical
tool, and should not be considered in isolation, or as a substitute for analysis of our operating results as reported under GAAP. Additionally,
we do not consider our non-GAAP Adjusted EBITDA as superior to, or a substitute for, the equivalent measures calculated and presented
in accordance with GAAP. Some of the limitations is that Adjusted EBITDA:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
                                            not reflect interest expense and financing fees, or the cash required to service our debt,
                                            which reduces cash available to us;</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
                                            not reflect income tax provision or benefit, which is a noncash income or expense;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
                                            not reflect depreciation and amortization expense and, although this is a noncash expense,
                                            the assets being depreciated may have to be replaced in the future, increasing our cash requirements;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
                                            not reflect stock-based compensation and, therefore, does not include all of our compensation
                                            costs;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
                                            not reflect the change in valuation of contingent consideration and, although this is a noncash
                                            income or expense, the change in the valuations each reporting period are not impacted by
                                            our actual business operations but is instead strongly tied to the change in the market value
                                            of our common stock;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
                                            not reflect liquidated damages and, therefore, does not include future cash requirements
                                            if we repay the liquidated damages in cash instead of shares of our common stock (which the
                                            investor would need to agree to);</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
                                            not reflect any losses from the impairment of assets, which is a noncash operating expense;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
                                            not reflect any losses from the sale of assets, which is a noncash operating expense</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
                                            not reflect the employee retention credits recorded by us for payroll related tax credits
                                            under the CARES Act;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
                                            not reflect payments related to employee severance and employee restructuring changes for
                                            our former executives; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
                                            not reflect the professional and vendor fees incurred by us for services provided by consultants,
                                            accountants, lawyers, and other vendors, which services were related to certain types of
                                            events that are not reflective of our business operations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents a reconciliation of Adjusted EBITDA to net loss, which is the most directly comparable GAAP measure, for the
periods indicated:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-left: 1.45pt">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(55,582</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(70,858</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 1.45pt">Loss from discontinued operations, net of tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,470</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 1.45pt">Loss from continuing operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(55,582</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(67,388</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 1.45pt">Add (deduct):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Interest expense, net (1)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,965</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,428</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Income tax provision (benefit)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">222</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,063</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Depreciation and amortization (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,706</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,109</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Stock-based compensation (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,060</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,345</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Change in fair value of contingent consideration (4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,010</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Liquidated damages (5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">583</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,140</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Loss on impairment of assets (6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">119</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">257</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Loss on sale of assets (7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">325</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Employee retention credit (8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,868</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Employee restructuring expenses (9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,367</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">679</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Professional and vendor fees (10)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,194</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Adjusted EBITDA</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,101</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,507</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
                                            expense is related to our capital structure and varies over time due to a variety of financing
                                            transactions. Interest expense includes $2,378 and $1,581 for amortization of debt discounts
                                            for the years ended December 31, 2023 and 2022, respectively, as presented in our consolidated
                                            statements of cash flows, which are noncash items. Investors should note that interest expense
                                            will recur in future periods.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
                                            and amortization related to our developed technology and Platform is included within cost
                                            of revenue of $8,782 and $9,459, for the years ending December 31, 2023 and 2022, respectively,
                                            and depreciation and amortization is included within operating expenses of $18,924 and $17,650
                                            for the years ending December 31, 2023 and 2022, respectively. We believe (i) the amount
                                            of depreciation and amortization expense in any specific period may not directly correlate
                                            to the underlying performance of our business operations and (ii) such expenses can vary
                                            significantly between periods as a result of new acquisitions and full amortization of previously
                                            acquired tangible and intangible assets. Investors should note that the use of tangible and
                                            intangible assets contributed to revenue in the periods presented and will contribute to
                                            future revenue generation and should also note that such expense will recur in future periods.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
                                            compensation represents noncash costs arise from the grant of stock-based awards to employees,
                                            consultants and directors. We believe that excluding the effect of stock-based compensation
                                            from Adjusted EBITDA assists management and investors in making period-to-period comparisons
                                            in our operating performance because (i) the amount of such expenses in any specific period
                                            may not directly correlate to the underlying performance of our business operations, and
                                            (ii) such expenses can vary significantly between periods as a result of the timing of grants
                                            of new stock-based awards, including grants in connection with acquisitions. Additionally,
                                            we believe that excluding stock-based compensation from Adjusted EBITDA assists management
                                            and investors in making meaningful comparisons between our operating performance and the
                                            operating performance of other companies that may use different forms of employee compensation
                                            or different valuation methodologies for their stock-based compensation. Investors should
                                            note that stock-based compensation is a key incentive offered to employees whose efforts
                                            contributed to the operating results in the periods presented and are expected to contribute
                                            to operating results in future periods. Investors should also note that such expenses will
                                            recur in the future.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
                                            in fair value of contingent consideration represents the change in the put option on our
                                            common stock in connection with the acquisition of Fexy Studios.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidated
                                            damages (or interest expense related to accrued liquidated damages) represents amounts we
                                            owe to certain of our investors in private placements offerings conducted in fiscal years
                                            2018 through 2020, pursuant to which we agreed to certain covenants in the respective securities
                                            purchase agreements and registration rights agreements, including the filing of resale registration
                                            statements and becoming current in our reporting obligations, which we were not able to timely
                                            meet.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
                                            on impairment of assets represents certain assets that are no longer useful.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
                                            on sale of assets represents non-recurring losses for sale of assets.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
                                            retention credit represents payroll related tax credits under the CARES Act.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
                                            restructuring payments represents severance payments to employees under employer restructuring
                                            arrangements and payments to our former Chief Executive Officer for the years ended December
                                            31, 2023 and 2022, respectively.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
                                            and vendor fees represents fees that are nonrecurring in connection with the Business Combination
                                            resulting in a change of control, including fees incurred by consultants, accountants, lawyers,
                                            and other vendors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Policies and Estimates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amount of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses
during the reported periods. The more critical accounting estimates include estimates related to revenue recognition, platform development,
impairment of long-lived assets, and stock-based compensation. We also have other key accounting policies, which involve the use of estimates,
judgments and assumptions that are significant to understanding our results, which are described in Note 2, <i>Summary of Significant
Accounting Policies</i>, in our accompanying consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
discussion and analysis of the financial condition and results of operations is based upon our consolidated financial statements included
elsewhere in this Annual Report on Form 10-K, which have been prepared in accordance with GAAP. We believe the following critical accounting
policies affect our more significant judgments and estimates used in the preparation of the financial statements. Actual results may
differ from these estimates under different assumptions or conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606, <i>Revenue from Contracts with Customers</i>, revenues are
recognized when control of the promised goods or services are transferred to our customers, in an amount that reflects the consideration
that we expect to receive in exchange for those goods or services. We generate all of our revenue from contracts with customers. We account
for revenue on a gross basis, as compared to a net basis, in our statement of operations. We have made this determination based on our
control of the advertising inventory and the ability to monetize the advertising inventory or publications before transfer to the customer
and because we are also the primary obligor responsible for providing the services to the customer. Cost of revenue is presented as
a separate line item on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a description of the principal activities from which we generate revenue:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advertising
Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Digital
Advertising</span>. We recognize revenue from digital advertisements at the point when each ad is viewed. The quantity of advertisements,
the impression bid prices, and revenue are reported on a real-time basis. We enter into contracts with advertising networks to serve
display or video advertisements on the digital media pages associated with our various channels. Although reported advertising transactions
are subject to adjustment by the advertising network partners, any such adjustments are known within a few days of month end. We owe
our independent Publisher Partners a revenue share of the advertising revenue earned, which is recorded as service costs in the same
period in which the associated advertising revenue is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising
revenue that is comprised of fees charged for the placement of advertising on the websites that we own and operate, is recognized as
the advertising or sponsorship is displayed, provided that collection of the resulting receivable is reasonably assured.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Print
Advertising</span>. Advertising related revenues for print advertisements are recognized when advertisements are published (defined as an
issue&#8217;s on-sale date), net of provisions for estimated rebates, rate adjustments, and discounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Subscription
Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Digital
Subscriptions</span>. We enter into contracts with internet users that subscribe to premium content on our owned and operated media channels
and facilitate such contracts between internet users and our Publisher Partners. These contracts provide internet users with a membership
subscription to access the premium content. For subscription revenue generated by our independent Publisher Partners&#8217; content,
we owe our Publisher Partners a revenue share of the membership subscription revenue earned, which is initially deferred and recorded
as deferred contract costs. We recognize deferred contract costs over the membership subscription term in the same pattern that the associated
membership subscription revenue is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Digital
subscription revenue generated from our websites that we own and operate are charged to customers&#8217; credit cards or are directly
billed to corporate subscribers, and are generally billed in advance on a monthly, quarterly or annual basis. We calculate net subscription
revenue by deducting from gross revenue an estimate of potential refunds from cancelled subscriptions as well as chargebacks of disputed
credit card charges. Net subscription revenue is recognized ratably over the subscription periods. Unearned revenue relates to payments
for subscription fees for which revenue has not been recognized because services have not yet been provided.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Print
Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print
revenue includes magazine subscriptions and single copy sales at newsstands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Print
Subscriptions</span>. Revenue from magazine subscriptions is deferred and recognized proportionately as products are distributed to subscribers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Newsstand</span>.
Single copy revenue is recognized on the publication&#8217;s on-sale date, net of provisions for estimated returns. We base our estimates
for returns on historical experience and current marketplace conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Licensing
and Syndication Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Content
licensing-based revenues and syndication revenues are accrued generally monthly or quarterly based on the specific mechanisms of each
contract. Generally, revenues are accrued based on estimated sales and adjusted as actual sales are reported by partners. These adjustments
are typically recorded within three months of the initial estimates and have not been material. Any minimum guarantees are typically
earned evenly over the fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Contract
Modifications</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
occasionally enter into amendments to previously executed contracts that constitute contract modifications. We assess each of these contract
modifications to determine:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the additional services and goods are distinct from the services and goods in the original arrangement; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the amount of consideration expected for the added services or goods reflects the stand-alone selling price of those services and
    goods.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
contract modification meeting both criteria is accounted for as a separate contract. A contract modification not meeting both criteria
is considered a change to the original contract and is accounted for on either a prospective basis as a termination of the existing contract
and the creation of a new contract, or a cumulative catch-up basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Platform
Development</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 32.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years presented, substantially all of our technology expenses are development costs for our Platform that were expensed as incurred
or capitalized as intangible costs. Technology costs are expensed as incurred or in accordance with applicable guidance that requires
costs incurred in the preliminary project and post-implementation stages of an internal use software project be expensed as incurred
and that certain costs incurred in the application development stage of a project be capitalized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
capitalize internal labor costs, including compensation, benefits and payroll taxes, incurred for certain capitalized platform development
projects. Our policy with respect to capitalized internal labor stipulates that labor costs for employees working on eligible internal
use capital projects are capitalized as part of the historical cost of the project when the impact, as compared to expensing such labor
costs, is material. Our Platform development capitalized during the application development stage of a project include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 32.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">payroll
                                            and related expenses for personnel; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">stock-based
                                            compensation of related personnel.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 20pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combinations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
account for business combinations using the acquisition method of accounting. The acquisition method of accounting requires that the
purchase price, including the fair value of contingent consideration, of the acquisition be allocated to the assets acquired and liabilities
assumed using the estimated fair values determined by management as of the acquisition date. Goodwill is measured as the excess of consideration
transferred and the net fair values of the assets acquired, and the liabilities assumed at the date of acquisition. While we use best
estimates and assumptions as part of the purchase price allocation process to accurately value assets acquired and liabilities assumed
at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period,
we record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill to the extent we identified
adjustments to the preliminary purchase price allocation. Upon the conclusion of the measurement period, which may be up to one year
from the acquisition date, or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any
subsequent adjustments are recorded to the consolidated statements of operations. Additionally, we identify acquisition-related contingent
payments and determine their respective fair values as of the acquisition date, which are recorded as accrued liabilities on the consolidated
balance sheets. Subsequent changes in fair value of contingent payments are recorded on the consolidated statements of operations. We
expense transaction costs related to the acquisition as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Goodwill</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
represents the excess of the purchase price over the fair value of the net tangible and intangible assets of businesses acquired in a
business combination. Goodwill is not amortized but rather is tested for impairment at least annually on December 31, or more frequently
if events or changes in circumstances indicate that the carrying amount of goodwill may not be recoverable. We operate as&#160;one&#160;reporting
unit, therefore, the impairment test is performed at the consolidated entity level. Recoverability of goodwill is determined by comparing
the fair value of our reporting unit to the carrying value of the underlying net assets in the reporting unit. If the fair value of our
reporting unit is determined to be less than the carrying value of our net assets, goodwill is deemed impaired, and an impairment loss
is recognized to the extent that the carrying value of goodwill exceeds the difference between the fair value of the reporting unit and
the fair value of our other assets and liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock-Based
Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">We provide stock-based compensation in the form of (a) stock awards
to employees and directors, comprised of restricted stock awards and restricted stock units, (b) stock option grants to employees, directors
and consultants, (c) common stock warrants to Publisher Partners (no warrants were issued during the years ended December 31, 2022 or
2021), and (d) common stock warrants to ABG (all as further described in Note 22, <i>Stock-Based Compensation, </i>in our accompanying
consolidated financial statements).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
account for stock awards and stock option grants to employees, directors and consultants, and non-employee awards to certain directors
and consultants by measuring the cost of services received in exchange for the stock-based payments as compensation expense our consolidated
financial statements. Stock awards and stock option grants to employees and non-employees which are time-vested, are measured at fair
value on the grant date, and charged to operations ratably over the vesting period. Stock awards and stock option grants to employees
and non-employees which are performance-vested, are measured at fair value on the grant date and charged to operations when the performance
condition is satisfied or over the service period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value measurement of equity awards and grants used for stock-based compensation is as follows: (1) restricted stock awards and restricted
stock units which are time-vested, are determined using the quoted market price of our common stock at the grant date; (2) stock option
grants which are time-vested and performance-vested, are determined utilizing the Black-Scholes option-pricing model at the grant date;
(3) restricted stock units and stock option grants which provide for market-based vesting with a time-vesting overlay, are determined
through consultants with our independent valuation firm using the Monte Carlo model at the grant date; (4) Publisher Partner Warrants
are determined utilizing the Black-Scholes option-pricing model; and (5) ABG warrants are determined utilizing the Monte Carlo model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value determined under the Black-Scholes option-pricing model and Monte Carlo model is affected by several variables, the most significant
of which are the life of the stock award, the exercise price of the stock option or warrant, as compared to the fair market value of
our common stock on the grant date, and the estimated volatility of our common stock over the term of the stock award. Estimated volatility
was determined under the (1) &#8220;Probability Weighted Scenarios&#8221; (prior to our reverse stock split on February 8, 2022) where
one scenario assumes that our common stock will be up-listed on a national stock exchange (the &#8220;Exchange&#8221;) on a certain listing
date (the &#8220;Up-list&#8221;) where the estimated volatility was based on evaluating the average historical volatility of a group
of peer companies that are publicly traded and the second scenario assumes our common stock is not up-listed on the Exchange prior to
the final vesting date of the grants (the &#8220;No Up-list&#8221;) where the historical volatility of our common stock was evaluated
based upon market comparisons; and the (2) &#8220;Up-list Scenario&#8221; (after our reverse stock split on February 8, 2022) where our
estimated volatility is based on evaluating the average historical volatility of a group of peer companies that are publicly traded after
we up-listed to the NYSE American. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant.
The fair market value of common stock is determined by reference to the quoted market price of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have elected to recognize forfeitures as they occur and to recognize stock-based compensation cost on a straight-line basis over the
total requisite service period for awards with graded vesting. We classify stock-based compensation cost on our consolidated statements
of operations in the same manner in which the award recipient&#8217;s cash compensation cost is classified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recently
Issued Accounting Pronouncements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
2, <i>Summary of Significant Accounting Policies,</i> in our accompanying consolidated financial statements appearing elsewhere in this
Annual Report includes Recently Issued Accounting Pronouncements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="K_001"></span>Item
7A. Quantitative and Qualitative Disclosures about Market Risk</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise
required under this item.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="K_002"></span>Item
8. Financial Statements and Supplementary Data</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
information required by this item is listed in the Index to Financial Statements in Part IV, Item 15(a)(1) of this Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="K_003"></span>Item
9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="K_004"></span>Item
9A. Controls and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Evaluation
of Disclosure Controls and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e)
and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports we file
or submit under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified in the SEC&#8217;s
rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information
required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated
to the issuer&#8217;s management, including its principal executive officer(s) and principal financial officer(s), or persons performing
similar functions, as appropriate to allow timely decisions regarding required disclosure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Exchange Act Rules 13a-15 and 15d-15, an evaluation was completed under the supervision and with the participation of
our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of
our disclosure controls and procedures as of December 31, 2023. Based on that evaluation, our management, including our Chief Executive
Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were effective in providing reasonable assurance
that information required to be disclosed in our reports filed or submitted under the Exchange Act was recorded, processed, summarized,
and reported within the time periods specified in the SEC&#8217;s rules and forms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Remediation of the Previously Reported Material
Weaknesses in Internal Control Over Financial Reporting</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">A material weakness is a deficiency, or a combination
of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement
of the Company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis. As reported in Part
II, Item 9A to our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 31, 2023, we did not maintain
effective internal control over financial reporting because of the material weaknesses described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Specifically, in preparing our
financial statements for the year ended December 31, 2022, we identified the following control deficiencies that constituted
material weaknesses in our internal control over financial reporting as of December 31, 2022: (i) we had inadequate segregation of
duties consistent with control objectives related to our information technology general controls (&#8220;ITGCs&#8221;), specifically
as it relates to change management; and (ii) there was insufficient validation of non-Google impression data provided by certain
third party service providers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
material weaknesses were remedied in fiscal 2023 by (i) implementing new permissions and approval requirements in our change
management process in our systems previously identified with inadequate segregation of duties and (ii) obtaining, reviewing, and
mapping a System and Organization Controls &#8211; SOC 1 Type 2 report from third party service providers for the effectiveness of
third party controls relevant to our internal control over financial reporting, including validation of impression data, and
implementing compensating management controls to further validate non-Google impressions data provided by certain third party
service providers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Management&#8217;s
Annual Report on Internal Control over Financial Reporting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f)
and 15d-15(f) under the Exchange Act). Internal control over financial reporting is a process, including policies and procedures, designed
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
reporting purposes in accordance with U.S. generally accepted accounting principles. Our management assessed our internal control over
financial reporting based on the Internal Control&#8212;Integrated Framework (2013 Framework) issued by the Committee of Sponsoring Organizations
of the Treadway Commission (&#8220;COSO&#8221;). Our system of internal control over financial reporting is designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with GAAP. <span style="background-color: white">Based on the above evaluation, our management concluded that our internal control over
financial reporting was effective as of </span>December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Annual Report does not include an attestation report of the Company&#8217;s registered public accounting firm regarding internal
control over financial reporting. Management&#8217;s report was not subject to attestation by the Company&#8217;s registered public accounting
firm pursuant to rules of the SEC that permit the Company to provide only management&#8217;s report in this Annual Report.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Changes
in Internal Control over Financial Reporting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as described above under &#8220;Remediation of the Previously Reported Material Weaknesses in Internal Control
Over Financial Reporting,&#8221; there
have not been any changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f)
under the Exchange Act) that occurred during quarter ended December 31, 2023 that have materially affected, or are reasonably likely
to materially affect, our internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inherent
Limitations on the Effectiveness of Controls</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effectiveness of any system of internal control over financial reporting, including ours, is subject to inherent limitations, including
the exercise of judgment in designing, implementing, operating, and evaluating the controls and procedures, and the inability to eliminate
misconduct completely. Accordingly, in designing and evaluating the disclosure controls and procedures, management recognizes that any
system of internal control over financial reporting, including ours, no matter how well designed and operated, can only provide reasonable,
not absolute assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must
reflect the fact that there are resource constraints, and that management is required to apply its judgment in evaluating the benefits
of possible controls and procedures relative to their costs. Projections of any evaluation of effectiveness to future periods are subject
to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies
or procedures may deteriorate. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our
business but cannot assure you that such improvements will be sufficient to provide us with effective internal control over financial
reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="K_005"></span>Item
9B. Other Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, we failed to make the interest payment due pursuant to the Third A&amp;R NPA (as defined in &#8220;Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations &#8211; Liquidity and Capital Resources &#8211; Senior Secured
Notes&#8221;) in the amount of approximately $2.8 million, resulting in an event of default under the Arena Notes. On January 5, 2024,
we entered into a forbearance agreement (the &#8220;Forbearance Agreement&#8221;) with Renew Group Private Limited, the lender under
the Third A&amp;R NPA, pursuant to which Renew agreed to a forbearance period through March 29, 2024, while reserving its rights and
remedies. On March 27, 2024, the forbearance period was extended through the earlier of the following: (a) April 30, 2024; (b) the occurrence
of the closing of the Business Combination and (c) the termination of the Business Combination prior to closing. The outstanding principal
on the Arena Notes was approximately $110.7 million as of December 31, 2023<span style="line-height: 115%">.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="K_006"></span>Item
9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="K_007"></span>Part
III</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="K_008"></span>Item
10. Directors, Executive Officers and Corporate Governance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information required under this item is incorporated herein by reference to our proxy statement for our 2024 Annual Meeting of Stockholders
to be filed with the SEC not later than 120 days after December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="K_009"></span>Item
11. Executive Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information required under this item is incorporated herein by reference to our proxy statement for our 2024 Annual Meeting of Stockholders
to be filed with the SEC not later than 120 days after December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="K_010"></span>Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information required under this item is incorporated herein by reference to our proxy statement for our 2024 Annual Meeting of Stockholders
to be filed with the SEC not later than 120 days after December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="K_011"></span>Item
13. Certain Relationships and Related Transactions, and Director Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information required under this item is incorporated herein by reference to our proxy statement for our 2024 Annual Meeting of Stockholders
to be filed with the SEC not later than 120 days after December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="K_012"></span>Item
14. Principal Accountant Fees and Services</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information required under this item is incorporated herein by reference to our proxy statement for our 2024 Annual Meeting of Stockholders
to be filed with the SEC not later than 120 days after December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="K_013"></span>Part
IV</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="K_014"></span>Item
15. Exhibits and Financial Statement Schedules</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    following documents are filed as part of this Annual Report:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<span style="text-decoration: underline">Index to Consolidated Financial Statements</span>. Our consolidated financial statements and the Report of Marcum LLP, Independent Registered
Public Accounting Firms are included in Part IV of this Annual Report on the pages indicated:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#F_015">Report of Independent Registered Public Accounting Firm</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#F_016">Consolidated Balance Sheets as of December 31, 2023 and 2022</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#F_017">Consolidated Statements of Operations for the Years Ended December 31, 2023 and 2022</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</span>4</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#F_018">Consolidated Statements of Stockholders&#8217; Deficiency for the Years Ended December 31, 2023 and 2022</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#F_020">Consolidated Statements of Cash Flows for the Years Ended December 31, 2023 and 2022</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#F_021">Notes to Consolidated Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-8</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<span style="text-decoration: underline">Financial Statement Schedules</span>. Schedule II &#8211; Valuation and Qualifying Accounts for the Years Ended December 31, 2023 and
2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 44; Options: NewSection; Value: 44 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description<sup></sup></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418015662/tv488836_ex10-1.htm" style="-sec-extract: exhibit">Agreement and Plan of Merger, dated as of March 13, 2018, by and among the Company, HP Acquisition Co., Inc., HubPages, Inc., and Paul Edmondson as the securityholder representative, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on March 19, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221000653/ex2-2.htm" style="-sec-extract: exhibit">Amendment to Agreement and Plan of Merger, dated as of April 25, 2018, by and among TheMaven, Inc., HP Acquisition Co., Inc., HubPages, Inc., and Paul Edmondson as the securityholder representative, which was filed as Exhibit 2.2 to our Annual Report on Form 10-K filed on January 8, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418032710/tv495828_ex10-1.htm" style="-sec-extract: exhibit">Second Amendment to Agreement and Plan of Merger, dated as of June 1, 2018, by and among TheMaven, Inc., HP Acquisition Co., Inc., HubPages, Inc., and Paul Edmondson as the securityholder representative, which was filed as Exhibit 10.1 to our Current Report on Form 8-K/A filed on June 4, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221000653/ex2-4.htm" style="-sec-extract: exhibit">Third Amendment to Agreement and Plan of Merger, dated as of May 31, 2019, by and among TheMaven, Inc., HP Acquisition Co., Inc., HubPages, Inc., and Paul Edmondson as the securityholder representative, which was filed as Exhibit 2.4 to our Annual Report on Form 10-K filed on January 8, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315220023992/ex10-1.htm" style="-sec-extract: exhibit">Fourth Amendment to Agreement and Plan of Merger, dated as of December 15, 2020, by and among TheMaven, Inc., HP Acquisition Co., Inc., HubPages, Inc., and Paul Edmondson as the securityholder representative, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on December 21, 2020.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418043357/tv500083_ex10-1.htm" style="-sec-extract: exhibit">Amended and Restated Asset Purchase Agreement, dated as of August 4, 2018, by and among the Company, Maven Coalition, Inc., and Say Media, Inc., which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on August 9, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418047099/tv501999_ex10-1.htm" style="-sec-extract: exhibit">Amendment to Amended and Restated Asset Purchase Agreement, dated as of August 24, 2018, by and among the Company, Maven Coalition, Inc., and Say Media, Inc., which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on August 29, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418054227/tv504794_ex10-1.htm" style="-sec-extract: exhibit">Agreement and Plan of Merger, dated as of October 12, 2018, by and among the Company, SM Acquisition Co., Inc., Say Media, Inc., and Matt Sanchez as the Securityholder Representative, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on October 17, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418054227/tv504794_ex10-2.htm" style="-sec-extract: exhibit">Amendment to Agreement and Plan of Merger, dated as of October 17, 2018, by and among the Company, SM Acquisition Co., Inc., Say Media, Inc., and Matt Sanchez as the Securityholder Representative, which was filed as Exhibit 10.2 to our Current Report on Form 8-K filed on October 17, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420419030656/tv523376_ex10-1.htm" style="-sec-extract: exhibit">Agreement and Plan of Merger, dated as of June 11, 2019, by and among the Company, TST Acquisition Co., Inc., and TheStreet, Inc., which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on June 12, 2019.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315222036014/ex2-1.htm" style="-sec-extract: exhibit">Asset Purchase Agreement, dated December 7, 2022, by and among The Arena Media Brands, LLC, Weider Publications, LLC and A360 Media, LLC, which was filed as Exhibit 2.1 to our Current Report on Form 8-K filed on December 20, 2022.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">2.12</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223039749/ex2-1.htm" style="-sec-extract: exhibit">Business Combination Agreement, dated as of November 5, 2023, among The Arena Group Holdings, Inc., Simplify Inventions, LLC, Bridge Media Networks, LLC, New Arena Holdco, Inc., Energy Merger Sub I, LLC and Energy Merger Sub II, which was filed as Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on November 7, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">2.13</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223043697/ex10-1.htm" style="-sec-extract: exhibit">Amendment No. 1 to Business Combination Agreement, dated December 1, 2023, by and between the Company, Simplify Inventions, LLC, Bridge Media Networks, LLC, New Arena Holdco, Inc., Energy Merger Sub I, LLC and Energy Merger Sub II, which was filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 5, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221025314/ex3-1.htm" style="-sec-extract: exhibit">Amended and Restated Certificate of Incorporation of the Registrant, which was filed as Exhibit 3.1 to our Current Report on Form 8-K filed on October 13, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221025314/ex3-2.htm" style="-sec-extract: exhibit">Second Amended and Restated Bylaws, which was filed as Exhibit 3.2 to our Current Report on Form 8-K filed on October 13, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221022577/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Elimination of Series F Convertible Preferred Stock as filed with the Delaware Secretary of State on September 7, 2021, which was filed as Exhibit 3.1 to our Current Report on Form 8-K filed September 13, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221022577/ex3-2.htm" style="-sec-extract: exhibit">Certificate of Elimination of Series I Convertible Preferred Stock as filed with the Delaware Secretary of State on September 7, 2021, which was filed as Exhibit 3.2 to our Current Report on Form 8-K filed September 13, 2021.</a></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 45; Value: 44 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221022577/ex3-3.htm" style="-sec-extract: exhibit">Certificate of Elimination of Series J Convertible Preferred Stock as filed with the Delaware Secretary of State on September 7, 2021, which was filed as Exhibit 3.3 to our Current Report on Form 8-K filed September 13, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221022577/ex3-4.htm" style="-sec-extract: exhibit">Certificate of Elimination of Series K Convertible Preferred Stock as filed with the Delaware Secretary of State on September 7, 2021, which was filed as Exhibit 3.4 to our Current Report on Form 8-K filed September 13, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315222002306/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Amendment as filed with the Delaware Secretary of State on January 20, 2022, which was filed Exhibit 3.1 to our Current Report on Form 8-K filed January 26, 2022.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315222002306/ex3-2.htm" style="-sec-extract: exhibit">Certificate of Correction of the Certificate of Amendment of the Amended and Restated Certificate of Incorporation, filed with the Secretary of State of the State of Delaware on January 26, 2022, which was filed as Exhibit 3.2 to our Current Report on Form 8-K filed January 26, 2022.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315222003602/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Correction of the Certificate of Amendment of the Amended and Restated Certificate of Incorporation, filed with the Secretary of State of the State of Delaware on February 3, 2022, which was filed as Exhibit 3.1 to our Current Report on Form 8-K filed February 9, 2022.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">3.10</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223019985/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Amendment to the Amended and Restated Certificate of Incorporation, which was filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on June 2, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/0000950123-96-005146.txt" style="-sec-extract: exhibit">Specimen Common Stock Certificate, which was filed as Exhibit 4.3 to Amendment No. 1 to Registration Statement on Form SB-2/A (Registration No. 333-48040) on September 23, 1996.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418033931/tv496303_ex10-3.htm" style="-sec-extract: exhibit">Common Stock Purchase Warrant issued on June 6, 2018 to L2 Capital, LLC, which was filed as Exhibit 10.3 to our Current Report on Form 8-K filed on June 12, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418035163/tv496946_ex10-4.htm" style="-sec-extract: exhibit">Common Stock Purchase Warrant issued on June 15, 2018 to Strome Mezzanine Fund LP, which was filed as Exhibit 10.4 to our Current Report on Form 8-K filed on June 21, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418055146/tv505297_ex10-3.htm" style="-sec-extract: exhibit">Form of Common Stock Purchase Warrant issued on October 18, 2018, which was filed as Exhibit 10.3 to our Current Report on Form 8-K filed on October 24, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420417026149/v463892_ex4-3.htm" style="-sec-extract: exhibit">Form of Warrant for Channel Partners Program, which was filed as Exhibit 4.3 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420416131889/v452130_ex10-3.htm" style="-sec-extract: exhibit">Form of MDB Warrant issued in connection with the Share Exchange Agreement, which was filed as Exhibit 10.3 to our Current Report on Form 8-K, filed on November 7, 2016.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221019973/ex4-16.htm" style="-sec-extract: exhibit">Common Stock Purchase Warrant (exercise price $0.42 per share), dated June 14, 2019, issued to ABG-SI LLC, which was filed as Exhibit 4.16 to our Annual Report on Form 10-K, filed on August 16, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221000653/ex4-17.htm" style="-sec-extract: exhibit">Common Stock Purchase Warrant (exercise price $0.84 per share), dated June 14, 2019, issued to ABG-SI LLC, which was filed as Exhibit 4.17 to our Annual Report on Form 10-K filed on January 8, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221008388/ex4-18.htm" style="-sec-extract: exhibit">Form of 2019 Warrant for Channel Partners Program, which was filed as Exhibit 4.18 to our Annual Report on Form 10-K filed on April 9, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221008388/ex4-19.htm" style="-sec-extract: exhibit">Form of 2020 Warrant for Channel Partners Program, which was filed as Exhibit 4.19 to our Annual Report on Form 10-K filed on April 9, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315222036014/ex4-1.htm" style="-sec-extract: exhibit">Form of Bridge Notes. which was filed as Exhibit 4.1 to our Current Report on Form 8-K filed on December 20, 2022.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">4.19</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223041192/ex4-1.htm" style="-sec-extract: exhibit">Form of 2023 Notes, which was filed as Exhibit 4.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 14, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-20.htm">Description of Securities.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418000929/tv482764_ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated January 4, 2018, by and between the Company and certain investors named therein, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on January 5, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418000929/tv482764_ex10-2.htm" style="-sec-extract: exhibit">Registration Rights Agreement, dated January 4, 2018, by and between the Company and certain investors named therein, which was filed as Exhibit 10.2 to our Current Report on Form 8-K filed on January 5, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221000653/ex10-11.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated March 30, 2018, by and among the Company and certain investors named therein, which was filed as Exhibit 10.11 to our Annual Report on Form 10-K filed on January 8, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221000653/ex10-12.htm" style="-sec-extract: exhibit">Registration Rights Agreement, dated March 30, 2018, by and among the Company and certain investors named therein, which was filed as Exhibit 10.12 to our Annual Report on Form 10-K filed on January 8, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418035163/tv496946_ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated June 15, 2018, between the Company and each purchaser named therein, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on June 21, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418035163/tv496946_ex10-3.htm" style="-sec-extract: exhibit">Registration Rights Agreement, dated June 15, 2018, by and between the Company and each purchaser named therein, which was filed as Exhibit 10.3 to our Current Report on Form 8-K filed on June 21, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418043618/tv500678_ex10-1.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement, dated as of August 9, 2018, by and between the Company and each purchaser named therein, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on August 10, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418043618/tv500678_ex10-2.htm" style="-sec-extract: exhibit">Form of Registration Rights Agreement, dated as of August 9, 2018, by and between the Company and each purchaser named therein, which was filed as Exhibit 10.2 to our Current Report on Form 8-K filed on August 10, 2018.</a></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 46; Value: 44 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418055146/tv505297_ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated October 18, 2018, by and between the Company and each investor named therein, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on October 24, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418064480/tv509108_ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated December 12, 2018, by and between the Company and each investor named therein, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on December 13, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420418064480/tv509108_ex10-3.htm" style="-sec-extract: exhibit">Registration Rights Agreement, dated December 12, 2018, by and between the Company and each investor named therein, which was filed as Exhibit 10.3 to our Current Report on Form 8-K filed on December 13, 2018.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420419015417/tv516833_ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated March 18, 2019, by and between the Company and each investor named therein, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on March 22, 2019.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420419015417/tv516833_ex10-3.htm" style="-sec-extract: exhibit">Registration Rights Agreement, dated March 18, 2019, by and between the Company and each investor named therein, which was filed as Exhibit 10.3 to our Current Report on Form 8-K filed on March 22, 2019.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420419016657/tv517346_ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated March 27, 2019, by and between the Company and each investor named therein, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on March 28, 2019.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420419016657/tv517346_ex10-3.htm" style="-sec-extract: exhibit">Registration Rights Agreement, dated March 27, 2019, by and between the Company and each investor named therein, which was filed as Exhibit 10.3 to our Current Report on Form 8-K filed on March 28, 2019.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420419019438/tv518727_ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated April 8, 2019, by and between the Company and each investor named therein, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on April 12, 2019.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420419019438/tv518727_ex10-3.htm" style="-sec-extract: exhibit">Registration Rights Agreement, dated April 8, 2019, by and between the Company and each investor named therein, which was filed as Exhibit 10.3 to our Current Report on Form 8-K filed on April 12, 2019.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420419030656/tv523376_ex10-5.htm" style="-sec-extract: exhibit">Pledge and Security Agreement, dated June 10, 2019, by and among the Company, Maven Coalition, Inc., HubPages, Inc., Say Media, Inc., TST Acquisition Co., Inc., and the investor named therein, which was filed as Exhibit 10.5 to our Current Report on Form 8-K filed on June 12, 2019.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420419031484/tv523829_ex10-3.htm" style="-sec-extract: exhibit">Confirmation and Ratification Agreement, dated June 14, 2019, by and among the Company, Maven Coalition, Inc., HubPages, Inc., Say Media, Inc., TST Acquisition Co., Inc., and the investor named therein, which was filed as Exhibit 10.3 to our Current Report on Form 8-K filed on June 19, 2019.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420419033779/tv524772_ex10-1.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement, dated as of June 28, 2019, by and among the Company and each of the several purchasers named thereto, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on July 3, 2019.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420419033779/tv524772_ex10-2.htm" style="-sec-extract: exhibit">Form of Registration Rights Agreement, dated as of June 28, 2019, by and among the Company and each of the several purchasers named thereto, which was filed as Exhibit 10.2 to our Current Report on Form 8-K filed on July 3, 2019.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315219013606/ex10-2.htm" style="-sec-extract: exhibit">Form of Second Amended and Restated Promissory Note due June 14, 2022, which was filed as Exhibit 10.2 to our Current Report on Form 8-K filed on September 3, 2019.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315219015412/ex10-1.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement, dated as of October 7, 2019, by and among the Company and each of the several purchasers named therein, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on October 11, 2019.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315219015412/ex10-2.htm" style="-sec-extract: exhibit">Form of Registration Rights Agreement, dated as of October 7, 2019, by and among the Company and each of the several purchasers named therein, which was filed as Exhibit 10.2 to our Current Report on Form 8-K filed on October 11, 2019.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315222036014/ex10-1.htm" style="-sec-extract: exhibit">Third Amended and Restated Note Purchase Agreement, dated December 15, 2022, by and among the Company, the subsidiary guarantors party thereto, BRF Finance Co., LLC, as agent and purchaser, and the other purchasers from time to time party thereto, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on December 20, 2022.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315222036014/ex10-2.htm" style="-sec-extract: exhibit">Sixth Amendment to Financing and Security Agreement, dated December 15, 2022, by and among the Company, the subsidiaries of the Company party thereto and SLR Digital Finance LLC, which was filed as Exhibit 10.2 to our Current Report on Form 8-K filed on December 20, 2022.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315220005077/ex10-2.htm" style="-sec-extract: exhibit">Form of 15% Delayed Draw Term Note, issued on March 24, 2020, which was filed as Exhibit 10.2 to our Current Report on Form 8-K filed on March 30, 2020.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315220016418/ex10-1.htm" style="-sec-extract: exhibit">Form of Series H Securities Purchase Agreement, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on August 20, 2020.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221019973/ex10-51.htm" style="-sec-extract: exhibit">Sublease, dated January 14, 2020, by and between Saks &amp; Company LLC and Maven Coalition, Inc., which was filed as Exhibit 10.51 to our Annual Report on Form 10-K filed on August 16, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221019973/ex10-54.htm" style="-sec-extract: exhibit">Office Lease Agreement, dated October 25, 2019, by and between Street Retail West I, LP and the Company, which was filed as Exhibit 10.54 to our Annual Report on Form 10-K filed on August 16, 2021.</a></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 47; Value: 44 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221019973/ex10-59.htm" style="-sec-extract: exhibit">Asset Purchase Agreement, dated March 9, 2020, by and among Maven Coalition, Inc., Petametrics Inc., doing business as LiftIgniter, and the Company, which was filed as Exhibit 10.59 to our Annual Report on Form 10-K filed on August 16, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221019973/ex10-62.htm" style="-sec-extract: exhibit">Form of Stock Option Award Agreement &#8211; 2016 Stock Incentive Plan, which was filed as Exhibit 10.62 to our Annual Report on Form 10-K filed on August 16, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.33+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221019973/ex10-63.htm" style="-sec-extract: exhibit">Form of Stock Option Award Agreement &#8211; 2019 Equity Incentive Plan, which was filed as Exhibit 10.63 to our Annual Report on Form 10-K filed on August 16, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.34+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221019973/ex10-71.htm" style="-sec-extract: exhibit">Independent Director Agreement, effective as of September 3, 2018, by and between the Company and Todd D. Sims, which was filed as Exhibit 10.71 to our Annual Report on Form 10-K filed on August 16, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.35+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221019973/ex10-80.htm" style="-sec-extract: exhibit">First Amendment to the 2016 Stock Incentive Plan, which was filed as Exhibit 10.80 to our Annual Report on Form 10-K filed on August 16, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.36+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221019973/ex10-81.htm" style="-sec-extract: exhibit">Second Amendment to the 2016 Stock Incentive Plan, which was filed as Exhibit 10.81 to our Annual Report on Form 10-K filed on August 16, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.37+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221019973/ex10-82.htm" style="-sec-extract: exhibit">Form of Restricted Equity Award Grant Notice &#8211; 2019 Equity Incentive Plan, which was filed as Exhibit 10.82 to our Annual Report on Form 10-K filed on August 16, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.38+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221019973/ex10-83.htm" style="-sec-extract: exhibit">Form of Restricted Stock Unit Grant Notice &#8211; 2019 Equity Incentive Plan, which was filed as Exhibit 10.83 to our Annual Report on Form 10-K filed on August 16, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.39+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221019973/ex10-84.htm" style="-sec-extract: exhibit">Stock Option Award Agreement, dated March 11, 2019, by and between the Company and Douglas B. Smith, which was filed as Exhibit 10.84 to our Annual Report on Form 10-K filed on August 16, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.40+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221019973/ex10-85.htm" style="-sec-extract: exhibit">Stock Option Award Agreement, dated March 11, 2019, by and between the Company and Douglas B. Smith, which was filed as Exhibit 10.85 to our Annual Report on Form 10-K filed on August 16, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.41</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221008388/ex10-112.htm" style="-sec-extract: exhibit">Channel Partners Warrant Program adopted on May 20, 2020, which was filed as Exhibit 10.112 to our Annual Report on Form 10-K filed on April 9, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.42+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221008388/ex10-119.htm" style="-sec-extract: exhibit">Stock Option Award Agreement, dated January 16, 2019, by and between the Company and Andrew Q. Kraft, which was filed as Exhibit 10.119 to our Annual Report on Form 10-K filed on April 9, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.43+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221008388/ex10-120.htm" style="-sec-extract: exhibit">Stock Award Agreement, dated January 16, 2019, by and between the Company and Andrew Q. Kraft, which was filed as Exhibit 10.120 to our Annual Report on Form 10-K filed on April 9, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.44+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221001014/ex10-1.htm" style="-sec-extract: exhibit">Maven Executive Bonus Plan, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on January 14, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.45</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221008388/ex10-122.htm" style="-sec-extract: exhibit">Amendment No. 1 to Agreement and Plan of Merger, dated July 12, 2019, by and among the Company, TheStreet, Inc., and TST Acquisition Co., Inc., which was filed as Exhibit 10.122 to our Annual Report on Form 10-K filed on April 9, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.46+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221004575/ex10-4.htm" style="-sec-extract: exhibit">Executive Employment Agreement, effective January 1, 2021, by and between the Company and Paul Edmondson, which was filed as Exhibit 10.4 to our Current Report on Form 8-K on February 23, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.47+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221004575/ex10-2.htm" style="-sec-extract: exhibit">Amended and Restated Executive Employment Agreement, effective January 1, 2021, by and between the Company and Douglas B. Smith, which was filed as Exhibit 10.2 to our Current Report on Form 8-K on February 23, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.48+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221008388/ex10-127.htm" style="-sec-extract: exhibit">Stock Option Grant Notice, dated April 10, 2019, by and between the Company and Paul Edmondson, which was filed as Exhibit 10.127 to our Annual Report on Form 10-K filed on April 9, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.49+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221008388/ex10-130.htm" style="-sec-extract: exhibit">Stock Option Grant Notice, dated April 10, 2019, by and between the Company and Douglas Smith, which was filed as Exhibit 10.130 to our Annual Report on Form 10-K filed on April 9, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.50+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221008388/ex10-131.htm" style="-sec-extract: exhibit">Form of Amendment to Stock Option Award Agreement, by and between the Company and certain grantees awarded stock options on April 10, 2019, which was filed as Exhibit 10.131 to our Annual Report on Form 10-K filed on April 9, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.51+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221004575/ex10-3.htm" style="-sec-extract: exhibit">Executive Employment Agreement, effective as of February 18, 2021, by and between the Company and Robertson Barrett, which was filed as Exhibit 10.3 to our Current Report on Form 8-K on February 23, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.52</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221008388/ex10-134.htm" style="-sec-extract: exhibit">Services Agreement, dated as of December 22, 2020, by and between the Company and Whisper Advisors, LLC, which was filed as Exhibit 10.134 to our Annual Report on Form 10-K on April 9, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.53+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221008388/ex10-135.htm" style="-sec-extract: exhibit">Stock Option Award Agreement, dated September 14, 2018, by and between the Company and Paul Edmondson, which was filed as Exhibit 10.135 to our Annual Report on Form 10-K on April 9, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.54+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221004575/ex10-6.htm" style="-sec-extract: exhibit">Amended and Restated Executive Employment Agreement, effective January 1, 2021, by and between the Company and Andrew Kraft, which was filed as Exhibit 10.6 to our Current Report on Form 8-K on February 23, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.55+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221004575/ex10-7.htm" style="-sec-extract: exhibit">Second Amended and Restated Executive Employment Agreement, effective January 1, 2021, by and between the Company and Avi Zimak, which was filed as Exhibit 10.7 to our Current Report on Form 8-K on February 23, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.56+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221004725/ex10-1.htm" style="-sec-extract: exhibit">Second Amendment to theMaven, Inc.&#8217;s 2019 Equity Incentive Plan, dated February 18, 2021, which was filed as Exhibit 10.1 to our Current Report on Form 8-K on February 24, 2021.</a></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 48; Value: 44 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.57+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221008388/ex10-141.htm" style="-sec-extract: exhibit">First Amendment to theMaven, Inc.&#8217;s 2019 Equity Incentive Plan, dated March 16, 2020, which was filed as Exhibit 10.141 to our Annual Report on Form 10-K on April 9, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.58+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221008388/ex10-142.htm" style="-sec-extract: exhibit">2019 Equity Incentive Plan, which was filed as Exhibit 10.142 to our Annual Report on Form 10-K on April 9, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.59</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000114420417026149/v463892_ex4-4.htm" style="-sec-extract: exhibit">2016 Stock Incentive Plan, which was filed as Exhibit 4.4 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.60</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221010779/ex10-8.htm" style="-sec-extract: exhibit">Financing and Security Agreement, dated February 2020, by and among Maven Coalition, Inc., theMaven, Inc., Maven Media Brands, LLC, TheStreet, Inc., and FPP Finance LLC, which was filed as Exhibit 10.8 to our Quarterly Report on Form 10-Q on May 7, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.61</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221010779/ex10-9.htm" style="-sec-extract: exhibit">First Amendment to Financing and Security Agreement, dated March 24, 2020, by and among Maven Coalition, Inc., theMaven, Inc., Maven Media Brands, LLC, TheStreet, Inc., and FPP Financing LLC, which was filed as Exhibit 10.9 to our Quarterly Report on Form 10-Q on May 7, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.62</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221010779/ex10-10.htm" style="-sec-extract: exhibit">Intercreditor Agreement, dated February 24, 2020, by and between FPP Finance LLC and BRF Finance Co., LLC, which was filed as Exhibit 10.10 to our Quarterly Report on Form 10-Q on May 7, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.63</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221010779/ex10-11.htm" style="-sec-extract: exhibit">Amendment No. 1 to Intercreditor Agreement, dated March 24, 2020, by and between FPP Finance LLC and BRF Finance Co., LLC, which was filed as Exhibit 10.11 to our Quarterly Report on Form 10-Q on May 7, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.64</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221012876/ex10-2.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement among the Company and each of the several purchasers signatory thereto, which was filed as Exhibit 10.2 to our Current Report on Form 8-K on May 25, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.65</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221012876/ex10-3.htm" style="-sec-extract: exhibit">Form of Registration Rights Agreement among the Company and each of the several purchasers signatory thereto, which was filed as Exhibit 10.3 to our Current Report on Form 8-K on May 25, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.66</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221013703/ex10-1.htm" style="-sec-extract: exhibit">Stock Purchase Agreement, dated June 4, 2021, by and among the Company, Maven Media Brands, LLC, College Spun Media Incorporated, Matthew Lombardi, Alyson Shontell Lombardi, Timothy Ray, Andrew Holleran, and the Representative, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on June 7, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.67</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221004575/ex10-1.htm" style="-sec-extract: exhibit">Second Amended and Restated Executive Employment Agreement, effective August 26, 2020, by and between the Company and Ross Levinsohn, which was filed as Exhibit 10.1 to our Current Report on Form 8-K on February 23, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.68</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221031084/ex10-1.htm" style="-sec-extract: exhibit">Third Amendment to Financing and Security Agreement, dated as of December 6, 2021, by and among theMaven, Inc., Maven Coalition, Inc., Maven Media Brands, LLC, TheStreet, Inc., College Spun Media Incorporated, and Fast Pay Partners LLC, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on December 10, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.69+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315222000850/ex10-2.htm" style="-sec-extract: exhibit">Amendment No. 1 to Second Amended &amp; Restated Executive Employment Agreement, dated as of December 22, 2021, by and between the Company and Ross Levinsohn, which was filed as Exhibit 10.2 to our Current Report on Form 8-K filed on January 10, 2022.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.70</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315222002573/ex10-1.htm" style="-sec-extract: exhibit">Form of Stock Purchase Agreement by and between the Company and certain investors, which was filed as Exhibit 10.1 to our Current Report on Form 8-K filed on January 28, 2022.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.71</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315221028521/ex10-5.htm" style="-sec-extract: exhibit">Asset Purchase Agreement between the Company and Fulltime Fantasy Sports, LLC, dated July 15, 2021, which was filed as Exhibit 10.5 to our Quarterly Report on Form 10-Q on November 15, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.72&#x5E;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315222033922/ex10-1.htm" style="-sec-extract: exhibit">Amended Licensing Agreement by and between the Company and ABG-SI LLC, which was filed as Exhibit 10.1 to our Current Report on Form 8-K/A filed on November 29, 2022.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.73&#x5E;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223009914/ex10-73.htm" style="-sec-extract: exhibit">Amendment No. 5 to Licensing Agreement by and between the Company and ABG-SI LLC, which was filed as Exhibit 10.73 to our Annual Report on Form 10-K filed on March 31, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.74</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223009930/ex10-1.htm" style="-sec-extract: exhibit">Form of Common Stock Purchase Agreement, which was filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on March 31, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.75+</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223019985/ex10-1.htm" style="-sec-extract: exhibit">Amended and Restated 2022 Stock and Incentive Compensation Plan, which was filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on June 2, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.76</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223041192/ex10-1.htm" style="-sec-extract: exhibit">Binding Letter of Intent, dated August 14, 2023, by and between the Company and Simplify Inventions, LLC, which was filed as Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 14, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.77</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223041192/ex10-2.htm" style="-sec-extract: exhibit">Form of Voting and Support Agreement, dated August 14, 2023, by and between the Company and certain stockholders. which was filed as Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 14, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.78</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223041192/ex10-3.htm" style="-sec-extract: exhibit">Amendment to Third Amended and Restated Note Purchase Agreement, dated August 14, 2023, by and between the Company, the subsidiary guarantors party thereto, BRF Finance Co., LLC, as agent and purchaser, and the other purchasers from time to time party thereto, which was filed as Exhibit 10.3 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 14, 2023.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.79+</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223041192/ex10-4.htm" style="-sec-extract: exhibit">Amendment No. 3 to Second Amended &amp; Restated Executive Employment Agreement, dated as of September 7, 2023, by and between the Company and Ross Levinsohn, which was filed as Exhibit 10.4 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 14, 2023.</a></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 49; Value: 44 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">10.80+</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223041192/ex10-5.htm" style="-sec-extract: exhibit">First Amendment to Executive Employment Agreement, dated August 15, 2023, by and between the Company and Henry Robertson Barrett, which was filed as Exhibit 10.5 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 14, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.81+</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223041192/ex10-6.htm" style="-sec-extract: exhibit">Severance Agreement, dated August 14, 2023, by and between the Company and Henry Robertson Barrett, which was filed as Exhibit 10.6 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 14, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.82+</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223041192/ex10-7.htm" style="-sec-extract: exhibit">Severance Agreement, dated August 14, 2023, by and between the Company and Douglas B. Smith, which was filed as Exhibit 10.7 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 14, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.83</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223041192/ex10-8.htm" style="-sec-extract: exhibit">Seventh Amendment to Financing and Security Agreement, dated August 31, 2023, by and among the Company, certain subsidiaries of the Company party thereto and SLR Digital Finance LLC, which was filed as Exhibit 10.8 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 14, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.84</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223041192/ex10-9.htm" style="-sec-extract: exhibit">Side Letter to Licensing Agreement, dated October 1, 2023, by and between the Company and ABG-SI LLC, which was filed as Exhibit 10.9 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 14, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.85</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223039749/ex10-1.htm" style="-sec-extract: exhibit">Common Stock Subscription Agreement, dated as of November 5, 2023, between New Arena Holdco, Inc. and 5-Hour International Corporation Pte. Ltd. , which was filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November 7, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.86#</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223039749/ex10-2.htm" style="-sec-extract: exhibit">Preferred Stock Subscription Agreement, dated as of November 5, 2023, between New Arena Holdco, Inc. and The Hans Foundation USA, which was filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on November 7, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.87</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223043697/ex10-2.htm" style="-sec-extract: exhibit">Amendment No. 2 to Third Amended and Restated Note Purchase Agreement, dated December 1, 2023, by and between the Company, the subsidiary guarantors party thereto, BRF Finance Co., LLC, as agent and purchaser, and the other purchasers from time to time party thereto, which was filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on December 5, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.88</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315223043697/ex10-3.htm" style="-sec-extract: exhibit">Waiver of Liquidated Damages and Release of Claims, dated December 1, 2023, by and among the Company, Simplify Inventions, LLC and B. Riley Principal Investments, LLC, which was filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on December 5, 2023.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.89</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315224001619/ex10-4.htm" style="-sec-extract: exhibit">Forbearance Letter, which was filed as Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed on January 5, 2024.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.90</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/894871/000149315224006754/ex10-1.htm" style="-sec-extract: exhibit">Subscription Agreement, dated February 14, 2024, by and between the Company and Simplify, which was filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 14, 2024.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.91*</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-91.htm">Forbearance Letter <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">between
<span>the </span>Company and Renew Group Private Limited dated as of March 27<span>,
2024.</span></span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex21-1.htm">Subsidiaries of the Arena Group Holdings, Inc.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex23-1.htm">Consent of Marcum LLP, independent registered accounting firm.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_002">Power of Attorney (included in the signature pages hereto)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex31-1.htm">Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex31-2.htm">Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-1.htm">Certification of Chief Executive Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-2.htm">Certification of Chief Financial Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex97-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clawback Policy of Arena Group Holdings, Inc<span style="line-height: 115%">.</span></span></a></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS
    Inline XBRL*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Instance
    Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH
    Inline XBRL*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxonomy
    Extension Schema Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL
    Inline XBRL*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxonomy
    Extension Calculation Linkbase Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF
    Inline XBRL*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxonomy
    Extension Definition Linkbase Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB
    Inline XBRL*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxonomy
    Extension Label Linkbase Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE
    Inline XBRL*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxonomy
    Presentation Linkbase Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data (embedded within the Inline XBRL document and contained in Exhibit 101)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 50; Value: 44 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    Herewith</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    certification is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange
    Act&#8221;), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing
    under the Securities Act of 1933, as amended, or the Exchange Act.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. Registrant agrees to furnish supplementally
    a copy of any omitted schedule or exhibit to the SEC upon request.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#x5E;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant
    has omitted portions of the exhibit as permitted under Item 601(b)(10) of Regulations S-K.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates
                                            a management or compensatory plan or arrangement in which directors or executive officers
                                            are eligible to participate.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Annual Report on Form 10-K and are not deemed
    &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall
    they be deemed incorporated by reference into any filing under the Securities Act of the Exchange Act.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits.
    See Item 15(a) above.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
ARENA GROUP HOLDINGS, INC. AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Annual
Report on Form 10-K</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Schedule
II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Valuation
of Qualifying Accounts</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Years
Ended December 31, 2023 and 2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>($
in thousands)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Additions</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balances at<br/>
 Beginning<br/>
 of Year</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Charge to<br/>
 Costs and<br/>
 Expenses</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Other</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deductions<br/>
 from<br/>
 Reserves</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Balances at</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">End of Year</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="text-decoration: underline">2023</span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 35%; text-align: left">Allowance for doubtful accounts receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,236</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">315</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,570</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">981</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Valuation allowances for deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,406</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,961</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">76,367</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; font-weight: bold; text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Allowance for doubtful accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,578</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">658</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,236</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Valuation allowances for deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,447</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,959</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,406</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="K_022"></span>Item
16. Form 10&#8211;K Summary</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 51; Value: 44 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sw_001"></span>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has caused this Annual
Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
    Arena Group Holdings, Inc.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    April 1, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    CAVITT RANDALL</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cavitt
                                            Randall</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    DOUGLAS B. SMITH</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas
                                            B. Smith</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sw_002"></span>Power
of Attorney</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNOW
ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Cavitt Randall and Douglas B.
Smith, jointly and severally, as his or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities,
to sign any amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection
therewith, with the U.S. Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact,
or his substitute or substitutes, may do or cause to be done by virtue hereof</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, this Annual Report on Form 10-K has been signed below by the
following persons on behalf of the Registrant and in the capacities indicated and on the dates indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    CAVITT RANDALL</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Chairman of the Board</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cavitt
    Randall</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 1, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    DOUGLAS B. SMITH</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas
    B. Smith</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 1, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    H. HUNT ALLRED</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.
    Hunt Allred</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 1, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    CARLO ZOLA</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carlo
    Zola</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 1, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    CHRISTOPHER PETZEL</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher
    Petzel</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 1, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    LAURA LEE</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
    Laura Lee</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 1, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    CHRISTOPHER FOWLER</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher
    Fowler</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 1, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 52; Value: 44 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Arena Group Holdings, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Index
to Consolidated Financial Statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.1in">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PAGE</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><a href="#F_015">Report of Independent Registered Public Accounting Firm</a></span> (PCAOB ID NO: <span id="xdx_908_edei--AuditorFirmId_c20230101__20231231_zLYGDntNc1Tf"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000047" name="dei:AuditorFirmId">688</ix:nonNumeric></span>)</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#F_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Consolidated Balance Sheets as of December 31, 2023 and 2022 </span></span></a></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#F_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Consolidated Statements of Operations for the Years Ended December 31, 2023 and 2022</span></span></a></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#F_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Consolidated Statements of Stockholders&#8217; Deficiency for the Years Ended December 31, 2023 and 2022</span></span></a></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#F_020"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Consolidated Statements of Cash Flows for the Years Ended December 31, 2023 and 2022</span></span></a></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#F_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Notes to Consolidated Financial Statements</span></span></a></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-8</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 53; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F_015"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Shareholders and Board of Directors of</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Arena Group Holdings, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of The Arena Group Holdings, Inc. and Subsidiaries (the &#8220;Company&#8221;)
as of December 31, 2023 and 2022, the related consolidated statements of operations, stockholders&#8217; deficiency and cash flows for
each of the two years in the period ended December 31, 2023, and the related notes (collectively referred to as the &#8220;financial
statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the
Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the two years in the period
ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Explanatory
Paragraph &#8211; Going Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As more
fully described in Note 1, the Company has a significant working capital deficiency, has incurred significant losses and may need to restructure its debt to meet its obligations and sustain its operations. These conditions raise substantial doubt about the Company&#8217;s
ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 1. The consolidated
financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent
with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities
and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our audits
included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud,
and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts
and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates
made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a
reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Audit Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical audit matters are matters arising from the current period audit of the financial statements that were communicated
or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial
statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Marcum <span style="font-variant: small-caps">llp</span></i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--AuditorName_c20230101__20231231_zGyJuWXvgESc"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000048" name="dei:AuditorName">Marcum
    LLP</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--AuditorLocation_c20230101__20231231_zXTSLtGW3tlk"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000049" name="dei:AuditorLocation">New York, NY</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">April 1, 2024</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
ARENA GROUP HOLDINGS, INC. AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F_016"></span>CONSOLIDATED
BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_111_pn3n3_zXS6Itt2v84c" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_494_20231231_z6BNjZJ7PYuf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20221231_z6BO1S91FsGj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-style: italic">&#160;</td>
    <td colspan="6" style="font-style: italic; text-align: center">($ in thousands, except share data)</td><td style="font-style: italic">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsAbstract_iB_zVhjXhG8KN93" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AssetsCurrentAbstract_i01B_zmStJ7YaaQy" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maACzZE4_zYyOgRgVfaY3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact000057" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,284</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31" id="Fact000058" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,871</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RestrictedCashCurrent_i02I_maACzZE4_zReSEsQcTNm6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Restricted cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0060">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RestrictedCashCurrent" contextRef="AsOf2022-12-31" id="Fact000061" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">502</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccountsReceivableNetCurrent_i02I_maACzZE4_zXSob40OuQZ2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-12-31" id="Fact000063" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,811</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-12-31" id="Fact000064" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,950</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CapitalizedContractCostNetCurrent_i02I_maACzZE4_z7cvcIJ30A4i" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Subscription acquisition costs, current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedContractCostNetCurrent" contextRef="AsOf2023-12-31" id="Fact000066" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,706</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedContractCostNetCurrent" contextRef="AsOf2022-12-31" id="Fact000067" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,931</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maACzZE4_zKztWAOnCMbb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Prepayments and other current assets</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-12-31" id="Fact000069" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,598</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-12-31" id="Fact000070" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,441</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AssetsCurrent_i02TI_mtACzZE4_maAzAbd_zKkIIlwdn2s1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0pt; text-align: left">Total current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31" id="Fact000072" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90,399</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31" id="Fact000073" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">78,695</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maAzAbd_zuugC5pb3Um4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31" id="Fact000075" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">328</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31" id="Fact000076" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">735</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maAzAbd_zgs0zoilboMj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating lease right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-12-31" id="Fact000078" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">176</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-12-31" id="Fact000079" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">372</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--PlatformDevelopmentNet_i01I_maAzAbd_zglWFMr6DUr6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Platform development, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:PlatformDevelopmentNet" contextRef="AsOf2023-12-31" id="Fact000081" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,723</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:PlatformDevelopmentNet" contextRef="AsOf2022-12-31" id="Fact000082" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,330</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CapitalizedContractCostNetNoncurrent_i01I_maAzAbd_zDqPx76bEmFa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Subscription acquisition costs, net of current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedContractCostNetNoncurrent" contextRef="AsOf2023-12-31" id="Fact000084" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,215</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedContractCostNetNoncurrent" contextRef="AsOf2022-12-31" id="Fact000085" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,133</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OtherIntangibleAssetsNet_i01I_maAzAbd_z8ek2YYMogb1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Acquired and other intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2023-12-31" id="Fact000087" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,459</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2022-12-31" id="Fact000088" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58,970</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OtherAssetsNoncurrent_i01I_maAzAbd_zcAaa6atKWbb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other long-term assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2023-12-31" id="Fact000090" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,003</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2022-12-31" id="Fact000091" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,140</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Goodwill_i01I_maAzAbd_zrJ5ot45Ksyl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Goodwill</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-12-31" id="Fact000093" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42,575</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-12-31" id="Fact000094" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39,344</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Assets_i01TI_mtAzAbd_zmOeKjuCGsq6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total assets</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-12-31" id="Fact000096" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">188,878</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31" id="Fact000097" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">203,719</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zVP392K9St1k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Liabilities, mezzanine equity and stockholders&#8217; deficiency</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesCurrentAbstract_i01B_zV1Uu1wG2lc2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccountsPayableCurrent_i02I_maLCzll9_zowBIUMsjKng" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-12-31" id="Fact000105" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,357</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-12-31" id="Fact000106" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,863</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AccruedLiabilitiesCurrent_i02I_maLCzll9_zYI1SRqFH937" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accrued expenses and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000108" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,771</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31" id="Fact000109" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,102</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LinesOfCreditCurrent_i02I_maLCzll9_z1pqDAjPgomc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Line of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LinesOfCreditCurrent" contextRef="AsOf2023-12-31" id="Fact000111" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,609</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LinesOfCreditCurrent" contextRef="AsOf2022-12-31" id="Fact000112" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,092</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ContractWithCustomerLiabilityCurrent_i02I_maLCzll9_z717NJLndpb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2023-12-31" id="Fact000114" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59,786</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2022-12-31" id="Fact000115" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58,703</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ContractWithCustomerRefundLiabilityCurrent_i02I_maLCzll9_zPjgtr1o05Zf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Subscription refund liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" contextRef="AsOf2023-12-31" id="Fact000117" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">449</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" contextRef="AsOf2022-12-31" id="Fact000118" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">845</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maLCzll9_zJYmY2OWbjK3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-12-31" id="Fact000120" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">358</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-12-31" id="Fact000121" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">427</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AssetAcquisitionContingentConsiderationLiabilityCurrent_i02I_maLCzll9_zVz6DShg4QYj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Contingent consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent" contextRef="AsOf2023-12-31" id="Fact000123" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,571</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0124">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--LiquidatedDamagesPayableCurrent_i02I_maLCzll9_zpLpbn7Dcmde" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Liquidated damages payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrent" contextRef="AsOf2023-12-31" id="Fact000126" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,924</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrent" contextRef="AsOf2022-12-31" id="Fact000127" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,843</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--BridgeNotes_i02I_maLCzll9_zuwN1JBgW5a4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Bridge notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:BridgeNotes" contextRef="AsOf2023-12-31" id="Fact000129" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,887</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:BridgeNotes" contextRef="AsOf2022-12-31" id="Fact000130" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,805</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LongTermDebtCurrent_i02I_maLCzll9_zx1iufhBZipf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"> Debt</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2023-12-31" id="Fact000132" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102,309</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2022-12-31" id="Fact000133" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">65,684</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesCurrent_i02TI_mtLCzll9_maLzO5v_zvaPulJ2NTtf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000135" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">236,021</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31" id="Fact000136" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">216,364</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ContractWithCustomerLiabilityNoncurrent_i01I_maLzO5v_zxjVZHUr6u29" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Unearned revenue, net of current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="AsOf2023-12-31" id="Fact000138" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,679</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="AsOf2022-12-31" id="Fact000139" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,701</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maLzO5v_zGQDX9ypI91i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating lease liability, net of current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0141">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-12-31" id="Fact000142" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">358</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--LiquidatingDamagesPayableNonCurrent_i01I_maLzO5v_znoe7couoE3i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Liquidating damages payable, net of current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0144">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:LiquidatingDamagesPayableNonCurrent" contextRef="AsOf2022-12-31" id="Fact000145" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">494</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherLiabilitiesNoncurrent_i01I_maLzO5v_zp55h7va4GWd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other long-term liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-12-31" id="Fact000147" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">406</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2022-12-31" id="Fact000148" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,307</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAndOtherLiabilitiesNoncurrent_i01I_maLzO5v_zmIv44qw6uck" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">Deferred tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" contextRef="AsOf2023-12-31" id="Fact000150" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">599</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" contextRef="AsOf2022-12-31" id="Fact000151" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">465</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--Liabilities_i01TI_mtLzO5v_maLASEzb6C_zl3DKdCoQoM1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-12-31" id="Fact000153" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">247,705</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31" id="Fact000154" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">242,689</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzb6C_z4VmIAXzPGN6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Commitments and contingencies (Note 27)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0156">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0157">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--TemporaryEquityAbstract_i01B_zrNat0ST1jbk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Mezzanine equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i01I_hus-gaap--StatementClassOfStockAxis__custom--SeriesGRedeemableAndConvertiblePreferredStockMember_zS8v3cofsfAg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Series G redeemable and convertible preferred stock, $<span id="xdx_901_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesGRedeemableAndConvertiblePreferredStockMember_zuUKXHE9YQY1" title="Temporary equity, par value"><span id="xdx_908_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesGRedeemableAndConvertiblePreferredStockMember_zneBuLkytbm2" title="Temporary equity, par value"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000165" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000167" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></ix:nonFraction></span></span> par value, $<span id="xdx_900_eus-gaap--TemporaryEquityLiquidationPreferencePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesGRedeemableAndConvertiblePreferredStockMember_zWgZNuD210j6" title="Temporary equity, liquidation preference per share value"><span id="xdx_903_eus-gaap--TemporaryEquityLiquidationPreferencePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesGRedeemableAndConvertiblePreferredStockMember_zEwfjzuhfjqh" title="Temporary equity, liquidation preference per share value"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000169" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" contextRef="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000171" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,000</ix:nonFraction></ix:nonFraction></span></span> per share liquidation value and <span id="xdx_90B_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesGRedeemableAndConvertiblePreferredStockMember_zkEUgoDaQSfa" title="Temporary equity, shares designated"><span id="xdx_90C_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesGRedeemableAndConvertiblePreferredStockMember_zZYMp3QQWwmd" title="Temporary equity, shares designated"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000173" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000175" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,800</ix:nonFraction></ix:nonFraction></span></span> shares designated; aggregate liquidation value: $<span id="xdx_90F_eus-gaap--TemporaryEquityLiquidationPreference_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesGRedeemableAndConvertiblePreferredStockMember_z41WP7QZ2Y1h" title="Temporary equity, liquidation preference value"><span id="xdx_901_eus-gaap--TemporaryEquityLiquidationPreference_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesGRedeemableAndConvertiblePreferredStockMember_zBrb0ZL9OJgh" title="Temporary equity, liquidation preference value"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000177" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000179" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">168</ix:nonFraction></ix:nonFraction></span></span>; Series G shares issued and outstanding: <span id="xdx_909_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesGRedeemableAndConvertiblePreferredStockMember_zTAoohNoRaud" title="Temporary equity, shares issued"><span id="xdx_902_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesGRedeemableAndConvertiblePreferredStockMember_zCH5eBfvppNe" title="Temporary equity, shares issued"><span id="xdx_900_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesGRedeemableAndConvertiblePreferredStockMember_zUMNbowb7ate" title="Temporary equity, shares outstanding"><span id="xdx_900_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesGRedeemableAndConvertiblePreferredStockMember_zC7IJZaghoch" title="Temporary equity, shares outstanding"><span id="xdx_900_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesGRedeemableAndConvertiblePreferredStockMember_zBlEHMW2el1d" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000181" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000183" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000185" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000187" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000189" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">168</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span></span>; common shares issuable upon conversion: <span id="xdx_902_ecustom--TemporaryEquityCommonSharesIssuableUponConversion_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesGRedeemableAndConvertiblePreferredStockMember_zVG5CesjJuZ7" title="Temporary equity, common shares issuable upon conversion"><span id="xdx_901_ecustom--TemporaryEquityCommonSharesIssuableUponConversion_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesGRedeemableAndConvertiblePreferredStockMember_zIVr410aZVMk" title="Temporary equity, common shares issuable upon conversion"><ix:nonFraction name="AREN:TemporaryEquityCommonSharesIssuableUponConversion" contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000191" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="AREN:TemporaryEquityCommonSharesIssuableUponConversion" contextRef="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000193" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,582</ix:nonFraction></ix:nonFraction></span></span> at December 31, 2023 and 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000162" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">168</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember" id="Fact000163" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">168</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i01I_hus-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_ziABoZuQXWu5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Series H convertible preferred stock, $<span id="xdx_905_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHRedeemableAndConvertiblePreferredStockMember_zqAFWQhKgds9" title="Temporary equity, par value"><span id="xdx_90C_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHRedeemableAndConvertiblePreferredStockMember_zH9pzZZVlHdi" title="Temporary equity, par value"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2023-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember" id="Fact000198" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2022-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember" id="Fact000200" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></ix:nonFraction></span></span> par value, $<span id="xdx_904_eus-gaap--TemporaryEquityLiquidationPreferencePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHRedeemableAndConvertiblePreferredStockMember_zpeMKxWImTOf" title="Temporary equity, liquidation preference per share value"><span id="xdx_90F_eus-gaap--TemporaryEquityLiquidationPreferencePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHRedeemableAndConvertiblePreferredStockMember_zllaNHRUpN1e" title="Temporary equity, liquidation preference per share value"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" contextRef="AsOf2023-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember" id="Fact000202" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" contextRef="AsOf2022-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember" id="Fact000204" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,000</ix:nonFraction></ix:nonFraction></span></span> per share liquidation value and <span id="xdx_906_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHRedeemableAndConvertiblePreferredStockMember_z1LwRD080LLc" title="Temporary equity, shares designated"><span id="xdx_909_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHRedeemableAndConvertiblePreferredStockMember_zSozDevWhSj4" title="Temporary equity, shares designated"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2023-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember" id="Fact000206" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2022-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember" id="Fact000208" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,000</ix:nonFraction></ix:nonFraction></span></span> shares designated; aggregate liquidation value: $<span id="xdx_901_eus-gaap--TemporaryEquityLiquidationPreference_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHRedeemableAndConvertiblePreferredStockMember_zR4FyfeZfTu6" title="Temporary equity, liquidation preference value"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="AsOf2023-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember" id="Fact000210" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--TemporaryEquityLiquidationPreference_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHRedeemableAndConvertiblePreferredStockMember_zexcmKP1sbkk" title="Temporary equity, liquidation preference value"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="AsOf2022-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember" id="Fact000212" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,356</ix:nonFraction></span>; Series H shares issued and outstanding: <span id="xdx_906_eus-gaap--TemporaryEquitySharesIssued_iI_pid_dn_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHRedeemableAndConvertiblePreferredStockMember_zSkNjEWskA82" title="Temporary equity, shares issued"><span id="xdx_907_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_dn_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHRedeemableAndConvertiblePreferredStockMember_zqyM7Cg1QUDg" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2023-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember" id="Fact000214" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember" id="Fact000216" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_901_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHRedeemableAndConvertiblePreferredStockMember_zFdGGqV19SEb" title="Temporary equity, shares issued"><span id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHRedeemableAndConvertiblePreferredStockMember_zRXK0zOCtMxd" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2022-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember" id="Fact000218" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember" id="Fact000220" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,356</ix:nonFraction></ix:nonFraction></span></span>; common shares issuable upon conversion: <span id="xdx_906_ecustom--TemporaryEquityCommonSharesIssuableUponConversion_iI_pid_dn_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHRedeemableAndConvertiblePreferredStockMember_zM6jpDZV2Ueb" title="Temporary equity, common shares issuable upon conversion"><ix:nonFraction name="AREN:TemporaryEquityCommonSharesIssuableUponConversion" contextRef="AsOf2023-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember" id="Fact000222" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></span> and <span id="xdx_90B_ecustom--TemporaryEquityCommonSharesIssuableUponConversion_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHRedeemableAndConvertiblePreferredStockMember_zeD0teqceYRc" title="Temporary equity, common shares issuable upon conversion"><ix:nonFraction name="AREN:TemporaryEquityCommonSharesIssuableUponConversion" contextRef="AsOf2022-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember" id="Fact000224" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,981,128</ix:nonFraction></span> at December 31, 2023 and 2022, respectively</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0195">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact000196" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,008</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i01I_maLASEzb6C_zhj2BtutHZN2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total mezzanine equity</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31" id="Fact000226" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">168</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31" id="Fact000227" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,176</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stockholders&#8217; deficiency:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CommonStockValue_i02I_maSEzcYs_zJAi6f39wDje" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Common stock, $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_z9CMiggsufKg" title="Common stock, par value"><span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_z2sXIy67k0pe" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000235" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" id="Fact000237" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></ix:nonFraction></span></span> par value, authorized <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zRMxvND4q0al" title="Common stock, shares authorized"><span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zk5nOmtAULWi" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact000239" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31" id="Fact000241" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000,000</ix:nonFraction></ix:nonFraction></span></span> shares: issued and outstanding; <span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zKlpmOKNZVdc" title="Common stock, shares issued"><span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zJX6yJLRWnRj" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact000243" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact000245" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,836,706</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zAAzIbQjNXq1" title="Common stock, shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zmO5cxYkMh17" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31" id="Fact000247" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31" id="Fact000249" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,303,193</ix:nonFraction></ix:nonFraction></span></span> shares December 31, 2023 and 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31" id="Fact000232" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">237</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31" id="Fact000233" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">182</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--CommonStockToBeIssuedDuringPeriod_i02I_maSEzcYs_zKR9Wu5apdQe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Common stock to be issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0251">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0252">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AdditionalPaidInCapitalCommonStock_i02I_maSEzcYs_z2yptYIdbp8h" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2023-12-31" id="Fact000254" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">319,421</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2022-12-31" id="Fact000255" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">270,743</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzcYs_zhW8Q4fOypNl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accumulated deficit</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31" id="Fact000257" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">378,653</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31" id="Fact000258" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">323,071</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--StockholdersEquity_i02TI_mtSEzcYs_maLASEzb6C_zTjZnbs0bXPj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0pt; text-align: left">Total stockholders&#8217; deficiency</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000260" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">58,995</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" id="Fact000261" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">52,146</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzb6C_z3vimkQhqrZb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left">Total liabilities, mezzanine equity and stockholders&#8217; deficiency</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000263" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">188,878</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31" id="Fact000264" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">203,719</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><br/>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
accompanying notes to consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
ARENA GROUP HOLDINGS, INC. AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F_017"></span>CONSOLIDATED
STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_113_pn3n3_z9nRLmPfTaW" summary="xdx: Statement - Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20230101__20231231_zIGLZWIzQ2wh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20221231_z9jYmKTGzClj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-style: italic">&#160;</td>
    <td colspan="6" style="font-style: italic; text-align: center">($ in thousands, except share data)</td><td style="font-style: italic">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzjkV_z8bhj4x35EJk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; font-weight: bold">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-01to2023-12-31" id="Fact000266" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244,203</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31" id="Fact000267" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">220,935</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CostOfRevenue_msGPzjkV_z7iKeWiIOJjc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Cost of revenue (includes amortization for developed technology and platform development for 2023 and 2022 of $<span id="xdx_906_eus-gaap--CostOfGoodsAndServicesSoldAmortization_pn3n3_c20230101__20231231_zK3E7xBDsfaa" title="Amortization cost of developed technology and platform development"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSoldAmortization" contextRef="From2023-01-01to2023-12-31" id="Fact000272" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,782</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--CostOfGoodsAndServicesSoldAmortization_pn3n3_c20220101__20221231_z2cin3Ef2yxa" title="Amortization cost of developed technology and platform development"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSoldAmortization" contextRef="From2022-01-012022-12-31" id="Fact000274" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,459</ix:nonFraction></span>, respectively)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-01-01to2023-12-31" id="Fact000269" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">142,240</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-01-012022-12-31" id="Fact000270" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">132,923</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--GrossProfit_iT_mtGPzjkV_maOILzSeQ_zjNtft2N1ncd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Gross profit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-01-01to2023-12-31" id="Fact000276" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">101,963</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-01-012022-12-31" id="Fact000277" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">88,012</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zO5tkPLN3Tw3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--SellingAndMarketingExpense_i01_maOEzLRp_zxjcCLjnCKD2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Selling and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-01-01to2023-12-31" id="Fact000282" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">74,245</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-01-012022-12-31" id="Fact000283" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72,489</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzLRp_zdCOD1Bp5MJg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-01to2023-12-31" id="Fact000285" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,152</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-012022-12-31" id="Fact000286" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53,499</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DepreciationAndAmortization_i01_maOEzLRp_zSdUBxN2j252" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-01-01to2023-12-31" id="Fact000288" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,924</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-01-012022-12-31" id="Fact000289" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,650</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AssetImpairmentCharges_i01_maOEzLRp_zgNVkC7CMfNf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Loss on impairment of assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetImpairmentCharges" contextRef="From2023-01-01to2023-12-31" id="Fact000291" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetImpairmentCharges" contextRef="From2022-01-012022-12-31" id="Fact000292" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">257</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--LossOnSaleOfAssets_i01_maOEzLRp_zwScR7igs7n" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Loss on sale of assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:LossOnSaleOfAssets" contextRef="From2023-01-01to2023-12-31" id="Fact000294" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">325</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0295">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingExpenses_i01T_mtOEzLRp_msOILzSeQ_zSrGTy8lTs53" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-01to2023-12-31" id="Fact000297" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">137,765</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-01-012022-12-31" id="Fact000298" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">143,895</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingIncomeLoss_iT_mtOILzSeQ_maILFCOzfQh_zHrPMBDVuq0b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-01to2023-12-31" id="Fact000300" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">35,802</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact000301" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">55,883</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zdmApBdCcxQb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DerivativeGainLossOnDerivativeNet_i01_maNIEzi1Q_zVLlvQFhdVf8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in valuation of contingent consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2023-01-01to2023-12-31" id="Fact000306" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,010</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0307">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--InterestExpense_i01N_di_msNIEzi1Q_zxIYWsXjGqJ7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expense, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-01-01to2023-12-31" id="Fact000309" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,965</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-01-012022-12-31" id="Fact000310" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,428</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--LiquidatedDamagesUnderRegistrationRightsAgreements_i01_maNIEzi1Q_zxA9RkQ3ucmc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Liquidated damages</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AREN:LiquidatedDamagesUnderRegistrationRightsAgreements" contextRef="From2023-01-01to2023-12-31" id="Fact000312" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">583</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AREN:LiquidatedDamagesUnderRegistrationRightsAgreements" contextRef="From2022-01-012022-12-31" id="Fact000313" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,140</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--NonoperatingIncomeExpense_i01T_mtNIEzi1Q_maILFCOzfQh_zIBYZDvKLdJe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-01-01to2023-12-31" id="Fact000315" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">19,558</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31" id="Fact000316" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12,568</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOzfQh_maILFCOzqN8_zPk9jyqysn1d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-01to2023-12-31" id="Fact000318" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">55,360</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-12-31" id="Fact000319" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">68,451</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msILFCOzqN8_zbWkFLKNoefa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Income tax (provision) benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-01to2023-12-31" id="Fact000321" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">222</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="Fact000322" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,063</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperations_iT_mtILFCOzqN8_maNILzy6c_zqHfTfyHUEI2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss from continuing operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-01-01to2023-12-31" id="Fact000324" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">55,582</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-01-012022-12-31" id="Fact000325" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">67,388</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_maNILzy6c_zb3QHgi39oL1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from discontinued operations, net of tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0327">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" contextRef="From2022-01-012022-12-31" id="Fact000328" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,470</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLoss_iT_mtNILzy6c_zXc88FC9yaF8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-12-31" id="Fact000330" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">55,582</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact000331" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">70,858</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareBasicAbstract_iB_zRbLBKAfThR1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic and diluted net loss per common share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Continuing operations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_c20230101__20231231_zbnNq4lQ0xX4" title="Continuing operations - Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_905_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_c20230101__20231231_z34JksBB0hQf" title="Continuing operations - Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-01-01to2023-12-31" id="Fact000336" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="From2023-01-01to2023-12-31" id="Fact000338" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">2.49</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_909_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_c20220101__20221231_zqwU4BHdbWMl" title="Continuing operations - Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2022-01-012022-12-31" id="Fact000340" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">3.82</ix:nonFraction></span></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Discontinued operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_906_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_pid_c20230101__20231231_zuZhkz43bf8e" title="Discontinued operations - Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_904_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_pid_c20230101__20231231_zn3IyNJbGkNh" title="Discontinued operations - Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span style="-sec-ix-hidden: xdx2ixbrl0342"><span style="-sec-ix-hidden: xdx2ixbrl0344">-</span></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90A_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_pid_c20220101__20221231_zmqjPLAPrZw6" title="Discontinued operations - Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_90D_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_pid_c20220101__20221231_zVOq7dUld573" title="Discontinued operations - Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="From2022-01-012022-12-31" id="Fact000346" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextRef="From2022-01-012022-12-31" id="Fact000348" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.20</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zHiIKduMYDde" title="Basic net loss per common share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_zcxxzk0THhy6" title="Diluted net loss per common share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-01to2023-12-31" id="Fact000350" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-01to2023-12-31" id="Fact000352" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">2.49</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--EarningsPerShareBasic_pid_c20220101__20221231_zYLWY7ulrRC5" title="Basic net loss per common share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pid_c20220101__20221231_zQ61ZFp0JYuf" title="Diluted net loss per common share" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-12-31" id="Fact000354" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-12-31" id="Fact000356" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">4.02</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding &#8211; basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231_znL7VEpcwl04" title="Weighted average number of common shares outstanding - Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231_zgIoB8vgNBkc" title="Weighted average number of common shares outstanding - Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-01to2023-12-31" id="Fact000358" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-01to2023-12-31" id="Fact000360" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">22,323,763</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20220101__20221231_znXaO6hGPjk2" title="Weighted average number of common shares outstanding - Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20220101__20221231_zVGHMnXw9ARa" title="Weighted average number of common shares outstanding - Diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-12-31" id="Fact000362" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-012022-12-31" id="Fact000364" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,625,619</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
accompanying notes to consolidated financial statements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
ARENA GROUP HOLDINGS, INC. AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F_018"></span>CONSOLIDATED
STATEMENTS OF STOCKHOLDERS&#8217; DEFICIENCY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
Ended December 31, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_303_114_pn3n3_zjrtuVxLza6b" summary="xdx: Statement - Consolidated Statements of Stockholders' Deficiency" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zGGOf0KVvzEf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Par
    Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_custom--CommonStockToBeIssuedMember_z3EpBjRMtejf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Par
    Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zUtrJPSG0otb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_z8TNxlxGHStj" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deficit</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_4BB_zMIzc2NlGzs5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deficiency</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock <br/>
to be Issued</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    Paid-in</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 2.9pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 2.9pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stockholders&#8217;</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Par
    Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Par
    Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deficit</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deficiency</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="26" style="font: italic 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
    in thousands, except share data)</span></td><td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_436_c20230101__20231231_eus-gaap--StockholdersEquity_iS_pn3n3_zRmFt7R2hyhe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at January 1, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVtjEmjHy8B6" title="Balance, shares" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000372" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,303,193</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000366" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">182</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockToBeIssuedMember_zNMXDeNBbGq3" title="Balance, shares" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_CommonStockToBeIssuedMember" id="Fact000374" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">41,283</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0367">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000368" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">270,743</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" id="Fact000369" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">323,071</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" id="Fact000370" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">52,146</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering_zHq8kCxLLAw3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of common stock in connection with registered direct offering</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxnNJ1Mb6nob" title="Issuance of common stock in connection with registered direct offering, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000382" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,963,918</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000376" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0377">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000378" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,114</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0379">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" contextRef="From2023-01-01to2023-12-31" id="Fact000380" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,144</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pn3n3_zY5TVKphBTR9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of common stock upon conversion of series H convertible preferred stock</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgNd90723HQi" title="Issuance of common stock upon conversion of series H convertible preferred stock, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000390" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,981,128</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000384" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0385">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000386" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,988</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0387">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-01-01to2023-12-31" id="Fact000388" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,008</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne_pn3n3_zPQowBmqhmxe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of common stock in connection with the acquisition of Fexy Studios</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJwyOIZGsRe1" title="Issuance of common stock in connection with the acquisition of Fexy Studios, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000398" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">274,692</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000392" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0393">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000394" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,997</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0395">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne" contextRef="From2023-01-01to2023-12-31" id="Fact000396" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_pn3n3_zE3gttALqXrd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of common stock in connection with settlement of liquidated damages</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpJks5r9DjJ3" title="Issuance of common stock in connection with settlement of liquidated damages, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000406" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">47,252</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0400">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0401">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000402" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">369</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0403">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2023-01-01to2023-12-31" id="Fact000404" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">369</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_pn3n3_zB41O8Ty2dh1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
    upon issuance of common stock in connection with settlement of liquidated damages</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0408">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0409">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000410" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">130</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0411">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2023-01-01to2023-12-31" id="Fact000412" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">130</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_pn3n3_zmNk6JpQ3ei6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of common stock for restricted stock units</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zO6wRnMhNRR5" title="Issuance of common stock for restricted stock units, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000420" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">429,528</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000414" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0415">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000416" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0417">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0418">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--StockIssuedDuringPeriodValueCommonStockWithheldForTaxes_pn3n3_zZrIMG7glGb8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock withheld for taxes</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_985_ecustom--StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpbPtZp6fNO3" title="Common stock withheld for taxes, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="AREN:StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000428" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">202,382</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000422" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0423">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000424" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,421</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0425">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" contextRef="From2023-01-01to2023-12-31" id="Fact000426" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,423</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_zsx1Wa4GHi19" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of common stock upon exercise of stock options</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zu98GsMQeLX8" title="Issuance of common stock upon  exercise of stock option, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000436" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">795</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0430">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0431">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0432">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0433">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0434">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pn3n3_z67t9dHys993" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of common stock in connection with acquisition</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBF4k1G3UAE2" title="Issuance of common stock in connection with acquisition, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000444" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,582</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0438">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockToBeIssuedMember_zBgknKE3yPD1" title="Issuance of common stock in connection with acquisition, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember" id="Fact000446" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">38,582</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0439">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0440">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0441">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0442">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_pn3n3_zl36hQuR9fjg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reclassification
    to liability upon modification of common stock option</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0448">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0449">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000450" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">68</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0451">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2023-01-01to2023-12-31" id="Fact000452" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">68</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_404_ecustom--AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages_pn3n3_zGo8U6RKn7nf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
    upon forgiveness of liquidated damages with principal stockholder</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0454">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0455">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000456" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,497</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0457">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" contextRef="From2023-01-01to2023-12-31" id="Fact000458" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,497</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_zSchBgUEc798" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
    compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0460">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0461">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000462" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,076</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0463">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-01to2023-12-31" id="Fact000464" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,076</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_pn3n3_ztwcXmh2go3i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0466">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0467">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0468">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="Fact000469" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">55,582</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-12-31" id="Fact000470" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">55,582</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_43B_c20230101__20231231_eus-gaap--StockholdersEquity_iE_pn3n3_zW747ZyzdFUd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zr7z7hrxWVOj" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000478" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,836,706</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000472" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">237</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockToBeIssuedMember_z48ViEgt2q99" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_custom_CommonStockToBeIssuedMember" id="Fact000480" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,701</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0473">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000474" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">319,421</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact000475" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">378,653</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000476" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">58,995</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
ARENA GROUP HOLDINGS, INC. AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F_019"></span>CONSOLIDATED
STATEMENTS OF STOCKHOLDERS&#8217; DEFICIENCY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
Ended December 31, 2022</b></span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock<br/>
 to be Issued</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 2.9pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional
Paid-in</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 2.9pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 2.9pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 2.9pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stockholders&#8217;</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Par
    Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Par
    Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deficit</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deficiency</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="26" style="font: italic 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
    in thousands, except share data)</span></td><td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_436_c20220101__20221231_eus-gaap--StockholdersEquity_iS_pn3n3_z3NBxGWIMHH1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zAGeS4xBUAJa" title="Balance, shares" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" id="Fact000488" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,635,591</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" id="Fact000482" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">126</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockToBeIssuedMember_zGqftHGtDQh2" title="Balance, shares" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_CommonStockToBeIssuedMember" id="Fact000490" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,134</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0483">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000484" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200,410</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" id="Fact000485" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">252,213</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" id="Fact000486" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">51,677</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_439_c20220101__20221231_eus-gaap--StockholdersEquity_iS_pn3n3_ziMqhMWX9Hre" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zn9rmlXXKbrl" title="Balance, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" id="Fact000498" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,635,591</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" id="Fact000492" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">126</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockToBeIssuedMember_zKbQLnspv1gi" title="Balance, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_CommonStockToBeIssuedMember" id="Fact000500" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,134</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0493">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000494" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200,410</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" id="Fact000495" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">252,213</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" id="Fact000496" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">51,677</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pn3n3_zWsTibrMjG2g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of common stock upon conversion of series H preferred stock</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgW5JZmwE4U6" title="Issuance of common stock upon conversion of series H preferred stock, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000508" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">97,980</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000502" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000504" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">709</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0505">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2022-01-012022-12-31" id="Fact000506" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">710</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pn3n3_zIa1gikjMRPk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of stock in connection with acquisitions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxf9L6kidS3" title="Issuance of common stock in connection with acquisition, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000516" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">330,863</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000510" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0511">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000512" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,138</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0513">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-01-012022-12-31" id="Fact000514" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,141</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger_pn3n3_zl4juqV4rOs2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of stock in connection with the merger of Say Media</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98D_ecustom--StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcT2vgDiQBUb" title="Issuance of common stock in connection with the merger of SayMedia, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000524" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,851</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0518">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockToBeIssuedMember_zNZdO0uf7gIb" title="Issuance of common stock in connection with the merger of SayMedia, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="AREN:StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember" id="Fact000526" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">7,851</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0519">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0520">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0521">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0522">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_zt1mKYUufst2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of common stock in connection with professional services</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zql7AzBf4MPc" title="Issuance of common stock in connection with professional services, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000534" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,617</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0528">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0529">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000530" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0531">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31" id="Fact000532" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_pn3n3_zGwjW363Mw7h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of common stock in connection with settlement of liquidated damages</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_983_ecustom--StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zB8SQoUeenui" title="Issuance of common stock in connection with settlement of liquidated damages, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000542" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">505,655</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000536" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0537">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000538" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,680</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0539">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2022-01-012022-12-31" id="Fact000540" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,685</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_pn3n3_z3O6ckVHbNP3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
    upon issuance of common stock in connection with settlement of liquidated damages</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0544">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0545">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000546" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">323</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0547">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2022-01-012022-12-31" id="Fact000548" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">323</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_zzhXGb0E1qEh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of common stock in connection with the exercise of stock options</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeA31YtYSD05" title="Issuance of common stock in connection with the exercise of stock options, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000556" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">96,408</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000550" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0551">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000552" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0553">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31" id="Fact000554" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">95</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_pn3n3_zJhLjBv8tpTf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of common stock for restricted stock units</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkkZSCb4TV1d" title="Issuance of common stock for restricted stock units, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000564" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">832,233</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000558" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0559">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000560" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0561">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0562">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--StockIssuedDuringPeriodValueCommonStockWithheldForTaxes_pn3n3_zsGhiaqCcQdl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock withheld for taxes upon issuance of underlying shares for restricted stock units</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1UUCay6B8ra" title="Common stock withheld for taxes upon issuance of underlying shares for restricted stock units, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="AREN:StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000572" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">373,394</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000566" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0567">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000568" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,464</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0569">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" contextRef="From2022-01-012022-12-31" id="Fact000570" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,468</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_zLWznR3QbPm9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchase
    restricted stock awards in connection with HubPages merger</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSI9qNClpdL3" title="Repurchase restricted stock awards in connection with HubPages merger, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000580" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">26,214</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0574">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0575">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0576">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0577">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0578">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_zs5FU9aES3Uj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of common stock in connection with public offering</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8i2qPt539yb" title="Issuance of common stock in connection with public offering, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000588" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,181,603</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000582" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0583">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000584" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,448</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0585">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-12-31" id="Fact000586" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,490</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_zX3uxezI3Guf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
    compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0590">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0591">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000592" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,229</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0593">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31" id="Fact000594" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,229</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_pn3n3_zgbr87CuXr3k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0596">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0597">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0598">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="Fact000599" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">70,858</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact000600" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">70,858</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_434_c20220101__20221231_eus-gaap--StockholdersEquity_iE_pn3n3_zjKiBQo4Vbdf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98A_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXNWd6Myq1Xi" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000608" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,303,193</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000602" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">182</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockToBeIssuedMember_zfcdAl3cy2Vf" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_CommonStockToBeIssuedMember" id="Fact000610" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">41,283</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0603">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000604" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">270,743</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" id="Fact000605" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">323,071</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" id="Fact000606" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">52,146</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_43F_c20220101__20221231_eus-gaap--StockholdersEquity_iE_pn3n3_zqJybOUNrQPa" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zY1yijdW2c32" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000618" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,303,193</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000612" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">182</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockToBeIssuedMember_z4q2cVPWST" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_CommonStockToBeIssuedMember" id="Fact000620" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">41,283</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0613">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000614" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">270,743</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" id="Fact000615" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">323,071</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" id="Fact000616" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">52,146</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
accompanying notes to consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
ARENA GROUP HOLDINGS, INC. AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F_020"></span>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_112_pn3n3_zUhjza40CBre" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230101__20231231_zByP5GLIe2ke" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220101__20221231_zFJ4qoigbLJ" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-style: italic">&#160;</td>
    <td colspan="6" style="font-style: italic; text-align: center">($ in thousands)</td><td style="font-style: italic">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zaSoPdNrvVQh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_i01_maNCPBUzruh_z7GslHdoFvM8" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-12-31" id="Fact000625" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">55,582</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact000626" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">70,858</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zR2w5WsibkYf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--Depreciation_i02_maNCPBUzruh_z5hn84xqogZa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-01-01to2023-12-31" id="Fact000631" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">352</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-01-012022-12-31" id="Fact000632" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">539</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AmortizationOfIntangibleAssets_i02_maNCPBUzruh_zpKXezDzTBO1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Amortization of platform development and intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-01-01to2023-12-31" id="Fact000634" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">27,354</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-01-012022-12-31" id="Fact000635" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,570</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AmortizationOfFinancingCosts_i02_maNCPBUzruh_zNy9jGqs4lAi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Amortization of debt costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2023-01-01to2023-12-31" id="Fact000637" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,378</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2022-01-012022-12-31" id="Fact000638" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,581</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--NoncashAndAccruedInterest_i02N_di_msNCPBUzruh_zumitrJyVpL7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Noncash and accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2023-01-01to2023-12-31" id="Fact000640" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,824</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2022-01-012022-12-31" id="Fact000641" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">320</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_i02_maNCPBUzruh_zB5pEQsZ9vR4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Loss on impairment of assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" contextRef="From2023-01-01to2023-12-31" id="Fact000643" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" contextRef="From2022-01-012022-12-31" id="Fact000644" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">466</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--LossOnSaleOfAssets_i02_maNCPBUzruh_zRKcCHMVxryh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Loss on sale of assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:LossOnSaleOfAssets" contextRef="From2023-01-01to2023-12-31" id="Fact000646" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">325</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0647">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DerivativeGainLossOnDerivativeNet_i02N_di_msNCPBUzruh_zJOfHorpaiJ8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in valuation of contingent consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2023-01-01to2023-12-31" id="Fact000649" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,010</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0650">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--LiquidatingDamagesPayable_i02_maNCPBUzruh_z94cCySKcUA2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Liquidated damages</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:LiquidatingDamagesPayable" contextRef="From2023-01-01to2023-12-31" id="Fact000652" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">583</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:LiquidatingDamagesPayable" contextRef="From2022-01-012022-12-31" id="Fact000653" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,140</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ShareBasedCompensation_i02_maNCPBUzruh_zJIm3CTtDo0l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-01to2023-12-31" id="Fact000655" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,060</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-12-31" id="Fact000656" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,345</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredIncomeTaxesAndTaxCredits_i02_maNCPBUzruh_ztyOucead3Ng" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Deferred income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextRef="From2023-01-01to2023-12-31" id="Fact000658" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">134</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextRef="From2022-01-012022-12-31" id="Fact000659" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,200</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--ProvisionForDoubtfulAccounts_i02_maNCPBUzruh_zRrgL9a5et55" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Bad debt expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2023-01-01to2023-12-31" id="Fact000661" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">315</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2022-01-012022-12-31" id="Fact000662" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">658</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherOperatingActivitiesCashFlowStatement_i02_maNCPBUzruh_zLl4AZNkKnV1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0664">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherOperatingActivitiesCashFlowStatement" contextRef="From2022-01-012022-12-31" id="Fact000665" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zLvSYtf2ruVg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in operating assets and liabilities net of effect of acquisitions:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUzruh_zflDts0XeWTb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-01-01to2023-12-31" id="Fact000670" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,599</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-01-012022-12-31" id="Fact000671" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,038</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_ecustom--IncreaseDecreaseInSubscriptionAcquisitionCosts_i03N_di_msNCPBUzruh_zhe2yjLmnBcg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Subscription acquisition costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:IncreaseDecreaseInSubscriptionAcquisitionCosts" contextRef="From2023-01-01to2023-12-31" id="Fact000673" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,143</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="AREN:IncreaseDecreaseInSubscriptionAcquisitionCosts" contextRef="From2022-01-012022-12-31" id="Fact000674" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,667</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInPrepaidRoyalties_i03N_di_msNCPBUzruh_zIjb2CDR6r04" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Royalty fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0676">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidRoyalties" contextRef="From2022-01-012022-12-31" id="Fact000677" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,250</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i03N_di_msNCPBUzruh_zNVH5C4t9en7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Prepayments and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2023-01-01to2023-12-31" id="Fact000679" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,157</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2022-01-012022-12-31" id="Fact000680" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,280</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInOtherNoncurrentAssets_i03N_di_msNCPBUzruh_znk4QRv65l48" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Other long-term assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2023-01-01to2023-12-31" id="Fact000682" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">77</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2022-01-012022-12-31" id="Fact000683" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">285</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccountsPayable_i03_maNCPBUzruh_zcgmNsMA7VX2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2023-01-01to2023-12-31" id="Fact000685" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,663</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2022-01-012022-12-31" id="Fact000686" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,535</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i03_maNCPBUzruh_ztuyRFpUX8db" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Accrued expenses and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2023-01-01to2023-12-31" id="Fact000688" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,453</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2022-01-012022-12-31" id="Fact000689" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,996</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_i03_maNCPBUzruh_zVdffQvzdRPb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2023-01-01to2023-12-31" id="Fact000691" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,970</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2022-01-012022-12-31" id="Fact000692" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,898</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--IncreaseDecreaseInSubscriptionRefundLiability_i03_maNCPBUzruh_zDi8PWis7HK6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Subscription refund liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="AREN:IncreaseDecreaseInSubscriptionRefundLiability" contextRef="From2023-01-01to2023-12-31" id="Fact000694" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">396</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="AREN:IncreaseDecreaseInSubscriptionRefundLiability" contextRef="From2022-01-012022-12-31" id="Fact000695" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,379</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i03_maNCPBUzruh_ztlWdKABHkG4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Operating lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2023-01-01to2023-12-31" id="Fact000697" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">231</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2022-01-012022-12-31" id="Fact000698" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">218</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInOtherNoncurrentLiabilities_i03_maNCPBUzruh_zZMLGqg45KA5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Other long-term liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" contextRef="From2023-01-01to2023-12-31" id="Fact000700" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,147</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" contextRef="From2022-01-012022-12-31" id="Fact000701" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,359</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtNCPBUzruh_maCCERCzpmT_zpBh2C1YVMli" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0pt; text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000703" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">24,772</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-012022-12-31" id="Fact000704" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,304</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_z6AL18hOVM8i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt; font-weight: bold; text-align: left">Cash flows from investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUzO8B_zlBSyoV4nUq6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Purchases of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0709">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31" id="Fact000710" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">530</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--PaymentsForCapitalizedPlatformDevelopment_i01N_di_msNCPBUzO8B_zZOh3uxVacBj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Capitalized platform development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="AREN:PaymentsForCapitalizedPlatformDevelopment" contextRef="From2023-01-01to2023-12-31" id="Fact000712" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,773</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="AREN:PaymentsForCapitalizedPlatformDevelopment" contextRef="From2022-01-012022-12-31" id="Fact000713" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,179</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromSaleOfProductiveAssets_i01_maNCPBUzO8B_zXSwfl5WGf0i" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Proceeds from sale of assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="From2023-01-01to2023-12-31" id="Fact000715" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,061</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0716">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromSaleOfEquityMethodInvestments_i01_maNCPBUzO8B_zQ9j3qmBIIa2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Proceeds from sale of equity investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0718">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" contextRef="From2022-01-012022-12-31" id="Fact000719" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,450</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_i01N_di_msNCPBUzO8B_z70TfrYuF5Th" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Payments for acquisitions, net of cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="From2023-01-01to2023-12-31" id="Fact000721" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="From2022-01-012022-12-31" id="Fact000722" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,331</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUzO8B_maCCERCzpmT_znpaO9g6Frrl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000724" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,212</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-012022-12-31" id="Fact000725" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">38,590</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_znwmtA6FCGXa" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ProceedsFromShortTermDebt_i01_maNCPBUzvfR_zvpTeshqWl8l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from bridge notes, net of debt costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromShortTermDebt" contextRef="From2023-01-01to2023-12-31" id="Fact000730" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromShortTermDebt" contextRef="From2022-01-012022-12-31" id="Fact000731" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,728</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RepaymentsOfLongTermDebt_i01N_di_msNCPBUzvfR_zLAGiaLQUQ63" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payments of long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0733">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2022-01-012022-12-31" id="Fact000734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,928</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--ProceedsFromLinesOfCredit_i01_maNCPBUzvfR_zZUK3GBSwGt5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds, net of repayments, under line of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" contextRef="From2023-01-01to2023-12-31" id="Fact000736" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,517</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" contextRef="From2022-01-012022-12-31" id="Fact000737" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,104</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_i01_maNCPBUzvfR_zVDsjXGjF05c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from common stock public offering, net of offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2023-01-01to2023-12-31" id="Fact000739" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2022-01-012022-12-31" id="Fact000740" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32,058</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--PaymentsOfStockIssuanceCosts_i01N_di_msNCPBUzvfR_z5KHcQVhiOVk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payments of issuance costs from common stock public offering</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2023-01-01to2023-12-31" id="Fact000742" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">167</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2022-01-012022-12-31" id="Fact000743" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,568</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--PaymentsOfDebtIssuanceCosts_i01N_di_msNCPBUzvfR_zWo0DmQK2Ncl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payments of debt issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="From2023-01-01to2023-12-31" id="Fact000745" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">457</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzvfR_zqoqlQqUx6E5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from exercise of common stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0748">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2022-01-012022-12-31" id="Fact000749" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">95</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--PaymentOfDeferredCashPayment_i01N_di_msNCPBUzvfR_ztIUzgdRmoH7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payment of deferred cash payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="AREN:PaymentOfDeferredCashPayment" contextRef="From2023-01-01to2023-12-31" id="Fact000751" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">75</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="AREN:PaymentOfDeferredCashPayment" contextRef="From2022-01-012022-12-31" id="Fact000752" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">453</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsRelatedToTaxWithholdingForShareBasedCompensation_i01N_di_msNCPBUzvfR_zG6Rf7pRozRf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payment for taxes related to common stock withheld for taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="From2023-01-01to2023-12-31" id="Fact000754" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,423</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="From2022-01-012022-12-31" id="Fact000755" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,468</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_ecustom--PaymentOfRestrictedStockLiabilities_i01N_di_msNCPBUzvfR_zacMdWoQoLq5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Payment of restricted stock liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0757">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AREN:PaymentOfRestrictedStockLiabilities" contextRef="From2022-01-012022-12-31" id="Fact000758" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,152</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzvfR_maCCERCzpmT_z1i7iyc6WxBa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000760" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,895</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-012022-12-31" id="Fact000761" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">54,416</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzpmT_zfYpfiVPH6Ub" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net (decrease) increase in cash, cash equivalents, and restricted cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-01-01to2023-12-31" id="Fact000763" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,089</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-012022-12-31" id="Fact000764" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,522</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_z7Sca8ZD5mD6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Cash, cash equivalents, and restricted cash &#8211; beginning of year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" id="Fact000766" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,373</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-12-31" id="Fact000767" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,851</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zvnxaasETM69" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash, cash equivalents, and restricted cash &#8211; end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-12-31" id="Fact000769" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,284</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" id="Fact000770" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,373</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_iB_zcRyPkVZaKzc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash, cash equivalents, and restricted cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01E_zJSlhuYXZ2Zi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact000775" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,284</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31" id="Fact000776" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,871</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--RestrictedCash_i01E_zeAh91t7Ecs1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0778">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RestrictedCash" contextRef="AsOf2022-12-31" id="Fact000779" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">502</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01E_zkvjUwMdCVs3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total cash, cash equivalents, and restricted cash</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-12-31" id="Fact000781" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,284</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-12-31" id="Fact000782" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,373</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zHy9T3uF5F7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental disclosure of cash flow information</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--InterestPaidNet_i01_zjqzeZCjITvb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Cash paid for interest</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-01-01to2023-12-31" id="Fact000787" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,101</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-01-012022-12-31" id="Fact000788" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,528</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeTaxesPaidNet_i01_zafkEDbXMyGg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Cash paid for income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2023-01-01to2023-12-31" id="Fact000790" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">85</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0791">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_zZdtm8yLnpul" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Noncash investing and financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--ReclassificationOfStockbasedCompensationToPlatformDevelopment_i01_zSfZa3ulVvjd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Reclassification of stock-based compensation to platform development</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="AREN:ReclassificationOfStockbasedCompensationToPlatformDevelopment" contextRef="From2023-01-01to2023-12-31" id="Fact000796" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,016</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="AREN:ReclassificationOfStockbasedCompensationToPlatformDevelopment" contextRef="From2022-01-012022-12-31" id="Fact000797" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,884</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_i01_zEpUsoY9S2y8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Debt costs recorded in accrued expenses and other and in other long-term liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" contextRef="From2023-01-01to2023-12-31" id="Fact000799" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">189</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" contextRef="From2022-01-012022-12-31" id="Fact000800" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">441</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ConversionOfStockAmountIssued1_i01_zMzT9IJfIIXb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Issuance of common stock upon conversion of Series H convertible preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2023-01-01to2023-12-31" id="Fact000802" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,008</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2022-01-012022-12-31" id="Fact000803" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">511</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockIssued1_i01_zm3H9FdnVVs4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Issuance of common stock in connection with settlement of liquidated damages</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2023-01-01to2023-12-31" id="Fact000805" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">499</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2022-01-012022-12-31" id="Fact000806" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,008</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IssuanceOfCommonStockInConnectionWithAcquisition_i01_zVHtpjaN6Nx" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Issuance of common stock in connection with an acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:IssuanceOfCommonStockInConnectionWithAcquisition" contextRef="From2023-01-01to2023-12-31" id="Fact000808" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:IssuanceOfCommonStockInConnectionWithAcquisition" contextRef="From2022-01-012022-12-31" id="Fact000809" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,141</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DeferredCashPaymentsRecordedInConnectionWithAcquisitions_i01_z9kRQDuByJve" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Deferred cash payments recorded in connection with acquisitions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:DeferredCashPaymentsRecordedInConnectionWithAcquisitions" contextRef="From2023-01-01to2023-12-31" id="Fact000811" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">246</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:DeferredCashPaymentsRecordedInConnectionWithAcquisitions" contextRef="From2022-01-012022-12-31" id="Fact000812" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">949</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_i01_z311bdNaeGD3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Assumption of liabilities in connection with acquisitions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" contextRef="From2023-01-01to2023-12-31" id="Fact000814" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,246</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" contextRef="From2022-01-012022-12-31" id="Fact000815" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,110</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ReclassificationToLiabilityUponCommonStockModification_i01_zXsYhmy1ocWj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Reclassification to liability upon common stock modification</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:ReclassificationToLiabilityUponCommonStockModification" contextRef="From2023-01-01to2023-12-31" id="Fact000817" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">68</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0818">-</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See
accompanying notes to consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
ARENA GROUP HOLDINGS, INC. AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F_021"></span>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>($
in thousands, unless otherwise stated)</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 23.75pt; text-transform: uppercase; text-align: justify; text-indent: -23.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000820" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_80C_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z7AmhcPvGa02" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>1.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_829_zuTWLdwyfM03">Organization and Basis of Presentation</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organization</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Arena Holdings Group, Inc. (formerly known as TheMaven, Inc.) (&#8220;The Arena Group&#8221; or the &#8220;Company&#8221;), was incorporated
in Delaware on October 1, 1990. On October 11, 2016, the predecessor entity now known as The Arena Group exchanged its shares with another
entity that was incorporated in Delaware on July 22, 2016. On November 4, 2016, these entities consummated a recapitalization. This resulted
in The Arena Group becoming the parent entity, and the other Delaware entity becoming the wholly owned subsidiary. On December 19, 2019,
the Company&#8217;s wholly owned subsidiaries The Arena Platform, Inc. (formerly known as Maven Coalition, Inc.), and HubPages, Inc.
(&#8220;HubPages&#8221;), which was acquired by the Company in a merger during 2018, were merged into another of the Company&#8217;s
wholly owned subsidiaries, Say Media, Inc. (&#8220;Say Media&#8221;), which was acquired by the Company in a merger during 2018, with
Say Media as the surviving corporation. On January 6, 2020, Say Media changed its name to The Arena Platform, Inc. (&#8220;Arena Platform&#8221;).
As of December 31, 2023, the Company&#8217;s wholly owned subsidiaries consist of The Arena Platform, The Arena Media Brands, LLC (&#8220;Arena
Media&#8221;) (formerly known as Maven Media Brands, LLC) formed during 2019 as a wholly owned subsidiary of The Arena Group), TheStreet,
Inc. (&#8220;TheStreet&#8221; acquired by the Company in a merger during 2019), College Spun Media Incorporated (&#8220;The Spun&#8221;
acquired by the Company in a merger during 2021) and Athlon Holdings, Inc. (&#8220;Parade&#8221; acquired by the Company in a merger
during 2022 as further described in Note 4).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company changed its legal name to The Arena Group Holdings, Inc. from TheMaven, Inc. on February 8, 2022. The Company&#8217;s subsidiaries
changed their corporate names to The Arena Platform, Inc. from Maven Coalition, Inc. and to The Arena Media Brands, LLC from Maven Media
Brands, LLC on February 18, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
the context indicates otherwise, The Arena Group, The Arena Platform, TheStreet, The Spun and Parade, are together hereinafter referred
to as the &#8220;Company.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reverse
Stock Split</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2022, the Board approved a <span id="xdx_902_eus-gaap--StockholdersEquityReverseStockSplit_c20220208__20220208_zH7I3iuuXedl"><ix:nonNumeric contextRef="From2022-02-082022-02-08" id="Fact000821" name="us-gaap:StockholdersEquityReverseStockSplit">one-for-twenty-two (1-for-22) reverse stock split</ix:nonNumeric></span> of its outstanding shares of common stock that
was effective February 8, 2022. The Company&#8217;s common stock began trading on the NYSE American (the &#8220;NYSE American&#8221;)
on February 9, 2022 (as further described below). At the effective time, every twenty-two shares of issued and outstanding common stock
were automatically combined into one issued and outstanding share of common stock, without any change in the number of authorized shares.
No fractional shares were issued as a result of the reverse stock split. Any fractional shares that would otherwise have resulted from
the reverse stock split were rounded up to the next whole number.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements and notes to the financial statements give effect to the reverse stock split for all periods presented.
The shares of common stock retained a par value of $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_znh03xD8wsM4" title="Common stock par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000823" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> per share. Accordingly, stockholders&#8217; deficiency reflects the reverse
stock split by reclassifying from &#8220;common stock&#8221; to &#8220;additional paid-in capital&#8221; in an amount equal to the par
value of the decreased shares resulting from the reverse stock split. In connection with the reverse stock split, proportionate adjustments
were made to increase the per share exercise prices and decrease the number of shares of common stock issuable upon exercise of common
stock options and warrants whereby approximately the same aggregate price is required to be paid for such securities upon exercise as
had been payable immediately preceding the reverse stock split. Any fractional shares that would otherwise be issued as a result of the
reverse stock split were rounded up to the nearest whole share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 9, 2022, in connection with the Company&#8217;s legal name change and reverse stock split, the Company up-listed its common
stock to the NYSE American, which began trading on February 9, 2022 under the symbol &#8220;AREN.&#8221; The Company&#8217;s common stock,
prior to the up-list, was quoted on the OTC Markets Group Inc.&#8217;s (&#8220;OTCM&#8221;) OTCQX<sup>&#174;</sup> Best Market (the &#8220;OTCQX&#8221;)
under the symbol &#8220;MVEN.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Operations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company is a media company that leverages technology to build deep content verticals powered by anchor brands and a best-in-class digital
media platform (the &#8220;Platform&#8221;) empowering publishers who impact, inform, educate, and entertain. The Company&#8217;s strategy
is to focus on key subject matter verticals where audiences are passionate about a topic category (e.g., sports and finance) where it
can leverage the strength of its core brands to grow its audience and increase monetization both within its core brands as well as for
its media publisher partners (each, a &#8220;Publisher Partner&#8221;). The Company&#8217;s focus is on leveraging its Platform and brands
in targeted verticals to maximize audience reach, enhance engagement, and optimize monetization of digital publishing assets for the
benefit of its users, its advertiser clients, and its greater than 40 owned and operated properties as well as properties it runs on
behalf of independent Publisher Partners. The Company owns and operates TheStreet, The Spun, Parade, and Men&#8217;s Journal and powers
more than 320 independent Publisher Partners, including the many sports team sites that comprise FanNation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Each
Publisher Partner joins the Platform by invitation only with the objective of improving our position in key verticals while optimizing
the performance of the Publisher Partner. Publisher Partners incur the costs in content creation on their respective channels and receive
a share of the revenue associated with their content. Because of the state-of-the-art technology and large scale of the Platform and
our expertise in search engine optimization, social media, ad monetization and subscription marketing, Publisher Partners continually
benefit from our ongoing technological advances and audience development expertise. Additionally, we believe the lead brands within our
verticals create a halo benefit for all Publisher Partners while each of them adds to the breadth and quality of content.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Platform</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company developed the Platform, a proprietary online publishing platform that provides its owned and operated media businesses, Publisher
Partners (who are third parties producing and publishing content on their own domains), and individual creators contributing content
to its owned and operated sites (&#8220;Expert Contributors&#8221;), the ability to produce and manage editorially focused content through
tools and services provided by it. The Company has also developed proprietary advertising technology, techniques and relationships that
allow it, its Publisher Partners, and its Expert Contributors to monetize editorially focused online content through various display
and video advertisements and tools and services for driving a subscription or membership based business and other monetization services
(the &#8220;Monetization Solutions&#8221; and, together with the Platform, the &#8220;Platform Services&#8221;). The Company&#8217;s
Platform offers audiences bespoke content with optimized design and page construction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Platform comprises state-of-the-art publishing tools, video platforms, social distribution channels, newsletter technology, machine learning
content recommendations, notifications, and other technology that deliver a complete set of features to drive a digital media business
in an entirely cloud-based suite of services. The Company&#8217;s software engineering and product development teams are experienced
at delivering these services at scale. The Company continues to develop the Platform software by combining proprietary code with components
from the open-source community, plus select commercial services as well as identifying, acquiring, and integrating other platform technologies
where it sees unique long-term benefits to it.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Seasonality</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does experience seasonality during the year, as a result of advertising seasonality and sports seasons and major sporting events.
Advertising typically peaks in the fourth quarter of the Company&#8217;s fiscal year as advertisers concentrate their budgets during
the holiday season. This trend is magnified as it also includes the professional sports and college football seasons, which account for
a significant portion of the Company&#8217;s advertising revenue during that period of the year. Other sporting events such as the Super
Bowl, Winter and Summer Olympics, soccer&#8217;s World Cup, and major golf, tennis and cycling events create increased traffic surrounding
the respective events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going
Concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company performed an annual reporting period going concern assessment. Management is required to assess the Company&#8217;s ability to
continue as a going concern. These consolidated financial statements have been prepared assuming that the Company will continue as a
going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. The
Company&#8217;s consolidated financial statements do not include any adjustments that might be necessary if it is unable to continue
as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
recently, for the year ended December 31, 2023, the Company incurred a net loss from continuing operations of $<span id="xdx_903_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_iN_pn3n3_di_c20230101__20231231_zENQiOCp4Ul9"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2023-01-01to2023-12-31" id="Fact000824" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">55,582</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
had cash on hand of $<span id="xdx_90F_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20231231_zg42Hh1wYD1b"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact000825" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,284</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
a working capital deficit of $<span id="xdx_902_ecustom--WorkingCapitalDeficit_iI_pn3n3_c20231231_z7oLjDxbA0T9"><ix:nonFraction name="AREN:WorkingCapitalDeficit" contextRef="AsOf2023-12-31" id="Fact000826" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">145,622</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Company&#8217;s net loss from continuing operations and working capital deficit have been evaluated by management to determine
if the significance of those conditions or events would limit its ability to meet its obligations when due. Also, since the
Company&#8217;s 2023 Notes (see Note 18), Senior Secured Notes, Delayed Draw Term Notes and 2022 Bridge Notes (see Note 19)
(collectively &#8220;its current debt&#8221;) are subject to a <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%">forbearance
period through the earlier of the following: (a) April 30, 2024</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #393A39; line-height: 115%">;
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%">(b) the occurrence
of the closing of the Business Combination and (c) the termination of the Business Combination prior to closing</span> (as further described in Note 28) unless the Company is
able to refinance or modify the terms of its current debt it runs the risk that its debt could be called, therefore, it may not be able to meet its
obligations when due.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
its evaluation, management determined there is substantial doubt about the Company&#8217;s ability to continue as a going concern for
a one-year period following the financial statement issuance date, unless it is able to refinance or modify its current debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company plans to refinance or modify the maturities of its current debt and complete the Business Combination to alleviate the
conditions that raise substantial doubt about its ability to continue as a going concern, however, there can be no assurance that the Company will be able to refinance or modify its current debt and complete
the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000828" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_z0PJwvau6Jt5" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82F_zW3uYdnXz5tg">Summary of Significant Accounting Policies</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000830" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zzFtoQvQnNx7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zy3G9ui5Z5Z5">Principles
of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#8220;GAAP&#8221;) and include the financial statements of The Arena Group and its wholly owned subsidiaries,
Arena Media, Arena Platform, TheStreet, The Spun and Parade. Intercompany balances and transactions have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000832" name="us-gaap:UseOfEstimates"><p id="xdx_84B_eus-gaap--UseOfEstimates_z8NcpjojKmQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_z4pyTs3jB2Ci">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make certain estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of
the date of the consolidated financial statements and the reported results of operations during the reporting period. Significant estimates
include: reserves for bad debt; capitalization of platform development and associated useful lives; goodwill and other acquired intangible
assets and associated useful lives; assumptions used in accruals for potential liabilities; revenue recognition and estimates of standalone
selling price of performance obligations for revenue contracts with multiple performance obligations; stock-based compensation and the
determination of the fair value; valuation allowances for deferred tax assets and uncertain tax positions; accounting for business combinations;
and assumptions used to calculate contingent liabilities. These estimates are based on information available as of the date of the consolidated
financial statements; therefore, actual results could differ from management&#8217;s estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000834" name="AREN:RisksAndUncertaintiesPolicy"><p id="xdx_849_ecustom--RisksAndUncertaintiesPolicy_zeQRbLriArwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zsjI6LF7LMy2">Risks
and Uncertainties</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s business and operations are sensitive to general business and economic conditions in the United States and worldwide.
These conditions include short-term and long-term interest rates, inflation, fluctuations in debt and equity capital markets and the
general condition of the United States and world economy. A host of factors beyond the Company&#8217;s control could cause fluctuations
in these conditions. Adverse developments in these general business and economic conditions could have a material adverse effect on the
Company&#8217;s financial condition and the results of its operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company will compete with many companies that currently have extensive and well-funded projects, marketing and sales operations
as well as extensive human capital. The Company may be unable to compete successfully against these companies. The Company&#8217;s industry
is characterized by rapid changes in technology and market demands. As a result, the Company&#8217;s products, services, or expertise
may become obsolete or unmarketable. The Company&#8217;s future success will depend on its ability to adapt to technological advances,
anticipate customer and market demands, and enhance its current technology under development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Uncertainty
in the global economy presents significant risks to the Company&#8217;s business. Increases in inflation, rising interest rates,
instability in the global banking system, geopolitical factors, including the ongoing conflicts in Ukraine and Israel and the
responses thereto, and the remaining effects of the COVID-19 pandemic may have an adverse effect on the Company&#8217;s business.
While the Company is closely monitoring the impact of the current macroeconomic conditions on all aspects of its business, the
ultimate extent of the impact on its business remains highly uncertain and will depend on future developments and factors that
continue to evolve. Most of these developments and factors are outside of the Company&#8217;s control and could exist for an
extended period of time. As a result, the Company is subject to continuing risks and uncertainties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
December 1, 2023, B. Riley FBR, Inc. (&#8220;B. Riley FBR&#8221;), a registered broker-dealer owned by B. Riley Financial, Inc., a diversified
publicly traded financial services company (&#8220;B. Riley&#8221;) that was instrumental in providing investment banking services to
the Company and in raising debt and equity capital for the Company, and Renew Group Private Limited (&#8220;Renew&#8221;) entered into
agreement where Renew purchased $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20231201__us-gaap--DebtInstrumentAxis__custom--BRileyFBRIncMember_zTC4YweVY0wd"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-12-01_custom_BRileyFBRIncMember" id="Fact000835" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,691</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in aggregate principal amount of the notes outstanding
with B. Riley, including the 2023 Notes (as described in Note 18), Senior Secured Notes, Delayed Draw Term Notes and 2022 Bridge Notes
(as described in Note 19), which constitute all of the notes outstanding with B. Riley and also assumed the role of agent under the Note
Purchase Agreement, as further described in Note 26. The indirect owner of Renew also has an indirect non-controlling interest in Simplify
Inventions, LLC (&#8220;Simplify&#8221;), a principal stockholder (as further described in Note 26).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000837" name="us-gaap:SegmentReportingPolicyPolicyTextBlock"><p id="xdx_840_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zHxbngcdmK8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zNDHompCPvHb">Segment
Reporting</span> </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates in one reportable segment which focuses on a publishing platform. The Company&#8217;s business offerings have similar
operating characteristics and similar long-term operating performance, including the types of customers, nature of product or services,
distribution methods and regulatory environment. The chief operating decision maker (the &#8220;CODM&#8221;) of the Company reviews specific
financial and operational data and other key metrics to make resource allocation decisions and assesses performance by review of profit
and loss information on a consolidated basis. The CODM does not review specific financial or operational data on a disaggregated basis
or by aggregating operating segments into one reportable segment. The consolidated financial statements reflect the financial results
of the Company&#8217;s one reportable segment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000839" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_846_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zGkVoSwSsy6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zbJUQHQnkXde">Revenue
Recognition</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606, <i>Revenue from Contracts with Customers</i>, revenues are
recognized when control of the promised goods or services are transferred to the Company&#8217;s customers, in an amount that reflects
the consideration that the Company expects to receive in exchange for those goods or services. The Company generates all of its revenue
from contracts with customers. The Company accounts for revenue on a gross basis, as compared to a net basis, on its statements of operations.
The Company has made this determination based on its control of the advertising inventory and the ability to monetize the advertising
inventory or publications before transfer to the customer and because it is also the primary obligor responsible for providing the services
to the customer. Cost of revenue is presented as a separate line item on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a description of the principal activities from which the Company generates revenue:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advertising
Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Digital
Advertising &#8211; </i>The Company recognizes revenue from digital advertisements at the point when each ad is viewed. The quantity
of advertisements, the impression bid prices and revenue are reported on a real-time basis. The Company enters into contracts with advertising
networks to serve display or video advertisements on the digital media pages associated with its various channels. Although reported
advertising transactions are subject to adjustment by the advertising network partners, any such adjustments are known within a few days
of month end. The Company owes its independent Publisher Partners a revenue share of the advertising revenue earned, which is recorded
as service costs in the same period in which the associated advertising revenue is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising
revenue that is comprised of fees charged for the placement of advertising, on the Company&#8217;s flagship website, <i>TheStreet.com,
</i>is recognized as the advertising or sponsorship is displayed, if collection of the resulting receivable is reasonably assured.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Print
Advertising &#8211; </i>Advertising related revenues for print advertisements are recognized when advertisements are published (defined
as an issue&#8217;s on-sale date), net of provisions for estimated rebates, rate adjustments, and discounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Subscription
Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Digital
Subscriptions</i> &#8211; The Company enters into contracts with internet users that subscribe to premium content on the owned and operated
media channels and facilitate such contracts between internet users and its Publisher Partners. These contracts provide internet users
with a membership subscription to access the premium content. The Company owes its independent Publisher Partners a revenue share of
the membership subscription revenue earned, which is initially deferred and recorded as deferred contract costs. The Company recognizes
deferred contract costs over the membership subscription term in the same pattern that the associated membership subscription revenue
is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
revenue generated from the Company&#8217;s flagship website <i>TheStreet.com</i> from institutional and retail customers is comprised
of subscriptions and license fees for access to securities investment information, stock market commentary, director and officer profiles,
relationship capital management services, and transactional information pertaining to mergers and acquisitions and other changes in the
corporate control environment. Subscriptions are charged to customers&#8217; credit cards or are directly billed to corporate subscribers,
and are generally billed in advance on a monthly, quarterly or annual basis. The Company calculates net subscription revenue by deducting
from gross revenue an estimate of potential refunds from cancelled subscriptions as well as chargebacks of disputed credit card charges.
Net subscription revenue is recognized ratably over the subscription periods. Unearned revenue relates to payments for subscription fees
for which revenue has not been recognized because services have not yet been provided.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Print
Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print
revenue includes magazine subscriptions and single copy sales at newsstands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Print
Subscriptions &#8211;</i> Revenue from magazine subscriptions is deferred and recognized proportionately as products are distributed
to subscribers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Newsstand
</i>&#8211; Single copy revenue is recognized on the publication&#8217;s on-sale date, net of provisions for estimated returns. The Company
bases its estimates for returns on historical experience and current marketplace conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Licensing
and Syndication Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Content
licensing-based revenues and syndication revenues are accrued generally monthly or quarterly based on the specific mechanisms of each
contract. Generally, revenues are accrued based on estimated sales and adjusted as actual sales are reported by partners. These adjustments
are typically recorded within three months of the initial estimates and have not been material. Any minimum guarantees are typically
earned evenly over the fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nature
of Performance Obligations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
contract inception, the Company assesses the obligations promised in its contracts with customers and identifies a performance obligation
for each promise to transfer a good or service or bundle that is distinct. To identify the performance obligations, the Company considers
all the promises in the contract, whether explicitly stated or implied based on customary business practices. For a contract that has
more than one performance obligation, the Company allocates the total contract consideration to each distinct performance obligation
on a relative standalone selling price basis. Revenue is recognized when, or as, the performance obligations are satisfied, and control
is transferred to the customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Digital
Advertising</i> &#8211; The Company sells digital advertising inventory on its websites directly to advertisers or through advertising
agencies. The Company&#8217;s performance obligations related to digital advertising are generally satisfied when the advertisement is
run on the Company&#8217;s platform. The price for direct digital advertising is determined in contracts with the advertisers. Revenue
from the sale of direct digital advertising is recognized when the advertisements are delivered based on the contract. The customer is
invoiced the agreed-upon price in the month following the month that the advertisements are delivered with normal trade terms. The agreed
upon price is adjusted for estimated provisions for rebates, rate adjustments, and discounts. As part of the Company&#8217;s customary
business practices, digital advertising contracts may include a guaranteed number of impressions and sales incentives to its customers
including volume discounts, rebates, value added impressions, etc. For all such contracts that include these types of variable consideration,
the Company estimates the variable consideration and factors in such an estimate when determining the transaction price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Print
Advertising</i> <b>&#8211; </b>The Company provides advertisement placements in print media directly to advertisers or through advertising
agencies. The Company&#8217;s performance obligations related to print advertising are satisfied when the magazine in which an advertisement
appears is published, which is defined as an issue&#8217;s on-sale date. The customer is invoiced the agreed-upon price when the advertisements
are published under normal industry trade terms. The agreed upon price is adjusted for estimated provisions for rebates, rate adjustments,
and discounts. As part of the Company&#8217;s customary business practices, print advertising contracts include guaranteed circulation
levels of magazines, referred to as rate base, and a number of sales incentives to its customers including volume discounts, rebates,
bonus pages, etc. For all such contracts that include these types of variable consideration, the Company estimates such when determining
the transaction price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Digital
Subscriptions</i> &#8211; The Company recognizes revenue from each membership subscription to access the premium content over time based
on a daily calculation of revenue during the reporting period, which is generally one year. Subscriber payments are initially recorded
as unearned revenue on the balance sheets. As the Company provides access to the premium content over the membership subscription term,
the Company recognizes revenue and proportionately reduces the unearned revenue balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Print
Subscriptions</i> &#8211; The Company sells magazines to consumers through subscriptions. Each copy of a magazine is determined to be
a distinct performance obligation that is satisfied when the publication is sent to the customer. The majority of the Company&#8217;s
subscription sales are prepaid at the time of order. Subscriptions may be canceled at any time for a refund of the price paid for remaining
issues. As the contract may be canceled at any time for a full refund of the unserved copies, the contract term is determined to be on
an issue-to-issue basis as these contracts do not have substantive termination penalties. Revenues from subscriptions are deferred and
recognized proportionately as subscribers are served. Some magazine subscription offers contain more than one magazine title in a bundle.
The Company allocates the total contract consideration to each distinct performance obligation, or magazine title, based on a standalone-selling
price basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Newsstand
</i>&#8211; The Company sells single copy magazines, or bundles of single copy magazines, to wholesalers for ultimate resale on newsstands
primarily at major retailers and grocery/drug stores, and in digital form on tablets and other electronic devices. Publications sold
to magazine wholesalers are sold with the right to receive credit from the Company for magazines returned to the wholesaler by retailers.
Revenue is recognized on the issue&#8217;s on-sale date as the date aligns most closely with the date that control is transferred to
the customer. The Company bases its estimates for returns on historical experience and current marketplace conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Licensing
and Syndication &#8211; </i>The Company has entered into various licensing and syndication agreements that provide third party
partners with the right to utilize the Company&#8217;s content. Functional licenses in national media consist of content
licensing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Timing
of Satisfaction of Performance Obligations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Point-in-Time
Performance Obligations &#8211; </i>For performance obligations related to certain digital advertising space and sales of print advertisements,
the Company determines that the customer can direct the use of and obtain substantially all the benefits from the advertising products
as the digital impressions are served or on the issue&#8217;s on-sale date. For performance obligations related to sales of magazines
through subscriptions, the customer obtains control when each magazine issue is mailed to the customer on or before the issue&#8217;s
on-sale date. For sales of single copy magazines on newsstands, revenue is recognized on the issue&#8217;s on-sale date as the date aligns
most closely with the date that control is transferred to the customer. Revenues from functional licenses and syndication arrangements
are recognized at a point-in-time when access to the completed content is granted to the partner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Over-Time
Performance Obligations</i> <b>&#8211; </b>For performance obligations related to sales of certain digital advertising space, the Company
transfers control and recognizes revenue over time by measuring progress towards complete satisfaction using the most appropriate method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
performance obligations related to digital advertising, the Company satisfies its performance obligations on some flat-fee digital advertising
placements over time using a time-elapsed output method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determining
a measure of progress requires management to make judgments that affect the timing of revenue recognized. The Company has determined
that the above method provides a faithful depiction of the transfer of goods or services to the customer. For performance obligations
recognized using a time-elapsed output method, the Company&#8217;s efforts are expended evenly throughout the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
obligations related to subscriptions to premium content on the digital media channels provides access for a given period of time, which
is generally one year. The Company recognizes revenue from each membership subscription over time based on a daily calculation of revenue
during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transaction
Price and Amounts Allocated to Performance Obligations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Determining
the Transaction Price &#8211; </i>Certain advertising contracts contain variable components of the transaction price, such as volume
discounts and rebates. The Company has sufficient historical data and has established processes to reliably estimate these variable components
of the transaction price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
revenue generated from the flagship website <i>TheStreet.com</i> is subject to estimation and variability due to the fact that, in the
normal course of business, subscribers may for various reasons contact the Company or their credit card companies to request a refund
or other adjustment for a previously purchased subscription. With respect to many of the Company&#8217;s annual newsletter subscription
products, the Company offers the ability to receive a refund during the first 30 days but none thereafter. Accordingly, the Company maintains
a provision for estimated future revenue reductions resulting from expected refunds and chargebacks related to subscriptions for which
revenue was recognized in a prior period. The calculation of this provision is based upon historical trends and is reevaluated each quarter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company typically does not offer any type of variable consideration in standard magazine subscription contracts. For these contracts,
the transaction price is fixed upon establishment of the contract that contains the final terms of the sale including description, quantity
and price of each subscription purchased. Therefore, the Company does not estimate variable consideration or perform a constraint analysis
for these contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
right of return exists for newsstand contracts. The Company has sufficient historical data to estimate the final amount of returns and
reduces the transaction price at contract inception for the expected return reserve.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no variable consideration related to functional licenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Estimating
Standalone-Selling Prices</i> <b>&#8211; </b>For contracts that contain multiple performance obligations, the Company allocates the transaction
price to each performance obligation on a relative standalone-selling price basis. The standalone-selling price is the price at which
the Company would sell a promised good or service separately to the customer. In situations in which an obligation is bundled with other
obligations and the total amount of consideration does not reflect the sum of individual observable prices, the Company allocates the
discount to (1) a single obligation if the discount is attributable to that obligation or (2) prorates across all obligations if the
discount relates to the bundle. When standalone-selling price is not directly observable, the Company estimates and considers all the
information that is reasonably available to the Company, including market conditions, entity specific factors, customer information,
etc. The Company maximizes the use of observable inputs and applies estimation methods consistently in similar circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Measuring
Obligations for Returns and Refunds</i> &#8211; The Company accepts product returns in some cases. The Company establishes provisions
for estimated returns concurrently with the recognition of revenue. The provisions are established based upon consideration of a variety
of factors, including, among other things, recent and historical return rates for both specific products and distributors and the impact
of any new product releases and projected economic conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023 and 2022, a subscription refund liability of $<span id="xdx_903_eus-gaap--ContractWithCustomerRefundLiabilityCurrent_iI_pn3n3_c20231231_zPBgu0X43SHc" title="Subscription refund liability"><ix:nonFraction name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" contextRef="AsOf2023-12-31" id="Fact000841" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">449</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--ContractWithCustomerRefundLiabilityCurrent_iI_pn3n3_c20221231_zn36hWjiWCki" title="Subscription refund liability"><ix:nonFraction name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" contextRef="AsOf2022-12-31" id="Fact000843" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">845</ix:nonFraction></span>, respectively, was recorded for the provision for the
estimated returns and refunds on the consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Contract
Modifications</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company occasionally enters into amendments to previously executed contracts that constitute contract modifications. The Company assesses
each of these contract modifications to determine:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the additional services and goods are distinct from the services and goods in the original arrangement; and</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the amount of consideration expected for the added services or goods reflects the stand-alone selling price of those services and
    goods.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
contract modification meeting both criteria is accounted for as a separate contract. A contract modification not meeting both criteria
is considered a change to the original contract and is accounted for on either a prospective basis as a termination of the existing contract
and the creation of a new contract, or a cumulative catch-up basis (further details are provided under the headings <i>Contract Balances
</i>and <i>Subscription Acquisition Costs</i>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Disaggregation
of Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000845" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><p id="xdx_895_eus-gaap--DisaggregationOfRevenueTableTextBlock_zqIHuXdmsySi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information about disaggregated revenue by category, geographical market and timing of revenue recognition:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_z6Kcyvj050lh" style="display: none">Schedule
of Disaggregation of Revenue</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230101__20231231_zkXxx6cmdky8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20221231_ztGAhuYNbwml" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Revenue by category:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><b>Digital revenue</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalAdvertisingMember_zo01p5dvBfP" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 60%; text-align: justify">Digital advertising</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_custom_DigitalAdvertisingMember" id="Fact000847" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">135,376</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_DigitalAdvertisingMember" id="Fact000848" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">109,317</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalSubscriptionsMember_zD0kRLElyCW" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Digital subscriptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_custom_DigitalSubscriptionsMember" id="Fact000850" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,764</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_DigitalSubscriptionsMember" id="Fact000851" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,156</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--LicensingAndSyndicationRevenueMember_zfNDuHqh6Ld8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Licensing and syndication revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_custom_LicensingAndSyndicationRevenueMember" id="Fact000853" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,482</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_LicensingAndSyndicationRevenueMember" id="Fact000854" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,173</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__us-gaap--ProductAndServiceOtherMember_zx2y2DOEFCp1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Other digital revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_us-gaap_ProductAndServiceOtherMember" id="Fact000856" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,384</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_us-gaap_ProductAndServiceOtherMember" id="Fact000857" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,166</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zgsNr7azyhMl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify; padding-bottom: 1.5pt">Total digital revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_custom_DigitalRevenueMember" id="Fact000859" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">172,006</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_DigitalRevenueMember" id="Fact000860" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">149,812</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><b>Print revenue</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintAdvertisingMember_zbRG7M168fX4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Print advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_custom_PrintAdvertisingMember" id="Fact000862" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,881</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_PrintAdvertisingMember" id="Fact000863" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,214</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintSubscriptionsMember_zv5dvOGnfQz2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Print subscriptions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_custom_PrintSubscriptionsMember" id="Fact000865" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62,316</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_PrintSubscriptionsMember" id="Fact000866" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60,909</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_zzQN9CQzquF8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify; padding-bottom: 1.5pt">Total print revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_custom_PrintRevenueMember" id="Fact000868" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72,197</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_PrintRevenueMember" id="Fact000869" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">71,123</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zUzRiEu6CZTh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-01to2023-12-31" id="Fact000871" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244,203</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31" id="Fact000872" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">220,935</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Revenue by geographical market:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__country--US_zKX1xgZJTcp9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_country_US" id="Fact000874" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">234,012</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_country_US" id="Fact000875" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">218,110</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__custom--OtherMember_zS4cb0vzdZL4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_custom_OtherMember" id="Fact000877" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,191</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_OtherMember" id="Fact000878" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,825</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zgadvHNx3Wz9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-01to2023-12-31" id="Fact000880" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244,203</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31" id="Fact000881" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">220,935</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Revenue by timing of recognition:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_zumKpCgm0fo5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">At point in time</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_us-gaap_TransferredAtPointInTimeMember" id="Fact000883" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">231,439</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_us-gaap_TransferredAtPointInTimeMember" id="Fact000884" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">199,779</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zpFUGfTLJXS6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Over time</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_us-gaap_TransferredOverTimeMember" id="Fact000886" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,764</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_us-gaap_TransferredOverTimeMember" id="Fact000887" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,156</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zmjvuJAzMUPa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0pt; text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-01to2023-12-31" id="Fact000889" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244,203</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31" id="Fact000890" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">220,935</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zErk4ulyJWh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000892" name="AREN:CostOfRevenuePolicyTextBlock"><p id="xdx_849_ecustom--CostOfRevenuePolicyTextBlock_zBsWZ7XiYoJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zMoE01NyV7Ge">Cost
of Revenue</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenue represents the cost of providing the Company&#8217;s digital media channels and advertising and membership services. The cost
of revenue that the Company has incurred in the periods presented primarily include: Publisher Partner guarantees and revenue share payments;
amortization of developed technology and platform development; royalty fees; hosting and bandwidth and software license fees; printing
and distribution costs; payroll and related expenses for customer support, technology maintenance; fees paid for data analytics and to
other outside service providers; and stock-based compensation of related personnel (as described in Note 22).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000894" name="AREN:ContractBalancesPolicyTextBlock"><p id="xdx_844_ecustom--ContractBalancesPolicyTextBlock_zyCXvDn3m8ee" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zZnVYYxSPCql">Contract
Balances</span> </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
timing of the Company&#8217;s performance under its various contracts often differs from the timing of the customer&#8217;s payment,
which results in the recognition of a contract asset or a contract liability. A contract asset is recognized when a good or service is
transferred to a customer and the Company does not have the contractual right to bill for the related performance obligations. An asset
is recognized when certain costs incurred to obtain a contract meet the capitalization criteria (further details are provided under the
heading <i>Subscription Acquisition Costs</i>). A contract liability is recognized when consideration is received from the customer prior
to the transfer of goods or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000896" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock"><p id="xdx_898_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_zaHl7ipmaYU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information about contract balances:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zB03ZNauj0wc" style="display: none">Schedule
of Contract with Customer, Asset and Liability</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20231231_zaeO3S0cr5pd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20221231_z3Gw4AyXnoya" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unearned revenue (short-term contract liabilities):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zNXnIczbDXRb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Digital revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2023-12-31_custom_DigitalRevenueMember" id="Fact000898" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,397</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2022-12-31_custom_DigitalRevenueMember" id="Fact000899" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,571</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_z7Oqs9MAbBK9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Print revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2023-12-31_custom_PrintRevenueMember" id="Fact000901" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45,389</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2022-12-31_custom_PrintRevenueMember" id="Fact000902" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,132</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_z1TaModhTRyk" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total short-term contract
    liabilities</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2023-12-31" id="Fact000904" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59,786</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2022-12-31" id="Fact000905" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58,703</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unearned revenue (long-term contract liabilities):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zce7hTDFpFCe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Digital revenue</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="AsOf2023-12-31_custom_DigitalRevenueMember" id="Fact000907" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">542</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="AsOf2022-12-31_custom_DigitalRevenueMember" id="Fact000908" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,118</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_zUy5wqyC5QDa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Print revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="AsOf2023-12-31_custom_PrintRevenueMember" id="Fact000910" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,137</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="AsOf2022-12-31_custom_PrintRevenueMember" id="Fact000911" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,583</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_zxVz3y32mAu9" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total long-term contract
    liabilities</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="AsOf2023-12-31" id="Fact000913" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,679</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="AsOf2022-12-31" id="Fact000914" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,701</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zGBCCJVDLCcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unearned
Revenue</i> &#8211; Unearned revenue, also referred to as contract liabilities, include payments received in advance of performance under
the contracts and are recognized as revenue over time. The Company records contract liabilities as unearned revenue on the consolidated
balance sheets. Digital subscription and print subscription revenue of $<span id="xdx_901_ecustom--UnearnedRevenue_iI_pn3n3_c20231231__srt--ProductOrServiceAxis__custom--DigitalAndPrintSubscriptionsMember_zavJ3vDtUiH8" title="Contract with customer liability noncurrent"><ix:nonFraction name="AREN:UnearnedRevenue" contextRef="AsOf2023-12-31_custom_DigitalAndPrintSubscriptionsMember" id="Fact000916" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">68,985</ix:nonFraction></span> was recognized during the year ended December 31, 2023
from unearned revenue at the beginning of the year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
January 2020, February 2020 and December 2021, the Company modified certain digital and print subscription contracts that prospectively
changed the frequency of the related issues (or magazines) required to be delivered on a yearly basis (the &#8220;Contract Modifications&#8221;).
The Company determined that the remaining digital content and magazines to be delivered are distinct from the digital content or magazines
already provided under the original contract. As a result, the Company in effect established a new contract that included only the remaining
digital content or magazines. Accordingly, the Company allocated the remaining performance obligations in the contracts as consideration
from the original contract that has not yet been recognized as revenue. For the years ended December 31, 2023 and 2022, the Company recognized
revenue of $<span id="xdx_90E_eus-gaap--ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_pn3n3_c20230101__20231231_zJWXinQwW492" title="Contract modification - revenue"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" contextRef="From2023-01-01to2023-12-31" id="Fact000918" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">554</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_pn3n3_c20220101__20221231_zDp3CYXxDNIk" title="Contract modification - revenue"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" contextRef="From2022-01-012022-12-31" id="Fact000920" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,986</ix:nonFraction></span>, respectively, resulting from the Contract Modifications.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000922" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"><p id="xdx_84B_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_z9UwVGtuxJeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zAzFgaT3AaBg">Cash,
Cash Equivalents, and Restricted Cash</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains cash, cash equivalents, and restricted cash at banks where amounts on deposit may exceed the Federal Deposit Insurance
Corporation limit during the year. Cash and cash equivalents represent cash and highly liquid investments with an original contractual
maturity at the date of purchase of three months. As of December 31, 2023 and 2022, cash and cash equivalents consist primarily of checking,
savings deposits and money market accounts. These deposits exceeded federally insured limits. The Company has not experienced any losses
in such accounts and believes it is not exposed to significant credit risk regarding its cash and cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000924" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_zWFdppVl58t5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reconciles total cash, cash equivalents, and restricted cash:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zTCWT3MYdZO7" style="display: none">Schedule
of Cash and Restricted Cash</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20231231_zUskfSfE2iV1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20221231_znUZ7fvHtDW2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_zno6kDP5lx" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact000926" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,284</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31" id="Fact000927" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,871</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RestrictedCashCurrent_iI_pn3n3_zdHIlDDBpFjf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0929">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RestrictedCashCurrent" contextRef="AsOf2022-12-31" id="Fact000930" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">502</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_zznDqR4ifFL" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total cash, cash equivalents, and restricted cash</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-12-31" id="Fact000932" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,284</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-12-31" id="Fact000933" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,373</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_z4OLwY6zlTZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023 and 2022, the Company had restricted cash of $<span id="xdx_900_eus-gaap--RestrictedCashCurrent_iI_pn3n3_dxL_c20231231_zOooSWMkC0Wa" title="Restricted cash::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0935">0</span></span> and $<span id="xdx_901_eus-gaap--RestrictedCashCurrent_iI_pn3n3_c20221231_zl4OXUGn5BEj" title="Restricted cash"><ix:nonFraction name="us-gaap:RestrictedCashCurrent" contextRef="AsOf2022-12-31" id="Fact000937" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">502</ix:nonFraction></span>, which served as collateral for certain credit card merchant
accounts with a bank.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000939" name="us-gaap:TradeAndOtherAccountsReceivablePolicy"><p id="xdx_84C_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zS2uwglgvJDc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_z8Sbs2Iwcjt7">Accounts
Receivable and Allowance for Doubtful Accounts</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company receives payments from advertising customers based upon contractual payment terms; accounts receivable is recorded when the right
to consideration becomes unconditional and are generally collected within 90 days. The Company generally receives payments from digital
and print subscription customers at the time of sign up for each subscription; accounts receivable from merchant credit card processors
are recorded when the right to consideration becomes unconditional and are generally collected weekly. Accounts receivable have been
reduced by an allowance for doubtful accounts. The Company maintains the allowance for estimated losses resulting from the inability
of the Company&#8217;s customers to make required payments. The allowance represents the current estimate of lifetime expected credit
losses over the remaining duration of existing accounts receivable considering current market conditions and supportable forecasts when
appropriate. The estimate is a result of the Company&#8217;s ongoing evaluation of collectability, customer creditworthiness, historical
levels of credit losses, and future expectations. Accounts receivable are written off when deemed uncollectible and collection of the
receivable is no longer being actively pursued. Accounts receivable as of December 31, 2023 and 2022 of $<span id="xdx_90F_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20231231_zl4wAyzTyJxj" title="Accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-12-31" id="Fact000941" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,811</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20221231_zk8tBgn9UdK9" title="Accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-12-31" id="Fact000943" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,950</ix:nonFraction></span>, respectively,
are presented net of allowance for doubtful accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000945" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock"><p id="xdx_89D_eus-gaap--AccountsReceivableAllowanceForCreditLossTableTextBlock_zE6UsT17gkr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the allowance for doubtful accounts activity:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_8BF_zEgFA9pr0K7c" style="display: none">Schedule
of Allowance For Doubtful Accounts</span></i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230101__20231231_z2oNAD11QwDd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220101__20221231_zEvHgtnlkRJb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pn3n3_z52Kpe9D4YZ1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Allowance for doubtful accounts beginning of year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-12-31" id="Fact000947" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,236</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-12-31" id="Fact000948" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,578</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_pn3n3_zbWpUqbjztzi" style="vertical-align: bottom; background-color: White">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" contextRef="From2023-01-01to2023-12-31" id="Fact000950" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">315</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" contextRef="From2022-01-012022-12-31" id="Fact000951" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">658</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_pn3n3_di_zVYZVuWNQZE7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Deductions - write-offs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" contextRef="From2023-01-01to2023-12-31" id="Fact000953" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,570</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0954">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pn3n3_zAW7wIVI4Tvi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Allowance for doubtful accounts end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-12-31" id="Fact000956" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">981</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-12-31" id="Fact000957" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,236</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_z90ATvKk8wH" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000959" name="AREN:SubscriptionAcquisitionCostsPoliceTextBlock"><p id="xdx_844_ecustom--SubscriptionAcquisitionCostsPoliceTextBlock_z22oJSGvtoSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zKboqtjKDKK1">Subscription
Acquisition Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
acquisition costs include the incremental costs of obtaining a contract with a customer, paid to external parties, if the Company
expects to recover those costs. The Company has determined that sales commissions paid on all third party agent sales of
subscriptions are direct and incremental costs of obtaining a contract with a customer and, therefore, meet the capitalization
criteria. The Company has elected to apply the practical expedient to amortize these costs at the portfolio level. The sales
commissions paid to third party agents are amortized as the magazines are sent to the subscriber on an issue-by-issue basis. The
Company determined that commissions paid for subscriber renewal contracts to all third party agents are not from a specifically
anticipated future contract, therefore, the commissions paid on renewals are amortized as the magazines are sent to the subscriber
over the renewal term on an issue-by-issue basis. Direct mail costs for renewal subscriptions are expensed as incurred since they do
not meet the capitalization criteria.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
of subscription acquisition costs of $<span id="xdx_900_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20230101__20231231_z3yqarK4qbT2" title="Amortization subscription costs"><ix:nonFraction name="us-gaap:CapitalizedContractCostAmortization" contextRef="From2023-01-01to2023-12-31" id="Fact000961" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,112</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20220101__20221231_zetPKUQdqnV" title="Amortization subscription costs"><ix:nonFraction name="us-gaap:CapitalizedContractCostAmortization" contextRef="From2022-01-012022-12-31" id="Fact000963" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,190</ix:nonFraction></span> for the years ended December 31, 2023 and 2022, respectively, are included within
selling and marketing expenses on the consolidated statements of operations. No impairment losses have been recognized for subscription
acquisition costs for the years ended December 31, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Contract Modifications resulted in subscription acquisition costs to be recognized on a prospective basis in the same proportion as the
revenue that has not yet been recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current portion of the subscription acquisition costs as of December 31, 2023 and 2022 was $<span id="xdx_90D_eus-gaap--CapitalizedContractCostNet_iI_pn3n3_c20231231_zuQHX4IgjvLj" title="Subscription acquisition cost"><ix:nonFraction name="us-gaap:CapitalizedContractCostNet" contextRef="AsOf2023-12-31" id="Fact000965" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,706</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--CapitalizedContractCostNet_iI_pn3n3_c20221231_zHgzmcuDTO2c" title="Subscription acquisition cost"><ix:nonFraction name="us-gaap:CapitalizedContractCostNet" contextRef="AsOf2022-12-31" id="Fact000967" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,931</ix:nonFraction></span>, respectively. The noncurrent
portion of the subscription acquisition costs as of December 31, 2023 and 2022 was $<span id="xdx_90F_eus-gaap--CapitalizedContractCostNetNoncurrent_iI_pn3n3_c20231231_zuQZ8za8uVQ1" title="Acquisition cost long term"><ix:nonFraction name="us-gaap:CapitalizedContractCostNetNoncurrent" contextRef="AsOf2023-12-31" id="Fact000969" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,215</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--CapitalizedContractCostNetNoncurrent_iI_pn3n3_c20221231_zT9PoCGd3K8" title="Subscription acquisition cost noncurrent"><ix:nonFraction name="us-gaap:CapitalizedContractCostNetNoncurrent" contextRef="AsOf2022-12-31" id="Fact000971" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,133</ix:nonFraction></span>, respectively. Subscription acquisition
costs as of December 31, 2023 presented as current assets of $<span id="xdx_90F_eus-gaap--CapitalizedContractCostNetCurrent_iI_pn3n3_c20231231_zo1MLlajxgTa" title="Subscription acquisition cost current"><ix:nonFraction name="us-gaap:CapitalizedContractCostNetCurrent" contextRef="AsOf2023-12-31" id="Fact000973" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,706</ix:nonFraction></span> are expected to be amortized over a one-year period, or through
December 31, 2024, and presented as long-term assets of $<span id="xdx_903_eus-gaap--CapitalizedContractCostNetNoncurrent_iI_pn3n3_c20231231_zxsAKyrm7EHd" title="Acquisition cost long term"><ix:nonFraction name="us-gaap:CapitalizedContractCostNetNoncurrent" contextRef="AsOf2023-12-31" id="Fact000975" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,215</ix:nonFraction></span> are expected to be amortized after the one-year period ending December
31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000977" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zuFwj24pNbIb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zdfqSnGTBc5i">Concentrations</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Significant
Customers</i> &#8211; Concentration of credit risk with respect to accounts receivable is limited to customers to whom the Company makes
significant sales. While a reserve for the potential write-off of accounts receivable is maintained, the Company has not written off
any material accounts to date. To control credit risk, the Company performs regular credit evaluations of its customers&#8217; financial
condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Revenue from significant customers
as a percentage of the Company&#8217;s total revenue represent approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zThted2Odbo8" title="Percentage of revenue"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember" id="Fact000979" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.0</ix:nonFraction>%</span> from a customer for the year ended December 31,
2023. Revenue from significant customers as a percentage of the Company&#8217;s total revenue represent <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_ziHFVgMQvzek" title="Percentage of revenue"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember" id="Fact000981" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13.9</ix:nonFraction></span>%
from a customer for the year ended December 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Significant
Vendors</i> &#8211; Concentrations of risk with respect to third party vendors who provide products and services to the Company are limited.
If not limited, such concentrations could impact profitability if a vendor failed to fulfill their obligations or if a significant vendor
was unable to renew an existing contract and the Company was not able to replace the related product or service at the same cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
accounts payable balances as a percentage of the Company&#8217;s total accounts payable represent <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zLCCYvLPg5sa" title="Percentage of revenue"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember" id="Fact000983" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.2</ix:nonFraction></span>%, and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zt1aDfZZD7h8" title="Percentage of revenue"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember" id="Fact000985" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">14.1</ix:nonFraction></span>% from a vendor for
the years ended December 31, 2023, and 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000987" name="us-gaap:LesseeLeasesPolicyTextBlock"><p id="xdx_84D_eus-gaap--LesseeLeasesPolicyTextBlock_zgFMOy83caE9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zaJmjfnbPHh1">Leases</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has lease arrangements for its offices. Leases are recorded as an operating lease right-of-use assets and
operating lease liabilities on the consolidated balance sheets. Leases with an initial term of 12 months or less are not recorded on
the consolidated balance sheets. At inception, the Company determines whether an arrangement that provides control over the use of an
asset is a lease. When it is reasonably certain that the Company will exercise the renewal period, the Company includes the impact of
the renewal in the lease term for purposes of determining total future lease payments. Rent expense is recognized on a straight-line
basis over the lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000989" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zDl5ILyJlW6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zfB4YD9VIXwd">Property
and Equipment</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment is stated at cost less accumulated depreciation. Maintenance and repairs are charged to expense as incurred. Gains and
losses from disposition of property and equipment are included on the consolidated statements of operations when realized.
Depreciation and amortization are provided using the straight-line method over the following estimated useful lives:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000991" name="AREN:ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock"><p id="xdx_89B_ecustom--ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock_zW0c7n0xBdG" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zTBFGihIfjp5" style="display: none">Schedule
of Depreciation and Amortization, Useful Lives of Assets</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; background-color: white; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Office equipment and computers</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember__srt--RangeAxis__srt--MinimumMember_zcxEM3qmqqvh" title="Property plant and equipment useful life"><ix:nonNumeric contextRef="AsOf2023-12-31_custom_OfficeEquipmentAndComputersMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact000993" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">1</ix:nonNumeric></span>
    &#8211; <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember__srt--RangeAxis__srt--MaximumMember_zJxfuGiMd98k" title="Property plant and equipment useful life"><ix:nonNumeric contextRef="AsOf2023-12-31_custom_OfficeEquipmentAndComputersMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact000995" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span> years </span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Furniture and fixtures</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zswoOMa1XqJ5" title="Property plant and equipment useful life"><ix:nonNumeric contextRef="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact000997" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">1</ix:nonNumeric></span>
    &#8211; <span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_ziKDN4X4JdCf" title="Property plant and equipment useful life"><ix:nonNumeric contextRef="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact000999" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span> years </span></td>
    </tr>
  </table>
</ix:nonNumeric><p id="xdx_8A9_zMfJETCLDmIl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001001" name="AREN:PlatformDevelopmentPolicyTextBlock"><p id="xdx_846_ecustom--PlatformDevelopmentPolicyTextBlock_zy56NXyb0kWf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zyaIkOWXtRzd">Platform
Development</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes platform development costs for internal use when planning and design efforts are successfully completed, and development
is ready to commence. The Company places capitalized platform development assets into service and commences amortization when the applicable
project or asset is substantially complete and ready for its intended use. Once placed into service, the Company capitalizes qualifying
costs of specified upgrades or enhancements to capitalized platform development assets when the upgrade or enhancement will result in
new or additional functionality.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes internal labor costs, including payroll-based and stock-based compensation, benefits and payroll taxes, that are
incurred for certain capitalized platform development projects related to the Platform. The Company&#8217;s policy with respect to capitalized
internal labor stipulates that labor costs for employees working on eligible internal use capital projects are capitalized as part of
the historical cost of the project when the impact, as compared to expensing such labor costs, is material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Platform
development costs are amortized on a straight-line basis over three years, which is the estimated useful life of the related asset and
is recorded in cost of revenue on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001003" name="us-gaap:BusinessCombinationsPolicy"><p id="xdx_845_eus-gaap--BusinessCombinationsPolicy_zT2MpaT5HXH9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zJI7DmkaUBF4">Business
Combinations</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for business combinations using the acquisition method of accounting. The acquisition method of accounting requires
that the purchase price, including the fair value of contingent consideration, of the acquisition be allocated to the assets acquired
and liabilities assumed using the estimated fair values determined by management as of the acquisition date. Goodwill is measured as
the excess of consideration transferred and the net fair values of the assets acquired, and the liabilities assumed at the date of acquisition.
While the Company uses its best estimates and assumptions as part of the purchase price allocation process to accurately value assets
acquired and liabilities assumed at the acquisition date, the Company&#8217;s estimates are inherently uncertain and subject to refinement.
As a result, during the measurement period, the Company records adjustments to the assets acquired and liabilities assumed, with the
corresponding offset to goodwill to the extent the Company identifies adjustments to the preliminary purchase price allocation. Upon
the conclusion of the measurement period, which may be up to one year from the acquisition date, or final determination of the values
of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements
of operations. Additionally, the Company identifies acquisition-related contingent payments and determines their respective fair values
as of the acquisition date, which are recorded as accrued liabilities on the consolidated balance sheets. Subsequent changes in fair
value of contingent payments are recorded on the consolidated statements of operations. The Company expenses transaction costs related
to the acquisition as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001005" name="us-gaap:IntangibleAssetsFiniteLivedPolicy"><p id="xdx_849_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zRmHtX5pTvZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zer3MX8n32Zc">Intangible
Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets with finite lives, consisting of developed technology and trade names, are amortized using the straight-line method over the estimated
economic lives of the assets. A finite lived intangible asset is tested for recoverability whenever events or changes in circumstances
indicate that its carrying amount may not be recoverable. Determination of recoverability is based on an estimate of undiscounted future
cash flows resulting from the use of the asset and its eventual disposition. Intangible assets with an indefinite useful life are not
amortized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001007" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zKkJeRxhDs7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zvWY7l29zly8">Long-Lived
Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company periodically evaluates the carrying value of long-lived assets to be held and used when events or circumstances warrant such
a review. The carrying value of a long-lived asset to be held and used is considered impaired when the anticipated separately identifiable
undiscounted cash flows from such an asset are less than the carrying value of the asset. In that event, a loss is recognized based on
the amount by which the carrying value exceeds the fair value of the long-lived asset. Fair value is determined primarily by reference
to the anticipated cash flows discounted at a rate commensurate with the risk involved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001009" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy"><p id="xdx_844_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zqeKGDJnsdl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_z2AQsN3mg3vf">Goodwill</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
represents the excess of the purchase price over the fair value of the net tangible and intangible assets of businesses acquired in a
business combination. Goodwill is not amortized but rather is tested for impairment at least annually on December 31, or more frequently
if events or changes in circumstances indicate that the carrying amount of goodwill may not be recoverable. The Company operates as one
reporting unit, therefore, the impairment test is performed at the consolidated entity level. Recoverability of goodwill is determined
by comparing the fair value of Company&#8217;s reporting unit to the carrying value of the underlying net assets in the reporting unit.
If the fair value of the reporting unit is determined to be less than the carrying value of its net assets, goodwill is deemed impaired,
and an impairment loss is recognized to the extent that the carrying value of goodwill exceeds the difference between the fair value
of the reporting unit and the fair value of its other assets and liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001011" name="us-gaap:DebtPolicyTextBlock"><p id="xdx_849_eus-gaap--DebtPolicyTextBlock_zSYHH4D9R5m2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zsLTIsIEsTe5">Debt
Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt
costs consist of cash and noncash consideration paid to lenders and third parties with respect to debt and other financing transactions,
including legal fees and placement fees. Such costs are deferred and amortized over the term of the related debt. Upon the settlement
of debt the pro rata portion of any related unamortized debt costs are charged to operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
consideration in the form of warrants and other derivative financial instruments issued to lenders are accounted for at fair value utilizing
information determined by consultants with the Company&#8217;s independent valuation firm. The fair value of warrants and derivatives
are recorded as a reduction to the carrying amount of the related debt and amortized to interest expense over the term of such debt,
with the initial offsetting entries recorded as a liability on the balance sheet. Upon the settlement of the debt the pro rata portion
of any related unamortized debt cost is charged to operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001013" name="AREN:LiquidatedDamagesPolicyTextBlock"><p id="xdx_844_ecustom--LiquidatedDamagesPolicyTextBlock_zO8iSJcjfLf1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z8RIaUQLlYs4">Liquidated
Damages</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--LiquidatedDamagesDescription_c20230101__20231231_zonRRIz47iA3" title="Liquidated damages description"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact001015" name="AREN:LiquidatedDamagesDescription">The
Company incurred liquidated damages when: (i) a registration rights agreement provides for damages if the Company does not register the
shares of the Company&#8217;s common stock within the requisite time frame (the &#8220;Registration Rights Damages&#8221;), which, in
general, provides for a cash payment equal to 1.0% per month of the amount invested, on a daily pro rata basis for any portion of a month,
as partial liquidated damages per month, upon the occurrence of certain events, up to a maximum amount of 6.0% of the aggregate amount
invested, subject to interest at the rate of 1.0% per month until paid in full; and (ii) a securities purchase agreement provides for
damages if the Company fails for any reason to satisfy a public information requirement within the requisite time frame with the Securities
and Exchange Commission (&#8220;SEC&#8221;) (the &#8220;Public Information Failure Damages&#8221;), which, in general, provides for a
cash payment equal to 1.0% of the aggregate amount invested for each 30-day period, or pro rata portion thereof, as partial liquidated
damages per month, up to a maximum of 6 months, subject to interest at the rate of 1.0% per month until paid in full.</ix:nonNumeric> </span>Collectively, the
Registration Rights Damages and the Public Information Failure Damages are referred to as the &#8220;Liquidated Damages&#8221; on the
consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001017" name="AREN:SellingAndMarketingPolicyTextBlock"><p id="xdx_844_ecustom--SellingAndMarketingPolicyTextBlock_z0QK2t5Wt1Td" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_z3MWHRefDrKh">Selling
and Marketing</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
and marketing expenses consist of compensation, employee benefits and stock-based compensation of selling and marketing, account management
support teams, as well as commissions, travel, trade show sponsorships and events, conferences and advertising costs. The Company&#8217;s
advertising expenses relate to direct-mail costs for magazine subscription acquisition efforts, and print and digital advertising that
are expensed when an advertisement takes place. During the years ended December 31, 2023 and 2022, the Company incurred advertising expenses
of $<span id="xdx_90B_eus-gaap--AdvertisingExpense_pn3n3_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zPoX2qm3OAc8" title="Advertising expense"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2023-01-012023-12-31_us-gaap_SellingAndMarketingExpenseMember" id="Fact001019" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,372</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--AdvertisingExpense_pn3n3_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zxjpFaaFJ06g" title="Advertising expense"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2022-01-012022-12-31_us-gaap_SellingAndMarketingExpenseMember" id="Fact001021" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,987</ix:nonFraction></span>, respectively, which are included within selling and marketing on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001023" name="AREN:GeneralandAdministrativePolicyTextBlock"><p id="xdx_84A_ecustom--GeneralandAdministrativePolicyTextBlock_zCq43ynBTIca" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zHESIMYAoQnd">General
and Administrative</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses consist primarily of payroll for executive personnel, technology personnel incurred in developing conceptual
formulation and determination of existence of needed technology, and administrative personnel along with any related payroll costs; professional
services, including accounting, legal and insurance; facilities costs; conferences; other general corporate expenses; and stock-based
compensation of related personnel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001025" name="us-gaap:DerivativesPolicyTextBlock"><p id="xdx_84A_eus-gaap--DerivativesPolicyTextBlock_z3pQuzSXL8qj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zfzZMmqi8hhf">Derivative
Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for freestanding contracts that are settleable in the Company&#8217;s equity securities, including the put option
on the Company&#8217;s common stock, to be designated as an equity instrument, generally as a liability. A contract so
designated is carried at fair value on the consolidated balance sheets, with any changes in fair value recorded as a gain or loss
on the consolidated statements of operations, with no impact on cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the date of settlement of a freestanding equity contract, the pro rata fair value of the related liability is transferred to additional
paid-in capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001027" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zmMSvz7HBx56" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zzFyoRQo3clh">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
authoritative guidance with respect to fair value established a fair value hierarchy that prioritizes the inputs to valuation techniques
used to measure fair value into three levels and requires that assets and liabilities carried at fair value be classified and disclosed
in one of three categories, as presented below. Disclosure as to transfers in and out of Levels 1 and 2, and activity in Level 3 fair
value measurements, is also required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
1</i>. Observable inputs such as quoted prices in active markets for an identical asset or liability that the Company has the ability
to access as of the measurement date. Financial assets and liabilities utilizing Level 1 inputs include active-exchange traded securities
and exchange-based derivatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
2</i>. Inputs, other than quoted prices included within Level 1, which are directly observable for the asset or liability or indirectly
observable through corroboration with observable market data. Financial assets and liabilities utilizing Level 2 inputs include fixed
income securities, non-exchange-based derivatives, mutual funds, and fair-value hedges.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
3</i>. Unobservable inputs in which there is little or no market data for the asset or liability which requires the reporting entity
to develop its own assumptions. Financial assets and liabilities utilizing Level 3 inputs include infrequently traded non-exchange-based
derivatives and commingled investment funds and are measured using present value pricing models.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines the level in the fair value hierarchy within which each fair value measurement falls in its entirety, based on the
lowest level input that is significant to the fair value measurement in its entirety. In determining the appropriate levels, the Company
performs an analysis of the assets and liabilities at each reporting period end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of the Company&#8217;s financial instruments comprising of cash, restricted cash, accounts receivable, accounts payable
and accrued expenses and other approximate fair value because of the short-term maturity of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001029" name="AREN:PreferredStockPolicyTextBlock"><p id="xdx_84E_ecustom--PreferredStockPolicyTextBlock_zDlpskR8gWFg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zMpV7zgSR8na">Preferred
Stock</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
stock (the &#8220;Preferred Stock&#8221;) (as described in Note 20) is reported as a mezzanine obligation between liabilities and stockholders&#8217;
deficiency. If it becomes probable that the Preferred Stock will become redeemable, the Company will re-measure the Preferred Stock by
adjusting the carrying value to the redemption value of the Preferred Stock assuming each balance sheet date is a redemption date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001031" name="us-gaap:CompensationRelatedCostsPolicyTextBlock"><p id="xdx_84D_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zIuIuxLGOIB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zpSOz2pWbCmh">Stock-Based
Compensation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides stock-based compensation in the form of (a) stock awards to employees and directors, comprised of restricted stock awards
and restricted stock units, (b) stock option grants to employees, directors and consultants, (c) common stock warrants to Publisher Partners
(no warrants were issued during the year ended December 31, 2022) (further details are provided under the headings <i>Publisher Partner
Warrants</i> and <i>New Publisher Partner Warrants</i> in Note 22), and (d) common stock warrants to ABG (further details are provided
under the heading <i>ABG Warrants</i> in Note 22).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for stock awards and stock option grants to employees, directors and consultants, and non-employee awards to certain
directors and consultants by measuring the cost of services received in exchange for the stock-based payments as compensation expense
in the Company&#8217;s consolidated financial statements. Stock awards and stock option grants to employees and non-employees which are
time-vested, are measured at fair value on the grant date, and charged to operations ratably over the vesting period. Stock awards and
stock option grants to employees and non-employees which are performance-vested, are measured at fair value on the grant date and charged
to operations when the performance condition is satisfied or over the service period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value measurement of stock awards and grants used for stock-based compensation is as follows: (1) restricted stock awards and restricted
stock units which are time-vested, are determined using the quoted market price of the Company&#8217;s common stock at the grant date;
(2) stock option grants which are time-vested and performance-vested, are determined utilizing the Black-Scholes option-pricing model
at the grant date; (3) restricted stock units and stock option grants which provide for market-based vesting with a time-vesting overlay,
are determined through consultants with the Company&#8217;s independent valuation firm using the Monte Carlo model at the grant date;
(4) Publisher Partner Warrants were determined utilizing the Black-Scholes option-pricing model; and (5) ABG warrants are determined
utilizing the Monte Carlo model (further details are provided in Note 22). Estimated volatility was determined under the (1) &#8220;Probability
Weighted Scenarios&#8221; (prior to the reverse stock split on February 8, 2022) where one scenario assumes that the Company&#8217;s
common stock will be up-listed on a national stock exchange (the &#8220;Exchange&#8221;) on a certain listing date (the &#8220;Up-list&#8221;)
where the estimated volatility was based on evaluating the average historical volatility of a group of peer companies that are publicly
traded and the second scenario assumes that the Company&#8217;s common stock is not up-listed on the Exchange prior to the final vesting
date of the grants (the &#8220;No Up-list&#8221;) where the historical volatility of the Company&#8217;s common stock was evaluated based
upon market comparisons; and the (2) &#8220;Up-list Scenario&#8221; (after the reverse stock split on February 8, 2022) where the Company
estimated volatility based on evaluating the average historical volatility of a group of peer companies that are publicly traded after
the Company up-listed to the NYSE American. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time
of grant. The fair market value of common stock is determined by reference to the quoted market price of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has elected to recognize forfeitures as they occur and to recognize stock-based compensation cost on a straight-line basis over
the total requisite service period for awards with graded vesting. The Company classifies stock-based compensation cost on its consolidated
statements of operations in the same manner in which the award recipient&#8217;s cash compensation cost is classified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001033" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84F_eus-gaap--IncomeTaxPolicyTextBlock_zDKKsMkd28U" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zMvqGY6kRZR3">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the future
tax consequences attributable to operating loss carryforwards and temporary differences between financial statement bases of existing
assets and liabilities and their respective income tax bases. Deferred tax assets and liabilities are measured using enacted income tax
rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
The effect of a change in the income tax rates on deferred tax asset and liability balances is recognized in income in the period that
includes the enactment date of such rate change. A valuation allowance is recorded for loss carryforwards and other deferred tax assets
when it is determined that it is more likely than not that such loss carryforwards and deferred tax assets will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows accounting guidance that sets forth a threshold for financial statement recognition, measurement, and disclosure of a
tax position taken or expected to be taken on a tax return. Such guidance requires the Company to determine whether a tax position of
the Company is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any
related appeals or litigation processes, based on technical merits of the position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001035" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zW0EOEfnZsc4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zP4yJZ86ccOj">Loss
per Common Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
loss per share is computed using the weighted average number of common shares outstanding during the period and excludes any dilutive
effects of common stock equivalent shares, such as stock options, restricted stock, and warrants. All restricted stock awards are considered
outstanding but are included in the computation of basic loss per common share only when the restrictions expire, the shares are no longer
forfeitable, and are thus vested. Restricted stock units are included in the computation of basic loss per common share only when the
restrictions expire, the shares are no longer forfeitable, and are thus vested. Contingently issuable shares are included in basic loss
per common share only when there are no circumstances under which those shares would not be issued. Diluted loss per common share is
computed using the weighted average number of common shares outstanding and common stock equivalent shares outstanding during the period
using the treasury stock method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company excluded the outstanding securities summarized below (capitalized terms are described herein), which entitle the holders thereof
to acquire shares of the Company&#8217;s common stock, from its calculation of net loss per common share, as their effect would have
been anti-dilutive. Common stock equivalent shares are excluded from the diluted calculations when a net loss is incurred as they would
be anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001037" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zcNoxzT4AHKc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zUHosAth0BJk" style="display: none">Schedule of Net Income (Loss) Per Common Share</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Series G Preferred Stock</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesGConvertiblePreferredStockMember_zxS1HyVzT6Hg" title="Antidilutive securities excluded from computation of earnings per share amount" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31_custom_SeriesGConvertiblePreferredStockMember" id="Fact001039" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">8,582</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesGConvertiblePreferredStockMember_zy05uUvS9Bi8" title="Antidilutive securities excluded from computation of earnings per share amount" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_custom_SeriesGConvertiblePreferredStockMember" id="Fact001041" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">8,582</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series H Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_zs3G5RlmtVc5" title="Antidilutive securities excluded from computation of earnings per share amount" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1043">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_zPxiV0ZDttT2" title="Antidilutive securities excluded from computation of earnings per share amount" style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_us-gaap_SeriesHPreferredStockMember" id="Fact001045" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">1,981,128</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Financing Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--FinancingWarrantsMember_zWBVv26ftGIb" title="Antidilutive securities excluded from computation of earnings per share amount" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1047">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--FinancingWarrantsMember_zZoIMd1yBJEk" title="Antidilutive securities excluded from computation of earnings per share amount" style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_custom_FinancingWarrantsMember" id="Fact001049" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">107,956</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">ABG Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ABGWarrantsMember_znZyyHEUN9n8" title="Antidilutive securities excluded from computation of earnings per share amount" style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember" id="Fact001051" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">999,540</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ABGWarrantsMember_zZnThCEIVN0l" title="Antidilutive securities excluded from computation of earnings per share amount" style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_custom_ABGWarrantsMember" id="Fact001053" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">999,540</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">AllHipHop Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--AllHipHopWarrantsMember_zHrXsJSzGy91" title="Antidilutive securities excluded from computation of earnings per share amount" style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31_custom_AllHipHopWarrantsMember" id="Fact001055" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">5,682</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--AllHipHopWarrantsMember_zPa0CoHEe7p4" title="Antidilutive securities excluded from computation of earnings per share amount" style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_custom_AllHipHopWarrantsMember" id="Fact001057" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">5,682</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Publisher Partner Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublisherPartnerWarrantsMember_z12mD82wm2fk" title="Antidilutive securities excluded from computation of earnings per share amount" style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31_custom_PublisherPartnerWarrantsMember" id="Fact001059" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">9,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublisherPartnerWarrantsMember_zzrC8Hp0G7fc" title="Antidilutive securities excluded from computation of earnings per share amount" style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_custom_PublisherPartnerWarrantsMember" id="Fact001061" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">4,154</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Restricted stock awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockAwardsMember_zzBBvqBjcCLa" title="Antidilutive securities excluded from computation of earnings per share amount" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1063">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockAwardsMember_zQPv2XEZ5SN1" title="Antidilutive securities excluded from computation of earnings per share amount" style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_custom_RestrictedStockAwardsMember" id="Fact001065" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">97,403</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Restricted stock units</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_z7eIQKbpKSIg" title="Antidilutive securities excluded from computation of earnings per share amount" style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="Fact001067" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">199,267</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zFC86bgITA7d" title="Antidilutive securities excluded from computation of earnings per share amount" style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="Fact001069" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">994,766</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Common stock options</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockOptionsMember_z0wnOpFkLHua" title="Antidilutive securities excluded from computation of earnings per share amount" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31_custom_CommonStockOptionsMember" id="Fact001071" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">5,451,968</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockOptionsMember_zh8GnBEkgfRl" title="Antidilutive securities excluded from computation of earnings per share amount" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_custom_CommonStockOptionsMember" id="Fact001073" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,199,521</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231_zip2RniEz9B6" title="Antidilutive securities excluded from computation of earnings per share amount" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-01to2023-12-31" id="Fact001075" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,674,839</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zLIoGGwnyhJ9" title="Antidilutive securities excluded from computation of earnings per share amount" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31" id="Fact001077" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">10,398,732</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zyEVyspNnUD7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001079" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z6eBmGl1Tudc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zX0scoSqXuz6">Recent
Accounting Pronouncements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recently
Adopted Accounting Standards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2022, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued ASU 2022-02, <i>Financial Instruments-Credit Losses(Topic
326): Troubled Debt Restructurings and Vintage Disclosures, </i>addressing areas identified by the FASB as part of its post-implementation
review of its previously issued credit losses standard (ASU 2016-13) that introduced the current expected credit losses (CECL) model.
ASU 2022-02 eliminates the accounting guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhances
disclosure requirements for certain loan refinancings and restructurings made with borrowers experiencing financial difficulty. This
update requires an entity to disclose current-period gross write-offs for financing receivables and net investment in leases by year
of origination in the vintage disclosures. As the Company has already adopted ASU 2016-13, the new guidance was adopted on January 1,
2023. The adoption of ASU 2022-02 did not have a material impact on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recently
Issued Accounting Standards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the FASB issued ASU 2022-03, <i>Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to
Contractual Sale Restrictions</i>, which clarifies that a contractual restriction on the sale of an equity security is not considered
part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. This update also clarifies
that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction and requires certain disclosures
for equity securities subject to contractual sale restrictions. ASU 2022-03 is effective for the Company in the fiscal year beginning
after December 15, 2023, and interim periods within the fiscal year. Early adoption is permitted for both interim and annual financial
statements that have not yet been issued or made available for issuance. The Company is currently evaluating the impact that the adoption
of this new accounting standard will have on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2023, the FASB issued ASU 2023-06, <i>Disclosure Improvements: Codification Amendments in Response to the SEC&#8217;s Disclosure
Update and Simplification Initiative</i>, which incorporates certain SEC disclosure requirements into the FASB Accounting Standards Codification
(&#8220;Codification&#8221;). The amendments are expected to clarify or improve disclosure and presentation requirements of a variety
of Codification Topics, allow users to more easily compare entities subject to the SEC&#8217;s existing disclosures with those entities
that were not previously subject to the requirements, and align the requirements in the Codification with the SEC&#8217;s regulations.
ASU 2023-06 will become effective for each amendment on the effective date of the SEC&#8217;s corresponding disclosure rule changes.
The Company is currently evaluating the impact that the adoption of this new standard will have on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes</i> (Topic 740): Improvements to Income Tax Disclosures, which will require
the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for
reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid
disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. The provisions
of ASU 2023-09 are effective for annual periods beginning after December 15, 2024; early adoption is permitted using either a prospective
or retrospective transition method. The Company expects ASU 2023-09 to require additional disclosures in the notes to its consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material
impact on the Company&#8217;s financial statement presentation or disclosures.</span></p>

</ix:nonNumeric><p id="xdx_859_z98cXF9iWlm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001081" name="AREN:DiscontinuedOperationsTextBlock"><p id="xdx_80F_ecustom--DiscontinuedOperationsTextBlock_zUwU0ixC1G12" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>3.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82C_zoLhDU1Nkc43">Discontinued Operations</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, upon Board approval on September 15, 2022, discontinued (i.e., the &#8220;discontinued operations&#8221;) the Parade print business
(&#8220;Parade Print&#8221;) that was acquired on April 1, 2022 (as part of the Parade acquisition, as further described below in Note
4), on November 13, 2022 (the last date of any obligation to deliver issues of Parade Print).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001083" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zDQuJsdj6e0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets forth the loss from discontinued operations for the period from April 1, 2022 to December 31, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zn22JF4NU2u1" style="display: none">Schedule
of Discontinued Operations</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20230101__20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ParadePrintMember_zpAqssYGLUo4" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_pn3n3_maDGIDOzNh5_z1Oaknj4Fcv3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-weight: bold; text-align: justify">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" contextRef="From2023-01-012023-12-31_custom_ParadePrintMember" id="Fact001085" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,817</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_pn3n3_msDGIDOzNh5_z01J6AkuB3R3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Cost of revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" contextRef="From2023-01-012023-12-31_custom_ParadePrintMember" id="Fact001087" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,015</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_pn3n3_mtDGIDOzNh5_maDOILFz1bv_zyA3TSwAKUr4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Gross profit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" contextRef="From2023-01-012023-12-31_custom_ParadePrintMember" id="Fact001089" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,802</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingExpensesAbstract_iB_zPiAToi6biSf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Operating expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense_i01_pn3n3_maDGIDOz1uJ_zYCavD1n3Xsh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Selling and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense" contextRef="From2023-01-012023-12-31_custom_ParadePrintMember" id="Fact001093" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,396</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_i01_pn3n3_maDGIDOz1uJ_znzXXSt0ioXc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31_custom_ParadePrintMember" id="Fact001095" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,722</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges_i01_pn3n3_maDGIDOz1uJ_zp1wni88eKt4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Loss on impairment of assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges" contextRef="From2023-01-012023-12-31_custom_ParadePrintMember" id="Fact001097" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">209</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_i01T_pn3n3_mtDGIDOz1uJ_msDOILFz1bv_zyiQLv9Zvla9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" contextRef="From2023-01-012023-12-31_custom_ParadePrintMember" id="Fact001099" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,327</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_iT_pn3n3_mtDOILFz1bv_maILFDOzJiH_zEUMX57Z38xe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Loss from discontinued operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" contextRef="From2023-01-012023-12-31_custom_ParadePrintMember" id="Fact001101" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,525</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--DiscontinuedOperationTaxEffectOfDiscontinuedOperation_pn3n3_msILFDOzJiH_zNYoXAHTZAH" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Income tax benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" contextRef="From2023-01-012023-12-31_custom_ParadePrintMember" id="Fact001103" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_iT_pn3n3_mtILFDOzJiH_zySvqJIUxHYk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net loss from discontinued operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" contextRef="From2023-01-012023-12-31_custom_ParadePrintMember" id="Fact001105" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,470</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_z6m7i83rvf6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discontinued operations of Parade Print also included Relish and Spry Living print products that were acquired as part of the Parade
acquisition. Further information is provided under the heading Supplemental Pro Forma Information in Note 4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2022, the Company recorded depreciation and amortization of $<span id="xdx_90F_eus-gaap--DepreciationAndAmortizationDiscontinuedOperations_pn3n3_c20220101__20221231_zg28MDVAUFI9" title="Depreciation and amortization"><ix:nonFraction name="us-gaap:DepreciationAndAmortizationDiscontinuedOperations" contextRef="From2022-01-012022-12-31" id="Fact001107" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction></span>; and operating and investing noncash items
of $<span id="xdx_90C_eus-gaap--GainLossOnDispositionOfAssets_pn3n3_c20230101__20231231_zD5UBQYu3Fva" title="Loss on impairment of assets"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets" contextRef="From2023-01-01to2023-12-31" id="Fact001109" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">209</ix:nonFraction></span> and $<span id="xdx_90D_eus-gaap--GainLossOnDispositionOfAssets_pn3n3_c20220101__20221231_z2iNy06Wludb" title="Loss on impairment of assets"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets" contextRef="From2022-01-012022-12-31" id="Fact001111" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction></span>, respectively, as part of the discontinued operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001113" name="us-gaap:BusinessCombinationDisclosureTextBlock"><p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_zr9YDOCgzFi6" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>4.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_823_zbxv6U8Ff2U1">Acquisitions and Dispositions</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the acquisition method of accounting, which is based on ASC, <i>Business Combinations (Topic 805)</i>, and uses the fair
value concepts which requires, among other things, that most assets acquired, and liabilities assumed be recognized at their fair values
as of the acquisition date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2023
Acquisition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i>Teneology,
Inc.</i> &#8211; On January 11, 2023, the Company entered into an asset purchase agreement with Teneology, Inc., (&#8220;Teneology&#8221;)
pursuant to which it acquired certain assets (consisting of the RoadFood media business, including digital and television assets; the
Moveable Feast media business, including digital and television assets; the Fexy-branded content studio business; and the MonkeySee YouTube
Channel media business, collectively &#8220;Fexy Studios&#8221;), for a purchase price of $<span id="xdx_906_eus-gaap--AssetAcquisitionConsiderationTransferred_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zkB6Twoqkfla" title="Purchase price"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferred" contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001115" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,307</ix:nonFraction></span>. The purchase price consisted of the
following: (1) $<span id="xdx_90C_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zm3r9O5uzLZ2" title="Cash paid for consideration"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001117" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">500</ix:nonFraction></span> cash paid at closing (including an advance payment of $<span id="xdx_907_eus-gaap--PaymentsForAdvanceToAffiliate_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_z8eky2HvceZ8" title="Advance payments of cash"><ix:nonFraction name="us-gaap:PaymentsForAdvanceToAffiliate" contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001119" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">250</ix:nonFraction></span> prior to closing); (2) $<span id="xdx_90B_ecustom--DeferredCashPayments_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zoRqkNoHFbHe" title="Deferred cash payments"><ix:nonFraction name="AREN:DeferredCashPayments" contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001121" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">75</ix:nonFraction></span> deferred cash payments due
in three equal installments of $<span id="xdx_90D_ecustom--DeferredCashPayments_pn3n3_c20230301__20230301__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zww3AfErgiv2" title="Deferred cash payments"><span id="xdx_909_ecustom--DeferredCashPayments_pn3n3_c20230401__20230401__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zwANedERU5G2" title="Deferred cash payments"><span id="xdx_90C_ecustom--DeferredCashPayments_pn3n3_c20230501__20230501__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_z5EhHyhMZAii" title="Deferred cash payments"><ix:nonFraction name="AREN:DeferredCashPayments" contextRef="From2023-03-012023-03-01_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001123" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD"><ix:nonFraction name="AREN:DeferredCashPayments" contextRef="From2023-04-012023-04-01_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001125" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD"><ix:nonFraction name="AREN:DeferredCashPayments" contextRef="From2023-05-012023-05-01_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001127" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25</ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span> on March 1, 2023 (paid), April 1, 2023 (paid) and May 1, 2023 (paid); (3) $<span id="xdx_903_ecustom--DeferredCashPaymentsDue_iI_pn3n3_c20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zfbK4Dm4gmG8" title="Deferred cash payment due"><ix:nonFraction name="AREN:DeferredCashPaymentsDue" contextRef="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001129" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200</ix:nonFraction></span> deferred cash payment
due on the first anniversary of the closing date, subject to certain indemnity provisions (not paid in January 2024, further details
are provided under the heading <i>Fexy Put Option</i> in Note 28); and (4) the issuance of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_pid_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zz6I3R6Sh8ki" title="Number of shares issued for asset acquisition"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets" contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001131" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">274,692</ix:nonFraction></span> shares of the Company&#8217;s common
stock, subject to certain lock-up provisions, with a fair value of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_ze7ZQJ0APTyl" title="Fair value of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets" contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001133" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></span> on the transaction closing date (fair value was determined
based on an independent appraisal); and which is subject to a put option under certain conditions (the &#8220;contingent consideration&#8221;)
(as further described below in Note 17). The number of shares of the Company&#8217;s common stock issued was determined based on a $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zornQjl2prQ9" title="Share value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001135" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,225</ix:nonFraction></span>
value using the common stock trading price on the day immediately preceding the January 11, 2023 closing date (on the closing date the
common stock trading price was $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zcv9PW7bd62g" title="Common stock trading price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001137" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.94</ix:nonFraction></span> per share). The agreement also provided for a cash retention pool for certain employees of $<span id="xdx_908_eus-gaap--PaymentsToEmployees_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zBlk6jWxkmn1" title="Cash retention pool for employees"><ix:nonFraction name="us-gaap:PaymentsToEmployees" contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001139" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">300</ix:nonFraction></span>,
subject to vesting over three years upon continued employment and other conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_FexyStudiosMember" escape="true" id="Fact001141" name="us-gaap:AssetAcquisitionTableTextBlock"><p id="xdx_89D_eus-gaap--AssetAcquisitionTableTextBlock_hus-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zZ04CRkYXmLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of the purchase price is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zmnG52KIiqZf" style="display: none">Schedule
of Composition Preliminary Assets Purchase Price</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_494_20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zgZD4Tm5K2T" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_zVVk8z3HmHfe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001143" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_pn3n3_zpj6GXTndzJ3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001145" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AssetAcquisitionConsiderationTransferredContingentConsideration_pn3n3_z6AIBH3OCEt3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Contingent consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration" contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001147" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">561</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted_pn3n3_zwucxxjQkZTf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Deferred cash payments, as discounted</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted" contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001149" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">246</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetAcquisitionConsiderationTransferred_pn3n3_znH0qohjrN09" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total purchase consideration</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferred" contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001151" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,307</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zMZX6QIg5r8e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for the asset acquisition as a business combination in accordance with ASC 805 since the acquisition met the definition
of a business under the applicable guidance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred $<span id="xdx_903_eus-gaap--AssetAcquisitionConsiderationTransferredTransactionCost_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zZFrRzv1dRyk" title="Asset acquisition transaction cost"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost" contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001153" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">99</ix:nonFraction></span> in transaction costs related to the acquisition, which primarily consisted of legal and accounting expenses. The
acquisition-related expenses were recorded in general and administrative expenses on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_FexyStudiosMember" escape="true" id="Fact001155" name="AREN:ScheduleOfAssetsAcquiredTableTextBlock"><p id="xdx_89A_ecustom--ScheduleOfAssetsAcquiredTableTextBlock_hus-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zkjMMaoHiFE3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the closing
date of the acquisition based upon their respective fair values as summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zVECqHb6rdrc" style="display: none">Summary
of Preliminary Assets Purchase Price Allocation</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_z43ZG3xIYba9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zEJ8X7Od0Yb1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Advertiser relationships</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="AREN:AssetAcquisitionAssetsAcquired" contextRef="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember_custom_AdvertiserRelationshipsMember" id="Fact001157" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">663</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zsr2ZG29ddp5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Brand names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:AssetAcquisitionAssetsAcquired" contextRef="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember_custom_BrandNamesMember" id="Fact001159" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">659</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_z3qPiUF5h4cf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:AssetAcquisitionAssetsAcquired" contextRef="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember_us-gaap_GoodwillMember" id="Fact001161" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,985</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zikUkgFTNWY1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net assets acquired</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AREN:AssetAcquisitionAssetsAcquired" contextRef="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001163" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,307</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zt48EeFz4Wzg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilized an independent appraisal firm to assist in the determination of the fair values of the assets acquired and
liabilities assumed, which required certain significant management assumptions and estimates. The fair value of the advertiser relationships
were valued using the excess earnings method of the income approach and the brand names were valued using the relief-from-royalty method
of the income approach. The estimated useful life is fifteen years (<span id="xdx_90A_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zKmWkfNaDWT7" title="Weighted average useful lives"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AdvertiserRelationshipsMember" format="ixt-sec:duryear" id="Fact001165" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">15.0</ix:nonNumeric></span> years) for the advertiser relationships and twelve years (<span id="xdx_901_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zpRG4Lazyb82" title="Estimated useful life"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_BrandNamesMember" format="ixt-sec:duryear" id="Fact001167" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">12.0</ix:nonNumeric></span>
years) for the brand names.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
excess-of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents goodwill from
the acquisition. Goodwill is recorded as a non-current asset that is not amortized but is subject to an annual review for impairment.
The Company expects $<span id="xdx_909_eus-gaap--Goodwill_iI_pn3n3_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zMA2p2fGhgXd" title="Goodwill"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-12-31_custom_TeneologyIncMember_custom_FexyStudiosMember" id="Fact001169" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,678</ix:nonFraction></span> of goodwill to be deductible for tax purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Supplemental
Pro Forma Information</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma disclosures have been deemed impracticable for this acquisition since after making reasonable efforts the Company is unable
to accept assumptions made by Teneology. The Company has determined, based on the information provided by Teneology and made available
to the Company, that the earnings from the prior periods could not be verified since the acquisition only included certain activities
of Teneology and financial statements were not available. In this regard, the Company: (1) made reasonable effort to obtain certain financial
results of the certain activities but Teneology was unable to comply with this request; and (2) the presentation of the pro forma results
and the assumptions made by Teneology management were unable to be independently substantiated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2023
Disposition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 17, 2023, the Company sold certain assets related to one of Parade&#8217;s business components known as Athlon Outdoors for
cash proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromSaleOfOtherAssetsInvestingActivities_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zYVtY7panr0g" title="Cash proceeds"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities" contextRef="From2023-11-172023-11-17_custom_Disposition2023Member" id="Fact001171" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,061</ix:nonFraction></span> ($<span id="xdx_907_ecustom--SalePrice_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zAgeQwsg5Wnf" title="Sale price"><ix:nonFraction name="AREN:SalePrice" contextRef="From2023-11-172023-11-17_custom_Disposition2023Member" id="Fact001173" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></span> sale price (with a target working capital of $<span id="xdx_90C_ecustom--WorkingCapital_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zTVZKW7x1C12" title="Working capital"><ix:nonFraction name="AREN:WorkingCapital" contextRef="From2023-11-172023-11-17_custom_Disposition2023Member" id="Fact001175" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">272</ix:nonFraction></span>) plus a preliminary working capital adjustment of $<span id="xdx_907_ecustom--PreliminaryWorkingCapital_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zPUfa07j0Kcd" title="Preliminary working capital"><ix:nonFraction name="AREN:PreliminaryWorkingCapital" contextRef="From2023-11-172023-11-17_custom_Disposition2023Member" id="Fact001177" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">61</ix:nonFraction></span>),
as further reduced by a final working capital adjustment of $<span id="xdx_90F_ecustom--WorkingCapitalAdjustments_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zm3ueyp1hCE1" title="Adjustment for working capital"><ix:nonFraction name="AREN:WorkingCapitalAdjustments" contextRef="From2023-11-172023-11-17_custom_Disposition2023Member" id="Fact001179" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">153</ix:nonFraction></span>, as reflected in accrued expenses and other on the consolidated balance
sheets, resulting in a final sale price of $<span id="xdx_90A_ecustom--FinalSalePrice_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zo9Qz0cZi1Sd" title="Sale price"><ix:nonFraction name="AREN:FinalSalePrice" contextRef="From2023-11-172023-11-17_custom_Disposition2023Member" id="Fact001181" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">908</ix:nonFraction></span>. In connection with the sale, the Company disposed of certain advertiser relationships
and trade name relating to that business component with a carrying value of $<span id="xdx_90A_eus-gaap--ProceedsFromDivestitureOfBusinesses_pn3n3_c20230101__20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zE1hwQ2cQwi9" title="Business component carrying value"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" contextRef="From2023-01-012023-12-31_custom_Disposition2023Member" id="Fact001183" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">639</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--ProceedsFromDivestitureOfBusinesses_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zfszcMsfqk1i" title="Business component carrying value"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" contextRef="From2023-11-172023-11-17_custom_Disposition2023Member" id="Fact001185" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">172</ix:nonFraction></span>, respectively, along with the accounts receivable
and accounts payable of the business component of $<span id="xdx_904_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_z0jzp9bQwLE8" title="Accounts receivable net current"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-12-31_custom_Disposition2023Member" id="Fact001187" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">453</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zrjtY0gR8S0k" title="Accounts payable current"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-12-31_custom_Disposition2023Member" id="Fact001189" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></span>, respectively, resulting in a recognized loss on sale of assets of $<span id="xdx_909_eus-gaap--GainLossOnDispositionOfAssets1_pn3n3_c20230101__20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zs3PQpNKBa22" title="Loss on assets"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2023-01-012023-12-31_custom_Disposition2023Member" id="Fact001191" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">325</ix:nonFraction></span>
as reflected on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2022
Acquisitions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Athlon
Holdings, Inc</i>. - On April 1, 2022, the Company acquired <span id="xdx_90D_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z9HgGxh3cAuj" title="Acquired percentage"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember" id="Fact001193" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the issued and outstanding capital stock of Athlon Holdings, Inc.
(or Parade), a Tennessee corporation, for a purchase price of $<span id="xdx_904_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zUAWqPJKXJDd" title="Acquisition purchase price"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember" id="Fact001195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,854</ix:nonFraction></span>, as adjusted for the working capital adjustment as of the closing
date of the transaction. The working capital adjustment is pending acceptance by the sellers (further details are provided in Note 27).
As a part of the closing consideration, the Company also acquired cash of $<span id="xdx_90C_eus-gaap--CashAcquiredFromAcquisition_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zm43dQOyHe44" title="Acquired cash"><ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember" id="Fact001197" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,840</ix:nonFraction></span>, that was further adjusted post-closing for the working
capital adjustment. The purchase price of $<span id="xdx_900_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zOtEhTzgp1Ua" title="Business combination consideration transferred1"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember" id="Fact001199" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,854</ix:nonFraction></span>, as discounted, is comprised of (i) a cash portion of $<span id="xdx_902_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zZBeHq6smHrk" title="Cash portion in acquisition"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember" id="Fact001201" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,827</ix:nonFraction></span>, with $<span id="xdx_906_ecustom--PaymentsToAcquireBusinessesAtClosing_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zXH5IKgiGrF" title="Cash payments paid at closing"><ix:nonFraction name="AREN:PaymentsToAcquireBusinessesAtClosing" contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember" id="Fact001203" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,840</ix:nonFraction></span> paid at
closing and $<span id="xdx_903_eus-gaap--OtherPaymentsToAcquireBusinesses_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zkdKe6lpRpAd" title="Payments for acquire"><ix:nonFraction name="us-gaap:OtherPaymentsToAcquireBusinesses" contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember" id="Fact001205" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">987</ix:nonFraction></span> estimated to be paid post-closing (as further described below) and (ii) the issuance of <span id="xdx_901_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zNIlktA6ypNg" title="Number of shares issued in acquisition"><ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember" id="Fact001207" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">314,103</ix:nonFraction></span> shares of the Company&#8217;s
common stock with a fair market value of $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zP8egd6CyLU" title="Fair value of shares issued in acquisition"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember" id="Fact001209" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,141</ix:nonFraction></span>. The number of shares of the Company&#8217;s common stock issued was determined based
on a $<span id="xdx_908_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_pn3n3_c20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDW7ZUveSKib" title="Stock value assigned"><ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember_us-gaap_CommonStockMember" id="Fact001211" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,000</ix:nonFraction></span> value using the common stock trading price for the 10 trading days preceding the April 1, 2022 closing date. Certain of Parade&#8217;s
key employees entered into either advisory agreements or employment agreements with the Company. Parade operates in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z6UcP99iQgG9" title="Acquisition description"><ix:nonNumeric contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember" id="Fact001213" name="us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity">The
amount estimated to be paid post-closing of $987 will be or was paid as follows: (i) $742 is expected to be paid upon receipts of certain
tax refunds due to the sellers (consisting of $3,000 for the deferred cash payments, as discounted, less a $2,258 cash adjustment); and
(ii) $245 was paid within two business days from the date the Company received proceeds from the sale of the equity interest in Just
Like Falling Off a Bike, LLC that was held by Parade as of the closing date (paid on April 7, 2022).</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--BusinessCombinationContingentConsiderationArrangementsDescription_c20220701__20220930__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zqTF2EckKdNe" title="Acquisition description"><ix:nonNumeric contextRef="From2022-07-012022-09-30_custom_AthlonHoldingsIncMember" id="Fact001215" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsDescription">The
Company received a final valuation report from a third party valuation firm after the preliminary purchase price was adjusted during
the quarterly period ended September 30, 2022. After considering the results of the final valuation report, the Company estimated
that the purchase consideration decreased by $321. The decrease in the purchase price was related to an increase in identifiable
assets of $54, an increase in deferred tax liabilities of $27, with a decrease in the working capital adjustment of $321, resulting
in a decrease in goodwill of $348.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AthlonHoldingsIncMember" escape="true" id="Fact001217" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zVU71i5ront5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of the purchase price is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zwoDcSHUgxF3" style="display: none">Schedule
of Composition of Purchase Price</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20220401__20220401_zwWFAR22WvQk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PaymentsToAcquireBusinessesGross_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z06h1E9eddT8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember" id="Fact001219" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,085</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zKefsckbnuA3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember" id="Fact001221" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,141</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--BusinessCombinationConsiderationTransferredOther1_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zWMQEOG6nLX5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred cash payments, as discounted</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferredOther1" contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember" id="Fact001223" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">628</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zfMsmFECWBY2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total purchase consideration</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember" id="Fact001225" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,854</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zm4vRXrEeEP5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred $<span id="xdx_90F_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zHx04YDc0O43" title="Transaction cost"><ix:nonFraction name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember" id="Fact001227" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200</ix:nonFraction></span> in transaction costs related to the acquisition, which primarily consisted of legal and accounting expenses. The
acquisition-related expenses were recorded within general and administrative expense on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AthlonHoldingsIncMember" escape="true" id="Fact001229" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zkjC4t2Uej3a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the closing
date of the acquisition based upon their respective fair values as summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span id="xdx_8B3_zz11kMAZmCik" style="display: none">Summary
of Purchase Price Allocation</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20220401_zwJKPlcE4Bz5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zJSpTofVvLOf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember" id="Fact001231" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,604</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zH4qtZRDuZga" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember" id="Fact001233" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,855</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zBgAJM5kdXSd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember" id="Fact001235" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,337</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z3GlLmnxNIYf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Equity investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember" id="Fact001237" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,450</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zqRHG02u1aaa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fixed assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember" id="Fact001239" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">108</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z7lf3nyVTBD9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Digital content</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember" id="Fact001241" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">355</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zBZ8aVJw4Pk3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Advertiser relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember" id="Fact001243" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,202</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zUzZt8DEbBq2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember" id="Fact001245" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,261</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Goodwill_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zYFqYAyq6HIk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember" id="Fact001247" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,587</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zQYCeWwBC2db" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember" id="Fact001249" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,416</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z1rSZYK6FWCj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued expenses and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember" id="Fact001251" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,440</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zDwmMH6zpqRc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember" id="Fact001253" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,203</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zt1sMzBsO7wl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other long-term liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember" id="Fact001255" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">543</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zFmtJ1scgfze" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred tax liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember" id="Fact001257" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,303</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pn3n3_zEMBrdmRhRqc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net assets acquired</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" contextRef="AsOf2022-04-01" id="Fact001259" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,854</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zidnkAUjyobb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilized an independent appraisal firm to assist in the determination of the fair values of the assets acquired and liabilities
assumed, which required certain significant management assumptions and estimates. The fair value of the digital content was determined
using a cost approach. The fair values of the advertiser relationships were determined by projecting the acquired entity&#8217;s cash
flows, deducting notional contributory asset charges on supporting assets (working capital, tangible assets, trade names, and the assembled
workforce) to compute the excess cash flows associated with the advertiser relationships. The fair values of the trade names were determined
by projecting revenue associated with each trade name and applying a royalty rate to compute the amount of the royalty payments the company
is relieved from paying due to its ownership of the trade names. The estimated weighted average useful life is two years (<span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_z4B0hPvLFXWj" title="Estimated weighted average useful life"><ix:nonNumeric contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember_custom_DigitalContentMember" format="ixt-sec:duryear" id="Fact001261" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">2.00</ix:nonNumeric></span> years)
for digital content, eight point seventy-five years (<span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zBrWFJAucMBe" title="Estimated weighted average useful life"><ix:nonNumeric contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember_custom_AdvertiserRelationshipsMember" format="ixt-sec:duryear" id="Fact001263" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">8.75</ix:nonNumeric></span> years) for advertiser relationships, and fourteen point five years (<span id="xdx_908_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z0rpFjbmxZ8f" title="Estimated weighted average useful life"><ix:nonNumeric contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember_us-gaap_TradeNamesMember" format="ixt-sec:duryear" id="Fact001265" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">14.50</ix:nonNumeric></span> years)
for trade names.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
excess purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents goodwill from the
acquisition. Goodwill is recorded as a non-current asset that is not amortized but is subject to an annual review for impairment. No
portion of the goodwill related to the acquisition will be deductible for tax purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Supplemental
Pro Forma Information</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001267" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock"><p id="xdx_899_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zG6IKhpF3Y11" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the results of continuing operations of the Parade acquisition from the acquisition date included in the consolidated
results of continuing operations and the unaudited pro forma results of continuing operations of the combined entity had the date of
the acquisition been January 1, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zcU5rNh4TdRb" style="display: none">Schedule
of Supplemental Proforma Information</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_495_20220101__20221231_z7remYnAFZUe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended<br/>
 December 31, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Parade continuing operations from acquisition date of April 1, 2022 (unaudited):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_z0IgHpsFega5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 80%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-12-31_custom_ParadeMember" id="Fact001269" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,071</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_zmLU31f2hiYe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_ParadeMember" id="Fact001271" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,494</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Combined entity continuing operations supplemental pro forma information had the acquisition date been January 1, 2022 (unaudited):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Revenue:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_z56KFyPQBJTd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Parade</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2022-01-012022-12-31_custom_ParadeMember" id="Fact001273" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55,981</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ArenaMember_zXoW2umzo1Mh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt">Arena</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2022-01-012022-12-31_custom_ArenaMember" id="Fact001275" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">207,681</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_zKkEAGwHIyVd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Total continuing operations supplemental pro forma revenue</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2022-01-012022-12-31" id="Fact001277" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">263,662</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Net loss:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_zXre08hcmKIg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Parade</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_ParadeMember" id="Fact001279" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,070</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ArenaMember_zkGp4Jcz3AUl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt">Arena</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_ArenaMember" id="Fact001281" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">67,788</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AdjustmentsMember_z8RHDUqrILie" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Adjustments</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_AdjustmentsMember" id="Fact001283" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,940</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_zFokrXxMi8Ii" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Total continuing operations supplemental pro forma net loss</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact001285" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">72,798</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zDWUwa8mob3c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information presented above is for illustrative purposes only and is not necessarily indicative of results that would have been achieved
if the acquisition had occurred at the beginning of the Company&#8217;s reporting period and does not reflect the discontinued operations
of Parade Print that was acquired on April 1, 2022 (as part of the Parade acquisition).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments_c20220101__20221231_zcNg9RGyUL54" title="Adjustment description"><ix:nonNumeric contextRef="From2022-01-012022-12-31" id="Fact001287" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments">The
adjustments for the year ended December 31, 2022 of ($1,940), represents adjustments: (1) to record depreciation and amortization expense
related to the fixed and intangible assets acquired from the acquisition of ($864); (2) to reverse the nonrecurring transaction cost
related to the acquisition of $200; and (3) to reverse the deferred tax benefit related to the acquisition of ($1,276).</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Buffalo
Groupe, LLC </i>&#8211; On September 27, 2022, the Company entered into an asset purchase agreement with Buffalo Groupe, LLC, doing business
as Morning Read, where it purchased certain intellectual properties, certain assumed contracts, and other certain rights related to the
intellectual properties (collectively, the &#8220;Morning Read Purchased Assets&#8221;) and assumed certain liabilities related to the
Morning Read Purchased Assets. The purchase consideration consisted of a cash payment of $<span id="xdx_905_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220927__20220927__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BuffaloGroupeLLCMember__us-gaap--AssetAcquisitionAxis__custom--IntellectualPropertiesMember_zUe34YN2It35" title="Cash paid for consideration"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2022-09-272022-09-27_custom_BuffaloGroupeLLCMember_custom_IntellectualPropertiesMember" id="Fact001289" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">850</ix:nonFraction> </span>at closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for the acquisition as an asset acquisition in accordance with ASC 805-50, as substantially all of the fair value of
the gross assets acquired by the Company is concentrated in a group of similar identifiable assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase consideration totaled $<span id="xdx_902_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220927__20220927__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BuffaloGroupeLLCMember__us-gaap--AssetAcquisitionAxis__custom--IntellectualPropertiesMember_zbKA6r7JVPhk" title="Cash paid for consideration"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2022-09-272022-09-27_custom_BuffaloGroupeLLCMember_custom_IntellectualPropertiesMember" id="Fact001291" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">850</ix:nonFraction></span>, which was assigned to the brand name acquired on the closing date of the acquisition. The useful
life for the brand name is ten years (<span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220927_zuhMxXWOiquh" title="Useful lives"><ix:nonNumeric contextRef="AsOf2022-09-27" format="ixt-sec:duryear" id="Fact001293" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">10.0</ix:nonNumeric></span> years).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>A360
Media, </i>LLC &#8211; On December 15, 2022 (the closing date), pursuant to an asset purchase agreement entered into December 7, 2022,
the Company acquired certain assets and liabilities from Weider Publications, a subsidiary of A360 Media, LLC (or Men&#8217;s Journal)
related to the digital media operations of Men&#8217;s Journal and other men&#8217;s active lifestyle brands. The Company paid $<span id="xdx_90F_eus-gaap--CashAcquiredFromAcquisition_pn3n3_c20221215__20221215_z8idO6AGKLp4" title="Cash acquired for acquisition"><ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" contextRef="From2022-12-152022-12-15" id="Fact001295" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,000</ix:nonFraction></span>
in cash for the acquisition consisting of: (i) $<span id="xdx_90E_eus-gaap--CashAcquiredFromAcquisition_pn3n3_c20221207__20221207_zDcZE9nzLx7k" title="Cash acquired for acquisition"><ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" contextRef="From2022-12-072022-12-07" id="Fact001297" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,000</ix:nonFraction></span> paid at closing; (ii) $<span id="xdx_900_eus-gaap--EscrowDeposit_iI_pn3n3_c20221215_zQMkN66ZRDvj" title="Escrow deposit"><ix:nonFraction name="us-gaap:EscrowDeposit" contextRef="AsOf2022-12-15" id="Fact001299" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></span> deposited into an escrow account to be released in
accordance with the terms of the agreement, subject to adjustments for any indemnification payments; and (iii) $<span id="xdx_909_eus-gaap--EscrowDeposit_iI_pn3n3_c20221130_z6VrpKYk2xd" title="Escrow deposit"><ix:nonFraction name="us-gaap:EscrowDeposit" contextRef="AsOf2022-11-30" id="Fact001301" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction> </span>paid in November
2022. The Company also assumed certain liabilities consisting of: (i) $<span id="xdx_906_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_iI_pn3n3_c20221130_znkFSBJ1qpFj" title="Assumed lease obligation"><ix:nonFraction name="AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" contextRef="AsOf2022-11-30" id="Fact001303" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,676</ix:nonFraction></span> an assumed lease obligation, as discounted (representing
$<span id="xdx_90B_eus-gaap--DeferredRevenue_iI_pn3n3_c20221130_znWoFZfYJNza" title="Deferred payments"><ix:nonFraction name="us-gaap:DeferredRevenue" contextRef="AsOf2022-11-30" id="Fact001305" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,189</ix:nonFraction></span> in deferred payments over twenty-seven months (27) for the assumption of a lease obligation); and (ii) $<span id="xdx_907_ecustom--DeferredRevenueObligation_iI_c20221130_znB9NBy8zfNa" title="Deferred revenue obligation"><ix:nonFraction name="AREN:DeferredRevenueObligation" contextRef="AsOf2022-11-30" id="Fact001307" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,078</ix:nonFraction></span> in deferred revenue
obligations to deliver certain publications to the subscribers of Men&#8217;s Journal ($<span id="xdx_905_eus-gaap--UnearnedPremiums_iI_pn3n3_c20221130_zAl6StEbg4U6" title="Unearned revenue"><ix:nonFraction name="us-gaap:UnearnedPremiums" contextRef="AsOf2022-11-30" id="Fact001309" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,941</ix:nonFraction></span> in unearned revenue after consideration
of an estimated subscription refund liability of $<span id="xdx_905_eus-gaap--CustomerRefundLiabilityCurrent_iI_pn3n3_c20221130_zQoCOpzKx0W3" title="Refund liability"><ix:nonFraction name="us-gaap:CustomerRefundLiabilityCurrent" contextRef="AsOf2022-11-30" id="Fact001311" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">137</ix:nonFraction></span>). In accordance with the practical expedients under ASU 2021-08, the Company has
elected to apply (i) the practical expedient to the modification of the subscriber contracts at the acquisition date to determine the
performance obligations and transaction price; and (ii) to use the estimated selling price of a subscriber contract as the standalone
selling price of the replacement magazine based on the number of magazines expected to be delivered to the Men&#8217;s Journal subscribers
to satisfy the performance obligations. The agreement contains customary representations, warranties and covenants. Men&#8217;s Journal
operates in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for the asset acquisition as a business combination in accordance with ASC 805 since the acquisition met the definition
of a business under the applicable guidance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred $<span id="xdx_902_eus-gaap--AssetAcquisitionConsiderationTransferredTransactionCost_pn3n3_c20221215__20221215_zwHGEE9bmldh" title="Transaction cost"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost" contextRef="From2022-12-152022-12-15" id="Fact001313" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">283</ix:nonFraction></span> in transaction costs related to the acquisition, which primarily consisted of legal and accounting expenses. The
acquisition-related expenses were recorded within general and administrative expense on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the acquisition of Men&#8217;s Journal, the Company received a final valuation report during the quarterly period
ended September 30, 2023 from a third party valuation firm after the preliminary purchase price was determined. After considering
the results of the final valuation report, the Company estimated that the purchase consideration increased by $<span id="xdx_900_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--MensJournalMember_zkiEGp6ZOQac" title="Goodwill, acquired during period"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2023-01-012023-12-31_custom_MensJournalMember" id="Fact001315" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,246</ix:nonFraction></span>
as a result of an increase in the fair value of the assumed lease obligation with an offset recorded to goodwill (see Note
11).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001317" name="AREN:PreliminaryPriceAllocationTableTextBlock"><p id="xdx_895_ecustom--PreliminaryPriceAllocationTableTextBlock_z0FbDxu0hiZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the closing
date of the acquisition based upon their respective fair values as summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zchIUZR7TZh6" style="display: none">Schedule
of Preliminary Price Allocation</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20231231_zW26LEiBXS28" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zFW5k6qyBLhb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Lease deposit receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable" contextRef="AsOf2023-12-31_custom_AthlonHoldingsIncMember" id="Fact001319" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">420</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zRgr58wPNMi3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Advertiser relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship" contextRef="AsOf2023-12-31_custom_AthlonHoldingsIncMember" id="Fact001321" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,860</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_znh0LJ8NCxah" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Brand names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName" contextRef="AsOf2023-12-31_custom_AthlonHoldingsIncMember" id="Fact001323" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,090</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zQLSP7Se0Wjl" style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill" contextRef="AsOf2023-12-31_custom_AthlonHoldingsIncMember" id="Fact001325" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,384</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zrbigUcHcuLf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue" contextRef="AsOf2023-12-31_custom_AthlonHoldingsIncMember" id="Fact001327" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,941</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zA3ssgNovCO1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Subscription refund liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability" contextRef="AsOf2023-12-31_custom_AthlonHoldingsIncMember" id="Fact001329" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">137</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_ztHG9TXJ02Gk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Assumed lease obligation</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" contextRef="AsOf2023-12-31_custom_AthlonHoldingsIncMember" id="Fact001331" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,676</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_mtBCRIAzrWD_zihQ2yobSH02" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net assets acquired</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2023-12-31_custom_AthlonHoldingsIncMember" id="Fact001333" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zemWWPYCIq4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilized an independent appraisal firm to assist in the determination of the fair values of the assets acquired and liabilities
assumed, which required certain significant management assumptions and estimates. The fair value of the advertiser relationships were
determined by applying the multi-period earnings method of the income approach and the fair values of the brand names were determined
by applying the relief-from-royalty method. The estimated weighted average useful life is twelve and one-half years (<span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--A360MediaLLCMember__srt--TitleOfIndividualAxis__custom--AdvertiserRelationshipMember_zGUyHjiSdQrb" title="Weighted average useful lives"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_A360MediaLLCMember_custom_AdvertiserRelationshipMember" format="ixt-sec:duryear" id="Fact001335" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">12.5</ix:nonNumeric> </span>years) for
the advertiser relationships and eleven years (<span id="xdx_901_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--A360MediaLLCMember__srt--TitleOfIndividualAxis__custom--BrandNameMember_zRzlOfNNqAz3" title="Weighted average useful lives"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_A360MediaLLCMember_custom_BrandNameMember" format="ixt-sec:duryear" id="Fact001337" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">11.0</ix:nonNumeric></span> years) for the brand names.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
excess-of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents goodwill from
the acquisition. Goodwill is recorded as a non-current asset that is not amortized but is subject to an annual review for impairment.
The Company expects $<span id="xdx_906_eus-gaap--BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_iI_pn3n3_c20231231_z44haoaboe22" title="Goodwill for tax"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" contextRef="AsOf2023-12-31" id="Fact001339" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,299</ix:nonFraction></span> of goodwill to be deductible for tax purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Supplemental
Pro Forma Information</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma disclosures have been deemed impracticable for this acquisition since after making reasonable efforts the Company is unable
to accept assumptions made by Men&#8217;s Journal. The Company has determined, based on the information provided by Men&#8217;s Journal
and made available to the Company, that the earnings from the prior periods could not be verified since the acquisition only included
certain activities of Men&#8217;s Journal and financial statements were not available. In this regard, the Company: (1) made reasonable
effort to obtain certain financial results of the certain activities but Men&#8217;s Journal was unable to apply the requirement; and
(2) the presentation of the pro forma results and the assumptions made by management were unable be independently substantiated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001341" name="AREN:PrepaymentsAndOtherCurrentAssetsTextBlock"><p id="xdx_80F_ecustom--PrepaymentsAndOtherCurrentAssetsTextBlock_zPuocP0aOew4" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>5</b>.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_825_z1TzmsbZPEZf">Prepayments and Other Current Assets</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001343" name="AREN:ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock"><p id="xdx_89B_ecustom--ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock_zK21i0AyAXs3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments
and other current assets are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z52qj90FVIZ1" style="display: none">Schedule
of Prepayments and Other Current Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20231231_zxRSM98gSmEd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20221231_z2aVu4WSZfWc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--PrepaidExpenseCurrent_iI_pn3n3_maPEAOAz2Qi_zJXP5KDmgx51" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Prepaid expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2023-12-31" id="Fact001345" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,946</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2022-12-31" id="Fact001346" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,321</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--PrepaidSuppliesCurrent_iI_pn3n3_maPEAOAz2Qi_zmQmNq1cyVU8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepaid supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:PrepaidSuppliesCurrent" contextRef="AsOf2023-12-31" id="Fact001348" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">773</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:PrepaidSuppliesCurrent" contextRef="AsOf2022-12-31" id="Fact001349" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">927</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--RefundableIncomeAndFranchiseTaxes_iI_pn3n3_maPEAOAz2Qi_zccHzQlbKAsf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Refundable income and franchise taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:RefundableIncomeAndFranchiseTaxes" contextRef="AsOf2023-12-31" id="Fact001351" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">157</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:RefundableIncomeAndFranchiseTaxes" contextRef="AsOf2022-12-31" id="Fact001352" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">957</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--UnamortizedDebtIssuanceExpense_iI_pn3n3_maPEAOAz2Qi_za6mXI3yoJq2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Unamortized debt costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:UnamortizedDebtIssuanceExpense" contextRef="AsOf2023-12-31" id="Fact001354" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">209</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:UnamortizedDebtIssuanceExpense" contextRef="AsOf2022-12-31" id="Fact001355" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">216</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--EmployeeRetentionCredits_iI_pn3n3_maPEAOAz2Qi_zcFBlFeyijPi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Employee retention credits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:EmployeeRetentionCredits" contextRef="AsOf2023-12-31" id="Fact001357" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,468</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1358">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OtherReceivablesNetCurrent_iI_pn3n3_maPEAOAz2Qi_zrOUrSKRot2j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Other receivables</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2023-12-31" id="Fact001360" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2022-12-31" id="Fact001361" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pn3n3_mtPEAOAz2Qi_zPhGd2b5E9Ek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Total prepayments and other current assets</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-12-31" id="Fact001363" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,598</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-12-31" id="Fact001364" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,441</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zX2WTuWHqDVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the provisions of the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) and the subsequent extensions
of the CARES Act, the Company was eligible for a refundable employee retention credit subject to certain criteria. The Company determined
that it qualifies for the tax credit under the CARES Act. In connection with the CARES Act, the Company adopted a policy to recognize
the employee retention credit when earned and to offset the credit against the related expenditure. During the year ended December 31,
2023, the Company recorded the employee retention credits as a reduction to payroll and related expenses of $<span id="xdx_906_eus-gaap--OtherLaborRelatedExpenses_pn3n3_c20230101__20231231_zO4xbNltNFK5" title="Employee retention credits"><ix:nonFraction name="us-gaap:OtherLaborRelatedExpenses" contextRef="From2023-01-01to2023-12-31" id="Fact001366" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,868</ix:nonFraction></span> in operating expenses
on the consolidated statements of operations with a corresponding receivable included in prepaid expenses and other current assets on
the consolidated balance sheets for the respective periods. During the year ended December 31, 2023, the Company received $<span id="xdx_90D_ecustom--EmployeeRetentionPayable_pn3n3_c20230101__20231231_zG672UcrBTha" title="Retention Payable"><ix:nonFraction name="AREN:EmployeeRetentionPayable" contextRef="From2023-01-01to2023-12-31" id="Fact001368" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,400</ix:nonFraction> </span>in employee
retention credits and has a receivable balance remaining of $<span id="xdx_909_ecustom--EmployeeRetentionCredits_iI_pn3n3_c20231231_zduN6gOwQ9Ga" title="Employee retention credits"><ix:nonFraction name="AREN:EmployeeRetentionCredits" contextRef="AsOf2023-12-31" id="Fact001370" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,468</ix:nonFraction></span> as of December 31, 2023.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001372" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_805_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z3Hg37ldTFh" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>6.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_822_zdVfLk3g2l52">Property and Equipment</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001374" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_894_eus-gaap--PropertyPlantAndEquipmentTextBlock_zrVBM4nfXDV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z00fXVxvVns5" style="display: none">Schedule
of Property and Equipment</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20231231_ztUb904c6zD9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20221231_zxMkf96zdw12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember_zG7nYHo7rrqg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Office equipment and computers</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_custom_OfficeEquipmentAndComputersMember" id="Fact001376" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,744</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_OfficeEquipmentAndComputersMember" id="Fact001377" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,744</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zw5uzQL0rvOe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Furniture and fixtures</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember" id="Fact001379" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_us-gaap_FurnitureAndFixturesMember" id="Fact001380" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">240</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzTTM_zxgEiOJC5C5b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross property and equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31" id="Fact001382" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,910</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31" id="Fact001383" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,984</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzTTM_zPkDfoa6qxae" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-12-31" id="Fact001385" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,582</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-12-31" id="Fact001386" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,249</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzTTM_zwnAoQd435qf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net property and equipment</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31" id="Fact001388" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">328</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31" id="Fact001389" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">735</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8AF_zuYWTEt2IYlh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
and amortization expense for the years ended December 31, 2023 and 2022 was $<span id="xdx_90D_eus-gaap--Depreciation_pn3n3_c20230101__20231231_zdaL43uw8j8c" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-01-01to2023-12-31" id="Fact001391" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">352</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--Depreciation_pn3n3_c20220101__20221231_zoH8zUsisaW4" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-01-012022-12-31" id="Fact001393" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">539</ix:nonFraction></span>, respectively. Impairment charges for property
and equipment for the years ended December 31, 2023 and 2022 of $<span id="xdx_908_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_pn3n3_c20230101__20231231__us-gaap--FairValueByAssetClassAxis__us-gaap--PropertyPlantAndEquipmentMember_z0nDHDAYQZjl" title="Impairment charges for property and equipment"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="From2023-01-012023-12-31_us-gaap_PropertyPlantAndEquipmentMember" id="Fact001395" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55</ix:nonFraction></span> and $<span id="xdx_90E_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_pn3n3_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--PropertyPlantAndEquipmentMember_z5xbJahBsWO2" title="Impairment charges for property and equipment"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="From2022-01-012022-12-31_us-gaap_PropertyPlantAndEquipmentMember" id="Fact001397" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction></span>, respectively, have been recorded on the consolidated statements
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001399" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_808_eus-gaap--LesseeOperatingLeasesTextBlock_zp7r0tGPOlvc" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>7.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82A_zURCtNm2fX9f">Leases</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s real estate lease for the use of office space was subleased during the year ended December 31, 2023. The Company determines
whether an arrangement contains a lease at inception. Lease assets and liabilities are recognized upon commencement of the lease based
on the present value of the future minimum lease payments over the lease term. The lease term includes options to extend the lease when
it is reasonably certain that the Company will exercise that option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company&#8217;s current operating lease
has a remaining fixed payment term of <span id="xdx_902_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20231231_z5DwXVVTobC2" title="Operating lease, remaining fixed payment term"><ix:nonNumeric contextRef="AsOf2023-12-31" format="ixt-sec:duryear" id="Fact001401" name="us-gaap:LesseeOperatingLeaseTermOfContract">0.75</ix:nonNumeric></span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001403" name="AREN:SupplementalInformationRelatedToOperatingLeasesTableTextBlock"><p id="xdx_890_ecustom--SupplementalInformationRelatedToOperatingLeasesTableTextBlock_z52YZlcmodh3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below presents supplemental information related to the operating lease:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zbc8Sd4pa3G1" style="display: none">Schedule
of Supplemental Information Related to Operating Leases</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Operating lease costs during the year (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--LeaseCost_pn3n3_c20230101__20231231_fKDEp_zwycTJTBHuPg" title="Operating lease costs during the year" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2023-01-01to2023-12-31" id="Fact001405" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,052</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--LeaseCost_pn3n3_c20220101__20221231_fKDEp_z73jF7LNQxa5" title="Operating lease costs during the year" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2022-01-012022-12-31" id="Fact001407" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">969</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash payments included in the measurement of operating lease liability during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--OperatingLeasePayments_pn3n3_c20230101__20231231_z2yyjd2lZEh9" title="Cash payments included in the measurement of operating lease liabilities during the year" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2023-01-01to2023-12-31" id="Fact001409" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">486</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--OperatingLeasePayments_pn3n3_c20220101__20221231_zV3eA2wVOeb8" title="Cash payments included in the measurement of operating lease liabilities during the year" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2022-01-012022-12-31" id="Fact001411" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">469</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted-average remaining lease term (in years) as of year-end</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_zvVHFKuBJfxf" title="Weighted-average remaining lease term (in years) as of year-end"><ix:nonNumeric contextRef="AsOf2023-12-31" format="ixt-sec:duryear" id="Fact001413" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">0.75</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zV1asf4n4CX6" title="Weighted-average remaining lease term (in years) as of year-end"><ix:nonNumeric contextRef="AsOf2022-12-31" format="ixt-sec:duryear" id="Fact001415" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">1.75</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted-average discount rate during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20231231_z3naXHOK2tSf" title="Weighted-average discount rate during the year"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2023-12-31" id="Fact001417" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.90</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231_z3QuF40HSk5c" title="Weighted-average discount rate during the year"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2022-12-31" id="Fact001419" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.90</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F08_zb7OynYi8UTh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F18_zEBwpg9r4gh8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001420" xml:lang="en-US">Operating lease
costs is presented net of sublease income that is not material.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A6_zPM9gRvgFt43" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generally utilizes its incremental borrowing rate based on information available at the commencement of the lease in determining
the present value of future payments since the implicit rate for the Company&#8217;s lease is not readily determinable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Variable
lease expense includes rental increases that are not fixed, such as those based on amounts paid to the lessor based on cost or consumption,
such as maintenance and utilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001422" name="us-gaap:LeaseCostTableTextBlock"><p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zJfBLkQAHXFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of operating lease costs were follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zO2LqGqlKC0c" style="display: none">Schedule
of Operating Lease Costs</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230101__20231231_zinowhJF3MF8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220101__20221231_zG8RsxWcdt29" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating lease costs:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingLeaseCost_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zV0B4SpXnKy7" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">General and administrative</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001424" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,344</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2022-01-012022-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001425" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,187</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseCost_pn3n3_maLCzoNR_zpSk8bcA8Md1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Total operating costs (<span id="xdx_F4B_zLdAqtn6mQj3">1</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2023-01-01to2023-12-31" id="Fact001427" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,344</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2022-01-012022-12-31" id="Fact001428" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,187</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--SubleaseIncome_iN_pn3n3_di_msLCzoNR_zkt2DSPB3R76" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Less sublease income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2023-01-01to2023-12-31" id="Fact001430" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">292</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2022-01-012022-12-31" id="Fact001431" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">218</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--LeaseCost_iT_pn3n3_mtLCzoNR_zBWuVL4CSMb2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total operating lease costs</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2023-01-01to2023-12-31" id="Fact001433" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,052</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2022-01-012022-12-31" id="Fact001434" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">969</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F02_zTMXHN40VhG6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1D_zEregB25HjTh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001435" xml:lang="en-US">Includes certain
costs associated with a business membership agreement (see below) that permits access to certain office space for the years ended December
31, 2023 and 2022 of $<span id="xdx_904_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessMembershipAgreementMember_zU6h5otEQ9t7" title="Operating lease cost" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2023-01-012023-12-31_custom_BusinessMembershipAgreementMember" id="Fact001437" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">620</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--OperatingLeaseCost_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--BusinessMembershipAgreementMember_z6Ipd2wuVVn6" title="Operating lease cost" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2022-01-012022-12-31_custom_BusinessMembershipAgreementMember" id="Fact001439" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">668</ix:nonFraction></span>, respectively, and month-to-month lease arrangements for the years ended December 31, 2023 and 2022
of $<span id="xdx_90F_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--MonthToMonthLeaseArrangementMember_zKURtxpM8Jmd" title="Operating lease cost" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2023-01-012023-12-31_custom_MonthToMonthLeaseArrangementMember" id="Fact001441" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">396</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--OperatingLeaseCost_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--MonthToMonthLeaseArrangementMember_zmCHQMmJCq5d" title="Operating lease cost" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2022-01-012022-12-31_custom_MonthToMonthLeaseArrangementMember" id="Fact001443" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">320</ix:nonFraction></span>, respectively.</ix:footnote></span></td>
</tr></table>


</ix:nonNumeric><p id="xdx_8A3_zj6IvB2CrPGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001445" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zmOuJ48hGynk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturities
of the operating lease liability as of December 31, 2023 are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zVtIOD6SsG02" style="display: none">Summary
of Maturity of Lease Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20231231_zQ9FCrzvbBFa" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtLOLLPzG3L_zYptFfV4rQMa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Minimum lease payments - 2024</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2023-12-31" id="Fact001447" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">373</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_zKMGTQFvJeW6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2023-12-31" id="Fact001449" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zdX0MRz6KWX3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Present value of operating lease liability</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2023-12-31" id="Fact001451" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">358</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_z45RPMTavPHc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Current portion of operating lease liability</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-12-31" id="Fact001453" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">358</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zyDmUs7j4Ru9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Long-term portion of operating lease liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1455">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zrTlsJVExJT6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total operating lease liability</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2023-12-31" id="Fact001457" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">358</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A2_z5VISfiKK3T2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sublease
Agreement </i>&#8211; The Company has entered into agreements to sublease certain space that it does not occupy, through the duration
of the lease terms, with one sublease through September 2024 and two other subleases through March 2024. As of December 31, 2023, the
Company is entitled to receive total sublease income of $<span id="xdx_90A_eus-gaap--SubleaseIncome_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SubleaseAgreementMember_z7BmfQ5fLWy1" title="Sublease income"><ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2023-01-012023-12-31_custom_SubleaseAgreementMember" id="Fact001459" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">537</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Business
Membership</i> &#8211; Effective October 1, 2021, the Company entered into a business membership agreement with York Factory LLC, doing
business as SaksWorks, that permits access to certain office space with furnishings, referred to as SaksWorks Memberships. This membership
provides a certain number of accounts that equate to the use of the space granted. Effective June 1, 2022, the SaksWorks membership agreement
was amended and assigned to Convene SW MSA Holdings, LLC (&#8220;Convene&#8221;). The initial term of the agreement with Convene was
through December 31, 2023, with provisions for renewals. The Company terminated the arrangement effective December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lease
Termination </i>&#8211; Effective September 30, 2021, the Company terminated a certain lease arrangement for office space. In connection
with the termination, the Company agreed to pay the landlord cash of $<span id="xdx_90B_eus-gaap--ProceedsFromLeasePayments_pn3n3_c20210901__20210930__us-gaap--TypeOfArrangementAxis__custom--LeaseArrangementMember_zVQwRn51UMvi" title="Proceeds from lease payments"><ix:nonFraction name="us-gaap:ProceedsFromLeasePayments" contextRef="From2021-09-012021-09-30_custom_LeaseArrangementMember" id="Fact001461" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,000</ix:nonFraction></span> (the &#8220;Cash Payments&#8221;) and $<span id="xdx_909_eus-gaap--AdvertisingExpense_pn3n3_c20210901__20210930__us-gaap--TypeOfArrangementAxis__custom--LeaseArrangementMember_zI2X2wgvnx7b" title="Advertising expense"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2021-09-012021-09-30_custom_LeaseArrangementMember" id="Fact001463" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,475</ix:nonFraction></span> in market rate
advertising. The Cash Payments were paid or remain due as follows: $<span id="xdx_90D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_c20211231_zbZxuqy619hd" title="Cash payments"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2021-12-31" id="Fact001465" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></span> paid in December 2021; $<span id="xdx_909_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_c20221031_zMMB9veji3Wl" title="Cash payments"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2022-10-31" id="Fact001467" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></span> paid in October 2022; $<span id="xdx_906_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_c20231031_zic96oG2Ioe1" title="Cash payments"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2023-10-31" id="Fact001469" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,000</ix:nonFraction></span>
paid in October 2023; and $<span id="xdx_907_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_c20231231__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandAndTwentyFourMember_zT6tXoNfElPj" title="Cash payments"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2023-12-31_custom_OctoberOneTwoThousandAndTwentyFourMember" id="Fact001471" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,000</ix:nonFraction></span> due on October 1, 2024, with imputed interest recognized at <span id="xdx_90B_ecustom--ImputedInterestRate_pid_dp_uPure_c20230101__20231231__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandAndTwentyFourMember_zhGVlKA0zrI9" title="Imputed interest recognized"><ix:nonFraction name="AREN:ImputedInterestRate" contextRef="From2023-01-012023-12-31_custom_OctoberOneTwoThousandAndTwentyFourMember" id="Fact001473" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.0</ix:nonFraction></span>% per annum, and the market advertising
of $<span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_pn3n3_c20230101__20231231_zWw3wEyELd4f" title="Market advertising"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2023-01-01to2023-12-31" id="Fact001475" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">615</ix:nonFraction></span> has been delivered during the year ended December 31, 2023, leaving $<span id="xdx_90C_ecustom--MarketingAndAdvertisingExpenseRemaining_pn3n3_c20230101__20231231_z6Y52a9imf4e" title="Market advertising leaving"><ix:nonFraction name="AREN:MarketingAndAdvertisingExpenseRemaining" contextRef="From2023-01-01to2023-12-31" id="Fact001477" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">860</ix:nonFraction></span> to be delivered as of December 31, 2023, with the current amount due, net of imputed interest, reflected in accrued expenses and other on the consolidated
balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001479" name="AREN:PlatformDevelopmentDisclosureTextBlock"><p id="xdx_807_ecustom--PlatformDevelopmentDisclosureTextBlock_z8pHwPLaU6Wd" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>8.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82C_zDP3yfcPuCMf">Platform Development</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001481" name="AREN:SummaryOfPlatformDevelopmentCostsTableTextBlock"><p id="xdx_895_ecustom--SummaryOfPlatformDevelopmentCostsTableTextBlock_zIxqj5lvxKH1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Platform
development costs are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zCGkr6fcwnh" style="display: none">Summary
of Platform Development Costs</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20231231_zScIWEATpF9e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20221231_zoi0Y6qHmrOh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_maPPAENzOa4_zpkMwALs7ny4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Platform development</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-12-31_custom_PlatformDevelopmentMember" id="Fact001483" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,054</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_custom_PlatformDevelopmentMember" id="Fact001484" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,493</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pn3n3_di_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_msPPAENzOa4_zb7BOt9cBcWi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less accumulated amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-12-31_custom_PlatformDevelopmentMember" id="Fact001486" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,331</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_custom_PlatformDevelopmentMember" id="Fact001487" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,163</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_mtPPAENzOa4_zg9J7Ivq3mdj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net platform development</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-12-31_custom_PlatformDevelopmentMember" id="Fact001489" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,723</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-12-31_custom_PlatformDevelopmentMember" id="Fact001490" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,330</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A3_zxpBfsFw1Khe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001492" name="AREN:SummaryOfPlatformDevelopmentCostActivityTableTextBlock"><p id="xdx_89A_ecustom--SummaryOfPlatformDevelopmentCostActivityTableTextBlock_zA9So66Ye86b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of platform development activity is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zvFdcOV5qJ31" style="display: none">Summary
of Platform Development Cost Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Platform development beginning of year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentOther_iS_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zEedoL1Wx1Jf" title="Platform development beginning of year" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2022-12-31_custom_PlatformDevelopmentMember" id="Fact001494" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,493</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentOther_iS_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zSMpkLYBnVe7" title="Platform development beginning of year" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2021-12-31_custom_PlatformDevelopmentMember" id="Fact001496" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,997</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payroll-based costs capitalized</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FinitelivedIntangibleAssetsAcquired1_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zi8ilA0LQW37" title="Payroll-based costs capitalized" style="text-align: right"><ix:nonFraction name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="From2023-01-012023-12-31_custom_PlatformDevelopmentMember" id="Fact001498" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,773</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FinitelivedIntangibleAssetsAcquired1_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_z4lU2ZiU6H7k" title="Payroll-based costs capitalized" style="text-align: right"><ix:nonFraction name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="From2022-01-012022-12-31_custom_PlatformDevelopmentMember" id="Fact001500" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,179</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less dispositions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--GainLossOnDispositionOfAssets1_iN_pn3n3_di_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zBDuanU1FMJf" title="Less dispositions" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2023-01-012023-12-31_custom_PlatformDevelopmentMember" id="Fact001502" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">164</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--GainLossOnDispositionOfAssets1_iN_pn3n3_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zntQAbyAsiml" title="Less dispositions" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2022-01-012022-12-31_custom_PlatformDevelopmentMember" id="Fact001504" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,357</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total capitalized payroll-based costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zbgJijmJSww3" title="Total capitalized payroll-based costs" style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedContractCostAmortization" contextRef="From2023-01-012023-12-31_custom_PlatformDevelopmentMember" id="Fact001506" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,102</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zm28SsBRk7Ui" title="Total capitalized payroll-based costs" style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedContractCostAmortization" contextRef="From2022-01-012022-12-31_custom_PlatformDevelopmentMember" id="Fact001508" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,819</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zRXwggsvC8a8" title="Stock-based compensation" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-12-31_custom_PlatformDevelopmentMember" id="Fact001510" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,016</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zGBZkksY9Unk" title="Stock-based compensation" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-12-31_custom_PlatformDevelopmentMember" id="Fact001512" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,884</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Impairments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pn3n3_di_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zD3wrHAZConj" title="Impairments" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2023-01-012023-12-31_custom_PlatformDevelopmentMember" id="Fact001514" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">64</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pn3n3_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zQDa9e618Mf3" title="Impairments" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2022-01-012022-12-31_custom_PlatformDevelopmentMember" id="Fact001516" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">210</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Platform development end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentOther_iE_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zifcqCCr2A97" title="Platform development end of year" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2023-12-31_custom_PlatformDevelopmentMember" id="Fact001518" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,054</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentOther_iE_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zwvUFv2XESl9" title="Platform development end of year" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2022-12-31_custom_PlatformDevelopmentMember" id="Fact001520" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,493</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A1_zzTfVgXOcT3l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for platform development for the year ended December 31, 2023 and 2022 was $<span id="xdx_908_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_ziaWLfP2j086" title="Amortization expense of intangible asset"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-01-012023-12-31_custom_PlatformDevelopmentMember" id="Fact001522" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,332</ix:nonFraction></span> and $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_z0QRcEi260Oe" title="Amortization expense of intangible asset"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-01-012022-12-31_custom_PlatformDevelopmentMember" id="Fact001524" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,822</ix:nonFraction></span>, respectively. Amortization expense
for platform development is included in cost of revenue on the consolidated statements of operations. Impairment charges for platform
development for the years ended December 31, 2023 and 2022 of $<span id="xdx_903_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zDfRxxhbd1L1" title="Impairment charges"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2023-01-012023-12-31_custom_PlatformDevelopmentMember" id="Fact001526" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">64</ix:nonFraction> </span>and $<span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zDcG0HxUfJM5" title="Impairment charges"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2022-01-012022-12-31_custom_PlatformDevelopmentMember" id="Fact001528" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">210</ix:nonFraction></span>, <span id="xdx_90E_eus-gaap--ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_dxL_c20230101__20231231_zUYFQGCbiRFg" title="::XDX::http%3A%2F%2Ffasb.org%2Fus-gaap%2F2023%23AssetImpairmentCharges"><span style="-sec-ix-hidden: xdx2ixbrl1529">respectively</span></span>, have been recorded on the consolidated statements
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001531" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_806_eus-gaap--IntangibleAssetsDisclosureTextBlock_z64g7eKbPyo" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>9.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_827_zSv6iL6pkzo">Intangible Assets</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001533" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zGqPiHulnNc8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets subject to amortization consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zUxXsWZaoRVi" style="display: none">Schedule
of Intangible Assets Subject to Amortization</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 7pt"/><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/>
 Average<br/>
 Useful<br/>
 Life (in<br/>
 years)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Carrying<br/>
 Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Accumulated<br/>
 Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Net<br/>
 Carrying<br/>
 Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Carrying<br/>
 Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Accumulated<br/>
 Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Net<br/>
 Carrying<br/>
 Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left">Developed technology</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zUlmoVeH7gKg" title="Intangible assets, weighted average useful life" style="width: 6%; text-align: center"><ix:nonNumeric contextRef="AsOf2023-12-31_custom_DevelopedTechnologyMember" format="ixt-sec:duryear" id="Fact001535" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">4.70</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zPLtTlPFqcP2" title="Intangible assets, gross" style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-12-31_custom_DevelopedTechnologyMember" id="Fact001537" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,333</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zMgGGax6T5D4" title="Intangible assets, accumulated amortization" style="width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-12-31_custom_DevelopedTechnologyMember" id="Fact001539" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,333</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zjAkav9a8Sx7" title="Intangible assets, net" style="width: 6%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1541">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_z7Wjm0Ok4Wt3" title="Intangible assets, gross" style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_custom_DevelopedTechnologyMember" id="Fact001543" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,333</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zLxS893m0ogd" title="Intangible assets, accumulated amortization" style="width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_custom_DevelopedTechnologyMember" id="Fact001545" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,883</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zBCHpRcyDwM" title="Intangible assets, net" style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-12-31_custom_DevelopedTechnologyMember" id="Fact001547" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,450</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade name</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zzVktJNWpdne" title="Intangible assets, weighted average useful life" style="text-align: center"><ix:nonNumeric contextRef="AsOf2023-12-31_us-gaap_TradeNamesMember" format="ixt-sec:duryear" id="Fact001549" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">16.10</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zDUrUFaiScql" title="Intangible assets, gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-12-31_us-gaap_TradeNamesMember" id="Fact001551" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,181</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zlgZtjptU8Qb" title="Intangible assets, accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-12-31_us-gaap_TradeNamesMember" id="Fact001553" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,547</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zPuAiq2cDMO9" title="Intangible assets, net" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-12-31_us-gaap_TradeNamesMember" id="Fact001555" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,634</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zll02mCKq6qj" title="Intangible assets, gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_us-gaap_TradeNamesMember" id="Fact001557" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,380</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zeJxzjxEVDK7" title="Intangible assets, accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_us-gaap_TradeNamesMember" id="Fact001559" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,180</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zY63KfZKeS52" title="Intangible assets, net" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-12-31_us-gaap_TradeNamesMember" id="Fact001561" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Brand name</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z5YUIFZbkNLj" title="Intangible assets, weighted average useful life" style="text-align: center"><ix:nonNumeric contextRef="AsOf2023-12-31_custom_BrandNamesMember" format="ixt-sec:duryear" id="Fact001563" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">9.70</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zBFW48O2JV3e" title="Intangible assets, gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-12-31_custom_BrandNamesMember" id="Fact001565" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,774</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zugLjIgyb9g5" title="Intangible assets, accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-12-31_custom_BrandNamesMember" id="Fact001567" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,374</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zkmEvK9I8C44" title="Intangible assets, net" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-12-31_custom_BrandNamesMember" id="Fact001569" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z2PJ48WtLwAc" title="Intangible assets, gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_custom_BrandNamesMember" id="Fact001571" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,115</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zPp8GVRc0Fyd" title="Intangible assets, accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_custom_BrandNamesMember" id="Fact001573" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">908</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zkqmfZtDPs1b" title="Intangible assets, net" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-12-31_custom_BrandNamesMember" id="Fact001575" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,207</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Subscriber relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zuJYxejpJFEh" title="Intangible assets, weighted average useful life" style="text-align: center"><ix:nonNumeric contextRef="AsOf2023-12-31_custom_SubscriberRelationshipsMember" format="ixt-sec:duryear" id="Fact001577" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">5.10</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_z1En2GiaAO69" title="Intangible assets, gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-12-31_custom_SubscriberRelationshipsMember" id="Fact001579" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">73,459</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_z9zrN0oCQVFd" title="Intangible assets, accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-12-31_custom_SubscriberRelationshipsMember" id="Fact001581" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">61,654</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zU7gGu6Memo1" title="Intangible assets, net" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-12-31_custom_SubscriberRelationshipsMember" id="Fact001583" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,805</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zPjVJZuHqYA1" title="Intangible assets, gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_custom_SubscriberRelationshipsMember" id="Fact001585" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">73,459</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zDRJ180J2Upb" title="Intangible assets, accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_custom_SubscriberRelationshipsMember" id="Fact001587" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">47,146</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zGE6F5MhgFyk" title="Intangible assets, net" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-12-31_custom_SubscriberRelationshipsMember" id="Fact001589" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,313</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Advertiser relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zgkNT25EFh74" title="Intangible assets, weighted average useful life" style="text-align: center"><ix:nonNumeric contextRef="AsOf2023-12-31_custom_AdvertiserRelationshipsMember" format="ixt-sec:duryear" id="Fact001591" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">10.20</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zEWRXOtzKjb1" title="Intangible assets, gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-12-31_custom_AdvertiserRelationshipsMember" id="Fact001593" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,182</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_z95TgOZE8c4a" title="Intangible assets, accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-12-31_custom_AdvertiserRelationshipsMember" id="Fact001595" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,832</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zAqCXJVxhvSb" title="Intangible assets, net" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-12-31_custom_AdvertiserRelationshipsMember" id="Fact001597" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,350</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zbBtoclSBlFl" title="Intangible assets, gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_custom_AdvertiserRelationshipsMember" id="Fact001599" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,302</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zsk0z7qULDdb" title="Intangible assets, accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_custom_AdvertiserRelationshipsMember" id="Fact001601" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,368</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zryIDTvmRqsc" title="Intangible assets, net" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-12-31_custom_AdvertiserRelationshipsMember" id="Fact001603" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,934</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Database</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zT3XTIqhh8Ki" title="Intangible assets, weighted average useful life" style="text-align: center"><ix:nonNumeric contextRef="AsOf2023-12-31_us-gaap_DatabasesMember" format="ixt-sec:duryear" id="Fact001605" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">3.00</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zQgKWkLR70Zf" title="Intangible assets, gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-12-31_us-gaap_DatabasesMember" id="Fact001607" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,397</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zVrkRWfZWgY1" title="Intangible assets, accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-12-31_us-gaap_DatabasesMember" id="Fact001609" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,171</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_z9vGaJNNZMVi" title="Intangible assets, net" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-12-31_us-gaap_DatabasesMember" id="Fact001611" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">226</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zmXwPweU27Yb" title="Intangible assets, gross" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_us-gaap_DatabasesMember" id="Fact001613" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,397</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zqzxbu8f1RAl" title="Intangible assets, accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_us-gaap_DatabasesMember" id="Fact001615" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,753</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zbcCyeO2Oluf" title="Intangible assets, net" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-12-31_us-gaap_DatabasesMember" id="Fact001617" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">644</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Digital content</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zoenZA2G2Wu3" title="Intangible assets, weighted average useful life" style="padding-bottom: 1.5pt; text-align: center"><ix:nonNumeric contextRef="AsOf2023-12-31_custom_DigitalContentMember" format="ixt-sec:duryear" id="Fact001619" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">2.00</ix:nonNumeric></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_z27QSShJFPH" title="Intangible assets, gross" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-12-31_custom_DigitalContentMember" id="Fact001621" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">355</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zv39eNcxRjX" title="Intangible assets, accumulated amortization" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-12-31_custom_DigitalContentMember" id="Fact001623" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">311</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zMJTMqwTBTWa" title="Intangible assets, net" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-12-31_custom_DigitalContentMember" id="Fact001625" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zrN1I2QkoX6l" title="Intangible assets, gross" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_custom_DigitalContentMember" id="Fact001627" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">355</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zxf7JUM4GUma" title="Intangible assets, accumulated amortization" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_custom_DigitalContentMember" id="Fact001629" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">133</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zWUfzZ9F9TQ" title="Intangible assets, net" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-12-31_custom_DigitalContentMember" id="Fact001631" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">222</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Total intangible assets</td><td style="padding-bottom: 2.5pt; font-size: 10pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 7pt; text-align: center"/><td style="padding-bottom: 2.5pt; font-size: 7pt; text-align: left"/><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231_zRnBAslxkjLj" title="Intangible assets, gross" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-12-31" id="Fact001633" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">126,681</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231_zGiKhMSlei9f" title="Intangible assets, accumulated amortization" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-12-31" id="Fact001635" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">88,222</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231_zI4CGWw40rwe" title="Intangible assets, net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-12-31" id="Fact001637" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,459</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231_zYd3UO3kWlVc" title="Intangible assets, gross" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31" id="Fact001639" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">126,341</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231_z9iw7ItRHiK4" title="Intangible assets, accumulated amortization" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31" id="Fact001641" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">67,371</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231_zhQzPuBKRfg8" title="Intangible assets, net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-12-31" id="Fact001643" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58,970</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><p id="xdx_8AA_zTaibOTCoOHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets subject to amortization were recorded as part of the Company&#8217;s business acquisitions. Amortization expense for the years
ended December 31, 2023 and 2022 was $<span id="xdx_90E_eus-gaap--AmortizationOfAcquisitionCosts_pn3n3_c20230101__20231231_zs4lzgZp8O2g" title="Amortization expense of intangible asset acquisition"><ix:nonFraction name="us-gaap:AmortizationOfAcquisitionCosts" contextRef="From2023-01-01to2023-12-31" id="Fact001645" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,022</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--AmortizationOfAcquisitionCosts_pn3n3_c20220101__20221231_zrCmGdf9pGg4" title="Amortization expense of intangible asset acquisition"><ix:nonFraction name="us-gaap:AmortizationOfAcquisitionCosts" contextRef="From2022-01-012022-12-31" id="Fact001647" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,748</ix:nonFraction></span>, respectively, of which amortization expense for developed technology of $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_z1HR0AfETNy3" title="Amortization expense of intangible asset"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-01-012023-12-31_custom_DevelopedTechnologyMember" id="Fact001649" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,130</ix:nonFraction></span>
and $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zUhwB378ynN7" title="Amortization expense of intangible asset"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-01-012022-12-31_custom_DevelopedTechnologyMember" id="Fact001651" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,831</ix:nonFraction></span>, respectively, is included in cost of revenue on the consolidated statements of operations. <span id="xdx_906_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pn3n3_do_c20230101__20231231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zzA0oEBDS5F1" title="Impairment charges"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2023-01-012023-12-31_us-gaap_FiniteLivedIntangibleAssetsMember" id="Fact001653" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="USD">No</ix:nonFraction></span> impairment charges
for the year ended December 31, 2023 was recorded for the intangible assets. Impairment charges for the year ended December 31, 2022
of $<span id="xdx_90C_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pn3n3_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zzFxP0iBySGh" title="Impairment charges"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2022-01-012022-12-31_us-gaap_FiniteLivedIntangibleAssetsMember" id="Fact001655" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></span> were recorded for the intangible assets on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001657" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zuyRfzrqd0T8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
total amortization expense for the next five years and thereafter related to the Company&#8217;s intangible assets subject to amortization
as of December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zqqKW07qTw9h" style="display: none">Schedule
of Future Estimated Amortization expense For Intangible Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: left; font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_497_20231231_zYAjGNyCvCJ4">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-weight: bold">Years Ending December 31,</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_iI_pn3n3_maFLIANzfm1_z9gvHtQccBsg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 79%; text-align: left">2024</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" contextRef="AsOf2023-12-31" id="Fact001659" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,544</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo_iI_pn3n3_maFLIANzfm1_z1H3hJWm4jr1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" contextRef="AsOf2023-12-31" id="Fact001661" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,427</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree_iI_pn3n3_maFLIANzfm1_zyzr9y1cm7nd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree" contextRef="AsOf2023-12-31" id="Fact001663" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,214</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour_iI_pn3n3_maFLIANzfm1_zIeuwnD8FEI6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2027</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour" contextRef="AsOf2023-12-31" id="Fact001665" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,214</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive_iI_pn3n3_maFLIANzfm1_zvTboWyk7Kwa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive" contextRef="AsOf2023-12-31" id="Fact001667" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,964</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive_iI_pn3n3_maFLIANzfm1_zfDcpcwcmJFh" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive" contextRef="AsOf2023-12-31" id="Fact001669" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,096</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzfm1_zWG5Dwvonkjb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
    assets ,net</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-12-31" id="Fact001671" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,459</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zf2eXqoM1kx5" style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001673" name="us-gaap:OtherAssetsDisclosureTextBlock"><p id="xdx_809_eus-gaap--OtherAssetsDisclosureTextBlock_ztJKIVhtI4Xe" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>10.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span><span id="xdx_82B_zXOQ596nflp2">Other
Long-Term Assets</span></span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001675" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfOtherAssetsNoncurrentTextBlock_zbLVWHPCANGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
assets are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zm2wbNP0GrZc" style="display: none">Summary
of Other Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20231231_zWHtJmgelNKj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20221231_z8aJMAK8Mkoh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--SecurityDeposit_iI_pn3n3_maOANzDET_zpVxvTTopPo8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Security deposit</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2023-12-31" id="Fact001677" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">420</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2022-12-31" id="Fact001678" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">420</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OtherReceivables_iI_pn3n3_maOANzDET_zqWGhbImfvfk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2023-12-31" id="Fact001680" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1681">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PrepaidInsurance_iI_pn3n3_maOANzDET_zNU3A6qIzWaf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Prepaid insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidInsurance" contextRef="AsOf2023-12-31" id="Fact001683" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">284</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidInsurance" contextRef="AsOf2022-12-31" id="Fact001684" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">504</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--UnamortizedDebtCost_iI_pn3n3_maOANzDET_zYhHCihRnmad" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Unamortized debt cost</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:UnamortizedDebtCost" contextRef="AsOf2023-12-31" id="Fact001686" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">209</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:UnamortizedDebtCost" contextRef="AsOf2022-12-31" id="Fact001687" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">216</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherAssetsNoncurrent_iTI_pn3n3_mtOANzDET_zc71b3mHVZM5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total other assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2023-12-31" id="Fact001689" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,003</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2022-12-31" id="Fact001690" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,140</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A8_z2wbWsdTyIij" style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001692" name="us-gaap:GoodwillDisclosureTextBlock"><p id="xdx_803_eus-gaap--GoodwillDisclosureTextBlock_zLo7pNSDpYqh" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>11.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_822_zA8SAqcy52jf">Goodwill</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001694" name="us-gaap:ScheduleOfGoodwillTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfGoodwillTextBlock_zgqiNgwIwcP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
changes in carrying value of goodwill are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BD_z6oMhibAbeTg" style="display: none">Schedule
of Changes in Carrying Value of Goodwill</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_z54GMFz6llBd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20220101__20221231_zpKLTNlPeqpc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Goodwill_iS_pn3n3_zY5bhtZukAuj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Carrying value at beginning of year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-12-31" id="Fact001696" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39,344</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2021-12-31" id="Fact001697" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,619</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_z7sIbTW6gjMb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Goodwill acquired in acquisition of Parade</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1699">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2022-01-012022-12-31_custom_ParadeMember" id="Fact001700" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,587</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--MensJournalMember_zhQrkm1SyGji" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Goodwill acquired in acquisition of Men&#8217;s Journal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2023-01-012023-12-31_custom_MensJournalMember" id="Fact001702" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,246</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2022-01-012022-12-31_custom_MensJournalMember" id="Fact001703" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,138</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zi5zzU65rDze" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Goodwill acquired in acquisition of Fexy Studios</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2023-01-012023-12-31_custom_FexyStudiosMember66260062" id="Fact001705" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,985</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1706">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--GoodwillImpairmentLoss_pn3n3_zPl4H5Aggyg8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss on impairment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1708">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1709">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--Goodwill_iE_pn3n3_z1MlBj06RKPd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Carrying value at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-12-31" id="Fact001711" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42,575</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-12-31" id="Fact001712" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39,344</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zn1uAjHx8ish" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company performs its annual impairment test at the reporting unit level, which is the operating segment or one level below the operating
segment. Management determined that the Company would be aggregated into a single reporting unit for purposes of performing the impairment
test for goodwill.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, as part of its annual impairment evaluation of goodwill of its one reporting unit, performs the goodwill impairment test in
accordance with applicable guidance. The guidance provides an entity the option to first perform a qualitative assessment to determine
whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines
that this is the case, it is required to perform the goodwill impairment test to identify potential goodwill impairment and measure the
amount of goodwill impairment loss to be recognized for that reporting unit, if any. If an entity determines that the fair value of a
reporting unit is greater than its carrying amount, the goodwill impairment test is not required. The annual impairment test was performed
on December 31, 2023. <span id="xdx_90F_eus-gaap--GoodwillImpairmentLoss_doxL_c20230101__20231231_zZjLeV4bDb93" title="Impairment of goodwill::XDX::-"><span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_doxL_c20220101__20221231_zd6stMLXluWg" title="Impairment of goodwill::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1714"><span style="-sec-ix-hidden: xdx2ixbrl1716">No</span></span></span></span> goodwill impairment was identified during the years ended December 31, 2023 and 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001718" name="AREN:RestrictedStockLiabilitiesTextBlock"><p id="xdx_801_ecustom--RestrictedStockLiabilitiesTextBlock_zxC9Yj5Go6V1" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>12.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82B_zbCIX0GXUBy7">Restricted Stock Liabilities</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded the repurchase of <span id="xdx_90A_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zVXRrfTOivV" title="Stock repurchased during period, shares"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember" id="Fact001720" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,214</ix:nonFraction></span> shares of the Company&#8217;s restricted common stock during the year ended December 31, 2022
on the consolidated statement of stockholders&#8217; deficiency. Effective April 4, 2022, there are no longer any shares of
the Company&#8217;s common stock subject to repurchase. During the year ended December 31, 2022, the Company paid $<span id="xdx_904_eus-gaap--PaymentsForRepurchaseOfEquity_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z3kzbOibPQni" title="Payments for repurchase Of equity"><ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfEquity" contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember" id="Fact001722" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,307</ix:nonFraction></span> in cash for
the repurchase ($<span id="xdx_903_ecustom--RestrictedStockPrincipalAmount_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQmyduDaybp9" title="Restricted stock principal amount"><ix:nonFraction name="AREN:RestrictedStockPrincipalAmount" contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember" id="Fact001724" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,152</ix:nonFraction></span> in principal and $<span id="xdx_909_ecustom--RestrictedStockInterestPayment_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zr92X15tTDFb" title="Restricted stock interest payment"><ix:nonFraction name="AREN:RestrictedStockInterestPayment" contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember" id="Fact001726" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">155</ix:nonFraction></span> in interest).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001728" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_80E_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zFMTPtkEIuTh" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>13.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82A_z3pgpIuYtbk4">Accrued Expenses and Other</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001730" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zoKITz2tC5r3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
expenses and other are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_zXRiw98G4eza" style="display: none">Schedule
of Accrued Expenses</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20231231_z2IvZHnY1aE8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20221231_zaDWqhP6fpY8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_401_ecustom--GeneralAccruedExpenses_iI_pn3n3_maALCzErP_zvEVHQmS9p6i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">General accrued expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="AREN:GeneralAccruedExpenses" contextRef="AsOf2023-12-31" id="Fact001732" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,486</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="AREN:GeneralAccruedExpenses" contextRef="AsOf2022-12-31" id="Fact001733" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,339</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccruedPayrollTaxesCurrent_iI_pn3n3_maALCzErP_zgADpXqNjNK4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Accrued payroll and related taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="AsOf2023-12-31" id="Fact001735" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,448</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="AsOf2022-12-31" id="Fact001736" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,221</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccruedAdvertisingCurrent_iI_pn3n3_maALCzErP_zWhsjuBqslfc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Accrued publisher expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedAdvertisingCurrent" contextRef="AsOf2023-12-31" id="Fact001738" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,596</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedAdvertisingCurrent" contextRef="AsOf2022-12-31" id="Fact001739" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,911</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InterestPayableCurrent_iI_pn3n3_maALCzErP_z2DpbicCVEEc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2023-12-31" id="Fact001741" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,824</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1742">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--LiabilitiesInConnectionWithAcquisitionsAndDispositions_iI_pn3n3_maALCzErP_za2u7I06ihW1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Liabilities in connection with acquisitions and dispositions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:LiabilitiesInConnectionWithAcquisitionsAndDispositions" contextRef="AsOf2023-12-31" id="Fact001744" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,119</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:LiabilitiesInConnectionWithAcquisitionsAndDispositions" contextRef="AsOf2022-12-31" id="Fact001745" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,123</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LeaseDepositLiability_iI_pn3n3_maALCzErP_znl7JMQaCdDh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Assumed lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LeaseDepositLiability" contextRef="AsOf2023-12-31" id="Fact001747" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,328</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1748">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--LeaseTerminationLiability_iI_pn3n3_maALCzErP_zBb3Qlhezbwe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Lease termination liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:LeaseTerminationLiability" contextRef="AsOf2023-12-31" id="Fact001750" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,481</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:LeaseTerminationLiability" contextRef="AsOf2022-12-31" id="Fact001751" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,753</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maALCzErP_z4rq3OtxmYk3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact001753" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">489</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31" id="Fact001754" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">755</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedLiabilitiesCurrent_iTI_pn3n3_mtALCzErP_zUGWjDkRuT75" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total accrued expenses and other</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact001756" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,771</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31" id="Fact001757" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,102</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A7_zcEexnx63Vq7" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0"></p>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001759" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_804_eus-gaap--DebtDisclosureTextBlock_zrnxQidmTccf" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>14.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_820_z4tzOq8IFphl">Line of Credit</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Arena
Credit Agreement</i> &#8211; On December 15, 2022, the Company entered into an amendment to its financing and security agreement for
its line of credit with SLR Digital Finance LLC (&#8220;SLR&#8221; or the &#8220;amended line of credit&#8221;), as further amended
on August 31, 2023 in connection with the Business Combination (see Note 28) (the &#8220;SLR Amendment&#8221;) pursuant to which the
SLR Amendment provided for an extension of the maturity date, additional event of default provisions in connection with the Business
Combination, payment of certain fees in connection with the Business Combination, additional borrowings under the 2023 Notes (see
Note 18) pursuant to the First Amendment (see Note 18 and Note 27), and issuance of Series A preferred stock in connection with the
Business Combination, all of which are more fully described herein. Collectively the amended line of credit and SLR Amendment are
referred to as the &#8220;line of credit&#8221; (or the &#8220;Arena Credit Agreement&#8221;). In connection with the Arena Notes
Default (as further described under the heading <i>Arena Loan Agreement </i> in Note 28) there was a cross-default of the line of
credit, or the SLR Default (as further described under the heading <i>Arena Credit Agreement Default</i> in Note 28). The line of
credit provided for (i) $<span id="xdx_901_eus-gaap--LineOfCredit_iI_pn3n3_c20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember__srt--RangeAxis__srt--MaximumMember_zJMANQ2LEqMb" title="Line of credit"><ix:nonFraction name="us-gaap:LineOfCredit" contextRef="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember_srt_MaximumMember" id="Fact001761" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">maximum
amount of advances available (subject to certain limits and eighty-five (<span id="xdx_90B_ecustom--AccountsReceivablePercentage_pid_dp_uPure_c20221215__20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember__srt--RangeAxis__srt--MaximumMember_zX0c7yycZAOd" title="Accounts receivable percentage"><ix:nonFraction name="AREN:AccountsReceivablePercentage" contextRef="From2022-12-152022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember_srt_MaximumMember" id="Fact001763" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">85</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%)
of eligible accounts receivable) pursuant to the amended line of credit, (ii) <span id="xdx_905_eus-gaap--LineOfCreditFacilityInterestRateDescription_c20221215__20221215__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember_zie0R2Wjyvka" title="Line of credit facility, interest rate description"><ix:nonNumeric contextRef="From2022-12-152022-12-15_custom_SLRDigitalFinanceLLCMember_custom_FinancingAndSecurityAgreementMember" id="Fact001765" name="us-gaap:LineOfCreditFacilityInterestRateDescription">an
interest rate at the prime rate plus 4.0% per annum of the amount advanced (subject to minimum utilization of at least 10% of the
maximum amount of advances available) (as of December 31, 2023 the stated interest rate was 12.5%), (iii) payment of a fee equal to
2.25% of the maximum line amount with respect to any termination of the agreement prior to December 31, 2025 at the option of the
Company at any time with 60 day notice pursuant to the SLR Amendment, (iv) a payment of a performance fee in the amount equal to
2.25% of the maximum line amount, under certain circumstances pursuant to the Business Combination in connection with a deal
deadline or in the event of a deal failure, as defined in the SLR Amendment, further the performance fee will survive the
termination of the agreement, pursuant to the SLR Amendment, (v) a payment of a success fee if the Business Combination is
consummated, of 0.3% or 0.6% of the maximum line amount if the transaction closes on or before December 31, 2023 or after December
31, 2023, respectively, or $0 if the transaction closes after the deal deadline, pursuant to the SLR Amendment, and (vi) a maturity
date of</ix:nonNumeric> </span></span><span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_dd_c20221215__20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember_zhS9HlaoRw8i" title="Maturity date" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2022-12-152022-12-15_custom_SLRDigitalFinanceLLCMember_custom_FinancingAndSecurityAgreementMember" format="ixt:datemonthdayyearen" id="Fact001767" name="us-gaap:DebtInstrumentMaturityDate">December
31, 2025</ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The SLR Amendment also permitted the
Company to enter into the 2023 Notes in an aggregate of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember__us-gaap--LongtermDebtTypeAxis__custom--TwoThousandTwentyThreeNotesMember_zs21Rbo6NxW5" title="Debt instrument, face amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember_custom_TwoThousandTwentyThreeNotesMember" id="Fact001769" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(as
further described under the heading <i>2023 Bridge Notes</i> in Note 18) and permitted the issuance of the Series A preferred stock
for $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember__us-gaap--StatementEquityComponentsAxis__custom--SeriesLPreferredStockMember_zsRlgIbqohBa" title="Debt instrument, face amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember_custom_SeriesLPreferredStockMember" id="Fact001771" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
connection with the Business Combination. The line of credit was for working capital purposes and was secured by a first lien on all
the Company&#8217;s cash and accounts receivable and a second lien on all other assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the SLR Amendment and amended line of credit, the Company incurred debt costs of $<span id="xdx_902_eus-gaap--DebtDefaultLongtermDebtAmount_iI_pn3n3_c20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zDVkDo1n3TXj" title="Debt costs"><ix:nonFraction name="us-gaap:DebtDefaultLongtermDebtAmount" contextRef="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember" id="Fact001773" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90A_eus-gaap--UnamortizedDebtIssuanceExpense_iI_pn3n3_c20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zEGAqll9zEc7" title="Debt costs"><ix:nonFraction name="us-gaap:UnamortizedDebtIssuanceExpense" contextRef="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember" id="Fact001775" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">441</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, with the SLR Amendment debt cost plus the unamortized debt cost at the time of the SLR Amendment being amortized over the
life of the extended maturity date of the line of credit. The unamortized balance, as of December 31, 2023 and 2022, was reflected in
prepayment and other current assets of $<span id="xdx_907_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zQxBwKN4cXne" title="Prepayment and other current assets"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember" id="Fact001777" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">209</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_903_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zOyUXz8lMqNe" title="Prepayment and other current assets"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember" id="Fact001779" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">216</ix:nonFraction></span><span style="line-height: 115%">, respectively,
and </span>other long-term assets of $<span id="xdx_905_eus-gaap--OtherAssetsNoncurrent_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zEhEOTKWbum" title="Other long-term assets"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2023-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember" id="Fact001781" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">209</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_900_eus-gaap--OtherAssetsNoncurrent_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zG2A5BKdb7aj" title="Other long-term assets"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2022-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember" id="Fact001783" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">216</ix:nonFraction></span>,
respectively</span>. As of December 31, 2023, the effective interest rate on the line of credit was <span id="xdx_905_eus-gaap--LineOfCreditFacilityInterestRateAtPeriodEnd_iI_pid_dp_uPure_c20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zzpTpnqbnAji" title="Effective interest rate, line of credit"><ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" contextRef="AsOf2023-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember" id="Fact001785" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13.7</ix:nonFraction></span>%.
As of December 31, 2023 and 2022, the balance outstanding under the line of credit was $<span id="xdx_907_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zlvzovJVkXU3" title="Line of credit"><ix:nonFraction name="us-gaap:LinesOfCreditCurrent" contextRef="AsOf2023-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember" id="Fact001787" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,609</ix:nonFraction>
</span>and $<span id="xdx_906_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zWdoiiaI8br6" title="Line of credit"><ix:nonFraction name="us-gaap:LinesOfCreditCurrent" contextRef="AsOf2022-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember" id="Fact001789" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,092</ix:nonFraction></span>,
respectively, as reflected on the consolidated balance sheets. As of December 31, 2023, in connection with the SLR Default, the Company
recorded a $<span id="xdx_908_eus-gaap--DebtInstrumentFeeAmount_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zfskYoJYzka7" title="Termination fee"><ix:nonFraction name="us-gaap:DebtInstrumentFeeAmount" contextRef="AsOf2023-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember" id="Fact001791" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">900</ix:nonFraction>
</span>termination fee representing <span id="xdx_903_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zLNTD6t2LLp8" title="Interest rate, line of credit"><ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" contextRef="From2023-01-012023-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember" id="Fact001793" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.25</ix:nonFraction></span>%
of the maximum line amount, as reflected in accrued expenses and other on the consolidated balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001795" name="AREN:LiquidatedDamagesPayableTextBlock"><p id="xdx_809_ecustom--LiquidatedDamagesPayableTextBlock_zpxEob7RK7ni" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>15.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_824_zRrpr5VZnOEd">Liquidated Damages Payable</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidated
damages were recorded as a result of the following: (i) certain registration rights agreements provide for damages if the Company does
not register certain shares of the Company&#8217;s common stock within the requisite time frame (the &#8220;Registration Rights Damages&#8221;);
and (ii) certain securities purchase agreements provide for damages if the Company does not maintain its periodic filings with the SEC
within the requisite time frame (the &#8220;Public Information Failure Damages&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" continuedAt="ConU001799-01" escape="true" id="Fact001799" name="AREN:SummaryOfLiquidatedDamagesTableTextBlock"><p id="xdx_895_ecustom--SummaryOfLiquidatedDamagesTableTextBlock_gL3SOLDTTB-KNKL_zDGTwIincM2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations
with respect to the liquidated damages payable are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B5_zMegz0GqMS1a" style="display: none">Summary
of Liquidated Damages</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Registration<br/>
 Rights Damages</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Public<br/>
 Information<br/>
 Failure Damages</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accrued<br/>
 Interest</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">MDB common stock to be issued (<span id="xdx_F42_zZAapBO2gps9">1</span>)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zDqlJnuraLZh" title="Registration Rights Damages" style="width: 12%; text-align: right"><ix:nonFraction name="AREN:RegistrationRightsDamages" contextRef="AsOf2023-12-31_custom_MDBCommonStockToBeIssuedMember" id="Fact001801" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zirnilVnafnd" title="Public Information Failure Damages" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1803">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_z4G7I3rqJu3l" title="Accrued Interest" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1805">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_z35RJgXoCam" title="Balance" style="width: 12%; text-align: right"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrentAndNonCurrent" contextRef="AsOf2023-12-31_custom_MDBCommonStockToBeIssuedMember" id="Fact001807" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series H convertible preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zZMZaArqvnu3" title="Registration Rights Damages" style="text-align: right"><ix:nonFraction name="AREN:RegistrationRightsDamages" contextRef="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact001809" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">565</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zPBLMRLCtnKk" title="Public Information Failure Damages" style="text-align: right"><ix:nonFraction name="AREN:PublicInformationFailureDamages" contextRef="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact001811" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">574</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zmj1VuA20GT2" title="Accrued Interest" style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact001813" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">659</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zrdXkHLPLGEd" title="Balance" style="text-align: right"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrentAndNonCurrent" contextRef="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact001815" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,798</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_F4E_zs8iFrZCBsvi" style="text-align: left">Convertible debentures (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zHjuFFJuUt69" title="Registration Rights Damages" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1817">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zkACreHtTaZ6" title="Public Information Failure Damages" style="text-align: right"><ix:nonFraction name="AREN:PublicInformationFailureDamages" contextRef="AsOf2023-12-31_custom_ConvertibleDebenturesMember" id="Fact001819" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">144</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zyVXLmuIRu22" title="Accrued Interest" style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2023-12-31_custom_ConvertibleDebenturesMember" id="Fact001821" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zNi1hi2GuUxe" title="Balance" style="text-align: right"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrentAndNonCurrent" contextRef="AsOf2023-12-31_custom_ConvertibleDebenturesMember" id="Fact001823" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">216</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series J convertible preferred stock (<span id="xdx_F42_zB3Dv8wiU987">2</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zDDZEmJvDOP7" title="Registration Rights Damages" style="text-align: right"><ix:nonFraction name="AREN:RegistrationRightsDamages" contextRef="AsOf2023-12-31_custom_SeriesJPreferredStockMember" id="Fact001825" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">152</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zuDyvhBzhao" title="Public Information Failure Damages" style="text-align: right"><ix:nonFraction name="AREN:PublicInformationFailureDamages" contextRef="AsOf2023-12-31_custom_SeriesJPreferredStockMember" id="Fact001827" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">152</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zMMbTt20YTBd" title="Accrued Interest" style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2023-12-31_custom_SeriesJPreferredStockMember" id="Fact001829" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">129</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zOcPtTGLre05" title="Balance" style="text-align: right"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrentAndNonCurrent" contextRef="AsOf2023-12-31_custom_SeriesJPreferredStockMember" id="Fact001831" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">433</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series K convertible preferred stock (<span id="xdx_F4C_zQ7O58bIoMu3">2</span>)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zjdbdtNBHFgi" title="Registration Rights Damages" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:RegistrationRightsDamages" contextRef="AsOf2023-12-31_custom_SeriesKPreferredStockMember" id="Fact001833" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zdTZF3ORJqHj" title="Public Information Failure Damages" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:PublicInformationFailureDamages" contextRef="AsOf2023-12-31_custom_SeriesKPreferredStockMember" id="Fact001835" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">70</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zs968JTFeeP4" title="Accrued Interest" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2023-12-31_custom_SeriesKPreferredStockMember" id="Fact001837" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">226</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zDnuJNHOtOw" title="Balance" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrentAndNonCurrent" contextRef="AsOf2023-12-31_custom_SeriesKPreferredStockMember" id="Fact001839" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">462</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231_zZTVJj6CNDbi" title="Registration Rights Damages" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AREN:RegistrationRightsDamages" contextRef="AsOf2023-12-31" id="Fact001841" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">898</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231_zfymHuAEnpak" title="Public Information Failure Damages" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AREN:PublicInformationFailureDamages" contextRef="AsOf2023-12-31" id="Fact001843" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">940</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231_zq2lIzgEeo12" title="Accrued Interest" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2023-12-31" id="Fact001845" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,086</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231_zRxTxJkYT124" title="Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrentAndNonCurrent" contextRef="AsOf2023-12-31" id="Fact001847" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,924</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F04_z3VFS35LQHIc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F16_zwNEu3NvNq85" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001848" xml:lang="en-US">Shares
                                            of common stock issuable to MDB Capital Group, LLC (&#8220;MDB&#8221;) (see <i>Common Stock
                                            to be Issued</i> in Note 21).</ix:footnote></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F09_zPiUdwXpxay2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F13_zjoO0f4ruTR7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001849" xml:lang="en-US">Represents
                                            previously issued and converted debt or equity securities.</ix:footnote></span></td></tr></table>

</ix:nonNumeric><p id="xdx_8A9_zZej9dRcH5z7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2023, the Company entered into a stock purchase agreement with an investor, where the Company was liable for liquidated damages,
pursuant to which the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230208__20230208__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zia0jNW8KAwh" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-082023-02-08_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember" id="Fact001851" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">47,252</ix:nonFraction></span>
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock, in satisfaction of
the liquidated damages, at a price equal to $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230208__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z9kj8PGe283d"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-02-08_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember" id="Fact001852" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.56</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (determined based on the volume-weighted
average price of the Company&#8217;s common stock at the close of trading on the sixty (60) previous trading days), to the investor in
lieu of an aggregate of $<span id="xdx_900_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20230208__20230208__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zOPFfCfo6Dag"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2023-02-082023-02-08_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember" id="Fact001853" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">499</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">owed in liquidated damages as of the conversion
date. The Company prepared and filed a registration statement covering the resale of these shares of the Company&#8217;s common stock
issued in lieu of payment of these liquidated damages in cash. During the year ended December 31, 2023, the Company recorded $<span id="xdx_90E_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zswDtd90Csnh"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2023-01-012023-12-31_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember" id="Fact001854" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">499</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in connection with the issuance of shares of
the Company&#8217;s common stock on the consolidated statements of stockholders&#8217; deficiency (further details are provided under
the heading <i>Common Stock for Liquidated Damages </i>in Note 21).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 1, 2023, the Company entered into a waiver of liquidated damages and release of claims, where B. Riley, a principal stockholder
at the time, relinquished any claims to liquidated damages and accrued interest thereon amounting to $<span id="xdx_90C_eus-gaap--DebtInstrumentDecreaseForgiveness_pn3n3_c20231201__20231201__srt--TitleOfIndividualAxis__custom--BRileyMember_zIYo9Q7aV9N7" title="Gain on forgiveness of debt"><ix:nonFraction name="us-gaap:DebtInstrumentDecreaseForgiveness" contextRef="From2023-12-012023-12-01_custom_BRileyMember" id="Fact001856" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,497</ix:nonFraction></span>, which resulted in a gain
on forgiveness of debt. Given this transaction was with a related party and in connection with other contemporaneous transactions with
another principal stockholder, Simplify (further described in Note 26), the gain of $<span id="xdx_902_ecustom--AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zk5ceR3Z9qKh" title="Gain on forgiveness of debt"><ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" contextRef="From2023-01-012023-12-31_custom_BRileyMember" id="Fact001858" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,497</ix:nonFraction></span> was recorded within additional paid-in capital
on the consolidated statement of stockholders&#8217; deficiency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the short-term liquidated damages payable was $<span id="xdx_90C_ecustom--LiquidatedDamagesPayableCurrent_iI_pn3n3_c20231231_zf5LCJ8OR7qh" title="Short-term liquidated damages"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrent" contextRef="AsOf2023-12-31" id="Fact001860" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,924</ix:nonFraction></span>. The Company will continue to accrue interest on the liquidated
damages balance at <span id="xdx_90B_ecustom--LiquidatedDamagesPayableAccruedInterestPercentage_pid_dp_uPure_c20230101__20231231_zQDnSBsX4mpe" title="Liquidated damages payable accrued interest percentage"><ix:nonFraction name="AREN:LiquidatedDamagesPayableAccruedInterestPercentage" contextRef="From2023-01-01to2023-12-31" id="Fact001862" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction></span>% per month based on the balance outstanding as of December 31, 2023, or $<span id="xdx_906_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231_zn0R0h5fDQXe" title="Liquidated damages outstanding amount"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrentAndNonCurrent" contextRef="AsOf2023-12-31" id="Fact001864" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,924</ix:nonFraction></span>, until paid. There is no scheduled
date when the unpaid liquidated damages become due. The previously issued and converted Series K convertible preferred stock remains
subject to Registration Rights Damages and Public Information Failure Damages, which will accrue in certain circumstances, limited to
<span id="xdx_907_ecustom--PercentageOfAggregateAmountInvested_pid_dp_uPure_c20230101__20231231_zjUxwAOvDBic" title="Percentage of aggregate amount invested"><ix:nonFraction name="AREN:PercentageOfAggregateAmountInvested" contextRef="From2023-01-01to2023-12-31" id="Fact001866" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6</ix:nonFraction></span>% of the aggregate amount invested.</span></p>

<div id="xdx_C05_gL3SOLDTTB-KNKL_zg0S3T9Doi9j"><ix:continuation continuedAt="ConU001799-02" id="ConU001799-01"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_306_134_zLWqsaxl7i5c" summary="xdx: Disclosure - Summary of Liquidated Damages (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap">&#160;</td><td style="white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Registration<br/>
 Rights Damages</td><td style="white-space: nowrap; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Public<br/>
 Information<br/>
 Failure
    Damages</td><td style="white-space: nowrap; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Accrued<br/>
 Interest</td><td style="white-space: nowrap; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Balance</td><td style="white-space: nowrap; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">MDB common stock to be issued (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zhbG7wqvMsp4" title="Registration Rights Damages" style="width: 12%; text-align: right"><ix:nonFraction name="AREN:RegistrationRightsDamages" contextRef="AsOf2022-12-31_custom_MDBCommonStockToBeIssuedMember" id="Fact001868" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zOkqE9IM4m54" title="Public Information Failure Damages" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1870">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_znOKNlmxcGVg" title="Accrued Interest" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1872">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zh4pS70UZ014" title="Balance" style="width: 12%; text-align: right"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrentAndNonCurrent" contextRef="AsOf2022-12-31_custom_MDBCommonStockToBeIssuedMember" id="Fact001874" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series H Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zcnVr4RdmnCl" title="Registration Rights Damages" style="text-align: right"><ix:nonFraction name="AREN:RegistrationRightsDamages" contextRef="AsOf2022-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact001876" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">618</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zvsojiPfENoc" title="Public Information Failure Damages" style="text-align: right"><ix:nonFraction name="AREN:PublicInformationFailureDamages" contextRef="AsOf2022-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact001878" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">626</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zMJ2eqMVY7s2" title="Accrued Interest" style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2022-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact001880" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">570</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zzjK3JA7zvd3" title="Balance" style="text-align: right"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrentAndNonCurrent" contextRef="AsOf2022-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact001882" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,814</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible debentures (<span id="xdx_F49_zphT2fK5b3u">2</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zY0wmjJ2jXTj" title="Registration Rights Damages" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1884">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zz3S6lbFCXcg" title="Public Information Failure Damages" style="text-align: right"><ix:nonFraction name="AREN:PublicInformationFailureDamages" contextRef="AsOf2022-12-31_custom_ConvertibleDebenturesMember" id="Fact001886" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">704</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zGUIY42ddsl4" title="Accrued Interest" style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2022-12-31_custom_ConvertibleDebenturesMember" id="Fact001888" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">280</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zebUolESDQMj" title="Balance" style="text-align: right"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrentAndNonCurrent" contextRef="AsOf2022-12-31_custom_ConvertibleDebenturesMember" id="Fact001890" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">984</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series J convertible preferred stock (<span id="xdx_F42_zQxUbIHB1zl9">2</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_z1KydlfNJPpi" title="Registration Rights Damages" style="text-align: right"><ix:nonFraction name="AREN:RegistrationRightsDamages" contextRef="AsOf2022-12-31_custom_SeriesJPreferredStockMember" id="Fact001892" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">932</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zwPaFfQdUg08" title="Public Information Failure Damages" style="text-align: right"><ix:nonFraction name="AREN:PublicInformationFailureDamages" contextRef="AsOf2022-12-31_custom_SeriesJPreferredStockMember" id="Fact001894" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">932</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_z7WnqsPmvlP" title="Accrued Interest" style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2022-12-31_custom_SeriesJPreferredStockMember" id="Fact001896" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">525</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zQ8chrfdJ2k" title="Balance" style="text-align: right"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrentAndNonCurrent" contextRef="AsOf2022-12-31_custom_SeriesJPreferredStockMember" id="Fact001898" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,389</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series K convertible preferred stock (<span id="xdx_F4C_zUqtmOqrq3F5">2</span>)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_z11OeUxmZJqa" title="Registration Rights Damages" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:RegistrationRightsDamages" contextRef="AsOf2022-12-31_custom_SeriesKPreferredStockMember" id="Fact001900" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">437</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zYBRUpEoQfY1" title="Public Information Failure Damages" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:PublicInformationFailureDamages" contextRef="AsOf2022-12-31_custom_SeriesKPreferredStockMember" id="Fact001902" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">478</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zVkGyt4b2GZc" title="Accrued Interest" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2022-12-31_custom_SeriesKPreferredStockMember" id="Fact001904" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">220</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zqvyX3zC2VUh" title="Balance" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrentAndNonCurrent" contextRef="AsOf2022-12-31_custom_SeriesKPreferredStockMember" id="Fact001906" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,135</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231_zl7QFhHFxK3g" title="Registration Rights Damages" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AREN:RegistrationRightsDamages" contextRef="AsOf2022-12-31" id="Fact001908" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,002</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231_zHm8sHhnuF51" title="Public Information Failure Damages" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AREN:PublicInformationFailureDamages" contextRef="AsOf2022-12-31" id="Fact001910" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,740</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231_zrgH99cf9FDj" title="Accrued Interest" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2022-12-31" id="Fact001912" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,595</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231_zdSVTzUMvWv6" title="Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrentAndNonCurrent" contextRef="AsOf2022-12-31" id="Fact001914" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,337</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_zVQwPxgU9mH3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_zE3iDtl8Jxl1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001915" xml:lang="en-US">Shares
                                            of common stock issuable to MDB.</ix:footnote></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F02_zTnG0ctsL4vj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F16_zV2VYzn6F8v5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001916" xml:lang="en-US">Represents
                                            previously issued and converted debt or equity securities.</ix:footnote></span></td></tr></table>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C0E_gL3SOLDTTB-KNKL_zvYv4swqcvYg"><ix:continuation id="ConU001799-02">&#160;</ix:continuation></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the short-term and long-term liquidated damages payable were $<span id="xdx_905_ecustom--LiquidatedDamagesPayableCurrent_iI_pn3n3_c20221231_zm6OdE0Kk7ob" title="Short-term liquidated damages"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrent" contextRef="AsOf2022-12-31" id="Fact001918" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,843</ix:nonFraction></span> and $<span id="xdx_90A_ecustom--LiquidatedDamagesPayableNonCurrent_iI_pn3n3_c20221231_z96EcSHe8Yrd" title="Long-term liquidated damages"><ix:nonFraction name="AREN:LiquidatedDamagesPayableNonCurrent" contextRef="AsOf2022-12-31" id="Fact001920" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">494</ix:nonFraction></span>, respectively, totaling $<span id="xdx_90C_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231_zn9OueICee1d" title="Liquidated damages outstanding amount"><ix:nonFraction name="AREN:LiquidatedDamagesPayableCurrentAndNonCurrent" contextRef="AsOf2022-12-31" id="Fact001922" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,337</ix:nonFraction></span>. The
long-term portion was converted into shares of the Company&#8217;s common stock on January 24, 2022 (further details are provided under
heading <i>Common Stock for Liquidated Damages </i>in Note 21).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to the liquidated damages recognized on the consolidated statements of operations is provided in Note 23.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001924" name="AREN:OtherLongtermLiabilitiesTextBlock"><p id="xdx_80D_ecustom--OtherLongtermLiabilitiesTextBlock_zYlNZNPv9GB2" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>16.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_820_z89ie0sHKZSc">Other Long-term Liabilities</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001926" name="AREN:OtherLongtermLiabilitiesTableTextBlock"><p id="xdx_89A_ecustom--OtherLongtermLiabilitiesTableTextBlock_znxixkzx3hJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
long-term liabilities consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BC_zmw0NNfxV0j6" style="display: none">Schedule
of Other long- term liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20231231_zGeXXw97s7B3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20221231_znXhoVIujHrf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--LeaseTerminationLiabilityNonCurrent_iI_pn3n3_maOLNz6kY_zReJPruxu3sa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Lease termination liability</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1928">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="AREN:LeaseTerminationLiabilityNonCurrent" contextRef="AsOf2022-12-31" id="Fact001929" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,621</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_maOLNz6kY_zc2YXmiWK5Ud" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Assumed lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact001931" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">350</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-12-31" id="Fact001932" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,486</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--OtherLongTermLiabilitiesNoncurrent_iI_pn3n3_maOLNz6kY_zH2eDVGxNCYj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Other</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:OtherLongTermLiabilitiesNoncurrent" contextRef="AsOf2023-12-31" id="Fact001934" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">56</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:OtherLongTermLiabilitiesNoncurrent" contextRef="AsOf2022-12-31" id="Fact001935" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OtherLiabilitiesNoncurrent_iTI_pn3n3_mtOLNz6kY_zAWc9uR9NT55" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total other long-term liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-12-31" id="Fact001937" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">406</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2022-12-31" id="Fact001938" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,307</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AF_zIR6v2kKDJRd" style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001940" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_802_eus-gaap--FairValueDisclosuresTextBlock_zumazjFcEkde" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>17.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_828_zqFuGY3YLiOl">Fair Value Measurement</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of level 1, Level 2 and level 3 assets as of December 31, 2023 and 2022. As of December
31, 2023 and 2022, the Company&#8217;s cash and cash equivalents of $<span id="xdx_904_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20231231_zahS6RvGe688" title="Cash and cash equivalents"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact001942" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,284</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20221231_zdUWJGS2R9t5" title="Cash and cash equivalents"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31" id="Fact001944" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,871</ix:nonFraction></span>, respectively, were Level 1 assets and included
savings deposits, overnight investments, and other liquid funds with financial institutions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for certain common stock issued in connection with the acquisition of Fexy Studios that is subject to a put option
(which provides for a cash payment to the sellers on the first anniversary date of the closing (or January 11, 2024) in the event the
common stock trading price on such date is less than the common stock trading price on the day immediately preceding the acquisition
date, or $<span id="xdx_904_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_c20231231__us-gaap--BusinessAcquisitionAxis__custom--FlexyStudiosMember_zNLVWV04Ez48" title="Preceding acquistion price per share"><ix:nonFraction name="us-gaap:BusinessAcquisitionSharePrice" contextRef="AsOf2023-12-31_custom_FlexyStudiosMember" id="Fact001946" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.10</ix:nonFraction></span> per share), as a derivative liability, which requires the Company to carry such amounts on its consolidated
balance sheets as a liability at fair value, as adjusted at each reporting period-end (further details are provided under the heading
<i>Fexy Put Option</i> in Note 28).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments measured at fair value during
the year ended December 31, 2023, related to the Company&#8217;s current debt, with a carrying value of $<span id="xdx_906_eus-gaap--FinancialInstrumentsOwnedAtFairValue_iI_pn3n3_c20231231_zyTLzCow57y3" title="Financial instruments measured fair value debt bridge notes"><ix:nonFraction name="us-gaap:FinancialInstrumentsOwnedAtFairValue" contextRef="AsOf2023-12-31" id="Fact001948" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,887</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--FinancialInstrumentsOwnedOtherAtFairValue_iI_pn3n3_c20231231_zGBXXbZNEkI7" title="Debt fair value"><ix:nonFraction name="us-gaap:FinancialInstrumentsOwnedOtherAtFairValue" contextRef="AsOf2023-12-31" id="Fact001950" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102,309</ix:nonFraction></span> for the Bridge Notes
and Debt as of December 31, 2023, respectively, approximates fair value due to their short nature and based on current market interest
rates for debt instruments of similar credit standing.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001952" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zfaz0sRL9HOl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments measured at fair value during the year consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BD_zDRBiyiFr0F5" style="display: none">Schedule
of Fair Value of Financial Instruments</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted
Prices <br/>
in Active <br/>
Markets for<br/>
Identical <br/>
Assets (Level 1)</b></span></p></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant<br/>
Other <br/>
Observable<br/>
Inputs (Level 2)</b></span></p></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant
<br/>
Unobservable<br/>
Inputs (Level 3)</b></span></p></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left; width: 36%">Contingent consideration</td><td style="padding-bottom: 2.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td id="xdx_985_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember_zBqy5pqnWLte" title="Long term debt fair value" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="AsOf2023-12-31_custom_ContingentConsiderationMember" id="Fact001954" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,571</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 2.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td id="xdx_986_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zAnw5mckc7L6" title="Long term debt fair value" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1956">-</span></td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 2.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td id="xdx_982_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z3BUQe1t0cZj" title="Long term debt fair value" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="AsOf2023-12-31_custom_ContingentConsiderationMember_us-gaap_FairValueInputsLevel2Member" id="Fact001958" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,571</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 2.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td id="xdx_98E_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember_zYFQ4GVPfRS5" title="Long term debt fair value" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1960">-</span></td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted
Prices <br/>
in Active <br/>
Markets for<br/>
Identical <br/>
Assets (Level 1)</b></span></p></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant<br/>
Other <br/>
Observable<br/>
Inputs (Level 2)</b></span></p></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant
<br/>
Unobservable<br/>
Inputs (Level 3)</b></span></p></td><td>&#160;</td></tr>
  <tr id="xdx_433_c20231231_zLh1urT9FVq4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Senior Secured Notes</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember_z3l5qJvtiOAj" title="Long term debt fair value" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember" id="Fact001963" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">61,787</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zzH51p02O4m2" title="Long term debt fair value" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1965">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zTWvTclZT9Ij" title="Long term debt fair value" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember_us-gaap_FairValueInputsLevel2Member" id="Fact001967" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">61,787</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zhxdxdUbSY4g" title="Long term debt fair value" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1969">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zBTOL38MkJtk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contingent
Consideration &#8211;</i> The fair value of the contingent consideration is primarily dependent on the common stock trading price on
the first anniversary of the closing of the Fexy Studios acquisition, or January 11, 2024. The estimated fair value was calculated based
on the $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20231231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zExRuvR838D7" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2023-12-31_us-gaap_PutOptionMember" id="Fact001971" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.10</ix:nonFraction></span> put option amount based on the exercise price of the Company&#8217;s common stock at the acquisition date, less the $<span id="xdx_90C_eus-gaap--SharePrice_iI_pid_c20231231_zdoZdr6vE384" title="Common stock trading price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-12-31" id="Fact001973" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.38</ix:nonFraction></span>
the Company&#8217;s common stock trading price as of the reporting date, or $<span id="xdx_903_eus-gaap--SharePrice_iI_pid_c20231231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zyRVw0UK22U9" title="Trading price, per share"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-12-31_us-gaap_PutOptionMember" id="Fact001975" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.72</ix:nonFraction></span> per share, multiplied by the number of shares subject
to the put option of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230101__20231231__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosAcquistionMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zdu0NU0Z7pbc" title="Issuance of common stock in connection with acquisitions, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-01-012023-12-31_custom_FexyStudiosAcquistionMember_us-gaap_PutOptionMember" id="Fact001977" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">274,692</ix:nonFraction></span>, which approximated the value if the Black-Scholes option-pricing model was used given the proximity date
of the put option. For the year ended December 31, 2023, the change in valuation of the contingent consideration of $<span id="xdx_902_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_pn3n3_di_c20230101__20231231_z1BxlaWtbgEa" title="Change in valuation of contingent consideration"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2023-01-01to2023-12-31" id="Fact001979" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,010</ix:nonFraction></span> was recognized
in other expenses on the consolidated statement of operations. Further details are provided under the heading <i>Fexy Put Option
</i>in Note 28.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<ix:exclude><!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Senior
Secured Notes</i> &#8211; The carrying value of the Senior Secured Notes (as defined below) approximates fair value based on current
market interest rates for debt instruments of similar credit standing and, consequently, their fair values are based on Level 2 inputs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
quantitative information utilized in the fair value calculation of the Level 3 liabilities are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unearned
Revenue</i> &#8211; The fair value of unearned revenue remaining in connection with the 2019 acquisitions of Sports Illustrated licensed
brands, was determined with the following inputs: (1) projection of when unearned revenue will be earned; (2) expense necessary to fulfill
the subscriptions; (3) gross up of the fulfillment costs to include a market participant level of profitability; (4) slight premium to
the fulfillment-costs plus a reasonable profit metric; and (5) reduce projected future cash flows to present value using an appropriate
discount rate. The unearned revenue remaining from the acquisitions as of December 31, 2023 and 2022 was $<span id="xdx_90C_ecustom--UnearnedRevenue_iI_pn3n3_c20231231_zhL6nZnj0Hnb" title="Unearned revenue"><ix:nonFraction name="AREN:UnearnedRevenue" contextRef="AsOf2023-12-31" id="Fact001981" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">523</ix:nonFraction></span> and $<span id="xdx_904_ecustom--UnearnedRevenue_iI_pn3n3_c20221231_zhGuGn2hJAw8" title="Unearned revenue"><ix:nonFraction name="AREN:UnearnedRevenue" contextRef="AsOf2022-12-31" id="Fact001983" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,154</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
changes in unearned revenue with inputs classified as Level 3 of the fair value hierarchy are reflected within revenue on the consolidated
statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001985" name="us-gaap:ShortTermDebtTextBlock"><p id="xdx_803_eus-gaap--ShortTermDebtTextBlock_z9lEydQ2F7X1" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>18.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82B_zpgVzjwg75f5">Bridge Notes</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2023
Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Note Purchase Agreement, First Amendment and Second Amendment (as further described under the heading <i>Principal
Stockholders</i> in Note 26), on August 31, 2023, the Company issued $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20230831__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zv65i3wDg7Uj" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-08-31_custom_TwoThousandTwentyThreeNotesMember" id="Fact001987" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,000</ix:nonFraction></span> aggregate principal amount of senior secured notes (the &#8220;2023
Notes&#8221;). The provisions of the First Amendment also permit certain incremental borrowings in the amount up to $<span id="xdx_904_eus-gaap--OtherBorrowings_iI_pn3n3_c20230831__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zoXVmz2bb103" title="Incremental borrowings"><ix:nonFraction name="us-gaap:OtherBorrowings" contextRef="AsOf2023-08-31_custom_TwoThousandTwentyThreeNotesMember" id="Fact001989" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,000</ix:nonFraction></span> at the sole
discretion of the purchaser (the &#8220;Incremental 2023 Notes&#8221;), subject to a minimum amount of $<span id="xdx_90C_ecustom--AggregatePrincipalMinimumAmount_pn3n3_c20230831__20230831__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zgdEQ2qI3ZBc" title="Incremental borrowings"><ix:nonFraction name="AREN:AggregatePrincipalMinimumAmount" contextRef="From2023-08-312023-08-31_custom_TwoThousandTwentyThreeNotesMember" id="Fact001991" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></span> and other conditions. On
September 29, 2023, the Company issued $<span id="xdx_90C_ecustom--AggregatePrincipalMinimumAmount_pn3n3_c20230929__20230929__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zcfaZftKQxjc" title="Incremental borrowings"><ix:nonFraction name="AREN:AggregatePrincipalMinimumAmount" contextRef="From2023-09-292023-09-29_custom_TwoThousandTwentyThreeNotesMember" id="Fact001993" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></span> aggregate principal amount of senior secured notes pursuant to the incremental borrowings.
On November 27, 2023, the Company issued $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231127__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zKapEXhgsnh4" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-11-27_custom_TwoThousandTwentyThreeNotesMember" id="Fact001995" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></span> aggregate principal amount of senior secured notes pursuant to the incremental borrowings.
In connection with the issuance of the 2023 Notes, the Company received net proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfDebt_pn3n3_c20230929__20230929__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zyevAeVBXR2i" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2023-09-292023-09-29_custom_TwoThousandTwentyThreeNotesMember" id="Fact001997" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,643</ix:nonFraction></span> from the issuance of the notes and incurred
debt costs of $<span id="xdx_904_eus-gaap--DebtSecuritiesAvailableForSaleAmortizedCostCurrent_iI_pn3n3_c20230929__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zm0eUc6Hf2ag" title="Amortized debt cost"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" contextRef="AsOf2023-09-29_custom_TwoThousandTwentyThreeNotesMember" id="Fact001999" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">357</ix:nonFraction></span> that is being amortized over the expected life of the debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The terms of 2023 Notes provide for:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    interest rate fixed at <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_c20230831__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zeFXSz2zznB1" title="Debt instrument interest rate effective percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2023-08-31_custom_TwoThousandTwentyThreeNotesMember" id="Fact002001" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.0</ix:nonFraction></span>% per annum;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    maturity date of <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--BridgeNotesMember_zAjgeSddw7Dj" title="Debt maturity term"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_BridgeNotesMember" format="ixt:datemonthdayyearen" id="Fact002003" name="us-gaap:DebtInstrumentMaturityDate">April
    30, 2024</ix:nonNumeric></span>, as amended pursuant to the Second Amendment from December 31, 2023, subject to consummation of the Business
    Combination (see Note 28) on or prior to April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, which
    may result in an event of default if not consummated, and a prepayment requirement to apply a portion of the net proceeds from the
    Business Combination to repay $<span id="xdx_907_eus-gaap--ProceedsFromDebtNetOfIssuanceCosts_pn3n3_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zRbUM4KJsrB" title="Net proceeds from business combination"><ix:nonFraction name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeNotesMember" id="Fact002005" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,000</ix:nonFraction></span>
    (and any additional amounts borrowed pursuant to the incremental borrowing arrangement described above) under the notes;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    provision for the failure to repay the $<span id="xdx_904_eus-gaap--PrepaymentFeesOnAdvancesNet_pn3n3_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zMWY2jyyosR3" title="Prepayment fees on advances, net"><ix:nonFraction name="us-gaap:PrepaymentFeesOnAdvancesNet" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeNotesMember" id="Fact002007" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,000</ix:nonFraction></span> prepayment requirement in full with the proceeds of the Business Combination or failure
    to consummate the Business Combination by April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, will
    result in an event of default under the notes; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    election to prepay the notes, at any time, at <span id="xdx_906_ecustom--PrincipalAmountPrepayDue_iI_pid_dp_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_z6BcoGL0gzjj" title="Principal amount prepay due percentage"><ix:nonFraction name="AREN:PrincipalAmountPrepayDue" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyThreeNotesMember" id="Fact002009" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the principal amount due with no premium or penalty.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
debt issuance cost incurred under the debt modifications pursuant to the First Amendment are being amortized over the term of the
2023 Notes. The debt modification pursuant to the Second Amendment resulted in the unamortized debt issuance cost being amortized
over the extended term of the 2023 Notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, the Company failed to make the interest payment due on the 2023  Notes resulting in an event of default with
subsequent agreement to a forbearance period through the earlier of the following: (a) April 30, 2024; <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%">(b)
the occurrence of the closing of the Business Combination and (c) the termination of the Business Combination prior</span> to closing (collectively the &#8220;forbearance&#8221;) <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">(</span>further details are provided for under the heading <i>Arena Loan
Agreement </i> in Note 28).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the effective interest rate on the 2023 Notes was <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20231231__us-gaap--DebtInstrumentAxis__custom--BridgeNotesMember_zp0h855GaQ6e"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-12-31_custom_BridgeNotesMember" id="Fact002010" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">14.2</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%. As of <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">December 31, 2023,
the current balance outstanding under the 2023 Notes was $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--BridgeNotesMember_znbSSFnkRLd1" title="Balance outstanding"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-12-31_custom_BridgeNotesMember" id="Fact002012" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,887</ix:nonFraction></span>, net of unamortized cost of $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--BridgeNotesMember_zKigqmHGNRK2" title="Debt instrument, unamortized discount, current"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" contextRef="AsOf2023-12-31_custom_BridgeNotesMember" id="Fact002014" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">113</ix:nonFraction></span>, with the principal balance due of $<span id="xdx_909_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--BridgeNotesMember_zP67bvywf1X4" title="Debt payment principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2023-01-012023-12-31_custom_BridgeNotesMember" id="Fact002016" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,000</ix:nonFraction></span>,
subject to the forbearance.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
for the years ended December 31, 2023 and 2022, with respect to interest expense related to the 2023 Notes is provided under the heading
<i>Interest Expense</i> in Note 19.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2022
Bridge Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 15, 2022, the Company issued $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20221215__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zR0yh62J8pEe" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-12-15_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002018" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">aggregate principal amount of senior secured
notes (the &#8220;2022 Bridge Notes&#8221;) pursuant to the Note Purchase Agreement. In connection with the issuance of the notes, the
Company received net proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfDebt_pn3n3_c20221215__20221215__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zb1z9Gy3G76i" title="Proceeds from issuance of debt"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2022-12-152022-12-15_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002020" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,728</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and incurred debt costs of $<span id="xdx_90E_eus-gaap--DeferredFinanceCostsNet_iI_pn3n3_c20221215__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zSZysIUc0Vak" title="Incurred debt costs"><ix:nonFraction name="us-gaap:DeferredFinanceCostsNet" contextRef="AsOf2022-12-15_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002022" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,272</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that were being amortized over the expected life
of the debt. As of December 31, 2022, the balance outstanding under the 2022 Bridge Notes was $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zuP3Ch37Qpt" title="Principal balance"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002024" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,805</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($<span id="xdx_909_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zUPAGcu3Wf35" title="Principal balance"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002026" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">principal balance less unamortized debt costs
of $<span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zyYh1XdIBlo7" title="Unamortized debt costs"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002028" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,195</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">),
that was modified during the year ended December 31, 2023 (further details are provided under the heading <i>2022 Bridge Notes</i> in
Note 19).</span></p>
<!-- Field: Split-Segment; Name: 001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002030" name="us-gaap:LongTermDebtTextBlock"><p id="xdx_802_eus-gaap--LongTermDebtTextBlock_zFjkIytLbso2" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>19.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_822_zX99Dffbm6J">Long-term Debt</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Senior
Secured Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Pursuant
to the Note Purchase Agreement, as amended by the First Amendment and Second Amendment (<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">as further described
under the heading <i>Principal Stockholders</i> in Note 26),</span> as of December 31, 2023 and 2022, the
Company has notes outstanding referred to as the senior secured notes (the &#8220;Senior Secured Notes&#8221;), the delayed draw term notes (the &#8220;Delayed Draw Term Notes&#8221;) and the 2022 Bridge Notes, as further
described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The terms of the Senior Secured Notes
provide for:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
provision for the Company to enter into Delayed Draw Term Notes (as described below);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    provision where the Company added $<span id="xdx_902_eus-gaap--InterestPayableCurrent_iI_pn3n3_c20220101_z702hnpMYyzk" title="Interest payable"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2022-01-01" id="Fact002032" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,852</ix:nonFraction></span> to the principal balance of the notes for interest payable prior to January 1, 2022 as
    payable in-kind;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    provision where the paid in-kind interest can be paid in shares of the Company&#8217;s common stock based upon the conversion rate
    specified in the Certificate of Designation for the Series K convertible preferred stock, subject to certain adjustments;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    interest rate of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateIncreaseDecrease_pid_dp_uPure_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zgy9GRsORt06" title="Debt instrument interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateIncreaseDecrease" contextRef="From2023-01-012023-12-31_custom_SeniorSecuredNoteMember" id="Fact002034" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.0</ix:nonFraction></span>% per annum, subject to adjustment in the event of default, with a provision that within one (1) business day
    after receipt of cash proceeds from any issuance of equity interests, unless waived, the Company will prepay certain obligations
    in an amount equal to such cash proceeds, net of underwriting discounts and commissions; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest
    on the notes payable after February 15, 2022, at the agent&#8217;s sole discretion, either (a) in cash quarterly in arrears on the
    last day of each fiscal quarter or (b) by continuing to add such interest due on such payment dates to the principal amount of the
    notes;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    maturity date of <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zCwbqEp4aKvh" title="Debt instrument maturity date"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SeniorSecuredNoteMember" format="ixt:datemonthdayyearen" id="Fact002036" name="us-gaap:DebtInstrumentMaturityDate">December
    31, 2026</ix:nonNumeric></span> (as amended from December 31, 2023 pursuant to the First Amendment), subject to consummation of the Business
    Combination (see Note 28) on or prior to April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, which
    may result in an event of default if not consummated, and subject to certain acceleration conditions; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company to enter into the 2022 Bridge Notes for $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231231__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember_zflF9Vb2tgF8" title="Principal amount of debt"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-12-31_custom_SLRDigitalFinanceLLCMember" id="Fact002038" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,000</ix:nonFraction></span> and to increase the line of credit with SLR in an aggregate principal amount
    not to exceed $<span id="xdx_901_eus-gaap--LineOfCredit_iI_pn3n3_c20231231__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember_z2iced0m17jf" title="Line of credit"><ix:nonFraction name="us-gaap:LineOfCredit" contextRef="AsOf2023-12-31_custom_SLRDigitalFinanceLLCMember" id="Fact002040" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40,000</ix:nonFraction></span>. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="margin: 0"></p>

<p style="margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0"></p>

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Delayed
Draw Term Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Delayed Draw Term Notes provide for:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    interest rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--LongtermDebtTypeAxis__custom--DelayedDrawTermNotesMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zqpTRfThzMBe" title="Debt instrument interest rate percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-12-31_custom_DelayedDrawTermNotesMember_custom_PurchaseAgreementMember" id="Fact002042" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.0</ix:nonFraction></span>% per annum, subject to adjustment in the event of default; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest
    on the notes payable after February 15, 2022, at the agent&#8217;s sole discretion, either (a) in cash quarterly in arrears on the
    last day of each fiscal quarter or (b) by continuing to add such interest due on such payment dates to the principal amount of the
    notes; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    maturity date on <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--DelayedDrawTermNotesMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zPJ250sUHu5e" title="Debt instrument maturity date"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_DelayedDrawTermNotesMember_custom_PurchaseAgreementMember" format="ixt:datemonthdayyearen" id="Fact002044" name="us-gaap:DebtInstrumentMaturityDate">December 31, 2026</ix:nonNumeric></span> (as amended from December 31, 2023 pursuant to the First Amendment), subject to consummation of
    the Business Combination on or prior to April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, which
    may result in an event of default if not consummated, and subject to certain acceleration terms.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2022
Bridge Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the First Amendment, the 2022 Bridge Notes outstanding as of December 31, 2022 were amended and reclassified from a current liability
to a noncurrent liability. In connection with the debt modification, the Company incurred debt issuance costs of $<span id="xdx_903_eus-gaap--DeferredFinanceCostsNet_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zfpiTnMvEr9" title="Incurred debt costs"><ix:nonFraction name="us-gaap:DeferredFinanceCostsNet" contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002046" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction> </span>that are being amortized
over the life of the 2022 Bridge Notes and a portion of the note maturity was extended as further described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The terms of the 2022 Bridge Notes provide
for:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    interest rate fixed at <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20221215__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zInSABbLegIl" title="Debt fixed rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2022-12-15_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002048" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.0</ix:nonFraction></span>% per annum (as amended from interest that was payable in cash at an interest rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_z9gnhLJEHLPi" title="Debt due rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002050" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% per annum quarterly;
    with interest rate increases of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230301__20230301__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zYJEziTRMZle" title="Debt interest rate"><span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230501__20230501__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zF40MQFoXpd7" title="Debt interest rate"><span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230701__20230701__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zo4mBMc1QcOc" title="Debt interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2023-03-012023-03-01_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002052" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2023-05-012023-05-01_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002054" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2023-07-012023-07-01_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002056" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.5</ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span>% per annum on March 1, 2023, May 1, 2023, and July 1, 2023, pursuant to the First Amendment);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    maturity date of <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20221231__20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zu54uwhUn8ia" title="Debt maturity date"><ix:nonNumeric contextRef="From2022-12-312022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" format="ixt:datemonthdayyearen" id="Fact002058" name="us-gaap:DebtInstrumentMaturityDate">December 31, 2026</ix:nonNumeric></span> (as amended from December 31, 2023 pursuant to the First Amendment), subject to consummation of
    the Business Combination on or prior to April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, which
    may result in an event of default if not consummated, and subject to certain mandatory prepayment requirements, including, but not
    limited to, a requirement that the Company apply the net proceeds from certain debt incurrences or equity offerings to repay the
    notes;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    prepayment requirement to apply a portion of the net proceeds from the Business Combination to repay $<span id="xdx_90B_ecustom--DebtInstrumentPeriodicPaymentPrincipalBalance_pn3n3_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zPgKN6jglPff" title="Principal amount of debt"><ix:nonFraction name="AREN:DebtInstrumentPeriodicPaymentPrincipalBalance" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002060" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,000</ix:nonFraction></span> of the principal balance
    under the notes upon the earlier of April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023 or the closing
    of the Business Combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    provision for the failure to repay the $<span id="xdx_90C_eus-gaap--RepaymentsOfDebt_pn3n3_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zsgYS7fPpoU4" title="Repayment of debt"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002062" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,000</ix:nonFraction></span> prepayment requirement in full with the proceeds of the Business Combination or failure
    to consummate the Business Combination by April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, will
    result in an event of default under the notes; and</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    election to prepay the notes, at any time, in whole or in part with no premium or penalty.</span></td></tr>
  </table>
<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0"></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002064" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zpNVfkEbXUk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the  debt:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B7_zPf0exAAQenh" style="display: none">Schedule of long term debt</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal<br/>
 Balance</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unamortized<br/>
 Discount<br/>
 and Debt<br/>
 Issuance<br/>
 Costs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carrying<br/>
 Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal<br/>
 Balance</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unamortized<br/>
 Discount<br/>
 and Debt<br/>
 Issuance<br/>
 Costs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carrying<br/>
 Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Senior Secured Notes, effective interest rate of 10.1% as of December 31, 2023, as amended, matures December 31, 2026, subject to acceleration</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zcYjvd5gaSGj" title="Principal balance (including accrued interest), total" style="text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2023-12-31_custom_SeniorSecuredNoteMember" id="Fact002066" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62,691</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zIoRVimMAX1" title="Unamortized discount and debt issuance cost, total" style="text-align: right">&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2023-12-31_custom_SeniorSecuredNoteMember" id="Fact002068" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">272</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zpgzjUR1Fm4i" title="Carrying value, total" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-12-31_custom_SeniorSecuredNoteMember" id="Fact002070" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62,419</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zt0PoFfmwV63" title="Principal balance (including accrued interest), total" style="text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember66266859" id="Fact002072" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62,691</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zIbv1nQL0m4d" title="Unamortized discount and debt issuance cost, total" style="text-align: right">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember66266859" id="Fact002074" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">904</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zEBYgjSV3fn9" title="Carrying value" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember66266859" id="Fact002076" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">61,787</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left">Senior Secured Notes, effective interest rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zJw5w7uSa7dl" title="Debt instrument interest rate, percentage" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zGWrxq55TJqk" title="Debt instrument interest rate, percentage" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-12-31_custom_SeniorSecuredNoteMember" id="Fact002078" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember66266859" id="Fact002080" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.1</ix:nonFraction></ix:nonFraction></span></span>% as of December 31, 2023, as amended</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zOtoQbAeGPW7" title="Principal balance (including accrued interest), total" style="width: 7%; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2023-12-31_custom_SeniorSecuredNoteMember" id="Fact002082" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62,691</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zOv0sS3e9dff" title="Unamortized discount and debt issuance cost, total" style="width: 7%; text-align: right">&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2023-12-31_custom_SeniorSecuredNoteMember" id="Fact002084" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">272</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zSHfX28sCHvh" title="Carrying value, total" style="width: 7%; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-12-31_custom_SeniorSecuredNoteMember" id="Fact002086" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62,419</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zrD5MKTDiFtk" title="Principal balance (including accrued interest), total" style="width: 7%; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember66266859" id="Fact002088" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62,691</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zpZVojmgZyH7" title="Unamortized discount and debt issuance cost, total" style="width: 7%; text-align: right">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember66266859" id="Fact002090" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">904</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zn5vQAeU1A5j" title="Carrying value" style="width: 7%; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember66266859" id="Fact002092" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">61,787</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Delayed Draw Term Notes, effective interest rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--LongtermDebtTypeAxis__custom--DelayedDrawTermNoteMember_z9eaQhOl32Ti" title="Debt instrument interest rate, percentage" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--DelayedDrawTermNoteMember_z3BQWOUedm7e" title="Debt instrument interest rate, percentage" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-12-31_custom_DelayedDrawTermNoteMember66267140" id="Fact002094" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2022-12-31_custom_DelayedDrawTermNoteMember66267140" id="Fact002096" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.2</ix:nonFraction></ix:nonFraction></span></span>% as of December 31, 2023, as amended</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_znsgAfdfFlJ8" title="Principal balance (including accrued interest), total" style="text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2023-12-31_custom_DelayedDrawTermNoteMember" id="Fact002098" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zQ2sW6iDmSt" title="Unamortized discount and debt issuance cost, total" style="text-align: right">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2023-12-31_custom_DelayedDrawTermNoteMember" id="Fact002100" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_z0KbI0jXYPSf" title="Carrying value, total" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-12-31_custom_DelayedDrawTermNoteMember" id="Fact002102" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,969</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_z8SDiNHSNT3a" title="Principal balance (including accrued interest), total" style="text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2022-12-31_custom_DelayedDrawTermNoteMember" id="Fact002104" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zrvkIJYG2xN5" title="Unamortized discount and debt issuance cost, total" style="text-align: right">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2022-12-31_custom_DelayedDrawTermNoteMember" id="Fact002106" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">103</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zHTNTPXwimZ4" title="Carrying value, total" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_DelayedDrawTermNoteMember" id="Fact002108" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,897</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">2022 Bridge Notes, effective interest rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--LongtermDebtTypeAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zF1L3SxJJaJ2" title="Debt instrument interest rate, percentage" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zTJxSXHR4Vvj" title="Debt instrument interest rate, percentage" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember66267156" id="Fact002110" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember66267156" id="Fact002112" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.2</ix:nonFraction></ix:nonFraction></span></span>% as of December 31, 2023, as amended</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zdUBkwGStIof" title="Principal balance (including accrued interest), total" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002114" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zw0Zy88ndiek" title="Unamortized discount and debt issuance cost, total" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002116" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zyt6vREqIKX1" title="Carrying value, total" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002118" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,921</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zGhack6rDr58" title="Principal balance (including accrued interest), total" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2120">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zVncpNjyPBEb" title="Unamortized discount and debt issuance cost, total" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2122">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zQEqEstGdft7" title="Carrying value, total" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2124">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231_zVNZ4l9s8c1h" title="Principal balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2023-12-31" id="Fact002126" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102,691</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231_z1J5bKDJw1U1" title="Unamortized discount and debt issuance costs" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2023-12-31" id="Fact002128" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">382</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--LongTermDebt_iI_pn3n3_c20231231_zBSXt3ukQq22" title="Carrying value" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-12-31" id="Fact002130" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102,309</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231_zf5GkLDyXwuk" title="Principal balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2022-12-31" id="Fact002132" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">66,691</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231_z4NOVAQZhEvf" title="Unamortized discount and debt issuance costs" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2022-12-31" id="Fact002134" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,007</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20221231_zfrOgT9VrQx6" title="Carrying value" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31" id="Fact002136" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">65,684</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A0_zdmS0w4zSoFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
debt issuance costs incurred under the debt modification pursuant to the First Amendment are being amortized over the term of the
long-term debt. The debt modification pursuant to the Second Amendment resulted in the unamortized debt issuance cost being
amortized over the extended term of the long-term debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, the Company failed to make the interest payment due on the Secured Senior Notes, Delayed Draw Term Notes and 2022
Bridge Notes (collectively the &#8220;debt&#8221;) resulting in an event of default with subsequent agreement to a forbearance
period through the earlier of the following: (a) April 30, 2024; <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%">(b)
the occurrence of the closing of the Business Combination and (c) the termination of the Business Combination prior</span> to closing (or the forbearance) (further details are provided for under the <i>heading Arena Loan Agreement </i> in Note
28).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">As of December 31, 2023,
the current maturities of the debt were $<span id="xdx_906_eus-gaap--ShortTermBorrowings_iI_pn3n3_c20231231_zLFHH9qcNzje" title="current maturities of debt"><ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2023-12-31" id="Fact002138" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102,309</ix:nonFraction></span>, with the principal balance due of $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20230101__20231231_z4bjzhK0PrZk" title="Principal balance"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2023-01-01to2023-12-31" id="Fact002140" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102,691</ix:nonFraction></span>, subject to the forbearance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
for the years ended December 31, 2023 and 2022 with respect to interest expense related to long-term debt is provided below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interest
Expense</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002142" name="AREN:SummaryOfInterestExpenseTableTextBlock"><p id="xdx_89B_ecustom--SummaryOfInterestExpenseTableTextBlock_zDVNRtWPBTKg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table represents interest expense:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zky9uH4bGeCi" style="display: none">Summary
of Interest Expense</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_zeCyTRvlvGO4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20220101__20221231_zAVowYRW2j12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Amortization of debt costs:</td><td>&#160;</td>
    <td style="text-align: right"/>
    <td style="text-align: right"/><td>&#160;</td><td>&#160;</td>
    <td style="text-align: right"/>
    <td style="text-align: right"/><td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember_z3uCtcZZPluj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: justify">Line of credit</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-01-012023-12-31_us-gaap_LineOfCreditMember" id="Fact002144" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">214</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-01-012022-12-31_us-gaap_LineOfCreditMember" id="Fact002145" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zHBh3OAeO4f4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">2023 Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002147" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2148">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredNotesMember_ztQMvMlKGe5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Senior Secured Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-01-012023-12-31_custom_SeniorSecuredNotesMember" id="Fact002150" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">632</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-01-012022-12-31_custom_SeniorSecuredNotesMember" id="Fact002151" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,031</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zsTNebWWvqNd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Delayed Draw Term Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-01-012023-12-31_custom_DelayedDrawTermNoteMember" id="Fact002153" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-01-012022-12-31_custom_DelayedDrawTermNoteMember" id="Fact002154" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">464</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zfqQMFiR5dBe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">2022 Bridge Notes</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeNotesMember" id="Fact002156" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,216</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyThreeNotesMember" id="Fact002157" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">77</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_zV2buGQgkoq5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total amortization of debt costs</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-01-01to2023-12-31" id="Fact002159" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,378</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-01-012022-12-31" id="Fact002160" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,581</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Noncash and accrued interest:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zYag8MI0MKOb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">2023 Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeNotesMember" id="Fact002162" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">173</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2163">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredNotesMember_zLmj52I0E0ic" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Senior Secured Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2023-01-012023-12-31_custom_SeniorSecuredNotesMember" id="Fact002165" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,602</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2166">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zKKNOX7J7Src" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Delayed Draw Term Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2023-01-012023-12-31_custom_DelayedDrawTermNoteMember" id="Fact002168" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">102</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2169">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zA0NRFaiAE9h" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">2022 Bridge Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002171" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">920</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2172">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--LineOfCreditTerminationFeeMember_zlUzagbdPRMg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Line of credit termination fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2023-01-012023-12-31_custom_LineOfCreditTerminationFeeMember" id="Fact002174" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">900</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2175">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--ParadeMember_zncKzyrvJ63a" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Parade</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2177">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2022-01-012022-12-31_custom_ParadeMember66267484" id="Fact002178" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">116</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--OtherAccruedInterestMember_zLp5ARGseRnl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Other accrued interest</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2023-01-012023-12-31_custom_OtherAccruedInterestMember" id="Fact002180" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">127</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2022-01-012022-12-31_custom_OtherAccruedInterestMember" id="Fact002181" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">204</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_z71CZWLWfwP8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total noncash and accrued interest</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2023-01-01to2023-12-31" id="Fact002183" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,824</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:NoncashAndAccruedInterest" contextRef="From2022-01-012022-12-31" id="Fact002184" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">320</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--CashPaidInterestAbstract_iB_z9kBsiDehMz2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash paid interest:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember_zpx9gtOYVFSc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Line of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2023-01-012023-12-31_us-gaap_LineOfCreditMember" id="Fact002189" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,023</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2022-01-012022-12-31_us-gaap_LineOfCreditMember" id="Fact002190" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,328</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zUQMLl338i0f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">2023 Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeNotesMember" id="Fact002192" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2193">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredNotesMember_zr5e4IRGTU9l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Senior Secured Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2023-01-012023-12-31_custom_SeniorSecuredNotesMember" id="Fact002195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,754</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2022-01-012022-12-31_custom_SeniorSecuredNotesMember" id="Fact002196" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,356</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zGOTGbNiJAoj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Delayed Draw Term Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2023-01-012023-12-31_custom_DelayedDrawTermNoteMember" id="Fact002198" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">303</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2022-01-012022-12-31_custom_DelayedDrawTermNoteMember" id="Fact002199" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">980</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zH2xXv4O9SRl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">2022 Bridge Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember" id="Fact002201" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,763</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2202">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--OtherMember_zfd4GF6yJhOj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Other</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2023-01-012023-12-31_custom_OtherMember66267546" id="Fact002204" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,214</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2022-01-012022-12-31_custom_OtherMember66267562" id="Fact002205" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">863</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--InterestPaid_pn3n3_zEFpui48U3t8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total cash paid interest</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2023-01-01to2023-12-31" id="Fact002207" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,101</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2022-01-012022-12-31" id="Fact002208" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,527</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--InterestExpenseDebt_iN_pn3n3_di_zI2XsWYeUMK6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less interest income <sup id="xdx_F4F_zmG8jzJPWYke">(1)</sup></span></td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2023-01-01to2023-12-31" id="Fact002210" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">338</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2211">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--InterestExpense_pn3n3_z9NYNIQG58B8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total interest expense</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-01-01to2023-12-31" id="Fact002213" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,965</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-01-012022-12-31" id="Fact002214" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,428</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0C_znEq8p3u86Ed" style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/><td id="xdx_F1B_zvNUkNYeBRtb" style="text-align: justify"><ix:footnote id="Footnote002215" xml:lang="en-US">During the year ended December 31, 2023, the Company recorded interest income of $<span id="xdx_904_eus-gaap--InterestExpenseDebt_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zb04DjNbtnCa"><ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2023-01-012023-12-31_custom_BRileyMember" id="Fact002216" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">338</ix:nonFraction></span> related
to the refunds received from the employee retention credits.</ix:footnote></td>
</tr></table>



</ix:nonNumeric><p id="xdx_8AE_zDoQxTVhUU5l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncash
and accrued interest of $<span id="xdx_90E_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20221231__20221231__srt--TitleOfIndividualAxis__custom--BRileyMember_zlaNPA6JAR87" title="Paid in cash"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2022-12-312022-12-31_custom_BRileyMember" id="Fact002218" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">204</ix:nonFraction></span> as of December 31, 2022 related to the 2022 Bridge Notes, was paid in cash during the year ended December
31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002220" name="us-gaap:PreferredStockTextBlock"><p id="xdx_80C_eus-gaap--PreferredStockTextBlock_z3mUDii3kv3h" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>20.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82C_zPHkqxw12jxg">Preferred Stock</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has the authority to issue <span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zGhtKgwDGmyl" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact002222" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> shares of Preferred Stock, $<span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zRg31xm4A8p4" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact002224" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> par value per share, consisting of authorized and/or outstanding
shares as of December 31, 2023 as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zosvyr74CWXj" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2023-12-31_custom_SeriesGConvertiblePreferredStockMember" id="Fact002226" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,800</ix:nonFraction></span>
    authorized shares designated as &#8220;Series G Convertible Preferred Stock&#8221; (as further described below), of which <span id="xdx_900_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zIEkzNELXHpk" title="Temporary equity, shares outstanding"><span id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zp9OsraaPQP6" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002228" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002230" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">168</ix:nonFraction></ix:nonFraction></span></span> shares
    are outstanding as of December 31, 2023 and 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zmQ44GoHucpl" title="Preferred stock, designated shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2023-12-31_us-gaap_SeriesHPreferredStockMember" id="Fact002232" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,000</ix:nonFraction></span>
    authorized shares designated as &#8220;Series H Convertible Preferred Stock&#8221; (as further described below), of which <span id="xdx_908_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_dn_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zSwI4TfYaNSc" title="Shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_SeriesGPreferredStockMember" id="Fact002234" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></span> and
    <span id="xdx_907_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_ztHiKRyZuSFb" title="Shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_SeriesGPreferredStockMember" id="Fact002236" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,356</ix:nonFraction></span> shares were outstanding as of December 31, 2023 and 2022, respectively.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<ix:exclude><!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
G Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 30, 2000, the Company sold <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20000530__20000530__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zY0xgPAO6DD7" title="Shares sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2000-05-302000-05-30_us-gaap_SeriesGPreferredStockMember" id="Fact002238" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,800</ix:nonFraction></span> shares of its Series G convertible Preferred Stock (the &#8220;Series G Preferred Stock&#8221;),
of which <span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_pid_c20000530__20000530__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zMtySjRsJxM" title="Conversion Of stock shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2000-05-302000-05-30_us-gaap_SeriesGPreferredStockMember" id="Fact002240" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,631.504</ix:nonFraction></span> were converted prior to November 2001 and <span id="xdx_90C_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20000530__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zybYhOgaG4Pl" title="Temporary equity shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2000-05-30_us-gaap_SeriesGPreferredStockMember" id="Fact002242" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">168.496</ix:nonFraction></span> shares continue to be outstanding, at a stated value of $<span id="xdx_900_eus-gaap--PreferredStockLiquidationPreference_iI_pid_c20000530__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zyozSB9nBaJ3" title="Preferred stock liquidation preference"><ix:nonFraction name="us-gaap:PreferredStockLiquidationPreference" contextRef="AsOf2000-05-30_us-gaap_SeriesGPreferredStockMember" id="Fact002244" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,000</ix:nonFraction></span> per
share, convertible into shares of the Company&#8217;s common stock, as adjusted for the stock split on February 8, 2022, and will be
further adjusted in the event of another stock splits, stock dividends, combinations of shares and similar transactions subject to stock
splits. The Series G Preferred Stock is convertible into shares of common stock, at the option of the holder, subject to certain limitations.
The Company may require holders to convert all (but not less than all) of the Series G Preferred Stock or buy out all outstanding shares
of Series G Preferred Stock at the liquidation value of $<span id="xdx_90A_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_pn3n3_c20231231__srt--TitleOfIndividualAxis__custom--OriginalInvestorMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zig4c3HzJV4" title="Preferred stock liquidation preference value"><ix:nonFraction name="us-gaap:PreferredStockLiquidationPreferenceValue" contextRef="AsOf2023-12-31_custom_OriginalInvestorMember_us-gaap_SeriesGPreferredStockMember" id="Fact002246" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">168</ix:nonFraction></span>. Holders of Series G Preferred Stock are not entitled to dividends and have
no voting rights, unless required by law or with respect to certain matters relating to the Series G Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
a change in control, sale of or similar transaction, as defined in the Certificate of Designation for the Series G Preferred Stock, the
holder of the Series G Preferred Stock has the option to deem such transaction as a liquidation and may redeem their <span id="xdx_909_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__srt--TitleOfIndividualAxis__custom--OriginalInvestorMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zAAZpynwqfyi" title="Shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-12-31_custom_OriginalInvestorMember_us-gaap_SeriesGPreferredStockMember" id="Fact002248" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">168.496</ix:nonFraction></span> shares at
the liquidation value of $<span id="xdx_906_eus-gaap--TemporaryEquityLiquidationPreferencePerShare_iI_pid_c20231231__srt--TitleOfIndividualAxis__custom--OriginalInvestorMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zIKMupV8n4Vf" title="Temporary equity, liquidation preference per share value"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" contextRef="AsOf2023-12-31_custom_OriginalInvestorMember_us-gaap_SeriesGPreferredStockMember" id="Fact002250" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,000</ix:nonFraction></span> per share, or an aggregate amount of $<span id="xdx_900_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_pn3n3_c20231231__srt--TitleOfIndividualAxis__custom--OriginalInvestorMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zlg8nmYRcT2f" title="Preferred stock, liquidation aggregate amount"><ix:nonFraction name="us-gaap:PreferredStockLiquidationPreferenceValue" contextRef="AsOf2023-12-31_custom_OriginalInvestorMember_us-gaap_SeriesGPreferredStockMember" id="Fact002252" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">168</ix:nonFraction></span>. The sale of all the assets of the Company on June 28, 2007
triggered the redemption option. As such redemption was not in the control of the Company, the Series G Preferred Stock has been accounted
for as if it is redeemable preferred stock and is classified on the consolidated balance sheets as a mezzanine obligation between liabilities
and stockholders&#8217; deficiency. The holder of the Series G Preferred Stock still has the ability to exercise the redemption option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
H Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the then outstanding shares of Series H convertible Preferred Stock (the &#8220;Series H Preferred Stock&#8221;) automatically converted
into shares of the Company&#8217;s common stock on the fifth anniversary date of the initial first closing of the Series H Preferred
Stock, or on August 10, 2023, at the conversion price of $<span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230810__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zvuXSbn0iDQ2" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2023-08-10_custom_SeriesHConvertiblePreferredStockMember" id="Fact002254" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.26</ix:nonFraction></span> per share (the &#8220;automatic mandatory conversion&#8221;). Further
details are provided under the heading <i>Common Stock</i> in Note 21.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002256" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z35WgF19zLz3" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>21.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span><span id="xdx_829_zX1ofr9feBa4">Stockholders&#8217; Deficiency</span></span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has the authority to issue <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zln4hIMbuXXe" title="Common stock authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact002258" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000,000</ix:nonFraction></span> shares of common stock, as the result of filing on December 18, 2020, a Certificate
of Amendment with the Secretary of the State of Delaware to increase the number of authorized shares of its common stock from <span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20201218_z1wOL00qXDp2" title="Common stock authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-12-18" id="Fact002260" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></span>
shares to <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zOvaTyIrbM1b" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact002262" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000,000</ix:nonFraction></span> shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock Registered Direct Offering</i> &#8211; On March 31, 2023, the Company entered into common stock purchase agreements with certain
purchasers, pursuant to which the Company issued and sold in a registered direct offering an aggregate of <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20230330__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_zpsQQs9hZLM3" title="Sale of stock number of shares issued in transaction"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-03-302023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember" id="Fact002264" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,963,918</ix:nonFraction></span> shares of the Company&#8217;s
common stock, at a purchase price of $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_z2uLwox69Qp6" title="Sale of stock price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember" id="Fact002266" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.88</ix:nonFraction></span> per share. The gross proceeds received were $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20230330__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_znd67qF6gIrc" title="Proceeds from issuance of offering"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2023-03-302023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember" id="Fact002268" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,500</ix:nonFraction></span> and after deducting offering expenses
of $<span id="xdx_904_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_c20230330__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_zKl2L8CaC2Oe" title="Payments of stock issuance costs"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2023-03-302023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember" id="Fact002270" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">356</ix:nonFraction></span>, the Company received net proceeds of $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn3n3_c20230330__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_zyWyE7iVLn2k" title="Net proceeds from common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-03-302023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember" id="Fact002272" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,144</ix:nonFraction></span>, as reflected on the consolidated statements of stockholder&#8217;s deficiency.
No underwriter or placement agent participated in the registered direct offering. The net proceeds were intended for working capital
and other general corporate purposes. Further information is provided in Note 26.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock for Series H Preferred Stock</i> &#8211; During the years ended December 31, 2023 and 2022, the Company recorded the issuance of
<span id="xdx_907_eus-gaap--ConversionOfStockSharesIssued1_pid_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zYOi6gClbF23" title="Conversion of shares issued"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2023-01-012023-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002274" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,981,128</ix:nonFraction></span> (of which <span id="xdx_90E_eus-gaap--ConversionOfStockSharesIssued1_pid_c20230101__20231231_zl3qLq6ItiQ3" title="Conversion of shares issued"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2023-01-01to2023-12-31" id="Fact002276" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,759,224</ix:nonFraction></span> were issued in accordance with the automatic mandatory conversion) and <span id="xdx_90C_eus-gaap--ConversionOfStockSharesIssued1_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq8JyTuCpIok" title="Conversion of shares issued"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact002278" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">97,980</ix:nonFraction></span> shares of common stock, respectively,
upon conversion of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zZzdd0KAVeia" title="Conversion of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2022-01-012022-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002280" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,356</ix:nonFraction></span> (of which <span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_pid_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zf23UXfQZZ97" title="Conversion of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2022-01-012022-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002282" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,748</ix:nonFraction></span> were issued were issued in accordance with the automatic mandatory conversion) and <span id="xdx_90A_eus-gaap--ConversionOfStockSharesConverted1_pid_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_znbsy6v4U2D5" title="Conversion of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2023-01-012023-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002284" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">710</ix:nonFraction></span> shares
of Series H Preferred Stock, respectively, with a corresponding amount of $<span id="xdx_906_eus-gaap--ConversionOfStockAmountConverted1_pn3n3_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z11jM5ipSV2g" title="Conversion of stock amount"><ix:nonFraction name="us-gaap:ConversionOfStockAmountConverted1" contextRef="From2023-01-012023-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002286" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,008</ix:nonFraction></span> (representing <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z8pNLJqWmjqd" title="Conversion of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-01-012023-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002288" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,356</ix:nonFraction></span> shares of Series H Preferred Stock
at $<span id="xdx_90F_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z41Wk5RczIxc" title="Preferred stock stated par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002290" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,000</ix:nonFraction></span> stated par value per share, less issuance cost of $<span id="xdx_90F_eus-gaap--ConversionOfStockAmountConverted1_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqMtH0EwwMUk" title="Conversion of stock amount"><ix:nonFraction name="us-gaap:ConversionOfStockAmountConverted1" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact002292" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,348</ix:nonFraction></span>) and $<span id="xdx_90A_eus-gaap--ConversionOfStockAmountConverted1_pn3n3_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zb6ffPYdgMZ1" title="Conversion of stock amount"><ix:nonFraction name="us-gaap:ConversionOfStockAmountConverted1" contextRef="From2022-01-012022-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002294" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">710</ix:nonFraction></span> (representing <span id="xdx_900_eus-gaap--ConversionOfStockSharesConverted1_pid_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zPBPNpARpTAi" title="Conversion of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2023-01-012023-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002296" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">710</ix:nonFraction></span> shares of Series H Preferred Stock at
$<span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z5oHjoV8SS38" title="Preferred stock stated par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002298" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,000</ix:nonFraction></span> stated par value per share), respectively, as reflected on the consolidated statements of stockholders&#8217; deficiency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock for Acquisitions</i> &#8211; During the years ended December 31, 2023 and 2022, the Company recorded the issuance of <span id="xdx_90E_ecustom--StockIssuedDuringPeriodSharesAcquisition_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgnakdszlnXc" title="Common stock shares issuance fo acquisitions"><ix:nonFraction name="AREN:StockIssuedDuringPeriodSharesAcquisition" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact002300" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">274,692</ix:nonFraction></span> and
<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDVV76cCHWCd" title="Common stock shares issuance fo acquisitions"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact002302" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">330,863</ix:nonFraction></span> shares of the Company&#8217;s common stock, respectively, as reflected on the consolidated statements of stockholders&#8217;
deficiency as follows: (i) <span id="xdx_90F_ecustom--BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares_pid_c20230110__20230111__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosAcquisitionMember_zuo4bhTp7Dw3" title="Issuance of common stock"><ix:nonFraction name="AREN:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares" contextRef="From2023-01-102023-01-11_custom_FexyStudiosAcquisitionMember" id="Fact002304" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">274,692</ix:nonFraction></span> shares issued pursuant to the Fexy Studios asset acquisition on January 11, 2023, with a fair value
of $<span id="xdx_902_eus-gaap--BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_pn3n3_c20230110__20230111__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosAcquisitionMember_zEhrULxF2B79" title="Fair value of acquisition"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" contextRef="From2023-01-102023-01-11_custom_FexyStudiosAcquisitionMember" id="Fact002306" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></span> on the transaction closing date, as further described in Note 4; and (ii) <span id="xdx_90D_eus-gaap--SharesIssued_iI_pid_c20231101__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zvtFKryjx3A4" title="Shares issued"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2023-11-01_custom_AssetPurchaseAgreementMember" id="Fact002308" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">330,863</ix:nonFraction></span> shares issued consisted of (a) <span id="xdx_906_ecustom--BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares_pid_c20220328__20220402__us-gaap--BusinessAcquisitionAxis__custom--ParadeStockMember_zLd796zCQ6N6" title="Issuance of common stock"><ix:nonFraction name="AREN:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares" contextRef="From2022-03-282022-04-02_custom_ParadeStockMember" id="Fact002310" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">314,103</ix:nonFraction></span> shares
issued pursuant to the Parade stock acquisition on April 1, 2022, with a fair market value of $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_pn3n3_c20220328__20220402__us-gaap--BusinessAcquisitionAxis__custom--ParadeStockMember_zfgI8N1Kw3ml" title="Fair value of acquisition"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" contextRef="From2022-03-282022-04-02_custom_ParadeStockMember" id="Fact002312" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,141</ix:nonFraction></span>, as further described in Note 4;
and (b) <span id="xdx_901_eus-gaap--SharesIssued_iI_pid_c20220309__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zVBeHIkxrnA9" title="Shares issued"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2022-03-09_custom_AssetPurchaseAgreementMember" id="Fact002314" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,760</ix:nonFraction></span> shares issued on March 9, 2022, pursuant to an asset acquisition entered into March 9, 2020 with no fair value recognized
at the time of issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock for Liquidated Damages</i> &#8211; During the years ended December 31, 2023 and 2022, the Company entered into several stock purchase
agreements with an investor where it was liable for liquidated damages, pursuant to which the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zdUdQ1rKCgNl" title="Stock issued during period shares new issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember" id="Fact002316" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">47,252</ix:nonFraction></span> and <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_z0GPIG3rik1h" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember" id="Fact002318" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">505,655</ix:nonFraction></span>, respectively,
shares of its common stock, as follows: <span id="xdx_90F_eus-gaap--LossContingencyDamagesSought_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_ziHB0OAqsXld" title="Loss contingency damages sought"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember" id="Fact002320" name="us-gaap:LossContingencyDamagesSought">(i) <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zGSuS9BiyTIg" title="Stock issued during period shares new issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember" id="Fact002322" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">47,252</ix:nonFraction></span> shares of common stock were issued to the investor in lieu of an aggregate of $<span id="xdx_90C_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zQyoedeEJMW8" title="Loss contingency damages sought value"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2023-01-012023-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember" id="Fact002324" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">499</ix:nonFraction></span>
owed in liquidated damages as of the conversion date ($494 as of December 31, 2022 plus $5 in additional interest through the conversion
date), where the Company recorded $369 in connection with the issuance of shares of the Company&#8217;s common stock and a gain of $130
on the settlement of the liquidated damages, both as reflected in additional paid-in capital, totaling $499;</ix:nonNumeric></span> and (ii) <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zMuGabh2hlWl" title="Stock issued during period shares new issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember" id="Fact002326" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">505,655</ix:nonFraction></span> shares
of common stock were issued at a price equal to $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zyRQh8fFmoA8" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember" id="Fact002328" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.86</ix:nonFraction></span> per share (determined based on the volume-weighted average price of the Company&#8217;s
common stock at the close of trading on the sixty (60) previous trading days), to the investors in lieu of an aggregate of $<span id="xdx_904_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zfy7gH7QE3h6" title="Loss contingency damages sought value"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2022-01-012022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember" id="Fact002330" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,008</ix:nonFraction></span> owed
in liquidated damages, where the Company recorded $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zsx5joUi6ek1" title="Number of share issued value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember" id="Fact002332" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,685</ix:nonFraction></span> in connection with the issuance of shares of the Company&#8217;s common stock
and recognized a gain of $<span id="xdx_909_ecustom--AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zrYy7GE4iU1d" title="Liquidated damages"><ix:nonFraction name="AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" contextRef="From2022-01-012022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember" id="Fact002334" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">323</ix:nonFraction></span> on the settlement of the liquidated damages, both of which were recorded as additional paid-in capital
on the consolidated statements of stockholders&#8217; deficiency. In connection with the <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zULnLdSG3r0h" title="Stock issued during period shares new issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember" id="Fact002336" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">505,655</ix:nonFraction></span> shares of common stock issued, the Company
filed a registration statement covering the resale of those shares of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
Stock Units</i> &#8211; The Company issued, in connection with the vesting of restricted stock units, <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zE6WuCMlLyL" title="Vesting of restricted stock units"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_CommonStockMember_custom_EmployeesMember" id="Fact002338" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">429,528</ix:nonFraction></span> shares of the Company&#8217;s
common stock and <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zoymioKrOZlh" title="Vesting of restricted stock units"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2021-01-012021-12-31_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_CommonStockMember_custom_EmployeesMember" id="Fact002340" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">832,233</ix:nonFraction></span> shares of the Company&#8217;s common stock (as described in Note 22) during the years ended December 31, 2023
and 2022, respectively, as reflected on the consolidated statements of stockholders&#8217; equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock Withheld</i> &#8211; The Company recorded the repurchase of vested restricted common stock of <span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--RestrictedCommonStockMember_z3ggkQQuYtg" title="Repurchase of restricted common stock"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember_custom_RestrictedCommonStockMember" id="Fact002342" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">202,382</ix:nonFraction></span> shares for the payment for
taxes of $<span id="xdx_900_eus-gaap--PaymentsRelatedToTaxWithholdingForShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--RestrictedCommonStockMember_zZ0jpYiH6EH8" title="Payment of taxes"><ix:nonFraction name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember_custom_RestrictedCommonStockMember" id="Fact002344" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,423</ix:nonFraction></span>, and <span id="xdx_901_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--RestrictedCommonStockMember_zCmGCbrE4ork" title="Repurchase of restricted common stock"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_custom_RestrictedCommonStockMember" id="Fact002346" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">373,394</ix:nonFraction></span> shares for the payment for taxes of $<span id="xdx_907_eus-gaap--PaymentsRelatedToTaxWithholdingForShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--RestrictedCommonStockMember_znLyfhUuMdhi" title="Payment of taxes"><ix:nonFraction name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_custom_RestrictedCommonStockMember" id="Fact002348" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,468</ix:nonFraction></span>, during the years ended December 31, 2023 and 2022, respectively,
as reflected on the consolidated statements of stockholders&#8217; deficiency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise
of Stock Options</i> &#8211; The Company recorded the exercise of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--ExerciseOfStockOptionMember_znK3TD0xTVj8" title="Exercise of stock options, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-01-012023-12-31_custom_ExerciseOfStockOptionMember" id="Fact002350" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">795</ix:nonFraction></span> and <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--ExerciseOfStockOptionMember_z2eTo8oRBQeb" title="Exercise of stock options, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-01-012022-12-31_custom_ExerciseOfStockOptionMember" id="Fact002352" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">96,408</ix:nonFraction></span> common stock options for shares of the Company&#8217;s
common stock for cash of $<span id="xdx_902_ecustom--StockIssuedDuringPeriodValueForCash_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--ExerciseOfStockOptionMember_zMwmUQWepjHi" title="Exercise of stock options"><ix:nonFraction name="AREN:StockIssuedDuringPeriodValueForCash" contextRef="From2023-01-012023-12-31_custom_ExerciseOfStockOptionMember" id="Fact002354" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_90D_ecustom--StockIssuedDuringPeriodValueForCash_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--ExerciseOfStockOptionMember_zsaRLsxQLKKc" title="Exercise of stock options"><ix:nonFraction name="AREN:StockIssuedDuringPeriodValueForCash" contextRef="From2022-01-012022-12-31_custom_ExerciseOfStockOptionMember" id="Fact002356" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">95</ix:nonFraction></span>, during the years ended December 31, 2023 and 2022, respectively, as reflected on the consolidated
statements of stockholders&#8217; deficiency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock to be Issued <b>&#8211; </b></i>In connection with the Say Media merger on December 12, 2018, the Company issued <span id="xdx_90C_ecustom--StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRUHxDyEEtz7" title="Common stock to be issued"><ix:nonFraction name="AREN:StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact002358" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,582</ix:nonFraction></span> and <span id="xdx_905_ecustom--StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKanTW5gPZe2" title="Common stock to be issued"><ix:nonFraction name="AREN:StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact002360" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,851</ix:nonFraction></span>
shares of the Company&#8217;s common stock during the year ended December 31, 2023 and 2022, respectively, which were required to be issued
as of January 1, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
Services</i> &#8211; During the year ended December 31, 2022, the Company issued, in connection with entering into several professional
services agreements, <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220120__20220121__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zbcis00NAI4f" title="Stock issued for professional services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-01-202022-01-21_custom_ServicesAgreementMember" id="Fact002362" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,617</ix:nonFraction></span> shares of the Company&#8217;s common stock (<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220111__20220112__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zydJiS3DrYya" title="Stock issued for professional services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-01-112022-01-12_custom_ServicesAgreementMember" id="Fact002364" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,617</ix:nonFraction></span> shares consisted of <span id="xdx_90A_eus-gaap--SharesIssued_iI_pid_c20220112__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zNAcVYlBe3Nb" title="Stock issued for professional services"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2022-01-12_custom_ServicesAgreementMember" id="Fact002366" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,134</ix:nonFraction></span> shares issued on January 12,
2022 at $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20220112__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zyoFLCMqRCa6" title="Trading price, per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-01-12_custom_ServicesAgreementMember" id="Fact002368" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.20</ix:nonFraction></span> and <span id="xdx_90F_eus-gaap--SharesIssued_iI_pid_c20220126__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zDJ0OkLznDBl" title="Stock issued for professional services"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2022-01-26_custom_ServicesAgreementMember" id="Fact002370" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,483</ix:nonFraction></span> shares issued on January 26, 2022 at $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20220126__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zkoDoMaXPcE9" title="Trading price, per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-01-26_custom_ServicesAgreementMember" id="Fact002372" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.54</ix:nonFraction></span>) that were recorded at the trading price on the issuance date of
$<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zd2X0hoRFxx4" title="Trading price, per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-12-31_custom_ServicesAgreementMember" id="Fact002374" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USDPShares">184</ix:nonFraction></span>, as reflected on the consolidated statements of stockholders&#8217; deficiency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock Public Offering</i> &#8211; On February 15, 2022 and March 11, 2022, the Company raised gross proceeds of $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20220311__20220311__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zDVf3WMCYJh3" title="Gross proceed from offerings"><span id="xdx_906_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20220215__20220215__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zVvCYFYmPEKf" title="Gross proceed from offerings"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2022-03-112022-03-11_custom_UnderwritingPublicOfferingMember" id="Fact002376" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2022-02-152022-02-15_custom_UnderwritingPublicOfferingMember" id="Fact002378" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,498</ix:nonFraction></ix:nonFraction></span></span> pursuant to a
firm commitment underwritten public offering of <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20220311__20220311__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zCoCinSO9LV1" title="Number of common shares sold"><span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20220215__20220215__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zg079kzNRsbk" title="Number of common shares sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2022-03-112022-03-11_custom_UnderwritingPublicOfferingMember" id="Fact002380" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2022-02-152022-02-15_custom_UnderwritingPublicOfferingMember" id="Fact002382" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,181,603</ix:nonFraction></ix:nonFraction></span></span> shares of the Company&#8217;s common stock (on February 15, 2022 the Company
issued <span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20220215__20220215__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingOverallotmentMember_zcoL6IMu7JB" title="Number of common shares sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2022-02-152022-02-15_custom_UnderwritingOverallotmentMember" id="Fact002384" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,636,364</ix:nonFraction></span> shares and on March 11, 2022 the Company issued <span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20220311__20220311__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingOverallotmentMember_zlej33QPmm7d" title="Number of common shares sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2022-03-112022-03-11_custom_UnderwritingOverallotmentMember" id="Fact002386" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">545,239</ix:nonFraction></span> shares pursuant to the underwriter&#8217;s overallotment that
was exercised on March 10, 2022), at a public offering price of $<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20220310_zQHAqKej2gBb" title="Stock price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2022-03-10" id="Fact002388" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.25</ix:nonFraction></span> per share. The Company received net proceeds of $<span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20230101__20231231_zZuUPenhoMq3" title="Net proceed from offerings"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-01-01to2023-12-31" id="Fact002390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32,058</ix:nonFraction></span>, after
deducting underwriting discounts and commissions and other offering costs payable by the Company of $<span id="xdx_907_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--BRileyMember_zdMnLGMFtd7c" title="Offering costs"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2023-01-012023-12-31_custom_BRileyMember66269906" id="Fact002392" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,440</ix:nonFraction></span> to B. Riley (see Note 26).
In addition, the Company directly incurred offering costs of $<span id="xdx_900_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zrMhq89D7obk" title="Offering costs"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2023-01-012023-12-31_custom_UnderwritingPublicOfferingMember" id="Fact002394" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,568</ix:nonFraction></span> and recorded $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn3n3_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zH4i03weUSS9" title="Proceeds from issuance of common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-01-012023-12-31_custom_UnderwritingPublicOfferingMember" id="Fact002396" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,490</ix:nonFraction></span> upon the issuance of its common stock, as reflected
on the consolidated statements of stockholders&#8217; deficiency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted
Stock Awards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise stated, the fair value of a restricted stock award is determined based on the number of shares granted and the quoted price
of the Company&#8217;s common stock on the date issued. The estimated fair value of these shares is being recognized as compensation
expense over the vesting period of the award (see Note 22).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002398" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zCiZ4l6nK3Q8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the restricted stock award activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zVV9BCcrulei" style="display: none">Summary of Restricted Stock Award Activity</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of <br/>
Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
                                            Average <br/>
                                            Grant-Date</b></span></p>
                                                                  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    stock awards outstanding at January 1, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zNmNgl4Ptij7" title="Number of Shares, Restricted Stock Awards Outstanding, Beginning balance" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_us-gaap_RestrictedStockMember" id="Fact002400" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">97,403</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zpakTQuXhBg1" title="Weighted Average Grant-Fair Value Date, Beginning balance" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2022-12-31_us-gaap_RestrictedStockMember" id="Fact002402" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.94</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQoE7Sbc3j99" title="Number of Shares,  Vested" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember" id="Fact002404" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">97,403</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zkrHmNS326Ie" title="Weighted Average Grant-Fair Value Date, Vested" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember" id="Fact002406" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.94</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    stock awards outstanding at December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zCipvKPr5vTj" title="Number of Shares, Restricted stock awards outstanding, Unvested at Beginning balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2408">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><p id="xdx_8A4_zbKyH6P0Vxj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to stock-based compensation cost and unrecognized stock-based compensation cost related to the restricted stock awards is
provided under the heading <i>Stock-Based Compensation</i> in Note 22.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock to be Issued</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with a closing of a private placement on January 4, 2018, MDB, as the placement agent, was entitled to receive <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20180103__20180104__dei--LegalEntityAxis__custom--MDBCapitalGroupLLCMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zkWcbDGPFQN2" title="Number of common shares sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2018-01-032018-01-04_custom_MDBCapitalGroupLLCMember_us-gaap_PrivatePlacementMember" id="Fact002410" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,701</ix:nonFraction></span> shares
of the Company&#8217;s common stock (<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">subject to liquidated
damages, see Note 15), which</span> have not been issued as of December 31, 2023, as reflected on the consolidated statements of
stockholders&#8217; deficiency as common stock to be issued (see Note 15).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Warrants
were issued to purchase shares of the Company&#8217;s common stock in connection with various financings (the &#8220;Financing Warrants&#8221;), all of which have expired.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002412" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z0ULsOccHYhj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the Financing Warrants activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BF_zUdfua79NEC7" style="display: none">Summary of Warrant Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"/><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Life</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in Years)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify">Financing Warrants outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zaOyrerdlMWi" title="Number of Shares, outstanding, at beginning of year" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-12-31_custom_CommonStockFinancingWarrantMember" id="Fact002414" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">107,956</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zJjhjE20OUG5" title="Weighted Average Exercise Price, outstanding, at beginning of year" style="width: 12%; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber" contextRef="AsOf2022-12-31_custom_CommonStockFinancingWarrantMember" id="Fact002416" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.61</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zGcSY18wELGc" title="Weighted Average Remaining Contractual Life, Outstanding at beginning of year"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CommonStockFinancingWarrantMember" format="ixt-sec:duryear" id="Fact002418" name="AREN:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1">0.58</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zbYMGmEGCjql" title="Number of Shares, Expired" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2023-01-012023-12-31_custom_CommonStockFinancingWarrantMember" id="Fact002420" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">107,956</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zZIKYHxtdEjj" title="Weighted Average Exercise Price, Expired" style="text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice" contextRef="From2023-01-012023-12-31_custom_CommonStockFinancingWarrantMember" id="Fact002422" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.61</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Financing Warrants outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zZs6o4s8Szg9" title="Number of Shares, outstanding at end of year" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2424">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zU2fcnw5J3E4" title="Weighted Average Exercise Price, outstanding, at end of year" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2426">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zAVzRdzdPUS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>AllHipHop
Warrants</i> &#8211; On October 26, 2020, the Company granted AllHipHop, LLC an aggregate of <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20201026__us-gaap--StatementEquityComponentsAxis__custom--AllHipHopWarrantsMember_zJR8rRUHfsij" title="Exeercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2020-10-26_custom_AllHipHopWarrantsMember" id="Fact002428" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,682</ix:nonFraction></span> warrants for shares of the Company&#8217;s
common stock with an exercise price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201026__us-gaap--StatementEquityComponentsAxis__custom--AllHipHopWarrantsMember_zWL6VHm6rIVg" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-10-26_custom_AllHipHopWarrantsMember" id="Fact002430" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.30</ix:nonFraction></span> (the &#8220;AllHipHop Warrants&#8221;). The AllHipHop Warrants are exercisable for a period
of five years, subject to customary anti-dilution adjustments, and may be exercised on a cashless basis. The AllHipHop Warrants were
in exchange for the surrender and termination of <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20201026__us-gaap--StatementEquityComponentsAxis__custom--PublisherPartnerWarrantsMember_zoy0etW5Z4Ag" title="Exeercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2020-10-26_custom_PublisherPartnerWarrantsMember" id="Fact002432" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,819</ix:nonFraction></span> previously issued Publisher Partner Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<ix:exclude><!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ABG
Warrants</i> &#8211; On June 14, 2019, the Company issued <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20190614__us-gaap--StatementEquityComponentsAxis__custom--ABGWarrantsMember_zfQjNQ9hgAG4" title="Warrants issued"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2019-06-14_custom_ABGWarrantsMember" id="Fact002434" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">999,540</ix:nonFraction></span> warrants to acquire the Company&#8217;s common stock to ABG (the &#8220;ABG
Warrants&#8221;) in connection with the Licensing Agreement, expiring in <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dt_c20190614__us-gaap--StatementEquityComponentsAxis__custom--ABGWarrantsMember_zsl6OLvWHBMl" title="Expiration date"><ix:nonNumeric contextRef="AsOf2019-06-14_custom_ABGWarrantsMember" format="ixt-sec:durwordsen" id="Fact002436" name="us-gaap:WarrantsAndRightsOutstandingTerm">ten years</ix:nonNumeric></span>. The warrants provided time-based vesting in equal
monthly increments over a period of two years beginning on the one year anniversary of the date of issuance of the warrants (the &#8220;Time-Based
Warrants&#8221;) and performance based vesting based on the achievement of certain performance goals for the licensed brands in calendar
years 2020, 2021, 2022, or 2023 (the &#8220;Performance-Based Warrants&#8221;). The warrants also provide that <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20190613__20190614__us-gaap--StatementEquityComponentsAxis__custom--ABGWarransMember_zrJ50wbDFPlj" title="Warrant or right, reason for issuance, description"><ix:nonNumeric contextRef="From2019-06-132019-06-14_custom_ABGWarransMember" id="Fact002438" name="us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees">(1) under certain circumstances
the Company may require ABG to exercise all (and not less than all) of the warrants, in which case all of the warrants will be vested;
(2) all of the warrants automatically vest upon certain terminations of the Licensing Agreement by ABG or upon a change of control of
the Company; and (3) ABG has the right to participate, on a pro-rata basis (including vested and unvested warrants, exercised or unexercised),
in any future equity issuance of the Company (subject to customary exceptions).</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As
of December 31, 2023, <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--ABGTimeBasedWarrantsMember_zRBrE5cRHKL8" title="Number of warrant shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2023-12-31_custom_ABGTimeBasedWarrantsMember" id="Fact002440" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">399,816</ix:nonFraction></span> Time-Based Warrants vested and <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--ABGPerformanceBasedWarrantsMember_z3LZRRyUkxX" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-12-31_custom_ABGPerformanceBasedWarrantsMember" id="Fact002442" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">599,724</ix:nonFraction></span> Performance-Based Warrants vested as of the issuance date
of these consolidated financial statements were issued (further details are provided under the heading <i>ABG Warrants</i> in Note 28 as to the full vesting of the ABG Warrants in January 2024).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to stock-based compensation cost and unrecognized stock-based compensation cost related to the ABG Warrants is provided
in Note 22.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Publisher
Partner Warrants</i> &#8211; On May 20, 2020, the Board approved a third publisher partner warrant program, which superseded the second
publisher partner warrant program and authorized the Company to grant publisher partner warrants to purchase up to <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20200520__us-gaap--StatementEquityComponentsAxis__custom--PublisherPartnerWarrantsMember_zqHJZHmBLYsj" title="Number of warrant shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2020-05-20_custom_PublisherPartnerWarrantsMember" id="Fact002444" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">90,910</ix:nonFraction></span> shares of the
Company&#8217;s common stock (the &#8220;Publisher Partner Warrants&#8221;). The issuance of the Publisher Partner Warrants is administered
by management and approved by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>New
Publisher Partner Warrants</i> &#8211; On November 2, 2022, the Board approved a warrant incentive program to grant warrants to certain
publishers (the &#8220;New Publisher Partner Warrants&#8221;), that authorized the Company to grant New Publisher Partner Warrants to
purchase up to <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20221102__us-gaap--StatementEquityComponentsAxis__custom--NewPublisherPartnerWarrantsMember_zSuIlsiLiOdd" title="Number of warrant shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-11-02_custom_NewPublisherPartnerWarrantsMember" id="Fact002446" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,000</ix:nonFraction></span> shares of the Company&#8217;s common stock. The New Publisher Partner Warrants will have the following terms: (i)
one-third will become exercisable and vest on the one-year anniversary of the issuance; (ii) the remaining warrants will become exercisable
and vest in a series of twenty-four (24) successive equal monthly installments following the first anniversary of the issuance; and (iii)
a five-year term. The issuance of the New Publisher Partner Warrants is administered by management and approved by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to stock-based compensation cost and unrecognized stock-based compensation cost related to the New Publisher Partner Warrants
is provided in Note 22.</span></p>
<!-- Field: Split-Segment; Name: 002 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002448" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p id="xdx_804_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zhw8Z4lehdud" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>22.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span><span id="xdx_82D_zCXtdm1zesO9">Stock&#8211;Based Compensation</span></span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued stock-based compensation awards under several plans as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2016
                                            Plan</i> &#8211; On December 19, 2016, the Board adopted the 2016 Stock Incentive Plan (the
                                            &#8220;2016 Plan&#8221;) that allowed the Company to grant restricted stock awards and statutory
                                            and non-statutory common stock options to acquire shares of the Company&#8217;s common stock
                                            to employees, directors and consultants, with vesting variable vesting provisions consisting
                                            of time-based and performance-based. The Company is no longer issuing awards under the 2016
                                            Plan.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2019
                                            Plan</i> &#8211; On April 4, 2019, the Board adopted the 2019 Equity Incentive Plan (the
                                            &#8220;2019 Plan&#8221;) that allowed awards of stock options, restricted stock awards, restricted
                                            stock units, unrestricted stock awards, and stock appreciation rights, with variable vesting
                                            provisions consisting of time-based, performance-based, or market-based. The Company is no
                                            longer issuing option awards under the 2019 Plan.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Outside
                                            Options</i> &#8211; The Company granted stock options outside the 2016 Plan and 2019 Plan
                                            (the &#8220;Outside Options&#8221;) that allowed the Company to grant statutory and non-statutory
                                            common stock options, with variable vesting provisions consisting time-based, performance-based
                                            targets and certain performance achievements. The Company is no longer issuing Outside Options.</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0"></p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2022
                                            Plan</i> &#8211; On April 18, 2022, the Board adopted the 2022 Stock and Equity Compensation
                                            Plan (the &#8220;2022 Plan&#8221;) that was approved by the Company&#8217;s stockholders
                                            on June 2, 2022 with a maximum number of shares authorized to be issued under the plan of
                                            <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20220602__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zR6Y0nnNjH35" title="Number of shares authorized to issue"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="AsOf2022-06-02_custom_TwoThousandTwentyTwoPlanMember" id="Fact002450" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,800,000</ix:nonFraction></span>. The purpose of the 2022 Plan is to foster the growth and success of the Company
                                            by providing a means to attract, motivate and retain officers, directors, key employees,
                                            and consultants through awards of stock options, stock appreciation rights, restricted stock
                                            awards, unrestricted stock awards and restricted stock units. Shares subject to an award
                                            that have been canceled, expired, settled in cash, or not issued or forfeited for any reason
                                            will not reduce the aggregate number of shares that may be subject to or delivered under
                                            the 2022 Plan and will be available for future awards granted under the 2022 Plan. Common
                                            stock options issued under the 2022 Plan may have a term of up to ten years and may have
                                            variable vesting provisions based on time and performance. The issuance of awards under the
                                            2022 Plan is administered by the Board or any committee of directors designated by the Board.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted
Stock Units</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2023 and 2022, the Company issued restricted stock units to various employees and members of the board subject
to continued service. Upon vesting of the award, subject to certain conditions for release of the award, the Company issues the underlying
common stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of a restricted stock unit was determined based on the number of shares granted and the quoted price of the Company&#8217;s
common stock on the date issued during the years ended December 31, 2023, and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember" escape="true" id="Fact002452" name="AREN:ScheduleOfRestrictedStockUnitsActivityTableTextBlock"><p id="xdx_89F_ecustom--ScheduleOfRestrictedStockUnitsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zGuBZFrp1rZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the restricted stock unit activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span id="xdx_8BB_zIHR8WiR6UKk" style="display: none">Schedule of Restricted Stock Units Activity</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of Shares</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Weighted<br/>
 Average<br/>
 Grant-Date</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Unvested</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Vested</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"> Fair Value</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Restricted stock units outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zrFTbYnzKOga" title="Number of Shares, Unvested, outstanding, at beginning of year" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2022-12-31_custom_RestrictedStockUnitsMember" id="Fact002454" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">994,766</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_z22DVdAYusBb" title="Number of Shares, Vested, outstanding, at beginning of year" style="width: 12%; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" contextRef="AsOf2022-12-31_custom_RestrictedStockUnitsMember" id="Fact002456" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">397,376</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zQg3Vc1Fe4bc" title="Weighted Average Exercise Price, outstanding, at beginning of year" style="width: 12%; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2022-12-31_custom_RestrictedStockUnitsMember" id="Fact002458" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.44</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zaj3ujE8Nqw8" title="Number of Shares, Unvested granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember" id="Fact002460" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">148,970</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zGY5Y5ndefia" title="Weighted Average Exercise Price,Granted" style="text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember" id="Fact002462" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.77</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zqJM1VHKCyx2" title="Number of Shares, Unvested, Vested" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember" id="Fact002464" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">645,023</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zuOov30y7j7e" title="Number of Shares, Vested" style="text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested" contextRef="AsOf2022-12-31_custom_RestrictedStockUnitsMember" id="Fact002466" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">645,023</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Released</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased_iNS_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zzaTB17oOD1f" title="Number of Shares, Vested, Released" style="text-align: right">(<ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased" contextRef="AsOf2022-12-31_custom_RestrictedStockUnitsMember" id="Fact002468" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">429,528</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Cancelled</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zFDvmEEZBKe7" title="Number of Shares, Unvested, Cancelled" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember" id="Fact002470" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">299,446</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Restricted stock units outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_ziKU1b60cNCi" title="Number of Shares, Unvested, outstanding at end of year" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2023-12-31_custom_RestrictedStockUnitsMember" id="Fact002472" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">199,267</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zHFYcTzEM0n" title="Number of Shares, Vested, outstanding, at end of year" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" contextRef="AsOf2023-12-31_custom_RestrictedStockUnitsMember" id="Fact002474" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">612,871</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20231231_zJ8I064rZMEl" title="Weighted Average Exercise Price, outstanding, at end of year" style="text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2023-12-31" id="Fact002476" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.55</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><p id="xdx_8A5_zRnKkIYL4Tmj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 28, 2023 and June 30, 2023, the Company modified certain restricted stock units as a result of the resignation of two senior
executives, where <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230227__20230228_zpyxXalA0mCb" title="Number of Shares, Granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-02-272023-02-28" id="Fact002478" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,026</ix:nonFraction></span> and <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230629__20230630_zDJkmmLH3mKe" title="Number of Shares, Granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-06-292023-06-30" id="Fact002480" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,635</ix:nonFraction></span> restricted stock units with time-based vesting that were unvested were vested, respectively, subject
to certain provisions, resulting in no incremental cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 22, 2022, the Company modified <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20221120__20221122_zZawFToWBvT8" title="Number of Shares, Granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-11-202022-11-22" id="Fact002482" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">232,816</ix:nonFraction></span> restricted stock units that were issued to one former employee (Ross Levinsohn) to remove
the market trading volume condition, resulting in incremental cost of $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_pn3n3_c20221120__20221122_zrcp0Z2Dmkbe" title="Incremental cost"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" contextRef="From2022-11-202022-11-22" id="Fact002484" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">321</ix:nonFraction></span> at the modification date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s policy is to repurchase the number of shares of its common stock at the fair market value at the time of issuance of
new shares of its common stock upon conversion of a restricted stock unit to cover the tax obligations. During the year ending December
31, 2024, the Company expects to repurchase approximately <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zz2qlVCwELda" title="Conversion of restricted stock units"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2024-01-012024-12-31_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_SubsequentEventMember" id="Fact002486" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">295,000</ix:nonFraction></span> shares of its common stock upon conversion of restricted stock units
that are expected to vest and be released during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total intrinsic value of shares of the Company&#8217;s common stock issued for restricted stock units that were released during the years
ended December 31, 2023 and 2022 were $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zVAGeNe2iFJi" title="Common stock issued for restricted stock units"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember66271921" id="Fact002488" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,955</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z2CgUYCaAy9c" title="Common stock issued for restricted stock units"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember66271937" id="Fact002490" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,707</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to stock-based compensation cost related to the restricted stock units is included within the Restricted Stock caption under
the heading <i>Stock-Based Compensation</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<ix:exclude><!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock Options</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2023 and 2022, the Company issued common stock options under the 2022 Plan, consisting of primarily of incentive
stock options with a term of up to ten years with time-based vesting provisions over three years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of common stock option awards granted during the years ended December 31, 2023 and 2022 was calculated using a Black-Scholes
options-pricing model for the time-based awards under the Up-list Scenario, after the Company&#8217;s common stock was listed on the
NYSE American. The fair value of common stock option awards granted during the year ended December 31, 2022 was calculated using the
Black-Scholes option-pricing model for the time-based under the Probability Weighted Scenarios, prior to the Company&#8217;s common stock
being listed on the NYSE American. The assumptions utilized are as follows:</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CommonEquityAwardsMember" escape="true" id="Fact002492" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--AwardTypeAxis__custom--CommonEquityAwardsMember_zruV6hVDiU3a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_zat2CAmRKCAe" style="display: none">Schedule of Fair Value of Stock Options Assumptions</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Up-list</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Up-list</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">No Up-list</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zCj3B41l2gfl" title="Risk-free interest rate, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember" id="Fact002494" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.46</ix:nonFraction></span>% - <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zrMKGLP8Xsd5" title="Risk-free interest rate, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember" id="Fact002496" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.82</ix:nonFraction></span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zRiwnCvK9OZ8" title="Risk-free interest rate, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember" id="Fact002498" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.97</ix:nonFraction></span>% - <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zTqp9zaL2xW" title="Risk-free interest rate, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember" id="Fact002500" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.36</ix:nonFraction></span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_ziL8E5Pl3Wxd" title="Risk-free interest rate, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember" id="Fact002502" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.97</ix:nonFraction></span>% - <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_z0ASPaVHQ5G3" title="Risk-free interest rate, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember" id="Fact002504" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.44</ix:nonFraction></span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left">Expected dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z9ylUE08FYIa" title="Expected dividend yield" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember" id="Fact002506" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.00</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z8CJWlg43aUc" title="Expected dividend yield" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember" id="Fact002508" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.00</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_zcG9GjR1dJ1g" title="Expected dividend yield" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember" id="Fact002510" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.00</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zCCvMSb8Rqmj" title="Expected volatility, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember" id="Fact002512" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">46.43</ix:nonFraction></span>% - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zEDWfeYi1oRg" title="Expected volatility, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember" id="Fact002514" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">47.27</ix:nonFraction></span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zmNf6DQKDVA7" title="Expected volatility, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember" id="Fact002516" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">42.00</ix:nonFraction></span>% - <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z7FebLjn403h" title="Expected volatility, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember" id="Fact002518" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">82.00</ix:nonFraction></span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_zVBOkOksxVDb" title="Expected volatility, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember" id="Fact002520" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">82.00</ix:nonFraction></span>% - <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_z8i5zmjNevi7" title="Expected volatility, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember" id="Fact002522" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">137.00</ix:nonFraction></span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z5vbyqVED6q" title="Expected life"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember" format="ixt-sec:duryear" id="Fact002524" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">6</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember__srt--RangeAxis__srt--MinimumMember_z1xhfG7PfEfd" title="Expected life"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact002526" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">3.0</ix:nonNumeric></span> &#8211; <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember__srt--RangeAxis__srt--MaximumMember_zjcp9qiN2bz9" title="Expected life"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact002528" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">6.0</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember__srt--RangeAxis__srt--MinimumMember_zA6mEhz5mcki" title="Expected life"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact002530" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">3.0</ix:nonNumeric></span> &#8211; <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember__srt--RangeAxis__srt--MaximumMember_zYyKMk3xpJ85" title="Expected life"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact002532" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">6.0</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_z7GBRL7pFh3f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CommonEquityAwardsMember" escape="true" id="Fact002534" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--CommonEquityAwardsMember_zb4madCHi1g8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the common stock option activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zQFCpcZeQdZ" style="display: none">Summary of Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"/><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Life</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in Years)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify">Common stock options outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zRzWUNDrYcgj" title="Number of Shares Common stock options, outstanding at Beginning balance" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002536" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,199,521</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zgkUt0bimyBg" title="Weighted Average Exercise Price, outstanding at Beginning balance" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002538" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.26</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zq4o4r2EGbCb" title="Weighted Average Remaining Contractual Life (in Years), outstanding at Beginning balance"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember" format="ixt-sec:duryear" id="Fact002540" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">8.20</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zx1VcSd4ruT5" title="Number of Shares, Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002542" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">287,993</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zKL9zbaQ7nuj" title="Weighted Average Exercise Price, Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002544" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.22</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zcRP5JHduar1" title="Number of Shares, Exercised" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002546" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,927</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zDKEqdFQ8Pm6" title="Weighted Average Exercise Price, Exercised" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002548" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.82</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zdTsjUIDAtq" title="Number of Shares, Forfeited" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002550" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">449,333</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zxXJj1flaRj7" title="Weighted Average Exercise Price, Forfeited" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002552" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.70</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pid_di_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zr2BNgAs937f" title="Number of Shares, Expired" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002554" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">579,286</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zU8ZFRa4Ryie" title="Weighted Average Exercise Price, Expired" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002556" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.38</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Common stock options outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zgYeuo0oOi5c" title="Number of Shares Common stock options, outstanding at Ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002558" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,451,968</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zzUZXLPvCyyg" title="Weighted Average Exercise Price, outstanding at Ending balance" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002560" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.56</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zwHIAIuMyNh7" title="Weighted Average Remaining Contractual Life (in Years), outstanding at Beginning balance"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember" format="ixt-sec:duryear" id="Fact002562" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.43</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Common stock options exercisable at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zdi9CFLomXwh" title="Number of Shares Common stock options, exercisable at Ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002564" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,049,393</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z3Y4yhhdaT64" title="Weighted Average Exercise Price, exercisable at Ending balance" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002566" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.64</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z9TfaB3o0pkk" title="Weighted Average Remaining Contractual Life (in Years), exercisable at Ending balance"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember" format="ixt-sec:duryear" id="Fact002568" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">5.06</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Common stock options not vested at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zEYc8CtZ4ave" title="Number of Shares Common stock options, not vested at Ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002570" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,402,575</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Common stock options available for future grants at December 31, 2023 (1)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_fKDEp_zEG4P5zCTLNf" title="Number of Shares Common stock options, available for future grants at Ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002572" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">542,847</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F04_zrM5Mcwlca8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span id="xdx_F1A_z6kmn735Og68" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002573" xml:lang="en-US">Common stock available
for future issuance under the 2022 Plan represent <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zz0cVnn4Bci8" title="Number of shares authorized to issue" class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002575" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,800,000</ix:nonFraction></span> of authorized shares; less <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zbkmhNt13S1c" title="Number of shares common stock options, outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002577" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,066,597</ix:nonFraction></span> common stock options outstanding and
<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzOJA6aChy6g" title="Number of shares common stock options, outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_us-gaap_RestrictedStockUnitsRSUMember" id="Fact002579" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">190,556</ix:nonFraction></span> restricted stock units outstanding.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8AF_zqAfSb9Yy35g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate grant date fair value of common stock options granted during the years ended December 31, 2023 and 2022 was $<span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_pn3n3_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zstBiXwIEsa7" title="Aggregate grant date fair value"><ix:nonFraction name="AREN:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002581" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">610</ix:nonFraction></span> and $<span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_pn3n3_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zsTZLPyU2sp6" title="Aggregate grant date fair value"><ix:nonFraction name="AREN:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002583" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,194</ix:nonFraction></span>,
respectively. The weighted-average grant-date fair value of common stock options granted during the years ended December 31, 2023 and
2022 were $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zXfmHqpL6byi" title="Weighted-average grant-date fair value"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002585" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.12</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_znNNc3xZGPda" title="Weighted-average grant-date fair value"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002587" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.25</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total intrinsic value of common stock options exercised during the years ended December 31, 2023 and 2022 were $<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pn3n3_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zYiTLMVP0Ujh" title="Common stock options vested"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002589" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></span> and $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pn3n3_c20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zSdUx6TDNbJb" title="Common stock options vested"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002591" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,507</ix:nonFraction></span>, respectively.
The total fair value of common stock options vested during the years ended December 31, 2023 and 2022 were $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_pn3n3_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zYEOLj5qqCj" title="Common stock options vested"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002593" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,155</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_pn3n3_c20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z7tRRnmSZKDl" title="Common stock options vested"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002595" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,694</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unvested common stock options for which the vesting is expected based on achievement of a performance condition as of December 31, 2023
were <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20230101__20231231_z6lOn1KHdx92"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2023-01-01to2023-12-31" id="Fact002596" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">583,143</ix:nonFraction></span> with a weighted average remaining contractual term of <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zb0eoVKFX778" title="Weighted average remaining contractual term"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt-sec:duryear" id="Fact002598" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">5.28</ix:nonNumeric></span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s policy is to repurchase the number of shares of its common stock at the fair market value at the time of issuance of
its common stock upon exercise of common stock options to cover the tax obligations and any cashless exercise. In addition, the Company&#8217;s
policy is to issue new shares of its common stock upon exercise of common stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pn3n3_do_c20231231_zgpKiCetfCm4" title="Intrinsic value of stock option"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2023-12-31" id="Fact002600" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="USD">no</ix:nonFraction></span> intrinsic value of exercisable but unexercised in-the-money common stock option awards as of December 31, 2023 based on a fair
market value of the Company&#8217;s common stock of $<span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20231231_zV9lv5OuiQ3l" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-12-31" id="Fact002602" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.38</ix:nonFraction></span> per share on December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CommonStockAwardsMember" escape="true" id="Fact002604" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_hus-gaap--AwardTypeAxis__custom--CommonStockAwardsMember_zJz3KNt0Xhbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise prices under the common stock options outstanding and exercisable are as follows as of December 31, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zcMgSiYQCtbc" style="display: none">Schedule of Exercise Prices of Common Stock Options</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Outstanding</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Vested</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">$</td><td style="width: 30%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z50C95osBHK3" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeOneMember" id="Fact002606" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.48</ix:nonFraction></span> to $<span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_ztJWvaRdXPv9" title="Exercise price upper range"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeOneMember" id="Fact002608" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.50</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z5b9S5kSuBhe" title="Number of Shares, Outstanding" style="width: 30%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeOneMember" id="Fact002610" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,318,901</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zHdvtffEfP85" title="Number of Shares, Vested" style="width: 30%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeOneMember" id="Fact002612" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,308,790</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zpYczAq7Kiy7" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeTwoMember" id="Fact002614" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.51</ix:nonFraction></span> to $<span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zbHV55BXbYFl" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeTwoMember" id="Fact002616" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.52</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zQZiDOZv3Mz" title="Number of Shares, Outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeTwoMember" id="Fact002618" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,062,379</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zfyfeAz1xzfl" title="Number of Shares, Vested" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeTwoMember" id="Fact002620" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">670,956</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zsNlWqFs4FUa"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeThreeMember" id="Fact002621" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.53</ix:nonFraction></span> to $<span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zVUNs0wKDLqh" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeThreeMember" id="Fact002623" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">20.54</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zhYcjlp21bDd" title="Number of Shares, Outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeThreeMember" id="Fact002625" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,091</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zJSsI8WWigoi" title="Number of Shares, Vested" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeThreeMember" id="Fact002627" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,091</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zLdUQpQ3VgH2" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFourMember" id="Fact002629" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">20.55</ix:nonFraction></span> to $<span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zSGZ3rihBIha" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFourMember" id="Fact002631" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">25.56</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zVftdPZkIC0g" title="Number of Shares, Outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFourMember" id="Fact002633" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,683</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zbwDFxcG4ZE5" title="Number of Shares, Vested" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFourMember" id="Fact002635" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">24,642</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zb6SBS9cAY9l" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFiveMember" id="Fact002637" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">25.57</ix:nonFraction></span> to $<span id="xdx_904_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_ziWt5byD4axk" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFiveMember" id="Fact002639" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">30.58</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zXqFcRVHLpEd" title="Number of Shares, Outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFiveMember" id="Fact002641" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">910</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_z6nzf57X6me9" title="Number of Shares, Vested" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFiveMember" id="Fact002643" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">910</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z1Hko8NG4tAk" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSixMember" id="Fact002645" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">30.59</ix:nonFraction></span> to $<span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z9NRzZF1ocEc" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSixMember" id="Fact002647" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">35.60</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zbdhVFh44NUe" title="Number of Shares, Outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSixMember" id="Fact002649" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,320</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zOQC17slKSlf" title="Number of Shares, Vested" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSixMember" id="Fact002651" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,320</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_ziFaBhOV5pI9" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSevenMember" id="Fact002653" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">35.61</ix:nonFraction></span> to $<span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zk7x5rdyPcrg" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSevenMember" id="Fact002655" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">40.62</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_z6QC6tOpZkx9" title="Number of Shares, Outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSevenMember" id="Fact002657" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,728</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_z9UpFiDuxfde" title="Number of Shares, Vested" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSevenMember" id="Fact002659" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,728</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zeoRnjPZFH89" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeEightMember" id="Fact002661" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">40.63</ix:nonFraction></span> to $<span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zfCESoZlc248" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeEightMember" id="Fact002663" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">48.40</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zsYPY0Ab4wPe" title="Number of Shares, Outstanding" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeEightMember" id="Fact002665" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,956</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zkNlqkOYJl1f" title="Number of Shares, Vested" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeEightMember" id="Fact002667" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,956</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_ztdxMZPyshXj" title="Number of Shares, Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002669" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,451,968</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z0JBAg8wcuCb" title="Number of Shares, Vested" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember" id="Fact002671" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,049,393</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A5_zCHH1ENW3W82" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Modification
of Awards </i>&#8211; On February 28, 2023, the Company modified certain equity awards as a result of the resignation of a senior executive
employee where <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20230228__20230228__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7jQDWrloFHc" title="Share based compensation, vesting, number"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" contextRef="From2023-02-282023-02-28_us-gaap_RestrictedStockUnitsRSUMember" id="Fact002673" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,026</ix:nonFraction></span> restricted stock units with time-based vesting that were unvested were vested and <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20230228__20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zVW07Kv2xs59" title="Share based compensation, vesting, number"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" contextRef="From2023-02-282023-02-28_custom_CommonStockOptionsMember" id="Fact002675" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">21,117</ix:nonFraction></span> options to purchase shares
of the Company&#8217;s common stock with time-based vesting that were unvested were vested, each subject to compliance with applicable
securities laws and certain other provisions. In connection with the modification of these equity awards, the Company agreed to purchase
a total of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20230228__20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_z4MWBU2bxrUe" title="Number of shares, agreed to purchase"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2023-02-282023-02-28_custom_CommonStockOptionsMember" id="Fact002677" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,632</ix:nonFraction></span> options to purchase shares of the Company&#8217;s common stock (including previously vested options to purchase shares
of the Company&#8217;s common stock of <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20230228__20230228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVxBLegbVplb" title="Sharebased compensation arrangement by sharebased payment award options vested number of shares"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2023-02-282023-02-28_us-gaap_CommonStockMember" id="Fact002679" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">24,515</ix:nonFraction></span>) as of the resignation date of the employee at a price of $<span id="xdx_905_eus-gaap--SharePrice_iI_pid_c20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zQYMCCCZmuja" title="Share price per share"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-02-28_custom_CommonStockOptionsMember" id="Fact002681" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.29</ix:nonFraction></span> per share, reduced by
the exercise price and required tax withholdings, subject to certain conditions. The modification of the equity awards resulted in the
unamortized costs being recognized at the modification date. The cash price of $<span id="xdx_90C_eus-gaap--SharePrice_iI_pid_c20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_z7DE7rQeiIN5" title="Share price per share"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-02-28_custom_CommonStockOptionsMember" id="Fact002683" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.29</ix:nonFraction></span> per option less the strike price of $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zMfwp12qxcfe" title="Strike price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-02-28_custom_CommonStockOptionsMember" id="Fact002685" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.82</ix:nonFraction></span> per option
resulted in incremental cost of $<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_pn3n3_c20230228__20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zGhkRHhIXlA1" title="Incremental cost"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" contextRef="From2023-02-282023-02-28_custom_CommonStockOptionsMember" id="Fact002687" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">68</ix:nonFraction></span> being recognized at the modification date. The modification resulted in liability classification
of the equity awards, with $<span id="xdx_909_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_z4DCGMw2DeAb" title="Accrued expenses and other"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_custom_CommonStockOptionsMember" id="Fact002689" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">68</ix:nonFraction></span> paid during the year ended December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 30, 2023, the Company modified certain equity awards upon the resignation of a senior executive employee pursuant to which unvested
restricted stock units for <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zCXncc0kVgS4" title="Unvested restricted stock units"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" contextRef="From2023-01-012023-06-30_us-gaap_RestrictedStockUnitsRSUMember" id="Fact002691" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,635</ix:nonFraction></span> shares of the Company&#8217;s common stock vested, and unvested options for <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_z3kHG8wPiKob" title="Common stock vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" contextRef="From2023-01-012023-06-30_custom_CommonStockOptionsMember" id="Fact002693" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,701</ix:nonFraction></span> shares of the Company&#8217;s
common stock vested with the exercise period extended for the <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zn7JvjGrRSjf" title="Vested contractual term"><ix:nonNumeric contextRef="From2023-01-012023-06-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt-sec:duryear" id="Fact002695" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">10</ix:nonNumeric></span>-year contractual term of the options from the grant date of the award.
In connection with the termination, the unamortized costs of the awards of $<span id="xdx_904_eus-gaap--UnamortizedDebtIssuanceExpense_iI_pn3n3_c20230630__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zoYdDF500SX3" title="Unamortized costs"><ix:nonFraction name="us-gaap:UnamortizedDebtIssuanceExpense" contextRef="AsOf2023-06-30_custom_CommonStockOptionsMember" id="Fact002697" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">773</ix:nonFraction></span> was recognized at the termination date and $<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_pn3n3_c20230629__20230630__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zvdeDCjbMYUl" title="Incremental cost"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" contextRef="From2023-06-292023-06-30_custom_CommonStockOptionsMember" id="Fact002699" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">284</ix:nonFraction></span> of incremental
cost was recognized as a result of the option award modification upon termination of the senior executive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 2, 2023, the Company modified options of former a senior executive officer for <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20231101__20231102_zL0cWRhIu2g2" title="Unvested restricted stock units"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" contextRef="From2023-11-012023-11-02" id="Fact002701" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">450,560</ix:nonFraction></span>
shares of the Company&#8217;s common stock, pursuant to which the exercise period would be extended for the <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20231101__20231102_zczDkQp8qeA7" title="Vested contractual term"><ix:nonNumeric contextRef="From2023-11-012023-11-02" format="ixt-sec:duryear" id="Fact002703" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">10</ix:nonNumeric></span>-year
contractual term from the grant date of the award subject to continued employment through the closing date of the Business
Combination (see Note 28) (the &#8220;conditions&#8221;). Incremental costs in connection with the modification was $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_pn3n3_c20231101__20231102_ztTmD6xKqNze" title="Incremental cost"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" contextRef="From2023-11-012023-11-02" id="Fact002705" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">380</ix:nonFraction></span>,
of which no cost was recognized at the modification date since the conditions were not satisfied and the employment of the officer
was terminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<ix:exclude><!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2022
Stock Option Repricing</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 18, 2022, the Company approved a repricing of certain outstanding stock options (the &#8220;Stock Option Repricing&#8221;) granted
under the Company&#8217;s 2016 Plan and 2019 Plan that had an exercise price above $ <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220315__20220318_zuASn8tuxWVg" title="Weighted Average Exercise Price, Granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-03-152022-03-18" id="Fact002707" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.82</ix:nonFraction></span> per share, as well as certain outstanding stock
options held by senior management of the Company under the Outside Options. The Stock Options Repricing was approved by the Board and
stockholders. As a result of the Stock Option Repricing, the exercise prices were set to $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220315__20220318_z3ksuL735Nwc" title="Weighted Average Exercise Price, Granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-03-152022-03-18" id="Fact002709" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.82</ix:nonFraction></span> per share, which was the closing sale
price of the Company&#8217;s common stock as listed on the NYSE American exchange on March 18, 2022. Except for the repricing of the
stock options under the 2019 Plan, all terms and conditions of each stock option remain in full force and effect. For the repricing of
the stock options under the 2019 Plan, the Company (i) modified the exercise price; (ii) will allow cashless exercise as a method of
paying the exercise price, and (iii) will waive a lock-up provision in the stock option agreements. All other term and conditions of
each of the stock options under the 2019 Plan remain in full force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Stock Option Repricing of approximately <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220315__20220318_zAfYh6i525d6" title="Share based compensation arrangement options grants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-03-152022-03-18" id="Fact002711" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,343,017</ix:nonFraction> </span>stock option grants (for 340 employees) that were issued to employees of the Company,
including senior management, resulted in incremental cost of $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_pn3n3_c20220315__20220318_zN8JJMv7xsn7" title="Share based compensation incremental cost"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" contextRef="From2022-03-152022-03-18" id="Fact002713" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,061</ix:nonFraction></span>, of which $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_pn3n3_c20220318_zRoUabhVXRf5" title="Share based compensation aggregate intrinsic value"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2022-03-18" id="Fact002715" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">143</ix:nonFraction></span> was recognized at the time of the Stock Option Repricing
for the fully vested awards and included on the consolidated statements of operations, and $<span id="xdx_909_ecustom--OriginalAwardAtTheRepricingDate_pn3n3_c20220315__20220318_z3WFenVEnsf1" title="Original award repricing date"><ix:nonFraction name="AREN:OriginalAwardAtTheRepricingDate" contextRef="From2022-03-152022-03-18" id="Fact002717" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,918</ix:nonFraction></span> will recognized over the remaining
vesting term of the original award at the repricing date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to stock-based compensation cost and unrecognized stock-based compensation cost related to the common stock options is provided
under the heading <i>Stock-Based Compensation</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>ABG
Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Licensing Agreement and issuance of the ABG Warrants to purchase up to <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231231__us-gaap--TypeOfArrangementAxis__custom--SportsIllustratedLicensingAgreementMember__us-gaap--RelatedPartyTransactionAxis__custom--ABGWarrantsMember_znWHc0pp6vWj" title="Exeercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2023-12-31_custom_SportsIllustratedLicensingAgreementMember_custom_ABGWarrantsMember" id="Fact002719" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">999,540</ix:nonFraction></span> shares of the Company&#8217;s common
stock, the Company recorded the issuance of the warrants as stock-based compensation with the fair value of the warrants measured at
the time of issuance and expensed over the requisite service period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember66273406" escape="true" id="Fact002721" name="AREN:ScheduleOfWarrantsActivityTableTextBlock"><p id="xdx_894_ecustom--ScheduleOfWarrantsActivityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--ABGWarrantsMember_zNoWOLPinfg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the ABG Warrant activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zsfds2bgUzxf" style="display: none">Schedule of Warrants Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Weighted<br/>
 Average</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Weighted<br/>
 Average<br/>
 Remaining <br/>
Contractual<br/>
 Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unvested</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Vested</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">ABG Warrants outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zpYtxuK091Oi" title="Number of Shares, unvested outstanding, at beginning of year" style="width: 11%; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber" contextRef="AsOf2022-12-31_custom_ABGWarrantsMember" id="Fact002723" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">599,724</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zI955IU90hX8" title="Number of Shares, vested outstanding, at beginning of year" style="width: 11%; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber" contextRef="AsOf2022-12-31_custom_ABGWarrantsMember" id="Fact002725" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">399,816</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_z5xwTK6i8sXk" title="Weighted Average Exercise Price, outstanding, at beginning of year" style="width: 11%; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" contextRef="AsOf2022-12-31_custom_ABGWarrantsMember" id="Fact002727" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.55</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span id="xdx_909_ecustom--WeightedAverageRemainingContractualLifeOutstanding_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zWh6N91O9Ndb" title="Weighted Average Remaining Contractual Life, Outstanding at beginning of year"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_ABGWarrantsMember66276281" format="ixt-sec:duryear" id="Fact002729" name="AREN:WeightedAverageRemainingContractualLifeOutstanding">6.46</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zxEdsvqKDzha" title="Number of Shares, unvested issued" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2731">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zkUIJoVr7rLb" title="Number of Shares, vested" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2733">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">ABG Warrants outstanding at December 31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zLK1LvPlKc24" title="Number of Shares, unvested outstanding, at end of year" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber" contextRef="AsOf2023-12-31_custom_ABGWarrantsMember" id="Fact002735" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">599,724</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zsRYxtLY03M9" title="Number of Shares, vested outstanding, at end of year" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber" contextRef="AsOf2023-12-31_custom_ABGWarrantsMember" id="Fact002737" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">399,816</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_z1qAdjUfb1U6" title="Weighted Average Exercise Price, outstanding, at end of year" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" contextRef="AsOf2023-12-31_custom_ABGWarrantsMember" id="Fact002739" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.55</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_905_ecustom--WeightedAverageRemainingContractualLifeOutstanding_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zbHIJqMqOmG2" title="Weighted Average Remaining Contractual Life, Outstanding at ending of year"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember66276312" format="ixt-sec:duryear" id="Fact002741" name="AREN:WeightedAverageRemainingContractualLifeOutstanding">5.46</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A9_zaK24Z9Zj0W2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pn3n3_do_c20231231__us-gaap--TypeOfArrangementAxis__custom--SportsIllustratedLicensingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ABGWarrantsMember_zCpw5eySBgGe" title="Intrinsic value of stock option"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2023-12-31_custom_SportsIllustratedLicensingAgreementMember_custom_ABGWarrantsMember66272984" id="Fact002743" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="USD">no</ix:nonFraction></span> intrinsic value of exercisable but unexercised in-the-money ABG Warrants as of December 31, 2023 based on a fair market value
of the Company&#8217;s common stock of $<span id="xdx_900_ecustom--FairMarketValueOfStockOption_iI_pid_c20231231__us-gaap--TypeOfArrangementAxis__custom--SportsIllustratedLicensingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ABGWarrantsMember_zqJdcgu2VEV7" title="Fair market value of stock option"><ix:nonFraction name="AREN:FairMarketValueOfStockOption" contextRef="AsOf2023-12-31_custom_SportsIllustratedLicensingAgreementMember_custom_ABGWarrantsMember66272984" id="Fact002745" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.38</ix:nonFraction></span> per share on December 31, 2023. Information on the acceleration of the vesting of the ABG
Warrants is provided in Note 28.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember66273406" escape="true" id="Fact002747" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--ABGWarrantsMember_z4J5vzOaTKMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise prices of the ABG Warrants outstanding and exercisable are as follows as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zrRikuEiWc3k" style="display: none">Schedule of Exercise Prices of Common Stock Options</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Outstanding</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercisable</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">$</td><td style="width: 30%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zKgPGThkQJp" title="Exercise price lower range"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeOneMember" id="Fact002749" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.24</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zU50JB6QzUpa" title="Number of shares, outstanding" style="width: 30%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeOneMember" id="Fact002751" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">749,655</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zmLSzRp7LgZ6" title="Number of shares, exercisable" style="width: 30%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeOneMember" id="Fact002753" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">299,862</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z4BtTlp0SgTg" title="Exercise price lower range"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeTwoMember" id="Fact002755" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.48</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z0Ui8koEijLc" title="Number of shares, outstanding" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeTwoMember" id="Fact002757" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">249,885</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zmz0wrBVcrR2" title="Number of shares, exercisable" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeTwoMember" id="Fact002759" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">99,954</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zHK5IRpMCj1g" title="Number of shares, outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_ABGWarrantsMember" id="Fact002761" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">999,540</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_z7pIqsolUyp7" title="Number of shares, exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2023-12-31_custom_ABGWarrantsMember" id="Fact002763" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">399,816</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zVoemDEMnQk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to compensation cost and unrecognized compensation cost related to the ABG Warrants is provided under the heading <i>Stock-Based
Compensation</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<ix:exclude><!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Publisher
Partner Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Publisher
Partner Warrants</i> &#8211; Publisher Partner Warrants outstanding as of January 1, 2023, totaling <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--PublisherPartnerWarrantProgramMember_zJSpsWIjsGfl" title="Warrant to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2023-12-31_custom_PublisherPartnerWarrantProgramMember" id="Fact002765" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,154</ix:nonFraction></span>, expired during the year ended
December 31, 2023. As of December 31, 2023, there are no Publisher Partner Warrants outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>New
Publisher Partner Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_NewPublisherPartnerWarrantMember" escape="true" id="Fact002767" name="AREN:ScheduleOfWarrantsActivityTableTextBlock"><p id="xdx_89B_ecustom--ScheduleOfWarrantsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zWf6xvowhFOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the New Publisher Partner Warrants activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zMUmq9oxdM1i" style="display: none">Schedule of Warrants Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"/><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Life</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in Years)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">New Publisher Partner Warrants outstanding at January 1, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z2gAsbkB70j6" title="Number of Shares, outstanding, at beginning of year" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2769">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zB6OeYbpL0I2" title="Weighted Average Exercise Price, outstanding, at beginning of year" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2771">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: justify">Granted</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z9IT6Os7LKw9" title="Number of Shares, Forfeited" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" contextRef="From2023-01-012023-12-31_custom_NewPublisherPartnerWarrantMember" id="Fact002773" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,800</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zxaq3necnJlb" title="Weighted Average Exercise Price, Ending Balance" style="width: 12%; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember" id="Fact002775" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.91</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">New Publisher Partner Warrants outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zKibk2Uz7Mzl" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember" id="Fact002776" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z0KXTc7fuHq5" title="Weighted Average Exercise Price, Ending Balance" style="text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember" id="Fact002778" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.91</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--WeightedAverageRemainingContractualLifeOutstanding1_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zZFv88FPShT7" title="Weighted Average Remaining Contractual Life, Outstanding at ending of year"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_NewPublisherPartnerWarrantMember" format="ixt-sec:duryear" id="Fact002780" name="AREN:WeightedAverageRemainingContractualLifeOutstanding1">4.15</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">New Publisher Partner Warrants exercisable at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zImrjS8X6red" title="Number of Shares, Exercisable at end of year" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember" id="Fact002782" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,084</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zkDCeOQoEOUh" title="Weighted Average Exercise Price, Exercisable at end of year" style="text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable" contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember" id="Fact002784" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.56</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--WeightedAverageRemainingContractualLifeExercisable_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_ztp3qO5ifYu5" title="Weighted Average Remaining Contractual Life, Exercisable"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_NewPublisherPartnerWarrantMember" format="ixt-sec:duryear" id="Fact002786" name="AREN:WeightedAverageRemainingContractualLifeExercisable">3.92</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">New Publisher Partner Warrants not vested at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zBtAAmFtMima" title="Number of Shares, not vested at end of year" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested" contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember" id="Fact002788" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,716</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">New Publisher Partner Warrants available for future grants at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zT2cm3ei9vM2" title="Number of Shares, Available for future grants at end of year" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber" contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember" id="Fact002790" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zUyjfep3fcDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_do_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zB98MN8IsIQ3" title="Intrinsic value of stock option"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember" id="Fact002792" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> intrinsic value of exercisable but unexercised in-the-money New Publisher Partner Warrants since the fair market value of $<span id="xdx_907_ecustom--FairMarketValueOfStockOption_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zN4HxOPx2by1" title="Fair market value of stock option"><ix:nonFraction name="AREN:FairMarketValueOfStockOption" contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember" id="Fact002794" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.38</ix:nonFraction></span>
per share of the Company&#8217;s common stock was lower than the exercise prices on December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_NewPublisherPartnerWarrantMember" escape="true" id="Fact002796" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_hus-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z8BjKnMgfMCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise prices of the New Publisher Partner Warrants outstanding and exercisable are as follows as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_z8TEOqBkMmBg" style="display: none">Schedule of Exercise Prices of Common Stock Options</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Outstanding</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercisable</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">$</td><td style="width: 30%; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z6kXo03sJvla" title="Exercise price lower range"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2023-01-012023-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeOneMember" id="Fact002798" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.30</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zkf8QRw8NRR9" title="Number of Shares, Outstanding" style="width: 30%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeOneMember" id="Fact002800" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,800</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z3GJQ8PdBt8h" title="Number of Shares, Exercisable" style="width: 30%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2802">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zSD2JPrm9F2b" title="Exercise price lower range"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2022-01-012022-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeTwoMember" id="Fact002804" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.56</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zOCapmwRMr9h" title="Number of Shares, Outstanding" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne" contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeTwoMember" id="Fact002806" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z0Tlm5Wc0sX6" title="Number of Shares, Exercisable" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne" contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeTwoMember" id="Fact002808" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,084</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zK0kEaqALdS2" title="Number of Shares, Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember" id="Fact002810" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zpWefQy49wkd" title="Number of Shares, Exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember" id="Fact002812" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,084</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_z3kyW9jPavQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock-Based
Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember66273406" escape="true" id="Fact002814" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--ABGWarrantsMember_zkMesvIjkW3i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock&#8211;based
compensation and equity-based expense charged to operations or capitalized during the years ended December 31, 2023 and 2022 are summarized
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zqWOdX3kw9E" style="display: none">Summary of Stock-based Compensation</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Restricted<br/>
 Stock</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/>
Stock Options</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">ABG Warrants</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Totals</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Cost of revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zS4aB10vPkx7" title="Cost of revenue" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember" id="Fact002816" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,092</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zjfeLSqdTWH1" title="Cost of revenue" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-01-012023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember" id="Fact002818" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,460</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z4SWUTwrHBPk" title="Cost of revenue" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember" id="Fact002820" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zuh3OCpomXM" title="Cost of revenue" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-01-012023-12-31_custom_StockBasedCompensationMember" id="Fact002822" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,562</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Selling and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zv3oA1jKt3V1" title="Selling and marketing" style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember" id="Fact002824" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">257</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z9sW55HnO8o5" title="Selling and marketing" style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-01-012023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember" id="Fact002826" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,402</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_ziehUIhFx4L9" title="Selling and marketing" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2828">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zQIXd86TXcBg" title="Selling and marketing" style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-01-012023-12-31_custom_StockBasedCompensationMember" id="Fact002830" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,659</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zj34EBLFgL9b" title="General and administrative" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember" id="Fact002832" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,372</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zJIAxKFs8dm6" title="General and administrative" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember" id="Fact002834" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,457</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zVOIDSewmT25" title="General and administrative" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember" id="Fact002836" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,010</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zyxbAKu6wZi" title="General and administrative" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31_custom_StockBasedCompensationMember" id="Fact002838" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,839</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total costs charged to operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z1qDiccyYDI6" title="Total costs charged to operations" style="text-align: right"><ix:nonFraction name="AREN:CostsChargedToOperations" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember" id="Fact002840" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,721</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zDvdTPfm9Q0c" title="Total costs charged to operations" style="text-align: right"><ix:nonFraction name="AREN:CostsChargedToOperations" contextRef="From2023-01-012023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember" id="Fact002842" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,319</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zohVYeJuar94" title="Total costs charged to operations" style="text-align: right"><ix:nonFraction name="AREN:CostsChargedToOperations" contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember" id="Fact002844" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,020</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zSBKQGqlB3V4" title="Total costs charged to operations" style="text-align: right"><ix:nonFraction name="AREN:CostsChargedToOperations" contextRef="From2023-01-012023-12-31_custom_StockBasedCompensationMember" id="Fact002846" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,060</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Capitalized platform development</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z8avxe0oOTc2" title="Capitalized platform development" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2848">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zirhH6aEfK6f" title="Capitalized platform development" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DevelopmentCosts" contextRef="From2023-01-012023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember" id="Fact002850" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,016</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z0jtwB0FCUHb" title="Capitalized platform development" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2852">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zprrWOJiUQQc" title="Capitalized platform development" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DevelopmentCosts" contextRef="From2023-01-012023-12-31_custom_StockBasedCompensationMember" id="Fact002854" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,016</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total stock-based compensation</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zdfE9zZ40QZ3" title="Total stock-based compensation" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember" id="Fact002856" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,721</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zm6IXAv1zbCe" title="Total stock-based compensation" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember" id="Fact002858" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,335</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zpksmIkYPFR9" title="Total stock-based compensation" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember" id="Fact002860" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,020</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z1UlLBoEHiR9" title="Total stock-based compensation" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-12-31_custom_StockBasedCompensationMember" id="Fact002862" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,076</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Restricted<br/>
 Stock</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/>
Stock Options</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">ABG Warrants</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Totals</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Cost of revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zbc4io1WKOTl" title="Cost of revenue" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember" id="Fact002864" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,730</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zmYy9EsXMQpf" title="Cost of revenue" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-01-012022-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember" id="Fact002866" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,505</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zXQelMvmOKii" title="Cost of revenue" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2868">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zHgmqrdHBuIk" title="Cost of revenue" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-01-012022-12-31_custom_StockBasedCompensationMember" id="Fact002870" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,235</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Selling and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zzI21pyXIxUl" title="Selling and marketing" style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember" id="Fact002872" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">270</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zqHeRFs34xsf" title="Selling and marketing" style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-01-012022-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember" id="Fact002874" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,502</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zp6hLT9CnNcl" title="Selling and marketing" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2876">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zUD4N25qWy57" title="Selling and marketing" style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-01-012022-12-31_custom_StockBasedCompensationMember" id="Fact002878" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,772</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zY3IthpAUkla" title="General and administrative" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember" id="Fact002880" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,067</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zGOlOGCYdgG9" title="General and administrative" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-012022-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember" id="Fact002882" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,776</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zjITvekToWN9" title="General and administrative" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-012022-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember" id="Fact002884" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,495</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zBl31ToAqh1c" title="General and administrative" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-012022-12-31_custom_StockBasedCompensationMember" id="Fact002886" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,338</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total costs charged to operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zBl2pwO6bKue" title="Total costs charged to operations" style="text-align: right"><ix:nonFraction name="AREN:CostsChargedToOperations" contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember" id="Fact002888" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,067</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zSnjNhzBUna4" title="Total costs charged to operations" style="text-align: right"><ix:nonFraction name="AREN:CostsChargedToOperations" contextRef="From2022-01-012022-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember" id="Fact002890" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,783</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zq4l8XzjoUo5" title="Total costs charged to operations" style="text-align: right"><ix:nonFraction name="AREN:CostsChargedToOperations" contextRef="From2022-01-012022-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember" id="Fact002892" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,495</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zyxMhPgM26Fa" title="Total costs charged to operations" style="text-align: right"><ix:nonFraction name="AREN:CostsChargedToOperations" contextRef="From2022-01-012022-12-31_custom_StockBasedCompensationMember" id="Fact002894" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,345</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Capitalized platform development</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zDUTrOX49saj" title="Capitalized platform development" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2896">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zLU4MABAJzF4" title="Capitalized platform development" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DevelopmentCosts" contextRef="From2022-01-012022-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember" id="Fact002898" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,884</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zKZN0rxKseac" title="Capitalized platform development" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2900">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zbx2FBLwBMlc" title="Capitalized platform development" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DevelopmentCosts" contextRef="From2022-01-012022-12-31_custom_StockBasedCompensationMember" id="Fact002902" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,884</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total stock-based compensation</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zWiko2EKKVy7" title="Total stock-based compensation" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember" id="Fact002904" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,067</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zo7kdn5kDXp" title="Total stock-based compensation" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember" id="Fact002906" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,667</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zTn3jXVl4HJ1" title="Total stock-based compensation" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember" id="Fact002908" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,495</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_ztpqGxcsOFk8" title="Total stock-based compensation" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-12-31_custom_StockBasedCompensationMember" id="Fact002910" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,229</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zG2z1g1GxoW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002912" name="AREN:ScheduleOfUnrecognizedCompensationExpense"><p id="xdx_89A_ecustom--ScheduleOfUnrecognizedCompensationExpense_z5zoP8UKu54f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrecognized
compensation expense related to the stock-based compensation awards and equity-based awards as of December 31, 2023 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zSpQfxxmfmD5" style="display: none">Schedule of Unrecognized Compensation Expense</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Restricted<br/>
 Stock</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/>
Stock Options</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">ABG Warrants</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Totals</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Unrecognized compensation expense</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zK2fgOgUbWok" title="Unrecognized compensation expense" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember" id="Fact002914" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,191</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zIfBhtP9vhp" title="Unrecognized compensation expense" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember" id="Fact002916" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,192</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zTvMG4y7ZrHf" title="Unrecognized compensation expense" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember" id="Fact002918" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zxz6nz9YmTF6" title="Unrecognized compensation expense" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2023-12-31_custom_StockBasedCompensationMember" id="Fact002920" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,409</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted average period expected to be recognized (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zmt8Fp8nBx29" title="Weighted average period expected to be recognized (in years)"><ix:nonNumeric contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember" format="ixt-sec:duryear" id="Fact002922" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">1.84</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zEXcy2KCOGzd" title="Weighted average period expected to be recognized (in years)"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember" format="ixt-sec:duryear" id="Fact002924" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">1.33</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zbEEcYF3gId7" title="Weighted average period expected to be recognized (in years)"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember" format="ixt-sec:duryear" id="Fact002926" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">2.01</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zPB1D1Ix63w8" title="Weighted average period expected to be recognized (in years)"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_StockBasedCompensationMember" format="ixt-sec:duryear" id="Fact002928" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">1.45</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zwb7DtE161Qk" style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002930" name="AREN:LiquidatingDamagesPayableDisclosureTextBlock"><p id="xdx_80C_ecustom--LiquidatingDamagesPayableDisclosureTextBlock_zjzExnaKew2c" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>23.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82C_z8ixUqsRSkgd">Liquidated Damages</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years December 31, 2023 and 2022, the Company recorded liquidated damages of $<span id="xdx_907_ecustom--LiquidatedDamagesPayable_iI_pn3n3_c20231231_zDZp8iqLS5Wd" title="Liquidated damages payable"><ix:nonFraction name="AREN:LiquidatedDamagesPayable" contextRef="AsOf2023-12-31" id="Fact002932" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">583</ix:nonFraction></span> and $<span id="xdx_90C_ecustom--LiquidatedDamagesPayable_iI_pn3n3_c20221231_z7Uq5ALjKB1h" title="Liquidated damages payable"><ix:nonFraction name="AREN:LiquidatedDamagesPayable" contextRef="AsOf2022-12-31" id="Fact002934" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,140</ix:nonFraction></span> (including accrued interest of $<span id="xdx_90D_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20230101__20231231_zdBOTwREbmb1" title="Liquidated damages payable accrued interest percentage"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseAccruedInterest" contextRef="From2023-01-01to2023-12-31" id="Fact002936" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">583</ix:nonFraction></span>
and $<span id="xdx_90E_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20220101__20221231_zOdKMetvwysf" title="Liquidated damages payable accrued interest percentage"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseAccruedInterest" contextRef="From2022-01-012022-12-31" id="Fact002938" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">652</ix:nonFraction></span>), respectively. During the year December 31, 2022, liquidated damages of $<span id="xdx_905_ecustom--LiquidatedDamagesPayable_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_zKySdlFvUyY3" title="Liquidating damages payable"><ix:nonFraction name="AREN:LiquidatedDamagesPayable" contextRef="AsOf2022-12-31_custom_SeriesKPreferredStockMember" id="Fact002940" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">488</ix:nonFraction></span> were recorded as a result of Registration Rights
Damages resulting from not registering the Series K convertible preferred stock timely.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002942" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_808_eus-gaap--IncomeTaxDisclosureTextBlock_zmjbbzkwqF15" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>24.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82E_z0qHBN64Qysc">Income Taxes</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002944" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zh5bOd87Uomb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of the (provision) benefit for income taxes consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_zJxUib8MGzf" style="display: none">Schedule of Income Taxes</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230101__20231231_zo2q3k3R6nF1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220101__20221231_zDAfweOglcij" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current tax (provision) benefit:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_maCFSALzf1Y_zzi04Day80Ke" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Federal</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2946">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2947">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pn3n3_maCFSALzf1Y_zQzMzV1Bz3w1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 60%; text-align: left; padding-bottom: 1.5pt">State and local</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2023-01-01to2023-12-31" id="Fact002949" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">88</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="Fact002950" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">77</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_iT_pn3n3_mtCFSALzf1Y_maITEBzavD_maOTEBzTPw_zKfHARmqo5cb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total current tax (provision) benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit" contextRef="From2023-01-01to2023-12-31" id="Fact002952" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">88</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="Fact002953" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">77</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax (provision) benefit:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_iN_pn3n3_di_maDITEBzGRA_zPXuvLKDRKsa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2023-01-01to2023-12-31" id="Fact002955" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">57</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="Fact002956" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">985</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_pn3n3_di_maDITEBzGRA_zxHSDpKfudGg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">State and local</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2023-01-01to2023-12-31" id="Fact002958" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">77</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="Fact002959" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">155</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredIncomeTaxExpenseBenefit_iNT_pn3n3_di_maITEBzavD_mtDITEBzGRA_maOTEBzTPw_zyIkaH8oJeDc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total deferred tax (provision) benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2023-01-01to2023-12-31" id="Fact002961" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">134</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="Fact002962" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,140</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iNT_pn3n3_di_mtOTEBzTPw_zp500xwh83S" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total income tax (provision) benefit</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-01to2023-12-31" id="Fact002964" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">222</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="Fact002965" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,063</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8A9_zLUTegjAUkt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002967" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ztTl5HtUJgW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of deferred tax assets and liabilities were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BD_zT2pwna5LL4g" style="display: none">Schedule of Components of Deferred Tax Assets and Liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20231231_znBJW5Og44Z1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20221231_zlVTQSX3TqH" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzAs8_z7fuwzQTwAah" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left">Net operating loss carryforwards</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2023-12-31" id="Fact002969" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52,353</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2022-12-31" id="Fact002970" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">51,023</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pn3n3_maDTAGzAs8_zA0j0FMZH0A4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Interest limitation carryforward</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetInterestCarryforward" contextRef="AsOf2023-12-31" id="Fact002972" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,028</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetInterestCarryforward" contextRef="AsOf2022-12-31" id="Fact002973" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,444</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_iI_pn3n3_maDTAGzAs8_zlpBsrKm3E99" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Tax credit carryforwards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="AsOf2023-12-31" id="Fact002975" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">264</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="AsOf2022-12-31" id="Fact002976" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">264</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_iI_pn3n3_maDTAGzAs8_zTGa0ENod1Vk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Allowance for doubtful accounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="AsOf2023-12-31" id="Fact002978" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">388</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="AsOf2022-12-31" id="Fact002979" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">757</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_iI_pn3n3_maDTAGzAs8_zT1mRYg7xvL9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accrued expenses and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" contextRef="AsOf2023-12-31" id="Fact002981" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">891</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" contextRef="AsOf2022-12-31" id="Fact002982" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,340</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--LeaseTermination_iI_pn3n3_maDTAGzAs8_zVEZ4UGK5Tzc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Lease termination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:LeaseTermination" contextRef="AsOf2023-12-31" id="Fact002984" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,017</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:LeaseTermination" contextRef="AsOf2022-12-31" id="Fact002985" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,869</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsLiquidatingDamagesPayable_iI_pn3n3_maDTAGzAs8_zssmQy207hS5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Liquidated damages</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:DeferredTaxAssetsLiquidatingDamagesPayable" contextRef="AsOf2023-12-31" id="Fact002987" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">794</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:DeferredTaxAssetsLiquidatingDamagesPayable" contextRef="AsOf2022-12-31" id="Fact002988" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,717</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_pn3n3_maDTAGzAs8_ztMZUlzFsGql" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2023-12-31" id="Fact002990" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,148</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2022-12-31" id="Fact002991" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,744</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pn3n3_maDTAGzAs8_zdesa3BX48A5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2023-12-31" id="Fact002993" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,229</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2022-12-31" id="Fact002994" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,931</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DeferredTaxAssetsOperatingLeaseLiability_iI_pn3n3_maDTAGzAs8_zLH6m1yltgx1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Operating lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:DeferredTaxAssetsOperatingLeaseLiability" contextRef="AsOf2023-12-31" id="Fact002996" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="AREN:DeferredTaxAssetsOperatingLeaseLiability" contextRef="AsOf2022-12-31" id="Fact002997" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">118</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsDepreciationAndAmortization_iI_pn3n3_maDTAGzAs8_znyngA1yTyN7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:DeferredTaxAssetsDepreciationAndAmortization" contextRef="AsOf2023-12-31" id="Fact002999" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,146</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="AREN:DeferredTaxAssetsDepreciationAndAmortization" contextRef="AsOf2022-12-31" id="Fact003000" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,706</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzAs8_maDTANzxgS_zYQ2APvNmCDb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2023-12-31" id="Fact003002" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">82,316</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2022-12-31" id="Fact003003" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76,913</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzxgS_za38z5xoLyl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Valuation allowance</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-12-31" id="Fact003005" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76,367</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-12-31" id="Fact003006" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">65,406</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzxgS_maDTALNz54l_zwo4JkolOVDc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Total deferred tax assets</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-12-31" id="Fact003008" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,949</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2022-12-31" id="Fact003009" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,507</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred tax liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pn3n3_di_maDTLzOWA_zHE4CMkLB3T2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Acquisition-related intangibles</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" contextRef="AsOf2023-12-31" id="Fact003011" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,548</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" contextRef="AsOf2022-12-31" id="Fact003012" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,972</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxLiabilities_iNTI_pn3n3_di_mtDTLzOWA_msDTALNz54l_zgYFLmlwBfld" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Total deferred tax liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2023-12-31" id="Fact003014" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,548</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2022-12-31" id="Fact003015" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,972</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNTI_pn3n3_di_mtDTALNz54l_zKIpt2xb1Wne" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net deferred tax liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2023-12-31" id="Fact003017" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">599</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2022-12-31" id="Fact003018" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">465</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_z6OXf6EZELB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company must make judgements as to the realization of deferred tax assets that are dependent upon a variety of factors, including the
generation of future taxable income, the reversal of deferred tax liabilities, and tax planning strategies. To the extent that the Company
believes that recovery is not likely, it must establish a valuation allowance. A valuation allowance has been established for deferred
tax assets which the Company does not believe meet the &#8220;more likely than not&#8221; criteria. The Company&#8217;s judgments regarding
future taxable income may change due to changes in market conditions, changes in tax laws, tax planning strategies or other factors.
If the Company&#8217;s assumptions and consequently its estimates change in the future, the valuation allowances it has established may
be increased or decreased, resulting in a respective increase or decrease in income tax expense. Based upon the Company&#8217;s historical
operating losses and the uncertainty of future taxable income, the Company has provided a valuation allowance primarily against its deferred
tax assets up to the deferred tax liabilities, except for deferred tax liabilities on indefinite lived intangible assets, as of December
31, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the Company had federal, state, and local net operating loss carryforwards available of $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zypOj2es3t21" title="Net operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-12-31_us-gaap_DomesticCountryMember" id="Fact003020" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">193,801</ix:nonFraction></span>, $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20231231__us-gaap--IncomeTaxAuthorityAxis__custom--StateMember_zeRdK5W1GFZ7" title="Net operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-12-31_custom_StateMember" id="Fact003022" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">145,968</ix:nonFraction></span> and
$<span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20231231__us-gaap--IncomeTaxAuthorityAxis__custom--LocalJurisdictionMember_ziiZMZ2vWA7h" title="Net operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-12-31_custom_LocalJurisdictionMember" id="Fact003024" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53,002</ix:nonFraction></span> respectively, to offset future taxable income. Net operating losses for U.S. federal tax purposes of $<span id="xdx_908_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20231231__us-gaap--IncomeTaxAuthorityAxis__custom--USFederalTaxMember_zpG51Ef0QGL2" title="Net operating loss"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-12-31_custom_USFederalTaxMember" id="Fact003026" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">138,243</ix:nonFraction></span> do not expire (limited
to 80% of taxable income in a given year) and $<span id="xdx_90C_ecustom--NetOperatingLossExpirationAmount_pn3n3_c20230101__20231231_zXfGBtQD5Ymd" title="Net operating losses expiration amount"><ix:nonFraction name="AREN:NetOperatingLossExpirationAmount" contextRef="From2023-01-01to2023-12-31" id="Fact003028" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55,558</ix:nonFraction></span> will expire, if not utilized, through 2037 in various amounts. As of December 31,
2022, the Company had federal, state, and local net operating loss carryforwards available of $<span id="xdx_903_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z1Z0L0AKrnGf" title="Net operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2022-12-31_us-gaap_DomesticCountryMember" id="Fact003030" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">190,070</ix:nonFraction></span>, $<span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20221231__us-gaap--IncomeTaxAuthorityAxis__custom--StateMember_zRv5TY6Wp9m3" title="Net operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2022-12-31_custom_StateMember" id="Fact003032" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">133,419</ix:nonFraction></span> and $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20221231__us-gaap--IncomeTaxAuthorityAxis__custom--LocalJurisdictionMember_zxqZKsr9tXwk" title="Net operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2022-12-31_custom_LocalJurisdictionMember" id="Fact003034" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">51,503</ix:nonFraction></span>, respectively,
to offset future taxable income</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sections
382 and 383 of the Internal Revenue Code imposes restrictions on the use of a corporation&#8217;s net operating losses, as well as certain
recognized built-in losses and other carryforwards, after an ownership change occurs. A section 382 ownership change occurs if one or
more stockholders or groups of stockholders who own at least 5% of the Company&#8217;s common stock increase their ownership by more
than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Future issuances or sales of the
Company&#8217;s common stock (including certain transactions involving the Company&#8217;s common stock that are outside of the Company&#8217;s
control) could also result in an ownership change under section 382. If an ownership change occurs, Section 382 would impose an annual
limit on the amount of pre-change net operating losses and other losses the Company can use to reduce its taxable income generally equal
to the product of the total value of the Company&#8217;s outstanding equity immediately prior to the ownership change (subject to certain
adjustments) and the long-term tax exempt interest rate for the month of the ownership change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes that it did have a change in control under these sections in connection with its recapitalization on November 4, 2016
and utilization of the carryforwards would be limited such that the majority of the carryforwards will never be available. Accordingly,
the Company has not recorded those net operating loss carryforwards and credit carryforwards in its deferred tax assets. The Company
completed a preliminary section 382 analysis as of December 31, 2023 and 2022 and concluded it may have experienced an ownership change
as a result of certain equity transactions during the rolling three-year period of 2021 to 2023. The Company concluded that its federal
net operating loss carryforwards, including any net operating loss carryforwards as a result of the mergers during 2018 and 2019, resulted
in annual limitations on the overall net operating loss carryforward and that an ownership change, if any, would impose an annual limit
on the net operating loss carryforwards and could cause federal income taxes (similar provisions apply for state and local income taxes)
to be paid earlier than otherwise would be paid if such limitations were not in effect. The federal, state, and local net operating loss
carryforwards are stated net of any such anticipated limitations as of December 31, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact003036" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z3R2TC0j2jk5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provision (benefit) for income taxes on the statements of operations differs from the amount computed by applying the statutory federal
income tax rate to loss before the benefit for income taxes, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_zrMosgqbD2J7" style="display: none">Schedule of Tax Benefit and Effective Income Tax</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percent</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percent</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Federal benefit expected at statutory rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_maABC_c20230101__20231231_zYcKZ9wqwXid" title="Federal benefit expected at statutory rate" style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2023-01-01to2023-12-31" id="Fact003038" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,626</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maDEF_c20230101__20231231_zdcDf2HfnJmb" title="Federal benefit expected at statutory rate, percentage"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2023-01-01to2023-12-31" id="Fact003040" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_maABC_c20220101__20221231_zq0T4YPWtUZk" title="Federal benefit expected at statutory rate" style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2022-01-012022-12-31" id="Fact003042" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,375</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maDEF_c20220101__20221231_zxfBfTilVLz8" title="Federal benefit expected at statutory rate, percentage"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2022-01-012022-12-31" id="Fact003044" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State and local taxes, net of federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_maABC_c20230101__20231231_zF4sqVqLVLJb" title="State and local taxes, net of federal benefit" style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="From2023-01-01to2023-12-31" id="Fact003046" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,526</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maDEF_c20230101__20231231_z4We90obneJe" title="State and local taxes, net of federal benefit, percentage"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2023-01-01to2023-12-31" id="Fact003048" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.6</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_maABC_c20220101__20221231_zcd5PBPGBppc" title="State and local taxes, net of federal benefit" style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="From2022-01-012022-12-31" id="Fact003050" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,429</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maDEF_c20220101__20221231_zPfrVpImLqbi" title="State and local taxes, net of federal benefit, percentage"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2022-01-012022-12-31" id="Fact003052" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_maABC_c20230101__20231231_zCeZznCT0nxf" title="Stock-based compensation" style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" contextRef="From2023-01-01to2023-12-31" id="Fact003054" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,472</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_maDEF_c20230101__20231231_zul7BhTmovs3" title="Stock-based compensation, percentage">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" contextRef="From2023-01-01to2023-12-31" id="Fact003056" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">6.3</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_maABC_c20220101__20221231_zRHueoy8qPrj" title="Stock-based compensation" style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" contextRef="From2022-01-012022-12-31" id="Fact003058" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,894</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_maDEF_c20220101__20221231_z4sjAtoOMpm6" title="Stock-based compensation, percentage">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" contextRef="From2022-01-012022-12-31" id="Fact003060" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">5.7</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenue_pn3n3_maABC_c20230101__20231231_zLcAf9CooIAc" title="Unearned revenue" style="text-align: right">(<ix:nonFraction name="AREN:EffectiveIncomeTaxRateReconciliationUnearnedRevenue" contextRef="From2023-01-01to2023-12-31" id="Fact003062" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">562</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage_pid_dp_uPure_maDEF_c20230101__20231231_z9XTWk39r5Be" title="Unearned revenue percentage"><ix:nonFraction name="AREN:EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage" contextRef="From2023-01-01to2023-12-31" id="Fact003064" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.0</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenue_pn3n3_maABC_c20220101__20221231_zoT5YCVvUiyi" title="Unearned revenue" style="text-align: right">(<ix:nonFraction name="AREN:EffectiveIncomeTaxRateReconciliationUnearnedRevenue" contextRef="From2022-01-012022-12-31" id="Fact003066" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">696</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage_pid_dp_uPure_maDEF_c20220101__20221231_zV8CHYMEE9Q2" title="Unearned revenue percentage"><ix:nonFraction name="AREN:EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage" contextRef="From2022-01-012022-12-31" id="Fact003068" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpense_pn3n3_maABC_c20230101__20231231_zaEQ1aIqW4ma" title="Interest expense" style="text-align: right"><ix:nonFraction name="AREN:EffectiveIncomeTaxRateReconciliationInterestExpense" contextRef="From2023-01-01to2023-12-31" id="Fact003070" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpensePercentage_pid_dp_uPure_maDEF_c20230101__20231231_zieWVxDyIBUa" title="Interest expense percentage">-<ix:nonFraction name="AREN:EffectiveIncomeTaxRateReconciliationInterestExpensePercentage" contextRef="From2023-01-01to2023-12-31" id="Fact003072" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.1</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpense_pn3n3_maABC_c20220101__20221231_zahXcV4gLeA4" title="Interest expense" style="text-align: right"><ix:nonFraction name="AREN:EffectiveIncomeTaxRateReconciliationInterestExpense" contextRef="From2022-01-012022-12-31" id="Fact003074" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">56</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpensePercentage_pid_dp_uPure_maDEF_c20220101__20221231_zVt6UnuYyYCl" title="Interest expense percentage">-<ix:nonFraction name="AREN:EffectiveIncomeTaxRateReconciliationInterestExpensePercentage" contextRef="From2022-01-012022-12-31" id="Fact003076" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.1</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Gain upon debt extinguishment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment_pn3n3_maABC_c20230101__20231231_ztrbDGN5pZ3k" title="Gain upon debt extinguishment" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3078">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage_pid_dp_uPure_maDEF_c20230101__20231231_zOW4KfX73CMk" title="Gain upon debt extinguishment percentage"><ix:nonFraction name="AREN:EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage" contextRef="From2023-01-01to2023-12-31" id="Fact003080" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment_pn3n3_maABC_c20220101__20221231_zuCUM6gET4Sf" title="Gain upon debt extinguishment" style="text-align: right">(<ix:nonFraction name="AREN:EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment" contextRef="From2022-01-012022-12-31" id="Fact003082" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">760</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage_pid_dp_uPure_maDEF_c20220101__20221231_z8T4PXGTY8i2" title="Gain upon debt extinguishment percentage"><ix:nonFraction name="AREN:EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage" contextRef="From2022-01-012022-12-31" id="Fact003084" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other differences, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pn3n3_maABC_c20230101__20231231_z91PVqepRv34" title="Other differences, net" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="From2023-01-01to2023-12-31" id="Fact003086" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">678</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maDEF_c20230101__20231231_zOe6P2h0ysWj" title="Other differences, net percentage">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2023-01-01to2023-12-31" id="Fact003088" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">1.2</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pn3n3_maABC_c20220101__20221231_zxvqTufnLFo4" title="Other differences, net" style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="From2022-01-012022-12-31" id="Fact003090" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">997</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maDEF_c20220101__20221231_zm3mp98Oi9B4" title="Other differences, net percentage"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2022-01-012022-12-31" id="Fact003092" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.6</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_maABC_c20230101__20231231_zw3bz20nJuNi" title="Valuation allowance" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2023-01-01to2023-12-31" id="Fact003094" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,961</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maDEF_c20230101__20231231_zSHiRkDePcgk" title="Valuation allowance percentage">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2023-01-01to2023-12-31" id="Fact003096" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">19.8</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_maABC_c20220101__20221231_zFjqdX2nH2Xk" title="Valuation allowance" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-01-012022-12-31" id="Fact003098" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,959</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maDEF_c20220101__20221231_zccpwDF5W146" title="Valuation allowance percentage">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-01-012022-12-31" id="Fact003100" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">21.9</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other permanent differences</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_pn3n3_maABC_c20230101__20231231_zgzNRO5F0zwh" title="Other permanent differences" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" contextRef="From2023-01-01to2023-12-31" id="Fact003102" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">237</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_maDEF_c20230101__20231231_zF2El0cOWnY2" title="Other permanent differences percentage"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" contextRef="From2023-01-01to2023-12-31" id="Fact003104" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.4</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_pn3n3_maABC_c20220101__20221231_zS6k4kCrh7i4" title="Other permanent differences" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" contextRef="From2022-01-012022-12-31" id="Fact003106" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">285</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_maDEF_c20220101__20221231_zx8ZIXsOxCYc" title="Other permanent differences percentage">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" contextRef="From2022-01-012022-12-31" id="Fact003108" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.4</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income tax provision (benefit) and effective income tax rate</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_mtABC_c20230101__20231231_zElUn0Rgf3hd" title="Income tax benefit and effective income tax rate" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-01to2023-12-31" id="Fact003110" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">222</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_mtDEF_c20230101__20231231_zEoPqHXa8xq4" title="Income tax benefit and effective income tax rate, percentage">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2023-01-01to2023-12-31" id="Fact003112" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.4</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_mtABC_c20220101__20221231_zgKibdO2kzq2" title="Income tax benefit and effective income tax rate" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="Fact003114" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,063</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_mtDEF_c20220101__20221231_zsxInu9KDHv7" title="Income tax benefit and effective income tax rate, percentage"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2022-01-012022-12-31" id="Fact003116" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.6</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zoxiihU6jSjf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes the tax benefit from uncertain tax positions only if it is &#8220;more likely than not&#8221; that the tax positions
will be sustained on examination by the tax authorities, based on the technical merits of the position. The tax benefit is measured based
on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The Company recognizes interest
and penalties related to income tax matters in income tax expense. The Company is also required to assess at each reporting date whether
it is reasonably possible that any significant increases or decreases to its unrecognized tax benefits will occur during the next 12
months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not recognize any uncertain tax position, or any accrued interest and penalties associated with uncertain tax positions for
the years ended December 31, 2023 and 2022. The Company files tax returns in the U.S. federal jurisdiction and New York, California,
and other states. The Company is generally subject to examination by income tax authorities for three years from the filing of a tax
return, therefore, the federal and certain state returns from 2020 forward and the California returns from 2019 forward are subject to
examination. The Company currently is under examination by a state tax authority.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact003118" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock"><p id="xdx_802_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zMDJZ7PE2awe" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>25.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_826_zvBSHxR64tJ5">Pension Plans</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a qualified 401(k) defined contribution plan that allows eligible employees of the Company to participate in the plan, subject
to limitations. <span id="xdx_901_eus-gaap--DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_c20230101__20231231_zROCOlyM4ys6" title="Pension plan, description"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact003120" name="us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans">The plan allows for discretionary matching contributions by the Company, up to 4% of eligible annual compensation made
by participants of the plan</ix:nonNumeric></span>. The Company contributions to the plan were $<span id="xdx_903_eus-gaap--MultiemployerPlanPensionSignificantPlanContribution_pn3n3_c20230101__20231231_zLwy8xk529Cg" title="Contribution to plan"><ix:nonFraction name="us-gaap:MultiemployerPlanPensionSignificantPlanContribution" contextRef="From2023-01-01to2023-12-31" id="Fact003122" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,125</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--MultiemployerPlanPensionSignificantPlanContribution_pn3n3_c20220101__20221231_zSIlOFDreld" title="Contribution to plan"><ix:nonFraction name="us-gaap:MultiemployerPlanPensionSignificantPlanContribution" contextRef="From2022-01-012022-12-31" id="Fact003124" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,808</ix:nonFraction></span> for the years ended December 31, 2023 and 2022,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact003126" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zdTu4q7zShOj" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>26.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_827_zBqRMTcZo3R5">Related Party Transactions</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Principal
Stockholders</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has an outstanding obligation with Renew, an affiliated entity of Simplify, where Renew purchased the all the outstanding
debt held by BRF Finance Co., LLC (&#8220;BRF&#8221;) an affiliated entity of B. Riley Financial, Inc. (&#8220;B. Riley&#8221;) (as
further described below), who now holds the debt in its capacity as agent for the purchasers and as purchaser, pursuant to the third
amended and restated note purchase agreement entered into on December 15, 2022 (the &#8220;Note Purchase Agreement&#8221;), as
amended by the first amendment to the Note Purchase Agreement on August 14, 2023 (the &#8220;First Amendment&#8221;) with an
effective date of August 31, 2023, as further amended by the second amendment to the Note Purchase Agreement on December 1, 2023
(the &#8220;Second Amendment&#8221;). The Note Purchase Agreement contains provisions related to the 2023 Notes, Senior Secured
Notes, Delayed Draw Term Notes and 2022 Bridge Notes, all as further described above and referred to as the &#8220;Notes&#8221;. Under the terms of the
Note Purchase Agreement, First Amendment and Second Amendment, in the event there is a mandatory prepayment requirement, the
principal payment of the Notes will be applied to: <span id="xdx_907_eus-gaap--DebtInstrumentDescription_c20230101__20231231_zy1ifPNug1G7" title="Note purchase agreement description"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact003128" name="us-gaap:DebtInstrumentDescription">(1)
the 2023 Notes until paid in full; (2) then to the 2022 Bridge Notes until paid in full; (3) then to the Delayed Draw Terms Notes
until paid in full; and (4) then to the Senior Secured Notes. All borrowings under the Notes are collateralized by substantially all
assets of the Company secured by liens and guaranteed by the Company&#8217;s subsidiaries. The Notes provide for a default interest
rate equal to the rate of interest in effect at the time of default plus 4.0%, along with other provision for acceleration of the
Notes under certain conditions. The Notes provide for certain affirmative covenants, including certain financial reporting
obligations.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 30, 2023, Simplify entered into a stock purchase and assignment agreement (the &#8220;Stock Purchase Agreement&#8221;),
pursuant to which it purchased an aggregate of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20231201__20231201__us-gaap--DebtInstrumentAxis__custom--BRileyFBRIncMember_z7sYFkHR9iY3" title="Debt instrument face amount"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-12-012023-12-01_custom_BRileyFBRIncMember" id="Fact003130" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,512,236</ix:nonFraction></span>
shares of the Company&#8217;s common stock for aggregate consideration of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_c20231201__20231201__us-gaap--DebtInstrumentAxis__custom--BRileyFBRIncMember_zANbzlCwBWB1" title="Debt instrument face amount"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-12-012023-12-01_custom_BRileyFBRIncMember" id="Fact003132" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,485</ix:nonFraction></span>
on December 1, 2023 from B. Riley and other affiliated entities of B. Riley and certain other sellers (collectively the &#8220;Sellers&#8221;),
resulting in Simplify becoming a principal stockholder and the Sellers no longer owning any of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 30, 2023, Renew, an affiliated entity of Simplify and a principal stockholder, and BRF, an affiliate of the Sellers, entered into a securities purchase
and assignment agreement (the &#8220;Debt Purchase Agreement&#8221;), pursuant to which BRF sold and assigned to Renew all of BRF&#8217;s
rights, duties, liabilities and obligations pursuant to the Note Purchase Agreement, as amended, and the Notes purchased thereunder and
the collateral securing such Notes on December 1, 2023 (further details are provided under the heading <i>Arena Loan Agreement
</i>in Note 28), resulting in BRF no longer holding any debt securities of the Company. The aggregate principal balance under the Notes was $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231231_z5WXmH88GNH8" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-12-31" id="Fact003134" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">110,691</ix:nonFraction></span> at the time of purchase by Renew.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of November 30, 2023, Daniel Shribman, Chief Investment Officer of BRF, and Todd Sims, President of B. Riley Venture Capital, a subsidiary
of BRF, resigned as members of the Board of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2023 and 2022, the Company paid in cash interest of $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zSJbgXl5E6Y" title="Paid in cash"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2023-01-012023-12-31_custom_BRileyMember" id="Fact003136" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,068</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BRileyMember_zeHi1PBZOkIe" title="Paid in cash"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2022-01-012022-12-31_custom_BRileyMember" id="Fact003138" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,132</ix:nonFraction></span>, respectively, on the Notes due to
BRF, an affiliated of B. Riley, a former principal stockholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2023, the Company incurred interest of $<span id="xdx_90E_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zFblG6JHQUY5" title="Interest on notes"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseAccruedInterest" contextRef="From2023-01-012023-12-31_custom_BRileyMember" id="Fact003140" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,797</ix:nonFraction></span> for the period from October 1, 2023 to December 31, 2023 on
the Notes held by Renew, an affiliated entity of Simplify, a principal stockholder, where the Company defaulted on the payment of $<span id="xdx_906_ecustom--DebtInstrumentIncreaseAccruedInterestAmountDue_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zYxCbzh4RSMc" title="Interest on notes"><ix:nonFraction name="AREN:DebtInstrumentIncreaseAccruedInterestAmountDue" contextRef="From2023-01-012023-12-31_custom_BRileyMember" id="Fact003142" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,797</ix:nonFraction></span>
interest due on December 29, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 31, 2023, in connection with the registered direct offering, the Company entered into common stock purchase agreements for <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__srt--TitleOfIndividualAxis__custom--BRileyMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__custom--DirectOfferingMember_zG4ZGy5plwta"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-03-312023-03-31_custom_BRileyMember_us-gaap_CommonStockMember_custom_DirectOfferingMember" id="Fact003143" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,009,021</ix:nonFraction></span>
shares of the Company&#8217;s common stock for a total of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__srt--TitleOfIndividualAxis__custom--BRileyMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__custom--DirectOfferingMember_z2UWVIOzITj"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-03-312023-03-31_custom_BRileyMember_us-gaap_CommonStockMember_custom_DirectOfferingMember" id="Fact003144" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,915</ix:nonFraction></span> in gross proceeds with B. Riley, a former principal stockholder, at
a price per share of $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230331__us-gaap--SubsidiarySaleOfStockAxis__custom--DirectOfferingMember__srt--TitleOfIndividualAxis__custom--BRileyMember_z2A3nKywT5kg" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-03-31_custom_DirectOfferingMember_custom_BRileyMember" id="Fact003146" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.88</ix:nonFraction></span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 10, 2023, the Series H Preferred Stock automatically converted into shares of the Company&#8217;s common stock at the conversion
price of $<span id="xdx_902_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_c20230810__srt--TitleOfIndividualAxis__custom--BRileyMember__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zhr9WZ3BO6Cl" title="Preferred Stock issued onversion price"><ix:nonFraction name="us-gaap:PreferredStockConvertibleConversionPrice" contextRef="AsOf2023-08-10_custom_BRileyMember_custom_SeriesHConvertiblePreferredStockMember" id="Fact003148" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.26</ix:nonFraction></span> per share, of which <span id="xdx_906_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_pid_c20230810__srt--TitleOfIndividualAxis__custom--BRileyMember__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zzh8bJxsd3s6" title="Preferred Stock issued upon conversion"><ix:nonFraction name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" contextRef="AsOf2023-08-10_custom_BRileyMember_custom_SeriesHConvertiblePreferredStockMember" id="Fact003150" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">134,550</ix:nonFraction></span> shares were issued to B. Riley, a former principal stockholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 31, 2023, September 29, 2023 and November 27, 2023, in connection with the 2023 Notes, BRF, an affiliated entity of B. Riley,
a former principal stockholder, issued $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20230831__srt--TitleOfIndividualAxis__custom--BRileyMember_zarAdcUjAFKg" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-08-31_custom_BRileyMember" id="Fact003152" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,000</ix:nonFraction></span>, $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20230929__srt--TitleOfIndividualAxis__custom--BRileyMember_zE2KUQFSh21b" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-09-29_custom_BRileyMember" id="Fact003154" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231127__srt--TitleOfIndividualAxis__custom--BRileyMember_zJnXdt5OeP17" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-11-27_custom_BRileyMember" id="Fact003156" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></span>, respectively, in aggregate principal amount under the 2023 Note, where
the Company incurred fees of $<span id="xdx_901_eus-gaap--DebtInstrumentFeeAmount_iI_pn3n3_c20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_z3EgDpVko6F4" title="Fee incurred"><ix:nonFraction name="us-gaap:DebtInstrumentFeeAmount" contextRef="AsOf2023-12-31_custom_BRileyMember" id="Fact003158" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">357</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into transactions with B. Riley, a former principal stockholder, where it borrowed funds under the 2022 Bridge Notes
of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231231__dei--LegalEntityAxis__custom--BRileyFinancialIncMember_zCccLpvi4P9j" title="Face amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-12-31_custom_BRileyFinancialIncMember" id="Fact003160" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,000</ix:nonFraction></span> during the year ended December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2022, the Company had certain transactions with B. Riley, a former principal stockholder, where it paid fees
associated with the common stock public offering totaling $<span id="xdx_900_eus-gaap--DebtInstrumentFeeAmount_iI_pn3n3_c20221231__srt--TitleOfIndividualAxis__custom--BRileyMember_z7xbHxEj0Pi7" title="Fee incurred"><ix:nonFraction name="us-gaap:DebtInstrumentFeeAmount" contextRef="AsOf2022-12-31_custom_BRileyMember" id="Fact003162" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,440</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registered
Direct Offering</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 31, 2023, in connection with the registered direct offering, the Company entered into common stock purchase agreements for <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_zqJAabGivp98" title="Sale of stock, number of shares issued in transaction"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember" id="Fact003164" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">317,518</ix:nonFraction></span>
shares of the Company&#8217;s common stock for a total of $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember_zi5GzaUcOLYh" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember" id="Fact003166" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,232</ix:nonFraction></span> in gross proceeds with certain directors and affiliates, at a price
of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_zTDiC9ENBgVc" title="Per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember" id="Fact003168" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.88</ix:nonFraction></span> per share, as follows: (i) <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HHuntAllredMember_zgdwa3orbRUi" title="Shares Issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_HHuntAllredMember" id="Fact003170" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">64,000</ix:nonFraction></span> shares for $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HHuntAllredMember_zVwRd0Vrgei7" title="Value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_HHuntAllredMember" id="Fact003172" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">248</ix:nonFraction></span> to H. Hunt Allred, a director, through certain trusts (<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__dei--LegalEntityAxis__custom--AllredTrustHHAMember_z6zM40T6LXTg" title="Shares issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_AllredTrustHHAMember" id="Fact003174" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">32,000</ix:nonFraction></span> shares are directly
beneficially owned by the Allred 2002 Trust - HHA and <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__dei--LegalEntityAxis__custom--AllredTrustNLAMember_zwuFiIfOmULf" title="Shares issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_AllredTrustNLAMember" id="Fact003176" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">32,000</ix:nonFraction></span> shares are directly beneficially owned by the by Allred 2002Trust - NLA);
(ii) <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneEightyDegreeCapitalCorpMember_zXIuYgqywgp5" title="Shares isssue"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_OneEightyDegreeCapitalCorpMember" id="Fact003178" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">195,529</ix:nonFraction></span> shares for $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneEightyDegreeCapitalCorpMember_znHR2ih8ybra" title="Value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_OneEightyDegreeCapitalCorpMember" id="Fact003180" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">759</ix:nonFraction></span> to 180 Degree Capital Corp, a beneficial holder of more than 5% of the Company&#8217;s common stock; (iii)
<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DanielShribmanMember_z5ZXcQp0KL1l" title="Shares isssue"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_DanielShribmanMember" id="Fact003182" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,773</ix:nonFraction></span> shares for $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DanielShribmanMember_zBc8xfHlk13f" title="Value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_DanielShribmanMember" id="Fact003184" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></span> to Daniel Shribman, a former director; (iv) <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RossLevinsohnMember_zK5tR119aRr6" title="Shares isssue"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_RossLevinsohnMember" id="Fact003186" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,773</ix:nonFraction></span> shares for $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RossLevinsohnMember_zY3UGNgNyTn8" title="Value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_RossLevinsohnMember" id="Fact003188" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></span> to Ross Levinsohn, a former director and the
Company&#8217;s former Chief Executive Officer; and (v) <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PaulEdmonsonMember_zEcbXl0nuWld" title="Shares isssue"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_PaulEdmonsonMember" id="Fact003190" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,443</ix:nonFraction></span> shares for $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PaulEdmonsonMember_zPcdEOpu6ol3" title="Value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_PaulEdmonsonMember" id="Fact003192" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25</ix:nonFraction></span> to Paul Edmonson, an executive officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Repurchases
of Restricted Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 15, 2020, the Company entered into an amendment for certain restricted stock awards and units that were previously issued to
certain employees in connection with the HubPages merger, pursuant to which the Company agreed to repurchase from certain key personnel
of HubPages, Inc., including Paul Edmondson, one of the Company&#8217;s officers, and his spouse, an aggregate of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20201214__20201215__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zis7RhGTkB1g" title="Stock issued during period, shares, issued for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2020-12-142020-12-15_us-gaap_RestrictedStockMember" id="Fact003194" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">764</ix:nonFraction></span> shares of the Company&#8217;s
common stock at a price of $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20201215__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_znhiR54eH0W7" title="Stock price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2020-12-15_us-gaap_RestrictedStockMember" id="Fact003196" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">88.00</ix:nonFraction></span> per share each month for a period of 24 months, for aggregate proceeds to Mr. Edmondson and his spouse
of $<span id="xdx_90C_ecustom--StockRepurchasedDuringPeriodValue1_iN_pn3n3_di_c20201214__20201215__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zaIRF2Tgy0n3" title="Proceeds from repurchase of restricted stock"><ix:nonFraction name="AREN:StockRepurchasedDuringPeriodValue1" contextRef="From2020-12-142020-12-15_us-gaap_RestrictedStockMember" id="Fact003198" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">67</ix:nonFraction></span> per month. For year ended December 31, 2022, the Company paid Mr. Edmonson and his spouse $<span id="xdx_90F_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrEdmonsonMember_zn4PpH4Ck8Fg" title="Stock repurchase value"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_MrEdmonsonMember" id="Fact003200" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">269</ix:nonFraction></span> for <span id="xdx_90D_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrEdmonsonMember_zR2Z4vqHk3Y1" title="Number of shares repurchased"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_MrEdmonsonMember" id="Fact003202" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,056</ix:nonFraction></span> shares of the Company&#8217;s
common stock.</span></p>
<!-- Field: Split-Segment; Name: 003 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact003204" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_801_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zki80sJsEYb7" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>27.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_822_zp5LkMTFOgNl">Commitments and Contingencies</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Claims
and Litigation</i> &#8211; From time to time, the Company may be subject to claims and litigation arising in the ordinary course of
business. The Company is not currently a party to any pending or threatened legal proceedings that it believes would reasonably be
expected to have a material adverse effect on the Company&#8217;s business, financial condition, results of operations or cash
flows. Further information is provided under the heading <i>Legal Contingencies</i> in Note 28.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Athlon working capital adjustment (as previously disclosed in Note 4), the Company prepared the working capital adjustment.
The sellers are challenging the Company&#8217;s adjustments and both parties have agreed to a standstill and tolling agreement while
the adjustments are being reviewed and discussed. The amount due from this challenge, if any, is not estimatable as of the issuance date
of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Royalty
Fees</i> &#8211; The Company guaranteed minimum annual royalties of $<span id="xdx_900_eus-gaap--RoyaltyExpense_pn3n3_c20230101__20231231__dei--LegalEntityAxis__custom--ABGSILLCMember__srt--RangeAxis__srt--MinimumMember_zh5Vw0XVo3G9" title="Royalty expense"><ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="From2023-01-012023-12-31_custom_ABGSILLCMember_srt_MinimumMember" id="Fact003206" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,000</ix:nonFraction></span> to ABG. The initial term of the minimum guarantee will expire
December 31, 2029. Further details are provided under the heading <i>Sports Illustrated Licensing Termination Rights</i> in Note 28.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact003208" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zCp6Ol96Daj3" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>28.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_821_zxE2lYifSQ1i">Subsequent Events</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company performed an evaluation of subsequent events through the date of filing of these consolidated financial statements with the SEC.
Other than the below described subsequent events, there were no material subsequent events which affected, or could affect, the amounts
or disclosures on the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 107; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Arena Loan Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 5, 2024, as part of negotiations with Renew, in connection with the Company&#8217;s failure on December 29, 2023 to make the
interest payment due on the Arena Loan Agreement, dated December 15, 2022 held by Renew (the &#8220;Arena Notes&#8221;) in the
amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240105__us-gaap--TypeOfArrangementAxis__custom--ArenaLoanAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8YACdNPQPwd" title="Renew note"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-01-05_custom_ArenaLoanAgreementMember_us-gaap_SubsequentEventMember" id="Fact003210" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,797</ix:nonFraction></span>,
that resulted in an event of default under the Arena Notes (the &#8220;Arena Notes Default&#8221;), Renew agreed in writing to a
forbearance period through March 29, 2024, subject to the Company retaining a chief restructuring officer acceptable to
Renew, while reserving its rights and remedies. The outstanding principal on the Arena Notes was $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--ArenaLoanAgreementMember_zhycx2GbxmCi" title="Outstanding principal"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-12-31_custom_ArenaLoanAgreementMember" id="Fact003212" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">110,691</ix:nonFraction></span>
as of December 31, 2023. In addition, while the Company continues discussions with Renew to restructure and/or amend the Arena
Notes, the Board engaged, and Renew accepted, FTI Consulting Inc., (&#8220;FTI&#8221;), a global business advisory firm, to assist
the Company with its turnaround plans and forge an expedited path to sustainable positive cash flow and earnings to create
shareholder value (the &#8220;FTI Engagement&#8221;). In connection with the FTI Engagement, Jason Frankl, a senior managing
director of FTI, was appointed as the Company&#8217;s Chief Business Transformation Officer. He was later appointed as interim
President in addition to his role as the Company&#8217;s Chief Business Transformation Officer, as referenced below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="color: #181717">On March 27, 2024, the
forbearance period was extended through the earlier of the following: (a) April 30, 2024</span><span style="color: #393A39">; </span><span style="color: #181717">(b)
the occurrence of the closing of the Business Combination (as further described below) and (c) the termination of the Business Combination
prior to closing.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sports
Illustrated License Termination Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 2, 2024, the Company failed to make a quarterly payment due to ABG, pursuant to the Licensing Agreement, of $<span id="xdx_902_ecustom--ExerciseRightTerminationAmount_iI_pn3n3_c20240102__us-gaap--TypeOfArrangementAxis__custom--LicensingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zd8t0QYGd1sc" title="Exercise right termination amount"><ix:nonFraction name="AREN:ExerciseRightTerminationAmount" contextRef="AsOf2024-01-02_custom_LicensingAgreementMember_us-gaap_SubsequentEventMember" id="Fact003214" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,750</ix:nonFraction></span> (the &#8220;ABG
Default&#8221;). On January 3, 2024, ABG issued a notice of breach with the intent to exercise its right of termination. On January 18,
2024, ABG notified the Company of its intention to terminate the Licensing Agreement, effective immediately, in accordance with its rights
under the Licensing Agreement. Upon such termination, a fee of $<span id="xdx_90B_ecustom--TerminationFeeDue_iI_pn3n3_c20240102__us-gaap--TypeOfArrangementAxis__custom--LicensingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyyqFH232IT4" title="Termination fee"><ix:nonFraction name="AREN:TerminationFeeDue" contextRef="AsOf2024-01-02_custom_LicensingAgreementMember_us-gaap_SubsequentEventMember" id="Fact003216" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45,000</ix:nonFraction></span> became immediately due and payable by the Company to ABG pursuant
to the terms and conditions of the Licensing Agreement. On March 18, 2024, ABG announced it had reached an agreement in principle with
a third party that will become the new operator of the Sports Illustrated media business. The Company is engaging in continuing discussions
with ABG regarding the timing and terms of the transition of the Sports Illustrated media business to this third party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>ABG
Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 2, 2024, in connection with the ABG Default, the Performance-Based Warrants totaling <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20240102__20240102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--ABGWarrantsMember_z244ZrEg9ee3" title="Performance based warrant vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2024-01-022024-01-02_us-gaap_SubsequentEventMember_custom_ABGWarrantsMember" id="Fact003218" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">599,724</ix:nonFraction></span> vested as a result of the default
pursuant to certain provisions where all of the warrants automatically vest upon certain terminations of the Licensing Agreement by ABG.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Resignation
and Appointments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify">On January 3, 2024, the Board appointed
Jason Frankl as Chief Business Transformation Officer of the Company, effective immediately, reporting directly to the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2024, the Board accepted the resignation of Manoj Bhargava from his position as interim Chief Executive Officer effective
immediately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 19, 2024, the Company accepted the resignation of Ross Levinsohn, the Company&#8217;s former Chief Executive Officer and Chairman
of the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 23, 2024, the Board appointed Jason Frankl as interim President of the Company, effective immediately, reporting directly to
the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 23, 2024, the Board appointed Cavitt Randall as Chairman of the Board, effective immediately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 9, 2024, the Board appointed Cavitt Randall as the Company&#8217;s Chief Executive Officer, effective February 13, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 16, 2024, the Board appointed Manoj Bhargava as the Company&#8217;s Co-President, effective immediately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combination</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 9, 2024, New Arena Holdco, Inc. (&#8220;New Arena&#8221;), a wholly owned subsidiary of the Company, filed a Registration Statement
on Form S-4 (File No. 333-276999) with the SEC in connection with the Business Combination Agreement by and among the Company, Simplify,
Bridge Media Networks, LLC (&#8220;Bridge Media&#8221;), New Arena and the other parties dated November 5, 2023, as amended on December
1, 2023 (the &#8220;Transaction Agreement&#8221;), that provides for the Company to combine its operations with those of Bridge Media,
a wholly owned subsidiary of Simplify by way of a series of mergers with and among New Arena (the &#8220;Mergers&#8221;), subject to
customary conditions, including the approval by the Company&#8217;s shareholders and certain regulatory approvals. Immediately following
the Mergers, the Transaction Agreement provides for: (i) the purchase by The Hans Foundation USA, a nonprofit nonstock corporation (the
&#8220;Hans Foundation&#8221;) of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TransactionAgreementMember_z5IESXxle1Na" title="Shares issue"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_custom_TransactionAgreementMember" id="Fact003220" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></span> shares of New Arena Series A Preferred Stock, par value $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TransactionAgreementMember_zcg0cc7Vktg1" title="Preffered stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_TransactionAgreementMember" id="Fact003222" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share, at a purchase price
of $<span id="xdx_905_eus-gaap--SharePrice_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TransactionAgreementMember_zFCMLhLLcusj" title="Purchase price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_TransactionAgreementMember" id="Fact003224" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,000.00</ix:nonFraction></span> per share, for an aggregate purchase price of $<span id="xdx_90A_eus-gaap--BusinessCombinationPriceOfAcquisitionExpected_pn3n3_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TransactionAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zw9K8jlgjmmi" title="Aggregate purchase price"><ix:nonFraction name="us-gaap:BusinessCombinationPriceOfAcquisitionExpected" contextRef="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_custom_TransactionAgreementMember_us-gaap_PreferredStockMember" id="Fact003226" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,000</ix:nonFraction></span> (such amount, the &#8220;Preferred Stock Financing Amount,&#8221;
and such financing, the &#8220;Preferred Stock Financing&#8221;) pursuant to the subscription agreement, dated as of November 5, 2023
(the &#8220;Preferred Stock Subscription Agreement&#8221;), by and between New Arena and the Hans Foundation; and (ii) the purchase by
5-Hour International Corporation Pte. Ltd. (&#8220;5-Hour&#8221;) of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1Zo1uOqRAL6" title="Shares issue"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-02-092024-02-09_us-gaap_SubsequentEventMember" id="Fact003228" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,000</ix:nonFraction></span> shares of New Arena common stock, par value $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zaY5Dc9i8Crc" title="Preffered stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember" id="Fact003230" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per
share at a purchase price of $<span id="xdx_903_eus-gaap--SharePrice_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zaXzcPfYg9L5" title="Purchase price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember" id="Fact003232" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.00</ix:nonFraction></span> per share, for an aggregate purchase price of $<span id="xdx_908_eus-gaap--BusinessCombinationPriceOfAcquisitionExpected_pn3n3_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOOWzwDLpFI1" title="Aggregate purchase price"><ix:nonFraction name="us-gaap:BusinessCombinationPriceOfAcquisitionExpected" contextRef="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" id="Fact003234" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,000</ix:nonFraction></span> (such amount, the &#8220;Common Stock Financing
Amount,&#8221; such financing, the &#8220;Common Stock Financing&#8221;) pursuant to the subscription agreement, dated as of November
5, 2023 (the &#8220;Common Stock Subscription Agreement&#8221;), by and between New Arena and 5-Hour. Further, concurrently with the
closing of the Mergers, pursuant to that certain Committed Equity Facility Term Sheet, dated November 5, 2023, by and between Arena and
Simplify (the &#8220;Committed Equity Facility Term Sheet&#8221;), New Arena will enter into a Stock Purchase Agreement (the &#8220;Stock
Purchase Agreement&#8221;) with Simplify, pursuant to which Simplify will agree to purchase, at New Arena&#8217;s request, up to $<span id="xdx_90B_eus-gaap--BusinessCombinationConsiderationTransferredOther1_pn3n3_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zvnd3cUhNVA9" title="Business combination, consideration amount"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferredOther1" contextRef="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember" id="Fact003236" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,000</ix:nonFraction></span>
in aggregate purchase price of shares of New Arena common stock from time to time during the 12 months following the closing date at
a price per share equal to the lesser of (i) the volume-weighted average price of the New Arena common stock for the last sixty trading
days prior to the purchase date and (ii) $<span id="xdx_905_eus-gaap--SharePrice_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zy52Sy7a5Po4" title="Purchase price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember" id="Fact003238" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.86</ix:nonFraction></span> per share (the &#8220;Equity Line of Credit&#8221;), along with New Arena <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zzkfCgDAZfd7" title="Shares issue"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember" id="Fact003240" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60,000</ix:nonFraction></span> shares
of New Arena&#8217;s common stock as payment of a <span id="xdx_904_eus-gaap--LineOfCreditFacilityCommitmentFeePercentage_pid_dp_uPure_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zfnQKM2Oioe3" title="Commitment fee percentage"><ix:nonFraction name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" contextRef="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember" id="Fact003242" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.5</ix:nonFraction></span>% commitment fee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
following the closing, (i) Simplify will own approximately <span id="xdx_90C_ecustom--SharesOutstandingPercentage_iI_pid_dp_uPure_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_z7yzS6Narce5" title="Shares outstanding percentage"><ix:nonFraction name="AREN:SharesOutstandingPercentage" contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember" id="Fact003244" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">79</ix:nonFraction></span>% of the outstanding shares of New Arena common stock, par value $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zEtyhgkaYSqg" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember" id="Fact003246" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span>
per share, on a fully diluted basis, (ii) 5-Hour will own approximately <span id="xdx_909_ecustom--OutstandingPercentage_iI_pid_dp_uPure_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zh1rWJvNHiRi" title="Shares outstanding percentage"><ix:nonFraction name="AREN:OutstandingPercentage" contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember" id="Fact003248" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6</ix:nonFraction></span>% of the outstanding New Arena common stock and (iii) former
Arena stockholders will own the remaining outstanding New Arena common stock. Such amounts exclude the ownership of shares of New Arena
common stock that may be issued from time to time pursuant to the Equity Line of Credit. Following the closing, Arena common stock will
be delisted from the NYSE American and deregistered under the Securities Exchange Act of 1934, as amended, and cease to be publicly traded.
New Arena and its subsidiaries will operate under Arena&#8217;s current name &#8220;The Arena Group Holdings, Inc.&#8221; The Company anticipates that New Arena
common stock will be traded on the NYSE American under Arena&#8217;s current stock ticker symbol &#8220;AREN.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock Private Placement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 14, 2024, the Company entered into a subscription agreement (the &#8220;Subscription Agreement&#8221;) with Simplify, pursuant
to which the Company agreed to sell and issue to Simplify in a private placement (the &#8220;Private Placement&#8221;) an aggregate of
<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240214__20240214__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_ziMLSO5Ld51e" title="Aggregate shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-02-142024-02-14_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SubscriptionAgreementMember" id="Fact003250" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,555,555</ix:nonFraction></span> shares (the &#8220;Private Placement Shares&#8221;) of the Company&#8217;s common stock, par value $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240214__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zd8ZU3NAdUth" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-02-14_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SubscriptionAgreementMember" id="Fact003252" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> per share, at a purchase
price of $<span id="xdx_90B_eus-gaap--SharePrice_iI_pid_c20240214__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zBIBDEknsrv6" title="Purchase price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-02-14_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SubscriptionAgreementMember" id="Fact003254" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.16</ix:nonFraction></span> per share, a price equal to the 60-day volume weighted average price of the Company&#8217;s common stock. The Private
Placement closed on February 14, 2024 and the Company received net proceeds from the Private Placement of approximately $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn3n3_c20240214__20240214__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zHCvsDNbv2g" title="Net proceeds from the Private Placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2024-02-142024-02-14_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SubscriptionAgreementMember" id="Fact003256" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,000</ix:nonFraction></span>. The
Company intends to use the net proceeds from the Private Placement for working capital and general corporate purposes. Prior to the consummation
of the Private Placement, the Company&#8217;s public stockholders held a majority of the outstanding shares of the Company&#8217;s common
stock. Following the issuance of the Private Placement Shares to Simplify, Simplify owns approximately <span id="xdx_907_ecustom--SharesOutstandingPercentage_iI_pid_dp_uPure_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zXIgK8DzCVb2" title="Shares outstanding percentage"><ix:nonFraction name="AREN:SharesOutstandingPercentage" contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_SubscriptionAgreementMember_us-gaap_PrivatePlacementMember" id="Fact003258" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">54.5</ix:nonFraction></span>% of the outstanding shares
of the Company&#8217;s common stock, resulting in a change in control. As a result, Simplify has the ability to determine the outcome of any issue submitted to the Company&#8217;s
stockholders for approval, including the election of directors. The funds used by Simplify to purchase the Private Placement Shares came
from the working capital of Simplify.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Arena
Credit Agreement Default</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Arena Notes Default created an event of cross-default under the Arena Credit Agreement with SLR (the &#8220;SLR Default&#8221;), resulting
in SLR no longer providing for any additional funding under the debt, while paying down the debt with payments received from the
Company&#8217;s customers in accordance with the terms of the agreement. The Company has refinanced the line of credit with a new
credit facility with Simplify (as described below under the heading <i>Simplify Loan</i>). As of the issuance date of the
consolidated financial statements, there was no principal amount due under the Arena Credit Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fexy
Put Option</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 15, 2024, in connection with the contingent consideration related to the acquisition of Fexy Studios, the Company agreed to
pay the amount due of $<span id="xdx_909_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_c20240215__20240215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zxZYW45Ejrfa" title="Total installment amount"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2024-02-152024-02-15_us-gaap_SubsequentEventMember_custom_FexyStudiosMember" id="Fact003260" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,478</ix:nonFraction></span> in four (4) equal installments of approximately $<span id="xdx_908_ecustom--BusinessCombinationConsiderationTransferredInstallmentDue_pn3n3_c20240215__20240215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zV2Avm38N1Zh" title="Total installment amount"><ix:nonFraction name="AREN:BusinessCombinationConsiderationTransferredInstallmentDue" contextRef="From2024-02-152024-02-15_us-gaap_SubsequentEventMember_custom_FexyStudiosMember" id="Fact003262" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">620</ix:nonFraction></span> starting February 16, 2024 and then on the 15th day
of each March, April and May of 2024 comprised of the following: <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20240215__20240215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zWy7inYuaea2" title="Flexy put option description"><ix:nonNumeric contextRef="From2024-02-152024-02-15_us-gaap_SubsequentEventMember_custom_FexyStudiosMember" id="Fact003264" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription">(i) $2,225 pursuant to the put option where the Company gave the recipients
of the contingent consideration a right to put their 274,692 shares of the Company&#8217;s common stock; (ii) $200 deferred payment due
under the purchase agreement; and (iii) $53 in other costs and reimbursable transition expenses payable.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Simplify
Loan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 13, 2024, the Company entered into a working capital loan with Simplify (the &#8220;Simplify Loan&#8221;), pursuant to which the Company has available up to
$<span id="xdx_90E_ecustom--WorkingCapital_pn3n3_c20240313__20240314__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQYPZZVrE1B2" title="Working capital"><ix:nonFraction name="AREN:WorkingCapital" contextRef="From2024-03-132024-03-14_us-gaap_SubsequentEventMember" id="Fact003266" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,000</ix:nonFraction></span> at <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240313__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SimplyfyLoanMember_zTgc3hEo0eP4" title="Interest rate"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2024-03-13_us-gaap_SubsequentEventMember_custom_SimplyfyLoanMember" id="Fact003268" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>%
interest rate per annum. The loan is secured by certain assets of the Company. On closing, the Company borrowed
$<span id="xdx_904_eus-gaap--ShortTermBorrowings_iI_pn3n3_c20240313__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zF1RzXfaknqe" title="Company borrowed"><ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2024-03-13_us-gaap_SubsequentEventMember" id="Fact003270" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,748</ix:nonFraction></span>,
of which $<span id="xdx_900_eus-gaap--DebtInstrumentFeeAmount_iI_pn3n3_c20240313__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z6t0Du8zRQg" title="Outstanding loan balance"><ix:nonFraction name="us-gaap:DebtInstrumentFeeAmount" contextRef="AsOf2024-03-13_us-gaap_SubsequentEventMember" id="Fact003272" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,448</ix:nonFraction></span>
was used to repay the outstanding loan balance, accrued interest, certain fees and contingency reserves under the Arena Credit
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Legal Contingencies</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 30, 2024, the former President&#160;of
Media filed an action against the Company and Manoj Bhargava, alleging claims for breach of contract, failure to pay wages and defamation, among
other things, in the United States District Court of the Southern District of New York, and seeking&#160;damages in an unspecified amount.
The Company believes that it has strong defenses to these claims and intends to vigorously defend itself and the allegations
made in this lawsuit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 21, 2024, the former CEO and Chairman of
the Board filed an action against the Company, members of the Board of directors and Simplify, alleging claims for retaliation, breach
of contract, wrongful termination and age discrimination, among other things, in the Superior Court of the State of California seeking
damages in an amount of $<span id="xdx_902_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20240321__20240321__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMiPbXOw0ZT" title="Damage, value"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2024-03-212024-03-21_us-gaap_SubsequentEventMember" id="Fact003274" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,000</ix:nonFraction></span>. The Company believes that it has strong defenses to these claims and intends to vigorously
defend itself and the allegations made in this lawsuit.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Common Stock</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">From January 1, 2024 through the date these consolidated
financial statements were issued, the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSzBp8bbCk7c" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-012024-01-01_us-gaap_SubsequentEventMember" id="Fact003276" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">378,292</ix:nonFraction></span> shares of its common stock as follows: (i) <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MembersOfBoardMember_zElhpoIO2Rqf" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-012024-01-01_us-gaap_SubsequentEventMember_custom_MembersOfBoardMember" id="Fact003278" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">36,608</ix:nonFraction></span> shares to members of the
Board; (ii) <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20240101__20240101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zMrsLvR24Jji" title="Vested restricted stock units"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2024-01-012024-01-01_us-gaap_SubsequentEventMember_us-gaap_RestrictedStockUnitsRSUMember" id="Fact003280" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">256,853</ix:nonFraction></span> shares pursuant to vested restricted stock units that were released; and (iii) <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--FormerEmployeesMember_zjhftOUyHp4l" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-012024-01-01_us-gaap_SubsequentEventMember_custom_FormerEmployeesMember" id="Fact003282" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">84,831</ix:nonFraction></span> shares to certain former employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Plans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
January 1, 2024 through the date these consolidated financial statements were issued, the Company granted common stock options and restricted
stock units totaling <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240101__20240314__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJJtSrikw8je" title="Granted common stock options"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2024-01-012024-03-14_us-gaap_SubsequentEventMember" id="Fact003284" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">22,843</ix:nonFraction></span> and <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20240101__20240314__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zE7fHtSJhsJe" title="Working capital"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2024-01-012024-03-14_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" id="Fact003286" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">222,396</ix:nonFraction></span>, respectively, to acquire shares of the Company&#8217;s common stock to officers, directors,
employees and consultants.</span></p>

</ix:nonNumeric><p id="xdx_817_zfoAAKCutx6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 110; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.20
<SEQUENCE>2
<FILENAME>ex4-20.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.20</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
OF THE REGISTRANT&rsquo;S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following is a summary of all material characteristics of the capital stock of The Arena Group Holdings, Inc., a Delaware corporation
(&ldquo;The Arena Group,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; or &ldquo;our&rdquo;), as set forth in
our Amended and Restated Certificate of Incorporation, as amended (&ldquo;Certificate of Incorporation&rdquo;) and our Second Amended
and Restated Bylaws (&ldquo;Bylaws&rdquo;), and as registered under Section 12 of the Securities Exchange Act of 1934, as amended (the
&ldquo;Exchange Act&rdquo;). The summary does not purport to be complete and is qualified in its entirety by reference to our Certificate
of Incorporation and our Bylaws, each of which are incorporated by reference as exhibits to the Annual Report on Form 10-K of which this
Exhibit 4.20 is a part and to the provisions of the Delaware General Corporate Law (the &ldquo;DGCL&rdquo;). We encourage you to review
complete copies of our Certificate of Incorporation and our Bylaws, and the applicable provisions of the DGCL for additional information.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized capital stock consists of 1,001,000,000 shares, divided into 1,000,000,000 shares of common stock, par value $0.01 per share
(&ldquo;Common Stock&rdquo;), and 1,000,000 shares of preferred stock, par value $0.01 per share (&ldquo;Preferred Stock&rdquo;). Under
our Certificate of Incorporation, our board of directors (our &ldquo;Board&rdquo;) has the authority to issue such shares of Common Stock
and Preferred Stock in one or more classes or series, with such voting powers, designations, preferences and relative, participating,
optional or other special rights, if any, and such qualifications, limitations or restrictions thereof, if any, as shall be provided
for in a resolution or resolutions adopted by our Board and filed as designations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, 23,836,706 shares of our common stock were outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of our Common Stock are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders, including
the election of directors, and are entitled to receive dividends when and as declared by our Board out of funds legally available therefore
for distribution to stockholders and to share ratably in the assets legally available for distribution to stockholders in the event of
the liquidation or dissolution, whether voluntary or involuntary, of The Arena Group. We have not paid any dividends and do not anticipate
paying any dividends on our Common Stock in the foreseeable future. It is our present policy to retain earnings, if any, for use in the
development of our business. Our Common Stockholders have cumulative voting rights in the election of directors and have no preemptive,
subscription, or conversion rights. Our Common Stock is not subject to redemption by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
the 1,000,000 shares of Preferred Stock authorized, our Board has previously designated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,800
    shares of Preferred Stock as Series G convertible Preferred Stock (&ldquo;Series G Preferred Stock&rdquo;), of which approximately
    168 shares remained outstanding as of December 31, 2023; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,000
    shares of Preferred Stock as Series H convertible Preferred Stock (&ldquo;Series H Preferred Stock&rdquo;), of which no shares
    were outstanding as of December 31, 2023.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
the 1,000,000 shares of Preferred Stock, 975,200 shares remained available for designation by our Board as of December 31, 2023. Accordingly,
our Board is empowered, without stockholder approval, to issue Preferred Stock with dividend, liquidation, conversion, voting or other
rights that could adversely affect the voting power or other rights of the holders of Common Stock. The issuance of Preferred Stock could
have the effect of restricting dividends on Common Stock, diluting the voting power of Common Stock, impairing the liquidation rights
of Common Stock, or delaying or preventing a change in control of us, all without further action by our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Series
G Preferred Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series G Preferred Stock is convertible into shares of Common Stock, at the option of the holder, subject to certain limitations. We
may require holders to convert all (but not less than all) of the Series G Preferred Stock or buy out all outstanding shares of Series
G Preferred Stock at the liquidation value of approximately $168,500. Holders of Series G Preferred Stock are not entitled to dividends
and have no voting rights, unless required by law or with respect to certain matters relating to the Series G Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
a change in control, sale of or similar transaction, as defined in the Certificate of Designation for the Series G Preferred Stock,
the holder of the Series G Preferred Stock has the option to deem such transaction as a liquidation and may redeem the approximately
168 shares outstanding as of December 31, 2023 at the liquidation value of $1,000 per share, or an aggregate amount of approximately
$168,500. The sale of all our assets on June 28, 2007, triggered the redemption option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Series
H Preferred Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Series H Preferred Stock has a stated value of
$1,000, with no shares outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certain
Anti-Takeover Provisions of Delaware Law and Our Certificate of Incorporation and Bylaws</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions
of the DGCL and our Certificate of Incorporation and Bylaws could make it more difficult to acquire us by means of a tender offer, a
proxy contest or otherwise, or to remove incumbent officers and directors. These provisions, summarized below, are intended to discourage
coercive takeover practices and inadequate takeover bids and to encourage persons seeking to acquire control of us to first negotiate
with the board of directors. We believe that the benefits of these provisions outweigh the disadvantages of discouraging certain takeover
or acquisition proposals because, among other things, negotiation of these proposals could result in an improvement of their terms and
enhance the ability of our Board to maximize stockholder value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Delaware
Law</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the provisions of Section 203 of the DGCL regulating corporate takeovers. In general, Section 203 prohibits a publicly
held Delaware corporation from engaging in a &ldquo;business combination&rdquo; with an &ldquo;interested stockholder&rdquo; for a period
of three years following the date on which the person became an interested stockholder unless:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prior
    to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction
    which resulted in the stockholder becoming an interested stockholder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced,
    excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the interested
    stockholder, (i) shares owned by persons who are directors and also officers and (ii) shares owned by employee stock plans in which
    employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered
    in a tender or exchange offer; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    or subsequent to the date of the transaction, the business combination is approved by the board of directors of the corporation and
    authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66.67%
    of the outstanding voting stock that is not owned by the interested stockholder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
a business combination includes a merger, asset or stock sale, or other transaction or series of transactions together resulting in a
financial benefit to the interested stockholder. An interested stockholder is a person who, together with affiliates and associates,
owns or, within three years prior to the determination of interested stockholder status, did own 15% or more of a corporation&rsquo;s
outstanding voting stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certificate
of Incorporation and Bylaws Provisions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation and Bylaws include a number of provisions that could deter hostile takeovers or delay or prevent changes
in control of our company, including the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Special
    Meetings of Stockholders.</I> Our Bylaws provide that special meetings of our stockholders may be called only by a majority of our
    Board, the Chairman of our Board, our Chief Executive Officer, or President (in the absence of our Chief Executive Officer).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stockholder
    Advance Notice Procedures.</I> Our Bylaws provide that stockholders seeking to present proposals before a meeting of stockholders
    or to nominate candidates for election as directors at a meeting of stockholders must provide timely notice in writing and also specify
    requirements as to the form and content of a stockholder&rsquo;s notice. These provisions may delay or preclude stockholders from
    bringing matters before a meeting of our stockholders or from making nominations for directors at a meeting of stockholders, which
    could delay or deter takeover attempts or changes in our management.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exclusive
    Forum.</I> Our Bylaws provide that unless we consent in writing to the selection of an alternative forum, the courts in the State
    of Delaware are, to the fullest extent permitted by applicable law, the sole and exclusive forum for (i) any derivative action or
    proceeding brought on behalf of the Company, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director,
    officer or other employee of the Company to the Company or the Company&rsquo;s stockholders, (iii) any action asserting a claim arising
    pursuant to any provision of the DGCL, the Certificate of Incorporation or the Bylaws, (iv) any action to interpret, apply, enforce,
    or determine the validity of the Certificate of Incorporation or the Bylaws, or (v) any action asserting a claim governed by the
    internal affairs doctrine.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    Action by Written Consent. </I>Our Certificate of Incorporation provides that any action required or permitted to be taken by our
    stockholders must be effected at a duly constituted annual or special meeting of the stockholders.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Amendments
    to our Certificate of Incorporation.</I> Any amendments to our Certificate of Incorporation requires an affirmative vote of at least
    sixty-six and two-thirds percent (66 2/3%) of the voting power of the outstanding shares (in aggregate and by each voting class)
    entitled to vote on such amendments unless our Board recommends to our stockholders that they approve such amendment, in which case
    only a majority of the voting power of capital stock (in aggregate and by each voting class) entitled to vote on such amendments
    is required.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Undesignated
    Preferred Stock.</I> Because our Board has the power to establish the preferences and rights of the shares of any additional series
    of Preferred Stock, it may afford holders of any Preferred Stock preferences, powers, and rights, including voting and dividend rights,
    senior to the rights of holders of our Common Stock, which could adversely affect the holders of Common Stock and could discourage
    a takeover of us even if a change of control of the Company would be beneficial to the interests of our stockholders.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
and other provisions contained in our Certificate of Incorporation and Bylaws are expected to discourage coercive takeover practices
and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate
with our Board. However, these provisions could delay or discourage transactions involving an actual or potential change in control of
us, including transactions in which stockholders might otherwise receive a premium for their shares over then current prices. Such provisions
could also limit the ability of stockholders to remove current management or approve transactions that stockholders may deem to be in
their best interests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
Agent and Registrar</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our Common Stock is Equiniti Trust Company, LLC, at 55 Challenger Road, Ridgefield Park, NJ 07660.
The transfer agent&rsquo;s telephone number at the EQ Shareholder Services Call Center is (800) 937-5449.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NYSE
American Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is traded on the NYSE American under the symbol &ldquo;AREN.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.91
<SEQUENCE>3
<FILENAME>ex10-91.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 10.91</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-91_001.jpg" ALT=""></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-91_002.jpg" ALT="">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-91_003.jpg" ALT="">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>ex21-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
21.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Subsidiaries
of the Arena Group Holdings, Inc.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsidiary</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Place
    of Incorporation</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Arena Media Brands, LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TheStreet,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Arena Platform, Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">College
    Spun Media Incorporated</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Jersey</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Athlon
    Holdings, Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tennessee</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Athlon
    Sports Communications, Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tennessee</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 23.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><U>Independent
Registered Public Accounting Firm&rsquo;s Consent</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the incorporation by reference in the Registration Statement of The Arena Group Holdings, Inc. and Subsidiaries on Form
S-1 (File No. 333-260597), Form S-3 (File Nos. 333-268487, 333-269393, <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">333-271240</FONT>)
and Form S-8 (File Nos. 333-26527, <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">333-272592</FONT>)
of our report dated April 1, 2024, which includes an explanatory paragraph as to the company&rsquo;s ability to continue as a going
concern, with respect to our audits of the consolidated financial statements of The Arena Group Holdings, Inc. and Subsidiaries as
of December 31, 2023 and 2022 and for each of the two years in the period ended December 31, 2023 which report is included in this
Annual Report on Form 10-K of The Arena Group Holdings, Inc. for the year ended December 31, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marcum
<FONT STYLE="font-variant: small-caps">llp</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, NY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 1, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
302 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Cavitt Randall, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have reviewed this Annual Report on Form 10-K of The Arena Group Holdings, Inc.;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
    the period covered by this report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
    respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
    this report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
    (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
    Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
    reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing
    the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in; text-indent: -3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 1, 2024</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Cavitt Randall</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cavitt
    Randall</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>ex31-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
302 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Douglas B. Smith, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have reviewed this Annual Report on Form 10-K of The Arena Group Holdings, Inc.;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
    the period covered by this report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
    respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
    this report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
    (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
    Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
    reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing
    the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in; text-indent: -3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 1, 2024</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Douglas B. Smith</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas
    B. Smith</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>ex32-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18
U.S.C. SECTION 1350,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO SECTION 906</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF
THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code),
the undersigned officer of The Arena Group Holdings, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), does hereby certify that,
to the best of his knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Annual Report on Form 10-K for the year ended December 31, 2023 (the &ldquo;Form 10-K&rdquo;) of the Company fully complies with
    the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations
    of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 1, 2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Cavitt Randall</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cavitt
                                            Randall</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>ex32-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
32.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18
U.S.C. SECTION 1350,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO SECTION 906</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF
THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code),
the undersigned officer of The Arena Group Holdings, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), does hereby certify that,
to the best of his knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Annual Report on Form 10-K for the year ended December 31, 2023 (the &ldquo;Form 10-K&rdquo;) of the Company fully complies with
    the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations
    of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 1, 2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Douglas B. Smith</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas
                                            B. Smith</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial Officer)</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>10
<FILENAME>ex97-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
97.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
ARENA GROUP HOLDINGS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPENSATION RECOVERY POLICY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Adopted
November 9, 2023)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has determined that it is in the best interests of the Company and its stockholders to adopt this Policy enabling the Company to
recover from specified current and former Company executives certain incentive-based compensation in the event of an accounting restatement
resulting from material noncompliance with any financial reporting requirements under the federal securities laws. Capitalized terms
are defined in Section 14.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Policy is designed to comply with Rule 10D-1 of the Exchange Act and shall become effective on the Effective Date and shall apply to
Incentive-Based Compensation Received by Covered Persons on or after the Listing Rule Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Administration</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Policy shall be administered by the Administrator. The Administrator is authorized to interpret and construe this Policy and to make
all determinations necessary, appropriate, or advisable for the administration of this Policy. The Administrator may retain, at the Company&rsquo;s
expense, outside legal counsel and such compensation, tax or other consultants as it may determine are advisable for purpose of administering
this Policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Covered
Persons and Applicable Compensation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Policy applies to any Incentive-Based Compensation Received by a person (a) after beginning service as a Covered Person; (b) who served
as a Covered Person at any time during the performance period for that Incentive-Based Compensation; and (c) was a Covered Person during
the Clawback Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
recovery is not required with respect to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive-Based
    Compensation Received prior to an individual becoming a Covered Person, even if the individual served as a Covered Person during
    the Clawback Period.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive-Based
    Compensation Received prior to the Listing Rule Effective Date.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive-Based
    Compensation Received prior to the Clawback Period.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive-Based
    Compensation Received while the Company did not have a class of listed securities on a national securities exchange or a national
    securities association, including the Exchange.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Administrator will not consider the Covered Person&rsquo;s responsibility or fault or lack thereof in enforcing this Policy with respect
to recoupment under the Final Rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. Triggering
Event</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to and in accordance with the provisions of this Policy, if there is a Triggering Event, the Administrator shall require a Covered Person
to reimburse or forfeit to the Company the Recoupment Amount applicable to such Covered Person. A Company&rsquo;s obligation to recover
the Recoupment Amount is not dependent on if or when the restated financial statements are filed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. Calculation
of Recoupment Amount</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Recoupment Amount will be calculated in accordance with the Final Rules, as provided in the Calculation Guidelines attached hereto as
<U>Exhibit B</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. Method
of Recoupment</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to compliance with the Final Rules and applicable law, the Administrator will determine, in its sole discretion, the method for recouping
the Recoupment Amount hereunder which may include, without limitation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Requiring
    reimbursement or forfeiture of the pre-tax amount of cash Incentive-Based Compensation previously paid;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offsetting
    the Recoupment Amount from any compensation otherwise owed by the Company to the Covered Person, including without limitation, any
    prior cash incentive payments, executive retirement benefits, wages, equity grants or other amounts payable by the Company to Covered
    Person in the future;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seeking
    recovery of any gain realized on the vesting, exercise, settlement, cash sale, transfer, or other disposition of any equity-based
    awards; and/or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taking
    any other remedial and recovery action permitted by law, as determined by the Administrator.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. Arbitration</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the fullest extent permitted by law, any disputes under this Policy shall be submitted to mandatory binding arbitration (the &ldquo;<B><I>Arbitrable
Claims</I></B>&rdquo;), governed by the Federal Arbitration Act (the &ldquo;<B><I>FAA</I></B>&rdquo;). Further, to the fullest extent
permitted by law, no class or collective actions can be asserted in arbitration or otherwise. All claims, whether in arbitration or otherwise,
must be brought solely in Covered Person&rsquo;s individual capacity, and not as a plaintiff or class member in any purported class or
collective proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUBJECT
TO THE ABOVE PROVISO, ANY RIGHTS THAT COVERED PERSON MAY HAVE TO TRIAL BY JURY IN REGARD TO ARBITRABLE CLAIMS ARE WAIVED. ANY RIGHTS
THAT COVERED PERSON MAY HAVE TO PURSUE OR PARTICIPATE IN A CLASS OR COLLECTIVE ACTION PERTAINING TO ANY CLAIMS BETWEEN COVERED PERSON
AND THE COMPANY ARE WAIVED.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Covered
Person is not restricted from filing administrative claims that may be brought before any government agency where, as a matter of law,
Covered Person&rsquo;s ability to file such claims may not be restricted. However, to the fullest extent permitted by law, arbitration
shall be the exclusive remedy for the subject matter of such administrative claims. The arbitration shall be conducted in [City, State]
through JAMS before a single neutral arbitrator, in accordance with the JAMS Comprehensive Arbitration Rules and Procedures then in effect,
provided however, that the FAA, including its procedural provisions for compelling arbitration, shall govern and apply to this Arbitration
provision. The arbitrator shall issue a written decision that contains the essential findings and conclusions on which the decision is
based. If, for any reason, any term of this Arbitration provision is held to be invalid or unenforceable, all other valid terms and conditions
herein shall be severable in nature and remain fully enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7. Recovery
Process; Impracticability</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actions
by the Administrator to recover the Recoupment Amount will be reasonably prompt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Administrator must cause the Company to recover the Recoupment Amount unless the Administrator shall have previously determined that
recovery is impracticable and one of the following conditions is met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    direct expense paid to a third party to assist in enforcing the policy would exceed the amount to be recovered; before concluding
    that it would be impracticable to recover any amount of erroneously awarded compensation based on expense of enforcement, the Company
    must make a reasonable attempt to recover such erroneously awarded compensation, document such reasonable attempt(s) to recover,
    and provide such documentation to the Exchange;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
    recovery would violate home country law where that law was adopted prior to November 28, 2022; before concluding that it would be
    impracticable to recover any amount of erroneously awarded compensation based on violation of home country law, the Company must
    obtain an opinion of home country counsel, acceptable to the Exchange, that recovery would result in such a violation, and must provide
    such opinion to the Exchange; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
    recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of
    the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and regulations thereunder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. Non-Exclusivity</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Administrator intends that this Policy will be applied to the fullest extent of the law. Without limitation to any broader or alternate
clawback authorized in any written document with a Covered Person, (i) the Administrator may require that any employment agreement, equity
award agreement, or similar agreement entered into on or after the Effective Date shall, as a condition to the grant of any benefit thereunder,
require a Covered Person to agree to abide by the terms of this Policy, and (ii) this Policy will nonetheless apply to Incentive-Based
Compensation as required by the Final Rules, whether or not specifically referenced in those arrangements. Any right of recoupment under
this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company pursuant
to the terms of any similar policy in any employment agreement, equity award agreement, or similar agreement and any other legal remedies
or regulations available or applicable to the Company (including SOX 304). If recovery is required under both SOX 304 and this Policy,
any amounts recovered pursuant to SOX 304 may be credited toward the amount recovered under this Policy, or vice versa.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9. No
Advancement and/or Indemnification</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall not advance and/or indemnify any Covered Persons against the loss of erroneously awarded Incentive-Based Compensation or
any adverse tax consequences associated with any incorrectly awarded Incentive-Based Compensation or any recoupment hereunder. For the
avoidance of doubt, this prohibition on advancement and/or indemnification will also prohibit the Company from reimbursing or paying
any premium or payment of any third-party insurance policy to fund potential recovery obligations obtained by the Covered Person directly.
No Covered Person will seek or retain any such prohibited advancement, indemnification or reimbursement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10. Covered
Person Acknowledgement and Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Covered Persons subject to this Policy must acknowledge their understanding of, and agreement to comply with, the Policy by executing
the certification attached hereto as <U>Exhibit A</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11. Successors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Policy shall be binding and enforceable against all Covered Persons and their beneficiaries, heirs, executors, administrators or other
legal representatives and shall inure to the benefit of any successor to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12. Interpretation
of Policy</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent there is any ambiguity between this Policy and the Final Rules, this Policy shall be interpreted so that it complies with
the Final Rules. If any provision of this Policy, or the application of such provision to any Covered Person or circumstance, shall be
held invalid, the remainder of this Policy, or the application of such provision to Covered Persons or circumstances other than those
as to which it is held invalid, shall not be affected thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event any provision of this Policy is inconsistent with any requirement of any Final Rules, the Administrator, in its sole discretion,
shall amend and administer this Policy and bring it into compliance with such rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
determination under this Policy by the Administrator shall be conclusive and binding on the applicable Covered Person. Determinations
of the Administrator need not be uniform with respect to Covered Persons or from one payment or grant to another.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13. Amendments;
Termination</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Administrator may make any amendments to this Policy as required under applicable law, rules and regulations, or as otherwise determined
by the Administrator in its sole discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Administrator may terminate this Policy at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14. Definitions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Administrator</I></B>&rdquo;
means the Compensation Committee of the Board, or in the absence of a committee of independent directors responsible for executive compensation
decisions, a majority of the independent directors serving on the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Board</I></B>&rdquo;
means the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Clawback Measurement Date</I></B>&rdquo; is the earlier to occur of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    date the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action
    is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an accounting restatement
    as described in this Policy; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    date a court, regulator, or other legally authorized body directs the Company to prepare an accounting restatement as described in
    this Policy.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Clawback
Period</I></B>&rdquo; means the three (3) completed fiscal years immediately prior to the Clawback Measurement Date and any transition
period between the last day of the Company&rsquo;s previous fiscal year end and the first day of its new fiscal year (that results from
a change in the Company&rsquo;s fiscal year) within or immediately following such three (3)-year period; provided that any transition
period between the last day of the Company&rsquo;s previous fiscal year end and the first day of its new fiscal year that comprises a
period of 9 to 12 months will be deemed a completed fiscal year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Company</I></B>&rdquo;
means The Arena Group Holdings, Inc., a Delaware corporation, or any successor corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Covered
Person</I></B>&rdquo; means any Executive Officer (as defined in the Final Rules), including, but not limited to, those persons who are
or have been determined to be &ldquo;officers&rdquo; of the Company within the meaning of Section 16 of Rule 16a-1(f) of the rules promulgated
under the Exchange Act, and &ldquo;executive officers&rdquo; of the Company within the meaning of Item 401(b) of Regulation S-K, Rule
3b-7 promulgated under the Exchange Act, and Rule 405 promulgated under the Securities Act of 1933, as amended; provided that the Administrator
may identify additional employees who shall be treated as Covered Persons for the purposes of this Policy with prospective effect, in
accordance with the Final Rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Effective
Date</I></B>&rdquo; means November 9, 2023, the date this Policy was adopted by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Exchange</I></B>&rdquo;
means the NYSE American LLC or any other national securities exchange or national securities association in the United States on which
the Company has listed its securities for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Exchange
Act</I></B>&rdquo; means the Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Final
Rules</I></B>&rdquo; means the final rules promulgated by the SEC under Section 954 of the Dodd-Frank Act, Rule 10D-1 and Exchange listing
standards, as may be amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Financial
Reporting Measure</I></B>&rdquo; are measures that are determined and presented in accordance with the accounting principles used in
preparing the Company&rsquo;s financial statements, and any measures that are derived wholly or in part from such measures. Stock price
and TSR are also financial reporting measures. A financial reporting measure need not be presented within the financial statements or
included in a filing with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Incentive-Based
Compensation</I></B>&rdquo; means compensation that is granted, earned or vested based wholly or in part on the attainment of any Financial
Reporting Measure. Examples of &ldquo;Incentive- Based Compensation&rdquo; include, but are not limited to: non-equity incentive plan
awards that are earned based wholly or in part on satisfying a Financial Reporting Measure performance goal; bonuses paid from a &ldquo;bonus
pool,&rdquo; the size of which is determined based wholly or in part on satisfying a Financial Reporting Measure performance goal; other
cash awards based on satisfaction of a Financial Reporting Measure performance goal; restricted stock, restricted stock units, performance
share units, stock options, and SARs that are granted or become vested based wholly or in part on satisfying a Financial Reporting Measure
goal; and proceeds received upon the sale of shares acquired through an incentive plan that were granted or vested based wholly or in
part on satisfying a Financial Reporting Measure goal. &ldquo;Incentive-Based Compensation&rdquo; excludes, for example, time-based awards
such as stock options or restricted stock units that are granted or vest <I>solely</I> upon completion of a service period; awards based
on non-financial strategic or operating metrics such as the consummation of a merger or achievement of non-financial business goals;
service-based retention bonuses; discretionary compensation; and salary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Listing
Rule Effective Date</I></B>&rdquo; means the effective date of the listing standards of the Exchange on which the Company&rsquo;s securities
are listed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Policy</I></B>&rdquo;
means this Compensation Recovery Policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive-Based
Compensation is deemed &ldquo;<B><I>Received</I></B>&rdquo; in the Company&rsquo;s fiscal period during which the relevant Financial
Reporting Measure specified in the Incentive-Based Compensation award is attained, irrespective of whether the payment or grant occurs
on a later date or if there are additional vesting or payment requirements, such as time-based vesting or certification or approval by
the Compensation Committee or Board, that have not yet been satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Recoupment
Amount</I></B>&rdquo; means the amount of Incentive-Based Compensation received by the Covered Person based on the financial statements
prior to the restatement that exceeds the amount such Covered Person would have received had the Incentive-Based Compensation been determined
based on the financial restatement, computed without regard to any taxes paid (<I>i.e</I>., gross of taxes withheld).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>SARs</I></B>&rdquo;
means stock appreciation rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>SEC</I></B>&rdquo;
means the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>SOX
304</I></B>&rdquo; means Section 304 of the Sarbanes-Oxley Act of 2002.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Triggering
Event</I></B>&rdquo; means any event in which the Company is required to prepare an accounting restatement due to the material noncompliance
of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct
an error in previously issued financial statements that is material to the previously issued financial statements, or that would result
in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>TSR</I></B>&rdquo;
means total stockholder return.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certification</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have read and understand the Company&rsquo;s Compensation Recovery Policy (the &ldquo;<B><I>Policy</I></B>&rdquo;). I understand
    that the General Counsel is available to answer any questions I have regarding the Policy.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    understand that the Policy applies to all of my existing and future compensation-related agreements with the Company, whether or
    not explicitly stated therein.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    agree that notwithstanding the Company&rsquo;s certificate of incorporation, bylaws, and any agreement I have with the Company, including
    any indemnity agreement I have with the Company, I will not be entitled to, and will not seek advancement and/or indemnification
    from the Company for, any amounts recovered or recoverable by the Company in accordance with the Policy.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    understand and agree that in the event of a conflict between the Policy and the foregoing agreements and understandings on the one
    hand, and any prior, existing or future agreement, arrangement or understanding, whether oral or written, with respect to the subject
    matter of the Policy and this Certification, on the other hand, the terms of the Policy and this Certification shall control, and
    the terms of this Certification shall supersede any provision of such an agreement, arrangement or understanding to the extent of
    such conflict with respect to the subject matter of the Policy and this Certification.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature:
______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
__________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
___________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
___________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
B</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calculation
Guidelines</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of calculating the Recoupment Amount:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    cash awards, the erroneously awarded compensation is the difference between the amount of the cash award (whether payable as a lump
    sum or over time) that was received and the amount that should have been received applying the restated Financial Reporting Measure.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    cash awards paid from bonus pools, the erroneously awarded compensation is the pro rata portion of any deficiency that results from
    the aggregate bonus pool that is reduced based on applying the restated Financial Reporting Measure.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    equity awards, if the shares, options, restricted stock units, or SARs are still held at the time of recovery, the erroneously awarded
    compensation is the number of such securities received in excess of the number that should have been received applying the restated
    Financial Reporting Measure (or the value of that excess number). If the options or SARs have been exercised, but the underlying
    shares have not been sold, the erroneously awarded compensation is the number of shares underlying the excess options or SARs (or
    the value thereof). If the underlying shares have been sold, the Company may recoup proceeds received from the sale of shares.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Incentive-Based Compensation based on stock price or TSR, where the amount of erroneously awarded compensation is not subject to
    mathematical recalculation directly from the information in an accounting restatement:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount must be based on a reasonable estimate of the effect of the accounting restatement on the stock price or TSR upon which the
    Incentive- Based Compensation was Received; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company must maintain documentation of the determination of that reasonable estimate and the Company must provide such documentation
    to the Exchange in all cases.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex10-91_001.jpg
<TEXT>
begin 644 ex10-91_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" .: M # 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #=QWE-K8"JV_
M'RDDL-H/]Y=N2/1E]:=110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?0/%2OI"_F]\7_\ @II^T/\ !#]HCXR?#?4_%W[*?Q!M_A__ ,%#OV:?V1_
M7[.%MX*\6> /VF/B[\-/VG/AG^SMX_B\9^ /%5[^T-XNT;Q)XN^#G_#0&H2>
M)XK7X&6OAGQ)X6^$?BK7M1NOA['J4]SX= /W_HK\L=9_X*<_ KX@-\,_^%&?
M%R]T**^_:B^%'P3\:7'Q-_8^_:JU"U\5R^,OBO\ &/X'ZI\)O!U]+H7PSM/
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MQYU6T@N[CQ1HGP_\(>'/ 4-QK5F?!7C.?5UU2P[#]E?]N?XS6O[)'[+WB_\
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M?AYIO@&YUS0]=^]/V(_V>/$W[)_[+GPB_9W\7?$+1?BOKGPMT&^T*[^(N@^
M;KX7V'BH7'B#6-8M]0_X0:\\>?$N71+P6^IQPZD(_&-_9WNHQ75_866C65U!
MH]C]5T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[X$U9?''Q/\ @Q:V=E\$-'^(GBRT\*M\/]?\"^)/',6D:K=^-1I6O_0>E?\
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MI\:-=;4O%=]\']/^'VB^)O"GAOX?> -;T2]\'_#OPKH]C\;?L4?''XV?%_\
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MM]>\/VFN:EK>E>/_  /H'BN+0K'QCJVC^--'TW0=(^)^I>,-"CD\":/^TE%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM=DB"
M0CJ$D(STR(GZU9JM=Y^SR8&3LDP,XR?*? SVSZT">S]'^3)(B>5[!4(_X$N3
MSQGGV%2U#%U;_=B_] J:@%LO1?D@HHHH&%%%% !1110 4444 %%%% !1110
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M8M-\1:U8_#^O5?AQ^SK\4?@7>?L:?#'X/_$QK#]F?]GSX*^(_A5\5/"GB5-
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MX5^&&@^)?$5CX0\/:QXPU%=*T_6_%VJVM]=:/X3TNYD4I>>)]>73[FW\/:!
M7U7Q#J(ATG1+34-4N;:SF\'N/^"D7[!]KHGASQ%-^U=\$_[)\7W?BK3_  O/
M#XUT^YG\0:GX$?3%\<Z3I&GVWFZC?:OX*BUO0+WQ=I,%H^I>&=+\1>&]7UNU
ML=+\1:)>7X!]M45\1ZQ_P4E_8,\/VOA>]UW]K'X(:-:>-?"P\<>$[C5/&VG6
M46O>#X?$VJ>"]8\3:>]P8Q-HGA'Q?HNJ>%_B#J'RV_PYU^RFTCQX_AR_VP-O
M>,OV^_V,O 6D?#?7_$?[2/PJ_L+XR>'KWQ9\(=;T#Q)#XQT?XK^&M,DBCU?7
M?AGJ?@Z/7[+QYI>AI/!>:_=^%I]5CT#3+BVU7638Z;<PW;@'U]17PU??\%+O
MV"-)A\/7FN?M9?!#PWIOBSP1??$;PYJ_BOQMI_A+1=6\%:/XSUWX>>(_$=OK
MGB7^RM&33?!OC;PUK7AGQ_)<7T,GP]U:R$'C:/05N[*2Y^K/$?Q-^'OA'P7'
M\1?$WC;PMH?@*9?#DD/C/4=;TZW\+S1>+]3TK1?"T\.N-<?V=-;^(=5US1[#
M1[B*Y>#4+C4[%+:23[1&6 .YHKQSQM^T'\%/AK\0OAS\)_B!\3_!G@_XE_%^
M>^M?A7X'U[6;?3_$GQ$N=+EM(=6MO!NESE;CQ#<Z3]OLYM6M],2XFTNSN([^
M_2WL3]H'4_$CXF> ?@_X%\0_$WXH>*]%\!_#WPC8+JWBWQIXGO8]+\->%=%^
MT06]SKOB35Y\6>AZ!IIN$N=:UW4I+;2-"TV.ZU?6;VPTJRO+VW .ZHKXZ3_@
MH)^Q4^E>-=='[3'PB31?AOX:LO&?Q!U.?Q;8VUIX*\&7^N6_AN+QCXF>Y\EM
M(\(6VM7EC9:QXINTCT'P^=0TV?7M0TVUU*PGN=S6?VXOV0?#HLFUW]H_X/:4
M+_X*6'[2EN+OQQHT;#]G;5/[0%C\=[E!<,UA\'YCI6I9^(]^+7PC!]@N_M&K
MP^1)@ ^J:*^0(?V__P!BBX\#77Q,MOVI/@?=^ -/\4^'/!&J^+++XA^'[W1]
M"\8^,[!]3\$>&/$D]I=S-X9UWQU8K!-X%TOQ#'IEYXU.I:)%X4BUB77M%2_V
M[S]MK]D>S^&.B_&Q_P!I#X+W/P=U_P ;Q_#73?BGIOQ"\-ZK\/S\1);Y])A\
M!WWBW3+^[T+2?&$NN12>'AX=U>^L-4C\1F+PY+:IKT]OILP!]256N_\ 42?[
MDG_HMZ^6[/\ ;G_8[U#P%K/Q0L/VEO@Q>?#_ ,.^-[+X9:WXIMO'V@S:;IOQ
M'U/0M,\4Z;X!N EVUS_PF5_X7UC3O$EIX:2W;6)] N5UF*S?3DEN8\[QO^WG
M^Q?X)\ ^#/B1XA_:D^ UIX#^)N@>*_$_PW\81_%3P5=^&?'/ACP4OE>+_%WA
MO7[769M'OO!'A.XGM;7Q5XZ%\G@WPQ<W^FPZ_KNG/J5B+@$]GZ/\F?7,?WGQ
MTVQ_^@U+5#3[VTO[2WU&RN(KFQOK2TO;.ZA8-#<VES"DUO<0L"0T4T3I)&P/
M*,I[U>R/4?G0"V7HOR0M%><2?%WX:Q?%JQ^!#^,]"_X7#J/P[U;XM6OP[6[$
MGB=OAKHOB;2/!FH>-9K"-7-IH*>*M=TW0K:[NW@_M#4'NX=/2Z_LS4VL_!3_
M ,% ?V)H_B=-\%KC]J;X'67Q8MO&5C\.;OX>ZE\0M TOQ58?$35?$EMX0T7P
M#J.EZC=VLUAXVU_Q'?Z3IOASPI>"#7O$)U[PY=:+87]CXDT*ZU &?8-%>7_#
M'XU_"3XT>&=2\9?";XD>"OB+X7T7Q!X@\):[K?@_Q)I.N66@>+/"=P;3Q7X4
M\1/974C^'_%'A:\'V/Q)X<UI+#6=!N_]'U6RM9<K6!X<_:5_9_\ %_PNT'XW
M^%OC-\,_$/P:\5^(-!\*>$OBQHWC/0=2^'/BOQ#XK^(&F_"GPKI?AGQE:7LO
MA_7Y_$_Q,UG2? GALZ1?WD6O^*-2L=(TB2\N[NWCD /;Z*\6\??M$?!3X6>-
MO!/PU^(GQ)\+>$OB'\3;;6[OX:>"=8OS;^*/B+%X8MDO?$\?@31!')J'BZZ\
M,6$B:GXELM @O[WP_H[QZUK%O8Z3+'>->^"OQX^#?[1O@F+XE? ?XE^#OB[\
M.[G4;S2;#QY\/]:M/$O@_5K_ $Y8/[1BT7Q%ILD^DZU%8RW"6MU=Z3>7MG!?
MQW>FRW"ZA8WMM;@'K=%%% !1110 4444 %%%% !@>E%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 444@(;."#@D''J#@CZ@\'T/% "T444 %
M%%% !1110 4444 %%%% !1110 4444 %?-G[7OP$;]IK]G+XG_!NQ\3W7@3Q
M5X@TO2?$'PQ^(=C/<PWOPQ^-?PX\2Z)\3/@5\5+,6LD;W=W\+_C)X.\#>/K?
M3+@3Z=JTGAX:7JMG?Z;>75E/])TA (P0"#U!&0?P- '\_P#\0O!W[1NO?L(7
M'QX^*OP:\:V7[57[57[:W_!/']HCQS\%/!GP^\;?%36/@MX$^#'[4G[*_B:U
M^'E_H/@[3]=U9=*^%_P.^".O_$#QW:ZBEGI*?$?Q)XY\/P2ZOKNNZ=8^(.5_
M:S\*_M0?$?XX:Y_P48^&?PG\97D_["_QL^''@+X#?!36?@;\4D_:(^*'PZ\*
M^(+WPC^U5XA^#MO<W4&F2>%/VJ?A_P#'+XD^";."[\)77A_5(?@;^S[\8-2\
M5:#+X5GTW2/Z*BJD8*@@= 0,#MTZ=.*-JXQ@8QC&!C!X(QTQCM0!^5W_  4\
MTWQ9\5?@%^S=8_#?1OC@VHZO^VU^PS\1AK'PS^$?B;Q)X[^'_@7P%\?O /Q/
M\9?$'7O"&L_#7Q>WA*?P#X.\/:IXBFTKXB^"U7_A(].L/">L>&]:OKV;P=JO
MSE\?/A'\1/@W\8OV(8;OXK_M;>,K_P .>*_VRO&GQJ_:]^#7[*.G_%+XO7MS
M\3?#-GX9^% ^(.@?#G]E_P",'PDO-7T_PS9^%/A5'J-G\)=+OXO#7PR\)3Z1
MI/@SP%YVAI^[Q /4 ]N0#QZ4AC0]40\$<J#P001TZ$$@^H)H _ _X/\ B_Q/
M\-?VF?V4_''B?X,_MC>(_"GPN_8*_:F^!FM?%76OV7OB_>^/?BU\2=:_:=_9
MW;0?B;\0/"O@GP'=:5X1\=_M-V?P(^)'[0FH1>+Y](UC1[/Q9I%S\1[+X?>+
MO&L/A6]^2/"7P#_:)^%_QS^"WQ1USP5^U5^S?X4\??M.?\%,_P!J6?2_V>/@
MMIOQV\>?LR?#']I*T^$.A?#'X?\ BC3[7X7_ +3WP=A\?_%WQ9X(\5_%?QUX
M(\$:)XI'@C4_'NM1W5SI]W:7?B+4?ZI]J_W5ZYZ#KDMGIUR2<^I)ZFE"J.B@
M8&!@ 8&,8^F !CT&* /Y?OBG\"?VR?CAXK^$>C? ^[_:7^%7CSPE_P $N_VT
MOV==-^//QG^$&D>'Y_CC\1-2^./[,(@NOC/=ZEX4\8>'/@SXG_;7TSX0?$WX
MDQ^)S::-\2/A?='PSX^\4:1=:IKL'PKUOV#XG?L_^)?VX?V=?V8/^"?OPJ^!
MGQ5_90_9K^&7[-%Y8_%KP7^TM\._BD-$T27PO\/!^S=\&_V>X?&5MJEEI_Q8
M\8?!>]UO6?VC] ^(FA>/M>T-/B;\#O@!\2/#FN>)Y=2N/$7A'^B$*HSA5&>N
M .>,<^O''TXHVKQ\HXQC@<8Z8],=O2@#^?70/BW\;/$FN_\ !)/]H3]HOX#?
MM067C+X#^ OVGO#G[4[>&?V:/CUXNU32OBU=_"/P7\++7QG9^"? WPQ\3^*M
M=\#_ !CU]]6\8>!HM*T9;VPT?7;:3Q2=!U;P?XST+3ON?]N37?%GQT_X)=_M
MMP^$?A)\64\5_%;]E;]I_P"&?PR^%]SX#\6-\4O&.L^-_ _CKX9_#$#X?Z-I
M]UXU\+GX@W^J>']82P\1Z9HFN^!?#^M#4/B+:>"9=&\0-HGZ1%$/55/4<J#P
M2"1T[D GU(!["EVKC&T8],#' P./8<?3B@#\,/A5\;-5^$<WQ"^)'C'PQ_P4
MC_;!32_V5-'T.X\#?$/]@G7/!=Y\,O%/@_Q!=PZS\'/@OIOAO]FCX&6GQ*OO
MVI-;^(7@W0-3_P"$<\.^,?!WA;PY^S;IWCCXV_%;1?!FG^$]2A^-]!^#?[0O
M[+W[)_\ P4M_8H^('P&\>_$3Q9\6/^">WB3Q#^SC\3O@#\+/CQ\7_ ^G:+XS
M^#_Q#^$_A7_@FWH/Q"G\->(]?&F_LC?$S7;W1_V=+#6&TU]5^ WQ(@\=^)?#
M'ACQ/8?$S6=3_J7VK_=7KGH.O//UY/YGUI B#&$48Z84<< <<<<*!QV ]!0!
M_.7\</V/O$WA#]GCP9^T3'XD_:8^+'[2GQM\9_\ !('P?J[:!^SX\VL_ KX(
M_LG?MJ?"_P#:9U9-$^!O@/X.#Q=8GX7:%)\4_%OB"_\ COI_C_QQJFJZ1X;^
M'DEZ\\ND^"-7\P\:?"_XN?#3]FSXR? 7QA\,?VE]9_:CU_\ X*G_ +('[5GQ
M:_:-^$?P"^*'Q0\+_M"^$O#/[6?[*OC^^_:@^&47A3X.>-_A5\/-6^'_ .S[
M\*])T?Q'^SAK7A;7;OP5XU^$6O:1;>%/B[::YHGC3X@_U"!5'15')/  Y)W$
M_4MR??GK31&@P0B C !"@8 Q@#CC&!CTP/2@#^<_XG^%6\>Z-X;G.N_\%0)O
M$7@C]H/7/C-\./\ @HO;_L@>)/#'Q\^%7Q1O?@?\0=#T3PQKO[*V@?LL>'O$
MGQT^"VE>![W5/A'XL:^_9L\.^"=5LOBKH7@CPGJ][XDTSQCXM\&> ?%WP]^T
M7JGP:^&_Q*U/X4_'#X'_ +9MK^R_^TCH/A.]^#'['GQO^+/[)7[7^G^/?VA/
MB6VI_ []K3]E70/ GBS4?V>6_:9T*/X:_'FQD\:_$7X9^._A3XK^.7CK3_$&
MJVC?";Q+X9UO^K#8@Z*HZG[HZGJ>G?O52^C0VTX*+\T-PK?*,E9(GWC.,_/@
M;O[V!G.!0)NR;WLF[=[)NWSM8_(O]O6'XYW'[-'[)G@CP-X ^/O@>Z\6>-O"
MFA_%^W_99\4_%JYN_@II&G?L^_$K5[/P[KO_  S/JOA/XV^-? $?Q*TWPIX!
M\.R_#GXT_ 3PX/'TOP\\3?%OXS6?P3L/'WA7QK^9_P 'KW_@HYKL_P )?BO\
M1;S]O:T^)FG>)O\ @AC:^(O".I:'\?=#^&\]SXVT_P '>#_^"G%UXE^&-IX:
MTKX:WGAVP\+6?C;6_B++K6GZCX9\">)9(?%6E1>&/&]_HEQ)_57&$95R Q"C
MEADX?#]6YYP"<\Y&3R*DV)TV+@9Q\HXR03V[D GW /6@$[I/:Z3MZG\]?_!.
MOP3\?V_; ^$?Q/\ C]X*_:ZM_B_+^P]^T)X*_:W\2?'<_%#6_@YH7[5FJ?M'
M? 77M=\,?L_:GXDN-6^$GA_X3>(]-\.^(M7^%>F?L_ZJGPIU;X9:%X3*VJ^-
M])\6-+B:./&W@?\ :,_;DUF\TO\ ;D.G>,/^"B.D?%KP+^SIX&_8JUOQY\!/
MVNO#NE_LN?LB?"3P_JWBCXX^-/V;/%.@?#G1'^,/PNU]V\??\-"_#3PGX<LO
M EM\09M&N?"-[I.J:W_1A@ Y  /K@9IOEH2243)P2=HR2!@$\<X' ST'% S^
M9GX2? 7]I6U\7_&WPWHWPN\;Z'^RI^WM^T%^USXW_:QGU'X;^//"WB#X;Z?\
M)_VW/CCXTO/%,7PI\2>%=#\<^-)O^"B?["?B'X2_L]R3^"M%U36+;4O"=CXG
MTRTDUB+5;;5.#\#_ ++O[1?[87[!G[#O[!^J>#_'7P)MO@O^Q5I7CCXT^(/C
M7\(/C3\+1IW[1?B#PCK?PJ^#X^'NJQ>";/0-7^*?[->LW'CGX]MHLVNI=>&_
MBC:?L[^-[+2=>N-,U.X\-?U1[$Y^1><Y^4<YSG/'.<G/KDYZT!5!)"J"<9(
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M0 4444 %%%?GY_P4?U?]H3P!^S3\:_CM\#?CAJ?PA'[//[-7[3/QENM%\/\
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M?XI?"^P\!>%M&^#FOZGX[U)OA!X[\0^*O$GB7P[X6\.^(O MUX7UJ+Q+X_\
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M^ _@/]F?_@IYK_[4GP/\1>$O 6J^,_"7QM_8<^,O[(_P]ETI+SPPWBC4]?\
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MX=?9X.0#ZC- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[1M<NM.O?#<+6FDW&G?0'["GQ;^-_P =_@KI?Q;^,NL?"2_/BJ[URP\.:?\
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MG:RO/#MUI\5M:0?4]% 'Y%Z3_P $;?V?-,\#_#WP!=_%[]I75-)^%OP)\3?
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MFZX^*D'@OQ3X*U'0_A;^V)X'_;*^,FO7O@WXZM<V_@'Q-;_%G]G?P'XU\0^
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MEUK0_#5_H?Q6@T&^L?AWJ7B;5A%I\FGIO_!23]B[6IOA2NA_&3^WK7XSZ?\
M##5/!6LZ#\.OBQK?ANQLOC7\2-?^#?PC?XD^*M*\"7?AKX*3_$CXO>%O$_PK
M\&67QFU;P#>:_P#$;PYK_@G3[>;Q)I%_IL'Y@7?_  3I^,?[*B_L9:#\%_%G
MP\\5^-?#W[7/PXNE^('@/]@[PMX+^&WPZ^&GPS_9,_:Y^$7A[XG?M"^!?@CX
MX\#>+?BW\0?%WC#X\Z/IGQ5\;M\;/AUX1N-1UNS\6?#WX4?#7PMX<^)FE^+.
MZ\1_\$7O&.HIX$70_P!J_1V7PIK?P;^+S6_Q%_9R'Q!TS1?VE_ 7[=?Q"_;^
M^*GQ2^$^CVWQS\'Z7\)/"?[0WQ5^)6H>%/B'X*TVVU[Q]'\./"/PY\$V?QKF
M\*^'-9T3Q. ?6DG_  5K_8NU;Q/\%_"GPT\8>./B]??&KXR#X)Z7=?#3X-?&
M'Q)I?A;Q*#\=[*:[\7ZA;> S'IMK%XA_9P^*WAJ.PMTO-:EG\/ZAXH?3K?X>
M:%XG\9Z';T/_ (*]?\$Z_$<FDQZ3^T*+FWUU_ $VCZK+\)OCE8^']3T7XE^+
MM7^'GAGQQ9^)-0^&=KH$_P ,8?B+HL_PY\8?%:/4C\-OAQ\1-0\-^ _B+XJ\
M*^+?%WA31M9P?!?[ GQ<\'^#/@QI$7[17@6?QM\#_P#@H7^TC^W+X8\7P?L]
M:BN@ZIHG[5&L?M3WWQ.^$.N>#=5^.NKZA%JUEIW[8?Q8TCP;\4M$\::6VD#2
M? MWK'@/Q';67BS2?%WS))_P1]^-TOPRN? 7_#8_P]M]8O/V1YOV7Y/%EI^R
MGXCB2WO[W]J]_P!I#5?B';Z%<_M5WH:SU;0)9/AO>>!KG5IP=26W\=)XL73X
M9_A[>@'W_P#$#_@I'^Q?\*]:^).A^/\ XS0>&+GX4>%/B=XT\5ZE?^ OB@?"
MMUH?P2O-%TWXU)X%\<V_@J7P1\4]=^#>I>(=*T[XN>%?AAXB\7>)OAC>SRVO
MCG2-!FL]06TR?$/_  4E_9HTOQE\'? ^A:GX\\<:S\7?VB=>_9E">#_A-\5M
M6D^'WQ'\._!?6/CO<1?$;3H_! U?PYINK_#ZV\.>)_"MS+I\G_"5^ ?%]K\9
M-!%[\$O"OQ ^(_A/XC\>_P#!&2^\26G[9V@^#OC1\$_!6@_M6Z/^UM'I.OZA
M^Q1\/?%'QR\"Z]^VW<>*]1^-</C3]H.Q^(OA#Q_\7/AUH6M_$KXF:_\ "#P3
M8_\ "K-=\(ZCK/A/2?&?CSXE> / EAX%U7WX?\$\_BZ_[1-U^T=<?M(^ E\3
M/^VI\,OVO;72+#]GGQ/%IL$'AK]A3Q1^P)\1OAI*^I_M)ZP\\?C+X9^)!XR\
M$^*XHK-?AUX^M[V]UOPO\3-+U1]*M0#]6$8.JL.C#/O^/OZU!=_ZB3_<D_\
M1;U87H.".W/7CC]>O:J]W_J)/]R3_P!%O0)[/T?Y,?%U;_=C_P#0:FJ&+JW^
M['_Z#4U +9>B_)!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B@\ G&<#IZ^U5[
M:X^T([B&>$)-<0;9XGA=C;7$MNTB(X#&"5HC);RXVSP/'/%NADC=@"Q1110
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M/U3^,?\ P3:^$/BCPK'IOPCTCPCX-U&#Q?\ %OQCJGAGXG:+XL^,OP>\>_\
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MN1X-U1? -B =-XL_X*4?&GX?^+OBQHWBW]GCX:W>F?LI>(_V9/!?[75M\/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD:GKNB?\%5/A_P##GXM_&SQAHW[-_B&X_8F^''BS_@FW\*-.M?BM8?$7PO\
ML;?%_7/@GH_A[XTZ-_PP3J?CSXF?#/X@?#SPWX7N?B5H/Q3TG3?B]/\ $?XQ
M6'M.C_MG?MO7VF?M+ZEX7_:?T[XT?$?]GO\ 8$_9"^.L'PJ\$? KPMX6TSQE
MXE^)_BC]K#X=_&/XJ+\-_$7PFO\ ]IW2QIWP\\!_!W]I[2/!$&AZK>W=QKO@
MJ+PC\-/$O@?XG>'? 'BD _IOHK^3R\_;P_:T;P_X3LH?^"C'AC6--NOV;?\
M@IW\:?"'Q3^&_P +O@EJ%M\5T_9M\+?LQ^-O@/;7_B_XO_LY_"CP9\1K[1?$
M7Q(^-/@/Q-\2_@3\)_!7PU\>>'OAIJ/@VV\$:#\5/"/Q%^(?A'Z1^'W_  41
M^-GQ3^).N:SHGQPG@^+$_@+X9^,?V8_V#O"GP7\/^+_AM^V+\'?BK^PGX:^+
M&D_'K2?B0WAR#XI:#;:+^U_J'Q8\ ^*_BWH'QO3X+_#[P/\ !*P^#WC+X1Q_
M&/X@>'_'/B  _HQ) ZD#) &3C))P!]22 /<XJCIVJ:;J]L;S2M0L=2LUNKZR
M-WI]W;WMM]LTR]N--U*U\^VDEB^TZ?J-I=:??0%Q-:7MM<6EPD<\,D:_C=_P
M24_:E^+G[3=E\5]:^(G[1_AO]H'1(M ^$6M6FE:5X"U?PYXH^ _Q'UQ/&%E\
M4O@]X]\1VG[.O[.?A72]<TZXT?PYJ%G\#=;T3QC\<_@Z)-0NOB;\0/$_AOQ[
M\,]3D^ /A;_P4 ^(^EZC^R3X:\/?M*>!K;PQXR_;H_:0^%'C?X6?!#P=^S?H
MGQ(\<:5KG_!6CXI?";X;^)M-^&NL?#V#0_C%\+M9^#%G WQXU;]FSQUX'_:'
M^"VA>+]%_;!\::9\<-!\93SD _J?HK\"/^"K7[:OQP_9J^+OC;0OA=^TEX?^
M#NE_#?\ X)8?MD?MJV/@[5/#OP<UL>./C=^SO\3O@59?!KP/KTOQ T75_$B>
M$OC0GB[QO\.]3T+PO>>&_$?B2UL]3'PX\0Z)XUTO^W-&\*^+O[?7QV^']G\=
M/@YHG[<&@>)O''A#_@H/X2^"'P^^,S>'?V=/#,=QX!\<_P#!/#0?VGM&\!>-
MO%UO\-?B+\,O EC?_&Y_&'@[X<7VG? ;XN_&;XSS>%&_9[\$Z4?'FL:O\:OA
MZ ?TN:AJ^EZ5]D&IZE8:>;^]MM-L!?7EM:&]U&\<1VFGVGVF6+[3?7<AV6UI
M#OGG?Y8HW;BI[LC[/*V1M$<A+$@ #RWY)Z <]2<5_(UJ/[>.K?M9-^PYXL_:
M!^-O@7P%XKE_:+_X([?%'X5?LV0>%/AOI&A?%GP_\6O#/P1\6_&7]J#P;XH\
M56VL_%>RN_A]^TEX]^,G[-6M6W@3X@6G@KX=6?P?O?AK\0M$UOQA\5K>_'Z-
M?\$F_P!L?]H']JO5/B"_QP^,'@SQ;K$'PN\+:_\ $SX$Z#X#\8Z5XV_9"^/<
MWB+7+3XF_!/QWXC'P*^"FC_#RWT.6YC\(^"O@SX^UOXV?&:\T[X<:E\8;;XX
M^.O GCK29-.!2^&7^%_DS]SHNK<C[L??_8_S_.I20,^H&<#D\>W6OY._!/[7
M7Q.^#OA3Q?\ #S7O^"A'CCX<:=9_&+_@M-JOBOXW_$7P_P#LY^-->T7]IS]G
M7]K>33_V7/V6_$-GK?P/T_PYI\'Q\^ OB?Q?^TI)\'+#2O#/Q6^(6G^'],TK
M]F;7?@]\(]$M/A^?T)_;,^,'QDN?V6?^"9'Q<^*7Q%^)G[&/BWXF_M#_ +(#
M?M,Z-\/IO &CVGP[\0?$?X>ZIXB\4^"_&5Y\7_ WQ AM-%\%?%*ST_PM9:)J
MGEIXAUF6Q\+ZW8>*]2U/3-)F 6ROV7Y'[4:/KFB^(;234-!U?3-;L(M0U?29
M+[2-0M-2LTU30-6OM!UW3FN;*:>%;_1==TS4M%U:S9Q<Z;JVGWVFWL4%Y:7$
M,>GD=,C(.",]">0/J1S7\?/PA_;>UO\ 9;^#%UIGPT_:J\-Z)\(?'WPY_P""
MNWQ!\&>$?#'@GX"^.+7X%^,_@U_P5V\,_#OX??$#X>VMN?!]O%X6\8?#7]HW
MQ]X@\4ZM\5?&GB?X"?#;PS\,[?XNPZ#I'PC^'7Q!TW7_ *H_8G_:_P#B#\:/
MVLOV.Y/C-^V5'K]T^E_\%7_@6V@?#WQU\&==^%/QJ^(7P0_:I_9AC^"6FWSZ
M!\!/AO\ \+ ^(GBK]F/XA0_$;3_&/A/PG\*KSQ'\+_AW9?&'X5>#/AW\*_B+
M\6C\0@9_2_17X9?&C]MKXQ^%OVM_VI?A9H7Q/URS^+GP-M8M1_9H_8'T3X(6
M'C6^_;0^$GB/]CG4O'.@?&BW\4?8+#XG:986/[7FH^)?ACXF^)'@OQ_HWPD\
M!Z3\!X?AAXO\.VOQ ^+FC^,;;XN^#'[?G[2WQ93]E'PI9?\ !1'X37]A^TM^
MUK:_!RU^)O@;P5X%\9^)?#-MXS_86_:@^(C?#/Q+>_$?]E?]FSX=I\3O 7Q^
M^&?P6U.Z^#&E^ 3\9/@K>_%?PW\(OCYJ?C:]\6^!KWQB ?U.@@YP0<<'!'!P
M#@^G!!Y[$'H:IVFI:=?R7T-C?V5Y-IEX=.U**TNH+B33]0%M;7IL;Y(9':TO
M!9WMG=FUN!'.+:[MIRGE3Q._\@'Q6_X*%?'/]F7]GCXK>'_ O[=7B;7OCS\-
M?CI_P6J\9:Y9?%[1_@!<ZGJFM_LD_M+>+-4^"WP4U[Q-?_##4+:XO/'GP@U7
MP9X[T_\ 9?\ AO\ "CPO\2/'7PU\:ZK\2_A[\?OV4?@%\(+2SUO[&L/VU=3\
M2?M7>+O@]\'_ -LWX-_#GPM\6?\ @J+X\^%%UX@\(Z%^S'>^,=1^#-S_ ,$=
M?A7^TM8>+[0:KX>=_$OBOP9\?]';X?Q_$3QQH?C._MX9K/X:>/KC5W\->'/#
M]J ?T9ZOK6CZ!8OJ>NZKINBZ;%/9VTNHZM?VFFV,5QJ%Y!I]A!)=WLT%NDU[
M?W5M8VD32"2YO+B"V@62::-&T@P(!Z \<\'.< $'N3P!ZU_/1\;?VDA^TW_P
M0P_9>_:7^)WB3X;:WXF^*_BC_@F'XW\<Z]X8U?0H/!:_$.+]M?\ 9CG^(\NC
M2W%SJ>G:+>>%]:TGQ9)K'AZ*]FN_"E]HVNZ UY:SZ-/=6_R5^TG^VG^VGX^\
M'?\ !5'P=IWQ_3P#XE^$/@3]L[1F_9P\&>#K^Z^-7PJ\*_!KXV:)I/P:^*6C
MW.N?LE^&$^&OPM^/O[,<MSXI\2?$'QW\</C*_P 5+3XGV'C7]F#Q;^S_ *C\
M//$0\*@']9*RJS;1P2"P!*Y(4A6. 2>&.#Q@'@X/%25_)MXV_;/^._P?U_\
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M5/D\,^"OAS\.?&OPMU#XR_&/6?&'P)_9/\&Z98>$? 7A[5+'QAXMNY?C9?\
MQ2M=:6&PN;;2O&5A\5/$&M7B3V7B[5U /Z&&(4$GM]/QZD#@<GGH#1N7.-PS
M@'&1G!S@X]#@X/?!QTK^2*__ &[?VJ?BM\)_&7CSXF_MIZ-\#-.\*?';]AK7
M/CY\./A_8>%K/Q[^PQ?2?\%&O@Q\%?CW\-?CSXX^(/[*_A;P%\$_A;H_PQ\8
M:_XI@\'?&SQ1\6_&?Q1L/A%K7QF\,?&OQW^R5K7C3PWJSK[]M']I7X,V_CWP
ME:?MVZ?X7?Q'^WI_P4(^'7B[XR?M-ZE\(M*\._!7QS\&?B%:S?LE?!3Q5?\
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M 4WBC1O''[3%]\8/"7[3/[)":18> -%^%<?C[X4^'_!/@;XZ6UGK_@>3XG_
ME_'-GX/^,D'C"*ZTK1M3 /ZB:IQZA92S&WBN[:6=5E=H8[B!Y42WG-M<.\2R
M&15@N 8)F*XBF!B<K("H_!3_ ()H_ME?'GXP?'3X:>$?BQ^U#X4^-^C?%[]G
MK]K7Q@O@^'PQ\&?"VH^&]7_92_;,TW]F3X9?$GPK;_#C3](\4OI_[1OPS7Q'
M\2?':>+&U[PEJWCSP_K>H_!*V^'G@?2-6\ Z/^9?[27AGX6Z[^V=_P %"_B/
MIF@?!N#X(?!?_@I;^Q%\2OVJ?VA_@]X3\.>(/VP?V5/!GA']F[]G^Y\7?&+X
M5>*=$U:RU#PIX"E^.O@GQ!\,/VP?$VG6^K^+_AU\-KS]HGQ'?>&/&<]OXPLO
M"@!_94"",@@CU!!'IUZ=>*7(YY' R?8'."?;@_D?2OY7OC/_ ,%/?VFK7XF_
MMS^*? G[37P6\%^!/A=\#/VF/'?P2^#V_P /?$W6/$'PB\+_ +)4_P 9OV8O
MVT?A_>:+^SG<>'_^%3_%?X@6&B2_\+Y^(_[3WC3]FWQ5#\2;/]F;0? /AG]H
M:S\*WOBEOQ9_X*3_ +2OA"_^)'P;TW]M7]GNX\/:5\;OV9[#Q3^V9J6H?!?X
M7Z1^S[\//VCOV//&'QK\-6_CG68?AI^TW\)_A]X$\:?'?0_!O@CX;_$SXI?!
MSQ7X?'P^\;6?PXUSXD:E\3?&'@SXMV !_5'17\UGQ*_;E_;[^%MU\.M:U+7D
M^(6A:I\(/V9OV_/&%_\ #SX*7GA#PA>?LD?!WP;JVB_\%/?AWX*\)?%3X;67
MQ>T[5=+UF/X3?$[X":#X^N/#GQG\1:G^T?X1^'NFZF=(^'7CC49/WA_9K;XH
MW'P0^'NK?&C5M0U7XF>)=(N/&/B>WU31_#NB:AX4E\:ZI?\ BS3/AM=6GA6S
MT_1+N;X4Z+K.F_#237X+&WN_%#^%&\2ZI&-4U:\I75^6^MKV\@/<J***8!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>"?
M'K]HCP9\ +#P.NNZ7XL\:>-OBIXS'PX^$/PH^'>E66M_$7XJ>/1X9\0^-)_#
M7A6SU?5?#_AO3DTOP;X2\4>+?$?BGQMXH\(>!/"?AG0-3UKQ5XKT6Q@267WN
MOS[_ &L_V?\ XL^)/VAOV.OVM_@IIWAKQIXM_9;U#XV^%O%OPH\4:RGA>3X@
M?!S]HGPKX2T+QW_P@/BRYL-2TK0/BGX/U_X=^ _%7A-/$,>E>'O%&EVGBOP/
MJOBOPA;^*/\ A(M. /HWX(_'>R^,]AXM2[^'/Q-^#OC'P#XKL_!?C3X;?&#2
MO#.D^+=%UO4?!WAKQWI[V&H^"_%OCOX?^-M OO#_ (JT\6OB[X=^./%_A276
M['Q+X876CXD\)>)]*TGW!KB-=VYD7:(V;?(B%5E9DB9@S JLKJR1EL!V4JI)
M&*_!/QO^PY\9/CW\1](\<?&OX MXX^%'BW_@I)H'QON_@#\>/BOH/QDL/A3^
MRL_["WB']GSX@>&Y?"'B#XA^-?A+X<?QK^T3X_\ '_Q7UCX8_!NZUGPQXH\
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M2QN/YE?V@?V>/$6B?%CP;\5/VJOV-?A?/X"_:)_;D_8=\.>&/@+XN^(/[/\
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M\0]-\/Z;XC\1^#]7LH;_ $+Q7%HWAOQ1XM;3M-UZRG^T:?IVMW&F>)(XT/\
M:6A:?YD ET]('P3^(OA.P_:#^&O@_P !?%O_ (2K3]&^*7@WQAX3T?P-J>N>
M/-1T7PQK&G^!]6T'Q9KL^DV)U^'P_K6K>%?#6KZYXET:/P]IVNZGI%QJ^A:;
M<:F$_&;PG^S[^WY>_P#!*[P)_P $Y],^!UA\(?&OA7]D/Q%\#_B%\6_'7Q9^
M'NN> ?%.I>%?A')X=\->$?AN_P ./&OBGQUI/AGXJ>.;BST#6_$_CCP.D7@G
MX4V'B6QG\':[K>M:2^F GL_1[[;=3^@6UO[2\A2ZM+RVO+6X)6VN;:YAFMIV
M#R1NL$\<C12LKH\9$;%@\;H0&5@/"OCC^T=X*^ -_P#!*Q\7:-XQUEOCS\=?
M!_[/?A.?PAI6G:PFB>-/'-AXBO\ 1]5\71W6LZ7>Z=X0A_X1C4K;5=9TRUUF
M;3;AK<W&G+;&:Y@_ B#_ ()=^(?&&J?#H_$'_@GM\.8/AG!IW[>'C/7_ (5_
M$#XP_"G]HFVT#XC_ !K^"_P"T3X?W8MO%%EX,\ >&[KQ!\3OAKXMFTGP;\.O
M">H?"_PQ/_8GQF\1ZCI/Q.\5:\WA6OX>_P""=_[8=QXW_9EU/Q[^S_X+\7>/
M/!W[2/\ P3B^/>H?M-ZU\5O ^L>*/@]\(OV>_P!DSX6?!'XQ_L[FTU2?4_&%
M_J?ACXX>$OB/\;/#^@_#NZO_ (0?$3_A:^L>,M0\0Z7\1WUS1=<!_P"2/Z>(
M[RUD,RI<12/;3QVMRJS(3;W4B6\B6TX#DPW#QW5M(D$H69DN(&"$31EOS]\0
M?\%*O@;X?\8:]X"N/A]^TO?^)_#OQ$^-7PQU#3=-_9\^(<S7OB+X">#/AS\5
M?'!\+2SZ?;1>-H-9^"?Q%3XV?"JT\(/KFN?&WX?>#/'"?"'1O&OC73M&\&Z_
M^('P[_X),?':+X8?"/P/\4OV,?A?XAUWPS\?OV#9_P!I7Q%JGQQ\'?&#PS^U
M##^SC\0_&5W\8OV@],^%_BS2OA]X%TG1/'_P]U[Q#)<WGQ$TG5_VFOB%JWQA
M\2?#?Q_)+\/_ (?1ZM\3OZ0]?A_9P_9(^$[^/M0\/> OA%\+_@KX.N]-T^]\
M/^#;:W_X1?PM=/X<T_\ X1'P=HWAC2+GQ#J>I>+[_P />"] T7P3X4T_4O$?
MC[Q/8>#?#FCZ1K_B,>'M/< Z_7_CC\(/#?PFL_CGJ/Q \-7'P>U30_"OB;1_
MB%H^HKXD\,Z_H'CJ?2+;P/JOAJ]\.KJI\3VGC.ZU_0K?PF?#T>IOXBGUG2X]
M(2\:]M]_I=OJ%C=,B07-K-++:6UX8XKF&5S8W32I:W857+/9W#QSK;W2J8+A
MHY?)D?:QK\.='_8N^,&J?\$2/@C^S%XF^$GAWQS\;?!7@/X!^.X?@/X^?PGJ
M-GID_@3XO^$/C+)\ /[6\93_ /"&6.M>%_AW8:A\"]-U?4M3M/"MO>6BQ/K4
M'AV5[PX_P0_82^.^A?M1_"[XC>(/@WX*^&_B3X:?MB_&']H+6?VFM USX<?;
MO%_[(GQ9_9T\>?#[P%^PGIEOX=MYOB/JMK\#O$_B+X1_#;_A%O$?A[P=\$[;
MX<_LU_#[XH^!?%-[XUAT+X>Z$ ?H)\;_ -N[PK\#_B#:?#J[^!'[1_Q OM4\
M?^"?A#H7B/P'X1\"VW@[Q)\7_B%X5NO'7ACX9^&=<^)'Q,^'3:]K$G@^TDUW
M6?$VF6=Q\./"R+)I7BCQQI&O6UYI5MW?[/7[7/@W]HKQ%\1?"FD?#WXR?#'Q
M!\+]*^%>I^)M#^-7@B#P#K9;XL^#KCQEIFEVNA2ZYJ>MQZIX9MK.]TGQ=;ZI
MI^F1VFK6DLFCS:WH4MGK=UY-^W=\,?BW\1];_8HO_A+\/-2\>0?"#]MCX8?&
MWXEIIGB?P5X;DTCX<^$O!7Q+\+:[=PIXQ\4^&?[=U,WGCK2;NQT;39)#=6>F
M:M)=7$<\&GZ;K'YV?'C]B;]H7Q;^WK\0_P!I?PO\ -/U34-,_;5_X)Y>,O@]
M\;7\3_!T>+/#/P"\!_!S7_!'[5MYX.;7?&FD^+/">GLEY=^'?$GA*^LY)OBK
M;ZEI<-IX6U?2;%]?T( _H+LM0TW47O/L%]9WKV%[-IM\MG=P7)L]0MDB:XLK
MM8)'-M>P1S0M-;3;+B))8F>-0Z$^+:C^TA\(=-_:/\,_LFW'BFV3XZ>*_@YX
MN^/6C^#@IDE/PR\%>,/"?@35M<NKA':*QENO$/C"SMM$L+KRKO7;;2?%5[I4
M5U:^%=>DL?S#_P""2_[&7QJ_9,O/'C_&#X2Z%X.\9WOP>^#'PI^)7Q;TCXXZ
M;\2;7]IWX@?!J]\=65I\7O#G@SP]\/OA[+X2LO$>G^)=8\5>(_%_QLE\9_M!
M>,M=\<VGA?QAXCN[3X8)XO\ B'YC\1_V8?VR-?UG2?VZ?#/@7XCWO[7G@O\
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MO]-T_4=2L([^#2+W4=>6*Z6XL=&OH8+M[?\ GH_9/_9UGT;Q1^QI^UK^S?\
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M3P,RB5$+ 'Y=_:2_;'^#G[+3V4?Q*E\2W$C?#[XM?&/Q(?"^DVVJ0_#SX+?
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MPUN^\/OJ>MZ!K'Q%_:6_9@USX_:FFN3V^L:SK'B3PGXNU.*P\7VVJZ5H>/\
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MQ/X7\/\ PUL_ >BZ-K?A_P 5Z[K(!^R&H?M4_ BS^#'Q-_:"\7Z[<>'?A/\
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M\$^*X?A[\:K#P5:>&_!\WBY8_$_@;7O#7A'PO:>+_A7XGOM$TS4[+Y(^,?\
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M!X(\!>$] \;Z;;Z4_B^S\86O"?\ P2CTWP+\&?V1?AEX%_:E^-WPZ\6_LF_
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MAOX=>&/$'CSXG^*?BEKOB'5/C;\1O'&LZ[XC^*VL^,O''BC59;#6]7T:7PX
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M/P/JWPIT&]^/OPZ\=_'SXH?M'V_A;QV-6^&'B>3P1JO@;QY\:?BKHO@7XD?
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MTVKP+XLZ;^SQXC^(?P%\-_&3PG\/O%?Q$C\:ZYXW_9X7QOX&T[Q9J?A[XB>
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MA:7-XWU.]_X2#7VN=2\3/J=]*VMZO(UQOU"Z:4 _G^_9,^)7Q1_9\_8?T/\
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M_P#X)M_LX>//@'\&;SX3? [P'XRT7QII?B[X'^'O"WP'34K3X5>._BAK%O\
M"SPU\0)M?\&>!-5\/? O6OBKK]K%\*O!GQ"\;ZUX&D^(^L:?>?#KPQKNNWEE
MJ>AQ@'Y.>!OV]OVB?V)OA/\ $WXC^*O#W@+XT?L]S_M;?\%OO#/AW0M1\:_$
M2;X^:)KO[)_Q+_;K_:'\):UK/COQ7J7B708_@K_PA_[/>H_ >7PS9^$[J_\
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M:H_CK1/UNU[]GO\ 8 AU2/\ 98\1_ ']G,GXXV=]\9Y_@Q??!?P3+X5^)*?
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MH&FM;:9X9OKN^N=%M[&YNKF60 _)F[_X*W_M"_#7P/K7Q$^,GPP^ \'AK5_
MW[;-WX&E\(>(_B%:VGACQO\ L@_\%!/@A^P;_:OQ:U[Q%HHMM.^&7BC6?CYH
MOQ"\4SZ1I4/B+X;>$?A[XHN;I_%%WK4=KX9[GXT?\%#OVT_A#XPM_@7H/PQ_
M9=^,/QX^'OA7]H'XJ_%>Y\&_$_PKX(^&WB3X;?!+Q#\+9-(TS4KCXV_''X8R
M?LN^,?$'PN^*OAWXI_%][[Q1^UB/V<- \2_"N^N?#GQ;\.?%!_$?@K]/[/\
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MX+KI7P=\&]GH_@3]N+4?"_[06H^&/%?_  4TUCXH_!3]A#]D6^^#5I\8-?\
MB+\/[[XT>+C?_M):%^T5&?#WA[Q-;_LYZY^U3XC_ &;];^$EM:Z?%XAUS4?
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M#^IZAXK\8^!--TOQ!\9/AUX>U*_\;_#OQOI'PT\=>$;'3]:\1:?>77B3P?\
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M#\&:3H?Q#G\>Z#XCL['6;;Q'=^+].UBZO;NZ@=-7\Y-9L[N_L=0MKZX^4_\
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M\3>,_&OBW1F\2:/9Z%/I&C>%+:[B\#^%\[P__P $U_VSO#WP0\"_L\W7CO\
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M77_!0_P1^R!\2OAUX \8?#7QKXEL/&T?@^]U3Q?H?B#X;6-MH>F^,_C1\/\
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M'X5^(KSX:>'?$EI\1-5\:R?'_P 4Z0/&&CP^"+WZ_P#V(?CQ\<OC+\<?V\M
M^-7A_P 8_#N#X6?%KX*Z)\//A!XU3X27NH?"SPWXL_9F^%OC?5M&M?&7PBU/
MQ#I/CRTUSQCKOB'Q3_;^L^)M7U?3KK6)_"48MM*\-:<]UXU_:7[7_P 7_P!N
M/]N3X/?#C]KWQ?\ "?P_\ ?AO^RGXQ^#GAK5_@M\!O'OPONO%7QV\-_' ^)]
M*^(\,WP^\/\ Q>\8>"M,U/X>^%M3L],\'_&WX9>,K,W&L03^+9[&]TH6C P/
M@1^P5^U)\/?VB/!GQT^)>L?LT^.$T[XU?MV?&C7]&T(_$31[W2K[]J;1_@G>
M_#S0O"VI:YX9\1F_E\ ^*?A/?:)X@\2:E'IDEYX7UK1=:T+0[+4/#"^'-5^>
M++_@D!\?]+_9U_8J^'$OB/\ 90^(OB[]G?X"?M._LV?&#P-\9_"7Q@\5_ OX
MI>$_VDO''@+QDWC[1)/!_BSX?^+(M?\ "MW\)_" \6_#[Q?H^M>$OB_X:U_Q
M3X!U/7/"4VG>&?B!:>T?LP?\%H?#?[1?A[]E^WM?V<OC7JGBKXWZ'\$+;XI:
MS\)- ;XH?#CX(>.?CK/XALO#Z7^JZ:MEXCU;X>:)_8FE>,_&/CV[T71O#_A'
MX:^._"FOWFIZE?Z7\1--\#?-_P +?^"M_P"T#X$_81TG5_'WP>^)?Q&_:6A_
M9^\3_%?X<?%[XNR? /PSX"_:DD^'O[0_PR^!?QP\8>'_  A\$_&B:IX1T[X/
M:]\>OA7+_P (-XV\&_ ;5?B3I=]?Z?X&?2K;2=0\368!].>&_P#@G5^T5X?^
M)NE>*HO%/P<AT6P_X*3>+_VRIK^PU7Q##XC_ .%:7/\ P3BN_P#@GYX5\/Z?
MHB_#6WT"T^(ES#JVH_%KQ!;)JD'AG2M3B3PQH>O7<.J2:[H_CNL?L<^/O@9\
M%_&%O^U;X6NOC;X-\:?\$SOV?/\ @FK>>$OV+? OQN^)GQ;UKQ9\'M?^/MSX
M2^(.@Z+:>!]2O? EI?:9\4-#?3_B'XDU^QT'X4^/]#_X2S6_$VEZ+JEO>:']
MD3?\%0]!T_Q%!;ZI\ /B8O@;4_C%XX_9<T/XAZ7XN^$-[I5U^UI\-OA9XL^(
MOC/X(:WI][XYTJX\)V%MXD\">,O@CH'Q6U^YM? >L_%_PW=0:A=:!\-]>\#_
M !&\6?8/[+/Q_O/VHO@UX8^-)^#_ ,2?@QX>\>Z;HOB7P)I7Q0U#X8WWB#Q9
M\/O%7A;0/%OA3Q]8)\+/'_Q$TS2M(\0Z;XACAM=&\2:GHWC/3;[2]2@U_P +
MZ4HLI;\ ^:O#G[$OBWQ1_P $U?'_ .R'\4/'_P#9'QO_ &E_@'\6?#W[1_QF
MT73[+Q"\OQ__ &F?"^O2_&_Q]I.FS#1X=;\+Z1XX\8ZS:>!_"-Q<:;;6/PVT
M'PI\/K+4=)T?1]-N+#YC^&?_  3H^/OAOXC_ +-OQC\1>%?V'?"WC?X5?&KQ
M[\9?BE:_!#PU\4_"LGQ%U>\_8Q^*/[+'@RYO?B)X]C^(7C+Q)JTNK_$J;Q$L
MGB6UCTSX4_#S0]&^''AK3_'NHV]WXUU#F?V8_P#@J1XC\*?!76[/X^>"OCS\
M7/&6@Z/_ ,%+OBMX%^+T]K^RSX=TSXW?"G]B/]MZX^!M_H]M'X/\:_##PUX(
MUSP/X*^)_P '](U?Q?\ $?P%\'/!5YIOA;Q]X[UW4[/3M(DUW7?:O"7_  5_
M^&'BM?@OI47P9^)5GXN^,7QB^)WP#M--OO&/P/TKPC9_%7X2_$?X:^ M>\*^
M&_BAXC^)F@>!OB3K7BW0OB-)\9/A-X/\&ZA>?$SXI_![P-X_UKPEX N_%GAY
MO!=P ?C[H7P$^.7[+_QV^"OP>N?@YXX^.4O[._P8_P""9_PJ'PQT+X??M2^#
M_A!^TE\2_P!@SX:R7/@;]H;P1^T!X4_8R_:*^%<O]D^+OB=INCVGASQS\>OV
M/O#W@CXA?#*;3/CU;:K\,;32OBQX_P"J_: _X)Z_MB?L_:5:?%SQ#XK\-?$?
M7[SQ1^S/X;7QY\#?AW\=O'WBGX?:I\"?VX=9_; TCXWZ3\$OA_\ !OXT^'?@
MMX.\0Z#:1?#B_P# WP;_ &=/B=\//AIXOUYM;\9^%_B#X3\<_$7XA^&/Z/?V
MI_VE-._98^'GA7XB:C\-?'_Q1LO%?QF^"7P3M=!^'%W\-M/UVV\2?'WXF^&_
MA%X%U.ZD^*7Q ^&WA[^R9/'OB_PQHE_Y6NOJ%O)KEM?/9KI%GK&I:9\-S?\
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M$NN_L8_M->&;?P5\$?A=^T!\9-)^(=EX*^$_BWX6_#CXB?'3XK_L_:EKVH^
M?B-K_ASXBZI9>&/%WPEU'Q):K%X.L]2\7_#G7-'\7Z-IT7VK3]+U( \/\/\
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ME#6[SX]QZ[IGQ5USPE^T,/B[/XK^&6J?'7XNR?"OP=KG[0.I3ZW\</&?P>\
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MS3_BEK?C7XI>/?AY\4O%WQ]U3XT_$^Z_:1/Q#^#UW=7GP;\2^&OC<?$Z^-O
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MAC-X0\;^']!TRV\3^*9[VV\->,](N/$5QXEUF/Q+=:Q8W26<7WS10!\+2_\
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MHH **** "BBB@!&W;3MX;'!]/?G@XZX/6D3<% 8Y8#D\#)]<#@9ZX'3I3J*
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M'M.U7X5_ WQO\3OAU\0_%+:?XDUE?'7B#5-+\%ZGXE^#OQ,\)^%_&FF3>._
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M\/O%WA#XJ6OBSQ-\&_B_X;\=VOQD^$+_ !)\6Q>#/'NGRZ9\/;OP-]P_M(?
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MOVP/VF]&_P"":'P[_:U\?W7[/Q^,WQJTS]D;5/AQHWA?P7\1U\'02_M6ZS\
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M_8>!O#WPR^(">!H/!&O? WXG-X0^(MO<^"_AIXDUCPE,EIJJ^)]'M!K5LNI
M'YD?#+_@J/\ M>^(?#'P/T3QLG[+^D?$']K7X5_\$F?B;\'?'=G\+_BCI7PM
M^#=S_P %%E_::F\5>#OBYX6UG]H"]\3_ !1U'PDW[+^K^'_A1JOAOQE\'?\
MA/\ XC?%3X>>!M9TS0'ANM9UBGH?Q8^-_P %/^"*?Q'^(/PT^-7A?0/B=X>_
M:\_:O\#W'Q8DT;QC\3=(@M/%G_!6WXS_  @UVZ\#KXD^)EQXEM8;73O$IM_
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MQ3T'6/"M]XT;7?%G[6?Q3U/P#XM\<WFA>*?B/>>//CS+X"\4P@'TO\%/C_\
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M$'[*WQ3\5?LZZ[X>\)?\%</#O[(?Q<OS^SSXU\1? []I/2]3_P"">6O?MK>
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MH%C0&&,K4E_9O_9XN-)\9Z!=_ CX-W6@_$71O"WAOXAZ'/\ "OP3)H_CS0/
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MS6? _B_XE?!;XQ7'P-A\0:EH>E^+O#6M?#WQ;I4OP?FU[X>_$1_"5CXCL(_
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MS^+'Q0T'P3\:OAP-;_X*,6'[2C_'.Q^,FG:#^S)XD_8KN_V)?@A\*/BAX?\
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M:^'W[2WB;X9?$WPQXN\6?%?X#_$_]DKXR^*OBE\0?CYIOC+7O@5#X8TGXV^
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M_#NY\?\ @30]:M- \6^%&^(NAVWQ#TV7P3XMMO"4>H>&M>\1:7Q"_P""K'P
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M,WQ0^)/ASPSX@\"?&?Q_\;/"GQI^%W@?]E[5_P!HK2_BW^S+XF\*? G2M/\
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M="^,OPH^'7Q!\">*C^S[H5G\3?&'A[QUX=L--\'Z@=?\*Z?XO\7P:-8>(=;
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M_P#V:?"WA_PO^S5^TQ\-OCA\&/\ @EIH'@3P$W@WXCV'AS[1^VUX*_:4N_\
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M&H?"+XZZSI7PK\8>)/!W@W3;CXE>&OB?X5\'>/KOP3XXE\5^#==\"V(!X?\
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MC>,/!/@?7_"'B+X;:9X1\$WNJ1B+Q-HWB&S^(.D:K8:]872:CX:TGYC^,_\
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MA>_'*Z\8ZSHGC75?&?B;P=8^(]/ATS._:$_9%_:M^,7[1'A/XP^#OVL_A/\
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M1]'\,\)XE_X*H?$3P[HWQI\;ZS^RC%X&^&WP-T']FR7X@ZY\4OCGIO@SQ?\
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M^+8/&/PD\/:)X9TOXK?%Z76[V'QE\+/%7QX_X5;X+\/W.I_%?PYX7UF8:!"
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MH6A_,MU_P5K^(FG^"_%/[43?L\:A)J7A3]@FX^,WBCX/ZC^T?XNT;P%9>,?
M7[:/BC]GKQOX8TO0[_\ 9S,VF>(;BWT;Q%XA\.?$KQ%;:=K'B>RTS1?A_P"(
M? G@"PL=6\=1?K1^R9^T/X_^.9_:'\*_%;X;^%/AG\4?V:_V@]0^!'CC2/ 7
MQ USXF^ ]6N;SX._!KX^>$]>\*^+_$_PY^$OB2]M;GX??'7P=INM1ZO\/=!,
M/BS2O$)TE=2\.R:)J^H@'YL^(_\ @BMJLNA_M6>$?A]^TKX%\ ^'/V@-=^+F
MO^"=;3]CKX3:O\:? #_'CXX:-\=/B'X<^(GQ_L_$OAWXI?&KP?H7B%?&VF_"
M;3HM;^&6O^&]/\=3?\+*\4_&0>%/",&D[/[1O_!'OQS^T,G[1FFZE^U;X?TW
MPA^TE\5_VBOB9XH\ :U^SK<>,/!.CWOQL_9C^!O[,O@GQ)9>'Y_CKH]GKOQ>
M_9_T7X,7?BSX6_$'Q>FO^%-.\2?$CQ1JD7PJL?$.B> _$OA2/]C#]O[XA_%W
M]N#XH^$_&&J:[=? S]JKPAXX^(?["EAX@^'/C[P%X;TG3_V8?&-W\,?$]AI/
MQ&\8^%])TOXHZ7^U7\+-4^&?[9OPKU7P#:Z_;Z=\.M;\;+=O=Z=HVA:KXF\J
M\._\%K/V@M:^%6D_&F[_ &*?A%:>!+K]DGPK^VCJ,EE^V)XQO]:M_A#??%6_
M^%?BC3;'2I_V/=,>[^(-O<V\'B;P5X=N9+'1?$&C)>V'B_Q5\.]>6UTV< _4
M'XD_LH^/_B!XC_8$U^+XQ^&=&'[&'Q)_X6;XLM)/A3K6H_\ "YM6G_9W^(O[
M.=]IVCS6_P 7='7X7Z7<>'?BWX[\011:A;_%*:'6CX5@FEN]*T;6[/Q9\ZW_
M /P3;^(L?Q4^(GQTT']I#PIH/Q/U#]O#3/VZ/A#<0_ /4KGPAX'UD?LDQ_L.
M^*/A9\1?#!^.,-_\5O"OBK]GR+RI-<T#Q)\)=?T3XD7.I^,M+=="O1X'M_'_
M (F?\%=/B]X2L?VPO'WA#]C.T\5_ ;]EWPS^VW;:?\7-8_:#TWP;_P )/\7O
MV(WUT>*/AMXF\,:C\,[E/#P^(\'PZ^,.H^";GP)XC^+'B32]&\%>'/$/Q#\(
M>"O#'CPZ[X6](TC_ (*$?'CQ9\3M;_9,U?\ 9I^%N@_M.CX^>-/@S/IFD?M5
M>,Y/@ROP^\._LF_"S]J?4/B+H_QI?]F+0_'_ /PF]OH?QP^'O@-_A]IWP3DO
M=-\17FJ^,[/Q/?>%=#>XN #D=:_X)!ZCK=A8*O[35SH_B&P^&GQ@EMO%F@_!
M?1%OK3]J;XR?M]^"_P#@I!K/QYL]&U[QQX@\(?\ "NM!_:)^'_AR#0O@!J7A
M_4K@?#P:GX7U3XNZG=W-GK.GV=*_X)??M%^'OBAJ?[1_AK]MCP9X9_:<\0_'
MCXU_$SQ#XRTC]DYKWX1:I\,/VAO@;^S+\'/B;\&&^$'BG]HGQ-K\0AU?]DOX
M.?%+P'X]D^+-Q=^&_%7AN/1_$7A_QMX/O=9T#6/DG]G/_@J/^U%\-_V8_P!E
MK0=4^ >B_M$ZQX?_ &2/^"5OCWXO_%GQS^T_XET3XH_$#Q3_ ,%$?BOXN_98
M\*_V/X=;X">.-*\3^*-$^.O@J?5/&6LW_P 1+/0-4\%W5_JOA2YO-6.A^&]3
M^@-9_P""O7Q@A\->'=#\'_L@VWQ*_:3TZ;]M!OBM\#OA]\5?B-XM\/65C^Q+
M^TM!^S'XN;X3_$C1?V9+N[\33_$[Q7<)JO@;6OBSX+^"/@#P[%;WVA_$CQEX
M2U1;6>< ]8E_X)H_$#PMXBBO-&_:,E\7?"WPA^TYXD_;L\&^!M<^!_AW5OC=
M<?M2ZE\(O$7A*ZN;SXO)\5/ 'PZU#P!XG^*'B77_ (RZEX)B^%/@/4Y/$^OZ
MAX#M?BMX7^$T]OX>TC])/V>E^,J? SX0Q_M$3^'[KX[1_#CP<GQ?NO"NGP:5
MX=N?B*NAV8\6SZ5IMIJ6M6-A;RZR+N1K+3=8U;2K69I(=*U*^TY+:YE_)7Q#
M_P %:/BZOBWQ;X8T']FWX76.D7/Q#_;Z^"/PD\8ZS^T7X@U2Y\0?%?\ 8D^'
M7C#XHG4/'O@S1?@&ECX6^&OC+PMX1O+75M2T;XB^)/$F@>+Q)H.D:/XF\+OI
M_P 1+_\ 3G]C?X@_$SXL?LG?LW?%#XQV7AVP^)_Q%^"/PT\;^-HO"=WJ%WH$
M^N>*?"6E:W<ZA8)JOA[PM?:8=52]BU.[\/2Z+''X8O[NZ\.6NH:Y::7!KFH@
M'TG1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !7S%\1/AC^S?\ %/X^?"76?&FMP7W[0/P&T_Q-X\^%WAW1?C-XQ\(^
M*?#&C^/-'N_ GB3Q;=?#;P;XZT"#Q-HVMZ2;[PV=7\7^&=>TV%?M=G836\WG
M"OIVOR%_;Z^&4'QL_:U_8^^'_@OXT6'P)_:*\)_";]JSXQ?LU_$.VGL;_6?#
M?QB\':W^S38:5!X@\"-K6C7?Q.^$_C?X9ZO\9_!'Q4^'5W+)IOB;P%J?BF_T
MN;P_XV\+^%?'G@L ],\&_P#!/'_@G+XA\,>(OA=X0\'6'CGPQX'^#OA[]CKQ
M-X1_X:'^,?Q$C\ ^ _ASXZ@^+G@;P)?0:G\6=?O_  -\3OA;X^ELO&_P]^("
M2:/\:OAMJL6E7_A'Q?H2V.F?9^P^)7_!.+]G;QE\%_$WP8\(Z9XF^&=AXH\"
M?\*YF\5>&/B)\7!XHT[1M0^+VG_&SQ1XO@U6W^).FZAK'QI\0_$6"_\ '=]\
M9_%]]XE\;>(?'E_+K?Q)N_B-H5WXB\(^(_S$TW]H?X]:5XTNKKXW:QX\_P""
M</A+XR_M9?%:U_:P^+EI:_"[6-(^''Q?^%'[#G[)OA#X<^"_#'Q5^+OP[^*/
MPP7X+?'CQ-X;\8>./A+\7O%NA>';WQAIGA/P'\)I].\,_$/QZ/AY%^H7_!/W
M]I;QA\;O@1\'/#GQ_0^'_P!L33OV:?@'\7OVA/AZ_A/Q'X2O=!3XR67BVS\'
M>+=3T36-!T>R\)ZC\0;OX=^+]6U+X;)*^O\ PVUBRU7P=XAL+&YTF%KD ]/^
M.?[.W[/?[4/BGX?:;\4+SQ5J/CKX :T?BAX(LOAK^T%\9/@QXN^'NN>.O#GB
MSX>V_CJ9/@=\3/A]KXGUOPO<?$#P?X?USQ!]J4:1J/CW2-!GA@U?Q1!=>)ZC
M_P $O?V0[_6],U>Y\,_$^_N?^$6_:4\%^*M0UK]H[]H7Q)XG^(&D_M6>!O!/
MPY^+T_Q"^(7BCXFZU\2?&6O7O@;X:^ _"/A3Q%JGC)_$7P[\.^#/!ND^!-2\
M/Z;X)\)VFC<)\&X?AWIO_!7W]NI_#$'@W3O$OBK]B3]@2]\92^';GP[9ZMXG
M\;>%OBG^W):^(+GQ;8Z6L&I:[XV\+> /$/P6MM7U#6FU/6/#O@3Q%\)[.ZET
MW0/$/A"+4/D/]MWXM?%SX$?MH?M,^*_ /Q@^,&BSZC^RA_P3UOX/#^B>%O"?
MCW3?AU\$-?\ VU/C1\-/VU_CO\,/!NK?"3Q7-K'B;]FSX+2Z-\6M2D?5M7T7
M0=6\6V/B;XP>%?B'X*TCX?\ @K3 #]!M9_X)O_L%:'-J?Q$U[X0Z5I5WI'P7
M;X5Z]X[U?XG_ !0T^ZLOA[H/P=D^",_C'7_%5Y\089U^*.F_ :&?X6ZA^TEJ
MU^WQUC^%_P!K\*7WQ0/AN2YLW^$OB3^Q)X!_:I^)_AR\_8W_ &T_A':^!?@M
M^SC\+/V:K#P9X#^-W[5&N_$#X)Z9\/[_ ,<7OASQ./B3^R/^WG^SYXR\:7GB
M30/%VB:?-H?Q\O?%UW;/X*M]6\/^*K=O&_C>+5ON']A/XS>+/$_PR_:&\2?$
MGXS)\8_@O\,OCYX[T?X$?M5>)V^'>CV'Q@_9TT3X:_#+QC=?$34O$OP_\->
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M-*_96\4?!X?%6T\(_#GX0?$[P)\.OC@WC/4?"GACX$1^*[+P'X2U3X6+X_\
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M3]EW]C?]HG0_&K_LQ:%\3])_:%^-GQ/\>S3_ +3W[+&F>"O@9^SAJ=OXDO\
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M\1+CQ7/KNK3W?X8:Q_P4#_;4LO!WQZ\6>.?VK+_X#?$'PYJ_@G1/B'\#=6^
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MOVH/"EY\:/VK?V;/AU\3-6UK]C_3_A/XZ^!?B?X@_LX?M/V'QL^%L^J_M(?
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M;6/!FOZW>>!I]2CUK4H+)^?^&G[7_P"WGX\U3]@S4_%_[17QI^$T'B_]D/\
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M1?C=\0O@Q\._!>I?$Z*^^*#/\2 #^@GQ#^QM^P)X1^)?PUU#Q;X>\-:#X_\
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MT_X)7_M'_$G7/&GA==6^%OP9O=,^)?\ P5(^(?@G]L/P'XT\7:A\:/'?A/\
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M96VIWVG:2D/]K:E9V-Q<)=W-AI:7$)U&]ABDM[%9D:ZEB5U)_$OP_P#\$_\
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M^/\ 2;'P;=ZG\*_A]IVKZC_P73M-5\>:9\0?&/B'Q!X"LO\ @J#\2O%WQ*^
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MQ!^&OQ$CAU+2M2^&?@KQ3X/U_P ,MX<U?3-;T46NK76O>&M0U/P]>>$^(/\
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MY?BYH_BM]*U7Q+-XUT_1Y-3U2]T#2K/08@#NM$UO]IOX'Z_XP\7_ +3OQB^
M_C+]F/PK\%/''Q(\8?$_P[\*?$?P5\3_  R\5>"K[1=9UD:[9:A\7?BGI&N_
M#&;P)-XPUW2+JTL]/\0^$U\'FP\4:YXRN-8LM3'*?L!_M:^-/VI/"/Q<LOC!
MX'TWX7_&OX1?%J]TGQ)\-K.\BFO="^&'Q3\*^&OCS^S1J6JVZZKK$G_"22?
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M* "BBB@ HHHH 0C((/0\<$C]1@C\*:$4#'./=F)/.>23DG/.22:?10 4444
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MJOA#Q_\ $+X6>,;?P?\ $?QOX0\/> OB-'X.^(7PJ\>^%?%5W\/_ !'XEL]
MU#0EFU&>#3]7T.]U, ^BZ*\3^'_[0WPC^*/C[QG\-? ?BU/$WBCP'X#^$?Q0
MU\Z?I.M'PW)\/OCM;^,[KX4>+?#/C>73H_!GCO0O%UO\/O&#6VI^!M>\1V5A
M)HD]OJT]A<S6L,_:?#_XA>'OB9X:7Q9X9M_%-KI+:YXL\/>5XR\#>-/ASKJZ
MAX+\5:UX,UN27PO\0-!\,^)8=+DUK0-0DT'6I=)32/%6AMI_BCPQ>ZOX9UC2
M=6O0#N**\F\1?&_X;>%?C!\,O@-K>L:G;_%'XP>&/B/XS\ :%;^$_%VH:;JW
MAGX2MX1C^(&J7OB[3]"NO!OA[^PI_'O@VV2P\1:_I6J:Q/X@LTT*QU,0WS6G
M;ZUXN\,>'-1\*:/KWB#1M&U;QWX@N/"G@G3-4U2PT^_\7^)[3PMXD\<77A[P
MS:7MQ!-KNMVO@OP;XO\ %MQI>F)<WL/AOPMXAUN2!=.T>_N( #HJ*Y[POXL\
M->-O#ND>+_!VNZ/XJ\*>(=/M=6\/^)O#NJ:?K>@:]I%["MQ9ZOHVL:9<W6G:
MGIEW"XDM;ZTN);>YCQ+#))"R2-T- !17A_Q>_:0^"WP)TR[U;XG>.=/T*#3M
M>^"_AS5;2SMM0\1ZSHE]^T/\4X?@I\&+S7] \-6FKZWH'ASQ_P#$^2X\)Z/X
MOUK3[#PHE]I.O2WVLVEIH&LW%C[?N7)&X9'49&1P#R.HX(//8CU% "T5\Z_M
M ?M4_!S]F-?AZ?BU<?$B.;XK>*;[P/\ #VP^&OP*^.?QVUCQ-XPT_P ,ZSXS
MN/#EGH/P*^'/Q(UR#57\)^'/$GB&SMK[3K4ZCI7AOQ#=:>;E-%U(VW2_!G]H
M/X/_ +0.F>(=2^$_C.W\1S>#=</A;QWX;O\ 2M>\(>/_ (<^*A96NJ#PI\3/
MAIXUTKP[\0_AKXIDTC4--UJ#PYX[\,>'M:N-$U/3-9M[&73-0L[J8 ]EHKQ_
MPQ\=/A]XO^,OQ:^ FBW&OGXE?!/PI\*/&OCW3=2\)^)=%TJ#P[\:G^($?@#4
M/#GB/6-+L="\:6NH3?#'QE9ZA>^$;_6M/T75=(N]!U6\M=>LM1TRR[[PWXN\
M+^,=.N=8\)^(=$\2:39Z]XI\+7>J:%JMAJVGVWB?P-XIUCP/XU\.W%WI]Q<0
M0:YX0\:>'M>\)>)]*E=+[0_$NBZKHFI06VI:?=VT0!T5%(&!XZ'&<'AL9QG!
MYQ[]*"R@%BP"C.6)&!MSNR>@VX.<],'/2@!:*YOQ%XO\+^$+;2[OQ5K^C>'+
M76_$&@^$]'N-<U73]*AU7Q1XIU.WT;PUX=TV2_N;=;[6]?U:[MM-T?2[4RWN
MH7L\=O:P2R,%/*>$OC!X'\8'1;:VNM8\.:YXDOOB)9>'O!_Q#\->(/AGX\UZ
M+X5^)CX3\:ZUHO@/Q_IOASQ?JOA73]4DT^ZL/%]AHMQX7U_P]KWA7Q7H.KZE
MX9\6^&=6U8 ]/HK UOQ3X<\-OHB:]K6F:0_B77;;POX?34+ZUM'UKQ)>PWES
M9Z%IB3RQM?:K<V^GW\\-E;"2=H;*[F*"*WF=-[(XY'/3GKQGCUXYX[<T +13
M=RY W+DD@#(R2 20!G)( )('0 YZ4H()(!!(." 02#@'!'8X(//8@]"* %HI
MJNKKN1@Z\C*D,"5)5@""1D,"I'8@@\BOG31/VJ/A+XC\3Z_X/T+_ (6)JNO^
M%/VA;C]E_P 4V=E\(/BI<1>&?BS;?"K2?C8T?B.]B\(-9:!X G^&>OZ#XDT_
MXNZQ<67PJU7^W= TG2_&-YK>OZ)IVH 'T;17CJ?'?X<R?'J?]FN.^UIOBQ;?
M""V^.D^F'PMXD3P\OPYOO&=UX!L=1A\;R:6G@V]UBX\2V%_;2>%K#7+KQ-IU
MC;0ZOJ^DZ=I6K:%>:K[#D'!!!!Z<CG@GCUX!/'8&@!:*SM6U2UT;3M0U2\6[
MEM],L+O4[J'3=/OM7U)[2QA:>Y-CH^E6]YJVJW(C1A!I^EV5YJ-[,4M;&TN;
MN:&"3B/@[\6? _QZ^$OPP^.'PQU.XUSX;?&/X>^#/BG\/=<NM,U'19];\#?$
M#P[I_BOPEK,NCZQ;66L:4VJZ!JNGZA_9VK6-CJ=D+D6^H6=K=QS01@'I%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWQK\#_AGI/B7X?7GQ0UGP[X+\7>*O!7CV?Q3X3O_ !+HTMA\.?%VF/J.K:2
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M\1^*_'=I9_K5\?/BUXQ_:[_X)J?\+<_9V^$?Q3UC4OB_:?"/7M&^&T?B/2]
M^(<?@-_C=X,B^(&KQS?#;XQ^&?#?Q:\.:5\/M.\2>-)_ /@#]H'P[X7_ &GO
MAO;3> ?"'Q8L]%^)VF>(F]<\+_\ !2?]BSQCI'Q"U_1?C+'%HOPXT/PQXIU#
M4]=^'WQ1\)VOC+PEXZ\6_P#" > /&_P3?Q3X(TE_VA?!'Q"^(8B^'WP\\9?
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M'\(?B-X<^$OQ2UKXR^"[KX:Q^+?@'X1\ ?$;Q=X6\+>*?&_QOT3X?>#]'O\
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M5HGQ"\%>(-#^'WC?Q1I^NS>&/#&KZQ; 'X5?LW?L5_MG^!M+_P"">OAWQ!\
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MGXC^'OBA)\"8?AWXM\":[X7MUT2[F^'/AZ%_'/A_QII?AK2[_P"??BO^Q?\
MME:Y'KOPUT7X.?ML7'[/OP^_:'_;XTGX0>"_@9\?_P!F'P1\2O!,7Q$U_P"
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M* 'S)\8_@[^T=XI_X)G?LL_"27]F+3M;^)VA6/[)NG_';]GKX?\ Q1TO6H_
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MGXF>&?@CI?[2=]X$E^%\'P2D^(5IXHU/X!:UIWQ<\':1=^&H;KQ]X%ENM?\
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M2TOQ/:^.OCY:3W'QO\'?M\^%?VH+S0?A%<:')XWU#]NKQ3^S)XN3Q+\%8O\
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MZI%K]W96VH6U_:Z9,^J_,WQ1_P""EOQU\<> /C1X?\0? OPK\*_AKXQ\7?\
M!27]CKX<?&'X1_M3^+-6^,OAK]HK]B[X;?M4>,I_&%]X8/P0^%DOA+P-XC\+
M?LV>*-2\.>+O"'C[Q%XP\*>/9-"TK4?"UQH6I1^)[?BO@W^WE\6/@?H'AC3+
MKX=>,?C/\5?B7^RG_P $=?#?P?B\:?M0ZUJ.@?$WQ]^TA\-_VE'\0^)->T+X
MBZ#IWAWX1^.UO_@EX]?7)M!\6^-]2_:0\3Q?#/2=8\6>%_$FJ$>' #Z#\/\
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MX7_;6^'.M_#GQWJWP>\ ZEHAM_ GQ%9?$=EXG\">')_$?Q+^'6CZ;H/B'3?
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M[U1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7R3^TQ\ OV3?&D=O\ '?\ :>TOPU96/P/\)>+K^#XI>,OB'XB^'VB?
M"CP5>VMK?^/]4;Q-9>+?#.D^#]!U.PT33[CQKJTUS96VI6&B:8-?NKBST;3T
MM/K:OY^/^"VVM_&S5_"OQ:^#%G9?M1R?![XK_P#!.C]M#P]\+K#]F+X0?$[X
MIV7Q)_;+U?PO:Z!X%^%?QQN?@[\.?B-XT\.^&M7^'^JZ[+X(T_6(?#?PO\1Q
M7?Q.U3QMK'_"2>"_AM/I@!^I_P#PQQ^R!XL^#?PY^%>C?!/X:Z1\(/!FH7/C
M[X3Z/\--/_X5S;^#=7\66VO7&N>+_AWXA^&UYX9USPMJWCJQ\;>,(O&>N^&]
M8L[[QYI?CCQE9>*[O6]/\8>(H-3OS_L2?L>S?$SX:_&-OV:_@I%\3/@QX8\+
M^#/A;XMM/AYX:LM1\ ^%/!$-S:^ -!\-Q65A;V&G:=X MKW4+?X?1I9EO D&
MH:C%X1?15OKOSOP6O_&'_!1>?XN?&:3X5>+OVJ_#_P 7-%^!7Q*A_9R^!J_L
MC?&*P_9]\1> =0_8,M=5_9]\2>*/BY\:?BWH_P"S)X2\2^&_VEK71D\1^$KC
MX2^&OVO4_:'U/7OA!XR.H?LOV]YXA\(TOASJO[0WB1/V>/"&M_M&_P#!31/@
M?\3?C[\1V\=^)M7_ &8?VKOV;/&WP_\ A+:_L#_%"3QMX-\0^+/BOXW^._[3
M4,?@;]J+PI\&]4T/QYXG\4>!="OOBE\8?%W@?]G;Q;\4/#&C3V7PB /V;TW_
M ()7_P#!/#2+3Q#9Z'^R7\(=%C\56RZ?XA;1=&O=(O-4T:T^)?A[XR:-X:GO
M].U*VU"/PGX1^*/A3PUXV\!^$H+J+PU\/==T;3Y_!&E>'XX?);5\=? /]@K]
MF/2->_:5^*/A/X2_"G0?AKXO^+_QK\0?%;Q]K$NGZ%X<\9_M!Z?8^#?C'XNU
M34?$FKW%A-KGQ>LI-+\+Z_!<K=W/C#4+ZSTFSLKG4]1MK6;\(O WQC_X*-#]
MFZ^MM3\7?MJ^*O'?B[]B7_@F#\;?CK<^*OV:_C/J_COP9\4/$WQX^)?A/_@H
MKX8^#>D> ;']G?Q+HOC'P1\(H_AS!XB^#7P;\9:-\5[?1;*^\3_!];#XHW^M
M^,[[S_\ :KMOVO?%O[(GQ(^#?Q*;_@HA\>_"7BG]D7XDV_['OB/P_P#LK_M0
M^ _$/Q6^,I_:&^+UAXHT/]J3X7_#;5OCI\:K#1?#7[-NH? C3/@/IW[;6GV>
MN?$GPY_PGWC_ ,8>'-9_:*TJ6\T( _H#MOV2/^"='[,MU\$-%T?X.?!'X!7N
MI?'/5_\ A0EEX0M$^&$VH_'OQU\,O&NDW^G>#CX7O=&^V^*]2^#NE>/?#6G:
M*K26]C\,[77O"FB6=GX62ZTP^4> /@G_ ,$A_B^/A1\._A/X7_9:\9ZE)\,O
M%.G? Y/A=JFDR^,])^$7[.WQ^OGU2^^%?C+P=JT?C'PUX%^"G[1U]JL7@KQ-
MX4U[3=*^'_CO5=2L_ASJ^ES:C=QS>H?MI?$+QUHWBG]@23X=WGQDL-*\8_MK
M_#&R^)5A\/?!'Q.ODO/A+KGPQ^*D%S'\9;;PKX,UK5_ WPWM?'E_\-I-?U'Q
MPG@_PQIFOQ:58>-]8TW11K48_"GX:6?[5^F?#SX0:C^SK\,/CSX<^/5K^S=_
MP<6:E\)[WQ?\!/BGX/&@?%/X]_\ !1+X:?&G]G.7Q%#\3_ >A>%O WC/XN?"
MKPEXV\6?!71?C%J'ASP]K.NIH6EZS-'9W;"] /ZJ?AY\-_ 'PD\%Z#\//AOX
M5\/^!?!/AM+B'0?#'AG3K32=(TY[V^NM5U">&UMHU6:_U;5[^_UO6=2NC<:E
MK.MZCJ&L:K=WNI7]U<S<?HW[/7P&\++H*>%OA#\-O"I\)?#KQ;\(?"DGACP;
MH/AJ;PM\+/'.K:'X@\:?#_PW=:'9:?<>'O"'B77?#'AO7M<T;2);&QO]8T#1
MM6NHVO;"VN8_YC_%?Q>_:0\(^#/A[X)\,_$+_@H=X]\#^.OBA\9_%'@SPMXL
M^ O_  4O^"'Q8T?0]"_9VTK3#<3ZIX9T_P#;A_X*2ZW\)O@/^TCXQ\ 3>(KS
MXQ>$Y?AIXZ\>_%K6?#^A>(_$?P?^&_PX\!7G6Z7\<?VF[SX[_L;Z_P##?XE?
MMY_&'P#\/?%?[''P\^('Q'M?@5^UQXM^%/QF\(W6E^-_!?[8WCWQ'X,\*?#7
M2?A[\,=8\/?&6VOO 7Q8^'7[4V@_$K]J/X4?$?1&E\&:#^S)\/?AM=ZSXL /
MV?\ AE^R1_P3@^//P<\.^)?A9\'_ (%?$_X%>-?@-8? #PSJ_ANS37_ /C#]
MG'PUX[NO%>@?#73YX[Z72_$'PQ\/>.;"YU7PC8$7FBZ6@EC\-/!I%V5F^R/B
M9\*OAG\9/!=Q\/?BGX0T'QQX/NKO0]3.B^(K07<5MK?A;5K#Q%X5\2Z5<B1+
M_1?%/A/Q'I>E>)?"7BK1[NR\0^%_$6F:;X@T#4]/U>PL[Z'\>/V:[3]J_3?^
M"%IT7X!>!_'/PN_:[T?]GOXUZ;\.O 'Q#\$:Q\/OB7X3\=)XJ\=3:)IEAX5^
M)7AKP-'IWQ CT2XAF^&LOC#P[I7@;4/%D_A?4M;CE\&SWDLGRY>7W[2>I_%?
MX8>#/@YXJ_X*1:1^Q'XZ_:R_9D\%66M_$70_VO#^T%X.\/\ B?\ 97_:E\/?
MM/KXM\:_%OPK=_'?0_@GX?\ BSJW[(NNV/Q/^*FN:MX,\'?&C5OB,OAKQ5IW
MA#P;-I/AH _:KQA_P3Z_8@\?^"OA]\._'W[*OP)\=^#_ (7>(/$GBGP'I'C7
MX=>'/%(T#Q+XTU(:Q\0-;6^UVRO]1U/4_B;J8>]^*]YK5YJ4_P 5;F:[G^([
M^*9;V^:Y]S^)'P7^&/Q?B\!V_P 3/".D^+H?AC\0O"?Q9\ QZG]I"^%?B;X$
MFN[CP=XRTP6MS;E=8\-S7=U+I4DWFPP2.[F%W"M'\5?MW7'Q:^%WA?\ 8P\:
M_#O6_CYKFA_"C]K;X-G]H"Y^%N@?$[XE^./&'P'O_"'COP?XPE\:_"_X)Z%K
M'B/XEV6H^+=4\!:EK]MH_P /]=BT6]W^)X-*T/2-.U+4=._$O0?B)^V[8?"S
M4O$NI>)/^"C=MX@^#_P<_9S^(?@'1-7^&G[7,^K>,?'?AG_@J#^TQX*\9Z+X
MTTY_AYK.J_&"^NOV7]<^%MK\1?!-[=>*]+\3_#.'PC\0KQM9\'Z)I?Q!L0#]
M]K7_ ()L?L06'A&+P)!\ _#TG@ZW^$_B_P"!,7AN]\1^/-2TJ/X._$/QHWQ#
M^('PX6UU#Q9=(/"GCKQN;3Q-XTTLYA\5:GH_AN77OMZ^&?#J:9SGQ>_9P_X)
MR_!2S\+?'+XX_#+X#>$[[X?^$-$^$7A7XM_$33K+4/']OH&G>'=9\.^%/"&E
M^-M;DU'QWXH\1Z1X4NO$VC>#66_USQOHNCZEXHC\.7=K%J>O27/X??&#XF_\
M%!_#.D?MO>/+OQY^W3I?Q@\-Z1\9]%M/AQ\+_P!E[X_7WPDTR67]LWX:W'[-
M/B_X/_$;5_'GQ1^''Q2OO$7[.+7'A+1?#?[(?P<TO6+#X8:_\1?$W[4SZ;\9
M_!VF^)]9[W7=.\8:G\>OA%X.^(^J_MS^*_A[\&?^"V/CSPC\-O&.K:G^VM/J
M6B_LI>*O^"<E]HUQXWO_ (E>!;72KC6_A^W[8OCB?X=^#_C/KNI:AI_AGPUX
MS\1^"-(\=6/POU7QO)<@'[M_!;]GG]DRWT'X!_$_X%^#/!-YX5\$?!"'P-^S
MGXN\*ZYJ6N>&]&_9Z^(-OH?B>V\,?#^Z_MJ^TF7X:^+-.LO"6H6MA:+/H]]I
M/A_P3' CZ=X4\+V^E</I_P#P36_8(\,^!M7^'7A+]D3X ^%_!NM^.?"'Q&O]
M"\-?#7PWHD \9^"6O+/PAKFFW>FV<%_H<_A?2-8\0^'O#T6AW6FVNA>'/%/B
MO0-(ALM*\3:W:WOX$>./B#_P4CTW]GWXA:SX6UW]O'2_VC-&_91_:/3]MKP\
MGP[^.7C#2/#_ .V5X?\ VE_@?I/[.6H?L2:?!\*=2\*ZAX'\8>%G^.T&A^%_
MV8+G4_!1_99'AKQI\6]0'Q'/A_XH>)OL7X@ZG^UCX0^/_P 8O!G@N_\ V^_'
MWQ.\.6/@C5O^">>OWJ:[_P ,=?%OX:^*?V7/$^GZOI_[6GCV3P3>?!?2/%W@
M_P#:K\4>*_$WBU?BQ8^$_CCJ.E^%?V8/#'PEBO/#UU\0(->.J7=V]-&[_A^(
MI.T9/M%O[K,_;3PU^SI\"/!_P1_X9L\,_"'X=:5^S\?"&M^ 6^"</A+19?A?
M/X$\3IJ,/B3P;=^";JTGT"\\,:];ZQJMMJVAW=C/IE];ZC>6]Q:R03R1-\^_
M"CX"?L)0^.KSPE\)_!WPSU'XE?LJ_$W_ (3_ %N#3=4U#7O''PO^+GQ8^%NE
M:;9^+/%FN:IJVH:[=^-O$7P-_L+P=HFK>)=2U6_TWX/6VC_#_1Y=,\"6MGH,
M?\^P\8?MFR_ 33HU\>?\%4_$'ACXF?%GP)'KD^M_LJ_MK_!SQA\#?B#<?LM?
M'BY\<> M5TK1/C=\6/VW/B7I]Y\6K/X.7,U]\+OBG\&/V&]#^.^J^'-+\#?&
M[7?A ?B-\'K+H_V<D_;1\6_%GP9\8=0NOVU_AW^TS\6=?_X)%?$WQ+X77X*_
M$;X:_ WXM>#= ^$'P4\ _P#!1C4_VB-0\9? O1?!.D)X1\&^%_C[I?AWP7XE
M\7^$/%UC\0;/X=ZC\*O!"^(/B-\.Y?'@,_H_T*/]FC]L'P]\+_C;X6U;P7\;
MO"G@OQ9XYU?X0_$7PGXCFUGP[I'C'2QXS^"WCC7O!VLZ#J<>F3ZU86\GQ ^'
M%SK]D]S-!I.I^+M!L;T:7K^L0W_EVL?\$_\ ]A[1O!\EEJWP*\ 6'@KPS\.?
M '@6>VU*]UV'P_I'PG^!/C2;XM?"KP?<QW6O&Q@\"_!SQNDWC3X>:'=)+H7P
M^U.%;SPU9:7';QQ)_/+\/(_VUM'\"_ 3PQX.U/\ ;>^ _@4^)OVO_'7P.C^'
M7[('[1WCKQ#XA_:"O/\ @I)^T'\1(_ _Q[\%6GQ(^ OAWX;^'_C#\ /%GP<B
M^%FM?MM>'M<_90F\(^*_BOXLU_Q9\)O$'@/3?&ES_35I?QY^'OQH^%/QO\0_
M#W6OB%IUI\-=4^+WPO\ %>H-\+OB?X8\=^&/'?PXL;FU\0/X8\%>(_ ]OXS\
M47>G22VVJ>$-0\)^%O$EEXP,NGS>$AX@-S;PS 'QM^R/^P1^SA+X.^+7Q5U_
M7_A?^T_;?M>^-?VBOCCX;^)WACP]XA\/^'KGX&?MKZLWCC5O"WA:WN_BQ\1M
M/N+'Q'X9UB'PYJ7Q4\$R^![[XB^![7PUIVH:7;6FD1"Y]0^,/[)__!-WX2_"
MCQ]K_P =OA/^SYX,^"^L^ _@=\(/B+J?Q.M])T_X?7'@OX4ZQI?@[]F[PIJS
M^([P:+;77P_\2Z[HV@?!BYA$7B/P]XIUC3(/"%[!K=_"9_@7_@EOX?\ C!<?
M'?X:_$W]H32/VP$^)/Q$_P""0G_!-Y-?UWXNV7[4UCX+OOVC?ALW[1GA#]K?
MPO\ $F'Q?:P?"SPG\5O#OB/5/AIK4?@/QS%HOBC5M3\9^,/BG\.O#^MGQ#\1
M/%2_*_[8&I?M'^(O$7_!1#PK::3^VE\4_"'BGP#\1;?PWJ$OP<_;#/@SP/XB
MTC]K+]E_P%X ^&.E_ '7?A1\5_V??BW#_P (E;>+/'7P*_:-_9 DLH=1^"\/
MQ/UG]KGX'^-?%]LOQ+O0#]R?%7_!-;]@#QIIW@S3/%O['/[.6M:1\.O!\/P\
M\':;>_"KP@NF:)X#L_%,WCBT\&_8(=,AM=1\,6/CBYO?&UAHNL)?Z=9>,=2U
M3Q7;6\>O:KJ.H74_QLUK]ACXX:OH7PD^-'BSX4^*?%?@GX[Z-\-/"6B7GC*3
M2O'/A3]HK7_A?J/C"S\"^#=?T#6=*\7Z/\3M9^"?B'6=2\0^&_#6LV^L:E\)
MO$VMV_BRSE\%^(-0M[S\"OVK/B%^VYH-A^TE\)_@[K7_  4;>W^''QF_;8?]
MEOQUHOPI_;6^(5SJ5[X>_90_9C\1?L^^$]8OO!?PVL/B-\:/[<_:A\5?M!Z?
M\!_&?Q:^,EC^Q5;>$?!_C>7XVK\:K'1?A'X,G^@(M:\3^,?VF]4\>R?"CX^V
MNA^.?^"L_P"P_P#&73]?UW]E3]HOPM#'\/(O^"6W@#X>ZS\0-7L?$OPRTS5?
M 7AK2/BGH^K?##Q1K'BJST"S\"^+8KGPIXTO--OC=Z=& ?J#HGP"^&7A+]LS
MX77WB'XN>![:+X:_!+QIHW["_P"QQX4^'WP\^'FD_ _X9VGA_P"#WP\^-GC+
M0(=#:X\2^-+'2$TOP9X.\*2Z;:^"?!GPI\+_ !*UGP,=!\4-K7A;4O#WU=\7
M/V??@Q\=9O EU\6OAWX:\<WWPP\5GQQ\.M1UBVE36/!/BUM&U'0)->\+ZU8S
MV>JZ-J$NCZI?V<TEE>1)-%(CRQO-;6LL'Y6?\%2?"'BS4?CO^SCXJT35OVPO
M!5AIW[*'[>'P_P!!^(O[&7@?QQXL^(>F_'/QMXX_8<\3_!#P-J6L^#O GCZR
M\*Z?XWOOA?XMU.W?XBVWA#X6^()/!%QI'Q"\<Z?X6DU/PSXO\T_9;U#_ (*
M7?[>.FQ?M(>-_C[HVM:+<6VG_$?X:^"_V:_BA=_L>>+?AIJ'[,?AJ]MO%>A?
MM*>*?C@/V7=.T[PY\=G:"70/A-\(M._;%O?BYJ6KZ!KMCXM_9CL-7\6^%0#]
M+K7_ ()Y_L866C:+X>A^ GA2+2?#W@3X3_#'0K5+_P 4LVE?#WX#>,8?B-\$
MO!VG73^()+VUT#X1^/8(_&?PYTZ&Y$/@SQ&IUGP^-/OI99Y/2_A7^S)^SK\
MO$'C+QU\+/AMX5\ Z]XOBO!XIU[3OMC,FE77BSQ7\0[_ $>P?4[^]M?"?A27
MQOXX\8^-+CPUX:31/#(\0>(-6UR73?MEQ+<U^1_[5GQ#_:6M_P#@IA\-M$\-
M6G[:^E_!O0/'W[,?A7Q+#X'^'7[1/CSX$>,/AC\5O!G[0WA;XJ>(=,O_ -G_
M ,*Z!\.O .F>'?%'B+P#9^-O'/QG\7_%?XM>&O'/A_P=XV\#>&_@'\*O 6L_
M$'QO^>&N77[47QT_9]\"^%OC%X3_ ."F.IZI\/?V4/\ @DEJWQ]TS4_AU^W1
MX5M;_P"/?P2_;J\*^'OVZM5\/CPQX+T36/BU\1M$^!FI3>,-3D^#K>)9/B9:
M:/8_%7X1V/Q)\>>!-/\ &'@D _I&^(/[ O[&GQ>T[Q[HOQ8_9X^'/Q.T?XG?
M%?1?CMXXTGXA:1+XNTS6OC-X>\,0>!M)^)T6GZ]=7UEHGC:W\"VMOX"FUSP]
M;Z3=WO@2UMO!-\UQX7L[?2(KWB7]@W]BWQE-K<_B;]E[X%ZO-XEL/AQI6NO-
M\-_"T!U/2OA%+X=?X:Z7<)9:=:Q_V;X.M/"'A/2-(L8HX[9?#OACP_X:N8KC
MP]I%CID/X@>./%_[9]C>_&F3P/K?[?FD?&+PKXO_ ."ANF_$#3+KP-\=/%WP
MKG_8K?\ 9S^-^H_\$]_&WP!T/7?"6K^%?$/QTTOQW)^Q_HE@GPKU.7]J7QK\
M5KC]H_2_C)I/BS_A&_&8\#X_A/5_VL_!OQ:\':WI_CC_ (*,^-8?#W[0'_!+
MZ_T_0_&/AC]J+6/AKK/A+]ISPC:2_M[W/B&UN_AE?:#XO\#>$=#O9O%^NZ7X
MDU*[\!?LL^-=$L_"'@8?!;5)?$?AC70#]M-;_P"">W[!MQ=?%'7]3_94^ &E
MZI\:_%V@^.?C!XBTOX?>%?">K_$?QQH?C)?&_ASQ-XSU[P_9Z+J.MZ_9_$6>
M+QS97][=RW<OC]H_&#M/XL\G51W/B;PK^RC^VYX2UKPGXR\/?"[]H;PA\*_C
M'JNAZQI'B#2]/\4V7@7XX?"+4;K1-9LRE_"T^A^,_"4]_J6C7\ELT-S+H^MZ
MGIDT]WH>O7UO>_S)7%E^U'\4[#XA6?QC\+?\%/M7\&7OCG_@G7^T1JW@W6/#
MW[?\?C/X>^)OA%_P4FFT7]K?2]*\6_##2O"_A+QYX_\ "7[,NJ^%?'@^'O[(
M7@#P)\"I;W0?#7Q0_9&\+_%7XE?!V?X[#ZG\8^,/VF]1U+7O#GCU?^"HT7[.
M=[^TO_P4T\"/XO\ V=/!GQYTW]HCPE\1UU/X/3?L":[HW]H>';/QYJ_[.^G^
M$M4^-FC?#W7Y['5_V4]?^(C_  PU?]H.]UOP/I_B;7& /H[]I#_@DY\$O#TW
MQ#^)WAGXF?!#]DW]F_PY\&]$TO7QH_[/FA>#/&'[+'PP^$,GQ,^(&O\ BO\
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M /:(\8Z3'JOB&_OO&V@Q^/\ 4_AU8W6C>&?1/@EX _:%^(GC7]E;1_$^J?\
M!5/0?@[\6/VJ?C9JGBS2_'VH_M9?L_:A\+/@WIG[$]O:V7A7QEX@A_:3_:$^
M-F@>%++]J#P?X*3PIKWQP^.'AVT\6_$3Q%\8)_@GHLWP&U>TO_'(!^WGB+]B
MC]B+7M+MO OC+]F']FSQ)HFL?%/Q-\:M/\(^+_A%\-M>TN[^,WB*%KOQK\4-
M'T'7="NK1?B!XA@%Q=>,/$VFV@UK7+>YU&37KF\AO;LR]GK?[)7[+'B;Q/XD
M\;>)_P!G#X!^)?&?C#QUX"^)_BKQ;XB^#_P\UKQ-XC^(WPKT.Z\,?"WQ[K>N
MZCX>N-3U/QE\-O#FH:AH'@'Q+>7,VL>$='U+4-.T&[L;;4+Q+C\V/^"E7P:^
M//B7]J?]DWXK? 72/B[=>,=%^ ?[<OPQ\!>)/!GBKXJV7PS\!?M+^./!WPIU
M3]F+Q5\9])\':C?^#O#_ ,+8M:\._$=_'OBCQYX.U?PAKUEIVA^$/%T'BR\?
MP!X&UKX+^$?@S]J7Q3X@_9K\-^.O$_\ P5GT'X9_%G]LVR?XG1^((?VJ/A7K
MGPN\&VW["W[07PT\8:!)KFC_ !\_:-^)WAKX5:/^TM9_LO>(/$7CKXG?&J?X
M'>-?BGJGB;XD?LZ:19_#&S^(WBG6P#]^]&_8:_8L\.7^HZKX>_9%_9BT'4M8
M^*OA?XZZK?Z)\!/A5I5YJ7QN\$7>LZAX+^,-]=6/A2"YN_BAX1O_ !'XDU#P
MSX\GF?Q1H=]XC\07FFZI;7&LZA)<>F_&'X"_ []H7PYIGA'X]_!WX5?&WPGH
MOB"P\6Z/X:^+OP[\'_$KP_I?BK2[:]L]+\3Z;HWC31]:TVQ\0:?::GJ5K9:Q
M:VT5_;6NHW]M#.D-Y<))_+-X_P##W[4?BKP%\7]:T2[_ ."L>D^-=;_9O_X+
M>>/_  [_ &+K?_!4C2!!\9? W[:%C>?\$E=/\*>&KBYT"RT/4Q\"]1\6R^%/
MAS8Z1H]I\3O"=EI6G_'/P=XAAM/",4?Z;?!/5?CSXB_X*=ZYXK71_P!K#6_@
MWXQ\"ZSJ^O6GQ0\)?M0_ _X8?!">?X'_ +/Z^&(_"=AXM\4WO[+?QS\$>/->
M@UNXT7P=HWP\^'O[5_P ^+VI_&(?$;^U/#^J:_9:0 ;WC_\ X(G_ +,_B[XO
M:KXZT"U^'GPZ^'^IVG@*RTCX?^#?V6?V5+'Q1\$M.^'<-L^E^'OV5OC0?A*O
MCK]GGPYX@UB+5_%'BA_#\>M^-=-\6>/?B!XL^%GCCX8^*M3\,:[X-]\\,^%?
M^"8G[0+>-?V'M*^!7[-OQ,\+_!CQGXD\>Z[\#M4_9>T:_P#@)I'Q&T[Q!?Z3
M\0/$W@<>(OALOP,\7>/O"GCGQCKWA?XI:A\-]5\0^)?!7Q!USQ3X2^(,FC^,
M)_$6FU\K?&_PC^U=??MH>.;S23^U3!XGE_:A_8/US]EO7O 7C+XJ6W[)3?L7
M6<WP\T_]N#P1\7/#OASQ!8? ?2?B'I>AV/[5WB/5+GXZ:.?&_B^;Q;^S;'\"
M-:UOQ[X<\+Z-X$]K_P""5_PDM_#7[+7Q8\':_P"'/VDO!,WB;]J#]M]Y+/XR
M^*_VH_#_ (YG^&?CG]JOXY^+?@WXO\+ZU\9_$-G\2-(U3Q-\$?'7@G7]5^(^
MA7.A?$+6O&EQ?^)/B)J\_P 8;'Q#JL0![S/\-/\ @G;\4?CMXE\-7?P7_9=^
M(7Q^\9?LXQGQ?J=U\$_A]XH\4^+OV6=<U:Z^&,7AOQ!X\E\(7MOXB^$VLZAX
M>O/!Z^!-0\17NBZE9Z'=60T*?2]-F\GU4_L<_LD#7+3Q.O[,7[/D?B"Q\5?"
MKQU9ZU%\'/A[#J<'C7X$>'!X-^"'B^*\B\/QS?\ "4_!OPB%\*?"GQ"6;5_A
MWX;6/0O"%YH^F1QVJ?R[^'_@W^T5X#_9U^%>H>#?@[^WWX ^/?[+?_!)#X2>
M#O#Z^"]&_:MT_4_$/[8G@G]HO2M*\9^"H=3TB^UF+XL_#V3Q99:SKEI\*O$M
M[JGPXN_@OK</CWPOX U'X?V6A:IX._57]B/PQ^T[%^W#\>O$7Q@O_P!L^!8/
M&O[2%IJFE?$&U\06W['FL?!SQ5\8;KQ=^R7XC^%ESXS^+GCCPW=>+M'^%;:5
MX<TWPO\  OX:?"GQ9\.U/Q0\._M3IJ.M6_PAU;Q> ?:?@[X&?\$ZO%WQ8_:$
M^'/@;X#?LVO\6O"WQ(^$?Q:_:7TGPY\%O!_A[7;OXM:M'J/Q7^"_Q$^)6KV'
MA32X_&WCVUN;O4_B!X1\37VHZ]KGAS7[N;Q%%=Z7K]U]JF]"L?V:OV+/A_XI
MT+Q+IWP2_9T\(>,OA9XD\=_%7PYXAA\!?#S1_$/PZ\4?'.[AA^)'Q"TG5/[.
MM]0\)ZI\6]3\.VB>*_$MO-8OXSU;0;5=0NM0OM+@%O\ CY^U7X6_:?T[]JC]
MM+QK\/O!O[1UC\*-:^*G_!/.V^)_B/X2?#WXUW?BWQA\"O"_P3_:)T_Q;<_!
M:[^#/Q#^!OQ=^)2?#_XY>+/@_K'Q:\+_  #^*D/CBU\!V?BVR72/&=GJ>M_#
MKQ+\R_$C]F#XQ:AIWQ+U_P 9>#O^"D?C_P 12?LH?\$B/%3^+]4\<_M-P?$?
MXCZ'^S3^W-\4T_:3C\4>&_@!\2_^$(7X\I^S/JG@7XHP_L^>%+;5_B-:>-M>
M\;^/_"^E^(?CQXH^)7B;6@#^DGXA?LI?LU?%KQ%KOC#XF_ [X8>.O%7BC1/!
MWAKQ!XA\5>#]&U?6]5T3X=^)YO&_P^TR\U*YMWNY(O ?C"YO?%'@UA-Y_AC7
MK_4M6T2:RO-1O9Y_7/!/@KPC\./"?A_P)X"\.:+X/\&>$])LM!\,^%O#FG6N
MD:#H&BZ; EM8:7I.EV4<5I8V5K!&L<4,$2+D,[;G9F/\OOQ,TK]O;3-,_P""
M@5Y9ZS_P46L/B/X7^'G[8'A?X=Z/X-\)_M'>(_A[K7A#Q5X]L?$/[!'C+X:^
M.]+^.7Q%MO'/Q.\-_#N'P/X%O=,_91^"OPW^+GAB^;XX+^VOX@\2:[;Z!\3?
M'O\ 31\*_!VG^ _!&E^'-)\0>/?$^F176N:M8:K\3_$OB3Q=XX6U\3>(-5\3
MP:3K&O>,6D\6W,'A^/6%T#1;3Q--<:[I&A:;IFCZG=7-U823N >AT444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y3\
M2?CM\$?@W=^&K#XN_&'X6?"R_P#&MXVF^#;+XC?$+P?X&O/%VHI>Z7IIT[PQ
M;>*-9TJ;7KT:EKNBZ=]ETM+J9;[6-+M603ZA:I+ZM7XR_P#!4']@#]H/]LWQ
M+IU]\)_$?P;TK0[?]GWXC?#&V7QOXC^)?PT\1:/X^\2>-O ?C#3-6\1^(_A%
MX<U7Q+\:OA#K=AX-'AK6/@+XR\2^'/A)H/BB72?C7XC\$_&?QIX+^'6E^" #
M]$-?_:X_90\(>*?$O@3Q5^TM^SWX5\;>#+;4+[QCX,\1?&?X9Z'XJ\)V6C:
MGB?5;[Q-X=U+Q/;:MH5KI7A@Q^(-1GU2TM4L-"*:M=&'3BMP:VF_M@_LBZ[J
M/@S3=%_:D_9TUC5?B/XEU_P3\/--TGXW_#'4=1\?>,_"NL6?ASQ1X/\ !5G:
M>*)KKQ1XH\.>(;[3] U_0-"COM4TG6KZSTO4;6WO;F&!_P":2V^$?[57Q>^/
M'[27PVTW]G[XE27/Q.\3?\%3_A/\$]0^*6B?M'_#'X:_LFVG[6NM>.K/Q/\
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MX5/P]^(.E>-/ OA_]H;Q-I?A#XA^'EUZQL9?!VAV=]X5U3PAXM\2>#K7&/\
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MGI'U;X2_8'_::\/_ +3NG_':^UOX&ZMX?TG_ (*+?M"?MIIX4C\4^.["ZO\
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M;_ VH:7X)USQ]X&\&_"3P;X#UKS7XM?L<?'/X2^&O'/AY/!HU_XM?&SX.?\
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MQ'^#OAS]F^'5].^&7[1.@^!_BY+\&OA9X,F_2+PK^Q1^UKI7[0'AOXL:K/\
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MM0\(?"CX4Z/X(\2^(OB!XI^'?@_XH)X/\%_##7?B"8O$B^.8_"_PZ^Y? /\
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M'C+P3/X"T/Q#X9?5-:\,^"KC1OB?X:\3>!==L[#4M)3[9V'[27_!)+X->/O
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M^T%^T!\-OB=I?Q+^,ND:;X=^*T/AKXI?#7XG>$/B)X6^'7Q \.:'X?T'Q/\
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MA=J=K\3O#'CFQNX_!'C[Q_\ "SQ';^([?0/JJX^(/QJ_8C_9)T#Q3XENM?\
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M !>^%7_!03Q9K'PRM/B1K,?PH^'/Q N? WQ2\4^-_A!\1/#7B+P[=)X@\-^
M;;Q7IGQ<T[Q1\2I-!E^%^O?JK^T[^UYXV^#?Q+\$?!+X._!;3/CK\7_%/P/^
M//[2.H^$]9^+%C\([*P^$W[/NI_"WPWXDM]"UF?P9X^DU_XE>,_%WQB\':#\
M-_#&I:5X7\%Z@MKXJU+QI\3O MMH^GKKF9??\$Q_V-]4T.;P_J'@/Q[>6$O@
M+]E_X:6UU)^T1^TI#K^C^#_V,?%FH^._V9+3PUXHM/B_;>)/"VK_  L\7:WK
M_B&P\7>'M5TWQCXAU/Q%XCN/&6O^(AX@UE+[KOV@O@U^R!\=_B!\,_A;\8_$
M&E6'QDTSPG\0)/AAX7\&?'CQK\#OC7J/PQ\5VVD:=\5M$T:/X3_$7P#\2/%G
MPA\41>%_#W_"Q/"SOJ_@#5=4\(^&-8US3CKO@_P]J&D@'BO['G_!1.Z_;5^*
MOB_2/A1\$;N#X"^%/"'PF\8R_'/7/B'IMMK-Y8?'_P#9L^ '[3WP6C;X1#PX
M;^RD\5>#/C/KFE>((CXSNKSP5J_@.VEO+/4]-\:Z7>67R6O_  5:_:'\,^(/
MC!X2NOV5K?XT?$)?VD?VPO!GP6^'OP8\3_%WQ7J5[\&OV.=8^%WP[\:WWBB[
M\#_LR^.[S0_'?B/XA_%?X96G@O\ X2#0['X:SW'Q(U6#XC_%KX7:#\/;/7?%
M_P"MOP@_9A^"_P !O%_Q7\;?"CPK<>$-6^-5UX N_'VG6?B;Q;=>$)'^%W@+
M2OA=X!MO!W@'4M>O? OPSTOPW\/= \/>$;?2?AQX=\*Z=>Z1X?T2/5;>_GTN
MRGA\'\;?\$R/V,/B#<^(M0\0_#/Q3;ZOXE^+7COXW7&O^$OCG^T#\._$V@?$
M'XJ^'&\+?%FZ\ ^*/AY\5/"OB/X:^&/BUICO-\5OA[X!U7PY\/?B5K3#Q%XX
M\+:]K\4&IQ 'S5JO_!3GXRPWGQ/OM _8CUN\\&?#/]HS]G#]F>]UGQ7\>/"O
M@GQ3+X[_ &J[O]AR?X31:EX%N_!.K7>A7C^&OVU;#5_%>GG6M2A\+:M\,]?\
M-7FIS7.N:;>VO=?LL_\ !17Q_P#'KXU^!/A!X_\ V:8?A!;>/= _;&L=+\7V
M/QJT[XGVLOQ;_8,_:(\+?LX_M#>#[+2K#X>^$WN/A]-XL\76=[\+/B;>ZCIF
MN^+[;1/%%MXI^%OP]N+'1/\ A(_9-6_8M_8N\#V6N:#J6C1?#[0/C'\>O@!\
M4?\ A$X/C5\3O GA36OCQ\ ;+X=Z7^SV/ 'A2S^(^D>'_#M[X+L?@U\)=-\)
M?#?X>Z;H_AB^T_X4?#_3[CPGJ=OX/TA+38\#_LB?LB_!CXO_  X\4>'+2]T'
MXOVFL_M1^,OAE9Z_\=/BMJ^IZEJ?[2WC+0OBG^U9J&@^"/%?Q(U+2/$NG^,_
M'4&@>.?%6FKX>U+1?!VMR:;JF@67AAIK5G //_'/[=GB/PK\3OVA8-/^!3:[
M^S5^R#JNK^%OVHOCL/BEH&F>-/AWXCT3]DVU_; U'4O#'P.O="6;XA_#VT\"
M^+OA'X'N/$&G_$K2?'1^)?Q+6#3?A7JW@+P7XJ\>VOS'K'_!5[XO>%K?1O#G
MB/\ 8[T*T^+?BD_L$>,/"O@.Q_:4&H:'J/P?_P""@OQBUK]G_P"'>NW_ (XN
M/@9IO]E_%+X:_%S1CI7Q2^&"^&M0\-6OA.\B\9>#OBYXPM[/5M.L/T%\1?L0
M_LO>+?CO=_M)^)/A3INK_%K5-,TK2_$&HW.O^,_^$.\7G0/#'B7P3X=USQU\
M)8_$L?PB\=^-/#?@WQCXG\'^&O'WC'P)KGC;P[X2UF[\,Z+K]CHQCLT\\T'_
M ()I?L<>&=(\.Z)H_P -_%2:?X0\9? /QOX3CU+XY?M :_/X9O/V6=?\0^*O
MV<O"NAWNO_%/4[[3/A+\%O$?BSQ)K?P]^!EI<Q?!7P_JFM:C>6WP_P#,G&P
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M_P *^+/AOX5_93^.&N>+?#/P^^"'QH^V:%:> [[3-4-_XD\5Z/\ #[@?CO\
M\%$OV@/C)\+O#FD_#+X)^,_V=O&/@/QQ_P $UM>_:?@\8?%VX\!?$_X8:A^U
M1^V=X:^$R_ SPMX5M_@_XA/Q-AU;PKX>\3R_$B]\2^)OV>]4TKP;X[\$G0?M
M'C2Z\6^&/ WW/XU_X)Z_\$]O /PGNM.^(GA2W\$?";P?\)/V<?A##X@\7?M#
M_&KPKIWPV^'/[)OBG6==_9HE\-?$/5OB[8:E\,_%?PC\4^-=<D\&_%;PWXB\
M/?$N*X\13Z;/XRN[6XCLCT.O_P#!+K]A[Q*?##77P<U#3$\,^'O!GAIH_"OQ
M<^.O@9/&5E\._BA<?&SP1?\ Q:A\%_$_P[%\:_$_A?XP:AK?Q0TCQG\8XO'?
MC*T^('B;Q=XM&O'6_%_BB\U@ YS]MW]H/Q-\ _C/^RI=Z-X=\6^)[+7=%_;
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;$U3QG=:5HVM>-?CQ_PLG1KOX6ZQ:> ?$/B;X?ZC_P *VU/P98_$3^COX_\
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M[7.G?!S]L/XGZ=^VOX/T;Q1^S/\ LY_L">*$\.:/\"/ 7A+PA/\ $3]J32/
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M"X5!]>I/WF')SG!!R.IQZ=!C H _F6\._M>_M\^(_&7A?PGX*_: 3XE7F@_
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M7?#OPQ\-^(/"_P 0/VD_"_QRO?C%X.T^P^&7P\^'J1>#M&M_!/PK\0Z/X?\
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M]J:* /P#M?V'_C;/^UNWC/QO\ -)\9+X:_;)_:=^/7C/]J.35_A'JE_^TO\
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MOA_X3NY_#/AG3H]6_I8H(R"#T/!H _!7]@G]E+QY^RG^Q'^VSX#^+_P@\/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[O0"#R"".>1ST.#^1X/O10 4444 %%%% !1110 4444 %%%% !1110 4444
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MO@_X@P>.M1\#:WJ5L-8T[P'XA\.>#=3O-6E\*Q:K=@'O]%%% !1110 4444
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M<4 ?BSX(_8J_X*MO^T1\:_VC];_:_P#V7_AWXU^(M[XJ\,>%C+X!_:E_:?\
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M&[:QD&<DJP!&Y<996 ) *_-@D#@D'\U_&?\ P4]^$GPV\?\ QN\+_$CX0?M
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MP/H%_I<FO^)M#CN9HO$7G+87IU&WM[FUMYWC23N[NZ>R[?\ #@?%W[,WBO\
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MT?P+X;FUJ--(NSX7T"TN;JTT_P#4M5"C SU)Y)/)Z]2<9ZX'&<\<TM '\_\
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M=_\ #7XR^"/!_C5O%/C+P;X4^*?[/_QV\.?&'X1Q>/--\5_#WX:^/-2^&OQ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %-4[ADC!RPQU^ZQ'7CKC(IU% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %5KD9$0]9HNG_75*LU7N/\ EE_UVB_]
M&I2?ZHBI\#^7_I42Q1113+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ JM<?-L4'!$L)Z^LBD?\ H//U'K5FJLOW_<O!@^G[Q><=^,C\
M<]J/Z_$F2YHM._3;1[I[EJBBB@H**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KQCXN_M$? OX GPJWQN^+_ ,./
MA/%XZUVW\->#G^(/C#0O"G_"2:W<7-E9_8-&76+ZT>^>"YU/38[^>%6M=,_M
M"Q?4)[:.ZA9O9Z_-_P#:P_9(^-WQ1^..B?&GX&_$7X0:)=:[^SG\1_V4OB3X
M1_: ^&5Y\7/!%EX&^(?C/P=XVM_B=X%\*V^L:1I^I>-/#5_X:O;#Q'\.O%C+
MX&^+^FW?A.#Q1K.AI\/M/CU< ^DKO]KW]EW3O%?Q7\#ZE^T)\&--\8? KP=K
MWQ#^,OA?4/B7X-L-<^%_P_\ "FGZ9JGBSQSXZL+S68)O#?A+PC8ZUHLOB[Q!
MJ8M]+\+?VUHHUVYL/[7TXW/T#IVHV&L:?9:MI5Y:ZCI>IVEO?Z;J-C<P7ECJ
M%A=Q+/9WUC>6TDMO=V5Y;R1W-I=6\LD-Q;RQS1.R.I/YH_#3]E;]JCX1ZY\8
M4\+_ !$_9R\0^$(?$'[7WQ*_9^;Q9\)M;7XAZCXW_:\^*7B'X[ZS\-_CMXQL
MM:N!8_!;P7\5-9@?58_A)9:-XJ^+.B:#\.Y?$$OAR7X<WFG_ !#_ $@E.MVO
MA^1K>VTO4_$<&ENUO:RW-UH.AZAK<=N3##+=Q6OB.^T;1[J_"K)<1V6OWNG6
M,C2+::M<0B"X /EKP=^V9\._&G[9/Q6_8ST_3-;MO&7PN^&FA>.W\3WL)@\.
M^+=:_P"*5U'XE^!?##211O?ZU\'O"GQ=_9P\3^-[F&:XLX;?]H'P981F*^L=
M5C7C]6_X*B_\$XM#D\21:M^W)^RS9'P?%K$OBAY/C;X :#0O^$>\71^!-?AU
M*YBUQ[>WN]$\5S6^E:M8M*;S3OM=G?7<$.FW=M>2_'^D?\$VOC-X#U3]D7X_
M?#KQMX=3]L3X7?'#Q[\3OVF=?\5?&W]HS5?@5\6_!W[05O\ $"\_:E\!_#/X
M6ZAJ.N^"?A7I_P 4_'?BCP9\1_#D6C_#.R'@_7?A5\/K+4KWQ7%X6M-0O?-_
M&?\ P2\_:?\ %_A3Q%X=;QU\"+*X\1_#?_@M]X ^VR7WCN^ATF3_ (*O_&:V
M^-_@'6;6UD\&1RW)^#NMV7_",^+]/>]MX?%&CZE=ZII5Q:WEI;Z=. ?JIXA_
M;<_9"\)?$/7OA1XJ_:2^#7AKXA>%_#VM>*/$7AG7?'WAW2[G1M)\-?#Q?C!X
MC%_>7E]%I<&K>'_@\\7Q@USPZ;X^(M)^$L]O\3-0TJW\$7$.NOT_P/\ VJ/V
M;?VF8?$,W[//QU^%7QI3PFGAN;Q,?AKXX\/^+WT"U\8Z=<ZMX4OM5BT6^NY;
M+3O$MC8ZFVA:C/&MCJESH^N6-G<37VA:Q;6/Y-^(?^"97[6'B3XYZ'\<M2^-
MGP;O+[PEXOU[Q7X6\*:C:_%Z3P]I.A^-?V =<_9%UGX96&B>'_$GA;P'91^&
M_'.L7WCE/C7=?#O6_C)\3O#&H:#X6\5:OX>\/_"OP9X2N?K+]B3]C_XO_LV>
M-=&UOX@>)/ASX@TG2_V"/V'?V.U3P?-XH.I3^(/V/6^.-S>>-YEUO1[&W.B^
M/+OX[ZZUAI$ES-J?A6+P[:137_B ^([E]" ."^"'_!3#Q#\>M2\9^(_!7PJ^
M#C_!CP7XM_:*\!>-_&EY^T[-:_$+]GOQ9\ (_B,BV?[9OPIN/@A%9?LQ:=X[
MN/AQ<W6G:IJ_Q%\7R:#H&LZ;JFJZ<]Q-86.K_1?P_P#^"A'[*/B"R^#^@>,_
MVD?V8O#?QB^*7P]^ _C)/ASX;^//AOQ3927_ .T+H5GJ/PWM? VOZ[I_@+7/
M&GAKQWJERFF?##Q'?^!_".J^/K?4_"=S#X3T?4?&.@Z+<?(&A_\ !/;]HZ3X
M[^"?VBO&/C;]G4?'/X;?##XS_#_6?V@/AQX(\6?#_P")W[7ND^._A_K7@SX9
M^ ?VLM%T*ZT[P;J/@+X8ZQ<^$/B'>7]C!XQUW4/'_P .M UGX:Z?\'] U;Q1
MX,UGQ;P7_P $E/CWX0^$\GPW?XJ_!VXO(?V</^",/P'T_6$TWQLD/VO_ ()1
M?&_4/BUK'BJXM(X(+B ?&"WUB^TK0K*VO6G\$WMIIUW<WFNHTR1@'V[^TE_P
M4^_9R^%'PC_:5\1?"7XI?!'XO_&_]G_X0?&KXJ67P,U/XL6W@G4/B''\ ]-\
M2WOQ0TOPGKEKH/BRZ\1KX$O/!OBGPSXWU+P3X>\7:;X(\:Z/<>$?'5[X3U&*
M^EL/M7X2_'+X._'32_$.L?!KXI> /BII?A#Q1=^!_%>I?#_Q7HOBJR\-^,]/
MTS2=9OO"FN2Z/>W9TK7K?1M>T+6FTO4!;WCZ-KFC:JD3V.I6<\W\M?P?_9G_
M &J/CGX=^-GP!?X-:EX#USX^_ K]OW]G@WOQA^!'[2GPET+]@SX3?M3>/_B%
M\7[KP7X9\9ZSI ^ /Q]T#5/B-<_#'PJVC? [XN?&/5-.L=$T'4?AQXRT'X6>
M$]7#?M]X9^$?[6GP?_:4^)'Q \)-\)O%W@O]K3]J+X;?$3XMZ>VCZX;GX6?"
MOP)^R%X*^"'B*/3_ !)?^/O#4A\2:QXU^$?A+Q'X5U+3?A]XZ$Z>(;SP'X@\
M.:9II;XK>&@#3_:,_;0^)GP?_:G\'?LU^#_A5\"M7L_&'[-OQ(_:0_X6I\<O
MVH?$'P"\(Z'I'PE^(_PS^''C+PSJPTK]G'XR10ZA)=?&#P-K/AS43J:6VJ:?
M#XT74H?#\GAS26\5^N>"?VT/@G<V_@7PM\6OB-\*/A)\=?$'PUT+Q]XS^#=W
M\6?"?B:3P#>7?PTU#XJ^)M"/CBT.E:!X@L?#'@W0/%/BV/Q"L.D+K7P\\/S_
M !%BTJQ\,3I<I\Q_M;_L0_$WX^?M8^ OVA+'PG^RA\4O!?PY_9M^)_[/]G\'
M_P!IGPQKWB[P_P"(+GXS_$KX/^/?%GCAVL?#6L6OAO5= TKX-V/A#0$BL?$,
MFHVGC#7[ZZFTB*R&FZY\Y?$W_@EI^TE\<M3\?P?$'XW?!?X?P_&/]G3XH? '
MXP>,/@+X*^)/A8>/_!GQ'_96^)OP5T'P3XX^ ^O>.]4^%/Q$M?@/\4_B7%XV
M^!?Q>UG4](^,^@_!_P #6/P$\3:]XFTSQYXY\678!^M_P6_:?_9]_:,F\36_
MP-^+?@SXH3^#;7PQ?>*H?">IC49-!LO&T&K7O@Z[U)!&AM[;Q7IFBW^M>')V
M'EZUX?-CX@TYKC1-6TJ_O>$_;I_:3U?]CO\ 9+^.7[4.C^ K+XGO\#O!5W\0
M=4\"7OC.7P _B'P]HEU:R^([?3/$\?A#QRMMKT&B-?WF@:?<>'I;37-8M[+1
M+K4M#@OY-9L?@;]D;PA^V5HG[9G[:VN?$>U^'EMXAU2]_86T_P =>.]/^!?Q
MK\%?!3XH^!_"GP<^*EKXYT?]G#7?&'C:]L;_ ,<^&-=\0^%4U#7(=9\7>"M'
M>.\\,:QX7L/$&I7>K:-[U\3_ ()_M2_MJ?\ !,GXH?L]?&^]^&/PD_:+_:(^
M%GQ"^&'BS7=(\*ZS_P (;X'T'QIK^N:)H?BD> (_B'X[N[3QK:_"FYT/7M7\
M#VOQ:\4Z%HOQ+GO] L?B%K7A[3X=<N@#M? _[:=QX;TGXFZ]^UM;_LX_!;P[
MX%\2^%O"&C>-/@Y^TW??M&>#_%/BW6_#NN^+==\ 71U+X)?!+QQX?^)O@;P?
MH]G\0?%/A-/ 6MV%K\-/$FF>.(?$L^E:3XN'AOMF_;[_ &*[SQI:_#G1_P!J
M3X&>(?']^FEW-AX,\,?$GPKXI\1W]MJ7@"#XN:;-8:7X=U/4[F].K?"Z:/Q]
MH<-JDMQXA\+21:EH,.IQ7-MYOS1^TO\ \$T?#GQ3\$_ IO@GX+_96^$WC;X.
M?&'7/C=JOPV\9? 1OB'^RW\2?$OCKX0:W\)?B!IOBGX;>%_%7PIU6UOYTU'0
M/%?A7X@:/?VNO6&L>"K*TUW2=9T?Q1XJTZ^\3T'_ ()??&+P/XIT+4-*^)GP
M7N/#&F_MC_\ !/OX^'0?#GPVO/A-HVG> OV1_P!EGP-^S7XI\+^$? '@R2^\
M#>$)/$NK^"M,\6> /!VBV47@_P !^&6A\%?;[IM%TCQ!&">S]/U1]_Q_\%!?
MV,YM,;6X/VB?AU<:*OPX^'?Q>CUFTO[N\TJ^^&'Q=\=V_P ,/A9XXTK4K:RE
MLM8T+XB?$&[M?"/@VXTB>^DU_6[A+/3X9F60Q\WH?_!0?]G#1?AQ9>/?C?\
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M6/%MO8:)?ZIHFFWMWXBTKX&\/_\ !6_0=:T3XJZZ/AIX26R\-?\ !,CX*_\
M!2OX1K8?%[7-2O/C;X5^,FC^.XX/AU8Z<OP;BO\ P?<^'_B!X0TCP NN75OK
MOB?Q-<?$+P9J.A?#.74)M9\.:-^C/[-_@7XG?#;X/>$O!'Q7U'X07WB?PW9K
MH^GZ;\!/AOJOPG^#_@_PCI.S3/!7@3P)X*UWQCXYU>QT3PAX7L],TA;J\\0!
M-1NH+J[T_1_#6ER6&@:=^5?PV_X(L>%/ 'CSX3^+A\5-0N-,^&W[6WQN^*\G
MAFWT6UAL+_\ 91\8^)O#WQ1^"W['EG,7\ZR\"?!SXU_!G]F;Q\MS=_VG+KME
M\-_$_AB26WTCQ@\-F ?I O[8_P  ?#.J_P#"O_C!\:/@;\+/C9X<\ MXT^*7
MPNOOB_X:OF^'<NA?#FU^*7Q"TZX\1:O'X574[?P#X$FE\>ZS>76CZ%JT'PO.
MF_$S5O#FA^%=8L;I^0\)?\%$OV2?'WQ4^%/P=\$_%&#Q%XS^,6F?$V^\*6L&
MCZOI45EJ'PDO?A]8^,/!_BR#Q%9Z-J_A7X@6TGQ,\+W%OX$UC2[;Q0--GGU:
M_P!,L=,6VNKGXI\<_P#!*_QSJ/QS_:,^(WA;7/V-/%7@[XXZ_P#&/XJZ6O[1
M7[&FE_&;XS>&OB%\7/V;+SX :]\)M2^*UQ\1-&75OV:]=O95\2:]I=AX;TGX
MGI\/=7\:_L_:7XRB\!^*;;5/#WHG[.?[ WQZ^"7Q>^ 7Q-N_CAHNM^'?A3HG
M[6_P_N/AQXRU'XL_&C5/!_P<_:0UC]D[Q-X>^&GP[^-?C[QOIOQ$\7+\//$G
M[+"SZ+XD^,MOXIGTCPU\29?!&E:4=%^&_A":X /J7X<?M+^-?'G[8O[2W[+M
MS\-/#.C>'_V>_A[\"/B%'\3K;XDZOJ^L>+;+]H"/XC)X:TB;X>3_  OT;3_#
M>JZ#J'PD\;1^(&C^(GB.T32;KP5JUC+=7?B#6]"\(:GP"^/WC_XP_%;]K_X<
M^(?ASX0\&:3^R]\=-%^".F>)]$^)>J>-]3^(=UKWP/\ A%^T'8>(M2\+7?PX
M\#Q^ X8/ GQR\!V%[I2^(?%\C>*[7Q;865_=:#INA^)/$7SGXD_9<_;&T#]I
M[]KS]H7X&_%3]GWPW-^TU\._V?OA3X83Q_X'\?\ B?5/A/I7P(\-_%R#3?'L
MUKIWB?3=&\>^([KQG\:O$.OCP=<KX:\/3:+X9T'0KG6EO]7U?Q!;R>&_V7/V
MS_A[\0/VI-8^''QX^"^B:+^U3^T)X/\ B]KWC;6_AOXD\1?%;P%H/A?X#?L\
M_LUZC!X:T[^WM,^%FL_$#Q'X!^ %KXML=?U7PE9>"O"GQ \67,,WP^\7^$=
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MS!X@\(ZOK.CR+>GX&\+?\$Z?BQX*^&?['WA33OVBE\4_%/X!?%_XB?'/XO\
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MZDNIQP>&O$^H^)Y-=^[OV-O@9\3?V7OV<?V=/V??$_B?P3XTT#]GS]EOX*?
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M>904H1P52=5U:,HJTU24%6PSKQE55.4N2%"5?V<51;Q%2$HQJ4HV;_97Q?\
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MT:-C(&!GC QSWQCK[^Y]:3RD]_Z>G3&.G'L,#L*DHI_IMY>G;Y6 C\I.PQ]
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M7****"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *JW/
MS-#C.4GA8_1F*_ID9]C5JJTOW_\ @<'_ *,6@4DI1DGV_5%FBBB@84444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5W +G/9H2/KYBU8JO
M(2'X[M".F>/,7\NG4T">S]/U18HHHH&%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !12'..#@^N,_I2C.!DY..3C&3ZXYQ],T %%%% !1110 5!*K JR\YDB!
M' X#CN?4X%3U')_!_P!=%_K0'EW)**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ J.3^#_KHO]:DJ.3^#VD3\<G''TSD^P- $E%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5')_!_P!=
M%_K4E% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4QW"% 0QWOL&T9 )5FRWHN%(SZD#O3ZIQ_Q_P#7-OZ4 7**:GW%_P!U
F?Y"G4 %%%% !1110 4444 %%%% !2'.#@ GL#P*6B@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex10-91_002.jpg
<TEXT>
begin 644 ex10-91_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" .< M # 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %4-1 -N@/(^U69Z9Y%U$1^HSQ5^J5[AHE4YR)K9
M_P !<1]<YZG@^U!%3^'/_"R[11106%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !5.Z&0..C6Y/T$ZLQ^@ R>^!QS5RJMR< ^_E*/J\FT
M9]LD9/89.#TH!I-6>J>Z>Q:HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&WPNN;G_ (:6'Q>D^)GBJVN-/^!][\-8U^(,P!^L!('4@9.!GN?3ZT5^+?\
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M&H^#=,BT2_\ EO\ 9^_X*9_%*/P%\'M,@^&?Q._: T77?AK^V=\:/&7QP_:
M\4?!CX)_%_2/AM^QQ^V;X0^!?QHLO$'PN_9W\)_$KX0>*_&GPQ\%_%*T3PU>
M^ O$?@S2?CAK?POU.;3/"?PXTWQCIFH6(!^]-%?C)9?\%5O'>A:C\/?"OQ>_
M9DT+P/XZ^*UO^PU\0? FC>#OCMJ?C_0+WX#?MN?M2_#K]DW3O$FK^)M9^!'P
M\FTCXU?!SQ]\3/#.L_$3X-)H.H>#]3\*ZOI-[X(^.?B"_P#^$DT_PQ:D_P""
MGGQH\0_$[1O@U\)_V1O#'Q!^)&N^,?\ @H1X7T[1M0_:/O?!6FWEO^P#\5_A
M7\.]?U"TUB]^ &K+/<_$VQ^*NC7/AVP>VMK70?&@A\'ZKJ]WX<DU#XD:0 ?L
M@2!C/<X'!/)^G\^E+7Y"?M0_M:^*?&G[('["/[5_[.FO?%GPIIW[2WQK_86U
MS3?!_@Y/@U!X\\=?"?\ :<U+PQ>S?#'4(/C-;WW@+3M<U70/%MI$+ZU\1>#]
M1T[7+&(0^-K31&U>WU+Y^TG]OGXX^#OVPOVL]%\3>&/BK?W6J^*?^"?'P6_9
M;_9$^-/BGX$_#W2O!/Q0_:A3XSMXYU;Q3\2O@K8_&5M-\&KX3^#]Q\4I=3U7
M6/BOXLL-*TKQ+X;\&^'+_P 2^(])\(0@'[][ES@G!XZ\=<8&3QDY&!W/XT%E
M&<D#&,Y(XSTSZ9[5_/[\0/\ @J3JWA7XW^"OB;XYT_QU\._AK\"?@+_P5I3]
MJCX Z+<:!XGT3Q%\7_V%O&'[)FG^&M8^&WCO7?#'@V]\8:=XHT[XF:XOPEU7
M7I?AG:>);3X@>'_^$K\,>$O$FEZCI5I=T?\ :M_:;\+_ !T^/UI\>;;7]._L
MK_@H%_P3G^ ]O\-OA;\;- \0_#OX6:)^T1\.? ]O?6^A_$#Q;^SS\/\ 7OB)
M\-]5\8?$'PY?>+?#=U\/_ GCO6/$MSJ.@Z1\0/['T_3;B^ /WVJG=G 4]?GM
M^/I<1_\ Q5?B!8_\%C/%>G^"O%/C_P"(G[)[>$/#UI\ /VSOC7X+GT?XWQ^+
M7U:;]AW]J3P%^RM\6X/B"DOPC\-_\*P^&C:_\4O!?Q(@^+6?&*:+\*K'XA^*
M/$W@G2/^$-LK3Q/+J?\ P5Q\?Z;\,M6\?7_[-7P]32]"_:)^)'[.][\4I_VC
M_$NG_LH:EXH^%(\/V%U<:9^T]+^S1/X1\/Q?$WX@>)=-^$WP<USXGZ3\/_A!
MJ_Q>\._$GX5_$?XS?##X@>&?"WAOX@)--)K9V?J@::NMGJO1_P# ['[C45Y/
M\=KG5[3X)?%^]T#Q'JG@_7]/^&/CW4-$\4Z''ILVM>&]5L/#&JW.FZ[I<.M:
M=JVDS7VF7<,-Y;Q:GI6I:=-)$(KNRN[=WB?\-/A+_P %8?B]\+O@1^SLOQ$^
M$&O_ +0.LM^P9_P3R_;3_:/^-FM_%+P;X,\9?V+^W)XZ\5_#KQ*_AOX6>$/@
M[I_AO6O%O@CQ[H%U<>&/ NBR^"_!^J>"EN+"Y\4^#=0T+1K7Q@P/Z(Z"0.I
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M/5M+U"'2O%?A?PU=7G]M>'-:N?#^OV-YH6O7EA??1E?CO_P6 ^#L?[1WA_\
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ME;]I+XGZ;I7BG7XI_CQ\%-,NA#=_![X[_$/X+?M!> /"GC>/1M2U/0-;\3?
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M!]Q<6*>&5GGENGI?LV?L1?#O]E#Q!!#\&_$_Q(T/X1^'O@[X0^"_@#X'ZO\
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M^'7AT1&UJ5=6MK)HM(5]3E"6@>8?AW^U+_P3'^+]S\4OAWIO['WP;_9Z\+?
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M".F2K!=&TDU;5[J ZEJLEK<6GAW08-7\3ZHD>CZ)J-Q#Z^[!$9R<!5+$X)P
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+\+<+L^ /V9?V<_A/X&'PO\ A7\ O@I\-?AF/$NG>-/^%=> OA9X'\'^!/\
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M^!];^-6@?$CXX>(+KP)^R;%\&?$7A_3?V?+H^+?$WQ?\&>/]"_:#Q/\ L\?
M?QOH6H^&/&OP2^$'C'PUJ_CVQ^*NK^'O%?PV\'^(]$U7XHZ9/8W6F_$K4]*U
MG1[VQO\ X@:?=:9IMU9>,[N"7Q';7-A9W$.I)-;Q.N1)^RO^S++??&359?V=
MO@7+JW[1>GVVD_M!:K)\)/ 1U+X[:59V=UIUIIOQEOQH(N_B?86VGWUY8V]I
MXVFUR"&TNKBWCC6*:1&8'X*^&?VP_P!K?]F/P[\6/ACX:@T;XN_&?Q'^T_\
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M^I_$9T\>&ZU?XK>&-*U/2M"B\.WTVDZI?96M?MT?M)V/A?0!:_#;X;:CXO\
MB5^T!^U+\%/AX-$=KBRM?^&3?B1^T-X9\<7VN:3\0/BQ\(M*UJ^UGPM\(/#_
M (BTK3M$^).FZS%H$7Q9\9VOAW7G\"Z1X'\5]OXT_P""67P=\2?$NZ\7:!:_
M"_P7X.O[+PMI]GX5TO\ 9R^$#^,OA39>$8Y9M.MOV;/BU8:7H?B/X'?;/$&H
M^(O'E_?6.F^)M;L?B)XFU?Q;X6UCPYJ+HU>@_M8_L^_ S4OV?;;]G>R^#WPN
M&@_&[XW>"-%7PNW@#PO)X=B\4^.O&R^)OBC\3$T:33?[.A^(2>"].^(WC)?%
ML-LVOWGBXMJ=Q=O?ZC=WLFV'HO$5J5'FY%4FHRJ6YO9P]Z52KR]?94J=6JEU
M=-+J98BK[&C5JQBYNG3E.-.]G.:M&G#F7P\]6=*'-]GFYMD?GU\)/^"@?Q<\
M'^"OB;\8KSX.>';SP=#JS>._C;=3>./ $VK6?Q$^-'[,?A[]H+X(>'_"'B.W
M^+UYXH\8W%M8^(/@E^RQX4\!>'O@'J6F>-8F/Q<T?XL:79Z)K_PXL?K3]AFP
M\?:#\;?BGH7CCQ+I>NMJ7[(O["?Q#MT\)ZSXMU#P<=8^(?CG]L#4/%?B*.S\
M5:]K5L?&OBG7+6>Y\;^+O"T&@Z9\1Y[#2_'6I>&O#NKZ]<Z1;>\>,O@#\%?%
M?[4GPAUNP^$GPUL_&?PN\+OXTUKQ[9>!/#<'C>U\+65I?_#_ .%?PYM_%<6F
MC5]+\'7%[?\ B[74T2QO[.V>'P!%HT<,NAZEKFG7WM_PZ_9T^ 'P/N+Z^^#'
MP1^$?PEO=6M-.TG4[OX:_#KPCX&N-0TNSU66_LM+O)O#6D:;)<:=97E]=3V5
MC(QM;1YB+>*)%14WQ-7GA&;7)/%U)8R=-6Y:5)>TP^ H*UTX4L+"<H7LXI4I
M:N?,^?"PIKG45S+"TOJD9ZKFJ-PQ&+JM2;DI3K5%%MN5[RAS7I,_%37?^"NO
M[1UI\$],^//A/X2_!GQKH7QT_9:_:F_:<^ '@R.[^(6B>(_A8/V4/CG\&/A;
MXG^&'[1NIF?6/[5U[Q%X?^,MC>^*-=\/>&/AVWP1^+/A?6?@YKOA7QX]U8^-
M#^G/[._Q.^(_QVT_]LKX+?'?3?!S^+/@!^T%X@_9TU37_@_J'CSP+H?C_P (
M^-/V<?@9^T9X/UG3$O?$FI^.?A_XET_P%^T9H7@+Q)=Z/XXU">;Q?X.U;QQX
M8U+P_9:_IWASP]W7B']AC]C+Q5;?%^T\1?LJ?L\ZQ!^T!'<I\;DO?A!X$?\
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M_8/EVG_\%0O#^L:EH^DZ!^R7^U1XAU;Q/^U[\:_V(?#&DZ7J'[)\=[K?QO\
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ML4_BDQ64=KHDGB'P[:27,MU?R0VX!](T5\O_ !J_:H\,_"'XA^ ?@SHGP_\
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MIU*D8M*4H8=5,1&,;M7E4Q$,'1BE=.56/,N13:^Y_P!GYH_%=KXW^,X9I?\
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MZ:45^6WBG_@K+\"_AWK'CN/XK?"[XV_"CP%\+OVOC^Q7\2/C3XZD^!%K\)_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&-7EN+;2]8^+OB2YUO4K_P 0^.?%_P ;?VEK6'XA6MIXE\8>,/%>HWNL:_\
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MKF_U7P_K3Z_\.)-.U8>(?AIXITZQU"77M:NO$VCVOA4?_!*#]I;P)XN\9_\
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M>"?AG\,_B!^S!\,_"VM_"#X76VD?$[QY8_&/0M;^&OQK\5>$/ -UHOASP_\
MLW66DV>G^._"NB^,?&-GH>L:SXJ^/'@'P*?AUX?6_P##>F^"OB%=WEOXFT7]
M!O#UYJNH:'I%]KNDKH.MWFF6%SK&A)?PZLNB:I/:0RZAI"ZK;Q06^J+IMX\U
MDNI00007RPBZAB2*55&N% )(&">3[_YS2T %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBY1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?M^?M"^._ GP'^._B_\ 9U\70:)XB_9N71_VJ?C-\-_B??\ PMM]+\,GP_\
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M9H 6BDR/?\C_ (4@;/\ "P/H1UY(Z].<=R.,$X!% #J*0'(S@CV(P1VY%+0
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M6)X.^ GP;\7ZQH+:/X2B\;>*/!VH:5X=\-ZG<_\ ";^';:1K;4/!LC-K5IK
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M$A>R4S+\!?A?YY6&^@F&9CX8,K%Y%#3NSE[C"_:&DVKC["JE>X$:L2?]=;(
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MIX&\5?#*^U_4]'T>]M=,\5/-\/?'GCOP=_9WBJUUC2(]%\8Z^D=@MU=Q7-N
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MIAV^990RC\64#'4]!R10'1][:/L^C\[=BW1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %4[H@8S_ '[;MG_EX09_ D5<JE>?=4Y
MR]N.<X_X^8O0$Y.<>F<9P,F@4KJ,FK746U?;3N7:***!A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 52NP2 !C[]OUSWN8\],]AQQUZ\
M5=JG= $#)P,Q'.<<B>,J,^[8 '?.!UH_K\P>TGT46WYI+5?,N4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5&\Z#N-]O^?VF+^7
M'^15ZJET,@<$@- <>@$Z%B?8!<DYX )H%)7C):JZ:T=GKYENBBB@84444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4[LE0"#U: 'Z?:$!!
M]F#$$=QQ5RJ5Y]U?]^#_ -*8J.WK_F'27E%M>J+M%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 53N@" #G[T/3'7SXRH^A88)[#)
MR*N53NB% .,_-",9QSY\84_\!+;L=\8/!H_K\P>TO\+O;>UM;>?8N4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5&\S@#_:@/ R
M?^/F//X8'/H,FKU4[HE0#ZM"I^AG16'3NKD9Z^F#@T"DFXR2;5XO5=%U9<HH
MHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5.[&0H'
M]^#];B/_  -7*I7AP%(Z[[?_ -*8P.O'<^]';U$W92OMRN_33K\^Q=HHHH&%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%(1D
M@Y/&> >#GU'?':EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *J7([\<>43GGY1*"V/]K .WL&QG Y%NJ=VQ4 ^K0J?<&=%(^C!B#Q]*
M!-)IIJZL[KRZERBBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ JE> E5P"?GA/'H+B(D_0 $GT )J[
M5*\)"K@D?/".#C@W$0(^A&01W!(I/IZ_Y@_AE_AE^2+M%%%, HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *IW>,#/3?;\?6X3)_05<JC
M>= ?]N ?^3,7^-';U%*_+)I)M1;L]$_)^3+U%%% PHHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *I7GW5_P!^#_TIBJ[52Y .,C^.W_\
M2A: Z-=TU]Y;HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "JESV_W[;_ -*%JW52YQWS]Z#&/[WGC9G_ &=^W=CG;G'- %NBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *HWGW5/^W;C
MG_KYB_QX]ZO54N>/3EH%Y'9I@IQZ'!X/8X/:@32DG%JZ::^\MT444#"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JE><!2.N^#]+F+_$
M_G5VJ5YRJXY^>#_THB_P/Y&CMZ_Y@]I?X7;U_P R[1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %5+GIUQ\T!'&<L)@5'L&;"D]@
M2>U6ZIW1P 3TWV_Z7"#_ -FH#]-7Z(N4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !5.ZQ\N>F^W]Q_Q\)GC\1VJY5*\^ZO^_!_Z
M4Q4=O7_,'M+RBW]W?R[HNT444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !5.[QM7.0-T/3DY^T1;?P+8!]!DU<JG=C(4=/GM^?K<1_
M_$T=O7_,'M)=XM+U:+E%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 53NC@ G^_;_ *7"#^HJY5*\^ZO^_!_Z4Q4?U^8=&^R;^XNT
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5*\^ZO
M^_!_Z4Q5=JG=C( Z?/;_ *W$9_\ 9?UH[>O^8=)><6EZO8N4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5EZSK6E>'[!]4UF^@TZP2YT^S:ZN7$<7VO5=0M=*TVWW'
MCS;W4KVTLH%_CGN(TR-V:U*",_\ UB1_*@! <@'U /;O],C\B12T@   '0
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M_P"_!_Z4Q5=JG=@LJ@#)W0GKCA9XF8_@ 3COC H[>O\ F#^&7^&7Y%RBBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "JET-P QD!H&/L!.K,?P"Y/TXJW52Y[?[]O_Z/7(^AZ$=QP>* +=%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 54NQA __ $UM
MQC_MNG.?Q]*MU1O,[1Z;[?CW^TQ<_K1U)GS<DG'XE%M>J7F7J***"@HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *IW>,#/3?;^O_ #\)
MGI[XJY5.[P0 3@;[?T[W"9_D* >S]'Z?/R[ERBBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** &MNRI7L<,.,8/?\ #M3J** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JE>?=7_ 'X/
M_2F*KM5+G/;UA!.,X4S .?;"Y)/\.-W:@.C7=-?>6Z*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ JG=YP-N02T .#U#7" CZ%=P/
ML2.]7*J7/;_?MO\ TH6@._FK?\-YENBBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *J7/;_?MO_2A:MU3NP2 /1H"<<X N$)./0!2
M2>PYH#H_33S?;YERBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *IW>< #(): $@XX:X0$'')!&X$=""1SDBKE5+GM_OVW_I0M =&
MNZM]_;S\RW1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %5+GM_OVW_I0M6ZIW9V@'&?GM_\ TIC'I_M9_"@._DKOT1<HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J=V,A0/[\'ZW$?
M^!JY5*[!"ANV^W&>V1<QFC>WK_7YDRERQDWLHN]M[=;>9=HHHH*"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBH+=)HT=9YO/<SW#H^Q8RL,DSR00[4X/V>)DMQ(?GE$0E?#
MNP !/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !5*\8[0O;?;M^/VB,5=JE>?=7_?@_P#2
MF*C9KU_K\B91YH35[7C+7Y%VBBB@H**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 A. 3Z G\J <@'U
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HY?\
M5M^'_H0J2HY?]6WX?^A"@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *CE_P!6WX?^A"I*CE_U;?A_Z$* )**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **:_P!U
MO]T_R-"?=7_='\A0 ZBBB@ HHHH **** "BF2+D9R05Z$''4C\#^(IR]!SG@
-<GJ>.IH 6BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex10-91_003.jpg
<TEXT>
begin 644 ex10-91_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" .D M # 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4 5KN=[:WDFCMIKQT V6UNT"SSL2 L4374UO;B1R0J&>>&+<1YDL:Y8?SY_
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M_"WAG6=6LM:\0H+M&M=^D65XOVE6ASYBE0 ?DMHO_!/SX,Z=^TC\'=(\&?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?'C]FF>]\9?$#2O&_A31_B3^T1K?Q1^.4GQP^(/BKX>W7A'PKX>\!:5)X/\
M#'B3XJ?$/PO:Z]\2?T\M/VI_V:+WQ-XM\&6G[07P3G\7> ?"FJ>._''AF+XJ
M>!7USPAX*T+1_#/B'7?%WB33%UW[7HOAG0O#_C3P;KVMZ]J$5OI>CZ)XO\)Z
MMJ=U:Z?XFT.XOYM(_:?_ &;?$.E?$G7O#W[0'P2U[0_@U81:K\8-:T3XK> ]
M6TGX4:7-I-WX@BU+XEZCI^OW-IX$L)= L;_7(;OQ1-I<$VD65YJ,3M9VTTR
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M36]MJ<FCZ4]_#&ETVFV+2FUBTZ* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQG&2N-P SR2 *-Z8W;ACWX(.W<05/S!@O)4@,!DD#%?A'!X(_9OTKQW^W_\
M"'QS\'M<\:_LU_ KX]_L]:/\&/V6/",#_P#" :_\?OBC^R-X+O-6^%_PD^$F
MFZUH7@>0^)8_B%X*\?\ _".>)8=&^&_@#XN^(_$'[4VMW7@CQ#;^)_C#I_@G
M[57C[XO?!?\ 9[_8'^!6OZQ\;?'_ (6^ ?C_ /X)9Z/\4OC%\'])^)GQFTSX
M_P#Q^\$?MZ?L]?!KXN_"GQA\6]&L=3B71O UKX3^(=MX@\&_$*]7Q_\ &SXQ
M>./A5X8L[VTU[P!X_P##/CH _I:HJ"VG%S"DRH\8?=\DB-'(NUBOS(X5U/&<
M,JG!Y%3T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN].,EE+!+( =C1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?LD:?I5E%;?#Q=2D\!W7[,SZ9\&M1\+ZEJFH-<Z#H&F^*(]3M_B9=^(?'.N
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MIOBY?B/)87&J,^I>+/$BZE=:?IX!^;?P#_X*,>-_ ?P!^$OB_P",/A3]H?\
M:Y^)'QT^$W[4?[3FG3?!3PA^S+I'A_PW\+/V9/&G@[P7XI\)^&;+6/B7\$YK
MZXM]*\9^"_$VDMJC>+=8\;:[XD\1C2=?L+-?#G@/1?NSP%^W%X%^*WC[0/"O
MPM^&7QI^(/@O5_$G@7P;K'QL\-^%_#$OPO\  OBGXA?L[P_M0Z%IOCJ"\\:V
M?Q/T#3X_A7KWPU_M+Q<?AI<^!K3QK\8_AOX$7Q1<>)9O&-CX,\K^&_\ P2_^
M#?PH\"_";X=^#OB?\?(O#_P4^#O[1OP$\ 2:IXS\':MJNF_"S]J._P#!NL_$
MKPW=:E>?#EYKXZ;XA^'W@_Q!X OYE%_X,N-&AT'3KIO!;2^%Y.I^&G_!.WX:
M?"'Q_IOCGX??%K]H?P]I\6B_#NW\5?#2S^).GP_"SXF^,O@_\-]-^#WPJ^*_
MC[PM:^$K:YG^(7@WX5^'_!W@6X;PQJ_ACP9\0]*^'WPWOOBYX-^(7B#X?>$-
M8T@ ]6_;)^.FM_ +X+VGB7P@^@)X\\?_ !D_9R_9Z^'EQXFMYM1T32?&_P"T
MU^T#\-?@!H7B_4]!M-3T2^\5Z;\.I/B)-\1M8\'V&N:!>^*=&\(ZCH=OX@T!
M[TZS8?F3\5OVM/VHO!_[3_Q[^$NFWOQ6TSP=^QC\"/V7?$?AW5=4M_V4=9LO
MVSOC1^T!JWQQ^%_@+PE\=(]$M[GXB^![#]H?XG>%OAGX+^$1_9_^'OP9F\)?
M$C2_B7J_Q$TF#X9^(? /A^#]%_C?^RC=?%7]E7P[\!I?B9XJ\4?$'X9WOP.^
M('PR^-'Q.C\.:UXLO?CC^S3\1/ WQ?\ A'\0_B4OA/PSX0T;5H]3^(WPY\.R
M_%*U\&>'_!DWB/PGJ?B[1/#[>&YM8@NK/@]/_89T;Q5\?]4_:O\ &GQ ^+GA
MWQO\1_\ AGC6?BG\!-/\1?"?Q%\$[S6?V:+?Q/J_P>T!M=;X(Z/\6=7\._#+
MXC>-O$?Q-\/FU\?^'K;6_'9T_P 0ZWHHTZ%/"UN ?,G[%O[9WQKUKXT?M#?L
ML^-=0U3]J?Q_\$?VG-<\">.?B5;7'P,^%L/P.^ GAWX4? NP\+_$3XM^%O#I
M\-7CZI\9?B+)\<?$G@72?#?A/5+CQ#>^$_B#9VD_ACP7X2T>TTSJO!7_  4D
MTKX>0_ 32_CAX2^*UYJ?[7/C'X:^)OA1XA6U^%GA_P )^'_ _P"UI\=M8^'W
M[-?PYT:S\6>,_ 'C;XC^,/AUX%NOAIJ_[2ND?#/PS\5O$?P<F\;Z7XK\:36_
MACQ;X:\OL?%O_!)SX">+/B%\5/BG/\1OV@-*\:_%U?VG-*\2ZEX>\;^$-(6#
MP%^UQX.^'?A'XP?"BR@3X=2I>_#F6X^%G@WQSX/TKQ.?$>J^"?B-8WOC'P[K
M=GJ>KZFUUZ'\;O\ @G7\+OC=\8)/C'<_$WXZ_#?5KQ/V6WUGPU\,/%_A+2/!
MNO7O[&OQ=\4_&K]GZ]N]-\2_#_Q=JVDQ^#?&'CKQHEYX>\*:WX=\'>*]/\0S
M3>*?#>JZ_I7A[7M' /+_ /@J1\5OVF?V<O@IK?[0WP7^,NB>$-$T+QE^R-\,
MM.\"7GPN\+^,8M2USXZ?M>?#?X&_$#Q7XBUK7[G[;<V>F> /BEI]YX(\/Z!-
MX:^R>+O#\NH^(-8UG1[\Z(GD6K?M0_&7]C_]K/XB^ /V@/B9\:OVG/@[X+_9
MN^$7Q:UGQ)X>^&/[-'@71/@YH/Q0_:>^/W@:Z^+?QDUU7^$=SJEMX&^'O@SP
M#H%]H_P\U/6O$GBZ/2O'_C#P1\!=9NK:ZM?#/Z%?M>?LI>%?VRO@O=? CQUX
MY^(G@+P=?^,OA?X[O=3^%MWX*T_Q/-KGP?\ B%X>^*W@:!;SQUX%^(&EV^F:
M?\0/"'A+Q)=16VDQ7FH2^'K/2KJ\?0+[7=*U?ROXS_L >#_CSKOQD\0^-_C/
M\<+"Z^._[-?@W]EWQ]8^%KKX0Z9IX\%^!?&GB+QUH?BOP^][\'-4U72?'[:Q
MXS\;17NHG4[CPS)8^+]4CM?"-E<Z7X1NO#(!Y_XM_P""BWPT\5^-OBE\!/AQ
M#\5-/\9:#9?M"^&M#^-GAKPOX!\7?#G2/B;^SUX=U34?'/AK5+,^)?$WC#PO
M>:1K.@>,/#FGZY\4_A-X8^'7BGQ/X%\2>&?#OBC5M4OO!I\5?%'C?_@I=^T/
MH/\ P3U\036%UX"L/^"@?PPM?B5X'^+E[JOAJ[U#P7X?;X&?#_P?\6?&G[2F
MG^ [#[*\G@+XI_"7XF?L]^*/ACH^I7-AHWAKQG^UE\%/#'C6XV0ZIIEW^ANC
M_P#!/?PSX>O?B.-#_:(_::TKPK\2V^*GB?4_AQ9>*_AA!X!TCXV?&WPAKOA+
MXI_M Z1HZ?!\7MUXW\97'BKQ3X\O?AGXJU3Q/^RUIWQ4\1:C\2-"_9YTOQ4F
MGZC88WC_ /X)C_ WX@^%_BWH]WXL^)OAOQ=\;O@M\,?V?OB%\7/"MS\.+/XC
MZC\,/ACK=WJ=OINGC5/AEK'@#1M9\;:,?#_@/XD^(]-\ V^K^,/ W@'X:Z9<
M7-IJG@#PQK>G@&EKO[>W@KX:?M!>'?V.]4^'OQ]\=_&'4;?5_#?@OQ%=:;\$
M?#B_&[Q;X/\ V?\ 5_CW>/X4TS7/B7\--5N;#Q;X;\)>+O#UE\6XOASX/_9F
M3XS>&_%WPG;XE>'/$7AC5M&TKQ?4_P#@I1X-^,'P?\#^,_AOX/\ VF_"'A7X
MF>#_ -D/QVWQ+\!VG[*>J>+/A&?VH?VH9OV??"'@+X@>&?B+\0_'>@6WB.V\
M8^#_ !;X<^->GZ#X6\>:C\-_#5KXJMM.O;#XGZ9I]IIGMMO_ ,$[_ \'[0&A
M_M%-\;_V@;SQ7HWQGT?]H>X\+W6K_"1/ 7B+XSVG[+EO^QWXA\<>(=(LO@U:
M:S<77C;X&VJ:!J^DZ;XBTOP_X7O;C5;WX5Z1\.UU[7;?4M/5?^">'P4;X:?'
MWX8^"?$OQ4^%EA^T3^TKIO[6/B_Q)X*\4Z-J/BKP]\8M-\=_#GXGK?>!I_B-
MX6\?:!H7A>[^(7PUTWQ9<>#+OP]JWAV#4?$'B^'3;*PTS77T^W *'P__ ."@
M/ASQQ\?8_@)/\!/CSX/\[XV?&+]G>R^*GBE/@PWPVU'XK?!GP WQ6U+0]/3P
MS\:/%'Q&N=.\5_#*VU+QCX5\32?#^'0HH[$^%O&%[X3^(#7GA#3^P_X*"?$O
MQU\'?V5O'WQ(^&OCX_#;QKHFK_#K1M"\5R>'_#WBK3K"\^(/Q+\(?#6*75]
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M/CB_\;?#O0K6:#P;X]UGQ9J&M:3IFNZMJ\]ROA+]GK_@FU\1/!'Q%_9)\$?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ J*=G6&5H\EUC9E &XE@"0 N1DG& ,@$\$@<U+3)
MY1Q&RI(5(1W4NJL1A69 \98 \E0Z%N@9<Y !^)?C#]BO]JW6?#O_  T_IMW8
MVW[<6E?MQ^&_VJ;3X5VOQFTVT_9]U+P5X8U!_P!GV7X6+\0HO@E;>.18Z]_P
M3TO-8^&5U%?>'[;0+C]H35)OB3J.@FU:349*=O\ L%?%B#XNZOXVO/@5^SMX
MK\$?\/,=(_;9T#3/$GB'2+#Q1J?P_P#&'[)?CWX4Z[X:\6^'T^$'C+PSI/CS
MX+?''QH?B1X;?2O%OB[3?&%VVK>*M$\4>#?%#6LMW[Y\(?\ @I9\*_#O[-7P
M1^*7[97Q(\ ?"_QS\1='\:ZEXGU+PQX/^(=G\+= TKP-\8D^#6H_$7Q+?&3X
MB6_P5^%LWB'6/!\%SXQ^+WCO3_"6C7OB$6UWXQGBLKVYMO=-:_X*%?LC>'_'
M>O\ P\UCXJ7.FZOX9C^,LFL^)+SX;?%J+X36/_#.VB#7OCVLGQT'@1O@K._P
M9MA<:?\ $V.S\?W,O@OQ-I^K>#=>CLO%^CZIH=H ?E/^S9_P3^\;_!*V\*ZH
MO_!/[X%7$*_LD_\ !2?X=?%OX9W^L_ K2]%^/OC']I;]ICX5?&?X(?"GXLW^
ME:/XQTK5O!-Q\/OACJW@7Q/K6LZ1X^\/>!M1^(<NB:5X>UCP=IVHZM<?II^W
MA\.OBU\1?@C\+_!'P0^&%GXZU31OVJ?V.?B]KFC-XN\,> +'1_ G[,O[5?PA
M_:3\0QV%QK?E6U[K6LV/PE7PGX7T2WBL[276=<M+O6=7TG1[&]DG\Z\>?\%$
M?#VK>(/V9M/^ *_VU9_$C_@H!X9_8L^-VG_%;X8_%WX8^,_AS-JW[+/Q)_:<
MN8+?P5\1=%^&WBK2/%M_X:TSX5:QH6HZWH>I>'KKPGX^%U'9W>HR1KIWE'Q9
M_P""ANMZ'!!\3H_B?X,^$7P2\0>#OB#\4/A98VO[,_Q@_:P^*7C3X%?#&X@T
MC5_VMOB'IWPB^('A2Q^'?[./BO5=9T+4/ACX<\/V'BKQ]\3O!OB3X=^)M,\<
M^&O%WBWQ-\(O  !=_:=^%?[8_P"TGK'PZ\>#X%>&;#PC\"?BWHWB'PK^SWXF
M_:>\>?!;XD_%K0O$/P3^,'PT^)GCC4OC=^SIKGB7PMX*U[P[??%C0[;X<?#O
M6++Q?H'B'PYX1^)P\5^)='U;XG^"[KX4_DWXH^''PM^$W[27A'X(^-OAG\*-
M<T_X&-_P2O\ !<W[-'@KXHZ5X]^,^F>,_P!ES1;GXF>$;/\ 9"\.?M.:?>_'
M+XG_ +-WANS^)W@KPCK%[X3L=4'Q%U+X>?$5+;6?A%XL?XYQ^'OVSTS_ (*$
M6ND^)O"_P.^)GA6?PK\?]2^&G[5?BGQ;JVA>$?B5XK^!_@K4_P!EG4_A;I6H
M:YKOBY?#.G6F@^#?'6A_&+X>?$NW'C#Q/X7MO &@^(++P-X^\7Z9X_U#0K/6
MH/V8O^"E?P;^)/[+?PP^*'Q5\1Z_H?Q>_P"%,_LL>*?BWX @^!7QT\&>([WX
M@?M*>&=OA/\ X51\+?%?@]O''Q!\$>//&^@?$+3? GB3P$/'WA.>R\#^,KB?
MQE=6/@GQ3J^G 'Y5ZW_P3<_;FUKP!^U[X?\ ^%,_ 3P[K_[0?P%^'/P^LK3P
M1\4_"WASP)!\2?AI^V7X_P#V@=<;1]'T+X+>'=:'PU\6>&/BEXJUKP-XT^*G
MB3XB_&[4?%\>K6?Q6NM-7Q1'JNF?L1^W+\$OC?\ &O7OV(O$GP>\+^!=>'[.
MO[7NA_M(>.-,\>_$.]^'[7WA[PU\'OC-\-++P_X?O-+^'WQ)BOO$%WJ_Q:L-
M==;NUTO38=,\,:I#'K,>I7VEYT/"_P#P4Y_8F\92?#*/PM\9)_$"_%V\\!:9
MX/NM$^&/Q>U72;/5_BC\6O'7P%^'NA_$#7;#P!/H?PCUOQ9\:OA?\2?A7I&C
M_%G4?!&I7/C?P!XOT1;47&@ZB+?G]0_X*N_L0Z9X0U_QW=_$/XDP^%O#OBG6
M_!ESJ\O[+_[5D,&K>(O">L_%CP]XXLO!T4OP32Z^($7PZUCX'?%&R^)E]X#M
M_$MC\.9/"X7QG<:+)K_A6/70#Y _:#_8;_:H^,_CKXJ?M6>,?"7PD\1_$K6M
M9_9<\%^&OV4/"GQS^*G@OPMXL_9M_9?\2?'KQQ8>'?%7[2FB>&O!&IV7QI\4
M?%C]H*^^.NCR)\,/^%=>$O$7P;^%/PUN-8U[3KWQ5\39/@SQ-^PKHGB?XC?%
MW]B31OV7/@UIOQ<\6_\ !+;PUX+^'-_<?$JT^-%U^PY8?&#]KC]O'4? 'Q+L
M_'WQY\0:A^T'XMG^$O\ PF%MJ]SK7PCO[W^S?BSX4\/^&/AIX?\  WP]UGP]
MJ/A#]Z[/_@HU^QOJOQ'\+_"O1/BZ_B?Q-XPO_A%I_A[5O"/PY^+'C#X9WS?M
M >$CXV^!6IGXU>&? FK?!JP\-?&;04G;X5^+M3\>V7A;Q]J]EJ/AGPOK&I^)
M]-U#1[5=!_X*(?L8^(O#WQ-\9:1\98+GP[\)M%\*>+?$^I7'@CXG:?'JOAKX
MB>-/%GPR^&WBCX7VFJ>#;.Z^-F@?%7XB^#O%'P]^%.M?!:V\?:=\4_&VG'PI
MX N?$FO7EE8W0!^5WBW_ ()]?M5Z_P#M#?'GXD7'P<^!$/A3QK\*O^"JWPKT
M2'P#XN\$Z)I_C%?VTM6^&.M_!GQ-XET#6_A%9^-_$>J:[HGPOT^P_:5N/BG\
M4_%=QI'Q6U=W^!MOHGP(TA? VJY7QF_X)>>)+7]FNY^$_P"S5^Q'^S3X"?Q_
M_P $R/VH_P!F'Q=H>G?\*>^'^L^!/VG_ (E_#OPYX+\ ?%:WO=!\$W^F^,9]
M4OXO$">*O&]MXXT/Q-%X6U+4-8U2#6O$D.F^%[_]2-7_ ."H7[#7AOP])XC\
M4_&NY\*V,7Q \=?"<V7BOX4?&KPOXCE^)_PUT%?%'CGX>6W@W7_ASIWBV\\:
M>'M DCU*[\,VNB3:Q-%-"EG9W,\T43Z?BW_@I+^QUX%M_B+?>*/B9XBTO2_A
M9X0^+_C_ ,3ZP/@E\>[[1-1\&?L_>(]-\)_'?7_AUK>F_#"\TCXOV/P9UW5;
M.T^*9^$E]XWE\!1+>ZCXHATO2M*U2^LP#\LO$'_!.G4]!^+OQ.^)'P?_ &!/
M!'P^MYOVO_\ @FC\=?@VGA0_LT>']1^'/P[^ =S\*-:_:1T;P1ING^-],T;X
M7:WJ>E?#'5/ NI:;X,OK+3OB?<>(]"&I:I=^''UW4?#WET7_  2C^*LWPI^(
M'AGQI^R=\-?'GQCDB^$_@[Q5\7KW]H74/%FB?M+Z#\/_ -LSX9?M&CX@#X9^
M-(-%\)Z%XN\4:5IGQE\=?$?6?BQI.L_$/PY\7OB5-X!^%/BF^^"WB+Q1_9'[
MK^,OVX/V8OA[XD\1^#O''Q'N/#7BKPU\3=&^#-QX=U/P!\3(=8U_XI>)OA5K
M7QJ\*>!_A_IX\&M<_%'6_&7PZ\.:_J?@R#X;1^+(O&&MZ-J?@?PU+JGCJRG\
M-IT;_M<_LY)^SEJ/[6T/Q0T>_P#V<M&\.:IXKUKXI:/I^O:WHNA:!X=U.[T3
MQ?>Z[I^C:3?>(-";P!K&FZQI?Q(LM7T>RO\ X;WWA_Q+;>.;7P_+X:UY=. /
MRT^''["WQ4\ _M$^!/&VA_L\_#2U^#OPT_X*#_'_ .*GPX\!W'C+PI9:1\./
M@/\ '#X$?#KP1)XY^&7AV'2=?T[PE-9?&#PUXW^+=_\ "?0K7PH9/$/BNRUJ
MSECUZ]UN]TK]UXQMC0;0F$4; <A,*!M![A>@/<"OD)?V\?V89/!OBWQO!XS\
M7W5AX&^)5W\(/$OAFS^"GQRO?BK:?$:R\"VGQ5D\.67P1M/AO-\9=<-Q\);Z
MS^+NFZOH/@/4]!U?X27$?Q1TK5+SP$?^$A$WP>_;2^#WQY^./B_X+_"R?Q%X
MMMO#'P,^"'[0&F?%;2?"/BVZ^#?CSP-\>9/&L_@^Z\"?%,: G@'Q-#+HOA;3
MM9LK_1O$NH6'B5=9UK2O#4^HZS\,/BC8>% #ZZHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI"<#."?88S]>2/\
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MKPIXT^(&NVWA_P"&'BOX":Y OA#X:Z!^Q[JO[-6N> O NFR_T.4$ ]0#]>:
M/PZ_9:_93_:@\2:C\'_&7C:X^&'PLL/V=?VY?B5^T=H.LWGP"^+_ (7^(7[3
M7AOXJ?L\>-_@M\1;_P :>'OB1^VW^T-X]^'>OSZQ\9_B+>^'O%7Q ^(GBRYU
MQ/ OPQ*_!7P7X0\.:5'XC]4L?^"5NG+X$M?@MKGQEN-9^!/@;PC^V'X2^"WA
M"/X=VEKXX\%V7[9%AXUT+Q+:>.?'U[XQU?1OBCH/PT\*_$3Q7X8^'^E#X>>"
M=2OK Z'>^/M?\9:YI=SJVI_KB  ,  #T' HH _#GXQ_LO_M>^#/BI^S?\6-1
M^*/@;XV_$;Q-^U3^ST/$_B?P-^R7X\\.^$?AW-\//V<_VR/AMJ'Q7\=^%?#G
M[1'C#6IO!'BZS^)O@3P7KE[J/BFS7P/XCN;OQ1?>*=3\$:CX>^'/@3Z2\=?L
M'_$SQ5^R'\:_V1-)_:!\-Z'X;_:(^#_[<OA?XI^*;OX'_P!J7C?&']N3XG^)
M/B3XE^)?@O1],^*_AA?#?@SX<M\4/C1HGA/X8:IK/BG6M6A\4>!-5\6?%76=
M6\ ZW<_$3]-,#T''3VHH _''XZ_\$OO'?QL\6_$7XCZS\9?@3K7B_P 1_M%_
M []I;P?X4^)W[']K\6/@99>,?A;^RSJO[*OB_P /?$_X8>)/CO;:I\2/"OCS
MPSX@U3Q?X:ET+QU\-/%GPN\6Z5X*N[3Q-XPC\+W(\1_3?[/'[''BGX"?&J/X
MJ0?%?PGKF@ZY^R+^SY^S;X[\"Z1\#=#^'-M=>)?V</&GQS\4> _&GPW_ .$*
M\86/@KX6_#Z/2?VAO&W@^3X/6WPZ\37EIHOAGX8_8/BC WASQ1%XZ^\Z* "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+5]-7P=\<-"\(>"/&'Q'^&_BK7SXQO\ 1Y/%_A?5Y!K?C/X=^'M,T:?PY?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAMEN+^_G>ZO[Z=8(XQ->7UU+)<WEU*&GNKB22>>225V8W:** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBD;<%8J 6"G:"< MC@$]@
M3C)[4 +10.@SU[T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4UWB+^TC^SV]WXQL!\=/@[]M^'7C7PI\-?B'9_\ "T/ INO 'Q'\>:Q8>'O
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MQU\"/A7IOA[4-=N?AMHOQ8T'QQXQN+7]D_2/#7P[UKP%XG^(-C<^-)W^.?\
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MGU>.Q\$7-O"RRS6_BBXTJ:*-@\D:IR/R<\3_ +"G[1^I_M(?\+$T7PE\!X_
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M-H6D^)Y?B]XJC\-Z[\+/%GQ!\7>*?"_C"[T'Q,FL7)\*S7WAJQ\2>%E\5ZH
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MO>-)="\&1^%]6\/^)!XFFTOQ[\.Y_%?TW\%OVIO@]\?-5\7:!X U#QG;^(O
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M ."G/P^^+?@OX*:1\3M.URW^-7QBU?XK:3X9M_V>OA#^TA\?O@QX[\)?"_\
M:5\<_LV:7^T%X3^+O@'X.^(?!OA/X"_%F[\*>'OB7X5\7?$3Q+I.B>%O WQ+
M\&7NN^+M3T+4M&\:>(>G^&'_  4E_9^OOACX,UGQ;\3[_P ?>*+W]CCPK^VO
MKGB[X8?LT_M&Z+X(\=_ ?58/#%IJ/Q<^%/@6_P##_C[QDNC3ZWXFL_*^$+^(
M_&GQI\*64K1^(=$OC;Q7^H>Z^+O@'\0=8_:C\+_M(>%/B?X9T"R\)_L[?$CX
M&:;\/]8^&FI^(X+K5/B%XQ\&>-SXWU;Q-8_%#PO)<V_A[6OAQX/M=/\ "5IX
M?L&N-#E\;Z?+XHM;WQ-HFK^#/E?X<_\ !++P=X*^"G_!/#X0ZQ\1KO79O^"?
MCV'A_3O%NB>%?^$0O/C3\)M(TR*>U^%'CK3CXJ\10V'AS7_B+X$_9U^+OQ#C
MMKO4]+\9>-_@)HOEZ!H6AZ\=(T( [_XW_P#!4+]F?X0>#?CYK6GS_$+Q_P",
M?@-\)/CO\6+WP1H7P>^-5K9^-+']G+Q1X.^'OQ>TWP7\1[CX:3?#KQ.OPO\
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MHO#WA/PW\7-$\16 \>>.$T"^^)1U?X@^(H6LE\5:7X0M_"EMXBT)?!7JS?\
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MU5_C?X?^"&O_  NT7PO\1=&\7:'-I_B.ZUVY2&8:KI,5A?>)M,D\/RZ6L_\
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M'6[_ &<=:TL?"K_@G5\2_C-^T;^REXD_:OUW38/#7A[X4_M.>+=#UWQY\+-
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MTUWP/J_Q U+PGJ=KX5\#VUYH\MOX#\&Q:& ?*GP\_P""J]W\4/!>F_%CPQ\
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M?\$S?V.+;P7!\.M/\!>/=*\#V/P[^#WPGTWPSI'[17[36C:;HG@']GSXA_\
M"UO@AHF@0Z9\8[-_#US\*?'C2ZWX"U_1&L/$/AN"XN=$TW58O#]W<Z7. ?,_
MQD_X*I>*O@3X,UE_B=\"?AA\/?B?X;^/'Q/^"&OK\2/VGQX,_9JLKSX9_L_Z
M#^U!'=C]I:3X(:G>0>*/B/\ !OQ!'J7PN\!:W\&=#O?$/B/0?&&A:QK/AJU\
M.3:U<^I_#7_@H/XT\9?M#? [X!>,_P!GS3_A%J?Q=\&>&O$\Z_$'XNW'A_QH
MTFN_ K7?C9K%S\(/!_B#X5^']$^/?A;X;WMEH/PB^+,GA'Q]IGQ2^'?Q'UNY
MO]?^#L/PNTZP^)'B#BOBM_P3U\'>+?%36G[-GQ6N_"&HZ-X^^(OC_P"./A[7
M/VD/VT=2\91_&/XJ_"O0/!'A3XJ_\)W\)_VM/AQ\7?!FNZ!\/+;5-(?X;+XK
MT'PC\1_#'C6P\2/<Z#XH^'W@#Q-9^LZ-_P $U_@TMM8:_P"+?%WQ>^(OQ2M-
M$U0W'CCQ5\;/CG_95]\2]0_9\N_V5$^-'_"+:+\5]-N-,^*MA^SS>W?PEA^)
M6B^*--^+-[X;NKWQ#K/Q'U#XL7MS\3& -;_@J9\0OBM\*_V"?VA?B'\"O&/B
M3P-\7_"VA>%+SX?^(_"&GZ#K.O0^(+[X@^$M(MM-L]'\3>'O%FAZFGB&'49_
M#]Q:7GA[4I6MM3EETM;75XM/O[7SC6_^"@_COPI^TSXC^#6K_L]:#8_!/X??
MM/?\,Q>-_CW<_'66[\06>K:K^P_IO[;7AKQ7X<^#T/PHN]4\2V%MX<O7\'?$
M*RU?QYX8N= O;G1=;\$7WQ5>Y\2:+X3^E_'O['?PU^-?[.'@S]FGX^ZY\3OB
M?X3\.^%_AYHGB77M/^,7QF^$_C'XA:S\/=,T^VM?$_BWQE\(_B/X.\;ZI>:O
MK&GQ>)M6L-3\5ZI87NO):ZG?K?:C86=]%P5O^QC^R#9?&4:JE_XU/QHG^+_@
M[]KU]%N_VK_VCKSQ#>_$OP)\-&_9\\/?%*Y\$:A\;KF"_P! ;X70K\*_$6E7
M&@S_  Z\:Z#IVG:#XVT/Q"VAZ;'9 '>?LM?M _$_]H/0[3QQXL^ TGPH^''C
MCX9?"[XQ?!OQ:GQ+T+QZ_C#P=\5H?$^IV'ACQGHUAH?A^\^'_P 7/!/AS2O"
MFN?$'PSI;_$#X<6Z_$+0+'P-\8?'MWI/BE=&^=OV]]5^.'BGXP_L6_L[?#BZ
MNO#?@3XV?$_XES_%;QAX1_:+\>_L]_$BU\*_#_X,^+]4CL?#FN> OA'X]U:Z
M&B:OK&F?%2PT^/Q9X+T_Q=XO^&GA3X:>-3>?#+QMXXEB[3P'^Q1^PY^R_I%[
MI7@M=1^%.B>#]3^&?Q DLK[]IWXY6-C\.O#O@SQUJ7B/X9>$M!D\2?&*X;X9
M?LYKX[M]>2S_ &?_  _-X?\ V=O%4\OB#P[JWP[UNPEOM,'O'QP_9/\ @M^T
M1KG@WQ+\4-+\97VM_#_2OB)HOA&^\*_%OXO?#9-+L/BKX8;P9XZ2YT[X:^//
M".CZ_-K'AN2;3$N?$^G:W/I4<KR:1)83-(\@!^+N@_M@_%?X0_M0?LT:M<>.
MO%WQ0T?]LG]GS]H'5O@-\.?B'\0];\'_  ?^('Q&^('[0G[,G@']BG6?B#\0
M&\'>*/!?[/LFL_LJ^!)?&/B(0:%+>>,/BGXT^,VG? _X4?$WX\?$[1?A=XS^
MY?'_ .U)\6O GQ!\?>.9O"6D^(['P)JWP<_9K3X9Q_$W7='\":9\??%/PO\
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M _G(T+XX_M0?#W_@F=\$/^"@OAOX\?%OQ]\<XOC3\/\ PUX]^&'C;5].\9>
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MGAKQA\2]=\/>*/#/QK\2V-GXS\9^&O$6E:IH-SX^A?Q_::?:>-)I-=,FI_\
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M=\8V,$G[2U_\,/A?JL/AO5M$T^P@^*MI\0/%LS^#OA_XHTO6OI?Q9^T5\(O
M7Q=T_P"#/BK5KK0?&.N?!?XI?M"C4-1\/ZS8^#8_A7\$]?\ AQX3^)?B'5/'
M]Q8Q>$8;SPG?_%7P+_:.ARZPVNV>D:Q:ZI=V%KI$UG=W5GQU\"O"GQ0^(7PR
M^(_BC7/'UQ;_  O:76-!^&UOXLO]-^%>K^*Q=6&H^&O&?C;P-:""V\6^*_ 5
MU:M?^ Y==N;G2?#&N7$7B:WTB3Q1HGAC6=# /QRU#]J3]I_X5>/8OA3XU_:7
M'COX_?L]_'K]A+]EW4/@)+X/^"7A34?VY/"G[3/A/]F>W^-'[86G:+%\.=+^
M(.AVWP[\3_&#X]>(/!+?!4Z+\'?!FD_L@_$FU^+.B^*M/B\73^">G_8:_;L\
M5?%?]J+X+? #Q3^U9\.?C!KB?LS?MMW'QT^'T=U\%K#XCZ%\8OV?OVROAU\+
M?A7JNN^$O 6BZ#XB\)^+=0^$^N_$73_B3X?-CI/@_4;SP?I'B7PYX,\+M#KT
M^I?<FD?\%'OV,_$>I>$/^*[\7Z38>,/BQXQ^ ?@_XA>./V?OVB/A[\*-1^,G
MA'XA:W\)?$7POM/C=X_^$WAKX367B^]^)WA36_A_H>AW7C>SN/''BO1Y]!\)
MIK]]%' ???CE\5OA!^S#\+/B'^T%\3+&XT7P7X)TJ[\4^/-=\*^ O$'C/Q(E
M@PTC3M0U2ZT;P-H6N^)]2ABCT_1$U[5FLI=.T31=)AUKQ-J&E^&_#]UJ>G '
MX0?#[]KWPEX+_P""I7[:/P@U;]I;0/V;_@WXQ_;B/B5_B#I&J? [5=!^-7Q@
M^&?_  3T_P""<>A>(OV9?B!X@^(VA>*!\&HK6V\)?$Z_?4-,M]'\5?%76O#W
MQ0\&>%?B!\./'/PBOK;Q9YI\(?\ @J5^U#'\+/A%XS\<_'GX=?$B]^.'_!/'
M]B?]J+QYKFC> ? >G:1^S+>_$K]J[PK\ _VPOBG;^&_"MQ>:L/ _[*OP>U_Q
M7\5_BJ_Q+UKQ-X;T3QI\(?'_ (EU>+X??"[2/$W@7P=_3UK_ (I\*^%!HG_"
M3:QH^A/XBUZQ\)^'8]4O;6SFUWQ%J+7+Z5X?T>.XD234]7OTM+J[M-+M%GNG
M@M;N[6(PV5Q-%NBWLR2_D0AIR'8M$ \K>6ZY<LNYV$<DBX;+!7D7 #," ?SO
M^(OVP?VM-#N-6\;V/QO\7?$;]F[X9_MP^+?V(=,^*7PB^''P+\0^+/V@;7XT
M_!3X;#]G7XDQ7DGP_P!9^',_C+X;?MV^,[']B7Q1K'@:W^'OPBU[7?$M]?\
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M'DO/@[\,/C%\,O#7P^\8?M'^/;CQWIG]/:06L+/+!!"DK Y:.-(VDWO)* S
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M7T#2K;Q3I5UHWB'1+6\\&ZY'>-J7A75=5TUH]1G /S(_X)O^-/A7\1?VYO\
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M0M1M;0^./Q=^$/[/5CX;\3^+?!WB3Q!KVN:OK-CX.\.?"CX2>)?BK\3]9O\
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MVCI\%OBK\0-;^+7Q>MOB[+XXT/\ :#6/P[X7^(3>!M5M_"'A_P"&GP"^,'P
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MDQ'RHMWEQ*L:JHMT@(8 J00>A!R#VX-+0 4444 %%%% !1110 4444 %%%%
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M_#O[97P$\56WQ"^('A[XZ_LS>+/@!\/OA?X3^)>H_%;P'^T!X3\=W%EI^O\
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M'\0Z)9?$WQ1\ _#OQ:_85\>^'O%_A==0^(>D7NE067[)/PK\5?#/PS?7.O\
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MQ*UCQGXD^)FOZ?XR\7^-=4F2CXJ_9X_:1^,MB_@7Q;^S[\:9?[2_8H_X+_\
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M!UN_^)&J@>$K[0?#>DW&@WD=[XP\3^%?"F@I/!<H)O)@\^3Z1T+XL^'?BO\
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M/P/XLT[1_A[:^%/B9X1^&WP&TC]H2Z\1> [?Q)\3?#WC34_"GBOPMJ6J>%?
M_P 0=0\(:3\-?$/Q*\#?$+P:/&=I)X3O=18 ^9O W[*OQ$_9KG^"OQ'^/WA+
MX8>-?@K\#_@G_P %&/A9\6/#?PMT+XZ_'_Q]XKT#]NG]J'X0_&^RN_"?P2\
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M_!MUX_L=:T_QEX)^*_B?0KGQ#X-T?XQ7NM:UX"\,WL6A:]KWP8\1PZ?K":X
M>D?"G]@CXX_"G4_A-:IXC^&OB7PW^R1X$_;&\/?L_P"N-XI\<Z+X^^-5]^U'
MKFDZWH-M^T+=OX,\1VO@9?!<%A/;_$7Q1X.N?BI=_&3Q]_8OQ=T[PG\+$T1_
MAEJ?MWA3]FWXVZ#_ ,$O-,_8YNX?A;=?&K1/V0/^&6+?48/&'C%/A9JM_I'P
MI;X-Z-XWN?$L_P -V\8:78:QH=K8^,=5T-? FKW.A:K=7?@JTUGQ):V,/C?4
ML70?^"H?P<UC5? %W<_#_P"*>A?"'QU\1?!WP3F_:&\0K\-].^%G@SX[>/\
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M[-%AJ/Q$^)/BBP\)>./&$_Q&OM.72DLOASI4WC7Z#\:_\%:O 7@W2]#O+?\
M9:_:K\=:IJ7A+]N?QIK&A>!;;]FQI_"6B?\ !.GX\67[/'[3]QKFK>.?VE?
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MR>#-4T/XE0^!/@-\;)OB+\,/BA^PYX \0_#WQK'\'O#'B*VTC]O']H8?L_\
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M6L?@?PEKGQ3T/Q9X=C^*WA@^(_'-]J5EH'@;QE:6WPVUR^ .Z_X8&_:L\/\
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M&GPN\1^$?BO\-?VL_P!H+PQ\+O /C3P3<Q_%/6](MO#NJ66HZ=J/Q-\,>/\
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M1TGPU>^-/%UUH5A<V^F3^)M=EM6U.ZZF@ HHHH **** "BBB@ HHHH ****
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MP_\ #B]'PN\%:X_@*+XQ>(H/AS\+IO%'@6]&M>,];_031/VQ-1N/^"=_BO\
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M^$7UGPEKUI\+?CKH?Q)M=(^/^B6VK:O#\(_A!J'A#5_#]WSO['&K7^@>-_\
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MJR\+?%K2[GQ#=7U=U^RWXT^-?B[]I']M71O%?CC0-2^$_P )_B+\'/AU\/\
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M0M/FFTN]M[C6;35?R^\1_P#!2S]KNR\$:[J7@;PU^S%XSUGP5\/?^"R_Q/\
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M19_&+X9BQUZ.7P[XV%QIVOS>+OA[?7O@:X^-==_X*5?M27_PJ^&7C7P5X2^
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M OB-^SI\3?A]\.?@M^TQIVK:/;^,;KP#\:_B5KJ:#X[T3Q9XCN?B8OPK\/\
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M+X]?M$>,/A]\=])TWX;7W[-1U;P+^SWXV\*?$*'1[BUN?C-K=OH'C7PKX_\
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MM;_9N\4G2M+\>>$/!'A_X?\ PX^+?@OQ%JVB^ O@C\1/CKXIT_0;_P ">/\
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M@']L?P_^U!>^(_@IKGP\\-?$S6_''PI\9>&_@/XM?X*^$?BK\#O"_AWQ;?\
MPZL/'=]9?#CQ[IUC= '[HZ/^Q=^R)X>T*?PQX>_9B_9^T#PU<?"KQ?\  J30
M= ^#WP_T32?^%(^/M<U'Q-XX^#R66E:!9V\?PO\ %GB;5]7\1^(/ 4:)X6U/
M7]3OM8NM*DU*XEN6W/AS^RU^SS\)?%C^./AI\(/ ?@KQ0VER:'#J_A[0K:PG
ML-)GTCPCH-_8Z1&FZUT6/6-+^'_@:T\0/H\%A+XB3PAX<?79-1GTFUE3\$OA
M)^UM^T?\0?B!X6^"GC']NKQ+X T%OV[_ (^_"H_%?PQ:_LS>(]2\;_LH0_\
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M[GX+7=]^S-\!;F?]G&*WB^ 4D_PG\#2M\&%LM5TC7K7_ (5F\FB.?!HM-?\
M#^@>(+5-$-FEOX@T72M>A5-8T^UO8O3_ (L?!7X1?'?PS#X+^-/PR\ _%?PC
M!JMIKL/ACXC>$- \:Z##KFGQW$-AK,&D^(K#4;*#5;*&[O+>VU"&%+N*UO;Z
MT286U[=13?A/\,OVCOC5=>%M!\9_%?\ ;I^+EK\'?BY^W7^W'\#OB)\;Y_#_
M .R=X:\#_LO?"O\ 9R^)'[6%I^S;::3XNT_]G_0=&^'FC?M'?#KP]\&];U?X
MO_&W4OB3!X@N8?A[H7PQO/!MQ\9-)OKKP+Q[_P % ?VK=(\!?%GQ+XZ_;1TC
MX$_$7X'?\$X_AO\ M,:?\/;+P!\ =,M/B;XZO/VD_C;\+M'^)OCGPO\ %KX>
M^(/B5X=\%?%WX?Z7^SOXH\0_"'1=0^'OB/2M5^,GAWP]X6\4^ -2UFPC< _H
M_P!$_9Y^!WAKXF?\+DT#X2?#K1OBJ/"-CX 7XBZ7X-\/:?XTC\":7;VMKI?@
MB+Q)::=%J\7@[3(;*U&F^%XKU-"L'A66TT^&7+GR_P#:#^#'[$OE^,OV@/VH
M?AQ^S1;6VE>"] T+Q]\;/C?X5^%]A!HWP^\%^,+'QSX6TKQ;\3O'-E;II?A/
MPG\0ETSQMX:@UC7;?3?#?CF#3/%&A_8/$=M9W\?X^:E^V'XVTWXK:I\$]9_X
M*6:EH7P[\'?\%.-6_9L\4?'Z[D_8CL_&<7P"\8?\$>=4_;'\,W7BKQ#>? 9?
M@[X<DT3]J7POX[\*^#?&=K\.=#74M/\ ".O?#S6I?$FMZ!?WEI\W?%CQY\;/
M&/[/W_!3BY_:"^,OQ#F\>_$K_@WG^'&N^&?A%XKT'X=^";CXG^)/%TO_  4I
M^%T?BVW^&%E\/]%\8:1\0-6EU'X%ZAXP\+^$E\,MH?Q.^/VF>#/%G@_2;2[^
M$OP]\#@']$>M?L/_ +&GBGPGXO\  OBO]E#]G'Q9X'^(?Q,U+XU^/?!?B[X)
M?#CQ-X4\:?&36UO!K/Q9\6>&]>\.:AHVO?$S51J.H+J?CK4[*Y\47JWUW'=:
MI*D\BMW/[0,'[.R?![QA%^U-#\'#\ 5T^QA^( ^/Z>"I/@\NEMKFD_V9%XV/
MQ(SX*%@_B1=#_LY-?/V9M<321: Z@MD*^ Y_B?\ M12?MH6OP%\-?%#Q5XW^
M$?QWUKX:?M>_!WXPZ'IGP'E\(> OV4/AWH]OIG[0/P%T^[MOAI=GQDGBCXLM
M\$-+TOQIK.KWWQ%\0?"K]L&[U;X7^)](U']G+Q;XQO>V_;E^*'P^_:%_X)6_
MM@_$CX)>)/#_ ,4?!_B?]F+]H&#POK>EF>]T#5=2\.:+XM\,ZQ87\9FTF\AC
MT/Q7X=U70_%%G+<Z1J.E7&DZM9S7>E7EK)/;@'T+=_L+_L6WT,EO+^RE^SQ%
M:7'A7QKX)NM.M?@]X#L-.NO!?Q+DBF^)'A.\TJST.WT^Y\-_$*>WLYO'>AW-
MI+IOB^?3M+D\16VHR:7IS6O2>%OV4/V7?!OQ!\+_ !7\)?L^?!'P_P#%7P;X
M!LOA-X6^)VC?##P9:?$70?ACI&G6VDZ5\.M*\>0Z,/%=AX*T?2+:WTG3/#$.
ML+HVGZ4BZ7:V<5D[P/\ C?HWQZ^.'A;XJ>#O&%S^V'\9_CQ^Q;>_MMZU\'[/
MX_6?PX^''B6V^(OP.^,7_!-_QK\3%M-&\6?LY?!7P]X*\8^&_A]^VAH?PN\/
M_!OXU_#WP79WR^/?%_B+]GBY\:^*[RQU7PG7>?\ !.'XJ_$WXI?M&_"GQ/\
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M7T>^,8L=2LKTNMPT:65W%=;UM3;K<E4MWDW"V-Y:K/A3Y)N;=7VF6(-_-_\
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M@[P5X/\ B!J7PL@C\(:[INI_\(]X[T'R_7/^"6%[-X7^,UB_["%G\2+SQO\
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M;VVXW%6<%6&X\*C%".7.U44[=QV*HR$4!)$B<!FC\UXB7B5L[MXY&PN0%)(
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M<C**7P5R:_G7U+]B/XD:SXKL]:\-?L5>(O@I^S1XS_:Z_8D\>:I^QSX/\4?
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M_$'6M,^'WQ2\2^#;OQ!H7PN\>7#>#?B#J/AKQ+;7>F07?#7[=W[)?C;P5?\
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MXLMKKX8Z%XFM?"_AKX:>*WC\3'X::)X%U^Q\2_ DZ^-:T/7/%?BJ*'6+6O\
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M>$?@QHO[4GQU_9O\*?#W]F%?VD_'W[-WQ,\;^#?CS??$+Q]\%;[PC^U'XO\
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MOX.U.XN-,NY]1\*ZGJUA>7WAV^FN]%T>ZEN]'GLKB2YTK39WD:6QM7B[BB@
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M>E "T4F1G&1G@XR,X)P#CW/ ]3Q2T %%)N7CYAR2HY'+#.5'J1@Y'7@^E+0
M44 @C(((]1R** "BDR,XR,XSC/.,XSCTSQ]:6@ HHI,C)7(R "1D9 .<$CJ
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M)^%_Q3\)W.F:A\8[CQ3K%I;:SIOP8^']Q\&?&WQ]_?A?V9_V;X_$'PY\6Q_
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M]_"U-#\(^(_'B1)XV\0>'_#=[X-BMO#7B'QC'!%'XNU&SL+#6-=$20Z[+<M
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M@U'Q#8ZY=0V6EGSM'TW\ZM>_;Z_:EG^._P 7_AE\.?!OP5\?Z*OP:_;B\0_
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M$V[ET>2X\>Z1:Z5=WNGP:;XJ?5K."PNKJUC@6">6-_"/ ?PG_8)^+L6K^"?
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M]J?]F[PQJ?@;1/$/QK^%^F77Q-^'OCOXL?#\WGC/0DT_QE\,_A?IV@ZQX_\
M'/AO5EO'T;5O#?A31?$>D:YJ6HVM^\:Z-)=ZK:"YLM*U2>R /Q,_9O\ A7^V
M1\'/CI^SY\(_B]\3OVL+_P 3_L\V/[)WPDT75/AOX!^-'C[]E[]H_P" 6@?L
M3_ ;P7\;M2\<_$#Q1\2-!_9,\"#1?VFM/_:.^)?B?QA\4OA]:_MIZU'I?PV\
M/_!_Q+KVCZQIWPN\4_)GPQ^%OQ_N?V -/^&FC:9^WY)X%TO]A[_@FIIWQ_\
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MGHUU^P>%_9GT[XD_$W6/@#\2;']DF]_:PO\ Q'J&O?%*7X"^%->\%>)9+O\
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MBI\8/!'AGQW\-G.I6.D7<"^!/%-AXNT+1+3XCR^5X*M?%UV/#.I:U9:GMB8
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MLN-#^&GA#Q'XNT< _-/0_P#@C9\<_#W[+UC\)-'_ &:_V?M*^(5C_P $:O\
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M?&7PM^$UM)KGQ.N_%7[%?P2_:S7]HCP_\)_$WPF^$_CW0_C%KOBGPWH3:)X
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MI\7=3UY->T1/'W@&\M-)F^$'@'PP="M;K3M+U/X?^+_%4_BKQO;^+]#TW_A
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M/MS7O^"H?[%GACX>>&OBGKOQ1U?2_!GB"#Q]<ZK=WGPP^*T&L?#&'X3^+(/
M?Q77XY>%)/!2^*O@=>_"[QI+/X=^(.C_ !3T;PKKGA2XT7Q?J.K:9!H7@+QW
MJWAOZ/\ C?\ M&?"[]GOPEH7C;XBWGBE]!\2ZIJ&D:&W@7X?>/?BCJ5_<Z3X
M%\8?$W5+E=(^&_AOQ3J-MH^G^ O /B[Q)=:[?6]KHRP:3'I\5]+K&K:+IVH
M'XCVO[$O[3]G+^QBO@?]F;X>?#.[^"7BKP[++HVI^(?@;X^^!&A?#6S_ &W=
M0^-&M>$_B#\/'TJP\2>"?$7P[^&NA_#WXN_LR_$3]E/4IO$>D?M"6$WPT^)<
M4_PFT]?%%[^K'[5WP9^*'Q6^)_[$7B;P!#I4>A_ 7]HSQW\5OB!J]QXB.C^(
M=(T3Q;^R#^T[^S+I5]X0TMM&OK;Q'J^CZ]^T18^+KS3[O6/#:+HGA74_L=[?
MZO-INDWN=;?\%%_V5-02PGT[QCXNOM-U/QM^ROX!M->LOA)\6+O0/[3_ &VC
MI=O^RYX@;6;?P5+IR_#_ .*VLZ[HOA:Q^(IN#X+\.^,M5L_"7C+6O#NOM/80
M<G\.?^"DGP<\8?"R#XD:_P"#OC+X9U#4/BA^U'\/M%^&.D_!_P"*/Q(^+&K:
M)^R?\8/$_P *?B7\28_AY\/_  5K?BV'P1H4ND:!)XKUQM&?1/"WC?QEX:^$
M0UG6OB+K_A72/$P!^9WPR_X)D_M&?#_X._"^&_\ @!^SEJ'QM^"4W[!W@Z_N
MX?VI/VA?B#X<_:/\-?LC_%'Q/KK:I>/\8/!WB#P[\"O!NG^'?%%_XI\&>%K'
MP%XZ\6Z'XC\:?$_PI::P^B:;X;U#Q]ZA\5?V _VD?$=]&^I?!+]G[XT?#/2/
MCO\ M[>)/$'P7U']ICXL_!F7XX>%/VR_B1-XZ\$?$_Q%XX\ ?!6WNO#/C#X.
M>&]6\4? SQ-\,?$4/Q.T'QQ\)_B9\3[^T\3?:M.\,> O$OWEXK_X*??L:>$=
M??0KKQ_XX\10)9_ S5%\9_#KX!?M!_%+X6WFC?M."VA_9TU_1/BU\-_A;XI^
M&WBCP]\;];O].\'_  PUSPKXHUO3?&GCN]_X0?P_<:AXIT[6M*TRKXD_X*@_
MLD^$_AC;_%_7]=^)VE^"K>X^* \:MJOP+^,F@^*/A'I'P0\5>%?!GQB\3_&/
MP+XC\$:-XS^&OA[X<ZYX[\#MKMQXET*TO[O0O%FD>+O#^G:UX2%_K=B <=^P
M=^Q_+\!?BM^U;\2/''P3^&_A7QAX^^(7PVMOA=\3-&EL/%OC.[^#7A+]CW]D
M#X!:WX-;QUXANM>^+5KX;O\ XH_LS:UX_BT#QKXHU6^UG3M=\&^)/%5W?>/E
M\11:1\%?M$_LA?M":'^UY\7?VU_&?P\\":1\"OAA;_ME>+_%.M?!3XCZOX4^
M+GQ$^#7Q!_80TCX>V.MVFG^#?@YJOQ?\0?'>W\6?"WPUX/U>#4?B)JFC>'='
M\._"C7O@=X?@U#PYKFF:O^EM_P#ML:3K_C$^"_#MY>_#+4/#7[;?A3]D_6+K
MXC_ _P"*7C;2OB3=:A\.[WXAW^D^!];\):GX4T+P%?\ B73+.YF\)_%#Q9JW
MBKP1H^EQ^&;W7_#5YJ'Q/\&Z+6W)_P %%OV7)]*\7ZEI'B#Q]XB?PMIWA'5]
M)TS2?@O\85O/BKIOQ"^+[? 7X;ZO\"[K5? VEZ'\9_#GC_XOMIOA/PGXT^'N
MLZYX(OK+Q#X2\?S>);7X7^+_  MXWU@ _ /X%?LS^%/C-X5U;X:^%OV=_@E^
MTAXOM/$7_!)O4_C+X\^"FM_LI^/?V9_%'P._9#\8^']1U#P+=:_I T'1-1^,
M%YX(\/Z]-XD\$>*+T6_C#2O%'A"?P_H/@OX60:/%<_;7B7_@F/\ $6/XG_'[
M2_A5\)?A[\-M4\2>'OVAK/\ 9>_;%\*_'[XD^"(OV>O"_P 4OV/7_9G^&OPZ
ML_V1_ MAH7PYBU+X*W6E^ O ?@NQM--UGX>1? _X;>!_':ZCI_QD\)^'?#EG
M]+_$;_@H'XN\0ZAH&O?LUW?@'5?AWX\_X)^_\%%/VB?"<GQ0^&_Q$LO%F@?M
M ?L0_$_]FOX8Q>$?&FER^// MR/"</B3XQ^//"_Q!\%KHVA^)HO$'@&WU#P_
M\1TTF[DAD^C_ (?_ +>/P4U?PG?_ /"8>(-=L/'WP^\#_LIZ_P#%C1M+^#GQ
MM%A;:M^U[)8^'_@PWPXQX'U=/BCH/CSQ[)J?A'2+[X7ZO\1+?0M:TO4M%\5:
MII^I:-K'V4 _-7PO^P#\1-0^*7[+_P 1?&O[ O[/'@73_!'[5,'QM^,WA/PO
M\>M6_:%M-1@TW]B[]H3]G.^UOP]'\;="\*>'M#TJ7QO\3_@I)\,_AWX.\.Z4
M-(^''[/6CZGXMUVPUG1_A=\/_"?DGPX_X)E?M'^'/A!\+?A]X)^!/P;^!GCB
M']A;XE_![XS:MIOBKPG%X$^+/Q:?]IOX)_%+P?\ #SXI:M\.M/L_'6M_#/XA
M?##X.>/_ (;^)/B!;^%O$^M_"SPY\>[FT\)^$/$!MO%FF5^X7[1'[9'P4_9>
M\0?"_P )_% ?%;4/%?QHNO'5A\,?"WPE^ /QU^/7B+Q5?_#?PA+XZ\66-OI/
MP3^'7CZZL;VS\-Q-?65GJJV-UK$<5_/I4-W9Z+KMUI?DGA#_ (*@?L9>/- \
M0^)_"WQ"\8WNBZ)X/^#7Q TBXOO@C\<?#]Q\3?!?[0OC6'X:?!7Q)\#]-\1?
M#K2M3^.6E_$;XE75A\/O#MS\)[/Q?'-XLU?P]IER;8>)O#L^J 'YG)_P3.\8
M:WXOT_Q/JW[$GP+T#PYJ7P"_X*9>&[3X>^(/CEK?QPG\"?&;]KW3/V3-.\#>
M,-<^*?Q>L/$^O?\ "0^,(_@'\7[3X@>*?A5X4T[3? FC?'+3]%TGP]X\U2?X
MI^+/$/V3^S3\"?VFOV?OB???$[7/A/X%\=Q>.?V:OV ?@CK=U9_%:TL_B/X4
M\2_!^^\2>!?CMJ^K2ZMX3FT;Q=X=TOPWXO'Q,TW5;+QO:ZYX\3P=I?A'_A%-
M.UZ6TU"W^AO$7[<_PDUKX;ZI?_"G7=?U7XL:EJ/Q4^'GACX:W'P5^+7C+XB^
M%OBW\+O"<OB/Q3I'Q+^!GAK3=&^)^F:-X+AN_#.H^([B=O#>FZ]IOC7X<0>#
M_%5]/\7/A;=>*OB]/^"G_B[0/V!?'7[8FO0>"O%_CKX=_P#!+3]E_P#;8\0_
M!OP9\)/C#H6CV_Q&^/WPY^(OBBPUBV^*NK:]XD\.>(/@-X@\4>$I-)_L_P (
M0>(_&/P8\-^!O'/B?XD^,-:CUKPW:6 !]H_MN?#?XK_$AOV4V^%G@P>,(_AG
M^UY\)_C-\0HSXPT/PI/8_#WP!8>*FU5M)M]<GM[7Q1KUWJ>KZ-!IWAZXNM)L
M# +_ %>XURTO=*TS3M7SOV+OA]XP\$>*/VO]2\9_ *X^"DGQ1_:?\8_$;PU?
MG6?A1K4/C[P-=^&O"OA3PYKT5Q\-/$&L:IIU_<?\(GJ'B+5M"\:VMC?:/?\
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M_A/\4_&/AS1?A=XU\4>$-;L[G1K_ $K0?%>HW]RFE^*-8T*SUO2/"'B6\TP
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M?$8Z=X- ,$?\$J[N?X=ZMX!OOVH/&WE>(/V//V5?V0-;NM*^&7PTTVWFT/\
M8V^(&L^/_@]XXT^UN+#5-4L=;U&7QK\2]$^(FBOXBNM#UNS\;F]\(Q^ =0\.
M:)/#VFJ?\$R['Q'X$_:&^"OB?]J']H'4OV=_C_??&+Q-!\$[*'X0:=I/P?\
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MEK.@>'/'FB>"I_CA^UG^T#\*/VU?VAM7\!^/OV[_ (\:7^S[IGPB^!G[3_\
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MFF\&?&#Q3?:_)XMU?P_HWACPMHUCQI_P3;UKQWXV\5^/?$/[26O-J'B?Q?\
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MQ_\ #S6?%]_XC^+GA7XB^)CK/C3_ (0CP1XUU[PEI6E^/O.OA1_P5TU_XO\
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MKX:^(_P]T;Q/JOQ,\>Z#8S?$G4=$\+^"+)?#,M_HOA;1M!U.>U\0V.%\9O\
M@D9<?'CPS\6_!7CO]I74X_!GQCUS]M+4O$?A/1O@]X1O?#EB/VQ/#OA#03XI
MT?1_B#KWC^QT[XS_  8A\*ZCI7PT^,5C!;:WI/@GXC_%GPEI>E:))X[O=<M_
ML,?MK>"[+X&?M5?M1:EID&J_LX_LXV'Q.\4^&OB7\/==;QRWQJ^'7P7^$EAX
M^^)OC3P=IIT3P_I?E:/XTL?B'\+="MM'\2>+-*\5ZMX!N==L?$5MIVK06MI\
MM^._^"C7QY^''B34_A#XA_9=^&=U\?)9?V*M6\*Z#HW[3'C"Z^$&I>"OVTOC
MC\0/@!X=OO$GQ>N_V5].U;PGXQ^'OCGX=:Q<^)/!T'PN\1CQ+X1O-.U_P/KF
MOZC9>*O#7A< ]>UO]A3QUJ?C!/$\/[1US<647[6?P=_:WMM$\3_"?PWK'V+Q
M;\/?A$WPJ\<^'X=4\-:]X%FDTSXH-:Z/XM^U7-K/)X'U6#5M-T:VOM'U.QM]
M#\S\*?\ !-?XI>&/V?;C]EIOVS?%^L? OP/I_@#P3^S[X$U7X.?#R;3/"?P7
M^'OQ)\)^.-+^#7Q]C2]"?M(>$+GP9X,TC]GN_@BC^$5MK/P#NO$'A3Q7IWB;
MQ%XG\0>,-1^J/B9^T-\5OAEX@_8^\&ZE\(? E_XL_:B\5^,?A5KEO#\9M:AT
M7X:?%[PY^RU\8_VDM,TJPU;_ (4O->>//AWJES\#O&'@/4O'DFB>"_$NC)?>
M&O%=I\,->6_U7P[H?P1HO_!6CXH^*?!?P\^)/AS]DC09_ FM_L@?\$__ -L[
MXDZE??M)16FK^!OAY^WG\3/B'X T'PEX5T2S^!^JCXC?$+P58?#C6_%5M9S:
MGX(\(>+K>"[T>]\9>"]0&D'7 #T;PC_P2ZUOP-H?@SPYHO[1\NIZ;X/^"O\
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MQ3H]AKEK\+0?M,_%+Q=\/]"^(GCGX[_ CXC>'KS_ (+%S_LBZ/\ ##7?A/X
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M]T?]F^;]D.S^'&GR?LX3> M5^%I^%>I:MXCUO1(_AUJ]A=:3+X,MK_6=8O\
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M2VM[O4;:*]AT.RU/4X[:>2X33Y;2&\F@]MKXA_X*/_#_ .)GQ9_8H^/WPO\
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MCSXZ?#O4_P!CC5?%VN_M"?$S1_$"F'X+>'_BMH?PC^(?C[Q;XA\>?LTP>/\
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MX;_"WQ7\'/A/^S)\:_%VL6_P>^%/@7X7_$/6?B#XP^$/_"YM;T7Q-^GG@_\
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MTK4)M$UJP>^TZY47%A=/+:S_ +V)Q7H_DP.2VQ"6+$E>Y8!')*GDL$56SUV
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MW%O 45?*AGGM+6>>%-L<LUK;RR*SP1,DEQ96<[+)-:V\\L<,\$!FCC=ECN$
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M^-/''BOQ)K>IRS7FK^(_&7C3Q%X@\5^(;Z0I#<:SK5ZUK:V5F;>S@^(/V$_
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M\,M8OM#\.:SI7@[6M,?P;H_@G7[Z#X/Z1!X=\$:'K5S+X,@OW_-[]E7]C?\
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MQC^/O_!1+Q_\1M4^'7BOQDOQ$T;P;^UQ^SYX]^"GPKUCP=#J?PSLM-O?B7X
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MOPT\-^'O"WAW1\UO^"6_C_PA\#O'OPK\*:]X?^)T#?%WP)8?!*7Q?\<?C_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX"U/P!I5O\7_ !+KWQ)B\()\$/@]J:>*_CM8> =:L=9\.V0!])_L\?M/:/\
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M!%7) &68@#)( R>I IU(PW C)&>XX/7- "T444 %%%% !1110 4444 %%%%
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M1O$GC/XH?#_2/VF/%OQ@^(OB?]GOX(>!O!>B?LX_#?P5\7?BM\6_C[<_H?\
ML@?LY?%3]EW1A\'&\5?L^R_LS^!O#NBZ)\!?AQ\'/@#XK^"^M_#>T@DO&UCP
M_K^J:I\<_BOHOCK1/,:/4M,U^;1-#\=:IJNIZK?>-]>\5:P+C7]: /MDD $D
MX Y)/0#U->,_M$_&[PA^S9\"OBS\?/'<[Q^$_A%X#\1>/=9M[8/+J.KP^']/
MFOK?P[HEK#!=76H^(_%%[';>'/#6DV-I>:CJ^OZIINEZ;:75_=V]O)V7Q(\+
M7WCGX=^/?!.F>+?$_@#4O&/@OQ3X6T_QWX)N;6S\9^"K[Q#H=]I-IXM\(W=]
M;W=E:^)_#=Q=QZSH%S>6EU:P:K96DMQ;S1*\;?F39>%/VO\ ]J#QC^S1\(?V
MH/@MJ/PT\$?LY^*="^-G[1'Q;T3Q'\++KX/?M7?'7X'WOA+5O@#I7P2\(Z-\
M0O&7Q8T+X.:K\66N/VF_$%G\5_"7PZ\8_#WQ?\#_ (7?#N%_&>G:YK7B*0 ]
MO_9"\$0? ;PYX;F_:6\?> ?^&X?VO]2NOB3\7K.X\5Z2NH>*/B5I'ABUUC5O
M@S\$-.U"_CU;7O@Y^R]X,-OX%^'^C>'K.X-EX-T:]^*/BY)_&OQ"\=^*=?\
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MEV\,42>IX&2<<G )]<=,^N.U+10 4444 %%%% !1110 4444 %%%% !1110
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M0PI;NEP&@CAA2(HD2!>.B^"UL_QUG^.VK^._'&O7]EX$O_A]X(\ :@/!5IX
M^'.E^)-6\(Z[X^U7PU'H7@O1O&VK^(/B#JG@#P/)KM[\0?&_C>RT6U\,067@
M#3/!=OKOC!/$OM5% '.:+X0\+>'+76;'0/#F@:+9>(M:USQ'KUGI&C:;IEIK
M.O\ B:ZEOO$6MZK;65M##J&KZ_>S37NMZE>)->ZM>3376H3W%Q-+(]./X?\
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MPG_A(^ ] -N;9;@:WXP&L'P[I)MWO;-)QJ&I6WE/>6BOC[3!YGXJ?$[]F/\
M:&^$VE^,O''Q(\!?#?QC\%_@G?\ _!6WXNZWX]\#_&'XLV/QP^(WPZ_;-'Q(
M^+GA?3-!^'/@+]G_ %GQ?:_$KP0-8/PC\1>'_"/Q(THPZ5H'@CXF?##QI>7D
M#?!GPW\R? _]GKQO\9=,F\6?!JU^"OQK^.WPAA_8<\=>)/B-\.OVE[_2?V?/
MVC-$^!/P=^-WP.M?V:H?VB/V6_V<OV=M3^!7Q=^'Z>((OV@K'3Y?AM\1X-)U
M_4O@UIWB[PIX+^'EUX3TCPB ?N;^V9^W%\'/V,/V8?'O[3WC#6- \4Z#X5\
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M#POJ6L> _%MIX-O/"E]J>F?#VW'BWPAX$U"R\'Z)JMZ;;P5JWC+P<(GUN/\
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M?MK*XBM+NXT7]J+X&ZK!:W4T4<T-M<R6/CN=;>XEBECECAE*2212)(BE74D
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MC=ZGXKCF\*>%-"U73M3T;3]2M_".@>KT %%%% !1110 4444 %%%% !1110
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M/BCK^GZU,);F[O\ 4OVF_CK\9_A=XIATV?\ L4)\!?"EM/%'XCTO68;;]&,
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M0/8$4AB4C&^4<L<B63.6.?[V,#^$8V@< 8J6B@!B1J@X+,>?F=B[<XS\S$D
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ME:?\-/C7IG]H6?QI\&?$&+6-7%Z ?/'['GCSQU\>_P!IK_@H5%XJ^(/Q;L?
M6G6G[+NF_#'X8:MXCN/#UW\'M%^-W[+7@'XN>,8])TM-*T/QCX=\6_\ "6^*
M]3-OK6ORMJ_AZZM+C0?#T.A0Z--I\'XJ?&G5/V^?VA;O]DCX8?!CX[_M#?$'
MXD>$_P#@D-\+?^"BX^':Z?\ LZ^*K/XA?M\ZY<Z_X?\ V5=?\>R?$[P%HWA;
MP[X;L/COK<WQ5U:W\7Z[!\)-+T[]G_3+WPEX%T;QUX8TCQ/I_P#3%\3/V/?@
MS\0?B5XF^-5]??%#P'X\\8?#_P -_#3XD^(/A+\:OB=\&V^(?P^\"W_C#6/!
MNC>-9_A[XK\-O--X+N_B!X[E\.^+M,GTCQIHEGXIU>QL_$D=@+2VM?CG_@G/
M^SW\(?'/B37?^"D^G>%;G1O%GQRT'6OAA^S-%H7B'QQX>^'_ (&_X)S^#]4T
M/PS^RWX#\'?"NRU;0OAG#X-^('A3X=Z7^U'H+WGPZ3Q#X/U;X\>(?"^CZT^B
MVPFOP#MO^"AOC#XS>$_@)^S'J7A_Q5XX\#>-?%'[8/[&_P /?BMI7P;U&"PO
M_%O@OXG?%7PWX)^,?PYTC5;Q7U33=/\ $/A_6];T_0?$NAZ_X4\5>'M0CT?Q
M#IGC+0+FQEO!\._M0_M5?M-_"GXC?M\^,? WCKXD^"[;0O!'_!+/X5?!'X??
M$W1?!>K>&?@O\0OVZ/VB_$G[/'Q,^,L'ANPCU33/$S^$]$F^'_BCPEHGBCQ9
MK>@0_$;PCXKT76+ Z#XJUJTU#]UOBA\(O 7QDTSPOHWQ"TF\UC3?!OQ&^'WQ
M8\/6]EXB\3>&VL_'WPL\5:;XV\!ZS/<^%=9T2[U.UT3Q/H^G:G-X?U2>]\-Z
MX+86'B#2-5TV2:SD\L\7?L=_L_?$+7/CSKGQ$\$?\)]'^TU\*_ _P5^-GAOQ
MAK6NZ_X)\8_#;X<2>/YO!_AU?!NH:E/X>\/C2[CXG^-[Q]0\-6&D:G?7^LG4
M+Z\GO;'3I[0 ^$?BMJOQ._99^/7P:^ 'A_XY_&OXE^!?VK?@!^V+#JNI_$WQ
M;H_B'XA?#WXT?!#P-X9^(6@?%WX=>.X/">GWN@3^*[+7/%NC>)_A6ZGX2Z'>
MZ?X!U?X2>$?AC8>'?&7A[XAY-Q\6OC';_P#!![7?VG?^%S_$+4_V@Y_^":^H
M?M>0_%VY.AZ7XJ?XRR?LRK\?X;ZUT6W\(:'X9T;P['XX00P^ H/!5AX=M_"2
MOX1N="32WNK"OO[PE^R+\,O#OB,^-=?UKXD_%3QW8^ M8^%7A'QU\6O'FL>-
M/%GP[^&7B!X#KOA+P!JD[6@\-W?B2.PT*+QS\1+>"3XO?%(^%?!EQ\6?B'X[
MNO!GA6?1_)!_P3/_ &6Y/AGH?P8U&W^,GB'X3>%OA%X@^!GA/X=^*_VB/CEX
MI\+>%OAOXH\!'X4ZSIN@6&N^/KYM/UV7X5SZQ\-+#QNDS>-]!\#>*O&OA[P]
MXBTJS\9^)QJ@!X#K?B7XQ_L]?&K_ ()Y:+'^T3\4OB[\-OVU?%'C;X$?%#X<
M?$Y?!&N>,M)\5R_LM_%G]HO0_P!H#X8>,O!?@KP#KWA.Z\/:G\'KWP?X^\)M
M/J'PSA\/>.=(\0>"O!G@G6O#,KZY^?W[./[1/[=6M? ;]A7]I+P!\;OB/^T/
MXH\1?##]L/XX_M$? SQ#X<\)>([G]J;X6? O]HWX4?"JZ\&?!K3=.\-?#YOA
MO\=?#WPQ^(&K>._@VGA^Z\/:-\0O'W@S3/AO\0_#$VF^/]8\:^!_W=^'/['G
MP,^&/B_PS\0=%TOQOXF\=>"/"=UX)\#>*OBO\7/BQ\:=2\ ^&]3AL+;Q!8_#
MJ#XM>-?&6E?#B3Q7::3I%EXOO? .G>&K[Q98:-HNF^([G4]-T32+.QQOA%^P
M[^SQ\"[;X.V/PU\/>*=&L/@+=_'"Y^%]G?\ Q&\?^(X]$A_:,\22>+OBSINI
M2^(O$>J7/BK2=<\22'5M+L/%4^LP^%;F.V3PR-+M;.RM[8 _*+P?^UQXN^-_
MQ@\$>!?@C^TGX_U'X+?MT?ML>(?"O@'XVZ+K7AO4-<^&W[.O@[_@F;X1_;0M
M/!OP+TOQM\++G3_!_BWXD_$CQ#J5KXDC^)'A;Q'X[^'7@$>/?"&F7?AWQOX/
M\"ZQ\/O2_&_Q6_:-M==_;D_9U_9:\7_M+^//BI\']._92U3P_P"&_B_XA_9:
MTM]!T[X@?%;6=5^)OA_X!_'KQ)XAUK6=:^)'[17[/EMXMN/@;IO[1GA+4O#O
MPB^(?@O1+GQ7KWA'0/%>D^%-/_0/6?V ?V3M9\,?$GPD/A18Z%I?Q0_:$G_:
MQUFY\&:]XJ\!^(/#G[2]UI.@:1>_''X:>*_!6NZ!XI^%'Q(U*+P]%>ZQXE^&
MVL^%K_6]7UWQOJFKR7MWX_\ &;ZY3_X8$^ $FA_%"PNY?BS?^*?C+?\ PGU7
MXA_%FZ^-WQ57XR:MJGP%\2R>+O@G?:7\1[+Q79Z[X3_X5GKDDD^AZ=X3DT71
M=2M[K5;3Q5IGB&#7_$"ZH >??\$U?C3<_&[X1_$WQ!<?$_XW>/8/#GQGF\'6
MGA/]J#X>:/\ "[]ISX -8_"+X0:SK'P#^/\ X5T/X=?#C2V^('A#Q-K^N:_9
M>(K.'QQ#XO\  ?B_P5XGC^)WCM=5&L-XW^T1XH^+=U^W[XY^&GAOXZ_%;X?>
M M/_ ."87Q6^,^F>"O NHZ!$)/C%I_Q+;P!HOQ*T@^*/ _C'3UUCP=X?U3R[
M30M0E/@V\UZ]T'6];\"^,+FQEN-,^G/#W[&\'P\\4?#76?AM\2?B#:/IWQJ\
M5?'+X\>*/&OQ!^)?B;QC^T)KNL_ J3X#:1HWCRVT7QGX1\"^)+;2?#6E?#2/
M39/'/A/QEX;\):1\(O"]MX1\":?XVO[3XD>$_<?$_P"SS\+?%WQ-O_C#K&DZ
MT/B)J/P<\0? *ZU_3/&?C/1HV^%?BC6[?Q)K&@)H>DZ_9^'(]2?7+2WU#3_&
M"Z./&FB.LMMHGB'3[*ZN[:< _%CX1?MF?&_Q1+^P=\!OVB/BOXCLOVE]+\8:
M7XW^(FO?"/3M&\)^$?V^OV9Y_P!BO]H_XX^!_C=\--+M]#O;*ZLO$/Q#^%O@
M;2?C5\/_ (??\(YJWPY^*.G:YX;6PTWX+_%/X<-XV^F/V6M"_:T_:6_9C_9#
M_;)LOVR_B/X?^(?Q\\,_LO?M,>+?A#=>$?@2/V>M(^#/Q7UWP#\7?BC^SQHG
MAR/X)7WQ&-OIGP;\0>*?AUX#^*M[\27^*TOC&R\/^*/$/C8Z ^K^%W^XE_9
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV@N)84MOTCH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU<V[ZKXF\17[/J7B'7KW4=:U*6:_OKB5_4J** "BBB@ HHHH **** "BBB@
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MZ6NNQ^)M# /RL^+?[(?@+]F+X7_M[>(?'MW\-/V9/A9^T5KWP0\2?L<?L_\
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M1ZAK_P <T\-Z;+/;6\>J>)_AK\8?#6DF:\A^TVR'5-=^'NGV">=:_P"DHS7
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M40QF'_@H#)"!<K&LUOYLT)6.:(78M91/%!]VTFU>/E'R_=X'R_3TZ#IZ4 ?
MW_#8?[0S?9D7_@EA^W5$]U&7=[GXE_\ !,2.#3V$TD034'M_^"BUY-N=%CN4
M;3+;5(_(N;8.RW!N+>V&_:^_:-2WEE'_  2S_;?DGBN884M5^*'_  3/#7,,
MD5S)-=Q2O_P4$CB6.W:"*#RIF@GEFO+<K&+>.[GM_OJB@#XDO/VJOCK:QQM;
M_P#!-?\ ;6U-G<*\=GX[_P""<B/ I5B7E-_^W_IT11"H5O*>63<ZE49=S)+J
M_P"UC\5=!TS4];UK]@3]K+2M%T73KO5]7UC4OB%_P3VT[2]+TO3K9[S4M1U&
M_OOV[+>UL;'3K6*6XOKV[EAM;6"*2>6984,E?:Q /4 X.1GL?7ZU^,?Q ^'G
MPL_;;_X*+_'/]GG]KG3/#WQ!^"7[-'P:^ .I_!G]E_XA*L_PV^)GCC]H[1?V
MA;KQM\?O$G@^]:#0_B]KF@:#\,]6^''PRT;7[/Q-;?!^]\$_$7XB^'++0O%N
ML67B&P -'XW?'?5_^"A/['WQR^$_PC_9K_:2UOX>?'OX;_$'X-S_ !B^$/Q0
M_P"":/Q7T&QM?$>F7/ACQ9%ITNF_\% YO#&NW5M87M_I.IZ%JMZVGR&ZDL==
ML[BQDN;&Y@^#TGBG]GWQ=KGCW2/^"5?_  4+^,?QQ\5:):Z)X^_:H^)?Q2_X
M)<>+?C?\1=-$EMJ,^@ZAXKU3_@H-X5C\(^!4UN$ZU8?"'X6^%/AK\$/"FKO*
M_@/X:>'+,JK_ '/^SQ^RA\/OV7O$W[1%_P#"J"S\.^!OV@OB=I_QJU/X>:3H
M]MI>D>$_B2_PQ\ _"GQ=>>&9K*X2*V\/>*M ^%G@?4[?PQ:Z786WAWQ''XHO
M+&ZN['Q#9:9X?_,OXC>%/V5?&/[9OC;X0W/["?[47Q'^)&F>"+?XLV^H^$?C
M3K/PZM?&FE3^-?B+\-_%&L1^#OB)^U+\&?!>I_#G1;[PWX9MO#.JQMJMA>-X
MIT2.T\*^'=,L_">K:P ?%G@7XQ_%3]A32?A!\"OVA/V>?^"GUY^SG\)?&?B#
MQ=\ ?A1\(O@U^RTVJPV.G>+_ !O\=/ 'A+]JCXZ_!S_@I%^T5K/Q0@^$VE>#
M[R;P)X9\)_\ #.GACQGX9\*7EG\8_ /Q7TC5--T2S]G^'OP8USX@>%?"]WX&
M_9M_X*1W?[*NE>.+#]JS]BSP5X!^(O\ P1LUSX?_  /\;^*;ZW\=>%O&WP+^
M(MA^V5\0)_'?@&QB\2>.KGX'^"_&MUXJ^#G@OP;\7-7L-#TB_LO!_P "KKX4
M?LK\#?%/P=\+ZUXJ_9Q_9VT"]O\ PG\"-?AT+XFZE;ZQXFU3PK\._%/C'2]2
M\>W/@BT\7>([G79O$WQ!T^/5_#FO>*O VGZJ)/ GAWQYX:U/6+G3CJ>EZ+=\
M5^PK:6&FV7[6.B>#K33;7X-Z)^VY\?+3X.KI6C3Z-8&*\;PKK7[0$$,4NFZ5
M!=MI/[9FJ_M-:#->:?;26!GTJ6T@OM1-I)?7 !^-O@G]N/P;\/OVY_V?]3^%
M_P"RC^V%H7Q&^*>B_$+]EWXY_ S]H6[_ &<?!/[6/Q5U>RT;2O&_P5^/$<?Q
M7_:KLO'7Q'T?P);_  0\8^"Y?&>LW8^$EWX-^*EK?^$O&FDZUI&E^$/'_P!6
M?&/X:?$34HOA_K_P,_8'_;,^$OB_X<?M9>._VP-%BO-=_P""?GQ8^'L_QF^+
MGPW^*GPP^)/C"]^''C?_ (*5^&]-T=+ZV^,/C/XF6-IX%\1^$=/TSXR7=U\3
M+CPUXDU?7_&-AXH_= @<=1CH <#Z'';VZ4I /! (]#ST.1^1Y^M '\__ .S]
MI?[6G[+?A+QAX>^$W[(?_!5?Q=;ZGK'QI\>>%/"7QFUK_@AGJ'PX@^)OQA\1
M:WX_?7_&G_"G/VO/@[\2]:\.>'?B!K]]=Z/X6\)?$#P3I6G^"C8^#+"RCM]%
MTB\ML_XD_$'_ (*3?M*?$CX+:E\3_P#@D]\9O@'X)_9^^-W@;XQZ9XS^%7Q_
M_8'^,W[0_CA_!_B74-3;P9X%\7>(/VN/@7HGP$\%?$/1=*T;P;^T&I_X6A?_
M !.^$'CWXF_!6PL=,L=5/CN?^@_ ]!W[#OR?S/)]:,#T'7/0=<8S]<<?2@#X
M?L/VKOCW=>;]I_X)G?MN:88]FP7WCO\ X)NN+C=YA;R!IO\ P4'U$KY>Q0_V
MAHLM-&8]ZB7RO ?AU\3/VD? 7Q-_:.^(?_#N?]KNZB^-^K^%_&,?A>V^)'_!
M/B;2K+Q1X*\$V/PKMKQM<N_VZK6X2;QI\/O!'PO?6;#_ (1+[+X2UW3-:TRV
MUWQOI<>FZS<?J]M7G@<]>!SCIGZ4M 'X_P#[/?Q>_:]^&,OQX\:?$7_@F;^T
M_+XK_: ^.&H?&2;P+\*_BG_P3RUKPO\ #:QL?A+\*_@YH?A1/&?B[]M;X::C
MXVU_Q/8_!ZU^(WB;7I?!V@6MAXS^(FK^$[9]8T;PS;^,M=]8\8?M*_%_XB>&
M=<\%>//^"/'[<'C'P;XETZXTGQ!X8\2>-/\ @E/K6AZSIMRL8FL=3TR__P""
MDT]G>6[LI<QSQ,%D2"5 LL:NGZ3D ]0#G@Y .0<9'XX'Y"C /4#ICIV]/I[4
M ?SV>,O@[^T+\2?"^M?![5_@S_P7,T3]FWQUX5\6>!_'?P&\3?M ?\$9/B=H
M_B#P1XC\.S>'-<\&Z_\ ''XL?M,?&']KS5M,\5Z'=ZGI%W<R_M"WOB(G4I=0
M'BG0[JW6>XYJZ_8P\?>+-/\ BH_COX%_\%47\1^+?CEXH^+WP+\9>"?BQ_P3
M>\%^-/V0] \;?M*6_P"UEXN^'GP=U";]L[Q=HMW?^-/BR^JV7Q%^)7B_1_$_
MC/Q7X#/A;P#:7NB^&_ 7A2*P_HX  Z #Z"C YX'/!X'(]#^0_*@#\6/V<;;X
MX_L?^+/B'X5^$'[!'[=6L_LU^/=6;X@:'\+/$7CW]@_QCKOPP^,'B.9?^%J^
M(]+^,OQ _P""HM_XPU[P/\5=2M5^)OB;PMXG\'>)_&D?QL\5?%'XC3?$[6;3
MX@)X*\+_ %DO[-GP[^*W['S> X_V4_"7PY\12^%_BUK'PW^$7[3>G?"_XJ77
MPK^*_CR[\::D=:\3>(/"?B/]H7PC'=:MXP\17?B76M8\$^+_ !Q+%IVM7-NO
MG7D<^B0?>V!C&..F.V/2D "C   ]  !^0H ^9/@O^R]\._AY^R7\+/V3_&GA
M'P'\0O W@WX->!/A5XS\/:WX.T/4_ _C]_#/A72-#UW4=<\(:KIT^C:I!XFU
M/3I]:U"WU33Y_M=U=-/>+)<%GI_QC^#WB3XG_&K]DSQ*MQI5M\//@!\1?B+\
M:]?2::[DUO6O'MS\%_'GP.^'OA^&Q"G3[CP\FE?&_P"(?C75KZ^<W.G>)?!'
M@=].B:>YEN+7Z9HH 0   #@   >PX%+110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[%L>;>VW_8_V*/CG,5N@KK>;1<?M^VY>W9UCEMBQCE19GAE#FV%Q=6$\&?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY\4_#/E7/_"F?%=QXA^'GB+7-5O/"5UKNH>EZO\ &3X1>'K7PO?>(/BE\.M
ML_&^DSZ]X,NM;\;^&-*M_%NAVJZ.]SK7AF>]U6"'7](@3Q%X?DFU+2'O+*./
M7=&D:<)JEB9P#TFBOC+X6_MI?#7QW\9?CO\ !GQ+XA^&O@37/A5\:/ _P7\
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MXPT":[TVXN;>+6_"GBW1-9\+^)=*DD6_T+Q%I&IZ)JL%IJ=A=VL/BEI^U_\
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M.62XUSQE8^)OAEHWB30/BKXB\3^#_AWXE^$NJ_:(/BAX3^)UEJ%L?&OP<O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
K "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>14
<FILENAME>aren-20231231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWayJ+bP9z5Z82ekhvWB5bTnavygvJziYGi1XJxT2ISgL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:AREN="http://thearenagroup.net/20231231" elementFormDefault="qualified" targetNamespace="http://thearenagroup.net/20231231">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://thearenagroup.net/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/StatementsOfOperations" id="StatementsOfOperations">
          <link:definition>00000004 - Statement - Consolidated Statements of Operations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/StatementsOfOperationsParenthetical" id="StatementsOfOperationsParenthetical">
          <link:definition>00000005 - Statement - Consolidated Statements of Operations (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/StatementsOfStockholdersDeficiency" id="StatementsOfStockholdersDeficiency">
          <link:definition>00000006 - Statement - Consolidated Statements of Stockholders' Deficiency</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000007 - Statement - Consolidated Statements of Cash Flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/OrganizationAndBasisOfPresentation" id="OrganizationAndBasisOfPresentation">
          <link:definition>00000008 - Disclosure - Organization and Basis of Presentation</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>00000009 - Disclosure - Summary of Significant Accounting Policies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/DiscontinuedOperations" id="DiscontinuedOperations">
          <link:definition>00000010 - Disclosure - Discontinued Operations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/AcquisitionsAndDispositions" id="AcquisitionsAndDispositions">
          <link:definition>00000011 - Disclosure - Acquisitions and Dispositions</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssets" id="PrepaymentsAndOtherCurrentAssets">
          <link:definition>00000012 - Disclosure - Prepayments and Other Current Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/PropertyAndEquipment" id="PropertyAndEquipment">
          <link:definition>00000013 - Disclosure - Property and Equipment</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/Leases" id="Leases">
          <link:definition>00000014 - Disclosure - Leases</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/PlatformDevelopment" id="PlatformDevelopment">
          <link:definition>00000015 - Disclosure - Platform Development</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/IntangibleAssets" id="IntangibleAssets">
          <link:definition>00000016 - Disclosure - Intangible Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/OtherLong-termAssets" id="OtherLong-termAssets">
          <link:definition>00000017 - Disclosure - Other Long-Term Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/Goodwill" id="Goodwill">
          <link:definition>00000018 - Disclosure - Goodwill</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/RestrictedStockLiabilities" id="RestrictedStockLiabilities">
          <link:definition>00000019 - Disclosure - Restricted Stock Liabilities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/AccruedExpensesAndOther" id="AccruedExpensesAndOther">
          <link:definition>00000020 - Disclosure - Accrued Expenses and Other</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/LineOfCredit" id="LineOfCredit">
          <link:definition>00000021 - Disclosure - Line of Credit</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/LiquidatedDamagesPayable" id="LiquidatedDamagesPayable">
          <link:definition>00000022 - Disclosure - Liquidated Damages Payable</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/OtherLong-termLiabilities" id="OtherLong-termLiabilities">
          <link:definition>00000023 - Disclosure - Other Long-term Liabilities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/FairValueMeasurement" id="FairValueMeasurement">
          <link:definition>00000024 - Disclosure - Fair Value Measurement</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/BridgeNotes" id="BridgeNotes">
          <link:definition>00000025 - Disclosure - Bridge Notes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/Long-termDebt" id="Long-termDebt">
          <link:definition>00000026 - Disclosure - Long-term Debt</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/PreferredStock" id="PreferredStock">
          <link:definition>00000027 - Disclosure - Preferred Stock</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/StockholdersDeficiency" id="StockholdersDeficiency">
          <link:definition>00000028 - Disclosure - Stockholders&#8217; Deficiency</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/StockbasedCompensation" id="StockbasedCompensation">
          <link:definition>00000029 - Disclosure - Stock&#8211;Based Compensation</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/LiquidatedDamages" id="LiquidatedDamages">
          <link:definition>00000030 - Disclosure - Liquidated Damages</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>00000031 - Disclosure - Income Taxes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/PensionPlans" id="PensionPlans">
          <link:definition>00000032 - Disclosure - Pension Plans</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
          <link:definition>00000033 - Disclosure - Related Party Transactions</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>00000034 - Disclosure - Commitments and Contingencies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>00000035 - Disclosure - Subsequent Events</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>00000036 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
          <link:definition>00000037 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/DiscontinuedOperationsTables" id="DiscontinuedOperationsTables">
          <link:definition>00000038 - Disclosure - Discontinued Operations (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/AcquisitionsAndDispositionsTables" id="AcquisitionsAndDispositionsTables">
          <link:definition>00000039 - Disclosure - Acquisitions and Dispositions (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsTables" id="PrepaymentsAndOtherCurrentAssetsTables">
          <link:definition>00000040 - Disclosure - Prepayments and Other Current Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
          <link:definition>00000041 - Disclosure - Property and Equipment (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/LeasesTables" id="LeasesTables">
          <link:definition>00000042 - Disclosure - Leases (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/PlatformDevelopmentTables" id="PlatformDevelopmentTables">
          <link:definition>00000043 - Disclosure - Platform Development (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
          <link:definition>00000044 - Disclosure - Intangible Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/OtherLong-termAssetsTables" id="OtherLong-termAssetsTables">
          <link:definition>00000045 - Disclosure - Other Long-Term Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/GoodwillTables" id="GoodwillTables">
          <link:definition>00000046 - Disclosure - Goodwill (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/AccruedExpensesAndOtherTables" id="AccruedExpensesAndOtherTables">
          <link:definition>00000047 - Disclosure - Accrued Expenses and Other (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/LiquidatedDamagesPayableTables" id="LiquidatedDamagesPayableTables">
          <link:definition>00000048 - Disclosure - Liquidated Damages Payable (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/OtherLong-termLiabilitiesTables" id="OtherLong-termLiabilitiesTables">
          <link:definition>00000049 - Disclosure - Other Long-term Liabilities (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/FairValueMeasurementTables" id="FairValueMeasurementTables">
          <link:definition>00000050 - Disclosure - Fair Value Measurement (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/Long-termDebtTables" id="Long-termDebtTables">
          <link:definition>00000051 - Disclosure - Long-term Debt (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/StockholdersDeficiencyTables" id="StockholdersDeficiencyTables">
          <link:definition>00000052 - Disclosure - Stockholders&#8217; Deficiency (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/StockbasedCompensationTables" id="StockbasedCompensationTables">
          <link:definition>00000053 - Disclosure - Stock&#8211;Based Compensation (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>00000054 - Disclosure - Income Taxes (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/OrganizationAndBasisOfPresentationDetailsNarrative" id="OrganizationAndBasisOfPresentationDetailsNarrative">
          <link:definition>00000055 - Disclosure - Organization and Basis of Presentation (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails" id="ScheduleOfDisaggregationOfRevenueDetails">
          <link:definition>00000056 - Disclosure - Schedule of Disaggregation of Revenue (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails" id="ScheduleOfContractWithCustomerAssetAndLiabilityDetails">
          <link:definition>00000057 - Disclosure - Schedule of Contract with Customer, Asset and Liability (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfCashAndRestrictedCashDetails" id="ScheduleOfCashAndRestrictedCashDetails">
          <link:definition>00000058 - Disclosure - Schedule of Cash and Restricted Cash (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfAllowanceForDoubtfulAccountsDetails" id="ScheduleOfAllowanceForDoubtfulAccountsDetails">
          <link:definition>00000059 - Disclosure - Schedule of Allowance For Doubtful Accounts (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails" id="ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails">
          <link:definition>00000060 - Disclosure - Schedule of Depreciation and Amortization, Useful Lives of Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails" id="ScheduleOfNetIncomeLossPerCommonShareDetails">
          <link:definition>00000061 - Disclosure - Schedule of Net Income (Loss) Per Common Share (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>00000062 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails" id="ScheduleOfDiscontinuedOperationsDetails">
          <link:definition>00000063 - Disclosure - Schedule of Discontinued Operations (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/DiscontinuedOperationsDetailsNarrative" id="DiscontinuedOperationsDetailsNarrative">
          <link:definition>00000064 - Disclosure - Discontinued Operations (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails" id="ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails">
          <link:definition>00000065 - Disclosure - Schedule of Composition Preliminary Assets Purchase Price (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails" id="SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails">
          <link:definition>00000066 - Disclosure - Summary of Preliminary Assets Purchase Price Allocation (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails" id="ScheduleOfCompositionOfPurchasePriceDetails">
          <link:definition>00000067 - Disclosure - Schedule of Composition of Purchase Price (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails" id="SummaryOfPurchasePriceAllocationDetails">
          <link:definition>00000068 - Disclosure - Summary of Purchase Price Allocation (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails" id="ScheduleOfSupplementalProformaInformationDetails">
          <link:definition>00000069 - Disclosure - Schedule of Supplemental Proforma Information (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails" id="ScheduleOfPreliminaryPriceAllocationDetails">
          <link:definition>00000070 - Disclosure - Schedule of Preliminary Price Allocation (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative" id="AcquisitionsAndDispositionsDetailsNarrative">
          <link:definition>00000071 - Disclosure - Acquisitions and Dispositions (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails" id="ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails">
          <link:definition>00000072 - Disclosure - Schedule of Prepayments and Other Current Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsDetailsNarrative" id="PrepaymentsAndOtherCurrentAssetsDetailsNarrative">
          <link:definition>00000073 - Disclosure - Prepayments and Other Current Assets (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails" id="ScheduleOfPropertyAndEquipmentDetails">
          <link:definition>00000074 - Disclosure - Schedule of Property and Equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
          <link:definition>00000075 - Disclosure - Property and Equipment (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails" id="ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails">
          <link:definition>00000076 - Disclosure - Schedule of Supplemental Information Related to Operating Leases (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails" id="ScheduleOfOperatingLeaseCostsDetails">
          <link:definition>00000077 - Disclosure - Schedule of Operating Lease Costs (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetailsParenthetical" id="ScheduleOfOperatingLeaseCostsDetailsParenthetical">
          <link:definition>00000078 - Disclosure - Schedule of Operating Lease Costs (Details) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfMaturityOfLeaseLiabilitiesDetails" id="SummaryOfMaturityOfLeaseLiabilitiesDetails">
          <link:definition>00000079 - Disclosure - Summary of Maturity of Lease Liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/LeasesDetailsNarrative" id="LeasesDetailsNarrative">
          <link:definition>00000080 - Disclosure - Leases (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails" id="SummaryOfPlatformDevelopmentCostsDetails">
          <link:definition>00000081 - Disclosure - Summary of Platform Development Costs (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails" id="SummaryOfPlatformDevelopmentCostActivityDetails">
          <link:definition>00000082 - Disclosure - Summary of Platform Development Cost Activity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative" id="PlatformDevelopmentDetailsNarrative">
          <link:definition>00000083 - Disclosure - Platform Development (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails" id="ScheduleOfIntangibleAssetsSubjectToAmortizationDetails">
          <link:definition>00000084 - Disclosure - Schedule of Intangible Assets Subject to Amortization (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails" id="ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails">
          <link:definition>00000085 - Disclosure - Schedule of Future Estimated Amortization expense For Intangible Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative" id="IntangibleAssetsDetailsNarrative">
          <link:definition>00000086 - Disclosure - Intangible Assets (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfOtherAssetsDetails" id="SummaryOfOtherAssetsDetails">
          <link:definition>00000087 - Disclosure - Summary of Other Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails" id="ScheduleOfChangesInCarryingValueOfGoodwillDetails">
          <link:definition>00000088 - Disclosure - Schedule of Changes in Carrying Value of Goodwill (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/GoodwillDetailsNarrative" id="GoodwillDetailsNarrative">
          <link:definition>00000089 - Disclosure - Goodwill (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative" id="RestrictedStockLiabilitiesDetailsNarrative">
          <link:definition>00000090 - Disclosure - Restricted Stock Liabilities (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails" id="ScheduleOfAccruedExpensesDetails">
          <link:definition>00000091 - Disclosure - Schedule of Accrued Expenses (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/LineOfCreditDetailsNarrative" id="LineOfCreditDetailsNarrative">
          <link:definition>00000092 - Disclosure - Line of Credit (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails" id="SummaryOfLiquidatedDamagesDetails">
          <link:definition>00000093 - Disclosure - Summary of Liquidated Damages (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative" id="LiquidatedDamagesPayableDetailsNarrative">
          <link:definition>00000094 - Disclosure - Liquidated Damages Payable (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails" id="ScheduleOfOtherLong-TermLiabilitiesDetails">
          <link:definition>00000095 - Disclosure - Schedule of Other long- term liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails" id="ScheduleOfFairValueOfFinancialInstrumentsDetails">
          <link:definition>00000096 - Disclosure - Schedule of Fair Value of Financial Instruments (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative" id="FairValueMeasurementDetailsNarrative">
          <link:definition>00000097 - Disclosure - Fair Value Measurement (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/BridgeNotesDetailsNarrative" id="BridgeNotesDetailsNarrative">
          <link:definition>00000098 - Disclosure - Bridge Notes (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails" id="ScheduleOfLongTermDebtDetails">
          <link:definition>00000099 - Disclosure - Schedule of long term debt (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical" id="ScheduleOfLongTermDebtDetailsParenthetical">
          <link:definition>00000100 - Disclosure - Schedule of Long Term Debt (Details) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfInterestExpenseDetails" id="SummaryOfInterestExpenseDetails">
          <link:definition>00000101 - Disclosure - Summary of Interest Expense (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/Long-termDebtDetailsNarrative" id="Long-termDebtDetailsNarrative">
          <link:definition>00000102 - Disclosure - Long-term Debt (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/PreferredStockDetailsNarrative" id="PreferredStockDetailsNarrative">
          <link:definition>00000103 - Disclosure - Preferred Stock (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails" id="SummaryOfRestrictedStockAwardActivityDetails">
          <link:definition>00000104 - Disclosure - Summary of Restricted Stock Award Activity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfWarrantActivityDetails" id="SummaryOfWarrantActivityDetails">
          <link:definition>00000105 - Disclosure - Summary of Warrant Activity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative" id="StockholdersDeficiencyDetailsNarrative">
          <link:definition>00000106 - Disclosure - Stockholders&#8217; Deficiency (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails" id="ScheduleOfRestrictedStockUnitsActivityDetails">
          <link:definition>00000107 - Disclosure - Schedule of Restricted Stock Units Activity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails" id="ScheduleOfFairValueOfStockOptionsAssumptionsDetails">
          <link:definition>00000108 - Disclosure - Schedule of Fair Value of Stock Options Assumptions (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails" id="SummaryOfStockOptionActivityDetails">
          <link:definition>00000109 - Disclosure - Summary of Stock Option Activity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical" id="SummaryOfStockOptionActivityDetailsParenthetical">
          <link:definition>00000110 - Disclosure - Summary of Stock Option Activity (Details) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails" id="ScheduleOfExercisePricesOfCommonStockOptionsDetails">
          <link:definition>00000111 - Disclosure - Schedule of Exercise Prices of Common Stock Options (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails" id="ScheduleOfWarrantsActivityDetails">
          <link:definition>00000112 - Disclosure - Schedule of Warrants Activity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails" id="SummaryOfStock-basedCompensationDetails">
          <link:definition>00000113 - Disclosure - Summary of Stock-based Compensation (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails" id="ScheduleOfUnrecognizedCompensationExpenseDetails">
          <link:definition>00000114 - Disclosure - Schedule of Unrecognized Compensation Expense (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative" id="StockbasedCompensationDetailsNarrative">
          <link:definition>00000115 - Disclosure - Stock&#8211;Based Compensation (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/LiquidatedDamagesDetailsNarrative" id="LiquidatedDamagesDetailsNarrative">
          <link:definition>00000116 - Disclosure - Liquidated Damages (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails" id="ScheduleOfIncomeTaxesDetails">
          <link:definition>00000117 - Disclosure - Schedule of Income Taxes (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" id="ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails">
          <link:definition>00000118 - Disclosure - Schedule of Components of Deferred Tax Assets and Liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails" id="ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails">
          <link:definition>00000119 - Disclosure - Schedule of Tax Benefit and Effective Income Tax (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>00000120 - Disclosure - Income Taxes (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/PensionPlansDetailsNarrative" id="PensionPlansDetailsNarrative">
          <link:definition>00000121 - Disclosure - Pension Plans (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
          <link:definition>00000122 - Disclosure - Related Party Transactions (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
          <link:definition>00000123 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://thearenagroup.net/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>00000124 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="aren-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="aren-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="aren-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="aren-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="AREN_SeriesGRedeemableAndConvertiblePreferredStockMember" name="SeriesGRedeemableAndConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SeriesHConvertiblePreferredStockMember" name="SeriesHConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SeriesHRedeemableAndConvertiblePreferredStockMember" name="SeriesHRedeemableAndConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_CommonStockToBeIssuedMember" name="CommonStockToBeIssuedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BRileyFBRIncMember" name="BRileyFBRIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DigitalAndPrintSubscriptionsMember" name="DigitalAndPrintSubscriptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_CustomerMember" name="CustomerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DigitalAdvertisingMember" name="DigitalAdvertisingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DigitalSubscriptionsMember" name="DigitalSubscriptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LicensingAndSyndicationRevenueMember" name="LicensingAndSyndicationRevenueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DigitalRevenueMember" name="DigitalRevenueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PrintAdvertisingMember" name="PrintAdvertisingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PrintSubscriptionsMember" name="PrintSubscriptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PrintRevenueMember" name="PrintRevenueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_OtherMember" name="OtherMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_OfficeEquipmentAndComputersMember" name="OfficeEquipmentAndComputersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SeriesGConvertiblePreferredStockMember" name="SeriesGConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_FinancingWarrantsMember" name="FinancingWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ABGWarrantsMember" name="ABGWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_AllHipHopWarrantsMember" name="AllHipHopWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PublisherPartnerWarrantsMember" name="PublisherPartnerWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_RestrictedStockAwardsMember" name="RestrictedStockAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_CommonStockOptionsMember" name="CommonStockOptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ParadePrintMember" name="ParadePrintMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_TeneologyIncMember" name="TeneologyIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_FexyStudiosMember" name="FexyStudiosMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_AdvertiserRelationshipsMember" name="AdvertiserRelationshipsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BrandNamesMember" name="BrandNamesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_Disposition2023Member" name="Disposition2023Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_AthlonHoldingsIncMember" name="AthlonHoldingsIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DigitalContentMember" name="DigitalContentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BuffaloGroupeLLCMember" name="BuffaloGroupeLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_IntellectualPropertiesMember" name="IntellectualPropertiesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_MensJournalMember" name="MensJournalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_A360MediaLLCMember" name="A360MediaLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_AdvertiserRelationshipMember" name="AdvertiserRelationshipMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BrandNameMember" name="BrandNameMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ParadeMember" name="ParadeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ArenaMember" name="ArenaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_AdjustmentsMember" name="AdjustmentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SubleaseAgreementMember" name="SubleaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LeaseArrangementMember" name="LeaseArrangementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_OctoberOneTwoThousandAndTwentyFourMember" name="OctoberOneTwoThousandAndTwentyFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BusinessMembershipAgreementMember" name="BusinessMembershipAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_MonthToMonthLeaseArrangementMember" name="MonthToMonthLeaseArrangementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PlatformDevelopmentMember" name="PlatformDevelopmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DevelopedTechnologyMember" name="DevelopedTechnologyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SubscriberRelationshipsMember" name="SubscriberRelationshipsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_FinancingAndSecurityAgreementMember" name="FinancingAndSecurityAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SLRDigitalFinanceLLCMember" name="SLRDigitalFinanceLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_TwoThousandTwentyThreeNotesMember" name="TwoThousandTwentyThreeNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SeriesLPreferredStockMember" name="SeriesLPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_MDBCommonStockToBeIssuedMember" name="MDBCommonStockToBeIssuedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ConvertibleDebenturesMember" name="ConvertibleDebenturesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SeriesJPreferredStockMember" name="SeriesJPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SeriesKPreferredStockMember" name="SeriesKPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockPurchaseAgreementMember" name="StockPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BRileyMember" name="BRileyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_FlexyStudiosMember" name="FlexyStudiosMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_FexyStudiosAcquistionMember" name="FexyStudiosAcquistionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ContingentConsiderationMember" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SeniorSecuredNoteMember" name="SeniorSecuredNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BridgeNotesMember" name="BridgeNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_TwoThousandTwentyTwoBridgeNotesMember" name="TwoThousandTwentyTwoBridgeNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DelayedDrawTermNotesMember" name="DelayedDrawTermNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PurchaseAgreementMember" name="PurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DelayedDrawTermNoteMember" name="DelayedDrawTermNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SeniorSecuredNotesMember" name="SeniorSecuredNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LineOfCreditTerminationFeeMember" name="LineOfCreditTerminationFeeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_OtherAccruedInterestMember" name="OtherAccruedInterestMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_OriginalInvestorMember" name="OriginalInvestorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockPurchaseAgreementsMember" name="StockPurchaseAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PurchasersMember" name="PurchasersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_FexyStudiosAcquisitionMember" name="FexyStudiosAcquisitionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_AssetPurchaseAgreementMember" name="AssetPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ParadeStockMember" name="ParadeStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SeveralStockPurchaseAgreementsMember" name="SeveralStockPurchaseAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SeveralInvestorsMember" name="SeveralInvestorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_EmployeesMember" name="EmployeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_RestrictedCommonStockMember" name="RestrictedCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ExerciseOfStockOptionMember" name="ExerciseOfStockOptionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ServicesAgreementMember" name="ServicesAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_UnderwritingPublicOfferingMember" name="UnderwritingPublicOfferingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_UnderwritingOverallotmentMember" name="UnderwritingOverallotmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_MDBCapitalGroupLLCMember" name="MDBCapitalGroupLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ABGWarransMember" name="ABGWarransMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ABGTimeBasedWarrantsMember" name="ABGTimeBasedWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ABGPerformanceBasedWarrantsMember" name="ABGPerformanceBasedWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_NewPublisherPartnerWarrantsMember" name="NewPublisherPartnerWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_CommonStockFinancingWarrantMember" name="CommonStockFinancingWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_TwoThousandTwentyTwoPlanMember" name="TwoThousandTwentyTwoPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SportsIllustratedLicensingAgreementMember" name="SportsIllustratedLicensingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PublisherPartnerWarrantProgramMember" name="PublisherPartnerWarrantProgramMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_NewPublisherPartnerWarrantMember" name="NewPublisherPartnerWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_RestrictedStockUnitsMember" name="RestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_CommonEquityAwardsMember" name="CommonEquityAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_CommonStockAwardsMember" name="CommonStockAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BlackScholesOptionPricingModelMember" name="BlackScholesOptionPricingModelMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_UpListMember" name="UpListMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_NoUpListMember" name="NoUpListMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ExercisePriceRangeOneMember" name="ExercisePriceRangeOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ExercisePriceRangeTwoMember" name="ExercisePriceRangeTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ExercisePriceRangeThreeMember" name="ExercisePriceRangeThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ExercisePriceRangeFourMember" name="ExercisePriceRangeFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ExercisePriceRangeFiveMember" name="ExercisePriceRangeFiveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ExercisePriceRangeSixMember" name="ExercisePriceRangeSixMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ExercisePriceRangeSevenMember" name="ExercisePriceRangeSevenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ExercisePriceRangeEightMember" name="ExercisePriceRangeEightMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockBasedCompensationMember" name="StockBasedCompensationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StateMember" name="StateMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LocalJurisdictionMember" name="LocalJurisdictionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_USFederalTaxMember" name="USFederalTaxMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DirectOfferingMember" name="DirectOfferingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BRileyFinancialIncMember" name="BRileyFinancialIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_HHuntAllredMember" name="HHuntAllredMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_AllredTrustHHAMember" name="AllredTrustHHAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_AllredTrustNLAMember" name="AllredTrustNLAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_OneEightyDegreeCapitalCorpMember" name="OneEightyDegreeCapitalCorpMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DanielShribmanMember" name="DanielShribmanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_RossLevinsohnMember" name="RossLevinsohnMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PaulEdmonsonMember" name="PaulEdmonsonMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_MrEdmonsonMember" name="MrEdmonsonMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ABGSILLCMember" name="ABGSILLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ArenaLoanAgreementMember" name="ArenaLoanAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LicensingAgreementMember" name="LicensingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_TransactionAgreementMember" name="TransactionAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SubscriptionAgreementMember" name="SubscriptionAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SimplyfyLoanMember" name="SimplyfyLoanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_MembersOfBoardMember" name="MembersOfBoardMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_FormerEmployeesMember" name="FormerEmployeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PlatformDevelopmentNet" name="PlatformDevelopmentNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LiquidatedDamagesPayableCurrent" name="LiquidatedDamagesPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BridgeNotes" name="BridgeNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LiquidatingDamagesPayableNonCurrent" name="LiquidatingDamagesPayableNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_CommonStockToBeIssuedDuringPeriod" name="CommonStockToBeIssuedDuringPeriod" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_TemporaryEquityCommonSharesIssuableUponConversion" name="TemporaryEquityCommonSharesIssuableUponConversion" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LossOnSaleOfAssets" name="LossOnSaleOfAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LiquidatedDamagesUnderRegistrationRightsAgreements" name="LiquidatedDamagesUnderRegistrationRightsAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" name="StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" name="StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne" name="StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne" name="StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" name="StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares" name="StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" name="AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" name="StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares" name="StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" name="AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger" name="StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" name="StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes" name="StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_NoncashAndAccruedInterest" name="NoncashAndAccruedInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LiquidatingDamagesPayable" name="LiquidatingDamagesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts" name="IncreaseDecreaseInSubscriptionAcquisitionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_IncreaseDecreaseInSubscriptionRefundLiability" name="IncreaseDecreaseInSubscriptionRefundLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PaymentsForCapitalizedPlatformDevelopment" name="PaymentsForCapitalizedPlatformDevelopment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PaymentOfDeferredCashPayment" name="PaymentOfDeferredCashPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PaymentOfRestrictedStockLiabilities" name="PaymentOfRestrictedStockLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ReclassificationOfStockbasedCompensationToPlatformDevelopment" name="ReclassificationOfStockbasedCompensationToPlatformDevelopment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_IssuanceOfCommonStockInConnectionWithAcquisition" name="IssuanceOfCommonStockInConnectionWithAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DeferredCashPaymentsRecordedInConnectionWithAcquisitions" name="DeferredCashPaymentsRecordedInConnectionWithAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ReclassificationToLiabilityUponCommonStockModification" name="ReclassificationToLiabilityUponCommonStockModification" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DisclosureDiscontinuedOperationsAbstract" name="DisclosureDiscontinuedOperationsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DiscontinuedOperationsTextBlock" name="DiscontinuedOperationsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract" name="DisclosurePrepaymentsAndOtherCurrentAssetsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PrepaymentsAndOtherCurrentAssetsTextBlock" name="PrepaymentsAndOtherCurrentAssetsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DisclosureLeasesAbstract" name="DisclosureLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DisclosurePlatformDevelopmentAbstract" name="DisclosurePlatformDevelopmentAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PlatformDevelopmentDisclosureTextBlock" name="PlatformDevelopmentDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DisclosureRestrictedStockLiabilitiesAbstract" name="DisclosureRestrictedStockLiabilitiesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_RestrictedStockLiabilitiesTextBlock" name="RestrictedStockLiabilitiesTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DisclosureLiquidatedDamagesPayableAbstract" name="DisclosureLiquidatedDamagesPayableAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LiquidatedDamagesPayableTextBlock" name="LiquidatedDamagesPayableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DisclosureOtherLongtermLiabilitiesAbstract" name="DisclosureOtherLongtermLiabilitiesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_OtherLongtermLiabilitiesTextBlock" name="OtherLongtermLiabilitiesTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DisclosureLiquidatedDamagesAbstract" name="DisclosureLiquidatedDamagesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LiquidatingDamagesPayableDisclosureTextBlock" name="LiquidatingDamagesPayableDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_RisksAndUncertaintiesPolicy" name="RisksAndUncertaintiesPolicy" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_CostOfRevenuePolicyTextBlock" name="CostOfRevenuePolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ContractBalancesPolicyTextBlock" name="ContractBalancesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SubscriptionAcquisitionCostsPoliceTextBlock" name="SubscriptionAcquisitionCostsPoliceTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PlatformDevelopmentPolicyTextBlock" name="PlatformDevelopmentPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LiquidatedDamagesPolicyTextBlock" name="LiquidatedDamagesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SellingAndMarketingPolicyTextBlock" name="SellingAndMarketingPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_GeneralandAdministrativePolicyTextBlock" name="GeneralandAdministrativePolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PreferredStockPolicyTextBlock" name="PreferredStockPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock" name="ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ScheduleOfAssetsAcquiredTableTextBlock" name="ScheduleOfAssetsAcquiredTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PreliminaryPriceAllocationTableTextBlock" name="PreliminaryPriceAllocationTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" name="ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SupplementalInformationRelatedToOperatingLeasesTableTextBlock" name="SupplementalInformationRelatedToOperatingLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SummaryOfPlatformDevelopmentCostsTableTextBlock" name="SummaryOfPlatformDevelopmentCostsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SummaryOfPlatformDevelopmentCostActivityTableTextBlock" name="SummaryOfPlatformDevelopmentCostActivityTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SummaryOfLiquidatedDamagesTableTextBlock" name="SummaryOfLiquidatedDamagesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_OtherLongtermLiabilitiesTableTextBlock" name="OtherLongtermLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SummaryOfInterestExpenseTableTextBlock" name="SummaryOfInterestExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ScheduleOfRestrictedStockUnitsActivityTableTextBlock" name="ScheduleOfRestrictedStockUnitsActivityTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ScheduleOfWarrantsActivityTableTextBlock" name="ScheduleOfWarrantsActivityTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ScheduleOfUnrecognizedCompensationExpense" name="ScheduleOfUnrecognizedCompensationExpense" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_WorkingCapitalDeficit" name="WorkingCapitalDeficit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_UnearnedRevenue" name="UnearnedRevenue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LiquidatedDamagesDescription" name="LiquidatedDamagesDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense" name="DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges" name="DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted" name="AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_AssetAcquisitionAssetsAcquired" name="AssetAcquisitionAssetsAcquired" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DeferredCashPayments" name="DeferredCashPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DeferredCashPaymentsDue" name="DeferredCashPaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SalePrice" name="SalePrice" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_WorkingCapital" name="WorkingCapital" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PreliminaryWorkingCapital" name="PreliminaryWorkingCapital" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_WorkingCapitalAdjustments" name="WorkingCapitalAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_FinalSalePrice" name="FinalSalePrice" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PaymentsToAcquireBusinessesAtClosing" name="PaymentsToAcquireBusinessesAtClosing" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DeferredRevenueObligation" name="DeferredRevenueObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PrepaidSuppliesCurrent" name="PrepaidSuppliesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_RefundableIncomeAndFranchiseTaxes" name="RefundableIncomeAndFranchiseTaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_EmployeeRetentionCredits" name="EmployeeRetentionCredits" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_EmployeeRetentionPayable" name="EmployeeRetentionPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ImputedInterestRate" name="ImputedInterestRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_MarketingAndAdvertisingExpenseRemaining" name="MarketingAndAdvertisingExpenseRemaining" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_UnamortizedDebtCost" name="UnamortizedDebtCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_RestrictedStockPrincipalAmount" name="RestrictedStockPrincipalAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_RestrictedStockInterestPayment" name="RestrictedStockInterestPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_GeneralAccruedExpenses" name="GeneralAccruedExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LiabilitiesInConnectionWithAcquisitionsAndDispositions" name="LiabilitiesInConnectionWithAcquisitionsAndDispositions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LeaseTerminationLiability" name="LeaseTerminationLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_AccountsReceivablePercentage" name="AccountsReceivablePercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_RegistrationRightsDamages" name="RegistrationRightsDamages" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PublicInformationFailureDamages" name="PublicInformationFailureDamages" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LiquidatedDamagesPayableCurrentAndNonCurrent" name="LiquidatedDamagesPayableCurrentAndNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LiquidatedDamagesPayableAccruedInterestPercentage" name="LiquidatedDamagesPayableAccruedInterestPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PercentageOfAggregateAmountInvested" name="PercentageOfAggregateAmountInvested" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LiquidatedDamagesPayableNonCurrent" name="LiquidatedDamagesPayableNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LeaseTerminationLiabilityNonCurrent" name="LeaseTerminationLiabilityNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_OtherLongTermLiabilitiesNoncurrent" name="OtherLongTermLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_AggregatePrincipalMinimumAmount" name="AggregatePrincipalMinimumAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_PrincipalAmountPrepayDue" name="PrincipalAmountPrepayDue" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_CashPaidInterestAbstract" name="CashPaidInterestAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DebtInstrumentPeriodicPaymentPrincipalBalance" name="DebtInstrumentPeriodicPaymentPrincipalBalance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockIssuedDuringPeriodSharesAcquisition" name="StockIssuedDuringPeriodSharesAcquisition" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares" name="BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockIssuedDuringPeriodValueForCash" name="StockIssuedDuringPeriodValueForCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_WeightedAverageRemainingContractualLifeOutstanding" name="WeightedAverageRemainingContractualLifeOutstanding" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_WeightedAverageRemainingContractualLifeOutstanding1" name="WeightedAverageRemainingContractualLifeOutstanding1" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_WeightedAverageRemainingContractualLifeExercisable" name="WeightedAverageRemainingContractualLifeExercisable" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_CostsChargedToOperations" name="CostsChargedToOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_OriginalAwardAtTheRepricingDate" name="OriginalAwardAtTheRepricingDate" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_FairMarketValueOfStockOption" name="FairMarketValueOfStockOption" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LiquidatedDamagesPayable" name="LiquidatedDamagesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_LeaseTermination" name="LeaseTermination" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DeferredTaxAssetsLiquidatingDamagesPayable" name="DeferredTaxAssetsLiquidatingDamagesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DeferredTaxAssetsOperatingLeaseLiability" name="DeferredTaxAssetsOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DeferredTaxAssetsDepreciationAndAmortization" name="DeferredTaxAssetsDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue" name="EffectiveIncomeTaxRateReconciliationUnearnedRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage" name="EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_EffectiveIncomeTaxRateReconciliationInterestExpense" name="EffectiveIncomeTaxRateReconciliationInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_EffectiveIncomeTaxRateReconciliationInterestExpensePercentage" name="EffectiveIncomeTaxRateReconciliationInterestExpensePercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment" name="EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage" name="EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_NetOperatingLossExpirationAmount" name="NetOperatingLossExpirationAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DebtInstrumentIncreaseAccruedInterestAmountDue" name="DebtInstrumentIncreaseAccruedInterestAmountDue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_StockRepurchasedDuringPeriodValue1" name="StockRepurchasedDuringPeriodValue1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_ExerciseRightTerminationAmount" name="ExerciseRightTerminationAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_TerminationFeeDue" name="TerminationFeeDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_SharesOutstandingPercentage" name="SharesOutstandingPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_OutstandingPercentage" name="OutstandingPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_BusinessCombinationConsiderationTransferredInstallmentDue" name="BusinessCombinationConsiderationTransferredInstallmentDue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_AccruedAndNoncashConvertedInterest" name="AccruedAndNoncashConvertedInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DebtObligationsOutstanding" name="DebtObligationsOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_DeferredCashPaymentsInConnectionWithAcquisitions" name="DeferredCashPaymentsInConnectionWithAcquisitions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="AREN_NotePurchaseAgreementDefaultMember" name="NotePurchaseAgreementDefaultMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>15
<FILENAME>aren-20231231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://thearenagroup.net/role/Cover" xlink:href="aren-20231231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/BalanceSheets" xlink:href="aren-20231231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/BalanceSheetsParenthetical" xlink:href="aren-20231231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StatementsOfOperations" xlink:href="aren-20231231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StatementsOfOperationsParenthetical" xlink:href="aren-20231231.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StatementsOfStockholdersDeficiency" xlink:href="aren-20231231.xsd#StatementsOfStockholdersDeficiency" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StatementsOfCashFlows" xlink:href="aren-20231231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OrganizationAndBasisOfPresentation" xlink:href="aren-20231231.xsd#OrganizationAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfSignificantAccountingPolicies" xlink:href="aren-20231231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/DiscontinuedOperations" xlink:href="aren-20231231.xsd#DiscontinuedOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/AcquisitionsAndDispositions" xlink:href="aren-20231231.xsd#AcquisitionsAndDispositions" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssets" xlink:href="aren-20231231.xsd#PrepaymentsAndOtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PropertyAndEquipment" xlink:href="aren-20231231.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/Leases" xlink:href="aren-20231231.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PlatformDevelopment" xlink:href="aren-20231231.xsd#PlatformDevelopment" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IntangibleAssets" xlink:href="aren-20231231.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OtherLong-termAssets" xlink:href="aren-20231231.xsd#OtherLong-termAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/Goodwill" xlink:href="aren-20231231.xsd#Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/RestrictedStockLiabilities" xlink:href="aren-20231231.xsd#RestrictedStockLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/AccruedExpensesAndOther" xlink:href="aren-20231231.xsd#AccruedExpensesAndOther" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LineOfCredit" xlink:href="aren-20231231.xsd#LineOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LiquidatedDamagesPayable" xlink:href="aren-20231231.xsd#LiquidatedDamagesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OtherLong-termLiabilities" xlink:href="aren-20231231.xsd#OtherLong-termLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/FairValueMeasurement" xlink:href="aren-20231231.xsd#FairValueMeasurement" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/BridgeNotes" xlink:href="aren-20231231.xsd#BridgeNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/Long-termDebt" xlink:href="aren-20231231.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PreferredStock" xlink:href="aren-20231231.xsd#PreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockholdersDeficiency" xlink:href="aren-20231231.xsd#StockholdersDeficiency" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockbasedCompensation" xlink:href="aren-20231231.xsd#StockbasedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LiquidatedDamages" xlink:href="aren-20231231.xsd#LiquidatedDamages" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IncomeTaxes" xlink:href="aren-20231231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PensionPlans" xlink:href="aren-20231231.xsd#PensionPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/RelatedPartyTransactions" xlink:href="aren-20231231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/CommitmentsAndContingencies" xlink:href="aren-20231231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SubsequentEvents" xlink:href="aren-20231231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="aren-20231231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="aren-20231231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/DiscontinuedOperationsTables" xlink:href="aren-20231231.xsd#DiscontinuedOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/AcquisitionsAndDispositionsTables" xlink:href="aren-20231231.xsd#AcquisitionsAndDispositionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsTables" xlink:href="aren-20231231.xsd#PrepaymentsAndOtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PropertyAndEquipmentTables" xlink:href="aren-20231231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LeasesTables" xlink:href="aren-20231231.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PlatformDevelopmentTables" xlink:href="aren-20231231.xsd#PlatformDevelopmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IntangibleAssetsTables" xlink:href="aren-20231231.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OtherLong-termAssetsTables" xlink:href="aren-20231231.xsd#OtherLong-termAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/GoodwillTables" xlink:href="aren-20231231.xsd#GoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/AccruedExpensesAndOtherTables" xlink:href="aren-20231231.xsd#AccruedExpensesAndOtherTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LiquidatedDamagesPayableTables" xlink:href="aren-20231231.xsd#LiquidatedDamagesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OtherLong-termLiabilitiesTables" xlink:href="aren-20231231.xsd#OtherLong-termLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/FairValueMeasurementTables" xlink:href="aren-20231231.xsd#FairValueMeasurementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/Long-termDebtTables" xlink:href="aren-20231231.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockholdersDeficiencyTables" xlink:href="aren-20231231.xsd#StockholdersDeficiencyTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockbasedCompensationTables" xlink:href="aren-20231231.xsd#StockbasedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IncomeTaxesTables" xlink:href="aren-20231231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OrganizationAndBasisOfPresentationDetailsNarrative" xlink:href="aren-20231231.xsd#OrganizationAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails" xlink:href="aren-20231231.xsd#ScheduleOfDisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails" xlink:href="aren-20231231.xsd#ScheduleOfContractWithCustomerAssetAndLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfCashAndRestrictedCashDetails" xlink:href="aren-20231231.xsd#ScheduleOfCashAndRestrictedCashDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:href="aren-20231231.xsd#ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails" xlink:href="aren-20231231.xsd#ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails" xlink:href="aren-20231231.xsd#ScheduleOfNetIncomeLossPerCommonShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="aren-20231231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails" xlink:href="aren-20231231.xsd#ScheduleOfDiscontinuedOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/DiscontinuedOperationsDetailsNarrative" xlink:href="aren-20231231.xsd#DiscontinuedOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails" xlink:href="aren-20231231.xsd#ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails" xlink:href="aren-20231231.xsd#SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails" xlink:href="aren-20231231.xsd#ScheduleOfCompositionOfPurchasePriceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails" xlink:href="aren-20231231.xsd#SummaryOfPurchasePriceAllocationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails" xlink:href="aren-20231231.xsd#ScheduleOfSupplementalProformaInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails" xlink:href="aren-20231231.xsd#ScheduleOfPreliminaryPriceAllocationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative" xlink:href="aren-20231231.xsd#AcquisitionsAndDispositionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails" xlink:href="aren-20231231.xsd#ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsDetailsNarrative" xlink:href="aren-20231231.xsd#PrepaymentsAndOtherCurrentAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="aren-20231231.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PropertyAndEquipmentDetailsNarrative" xlink:href="aren-20231231.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails" xlink:href="aren-20231231.xsd#ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails" xlink:href="aren-20231231.xsd#ScheduleOfOperatingLeaseCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetailsParenthetical" xlink:href="aren-20231231.xsd#ScheduleOfOperatingLeaseCostsDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfMaturityOfLeaseLiabilitiesDetails" xlink:href="aren-20231231.xsd#SummaryOfMaturityOfLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LeasesDetailsNarrative" xlink:href="aren-20231231.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails" xlink:href="aren-20231231.xsd#SummaryOfPlatformDevelopmentCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails" xlink:href="aren-20231231.xsd#SummaryOfPlatformDevelopmentCostActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative" xlink:href="aren-20231231.xsd#PlatformDevelopmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails" xlink:href="aren-20231231.xsd#ScheduleOfIntangibleAssetsSubjectToAmortizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails" xlink:href="aren-20231231.xsd#ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative" xlink:href="aren-20231231.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfOtherAssetsDetails" xlink:href="aren-20231231.xsd#SummaryOfOtherAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails" xlink:href="aren-20231231.xsd#ScheduleOfChangesInCarryingValueOfGoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/GoodwillDetailsNarrative" xlink:href="aren-20231231.xsd#GoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative" xlink:href="aren-20231231.xsd#RestrictedStockLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails" xlink:href="aren-20231231.xsd#ScheduleOfAccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LineOfCreditDetailsNarrative" xlink:href="aren-20231231.xsd#LineOfCreditDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails" xlink:href="aren-20231231.xsd#SummaryOfLiquidatedDamagesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative" xlink:href="aren-20231231.xsd#LiquidatedDamagesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails" xlink:href="aren-20231231.xsd#ScheduleOfOtherLong-TermLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:href="aren-20231231.xsd#ScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative" xlink:href="aren-20231231.xsd#FairValueMeasurementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/BridgeNotesDetailsNarrative" xlink:href="aren-20231231.xsd#BridgeNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails" xlink:href="aren-20231231.xsd#ScheduleOfLongTermDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical" xlink:href="aren-20231231.xsd#ScheduleOfLongTermDebtDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfInterestExpenseDetails" xlink:href="aren-20231231.xsd#SummaryOfInterestExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/Long-termDebtDetailsNarrative" xlink:href="aren-20231231.xsd#Long-termDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PreferredStockDetailsNarrative" xlink:href="aren-20231231.xsd#PreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails" xlink:href="aren-20231231.xsd#SummaryOfRestrictedStockAwardActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfWarrantActivityDetails" xlink:href="aren-20231231.xsd#SummaryOfWarrantActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative" xlink:href="aren-20231231.xsd#StockholdersDeficiencyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="aren-20231231.xsd#ScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails" xlink:href="aren-20231231.xsd#ScheduleOfFairValueOfStockOptionsAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails" xlink:href="aren-20231231.xsd#SummaryOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical" xlink:href="aren-20231231.xsd#SummaryOfStockOptionActivityDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails" xlink:href="aren-20231231.xsd#ScheduleOfExercisePricesOfCommonStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails" xlink:href="aren-20231231.xsd#ScheduleOfWarrantsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails" xlink:href="aren-20231231.xsd#SummaryOfStock-basedCompensationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails" xlink:href="aren-20231231.xsd#ScheduleOfUnrecognizedCompensationExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative" xlink:href="aren-20231231.xsd#StockbasedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LiquidatedDamagesDetailsNarrative" xlink:href="aren-20231231.xsd#LiquidatedDamagesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails" xlink:href="aren-20231231.xsd#ScheduleOfIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="aren-20231231.xsd#ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails" xlink:href="aren-20231231.xsd#ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IncomeTaxesDetailsNarrative" xlink:href="aren-20231231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PensionPlansDetailsNarrative" xlink:href="aren-20231231.xsd#PensionPlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="aren-20231231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="aren-20231231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SubsequentEventsDetailsNarrative" xlink:href="aren-20231231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaapRestrictedCashCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapRestrictedCashCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetCurrent" xlink:label="loc_us-gaapCapitalizedContractCostNetCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCapitalizedContractCostNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PlatformDevelopmentNet" xlink:label="loc_ARENPlatformDevelopmentNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_ARENPlatformDevelopmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetNoncurrent" xlink:label="loc_us-gaapCapitalizedContractCostNetNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapCapitalizedContractCostNetNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLinesOfCreditCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerRefundLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerRefundLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaapAssetAcquisitionContingentConsiderationLiabilityCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableCurrent" xlink:label="loc_ARENLiquidatedDamagesPayableCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_ARENLiquidatedDamagesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BridgeNotes" xlink:label="loc_ARENBridgeNotes" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_ARENBridgeNotes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapContractWithCustomerLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatingDamagesPayableNonCurrent" xlink:label="loc_ARENLiquidatingDamagesPayableNonCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_ARENLiquidatingDamagesPayableNonCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredTaxAndOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredTaxAndOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockToBeIssuedDuringPeriod" xlink:label="loc_ARENCommonStockToBeIssuedDuringPeriod" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_ARENCommonStockToBeIssuedDuringPeriod" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapAssetImpairmentCharges" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LossOnSaleOfAssets" xlink:label="loc_ARENLossOnSaleOfAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_ARENLossOnSaleOfAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesUnderRegistrationRightsAgreements" xlink:label="loc_ARENLiquidatedDamagesUnderRegistrationRightsAgreements" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_ARENLiquidatedDamagesUnderRegistrationRightsAgreements" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Consolidated Statements of Operations (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StatementsOfStockholdersDeficiency" xlink:title="00000006 - Statement - Consolidated Statements of Stockholders&apos; Deficiency" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NoncashAndAccruedInterest" xlink:label="loc_ARENNoncashAndAccruedInterest" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ARENNoncashAndAccruedInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:label="loc_us-gaapDisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LossOnSaleOfAssets" xlink:label="loc_ARENLossOnSaleOfAssets" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ARENLossOnSaleOfAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatingDamagesPayable" xlink:label="loc_ARENLiquidatingDamagesPayable" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ARENLiquidatingDamagesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="loc_us-gaapDeferredIncomeTaxesAndTaxCredits" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxesAndTaxCredits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="loc_us-gaapOtherOperatingActivitiesCashFlowStatement" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherOperatingActivitiesCashFlowStatement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts" xlink:label="loc_ARENIncreaseDecreaseInSubscriptionAcquisitionCosts" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ARENIncreaseDecreaseInSubscriptionAcquisitionCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidRoyalties" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidRoyalties" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidRoyalties" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:calculationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_IncreaseDecreaseInSubscriptionRefundLiability" xlink:label="loc_ARENIncreaseDecreaseInSubscriptionRefundLiability" />
      <link:calculationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ARENIncreaseDecreaseInSubscriptionRefundLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:calculationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentLiabilities" />
      <link:calculationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PaymentsForCapitalizedPlatformDevelopment" xlink:label="loc_ARENPaymentsForCapitalizedPlatformDevelopment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_ARENPaymentsForCapitalizedPlatformDevelopment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_us-gaapProceedsFromSaleOfProductiveAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfProductiveAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfEquityMethodInvestments" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromShortTermDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PaymentOfDeferredCashPayment" xlink:label="loc_ARENPaymentOfDeferredCashPayment" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ARENPaymentOfDeferredCashPayment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PaymentOfRestrictedStockLiabilities" xlink:label="loc_ARENPaymentOfRestrictedStockLiabilities" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ARENPaymentOfRestrictedStockLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OrganizationAndBasisOfPresentation" xlink:title="00000008 - Disclosure - Organization and Basis of Presentation" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/DiscontinuedOperations" xlink:title="00000010 - Disclosure - Discontinued Operations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/AcquisitionsAndDispositions" xlink:title="00000011 - Disclosure - Acquisitions and Dispositions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssets" xlink:title="00000012 - Disclosure - Prepayments and Other Current Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PropertyAndEquipment" xlink:title="00000013 - Disclosure - Property and Equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Leases" xlink:title="00000014 - Disclosure - Leases" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PlatformDevelopment" xlink:title="00000015 - Disclosure - Platform Development" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IntangibleAssets" xlink:title="00000016 - Disclosure - Intangible Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OtherLong-termAssets" xlink:title="00000017 - Disclosure - Other Long-Term Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Goodwill" xlink:title="00000018 - Disclosure - Goodwill" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/RestrictedStockLiabilities" xlink:title="00000019 - Disclosure - Restricted Stock Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/AccruedExpensesAndOther" xlink:title="00000020 - Disclosure - Accrued Expenses and Other" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LineOfCredit" xlink:title="00000021 - Disclosure - Line of Credit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LiquidatedDamagesPayable" xlink:title="00000022 - Disclosure - Liquidated Damages Payable" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OtherLong-termLiabilities" xlink:title="00000023 - Disclosure - Other Long-term Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/FairValueMeasurement" xlink:title="00000024 - Disclosure - Fair Value Measurement" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/BridgeNotes" xlink:title="00000025 - Disclosure - Bridge Notes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Long-termDebt" xlink:title="00000026 - Disclosure - Long-term Debt" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PreferredStock" xlink:title="00000027 - Disclosure - Preferred Stock" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockholdersDeficiency" xlink:title="00000028 - Disclosure - Stockholders&#8217; Deficiency" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockbasedCompensation" xlink:title="00000029 - Disclosure - Stock&#8211;Based Compensation" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LiquidatedDamages" xlink:title="00000030 - Disclosure - Liquidated Damages" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IncomeTaxes" xlink:title="00000031 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PensionPlans" xlink:title="00000032 - Disclosure - Pension Plans" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/RelatedPartyTransactions" xlink:title="00000033 - Disclosure - Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/CommitmentsAndContingencies" xlink:title="00000034 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SubsequentEvents" xlink:title="00000035 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000036 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000037 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/DiscontinuedOperationsTables" xlink:title="00000038 - Disclosure - Discontinued Operations (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/AcquisitionsAndDispositionsTables" xlink:title="00000039 - Disclosure - Acquisitions and Dispositions (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsTables" xlink:title="00000040 - Disclosure - Prepayments and Other Current Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PropertyAndEquipmentTables" xlink:title="00000041 - Disclosure - Property and Equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LeasesTables" xlink:title="00000042 - Disclosure - Leases (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PlatformDevelopmentTables" xlink:title="00000043 - Disclosure - Platform Development (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IntangibleAssetsTables" xlink:title="00000044 - Disclosure - Intangible Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OtherLong-termAssetsTables" xlink:title="00000045 - Disclosure - Other Long-Term Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/GoodwillTables" xlink:title="00000046 - Disclosure - Goodwill (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/AccruedExpensesAndOtherTables" xlink:title="00000047 - Disclosure - Accrued Expenses and Other (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LiquidatedDamagesPayableTables" xlink:title="00000048 - Disclosure - Liquidated Damages Payable (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OtherLong-termLiabilitiesTables" xlink:title="00000049 - Disclosure - Other Long-term Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/FairValueMeasurementTables" xlink:title="00000050 - Disclosure - Fair Value Measurement (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Long-termDebtTables" xlink:title="00000051 - Disclosure - Long-term Debt (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockholdersDeficiencyTables" xlink:title="00000052 - Disclosure - Stockholders&#8217; Deficiency (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockbasedCompensationTables" xlink:title="00000053 - Disclosure - Stock&#8211;Based Compensation (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IncomeTaxesTables" xlink:title="00000054 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OrganizationAndBasisOfPresentationDetailsNarrative" xlink:title="00000055 - Disclosure - Organization and Basis of Presentation (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails" xlink:title="00000056 - Disclosure - Schedule of Disaggregation of Revenue (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails" xlink:title="00000057 - Disclosure - Schedule of Contract with Customer, Asset and Liability (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfCashAndRestrictedCashDetails" xlink:title="00000058 - Disclosure - Schedule of Cash and Restricted Cash (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:title="00000059 - Disclosure - Schedule of Allowance For Doubtful Accounts (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails" xlink:title="00000060 - Disclosure - Schedule of Depreciation and Amortization, Useful Lives of Assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails" xlink:title="00000061 - Disclosure - Schedule of Net Income (Loss) Per Common Share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000062 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails" xlink:title="00000063 - Disclosure - Schedule of Discontinued Operations (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense" xlink:label="loc_ARENDisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="loc_ARENDisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges" xlink:label="loc_ARENDisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="loc_ARENDisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:label="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/DiscontinuedOperationsDetailsNarrative" xlink:title="00000064 - Disclosure - Discontinued Operations (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails" xlink:title="00000065 - Disclosure - Schedule of Composition Preliminary Assets Purchase Price (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails" xlink:title="00000066 - Disclosure - Summary of Preliminary Assets Purchase Price Allocation (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails" xlink:title="00000067 - Disclosure - Schedule of Composition of Purchase Price (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails" xlink:title="00000068 - Disclosure - Summary of Purchase Price Allocation (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails" xlink:title="00000069 - Disclosure - Schedule of Supplemental Proforma Information (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails" xlink:title="00000070 - Disclosure - Schedule of Preliminary Price Allocation (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative" xlink:title="00000071 - Disclosure - Acquisitions and Dispositions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails" xlink:title="00000072 - Disclosure - Schedule of Prepayments and Other Current Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrepaidSuppliesCurrent" xlink:label="loc_ARENPrepaidSuppliesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_ARENPrepaidSuppliesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RefundableIncomeAndFranchiseTaxes" xlink:label="loc_ARENRefundableIncomeAndFranchiseTaxes" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_ARENRefundableIncomeAndFranchiseTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="loc_us-gaapUnamortizedDebtIssuanceExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapUnamortizedDebtIssuanceExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EmployeeRetentionCredits" xlink:label="loc_ARENEmployeeRetentionCredits" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_ARENEmployeeRetentionCredits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsDetailsNarrative" xlink:title="00000073 - Disclosure - Prepayments and Other Current Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000074 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000075 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails" xlink:title="00000076 - Disclosure - Schedule of Supplemental Information Related to Operating Leases (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails" xlink:title="00000077 - Disclosure - Schedule of Operating Lease Costs (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaapLeaseCost" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLeaseCost" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome" xlink:label="loc_us-gaapSubleaseIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLeaseCost" xlink:to="loc_us-gaapSubleaseIncome" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetailsParenthetical" xlink:title="00000078 - Disclosure - Schedule of Operating Lease Costs (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfMaturityOfLeaseLiabilitiesDetails" xlink:title="00000079 - Disclosure - Summary of Maturity of Lease Liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LeasesDetailsNarrative" xlink:title="00000080 - Disclosure - Leases (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails" xlink:title="00000081 - Disclosure - Summary of Platform Development Costs (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails" xlink:title="00000082 - Disclosure - Summary of Platform Development Cost Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative" xlink:title="00000083 - Disclosure - Platform Development (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails" xlink:title="00000084 - Disclosure - Schedule of Intangible Assets Subject to Amortization (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails" xlink:title="00000085 - Disclosure - Schedule of Future Estimated Amortization expense For Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative" xlink:title="00000086 - Disclosure - Intangible Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfOtherAssetsDetails" xlink:title="00000087 - Disclosure - Summary of Other Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsNoncurrent" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaapOtherReceivables" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsNoncurrent" xlink:to="loc_us-gaapOtherReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidInsurance" xlink:label="loc_us-gaapPrepaidInsurance" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsNoncurrent" xlink:to="loc_us-gaapPrepaidInsurance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UnamortizedDebtCost" xlink:label="loc_ARENUnamortizedDebtCost" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsNoncurrent" xlink:to="loc_ARENUnamortizedDebtCost" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails" xlink:title="00000088 - Disclosure - Schedule of Changes in Carrying Value of Goodwill (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/GoodwillDetailsNarrative" xlink:title="00000089 - Disclosure - Goodwill (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative" xlink:title="00000090 - Disclosure - Restricted Stock Liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails" xlink:title="00000091 - Disclosure - Schedule of Accrued Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_GeneralAccruedExpenses" xlink:label="loc_ARENGeneralAccruedExpenses" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_ARENGeneralAccruedExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaapAccruedPayrollTaxesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedPayrollTaxesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedAdvertisingCurrent" xlink:label="loc_us-gaapAccruedAdvertisingCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedAdvertisingCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiabilitiesInConnectionWithAcquisitionsAndDispositions" xlink:label="loc_ARENLiabilitiesInConnectionWithAcquisitionsAndDispositions" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_ARENLiabilitiesInConnectionWithAcquisitionsAndDispositions" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseDepositLiability" xlink:label="loc_us-gaapLeaseDepositLiability" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapLeaseDepositLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LeaseTerminationLiability" xlink:label="loc_ARENLeaseTerminationLiability" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_ARENLeaseTerminationLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LineOfCreditDetailsNarrative" xlink:title="00000092 - Disclosure - Line of Credit (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails" xlink:title="00000093 - Disclosure - Summary of Liquidated Damages (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative" xlink:title="00000094 - Disclosure - Liquidated Damages Payable (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails" xlink:title="00000095 - Disclosure - Schedule of Other long- term liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LeaseTerminationLiabilityNonCurrent" xlink:label="loc_ARENLeaseTerminationLiabilityNonCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:to="loc_ARENLeaseTerminationLiabilityNonCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OtherLongTermLiabilitiesNoncurrent" xlink:label="loc_ARENOtherLongTermLiabilitiesNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:to="loc_ARENOtherLongTermLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:title="00000096 - Disclosure - Schedule of Fair Value of Financial Instruments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative" xlink:title="00000097 - Disclosure - Fair Value Measurement (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/BridgeNotesDetailsNarrative" xlink:title="00000098 - Disclosure - Bridge Notes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails" xlink:title="00000099 - Disclosure - Schedule of long term debt (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical" xlink:title="00000100 - Disclosure - Schedule of Long Term Debt (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfInterestExpenseDetails" xlink:title="00000101 - Disclosure - Summary of Interest Expense (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Long-termDebtDetailsNarrative" xlink:title="00000102 - Disclosure - Long-term Debt (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PreferredStockDetailsNarrative" xlink:title="00000103 - Disclosure - Preferred Stock (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails" xlink:title="00000104 - Disclosure - Summary of Restricted Stock Award Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfWarrantActivityDetails" xlink:title="00000105 - Disclosure - Summary of Warrant Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative" xlink:title="00000106 - Disclosure - Stockholders&#8217; Deficiency (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:title="00000107 - Disclosure - Schedule of Restricted Stock Units Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails" xlink:title="00000108 - Disclosure - Schedule of Fair Value of Stock Options Assumptions (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails" xlink:title="00000109 - Disclosure - Summary of Stock Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical" xlink:title="00000110 - Disclosure - Summary of Stock Option Activity (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails" xlink:title="00000111 - Disclosure - Schedule of Exercise Prices of Common Stock Options (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails" xlink:title="00000112 - Disclosure - Schedule of Warrants Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails" xlink:title="00000113 - Disclosure - Summary of Stock-based Compensation (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails" xlink:title="00000114 - Disclosure - Schedule of Unrecognized Compensation Expense (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative" xlink:title="00000115 - Disclosure - Stock&#8211;Based Compensation (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LiquidatedDamagesDetailsNarrative" xlink:title="00000116 - Disclosure - Liquidated Damages (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails" xlink:title="00000117 - Disclosure - Schedule of Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000118 - Disclosure - Schedule of Components of Deferred Tax Assets and Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetInterestCarryforward" xlink:label="loc_us-gaapDeferredTaxAssetInterestCarryforward" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetInterestCarryforward" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LeaseTermination" xlink:label="loc_ARENLeaseTermination" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_ARENLeaseTermination" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredTaxAssetsLiquidatingDamagesPayable" xlink:label="loc_ARENDeferredTaxAssetsLiquidatingDamagesPayable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_ARENDeferredTaxAssetsLiquidatingDamagesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredTaxAssetsOperatingLeaseLiability" xlink:label="loc_ARENDeferredTaxAssetsOperatingLeaseLiability" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_ARENDeferredTaxAssetsOperatingLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredTaxAssetsDepreciationAndAmortization" xlink:label="loc_ARENDeferredTaxAssetsDepreciationAndAmortization" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_ARENDeferredTaxAssetsDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails" xlink:title="00000119 - Disclosure - Schedule of Tax Benefit and Effective Income Tax (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue" xlink:label="loc_ARENEffectiveIncomeTaxRateReconciliationUnearnedRevenue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_ARENEffectiveIncomeTaxRateReconciliationUnearnedRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationInterestExpense" xlink:label="loc_ARENEffectiveIncomeTaxRateReconciliationInterestExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_ARENEffectiveIncomeTaxRateReconciliationInterestExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment" xlink:label="loc_ARENEffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_ARENEffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInEnactedTaxRate" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage" xlink:label="loc_ARENEffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_ARENEffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationInterestExpensePercentage" xlink:label="loc_ARENEffectiveIncomeTaxRateReconciliationInterestExpensePercentage" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_ARENEffectiveIncomeTaxRateReconciliationInterestExpensePercentage" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage" xlink:label="loc_ARENEffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_ARENEffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IncomeTaxesDetailsNarrative" xlink:title="00000120 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PensionPlansDetailsNarrative" xlink:title="00000121 - Disclosure - Pension Plans (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000122 - Disclosure - Related Party Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000123 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SubsequentEventsDetailsNarrative" xlink:title="00000124 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>16
<FILENAME>aren-20231231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://thearenagroup.net/role/Cover" xlink:href="aren-20231231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/BalanceSheets" xlink:href="aren-20231231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/BalanceSheetsParenthetical" xlink:href="aren-20231231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StatementsOfOperations" xlink:href="aren-20231231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StatementsOfOperationsParenthetical" xlink:href="aren-20231231.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StatementsOfStockholdersDeficiency" xlink:href="aren-20231231.xsd#StatementsOfStockholdersDeficiency" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StatementsOfCashFlows" xlink:href="aren-20231231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OrganizationAndBasisOfPresentation" xlink:href="aren-20231231.xsd#OrganizationAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfSignificantAccountingPolicies" xlink:href="aren-20231231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/DiscontinuedOperations" xlink:href="aren-20231231.xsd#DiscontinuedOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/AcquisitionsAndDispositions" xlink:href="aren-20231231.xsd#AcquisitionsAndDispositions" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssets" xlink:href="aren-20231231.xsd#PrepaymentsAndOtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PropertyAndEquipment" xlink:href="aren-20231231.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/Leases" xlink:href="aren-20231231.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PlatformDevelopment" xlink:href="aren-20231231.xsd#PlatformDevelopment" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IntangibleAssets" xlink:href="aren-20231231.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OtherLong-termAssets" xlink:href="aren-20231231.xsd#OtherLong-termAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/Goodwill" xlink:href="aren-20231231.xsd#Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/RestrictedStockLiabilities" xlink:href="aren-20231231.xsd#RestrictedStockLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/AccruedExpensesAndOther" xlink:href="aren-20231231.xsd#AccruedExpensesAndOther" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LineOfCredit" xlink:href="aren-20231231.xsd#LineOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LiquidatedDamagesPayable" xlink:href="aren-20231231.xsd#LiquidatedDamagesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OtherLong-termLiabilities" xlink:href="aren-20231231.xsd#OtherLong-termLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/FairValueMeasurement" xlink:href="aren-20231231.xsd#FairValueMeasurement" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/BridgeNotes" xlink:href="aren-20231231.xsd#BridgeNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/Long-termDebt" xlink:href="aren-20231231.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PreferredStock" xlink:href="aren-20231231.xsd#PreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockholdersDeficiency" xlink:href="aren-20231231.xsd#StockholdersDeficiency" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockbasedCompensation" xlink:href="aren-20231231.xsd#StockbasedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LiquidatedDamages" xlink:href="aren-20231231.xsd#LiquidatedDamages" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IncomeTaxes" xlink:href="aren-20231231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PensionPlans" xlink:href="aren-20231231.xsd#PensionPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/RelatedPartyTransactions" xlink:href="aren-20231231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/CommitmentsAndContingencies" xlink:href="aren-20231231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SubsequentEvents" xlink:href="aren-20231231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="aren-20231231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="aren-20231231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/DiscontinuedOperationsTables" xlink:href="aren-20231231.xsd#DiscontinuedOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/AcquisitionsAndDispositionsTables" xlink:href="aren-20231231.xsd#AcquisitionsAndDispositionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsTables" xlink:href="aren-20231231.xsd#PrepaymentsAndOtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PropertyAndEquipmentTables" xlink:href="aren-20231231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LeasesTables" xlink:href="aren-20231231.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PlatformDevelopmentTables" xlink:href="aren-20231231.xsd#PlatformDevelopmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IntangibleAssetsTables" xlink:href="aren-20231231.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OtherLong-termAssetsTables" xlink:href="aren-20231231.xsd#OtherLong-termAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/GoodwillTables" xlink:href="aren-20231231.xsd#GoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/AccruedExpensesAndOtherTables" xlink:href="aren-20231231.xsd#AccruedExpensesAndOtherTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LiquidatedDamagesPayableTables" xlink:href="aren-20231231.xsd#LiquidatedDamagesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OtherLong-termLiabilitiesTables" xlink:href="aren-20231231.xsd#OtherLong-termLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/FairValueMeasurementTables" xlink:href="aren-20231231.xsd#FairValueMeasurementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/Long-termDebtTables" xlink:href="aren-20231231.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockholdersDeficiencyTables" xlink:href="aren-20231231.xsd#StockholdersDeficiencyTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockbasedCompensationTables" xlink:href="aren-20231231.xsd#StockbasedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IncomeTaxesTables" xlink:href="aren-20231231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OrganizationAndBasisOfPresentationDetailsNarrative" xlink:href="aren-20231231.xsd#OrganizationAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails" xlink:href="aren-20231231.xsd#ScheduleOfDisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails" xlink:href="aren-20231231.xsd#ScheduleOfContractWithCustomerAssetAndLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfCashAndRestrictedCashDetails" xlink:href="aren-20231231.xsd#ScheduleOfCashAndRestrictedCashDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:href="aren-20231231.xsd#ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails" xlink:href="aren-20231231.xsd#ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails" xlink:href="aren-20231231.xsd#ScheduleOfNetIncomeLossPerCommonShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="aren-20231231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails" xlink:href="aren-20231231.xsd#ScheduleOfDiscontinuedOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/DiscontinuedOperationsDetailsNarrative" xlink:href="aren-20231231.xsd#DiscontinuedOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails" xlink:href="aren-20231231.xsd#ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails" xlink:href="aren-20231231.xsd#SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails" xlink:href="aren-20231231.xsd#ScheduleOfCompositionOfPurchasePriceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails" xlink:href="aren-20231231.xsd#SummaryOfPurchasePriceAllocationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails" xlink:href="aren-20231231.xsd#ScheduleOfSupplementalProformaInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails" xlink:href="aren-20231231.xsd#ScheduleOfPreliminaryPriceAllocationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative" xlink:href="aren-20231231.xsd#AcquisitionsAndDispositionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails" xlink:href="aren-20231231.xsd#ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsDetailsNarrative" xlink:href="aren-20231231.xsd#PrepaymentsAndOtherCurrentAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="aren-20231231.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PropertyAndEquipmentDetailsNarrative" xlink:href="aren-20231231.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails" xlink:href="aren-20231231.xsd#ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails" xlink:href="aren-20231231.xsd#ScheduleOfOperatingLeaseCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetailsParenthetical" xlink:href="aren-20231231.xsd#ScheduleOfOperatingLeaseCostsDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfMaturityOfLeaseLiabilitiesDetails" xlink:href="aren-20231231.xsd#SummaryOfMaturityOfLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LeasesDetailsNarrative" xlink:href="aren-20231231.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails" xlink:href="aren-20231231.xsd#SummaryOfPlatformDevelopmentCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails" xlink:href="aren-20231231.xsd#SummaryOfPlatformDevelopmentCostActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative" xlink:href="aren-20231231.xsd#PlatformDevelopmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails" xlink:href="aren-20231231.xsd#ScheduleOfIntangibleAssetsSubjectToAmortizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails" xlink:href="aren-20231231.xsd#ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative" xlink:href="aren-20231231.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfOtherAssetsDetails" xlink:href="aren-20231231.xsd#SummaryOfOtherAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails" xlink:href="aren-20231231.xsd#ScheduleOfChangesInCarryingValueOfGoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/GoodwillDetailsNarrative" xlink:href="aren-20231231.xsd#GoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative" xlink:href="aren-20231231.xsd#RestrictedStockLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails" xlink:href="aren-20231231.xsd#ScheduleOfAccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LineOfCreditDetailsNarrative" xlink:href="aren-20231231.xsd#LineOfCreditDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails" xlink:href="aren-20231231.xsd#SummaryOfLiquidatedDamagesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative" xlink:href="aren-20231231.xsd#LiquidatedDamagesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails" xlink:href="aren-20231231.xsd#ScheduleOfOtherLong-TermLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:href="aren-20231231.xsd#ScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative" xlink:href="aren-20231231.xsd#FairValueMeasurementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/BridgeNotesDetailsNarrative" xlink:href="aren-20231231.xsd#BridgeNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails" xlink:href="aren-20231231.xsd#ScheduleOfLongTermDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical" xlink:href="aren-20231231.xsd#ScheduleOfLongTermDebtDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfInterestExpenseDetails" xlink:href="aren-20231231.xsd#SummaryOfInterestExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/Long-termDebtDetailsNarrative" xlink:href="aren-20231231.xsd#Long-termDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PreferredStockDetailsNarrative" xlink:href="aren-20231231.xsd#PreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails" xlink:href="aren-20231231.xsd#SummaryOfRestrictedStockAwardActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfWarrantActivityDetails" xlink:href="aren-20231231.xsd#SummaryOfWarrantActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative" xlink:href="aren-20231231.xsd#StockholdersDeficiencyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="aren-20231231.xsd#ScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails" xlink:href="aren-20231231.xsd#ScheduleOfFairValueOfStockOptionsAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails" xlink:href="aren-20231231.xsd#SummaryOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical" xlink:href="aren-20231231.xsd#SummaryOfStockOptionActivityDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails" xlink:href="aren-20231231.xsd#ScheduleOfExercisePricesOfCommonStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails" xlink:href="aren-20231231.xsd#ScheduleOfWarrantsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails" xlink:href="aren-20231231.xsd#SummaryOfStock-basedCompensationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails" xlink:href="aren-20231231.xsd#ScheduleOfUnrecognizedCompensationExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative" xlink:href="aren-20231231.xsd#StockbasedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LiquidatedDamagesDetailsNarrative" xlink:href="aren-20231231.xsd#LiquidatedDamagesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails" xlink:href="aren-20231231.xsd#ScheduleOfIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="aren-20231231.xsd#ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails" xlink:href="aren-20231231.xsd#ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IncomeTaxesDetailsNarrative" xlink:href="aren-20231231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PensionPlansDetailsNarrative" xlink:href="aren-20231231.xsd#PensionPlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="aren-20231231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="aren-20231231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SubsequentEventsDetailsNarrative" xlink:href="aren-20231231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesGRedeemableAndConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesGRedeemableAndConvertiblePreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesGRedeemableAndConvertiblePreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesHConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesHConvertiblePreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesHConvertiblePreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssetsCurrentAbstract_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaapRestrictedCashCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapRestrictedCashCurrent_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetCurrent" xlink:label="loc_us-gaapCapitalizedContractCostNetCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapCapitalizedContractCostNetCurrent_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapAssetsCurrent_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PlatformDevelopmentNet" xlink:label="loc_ARENPlatformDevelopmentNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_ARENPlatformDevelopmentNet_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetNoncurrent" xlink:label="loc_us-gaapCapitalizedContractCostNetNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapCapitalizedContractCostNetNoncurrent_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapOtherIntangibleAssetsNet_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapOtherAssetsNoncurrent_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapGoodwill_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssets_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapAccountsPayableCurrent_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapLinesOfCreditCurrent_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerRefundLiabilityCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapContractWithCustomerRefundLiabilityCurrent_70" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_70" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaapAssetAcquisitionContingentConsiderationLiabilityCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapAssetAcquisitionContingentConsiderationLiabilityCurrent_70" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableCurrent" xlink:label="loc_ARENLiquidatedDamagesPayableCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_ARENLiquidatedDamagesPayableCurrent_70" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BridgeNotes" xlink:label="loc_ARENBridgeNotes_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_ARENBridgeNotes_70" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapLongTermDebtCurrent_70" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrent_70" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapContractWithCustomerLiabilityNoncurrent_70" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_70" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatingDamagesPayableNonCurrent" xlink:label="loc_ARENLiquidatingDamagesPayableNonCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_ARENLiquidatingDamagesPayableNonCurrent_70" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent_70" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredTaxAndOtherLiabilitiesNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapDeferredTaxAndOtherLiabilitiesNoncurrent_70" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilities_70" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommitmentsAndContingencies_70" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaapTemporaryEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapTemporaryEquityAbstract_70" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_70" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapStockholdersEquityAbstract_70" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommonStockValue_70" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockToBeIssuedDuringPeriod" xlink:label="loc_ARENCommonStockToBeIssuedDuringPeriod_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_ARENCommonStockToBeIssuedDuringPeriod_70" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock_70" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_70" xlink:type="arc" order="44" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesGRedeemableAndConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesGRedeemableAndConvertiblePreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesGRedeemableAndConvertiblePreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesHRedeemableAndConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesHRedeemableAndConvertiblePreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesHRedeemableAndConvertiblePreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:label="loc_us-gaapTemporaryEquityLiquidationPreferencePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityLiquidationPreferencePerShare_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="loc_us-gaapTemporaryEquityLiquidationPreference_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityLiquidationPreference_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TemporaryEquityCommonSharesIssuableUponConversion" xlink:label="loc_ARENTemporaryEquityCommonSharesIssuableUponConversion_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENTemporaryEquityCommonSharesIssuableUponConversion_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_70" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Consolidated Statements of Operations (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StatementsOfStockholdersDeficiency" xlink:title="00000006 - Statement - Consolidated Statements of Stockholders&apos; Deficiency">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockToBeIssuedMember" xlink:label="loc_ARENCommonStockToBeIssuedMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENCommonStockToBeIssuedMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_260" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_260" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" xlink:label="loc_ARENStockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering_260" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" xlink:label="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering_260" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_260" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_260" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne" xlink:label="loc_ARENStockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne_260" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne" xlink:label="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne_260" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" xlink:label="loc_ARENStockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_260" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares" xlink:label="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares_260" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" xlink:label="loc_ARENAdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENAdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_260" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_260" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_260" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" xlink:label="loc_ARENStockIssuedDuringPeriodValueCommonStockWithheldForTaxes_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodValueCommonStockWithheldForTaxes_260" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares" xlink:label="loc_ARENStockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares_260" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_260" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_260" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_260" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_260" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_260" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" xlink:label="loc_ARENAdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENAdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages_260" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_260" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_260" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger" xlink:label="loc_ARENStockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger_260" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" xlink:label="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_260" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_260" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_260" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes" xlink:label="loc_ARENStockIssuedDuringPeriodSharesCommonStockWithheldForTaxes_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodSharesCommonStockWithheldForTaxes_260" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_260" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_260" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_260" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_260" xlink:type="arc" order="33" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OrganizationAndBasisOfPresentation" xlink:title="00000008 - Disclosure - Organization and Basis of Presentation" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/DiscontinuedOperations" xlink:title="00000010 - Disclosure - Discontinued Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/AcquisitionsAndDispositions" xlink:title="00000011 - Disclosure - Acquisitions and Dispositions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssets" xlink:title="00000012 - Disclosure - Prepayments and Other Current Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PropertyAndEquipment" xlink:title="00000013 - Disclosure - Property and Equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Leases" xlink:title="00000014 - Disclosure - Leases" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PlatformDevelopment" xlink:title="00000015 - Disclosure - Platform Development" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IntangibleAssets" xlink:title="00000016 - Disclosure - Intangible Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OtherLong-termAssets" xlink:title="00000017 - Disclosure - Other Long-Term Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Goodwill" xlink:title="00000018 - Disclosure - Goodwill" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/RestrictedStockLiabilities" xlink:title="00000019 - Disclosure - Restricted Stock Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/AccruedExpensesAndOther" xlink:title="00000020 - Disclosure - Accrued Expenses and Other" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LineOfCredit" xlink:title="00000021 - Disclosure - Line of Credit" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LiquidatedDamagesPayable" xlink:title="00000022 - Disclosure - Liquidated Damages Payable" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OtherLong-termLiabilities" xlink:title="00000023 - Disclosure - Other Long-term Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/FairValueMeasurement" xlink:title="00000024 - Disclosure - Fair Value Measurement" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/BridgeNotes" xlink:title="00000025 - Disclosure - Bridge Notes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Long-termDebt" xlink:title="00000026 - Disclosure - Long-term Debt" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PreferredStock" xlink:title="00000027 - Disclosure - Preferred Stock" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockholdersDeficiency" xlink:title="00000028 - Disclosure - Stockholders&#8217; Deficiency" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockbasedCompensation" xlink:title="00000029 - Disclosure - Stock&#8211;Based Compensation" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LiquidatedDamages" xlink:title="00000030 - Disclosure - Liquidated Damages" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IncomeTaxes" xlink:title="00000031 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PensionPlans" xlink:title="00000032 - Disclosure - Pension Plans" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/RelatedPartyTransactions" xlink:title="00000033 - Disclosure - Related Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/CommitmentsAndContingencies" xlink:title="00000034 - Disclosure - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SubsequentEvents" xlink:title="00000035 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000036 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000037 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/DiscontinuedOperationsTables" xlink:title="00000038 - Disclosure - Discontinued Operations (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/AcquisitionsAndDispositionsTables" xlink:title="00000039 - Disclosure - Acquisitions and Dispositions (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="loc_us-gaapAssetAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable" xlink:label="loc_us-gaapAssetAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosMember" xlink:label="loc_ARENFexyStudiosMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_ARENFexyStudiosMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AthlonHoldingsIncMember" xlink:label="loc_ARENAthlonHoldingsIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENAthlonHoldingsIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTableTextBlock" xlink:label="loc_us-gaapAssetAcquisitionTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionTableTextBlock_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ScheduleOfAssetsAcquiredTableTextBlock" xlink:label="loc_ARENScheduleOfAssetsAcquiredTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENScheduleOfAssetsAcquiredTableTextBlock_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PreliminaryPriceAllocationTableTextBlock" xlink:label="loc_ARENPreliminaryPriceAllocationTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENPreliminaryPriceAllocationTableTextBlock_40" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsTables" xlink:title="00000040 - Disclosure - Prepayments and Other Current Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PropertyAndEquipmentTables" xlink:title="00000041 - Disclosure - Property and Equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LeasesTables" xlink:title="00000042 - Disclosure - Leases (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PlatformDevelopmentTables" xlink:title="00000043 - Disclosure - Platform Development (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IntangibleAssetsTables" xlink:title="00000044 - Disclosure - Intangible Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OtherLong-termAssetsTables" xlink:title="00000045 - Disclosure - Other Long-Term Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/GoodwillTables" xlink:title="00000046 - Disclosure - Goodwill (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/AccruedExpensesAndOtherTables" xlink:title="00000047 - Disclosure - Accrued Expenses and Other (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LiquidatedDamagesPayableTables" xlink:title="00000048 - Disclosure - Liquidated Damages Payable (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OtherLong-termLiabilitiesTables" xlink:title="00000049 - Disclosure - Other Long-term Liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/FairValueMeasurementTables" xlink:title="00000050 - Disclosure - Fair Value Measurement (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Long-termDebtTables" xlink:title="00000051 - Disclosure - Long-term Debt (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockholdersDeficiencyTables" xlink:title="00000052 - Disclosure - Stockholders&#8217; Deficiency (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockbasedCompensationTables" xlink:title="00000053 - Disclosure - Stock&#8211;Based Compensation (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedStockUnitsMember" xlink:label="loc_ARENRestrictedStockUnitsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENRestrictedStockUnitsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonEquityAwardsMember" xlink:label="loc_ARENCommonEquityAwardsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENCommonEquityAwardsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockAwardsMember" xlink:label="loc_ARENCommonStockAwardsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENCommonStockAwardsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ARENABGWarrantsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NewPublisherPartnerWarrantMember" xlink:label="loc_ARENNewPublisherPartnerWarrantMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENNewPublisherPartnerWarrantMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ScheduleOfRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_ARENScheduleOfRestrictedStockUnitsActivityTableTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENScheduleOfRestrictedStockUnitsActivityTableTextBlock_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ScheduleOfWarrantsActivityTableTextBlock" xlink:label="loc_ARENScheduleOfWarrantsActivityTableTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENScheduleOfWarrantsActivityTableTextBlock_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ScheduleOfUnrecognizedCompensationExpense" xlink:label="loc_ARENScheduleOfUnrecognizedCompensationExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENScheduleOfUnrecognizedCompensationExpense_70" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IncomeTaxesTables" xlink:title="00000054 - Disclosure - Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OrganizationAndBasisOfPresentationDetailsNarrative" xlink:title="00000055 - Disclosure - Organization and Basis of Presentation (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails" xlink:title="00000056 - Disclosure - Schedule of Disaggregation of Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalAdvertisingMember" xlink:label="loc_ARENDigitalAdvertisingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENDigitalAdvertisingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalSubscriptionsMember" xlink:label="loc_ARENDigitalSubscriptionsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENDigitalSubscriptionsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LicensingAndSyndicationRevenueMember" xlink:label="loc_ARENLicensingAndSyndicationRevenueMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENLicensingAndSyndicationRevenueMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductAndServiceOtherMember" xlink:label="loc_us-gaapProductAndServiceOtherMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductAndServiceOtherMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalRevenueMember" xlink:label="loc_ARENDigitalRevenueMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENDigitalRevenueMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrintAdvertisingMember" xlink:label="loc_ARENPrintAdvertisingMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENPrintAdvertisingMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrintSubscriptionsMember" xlink:label="loc_ARENPrintSubscriptionsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENPrintSubscriptionsMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrintRevenueMember" xlink:label="loc_ARENPrintRevenueMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENPrintRevenueMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US" xlink:label="loc_countryUS_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OtherMember" xlink:label="loc_ARENOtherMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_ARENOtherMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:label="loc_us-gaapTransferredAtPointInTimeMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:to="loc_us-gaapTransferredAtPointInTimeMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferredOverTimeMember" xlink:label="loc_us-gaapTransferredOverTimeMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:to="loc_us-gaapTransferredOverTimeMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_270" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails" xlink:title="00000057 - Disclosure - Schedule of Contract with Customer, Asset and Liability (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalRevenueMember" xlink:label="loc_ARENDigitalRevenueMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENDigitalRevenueMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrintRevenueMember" xlink:label="loc_ARENPrintRevenueMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENPrintRevenueMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityNoncurrent_70" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfCashAndRestrictedCashDetails" xlink:title="00000058 - Disclosure - Schedule of Cash and Restricted Cash (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:title="00000059 - Disclosure - Schedule of Allowance For Doubtful Accounts (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails" xlink:title="00000060 - Disclosure - Schedule of Depreciation and Amortization, Useful Lives of Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OfficeEquipmentAndComputersMember" xlink:label="loc_ARENOfficeEquipmentAndComputersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_ARENOfficeEquipmentAndComputersMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails" xlink:title="00000061 - Disclosure - Schedule of Net Income (Loss) Per Common Share (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesGConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesGConvertiblePreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ARENSeriesGConvertiblePreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="loc_us-gaapSeriesHPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapSeriesHPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FinancingWarrantsMember" xlink:label="loc_ARENFinancingWarrantsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ARENFinancingWarrantsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ARENABGWarrantsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AllHipHopWarrantsMember" xlink:label="loc_ARENAllHipHopWarrantsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ARENAllHipHopWarrantsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PublisherPartnerWarrantsMember" xlink:label="loc_ARENPublisherPartnerWarrantsMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ARENPublisherPartnerWarrantsMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedStockAwardsMember" xlink:label="loc_ARENRestrictedStockAwardsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ARENRestrictedStockAwardsMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockOptionsMember" xlink:label="loc_ARENCommonStockOptionsMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ARENCommonStockOptionsMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_210" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000062 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyFBRIncMember" xlink:label="loc_ARENBRileyFBRIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENBRileyFBRIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalAndPrintSubscriptionsMember" xlink:label="loc_ARENDigitalAndPrintSubscriptionsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENDigitalAndPrintSubscriptionsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="loc_us-gaapRevenueFromContractWithCustomerMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapRevenueFromContractWithCustomerMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableMember" xlink:label="loc_us-gaapAccountsPayableMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsPayableMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CustomerMember" xlink:label="loc_ARENCustomerMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ARENCustomerMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaapSellingAndMarketingExpenseMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingAndMarketingExpenseMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerRefundLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerRefundLiabilityCurrent_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UnearnedRevenue" xlink:label="loc_ARENUnearnedRevenue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_ARENUnearnedRevenue_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:label="loc_us-gaapContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaapRestrictedCashCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRestrictedCashCurrent_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortization" xlink:label="loc_us-gaapCapitalizedContractCostAmortization_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCapitalizedContractCostAmortization_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNet" xlink:label="loc_us-gaapCapitalizedContractCostNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCapitalizedContractCostNet_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetNoncurrent" xlink:label="loc_us-gaapCapitalizedContractCostNetNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCapitalizedContractCostNetNoncurrent_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetCurrent" xlink:label="loc_us-gaapCapitalizedContractCostNetCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCapitalizedContractCostNetCurrent_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesDescription" xlink:label="loc_ARENLiquidatedDamagesDescription_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_ARENLiquidatedDamagesDescription_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense_130" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails" xlink:title="00000063 - Disclosure - Schedule of Discontinued Operations (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MultiemployerPlansLineItems" xlink:label="loc_us-gaapMultiemployerPlansLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMultiemployerPlansTable" xlink:label="loc_us-gaapScheduleOfMultiemployerPlansTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapScheduleOfMultiemployerPlansTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfMultiemployerPlansTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ParadePrintMember" xlink:label="loc_ARENParadePrintMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_ARENParadePrintMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense" xlink:label="loc_ARENDisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_20" xlink:to="loc_ARENDisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense_20" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_20" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_20" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges" xlink:label="loc_ARENDisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_20" xlink:to="loc_ARENDisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges_20" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_20" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense_20" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_20" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:label="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation_20" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_20" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/DiscontinuedOperationsDetailsNarrative" xlink:title="00000064 - Disclosure - Discontinued Operations (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails" xlink:title="00000065 - Disclosure - Schedule of Composition Preliminary Assets Purchase Price (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="loc_us-gaapAssetAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable" xlink:label="loc_us-gaapAssetAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TeneologyIncMember" xlink:label="loc_ARENTeneologyIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENTeneologyIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosMember" xlink:label="loc_ARENFexyStudiosMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_ARENFexyStudiosMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferredContingentConsideration_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferredContingentConsideration_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted" xlink:label="loc_ARENAssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENAssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferred_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferred_20" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails" xlink:title="00000066 - Disclosure - Summary of Preliminary Assets Purchase Price Allocation (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="loc_us-gaapAssetAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable" xlink:label="loc_us-gaapAssetAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TeneologyIncMember" xlink:label="loc_ARENTeneologyIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENTeneologyIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosMember" xlink:label="loc_ARENFexyStudiosMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_ARENFexyStudiosMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdvertiserRelationshipsMember" xlink:label="loc_ARENAdvertiserRelationshipsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENAdvertiserRelationshipsMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BrandNamesMember" xlink:label="loc_ARENBrandNamesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENBrandNamesMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillMember" xlink:label="loc_us-gaapGoodwillMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapGoodwillMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AssetAcquisitionAssetsAcquired" xlink:label="loc_ARENAssetAcquisitionAssetsAcquired_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENAssetAcquisitionAssetsAcquired_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails" xlink:title="00000067 - Disclosure - Schedule of Composition of Purchase Price (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AthlonHoldingsIncMember" xlink:label="loc_ARENAthlonHoldingsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENAthlonHoldingsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredOther1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredOther1_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_20" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails" xlink:title="00000068 - Disclosure - Summary of Purchase Price Allocation (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AthlonHoldingsIncMember" xlink:label="loc_ARENAthlonHoldingsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENAthlonHoldingsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapGoodwill_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_30" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails" xlink:title="00000069 - Disclosure - Schedule of Supplemental Proforma Information (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ParadeMember" xlink:label="loc_ARENParadeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENParadeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ArenaMember" xlink:label="loc_ARENArenaMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENArenaMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdjustmentsMember" xlink:label="loc_ARENAdjustmentsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENAdjustmentsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapRevenues_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapNetIncomeLoss_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails" xlink:title="00000070 - Disclosure - Schedule of Preliminary Price Allocation (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AthlonHoldingsIncMember" xlink:label="loc_ARENAthlonHoldingsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENAthlonHoldingsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue_20" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability_20" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_20" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_20" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative" xlink:title="00000071 - Disclosure - Acquisitions and Dispositions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="loc_us-gaapAssetAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable" xlink:label="loc_us-gaapAssetAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TeneologyIncMember" xlink:label="loc_ARENTeneologyIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENTeneologyIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BuffaloGroupeLLCMember" xlink:label="loc_ARENBuffaloGroupeLLCMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENBuffaloGroupeLLCMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosMember" xlink:label="loc_ARENFexyStudiosMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_ARENFexyStudiosMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_IntellectualPropertiesMember" xlink:label="loc_ARENIntellectualPropertiesMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_ARENIntellectualPropertiesMember_190" xlink:type="arc" order="192" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdvertiserRelationshipsMember" xlink:label="loc_ARENAdvertiserRelationshipsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENAdvertiserRelationshipsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BrandNamesMember" xlink:label="loc_ARENBrandNamesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENBrandNamesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalContentMember" xlink:label="loc_ARENDigitalContentMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENDigitalContentMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaapTradeNamesMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTradeNamesMember_170" xlink:type="arc" order="172" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosMember" xlink:label="loc_ARENFexyStudiosMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENFexyStudiosMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AthlonHoldingsIncMember" xlink:label="loc_ARENAthlonHoldingsIncMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENAthlonHoldingsIncMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MensJournalMember" xlink:label="loc_ARENMensJournalMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENMensJournalMember_250" xlink:type="arc" order="251" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_A360MediaLLCMember" xlink:label="loc_ARENA360MediaLLCMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENA360MediaLLCMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_Disposition2023Member" xlink:label="loc_ARENDisposition2023Member_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_ARENDisposition2023Member_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdvertiserRelationshipMember" xlink:label="loc_ARENAdvertiserRelationshipMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENAdvertiserRelationshipMember_260" xlink:type="arc" order="262" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BrandNameMember" xlink:label="loc_ARENBrandNameMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENBrandNameMember_270" xlink:type="arc" order="272" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferred_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferred_300" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets_300" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForAdvanceToAffiliate" xlink:label="loc_us-gaapPaymentsForAdvanceToAffiliate_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsForAdvanceToAffiliate_300" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredCashPayments" xlink:label="loc_ARENDeferredCashPayments_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENDeferredCashPayments_300" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredCashPaymentsDue" xlink:label="loc_ARENDeferredCashPaymentsDue_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENDeferredCashPaymentsDue_300" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets_300" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets_300" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_300" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_300" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToEmployees" xlink:label="loc_us-gaapPaymentsToEmployees_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToEmployees_300" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferredTransactionCost_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferredTransactionCost_300" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_300" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapGoodwill_300" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="loc_us-gaapProceedsFromSaleOfOtherAssetsInvestingActivities_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfOtherAssetsInvestingActivities_300" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SalePrice" xlink:label="loc_ARENSalePrice_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENSalePrice_300" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WorkingCapital" xlink:label="loc_ARENWorkingCapital_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENWorkingCapital_300" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PreliminaryWorkingCapital" xlink:label="loc_ARENPreliminaryWorkingCapital_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENPreliminaryWorkingCapital_300" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WorkingCapitalAdjustments" xlink:label="loc_ARENWorkingCapitalAdjustments_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENWorkingCapitalAdjustments_300" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FinalSalePrice" xlink:label="loc_ARENFinalSalePrice_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENFinalSalePrice_300" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaapProceedsFromDivestitureOfBusinesses_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapProceedsFromDivestitureOfBusinesses_300" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_300" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAccountsPayableCurrent_300" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1_300" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_300" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_300" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapCashAcquiredFromAcquisition_300" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesAndInterestInAffiliates_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesAndInterestInAffiliates_300" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PaymentsToAcquireBusinessesAtClosing" xlink:label="loc_ARENPaymentsToAcquireBusinessesAtClosing_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENPaymentsToAcquireBusinessesAtClosing_300" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses" xlink:label="loc_us-gaapOtherPaymentsToAcquireBusinesses_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapOtherPaymentsToAcquireBusinesses_300" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_300" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_300" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_300" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="loc_us-gaapBusinessAcquisitionDescriptionOfAcquiredEntity_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionDescriptionOfAcquiredEntity_300" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsDescription_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsDescription_300" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts_300" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments" xlink:label="loc_us-gaapBusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments_300" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_300" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDeposit" xlink:label="loc_us-gaapEscrowDeposit_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapEscrowDeposit_300" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_300" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapDeferredRevenue_300" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredRevenueObligation" xlink:label="loc_ARENDeferredRevenueObligation_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENDeferredRevenueObligation_300" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnearnedPremiums" xlink:label="loc_us-gaapUnearnedPremiums_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapUnearnedPremiums_300" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRefundLiabilityCurrent" xlink:label="loc_us-gaapCustomerRefundLiabilityCurrent_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapCustomerRefundLiabilityCurrent_300" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaapGoodwillAcquiredDuringPeriod_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapGoodwillAcquiredDuringPeriod_300" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="loc_us-gaapBusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_300" xlink:type="arc" order="44" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails" xlink:title="00000072 - Disclosure - Schedule of Prepayments and Other Current Assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsDetailsNarrative" xlink:title="00000073 - Disclosure - Prepayments and Other Current Assets (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000074 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OfficeEquipmentAndComputersMember" xlink:label="loc_ARENOfficeEquipmentAndComputersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_ARENOfficeEquipmentAndComputersMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000075 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems" xlink:label="loc_us-gaapImpairmentEffectsOnEarningsPerShareLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareTable" xlink:label="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareLineItems" xlink:to="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareLineItems" xlink:to="loc_us-gaapDepreciation_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails" xlink:title="00000076 - Disclosure - Schedule of Supplemental Information Related to Operating Leases (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails" xlink:title="00000077 - Disclosure - Schedule of Operating Lease Costs (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseCost_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome" xlink:label="loc_us-gaapSubleaseIncome_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSubleaseIncome_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaapLeaseCost_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseCost_50" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetailsParenthetical" xlink:title="00000078 - Disclosure - Schedule of Operating Lease Costs (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessMembershipAgreementMember" xlink:label="loc_ARENBusinessMembershipAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENBusinessMembershipAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MonthToMonthLeaseArrangementMember" xlink:label="loc_ARENMonthToMonthLeaseArrangementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENMonthToMonthLeaseArrangementMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOperatingLeaseCost_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfMaturityOfLeaseLiabilitiesDetails" xlink:title="00000079 - Disclosure - Summary of Maturity of Lease Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LeasesDetailsNarrative" xlink:title="00000080 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SubleaseAgreementMember" xlink:label="loc_ARENSubleaseAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENSubleaseAgreementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LeaseArrangementMember" xlink:label="loc_ARENLeaseArrangementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENLeaseArrangementMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OctoberOneTwoThousandAndTwentyFourMember" xlink:label="loc_ARENOctoberOneTwoThousandAndTwentyFourMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_ARENOctoberOneTwoThousandAndTwentyFourMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaapLesseeOperatingLeaseTermOfContract_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseTermOfContract_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome" xlink:label="loc_us-gaapSubleaseIncome_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSubleaseIncome_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLeasePayments" xlink:label="loc_us-gaapProceedsFromLeasePayments_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromLeasePayments_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapAdvertisingExpense_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ImputedInterestRate" xlink:label="loc_ARENImputedInterestRate_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ARENImputedInterestRate_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MarketingAndAdvertisingExpenseRemaining" xlink:label="loc_ARENMarketingAndAdvertisingExpenseRemaining_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ARENMarketingAndAdvertisingExpenseRemaining_100" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails" xlink:title="00000081 - Disclosure - Summary of Platform Development Costs (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PlatformDevelopmentMember" xlink:label="loc_ARENPlatformDevelopmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_ARENPlatformDevelopmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails" xlink:title="00000082 - Disclosure - Summary of Platform Development Cost Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PlatformDevelopmentMember" xlink:label="loc_ARENPlatformDevelopmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_ARENPlatformDevelopmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentOther" xlink:label="loc_us-gaapPropertyPlantAndEquipmentOther_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentOther_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaapFinitelivedIntangibleAssetsAcquired1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapFinitelivedIntangibleAssetsAcquired1_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortization" xlink:label="loc_us-gaapCapitalizedContractCostAmortization_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCapitalizedContractCostAmortization_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapShareBasedCompensation_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_60" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative" xlink:title="00000083 - Disclosure - Platform Development (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PlatformDevelopmentMember" xlink:label="loc_ARENPlatformDevelopmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_ARENPlatformDevelopmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails" xlink:title="00000084 - Disclosure - Schedule of Intangible Assets Subject to Amortization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DevelopedTechnologyMember" xlink:label="loc_ARENDevelopedTechnologyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENDevelopedTechnologyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaapTradeNamesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTradeNamesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BrandNamesMember" xlink:label="loc_ARENBrandNamesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENBrandNamesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SubscriberRelationshipsMember" xlink:label="loc_ARENSubscriberRelationshipsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENSubscriberRelationshipsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdvertiserRelationshipsMember" xlink:label="loc_ARENAdvertiserRelationshipsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENAdvertiserRelationshipsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DatabasesMember" xlink:label="loc_us-gaapDatabasesMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapDatabasesMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalContentMember" xlink:label="loc_ARENDigitalContentMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENDigitalContentMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_170" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails" xlink:title="00000085 - Disclosure - Schedule of Future Estimated Amortization expense For Intangible Assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative" xlink:title="00000086 - Disclosure - Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DevelopedTechnologyMember" xlink:label="loc_ARENDevelopedTechnologyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENDevelopedTechnologyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMember" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfAcquisitionCosts" xlink:label="loc_us-gaapAmortizationOfAcquisitionCosts_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfAcquisitionCosts_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfOtherAssetsDetails" xlink:title="00000087 - Disclosure - Summary of Other Assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails" xlink:title="00000088 - Disclosure - Schedule of Changes in Carrying Value of Goodwill (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ParadeMember" xlink:label="loc_ARENParadeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENParadeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MensJournalMember" xlink:label="loc_ARENMensJournalMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENMensJournalMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosMember" xlink:label="loc_ARENFexyStudiosMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENFexyStudiosMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGoodwill_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaapGoodwillAcquiredDuringPeriod_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGoodwillAcquiredDuringPeriod_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss_120" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/GoodwillDetailsNarrative" xlink:title="00000089 - Disclosure - Goodwill (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative" xlink:title="00000090 - Disclosure - Restricted Stock Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_us-gaapPaymentsForRepurchaseOfEquity_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPaymentsForRepurchaseOfEquity_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedStockPrincipalAmount" xlink:label="loc_ARENRestrictedStockPrincipalAmount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENRestrictedStockPrincipalAmount_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedStockInterestPayment" xlink:label="loc_ARENRestrictedStockInterestPayment_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENRestrictedStockInterestPayment_30" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails" xlink:title="00000091 - Disclosure - Schedule of Accrued Expenses (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LineOfCreditDetailsNarrative" xlink:title="00000092 - Disclosure - Line of Credit (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FinancingAndSecurityAgreementMember" xlink:label="loc_ARENFinancingAndSecurityAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENFinancingAndSecurityAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SLRDigitalFinanceLLCMember" xlink:label="loc_ARENSLRDigitalFinanceLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_ARENSLRDigitalFinanceLLCMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyThreeNotesMember" xlink:label="loc_ARENTwoThousandTwentyThreeNotesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_ARENTwoThousandTwentyThreeNotesMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesLPreferredStockMember" xlink:label="loc_ARENSeriesLPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENSeriesLPreferredStockMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SLRDigitalFinanceLLCMember" xlink:label="loc_ARENSLRDigitalFinanceLLCMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_ARENSLRDigitalFinanceLLCMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCredit_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AccountsReceivablePercentage" xlink:label="loc_ARENAccountsReceivablePercentage_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_ARENAccountsReceivablePercentage_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDescription_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDescription_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDefaultLongtermDebtAmount" xlink:label="loc_us-gaapDebtDefaultLongtermDebtAmount_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtDefaultLongtermDebtAmount_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="loc_us-gaapUnamortizedDebtIssuanceExpense_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapUnamortizedDebtIssuanceExpense_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapOtherAssetsNoncurrent_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateAtPeriodEnd_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateAtPeriodEnd_100" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLinesOfCreditCurrent_100" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFeeAmount" xlink:label="loc_us-gaapDebtInstrumentFeeAmount_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFeeAmount_100" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod_100" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails" xlink:title="00000093 - Disclosure - Summary of Liquidated Damages (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MDBCommonStockToBeIssuedMember" xlink:label="loc_ARENMDBCommonStockToBeIssuedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENMDBCommonStockToBeIssuedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesHConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesHConvertiblePreferredStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesHConvertiblePreferredStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ConvertibleDebenturesMember" xlink:label="loc_ARENConvertibleDebenturesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENConvertibleDebenturesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesJPreferredStockMember" xlink:label="loc_ARENSeriesJPreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesJPreferredStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesKPreferredStockMember" xlink:label="loc_ARENSeriesKPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesKPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RegistrationRightsDamages" xlink:label="loc_ARENRegistrationRightsDamages_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENRegistrationRightsDamages_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PublicInformationFailureDamages" xlink:label="loc_ARENPublicInformationFailureDamages_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENPublicInformationFailureDamages_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableCurrentAndNonCurrent" xlink:label="loc_ARENLiquidatedDamagesPayableCurrentAndNonCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENLiquidatedDamagesPayableCurrentAndNonCurrent_130" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative" xlink:title="00000094 - Disclosure - Liquidated Damages Payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockPurchaseAgreementMember" xlink:label="loc_ARENStockPurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENStockPurchaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapInvestorMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyMember" xlink:label="loc_ARENBRileyMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENBRileyMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaapLossContingencyDamagesSoughtValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLossContingencyDamagesSoughtValue_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="loc_us-gaapDebtInstrumentDecreaseForgiveness_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentDecreaseForgiveness_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" xlink:label="loc_ARENAdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ARENAdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableCurrent" xlink:label="loc_ARENLiquidatedDamagesPayableCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ARENLiquidatedDamagesPayableCurrent_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableAccruedInterestPercentage" xlink:label="loc_ARENLiquidatedDamagesPayableAccruedInterestPercentage_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ARENLiquidatedDamagesPayableAccruedInterestPercentage_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableCurrentAndNonCurrent" xlink:label="loc_ARENLiquidatedDamagesPayableCurrentAndNonCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ARENLiquidatedDamagesPayableCurrentAndNonCurrent_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PercentageOfAggregateAmountInvested" xlink:label="loc_ARENPercentageOfAggregateAmountInvested_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ARENPercentageOfAggregateAmountInvested_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableNonCurrent" xlink:label="loc_ARENLiquidatedDamagesPayableNonCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ARENLiquidatedDamagesPayableNonCurrent_90" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails" xlink:title="00000095 - Disclosure - Schedule of Other long- term liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:title="00000096 - Disclosure - Schedule of Fair Value of Financial Instruments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ContingentConsiderationMember" xlink:label="loc_ARENContingentConsiderationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ARENContingentConsiderationMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeniorSecuredNoteMember" xlink:label="loc_ARENSeniorSecuredNoteMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ARENSeniorSecuredNoteMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaapLongTermDebtFairValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapLongTermDebtFairValue_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative" xlink:title="00000097 - Disclosure - Fair Value Measurement (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FlexyStudiosMember" xlink:label="loc_ARENFlexyStudiosMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENFlexyStudiosMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" xlink:to="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" xlink:to="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PutOptionMember" xlink:label="loc_us-gaapPutOptionMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain" xlink:to="loc_us-gaapPutOptionMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosAcquistionMember" xlink:label="loc_ARENFexyStudiosAcquistionMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_ARENFexyStudiosAcquistionMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="loc_us-gaapBusinessAcquisitionSharePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessAcquisitionSharePrice_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:label="loc_us-gaapFinancialInstrumentsOwnedAtFairValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapFinancialInstrumentsOwnedAtFairValue_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedOtherAtFairValue" xlink:label="loc_us-gaapFinancialInstrumentsOwnedOtherAtFairValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapFinancialInstrumentsOwnedOtherAtFairValue_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapSharePrice_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UnearnedRevenue" xlink:label="loc_ARENUnearnedRevenue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_ARENUnearnedRevenue_70" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/BridgeNotesDetailsNarrative" xlink:title="00000098 - Disclosure - Bridge Notes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyThreeNotesMember" xlink:label="loc_ARENTwoThousandTwentyThreeNotesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENTwoThousandTwentyThreeNotesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BridgeNotesMember" xlink:label="loc_ARENBridgeNotesMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENBridgeNotesMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoBridgeNotesMember" xlink:label="loc_ARENTwoThousandTwentyTwoBridgeNotesMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoBridgeNotesMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaapOtherBorrowings_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapOtherBorrowings_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AggregatePrincipalMinimumAmount" xlink:label="loc_ARENAggregatePrincipalMinimumAmount_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ARENAggregatePrincipalMinimumAmount_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:label="loc_us-gaapDebtSecuritiesAvailableForSaleAmortizedCostCurrent_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtSecuritiesAvailableForSaleAmortizedCostCurrent_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_140" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="loc_us-gaapProceedsFromDebtNetOfIssuanceCosts_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromDebtNetOfIssuanceCosts_140" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaymentFeesOnAdvancesNet" xlink:label="loc_us-gaapPrepaymentFeesOnAdvancesNet_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapPrepaymentFeesOnAdvancesNet_140" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrincipalAmountPrepayDue" xlink:label="loc_ARENPrincipalAmountPrepayDue_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ARENPrincipalAmountPrepayDue_140" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_140" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent_140" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_140" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsNet_140" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedPremium" xlink:label="loc_us-gaapDebtInstrumentUnamortizedPremium_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedPremium_140" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails" xlink:title="00000099 - Disclosure - Schedule of long term debt (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeniorSecuredNoteMember" xlink:label="loc_ARENSeniorSecuredNoteMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENSeniorSecuredNoteMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DelayedDrawTermNoteMember" xlink:label="loc_ARENDelayedDrawTermNoteMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENDelayedDrawTermNoteMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoBridgeNotesMember" xlink:label="loc_ARENTwoThousandTwentyTwoBridgeNotesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoBridgeNotesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapLongTermDebt_90" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical" xlink:title="00000100 - Disclosure - Schedule of Long Term Debt (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeniorSecuredNoteMember" xlink:label="loc_ARENSeniorSecuredNoteMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENSeniorSecuredNoteMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DelayedDrawTermNoteMember" xlink:label="loc_ARENDelayedDrawTermNoteMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_ARENDelayedDrawTermNoteMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoBridgeNotesMember" xlink:label="loc_ARENTwoThousandTwentyTwoBridgeNotesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_ARENTwoThousandTwentyTwoBridgeNotesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfInterestExpenseDetails" xlink:title="00000101 - Disclosure - Summary of Interest Expense (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaapLineOfCreditMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapLineOfCreditMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoBridgeNotesMember" xlink:label="loc_ARENTwoThousandTwentyTwoBridgeNotesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoBridgeNotesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeniorSecuredNotesMember" xlink:label="loc_ARENSeniorSecuredNotesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENSeniorSecuredNotesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DelayedDrawTermNoteMember" xlink:label="loc_ARENDelayedDrawTermNoteMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENDelayedDrawTermNoteMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyThreeNotesMember" xlink:label="loc_ARENTwoThousandTwentyThreeNotesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENTwoThousandTwentyThreeNotesMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LineOfCreditTerminationFeeMember" xlink:label="loc_ARENLineOfCreditTerminationFeeMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENLineOfCreditTerminationFeeMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ParadeMember" xlink:label="loc_ARENParadeMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENParadeMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OtherAccruedInterestMember" xlink:label="loc_ARENOtherAccruedInterestMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENOtherAccruedInterestMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OtherMember" xlink:label="loc_ARENOtherMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENOtherMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyMember" xlink:label="loc_ARENBRileyMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENBRileyMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_220" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NoncashAndAccruedInterest" xlink:label="loc_ARENNoncashAndAccruedInterest_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ARENNoncashAndAccruedInterest_220" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CashPaidInterestAbstract" xlink:label="loc_ARENCashPaidInterestAbstract_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ARENCashPaidInterestAbstract_220" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestPaid_220" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestExpenseDebt_220" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestExpense_220" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Long-termDebtDetailsNarrative" xlink:title="00000102 - Disclosure - Long-term Debt (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeniorSecuredNoteMember" xlink:label="loc_ARENSeniorSecuredNoteMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENSeniorSecuredNoteMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoBridgeNotesMember" xlink:label="loc_ARENTwoThousandTwentyTwoBridgeNotesMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoBridgeNotesMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SLRDigitalFinanceLLCMember" xlink:label="loc_ARENSLRDigitalFinanceLLCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_ARENSLRDigitalFinanceLLCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DelayedDrawTermNotesMember" xlink:label="loc_ARENDelayedDrawTermNotesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_ARENDelayedDrawTermNotesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PurchaseAgreementMember" xlink:label="loc_ARENPurchaseAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENPurchaseAgreementMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyMember" xlink:label="loc_ARENBRileyMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENBRileyMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestPayableCurrent_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="loc_us-gaapDebtInstrumentInterestRateIncreaseDecrease_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateIncreaseDecrease_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapLineOfCredit_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsNet_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_170" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_170" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DebtInstrumentPeriodicPaymentPrincipalBalance" xlink:label="loc_ARENDebtInstrumentPeriodicPaymentPrincipalBalance_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ARENDebtInstrumentPeriodicPaymentPrincipalBalance_170" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt_170" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapShortTermBorrowings_170" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_170" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PreferredStockDetailsNarrative" xlink:title="00000103 - Disclosure - Preferred Stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesGConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesGConvertiblePreferredStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesGConvertiblePreferredStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesHConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesHConvertiblePreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesHConvertiblePreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="loc_us-gaapSeriesHPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesHPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesGPreferredStockMember" xlink:label="loc_us-gaapSeriesGPreferredStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesGPreferredStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OriginalInvestorMember" xlink:label="loc_ARENOriginalInvestorMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENOriginalInvestorMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:label="loc_us-gaapPreferredStockLiquidationPreference_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockLiquidationPreference_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="loc_us-gaapPreferredStockLiquidationPreferenceValue_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockLiquidationPreferenceValue_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:label="loc_us-gaapTemporaryEquityLiquidationPreferencePerShare_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquityLiquidationPreferencePerShare_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_120" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails" xlink:title="00000104 - Disclosure - Summary of Restricted Stock Award Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfWarrantActivityDetails" xlink:title="00000105 - Disclosure - Summary of Warrant Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockFinancingWarrantMember" xlink:label="loc_ARENCommonStockFinancingWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENCommonStockFinancingWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_ARENSharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ARENSharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice_40" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative" xlink:title="00000106 - Disclosure - Stockholders&#8217; Deficiency (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockPurchaseAgreementsMember" xlink:label="loc_ARENStockPurchaseAgreementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENStockPurchaseAgreementsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AssetPurchaseAgreementMember" xlink:label="loc_ARENAssetPurchaseAgreementMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENAssetPurchaseAgreementMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeveralStockPurchaseAgreementsMember" xlink:label="loc_ARENSeveralStockPurchaseAgreementsMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENSeveralStockPurchaseAgreementsMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExerciseOfStockOptionMember" xlink:label="loc_ARENExerciseOfStockOptionMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENExerciseOfStockOptionMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ServicesAgreementMember" xlink:label="loc_ARENServicesAgreementMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENServicesAgreementMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PurchasersMember" xlink:label="loc_ARENPurchasersMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENPurchasersMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeveralInvestorsMember" xlink:label="loc_ARENSeveralInvestorsMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENSeveralInvestorsMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EmployeesMember" xlink:label="loc_ARENEmployeesMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENEmployeesMember_170" xlink:type="arc" order="173" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesHConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesHConvertiblePreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesHConvertiblePreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AllHipHopWarrantsMember" xlink:label="loc_ARENAllHipHopWarrantsMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENAllHipHopWarrantsMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PublisherPartnerWarrantsMember" xlink:label="loc_ARENPublisherPartnerWarrantsMember_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENPublisherPartnerWarrantsMember_370" xlink:type="arc" order="371" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENABGWarrantsMember_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarransMember" xlink:label="loc_ARENABGWarransMember_390" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENABGWarransMember_390" xlink:type="arc" order="391" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGTimeBasedWarrantsMember" xlink:label="loc_ARENABGTimeBasedWarrantsMember_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENABGTimeBasedWarrantsMember_400" xlink:type="arc" order="401" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGPerformanceBasedWarrantsMember" xlink:label="loc_ARENABGPerformanceBasedWarrantsMember_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENABGPerformanceBasedWarrantsMember_410" xlink:type="arc" order="411" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NewPublisherPartnerWarrantsMember" xlink:label="loc_ARENNewPublisherPartnerWarrantsMember_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENNewPublisherPartnerWarrantsMember_430" xlink:type="arc" order="431" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosAcquisitionMember" xlink:label="loc_ARENFexyStudiosAcquisitionMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENFexyStudiosAcquisitionMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ParadeStockMember" xlink:label="loc_ARENParadeStockMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENParadeStockMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedCommonStockMember" xlink:label="loc_ARENRestrictedCommonStockMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENRestrictedCommonStockMember_190" xlink:type="arc" order="192" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UnderwritingPublicOfferingMember" xlink:label="loc_ARENUnderwritingPublicOfferingMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ARENUnderwritingPublicOfferingMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UnderwritingOverallotmentMember" xlink:label="loc_ARENUnderwritingOverallotmentMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ARENUnderwritingOverallotmentMember_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyMember" xlink:label="loc_ARENBRileyMember_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ARENBRileyMember_330" xlink:type="arc" order="331" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_350" xlink:type="arc" order="352" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MDBCapitalGroupLLCMember" xlink:label="loc_ARENMDBCapitalGroupLLCMember_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_ARENMDBCapitalGroupLLCMember_350" xlink:type="arc" order="351" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_450" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_450" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_450" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_450" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_450" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_450" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockSharesIssued1_450" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_450" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_450" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaapConversionOfStockAmountConverted1_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockAmountConverted1_450" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_450" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesAcquisition" xlink:label="loc_ARENStockIssuedDuringPeriodSharesAcquisition_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodSharesAcquisition_450" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_450" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares" xlink:label="loc_ARENBusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ARENBusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares_450" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_450" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharesIssued_450" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_450" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesSought" xlink:label="loc_us-gaapLossContingencyDamagesSought_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapLossContingencyDamagesSought_450" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaapLossContingencyDamagesSoughtValue_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapLossContingencyDamagesSoughtValue_450" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_450" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_450" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" xlink:label="loc_ARENAdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ARENAdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_450" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_450" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_450" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation_450" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_450" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueForCash" xlink:label="loc_ARENStockIssuedDuringPeriodValueForCash_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodValueForCash_450" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" xlink:label="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_450" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_450" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_450" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_450" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_450" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_450" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees_450" xlink:type="arc" order="33" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:title="00000107 - Disclosure - Schedule of Restricted Stock Units Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedStockUnitsMember" xlink:label="loc_ARENRestrictedStockUnitsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENRestrictedStockUnitsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_50" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails" xlink:title="00000108 - Disclosure - Schedule of Fair Value of Stock Options Assumptions (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoPlanMember" xlink:label="loc_ARENTwoThousandTwentyTwoPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BlackScholesOptionPricingModelMember" xlink:label="loc_ARENBlackScholesOptionPricingModelMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_ARENBlackScholesOptionPricingModelMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UpListMember" xlink:label="loc_ARENUpListMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_ARENUpListMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NoUpListMember" xlink:label="loc_ARENNoUpListMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_ARENNoUpListMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_30" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_80" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails" xlink:title="00000109 - Disclosure - Summary of Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoPlanMember" xlink:label="loc_ARENTwoThousandTwentyTwoPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber_50" xlink:type="arc" order="17" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical" xlink:title="00000110 - Disclosure - Summary of Stock Option Activity (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoPlanMember" xlink:label="loc_ARENTwoThousandTwentyTwoPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails" xlink:title="00000111 - Disclosure - Schedule of Exercise Prices of Common Stock Options (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoPlanMember" xlink:label="loc_ARENTwoThousandTwentyTwoPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENABGWarrantsMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NewPublisherPartnerWarrantMember" xlink:label="loc_ARENNewPublisherPartnerWarrantMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENNewPublisherPartnerWarrantMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeOneMember" xlink:label="loc_ARENExercisePriceRangeOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_ARENExercisePriceRangeOneMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeTwoMember" xlink:label="loc_ARENExercisePriceRangeTwoMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_ARENExercisePriceRangeTwoMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeThreeMember" xlink:label="loc_ARENExercisePriceRangeThreeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_ARENExercisePriceRangeThreeMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeFourMember" xlink:label="loc_ARENExercisePriceRangeFourMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_ARENExercisePriceRangeFourMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeFiveMember" xlink:label="loc_ARENExercisePriceRangeFiveMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_ARENExercisePriceRangeFiveMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeSixMember" xlink:label="loc_ARENExercisePriceRangeSixMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_ARENExercisePriceRangeSixMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeSevenMember" xlink:label="loc_ARENExercisePriceRangeSevenMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_ARENExercisePriceRangeSevenMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeEightMember" xlink:label="loc_ARENExercisePriceRangeEightMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_ARENExercisePriceRangeEightMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BlackScholesOptionPricingModelMember" xlink:label="loc_ARENBlackScholesOptionPricingModelMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_ARENBlackScholesOptionPricingModelMember_220" xlink:type="arc" order="222" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_280" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_280" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_280" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_280" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_280" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne_280" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne_280" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails" xlink:title="00000112 - Disclosure - Schedule of Warrants Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENABGWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NewPublisherPartnerWarrantMember" xlink:label="loc_ARENNewPublisherPartnerWarrantMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENNewPublisherPartnerWarrantMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WeightedAverageRemainingContractualLifeOutstanding" xlink:label="loc_ARENWeightedAverageRemainingContractualLifeOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENWeightedAverageRemainingContractualLifeOutstanding_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WeightedAverageRemainingContractualLifeOutstanding1" xlink:label="loc_ARENWeightedAverageRemainingContractualLifeOutstanding1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENWeightedAverageRemainingContractualLifeOutstanding1_80" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_80" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable_80" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WeightedAverageRemainingContractualLifeExercisable" xlink:label="loc_ARENWeightedAverageRemainingContractualLifeExercisable_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENWeightedAverageRemainingContractualLifeExercisable_80" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested_80" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber_80" xlink:type="arc" order="17" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails" xlink:title="00000113 - Disclosure - Summary of Stock-based Compensation (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockAwardsMember" xlink:label="loc_ARENCommonStockAwardsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENCommonStockAwardsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENABGWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockBasedCompensationMember" xlink:label="loc_ARENStockBasedCompensationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_ARENStockBasedCompensationMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCostOfRevenue_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSellingAndMarketingExpense_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CostsChargedToOperations" xlink:label="loc_ARENCostsChargedToOperations_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENCostsChargedToOperations_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopmentCosts" xlink:label="loc_us-gaapDevelopmentCosts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapDevelopmentCosts_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensation_90" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails" xlink:title="00000114 - Disclosure - Schedule of Unrecognized Compensation Expense (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockAwardsMember" xlink:label="loc_ARENCommonStockAwardsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENCommonStockAwardsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENABGWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockBasedCompensationMember" xlink:label="loc_ARENStockBasedCompensationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_ARENStockBasedCompensationMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_90" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative" xlink:title="00000115 - Disclosure - Stock&#8211;Based Compensation (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoPlanMember" xlink:label="loc_ARENTwoThousandTwentyTwoPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PublisherPartnerWarrantProgramMember" xlink:label="loc_ARENPublisherPartnerWarrantProgramMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENPublisherPartnerWarrantProgramMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NewPublisherPartnerWarrantMember" xlink:label="loc_ARENNewPublisherPartnerWarrantMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENNewPublisherPartnerWarrantMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockOptionsMember" xlink:label="loc_ARENCommonStockOptionsMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENCommonStockOptionsMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SportsIllustratedLicensingAgreementMember" xlink:label="loc_ARENSportsIllustratedLicensingAgreementMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENSportsIllustratedLicensingAgreementMember_250" xlink:type="arc" order="251" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_ARENABGWarrantsMember_250" xlink:type="arc" order="252" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENABGWarrantsMember_260" xlink:type="arc" order="262" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_300" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_300" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_300" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_300" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_300" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" xlink:label="loc_ARENSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_300" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_300" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_300" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_300" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_300" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_300" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_300" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharePrice_300" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_300" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_300" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_300" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent_300" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_300" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="loc_us-gaapUnamortizedDebtIssuanceExpense_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapUnamortizedDebtIssuanceExpense_300" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_300" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OriginalAwardAtTheRepricingDate" xlink:label="loc_ARENOriginalAwardAtTheRepricingDate_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENOriginalAwardAtTheRepricingDate_300" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_300" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FairMarketValueOfStockOption" xlink:label="loc_ARENFairMarketValueOfStockOption_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENFairMarketValueOfStockOption_300" xlink:type="arc" order="22" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LiquidatedDamagesDetailsNarrative" xlink:title="00000116 - Disclosure - Liquidated Damages (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesKPreferredStockMember" xlink:label="loc_ARENSeriesKPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesKPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayable" xlink:label="loc_ARENLiquidatedDamagesPayable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENLiquidatedDamagesPayable_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest_60" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails" xlink:title="00000117 - Disclosure - Schedule of Income Taxes (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000118 - Disclosure - Schedule of Components of Deferred Tax Assets and Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails" xlink:title="00000119 - Disclosure - Schedule of Tax Benefit and Effective Income Tax (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IncomeTaxesDetailsNarrative" xlink:title="00000120 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StateMember" xlink:label="loc_ARENStateMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_ARENStateMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LocalJurisdictionMember" xlink:label="loc_ARENLocalJurisdictionMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_ARENLocalJurisdictionMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_USFederalTaxMember" xlink:label="loc_ARENUSFederalTaxMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_ARENUSFederalTaxMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NetOperatingLossExpirationAmount" xlink:label="loc_ARENNetOperatingLossExpirationAmount_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_ARENNetOperatingLossExpirationAmount_90" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PensionPlansDetailsNarrative" xlink:title="00000121 - Disclosure - Pension Plans (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000122 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyFBRIncMember" xlink:label="loc_ARENBRileyFBRIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENBRileyFBRIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyMember" xlink:label="loc_ARENBRileyMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENBRileyMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PurchasersMember" xlink:label="loc_ARENPurchasersMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENPurchasersMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DirectOfferingMember" xlink:label="loc_ARENDirectOfferingMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ARENDirectOfferingMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesHConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesHConvertiblePreferredStockMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesHConvertiblePreferredStockMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyFinancialIncMember" xlink:label="loc_ARENBRileyFinancialIncMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_ARENBRileyFinancialIncMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AllredTrustHHAMember" xlink:label="loc_ARENAllredTrustHHAMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_ARENAllredTrustHHAMember_180" xlink:type="arc" order="182" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AllredTrustNLAMember" xlink:label="loc_ARENAllredTrustNLAMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_ARENAllredTrustNLAMember_190" xlink:type="arc" order="192" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockPurchaseAgreementsMember" xlink:label="loc_ARENStockPurchaseAgreementsMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENStockPurchaseAgreementsMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_HHuntAllredMember" xlink:label="loc_ARENHHuntAllredMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENHHuntAllredMember_170" xlink:type="arc" order="172" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OneEightyDegreeCapitalCorpMember" xlink:label="loc_ARENOneEightyDegreeCapitalCorpMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENOneEightyDegreeCapitalCorpMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DanielShribmanMember" xlink:label="loc_ARENDanielShribmanMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENDanielShribmanMember_210" xlink:type="arc" order="212" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RossLevinsohnMember" xlink:label="loc_ARENRossLevinsohnMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENRossLevinsohnMember_220" xlink:type="arc" order="222" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PaulEdmonsonMember" xlink:label="loc_ARENPaulEdmonsonMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENPaulEdmonsonMember_230" xlink:type="arc" order="232" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MrEdmonsonMember" xlink:label="loc_ARENMrEdmonsonMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENMrEdmonsonMember_260" xlink:type="arc" order="262" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription_280" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_280" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_280" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_280" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_280" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest_280" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DebtInstrumentIncreaseAccruedInterestAmountDue" xlink:label="loc_ARENDebtInstrumentIncreaseAccruedInterestAmountDue_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ARENDebtInstrumentIncreaseAccruedInterestAmountDue_280" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_280" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_280" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_280" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConvertibleConversionPrice" xlink:label="loc_us-gaapPreferredStockConvertibleConversionPrice_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapPreferredStockConvertibleConversionPrice_280" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion_280" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFeeAmount" xlink:label="loc_us-gaapDebtInstrumentFeeAmount_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentFeeAmount_280" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_280" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_280" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_280" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockRepurchasedDuringPeriodValue1" xlink:label="loc_ARENStockRepurchasedDuringPeriodValue1_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ARENStockRepurchasedDuringPeriodValue1_280" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_280" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_280" xlink:type="arc" order="18" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000123 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaapLossContingenciesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaapLossContingenciesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapLossContingenciesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGSILLCMember" xlink:label="loc_ARENABGSILLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_ARENABGSILLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapRoyaltyExpense_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SubsequentEventsDetailsNarrative" xlink:title="00000124 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ArenaLoanAgreementMember" xlink:label="loc_ARENArenaLoanAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENArenaLoanAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LicensingAgreementMember" xlink:label="loc_ARENLicensingAgreementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENLicensingAgreementMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TransactionAgreementMember" xlink:label="loc_ARENTransactionAgreementMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENTransactionAgreementMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockPurchaseAgreementMember" xlink:label="loc_ARENStockPurchaseAgreementMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENStockPurchaseAgreementMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SubscriptionAgreementMember" xlink:label="loc_ARENSubscriptionAgreementMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENSubscriptionAgreementMember_120" xlink:type="arc" order="123" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENABGWarrantsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosMember" xlink:label="loc_ARENFexyStudiosMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENFexyStudiosMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SimplyfyLoanMember" xlink:label="loc_ARENSimplyfyLoanMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_ARENSimplyfyLoanMember_170" xlink:type="arc" order="172" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MembersOfBoardMember" xlink:label="loc_ARENMembersOfBoardMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENMembersOfBoardMember_210" xlink:type="arc" order="212" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FormerEmployeesMember" xlink:label="loc_ARENFormerEmployeesMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENFormerEmployeesMember_230" xlink:type="arc" order="232" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_220" xlink:type="arc" order="222" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_270" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExerciseRightTerminationAmount" xlink:label="loc_ARENExerciseRightTerminationAmount_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ARENExerciseRightTerminationAmount_270" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TerminationFeeDue" xlink:label="loc_ARENTerminationFeeDue_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ARENTerminationFeeDue_270" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_270" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_270" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_270" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharePrice_270" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationPriceOfAcquisitionExpected" xlink:label="loc_us-gaapBusinessCombinationPriceOfAcquisitionExpected_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapBusinessCombinationPriceOfAcquisitionExpected_270" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredOther1_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredOther1_270" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaapLineOfCreditFacilityCommitmentFeePercentage_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityCommitmentFeePercentage_270" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SharesOutstandingPercentage" xlink:label="loc_ARENSharesOutstandingPercentage_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ARENSharesOutstandingPercentage_270" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_270" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OutstandingPercentage" xlink:label="loc_ARENOutstandingPercentage_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ARENOutstandingPercentage_270" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_270" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_270" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationConsiderationTransferredInstallmentDue" xlink:label="loc_ARENBusinessCombinationConsiderationTransferredInstallmentDue_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ARENBusinessCombinationConsiderationTransferredInstallmentDue_270" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_270" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WorkingCapital" xlink:label="loc_ARENWorkingCapital_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ARENWorkingCapital_270" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_270" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShortTermBorrowings_270" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFeeAmount" xlink:label="loc_us-gaapDebtInstrumentFeeAmount_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFeeAmount_270" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaapLossContingencyDamagesSoughtValue_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLossContingencyDamagesSoughtValue_270" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_270" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_270" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_270" xlink:type="arc" order="24" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapAssetImpairmentCharges" xlink:type="arc" order="1000" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>17
<FILENAME>aren-20231231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesGRedeemableAndConvertiblePreferredStockMember" xlink:label="AREN_SeriesGRedeemableAndConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeriesGRedeemableAndConvertiblePreferredStockMember" xlink:to="AREN_SeriesGRedeemableAndConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SeriesGRedeemableAndConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series G Redeemable And Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesHConvertiblePreferredStockMember" xlink:label="AREN_SeriesHConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeriesHConvertiblePreferredStockMember" xlink:to="AREN_SeriesHConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SeriesHConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series H Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesHRedeemableAndConvertiblePreferredStockMember" xlink:label="AREN_SeriesHRedeemableAndConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeriesHRedeemableAndConvertiblePreferredStockMember" xlink:to="AREN_SeriesHRedeemableAndConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SeriesHRedeemableAndConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series H Redeemable And Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockToBeIssuedMember" xlink:label="AREN_CommonStockToBeIssuedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CommonStockToBeIssuedMember" xlink:to="AREN_CommonStockToBeIssuedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_CommonStockToBeIssuedMember_lbl" xml:lang="en-US">Common Stock To Be Issued [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyFBRIncMember" xlink:label="AREN_BRileyFBRIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BRileyFBRIncMember" xlink:to="AREN_BRileyFBRIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BRileyFBRIncMember_lbl" xml:lang="en-US">B Riley FBR Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalAndPrintSubscriptionsMember" xlink:label="AREN_DigitalAndPrintSubscriptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DigitalAndPrintSubscriptionsMember" xlink:to="AREN_DigitalAndPrintSubscriptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DigitalAndPrintSubscriptionsMember_lbl" xml:lang="en-US">Digital And Print Subscriptions [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="us-gaap_RevenueFromContractWithCustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerMember" xlink:to="us-gaap_RevenueFromContractWithCustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerMember_lbl" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CustomerMember" xlink:label="AREN_CustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CustomerMember" xlink:to="AREN_CustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_CustomerMember_lbl" xml:lang="en-US">Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableMember" xlink:label="us-gaap_AccountsPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableMember" xlink:to="us-gaap_AccountsPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableMember_lbl" xml:lang="en-US">Accounts Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="us-gaap_SellingAndMarketingExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalAdvertisingMember" xlink:label="AREN_DigitalAdvertisingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DigitalAdvertisingMember" xlink:to="AREN_DigitalAdvertisingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DigitalAdvertisingMember_lbl" xml:lang="en-US">Digital Advertising [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalSubscriptionsMember" xlink:label="AREN_DigitalSubscriptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DigitalSubscriptionsMember" xlink:to="AREN_DigitalSubscriptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DigitalSubscriptionsMember_lbl" xml:lang="en-US">Digital Subscriptions [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LicensingAndSyndicationRevenueMember" xlink:label="AREN_LicensingAndSyndicationRevenueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LicensingAndSyndicationRevenueMember" xlink:to="AREN_LicensingAndSyndicationRevenueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LicensingAndSyndicationRevenueMember_lbl" xml:lang="en-US">Licensing And Syndication Revenue [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductAndServiceOtherMember" xlink:label="us-gaap_ProductAndServiceOtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductAndServiceOtherMember" xlink:to="us-gaap_ProductAndServiceOtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductAndServiceOtherMember_lbl" xml:lang="en-US">Product and Service, Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalRevenueMember" xlink:label="AREN_DigitalRevenueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DigitalRevenueMember" xlink:to="AREN_DigitalRevenueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DigitalRevenueMember_lbl" xml:lang="en-US">Digital Revenue [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrintAdvertisingMember" xlink:label="AREN_PrintAdvertisingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PrintAdvertisingMember" xlink:to="AREN_PrintAdvertisingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PrintAdvertisingMember_lbl" xml:lang="en-US">Print Advertising [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrintSubscriptionsMember" xlink:label="AREN_PrintSubscriptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PrintSubscriptionsMember" xlink:to="AREN_PrintSubscriptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PrintSubscriptionsMember_lbl" xml:lang="en-US">Print Subscriptions [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrintRevenueMember" xlink:label="AREN_PrintRevenueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PrintRevenueMember" xlink:to="AREN_PrintRevenueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PrintRevenueMember_lbl" xml:lang="en-US">Print Revenue [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US" xlink:label="country_US" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US">UNITED STATES</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OtherMember" xlink:label="AREN_OtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OtherMember" xlink:to="AREN_OtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_OtherMember_lbl" xml:lang="en-US">Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis_lbl" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:label="us-gaap_TransferredAtPointInTimeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransferredAtPointInTimeMember" xlink:to="us-gaap_TransferredAtPointInTimeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransferredAtPointInTimeMember_lbl" xml:lang="en-US">Transferred at Point in Time [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferredOverTimeMember" xlink:label="us-gaap_TransferredOverTimeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransferredOverTimeMember" xlink:to="us-gaap_TransferredOverTimeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransferredOverTimeMember_lbl" xml:lang="en-US">Transferred over Time [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OfficeEquipmentAndComputersMember" xlink:label="AREN_OfficeEquipmentAndComputersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OfficeEquipmentAndComputersMember" xlink:to="AREN_OfficeEquipmentAndComputersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_OfficeEquipmentAndComputersMember_lbl" xml:lang="en-US">Office Equipment And Computers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesGConvertiblePreferredStockMember" xlink:label="AREN_SeriesGConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeriesGConvertiblePreferredStockMember" xlink:to="AREN_SeriesGConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SeriesGConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series G Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="us-gaap_SeriesHPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesHPreferredStockMember" xlink:to="us-gaap_SeriesHPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesHPreferredStockMember_lbl" xml:lang="en-US">Series H Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FinancingWarrantsMember" xlink:label="AREN_FinancingWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FinancingWarrantsMember" xlink:to="AREN_FinancingWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_FinancingWarrantsMember_lbl" xml:lang="en-US">Financing Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="AREN_ABGWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ABGWarrantsMember" xlink:to="AREN_ABGWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ABGWarrantsMember_lbl" xml:lang="en-US">ABG Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AllHipHopWarrantsMember" xlink:label="AREN_AllHipHopWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AllHipHopWarrantsMember" xlink:to="AREN_AllHipHopWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_AllHipHopWarrantsMember_lbl" xml:lang="en-US">All Hip Hop Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PublisherPartnerWarrantsMember" xlink:label="AREN_PublisherPartnerWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PublisherPartnerWarrantsMember" xlink:to="AREN_PublisherPartnerWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PublisherPartnerWarrantsMember_lbl" xml:lang="en-US">Publisher Partner Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedStockAwardsMember" xlink:label="AREN_RestrictedStockAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RestrictedStockAwardsMember" xlink:to="AREN_RestrictedStockAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_RestrictedStockAwardsMember_lbl" xml:lang="en-US">Restricted Stock Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockOptionsMember" xlink:label="AREN_CommonStockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CommonStockOptionsMember" xlink:to="AREN_CommonStockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_CommonStockOptionsMember_lbl" xml:lang="en-US">Common Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ParadePrintMember" xlink:label="AREN_ParadePrintMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ParadePrintMember" xlink:to="AREN_ParadePrintMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ParadePrintMember_lbl" xml:lang="en-US">Parade Print [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TeneologyIncMember" xlink:label="AREN_TeneologyIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_TeneologyIncMember" xlink:to="AREN_TeneologyIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_TeneologyIncMember_lbl" xml:lang="en-US">Teneology Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="us-gaap_AssetAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionAxis_lbl" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosMember" xlink:label="AREN_FexyStudiosMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FexyStudiosMember" xlink:to="AREN_FexyStudiosMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_FexyStudiosMember_lbl" xml:lang="en-US">Fexy Studios [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdvertiserRelationshipsMember" xlink:label="AREN_AdvertiserRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AdvertiserRelationshipsMember" xlink:to="AREN_AdvertiserRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_AdvertiserRelationshipsMember_lbl" xml:lang="en-US">Advertiser Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BrandNamesMember" xlink:label="AREN_BrandNamesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BrandNamesMember" xlink:to="AREN_BrandNamesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BrandNamesMember_lbl" xml:lang="en-US">Brand Names [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_Disposition2023Member" xlink:label="AREN_Disposition2023Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_Disposition2023Member" xlink:to="AREN_Disposition2023Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_Disposition2023Member_lbl" xml:lang="en-US">Disposition 2023 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AthlonHoldingsIncMember" xlink:label="AREN_AthlonHoldingsIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AthlonHoldingsIncMember" xlink:to="AREN_AthlonHoldingsIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_AthlonHoldingsIncMember_lbl" xml:lang="en-US">Athlon Holdings Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalContentMember" xlink:label="AREN_DigitalContentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DigitalContentMember" xlink:to="AREN_DigitalContentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DigitalContentMember_lbl" xml:lang="en-US">Digital Content [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember" xlink:label="us-gaap_TradeNamesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeNamesMember" xlink:to="us-gaap_TradeNamesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeNamesMember_lbl" xml:lang="en-US">Trade Names [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BuffaloGroupeLLCMember" xlink:label="AREN_BuffaloGroupeLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BuffaloGroupeLLCMember" xlink:to="AREN_BuffaloGroupeLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BuffaloGroupeLLCMember_lbl" xml:lang="en-US">Buffalo Groupe LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_IntellectualPropertiesMember" xlink:label="AREN_IntellectualPropertiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_IntellectualPropertiesMember" xlink:to="AREN_IntellectualPropertiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_IntellectualPropertiesMember_lbl" xml:lang="en-US">Intellectual Properties [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MensJournalMember" xlink:label="AREN_MensJournalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_MensJournalMember" xlink:to="AREN_MensJournalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_MensJournalMember_lbl" xml:lang="en-US">Mens Journal [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_A360MediaLLCMember" xlink:label="AREN_A360MediaLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_A360MediaLLCMember" xlink:to="AREN_A360MediaLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_A360MediaLLCMember_lbl" xml:lang="en-US">A360 Media LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdvertiserRelationshipMember" xlink:label="AREN_AdvertiserRelationshipMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AdvertiserRelationshipMember" xlink:to="AREN_AdvertiserRelationshipMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_AdvertiserRelationshipMember_lbl" xml:lang="en-US">Advertiser Relationship [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BrandNameMember" xlink:label="AREN_BrandNameMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BrandNameMember" xlink:to="AREN_BrandNameMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BrandNameMember_lbl" xml:lang="en-US">Brand Name [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillMember" xlink:label="us-gaap_GoodwillMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillMember" xlink:to="us-gaap_GoodwillMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillMember_lbl" xml:lang="en-US">Goodwill [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ParadeMember" xlink:label="AREN_ParadeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ParadeMember" xlink:to="AREN_ParadeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ParadeMember_lbl" xml:lang="en-US">Parade [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ArenaMember" xlink:label="AREN_ArenaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ArenaMember" xlink:to="AREN_ArenaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ArenaMember_lbl" xml:lang="en-US">Arena [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdjustmentsMember" xlink:label="AREN_AdjustmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AdjustmentsMember" xlink:to="AREN_AdjustmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_AdjustmentsMember_lbl" xml:lang="en-US">Adjustments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xml:lang="en-US">Asset Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="us-gaap_PropertyPlantAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentMember" xlink:to="us-gaap_PropertyPlantAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SubleaseAgreementMember" xlink:label="AREN_SubleaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SubleaseAgreementMember" xlink:to="AREN_SubleaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SubleaseAgreementMember_lbl" xml:lang="en-US">Sublease Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LeaseArrangementMember" xlink:label="AREN_LeaseArrangementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LeaseArrangementMember" xlink:to="AREN_LeaseArrangementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LeaseArrangementMember_lbl" xml:lang="en-US">Lease Arrangement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateAxis" xlink:label="us-gaap_AwardDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateAxis_lbl" xml:lang="en-US">Award Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OctoberOneTwoThousandAndTwentyFourMember" xlink:label="AREN_OctoberOneTwoThousandAndTwentyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OctoberOneTwoThousandAndTwentyFourMember" xlink:to="AREN_OctoberOneTwoThousandAndTwentyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_OctoberOneTwoThousandAndTwentyFourMember_lbl" xml:lang="en-US">October One Two Thousand And Twenty Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessMembershipAgreementMember" xlink:label="AREN_BusinessMembershipAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessMembershipAgreementMember" xlink:to="AREN_BusinessMembershipAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BusinessMembershipAgreementMember_lbl" xml:lang="en-US">Business Membership Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MonthToMonthLeaseArrangementMember" xlink:label="AREN_MonthToMonthLeaseArrangementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_MonthToMonthLeaseArrangementMember" xlink:to="AREN_MonthToMonthLeaseArrangementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_MonthToMonthLeaseArrangementMember_lbl" xml:lang="en-US">Month To Month Lease Arrangement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PlatformDevelopmentMember" xlink:label="AREN_PlatformDevelopmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PlatformDevelopmentMember" xlink:to="AREN_PlatformDevelopmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PlatformDevelopmentMember_lbl" xml:lang="en-US">Platform Development [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DevelopedTechnologyMember" xlink:label="AREN_DevelopedTechnologyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DevelopedTechnologyMember" xlink:to="AREN_DevelopedTechnologyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DevelopedTechnologyMember_lbl" xml:lang="en-US">Developed Technology [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SubscriberRelationshipsMember" xlink:label="AREN_SubscriberRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SubscriberRelationshipsMember" xlink:to="AREN_SubscriberRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SubscriberRelationshipsMember_lbl" xml:lang="en-US">Subscriber Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DatabasesMember" xlink:label="us-gaap_DatabasesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DatabasesMember" xlink:to="us-gaap_DatabasesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DatabasesMember_lbl" xml:lang="en-US">Database Rights [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMember" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMember" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMember_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">Restricted Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FinancingAndSecurityAgreementMember" xlink:label="AREN_FinancingAndSecurityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FinancingAndSecurityAgreementMember" xlink:to="AREN_FinancingAndSecurityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_FinancingAndSecurityAgreementMember_lbl" xml:lang="en-US">Financing And Security Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SLRDigitalFinanceLLCMember" xlink:label="AREN_SLRDigitalFinanceLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SLRDigitalFinanceLLCMember" xlink:to="AREN_SLRDigitalFinanceLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SLRDigitalFinanceLLCMember_lbl" xml:lang="en-US">SLR Digital Finance LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyThreeNotesMember" xlink:label="AREN_TwoThousandTwentyThreeNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_TwoThousandTwentyThreeNotesMember" xlink:to="AREN_TwoThousandTwentyThreeNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_TwoThousandTwentyThreeNotesMember_lbl" xml:lang="en-US">2023 Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesLPreferredStockMember" xlink:label="AREN_SeriesLPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeriesLPreferredStockMember" xlink:to="AREN_SeriesLPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SeriesLPreferredStockMember_lbl" xml:lang="en-US">Series L Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityAxis_lbl" xml:lang="en-US">Lender Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MDBCommonStockToBeIssuedMember" xlink:label="AREN_MDBCommonStockToBeIssuedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_MDBCommonStockToBeIssuedMember" xlink:to="AREN_MDBCommonStockToBeIssuedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_MDBCommonStockToBeIssuedMember_lbl" xml:lang="en-US">MDB Common Stock To Be Issued [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ConvertibleDebenturesMember" xlink:label="AREN_ConvertibleDebenturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ConvertibleDebenturesMember" xlink:to="AREN_ConvertibleDebenturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ConvertibleDebenturesMember_lbl" xml:lang="en-US">Convertible Debentures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesJPreferredStockMember" xlink:label="AREN_SeriesJPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeriesJPreferredStockMember" xlink:to="AREN_SeriesJPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SeriesJPreferredStockMember_lbl" xml:lang="en-US">Series J Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesKPreferredStockMember" xlink:label="AREN_SeriesKPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeriesKPreferredStockMember" xlink:to="AREN_SeriesKPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SeriesKPreferredStockMember_lbl" xml:lang="en-US">Series K Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockPurchaseAgreementMember" xlink:label="AREN_StockPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockPurchaseAgreementMember" xlink:to="AREN_StockPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockPurchaseAgreementMember_lbl" xml:lang="en-US">Stock Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestorMember_lbl" xml:lang="en-US">Investor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyMember" xlink:label="AREN_BRileyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BRileyMember" xlink:to="AREN_BRileyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BRileyMember_lbl" xml:lang="en-US">B Riley [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FlexyStudiosMember" xlink:label="AREN_FlexyStudiosMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FlexyStudiosMember" xlink:to="AREN_FlexyStudiosMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_FlexyStudiosMember_lbl" xml:lang="en-US">Flexy Studios [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis_lbl" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PutOptionMember" xlink:label="us-gaap_PutOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PutOptionMember" xlink:to="us-gaap_PutOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PutOptionMember_lbl" xml:lang="en-US">Put Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosAcquistionMember" xlink:label="AREN_FexyStudiosAcquistionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FexyStudiosAcquistionMember" xlink:to="AREN_FexyStudiosAcquistionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_FexyStudiosAcquistionMember_lbl" xml:lang="en-US">Fexy Studios Acquistion [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ContingentConsiderationMember" xlink:label="AREN_ContingentConsiderationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ContingentConsiderationMember" xlink:to="AREN_ContingentConsiderationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ContingentConsiderationMember_lbl" xml:lang="en-US">Contingent Consideration [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeniorSecuredNoteMember" xlink:label="AREN_SeniorSecuredNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeniorSecuredNoteMember" xlink:to="AREN_SeniorSecuredNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SeniorSecuredNoteMember_lbl" xml:lang="en-US">Senior Secured Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BridgeNotesMember" xlink:label="AREN_BridgeNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BridgeNotesMember" xlink:to="AREN_BridgeNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BridgeNotesMember_lbl" xml:lang="en-US">Bridge Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoBridgeNotesMember" xlink:label="AREN_TwoThousandTwentyTwoBridgeNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_TwoThousandTwentyTwoBridgeNotesMember" xlink:to="AREN_TwoThousandTwentyTwoBridgeNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_TwoThousandTwentyTwoBridgeNotesMember_lbl" xml:lang="en-US">2022 Bridge Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DelayedDrawTermNotesMember" xlink:label="AREN_DelayedDrawTermNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DelayedDrawTermNotesMember" xlink:to="AREN_DelayedDrawTermNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DelayedDrawTermNotesMember_lbl" xml:lang="en-US">Delayed Draw Term Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PurchaseAgreementMember" xlink:label="AREN_PurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PurchaseAgreementMember" xlink:to="AREN_PurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PurchaseAgreementMember_lbl" xml:lang="en-US">Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DelayedDrawTermNoteMember" xlink:label="AREN_DelayedDrawTermNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DelayedDrawTermNoteMember" xlink:to="AREN_DelayedDrawTermNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_DelayedDrawTermNoteMember_lbl" xml:lang="en-US">Delayed Draw Term Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember" xlink:label="us-gaap_LineOfCreditMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditMember" xlink:to="us-gaap_LineOfCreditMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditMember_lbl" xml:lang="en-US">Line of Credit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeniorSecuredNotesMember" xlink:label="AREN_SeniorSecuredNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeniorSecuredNotesMember" xlink:to="AREN_SeniorSecuredNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SeniorSecuredNotesMember_lbl" xml:lang="en-US">Senior Secured Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LineOfCreditTerminationFeeMember" xlink:label="AREN_LineOfCreditTerminationFeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LineOfCreditTerminationFeeMember" xlink:to="AREN_LineOfCreditTerminationFeeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LineOfCreditTerminationFeeMember_lbl" xml:lang="en-US">Line Of Credit Termination Fee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OtherAccruedInterestMember" xlink:label="AREN_OtherAccruedInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OtherAccruedInterestMember" xlink:to="AREN_OtherAccruedInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_OtherAccruedInterestMember_lbl" xml:lang="en-US">Other Accrued Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesGPreferredStockMember" xlink:label="us-gaap_SeriesGPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesGPreferredStockMember" xlink:to="us-gaap_SeriesGPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesGPreferredStockMember_lbl" xml:lang="en-US">Series G Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OriginalInvestorMember" xlink:label="AREN_OriginalInvestorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OriginalInvestorMember" xlink:to="AREN_OriginalInvestorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_OriginalInvestorMember_lbl" xml:lang="en-US">Original Investor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockPurchaseAgreementsMember" xlink:label="AREN_StockPurchaseAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockPurchaseAgreementsMember" xlink:to="AREN_StockPurchaseAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockPurchaseAgreementsMember_lbl" xml:lang="en-US">Stock Purchase Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PurchasersMember" xlink:label="AREN_PurchasersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PurchasersMember" xlink:to="AREN_PurchasersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PurchasersMember_lbl" xml:lang="en-US">Purchasers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosAcquisitionMember" xlink:label="AREN_FexyStudiosAcquisitionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FexyStudiosAcquisitionMember" xlink:to="AREN_FexyStudiosAcquisitionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_FexyStudiosAcquisitionMember_lbl" xml:lang="en-US">Fexy Studios Acquisition [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AssetPurchaseAgreementMember" xlink:label="AREN_AssetPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AssetPurchaseAgreementMember" xlink:to="AREN_AssetPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_AssetPurchaseAgreementMember_lbl" xml:lang="en-US">Asset Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ParadeStockMember" xlink:label="AREN_ParadeStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ParadeStockMember" xlink:to="AREN_ParadeStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ParadeStockMember_lbl" xml:lang="en-US">Parade Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeveralStockPurchaseAgreementsMember" xlink:label="AREN_SeveralStockPurchaseAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeveralStockPurchaseAgreementsMember" xlink:to="AREN_SeveralStockPurchaseAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SeveralStockPurchaseAgreementsMember_lbl" xml:lang="en-US">Several Stock Purchase Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeveralInvestorsMember" xlink:label="AREN_SeveralInvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeveralInvestorsMember" xlink:to="AREN_SeveralInvestorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SeveralInvestorsMember_lbl" xml:lang="en-US">Several Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EmployeesMember" xlink:label="AREN_EmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EmployeesMember" xlink:to="AREN_EmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_EmployeesMember_lbl" xml:lang="en-US">Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedCommonStockMember" xlink:label="AREN_RestrictedCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RestrictedCommonStockMember" xlink:to="AREN_RestrictedCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_RestrictedCommonStockMember_lbl" xml:lang="en-US">Restricted Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExerciseOfStockOptionMember" xlink:label="AREN_ExerciseOfStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExerciseOfStockOptionMember" xlink:to="AREN_ExerciseOfStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ExerciseOfStockOptionMember_lbl" xml:lang="en-US">Exercise Of Stock Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ServicesAgreementMember" xlink:label="AREN_ServicesAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ServicesAgreementMember" xlink:to="AREN_ServicesAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ServicesAgreementMember_lbl" xml:lang="en-US">Services Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UnderwritingPublicOfferingMember" xlink:label="AREN_UnderwritingPublicOfferingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_UnderwritingPublicOfferingMember" xlink:to="AREN_UnderwritingPublicOfferingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_UnderwritingPublicOfferingMember_lbl" xml:lang="en-US">Underwriting Public Offering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UnderwritingOverallotmentMember" xlink:label="AREN_UnderwritingOverallotmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_UnderwritingOverallotmentMember" xlink:to="AREN_UnderwritingOverallotmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_UnderwritingOverallotmentMember_lbl" xml:lang="en-US">Underwriting Overallotment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MDBCapitalGroupLLCMember" xlink:label="AREN_MDBCapitalGroupLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_MDBCapitalGroupLLCMember" xlink:to="AREN_MDBCapitalGroupLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_MDBCapitalGroupLLCMember_lbl" xml:lang="en-US">MDB Capital Group LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarransMember" xlink:label="AREN_ABGWarransMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ABGWarransMember" xlink:to="AREN_ABGWarransMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ABGWarransMember_lbl" xml:lang="en-US">ABG Warrans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGTimeBasedWarrantsMember" xlink:label="AREN_ABGTimeBasedWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ABGTimeBasedWarrantsMember" xlink:to="AREN_ABGTimeBasedWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ABGTimeBasedWarrantsMember_lbl" xml:lang="en-US">ABG Time Based Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGPerformanceBasedWarrantsMember" xlink:label="AREN_ABGPerformanceBasedWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ABGPerformanceBasedWarrantsMember" xlink:to="AREN_ABGPerformanceBasedWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ABGPerformanceBasedWarrantsMember_lbl" xml:lang="en-US">ABG Performance Based Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NewPublisherPartnerWarrantsMember" xlink:label="AREN_NewPublisherPartnerWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_NewPublisherPartnerWarrantsMember" xlink:to="AREN_NewPublisherPartnerWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_NewPublisherPartnerWarrantsMember_lbl" xml:lang="en-US">New Publisher Partner Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockFinancingWarrantMember" xlink:label="AREN_CommonStockFinancingWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CommonStockFinancingWarrantMember" xlink:to="AREN_CommonStockFinancingWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_CommonStockFinancingWarrantMember_lbl" xml:lang="en-US">Common Stock Financing Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoPlanMember" xlink:label="AREN_TwoThousandTwentyTwoPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_TwoThousandTwentyTwoPlanMember" xlink:to="AREN_TwoThousandTwentyTwoPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_TwoThousandTwentyTwoPlanMember_lbl" xml:lang="en-US">2022 Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SportsIllustratedLicensingAgreementMember" xlink:label="AREN_SportsIllustratedLicensingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SportsIllustratedLicensingAgreementMember" xlink:to="AREN_SportsIllustratedLicensingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SportsIllustratedLicensingAgreementMember_lbl" xml:lang="en-US">Sports Illustrated Licensing Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PublisherPartnerWarrantProgramMember" xlink:label="AREN_PublisherPartnerWarrantProgramMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PublisherPartnerWarrantProgramMember" xlink:to="AREN_PublisherPartnerWarrantProgramMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PublisherPartnerWarrantProgramMember_lbl" xml:lang="en-US">Publisher Partner Warrant Program [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NewPublisherPartnerWarrantMember" xlink:label="AREN_NewPublisherPartnerWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_NewPublisherPartnerWarrantMember" xlink:to="AREN_NewPublisherPartnerWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_NewPublisherPartnerWarrantMember_lbl" xml:lang="en-US">New Publisher Partner Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedStockUnitsMember" xlink:label="AREN_RestrictedStockUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RestrictedStockUnitsMember" xlink:to="AREN_RestrictedStockUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_RestrictedStockUnitsMember_lbl" xml:lang="en-US">Restricted Stock Units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonEquityAwardsMember" xlink:label="AREN_CommonEquityAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CommonEquityAwardsMember" xlink:to="AREN_CommonEquityAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_CommonEquityAwardsMember_lbl" xml:lang="en-US">Common Equity Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockAwardsMember" xlink:label="AREN_CommonStockAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CommonStockAwardsMember" xlink:to="AREN_CommonStockAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_CommonStockAwardsMember_lbl" xml:lang="en-US">Common Stock Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BlackScholesOptionPricingModelMember" xlink:label="AREN_BlackScholesOptionPricingModelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BlackScholesOptionPricingModelMember" xlink:to="AREN_BlackScholesOptionPricingModelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BlackScholesOptionPricingModelMember_lbl" xml:lang="en-US">Black-Scholes Option Pricing Model [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UpListMember" xlink:label="AREN_UpListMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_UpListMember" xlink:to="AREN_UpListMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_UpListMember_lbl" xml:lang="en-US">Up-List [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NoUpListMember" xlink:label="AREN_NoUpListMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_NoUpListMember" xlink:to="AREN_NoUpListMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_NoUpListMember_lbl" xml:lang="en-US">No Up-List [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeOneMember" xlink:label="AREN_ExercisePriceRangeOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExercisePriceRangeOneMember" xlink:to="AREN_ExercisePriceRangeOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ExercisePriceRangeOneMember_lbl" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeTwoMember" xlink:label="AREN_ExercisePriceRangeTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExercisePriceRangeTwoMember" xlink:to="AREN_ExercisePriceRangeTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ExercisePriceRangeTwoMember_lbl" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeThreeMember" xlink:label="AREN_ExercisePriceRangeThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExercisePriceRangeThreeMember" xlink:to="AREN_ExercisePriceRangeThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ExercisePriceRangeThreeMember_lbl" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeFourMember" xlink:label="AREN_ExercisePriceRangeFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExercisePriceRangeFourMember" xlink:to="AREN_ExercisePriceRangeFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ExercisePriceRangeFourMember_lbl" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeFiveMember" xlink:label="AREN_ExercisePriceRangeFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExercisePriceRangeFiveMember" xlink:to="AREN_ExercisePriceRangeFiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ExercisePriceRangeFiveMember_lbl" xml:lang="en-US">Exercise Price Range Five [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeSixMember" xlink:label="AREN_ExercisePriceRangeSixMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExercisePriceRangeSixMember" xlink:to="AREN_ExercisePriceRangeSixMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ExercisePriceRangeSixMember_lbl" xml:lang="en-US">Exercise Price Range Six [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeSevenMember" xlink:label="AREN_ExercisePriceRangeSevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExercisePriceRangeSevenMember" xlink:to="AREN_ExercisePriceRangeSevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ExercisePriceRangeSevenMember_lbl" xml:lang="en-US">Exercise Price Range Seven [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeEightMember" xlink:label="AREN_ExercisePriceRangeEightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExercisePriceRangeEightMember" xlink:to="AREN_ExercisePriceRangeEightMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ExercisePriceRangeEightMember_lbl" xml:lang="en-US">Exercise Price Range Eight [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockBasedCompensationMember" xlink:label="AREN_StockBasedCompensationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockBasedCompensationMember" xlink:to="AREN_StockBasedCompensationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockBasedCompensationMember_lbl" xml:lang="en-US">Stock Based Compensation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StateMember" xlink:label="AREN_StateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StateMember" xlink:to="AREN_StateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StateMember_lbl" xml:lang="en-US">State [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LocalJurisdictionMember" xlink:label="AREN_LocalJurisdictionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LocalJurisdictionMember" xlink:to="AREN_LocalJurisdictionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LocalJurisdictionMember_lbl" xml:lang="en-US">Local [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_USFederalTaxMember" xlink:label="AREN_USFederalTaxMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_USFederalTaxMember" xlink:to="AREN_USFederalTaxMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_USFederalTaxMember_lbl" xml:lang="en-US">U.S Federal Tax [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DirectOfferingMember" xlink:label="AREN_DirectOfferingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DirectOfferingMember" xlink:to="AREN_DirectOfferingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DirectOfferingMember_lbl" xml:lang="en-US">Direct Offering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyFinancialIncMember" xlink:label="AREN_BRileyFinancialIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BRileyFinancialIncMember" xlink:to="AREN_BRileyFinancialIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BRileyFinancialIncMember_lbl" xml:lang="en-US">BRiley Financial Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_HHuntAllredMember" xlink:label="AREN_HHuntAllredMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_HHuntAllredMember" xlink:to="AREN_HHuntAllredMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_HHuntAllredMember_lbl" xml:lang="en-US">H Hunt Allred [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AllredTrustHHAMember" xlink:label="AREN_AllredTrustHHAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AllredTrustHHAMember" xlink:to="AREN_AllredTrustHHAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_AllredTrustHHAMember_lbl" xml:lang="en-US">Allred Trust HHA [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AllredTrustNLAMember" xlink:label="AREN_AllredTrustNLAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AllredTrustNLAMember" xlink:to="AREN_AllredTrustNLAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_AllredTrustNLAMember_lbl" xml:lang="en-US">Allred Trust NLA [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OneEightyDegreeCapitalCorpMember" xlink:label="AREN_OneEightyDegreeCapitalCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OneEightyDegreeCapitalCorpMember" xlink:to="AREN_OneEightyDegreeCapitalCorpMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_OneEightyDegreeCapitalCorpMember_lbl" xml:lang="en-US">One Eighty Degree Capital Corp [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DanielShribmanMember" xlink:label="AREN_DanielShribmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DanielShribmanMember" xlink:to="AREN_DanielShribmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DanielShribmanMember_lbl" xml:lang="en-US">Daniel Shribman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RossLevinsohnMember" xlink:label="AREN_RossLevinsohnMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RossLevinsohnMember" xlink:to="AREN_RossLevinsohnMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_RossLevinsohnMember_lbl" xml:lang="en-US">Ross Levinsohn [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PaulEdmonsonMember" xlink:label="AREN_PaulEdmonsonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PaulEdmonsonMember" xlink:to="AREN_PaulEdmonsonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PaulEdmonsonMember_lbl" xml:lang="en-US">Paul Edmonson [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MrEdmonsonMember" xlink:label="AREN_MrEdmonsonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_MrEdmonsonMember" xlink:to="AREN_MrEdmonsonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_MrEdmonsonMember_lbl" xml:lang="en-US">Mr. Edmonson [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGSILLCMember" xlink:label="AREN_ABGSILLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ABGSILLCMember" xlink:to="AREN_ABGSILLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ABGSILLCMember_lbl" xml:lang="en-US">ABG-SI, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ArenaLoanAgreementMember" xlink:label="AREN_ArenaLoanAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ArenaLoanAgreementMember" xlink:to="AREN_ArenaLoanAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ArenaLoanAgreementMember_lbl" xml:lang="en-US">Arena Loan Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LicensingAgreementMember" xlink:label="AREN_LicensingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LicensingAgreementMember" xlink:to="AREN_LicensingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LicensingAgreementMember_lbl" xml:lang="en-US">Licensing Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TransactionAgreementMember" xlink:label="AREN_TransactionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_TransactionAgreementMember" xlink:to="AREN_TransactionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_TransactionAgreementMember_lbl" xml:lang="en-US">Transaction Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SubscriptionAgreementMember" xlink:label="AREN_SubscriptionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SubscriptionAgreementMember" xlink:to="AREN_SubscriptionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SubscriptionAgreementMember_lbl" xml:lang="en-US">Subscription Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SimplyfyLoanMember" xlink:label="AREN_SimplyfyLoanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SimplyfyLoanMember" xlink:to="AREN_SimplyfyLoanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SimplyfyLoanMember_lbl" xml:lang="en-US">Simplyfy Loan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MembersOfBoardMember" xlink:label="AREN_MembersOfBoardMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_MembersOfBoardMember" xlink:to="AREN_MembersOfBoardMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_MembersOfBoardMember_lbl" xml:lang="en-US">Members Of Board [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FormerEmployeesMember" xlink:label="AREN_FormerEmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FormerEmployeesMember" xlink:to="AREN_FormerEmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_FormerEmployeesMember_lbl" xml:lang="en-US">Former Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xml:lang="en-US">Restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetCurrent" xlink:label="us-gaap_CapitalizedContractCostNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostNetCurrent" xlink:to="us-gaap_CapitalizedContractCostNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedContractCostNetCurrent_lbl" xml:lang="en-US">Subscription acquisition costs, current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepayments and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PlatformDevelopmentNet" xlink:label="AREN_PlatformDevelopmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PlatformDevelopmentNet" xlink:to="AREN_PlatformDevelopmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PlatformDevelopmentNet_lbl" xml:lang="en-US">Platform development, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetNoncurrent" xlink:label="us-gaap_CapitalizedContractCostNetNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostNetNoncurrent" xlink:to="us-gaap_CapitalizedContractCostNetNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedContractCostNetNoncurrent_lbl" xml:lang="en-US">Subscription acquisition costs, net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="us-gaap_OtherIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsNet_lbl" xml:lang="en-US">Acquired and other intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other long-term assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities, mezzanine equity and stockholders&#8217; deficiency</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LinesOfCreditCurrent" xlink:to="us-gaap_LinesOfCreditCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LinesOfCreditCurrent_lbl" xml:lang="en-US">Line of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Unearned revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerRefundLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerRefundLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerRefundLiabilityCurrent_lbl" xml:lang="en-US">Subscription refund liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:to="us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent_lbl" xml:lang="en-US">Contingent consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableCurrent" xlink:label="AREN_LiquidatedDamagesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPayableCurrent" xlink:to="AREN_LiquidatedDamagesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LiquidatedDamagesPayableCurrent_lbl" xml:lang="en-US">Liquidated damages payable</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BridgeNotes" xlink:label="AREN_BridgeNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BridgeNotes" xlink:to="AREN_BridgeNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BridgeNotes_lbl" xml:lang="en-US">Bridge notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xml:lang="en-US">Unearned revenue, net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability, net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatingDamagesPayableNonCurrent" xlink:label="AREN_LiquidatingDamagesPayableNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatingDamagesPayableNonCurrent" xlink:to="AREN_LiquidatingDamagesPayableNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LiquidatingDamagesPayableNonCurrent_lbl" xml:lang="en-US">Liquidating damages payable, net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Note 27)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAbstract_lbl" xml:lang="en-US">Mezzanine equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US">Total mezzanine equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; deficiency:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.01 par value, authorized 1,000,000,000 shares: issued and outstanding; 23,836,706 and 18,303,193 shares December 31, 2023 and 2022, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockToBeIssuedDuringPeriod" xlink:label="AREN_CommonStockToBeIssuedDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CommonStockToBeIssuedDuringPeriod" xlink:to="AREN_CommonStockToBeIssuedDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_CommonStockToBeIssuedDuringPeriod_lbl" xml:lang="en-US">Common stock to be issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; deficiency</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities, mezzanine equity and stockholders&#8217; deficiency</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US">Temporary equity, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:label="us-gaap_TemporaryEquityLiquidationPreferencePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:to="us-gaap_TemporaryEquityLiquidationPreferencePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityLiquidationPreferencePerShare_lbl" xml:lang="en-US">Temporary equity, liquidation preference per share value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US">Temporary equity, shares designated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreference" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xml:lang="en-US">Temporary equity, liquidation preference value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US">Temporary equity, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US">Temporary equity, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TemporaryEquityCommonSharesIssuableUponConversion" xlink:label="AREN_TemporaryEquityCommonSharesIssuableUponConversion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_TemporaryEquityCommonSharesIssuableUponConversion" xlink:to="AREN_TemporaryEquityCommonSharesIssuableUponConversion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_TemporaryEquityCommonSharesIssuableUponConversion_lbl" xml:lang="en-US">Temporary equity, common shares issuable upon conversion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenue (includes amortization for developed technology and platform development for 2023 and 2022 of $8,782 and $9,459, respectively)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Selling and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xml:lang="en-US">Loss on impairment of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LossOnSaleOfAssets" xlink:label="AREN_LossOnSaleOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LossOnSaleOfAssets" xlink:to="AREN_LossOnSaleOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LossOnSaleOfAssets_lbl" xml:lang="en-US">Loss on sale of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xml:lang="en-US">Change in valuation of contingent consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense, net</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesUnderRegistrationRightsAgreements" xlink:label="AREN_LiquidatedDamagesUnderRegistrationRightsAgreements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesUnderRegistrationRightsAgreements" xlink:to="AREN_LiquidatedDamagesUnderRegistrationRightsAgreements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LiquidatedDamagesUnderRegistrationRightsAgreements_lbl" xml:lang="en-US">Liquidated damages</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax (provision) benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">Loss from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_lbl" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="us-gaap_EarningsPerShareBasicAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_EarningsPerShareBasicAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAbstract_lbl" xml:lang="en-US">Basic and diluted net loss per common share:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xml:lang="en-US">Continuing operations - Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xml:lang="en-US">Continuing operations - Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" xml:lang="en-US">Discontinued operations - Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_lbl" xml:lang="en-US">Discontinued operations - Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic net loss per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted net loss per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average number of common shares outstanding - Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average number of common shares outstanding - Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:label="us-gaap_CostOfGoodsAndServicesSoldAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="us-gaap_CostOfGoodsAndServicesSoldAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSoldAmortization_lbl" xml:lang="en-US">Amortization cost of developed technology and platform development</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" xlink:label="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" xlink:to="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering_lbl" xml:lang="en-US">Issuance of common stock in connection with registered direct offering</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" xlink:label="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" xlink:to="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering_lbl" xml:lang="en-US">Issuance of common stock in connection with registered direct offering, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Issuance of common stock upon conversion of series H preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Issuance of common stock upon conversion of series H preferred stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne" xlink:label="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne" xlink:to="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne_lbl" xml:lang="en-US">Issuance of common stock in connection with the acquisition of Fexy Studios</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne" xlink:label="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne" xlink:to="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne_lbl" xml:lang="en-US">Issuance of common stock in connection with the acquisition of Fexy Studios, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" xlink:label="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" xlink:to="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_lbl" xml:lang="en-US">Issuance of common stock in connection with settlement of liquidated damages</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares" xlink:label="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares" xlink:to="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares_lbl" xml:lang="en-US">Issuance of common stock in connection with settlement of liquidated damages, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" xlink:label="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" xlink:to="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_lbl" xml:lang="en-US">Gain upon issuance of common stock in connection with settlement of liquidated damages</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US">Issuance of common stock for restricted stock units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Issuance of common stock for restricted stock units, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" xlink:label="AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" xlink:to="AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes_lbl" xml:lang="en-US">Common stock withheld for taxes upon issuance of underlying shares for restricted stock units</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares" xlink:label="AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares" xlink:to="AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares_lbl" xml:lang="en-US">Common stock withheld for taxes, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Issuance of common stock in connection with the exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Issuance of common stock in connection with the exercise of stock options, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Issuance of stock in connection with acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Issuance of common stock in connection with acquisition, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Reclassification to liability upon modification of common stock option</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" xlink:label="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" xlink:to="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages_lbl" xml:lang="en-US">Gain upon forgiveness of liquidated damages with principal stockholder</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger" xlink:label="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger" xlink:to="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger_lbl" xml:lang="en-US">Issuance of stock in connection with the merger of Say Media</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" xlink:label="AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" xlink:to="AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_lbl" xml:lang="en-US">Issuance of common stock in connection with the merger of SayMedia, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Issuance of common stock in connection with professional services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Issuance of common stock in connection with professional services, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes" xlink:label="AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes" xlink:to="AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes_lbl" xml:lang="en-US">Common stock withheld for taxes upon issuance of underlying shares for restricted stock units, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Repurchase restricted stock awards in connection with HubPages merger</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Repurchase restricted stock awards in connection with HubPages merger, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of common stock in connection with public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of common stock in connection with public offering, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of platform development and intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US">Amortization of debt costs</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NoncashAndAccruedInterest" xlink:label="AREN_NoncashAndAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_NoncashAndAccruedInterest" xlink:to="AREN_NoncashAndAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AREN_NoncashAndAccruedInterest_lbl" xml:lang="en-US">Noncash and accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:to="us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_lbl" xml:lang="en-US">Loss on impairment of assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_2_lbl" xml:lang="en-US">Change in valuation of contingent consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatingDamagesPayable" xlink:label="AREN_LiquidatingDamagesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatingDamagesPayable" xlink:to="AREN_LiquidatingDamagesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_LiquidatingDamagesPayable_lbl" xml:lang="en-US">Liquidated damages</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits_lbl" xml:lang="en-US">Deferred income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Bad debt expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="us-gaap_OtherOperatingActivitiesCashFlowStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Change in operating assets and liabilities net of effect of acquisitions:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts" xlink:label="AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts" xlink:to="AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts_lbl" xml:lang="en-US">Subscription acquisition costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidRoyalties" xlink:label="us-gaap_IncreaseDecreaseInPrepaidRoyalties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidRoyalties" xlink:to="us-gaap_IncreaseDecreaseInPrepaidRoyalties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidRoyalties_lbl" xml:lang="en-US">Royalty fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepayments and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other long-term assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Unearned revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_IncreaseDecreaseInSubscriptionRefundLiability" xlink:label="AREN_IncreaseDecreaseInSubscriptionRefundLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_IncreaseDecreaseInSubscriptionRefundLiability" xlink:to="AREN_IncreaseDecreaseInSubscriptionRefundLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_IncreaseDecreaseInSubscriptionRefundLiability_lbl" xml:lang="en-US">Subscription refund liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xml:lang="en-US">Other long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PaymentsForCapitalizedPlatformDevelopment" xlink:label="AREN_PaymentsForCapitalizedPlatformDevelopment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PaymentsForCapitalizedPlatformDevelopment" xlink:to="AREN_PaymentsForCapitalizedPlatformDevelopment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AREN_PaymentsForCapitalizedPlatformDevelopment_lbl" xml:lang="en-US">Capitalized platform development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" xml:lang="en-US">Proceeds from sale of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="us-gaap_ProceedsFromSaleOfEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="us-gaap_ProceedsFromSaleOfEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfEquityMethodInvestments_lbl" xml:lang="en-US">Proceeds from sale of equity investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xml:lang="en-US">Payments for acquisitions, net of cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="us-gaap_ProceedsFromShortTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromShortTermDebt" xlink:to="us-gaap_ProceedsFromShortTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromShortTermDebt_lbl" xml:lang="en-US">Proceeds from bridge notes, net of debt costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US">Payments of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US">Proceeds, net of repayments, under line of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Proceeds from common stock public offering, net of offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Payments of issuance costs from common stock public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US">Payments of debt issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of common stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PaymentOfDeferredCashPayment" xlink:label="AREN_PaymentOfDeferredCashPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PaymentOfDeferredCashPayment" xlink:to="AREN_PaymentOfDeferredCashPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AREN_PaymentOfDeferredCashPayment_lbl" xml:lang="en-US">Payment of deferred cash payment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xml:lang="en-US">Payment for taxes related to common stock withheld for taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PaymentOfRestrictedStockLiabilities" xlink:label="AREN_PaymentOfRestrictedStockLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PaymentOfRestrictedStockLiabilities" xlink:to="AREN_PaymentOfRestrictedStockLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AREN_PaymentOfRestrictedStockLiabilities_lbl" xml:lang="en-US">Payment of restricted stock liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net (decrease) increase in cash, cash equivalents, and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash, cash equivalents, and restricted cash &#8211; beginning of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash, cash equivalents, and restricted cash &#8211; end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xml:lang="en-US">Cash, cash equivalents, and restricted cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_RestrictedCash_lbl" xml:lang="en-US">Restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Total cash, cash equivalents, and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flow information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Cash paid for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Noncash investing and financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ReclassificationOfStockbasedCompensationToPlatformDevelopment" xlink:label="AREN_ReclassificationOfStockbasedCompensationToPlatformDevelopment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ReclassificationOfStockbasedCompensationToPlatformDevelopment" xlink:to="AREN_ReclassificationOfStockbasedCompensationToPlatformDevelopment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ReclassificationOfStockbasedCompensationToPlatformDevelopment_lbl" xml:lang="en-US">Reclassification of stock-based compensation to platform development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_lbl" xml:lang="en-US">Debt costs recorded in accrued expenses and other and in other long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="us-gaap_ConversionOfStockAmountIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountIssued1" xlink:to="us-gaap_ConversionOfStockAmountIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountIssued1_lbl" xml:lang="en-US">Issuance of common stock upon conversion of Series H convertible preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US">Issuance of common stock in connection with settlement of liquidated damages</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_IssuanceOfCommonStockInConnectionWithAcquisition" xlink:label="AREN_IssuanceOfCommonStockInConnectionWithAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_IssuanceOfCommonStockInConnectionWithAcquisition" xlink:to="AREN_IssuanceOfCommonStockInConnectionWithAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_IssuanceOfCommonStockInConnectionWithAcquisition_lbl" xml:lang="en-US">Issuance of common stock in connection with an acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredCashPaymentsRecordedInConnectionWithAcquisitions" xlink:label="AREN_DeferredCashPaymentsRecordedInConnectionWithAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredCashPaymentsRecordedInConnectionWithAcquisitions" xlink:to="AREN_DeferredCashPaymentsRecordedInConnectionWithAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DeferredCashPaymentsRecordedInConnectionWithAcquisitions_lbl" xml:lang="en-US">Deferred cash payments recorded in connection with acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_lbl" xml:lang="en-US">Assumption of liabilities in connection with acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ReclassificationToLiabilityUponCommonStockModification" xlink:label="AREN_ReclassificationToLiabilityUponCommonStockModification" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ReclassificationToLiabilityUponCommonStockModification" xlink:to="AREN_ReclassificationToLiabilityUponCommonStockModification_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ReclassificationToLiabilityUponCommonStockModification_lbl" xml:lang="en-US">Reclassification to liability upon common stock modification</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">Organization and Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureDiscontinuedOperationsAbstract" xlink:label="AREN_DisclosureDiscontinuedOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisclosureDiscontinuedOperationsAbstract" xlink:to="AREN_DisclosureDiscontinuedOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DisclosureDiscontinuedOperationsAbstract_lbl" xml:lang="en-US">Discontinued Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DiscontinuedOperationsTextBlock" xlink:label="AREN_DiscontinuedOperationsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DiscontinuedOperationsTextBlock" xlink:to="AREN_DiscontinuedOperationsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_DiscontinuedOperationsTextBlock_lbl" xml:lang="en-US">Discontinued Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">Acquisitions and Dispositions</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:label="AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:to="AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract_lbl" xml:lang="en-US">Prepayments And Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrepaymentsAndOtherCurrentAssetsTextBlock" xlink:label="AREN_PrepaymentsAndOtherCurrentAssetsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PrepaymentsAndOtherCurrentAssetsTextBlock" xlink:to="AREN_PrepaymentsAndOtherCurrentAssetsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PrepaymentsAndOtherCurrentAssetsTextBlock_lbl" xml:lang="en-US">Prepayments and Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureLeasesAbstract" xlink:label="AREN_DisclosureLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisclosureLeasesAbstract" xlink:to="AREN_DisclosureLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DisclosureLeasesAbstract_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosurePlatformDevelopmentAbstract" xlink:label="AREN_DisclosurePlatformDevelopmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisclosurePlatformDevelopmentAbstract" xlink:to="AREN_DisclosurePlatformDevelopmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DisclosurePlatformDevelopmentAbstract_lbl" xml:lang="en-US">Platform Development</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PlatformDevelopmentDisclosureTextBlock" xlink:label="AREN_PlatformDevelopmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PlatformDevelopmentDisclosureTextBlock" xlink:to="AREN_PlatformDevelopmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_PlatformDevelopmentDisclosureTextBlock_lbl" xml:lang="en-US">Platform Development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsDisclosureTextBlock" xlink:label="us-gaap_OtherAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsDisclosureTextBlock" xlink:to="us-gaap_OtherAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Other Long-Term Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="us-gaap_GoodwillDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillDisclosureTextBlock_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureRestrictedStockLiabilitiesAbstract" xlink:label="AREN_DisclosureRestrictedStockLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisclosureRestrictedStockLiabilitiesAbstract" xlink:to="AREN_DisclosureRestrictedStockLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DisclosureRestrictedStockLiabilitiesAbstract_lbl" xml:lang="en-US">Restricted Stock Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedStockLiabilitiesTextBlock" xlink:label="AREN_RestrictedStockLiabilitiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RestrictedStockLiabilitiesTextBlock" xlink:to="AREN_RestrictedStockLiabilitiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_RestrictedStockLiabilitiesTextBlock_lbl" xml:lang="en-US">Restricted Stock Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accrued Expenses and Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Line of Credit</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureLiquidatedDamagesPayableAbstract" xlink:label="AREN_DisclosureLiquidatedDamagesPayableAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisclosureLiquidatedDamagesPayableAbstract" xlink:to="AREN_DisclosureLiquidatedDamagesPayableAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DisclosureLiquidatedDamagesPayableAbstract_lbl" xml:lang="en-US">Liquidated Damages Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableTextBlock" xlink:label="AREN_LiquidatedDamagesPayableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPayableTextBlock" xlink:to="AREN_LiquidatedDamagesPayableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_LiquidatedDamagesPayableTextBlock_lbl" xml:lang="en-US">Liquidated Damages Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureOtherLongtermLiabilitiesAbstract" xlink:label="AREN_DisclosureOtherLongtermLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisclosureOtherLongtermLiabilitiesAbstract" xlink:to="AREN_DisclosureOtherLongtermLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DisclosureOtherLongtermLiabilitiesAbstract_lbl" xml:lang="en-US">Other Long-term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OtherLongtermLiabilitiesTextBlock" xlink:label="AREN_OtherLongtermLiabilitiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OtherLongtermLiabilitiesTextBlock" xlink:to="AREN_OtherLongtermLiabilitiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_OtherLongtermLiabilitiesTextBlock_lbl" xml:lang="en-US">Other Long-term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Fair Value Measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="us-gaap_ShortTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTextBlock" xlink:to="us-gaap_ShortTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTextBlock_lbl" xml:lang="en-US">Bridge Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">Long-term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockTextBlock" xlink:label="us-gaap_PreferredStockTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xml:lang="en-US">Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders&#8217; Deficiency</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Stock&#8211;Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureLiquidatedDamagesAbstract" xlink:label="AREN_DisclosureLiquidatedDamagesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisclosureLiquidatedDamagesAbstract" xlink:to="AREN_DisclosureLiquidatedDamagesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DisclosureLiquidatedDamagesAbstract_lbl" xml:lang="en-US">Liquidated Damages</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatingDamagesPayableDisclosureTextBlock" xlink:label="AREN_LiquidatingDamagesPayableDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatingDamagesPayableDisclosureTextBlock" xlink:to="AREN_LiquidatingDamagesPayableDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_LiquidatingDamagesPayableDisclosureTextBlock_lbl" xml:lang="en-US">Liquidated Damages</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xml:lang="en-US">Pension Plans</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RisksAndUncertaintiesPolicy" xlink:label="AREN_RisksAndUncertaintiesPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RisksAndUncertaintiesPolicy" xlink:to="AREN_RisksAndUncertaintiesPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_RisksAndUncertaintiesPolicy_lbl" xml:lang="en-US">Risks and Uncertainties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Segment Reporting</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CostOfRevenuePolicyTextBlock" xlink:label="AREN_CostOfRevenuePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CostOfRevenuePolicyTextBlock" xlink:to="AREN_CostOfRevenuePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_CostOfRevenuePolicyTextBlock_lbl" xml:lang="en-US">Cost of Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ContractBalancesPolicyTextBlock" xlink:label="AREN_ContractBalancesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ContractBalancesPolicyTextBlock" xlink:to="AREN_ContractBalancesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ContractBalancesPolicyTextBlock_lbl" xml:lang="en-US">Contract Balances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xml:lang="en-US">Cash, Cash Equivalents, and Restricted Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable and Allowance for Doubtful Accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SubscriptionAcquisitionCostsPoliceTextBlock" xlink:label="AREN_SubscriptionAcquisitionCostsPoliceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SubscriptionAcquisitionCostsPoliceTextBlock" xlink:to="AREN_SubscriptionAcquisitionCostsPoliceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SubscriptionAcquisitionCostsPoliceTextBlock_lbl" xml:lang="en-US">Subscription Acquisition Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentrations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PlatformDevelopmentPolicyTextBlock" xlink:label="AREN_PlatformDevelopmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PlatformDevelopmentPolicyTextBlock" xlink:to="AREN_PlatformDevelopmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_PlatformDevelopmentPolicyTextBlock_lbl" xml:lang="en-US">Platform Development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsPolicy" xlink:to="us-gaap_BusinessCombinationsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsPolicy_lbl" xml:lang="en-US">Business Combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xml:lang="en-US">Debt Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPolicyTextBlock" xlink:label="AREN_LiquidatedDamagesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPolicyTextBlock" xlink:to="AREN_LiquidatedDamagesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_LiquidatedDamagesPolicyTextBlock_lbl" xml:lang="en-US">Liquidated Damages</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SellingAndMarketingPolicyTextBlock" xlink:label="AREN_SellingAndMarketingPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SellingAndMarketingPolicyTextBlock" xlink:to="AREN_SellingAndMarketingPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SellingAndMarketingPolicyTextBlock_lbl" xml:lang="en-US">Selling and Marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_GeneralandAdministrativePolicyTextBlock" xlink:label="AREN_GeneralandAdministrativePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_GeneralandAdministrativePolicyTextBlock" xlink:to="AREN_GeneralandAdministrativePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_GeneralandAdministrativePolicyTextBlock_lbl" xml:lang="en-US">General and Administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Derivative Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PreferredStockPolicyTextBlock" xlink:label="AREN_PreferredStockPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PreferredStockPolicyTextBlock" xlink:to="AREN_PreferredStockPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_PreferredStockPolicyTextBlock_lbl" xml:lang="en-US">Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Loss per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl" xml:lang="en-US">Schedule of Contract with Customer, Asset and Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:label="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_lbl" xml:lang="en-US">Schedule of Cash and Restricted Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:label="us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_lbl" xml:lang="en-US">Schedule of Allowance For Doubtful Accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock" xlink:label="AREN_ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock" xlink:to="AREN_ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Depreciation and Amortization, Useful Lives of Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">Schedule of Net Income (Loss) Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xml:lang="en-US">Schedule of Discontinued Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable" xlink:label="us-gaap_AssetAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_AssetAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionTable_lbl" xml:lang="en-US">Asset Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="us-gaap_AssetAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionLineItems_lbl" xml:lang="en-US">Asset Acquisition [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTableTextBlock" xlink:label="us-gaap_AssetAcquisitionTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionTableTextBlock" xlink:to="us-gaap_AssetAcquisitionTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionTableTextBlock_lbl" xml:lang="en-US">Schedule of Composition Preliminary Assets Purchase Price</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ScheduleOfAssetsAcquiredTableTextBlock" xlink:label="AREN_ScheduleOfAssetsAcquiredTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ScheduleOfAssetsAcquiredTableTextBlock" xlink:to="AREN_ScheduleOfAssetsAcquiredTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ScheduleOfAssetsAcquiredTableTextBlock_lbl" xml:lang="en-US">Summary of Preliminary Assets Purchase Price Allocation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xml:lang="en-US">Schedule of Composition of Purchase Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US">Summary of Purchase Price Allocation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xml:lang="en-US">Schedule of Supplemental Proforma Information</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PreliminaryPriceAllocationTableTextBlock" xlink:label="AREN_PreliminaryPriceAllocationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PreliminaryPriceAllocationTableTextBlock" xlink:to="AREN_PreliminaryPriceAllocationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PreliminaryPriceAllocationTableTextBlock_lbl" xml:lang="en-US">Schedule of Preliminary Price Allocation</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" xlink:label="AREN_ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" xlink:to="AREN_ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Prepayments and Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SupplementalInformationRelatedToOperatingLeasesTableTextBlock" xlink:label="AREN_SupplementalInformationRelatedToOperatingLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SupplementalInformationRelatedToOperatingLeasesTableTextBlock" xlink:to="AREN_SupplementalInformationRelatedToOperatingLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SupplementalInformationRelatedToOperatingLeasesTableTextBlock_lbl" xml:lang="en-US">Schedule of Supplemental Information Related to Operating Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Schedule of Operating Lease Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Summary of Maturity of Lease Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SummaryOfPlatformDevelopmentCostsTableTextBlock" xlink:label="AREN_SummaryOfPlatformDevelopmentCostsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SummaryOfPlatformDevelopmentCostsTableTextBlock" xlink:to="AREN_SummaryOfPlatformDevelopmentCostsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SummaryOfPlatformDevelopmentCostsTableTextBlock_lbl" xml:lang="en-US">Summary of Platform Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SummaryOfPlatformDevelopmentCostActivityTableTextBlock" xlink:label="AREN_SummaryOfPlatformDevelopmentCostActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SummaryOfPlatformDevelopmentCostActivityTableTextBlock" xlink:to="AREN_SummaryOfPlatformDevelopmentCostActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SummaryOfPlatformDevelopmentCostActivityTableTextBlock_lbl" xml:lang="en-US">Summary of Platform Development Cost Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Intangible Assets Subject to Amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of Future Estimated Amortization expense For Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_lbl" xml:lang="en-US">Summary of Other Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xml:lang="en-US">Schedule of Changes in Carrying Value of Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SummaryOfLiquidatedDamagesTableTextBlock" xlink:label="AREN_SummaryOfLiquidatedDamagesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SummaryOfLiquidatedDamagesTableTextBlock" xlink:to="AREN_SummaryOfLiquidatedDamagesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SummaryOfLiquidatedDamagesTableTextBlock_lbl" xml:lang="en-US">Summary of Liquidated Damages</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OtherLongtermLiabilitiesTableTextBlock" xlink:label="AREN_OtherLongtermLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OtherLongtermLiabilitiesTableTextBlock" xlink:to="AREN_OtherLongtermLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_OtherLongtermLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Other long- term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US">Schedule of long term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SummaryOfInterestExpenseTableTextBlock" xlink:label="AREN_SummaryOfInterestExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SummaryOfInterestExpenseTableTextBlock" xlink:to="AREN_SummaryOfInterestExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SummaryOfInterestExpenseTableTextBlock_lbl" xml:lang="en-US">Summary of Interest Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xml:lang="en-US">Summary of Restricted Stock Award Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Summary of Warrant Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ScheduleOfRestrictedStockUnitsActivityTableTextBlock" xlink:label="AREN_ScheduleOfRestrictedStockUnitsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ScheduleOfRestrictedStockUnitsActivityTableTextBlock" xlink:to="AREN_ScheduleOfRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ScheduleOfRestrictedStockUnitsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Restricted Stock Units Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value of Stock Options Assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Summary of Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xml:lang="en-US">Schedule of Exercise Prices of Common Stock Options</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ScheduleOfWarrantsActivityTableTextBlock" xlink:label="AREN_ScheduleOfWarrantsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ScheduleOfWarrantsActivityTableTextBlock" xlink:to="AREN_ScheduleOfWarrantsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ScheduleOfWarrantsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Warrants Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US">Summary of Stock-based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ScheduleOfUnrecognizedCompensationExpense" xlink:label="AREN_ScheduleOfUnrecognizedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ScheduleOfUnrecognizedCompensationExpense" xlink:to="AREN_ScheduleOfUnrecognizedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ScheduleOfUnrecognizedCompensationExpense_lbl" xml:lang="en-US">Schedule of Unrecognized Compensation Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Components of Deferred Tax Assets and Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Tax Benefit and Effective Income Tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Stockholders' Equity, Reverse Stock Split</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WorkingCapitalDeficit" xlink:label="AREN_WorkingCapitalDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_WorkingCapitalDeficit" xlink:to="AREN_WorkingCapitalDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_WorkingCapitalDeficit_lbl" xml:lang="en-US">[custom:WorkingCapitalDeficit-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xml:lang="en-US">Over time</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3_lbl" xml:lang="en-US">Total revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_2_lbl" xml:lang="en-US">Total short-term contract liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_2_lbl" xml:lang="en-US">Total long-term contract liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Total cash, cash equivalents, and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Allowance for doubtful accounts beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_lbl" xml:lang="en-US">Deductions - write-offs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xml:lang="en-US">Allowance for doubtful accounts end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property plant and equipment useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UnearnedRevenue" xlink:label="AREN_UnearnedRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_UnearnedRevenue" xlink:to="AREN_UnearnedRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_UnearnedRevenue_lbl" xml:lang="en-US">Contract with customer liability noncurrent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:label="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:to="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_lbl" xml:lang="en-US">Contract modification - revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_2_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortization" xlink:label="us-gaap_CapitalizedContractCostAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostAmortization" xlink:to="us-gaap_CapitalizedContractCostAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedContractCostAmortization_lbl" xml:lang="en-US">Amortization subscription costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNet" xlink:label="us-gaap_CapitalizedContractCostNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostNet" xlink:to="us-gaap_CapitalizedContractCostNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedContractCostNet_lbl" xml:lang="en-US">Subscription acquisition cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostNetNoncurrent" xlink:to="us-gaap_CapitalizedContractCostNetNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CapitalizedContractCostNetNoncurrent_2_lbl" xml:lang="en-US">Acquisition cost long term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostNetCurrent" xlink:to="us-gaap_CapitalizedContractCostNetCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CapitalizedContractCostNetCurrent_2_lbl" xml:lang="en-US">Subscription acquisition cost current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Percentage of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesDescription" xlink:label="AREN_LiquidatedDamagesDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesDescription" xlink:to="AREN_LiquidatedDamagesDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LiquidatedDamagesDescription_lbl" xml:lang="en-US">Liquidated damages description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMultiemployerPlansTable" xlink:label="us-gaap_ScheduleOfMultiemployerPlansTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMultiemployerPlansTable" xlink:to="us-gaap_ScheduleOfMultiemployerPlansTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMultiemployerPlansTable_lbl" xml:lang="en-US">Multiemployer Plan [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MultiemployerPlansLineItems" xlink:label="us-gaap_MultiemployerPlansLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MultiemployerPlansLineItems" xlink:to="us-gaap_MultiemployerPlansLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MultiemployerPlansLineItems_lbl" xml:lang="en-US">Multiemployer Plan [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_2_lbl" xml:lang="en-US">Operating expense</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense" xlink:label="AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense" xlink:to="AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense_lbl" xml:lang="en-US">Selling and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges" xlink:label="AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges" xlink:to="AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges_lbl" xml:lang="en-US">Loss on impairment of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_lbl" xml:lang="en-US">Loss from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:label="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_lbl" xml:lang="en-US">Income tax benefit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_2_lbl" xml:lang="en-US">Net loss from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:label="us-gaap_DepreciationAndAmortizationDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:to="us-gaap_DepreciationAndAmortizationDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationAndAmortizationDiscontinuedOperations_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="us-gaap_GainLossOnDispositionOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-gaap_GainLossOnDispositionOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GainLossOnDispositionOfAssets_lbl" xml:lang="en-US">Loss on impairment of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_lbl" xml:lang="en-US">Common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_lbl" xml:lang="en-US">Contingent consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted" xlink:label="AREN_AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted" xlink:to="AREN_AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted_lbl" xml:lang="en-US">Deferred cash payments, as discounted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred_lbl" xml:lang="en-US">Total purchase consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AssetAcquisitionAssetsAcquired" xlink:label="AREN_AssetAcquisitionAssetsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AssetAcquisitionAssetsAcquired" xlink:to="AREN_AssetAcquisitionAssetsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_AssetAcquisitionAssetsAcquired_lbl" xml:lang="en-US">Net assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl" xml:lang="en-US">Common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredOther1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredOther1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredOther1_lbl" xml:lang="en-US">Deferred cash payments, as discounted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US">Total purchase consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_lbl" xml:lang="en-US">Other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement_lbl" xml:lang="en-US">Equity investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US">Fixed assets</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent_lbl" xml:lang="en-US">Digital content</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement_lbl" xml:lang="en-US">Advertiser relationships</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_lbl" xml:lang="en-US">Trade names</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_lbl" xml:lang="en-US">Accrued expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_lbl" xml:lang="en-US">Unearned revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_lbl" xml:lang="en-US">Other long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl" xml:lang="en-US">Deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Net assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xml:lang="en-US">Total continuing operations supplemental pro forma revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xml:lang="en-US">Total continuing operations supplemental pro forma net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable_lbl" xml:lang="en-US">Lease deposit receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship_lbl" xml:lang="en-US">Advertiser relationships</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName_lbl" xml:lang="en-US">Brand names</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue_lbl" xml:lang="en-US">Unearned revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability_lbl" xml:lang="en-US">Subscription refund liability</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_lbl" xml:lang="en-US">Assumed lease obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Net assets acquired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred_2_lbl" xml:lang="en-US">Purchase price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_2_lbl" xml:lang="en-US">Cash paid for consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForAdvanceToAffiliate" xlink:label="us-gaap_PaymentsForAdvanceToAffiliate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForAdvanceToAffiliate" xlink:to="us-gaap_PaymentsForAdvanceToAffiliate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForAdvanceToAffiliate_lbl" xml:lang="en-US">Advance payments of cash</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredCashPayments" xlink:label="AREN_DeferredCashPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredCashPayments" xlink:to="AREN_DeferredCashPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DeferredCashPayments_lbl" xml:lang="en-US">Deferred cash payments</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredCashPaymentsDue" xlink:label="AREN_DeferredCashPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredCashPaymentsDue" xlink:to="AREN_DeferredCashPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DeferredCashPaymentsDue_lbl" xml:lang="en-US">Deferred cash payment due</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xml:lang="en-US">Number of shares issued for asset acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_lbl" xml:lang="en-US">Fair value of shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Share value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Common stock trading price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToEmployees" xlink:label="us-gaap_PaymentsToEmployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToEmployees" xlink:to="us-gaap_PaymentsToEmployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToEmployees_lbl" xml:lang="en-US">Cash retention pool for employees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_lbl" xml:lang="en-US">Transaction cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xml:lang="en-US">Weighted average useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_lbl" xml:lang="en-US">Cash proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SalePrice" xlink:label="AREN_SalePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SalePrice" xlink:to="AREN_SalePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SalePrice_lbl" xml:lang="en-US">Sale price</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WorkingCapital" xlink:label="AREN_WorkingCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_WorkingCapital" xlink:to="AREN_WorkingCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_WorkingCapital_lbl" xml:lang="en-US">Working capital</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PreliminaryWorkingCapital" xlink:label="AREN_PreliminaryWorkingCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PreliminaryWorkingCapital" xlink:to="AREN_PreliminaryWorkingCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PreliminaryWorkingCapital_lbl" xml:lang="en-US">Preliminary working capital</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WorkingCapitalAdjustments" xlink:label="AREN_WorkingCapitalAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_WorkingCapitalAdjustments" xlink:to="AREN_WorkingCapitalAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_WorkingCapitalAdjustments_lbl" xml:lang="en-US">Adjustment for working capital</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FinalSalePrice" xlink:label="AREN_FinalSalePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FinalSalePrice" xlink:to="AREN_FinalSalePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_FinalSalePrice_lbl" xml:lang="en-US">Sale price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinesses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xml:lang="en-US">Business component carrying value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_3_lbl" xml:lang="en-US">Accounts receivable net current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableCurrent_2_lbl" xml:lang="en-US">Accounts payable current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xml:lang="en-US">Loss on assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Acquired percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_2_lbl" xml:lang="en-US">Business combination consideration transferred1</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xml:lang="en-US">Cash acquired for acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:label="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:to="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_lbl" xml:lang="en-US">Cash portion in acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PaymentsToAcquireBusinessesAtClosing" xlink:label="AREN_PaymentsToAcquireBusinessesAtClosing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PaymentsToAcquireBusinessesAtClosing" xlink:to="AREN_PaymentsToAcquireBusinessesAtClosing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PaymentsToAcquireBusinessesAtClosing_lbl" xml:lang="en-US">Cash payments paid at closing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPaymentsToAcquireBusinesses" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses_lbl" xml:lang="en-US">Payments for acquire</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xml:lang="en-US">Number of shares issued in acquisition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2_lbl" xml:lang="en-US">Fair value of shares issued in acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_lbl" xml:lang="en-US">Stock value assigned</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:to="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl" xml:lang="en-US">Acquisition description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription_lbl" xml:lang="en-US">Acquisition description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xml:lang="en-US">Transaction cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments" xlink:label="us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments" xlink:to="us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments_lbl" xml:lang="en-US">Adjustment description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDeposit" xlink:label="us-gaap_EscrowDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EscrowDeposit" xlink:to="us-gaap_EscrowDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EscrowDeposit_lbl" xml:lang="en-US">Escrow deposit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_2_lbl" xml:lang="en-US">Assumed lease obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenue_lbl" xml:lang="en-US">Deferred payments</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredRevenueObligation" xlink:label="AREN_DeferredRevenueObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredRevenueObligation" xlink:to="AREN_DeferredRevenueObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DeferredRevenueObligation_lbl" xml:lang="en-US">Deferred revenue obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnearnedPremiums" xlink:label="us-gaap_UnearnedPremiums" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnearnedPremiums" xlink:to="us-gaap_UnearnedPremiums_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnearnedPremiums_lbl" xml:lang="en-US">Unearned revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRefundLiabilityCurrent" xlink:label="us-gaap_CustomerRefundLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRefundLiabilityCurrent" xlink:to="us-gaap_CustomerRefundLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRefundLiabilityCurrent_lbl" xml:lang="en-US">Refund liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xml:lang="en-US">Goodwill, acquired during period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xml:lang="en-US">Goodwill for tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:to="AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract_2_lbl" xml:lang="en-US">Schedule Of Prepayments And Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrepaidSuppliesCurrent" xlink:label="AREN_PrepaidSuppliesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PrepaidSuppliesCurrent" xlink:to="AREN_PrepaidSuppliesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PrepaidSuppliesCurrent_lbl" xml:lang="en-US">Prepaid supplies</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RefundableIncomeAndFranchiseTaxes" xlink:label="AREN_RefundableIncomeAndFranchiseTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RefundableIncomeAndFranchiseTaxes" xlink:to="AREN_RefundableIncomeAndFranchiseTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_RefundableIncomeAndFranchiseTaxes_lbl" xml:lang="en-US">Refundable income and franchise taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense_lbl" xml:lang="en-US">Unamortized debt costs</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EmployeeRetentionCredits" xlink:label="AREN_EmployeeRetentionCredits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EmployeeRetentionCredits" xlink:to="AREN_EmployeeRetentionCredits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_EmployeeRetentionCredits_lbl" xml:lang="en-US">Employee retention credits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xml:lang="en-US">Other receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xml:lang="en-US">Total prepayments and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLaborRelatedExpenses" xlink:label="us-gaap_OtherLaborRelatedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLaborRelatedExpenses" xlink:to="us-gaap_OtherLaborRelatedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLaborRelatedExpenses_lbl" xml:lang="en-US">Employee retention credits</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EmployeeRetentionPayable" xlink:label="AREN_EmployeeRetentionPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EmployeeRetentionPayable" xlink:to="AREN_EmployeeRetentionPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_EmployeeRetentionPayable_lbl" xml:lang="en-US">Retention Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Gross property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Net property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareTable" xlink:label="us-gaap_ImpairmentEffectsOnEarningsPerShareTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentEffectsOnEarningsPerShareTable" xlink:to="us-gaap_ImpairmentEffectsOnEarningsPerShareTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentEffectsOnEarningsPerShareTable_lbl" xml:lang="en-US">Impairment Effects on Earnings Per Share [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems" xlink:label="us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems" xlink:to="us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_lbl" xml:lang="en-US">Impairment Effects on Earnings Per Share [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Depreciation_2_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xml:lang="en-US">Impairment charges for property and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisclosureLeasesAbstract" xlink:to="AREN_DisclosureLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_DisclosureLeasesAbstract_2_lbl" xml:lang="en-US">Schedule Of Supplemental Information Related To Operating Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US">Operating lease costs during the year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Cash payments included in the measurement of operating lease liabilities during the year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Weighted-average remaining lease term (in years) as of year-end</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted-average discount rate during the year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Total operating costs ()</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome" xlink:label="us-gaap_SubleaseIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SubleaseIncome_lbl" xml:lang="en-US">Less sublease income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LeaseCost_2_lbl" xml:lang="en-US">Total operating lease costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseCost_2_lbl" xml:lang="en-US">Operating lease cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisclosureLeasesAbstract" xlink:to="AREN_DisclosureLeasesAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="AREN_DisclosureLeasesAbstract_3_lbl" xml:lang="en-US">Summary Of Maturity Of Lease Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Minimum lease payments - 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less imputed interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total operating lease liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Current portion of operating lease liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Long-term portion of operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US">Operating lease, remaining fixed payment term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubleaseIncome_2_lbl" xml:lang="en-US">Sublease income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLeasePayments" xlink:label="us-gaap_ProceedsFromLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLeasePayments" xlink:to="us-gaap_ProceedsFromLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLeasePayments_lbl" xml:lang="en-US">Proceeds from lease payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Cash payments</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ImputedInterestRate" xlink:label="AREN_ImputedInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ImputedInterestRate" xlink:to="AREN_ImputedInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ImputedInterestRate_lbl" xml:lang="en-US">Imputed interest recognized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="us-gaap_MarketingAndAdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingAndAdvertisingExpense" xlink:to="us-gaap_MarketingAndAdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketingAndAdvertisingExpense_lbl" xml:lang="en-US">Market advertising</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MarketingAndAdvertisingExpenseRemaining" xlink:label="AREN_MarketingAndAdvertisingExpenseRemaining" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_MarketingAndAdvertisingExpenseRemaining" xlink:to="AREN_MarketingAndAdvertisingExpenseRemaining_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_MarketingAndAdvertisingExpenseRemaining_lbl" xml:lang="en-US">Market advertising leaving</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Platform development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Net platform development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentOther" xlink:label="us-gaap_PropertyPlantAndEquipmentOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentOther" xlink:to="us-gaap_PropertyPlantAndEquipmentOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentOther_lbl" xml:lang="en-US">Platform development beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="us-gaap_FinitelivedIntangibleAssetsAcquired1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1_lbl" xml:lang="en-US">Payroll-based costs capitalized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_2_lbl" xml:lang="en-US">Less dispositions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostAmortization" xlink:to="us-gaap_CapitalizedContractCostAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CapitalizedContractCostAmortization_2_lbl" xml:lang="en-US">Total capitalized payroll-based costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xml:lang="en-US">Impairments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentOther" xlink:to="us-gaap_PropertyPlantAndEquipmentOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentOther_2_lbl" xml:lang="en-US">Platform development end of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_2_lbl" xml:lang="en-US">Amortization expense of intangible asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2_lbl" xml:lang="en-US">Impairment charges</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:label="us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_lbl" xml:lang="en-US">Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_2_lbl" xml:lang="en-US">Intangible assets, weighted average useful life</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_2_lbl" xml:lang="en-US">Intangible assets, gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xml:lang="en-US">Intangible assets, accumulated amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_3_lbl" xml:lang="en-US">Intangible assets ,net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfAcquisitionCosts" xlink:label="us-gaap_AmortizationOfAcquisitionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfAcquisitionCosts" xlink:to="us-gaap_AmortizationOfAcquisitionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfAcquisitionCosts_lbl" xml:lang="en-US">Amortization expense of intangible asset acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Security deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables" xlink:label="us-gaap_OtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherReceivables_lbl" xml:lang="en-US">Other receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidInsurance" xlink:to="us-gaap_PrepaidInsurance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidInsurance_lbl" xml:lang="en-US">Prepaid insurance</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UnamortizedDebtCost" xlink:label="AREN_UnamortizedDebtCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_UnamortizedDebtCost" xlink:to="AREN_UnamortizedDebtCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_UnamortizedDebtCost_lbl" xml:lang="en-US">Unamortized debt cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_2_lbl" xml:lang="en-US">Total other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCostAndReserveLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_Goodwill_2_lbl" xml:lang="en-US">Carrying value at beginning of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod_2_lbl" xml:lang="en-US">Goodwill acquired in acquisition of Fexy Studios</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US">Loss on impairment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_Goodwill_3_lbl" xml:lang="en-US">Carrying value at end of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillImpairmentLoss_2_lbl" xml:lang="en-US">Impairment of goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xml:lang="en-US">Stock repurchased during period, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfEquity" xlink:to="us-gaap_PaymentsForRepurchaseOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity_lbl" xml:lang="en-US">Payments for repurchase Of equity</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedStockPrincipalAmount" xlink:label="AREN_RestrictedStockPrincipalAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RestrictedStockPrincipalAmount" xlink:to="AREN_RestrictedStockPrincipalAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_RestrictedStockPrincipalAmount_lbl" xml:lang="en-US">Restricted stock principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedStockInterestPayment" xlink:label="AREN_RestrictedStockInterestPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RestrictedStockInterestPayment" xlink:to="AREN_RestrictedStockInterestPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_RestrictedStockInterestPayment_lbl" xml:lang="en-US">Restricted stock interest payment</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_GeneralAccruedExpenses" xlink:label="AREN_GeneralAccruedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_GeneralAccruedExpenses" xlink:to="AREN_GeneralAccruedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_GeneralAccruedExpenses_lbl" xml:lang="en-US">General accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="us-gaap_AccruedPayrollTaxesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedPayrollTaxesCurrent" xlink:to="us-gaap_AccruedPayrollTaxesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedPayrollTaxesCurrent_lbl" xml:lang="en-US">Accrued payroll and related taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedAdvertisingCurrent" xlink:label="us-gaap_AccruedAdvertisingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedAdvertisingCurrent" xlink:to="us-gaap_AccruedAdvertisingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedAdvertisingCurrent_lbl" xml:lang="en-US">Accrued publisher expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrent_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiabilitiesInConnectionWithAcquisitionsAndDispositions" xlink:label="AREN_LiabilitiesInConnectionWithAcquisitionsAndDispositions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiabilitiesInConnectionWithAcquisitionsAndDispositions" xlink:to="AREN_LiabilitiesInConnectionWithAcquisitionsAndDispositions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LiabilitiesInConnectionWithAcquisitionsAndDispositions_lbl" xml:lang="en-US">Liabilities in connection with acquisitions and dispositions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseDepositLiability" xlink:label="us-gaap_LeaseDepositLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseDepositLiability" xlink:to="us-gaap_LeaseDepositLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseDepositLiability_lbl" xml:lang="en-US">Assumed lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LeaseTerminationLiability" xlink:label="AREN_LeaseTerminationLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LeaseTerminationLiability" xlink:to="AREN_LeaseTerminationLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LeaseTerminationLiability_lbl" xml:lang="en-US">Lease termination liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other accrued expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Total accrued expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US">Line of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AccountsReceivablePercentage" xlink:label="AREN_AccountsReceivablePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AccountsReceivablePercentage" xlink:to="AREN_AccountsReceivablePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_AccountsReceivablePercentage_lbl" xml:lang="en-US">Accounts receivable percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDescription_lbl" xml:lang="en-US">Line of credit facility, interest rate description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Maturity date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_2_lbl" xml:lang="en-US">Debt instrument, face amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDefaultLongtermDebtAmount" xlink:label="us-gaap_DebtDefaultLongtermDebtAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDefaultLongtermDebtAmount" xlink:to="us-gaap_DebtDefaultLongtermDebtAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDefaultLongtermDebtAmount_lbl" xml:lang="en-US">Debt costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense_2_lbl" xml:lang="en-US">Debt costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3_lbl" xml:lang="en-US">Prepayment and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_lbl" xml:lang="en-US">Effective interest rate, line of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFeeAmount" xlink:label="us-gaap_DebtInstrumentFeeAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFeeAmount" xlink:to="us-gaap_DebtInstrumentFeeAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFeeAmount_lbl" xml:lang="en-US">Termination fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xml:lang="en-US">Interest rate, line of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RegistrationRightsDamages" xlink:label="AREN_RegistrationRightsDamages" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RegistrationRightsDamages" xlink:to="AREN_RegistrationRightsDamages_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_RegistrationRightsDamages_lbl" xml:lang="en-US">Registration Rights Damages</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PublicInformationFailureDamages" xlink:label="AREN_PublicInformationFailureDamages" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PublicInformationFailureDamages" xlink:to="AREN_PublicInformationFailureDamages_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PublicInformationFailureDamages_lbl" xml:lang="en-US">Public Information Failure Damages</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableCurrentAndNonCurrent" xlink:label="AREN_LiquidatedDamagesPayableCurrentAndNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPayableCurrentAndNonCurrent" xlink:to="AREN_LiquidatedDamagesPayableCurrentAndNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LiquidatedDamagesPayableCurrentAndNonCurrent_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_2_lbl" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="us-gaap_LossContingencyDamagesSoughtValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesSoughtValue" xlink:to="us-gaap_LossContingencyDamagesSoughtValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesSoughtValue_lbl" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDecreaseForgiveness" xlink:to="us-gaap_DebtInstrumentDecreaseForgiveness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness_lbl" xml:lang="en-US">Gain on forgiveness of debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" xlink:to="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages_2_lbl" xml:lang="en-US">Gain on forgiveness of debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPayableCurrent" xlink:to="AREN_LiquidatedDamagesPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_LiquidatedDamagesPayableCurrent_2_lbl" xml:lang="en-US">Short-term liquidated damages</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableAccruedInterestPercentage" xlink:label="AREN_LiquidatedDamagesPayableAccruedInterestPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPayableAccruedInterestPercentage" xlink:to="AREN_LiquidatedDamagesPayableAccruedInterestPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LiquidatedDamagesPayableAccruedInterestPercentage_lbl" xml:lang="en-US">Liquidated damages payable accrued interest percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPayableCurrentAndNonCurrent" xlink:to="AREN_LiquidatedDamagesPayableCurrentAndNonCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_LiquidatedDamagesPayableCurrentAndNonCurrent_2_lbl" xml:lang="en-US">Liquidated damages outstanding amount</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PercentageOfAggregateAmountInvested" xlink:label="AREN_PercentageOfAggregateAmountInvested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PercentageOfAggregateAmountInvested" xlink:to="AREN_PercentageOfAggregateAmountInvested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PercentageOfAggregateAmountInvested_lbl" xml:lang="en-US">Percentage of aggregate amount invested</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableNonCurrent" xlink:label="AREN_LiquidatedDamagesPayableNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPayableNonCurrent" xlink:to="AREN_LiquidatedDamagesPayableNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LiquidatedDamagesPayableNonCurrent_lbl" xml:lang="en-US">Long-term liquidated damages</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisclosureOtherLongtermLiabilitiesAbstract" xlink:to="AREN_DisclosureOtherLongtermLiabilitiesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_DisclosureOtherLongtermLiabilitiesAbstract_2_lbl" xml:lang="en-US">Schedule Of Other Long- Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LeaseTerminationLiabilityNonCurrent" xlink:label="AREN_LeaseTerminationLiabilityNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LeaseTerminationLiabilityNonCurrent" xlink:to="AREN_LeaseTerminationLiabilityNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_LeaseTerminationLiabilityNonCurrent_lbl" xml:lang="en-US">Lease termination liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Assumed lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OtherLongTermLiabilitiesNoncurrent" xlink:label="AREN_OtherLongTermLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OtherLongTermLiabilitiesNoncurrent" xlink:to="AREN_OtherLongTermLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_OtherLongTermLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Total other long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_lbl" xml:lang="en-US">Schedule of Fair Value, off-Balance-Sheet Risks [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_lbl" xml:lang="en-US">Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="us-gaap_LongTermDebtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtFairValue" xlink:to="us-gaap_LongTermDebtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtFairValue_lbl" xml:lang="en-US">Long term debt fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="us-gaap_BusinessAcquisitionSharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xml:lang="en-US">Preceding acquistion price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue_lbl" xml:lang="en-US">Financial instruments measured fair value debt bridge notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedOtherAtFairValue" xlink:label="us-gaap_FinancialInstrumentsOwnedOtherAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsOwnedOtherAtFairValue" xlink:to="us-gaap_FinancialInstrumentsOwnedOtherAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentsOwnedOtherAtFairValue_lbl" xml:lang="en-US">Debt fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Trading price, per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2_lbl" xml:lang="en-US">Issuance of common stock in connection with acquisitions, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_UnearnedRevenue" xlink:to="AREN_UnearnedRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_UnearnedRevenue_2_lbl" xml:lang="en-US">Unearned revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_3_lbl" xml:lang="en-US">Principal balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherBorrowings" xlink:label="us-gaap_OtherBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherBorrowings" xlink:to="us-gaap_OtherBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherBorrowings_lbl" xml:lang="en-US">Incremental borrowings</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AggregatePrincipalMinimumAmount" xlink:label="AREN_AggregatePrincipalMinimumAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AggregatePrincipalMinimumAmount" xlink:to="AREN_AggregatePrincipalMinimumAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_AggregatePrincipalMinimumAmount_lbl" xml:lang="en-US">Incremental borrowings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Proceeds from issuance of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_lbl" xml:lang="en-US">Amortized debt cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xml:lang="en-US">Debt instrument interest rate effective percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentMaturityDate_2_lbl" xml:lang="en-US">Debt maturity term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl" xml:lang="en-US">Net proceeds from business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaymentFeesOnAdvancesNet" xlink:label="us-gaap_PrepaymentFeesOnAdvancesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaymentFeesOnAdvancesNet" xlink:to="us-gaap_PrepaymentFeesOnAdvancesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaymentFeesOnAdvancesNet_lbl" xml:lang="en-US">Prepayment fees on advances, net</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrincipalAmountPrepayDue" xlink:label="AREN_PrincipalAmountPrepayDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PrincipalAmountPrepayDue" xlink:to="AREN_PrincipalAmountPrepayDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PrincipalAmountPrepayDue_lbl" xml:lang="en-US">Principal amount prepay due percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_lbl" xml:lang="en-US">Debt instrument, unamortized discount, current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xml:lang="en-US">Principal balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xml:lang="en-US">Incurred debt costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedPremium" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="us-gaap_DebtInstrumentUnamortizedPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium_lbl" xml:lang="en-US">Unamortized debt costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US">Principal balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Unamortized discount and debt issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Carrying value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xml:lang="en-US">Debt instrument interest rate, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Total amortization of debt costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_NoncashAndAccruedInterest" xlink:to="AREN_NoncashAndAccruedInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="AREN_NoncashAndAccruedInterest_2_lbl" xml:lang="en-US">Total noncash and accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CashPaidInterestAbstract" xlink:label="AREN_CashPaidInterestAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CashPaidInterestAbstract" xlink:to="AREN_CashPaidInterestAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_CashPaidInterestAbstract_lbl" xml:lang="en-US">Cash paid interest:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Total cash paid interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Less interest income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Total interest expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_2_lbl" xml:lang="en-US">Interest Expense, Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestPayableCurrent_2_lbl" xml:lang="en-US">Interest payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:to="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" xml:lang="en-US">Debt instrument interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentMaturityDate_3_lbl" xml:lang="en-US">Debt maturity date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_3_lbl" xml:lang="en-US">Debt due rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_2_lbl" xml:lang="en-US">Debt fixed rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Debt interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DebtInstrumentPeriodicPaymentPrincipalBalance" xlink:label="AREN_DebtInstrumentPeriodicPaymentPrincipalBalance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DebtInstrumentPeriodicPaymentPrincipalBalance" xlink:to="AREN_DebtInstrumentPeriodicPaymentPrincipalBalance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DebtInstrumentPeriodicPaymentPrincipalBalance_lbl" xml:lang="en-US">Principal amount of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Repayment of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings" xlink:label="us-gaap_ShortTermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">current maturities of debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_2_lbl" xml:lang="en-US">Paid in cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_2_lbl" xml:lang="en-US">Preferred stock, designated shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_2_lbl" xml:lang="en-US">Shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Shares sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Conversion Of stock shares converted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:label="us-gaap_PreferredStockLiquidationPreference" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreference" xlink:to="us-gaap_PreferredStockLiquidationPreference_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockLiquidationPreference_lbl" xml:lang="en-US">Preferred stock liquidation preference</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xml:lang="en-US">Preferred stock, liquidation aggregate amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xml:lang="en-US">Number of Shares, Restricted Stock Awards Outstanding, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Fair Value Date, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Number of Shares, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Fair Value Date, Vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xml:lang="en-US">Number of Shares, Restricted stock awards outstanding, Unvested at Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Number of Shares, outstanding, at beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_lbl" xml:lang="en-US">Weighted Average Exercise Price, outstanding, at beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Outstanding at beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xml:lang="en-US">Number of Shares, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Shares, outstanding at end of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, outstanding, at end of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2_lbl" xml:lang="en-US">Number of common shares sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Stock price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_2_lbl" xml:lang="en-US">Gross proceed from offerings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xml:lang="en-US">Offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xml:lang="en-US">Conversion of shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xml:lang="en-US">Conversion of shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConversionOfStockSharesConverted1_2_lbl" xml:lang="en-US">Conversion of shares converted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="us-gaap_ConversionOfStockAmountConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xml:lang="en-US">Conversion of stock amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Preferred stock stated par value</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesAcquisition" xlink:label="AREN_StockIssuedDuringPeriodSharesAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodSharesAcquisition" xlink:to="AREN_StockIssuedDuringPeriodSharesAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockIssuedDuringPeriodSharesAcquisition_lbl" xml:lang="en-US">Common stock shares issuance fo acquisitions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_3_lbl" xml:lang="en-US">Common stock shares issuance fo acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares" xlink:label="AREN_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares" xlink:to="AREN_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares_lbl" xml:lang="en-US">Issuance of common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_3_lbl" xml:lang="en-US">Fair value of acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Stock issued for professional services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xml:lang="en-US">Stock issued during period shares new issues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesSought" xlink:label="us-gaap_LossContingencyDamagesSought" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesSought" xlink:to="us-gaap_LossContingencyDamagesSought_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesSought_lbl" xml:lang="en-US">Loss contingency damages sought</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesSoughtValue" xlink:to="us-gaap_LossContingencyDamagesSoughtValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LossContingencyDamagesSoughtValue_2_lbl" xml:lang="en-US">Loss contingency damages sought value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_3_lbl" xml:lang="en-US">Trading price, per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xml:lang="en-US">Number of share issued value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" xlink:to="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_2_lbl" xml:lang="en-US">Liquidated damages</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2_lbl" xml:lang="en-US">Vesting of restricted stock units</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_3_lbl" xml:lang="en-US">Repurchase of restricted common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_lbl" xml:lang="en-US">Payment of taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Exercise of stock options, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueForCash" xlink:label="AREN_StockIssuedDuringPeriodValueForCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodValueForCash" xlink:to="AREN_StockIssuedDuringPeriodValueForCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockIssuedDuringPeriodValueForCash_lbl" xml:lang="en-US">Exercise of stock options</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" xlink:to="AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_2_lbl" xml:lang="en-US">Common stock to be issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xml:lang="en-US">Stock issued for professional services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Net proceed from offerings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Number of warrant shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:to="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_lbl" xml:lang="en-US">Warrant or right, reason for issuance, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Number of Shares, Unvested, outstanding, at beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_lbl" xml:lang="en-US">Number of Shares, Vested, outstanding, at beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Exercise Price, outstanding, at beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Number of Shares, Unvested granted</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted_lbl" xml:lang="en-US">Weighted Average Exercise Price,Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Number of Shares, Unvested, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested_lbl" xml:lang="en-US">Number of Shares, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased_lbl" xml:lang="en-US">Number of Shares, Vested, Released</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Number of Shares, Unvested, Cancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xml:lang="en-US">Number of Shares, Unvested, outstanding at end of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_2_lbl" xml:lang="en-US">Number of Shares, Vested, outstanding, at end of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, outstanding, at end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Risk-free interest rate, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Risk-free interest rate, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US">Expected volatility, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Expected volatility, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number of Shares Common stock options, outstanding at Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, outstanding at Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life (in Years), outstanding at Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Number of Shares, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xml:lang="en-US">Number of Shares, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Number of Shares, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Number of Shares, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Shares Common stock options, outstanding at Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, outstanding at Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Number of Shares Common stock options, exercisable at Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, exercisable at Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life (in Years), exercisable at Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xml:lang="en-US">Number of Shares Common stock options, not vested at Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber_lbl" xml:lang="en-US">Number of Shares Common stock options, available for future grants at Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Number of shares authorized to issue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Number of shares common stock options, outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Number of shares common stock options, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xml:lang="en-US">Exercise price lower range</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Number of Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Number of Shares, Vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Number of Shares, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne_lbl" xml:lang="en-US">Number of Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne_lbl" xml:lang="en-US">Number of Shares, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_lbl" xml:lang="en-US">Number of Shares, unvested outstanding, at beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_lbl" xml:lang="en-US">Number of Shares, vested outstanding, at beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_lbl" xml:lang="en-US">Weighted Average Exercise Price, outstanding, at beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WeightedAverageRemainingContractualLifeOutstanding" xlink:label="AREN_WeightedAverageRemainingContractualLifeOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_WeightedAverageRemainingContractualLifeOutstanding" xlink:to="AREN_WeightedAverageRemainingContractualLifeOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_WeightedAverageRemainingContractualLifeOutstanding_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Outstanding at ending of year</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber_lbl" xml:lang="en-US">Number of Shares, unvested issued</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber_lbl" xml:lang="en-US">Number of Shares, vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_2_lbl" xml:lang="en-US">Number of Shares, unvested outstanding, at end of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_2_lbl" xml:lang="en-US">Number of Shares, vested outstanding, at end of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xml:lang="en-US">Number of Shares, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WeightedAverageRemainingContractualLifeOutstanding1" xlink:label="AREN_WeightedAverageRemainingContractualLifeOutstanding1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_WeightedAverageRemainingContractualLifeOutstanding1" xlink:to="AREN_WeightedAverageRemainingContractualLifeOutstanding1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_WeightedAverageRemainingContractualLifeOutstanding1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Outstanding at ending of year</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_lbl" xml:lang="en-US">Number of Shares, Exercisable at end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercisable at end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WeightedAverageRemainingContractualLifeExercisable" xlink:label="AREN_WeightedAverageRemainingContractualLifeExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_WeightedAverageRemainingContractualLifeExercisable" xlink:to="AREN_WeightedAverageRemainingContractualLifeExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_WeightedAverageRemainingContractualLifeExercisable_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested_lbl" xml:lang="en-US">Number of Shares, not vested at end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber_lbl" xml:lang="en-US">Number of Shares, Available for future grants at end of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CostOfRevenue_2_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CostsChargedToOperations" xlink:label="AREN_CostsChargedToOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CostsChargedToOperations" xlink:to="AREN_CostsChargedToOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_CostsChargedToOperations_lbl" xml:lang="en-US">Total costs charged to operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopmentCosts" xlink:label="us-gaap_DevelopmentCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopmentCosts" xlink:to="us-gaap_DevelopmentCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DevelopmentCosts_lbl" xml:lang="en-US">Capitalized platform development</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Total stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US">Unrecognized compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Weighted average period expected to be recognized (in years)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xml:lang="en-US">Share based compensation arrangement options grants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl" xml:lang="en-US">Share based compensation incremental cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_3_lbl" xml:lang="en-US">Conversion of restricted stock units</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" xlink:label="AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" xlink:to="AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_lbl" xml:lang="en-US">Aggregate grant date fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted-average grant-date fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xml:lang="en-US">Common stock options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US">Share based compensation aggregate intrinsic value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xml:lang="en-US">Sharebased compensation arrangement by sharebased payment award options vested number of shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2_lbl" xml:lang="en-US">Weighted average remaining contractual term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Intrinsic value of stock option</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_2_lbl" xml:lang="en-US">Share price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl" xml:lang="en-US">Unvested restricted stock units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xml:lang="en-US">Number of shares, agreed to purchase</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Accrued expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Vested contractual term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense_3_lbl" xml:lang="en-US">Unamortized costs</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OriginalAwardAtTheRepricingDate" xlink:label="AREN_OriginalAwardAtTheRepricingDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OriginalAwardAtTheRepricingDate" xlink:to="AREN_OriginalAwardAtTheRepricingDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_OriginalAwardAtTheRepricingDate_lbl" xml:lang="en-US">Original award repricing date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xml:lang="en-US">Warrant to purchase common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FairMarketValueOfStockOption" xlink:label="AREN_FairMarketValueOfStockOption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FairMarketValueOfStockOption" xlink:to="AREN_FairMarketValueOfStockOption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_FairMarketValueOfStockOption_lbl" xml:lang="en-US">Fair market value of stock option</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayable" xlink:label="AREN_LiquidatedDamagesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPayable" xlink:to="AREN_LiquidatedDamagesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LiquidatedDamagesPayable_lbl" xml:lang="en-US">Liquidating damages payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xml:lang="en-US">Liquidated damages payable accrued interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State and local</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Total current tax (provision) benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State and local</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total deferred tax (provision) benefit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Total income tax (provision) benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetInterestCarryforward" xlink:label="us-gaap_DeferredTaxAssetInterestCarryforward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetInterestCarryforward" xlink:to="us-gaap_DeferredTaxAssetInterestCarryforward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetInterestCarryforward_lbl" xml:lang="en-US">Interest limitation carryforward</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xml:lang="en-US">Tax credit carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xml:lang="en-US">Accrued expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LeaseTermination" xlink:label="AREN_LeaseTermination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LeaseTermination" xlink:to="AREN_LeaseTermination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LeaseTermination_lbl" xml:lang="en-US">Lease termination</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredTaxAssetsLiquidatingDamagesPayable" xlink:label="AREN_DeferredTaxAssetsLiquidatingDamagesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredTaxAssetsLiquidatingDamagesPayable" xlink:to="AREN_DeferredTaxAssetsLiquidatingDamagesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_DeferredTaxAssetsLiquidatingDamagesPayable_lbl" xml:lang="en-US">Liquidated damages</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">Unearned revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredTaxAssetsOperatingLeaseLiability" xlink:label="AREN_DeferredTaxAssetsOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredTaxAssetsOperatingLeaseLiability" xlink:to="AREN_DeferredTaxAssetsOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_DeferredTaxAssetsOperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredTaxAssetsDepreciationAndAmortization" xlink:label="AREN_DeferredTaxAssetsDepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredTaxAssetsDepreciationAndAmortization" xlink:to="AREN_DeferredTaxAssetsDepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_DeferredTaxAssetsDepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_lbl" xml:lang="en-US">Acquisition-related intangibles</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Federal benefit expected at statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Federal benefit expected at statutory rate, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State and local taxes, net of federal benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State and local taxes, net of federal benefit, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_lbl" xml:lang="en-US">Stock-based compensation, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue" xlink:to="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue_lbl" xml:lang="en-US">Unearned revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage" xlink:to="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage_lbl" xml:lang="en-US">Unearned revenue percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationInterestExpense" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EffectiveIncomeTaxRateReconciliationInterestExpense" xlink:to="AREN_EffectiveIncomeTaxRateReconciliationInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationInterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationInterestExpensePercentage" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationInterestExpensePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EffectiveIncomeTaxRateReconciliationInterestExpensePercentage" xlink:to="AREN_EffectiveIncomeTaxRateReconciliationInterestExpensePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationInterestExpensePercentage_lbl" xml:lang="en-US">Interest expense percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment" xlink:to="AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment_lbl" xml:lang="en-US">Gain upon debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage" xlink:to="AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage_lbl" xml:lang="en-US">Gain upon debt extinguishment percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other differences, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other differences, net percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl" xml:lang="en-US">Other permanent differences</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl" xml:lang="en-US">Other permanent differences percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Income tax benefit and effective income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Income tax benefit and effective income tax rate, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NetOperatingLossExpirationAmount" xlink:label="AREN_NetOperatingLossExpirationAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_NetOperatingLossExpirationAmount" xlink:to="AREN_NetOperatingLossExpirationAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_NetOperatingLossExpirationAmount_lbl" xml:lang="en-US">Net operating losses expiration amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xlink:label="us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xlink:to="us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_lbl" xml:lang="en-US">Pension plan, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MultiemployerPlanPensionSignificantPlanContribution" xlink:label="us-gaap_MultiemployerPlanPensionSignificantPlanContribution" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MultiemployerPlanPensionSignificantPlanContribution" xlink:to="us-gaap_MultiemployerPlanPensionSignificantPlanContribution_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MultiemployerPlanPensionSignificantPlanContribution_lbl" xml:lang="en-US">Contribution to plan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentDescription" xlink:label="us-gaap_DebtInstrumentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescription" xlink:to="us-gaap_DebtInstrumentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDescription_lbl" xml:lang="en-US">Note purchase agreement description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_3_lbl" xml:lang="en-US">Stock issued during period, shares, issued for services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2_lbl" xml:lang="en-US">Debt instrument face amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_2_lbl" xml:lang="en-US">Interest on notes</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DebtInstrumentIncreaseAccruedInterestAmountDue" xlink:label="AREN_DebtInstrumentIncreaseAccruedInterestAmountDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DebtInstrumentIncreaseAccruedInterestAmountDue" xlink:to="AREN_DebtInstrumentIncreaseAccruedInterestAmountDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_DebtInstrumentIncreaseAccruedInterestAmountDue_lbl" xml:lang="en-US">Interest on notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConvertibleConversionPrice" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleConversionPrice" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice_lbl" xml:lang="en-US">Preferred Stock issued onversion price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xml:lang="en-US">Preferred Stock issued upon conversion</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFeeAmount" xlink:to="us-gaap_DebtInstrumentFeeAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFeeAmount_2_lbl" xml:lang="en-US">Fee incurred</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_3_lbl" xml:lang="en-US">Sale of stock, number of shares issued in transaction</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Proceeds from issuance of private placement</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockRepurchasedDuringPeriodValue1" xlink:label="AREN_StockRepurchasedDuringPeriodValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockRepurchasedDuringPeriodValue1" xlink:to="AREN_StockRepurchasedDuringPeriodValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="AREN_StockRepurchasedDuringPeriodValue1_lbl" xml:lang="en-US">Proceeds from repurchase of restricted stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xml:lang="en-US">Stock repurchase value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingenciesTable_lbl" xml:lang="en-US">Loss Contingencies [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyExpense_lbl" xml:lang="en-US">Royalty expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExerciseRightTerminationAmount" xlink:label="AREN_ExerciseRightTerminationAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExerciseRightTerminationAmount" xlink:to="AREN_ExerciseRightTerminationAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ExerciseRightTerminationAmount_lbl" xml:lang="en-US">Exercise right termination amount</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TerminationFeeDue" xlink:label="AREN_TerminationFeeDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_TerminationFeeDue" xlink:to="AREN_TerminationFeeDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_TerminationFeeDue_lbl" xml:lang="en-US">Termination fee</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_3_lbl" xml:lang="en-US">Performance based warrant vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_3_lbl" xml:lang="en-US">Preffered stock, par value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_3_lbl" xml:lang="en-US">Purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationPriceOfAcquisitionExpected" xlink:label="us-gaap_BusinessCombinationPriceOfAcquisitionExpected" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationPriceOfAcquisitionExpected" xlink:to="us-gaap_BusinessCombinationPriceOfAcquisitionExpected_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationPriceOfAcquisitionExpected_lbl" xml:lang="en-US">Aggregate purchase price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredOther1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredOther1_2_lbl" xml:lang="en-US">Business combination, consideration amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="us-gaap_LineOfCreditFacilityCommitmentFeePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeePercentage_lbl" xml:lang="en-US">Commitment fee percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SharesOutstandingPercentage" xlink:label="AREN_SharesOutstandingPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SharesOutstandingPercentage" xlink:to="AREN_SharesOutstandingPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_SharesOutstandingPercentage_lbl" xml:lang="en-US">Shares outstanding percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OutstandingPercentage" xlink:label="AREN_OutstandingPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OutstandingPercentage" xlink:to="AREN_OutstandingPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="AREN_OutstandingPercentage_lbl" xml:lang="en-US">Shares outstanding percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2_lbl" xml:lang="en-US">Net proceeds from the Private Placement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_3_lbl" xml:lang="en-US">Total installment amount</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationConsiderationTransferredInstallmentDue" xlink:label="AREN_BusinessCombinationConsiderationTransferredInstallmentDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationConsiderationTransferredInstallmentDue" xlink:to="AREN_BusinessCombinationConsiderationTransferredInstallmentDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BusinessCombinationConsiderationTransferredInstallmentDue_lbl" xml:lang="en-US">Total installment amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xml:lang="en-US">Flexy put option description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShortTermBorrowings_2_lbl" xml:lang="en-US">Company borrowed</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFeeAmount" xlink:to="us-gaap_DebtInstrumentFeeAmount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFeeAmount_3_lbl" xml:lang="en-US">Outstanding loan balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesSoughtValue" xlink:to="us-gaap_LossContingencyDamagesSoughtValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LossContingencyDamagesSoughtValue_3_lbl" xml:lang="en-US">Damage, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xml:lang="en-US">Vested restricted stock units</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PlatformDevelopmentNet" xlink:to="AREN_PlatformDevelopmentNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PlatformDevelopmentNet_doc" xml:lang="en-US">Platform development net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPayableCurrent" xlink:to="AREN_LiquidatedDamagesPayableCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LiquidatedDamagesPayableCurrent_doc" xml:lang="en-US">Liquidated damages payable current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BridgeNotes" xlink:to="AREN_BridgeNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BridgeNotes_doc" xml:lang="en-US">Bridge notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatingDamagesPayableNonCurrent" xlink:to="AREN_LiquidatingDamagesPayableNonCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LiquidatingDamagesPayableNonCurrent_doc" xml:lang="en-US">Liquidating damages payable non current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CommonStockToBeIssuedDuringPeriod" xlink:to="AREN_CommonStockToBeIssuedDuringPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_CommonStockToBeIssuedDuringPeriod_doc" xml:lang="en-US">Common stock to be issued during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeriesGRedeemableAndConvertiblePreferredStockMember" xlink:to="AREN_SeriesGRedeemableAndConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SeriesGRedeemableAndConvertiblePreferredStockMember_doc" xml:lang="en-US">Series G Redeemable And Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeriesHRedeemableAndConvertiblePreferredStockMember" xlink:to="AREN_SeriesHRedeemableAndConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SeriesHRedeemableAndConvertiblePreferredStockMember_doc" xml:lang="en-US">Series H Redeemable And Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_TemporaryEquityCommonSharesIssuableUponConversion" xlink:to="AREN_TemporaryEquityCommonSharesIssuableUponConversion_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_TemporaryEquityCommonSharesIssuableUponConversion_doc" xml:lang="en-US">Temporary equity common shares issuable upon conversion.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesUnderRegistrationRightsAgreements" xlink:to="AREN_LiquidatedDamagesUnderRegistrationRightsAgreements_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LiquidatedDamagesUnderRegistrationRightsAgreements_doc" xml:lang="en-US">Liquidated damages under registration rights agreements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CommonStockToBeIssuedMember" xlink:to="AREN_CommonStockToBeIssuedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_CommonStockToBeIssuedMember_doc" xml:lang="en-US">Common Stock To Be Issued [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger" xlink:to="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger_doc" xml:lang="en-US">Stock issued during period value issuance of common stock in connection with merger.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" xlink:to="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_doc" xml:lang="en-US">Stock issued during period value issuance of common stock in connection with settlement of liquidated damages.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" xlink:to="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering_doc" xml:lang="en-US">Stock issued during period value issuance of common stock in connection with registered direct offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne" xlink:to="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne_doc" xml:lang="en-US">Stock issued during period value issuance of common stock in connection with acquisition one.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" xlink:to="AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes_doc" xml:lang="en-US">Stock issued during period value common stock withheld for taxes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" xlink:to="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering_doc" xml:lang="en-US">Stock issued during period shares issuance of common stock in connection with registered direct offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne" xlink:to="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne_doc" xml:lang="en-US">Stock issued during period shares issuance of common stock in connection with acquisition one.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares" xlink:to="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares_doc" xml:lang="en-US">Stock issued during period shares issuance of common stock in connection with settlement of liquidated damages shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares" xlink:to="AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares_doc" xml:lang="en-US">Stock issued during period shares common stock withheld for taxes shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" xlink:to="AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_doc" xml:lang="en-US">Stock issued during period shares issuance of stock in connection with merger.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" xlink:to="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages_doc" xml:lang="en-US">Adjustments to additional paid in capital gain upon issuance of common stock in connection with forgiveness of liquidated damages.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" xlink:to="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_doc" xml:lang="en-US">Adjustments to additional paid in capital gain upon issuance of common stock in connection with settlement of liquidated damages.</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AccruedAndNoncashConvertedInterest" xlink:label="AREN_AccruedAndNoncashConvertedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AccruedAndNoncashConvertedInterest" xlink:to="AREN_AccruedAndNoncashConvertedInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_AccruedAndNoncashConvertedInterest_doc" xml:lang="en-US">Accrued and noncash converted interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatingDamagesPayable" xlink:to="AREN_LiquidatingDamagesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LiquidatingDamagesPayable_doc" xml:lang="en-US">Liquidating damages payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts" xlink:to="AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts_doc" xml:lang="en-US">Increase decrease in subscription acquisition costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_IncreaseDecreaseInSubscriptionRefundLiability" xlink:to="AREN_IncreaseDecreaseInSubscriptionRefundLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_IncreaseDecreaseInSubscriptionRefundLiability_doc" xml:lang="en-US">Increase decrease in subscription refund liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PaymentsForCapitalizedPlatformDevelopment" xlink:to="AREN_PaymentsForCapitalizedPlatformDevelopment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PaymentsForCapitalizedPlatformDevelopment_doc" xml:lang="en-US">Payments for capitalized platform development.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PaymentOfRestrictedStockLiabilities" xlink:to="AREN_PaymentOfRestrictedStockLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PaymentOfRestrictedStockLiabilities_doc" xml:lang="en-US">Payment of restricted stock liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PaymentOfDeferredCashPayment" xlink:to="AREN_PaymentOfDeferredCashPayment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PaymentOfDeferredCashPayment_doc" xml:lang="en-US">Payment of deferred cash payment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ReclassificationOfStockbasedCompensationToPlatformDevelopment" xlink:to="AREN_ReclassificationOfStockbasedCompensationToPlatformDevelopment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ReclassificationOfStockbasedCompensationToPlatformDevelopment_doc" xml:lang="en-US">Reclassification of stockbased compensation to platform development.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_IssuanceOfCommonStockInConnectionWithAcquisition" xlink:to="AREN_IssuanceOfCommonStockInConnectionWithAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_IssuanceOfCommonStockInConnectionWithAcquisition_doc" xml:lang="en-US">Issuance of common stock in connection with acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredCashPaymentsRecordedInConnectionWithAcquisitions" xlink:to="AREN_DeferredCashPaymentsRecordedInConnectionWithAcquisitions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DeferredCashPaymentsRecordedInConnectionWithAcquisitions_doc" xml:lang="en-US">Deferred cash payments recorded in connection with acquisitions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ReclassificationToLiabilityUponCommonStockModification" xlink:to="AREN_ReclassificationToLiabilityUponCommonStockModification_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ReclassificationToLiabilityUponCommonStockModification_doc" xml:lang="en-US">Reclassification to liability upon common stock modification.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_WorkingCapitalDeficit" xlink:to="AREN_WorkingCapitalDeficit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_WorkingCapitalDeficit_doc" xml:lang="en-US">Working capital deficit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DelayedDrawTermNotesMember" xlink:to="AREN_DelayedDrawTermNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DelayedDrawTermNotesMember_doc" xml:lang="en-US">Delayed Draw Term Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeniorSecuredNotesMember" xlink:to="AREN_SeniorSecuredNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SeniorSecuredNotesMember_doc" xml:lang="en-US">Senior Secured Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPayableTextBlock" xlink:to="AREN_LiquidatedDamagesPayableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LiquidatedDamagesPayableTextBlock_doc" xml:lang="en-US">Liquidated Damages Payable [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SummaryOfLiquidatedDamagesTableTextBlock" xlink:to="AREN_SummaryOfLiquidatedDamagesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SummaryOfLiquidatedDamagesTableTextBlock_doc" xml:lang="en-US">Tabular disclosure of liquidation damages.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_UnearnedRevenue" xlink:to="AREN_UnearnedRevenue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_UnearnedRevenue_doc" xml:lang="en-US">Unearned Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DigitalAndPrintSubscriptionsMember" xlink:to="AREN_DigitalAndPrintSubscriptionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DigitalAndPrintSubscriptionsMember_doc" xml:lang="en-US">Digital And Print Subscriptions [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RegistrationRightsDamages" xlink:to="AREN_RegistrationRightsDamages_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_RegistrationRightsDamages_doc" xml:lang="en-US">Registration Rights Damages.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_MDBCommonStockToBeIssuedMember" xlink:to="AREN_MDBCommonStockToBeIssuedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_MDBCommonStockToBeIssuedMember_doc" xml:lang="en-US">MDB Common Stock To Be Issued [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PublicInformationFailureDamages" xlink:to="AREN_PublicInformationFailureDamages_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PublicInformationFailureDamages_doc" xml:lang="en-US">Public information failure damages.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPayableCurrentAndNonCurrent" xlink:to="AREN_LiquidatedDamagesPayableCurrentAndNonCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LiquidatedDamagesPayableCurrentAndNonCurrent_doc" xml:lang="en-US">Liquidated damages payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeriesHConvertiblePreferredStockMember" xlink:to="AREN_SeriesHConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SeriesHConvertiblePreferredStockMember_doc" xml:lang="en-US">Series H Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ConvertibleDebenturesMember" xlink:to="AREN_ConvertibleDebenturesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ConvertibleDebenturesMember_doc" xml:lang="en-US">Convertible Debentures [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeriesJPreferredStockMember" xlink:to="AREN_SeriesJPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SeriesJPreferredStockMember_doc" xml:lang="en-US">Series J Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeriesKPreferredStockMember" xlink:to="AREN_SeriesKPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SeriesKPreferredStockMember_doc" xml:lang="en-US">Series K Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockPurchaseAgreementMember" xlink:to="AREN_StockPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockPurchaseAgreementMember_doc" xml:lang="en-US">Stock Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPayableAccruedInterestPercentage" xlink:to="AREN_LiquidatedDamagesPayableAccruedInterestPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LiquidatedDamagesPayableAccruedInterestPercentage_doc" xml:lang="en-US">Liquidated damages payable accrued interest percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PercentageOfAggregateAmountInvested" xlink:to="AREN_PercentageOfAggregateAmountInvested_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PercentageOfAggregateAmountInvested_doc" xml:lang="en-US">Percentage of aggregate amount invested.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CustomerMember" xlink:to="AREN_CustomerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_CustomerMember_doc" xml:lang="en-US">Customer [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OtherLongtermLiabilitiesTextBlock" xlink:to="AREN_OtherLongtermLiabilitiesTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_OtherLongtermLiabilitiesTextBlock_doc" xml:lang="en-US">Other long term liabilities [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OtherLongtermLiabilitiesTableTextBlock" xlink:to="AREN_OtherLongtermLiabilitiesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_OtherLongtermLiabilitiesTableTextBlock_doc" xml:lang="en-US">Other long term liabilities [TableText Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OfficeEquipmentAndComputersMember" xlink:to="AREN_OfficeEquipmentAndComputersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_OfficeEquipmentAndComputersMember_doc" xml:lang="en-US">Office Equipment And Computers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LeaseTerminationLiabilityNonCurrent" xlink:to="AREN_LeaseTerminationLiabilityNonCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LeaseTerminationLiabilityNonCurrent_doc" xml:lang="en-US">Lease termination liability non current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OtherLongTermLiabilitiesNoncurrent" xlink:to="AREN_OtherLongTermLiabilitiesNoncurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_OtherLongTermLiabilitiesNoncurrent_doc" xml:lang="en-US">Other long term liabilities non current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesDescription" xlink:to="AREN_LiquidatedDamagesDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LiquidatedDamagesDescription_doc" xml:lang="en-US">Liquidated damages description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeriesGConvertiblePreferredStockMember" xlink:to="AREN_SeriesGConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SeriesGConvertiblePreferredStockMember_doc" xml:lang="en-US">Series G Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FinancingWarrantsMember" xlink:to="AREN_FinancingWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_FinancingWarrantsMember_doc" xml:lang="en-US">Financing Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ABGWarrantsMember" xlink:to="AREN_ABGWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ABGWarrantsMember_doc" xml:lang="en-US">ABG Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AllHipHopWarrantsMember" xlink:to="AREN_AllHipHopWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_AllHipHopWarrantsMember_doc" xml:lang="en-US">All Hip Hop Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PublisherPartnerWarrantsMember" xlink:to="AREN_PublisherPartnerWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PublisherPartnerWarrantsMember_doc" xml:lang="en-US">Publisher Partner Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RestrictedStockAwardsMember" xlink:to="AREN_RestrictedStockAwardsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_RestrictedStockAwardsMember_doc" xml:lang="en-US">Restricted Stock Awards [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CommonStockOptionsMember" xlink:to="AREN_CommonStockOptionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_CommonStockOptionsMember_doc" xml:lang="en-US">Common Stock Options [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BridgeNotesMember" xlink:to="AREN_BridgeNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BridgeNotesMember_doc" xml:lang="en-US">Bridge Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DiscontinuedOperationsTextBlock" xlink:to="AREN_DiscontinuedOperationsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DiscontinuedOperationsTextBlock_doc" xml:lang="en-US">Discontinued Operations [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FexyStudiosMember" xlink:to="AREN_FexyStudiosMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_FexyStudiosMember_doc" xml:lang="en-US">Fexy Studios [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_TwoThousandTwentyTwoBridgeNotesMember" xlink:to="AREN_TwoThousandTwentyTwoBridgeNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_TwoThousandTwentyTwoBridgeNotesMember_doc" xml:lang="en-US">2022 Bridge Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredCashPayments" xlink:to="AREN_DeferredCashPayments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DeferredCashPayments_doc" xml:lang="en-US">Deferred cash payments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DelayedDrawTermNoteMember" xlink:to="AREN_DelayedDrawTermNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DelayedDrawTermNoteMember_doc" xml:lang="en-US">Delayed Draw Term Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DebtObligationsOutstanding" xlink:label="AREN_DebtObligationsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DebtObligationsOutstanding" xlink:to="AREN_DebtObligationsOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DebtObligationsOutstanding_doc" xml:lang="en-US">Debt obligations outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PurchaseAgreementMember" xlink:to="AREN_PurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PurchaseAgreementMember_doc" xml:lang="en-US">Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredCashPaymentsDue" xlink:to="AREN_DeferredCashPaymentsDue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DeferredCashPaymentsDue_doc" xml:lang="en-US">Deferred cash payments due.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted" xlink:to="AREN_AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted_doc" xml:lang="en-US">Asset acquisition consideration transferred deferred cash payments as discounted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed advertisement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed trade name.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AthlonHoldingsIncMember" xlink:to="AREN_AthlonHoldingsIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_AthlonHoldingsIncMember_doc" xml:lang="en-US">Athlon Holdings Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed brand name.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AdvertiserRelationshipsMember" xlink:to="AREN_AdvertiserRelationshipsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_AdvertiserRelationshipsMember_doc" xml:lang="en-US">Advertiser Relationships [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BrandNamesMember" xlink:to="AREN_BrandNamesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BrandNamesMember_doc" xml:lang="en-US">Brand Names [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SummaryOfInterestExpenseTableTextBlock" xlink:to="AREN_SummaryOfInterestExpenseTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SummaryOfInterestExpenseTableTextBlock_doc" xml:lang="en-US">Summary Of Interest Expense [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_NoncashAndAccruedInterest" xlink:to="AREN_NoncashAndAccruedInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_NoncashAndAccruedInterest_doc" xml:lang="en-US">Noncash and accrued interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LineOfCreditTerminationFeeMember" xlink:to="AREN_LineOfCreditTerminationFeeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LineOfCreditTerminationFeeMember_doc" xml:lang="en-US">Line Of Credit Termination Fee [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CashPaidInterestAbstract" xlink:to="AREN_CashPaidInterestAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_CashPaidInterestAbstract_doc" xml:lang="en-US">Cash Paid Interest Abstract</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OriginalInvestorMember" xlink:to="AREN_OriginalInvestorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_OriginalInvestorMember_doc" xml:lang="en-US">Original Investor [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed equity investement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed digital content.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RestrictedStockLiabilitiesTextBlock" xlink:to="AREN_RestrictedStockLiabilitiesTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_RestrictedStockLiabilitiesTextBlock_doc" xml:lang="en-US">Restricted stock liabilities [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DigitalContentMember" xlink:to="AREN_DigitalContentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DigitalContentMember_doc" xml:lang="en-US">Digital Content [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RestrictedStockPrincipalAmount" xlink:to="AREN_RestrictedStockPrincipalAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_RestrictedStockPrincipalAmount_doc" xml:lang="en-US">Restricted stock principal amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RestrictedStockInterestPayment" xlink:to="AREN_RestrictedStockInterestPayment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_RestrictedStockInterestPayment_doc" xml:lang="en-US">Restricted stock interest payment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AdvertiserRelationshipMember" xlink:to="AREN_AdvertiserRelationshipMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_AdvertiserRelationshipMember_doc" xml:lang="en-US">Advertiser Relationship [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_GeneralAccruedExpenses" xlink:to="AREN_GeneralAccruedExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_GeneralAccruedExpenses_doc" xml:lang="en-US">General accrued expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LeaseTerminationLiability" xlink:to="AREN_LeaseTerminationLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LeaseTerminationLiability_doc" xml:lang="en-US">Lease termination liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockPurchaseAgreementsMember" xlink:to="AREN_StockPurchaseAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockPurchaseAgreementsMember_doc" xml:lang="en-US">Stock Purchase Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PurchasersMember" xlink:to="AREN_PurchasersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PurchasersMember_doc" xml:lang="en-US">Purchasers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredCashPaymentsInConnectionWithAcquisitions" xlink:label="AREN_DeferredCashPaymentsInConnectionWithAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredCashPaymentsInConnectionWithAcquisitions" xlink:to="AREN_DeferredCashPaymentsInConnectionWithAcquisitions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DeferredCashPaymentsInConnectionWithAcquisitions_doc" xml:lang="en-US">Deferred cash payments in connection with acquisitions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BuffaloGroupeLLCMember" xlink:to="AREN_BuffaloGroupeLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BuffaloGroupeLLCMember_doc" xml:lang="en-US">Buffalo Groupe LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_IntellectualPropertiesMember" xlink:to="AREN_IntellectualPropertiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_IntellectualPropertiesMember_doc" xml:lang="en-US">Intellectual Properties [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed assumed lease obligation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredRevenueObligation" xlink:to="AREN_DeferredRevenueObligation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DeferredRevenueObligation_doc" xml:lang="en-US">Deferred Revenue Obligation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PreliminaryPriceAllocationTableTextBlock" xlink:to="AREN_PreliminaryPriceAllocationTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PreliminaryPriceAllocationTableTextBlock_doc" xml:lang="en-US">Preliminary Price Allocation [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed lease deposit receivable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed advertisement relationship.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed goodwill.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed unearned revenue.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed subscription refund liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_A360MediaLLCMember" xlink:to="AREN_A360MediaLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_A360MediaLLCMember_doc" xml:lang="en-US">A360 Media LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BrandNameMember" xlink:to="AREN_BrandNameMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BrandNameMember_doc" xml:lang="en-US">Brand Name [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PrepaymentsAndOtherCurrentAssetsTextBlock" xlink:to="AREN_PrepaymentsAndOtherCurrentAssetsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PrepaymentsAndOtherCurrentAssetsTextBlock_doc" xml:lang="en-US">Prepayments And Other Current Assets [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" xlink:to="AREN_ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock_doc" xml:lang="en-US">Schedule Of Prepayments And Other Current Assets [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RefundableIncomeAndFranchiseTaxes" xlink:to="AREN_RefundableIncomeAndFranchiseTaxes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_RefundableIncomeAndFranchiseTaxes_doc" xml:lang="en-US">Refundable income and franchise taxes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EmployeeRetentionCredits" xlink:to="AREN_EmployeeRetentionCredits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_EmployeeRetentionCredits_doc" xml:lang="en-US">Employee retention credits</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EmployeeRetentionPayable" xlink:to="AREN_EmployeeRetentionPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_EmployeeRetentionPayable_doc" xml:lang="en-US">Employee retention payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SupplementalInformationRelatedToOperatingLeasesTableTextBlock" xlink:to="AREN_SupplementalInformationRelatedToOperatingLeasesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SupplementalInformationRelatedToOperatingLeasesTableTextBlock_doc" xml:lang="en-US">Supplemental Information Related to Operating Leases [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FexyStudiosAcquistionMember" xlink:to="AREN_FexyStudiosAcquistionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_FexyStudiosAcquistionMember_doc" xml:lang="en-US">Fexy Studios Acquistion [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LeaseTermination" xlink:to="AREN_LeaseTermination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LeaseTermination_doc" xml:lang="en-US">Lease termination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredTaxAssetsLiquidatingDamagesPayable" xlink:to="AREN_DeferredTaxAssetsLiquidatingDamagesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DeferredTaxAssetsLiquidatingDamagesPayable_doc" xml:lang="en-US">Deferred tax assets liquidating damages payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredTaxAssetsOperatingLeaseLiability" xlink:to="AREN_DeferredTaxAssetsOperatingLeaseLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DeferredTaxAssetsOperatingLeaseLiability_doc" xml:lang="en-US">Deferred tax assets Operating lease liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredTaxAssetsDepreciationAndAmortization" xlink:to="AREN_DeferredTaxAssetsDepreciationAndAmortization_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DeferredTaxAssetsDepreciationAndAmortization_doc" xml:lang="en-US">Deferred tax assets depreciation and amortization.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StateMember" xlink:to="AREN_StateMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StateMember_doc" xml:lang="en-US">State [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LocalJurisdictionMember" xlink:to="AREN_LocalJurisdictionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LocalJurisdictionMember_doc" xml:lang="en-US">Local [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_USFederalTaxMember" xlink:to="AREN_USFederalTaxMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_USFederalTaxMember_doc" xml:lang="en-US">U.S Federal Tax [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_NetOperatingLossExpirationAmount" xlink:to="AREN_NetOperatingLossExpirationAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_NetOperatingLossExpirationAmount_doc" xml:lang="en-US">Net operating losses expiration amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue" xlink:to="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue_doc" xml:lang="en-US">Effective income tax rate reconciliation, unearned revenue.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage" xlink:to="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage_doc" xml:lang="en-US">Effective income tax rate reconciliation, unearned revenue, percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EffectiveIncomeTaxRateReconciliationInterestExpense" xlink:to="AREN_EffectiveIncomeTaxRateReconciliationInterestExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationInterestExpense_doc" xml:lang="en-US">Effective income tax rate reconciliation, interest expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EffectiveIncomeTaxRateReconciliationInterestExpensePercentage" xlink:to="AREN_EffectiveIncomeTaxRateReconciliationInterestExpensePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationInterestExpensePercentage_doc" xml:lang="en-US">Effective income tax rate reconciliation, interest expense, percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment" xlink:to="AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment_doc" xml:lang="en-US">Gain upon debt extinguishment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage" xlink:to="AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage_doc" xml:lang="en-US">Gain upon debt extinguishment, percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares" xlink:to="AREN_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares_doc" xml:lang="en-US">Business combination step acquisition equity interest in acquiree fair value shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ParadeStockMember" xlink:to="AREN_ParadeStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ParadeStockMember_doc" xml:lang="en-US">Parade Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AssetPurchaseAgreementMember" xlink:to="AREN_AssetPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_AssetPurchaseAgreementMember_doc" xml:lang="en-US">Asset Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessMembershipAgreementMember" xlink:to="AREN_BusinessMembershipAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BusinessMembershipAgreementMember_doc" xml:lang="en-US">Business Membership Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_MonthToMonthLeaseArrangementMember" xlink:to="AREN_MonthToMonthLeaseArrangementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_MonthToMonthLeaseArrangementMember_doc" xml:lang="en-US">Month To Month Lease Arrangement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FexyStudiosAcquisitionMember" xlink:to="AREN_FexyStudiosAcquisitionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_FexyStudiosAcquisitionMember_doc" xml:lang="en-US">Fexy Studios Acquisition [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LeaseArrangementMember" xlink:to="AREN_LeaseArrangementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LeaseArrangementMember_doc" xml:lang="en-US">Lease Arrangement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeveralStockPurchaseAgreementsMember" xlink:to="AREN_SeveralStockPurchaseAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SeveralStockPurchaseAgreementsMember_doc" xml:lang="en-US">Several Stock Purchase Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeveralInvestorsMember" xlink:to="AREN_SeveralInvestorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SeveralInvestorsMember_doc" xml:lang="en-US">Several Investors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PlatformDevelopmentDisclosureTextBlock" xlink:to="AREN_PlatformDevelopmentDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PlatformDevelopmentDisclosureTextBlock_doc" xml:lang="en-US">Platform Development Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SummaryOfPlatformDevelopmentCostsTableTextBlock" xlink:to="AREN_SummaryOfPlatformDevelopmentCostsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SummaryOfPlatformDevelopmentCostsTableTextBlock_doc" xml:lang="en-US">Summary of Platform Development Costs [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SummaryOfPlatformDevelopmentCostActivityTableTextBlock" xlink:to="AREN_SummaryOfPlatformDevelopmentCostActivityTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SummaryOfPlatformDevelopmentCostActivityTableTextBlock_doc" xml:lang="en-US">Summary of Platform Development Cost Activity [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PlatformDevelopmentMember" xlink:to="AREN_PlatformDevelopmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PlatformDevelopmentMember_doc" xml:lang="en-US">Platform Development [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockRepurchasedDuringPeriodValue1" xlink:to="AREN_StockRepurchasedDuringPeriodValue1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockRepurchasedDuringPeriodValue1_doc" xml:lang="en-US">Stock repurchased during period value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_MrEdmonsonMember" xlink:to="AREN_MrEdmonsonMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_MrEdmonsonMember_doc" xml:lang="en-US">Mr. Edmonson [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_HHuntAllredMember" xlink:to="AREN_HHuntAllredMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_HHuntAllredMember_doc" xml:lang="en-US">H Hunt Allred [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DevelopedTechnologyMember" xlink:to="AREN_DevelopedTechnologyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DevelopedTechnologyMember_doc" xml:lang="en-US">Developed Technology [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SubscriberRelationshipsMember" xlink:to="AREN_SubscriberRelationshipsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SubscriberRelationshipsMember_doc" xml:lang="en-US">Subscriber Relationships [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EmployeesMember" xlink:to="AREN_EmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_EmployeesMember_doc" xml:lang="en-US">Employees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AllredTrustHHAMember" xlink:to="AREN_AllredTrustHHAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_AllredTrustHHAMember_doc" xml:lang="en-US">Allred Trust HHA [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AllredTrustNLAMember" xlink:to="AREN_AllredTrustNLAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_AllredTrustNLAMember_doc" xml:lang="en-US">Allred Trust NLA [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RestrictedCommonStockMember" xlink:to="AREN_RestrictedCommonStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_RestrictedCommonStockMember_doc" xml:lang="en-US">Restricted Common Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExerciseOfStockOptionMember" xlink:to="AREN_ExerciseOfStockOptionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ExerciseOfStockOptionMember_doc" xml:lang="en-US">Exercise Of Stock Option [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodValueForCash" xlink:to="AREN_StockIssuedDuringPeriodValueForCash_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockIssuedDuringPeriodValueForCash_doc" xml:lang="en-US">Stock issued during period value for cash.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BRileyFinancialIncMember" xlink:to="AREN_BRileyFinancialIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BRileyFinancialIncMember_doc" xml:lang="en-US">BRiley Financial Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ServicesAgreementMember" xlink:to="AREN_ServicesAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ServicesAgreementMember_doc" xml:lang="en-US">Services Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DirectOfferingMember" xlink:to="AREN_DirectOfferingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DirectOfferingMember_doc" xml:lang="en-US">Direct Offering [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ABGSILLCMember" xlink:to="AREN_ABGSILLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ABGSILLCMember_doc" xml:lang="en-US">ABG-SI, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_MDBCapitalGroupLLCMember" xlink:to="AREN_MDBCapitalGroupLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_MDBCapitalGroupLLCMember_doc" xml:lang="en-US">MDB Capital Group LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CommonStockFinancingWarrantMember" xlink:to="AREN_CommonStockFinancingWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_CommonStockFinancingWarrantMember_doc" xml:lang="en-US">Common Stock Financing Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_doc" xml:lang="en-US">Number of warrants outstanding, including both vested and non-vested options.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1_doc" xml:lang="en-US">Weighted average remaining contractual term for warrants awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice_doc" xml:lang="en-US">Award non option equity instruments expired price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_NewPublisherPartnerWarrantsMember" xlink:to="AREN_NewPublisherPartnerWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_NewPublisherPartnerWarrantsMember_doc" xml:lang="en-US">New Publisher Partner Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_TwoThousandTwentyTwoPlanMember" xlink:to="AREN_TwoThousandTwentyTwoPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_TwoThousandTwentyTwoPlanMember_doc" xml:lang="en-US">2022 Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_doc" xml:lang="en-US">Award equity instruments other than options vested number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_doc" xml:lang="en-US">Instruments other than option nonvested weighted average grant date fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted_doc" xml:lang="en-US">Sharebased compensation arrangement by sharebased payment award equity instrument sotherthanoptionnonvestedweightedaveragegrantdatefairvaluegranted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BlackScholesOptionPricingModelMember" xlink:to="AREN_BlackScholesOptionPricingModelMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BlackScholesOptionPricingModelMember_doc" xml:lang="en-US">Black-Scholes Option Pricing Model [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_UpListMember" xlink:to="AREN_UpListMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_UpListMember_doc" xml:lang="en-US">Up-List [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_NoUpListMember" xlink:to="AREN_NoUpListMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_NoUpListMember_doc" xml:lang="en-US">No Up-List [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber_doc" xml:lang="en-US">Number of shares common stock options, available for future grants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" xlink:to="AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_doc" xml:lang="en-US">Aggregate grant date fair value for the common equity awards granted during the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExercisePriceRangeOneMember" xlink:to="AREN_ExercisePriceRangeOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ExercisePriceRangeOneMember_doc" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExercisePriceRangeTwoMember" xlink:to="AREN_ExercisePriceRangeTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ExercisePriceRangeTwoMember_doc" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExercisePriceRangeThreeMember" xlink:to="AREN_ExercisePriceRangeThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ExercisePriceRangeThreeMember_doc" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExercisePriceRangeFourMember" xlink:to="AREN_ExercisePriceRangeFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ExercisePriceRangeFourMember_doc" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExercisePriceRangeFiveMember" xlink:to="AREN_ExercisePriceRangeFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ExercisePriceRangeFiveMember_doc" xml:lang="en-US">Exercise Price Range Five [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExercisePriceRangeSixMember" xlink:to="AREN_ExercisePriceRangeSixMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ExercisePriceRangeSixMember_doc" xml:lang="en-US">Exercise Price Range Six [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExercisePriceRangeSevenMember" xlink:to="AREN_ExercisePriceRangeSevenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ExercisePriceRangeSevenMember_doc" xml:lang="en-US">Exercise Price Range Seven [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExercisePriceRangeEightMember" xlink:to="AREN_ExercisePriceRangeEightMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ExercisePriceRangeEightMember_doc" xml:lang="en-US">Exercise Price Range Eight [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AccountsReceivablePercentage" xlink:to="AREN_AccountsReceivablePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_AccountsReceivablePercentage_doc" xml:lang="en-US">Accounts receivable percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OriginalAwardAtTheRepricingDate" xlink:to="AREN_OriginalAwardAtTheRepricingDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_OriginalAwardAtTheRepricingDate_doc" xml:lang="en-US">Original award repricing date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SportsIllustratedLicensingAgreementMember" xlink:to="AREN_SportsIllustratedLicensingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SportsIllustratedLicensingAgreementMember_doc" xml:lang="en-US">Sports Illustrated Licensing Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_doc" xml:lang="en-US">Equity instruments unvested outstanding number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_doc" xml:lang="en-US">Option equity instruments vested outstanding number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_doc" xml:lang="en-US">Weighted average exercise price outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_WeightedAverageRemainingContractualLifeOutstanding" xlink:to="AREN_WeightedAverageRemainingContractualLifeOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_WeightedAverageRemainingContractualLifeOutstanding_doc" xml:lang="en-US">Weighted average remaining contractual life outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber_doc" xml:lang="en-US">Option equity instruments unvested issued number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber_doc" xml:lang="en-US">Equity instruments vested outstanding vested in period number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_UnamortizedDebtCost" xlink:to="AREN_UnamortizedDebtCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_UnamortizedDebtCost_doc" xml:lang="en-US">Unamortized debt cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FairMarketValueOfStockOption" xlink:to="AREN_FairMarketValueOfStockOption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_FairMarketValueOfStockOption_doc" xml:lang="en-US">Fair market value of stock option.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FinancingAndSecurityAgreementMember" xlink:to="AREN_FinancingAndSecurityAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_FinancingAndSecurityAgreementMember_doc" xml:lang="en-US">Financing And Security Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SLRDigitalFinanceLLCMember" xlink:to="AREN_SLRDigitalFinanceLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SLRDigitalFinanceLLCMember_doc" xml:lang="en-US">SLR Digital Finance LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_TwoThousandTwentyThreeNotesMember" xlink:to="AREN_TwoThousandTwentyThreeNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_TwoThousandTwentyThreeNotesMember_doc" xml:lang="en-US">2023 Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeriesLPreferredStockMember" xlink:to="AREN_SeriesLPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SeriesLPreferredStockMember_doc" xml:lang="en-US">Series L Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RisksAndUncertaintiesPolicy" xlink:to="AREN_RisksAndUncertaintiesPolicy_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_RisksAndUncertaintiesPolicy_doc" xml:lang="en-US">Risks And Uncertainties [Policy]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CostOfRevenuePolicyTextBlock" xlink:to="AREN_CostOfRevenuePolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_CostOfRevenuePolicyTextBlock_doc" xml:lang="en-US">Cost Of Revenue [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ContractBalancesPolicyTextBlock" xlink:to="AREN_ContractBalancesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ContractBalancesPolicyTextBlock_doc" xml:lang="en-US">Contract Balances [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SubscriptionAcquisitionCostsPoliceTextBlock" xlink:to="AREN_SubscriptionAcquisitionCostsPoliceTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SubscriptionAcquisitionCostsPoliceTextBlock_doc" xml:lang="en-US">Subscription Acquisition Costs [Police Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BRileyMember" xlink:to="AREN_BRileyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BRileyMember_doc" xml:lang="en-US">B Riley [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock" xlink:to="AREN_ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock_doc" xml:lang="en-US">Schedule Of Depreciation And Amortization Useful Lives Of Assets [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPayableNonCurrent" xlink:to="AREN_LiquidatedDamagesPayableNonCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LiquidatedDamagesPayableNonCurrent_doc" xml:lang="en-US">Liquidated damages payable non current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PlatformDevelopmentPolicyTextBlock" xlink:to="AREN_PlatformDevelopmentPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PlatformDevelopmentPolicyTextBlock_doc" xml:lang="en-US">Platform Development [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPolicyTextBlock" xlink:to="AREN_LiquidatedDamagesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LiquidatedDamagesPolicyTextBlock_doc" xml:lang="en-US">Liquidated Damages [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SellingAndMarketingPolicyTextBlock" xlink:to="AREN_SellingAndMarketingPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SellingAndMarketingPolicyTextBlock_doc" xml:lang="en-US">Selling And Marketing [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_GeneralandAdministrativePolicyTextBlock" xlink:to="AREN_GeneralandAdministrativePolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_GeneralandAdministrativePolicyTextBlock_doc" xml:lang="en-US">Generaland Administrative [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PreferredStockPolicyTextBlock" xlink:to="AREN_PreferredStockPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PreferredStockPolicyTextBlock_doc" xml:lang="en-US">Preferred Stock [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AggregatePrincipalMinimumAmount" xlink:to="AREN_AggregatePrincipalMinimumAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_AggregatePrincipalMinimumAmount_doc" xml:lang="en-US">Aggregate principal minimum amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ParadePrintMember" xlink:to="AREN_ParadePrintMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ParadePrintMember_doc" xml:lang="en-US">Parade Print [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SeniorSecuredNoteMember" xlink:to="AREN_SeniorSecuredNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SeniorSecuredNoteMember_doc" xml:lang="en-US">Senior Secured Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ContingentConsiderationMember" xlink:to="AREN_ContingentConsiderationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ContingentConsiderationMember_doc" xml:lang="en-US">Contingent Consideration [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_TeneologyIncMember" xlink:to="AREN_TeneologyIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_TeneologyIncMember_doc" xml:lang="en-US">Teneology Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationConsiderationTransferredInstallmentDue" xlink:to="AREN_BusinessCombinationConsiderationTransferredInstallmentDue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BusinessCombinationConsiderationTransferredInstallmentDue_doc" xml:lang="en-US">Business combination consideration transferred installment due.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_WorkingCapital" xlink:to="AREN_WorkingCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_WorkingCapital_doc" xml:lang="en-US">Working capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CommonStockAwardsMember" xlink:to="AREN_CommonStockAwardsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_CommonStockAwardsMember_doc" xml:lang="en-US">Common Stock Awards [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ScheduleOfWarrantsActivityTableTextBlock" xlink:to="AREN_ScheduleOfWarrantsActivityTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ScheduleOfWarrantsActivityTableTextBlock_doc" xml:lang="en-US">Schedule Of Warrants Activity [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BRileyFBRIncMember" xlink:to="AREN_BRileyFBRIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_BRileyFBRIncMember_doc" xml:lang="en-US">B Riley FBR Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_WeightedAverageRemainingContractualLifeOutstanding1" xlink:to="AREN_WeightedAverageRemainingContractualLifeOutstanding1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_WeightedAverageRemainingContractualLifeOutstanding1_doc" xml:lang="en-US">Weighted average remaining contractual life outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_doc" xml:lang="en-US">Financing warrant, exercisable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price outstanding exercisable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_WeightedAverageRemainingContractualLifeExercisable" xlink:to="AREN_WeightedAverageRemainingContractualLifeExercisable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_WeightedAverageRemainingContractualLifeExercisable_doc" xml:lang="en-US">Weighted average remaining contractual life exercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instrument non vested.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award nonoption equity instruments available for future grants number.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_Disposition2023Member" xlink:to="AREN_Disposition2023Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_Disposition2023Member_doc" xml:lang="en-US">Disposition 2023 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ScheduleOfAssetsAcquiredTableTextBlock" xlink:to="AREN_ScheduleOfAssetsAcquiredTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ScheduleOfAssetsAcquiredTableTextBlock_doc" xml:lang="en-US">Schedule Of Assets Acquired [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OneEightyDegreeCapitalCorpMember" xlink:to="AREN_OneEightyDegreeCapitalCorpMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_OneEightyDegreeCapitalCorpMember_doc" xml:lang="en-US">One Eighty Degree Capital Corp [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DanielShribmanMember" xlink:to="AREN_DanielShribmanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DanielShribmanMember_doc" xml:lang="en-US">Daniel Shribman [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RossLevinsohnMember" xlink:to="AREN_RossLevinsohnMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_RossLevinsohnMember_doc" xml:lang="en-US">Ross Levinsohn [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PaulEdmonsonMember" xlink:to="AREN_PaulEdmonsonMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PaulEdmonsonMember_doc" xml:lang="en-US">Paul Edmonson [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_UnderwritingPublicOfferingMember" xlink:to="AREN_UnderwritingPublicOfferingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_UnderwritingPublicOfferingMember_doc" xml:lang="en-US">Underwriting Public Offering [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_UnderwritingOverallotmentMember" xlink:to="AREN_UnderwritingOverallotmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_UnderwritingOverallotmentMember_doc" xml:lang="en-US">Underwriting Overallotment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DebtInstrumentIncreaseAccruedInterestAmountDue" xlink:to="AREN_DebtInstrumentIncreaseAccruedInterestAmountDue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DebtInstrumentIncreaseAccruedInterestAmountDue_doc" xml:lang="en-US">Debt instrument increase accrued interest amount due.</link:label>
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NotePurchaseAgreementDefaultMember" xlink:label="AREN_NotePurchaseAgreementDefaultMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_NotePurchaseAgreementDefaultMember" xlink:to="AREN_NotePurchaseAgreementDefaultMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_NotePurchaseAgreementDefaultMember_doc" xml:lang="en-US">Note Purchase Agreement Default [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ExerciseRightTerminationAmount" xlink:to="AREN_ExerciseRightTerminationAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ExerciseRightTerminationAmount_doc" xml:lang="en-US">Exercise right termination amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LicensingAgreementMember" xlink:to="AREN_LicensingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LicensingAgreementMember_doc" xml:lang="en-US">Licensing Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_TerminationFeeDue" xlink:to="AREN_TerminationFeeDue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_TerminationFeeDue_doc" xml:lang="en-US">Termination fee due.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_TransactionAgreementMember" xlink:to="AREN_TransactionAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_TransactionAgreementMember_doc" xml:lang="en-US">Transaction Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ABGWarransMember" xlink:to="AREN_ABGWarransMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ABGWarransMember_doc" xml:lang="en-US">ABG Warrans [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ABGTimeBasedWarrantsMember" xlink:to="AREN_ABGTimeBasedWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ABGTimeBasedWarrantsMember_doc" xml:lang="en-US">ABG Time Based Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ABGPerformanceBasedWarrantsMember" xlink:to="AREN_ABGPerformanceBasedWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ABGPerformanceBasedWarrantsMember_doc" xml:lang="en-US">ABG Performance Based Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RestrictedStockUnitsMember" xlink:to="AREN_RestrictedStockUnitsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_RestrictedStockUnitsMember_doc" xml:lang="en-US">Restricted Stock Units [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ScheduleOfRestrictedStockUnitsActivityTableTextBlock" xlink:to="AREN_ScheduleOfRestrictedStockUnitsActivityTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ScheduleOfRestrictedStockUnitsActivityTableTextBlock_doc" xml:lang="en-US">Schedule Of Restricted Stock Units Activity [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SharesOutstandingPercentage" xlink:to="AREN_SharesOutstandingPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SharesOutstandingPercentage_doc" xml:lang="en-US">Shares outstanding percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award equity instruments other than options vested number vested.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award equity instruments other than options vested number released.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OutstandingPercentage" xlink:to="AREN_OutstandingPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_OutstandingPercentage_doc" xml:lang="en-US">Outstanding percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CommonEquityAwardsMember" xlink:to="AREN_CommonEquityAwardsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_CommonEquityAwardsMember_doc" xml:lang="en-US">Common Equity Awards [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SubscriptionAgreementMember" xlink:to="AREN_SubscriptionAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SubscriptionAgreementMember_doc" xml:lang="en-US">Subscription Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockBasedCompensationMember" xlink:to="AREN_StockBasedCompensationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockBasedCompensationMember_doc" xml:lang="en-US">Stock Based Compensation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_CostsChargedToOperations" xlink:to="AREN_CostsChargedToOperations_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_CostsChargedToOperations_doc" xml:lang="en-US">Costs charged to operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DebtInstrumentPeriodicPaymentPrincipalBalance" xlink:to="AREN_DebtInstrumentPeriodicPaymentPrincipalBalance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DebtInstrumentPeriodicPaymentPrincipalBalance_doc" xml:lang="en-US">Debt instrument periodic payment principal balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ScheduleOfUnrecognizedCompensationExpense" xlink:to="AREN_ScheduleOfUnrecognizedCompensationExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ScheduleOfUnrecognizedCompensationExpense_doc" xml:lang="en-US">Schedule of unrecognized compensation expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SalePrice" xlink:to="AREN_SalePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SalePrice_doc" xml:lang="en-US">Sale price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PreliminaryWorkingCapital" xlink:to="AREN_PreliminaryWorkingCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PreliminaryWorkingCapital_doc" xml:lang="en-US">Preliminary working capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_WorkingCapitalAdjustments" xlink:to="AREN_WorkingCapitalAdjustments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_WorkingCapitalAdjustments_doc" xml:lang="en-US">Working capital adjustments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatingDamagesPayableDisclosureTextBlock" xlink:to="AREN_LiquidatingDamagesPayableDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LiquidatingDamagesPayableDisclosureTextBlock_doc" xml:lang="en-US">Liquidating Damages Payable Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPayable" xlink:to="AREN_LiquidatedDamagesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LiquidatedDamagesPayable_doc" xml:lang="en-US">Liquidated damages payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FinalSalePrice" xlink:to="AREN_FinalSalePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_FinalSalePrice_doc" xml:lang="en-US">Final sale price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodSharesAcquisition" xlink:to="AREN_StockIssuedDuringPeriodSharesAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockIssuedDuringPeriodSharesAcquisition_doc" xml:lang="en-US">Stock issued during period shares acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options outstanding number one.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options exercisable number one.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FlexyStudiosMember" xlink:to="AREN_FlexyStudiosMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_FlexyStudiosMember_doc" xml:lang="en-US">Flexy Studios [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SimplyfyLoanMember" xlink:to="AREN_SimplyfyLoanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SimplyfyLoanMember_doc" xml:lang="en-US">Simplyfy Loan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes" xlink:to="AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes_doc" xml:lang="en-US">Stock issued during period shares common stock with held for taxes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OctoberOneTwoThousandAndTwentyFourMember" xlink:to="AREN_OctoberOneTwoThousandAndTwentyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_OctoberOneTwoThousandAndTwentyFourMember_doc" xml:lang="en-US">October One Two Thousand And Twenty Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense" xlink:to="AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense_doc" xml:lang="en-US">Disposal group including discontinued operation selling and marketing expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges" xlink:to="AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges_doc" xml:lang="en-US">Disposal group including discontinued operation asset impairment charges.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AssetAcquisitionAssetsAcquired" xlink:to="AREN_AssetAcquisitionAssetsAcquired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_AssetAcquisitionAssetsAcquired_doc" xml:lang="en-US">Asset acquisition assets acquired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PaymentsToAcquireBusinessesAtClosing" xlink:to="AREN_PaymentsToAcquireBusinessesAtClosing_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PaymentsToAcquireBusinessesAtClosing_doc" xml:lang="en-US">Payments to acquire businesses at closing.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PrepaidSuppliesCurrent" xlink:to="AREN_PrepaidSuppliesCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PrepaidSuppliesCurrent_doc" xml:lang="en-US">Prepaid supplies current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PrincipalAmountPrepayDue" xlink:to="AREN_PrincipalAmountPrepayDue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PrincipalAmountPrepayDue_doc" xml:lang="en-US">Principal amount prepay due.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_NewPublisherPartnerWarrantMember" xlink:to="AREN_NewPublisherPartnerWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_NewPublisherPartnerWarrantMember_doc" xml:lang="en-US">New Publisher Partner Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DigitalAdvertisingMember" xlink:to="AREN_DigitalAdvertisingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DigitalAdvertisingMember_doc" xml:lang="en-US">Digital Advertising [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DigitalSubscriptionsMember" xlink:to="AREN_DigitalSubscriptionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DigitalSubscriptionsMember_doc" xml:lang="en-US">Digital Subscriptions [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LicensingAndSyndicationRevenueMember" xlink:to="AREN_LicensingAndSyndicationRevenueMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LicensingAndSyndicationRevenueMember_doc" xml:lang="en-US">Licensing And Syndication Revenue [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PrintAdvertisingMember" xlink:to="AREN_PrintAdvertisingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PrintAdvertisingMember_doc" xml:lang="en-US">Print Advertising [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PrintSubscriptionsMember" xlink:to="AREN_PrintSubscriptionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PrintSubscriptionsMember_doc" xml:lang="en-US">Print Subscriptions [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OtherMember" xlink:to="AREN_OtherMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_OtherMember_doc" xml:lang="en-US">Other [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PrintRevenueMember" xlink:to="AREN_PrintRevenueMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_PrintRevenueMember_doc" xml:lang="en-US">Print Revenue [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DigitalRevenueMember" xlink:to="AREN_DigitalRevenueMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_DigitalRevenueMember_doc" xml:lang="en-US">Digital Revenue [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ParadeMember" xlink:to="AREN_ParadeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ParadeMember_doc" xml:lang="en-US">Parade [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ArenaMember" xlink:to="AREN_ArenaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ArenaMember_doc" xml:lang="en-US">Arena [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AdjustmentsMember" xlink:to="AREN_AdjustmentsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_AdjustmentsMember_doc" xml:lang="en-US">Adjustments [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_SubleaseAgreementMember" xlink:to="AREN_SubleaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_SubleaseAgreementMember_doc" xml:lang="en-US">Sublease Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_MarketingAndAdvertisingExpenseRemaining" xlink:to="AREN_MarketingAndAdvertisingExpenseRemaining_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_MarketingAndAdvertisingExpenseRemaining_doc" xml:lang="en-US">Marketing and advertising expense remaining carrying on.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiabilitiesInConnectionWithAcquisitionsAndDispositions" xlink:to="AREN_LiabilitiesInConnectionWithAcquisitionsAndDispositions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LiabilitiesInConnectionWithAcquisitionsAndDispositions_doc" xml:lang="en-US">Liabilities in connection with acquisitions and dispositions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_MembersOfBoardMember" xlink:to="AREN_MembersOfBoardMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_MembersOfBoardMember_doc" xml:lang="en-US">Members Of Board [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FormerEmployeesMember" xlink:to="AREN_FormerEmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_FormerEmployeesMember_doc" xml:lang="en-US">Former Employees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ImputedInterestRate" xlink:to="AREN_ImputedInterestRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ImputedInterestRate_doc" xml:lang="en-US">Imputed interest rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_MensJournalMember" xlink:to="AREN_MensJournalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_MensJournalMember_doc" xml:lang="en-US">Mens Journal [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LossOnSaleOfAssets" xlink:to="AREN_LossOnSaleOfAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_LossOnSaleOfAssets_doc" xml:lang="en-US">Loss on sale of assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ArenaLoanAgreementMember" xlink:to="AREN_ArenaLoanAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="AREN_ArenaLoanAgreementMember_doc" xml:lang="en-US">Arena Loan Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DelayedDrawTermNoteMember" xlink:to="AREN_DelayedDrawTermNoteMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DelayedDrawTermNoteMember_3_lbl" xml:lang="en-US">Delayed Draw Term Notes [Member] [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_NoncashAndAccruedInterest" xlink:to="AREN_NoncashAndAccruedInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_NoncashAndAccruedInterest_4_lbl" xml:lang="en-US">Noncash and accrued interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:to="us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_2_lbl" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatingDamagesPayable" xlink:to="AREN_LiquidatingDamagesPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LiquidatingDamagesPayable_3_lbl" xml:lang="en-US">LiquidatingDamagesPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts" xlink:to="AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts_3_lbl" xml:lang="en-US">IncreaseDecreaseInSubscriptionAcquisitionCosts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidRoyalties" xlink:to="us-gaap_IncreaseDecreaseInPrepaidRoyalties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidRoyalties_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Royalties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_IncreaseDecreaseInSubscriptionRefundLiability" xlink:to="AREN_IncreaseDecreaseInSubscriptionRefundLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_IncreaseDecreaseInSubscriptionRefundLiability_3_lbl" xml:lang="en-US">IncreaseDecreaseInSubscriptionRefundLiability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2_lbl" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PaymentsForCapitalizedPlatformDevelopment" xlink:to="AREN_PaymentsForCapitalizedPlatformDevelopment_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PaymentsForCapitalizedPlatformDevelopment_3_lbl" xml:lang="en-US">PaymentsForCapitalizedPlatformDevelopment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2_lbl" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PaymentOfDeferredCashPayment" xlink:to="AREN_PaymentOfDeferredCashPayment_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PaymentOfDeferredCashPayment_3_lbl" xml:lang="en-US">PaymentOfDeferredCashPayment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PaymentOfRestrictedStockLiabilities" xlink:to="AREN_PaymentOfRestrictedStockLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PaymentOfRestrictedStockLiabilities_3_lbl" xml:lang="en-US">PaymentOfRestrictedStockLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCash_2_lbl" xml:lang="en-US">Restricted Cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_2_lbl" xml:lang="en-US">Stock Issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DiscontinuedOperationsTextBlock" xlink:to="AREN_DiscontinuedOperationsTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DiscontinuedOperationsTextBlock_3_lbl" xml:lang="en-US">DiscontinuedOperationsTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_2_lbl" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PlatformDevelopmentDisclosureTextBlock" xlink:to="AREN_PlatformDevelopmentDisclosureTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PlatformDevelopmentDisclosureTextBlock_3_lbl" xml:lang="en-US">Platform Development Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillDisclosureTextBlock_2_lbl" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_RestrictedStockLiabilitiesTextBlock" xlink:to="AREN_RestrictedStockLiabilitiesTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_RestrictedStockLiabilitiesTextBlock_3_lbl" xml:lang="en-US">RestrictedStockLiabilitiesTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPayableTextBlock" xlink:to="AREN_LiquidatedDamagesPayableTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LiquidatedDamagesPayableTextBlock_3_lbl" xml:lang="en-US">Liquidated Damages Payable [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OtherLongtermLiabilitiesTextBlock" xlink:to="AREN_OtherLongtermLiabilitiesTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_OtherLongtermLiabilitiesTextBlock_3_lbl" xml:lang="en-US">OtherLongtermLiabilitiesTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatingDamagesPayableDisclosureTextBlock" xlink:to="AREN_LiquidatingDamagesPayableDisclosureTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LiquidatingDamagesPayableDisclosureTextBlock_3_lbl" xml:lang="en-US">LiquidatingDamagesPayableDisclosureTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_2_lbl" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PlatformDevelopmentPolicyTextBlock" xlink:to="AREN_PlatformDevelopmentPolicyTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PlatformDevelopmentPolicyTextBlock_3_lbl" xml:lang="en-US">Platform Development [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_2_lbl" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LiquidatedDamagesPolicyTextBlock" xlink:to="AREN_LiquidatedDamagesPolicyTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LiquidatedDamagesPolicyTextBlock_3_lbl" xml:lang="en-US">Liquidated Damages [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_PreferredStockPolicyTextBlock" xlink:to="AREN_PreferredStockPolicyTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_PreferredStockPolicyTextBlock_3_lbl" xml:lang="en-US">Preferred Stock [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_3_lbl" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_2_lbl" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Gross Profit (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense" xlink:to="AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense_3_lbl" xml:lang="en-US">DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, General and Administrative Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges" xlink:to="AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges_3_lbl" xml:lang="en-US">DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_2_lbl" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:to="us-gaap_DepreciationAndAmortizationDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortizationDiscontinuedOperations_2_lbl" xml:lang="en-US">Depreciation and Amortization, Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-gaap_GainLossOnDispositionOfAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets_2_lbl" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_2_lbl" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Contingent Consideration</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_2_lbl" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_3_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Revenues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship_3_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_3_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue_3_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability" xlink:to="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability_3_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_FinalSalePrice" xlink:to="AREN_FinalSalePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_FinalSalePrice_3_lbl" xml:lang="en-US">FinalSalePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription_2_lbl" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_2_lbl" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnearnedPremiums" xlink:to="us-gaap_UnearnedPremiums_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnearnedPremiums_2_lbl" xml:lang="en-US">Unearned Premiums</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLaborRelatedExpenses" xlink:to="us-gaap_OtherLaborRelatedExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLaborRelatedExpenses_2_lbl" xml:lang="en-US">Other Labor-related Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentOther" xlink:to="us-gaap_PropertyPlantAndEquipmentOther_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentOther_3_lbl" xml:lang="en-US">Property, Plant and Equipment, Other, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivables_2_lbl" xml:lang="en-US">Other Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_2_lbl" xml:lang="en-US">Long-Term Line of Credit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_LeaseTerminationLiabilityNonCurrent" xlink:to="AREN_LeaseTerminationLiabilityNonCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_LeaseTerminationLiabilityNonCurrent_3_lbl" xml:lang="en-US">Lease termination liability non current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OtherLongTermLiabilitiesNoncurrent" xlink:to="AREN_OtherLongTermLiabilitiesNoncurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_OtherLongTermLiabilitiesNoncurrent_3_lbl" xml:lang="en-US">Other long term liabilities non current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_AggregatePrincipalMinimumAmount" xlink:to="AREN_AggregatePrincipalMinimumAmount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_AggregatePrincipalMinimumAmount_3_lbl" xml:lang="en-US">AggregatePrincipalMinimumAmount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="us-gaap_DebtInstrumentUnamortizedPremium_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium_2_lbl" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_2_lbl" xml:lang="en-US">Long-Term Debt, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_2_lbl" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_2_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_WeightedAverageRemainingContractualLifeOutstanding1" xlink:to="AREN_WeightedAverageRemainingContractualLifeOutstanding1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_WeightedAverageRemainingContractualLifeOutstanding1_3_lbl" xml:lang="en-US">WeightedAverageRemainingContractualLifeOutstanding1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber" xlink:to="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current Federal, State and Local, Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_2_lbl" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredTaxAssetsLiquidatingDamagesPayable" xlink:to="AREN_DeferredTaxAssetsLiquidatingDamagesPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DeferredTaxAssetsLiquidatingDamagesPayable_3_lbl" xml:lang="en-US">DeferredTaxAssetsLiquidatingDamagesPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_2_lbl" xml:lang="en-US">Deferred Tax Assets, Deferred Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2_lbl" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredTaxAssetsOperatingLeaseLiability" xlink:to="AREN_DeferredTaxAssetsOperatingLeaseLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DeferredTaxAssetsOperatingLeaseLiability_3_lbl" xml:lang="en-US">DeferredTaxAssetsOperatingLeaseLiability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DeferredTaxAssetsDepreciationAndAmortization" xlink:to="AREN_DeferredTaxAssetsDepreciationAndAmortization_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DeferredTaxAssetsDepreciationAndAmortization_3_lbl" xml:lang="en-US">DeferredTaxAssetsDepreciationAndAmortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue" xlink:to="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue_3_lbl" xml:lang="en-US">EffectiveIncomeTaxRateReconciliationUnearnedRevenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_2_lbl" xml:lang="en-US">Operating Loss Carryforwards</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_DebtInstrumentIncreaseAccruedInterestAmountDue" xlink:to="AREN_DebtInstrumentIncreaseAccruedInterestAmountDue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_DebtInstrumentIncreaseAccruedInterestAmountDue_3_lbl" xml:lang="en-US">DebtInstrumentIncreaseAccruedInterestAmountDue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_StockRepurchasedDuringPeriodValue1" xlink:to="AREN_StockRepurchasedDuringPeriodValue1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_StockRepurchasedDuringPeriodValue1_3_lbl" xml:lang="en-US">StockRepurchasedDuringPeriodValue1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_TerminationFeeDue" xlink:to="AREN_TerminationFeeDue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_TerminationFeeDue_3_lbl" xml:lang="en-US">TerminationFeeDue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AREN_OutstandingPercentage" xlink:to="AREN_OutstandingPercentage_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="AREN_OutstandingPercentage_3_lbl" xml:lang="en-US">OutstandingPercentage</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>18
<FILENAME>aren-20231231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://thearenagroup.net/role/Cover" xlink:href="aren-20231231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/BalanceSheets" xlink:href="aren-20231231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/BalanceSheetsParenthetical" xlink:href="aren-20231231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StatementsOfOperations" xlink:href="aren-20231231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StatementsOfOperationsParenthetical" xlink:href="aren-20231231.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StatementsOfStockholdersDeficiency" xlink:href="aren-20231231.xsd#StatementsOfStockholdersDeficiency" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StatementsOfCashFlows" xlink:href="aren-20231231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OrganizationAndBasisOfPresentation" xlink:href="aren-20231231.xsd#OrganizationAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfSignificantAccountingPolicies" xlink:href="aren-20231231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/DiscontinuedOperations" xlink:href="aren-20231231.xsd#DiscontinuedOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/AcquisitionsAndDispositions" xlink:href="aren-20231231.xsd#AcquisitionsAndDispositions" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssets" xlink:href="aren-20231231.xsd#PrepaymentsAndOtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PropertyAndEquipment" xlink:href="aren-20231231.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/Leases" xlink:href="aren-20231231.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PlatformDevelopment" xlink:href="aren-20231231.xsd#PlatformDevelopment" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IntangibleAssets" xlink:href="aren-20231231.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OtherLong-termAssets" xlink:href="aren-20231231.xsd#OtherLong-termAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/Goodwill" xlink:href="aren-20231231.xsd#Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/RestrictedStockLiabilities" xlink:href="aren-20231231.xsd#RestrictedStockLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/AccruedExpensesAndOther" xlink:href="aren-20231231.xsd#AccruedExpensesAndOther" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LineOfCredit" xlink:href="aren-20231231.xsd#LineOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LiquidatedDamagesPayable" xlink:href="aren-20231231.xsd#LiquidatedDamagesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OtherLong-termLiabilities" xlink:href="aren-20231231.xsd#OtherLong-termLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/FairValueMeasurement" xlink:href="aren-20231231.xsd#FairValueMeasurement" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/BridgeNotes" xlink:href="aren-20231231.xsd#BridgeNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/Long-termDebt" xlink:href="aren-20231231.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PreferredStock" xlink:href="aren-20231231.xsd#PreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockholdersDeficiency" xlink:href="aren-20231231.xsd#StockholdersDeficiency" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockbasedCompensation" xlink:href="aren-20231231.xsd#StockbasedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LiquidatedDamages" xlink:href="aren-20231231.xsd#LiquidatedDamages" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IncomeTaxes" xlink:href="aren-20231231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PensionPlans" xlink:href="aren-20231231.xsd#PensionPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/RelatedPartyTransactions" xlink:href="aren-20231231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/CommitmentsAndContingencies" xlink:href="aren-20231231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SubsequentEvents" xlink:href="aren-20231231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="aren-20231231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="aren-20231231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/DiscontinuedOperationsTables" xlink:href="aren-20231231.xsd#DiscontinuedOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/AcquisitionsAndDispositionsTables" xlink:href="aren-20231231.xsd#AcquisitionsAndDispositionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsTables" xlink:href="aren-20231231.xsd#PrepaymentsAndOtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PropertyAndEquipmentTables" xlink:href="aren-20231231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LeasesTables" xlink:href="aren-20231231.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PlatformDevelopmentTables" xlink:href="aren-20231231.xsd#PlatformDevelopmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IntangibleAssetsTables" xlink:href="aren-20231231.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OtherLong-termAssetsTables" xlink:href="aren-20231231.xsd#OtherLong-termAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/GoodwillTables" xlink:href="aren-20231231.xsd#GoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/AccruedExpensesAndOtherTables" xlink:href="aren-20231231.xsd#AccruedExpensesAndOtherTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LiquidatedDamagesPayableTables" xlink:href="aren-20231231.xsd#LiquidatedDamagesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OtherLong-termLiabilitiesTables" xlink:href="aren-20231231.xsd#OtherLong-termLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/FairValueMeasurementTables" xlink:href="aren-20231231.xsd#FairValueMeasurementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/Long-termDebtTables" xlink:href="aren-20231231.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockholdersDeficiencyTables" xlink:href="aren-20231231.xsd#StockholdersDeficiencyTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockbasedCompensationTables" xlink:href="aren-20231231.xsd#StockbasedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IncomeTaxesTables" xlink:href="aren-20231231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/OrganizationAndBasisOfPresentationDetailsNarrative" xlink:href="aren-20231231.xsd#OrganizationAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails" xlink:href="aren-20231231.xsd#ScheduleOfDisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails" xlink:href="aren-20231231.xsd#ScheduleOfContractWithCustomerAssetAndLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfCashAndRestrictedCashDetails" xlink:href="aren-20231231.xsd#ScheduleOfCashAndRestrictedCashDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:href="aren-20231231.xsd#ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails" xlink:href="aren-20231231.xsd#ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails" xlink:href="aren-20231231.xsd#ScheduleOfNetIncomeLossPerCommonShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="aren-20231231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails" xlink:href="aren-20231231.xsd#ScheduleOfDiscontinuedOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/DiscontinuedOperationsDetailsNarrative" xlink:href="aren-20231231.xsd#DiscontinuedOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails" xlink:href="aren-20231231.xsd#ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails" xlink:href="aren-20231231.xsd#SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails" xlink:href="aren-20231231.xsd#ScheduleOfCompositionOfPurchasePriceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails" xlink:href="aren-20231231.xsd#SummaryOfPurchasePriceAllocationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails" xlink:href="aren-20231231.xsd#ScheduleOfSupplementalProformaInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails" xlink:href="aren-20231231.xsd#ScheduleOfPreliminaryPriceAllocationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative" xlink:href="aren-20231231.xsd#AcquisitionsAndDispositionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails" xlink:href="aren-20231231.xsd#ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsDetailsNarrative" xlink:href="aren-20231231.xsd#PrepaymentsAndOtherCurrentAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="aren-20231231.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PropertyAndEquipmentDetailsNarrative" xlink:href="aren-20231231.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails" xlink:href="aren-20231231.xsd#ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails" xlink:href="aren-20231231.xsd#ScheduleOfOperatingLeaseCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetailsParenthetical" xlink:href="aren-20231231.xsd#ScheduleOfOperatingLeaseCostsDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfMaturityOfLeaseLiabilitiesDetails" xlink:href="aren-20231231.xsd#SummaryOfMaturityOfLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LeasesDetailsNarrative" xlink:href="aren-20231231.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails" xlink:href="aren-20231231.xsd#SummaryOfPlatformDevelopmentCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails" xlink:href="aren-20231231.xsd#SummaryOfPlatformDevelopmentCostActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative" xlink:href="aren-20231231.xsd#PlatformDevelopmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails" xlink:href="aren-20231231.xsd#ScheduleOfIntangibleAssetsSubjectToAmortizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails" xlink:href="aren-20231231.xsd#ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative" xlink:href="aren-20231231.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfOtherAssetsDetails" xlink:href="aren-20231231.xsd#SummaryOfOtherAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails" xlink:href="aren-20231231.xsd#ScheduleOfChangesInCarryingValueOfGoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/GoodwillDetailsNarrative" xlink:href="aren-20231231.xsd#GoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative" xlink:href="aren-20231231.xsd#RestrictedStockLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails" xlink:href="aren-20231231.xsd#ScheduleOfAccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LineOfCreditDetailsNarrative" xlink:href="aren-20231231.xsd#LineOfCreditDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails" xlink:href="aren-20231231.xsd#SummaryOfLiquidatedDamagesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative" xlink:href="aren-20231231.xsd#LiquidatedDamagesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails" xlink:href="aren-20231231.xsd#ScheduleOfOtherLong-TermLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:href="aren-20231231.xsd#ScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative" xlink:href="aren-20231231.xsd#FairValueMeasurementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/BridgeNotesDetailsNarrative" xlink:href="aren-20231231.xsd#BridgeNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails" xlink:href="aren-20231231.xsd#ScheduleOfLongTermDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical" xlink:href="aren-20231231.xsd#ScheduleOfLongTermDebtDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfInterestExpenseDetails" xlink:href="aren-20231231.xsd#SummaryOfInterestExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/Long-termDebtDetailsNarrative" xlink:href="aren-20231231.xsd#Long-termDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PreferredStockDetailsNarrative" xlink:href="aren-20231231.xsd#PreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails" xlink:href="aren-20231231.xsd#SummaryOfRestrictedStockAwardActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfWarrantActivityDetails" xlink:href="aren-20231231.xsd#SummaryOfWarrantActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative" xlink:href="aren-20231231.xsd#StockholdersDeficiencyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="aren-20231231.xsd#ScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails" xlink:href="aren-20231231.xsd#ScheduleOfFairValueOfStockOptionsAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails" xlink:href="aren-20231231.xsd#SummaryOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical" xlink:href="aren-20231231.xsd#SummaryOfStockOptionActivityDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails" xlink:href="aren-20231231.xsd#ScheduleOfExercisePricesOfCommonStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails" xlink:href="aren-20231231.xsd#ScheduleOfWarrantsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails" xlink:href="aren-20231231.xsd#SummaryOfStock-basedCompensationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails" xlink:href="aren-20231231.xsd#ScheduleOfUnrecognizedCompensationExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative" xlink:href="aren-20231231.xsd#StockbasedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/LiquidatedDamagesDetailsNarrative" xlink:href="aren-20231231.xsd#LiquidatedDamagesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails" xlink:href="aren-20231231.xsd#ScheduleOfIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="aren-20231231.xsd#ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails" xlink:href="aren-20231231.xsd#ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/IncomeTaxesDetailsNarrative" xlink:href="aren-20231231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/PensionPlansDetailsNarrative" xlink:href="aren-20231231.xsd#PensionPlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="aren-20231231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="aren-20231231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://thearenagroup.net/role/SubsequentEventsDetailsNarrative" xlink:href="aren-20231231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesGRedeemableAndConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesGRedeemableAndConvertiblePreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesGRedeemableAndConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesHConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesHConvertiblePreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesHConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaapRestrictedCashCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapRestrictedCashCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetCurrent" xlink:label="loc_us-gaapCapitalizedContractCostNetCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCapitalizedContractCostNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PlatformDevelopmentNet" xlink:label="loc_ARENPlatformDevelopmentNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_ARENPlatformDevelopmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetNoncurrent" xlink:label="loc_us-gaapCapitalizedContractCostNetNoncurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapCapitalizedContractCostNetNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLinesOfCreditCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerRefundLiabilityCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerRefundLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaapAssetAcquisitionContingentConsiderationLiabilityCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableCurrent" xlink:label="loc_ARENLiquidatedDamagesPayableCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ARENLiquidatedDamagesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BridgeNotes" xlink:label="loc_ARENBridgeNotes" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ARENBridgeNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityNoncurrent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatingDamagesPayableNonCurrent" xlink:label="loc_ARENLiquidatingDamagesPayableNonCurrent" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_ARENLiquidatingDamagesPayableNonCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredTaxAndOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapDeferredTaxAndOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaapTemporaryEquityAbstract" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockToBeIssuedDuringPeriod" xlink:label="loc_ARENCommonStockToBeIssuedDuringPeriod" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_ARENCommonStockToBeIssuedDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesGRedeemableAndConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesGRedeemableAndConvertiblePreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesGRedeemableAndConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesHRedeemableAndConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesHRedeemableAndConvertiblePreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesHRedeemableAndConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:label="loc_us-gaapTemporaryEquityLiquidationPreferencePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityLiquidationPreferencePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="loc_us-gaapTemporaryEquityLiquidationPreference" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityLiquidationPreference" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TemporaryEquityCommonSharesIssuableUponConversion" xlink:label="loc_ARENTemporaryEquityCommonSharesIssuableUponConversion" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENTemporaryEquityCommonSharesIssuableUponConversion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapAssetImpairmentCharges" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LossOnSaleOfAssets" xlink:label="loc_ARENLossOnSaleOfAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_ARENLossOnSaleOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesUnderRegistrationRightsAgreements" xlink:label="loc_ARENLiquidatedDamagesUnderRegistrationRightsAgreements" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_ARENLiquidatedDamagesUnderRegistrationRightsAgreements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Consolidated Statements of Operations (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:label="loc_us-gaapCostOfGoodsAndServicesSoldAmortization" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSoldAmortization" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StatementsOfStockholdersDeficiency" xlink:title="00000006 - Statement - Consolidated Statements of Stockholders&apos; Deficiency">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockToBeIssuedMember" xlink:label="loc_ARENCommonStockToBeIssuedMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENCommonStockToBeIssuedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" xlink:label="loc_ARENStockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" xlink:label="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne" xlink:label="loc_ARENStockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne" xlink:label="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" xlink:label="loc_ARENStockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares" xlink:label="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" xlink:label="loc_ARENAdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENAdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes" xlink:label="loc_ARENStockIssuedDuringPeriodValueCommonStockWithheldForTaxes" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodValueCommonStockWithheldForTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares" xlink:label="loc_ARENStockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" xlink:label="loc_ARENAdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENAdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger" xlink:label="loc_ARENStockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" xlink:label="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes" xlink:label="loc_ARENStockIssuedDuringPeriodSharesCommonStockWithheldForTaxes" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodSharesCommonStockWithheldForTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NoncashAndAccruedInterest" xlink:label="loc_ARENNoncashAndAccruedInterest" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ARENNoncashAndAccruedInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:label="loc_us-gaapDisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LossOnSaleOfAssets" xlink:label="loc_ARENLossOnSaleOfAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ARENLossOnSaleOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatingDamagesPayable" xlink:label="loc_ARENLiquidatingDamagesPayable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ARENLiquidatingDamagesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="loc_us-gaapDeferredIncomeTaxesAndTaxCredits" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndTaxCredits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="loc_us-gaapOtherOperatingActivitiesCashFlowStatement" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherOperatingActivitiesCashFlowStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts" xlink:label="loc_ARENIncreaseDecreaseInSubscriptionAcquisitionCosts" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_ARENIncreaseDecreaseInSubscriptionAcquisitionCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidRoyalties" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidRoyalties" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidRoyalties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_IncreaseDecreaseInSubscriptionRefundLiability" xlink:label="loc_ARENIncreaseDecreaseInSubscriptionRefundLiability" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_ARENIncreaseDecreaseInSubscriptionRefundLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentLiabilities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PaymentsForCapitalizedPlatformDevelopment" xlink:label="loc_ARENPaymentsForCapitalizedPlatformDevelopment" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_ARENPaymentsForCapitalizedPlatformDevelopment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_us-gaapProceedsFromSaleOfProductiveAssets" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfProductiveAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfEquityMethodInvestments" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromShortTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PaymentOfDeferredCashPayment" xlink:label="loc_ARENPaymentOfDeferredCashPayment" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_ARENPaymentOfDeferredCashPayment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PaymentOfRestrictedStockLiabilities" xlink:label="loc_ARENPaymentOfRestrictedStockLiabilities" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_ARENPaymentOfRestrictedStockLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaapRestrictedCash" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="loc_us-gaapRestrictedCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ReclassificationOfStockbasedCompensationToPlatformDevelopment" xlink:label="loc_ARENReclassificationOfStockbasedCompensationToPlatformDevelopment" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_ARENReclassificationOfStockbasedCompensationToPlatformDevelopment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:label="loc_us-gaapDebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapDebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaapConversionOfStockAmountIssued1" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapConversionOfStockAmountIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaapStockIssued1" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapStockIssued1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_IssuanceOfCommonStockInConnectionWithAcquisition" xlink:label="loc_ARENIssuanceOfCommonStockInConnectionWithAcquisition" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_ARENIssuanceOfCommonStockInConnectionWithAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredCashPaymentsRecordedInConnectionWithAcquisitions" xlink:label="loc_ARENDeferredCashPaymentsRecordedInConnectionWithAcquisitions" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_ARENDeferredCashPaymentsRecordedInConnectionWithAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:label="loc_us-gaapNoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" />
      <link:presentationArc order="640" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapNoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ReclassificationToLiabilityUponCommonStockModification" xlink:label="loc_ARENReclassificationToLiabilityUponCommonStockModification" />
      <link:presentationArc order="650" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_ARENReclassificationToLiabilityUponCommonStockModification" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OrganizationAndBasisOfPresentation" xlink:title="00000008 - Disclosure - Organization and Basis of Presentation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/DiscontinuedOperations" xlink:title="00000010 - Disclosure - Discontinued Operations">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureDiscontinuedOperationsAbstract" xlink:label="loc_ARENDisclosureDiscontinuedOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DiscontinuedOperationsTextBlock" xlink:label="loc_ARENDiscontinuedOperationsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureDiscontinuedOperationsAbstract" xlink:to="loc_ARENDiscontinuedOperationsTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/AcquisitionsAndDispositions" xlink:title="00000011 - Disclosure - Acquisitions and Dispositions">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssets" xlink:title="00000012 - Disclosure - Prepayments and Other Current Assets">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:label="loc_ARENDisclosurePrepaymentsAndOtherCurrentAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrepaymentsAndOtherCurrentAssetsTextBlock" xlink:label="loc_ARENPrepaymentsAndOtherCurrentAssetsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:to="loc_ARENPrepaymentsAndOtherCurrentAssetsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PropertyAndEquipment" xlink:title="00000013 - Disclosure - Property and Equipment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Leases" xlink:title="00000014 - Disclosure - Leases">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureLeasesAbstract" xlink:label="loc_ARENDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PlatformDevelopment" xlink:title="00000015 - Disclosure - Platform Development">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosurePlatformDevelopmentAbstract" xlink:label="loc_ARENDisclosurePlatformDevelopmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PlatformDevelopmentDisclosureTextBlock" xlink:label="loc_ARENPlatformDevelopmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePlatformDevelopmentAbstract" xlink:to="loc_ARENPlatformDevelopmentDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IntangibleAssets" xlink:title="00000016 - Disclosure - Intangible Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OtherLong-termAssets" xlink:title="00000017 - Disclosure - Other Long-Term Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaapOtherAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Goodwill" xlink:title="00000018 - Disclosure - Goodwill">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="loc_us-gaapGoodwillDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapGoodwillDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/RestrictedStockLiabilities" xlink:title="00000019 - Disclosure - Restricted Stock Liabilities">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureRestrictedStockLiabilitiesAbstract" xlink:label="loc_ARENDisclosureRestrictedStockLiabilitiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedStockLiabilitiesTextBlock" xlink:label="loc_ARENRestrictedStockLiabilitiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureRestrictedStockLiabilitiesAbstract" xlink:to="loc_ARENRestrictedStockLiabilitiesTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/AccruedExpensesAndOther" xlink:title="00000020 - Disclosure - Accrued Expenses and Other">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LineOfCredit" xlink:title="00000021 - Disclosure - Line of Credit">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LiquidatedDamagesPayable" xlink:title="00000022 - Disclosure - Liquidated Damages Payable">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureLiquidatedDamagesPayableAbstract" xlink:label="loc_ARENDisclosureLiquidatedDamagesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableTextBlock" xlink:label="loc_ARENLiquidatedDamagesPayableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLiquidatedDamagesPayableAbstract" xlink:to="loc_ARENLiquidatedDamagesPayableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OtherLong-termLiabilities" xlink:title="00000023 - Disclosure - Other Long-term Liabilities">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureOtherLongtermLiabilitiesAbstract" xlink:label="loc_ARENDisclosureOtherLongtermLiabilitiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OtherLongtermLiabilitiesTextBlock" xlink:label="loc_ARENOtherLongtermLiabilitiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureOtherLongtermLiabilitiesAbstract" xlink:to="loc_ARENOtherLongtermLiabilitiesTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/FairValueMeasurement" xlink:title="00000024 - Disclosure - Fair Value Measurement">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaapFairValueDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/BridgeNotes" xlink:title="00000025 - Disclosure - Bridge Notes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="loc_us-gaapShortTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShortTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Long-termDebt" xlink:title="00000026 - Disclosure - Long-term Debt">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PreferredStock" xlink:title="00000027 - Disclosure - Preferred Stock">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockTextBlock" xlink:label="loc_us-gaapPreferredStockTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapPreferredStockTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockholdersDeficiency" xlink:title="00000028 - Disclosure - Stockholders&#8217; Deficiency">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockbasedCompensation" xlink:title="00000029 - Disclosure - Stock&#8211;Based Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LiquidatedDamages" xlink:title="00000030 - Disclosure - Liquidated Damages">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureLiquidatedDamagesAbstract" xlink:label="loc_ARENDisclosureLiquidatedDamagesAbstract" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatingDamagesPayableDisclosureTextBlock" xlink:label="loc_ARENLiquidatingDamagesPayableDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLiquidatedDamagesAbstract" xlink:to="loc_ARENLiquidatingDamagesPayableDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IncomeTaxes" xlink:title="00000031 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PensionPlans" xlink:title="00000032 - Disclosure - Pension Plans">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="loc_us-gaapCompensationAndEmployeeBenefitPlansTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapCompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/RelatedPartyTransactions" xlink:title="00000033 - Disclosure - Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/CommitmentsAndContingencies" xlink:title="00000034 - Disclosure - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SubsequentEvents" xlink:title="00000035 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000036 - Disclosure - Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RisksAndUncertaintiesPolicy" xlink:label="loc_ARENRisksAndUncertaintiesPolicy" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ARENRisksAndUncertaintiesPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CostOfRevenuePolicyTextBlock" xlink:label="loc_ARENCostOfRevenuePolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ARENCostOfRevenuePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ContractBalancesPolicyTextBlock" xlink:label="loc_ARENContractBalancesPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ARENContractBalancesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SubscriptionAcquisitionCostsPoliceTextBlock" xlink:label="loc_ARENSubscriptionAcquisitionCostsPoliceTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ARENSubscriptionAcquisitionCostsPoliceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PlatformDevelopmentPolicyTextBlock" xlink:label="loc_ARENPlatformDevelopmentPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ARENPlatformDevelopmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaapBusinessCombinationsPolicy" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessCombinationsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="loc_us-gaapDebtPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDebtPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPolicyTextBlock" xlink:label="loc_ARENLiquidatedDamagesPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ARENLiquidatedDamagesPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SellingAndMarketingPolicyTextBlock" xlink:label="loc_ARENSellingAndMarketingPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ARENSellingAndMarketingPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_GeneralandAdministrativePolicyTextBlock" xlink:label="loc_ARENGeneralandAdministrativePolicyTextBlock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ARENGeneralandAdministrativePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaapDerivativesPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PreferredStockPolicyTextBlock" xlink:label="loc_ARENPreferredStockPolicyTextBlock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ARENPreferredStockPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000037 - Disclosure - Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="loc_us-gaapContractWithCustomerAssetAndLiabilityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:label="loc_us-gaapScheduleOfRestrictedCashAndCashEquivalentsTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:label="loc_us-gaapAccountsReceivableAllowanceForCreditLossTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock" xlink:label="loc_ARENScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ARENScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/DiscontinuedOperationsTables" xlink:title="00000038 - Disclosure - Discontinued Operations (Tables)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureDiscontinuedOperationsAbstract" xlink:label="loc_ARENDisclosureDiscontinuedOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="loc_us-gaapScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureDiscontinuedOperationsAbstract" xlink:to="loc_us-gaapScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/AcquisitionsAndDispositionsTables" xlink:title="00000039 - Disclosure - Acquisitions and Dispositions (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable" xlink:label="loc_us-gaapAssetAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapAssetAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="loc_us-gaapAssetAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosMember" xlink:label="loc_ARENFexyStudiosMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_ARENFexyStudiosMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AthlonHoldingsIncMember" xlink:label="loc_ARENAthlonHoldingsIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENAthlonHoldingsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTableTextBlock" xlink:label="loc_us-gaapAssetAcquisitionTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ScheduleOfAssetsAcquiredTableTextBlock" xlink:label="loc_ARENScheduleOfAssetsAcquiredTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENScheduleOfAssetsAcquiredTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PreliminaryPriceAllocationTableTextBlock" xlink:label="loc_ARENPreliminaryPriceAllocationTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENPreliminaryPriceAllocationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsTables" xlink:title="00000040 - Disclosure - Prepayments and Other Current Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:label="loc_ARENDisclosurePrepaymentsAndOtherCurrentAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" xlink:label="loc_ARENScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:to="loc_ARENScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PropertyAndEquipmentTables" xlink:title="00000041 - Disclosure - Property and Equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LeasesTables" xlink:title="00000042 - Disclosure - Leases (Tables)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureLeasesAbstract" xlink:label="loc_ARENDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SupplementalInformationRelatedToOperatingLeasesTableTextBlock" xlink:label="loc_ARENSupplementalInformationRelatedToOperatingLeasesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLeasesAbstract" xlink:to="loc_ARENSupplementalInformationRelatedToOperatingLeasesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PlatformDevelopmentTables" xlink:title="00000043 - Disclosure - Platform Development (Tables)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosurePlatformDevelopmentAbstract" xlink:label="loc_ARENDisclosurePlatformDevelopmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SummaryOfPlatformDevelopmentCostsTableTextBlock" xlink:label="loc_ARENSummaryOfPlatformDevelopmentCostsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePlatformDevelopmentAbstract" xlink:to="loc_ARENSummaryOfPlatformDevelopmentCostsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SummaryOfPlatformDevelopmentCostActivityTableTextBlock" xlink:label="loc_ARENSummaryOfPlatformDevelopmentCostActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePlatformDevelopmentAbstract" xlink:to="loc_ARENSummaryOfPlatformDevelopmentCostActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IntangibleAssetsTables" xlink:title="00000044 - Disclosure - Intangible Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OtherLong-termAssetsTables" xlink:title="00000045 - Disclosure - Other Long-Term Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:label="loc_us-gaapScheduleOfOtherAssetsNoncurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/GoodwillTables" xlink:title="00000046 - Disclosure - Goodwill (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaapScheduleOfGoodwillTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfGoodwillTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/AccruedExpensesAndOtherTables" xlink:title="00000047 - Disclosure - Accrued Expenses and Other (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LiquidatedDamagesPayableTables" xlink:title="00000048 - Disclosure - Liquidated Damages Payable (Tables)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureLiquidatedDamagesPayableAbstract" xlink:label="loc_ARENDisclosureLiquidatedDamagesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SummaryOfLiquidatedDamagesTableTextBlock" xlink:label="loc_ARENSummaryOfLiquidatedDamagesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLiquidatedDamagesPayableAbstract" xlink:to="loc_ARENSummaryOfLiquidatedDamagesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OtherLong-termLiabilitiesTables" xlink:title="00000049 - Disclosure - Other Long-term Liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureOtherLongtermLiabilitiesAbstract" xlink:label="loc_ARENDisclosureOtherLongtermLiabilitiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OtherLongtermLiabilitiesTableTextBlock" xlink:label="loc_ARENOtherLongtermLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureOtherLongtermLiabilitiesAbstract" xlink:to="loc_ARENOtherLongtermLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/FairValueMeasurementTables" xlink:title="00000050 - Disclosure - Fair Value Measurement (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Long-termDebtTables" xlink:title="00000051 - Disclosure - Long-term Debt (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="loc_us-gaapScheduleOfDebtInstrumentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SummaryOfInterestExpenseTableTextBlock" xlink:label="loc_ARENSummaryOfInterestExpenseTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_ARENSummaryOfInterestExpenseTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockholdersDeficiencyTables" xlink:title="00000052 - Disclosure - Stockholders&#8217; Deficiency (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockbasedCompensationTables" xlink:title="00000053 - Disclosure - Stock&#8211;Based Compensation (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedStockUnitsMember" xlink:label="loc_ARENRestrictedStockUnitsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENRestrictedStockUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonEquityAwardsMember" xlink:label="loc_ARENCommonEquityAwardsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENCommonEquityAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockAwardsMember" xlink:label="loc_ARENCommonStockAwardsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENCommonStockAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ARENABGWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NewPublisherPartnerWarrantMember" xlink:label="loc_ARENNewPublisherPartnerWarrantMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENNewPublisherPartnerWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ScheduleOfRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_ARENScheduleOfRestrictedStockUnitsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENScheduleOfRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ScheduleOfWarrantsActivityTableTextBlock" xlink:label="loc_ARENScheduleOfWarrantsActivityTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENScheduleOfWarrantsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ScheduleOfUnrecognizedCompensationExpense" xlink:label="loc_ARENScheduleOfUnrecognizedCompensationExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENScheduleOfUnrecognizedCompensationExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IncomeTaxesTables" xlink:title="00000054 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/OrganizationAndBasisOfPresentationDetailsNarrative" xlink:title="00000055 - Disclosure - Organization and Basis of Presentation (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WorkingCapitalDeficit" xlink:label="loc_ARENWorkingCapitalDeficit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_ARENWorkingCapitalDeficit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails" xlink:title="00000056 - Disclosure - Schedule of Disaggregation of Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalAdvertisingMember" xlink:label="loc_ARENDigitalAdvertisingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENDigitalAdvertisingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalSubscriptionsMember" xlink:label="loc_ARENDigitalSubscriptionsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENDigitalSubscriptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LicensingAndSyndicationRevenueMember" xlink:label="loc_ARENLicensingAndSyndicationRevenueMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENLicensingAndSyndicationRevenueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductAndServiceOtherMember" xlink:label="loc_us-gaapProductAndServiceOtherMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductAndServiceOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalRevenueMember" xlink:label="loc_ARENDigitalRevenueMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENDigitalRevenueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrintAdvertisingMember" xlink:label="loc_ARENPrintAdvertisingMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENPrintAdvertisingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrintSubscriptionsMember" xlink:label="loc_ARENPrintSubscriptionsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENPrintSubscriptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrintRevenueMember" xlink:label="loc_ARENPrintRevenueMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENPrintRevenueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtStatementGeographicalAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OtherMember" xlink:label="loc_ARENOtherMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_ARENOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:label="loc_us-gaapTransferredAtPointInTimeMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:to="loc_us-gaapTransferredAtPointInTimeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferredOverTimeMember" xlink:label="loc_us-gaapTransferredOverTimeMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:to="loc_us-gaapTransferredOverTimeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_2" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails" xlink:title="00000057 - Disclosure - Schedule of Contract with Customer, Asset and Liability (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalRevenueMember" xlink:label="loc_ARENDigitalRevenueMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENDigitalRevenueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrintRevenueMember" xlink:label="loc_ARENPrintRevenueMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENPrintRevenueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfCashAndRestrictedCashDetails" xlink:title="00000058 - Disclosure - Schedule of Cash and Restricted Cash (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaapRestrictedCashCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRestrictedCashCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:title="00000059 - Disclosure - Schedule of Allowance For Doubtful Accounts (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableRecoveries" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableRecoveries" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableWriteOffs" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails" xlink:title="00000060 - Disclosure - Schedule of Depreciation and Amortization, Useful Lives of Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OfficeEquipmentAndComputersMember" xlink:label="loc_ARENOfficeEquipmentAndComputersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_ARENOfficeEquipmentAndComputersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails" xlink:title="00000061 - Disclosure - Schedule of Net Income (Loss) Per Common Share (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesGConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesGConvertiblePreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ARENSeriesGConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="loc_us-gaapSeriesHPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapSeriesHPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FinancingWarrantsMember" xlink:label="loc_ARENFinancingWarrantsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ARENFinancingWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ARENABGWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AllHipHopWarrantsMember" xlink:label="loc_ARENAllHipHopWarrantsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ARENAllHipHopWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PublisherPartnerWarrantsMember" xlink:label="loc_ARENPublisherPartnerWarrantsMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ARENPublisherPartnerWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedStockAwardsMember" xlink:label="loc_ARENRestrictedStockAwardsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ARENRestrictedStockAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockOptionsMember" xlink:label="loc_ARENCommonStockOptionsMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ARENCommonStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000062 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyFBRIncMember" xlink:label="loc_ARENBRileyFBRIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENBRileyFBRIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalAndPrintSubscriptionsMember" xlink:label="loc_ARENDigitalAndPrintSubscriptionsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ARENDigitalAndPrintSubscriptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="loc_us-gaapRevenueFromContractWithCustomerMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapRevenueFromContractWithCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableMember" xlink:label="loc_us-gaapAccountsPayableMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CustomerMember" xlink:label="loc_ARENCustomerMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ARENCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaapSellingAndMarketingExpenseMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingAndMarketingExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerRefundLiabilityCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerRefundLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UnearnedRevenue" xlink:label="loc_ARENUnearnedRevenue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_ARENUnearnedRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:label="loc_us-gaapContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaapRestrictedCashCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRestrictedCashCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortization" xlink:label="loc_us-gaapCapitalizedContractCostAmortization" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCapitalizedContractCostAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNet" xlink:label="loc_us-gaapCapitalizedContractCostNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCapitalizedContractCostNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetNoncurrent" xlink:label="loc_us-gaapCapitalizedContractCostNetNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCapitalizedContractCostNetNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetCurrent" xlink:label="loc_us-gaapCapitalizedContractCostNetCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCapitalizedContractCostNetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesDescription" xlink:label="loc_ARENLiquidatedDamagesDescription" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_ARENLiquidatedDamagesDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails" xlink:title="00000063 - Disclosure - Schedule of Discontinued Operations (Details)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureDiscontinuedOperationsAbstract" xlink:label="loc_ARENDisclosureDiscontinuedOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMultiemployerPlansTable" xlink:label="loc_us-gaapScheduleOfMultiemployerPlansTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureDiscontinuedOperationsAbstract" xlink:to="loc_us-gaapScheduleOfMultiemployerPlansTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MultiemployerPlansLineItems" xlink:label="loc_us-gaapMultiemployerPlansLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfMultiemployerPlansTable" xlink:to="loc_us-gaapMultiemployerPlansLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfMultiemployerPlansTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ParadePrintMember" xlink:label="loc_ARENParadePrintMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_ARENParadePrintMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense" xlink:label="loc_ARENDisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_ARENDisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges" xlink:label="loc_ARENDisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_ARENDisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:label="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/DiscontinuedOperationsDetailsNarrative" xlink:title="00000064 - Disclosure - Discontinued Operations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureDiscontinuedOperationsAbstract" xlink:label="loc_ARENDisclosureDiscontinuedOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:label="loc_us-gaapDepreciationAndAmortizationDiscontinuedOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureDiscontinuedOperationsAbstract" xlink:to="loc_us-gaapDepreciationAndAmortizationDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureDiscontinuedOperationsAbstract" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails" xlink:title="00000065 - Disclosure - Schedule of Composition Preliminary Assets Purchase Price (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable" xlink:label="loc_us-gaapAssetAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapAssetAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="loc_us-gaapAssetAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TeneologyIncMember" xlink:label="loc_ARENTeneologyIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENTeneologyIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosMember" xlink:label="loc_ARENFexyStudiosMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_ARENFexyStudiosMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferredContingentConsideration" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferredContingentConsideration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted" xlink:label="loc_ARENAssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENAssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferred" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferred" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails" xlink:title="00000066 - Disclosure - Summary of Preliminary Assets Purchase Price Allocation (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable" xlink:label="loc_us-gaapAssetAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapAssetAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="loc_us-gaapAssetAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TeneologyIncMember" xlink:label="loc_ARENTeneologyIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENTeneologyIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosMember" xlink:label="loc_ARENFexyStudiosMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_ARENFexyStudiosMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdvertiserRelationshipsMember" xlink:label="loc_ARENAdvertiserRelationshipsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENAdvertiserRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BrandNamesMember" xlink:label="loc_ARENBrandNamesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillMember" xlink:label="loc_us-gaapGoodwillMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapGoodwillMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AssetAcquisitionAssetsAcquired" xlink:label="loc_ARENAssetAcquisitionAssetsAcquired" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENAssetAcquisitionAssetsAcquired" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails" xlink:title="00000067 - Disclosure - Schedule of Composition of Purchase Price (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AthlonHoldingsIncMember" xlink:label="loc_ARENAthlonHoldingsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENAthlonHoldingsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredOther1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredOther1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails" xlink:title="00000068 - Disclosure - Summary of Purchase Price Allocation (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AthlonHoldingsIncMember" xlink:label="loc_ARENAthlonHoldingsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENAthlonHoldingsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails" xlink:title="00000069 - Disclosure - Schedule of Supplemental Proforma Information (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ParadeMember" xlink:label="loc_ARENParadeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENParadeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ArenaMember" xlink:label="loc_ARENArenaMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENArenaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdjustmentsMember" xlink:label="loc_ARENAdjustmentsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENAdjustmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails" xlink:title="00000070 - Disclosure - Schedule of Preliminary Price Allocation (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AthlonHoldingsIncMember" xlink:label="loc_ARENAthlonHoldingsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENAthlonHoldingsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative" xlink:title="00000071 - Disclosure - Acquisitions and Dispositions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable" xlink:label="loc_us-gaapAssetAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapAssetAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="loc_us-gaapAssetAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TeneologyIncMember" xlink:label="loc_ARENTeneologyIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENTeneologyIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BuffaloGroupeLLCMember" xlink:label="loc_ARENBuffaloGroupeLLCMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENBuffaloGroupeLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosMember" xlink:label="loc_ARENFexyStudiosMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_ARENFexyStudiosMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_IntellectualPropertiesMember" xlink:label="loc_ARENIntellectualPropertiesMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_ARENIntellectualPropertiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdvertiserRelationshipsMember" xlink:label="loc_ARENAdvertiserRelationshipsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENAdvertiserRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BrandNamesMember" xlink:label="loc_ARENBrandNamesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalContentMember" xlink:label="loc_ARENDigitalContentMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENDigitalContentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaapTradeNamesMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTradeNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosMember" xlink:label="loc_ARENFexyStudiosMember_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENFexyStudiosMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AthlonHoldingsIncMember" xlink:label="loc_ARENAthlonHoldingsIncMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENAthlonHoldingsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MensJournalMember" xlink:label="loc_ARENMensJournalMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENMensJournalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_A360MediaLLCMember" xlink:label="loc_ARENA360MediaLLCMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENA360MediaLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_Disposition2023Member" xlink:label="loc_ARENDisposition2023Member" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_ARENDisposition2023Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionTable" xlink:to="loc_srtTitleOfIndividualAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdvertiserRelationshipMember" xlink:label="loc_ARENAdvertiserRelationshipMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENAdvertiserRelationshipMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BrandNameMember" xlink:label="loc_ARENBrandNameMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENBrandNameMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferred" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferred" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForAdvanceToAffiliate" xlink:label="loc_us-gaapPaymentsForAdvanceToAffiliate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsForAdvanceToAffiliate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredCashPayments" xlink:label="loc_ARENDeferredCashPayments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENDeferredCashPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredCashPaymentsDue" xlink:label="loc_ARENDeferredCashPaymentsDue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENDeferredCashPaymentsDue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToEmployees" xlink:label="loc_us-gaapPaymentsToEmployees" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToEmployees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferredTransactionCost" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferredTransactionCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="loc_us-gaapProceedsFromSaleOfOtherAssetsInvestingActivities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SalePrice" xlink:label="loc_ARENSalePrice" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENSalePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WorkingCapital" xlink:label="loc_ARENWorkingCapital" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENWorkingCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PreliminaryWorkingCapital" xlink:label="loc_ARENPreliminaryWorkingCapital" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENPreliminaryWorkingCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WorkingCapitalAdjustments" xlink:label="loc_ARENWorkingCapitalAdjustments" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENWorkingCapitalAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FinalSalePrice" xlink:label="loc_ARENFinalSalePrice" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENFinalSalePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaapProceedsFromDivestitureOfBusinesses" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapProceedsFromDivestitureOfBusinesses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapCashAcquiredFromAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesAndInterestInAffiliates" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PaymentsToAcquireBusinessesAtClosing" xlink:label="loc_ARENPaymentsToAcquireBusinessesAtClosing" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENPaymentsToAcquireBusinessesAtClosing" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses" xlink:label="loc_us-gaapOtherPaymentsToAcquireBusinesses" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapOtherPaymentsToAcquireBusinesses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="loc_us-gaapBusinessAcquisitionDescriptionOfAcquiredEntity" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionDescriptionOfAcquiredEntity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsDescription" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsDescription" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments" xlink:label="loc_us-gaapBusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDeposit" xlink:label="loc_us-gaapEscrowDeposit" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapEscrowDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" xlink:label="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapDeferredRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredRevenueObligation" xlink:label="loc_ARENDeferredRevenueObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_ARENDeferredRevenueObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnearnedPremiums" xlink:label="loc_us-gaapUnearnedPremiums" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapUnearnedPremiums" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRefundLiabilityCurrent" xlink:label="loc_us-gaapCustomerRefundLiabilityCurrent" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapCustomerRefundLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaapGoodwillAcquiredDuringPeriod" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapGoodwillAcquiredDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="loc_us-gaapBusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails" xlink:title="00000072 - Disclosure - Schedule of Prepayments and Other Current Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:label="loc_ARENDisclosurePrepaymentsAndOtherCurrentAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrepaidSuppliesCurrent" xlink:label="loc_ARENPrepaidSuppliesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:to="loc_ARENPrepaidSuppliesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RefundableIncomeAndFranchiseTaxes" xlink:label="loc_ARENRefundableIncomeAndFranchiseTaxes" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:to="loc_ARENRefundableIncomeAndFranchiseTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="loc_us-gaapUnamortizedDebtIssuanceExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:to="loc_us-gaapUnamortizedDebtIssuanceExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EmployeeRetentionCredits" xlink:label="loc_ARENEmployeeRetentionCredits" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:to="loc_ARENEmployeeRetentionCredits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsDetailsNarrative" xlink:title="00000073 - Disclosure - Prepayments and Other Current Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:label="loc_ARENDisclosurePrepaymentsAndOtherCurrentAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLaborRelatedExpenses" xlink:label="loc_us-gaapOtherLaborRelatedExpenses" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:to="loc_us-gaapOtherLaborRelatedExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EmployeeRetentionPayable" xlink:label="loc_ARENEmployeeRetentionPayable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:to="loc_ARENEmployeeRetentionPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EmployeeRetentionCredits" xlink:label="loc_ARENEmployeeRetentionCredits" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePrepaymentsAndOtherCurrentAssetsAbstract" xlink:to="loc_ARENEmployeeRetentionCredits" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000074 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OfficeEquipmentAndComputersMember" xlink:label="loc_ARENOfficeEquipmentAndComputersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_ARENOfficeEquipmentAndComputersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000075 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareTable" xlink:label="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems" xlink:label="loc_us-gaapImpairmentEffectsOnEarningsPerShareLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" xlink:to="loc_us-gaapImpairmentEffectsOnEarningsPerShareLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareLineItems" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails" xlink:title="00000076 - Disclosure - Schedule of Supplemental Information Related to Operating Leases (Details)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureLeasesAbstract" xlink:label="loc_ARENDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaapLeaseCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLeasesAbstract" xlink:to="loc_us-gaapLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails" xlink:title="00000077 - Disclosure - Schedule of Operating Lease Costs (Details)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureLeasesAbstract" xlink:label="loc_ARENDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome" xlink:label="loc_us-gaapSubleaseIncome" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSubleaseIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaapLeaseCost" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetailsParenthetical" xlink:title="00000078 - Disclosure - Schedule of Operating Lease Costs (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureLeasesAbstract" xlink:label="loc_ARENDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLeasesAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessMembershipAgreementMember" xlink:label="loc_ARENBusinessMembershipAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENBusinessMembershipAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MonthToMonthLeaseArrangementMember" xlink:label="loc_ARENMonthToMonthLeaseArrangementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENMonthToMonthLeaseArrangementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfMaturityOfLeaseLiabilitiesDetails" xlink:title="00000079 - Disclosure - Summary of Maturity of Lease Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureLeasesAbstract" xlink:label="loc_ARENDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LeasesDetailsNarrative" xlink:title="00000080 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureLeasesAbstract" xlink:label="loc_ARENDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLeasesAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SubleaseAgreementMember" xlink:label="loc_ARENSubleaseAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENSubleaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LeaseArrangementMember" xlink:label="loc_ARENLeaseArrangementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENLeaseArrangementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapAwardDateAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OctoberOneTwoThousandAndTwentyFourMember" xlink:label="loc_ARENOctoberOneTwoThousandAndTwentyFourMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_ARENOctoberOneTwoThousandAndTwentyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaapLesseeOperatingLeaseTermOfContract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseTermOfContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome" xlink:label="loc_us-gaapSubleaseIncome" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSubleaseIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLeasePayments" xlink:label="loc_us-gaapProceedsFromLeasePayments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ImputedInterestRate" xlink:label="loc_ARENImputedInterestRate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ARENImputedInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MarketingAndAdvertisingExpenseRemaining" xlink:label="loc_ARENMarketingAndAdvertisingExpenseRemaining" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ARENMarketingAndAdvertisingExpenseRemaining" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails" xlink:title="00000081 - Disclosure - Summary of Platform Development Costs (Details)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosurePlatformDevelopmentAbstract" xlink:label="loc_ARENDisclosurePlatformDevelopmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePlatformDevelopmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PlatformDevelopmentMember" xlink:label="loc_ARENPlatformDevelopmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_ARENPlatformDevelopmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails" xlink:title="00000082 - Disclosure - Summary of Platform Development Cost Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosurePlatformDevelopmentAbstract" xlink:label="loc_ARENDisclosurePlatformDevelopmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePlatformDevelopmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PlatformDevelopmentMember" xlink:label="loc_ARENPlatformDevelopmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_ARENPlatformDevelopmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentOther" xlink:label="loc_us-gaapPropertyPlantAndEquipmentOther" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaapFinitelivedIntangibleAssetsAcquired1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapFinitelivedIntangibleAssetsAcquired1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortization" xlink:label="loc_us-gaapCapitalizedContractCostAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCapitalizedContractCostAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentOther" xlink:label="loc_us-gaapPropertyPlantAndEquipmentOther_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentOther_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative" xlink:title="00000083 - Disclosure - Platform Development (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosurePlatformDevelopmentAbstract" xlink:label="loc_ARENDisclosurePlatformDevelopmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosurePlatformDevelopmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PlatformDevelopmentMember" xlink:label="loc_ARENPlatformDevelopmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_ARENPlatformDevelopmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails" xlink:title="00000084 - Disclosure - Schedule of Intangible Assets Subject to Amortization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DevelopedTechnologyMember" xlink:label="loc_ARENDevelopedTechnologyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENDevelopedTechnologyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaapTradeNamesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTradeNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BrandNamesMember" xlink:label="loc_ARENBrandNamesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SubscriberRelationshipsMember" xlink:label="loc_ARENSubscriberRelationshipsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENSubscriberRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdvertiserRelationshipsMember" xlink:label="loc_ARENAdvertiserRelationshipsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENAdvertiserRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DatabasesMember" xlink:label="loc_us-gaapDatabasesMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapDatabasesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DigitalContentMember" xlink:label="loc_ARENDigitalContentMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENDigitalContentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails" xlink:title="00000085 - Disclosure - Schedule of Future Estimated Amortization expense For Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative" xlink:title="00000086 - Disclosure - Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DevelopedTechnologyMember" xlink:label="loc_ARENDevelopedTechnologyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_ARENDevelopedTechnologyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMember" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfAcquisitionCosts" xlink:label="loc_us-gaapAmortizationOfAcquisitionCosts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfAcquisitionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfOtherAssetsDetails" xlink:title="00000087 - Disclosure - Summary of Other Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaapOtherReceivables" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidInsurance" xlink:label="loc_us-gaapPrepaidInsurance" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapPrepaidInsurance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UnamortizedDebtCost" xlink:label="loc_ARENUnamortizedDebtCost" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_ARENUnamortizedDebtCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails" xlink:title="00000088 - Disclosure - Schedule of Changes in Carrying Value of Goodwill (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ParadeMember" xlink:label="loc_ARENParadeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENParadeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MensJournalMember" xlink:label="loc_ARENMensJournalMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENMensJournalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosMember" xlink:label="loc_ARENFexyStudiosMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENFexyStudiosMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaapGoodwillAcquiredDuringPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGoodwillAcquiredDuringPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGoodwill_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/GoodwillDetailsNarrative" xlink:title="00000089 - Disclosure - Goodwill (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative" xlink:title="00000090 - Disclosure - Restricted Stock Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureRestrictedStockLiabilitiesAbstract" xlink:label="loc_ARENDisclosureRestrictedStockLiabilitiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureRestrictedStockLiabilitiesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_us-gaapPaymentsForRepurchaseOfEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPaymentsForRepurchaseOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedStockPrincipalAmount" xlink:label="loc_ARENRestrictedStockPrincipalAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENRestrictedStockPrincipalAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedStockInterestPayment" xlink:label="loc_ARENRestrictedStockInterestPayment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENRestrictedStockInterestPayment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails" xlink:title="00000091 - Disclosure - Schedule of Accrued Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_GeneralAccruedExpenses" xlink:label="loc_ARENGeneralAccruedExpenses" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_ARENGeneralAccruedExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaapAccruedPayrollTaxesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedPayrollTaxesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedAdvertisingCurrent" xlink:label="loc_us-gaapAccruedAdvertisingCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedAdvertisingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiabilitiesInConnectionWithAcquisitionsAndDispositions" xlink:label="loc_ARENLiabilitiesInConnectionWithAcquisitionsAndDispositions" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_ARENLiabilitiesInConnectionWithAcquisitionsAndDispositions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseDepositLiability" xlink:label="loc_us-gaapLeaseDepositLiability" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapLeaseDepositLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LeaseTerminationLiability" xlink:label="loc_ARENLeaseTerminationLiability" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_ARENLeaseTerminationLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LineOfCreditDetailsNarrative" xlink:title="00000092 - Disclosure - Line of Credit (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FinancingAndSecurityAgreementMember" xlink:label="loc_ARENFinancingAndSecurityAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENFinancingAndSecurityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SLRDigitalFinanceLLCMember" xlink:label="loc_ARENSLRDigitalFinanceLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_ARENSLRDigitalFinanceLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyThreeNotesMember" xlink:label="loc_ARENTwoThousandTwentyThreeNotesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_ARENTwoThousandTwentyThreeNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesLPreferredStockMember" xlink:label="loc_ARENSeriesLPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENSeriesLPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SLRDigitalFinanceLLCMember" xlink:label="loc_ARENSLRDigitalFinanceLLCMember_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_ARENSLRDigitalFinanceLLCMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AccountsReceivablePercentage" xlink:label="loc_ARENAccountsReceivablePercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_ARENAccountsReceivablePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDefaultLongtermDebtAmount" xlink:label="loc_us-gaapDebtDefaultLongtermDebtAmount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtDefaultLongtermDebtAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="loc_us-gaapUnamortizedDebtIssuanceExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapUnamortizedDebtIssuanceExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateAtPeriodEnd" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLinesOfCreditCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFeeAmount" xlink:label="loc_us-gaapDebtInstrumentFeeAmount" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFeeAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails" xlink:title="00000093 - Disclosure - Summary of Liquidated Damages (Details)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureLiquidatedDamagesPayableAbstract" xlink:label="loc_ARENDisclosureLiquidatedDamagesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLiquidatedDamagesPayableAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MDBCommonStockToBeIssuedMember" xlink:label="loc_ARENMDBCommonStockToBeIssuedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENMDBCommonStockToBeIssuedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesHConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesHConvertiblePreferredStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesHConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ConvertibleDebenturesMember" xlink:label="loc_ARENConvertibleDebenturesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENConvertibleDebenturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesJPreferredStockMember" xlink:label="loc_ARENSeriesJPreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesJPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesKPreferredStockMember" xlink:label="loc_ARENSeriesKPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesKPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RegistrationRightsDamages" xlink:label="loc_ARENRegistrationRightsDamages" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENRegistrationRightsDamages" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PublicInformationFailureDamages" xlink:label="loc_ARENPublicInformationFailureDamages" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENPublicInformationFailureDamages" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableCurrentAndNonCurrent" xlink:label="loc_ARENLiquidatedDamagesPayableCurrentAndNonCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENLiquidatedDamagesPayableCurrentAndNonCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative" xlink:title="00000094 - Disclosure - Liquidated Damages Payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureLiquidatedDamagesPayableAbstract" xlink:label="loc_ARENDisclosureLiquidatedDamagesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLiquidatedDamagesPayableAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockPurchaseAgreementMember" xlink:label="loc_ARENStockPurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENStockPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyMember" xlink:label="loc_ARENBRileyMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENBRileyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaapLossContingencyDamagesSoughtValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLossContingencyDamagesSoughtValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="loc_us-gaapDebtInstrumentDecreaseForgiveness" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentDecreaseForgiveness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" xlink:label="loc_ARENAdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ARENAdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableCurrent" xlink:label="loc_ARENLiquidatedDamagesPayableCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ARENLiquidatedDamagesPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableAccruedInterestPercentage" xlink:label="loc_ARENLiquidatedDamagesPayableAccruedInterestPercentage" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ARENLiquidatedDamagesPayableAccruedInterestPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableCurrentAndNonCurrent" xlink:label="loc_ARENLiquidatedDamagesPayableCurrentAndNonCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ARENLiquidatedDamagesPayableCurrentAndNonCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PercentageOfAggregateAmountInvested" xlink:label="loc_ARENPercentageOfAggregateAmountInvested" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ARENPercentageOfAggregateAmountInvested" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayableNonCurrent" xlink:label="loc_ARENLiquidatedDamagesPayableNonCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ARENLiquidatedDamagesPayableNonCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails" xlink:title="00000095 - Disclosure - Schedule of Other long- term liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureOtherLongtermLiabilitiesAbstract" xlink:label="loc_ARENDisclosureOtherLongtermLiabilitiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LeaseTerminationLiabilityNonCurrent" xlink:label="loc_ARENLeaseTerminationLiabilityNonCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureOtherLongtermLiabilitiesAbstract" xlink:to="loc_ARENLeaseTerminationLiabilityNonCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureOtherLongtermLiabilitiesAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OtherLongTermLiabilitiesNoncurrent" xlink:label="loc_ARENOtherLongTermLiabilitiesNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureOtherLongtermLiabilitiesAbstract" xlink:to="loc_ARENOtherLongTermLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureOtherLongtermLiabilitiesAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:title="00000096 - Disclosure - Schedule of Fair Value of Financial Instruments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ContingentConsiderationMember" xlink:label="loc_ARENContingentConsiderationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ARENContingentConsiderationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeniorSecuredNoteMember" xlink:label="loc_ARENSeniorSecuredNoteMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ARENSeniorSecuredNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaapLongTermDebtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapLongTermDebtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative" xlink:title="00000097 - Disclosure - Fair Value Measurement (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FlexyStudiosMember" xlink:label="loc_ARENFlexyStudiosMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENFlexyStudiosMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" xlink:to="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PutOptionMember" xlink:label="loc_us-gaapPutOptionMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain" xlink:to="loc_us-gaapPutOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosAcquistionMember" xlink:label="loc_ARENFexyStudiosAcquistionMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_ARENFexyStudiosAcquistionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="loc_us-gaapBusinessAcquisitionSharePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessAcquisitionSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:label="loc_us-gaapFinancialInstrumentsOwnedAtFairValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapFinancialInstrumentsOwnedAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedOtherAtFairValue" xlink:label="loc_us-gaapFinancialInstrumentsOwnedOtherAtFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapFinancialInstrumentsOwnedOtherAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UnearnedRevenue" xlink:label="loc_ARENUnearnedRevenue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_ARENUnearnedRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/BridgeNotesDetailsNarrative" xlink:title="00000098 - Disclosure - Bridge Notes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyThreeNotesMember" xlink:label="loc_ARENTwoThousandTwentyThreeNotesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENTwoThousandTwentyThreeNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BridgeNotesMember" xlink:label="loc_ARENBridgeNotesMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENBridgeNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoBridgeNotesMember" xlink:label="loc_ARENTwoThousandTwentyTwoBridgeNotesMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoBridgeNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaapOtherBorrowings" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapOtherBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AggregatePrincipalMinimumAmount" xlink:label="loc_ARENAggregatePrincipalMinimumAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ARENAggregatePrincipalMinimumAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:label="loc_us-gaapDebtSecuritiesAvailableForSaleAmortizedCostCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="loc_us-gaapProceedsFromDebtNetOfIssuanceCosts" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaymentFeesOnAdvancesNet" xlink:label="loc_us-gaapPrepaymentFeesOnAdvancesNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapPrepaymentFeesOnAdvancesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PrincipalAmountPrepayDue" xlink:label="loc_ARENPrincipalAmountPrepayDue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ARENPrincipalAmountPrepayDue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedPremium" xlink:label="loc_us-gaapDebtInstrumentUnamortizedPremium" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedPremium" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails" xlink:title="00000099 - Disclosure - Schedule of long term debt (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeniorSecuredNoteMember" xlink:label="loc_ARENSeniorSecuredNoteMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENSeniorSecuredNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DelayedDrawTermNoteMember" xlink:label="loc_ARENDelayedDrawTermNoteMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENDelayedDrawTermNoteMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoBridgeNotesMember" xlink:label="loc_ARENTwoThousandTwentyTwoBridgeNotesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoBridgeNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical" xlink:title="00000100 - Disclosure - Schedule of Long Term Debt (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeniorSecuredNoteMember" xlink:label="loc_ARENSeniorSecuredNoteMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENSeniorSecuredNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DelayedDrawTermNoteMember" xlink:label="loc_ARENDelayedDrawTermNoteMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_ARENDelayedDrawTermNoteMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoBridgeNotesMember" xlink:label="loc_ARENTwoThousandTwentyTwoBridgeNotesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_ARENTwoThousandTwentyTwoBridgeNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfInterestExpenseDetails" xlink:title="00000101 - Disclosure - Summary of Interest Expense (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaapLineOfCreditMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapLineOfCreditMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoBridgeNotesMember" xlink:label="loc_ARENTwoThousandTwentyTwoBridgeNotesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoBridgeNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeniorSecuredNotesMember" xlink:label="loc_ARENSeniorSecuredNotesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENSeniorSecuredNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DelayedDrawTermNoteMember" xlink:label="loc_ARENDelayedDrawTermNoteMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENDelayedDrawTermNoteMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyThreeNotesMember" xlink:label="loc_ARENTwoThousandTwentyThreeNotesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENTwoThousandTwentyThreeNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LineOfCreditTerminationFeeMember" xlink:label="loc_ARENLineOfCreditTerminationFeeMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENLineOfCreditTerminationFeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ParadeMember" xlink:label="loc_ARENParadeMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENParadeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OtherAccruedInterestMember" xlink:label="loc_ARENOtherAccruedInterestMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENOtherAccruedInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OtherMember" xlink:label="loc_ARENOtherMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyMember" xlink:label="loc_ARENBRileyMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENBRileyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NoncashAndAccruedInterest" xlink:label="loc_ARENNoncashAndAccruedInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ARENNoncashAndAccruedInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CashPaidInterestAbstract" xlink:label="loc_ARENCashPaidInterestAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ARENCashPaidInterestAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestExpenseDebt_2" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/Long-termDebtDetailsNarrative" xlink:title="00000102 - Disclosure - Long-term Debt (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeniorSecuredNoteMember" xlink:label="loc_ARENSeniorSecuredNoteMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENSeniorSecuredNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoBridgeNotesMember" xlink:label="loc_ARENTwoThousandTwentyTwoBridgeNotesMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoBridgeNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SLRDigitalFinanceLLCMember" xlink:label="loc_ARENSLRDigitalFinanceLLCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_ARENSLRDigitalFinanceLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DelayedDrawTermNotesMember" xlink:label="loc_ARENDelayedDrawTermNotesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_ARENDelayedDrawTermNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PurchaseAgreementMember" xlink:label="loc_ARENPurchaseAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_srtTitleOfIndividualAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyMember" xlink:label="loc_ARENBRileyMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENBRileyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="loc_us-gaapDebtInstrumentInterestRateIncreaseDecrease" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DebtInstrumentPeriodicPaymentPrincipalBalance" xlink:label="loc_ARENDebtInstrumentPeriodicPaymentPrincipalBalance" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ARENDebtInstrumentPeriodicPaymentPrincipalBalance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PreferredStockDetailsNarrative" xlink:title="00000103 - Disclosure - Preferred Stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesGConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesGConvertiblePreferredStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesGConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesHConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesHConvertiblePreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesHConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="loc_us-gaapSeriesHPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesHPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesGPreferredStockMember" xlink:label="loc_us-gaapSeriesGPreferredStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesGPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OriginalInvestorMember" xlink:label="loc_ARENOriginalInvestorMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENOriginalInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:label="loc_us-gaapPreferredStockLiquidationPreference" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockLiquidationPreference" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="loc_us-gaapPreferredStockLiquidationPreferenceValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockLiquidationPreferenceValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:label="loc_us-gaapTemporaryEquityLiquidationPreferencePerShare" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquityLiquidationPreferencePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails" xlink:title="00000104 - Disclosure - Summary of Restricted Stock Award Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfWarrantActivityDetails" xlink:title="00000105 - Disclosure - Summary of Warrant Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockFinancingWarrantMember" xlink:label="loc_ARENCommonStockFinancingWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENCommonStockFinancingWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_ARENSharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ARENSharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative" xlink:title="00000106 - Disclosure - Stockholders&#8217; Deficiency (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockPurchaseAgreementsMember" xlink:label="loc_ARENStockPurchaseAgreementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENStockPurchaseAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AssetPurchaseAgreementMember" xlink:label="loc_ARENAssetPurchaseAgreementMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENAssetPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeveralStockPurchaseAgreementsMember" xlink:label="loc_ARENSeveralStockPurchaseAgreementsMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENSeveralStockPurchaseAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExerciseOfStockOptionMember" xlink:label="loc_ARENExerciseOfStockOptionMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENExerciseOfStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ServicesAgreementMember" xlink:label="loc_ARENServicesAgreementMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENServicesAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PurchasersMember" xlink:label="loc_ARENPurchasersMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENPurchasersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeveralInvestorsMember" xlink:label="loc_ARENSeveralInvestorsMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENSeveralInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EmployeesMember" xlink:label="loc_ARENEmployeesMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesHConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesHConvertiblePreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesHConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AllHipHopWarrantsMember" xlink:label="loc_ARENAllHipHopWarrantsMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENAllHipHopWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PublisherPartnerWarrantsMember" xlink:label="loc_ARENPublisherPartnerWarrantsMember" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENPublisherPartnerWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENABGWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarransMember" xlink:label="loc_ARENABGWarransMember" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENABGWarransMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGTimeBasedWarrantsMember" xlink:label="loc_ARENABGTimeBasedWarrantsMember" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENABGTimeBasedWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGPerformanceBasedWarrantsMember" xlink:label="loc_ARENABGPerformanceBasedWarrantsMember" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENABGPerformanceBasedWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NewPublisherPartnerWarrantsMember" xlink:label="loc_ARENNewPublisherPartnerWarrantsMember" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENNewPublisherPartnerWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosAcquisitionMember" xlink:label="loc_ARENFexyStudiosAcquisitionMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENFexyStudiosAcquisitionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ParadeStockMember" xlink:label="loc_ARENParadeStockMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENParadeStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapAwardTypeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedCommonStockMember" xlink:label="loc_ARENRestrictedCommonStockMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENRestrictedCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UnderwritingPublicOfferingMember" xlink:label="loc_ARENUnderwritingPublicOfferingMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ARENUnderwritingPublicOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UnderwritingOverallotmentMember" xlink:label="loc_ARENUnderwritingOverallotmentMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ARENUnderwritingOverallotmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyMember" xlink:label="loc_ARENBRileyMember" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ARENBRileyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_deiLegalEntityAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MDBCapitalGroupLLCMember" xlink:label="loc_ARENMDBCapitalGroupLLCMember" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_ARENMDBCapitalGroupLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaapConversionOfStockAmountConverted1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockAmountConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesAcquisition" xlink:label="loc_ARENStockIssuedDuringPeriodSharesAcquisition" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodSharesAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares" xlink:label="loc_ARENBusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ARENBusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesSought" xlink:label="loc_us-gaapLossContingencyDamagesSought" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapLossContingencyDamagesSought" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaapLossContingencyDamagesSoughtValue" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapLossContingencyDamagesSoughtValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" xlink:label="loc_ARENAdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ARENAdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodValueForCash" xlink:label="loc_ARENStockIssuedDuringPeriodValueForCash" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodValueForCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" xlink:label="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ARENStockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:title="00000107 - Disclosure - Schedule of Restricted Stock Units Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RestrictedStockUnitsMember" xlink:label="loc_ARENRestrictedStockUnitsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENRestrictedStockUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails" xlink:title="00000108 - Disclosure - Schedule of Fair Value of Stock Options Assumptions (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoPlanMember" xlink:label="loc_ARENTwoThousandTwentyTwoPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BlackScholesOptionPricingModelMember" xlink:label="loc_ARENBlackScholesOptionPricingModelMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_ARENBlackScholesOptionPricingModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtStatementScenarioAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_UpListMember" xlink:label="loc_ARENUpListMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_ARENUpListMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NoUpListMember" xlink:label="loc_ARENNoUpListMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_ARENNoUpListMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails" xlink:title="00000109 - Disclosure - Summary of Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoPlanMember" xlink:label="loc_ARENTwoThousandTwentyTwoPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical" xlink:title="00000110 - Disclosure - Summary of Stock Option Activity (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoPlanMember" xlink:label="loc_ARENTwoThousandTwentyTwoPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails" xlink:title="00000111 - Disclosure - Schedule of Exercise Prices of Common Stock Options (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoPlanMember" xlink:label="loc_ARENTwoThousandTwentyTwoPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENABGWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NewPublisherPartnerWarrantMember" xlink:label="loc_ARENNewPublisherPartnerWarrantMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENNewPublisherPartnerWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeOneMember" xlink:label="loc_ARENExercisePriceRangeOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_ARENExercisePriceRangeOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeTwoMember" xlink:label="loc_ARENExercisePriceRangeTwoMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_ARENExercisePriceRangeTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeThreeMember" xlink:label="loc_ARENExercisePriceRangeThreeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_ARENExercisePriceRangeThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeFourMember" xlink:label="loc_ARENExercisePriceRangeFourMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_ARENExercisePriceRangeFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeFiveMember" xlink:label="loc_ARENExercisePriceRangeFiveMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_ARENExercisePriceRangeFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeSixMember" xlink:label="loc_ARENExercisePriceRangeSixMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_ARENExercisePriceRangeSixMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeSevenMember" xlink:label="loc_ARENExercisePriceRangeSevenMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_ARENExercisePriceRangeSevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExercisePriceRangeEightMember" xlink:label="loc_ARENExercisePriceRangeEightMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_ARENExercisePriceRangeEightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BlackScholesOptionPricingModelMember" xlink:label="loc_ARENBlackScholesOptionPricingModelMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_ARENBlackScholesOptionPricingModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails" xlink:title="00000112 - Disclosure - Schedule of Warrants Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENABGWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NewPublisherPartnerWarrantMember" xlink:label="loc_ARENNewPublisherPartnerWarrantMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENNewPublisherPartnerWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WeightedAverageRemainingContractualLifeOutstanding" xlink:label="loc_ARENWeightedAverageRemainingContractualLifeOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENWeightedAverageRemainingContractualLifeOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WeightedAverageRemainingContractualLifeOutstanding1" xlink:label="loc_ARENWeightedAverageRemainingContractualLifeOutstanding1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENWeightedAverageRemainingContractualLifeOutstanding1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WeightedAverageRemainingContractualLifeExercisable" xlink:label="loc_ARENWeightedAverageRemainingContractualLifeExercisable" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENWeightedAverageRemainingContractualLifeExercisable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber" xlink:label="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails" xlink:title="00000113 - Disclosure - Summary of Stock-based Compensation (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockAwardsMember" xlink:label="loc_ARENCommonStockAwardsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENCommonStockAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENABGWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtStatementScenarioAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockBasedCompensationMember" xlink:label="loc_ARENStockBasedCompensationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_ARENStockBasedCompensationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CostsChargedToOperations" xlink:label="loc_ARENCostsChargedToOperations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENCostsChargedToOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopmentCosts" xlink:label="loc_us-gaapDevelopmentCosts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapDevelopmentCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails" xlink:title="00000114 - Disclosure - Schedule of Unrecognized Compensation Expense (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockAwardsMember" xlink:label="loc_ARENCommonStockAwardsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENCommonStockAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENABGWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtStatementScenarioAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockBasedCompensationMember" xlink:label="loc_ARENStockBasedCompensationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_ARENStockBasedCompensationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative" xlink:title="00000115 - Disclosure - Stock&#8211;Based Compensation (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TwoThousandTwentyTwoPlanMember" xlink:label="loc_ARENTwoThousandTwentyTwoPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENTwoThousandTwentyTwoPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PublisherPartnerWarrantProgramMember" xlink:label="loc_ARENPublisherPartnerWarrantProgramMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENPublisherPartnerWarrantProgramMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NewPublisherPartnerWarrantMember" xlink:label="loc_ARENNewPublisherPartnerWarrantMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ARENNewPublisherPartnerWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_CommonStockOptionsMember" xlink:label="loc_ARENCommonStockOptionsMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ARENCommonStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SportsIllustratedLicensingAgreementMember" xlink:label="loc_ARENSportsIllustratedLicensingAgreementMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENSportsIllustratedLicensingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_ARENABGWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember_2" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENABGWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" xlink:label="loc_ARENSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="loc_us-gaapUnamortizedDebtIssuanceExpense" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapUnamortizedDebtIssuanceExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OriginalAwardAtTheRepricingDate" xlink:label="loc_ARENOriginalAwardAtTheRepricingDate" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENOriginalAwardAtTheRepricingDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FairMarketValueOfStockOption" xlink:label="loc_ARENFairMarketValueOfStockOption" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_ARENFairMarketValueOfStockOption" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/LiquidatedDamagesDetailsNarrative" xlink:title="00000116 - Disclosure - Liquidated Damages (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DisclosureLiquidatedDamagesAbstract" xlink:label="loc_ARENDisclosureLiquidatedDamagesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ARENDisclosureLiquidatedDamagesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesKPreferredStockMember" xlink:label="loc_ARENSeriesKPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesKPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LiquidatedDamagesPayable" xlink:label="loc_ARENLiquidatedDamagesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ARENLiquidatedDamagesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails" xlink:title="00000117 - Disclosure - Schedule of Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000118 - Disclosure - Schedule of Components of Deferred Tax Assets and Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetInterestCarryforward" xlink:label="loc_us-gaapDeferredTaxAssetInterestCarryforward" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetInterestCarryforward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LeaseTermination" xlink:label="loc_ARENLeaseTermination" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_ARENLeaseTermination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredTaxAssetsLiquidatingDamagesPayable" xlink:label="loc_ARENDeferredTaxAssetsLiquidatingDamagesPayable" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_ARENDeferredTaxAssetsLiquidatingDamagesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredTaxAssetsOperatingLeaseLiability" xlink:label="loc_ARENDeferredTaxAssetsOperatingLeaseLiability" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_ARENDeferredTaxAssetsOperatingLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DeferredTaxAssetsDepreciationAndAmortization" xlink:label="loc_ARENDeferredTaxAssetsDepreciationAndAmortization" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_ARENDeferredTaxAssetsDepreciationAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails" xlink:title="00000119 - Disclosure - Schedule of Tax Benefit and Effective Income Tax (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue" xlink:label="loc_ARENEffectiveIncomeTaxRateReconciliationUnearnedRevenue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_ARENEffectiveIncomeTaxRateReconciliationUnearnedRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage" xlink:label="loc_ARENEffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_ARENEffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationInterestExpense" xlink:label="loc_ARENEffectiveIncomeTaxRateReconciliationInterestExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_ARENEffectiveIncomeTaxRateReconciliationInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationInterestExpensePercentage" xlink:label="loc_ARENEffectiveIncomeTaxRateReconciliationInterestExpensePercentage" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_ARENEffectiveIncomeTaxRateReconciliationInterestExpensePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment" xlink:label="loc_ARENEffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_ARENEffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage" xlink:label="loc_ARENEffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_ARENEffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInEnactedTaxRate" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/IncomeTaxesDetailsNarrative" xlink:title="00000120 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StateMember" xlink:label="loc_ARENStateMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_ARENStateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LocalJurisdictionMember" xlink:label="loc_ARENLocalJurisdictionMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_ARENLocalJurisdictionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_USFederalTaxMember" xlink:label="loc_ARENUSFederalTaxMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_ARENUSFederalTaxMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_NetOperatingLossExpirationAmount" xlink:label="loc_ARENNetOperatingLossExpirationAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_ARENNetOperatingLossExpirationAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/PensionPlansDetailsNarrative" xlink:title="00000121 - Disclosure - Pension Plans (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xlink:label="loc_us-gaapDescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapDescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MultiemployerPlanPensionSignificantPlanContribution" xlink:label="loc_us-gaapMultiemployerPlanPensionSignificantPlanContribution" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapMultiemployerPlanPensionSignificantPlanContribution" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000122 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyFBRIncMember" xlink:label="loc_ARENBRileyFBRIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ARENBRileyFBRIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyMember" xlink:label="loc_ARENBRileyMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENBRileyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PurchasersMember" xlink:label="loc_ARENPurchasersMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENPurchasersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DirectOfferingMember" xlink:label="loc_ARENDirectOfferingMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ARENDirectOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SeriesHConvertiblePreferredStockMember" xlink:label="loc_ARENSeriesHConvertiblePreferredStockMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ARENSeriesHConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_deiLegalEntityAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BRileyFinancialIncMember" xlink:label="loc_ARENBRileyFinancialIncMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_ARENBRileyFinancialIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AllredTrustHHAMember" xlink:label="loc_ARENAllredTrustHHAMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_ARENAllredTrustHHAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_AllredTrustNLAMember" xlink:label="loc_ARENAllredTrustNLAMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_ARENAllredTrustNLAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockPurchaseAgreementsMember" xlink:label="loc_ARENStockPurchaseAgreementsMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENStockPurchaseAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_HHuntAllredMember" xlink:label="loc_ARENHHuntAllredMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENHHuntAllredMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OneEightyDegreeCapitalCorpMember" xlink:label="loc_ARENOneEightyDegreeCapitalCorpMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENOneEightyDegreeCapitalCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DanielShribmanMember" xlink:label="loc_ARENDanielShribmanMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENDanielShribmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_RossLevinsohnMember" xlink:label="loc_ARENRossLevinsohnMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENRossLevinsohnMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_PaulEdmonsonMember" xlink:label="loc_ARENPaulEdmonsonMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENPaulEdmonsonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MrEdmonsonMember" xlink:label="loc_ARENMrEdmonsonMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ARENMrEdmonsonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapAwardTypeAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_DebtInstrumentIncreaseAccruedInterestAmountDue" xlink:label="loc_ARENDebtInstrumentIncreaseAccruedInterestAmountDue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ARENDebtInstrumentIncreaseAccruedInterestAmountDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConvertibleConversionPrice" xlink:label="loc_us-gaapPreferredStockConvertibleConversionPrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapPreferredStockConvertibleConversionPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFeeAmount" xlink:label="loc_us-gaapDebtInstrumentFeeAmount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentFeeAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockRepurchasedDuringPeriodValue1" xlink:label="loc_ARENStockRepurchasedDuringPeriodValue1" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ARENStockRepurchasedDuringPeriodValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000123 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaapLossContingenciesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLossContingenciesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaapLossContingenciesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapLossContingenciesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGSILLCMember" xlink:label="loc_ARENABGSILLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_ARENABGSILLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapRoyaltyExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thearenagroup.net/role/SubsequentEventsDetailsNarrative" xlink:title="00000124 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ArenaLoanAgreementMember" xlink:label="loc_ARENArenaLoanAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENArenaLoanAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_LicensingAgreementMember" xlink:label="loc_ARENLicensingAgreementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENLicensingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TransactionAgreementMember" xlink:label="loc_ARENTransactionAgreementMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENTransactionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_StockPurchaseAgreementMember" xlink:label="loc_ARENStockPurchaseAgreementMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENStockPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SubscriptionAgreementMember" xlink:label="loc_ARENSubscriptionAgreementMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ARENSubscriptionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ABGWarrantsMember" xlink:label="loc_ARENABGWarrantsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ARENABGWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FexyStudiosMember" xlink:label="loc_ARENFexyStudiosMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ARENFexyStudiosMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SimplyfyLoanMember" xlink:label="loc_ARENSimplyfyLoanMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_ARENSimplyfyLoanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_MembersOfBoardMember" xlink:label="loc_ARENMembersOfBoardMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENMembersOfBoardMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_FormerEmployeesMember" xlink:label="loc_ARENFormerEmployeesMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ARENFormerEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapAwardTypeAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_ExerciseRightTerminationAmount" xlink:label="loc_ARENExerciseRightTerminationAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ARENExerciseRightTerminationAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_TerminationFeeDue" xlink:label="loc_ARENTerminationFeeDue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ARENTerminationFeeDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationPriceOfAcquisitionExpected" xlink:label="loc_us-gaapBusinessCombinationPriceOfAcquisitionExpected" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapBusinessCombinationPriceOfAcquisitionExpected" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredOther1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredOther1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaapLineOfCreditFacilityCommitmentFeePercentage" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_SharesOutstandingPercentage" xlink:label="loc_ARENSharesOutstandingPercentage" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ARENSharesOutstandingPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_OutstandingPercentage" xlink:label="loc_ARENOutstandingPercentage" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ARENOutstandingPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_BusinessCombinationConsiderationTransferredInstallmentDue" xlink:label="loc_ARENBusinessCombinationConsiderationTransferredInstallmentDue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ARENBusinessCombinationConsiderationTransferredInstallmentDue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="aren-20231231.xsd#AREN_WorkingCapital" xlink:label="loc_ARENWorkingCapital" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ARENWorkingCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFeeAmount" xlink:label="loc_us-gaapDebtInstrumentFeeAmount" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFeeAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaapLossContingencyDamagesSoughtValue" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLossContingencyDamagesSoughtValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731915136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 28, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">THE
ARENA GROUP HOLDINGS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000894871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">68-0232575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">200
                                            Vesey Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">24th
    Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New
    York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(212)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">321-5002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AREN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,218,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,770,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference [Text Block]</a></td>
<td class="text">Portions
of the registrant&#8217;s definitive proxy statement for its 2024 Annual Meeting of Stockholders, or Proxy Statement, to be filed within
120 days after the end of the fiscal year covered by this Annual Report on Form 10-K, are incorporated by reference in Part III. Except
with respect to information specifically incorporated by reference in this Annual Report, the Proxy Statement shall not be deemed to
be filed as part hereof.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Marcum
    LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656823410528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 9,284<span></span>
</td>
<td class="nump">$ 13,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">44,811<span></span>
</td>
<td class="nump">33,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNetCurrent', window );">Subscription acquisition costs, current portion</a></td>
<td class="nump">29,706<span></span>
</td>
<td class="nump">25,931<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments and other current assets</a></td>
<td class="nump">6,598<span></span>
</td>
<td class="nump">4,441<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">90,399<span></span>
</td>
<td class="nump">78,695<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">328<span></span>
</td>
<td class="nump">735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PlatformDevelopmentNet', window );">Platform development, net</a></td>
<td class="nump">8,723<span></span>
</td>
<td class="nump">10,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNetNoncurrent', window );">Subscription acquisition costs, net of current portion</a></td>
<td class="nump">7,215<span></span>
</td>
<td class="nump">14,133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Acquired and other intangible assets, net</a></td>
<td class="nump">38,459<span></span>
</td>
<td class="nump">58,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">1,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">42,575<span></span>
</td>
<td class="nump">39,344<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">188,878<span></span>
</td>
<td class="nump">203,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">10,357<span></span>
</td>
<td class="nump">12,863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other</a></td>
<td class="nump">30,771<span></span>
</td>
<td class="nump">23,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of credit</a></td>
<td class="nump">19,609<span></span>
</td>
<td class="nump">14,092<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Unearned revenue</a></td>
<td class="nump">59,786<span></span>
</td>
<td class="nump">58,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent', window );">Subscription refund liability</a></td>
<td class="nump">449<span></span>
</td>
<td class="nump">845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability</a></td>
<td class="nump">358<span></span>
</td>
<td class="nump">427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent', window );">Contingent consideration</a></td>
<td class="nump">1,571<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesPayableCurrent', window );">Liquidated damages payable</a></td>
<td class="nump">2,924<span></span>
</td>
<td class="nump">5,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BridgeNotes', window );">Bridge notes</a></td>
<td class="nump">7,887<span></span>
</td>
<td class="nump">34,805<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Debt</a></td>
<td class="nump">102,309<span></span>
</td>
<td class="nump">65,684<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">236,021<span></span>
</td>
<td class="nump">216,364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Unearned revenue, net of current portion</a></td>
<td class="nump">10,679<span></span>
</td>
<td class="nump">19,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, net of current portion</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatingDamagesPayableNonCurrent', window );">Liquidating damages payable, net of current portion</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">406<span></span>
</td>
<td class="nump">5,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent', window );">Deferred tax liabilities</a></td>
<td class="nump">599<span></span>
</td>
<td class="nump">465<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">247,705<span></span>
</td>
<td class="nump">242,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 27)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Mezzanine equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total mezzanine equity</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">13,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; deficiency:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value, authorized 1,000,000,000 shares: issued and outstanding; 23,836,706 and 18,303,193 shares December 31, 2023 and 2022, respectively</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_CommonStockToBeIssuedDuringPeriod', window );">Common stock to be issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">319,421<span></span>
</td>
<td class="nump">270,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(378,653)<span></span>
</td>
<td class="num">(323,071)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; deficiency</a></td>
<td class="num">(58,995)<span></span>
</td>
<td class="num">(52,146)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, mezzanine equity and stockholders&#8217; deficiency</a></td>
<td class="nump">188,878<span></span>
</td>
<td class="nump">203,719<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesGRedeemableAndConvertiblePreferredStockMember', window );">Series G Redeemable And Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Mezzanine equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total mezzanine equity</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesHConvertiblePreferredStockMember', window );">Series H Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Mezzanine equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total mezzanine equity</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 13,008<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_BridgeNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Bridge notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_BridgeNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_CommonStockToBeIssuedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock to be issued during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_CommonStockToBeIssuedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LiquidatedDamagesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidated damages payable current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LiquidatedDamagesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LiquidatingDamagesPayableNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidating damages payable non current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LiquidatingDamagesPayableNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_PlatformDevelopmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Platform development net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_PlatformDevelopmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized from contingent consideration in asset acquisition, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRefundLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesGRedeemableAndConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=AREN_SeriesGRedeemableAndConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesHConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=AREN_SeriesHConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736484528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">23,836,706<span></span>
</td>
<td class="nump">18,303,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">23,836,706<span></span>
</td>
<td class="nump">18,303,193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesGRedeemableAndConvertiblePreferredStockMember', window );">Series G Redeemable And Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Temporary equity, liquidation preference per share value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares designated</a></td>
<td class="nump">1,800<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Temporary equity, liquidation preference value</a></td>
<td class="nump">$ 168<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_TemporaryEquityCommonSharesIssuableUponConversion', window );">Temporary equity, common shares issuable upon conversion</a></td>
<td class="nump">8,582<span></span>
</td>
<td class="nump">8,582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesHRedeemableAndConvertiblePreferredStockMember', window );">Series H Redeemable And Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Temporary equity, liquidation preference per share value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares designated</a></td>
<td class="nump">23,000<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Temporary equity, liquidation preference value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 14,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_TemporaryEquityCommonSharesIssuableUponConversion', window );">Temporary equity, common shares issuable upon conversion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,981,128<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_TemporaryEquityCommonSharesIssuableUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity common shares issuable upon conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_TemporaryEquityCommonSharesIssuableUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreferencePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesGRedeemableAndConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=AREN_SeriesGRedeemableAndConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesHRedeemableAndConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=AREN_SeriesHRedeemableAndConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735827744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 244,203<span></span>
</td>
<td class="nump">$ 220,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue (includes amortization for developed technology and platform development for 2023 and 2022 of $8,782 and $9,459, respectively)</a></td>
<td class="nump">142,240<span></span>
</td>
<td class="nump">132,923<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">101,963<span></span>
</td>
<td class="nump">88,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">74,245<span></span>
</td>
<td class="nump">72,489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">44,152<span></span>
</td>
<td class="nump">53,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">18,924<span></span>
</td>
<td class="nump">17,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Loss on impairment of assets</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LossOnSaleOfAssets', window );">Loss on sale of assets</a></td>
<td class="nump">325<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">137,765<span></span>
</td>
<td class="nump">143,895<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(35,802)<span></span>
</td>
<td class="num">(55,883)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in valuation of contingent consideration</a></td>
<td class="num">(1,010)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net</a></td>
<td class="num">(17,965)<span></span>
</td>
<td class="num">(11,428)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesUnderRegistrationRightsAgreements', window );">Liquidated damages</a></td>
<td class="num">(583)<span></span>
</td>
<td class="num">(1,140)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expenses</a></td>
<td class="num">(19,558)<span></span>
</td>
<td class="num">(12,568)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(55,360)<span></span>
</td>
<td class="num">(68,451)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (provision) benefit</a></td>
<td class="num">(222)<span></span>
</td>
<td class="nump">1,063<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Loss from continuing operations</a></td>
<td class="num">(55,582)<span></span>
</td>
<td class="num">(67,388)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Loss from discontinued operations, net of tax</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(3,470)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (55,582)<span></span>
</td>
<td class="num">$ (70,858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic and diluted net loss per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations - Basic</a></td>
<td class="num">$ (2.49)<span></span>
</td>
<td class="num">$ (3.82)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations - Diluted</a></td>
<td class="num">(2.49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations - Basic</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(0.20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations - Diluted</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(0.20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share</a></td>
<td class="num">(2.49)<span></span>
</td>
<td class="num">(4.02)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common share</a></td>
<td class="num">$ (2.49)<span></span>
</td>
<td class="num">$ (4.02)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding - Basic</a></td>
<td class="nump">22,323,763<span></span>
</td>
<td class="nump">17,625,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of common shares outstanding - Diluted</a></td>
<td class="nump">22,323,763<span></span>
</td>
<td class="nump">17,625,619<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LiquidatedDamagesUnderRegistrationRightsAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidated damages under registration rights agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LiquidatedDamagesUnderRegistrationRightsAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LossOnSaleOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on sale of assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LossOnSaleOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-18<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479836/810-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731283712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization cost of developed technology and platform development</a></td>
<td class="nump">$ 8,782<span></span>
</td>
<td class="nump">$ 9,459<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656734238448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Deficiency - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="num">$ (52,146)<span></span>
</td>
<td class="num">$ (51,677)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering', window );">Issuance of common stock in connection with registered direct offering</a></td>
<td class="nump">11,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock upon conversion of series H preferred stock</a></td>
<td class="nump">13,008<span></span>
</td>
<td class="nump">710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne', window );">Issuance of common stock in connection with the acquisition of Fexy Studios</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages', window );">Issuance of common stock in connection with settlement of liquidated damages</a></td>
<td class="nump">369<span></span>
</td>
<td class="nump">6,685<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages', window );">Gain upon issuance of common stock in connection with settlement of liquidated damages</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of common stock for restricted stock units</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes', window );">Common stock withheld for taxes upon issuance of underlying shares for restricted stock units</a></td>
<td class="num">(1,423)<span></span>
</td>
<td class="num">(4,468)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock in connection with the exercise of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of stock in connection with acquisitions</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Reclassification to liability upon modification of common stock option</a></td>
<td class="num">(68)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages', window );">Gain upon forgiveness of liquidated damages with principal stockholder</a></td>
<td class="nump">3,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">20,076<span></span>
</td>
<td class="nump">33,229<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(55,582)<span></span>
</td>
<td class="num">(70,858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="num">(58,995)<span></span>
</td>
<td class="num">(52,146)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger', window );">Issuance of stock in connection with the merger of Say Media</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock in connection with professional services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase restricted stock awards in connection with HubPages merger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="nump">$ 182<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="nump">18,303,193<span></span>
</td>
<td class="nump">12,635,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering', window );">Issuance of common stock in connection with registered direct offering</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering', window );">Issuance of common stock in connection with registered direct offering, shares</a></td>
<td class="nump">2,963,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock upon conversion of series H preferred stock</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock upon conversion of series H preferred stock, shares</a></td>
<td class="nump">1,981,128<span></span>
</td>
<td class="nump">97,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne', window );">Issuance of common stock in connection with the acquisition of Fexy Studios</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne', window );">Issuance of common stock in connection with the acquisition of Fexy Studios, shares</a></td>
<td class="nump">274,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages', window );">Issuance of common stock in connection with settlement of liquidated damages</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares', window );">Issuance of common stock in connection with settlement of liquidated damages, shares</a></td>
<td class="nump">47,252<span></span>
</td>
<td class="nump">505,655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages', window );">Gain upon issuance of common stock in connection with settlement of liquidated damages</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of common stock for restricted stock units</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of common stock for restricted stock units, shares</a></td>
<td class="nump">429,528<span></span>
</td>
<td class="nump">832,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes', window );">Common stock withheld for taxes upon issuance of underlying shares for restricted stock units</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares', window );">Common stock withheld for taxes, shares</a></td>
<td class="num">(202,382)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock in connection with the exercise of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock in connection with the exercise of stock options, shares</a></td>
<td class="nump">795<span></span>
</td>
<td class="nump">96,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of stock in connection with acquisitions</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock in connection with acquisition, shares</a></td>
<td class="nump">38,582<span></span>
</td>
<td class="nump">330,863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Reclassification to liability upon modification of common stock option</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages', window );">Gain upon forgiveness of liquidated damages with principal stockholder</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="nump">$ 237<span></span>
</td>
<td class="nump">$ 182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="nump">23,836,706<span></span>
</td>
<td class="nump">18,303,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger', window );">Issuance of stock in connection with the merger of Say Media</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger', window );">Issuance of common stock in connection with the merger of SayMedia, shares</a></td>
<td class="nump">38,582<span></span>
</td>
<td class="nump">7,851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock in connection with professional services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock in connection with professional services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes', window );">Common stock withheld for taxes upon issuance of underlying shares for restricted stock units, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(373,394)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase restricted stock awards in connection with HubPages merger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase restricted stock awards in connection with HubPages merger, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,214)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with public offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,181,603<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=AREN_CommonStockToBeIssuedMember', window );">Common Stock To Be Issued [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="nump">41,283<span></span>
</td>
<td class="nump">49,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering', window );">Issuance of common stock in connection with registered direct offering</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock upon conversion of series H preferred stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne', window );">Issuance of common stock in connection with the acquisition of Fexy Studios</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages', window );">Issuance of common stock in connection with settlement of liquidated damages</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages', window );">Gain upon issuance of common stock in connection with settlement of liquidated damages</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of common stock for restricted stock units</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes', window );">Common stock withheld for taxes upon issuance of underlying shares for restricted stock units</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock in connection with the exercise of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of stock in connection with acquisitions</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock in connection with acquisition, shares</a></td>
<td class="num">(38,582)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Reclassification to liability upon modification of common stock option</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages', window );">Gain upon forgiveness of liquidated damages with principal stockholder</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="nump">2,701<span></span>
</td>
<td class="nump">41,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger', window );">Issuance of stock in connection with the merger of Say Media</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger', window );">Issuance of common stock in connection with the merger of SayMedia, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,851)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock in connection with professional services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase restricted stock awards in connection with HubPages merger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="nump">$ 270,743<span></span>
</td>
<td class="nump">200,410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering', window );">Issuance of common stock in connection with registered direct offering</a></td>
<td class="nump">11,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock upon conversion of series H preferred stock</a></td>
<td class="nump">12,988<span></span>
</td>
<td class="nump">709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne', window );">Issuance of common stock in connection with the acquisition of Fexy Studios</a></td>
<td class="nump">1,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages', window );">Issuance of common stock in connection with settlement of liquidated damages</a></td>
<td class="nump">369<span></span>
</td>
<td class="nump">6,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages', window );">Gain upon issuance of common stock in connection with settlement of liquidated damages</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of common stock for restricted stock units</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes', window );">Common stock withheld for taxes upon issuance of underlying shares for restricted stock units</a></td>
<td class="num">(1,421)<span></span>
</td>
<td class="num">(4,464)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock in connection with the exercise of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of stock in connection with acquisitions</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Reclassification to liability upon modification of common stock option</a></td>
<td class="num">(68)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages', window );">Gain upon forgiveness of liquidated damages with principal stockholder</a></td>
<td class="nump">3,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">20,076<span></span>
</td>
<td class="nump">33,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="nump">319,421<span></span>
</td>
<td class="nump">270,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger', window );">Issuance of stock in connection with the merger of Say Media</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock in connection with professional services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase restricted stock awards in connection with HubPages merger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,448<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="num">(323,071)<span></span>
</td>
<td class="num">(252,213)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering', window );">Issuance of common stock in connection with registered direct offering</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock upon conversion of series H preferred stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne', window );">Issuance of common stock in connection with the acquisition of Fexy Studios</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages', window );">Issuance of common stock in connection with settlement of liquidated damages</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages', window );">Gain upon issuance of common stock in connection with settlement of liquidated damages</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of common stock for restricted stock units</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes', window );">Common stock withheld for taxes upon issuance of underlying shares for restricted stock units</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock in connection with the exercise of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of stock in connection with acquisitions</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Reclassification to liability upon modification of common stock option</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages', window );">Gain upon forgiveness of liquidated damages with principal stockholder</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(55,582)<span></span>
</td>
<td class="num">(70,858)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="num">$ (378,653)<span></span>
</td>
<td class="num">(323,071)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger', window );">Issuance of stock in connection with the merger of Say Media</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock in connection with professional services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase restricted stock awards in connection with HubPages merger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital gain upon issuance of common stock in connection with forgiveness of liquidated damages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital gain upon issuance of common stock in connection with settlement of liquidated damages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares common stock with held for taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares common stock withheld for taxes shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares issuance of common stock in connection with acquisition one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares issuance of common stock in connection with registered direct offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares issuance of common stock in connection with settlement of liquidated damages shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares issuance of stock in connection with merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value common stock withheld for taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value issuance of common stock in connection with acquisition one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value issuance of common stock in connection with merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value issuance of common stock in connection with registered direct offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value issuance of common stock in connection with settlement of liquidated damages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=AREN_CommonStockToBeIssuedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=AREN_CommonStockToBeIssuedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736385664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (55,582)<span></span>
</td>
<td class="num">$ (70,858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation of property and equipment</a></td>
<td class="nump">352<span></span>
</td>
<td class="nump">539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of platform development and intangible assets</a></td>
<td class="nump">27,354<span></span>
</td>
<td class="nump">26,570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt costs</a></td>
<td class="nump">2,378<span></span>
</td>
<td class="nump">1,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_NoncashAndAccruedInterest', window );">Noncash and accrued interest</a></td>
<td class="nump">3,824<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Loss on impairment of assets</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LossOnSaleOfAssets', window );">Loss on sale of assets</a></td>
<td class="nump">325<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in valuation of contingent consideration</a></td>
<td class="nump">1,010<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatingDamagesPayable', window );">Liquidated damages</a></td>
<td class="nump">583<span></span>
</td>
<td class="nump">1,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">19,060<span></span>
</td>
<td class="nump">31,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="nump">134<span></span>
</td>
<td class="num">(1,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="nump">315<span></span>
</td>
<td class="nump">658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities net of effect of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(11,599)<span></span>
</td>
<td class="num">(2,038)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts', window );">Subscription acquisition costs</a></td>
<td class="nump">3,143<span></span>
</td>
<td class="num">(1,667)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidRoyalties', window );">Royalty fees</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">11,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepayments and other current assets</a></td>
<td class="num">(2,157)<span></span>
</td>
<td class="nump">2,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="num">(77)<span></span>
</td>
<td class="num">(285)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(2,663)<span></span>
</td>
<td class="num">(6,535)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other</a></td>
<td class="nump">3,453<span></span>
</td>
<td class="num">(2,996)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Unearned revenue</a></td>
<td class="num">(7,970)<span></span>
</td>
<td class="nump">3,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_IncreaseDecreaseInSubscriptionRefundLiability', window );">Subscription refund liability</a></td>
<td class="num">(396)<span></span>
</td>
<td class="num">(2,379)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(231)<span></span>
</td>
<td class="num">(218)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="num">(6,147)<span></span>
</td>
<td class="num">(3,359)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(24,772)<span></span>
</td>
<td class="num">(11,304)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(530)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PaymentsForCapitalizedPlatformDevelopment', window );">Capitalized platform development</a></td>
<td class="num">(3,773)<span></span>
</td>
<td class="num">(5,179)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from sale of assets</a></td>
<td class="nump">1,061<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from sale of equity investment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments for acquisitions, net of cash</a></td>
<td class="num">(500)<span></span>
</td>
<td class="num">(35,331)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(3,212)<span></span>
</td>
<td class="num">(38,590)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from bridge notes, net of debt costs</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">34,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments of long-term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(5,928)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds, net of repayments, under line of credit</a></td>
<td class="nump">5,517<span></span>
</td>
<td class="nump">2,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from common stock public offering, net of offering costs</a></td>
<td class="nump">11,500<span></span>
</td>
<td class="nump">32,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of issuance costs from common stock public offering</a></td>
<td class="num">(167)<span></span>
</td>
<td class="num">(1,568)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of debt issuance costs</a></td>
<td class="num">(457)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of common stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PaymentOfDeferredCashPayment', window );">Payment of deferred cash payment</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(453)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment for taxes related to common stock withheld for taxes</a></td>
<td class="num">(1,423)<span></span>
</td>
<td class="num">(4,468)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PaymentOfRestrictedStockLiabilities', window );">Payment of restricted stock liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,152)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">22,895<span></span>
</td>
<td class="nump">54,416<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(5,089)<span></span>
</td>
<td class="nump">4,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents, and restricted cash &#8211; beginning of year</a></td>
<td class="nump">14,373<span></span>
</td>
<td class="nump">9,851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents, and restricted cash &#8211; end of year</a></td>
<td class="nump">9,284<span></span>
</td>
<td class="nump">14,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, cash equivalents, and restricted cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">9,284<span></span>
</td>
<td class="nump">13,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, and restricted cash</a></td>
<td class="nump">9,284<span></span>
</td>
<td class="nump">14,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">12,101<span></span>
</td>
<td class="nump">9,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">85<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Noncash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ReclassificationOfStockbasedCompensationToPlatformDevelopment', window );">Reclassification of stock-based compensation to platform development</a></td>
<td class="nump">1,016<span></span>
</td>
<td class="nump">1,884<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction', window );">Debt costs recorded in accrued expenses and other and in other long-term liabilities</a></td>
<td class="nump">189<span></span>
</td>
<td class="nump">441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Issuance of common stock upon conversion of Series H convertible preferred stock</a></td>
<td class="nump">13,008<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of common stock in connection with settlement of liquidated damages</a></td>
<td class="nump">499<span></span>
</td>
<td class="nump">7,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_IssuanceOfCommonStockInConnectionWithAcquisition', window );">Issuance of common stock in connection with an acquisition</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">3,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DeferredCashPaymentsRecordedInConnectionWithAcquisitions', window );">Deferred cash payments recorded in connection with acquisitions</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1', window );">Assumption of liabilities in connection with acquisitions</a></td>
<td class="nump">1,246<span></span>
</td>
<td class="nump">17,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ReclassificationToLiabilityUponCommonStockModification', window );">Reclassification to liability upon common stock modification</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DeferredCashPaymentsRecordedInConnectionWithAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred cash payments recorded in connection with acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DeferredCashPaymentsRecordedInConnectionWithAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in subscription acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_IncreaseDecreaseInSubscriptionRefundLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in subscription refund liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_IncreaseDecreaseInSubscriptionRefundLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_IssuanceOfCommonStockInConnectionWithAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in connection with acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_IssuanceOfCommonStockInConnectionWithAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LiquidatingDamagesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidating damages payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LiquidatingDamagesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LossOnSaleOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on sale of assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LossOnSaleOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_NoncashAndAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash and accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_NoncashAndAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_PaymentOfDeferredCashPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of deferred cash payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_PaymentOfDeferredCashPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_PaymentOfRestrictedStockLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of restricted stock liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_PaymentOfRestrictedStockLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_PaymentsForCapitalizedPlatformDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for capitalized platform development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_PaymentsForCapitalizedPlatformDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ReclassificationOfStockbasedCompensationToPlatformDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of stockbased compensation to platform development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ReclassificationOfStockbasedCompensationToPlatformDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ReclassificationToLiabilityUponCommonStockModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification to liability upon common stock modification.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ReclassificationToLiabilityUponCommonStockModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for royalties that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of [all] liabilities that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735004608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Basis of Presentation</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z7AmhcPvGa02" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>1.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_829_zuTWLdwyfM03">Organization and Basis of Presentation</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organization</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Arena Holdings Group, Inc. (formerly known as TheMaven, Inc.) (&#8220;The Arena Group&#8221; or the &#8220;Company&#8221;), was incorporated
in Delaware on October 1, 1990. On October 11, 2016, the predecessor entity now known as The Arena Group exchanged its shares with another
entity that was incorporated in Delaware on July 22, 2016. On November 4, 2016, these entities consummated a recapitalization. This resulted
in The Arena Group becoming the parent entity, and the other Delaware entity becoming the wholly owned subsidiary. On December 19, 2019,
the Company&#8217;s wholly owned subsidiaries The Arena Platform, Inc. (formerly known as Maven Coalition, Inc.), and HubPages, Inc.
(&#8220;HubPages&#8221;), which was acquired by the Company in a merger during 2018, were merged into another of the Company&#8217;s
wholly owned subsidiaries, Say Media, Inc. (&#8220;Say Media&#8221;), which was acquired by the Company in a merger during 2018, with
Say Media as the surviving corporation. On January 6, 2020, Say Media changed its name to The Arena Platform, Inc. (&#8220;Arena Platform&#8221;).
As of December 31, 2023, the Company&#8217;s wholly owned subsidiaries consist of The Arena Platform, The Arena Media Brands, LLC (&#8220;Arena
Media&#8221;) (formerly known as Maven Media Brands, LLC) formed during 2019 as a wholly owned subsidiary of The Arena Group), TheStreet,
Inc. (&#8220;TheStreet&#8221; acquired by the Company in a merger during 2019), College Spun Media Incorporated (&#8220;The Spun&#8221;
acquired by the Company in a merger during 2021) and Athlon Holdings, Inc. (&#8220;Parade&#8221; acquired by the Company in a merger
during 2022 as further described in Note 4).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company changed its legal name to The Arena Group Holdings, Inc. from TheMaven, Inc. on February 8, 2022. The Company&#8217;s subsidiaries
changed their corporate names to The Arena Platform, Inc. from Maven Coalition, Inc. and to The Arena Media Brands, LLC from Maven Media
Brands, LLC on February 18, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
the context indicates otherwise, The Arena Group, The Arena Platform, TheStreet, The Spun and Parade, are together hereinafter referred
to as the &#8220;Company.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reverse
Stock Split</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2022, the Board approved a <span id="xdx_902_eus-gaap--StockholdersEquityReverseStockSplit_c20220208__20220208_zH7I3iuuXedl">one-for-twenty-two (1-for-22) reverse stock split</span> of its outstanding shares of common stock that
was effective February 8, 2022. The Company&#8217;s common stock began trading on the NYSE American (the &#8220;NYSE American&#8221;)
on February 9, 2022 (as further described below). At the effective time, every twenty-two shares of issued and outstanding common stock
were automatically combined into one issued and outstanding share of common stock, without any change in the number of authorized shares.
No fractional shares were issued as a result of the reverse stock split. Any fractional shares that would otherwise have resulted from
the reverse stock split were rounded up to the next whole number.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements and notes to the financial statements give effect to the reverse stock split for all periods presented.
The shares of common stock retained a par value of $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_znh03xD8wsM4" title="Common stock par value">0.01</span> per share. Accordingly, stockholders&#8217; deficiency reflects the reverse
stock split by reclassifying from &#8220;common stock&#8221; to &#8220;additional paid-in capital&#8221; in an amount equal to the par
value of the decreased shares resulting from the reverse stock split. In connection with the reverse stock split, proportionate adjustments
were made to increase the per share exercise prices and decrease the number of shares of common stock issuable upon exercise of common
stock options and warrants whereby approximately the same aggregate price is required to be paid for such securities upon exercise as
had been payable immediately preceding the reverse stock split. Any fractional shares that would otherwise be issued as a result of the
reverse stock split were rounded up to the nearest whole share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 9, 2022, in connection with the Company&#8217;s legal name change and reverse stock split, the Company up-listed its common
stock to the NYSE American, which began trading on February 9, 2022 under the symbol &#8220;AREN.&#8221; The Company&#8217;s common stock,
prior to the up-list, was quoted on the OTC Markets Group Inc.&#8217;s (&#8220;OTCM&#8221;) OTCQX<sup>&#174;</sup> Best Market (the &#8220;OTCQX&#8221;)
under the symbol &#8220;MVEN.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Operations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company is a media company that leverages technology to build deep content verticals powered by anchor brands and a best-in-class digital
media platform (the &#8220;Platform&#8221;) empowering publishers who impact, inform, educate, and entertain. The Company&#8217;s strategy
is to focus on key subject matter verticals where audiences are passionate about a topic category (e.g., sports and finance) where it
can leverage the strength of its core brands to grow its audience and increase monetization both within its core brands as well as for
its media publisher partners (each, a &#8220;Publisher Partner&#8221;). The Company&#8217;s focus is on leveraging its Platform and brands
in targeted verticals to maximize audience reach, enhance engagement, and optimize monetization of digital publishing assets for the
benefit of its users, its advertiser clients, and its greater than 40 owned and operated properties as well as properties it runs on
behalf of independent Publisher Partners. The Company owns and operates TheStreet, The Spun, Parade, and Men&#8217;s Journal and powers
more than 320 independent Publisher Partners, including the many sports team sites that comprise FanNation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Each
Publisher Partner joins the Platform by invitation only with the objective of improving our position in key verticals while optimizing
the performance of the Publisher Partner. Publisher Partners incur the costs in content creation on their respective channels and receive
a share of the revenue associated with their content. Because of the state-of-the-art technology and large scale of the Platform and
our expertise in search engine optimization, social media, ad monetization and subscription marketing, Publisher Partners continually
benefit from our ongoing technological advances and audience development expertise. Additionally, we believe the lead brands within our
verticals create a halo benefit for all Publisher Partners while each of them adds to the breadth and quality of content.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Platform</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company developed the Platform, a proprietary online publishing platform that provides its owned and operated media businesses, Publisher
Partners (who are third parties producing and publishing content on their own domains), and individual creators contributing content
to its owned and operated sites (&#8220;Expert Contributors&#8221;), the ability to produce and manage editorially focused content through
tools and services provided by it. The Company has also developed proprietary advertising technology, techniques and relationships that
allow it, its Publisher Partners, and its Expert Contributors to monetize editorially focused online content through various display
and video advertisements and tools and services for driving a subscription or membership based business and other monetization services
(the &#8220;Monetization Solutions&#8221; and, together with the Platform, the &#8220;Platform Services&#8221;). The Company&#8217;s
Platform offers audiences bespoke content with optimized design and page construction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Platform comprises state-of-the-art publishing tools, video platforms, social distribution channels, newsletter technology, machine learning
content recommendations, notifications, and other technology that deliver a complete set of features to drive a digital media business
in an entirely cloud-based suite of services. The Company&#8217;s software engineering and product development teams are experienced
at delivering these services at scale. The Company continues to develop the Platform software by combining proprietary code with components
from the open-source community, plus select commercial services as well as identifying, acquiring, and integrating other platform technologies
where it sees unique long-term benefits to it.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Seasonality</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does experience seasonality during the year, as a result of advertising seasonality and sports seasons and major sporting events.
Advertising typically peaks in the fourth quarter of the Company&#8217;s fiscal year as advertisers concentrate their budgets during
the holiday season. This trend is magnified as it also includes the professional sports and college football seasons, which account for
a significant portion of the Company&#8217;s advertising revenue during that period of the year. Other sporting events such as the Super
Bowl, Winter and Summer Olympics, soccer&#8217;s World Cup, and major golf, tennis and cycling events create increased traffic surrounding
the respective events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going
Concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company performed an annual reporting period going concern assessment. Management is required to assess the Company&#8217;s ability to
continue as a going concern. These consolidated financial statements have been prepared assuming that the Company will continue as a
going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. The
Company&#8217;s consolidated financial statements do not include any adjustments that might be necessary if it is unable to continue
as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
recently, for the year ended December 31, 2023, the Company incurred a net loss from continuing operations of $<span id="xdx_903_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_iN_pn3n3_di_c20230101__20231231_zENQiOCp4Ul9">55,582</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
had cash on hand of $<span id="xdx_90F_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20231231_zg42Hh1wYD1b">9,284</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
a working capital deficit of $<span id="xdx_902_ecustom--WorkingCapitalDeficit_iI_pn3n3_c20231231_z7oLjDxbA0T9">145,622</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Company&#8217;s net loss from continuing operations and working capital deficit have been evaluated by management to determine
if the significance of those conditions or events would limit its ability to meet its obligations when due. Also, since the
Company&#8217;s 2023 Notes (see Note 18), Senior Secured Notes, Delayed Draw Term Notes and 2022 Bridge Notes (see Note 19)
(collectively &#8220;its current debt&#8221;) are subject to a <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%">forbearance
period through the earlier of the following: (a) April 30, 2024</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #393A39; line-height: 115%">;
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%">(b) the occurrence
of the closing of the Business Combination and (c) the termination of the Business Combination prior to closing</span> (as further described in Note 28) unless the Company is
able to refinance or modify the terms of its current debt it runs the risk that its debt could be called, therefore, it may not be able to meet its
obligations when due.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
its evaluation, management determined there is substantial doubt about the Company&#8217;s ability to continue as a going concern for
a one-year period following the financial statement issuance date, unless it is able to refinance or modify its current debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company plans to refinance or modify the maturities of its current debt and complete the Business Combination to alleviate the
conditions that raise substantial doubt about its ability to continue as a going concern, however, there can be no assurance that the Company will be able to refinance or modify its current debt and complete
the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731092656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_z0PJwvau6Jt5" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82F_zW3uYdnXz5tg">Summary of Significant Accounting Policies</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zzFtoQvQnNx7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zy3G9ui5Z5Z5">Principles
of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#8220;GAAP&#8221;) and include the financial statements of The Arena Group and its wholly owned subsidiaries,
Arena Media, Arena Platform, TheStreet, The Spun and Parade. Intercompany balances and transactions have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--UseOfEstimates_z8NcpjojKmQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_z4pyTs3jB2Ci">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make certain estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of
the date of the consolidated financial statements and the reported results of operations during the reporting period. Significant estimates
include: reserves for bad debt; capitalization of platform development and associated useful lives; goodwill and other acquired intangible
assets and associated useful lives; assumptions used in accruals for potential liabilities; revenue recognition and estimates of standalone
selling price of performance obligations for revenue contracts with multiple performance obligations; stock-based compensation and the
determination of the fair value; valuation allowances for deferred tax assets and uncertain tax positions; accounting for business combinations;
and assumptions used to calculate contingent liabilities. These estimates are based on information available as of the date of the consolidated
financial statements; therefore, actual results could differ from management&#8217;s estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_ecustom--RisksAndUncertaintiesPolicy_zeQRbLriArwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zsjI6LF7LMy2">Risks
and Uncertainties</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s business and operations are sensitive to general business and economic conditions in the United States and worldwide.
These conditions include short-term and long-term interest rates, inflation, fluctuations in debt and equity capital markets and the
general condition of the United States and world economy. A host of factors beyond the Company&#8217;s control could cause fluctuations
in these conditions. Adverse developments in these general business and economic conditions could have a material adverse effect on the
Company&#8217;s financial condition and the results of its operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company will compete with many companies that currently have extensive and well-funded projects, marketing and sales operations
as well as extensive human capital. The Company may be unable to compete successfully against these companies. The Company&#8217;s industry
is characterized by rapid changes in technology and market demands. As a result, the Company&#8217;s products, services, or expertise
may become obsolete or unmarketable. The Company&#8217;s future success will depend on its ability to adapt to technological advances,
anticipate customer and market demands, and enhance its current technology under development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Uncertainty
in the global economy presents significant risks to the Company&#8217;s business. Increases in inflation, rising interest rates,
instability in the global banking system, geopolitical factors, including the ongoing conflicts in Ukraine and Israel and the
responses thereto, and the remaining effects of the COVID-19 pandemic may have an adverse effect on the Company&#8217;s business.
While the Company is closely monitoring the impact of the current macroeconomic conditions on all aspects of its business, the
ultimate extent of the impact on its business remains highly uncertain and will depend on future developments and factors that
continue to evolve. Most of these developments and factors are outside of the Company&#8217;s control and could exist for an
extended period of time. As a result, the Company is subject to continuing risks and uncertainties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
December 1, 2023, B. Riley FBR, Inc. (&#8220;B. Riley FBR&#8221;), a registered broker-dealer owned by B. Riley Financial, Inc., a diversified
publicly traded financial services company (&#8220;B. Riley&#8221;) that was instrumental in providing investment banking services to
the Company and in raising debt and equity capital for the Company, and Renew Group Private Limited (&#8220;Renew&#8221;) entered into
agreement where Renew purchased $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20231201__us-gaap--DebtInstrumentAxis__custom--BRileyFBRIncMember_zTC4YweVY0wd">110,691
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in aggregate principal amount of the notes outstanding
with B. Riley, including the 2023 Notes (as described in Note 18), Senior Secured Notes, Delayed Draw Term Notes and 2022 Bridge Notes
(as described in Note 19), which constitute all of the notes outstanding with B. Riley and also assumed the role of agent under the Note
Purchase Agreement, as further described in Note 26. The indirect owner of Renew also has an indirect non-controlling interest in Simplify
Inventions, LLC (&#8220;Simplify&#8221;), a principal stockholder (as further described in Note 26).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_840_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zHxbngcdmK8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zNDHompCPvHb">Segment
Reporting</span> </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates in one reportable segment which focuses on a publishing platform. The Company&#8217;s business offerings have similar
operating characteristics and similar long-term operating performance, including the types of customers, nature of product or services,
distribution methods and regulatory environment. The chief operating decision maker (the &#8220;CODM&#8221;) of the Company reviews specific
financial and operational data and other key metrics to make resource allocation decisions and assesses performance by review of profit
and loss information on a consolidated basis. The CODM does not review specific financial or operational data on a disaggregated basis
or by aggregating operating segments into one reportable segment. The consolidated financial statements reflect the financial results
of the Company&#8217;s one reportable segment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_846_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zGkVoSwSsy6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zbJUQHQnkXde">Revenue
Recognition</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606, <i>Revenue from Contracts with Customers</i>, revenues are
recognized when control of the promised goods or services are transferred to the Company&#8217;s customers, in an amount that reflects
the consideration that the Company expects to receive in exchange for those goods or services. The Company generates all of its revenue
from contracts with customers. The Company accounts for revenue on a gross basis, as compared to a net basis, on its statements of operations.
The Company has made this determination based on its control of the advertising inventory and the ability to monetize the advertising
inventory or publications before transfer to the customer and because it is also the primary obligor responsible for providing the services
to the customer. Cost of revenue is presented as a separate line item on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a description of the principal activities from which the Company generates revenue:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advertising
Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Digital
Advertising &#8211; </i>The Company recognizes revenue from digital advertisements at the point when each ad is viewed. The quantity
of advertisements, the impression bid prices and revenue are reported on a real-time basis. The Company enters into contracts with advertising
networks to serve display or video advertisements on the digital media pages associated with its various channels. Although reported
advertising transactions are subject to adjustment by the advertising network partners, any such adjustments are known within a few days
of month end. The Company owes its independent Publisher Partners a revenue share of the advertising revenue earned, which is recorded
as service costs in the same period in which the associated advertising revenue is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising
revenue that is comprised of fees charged for the placement of advertising, on the Company&#8217;s flagship website, <i>TheStreet.com,
</i>is recognized as the advertising or sponsorship is displayed, if collection of the resulting receivable is reasonably assured.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Print
Advertising &#8211; </i>Advertising related revenues for print advertisements are recognized when advertisements are published (defined
as an issue&#8217;s on-sale date), net of provisions for estimated rebates, rate adjustments, and discounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Subscription
Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Digital
Subscriptions</i> &#8211; The Company enters into contracts with internet users that subscribe to premium content on the owned and operated
media channels and facilitate such contracts between internet users and its Publisher Partners. These contracts provide internet users
with a membership subscription to access the premium content. The Company owes its independent Publisher Partners a revenue share of
the membership subscription revenue earned, which is initially deferred and recorded as deferred contract costs. The Company recognizes
deferred contract costs over the membership subscription term in the same pattern that the associated membership subscription revenue
is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
revenue generated from the Company&#8217;s flagship website <i>TheStreet.com</i> from institutional and retail customers is comprised
of subscriptions and license fees for access to securities investment information, stock market commentary, director and officer profiles,
relationship capital management services, and transactional information pertaining to mergers and acquisitions and other changes in the
corporate control environment. Subscriptions are charged to customers&#8217; credit cards or are directly billed to corporate subscribers,
and are generally billed in advance on a monthly, quarterly or annual basis. The Company calculates net subscription revenue by deducting
from gross revenue an estimate of potential refunds from cancelled subscriptions as well as chargebacks of disputed credit card charges.
Net subscription revenue is recognized ratably over the subscription periods. Unearned revenue relates to payments for subscription fees
for which revenue has not been recognized because services have not yet been provided.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Print
Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print
revenue includes magazine subscriptions and single copy sales at newsstands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Print
Subscriptions &#8211;</i> Revenue from magazine subscriptions is deferred and recognized proportionately as products are distributed
to subscribers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Newsstand
</i>&#8211; Single copy revenue is recognized on the publication&#8217;s on-sale date, net of provisions for estimated returns. The Company
bases its estimates for returns on historical experience and current marketplace conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Licensing
and Syndication Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Content
licensing-based revenues and syndication revenues are accrued generally monthly or quarterly based on the specific mechanisms of each
contract. Generally, revenues are accrued based on estimated sales and adjusted as actual sales are reported by partners. These adjustments
are typically recorded within three months of the initial estimates and have not been material. Any minimum guarantees are typically
earned evenly over the fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nature
of Performance Obligations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
contract inception, the Company assesses the obligations promised in its contracts with customers and identifies a performance obligation
for each promise to transfer a good or service or bundle that is distinct. To identify the performance obligations, the Company considers
all the promises in the contract, whether explicitly stated or implied based on customary business practices. For a contract that has
more than one performance obligation, the Company allocates the total contract consideration to each distinct performance obligation
on a relative standalone selling price basis. Revenue is recognized when, or as, the performance obligations are satisfied, and control
is transferred to the customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Digital
Advertising</i> &#8211; The Company sells digital advertising inventory on its websites directly to advertisers or through advertising
agencies. The Company&#8217;s performance obligations related to digital advertising are generally satisfied when the advertisement is
run on the Company&#8217;s platform. The price for direct digital advertising is determined in contracts with the advertisers. Revenue
from the sale of direct digital advertising is recognized when the advertisements are delivered based on the contract. The customer is
invoiced the agreed-upon price in the month following the month that the advertisements are delivered with normal trade terms. The agreed
upon price is adjusted for estimated provisions for rebates, rate adjustments, and discounts. As part of the Company&#8217;s customary
business practices, digital advertising contracts may include a guaranteed number of impressions and sales incentives to its customers
including volume discounts, rebates, value added impressions, etc. For all such contracts that include these types of variable consideration,
the Company estimates the variable consideration and factors in such an estimate when determining the transaction price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Print
Advertising</i> <b>&#8211; </b>The Company provides advertisement placements in print media directly to advertisers or through advertising
agencies. The Company&#8217;s performance obligations related to print advertising are satisfied when the magazine in which an advertisement
appears is published, which is defined as an issue&#8217;s on-sale date. The customer is invoiced the agreed-upon price when the advertisements
are published under normal industry trade terms. The agreed upon price is adjusted for estimated provisions for rebates, rate adjustments,
and discounts. As part of the Company&#8217;s customary business practices, print advertising contracts include guaranteed circulation
levels of magazines, referred to as rate base, and a number of sales incentives to its customers including volume discounts, rebates,
bonus pages, etc. For all such contracts that include these types of variable consideration, the Company estimates such when determining
the transaction price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Digital
Subscriptions</i> &#8211; The Company recognizes revenue from each membership subscription to access the premium content over time based
on a daily calculation of revenue during the reporting period, which is generally one year. Subscriber payments are initially recorded
as unearned revenue on the balance sheets. As the Company provides access to the premium content over the membership subscription term,
the Company recognizes revenue and proportionately reduces the unearned revenue balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Print
Subscriptions</i> &#8211; The Company sells magazines to consumers through subscriptions. Each copy of a magazine is determined to be
a distinct performance obligation that is satisfied when the publication is sent to the customer. The majority of the Company&#8217;s
subscription sales are prepaid at the time of order. Subscriptions may be canceled at any time for a refund of the price paid for remaining
issues. As the contract may be canceled at any time for a full refund of the unserved copies, the contract term is determined to be on
an issue-to-issue basis as these contracts do not have substantive termination penalties. Revenues from subscriptions are deferred and
recognized proportionately as subscribers are served. Some magazine subscription offers contain more than one magazine title in a bundle.
The Company allocates the total contract consideration to each distinct performance obligation, or magazine title, based on a standalone-selling
price basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Newsstand
</i>&#8211; The Company sells single copy magazines, or bundles of single copy magazines, to wholesalers for ultimate resale on newsstands
primarily at major retailers and grocery/drug stores, and in digital form on tablets and other electronic devices. Publications sold
to magazine wholesalers are sold with the right to receive credit from the Company for magazines returned to the wholesaler by retailers.
Revenue is recognized on the issue&#8217;s on-sale date as the date aligns most closely with the date that control is transferred to
the customer. The Company bases its estimates for returns on historical experience and current marketplace conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Licensing
and Syndication &#8211; </i>The Company has entered into various licensing and syndication agreements that provide third party
partners with the right to utilize the Company&#8217;s content. Functional licenses in national media consist of content
licensing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Timing
of Satisfaction of Performance Obligations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Point-in-Time
Performance Obligations &#8211; </i>For performance obligations related to certain digital advertising space and sales of print advertisements,
the Company determines that the customer can direct the use of and obtain substantially all the benefits from the advertising products
as the digital impressions are served or on the issue&#8217;s on-sale date. For performance obligations related to sales of magazines
through subscriptions, the customer obtains control when each magazine issue is mailed to the customer on or before the issue&#8217;s
on-sale date. For sales of single copy magazines on newsstands, revenue is recognized on the issue&#8217;s on-sale date as the date aligns
most closely with the date that control is transferred to the customer. Revenues from functional licenses and syndication arrangements
are recognized at a point-in-time when access to the completed content is granted to the partner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Over-Time
Performance Obligations</i> <b>&#8211; </b>For performance obligations related to sales of certain digital advertising space, the Company
transfers control and recognizes revenue over time by measuring progress towards complete satisfaction using the most appropriate method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
performance obligations related to digital advertising, the Company satisfies its performance obligations on some flat-fee digital advertising
placements over time using a time-elapsed output method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determining
a measure of progress requires management to make judgments that affect the timing of revenue recognized. The Company has determined
that the above method provides a faithful depiction of the transfer of goods or services to the customer. For performance obligations
recognized using a time-elapsed output method, the Company&#8217;s efforts are expended evenly throughout the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
obligations related to subscriptions to premium content on the digital media channels provides access for a given period of time, which
is generally one year. The Company recognizes revenue from each membership subscription over time based on a daily calculation of revenue
during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transaction
Price and Amounts Allocated to Performance Obligations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Determining
the Transaction Price &#8211; </i>Certain advertising contracts contain variable components of the transaction price, such as volume
discounts and rebates. The Company has sufficient historical data and has established processes to reliably estimate these variable components
of the transaction price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
revenue generated from the flagship website <i>TheStreet.com</i> is subject to estimation and variability due to the fact that, in the
normal course of business, subscribers may for various reasons contact the Company or their credit card companies to request a refund
or other adjustment for a previously purchased subscription. With respect to many of the Company&#8217;s annual newsletter subscription
products, the Company offers the ability to receive a refund during the first 30 days but none thereafter. Accordingly, the Company maintains
a provision for estimated future revenue reductions resulting from expected refunds and chargebacks related to subscriptions for which
revenue was recognized in a prior period. The calculation of this provision is based upon historical trends and is reevaluated each quarter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company typically does not offer any type of variable consideration in standard magazine subscription contracts. For these contracts,
the transaction price is fixed upon establishment of the contract that contains the final terms of the sale including description, quantity
and price of each subscription purchased. Therefore, the Company does not estimate variable consideration or perform a constraint analysis
for these contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
right of return exists for newsstand contracts. The Company has sufficient historical data to estimate the final amount of returns and
reduces the transaction price at contract inception for the expected return reserve.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no variable consideration related to functional licenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Estimating
Standalone-Selling Prices</i> <b>&#8211; </b>For contracts that contain multiple performance obligations, the Company allocates the transaction
price to each performance obligation on a relative standalone-selling price basis. The standalone-selling price is the price at which
the Company would sell a promised good or service separately to the customer. In situations in which an obligation is bundled with other
obligations and the total amount of consideration does not reflect the sum of individual observable prices, the Company allocates the
discount to (1) a single obligation if the discount is attributable to that obligation or (2) prorates across all obligations if the
discount relates to the bundle. When standalone-selling price is not directly observable, the Company estimates and considers all the
information that is reasonably available to the Company, including market conditions, entity specific factors, customer information,
etc. The Company maximizes the use of observable inputs and applies estimation methods consistently in similar circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Measuring
Obligations for Returns and Refunds</i> &#8211; The Company accepts product returns in some cases. The Company establishes provisions
for estimated returns concurrently with the recognition of revenue. The provisions are established based upon consideration of a variety
of factors, including, among other things, recent and historical return rates for both specific products and distributors and the impact
of any new product releases and projected economic conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023 and 2022, a subscription refund liability of $<span id="xdx_903_eus-gaap--ContractWithCustomerRefundLiabilityCurrent_iI_pn3n3_c20231231_zPBgu0X43SHc" title="Subscription refund liability">449</span> and $<span id="xdx_907_eus-gaap--ContractWithCustomerRefundLiabilityCurrent_iI_pn3n3_c20221231_zn36hWjiWCki" title="Subscription refund liability">845</span>, respectively, was recorded for the provision for the
estimated returns and refunds on the consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Contract
Modifications</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company occasionally enters into amendments to previously executed contracts that constitute contract modifications. The Company assesses
each of these contract modifications to determine:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the additional services and goods are distinct from the services and goods in the original arrangement; and</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the amount of consideration expected for the added services or goods reflects the stand-alone selling price of those services and
    goods.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
contract modification meeting both criteria is accounted for as a separate contract. A contract modification not meeting both criteria
is considered a change to the original contract and is accounted for on either a prospective basis as a termination of the existing contract
and the creation of a new contract, or a cumulative catch-up basis (further details are provided under the headings <i>Contract Balances
</i>and <i>Subscription Acquisition Costs</i>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Disaggregation
of Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_eus-gaap--DisaggregationOfRevenueTableTextBlock_zqIHuXdmsySi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information about disaggregated revenue by category, geographical market and timing of revenue recognition:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_z6Kcyvj050lh" style="display: none">Schedule
of Disaggregation of Revenue</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230101__20231231_zkXxx6cmdky8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20221231_ztGAhuYNbwml" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Revenue by category:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><b>Digital revenue</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalAdvertisingMember_zo01p5dvBfP" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 60%; text-align: justify">Digital advertising</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">135,376</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">109,317</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalSubscriptionsMember_zD0kRLElyCW" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Digital subscriptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,764</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,156</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--LicensingAndSyndicationRevenueMember_zfNDuHqh6Ld8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Licensing and syndication revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,173</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__us-gaap--ProductAndServiceOtherMember_zx2y2DOEFCp1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Other digital revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,384</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,166</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zgsNr7azyhMl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify; padding-bottom: 1.5pt">Total digital revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">172,006</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">149,812</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><b>Print revenue</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintAdvertisingMember_zbRG7M168fX4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Print advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,881</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,214</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintSubscriptionsMember_zv5dvOGnfQz2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Print subscriptions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">62,316</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">60,909</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_zzQN9CQzquF8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify; padding-bottom: 1.5pt">Total print revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">72,197</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">71,123</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zUzRiEu6CZTh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">244,203</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">220,935</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Revenue by geographical market:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__country--US_zKX1xgZJTcp9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">234,012</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">218,110</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__custom--OtherMember_zS4cb0vzdZL4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,191</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,825</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zgadvHNx3Wz9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">244,203</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">220,935</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Revenue by timing of recognition:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_zumKpCgm0fo5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">At point in time</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">231,439</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">199,779</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zpFUGfTLJXS6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Over time</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,764</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,156</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zmjvuJAzMUPa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0pt; text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">244,203</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">220,935</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A1_zErk4ulyJWh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_849_ecustom--CostOfRevenuePolicyTextBlock_zBsWZ7XiYoJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zMoE01NyV7Ge">Cost
of Revenue</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenue represents the cost of providing the Company&#8217;s digital media channels and advertising and membership services. The cost
of revenue that the Company has incurred in the periods presented primarily include: Publisher Partner guarantees and revenue share payments;
amortization of developed technology and platform development; royalty fees; hosting and bandwidth and software license fees; printing
and distribution costs; payroll and related expenses for customer support, technology maintenance; fees paid for data analytics and to
other outside service providers; and stock-based compensation of related personnel (as described in Note 22).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_ecustom--ContractBalancesPolicyTextBlock_zyCXvDn3m8ee" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zZnVYYxSPCql">Contract
Balances</span> </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
timing of the Company&#8217;s performance under its various contracts often differs from the timing of the customer&#8217;s payment,
which results in the recognition of a contract asset or a contract liability. A contract asset is recognized when a good or service is
transferred to a customer and the Company does not have the contractual right to bill for the related performance obligations. An asset
is recognized when certain costs incurred to obtain a contract meet the capitalization criteria (further details are provided under the
heading <i>Subscription Acquisition Costs</i>). A contract liability is recognized when consideration is received from the customer prior
to the transfer of goods or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_898_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_zaHl7ipmaYU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information about contract balances:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zB03ZNauj0wc" style="display: none">Schedule
of Contract with Customer, Asset and Liability</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20231231_zaeO3S0cr5pd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20221231_z3Gw4AyXnoya" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unearned revenue (short-term contract liabilities):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zNXnIczbDXRb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Digital revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">14,397</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">18,571</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_z7Oqs9MAbBK9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Print revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,389</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">40,132</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_z1TaModhTRyk" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total short-term contract
    liabilities</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">59,786</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">58,703</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unearned revenue (long-term contract liabilities):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zce7hTDFpFCe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Digital revenue</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">542</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,118</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_zUy5wqyC5QDa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Print revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,137</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,583</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_zxVz3y32mAu9" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total long-term contract
    liabilities</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,679</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,701</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_zGBCCJVDLCcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unearned
Revenue</i> &#8211; Unearned revenue, also referred to as contract liabilities, include payments received in advance of performance under
the contracts and are recognized as revenue over time. The Company records contract liabilities as unearned revenue on the consolidated
balance sheets. Digital subscription and print subscription revenue of $<span id="xdx_901_ecustom--UnearnedRevenue_iI_pn3n3_c20231231__srt--ProductOrServiceAxis__custom--DigitalAndPrintSubscriptionsMember_zavJ3vDtUiH8" title="Contract with customer liability noncurrent">68,985</span> was recognized during the year ended December 31, 2023
from unearned revenue at the beginning of the year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
January 2020, February 2020 and December 2021, the Company modified certain digital and print subscription contracts that prospectively
changed the frequency of the related issues (or magazines) required to be delivered on a yearly basis (the &#8220;Contract Modifications&#8221;).
The Company determined that the remaining digital content and magazines to be delivered are distinct from the digital content or magazines
already provided under the original contract. As a result, the Company in effect established a new contract that included only the remaining
digital content or magazines. Accordingly, the Company allocated the remaining performance obligations in the contracts as consideration
from the original contract that has not yet been recognized as revenue. For the years ended December 31, 2023 and 2022, the Company recognized
revenue of $<span id="xdx_90E_eus-gaap--ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_pn3n3_c20230101__20231231_zJWXinQwW492" title="Contract modification - revenue">554</span> and $<span id="xdx_907_eus-gaap--ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_pn3n3_c20220101__20221231_zDp3CYXxDNIk" title="Contract modification - revenue">2,986</span>, respectively, resulting from the Contract Modifications.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_z9UwVGtuxJeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zAzFgaT3AaBg">Cash,
Cash Equivalents, and Restricted Cash</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains cash, cash equivalents, and restricted cash at banks where amounts on deposit may exceed the Federal Deposit Insurance
Corporation limit during the year. Cash and cash equivalents represent cash and highly liquid investments with an original contractual
maturity at the date of purchase of three months. As of December 31, 2023 and 2022, cash and cash equivalents consist primarily of checking,
savings deposits and money market accounts. These deposits exceeded federally insured limits. The Company has not experienced any losses
in such accounts and believes it is not exposed to significant credit risk regarding its cash and cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_zWFdppVl58t5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reconciles total cash, cash equivalents, and restricted cash:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zTCWT3MYdZO7" style="display: none">Schedule
of Cash and Restricted Cash</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20231231_zUskfSfE2iV1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20221231_znUZ7fvHtDW2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_zno6kDP5lx" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">9,284</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">13,871</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RestrictedCashCurrent_iI_pn3n3_zdHIlDDBpFjf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0929">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">502</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_zznDqR4ifFL" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total cash, cash equivalents, and restricted cash</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,284</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,373</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_z4OLwY6zlTZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023 and 2022, the Company had restricted cash of $<span id="xdx_900_eus-gaap--RestrictedCashCurrent_iI_pn3n3_dxL_c20231231_zOooSWMkC0Wa" title="Restricted cash::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0935">0</span></span> and $<span id="xdx_901_eus-gaap--RestrictedCashCurrent_iI_pn3n3_c20221231_zl4OXUGn5BEj" title="Restricted cash">502</span>, which served as collateral for certain credit card merchant
accounts with a bank.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_84C_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zS2uwglgvJDc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_z8Sbs2Iwcjt7">Accounts
Receivable and Allowance for Doubtful Accounts</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company receives payments from advertising customers based upon contractual payment terms; accounts receivable is recorded when the right
to consideration becomes unconditional and are generally collected within 90 days. The Company generally receives payments from digital
and print subscription customers at the time of sign up for each subscription; accounts receivable from merchant credit card processors
are recorded when the right to consideration becomes unconditional and are generally collected weekly. Accounts receivable have been
reduced by an allowance for doubtful accounts. The Company maintains the allowance for estimated losses resulting from the inability
of the Company&#8217;s customers to make required payments. The allowance represents the current estimate of lifetime expected credit
losses over the remaining duration of existing accounts receivable considering current market conditions and supportable forecasts when
appropriate. The estimate is a result of the Company&#8217;s ongoing evaluation of collectability, customer creditworthiness, historical
levels of credit losses, and future expectations. Accounts receivable are written off when deemed uncollectible and collection of the
receivable is no longer being actively pursued. Accounts receivable as of December 31, 2023 and 2022 of $<span id="xdx_90F_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20231231_zl4wAyzTyJxj" title="Accounts receivable">44,811</span> and $<span id="xdx_903_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20221231_zk8tBgn9UdK9" title="Accounts receivable">33,950</span>, respectively,
are presented net of allowance for doubtful accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_eus-gaap--AccountsReceivableAllowanceForCreditLossTableTextBlock_zE6UsT17gkr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the allowance for doubtful accounts activity:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_8BF_zEgFA9pr0K7c" style="display: none">Schedule
of Allowance For Doubtful Accounts</span></i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230101__20231231_z2oNAD11QwDd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220101__20221231_zEvHgtnlkRJb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pn3n3_z52Kpe9D4YZ1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Allowance for doubtful accounts beginning of year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,236</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,578</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_pn3n3_zbWpUqbjztzi" style="vertical-align: bottom; background-color: White">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">315</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">658</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_pn3n3_di_zVYZVuWNQZE7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Deductions - write-offs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,570</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0954">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pn3n3_zAW7wIVI4Tvi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Allowance for doubtful accounts end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">981</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,236</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_z90ATvKk8wH" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_844_ecustom--SubscriptionAcquisitionCostsPoliceTextBlock_z22oJSGvtoSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zKboqtjKDKK1">Subscription
Acquisition Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
acquisition costs include the incremental costs of obtaining a contract with a customer, paid to external parties, if the Company
expects to recover those costs. The Company has determined that sales commissions paid on all third party agent sales of
subscriptions are direct and incremental costs of obtaining a contract with a customer and, therefore, meet the capitalization
criteria. The Company has elected to apply the practical expedient to amortize these costs at the portfolio level. The sales
commissions paid to third party agents are amortized as the magazines are sent to the subscriber on an issue-by-issue basis. The
Company determined that commissions paid for subscriber renewal contracts to all third party agents are not from a specifically
anticipated future contract, therefore, the commissions paid on renewals are amortized as the magazines are sent to the subscriber
over the renewal term on an issue-by-issue basis. Direct mail costs for renewal subscriptions are expensed as incurred since they do
not meet the capitalization criteria.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
of subscription acquisition costs of $<span id="xdx_900_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20230101__20231231_z3yqarK4qbT2" title="Amortization subscription costs">38,112</span> and $<span id="xdx_909_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20220101__20221231_zetPKUQdqnV" title="Amortization subscription costs">37,190</span> for the years ended December 31, 2023 and 2022, respectively, are included within
selling and marketing expenses on the consolidated statements of operations. No impairment losses have been recognized for subscription
acquisition costs for the years ended December 31, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Contract Modifications resulted in subscription acquisition costs to be recognized on a prospective basis in the same proportion as the
revenue that has not yet been recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current portion of the subscription acquisition costs as of December 31, 2023 and 2022 was $<span id="xdx_90D_eus-gaap--CapitalizedContractCostNet_iI_pn3n3_c20231231_zuQHX4IgjvLj" title="Subscription acquisition cost">29,706</span> and $<span id="xdx_908_eus-gaap--CapitalizedContractCostNet_iI_pn3n3_c20221231_zHgzmcuDTO2c" title="Subscription acquisition cost">25,931</span>, respectively. The noncurrent
portion of the subscription acquisition costs as of December 31, 2023 and 2022 was $<span id="xdx_90F_eus-gaap--CapitalizedContractCostNetNoncurrent_iI_pn3n3_c20231231_zuQZ8za8uVQ1" title="Acquisition cost long term">7,215</span> and $<span id="xdx_90A_eus-gaap--CapitalizedContractCostNetNoncurrent_iI_pn3n3_c20221231_zT9PoCGd3K8" title="Subscription acquisition cost noncurrent">14,133</span>, respectively. Subscription acquisition
costs as of December 31, 2023 presented as current assets of $<span id="xdx_90F_eus-gaap--CapitalizedContractCostNetCurrent_iI_pn3n3_c20231231_zo1MLlajxgTa" title="Subscription acquisition cost current">29,706</span> are expected to be amortized over a one-year period, or through
December 31, 2024, and presented as long-term assets of $<span id="xdx_903_eus-gaap--CapitalizedContractCostNetNoncurrent_iI_pn3n3_c20231231_zxsAKyrm7EHd" title="Acquisition cost long term">7,215</span> are expected to be amortized after the one-year period ending December
31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zuFwj24pNbIb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zdfqSnGTBc5i">Concentrations</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Significant
Customers</i> &#8211; Concentration of credit risk with respect to accounts receivable is limited to customers to whom the Company makes
significant sales. While a reserve for the potential write-off of accounts receivable is maintained, the Company has not written off
any material accounts to date. To control credit risk, the Company performs regular credit evaluations of its customers&#8217; financial
condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Revenue from significant customers
as a percentage of the Company&#8217;s total revenue represent approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zThted2Odbo8" title="Percentage of revenue">10.0%</span> from a customer for the year ended December 31,
2023. Revenue from significant customers as a percentage of the Company&#8217;s total revenue represent <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_ziHFVgMQvzek" title="Percentage of revenue">13.9</span>%
from a customer for the year ended December 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Significant
Vendors</i> &#8211; Concentrations of risk with respect to third party vendors who provide products and services to the Company are limited.
If not limited, such concentrations could impact profitability if a vendor failed to fulfill their obligations or if a significant vendor
was unable to renew an existing contract and the Company was not able to replace the related product or service at the same cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
accounts payable balances as a percentage of the Company&#8217;s total accounts payable represent <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zLCCYvLPg5sa" title="Percentage of revenue">12.2</span>%, and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zt1aDfZZD7h8" title="Percentage of revenue">14.1</span>% from a vendor for
the years ended December 31, 2023, and 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--LesseeLeasesPolicyTextBlock_zgFMOy83caE9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zaJmjfnbPHh1">Leases</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has lease arrangements for its offices. Leases are recorded as an operating lease right-of-use assets and
operating lease liabilities on the consolidated balance sheets. Leases with an initial term of 12 months or less are not recorded on
the consolidated balance sheets. At inception, the Company determines whether an arrangement that provides control over the use of an
asset is a lease. When it is reasonably certain that the Company will exercise the renewal period, the Company includes the impact of
the renewal in the lease term for purposes of determining total future lease payments. Rent expense is recognized on a straight-line
basis over the lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zDl5ILyJlW6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zfB4YD9VIXwd">Property
and Equipment</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment is stated at cost less accumulated depreciation. Maintenance and repairs are charged to expense as incurred. Gains and
losses from disposition of property and equipment are included on the consolidated statements of operations when realized.
Depreciation and amortization are provided using the straight-line method over the following estimated useful lives:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_ecustom--ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock_zW0c7n0xBdG" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zTBFGihIfjp5" style="display: none">Schedule
of Depreciation and Amortization, Useful Lives of Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; background-color: white; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Office equipment and computers</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember__srt--RangeAxis__srt--MinimumMember_zcxEM3qmqqvh" title="Property plant and equipment useful life">1</span>
    &#8211; <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember__srt--RangeAxis__srt--MaximumMember_zJxfuGiMd98k" title="Property plant and equipment useful life">3</span> years </span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Furniture and fixtures</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zswoOMa1XqJ5" title="Property plant and equipment useful life">1</span>
    &#8211; <span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_ziKDN4X4JdCf" title="Property plant and equipment useful life">5</span> years </span></td>
    </tr>
  </table>
<p id="xdx_8A9_zMfJETCLDmIl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_ecustom--PlatformDevelopmentPolicyTextBlock_zy56NXyb0kWf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zyaIkOWXtRzd">Platform
Development</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes platform development costs for internal use when planning and design efforts are successfully completed, and development
is ready to commence. The Company places capitalized platform development assets into service and commences amortization when the applicable
project or asset is substantially complete and ready for its intended use. Once placed into service, the Company capitalizes qualifying
costs of specified upgrades or enhancements to capitalized platform development assets when the upgrade or enhancement will result in
new or additional functionality.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes internal labor costs, including payroll-based and stock-based compensation, benefits and payroll taxes, that are
incurred for certain capitalized platform development projects related to the Platform. The Company&#8217;s policy with respect to capitalized
internal labor stipulates that labor costs for employees working on eligible internal use capital projects are capitalized as part of
the historical cost of the project when the impact, as compared to expensing such labor costs, is material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Platform
development costs are amortized on a straight-line basis over three years, which is the estimated useful life of the related asset and
is recorded in cost of revenue on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_845_eus-gaap--BusinessCombinationsPolicy_zT2MpaT5HXH9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zJI7DmkaUBF4">Business
Combinations</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for business combinations using the acquisition method of accounting. The acquisition method of accounting requires
that the purchase price, including the fair value of contingent consideration, of the acquisition be allocated to the assets acquired
and liabilities assumed using the estimated fair values determined by management as of the acquisition date. Goodwill is measured as
the excess of consideration transferred and the net fair values of the assets acquired, and the liabilities assumed at the date of acquisition.
While the Company uses its best estimates and assumptions as part of the purchase price allocation process to accurately value assets
acquired and liabilities assumed at the acquisition date, the Company&#8217;s estimates are inherently uncertain and subject to refinement.
As a result, during the measurement period, the Company records adjustments to the assets acquired and liabilities assumed, with the
corresponding offset to goodwill to the extent the Company identifies adjustments to the preliminary purchase price allocation. Upon
the conclusion of the measurement period, which may be up to one year from the acquisition date, or final determination of the values
of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements
of operations. Additionally, the Company identifies acquisition-related contingent payments and determines their respective fair values
as of the acquisition date, which are recorded as accrued liabilities on the consolidated balance sheets. Subsequent changes in fair
value of contingent payments are recorded on the consolidated statements of operations. The Company expenses transaction costs related
to the acquisition as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zRmHtX5pTvZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zer3MX8n32Zc">Intangible
Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets with finite lives, consisting of developed technology and trade names, are amortized using the straight-line method over the estimated
economic lives of the assets. A finite lived intangible asset is tested for recoverability whenever events or changes in circumstances
indicate that its carrying amount may not be recoverable. Determination of recoverability is based on an estimate of undiscounted future
cash flows resulting from the use of the asset and its eventual disposition. Intangible assets with an indefinite useful life are not
amortized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zKkJeRxhDs7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zvWY7l29zly8">Long-Lived
Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company periodically evaluates the carrying value of long-lived assets to be held and used when events or circumstances warrant such
a review. The carrying value of a long-lived asset to be held and used is considered impaired when the anticipated separately identifiable
undiscounted cash flows from such an asset are less than the carrying value of the asset. In that event, a loss is recognized based on
the amount by which the carrying value exceeds the fair value of the long-lived asset. Fair value is determined primarily by reference
to the anticipated cash flows discounted at a rate commensurate with the risk involved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zqeKGDJnsdl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_z2AQsN3mg3vf">Goodwill</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
represents the excess of the purchase price over the fair value of the net tangible and intangible assets of businesses acquired in a
business combination. Goodwill is not amortized but rather is tested for impairment at least annually on December 31, or more frequently
if events or changes in circumstances indicate that the carrying amount of goodwill may not be recoverable. The Company operates as one
reporting unit, therefore, the impairment test is performed at the consolidated entity level. Recoverability of goodwill is determined
by comparing the fair value of Company&#8217;s reporting unit to the carrying value of the underlying net assets in the reporting unit.
If the fair value of the reporting unit is determined to be less than the carrying value of its net assets, goodwill is deemed impaired,
and an impairment loss is recognized to the extent that the carrying value of goodwill exceeds the difference between the fair value
of the reporting unit and the fair value of its other assets and liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--DebtPolicyTextBlock_zSYHH4D9R5m2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zsLTIsIEsTe5">Debt
Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt
costs consist of cash and noncash consideration paid to lenders and third parties with respect to debt and other financing transactions,
including legal fees and placement fees. Such costs are deferred and amortized over the term of the related debt. Upon the settlement
of debt the pro rata portion of any related unamortized debt costs are charged to operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
consideration in the form of warrants and other derivative financial instruments issued to lenders are accounted for at fair value utilizing
information determined by consultants with the Company&#8217;s independent valuation firm. The fair value of warrants and derivatives
are recorded as a reduction to the carrying amount of the related debt and amortized to interest expense over the term of such debt,
with the initial offsetting entries recorded as a liability on the balance sheet. Upon the settlement of the debt the pro rata portion
of any related unamortized debt cost is charged to operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_ecustom--LiquidatedDamagesPolicyTextBlock_zO8iSJcjfLf1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z8RIaUQLlYs4">Liquidated
Damages</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--LiquidatedDamagesDescription_c20230101__20231231_zonRRIz47iA3" title="Liquidated damages description">The
Company incurred liquidated damages when: (i) a registration rights agreement provides for damages if the Company does not register the
shares of the Company&#8217;s common stock within the requisite time frame (the &#8220;Registration Rights Damages&#8221;), which, in
general, provides for a cash payment equal to 1.0% per month of the amount invested, on a daily pro rata basis for any portion of a month,
as partial liquidated damages per month, upon the occurrence of certain events, up to a maximum amount of 6.0% of the aggregate amount
invested, subject to interest at the rate of 1.0% per month until paid in full; and (ii) a securities purchase agreement provides for
damages if the Company fails for any reason to satisfy a public information requirement within the requisite time frame with the Securities
and Exchange Commission (&#8220;SEC&#8221;) (the &#8220;Public Information Failure Damages&#8221;), which, in general, provides for a
cash payment equal to 1.0% of the aggregate amount invested for each 30-day period, or pro rata portion thereof, as partial liquidated
damages per month, up to a maximum of 6 months, subject to interest at the rate of 1.0% per month until paid in full. </span>Collectively, the
Registration Rights Damages and the Public Information Failure Damages are referred to as the &#8220;Liquidated Damages&#8221; on the
consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_844_ecustom--SellingAndMarketingPolicyTextBlock_z0QK2t5Wt1Td" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_z3MWHRefDrKh">Selling
and Marketing</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
and marketing expenses consist of compensation, employee benefits and stock-based compensation of selling and marketing, account management
support teams, as well as commissions, travel, trade show sponsorships and events, conferences and advertising costs. The Company&#8217;s
advertising expenses relate to direct-mail costs for magazine subscription acquisition efforts, and print and digital advertising that
are expensed when an advertisement takes place. During the years ended December 31, 2023 and 2022, the Company incurred advertising expenses
of $<span id="xdx_90B_eus-gaap--AdvertisingExpense_pn3n3_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zPoX2qm3OAc8" title="Advertising expense">4,372</span> and $<span id="xdx_90B_eus-gaap--AdvertisingExpense_pn3n3_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zxjpFaaFJ06g" title="Advertising expense">5,987</span>, respectively, which are included within selling and marketing on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84A_ecustom--GeneralandAdministrativePolicyTextBlock_zCq43ynBTIca" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zHESIMYAoQnd">General
and Administrative</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses consist primarily of payroll for executive personnel, technology personnel incurred in developing conceptual
formulation and determination of existence of needed technology, and administrative personnel along with any related payroll costs; professional
services, including accounting, legal and insurance; facilities costs; conferences; other general corporate expenses; and stock-based
compensation of related personnel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eus-gaap--DerivativesPolicyTextBlock_z3pQuzSXL8qj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zfzZMmqi8hhf">Derivative
Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for freestanding contracts that are settleable in the Company&#8217;s equity securities, including the put option
on the Company&#8217;s common stock, to be designated as an equity instrument, generally as a liability. A contract so
designated is carried at fair value on the consolidated balance sheets, with any changes in fair value recorded as a gain or loss
on the consolidated statements of operations, with no impact on cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the date of settlement of a freestanding equity contract, the pro rata fair value of the related liability is transferred to additional
paid-in capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zmMSvz7HBx56" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zzFyoRQo3clh">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
authoritative guidance with respect to fair value established a fair value hierarchy that prioritizes the inputs to valuation techniques
used to measure fair value into three levels and requires that assets and liabilities carried at fair value be classified and disclosed
in one of three categories, as presented below. Disclosure as to transfers in and out of Levels 1 and 2, and activity in Level 3 fair
value measurements, is also required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
1</i>. Observable inputs such as quoted prices in active markets for an identical asset or liability that the Company has the ability
to access as of the measurement date. Financial assets and liabilities utilizing Level 1 inputs include active-exchange traded securities
and exchange-based derivatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
2</i>. Inputs, other than quoted prices included within Level 1, which are directly observable for the asset or liability or indirectly
observable through corroboration with observable market data. Financial assets and liabilities utilizing Level 2 inputs include fixed
income securities, non-exchange-based derivatives, mutual funds, and fair-value hedges.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
3</i>. Unobservable inputs in which there is little or no market data for the asset or liability which requires the reporting entity
to develop its own assumptions. Financial assets and liabilities utilizing Level 3 inputs include infrequently traded non-exchange-based
derivatives and commingled investment funds and are measured using present value pricing models.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines the level in the fair value hierarchy within which each fair value measurement falls in its entirety, based on the
lowest level input that is significant to the fair value measurement in its entirety. In determining the appropriate levels, the Company
performs an analysis of the assets and liabilities at each reporting period end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of the Company&#8217;s financial instruments comprising of cash, restricted cash, accounts receivable, accounts payable
and accrued expenses and other approximate fair value because of the short-term maturity of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_84E_ecustom--PreferredStockPolicyTextBlock_zDlpskR8gWFg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zMpV7zgSR8na">Preferred
Stock</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
stock (the &#8220;Preferred Stock&#8221;) (as described in Note 20) is reported as a mezzanine obligation between liabilities and stockholders&#8217;
deficiency. If it becomes probable that the Preferred Stock will become redeemable, the Company will re-measure the Preferred Stock by
adjusting the carrying value to the redemption value of the Preferred Stock assuming each balance sheet date is a redemption date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zIuIuxLGOIB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zpSOz2pWbCmh">Stock-Based
Compensation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides stock-based compensation in the form of (a) stock awards to employees and directors, comprised of restricted stock awards
and restricted stock units, (b) stock option grants to employees, directors and consultants, (c) common stock warrants to Publisher Partners
(no warrants were issued during the year ended December 31, 2022) (further details are provided under the headings <i>Publisher Partner
Warrants</i> and <i>New Publisher Partner Warrants</i> in Note 22), and (d) common stock warrants to ABG (further details are provided
under the heading <i>ABG Warrants</i> in Note 22).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for stock awards and stock option grants to employees, directors and consultants, and non-employee awards to certain
directors and consultants by measuring the cost of services received in exchange for the stock-based payments as compensation expense
in the Company&#8217;s consolidated financial statements. Stock awards and stock option grants to employees and non-employees which are
time-vested, are measured at fair value on the grant date, and charged to operations ratably over the vesting period. Stock awards and
stock option grants to employees and non-employees which are performance-vested, are measured at fair value on the grant date and charged
to operations when the performance condition is satisfied or over the service period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value measurement of stock awards and grants used for stock-based compensation is as follows: (1) restricted stock awards and restricted
stock units which are time-vested, are determined using the quoted market price of the Company&#8217;s common stock at the grant date;
(2) stock option grants which are time-vested and performance-vested, are determined utilizing the Black-Scholes option-pricing model
at the grant date; (3) restricted stock units and stock option grants which provide for market-based vesting with a time-vesting overlay,
are determined through consultants with the Company&#8217;s independent valuation firm using the Monte Carlo model at the grant date;
(4) Publisher Partner Warrants were determined utilizing the Black-Scholes option-pricing model; and (5) ABG warrants are determined
utilizing the Monte Carlo model (further details are provided in Note 22). Estimated volatility was determined under the (1) &#8220;Probability
Weighted Scenarios&#8221; (prior to the reverse stock split on February 8, 2022) where one scenario assumes that the Company&#8217;s
common stock will be up-listed on a national stock exchange (the &#8220;Exchange&#8221;) on a certain listing date (the &#8220;Up-list&#8221;)
where the estimated volatility was based on evaluating the average historical volatility of a group of peer companies that are publicly
traded and the second scenario assumes that the Company&#8217;s common stock is not up-listed on the Exchange prior to the final vesting
date of the grants (the &#8220;No Up-list&#8221;) where the historical volatility of the Company&#8217;s common stock was evaluated based
upon market comparisons; and the (2) &#8220;Up-list Scenario&#8221; (after the reverse stock split on February 8, 2022) where the Company
estimated volatility based on evaluating the average historical volatility of a group of peer companies that are publicly traded after
the Company up-listed to the NYSE American. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time
of grant. The fair market value of common stock is determined by reference to the quoted market price of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has elected to recognize forfeitures as they occur and to recognize stock-based compensation cost on a straight-line basis over
the total requisite service period for awards with graded vesting. The Company classifies stock-based compensation cost on its consolidated
statements of operations in the same manner in which the award recipient&#8217;s cash compensation cost is classified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84F_eus-gaap--IncomeTaxPolicyTextBlock_zDKKsMkd28U" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zMvqGY6kRZR3">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the future
tax consequences attributable to operating loss carryforwards and temporary differences between financial statement bases of existing
assets and liabilities and their respective income tax bases. Deferred tax assets and liabilities are measured using enacted income tax
rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
The effect of a change in the income tax rates on deferred tax asset and liability balances is recognized in income in the period that
includes the enactment date of such rate change. A valuation allowance is recorded for loss carryforwards and other deferred tax assets
when it is determined that it is more likely than not that such loss carryforwards and deferred tax assets will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows accounting guidance that sets forth a threshold for financial statement recognition, measurement, and disclosure of a
tax position taken or expected to be taken on a tax return. Such guidance requires the Company to determine whether a tax position of
the Company is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any
related appeals or litigation processes, based on technical merits of the position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zW0EOEfnZsc4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zP4yJZ86ccOj">Loss
per Common Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
loss per share is computed using the weighted average number of common shares outstanding during the period and excludes any dilutive
effects of common stock equivalent shares, such as stock options, restricted stock, and warrants. All restricted stock awards are considered
outstanding but are included in the computation of basic loss per common share only when the restrictions expire, the shares are no longer
forfeitable, and are thus vested. Restricted stock units are included in the computation of basic loss per common share only when the
restrictions expire, the shares are no longer forfeitable, and are thus vested. Contingently issuable shares are included in basic loss
per common share only when there are no circumstances under which those shares would not be issued. Diluted loss per common share is
computed using the weighted average number of common shares outstanding and common stock equivalent shares outstanding during the period
using the treasury stock method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company excluded the outstanding securities summarized below (capitalized terms are described herein), which entitle the holders thereof
to acquire shares of the Company&#8217;s common stock, from its calculation of net loss per common share, as their effect would have
been anti-dilutive. Common stock equivalent shares are excluded from the diluted calculations when a net loss is incurred as they would
be anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zcNoxzT4AHKc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zUHosAth0BJk" style="display: none">Schedule of Net Income (Loss) Per Common Share</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Series G Preferred Stock</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesGConvertiblePreferredStockMember_zxS1HyVzT6Hg" style="width: 16%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">8,582</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesGConvertiblePreferredStockMember_zy05uUvS9Bi8" style="width: 16%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">8,582</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series H Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_zs3G5RlmtVc5" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"><span style="-sec-ix-hidden: xdx2ixbrl1043">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_zPxiV0ZDttT2" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">1,981,128</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Financing Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--FinancingWarrantsMember_zWBVv26ftGIb" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"><span style="-sec-ix-hidden: xdx2ixbrl1047">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--FinancingWarrantsMember_zZoIMd1yBJEk" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">107,956</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">ABG Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ABGWarrantsMember_znZyyHEUN9n8" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">999,540</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ABGWarrantsMember_zZnThCEIVN0l" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">999,540</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">AllHipHop Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--AllHipHopWarrantsMember_zHrXsJSzGy91" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">5,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--AllHipHopWarrantsMember_zPa0CoHEe7p4" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">5,682</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Publisher Partner Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublisherPartnerWarrantsMember_z12mD82wm2fk" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">9,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublisherPartnerWarrantsMember_zzrC8Hp0G7fc" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">4,154</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Restricted stock awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockAwardsMember_zzBBvqBjcCLa" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"><span style="-sec-ix-hidden: xdx2ixbrl1063">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockAwardsMember_zQPv2XEZ5SN1" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">97,403</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Restricted stock units</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_z7eIQKbpKSIg" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">199,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zFC86bgITA7d" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">994,766</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Common stock options</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockOptionsMember_z0wnOpFkLHua" style="border-bottom: Black 1.5pt solid; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">5,451,968</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockOptionsMember_zh8GnBEkgfRl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">6,199,521</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231_zip2RniEz9B6" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">6,674,839</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zLIoGGwnyhJ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">10,398,732</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AF_zyEVyspNnUD7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z6eBmGl1Tudc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zX0scoSqXuz6">Recent
Accounting Pronouncements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recently
Adopted Accounting Standards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2022, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued ASU 2022-02, <i>Financial Instruments-Credit Losses(Topic
326): Troubled Debt Restructurings and Vintage Disclosures, </i>addressing areas identified by the FASB as part of its post-implementation
review of its previously issued credit losses standard (ASU 2016-13) that introduced the current expected credit losses (CECL) model.
ASU 2022-02 eliminates the accounting guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhances
disclosure requirements for certain loan refinancings and restructurings made with borrowers experiencing financial difficulty. This
update requires an entity to disclose current-period gross write-offs for financing receivables and net investment in leases by year
of origination in the vintage disclosures. As the Company has already adopted ASU 2016-13, the new guidance was adopted on January 1,
2023. The adoption of ASU 2022-02 did not have a material impact on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recently
Issued Accounting Standards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the FASB issued ASU 2022-03, <i>Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to
Contractual Sale Restrictions</i>, which clarifies that a contractual restriction on the sale of an equity security is not considered
part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. This update also clarifies
that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction and requires certain disclosures
for equity securities subject to contractual sale restrictions. ASU 2022-03 is effective for the Company in the fiscal year beginning
after December 15, 2023, and interim periods within the fiscal year. Early adoption is permitted for both interim and annual financial
statements that have not yet been issued or made available for issuance. The Company is currently evaluating the impact that the adoption
of this new accounting standard will have on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2023, the FASB issued ASU 2023-06, <i>Disclosure Improvements: Codification Amendments in Response to the SEC&#8217;s Disclosure
Update and Simplification Initiative</i>, which incorporates certain SEC disclosure requirements into the FASB Accounting Standards Codification
(&#8220;Codification&#8221;). The amendments are expected to clarify or improve disclosure and presentation requirements of a variety
of Codification Topics, allow users to more easily compare entities subject to the SEC&#8217;s existing disclosures with those entities
that were not previously subject to the requirements, and align the requirements in the Codification with the SEC&#8217;s regulations.
ASU 2023-06 will become effective for each amendment on the effective date of the SEC&#8217;s corresponding disclosure rule changes.
The Company is currently evaluating the impact that the adoption of this new standard will have on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes</i> (Topic 740): Improvements to Income Tax Disclosures, which will require
the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for
reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid
disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. The provisions
of ASU 2023-09 are effective for annual periods beginning after December 15, 2024; early adoption is permitted using either a prospective
or retrospective transition method. The Company expects ASU 2023-09 to require additional disclosures in the notes to its consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material
impact on the Company&#8217;s financial statement presentation or disclosures.</span></p>

<p id="xdx_859_z98cXF9iWlm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656730045744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosureDiscontinuedOperationsAbstract', window );"><strong>Discontinued Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DiscontinuedOperationsTextBlock', window );">Discontinued Operations</a></td>
<td class="text"><p id="xdx_80F_ecustom--DiscontinuedOperationsTextBlock_zUwU0ixC1G12" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>3.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82C_zoLhDU1Nkc43">Discontinued Operations</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, upon Board approval on September 15, 2022, discontinued (i.e., the &#8220;discontinued operations&#8221;) the Parade print business
(&#8220;Parade Print&#8221;) that was acquired on April 1, 2022 (as part of the Parade acquisition, as further described below in Note
4), on November 13, 2022 (the last date of any obligation to deliver issues of Parade Print).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zDQuJsdj6e0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets forth the loss from discontinued operations for the period from April 1, 2022 to December 31, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zn22JF4NU2u1" style="display: none">Schedule
of Discontinued Operations</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20230101__20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ParadePrintMember_zpAqssYGLUo4" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_pn3n3_maDGIDOzNh5_z1Oaknj4Fcv3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-weight: bold; text-align: justify">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">26,817</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_pn3n3_msDGIDOzNh5_z01J6AkuB3R3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Cost of revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23,015</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_pn3n3_mtDGIDOzNh5_maDOILFz1bv_zyA3TSwAKUr4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Gross profit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,802</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingExpensesAbstract_iB_zPiAToi6biSf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Operating expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense_i01_pn3n3_maDGIDOz1uJ_zYCavD1n3Xsh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Selling and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,396</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_i01_pn3n3_maDGIDOz1uJ_znzXXSt0ioXc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,722</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges_i01_pn3n3_maDGIDOz1uJ_zp1wni88eKt4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Loss on impairment of assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">209</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_i01T_pn3n3_mtDGIDOz1uJ_msDOILFz1bv_zyiQLv9Zvla9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,327</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_iT_pn3n3_mtDOILFz1bv_maILFDOzJiH_zEUMX57Z38xe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Loss from discontinued operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,525</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--DiscontinuedOperationTaxEffectOfDiscontinuedOperation_pn3n3_msILFDOzJiH_zNYoXAHTZAH" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Income tax benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">55</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_iT_pn3n3_mtILFDOzJiH_zySvqJIUxHYk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net loss from discontinued operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,470</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A5_z6m7i83rvf6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discontinued operations of Parade Print also included Relish and Spry Living print products that were acquired as part of the Parade
acquisition. Further information is provided under the heading Supplemental Pro Forma Information in Note 4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2022, the Company recorded depreciation and amortization of $<span id="xdx_90F_eus-gaap--DepreciationAndAmortizationDiscontinuedOperations_pn3n3_c20220101__20221231_zg28MDVAUFI9" title="Depreciation and amortization">0</span>; and operating and investing noncash items
of $<span id="xdx_90C_eus-gaap--GainLossOnDispositionOfAssets_pn3n3_c20230101__20231231_zD5UBQYu3Fva" title="Loss on impairment of assets">209</span> and $<span id="xdx_90D_eus-gaap--GainLossOnDispositionOfAssets_pn3n3_c20220101__20221231_z2iNy06Wludb" title="Loss on impairment of assets">0</span>, respectively, as part of the discontinued operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosureDiscontinuedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosureDiscontinuedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DiscontinuedOperationsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operations [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DiscontinuedOperationsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731092656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Dispositions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions and Dispositions</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_zr9YDOCgzFi6" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>4.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_823_zbxv6U8Ff2U1">Acquisitions and Dispositions</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the acquisition method of accounting, which is based on ASC, <i>Business Combinations (Topic 805)</i>, and uses the fair
value concepts which requires, among other things, that most assets acquired, and liabilities assumed be recognized at their fair values
as of the acquisition date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2023
Acquisition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i>Teneology,
Inc.</i> &#8211; On January 11, 2023, the Company entered into an asset purchase agreement with Teneology, Inc., (&#8220;Teneology&#8221;)
pursuant to which it acquired certain assets (consisting of the RoadFood media business, including digital and television assets; the
Moveable Feast media business, including digital and television assets; the Fexy-branded content studio business; and the MonkeySee YouTube
Channel media business, collectively &#8220;Fexy Studios&#8221;), for a purchase price of $<span id="xdx_906_eus-gaap--AssetAcquisitionConsiderationTransferred_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zkB6Twoqkfla" title="Purchase price">3,307</span>. The purchase price consisted of the
following: (1) $<span id="xdx_90C_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zm3r9O5uzLZ2" title="Cash paid for consideration">500</span> cash paid at closing (including an advance payment of $<span id="xdx_907_eus-gaap--PaymentsForAdvanceToAffiliate_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_z8eky2HvceZ8" title="Advance payments of cash">250</span> prior to closing); (2) $<span id="xdx_90B_ecustom--DeferredCashPayments_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zoRqkNoHFbHe" title="Deferred cash payments">75</span> deferred cash payments due
in three equal installments of $<span id="xdx_90D_ecustom--DeferredCashPayments_pn3n3_c20230301__20230301__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zww3AfErgiv2" title="Deferred cash payments"><span id="xdx_909_ecustom--DeferredCashPayments_pn3n3_c20230401__20230401__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zwANedERU5G2" title="Deferred cash payments"><span id="xdx_90C_ecustom--DeferredCashPayments_pn3n3_c20230501__20230501__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_z5EhHyhMZAii" title="Deferred cash payments">25</span></span></span> on March 1, 2023 (paid), April 1, 2023 (paid) and May 1, 2023 (paid); (3) $<span id="xdx_903_ecustom--DeferredCashPaymentsDue_iI_pn3n3_c20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zfbK4Dm4gmG8" title="Deferred cash payment due">200</span> deferred cash payment
due on the first anniversary of the closing date, subject to certain indemnity provisions (not paid in January 2024, further details
are provided under the heading <i>Fexy Put Option</i> in Note 28); and (4) the issuance of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_pid_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zz6I3R6Sh8ki" title="Number of shares issued for asset acquisition">274,692</span> shares of the Company&#8217;s common
stock, subject to certain lock-up provisions, with a fair value of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_ze7ZQJ0APTyl" title="Fair value of shares issued">2,000</span> on the transaction closing date (fair value was determined
based on an independent appraisal); and which is subject to a put option under certain conditions (the &#8220;contingent consideration&#8221;)
(as further described below in Note 17). The number of shares of the Company&#8217;s common stock issued was determined based on a $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zornQjl2prQ9" title="Share value">2,225</span>
value using the common stock trading price on the day immediately preceding the January 11, 2023 closing date (on the closing date the
common stock trading price was $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zcv9PW7bd62g" title="Common stock trading price">7.94</span> per share). The agreement also provided for a cash retention pool for certain employees of $<span id="xdx_908_eus-gaap--PaymentsToEmployees_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zBlk6jWxkmn1" title="Cash retention pool for employees">300</span>,
subject to vesting over three years upon continued employment and other conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_eus-gaap--AssetAcquisitionTableTextBlock_hus-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zZ04CRkYXmLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of the purchase price is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zmnG52KIiqZf" style="display: none">Schedule
of Composition Preliminary Assets Purchase Price</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_494_20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zgZD4Tm5K2T" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_zVVk8z3HmHfe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_pn3n3_zpj6GXTndzJ3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AssetAcquisitionConsiderationTransferredContingentConsideration_pn3n3_z6AIBH3OCEt3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Contingent consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">561</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted_pn3n3_zwucxxjQkZTf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Deferred cash payments, as discounted</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">246</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetAcquisitionConsiderationTransferred_pn3n3_znH0qohjrN09" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total purchase consideration</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,307</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_zMZX6QIg5r8e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for the asset acquisition as a business combination in accordance with ASC 805 since the acquisition met the definition
of a business under the applicable guidance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred $<span id="xdx_903_eus-gaap--AssetAcquisitionConsiderationTransferredTransactionCost_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zZFrRzv1dRyk" title="Asset acquisition transaction cost">99</span> in transaction costs related to the acquisition, which primarily consisted of legal and accounting expenses. The
acquisition-related expenses were recorded in general and administrative expenses on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_ecustom--ScheduleOfAssetsAcquiredTableTextBlock_hus-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zkjMMaoHiFE3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the closing
date of the acquisition based upon their respective fair values as summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zVECqHb6rdrc" style="display: none">Summary
of Preliminary Assets Purchase Price Allocation</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_z43ZG3xIYba9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zEJ8X7Od0Yb1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Advertiser relationships</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">663</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zsr2ZG29ddp5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Brand names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">659</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_z3qPiUF5h4cf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,985</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zikUkgFTNWY1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net assets acquired</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,307</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AD_zt48EeFz4Wzg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilized an independent appraisal firm to assist in the determination of the fair values of the assets acquired and
liabilities assumed, which required certain significant management assumptions and estimates. The fair value of the advertiser relationships
were valued using the excess earnings method of the income approach and the brand names were valued using the relief-from-royalty method
of the income approach. The estimated useful life is fifteen years (<span id="xdx_90A_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zKmWkfNaDWT7" title="Weighted average useful lives">15.0</span> years) for the advertiser relationships and twelve years (<span id="xdx_901_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zpRG4Lazyb82" title="Estimated useful life">12.0</span>
years) for the brand names.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
excess-of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents goodwill from
the acquisition. Goodwill is recorded as a non-current asset that is not amortized but is subject to an annual review for impairment.
The Company expects $<span id="xdx_909_eus-gaap--Goodwill_iI_pn3n3_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zMA2p2fGhgXd" title="Goodwill">1,678</span> of goodwill to be deductible for tax purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Supplemental
Pro Forma Information</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma disclosures have been deemed impracticable for this acquisition since after making reasonable efforts the Company is unable
to accept assumptions made by Teneology. The Company has determined, based on the information provided by Teneology and made available
to the Company, that the earnings from the prior periods could not be verified since the acquisition only included certain activities
of Teneology and financial statements were not available. In this regard, the Company: (1) made reasonable effort to obtain certain financial
results of the certain activities but Teneology was unable to comply with this request; and (2) the presentation of the pro forma results
and the assumptions made by Teneology management were unable to be independently substantiated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2023
Disposition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 17, 2023, the Company sold certain assets related to one of Parade&#8217;s business components known as Athlon Outdoors for
cash proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromSaleOfOtherAssetsInvestingActivities_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zYVtY7panr0g" title="Cash proceeds">1,061</span> ($<span id="xdx_907_ecustom--SalePrice_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zAgeQwsg5Wnf" title="Sale price">1,000</span> sale price (with a target working capital of $<span id="xdx_90C_ecustom--WorkingCapital_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zTVZKW7x1C12" title="Working capital">272</span>) plus a preliminary working capital adjustment of $<span id="xdx_907_ecustom--PreliminaryWorkingCapital_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zPUfa07j0Kcd" title="Preliminary working capital">61</span>),
as further reduced by a final working capital adjustment of $<span id="xdx_90F_ecustom--WorkingCapitalAdjustments_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zm3ueyp1hCE1" title="Adjustment for working capital">153</span>, as reflected in accrued expenses and other on the consolidated balance
sheets, resulting in a final sale price of $<span id="xdx_90A_ecustom--FinalSalePrice_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zo9Qz0cZi1Sd" title="Sale price">908</span>. In connection with the sale, the Company disposed of certain advertiser relationships
and trade name relating to that business component with a carrying value of $<span id="xdx_90A_eus-gaap--ProceedsFromDivestitureOfBusinesses_pn3n3_c20230101__20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zE1hwQ2cQwi9" title="Business component carrying value">639</span> and $<span id="xdx_908_eus-gaap--ProceedsFromDivestitureOfBusinesses_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zfszcMsfqk1i" title="Business component carrying value">172</span>, respectively, along with the accounts receivable
and accounts payable of the business component of $<span id="xdx_904_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_z0jzp9bQwLE8" title="Accounts receivable net current">453</span> and $<span id="xdx_908_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zrjtY0gR8S0k" title="Accounts payable current">31</span>, respectively, resulting in a recognized loss on sale of assets of $<span id="xdx_909_eus-gaap--GainLossOnDispositionOfAssets1_pn3n3_c20230101__20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zs3PQpNKBa22" title="Loss on assets">325</span>
as reflected on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2022
Acquisitions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Athlon
Holdings, Inc</i>. - On April 1, 2022, the Company acquired <span id="xdx_90D_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z9HgGxh3cAuj" title="Acquired percentage">100</span>% of the issued and outstanding capital stock of Athlon Holdings, Inc.
(or Parade), a Tennessee corporation, for a purchase price of $<span id="xdx_904_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zUAWqPJKXJDd" title="Acquisition purchase price">15,854</span>, as adjusted for the working capital adjustment as of the closing
date of the transaction. The working capital adjustment is pending acceptance by the sellers (further details are provided in Note 27).
As a part of the closing consideration, the Company also acquired cash of $<span id="xdx_90C_eus-gaap--CashAcquiredFromAcquisition_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zm43dQOyHe44" title="Acquired cash">1,840</span>, that was further adjusted post-closing for the working
capital adjustment. The purchase price of $<span id="xdx_900_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zOtEhTzgp1Ua" title="Business combination consideration transferred1">15,854</span>, as discounted, is comprised of (i) a cash portion of $<span id="xdx_902_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zZBeHq6smHrk" title="Cash portion in acquisition">12,827</span>, with $<span id="xdx_906_ecustom--PaymentsToAcquireBusinessesAtClosing_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zXH5IKgiGrF" title="Cash payments paid at closing">11,840</span> paid at
closing and $<span id="xdx_903_eus-gaap--OtherPaymentsToAcquireBusinesses_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zkdKe6lpRpAd" title="Payments for acquire">987</span> estimated to be paid post-closing (as further described below) and (ii) the issuance of <span id="xdx_901_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zNIlktA6ypNg" title="Number of shares issued in acquisition">314,103</span> shares of the Company&#8217;s
common stock with a fair market value of $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zP8egd6CyLU" title="Fair value of shares issued in acquisition">3,141</span>. The number of shares of the Company&#8217;s common stock issued was determined based
on a $<span id="xdx_908_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_pn3n3_c20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDW7ZUveSKib" title="Stock value assigned">3,000</span> value using the common stock trading price for the 10 trading days preceding the April 1, 2022 closing date. Certain of Parade&#8217;s
key employees entered into either advisory agreements or employment agreements with the Company. Parade operates in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z6UcP99iQgG9" title="Acquisition description">The
amount estimated to be paid post-closing of $987 will be or was paid as follows: (i) $742 is expected to be paid upon receipts of certain
tax refunds due to the sellers (consisting of $3,000 for the deferred cash payments, as discounted, less a $2,258 cash adjustment); and
(ii) $245 was paid within two business days from the date the Company received proceeds from the sale of the equity interest in Just
Like Falling Off a Bike, LLC that was held by Parade as of the closing date (paid on April 7, 2022).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--BusinessCombinationContingentConsiderationArrangementsDescription_c20220701__20220930__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zqTF2EckKdNe" title="Acquisition description">The
Company received a final valuation report from a third party valuation firm after the preliminary purchase price was adjusted during
the quarterly period ended September 30, 2022. After considering the results of the final valuation report, the Company estimated
that the purchase consideration decreased by $321. The decrease in the purchase price was related to an increase in identifiable
assets of $54, an increase in deferred tax liabilities of $27, with a decrease in the working capital adjustment of $321, resulting
in a decrease in goodwill of $348.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89F_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zVU71i5ront5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of the purchase price is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zwoDcSHUgxF3" style="display: none">Schedule
of Composition of Purchase Price</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20220401__20220401_zwWFAR22WvQk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PaymentsToAcquireBusinessesGross_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z06h1E9eddT8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">12,085</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zKefsckbnuA3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,141</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--BusinessCombinationConsiderationTransferredOther1_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zWMQEOG6nLX5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred cash payments, as discounted</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">628</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zfMsmFECWBY2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total purchase consideration</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,854</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AF_zm4vRXrEeEP5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred $<span id="xdx_90F_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zHx04YDc0O43" title="Transaction cost">200</span> in transaction costs related to the acquisition, which primarily consisted of legal and accounting expenses. The
acquisition-related expenses were recorded within general and administrative expense on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zkjC4t2Uej3a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the closing
date of the acquisition based upon their respective fair values as summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span id="xdx_8B3_zz11kMAZmCik" style="display: none">Summary
of Purchase Price Allocation</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20220401_zwJKPlcE4Bz5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zJSpTofVvLOf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,604</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zH4qtZRDuZga" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,855</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zBgAJM5kdXSd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,337</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z3GlLmnxNIYf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Equity investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,450</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zqRHG02u1aaa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fixed assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">108</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z7lf3nyVTBD9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Digital content</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">355</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zBZ8aVJw4Pk3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Advertiser relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,202</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zUzZt8DEbBq2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,261</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Goodwill_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zYFqYAyq6HIk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,587</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zQYCeWwBC2db" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,416</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z1rSZYK6FWCj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued expenses and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,440</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zDwmMH6zpqRc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,203</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zt1sMzBsO7wl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other long-term liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(543</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zFmtJ1scgfze" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred tax liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,303</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pn3n3_zEMBrdmRhRqc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net assets acquired</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,854</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AF_zidnkAUjyobb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilized an independent appraisal firm to assist in the determination of the fair values of the assets acquired and liabilities
assumed, which required certain significant management assumptions and estimates. The fair value of the digital content was determined
using a cost approach. The fair values of the advertiser relationships were determined by projecting the acquired entity&#8217;s cash
flows, deducting notional contributory asset charges on supporting assets (working capital, tangible assets, trade names, and the assembled
workforce) to compute the excess cash flows associated with the advertiser relationships. The fair values of the trade names were determined
by projecting revenue associated with each trade name and applying a royalty rate to compute the amount of the royalty payments the company
is relieved from paying due to its ownership of the trade names. The estimated weighted average useful life is two years (<span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_z4B0hPvLFXWj" title="Estimated weighted average useful life">2.00</span> years)
for digital content, eight point seventy-five years (<span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zBrWFJAucMBe" title="Estimated weighted average useful life">8.75</span> years) for advertiser relationships, and fourteen point five years (<span id="xdx_908_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z0rpFjbmxZ8f" title="Estimated weighted average useful life">14.50</span> years)
for trade names.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
excess purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents goodwill from the
acquisition. Goodwill is recorded as a non-current asset that is not amortized but is subject to an annual review for impairment. No
portion of the goodwill related to the acquisition will be deductible for tax purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Supplemental
Pro Forma Information</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_899_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zG6IKhpF3Y11" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the results of continuing operations of the Parade acquisition from the acquisition date included in the consolidated
results of continuing operations and the unaudited pro forma results of continuing operations of the combined entity had the date of
the acquisition been January 1, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zcU5rNh4TdRb" style="display: none">Schedule
of Supplemental Proforma Information</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_495_20220101__20221231_z7remYnAFZUe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended<br/>
 December 31, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Parade continuing operations from acquisition date of April 1, 2022 (unaudited):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_z0IgHpsFega5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 80%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">40,071</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_zmLU31f2hiYe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,494</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Combined entity continuing operations supplemental pro forma information had the acquisition date been January 1, 2022 (unaudited):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Revenue:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_z56KFyPQBJTd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Parade</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">55,981</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ArenaMember_zXoW2umzo1Mh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt">Arena</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">207,681</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_zKkEAGwHIyVd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Total continuing operations supplemental pro forma revenue</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">263,662</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Net loss:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_zXre08hcmKIg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Parade</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(3,070</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ArenaMember_zkGp4Jcz3AUl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt">Arena</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(67,788</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AdjustmentsMember_z8RHDUqrILie" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Adjustments</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,940</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_zFokrXxMi8Ii" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Total continuing operations supplemental pro forma net loss</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(72,798</td><td style="text-align: left">)</td></tr>
  </table>

<p id="xdx_8A5_zDWUwa8mob3c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information presented above is for illustrative purposes only and is not necessarily indicative of results that would have been achieved
if the acquisition had occurred at the beginning of the Company&#8217;s reporting period and does not reflect the discontinued operations
of Parade Print that was acquired on April 1, 2022 (as part of the Parade acquisition).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments_c20220101__20221231_zcNg9RGyUL54" title="Adjustment description">The
adjustments for the year ended December 31, 2022 of ($1,940), represents adjustments: (1) to record depreciation and amortization expense
related to the fixed and intangible assets acquired from the acquisition of ($864); (2) to reverse the nonrecurring transaction cost
related to the acquisition of $200; and (3) to reverse the deferred tax benefit related to the acquisition of ($1,276).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Buffalo
Groupe, LLC </i>&#8211; On September 27, 2022, the Company entered into an asset purchase agreement with Buffalo Groupe, LLC, doing business
as Morning Read, where it purchased certain intellectual properties, certain assumed contracts, and other certain rights related to the
intellectual properties (collectively, the &#8220;Morning Read Purchased Assets&#8221;) and assumed certain liabilities related to the
Morning Read Purchased Assets. The purchase consideration consisted of a cash payment of $<span id="xdx_905_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220927__20220927__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BuffaloGroupeLLCMember__us-gaap--AssetAcquisitionAxis__custom--IntellectualPropertiesMember_zUe34YN2It35" title="Cash paid for consideration">850 </span>at closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for the acquisition as an asset acquisition in accordance with ASC 805-50, as substantially all of the fair value of
the gross assets acquired by the Company is concentrated in a group of similar identifiable assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase consideration totaled $<span id="xdx_902_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220927__20220927__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BuffaloGroupeLLCMember__us-gaap--AssetAcquisitionAxis__custom--IntellectualPropertiesMember_zbKA6r7JVPhk" title="Cash paid for consideration">850</span>, which was assigned to the brand name acquired on the closing date of the acquisition. The useful
life for the brand name is ten years (<span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220927_zuhMxXWOiquh" title="Useful lives">10.0</span> years).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>A360
Media, </i>LLC &#8211; On December 15, 2022 (the closing date), pursuant to an asset purchase agreement entered into December 7, 2022,
the Company acquired certain assets and liabilities from Weider Publications, a subsidiary of A360 Media, LLC (or Men&#8217;s Journal)
related to the digital media operations of Men&#8217;s Journal and other men&#8217;s active lifestyle brands. The Company paid $<span id="xdx_90F_eus-gaap--CashAcquiredFromAcquisition_pn3n3_c20221215__20221215_z8idO6AGKLp4" title="Cash acquired for acquisition">25,000</span>
in cash for the acquisition consisting of: (i) $<span id="xdx_90E_eus-gaap--CashAcquiredFromAcquisition_pn3n3_c20221207__20221207_zDcZE9nzLx7k" title="Cash acquired for acquisition">23,000</span> paid at closing; (ii) $<span id="xdx_900_eus-gaap--EscrowDeposit_iI_pn3n3_c20221215_zQMkN66ZRDvj" title="Escrow deposit">1,000</span> deposited into an escrow account to be released in
accordance with the terms of the agreement, subject to adjustments for any indemnification payments; and (iii) $<span id="xdx_909_eus-gaap--EscrowDeposit_iI_pn3n3_c20221130_z6VrpKYk2xd" title="Escrow deposit">1,000 </span>paid in November
2022. The Company also assumed certain liabilities consisting of: (i) $<span id="xdx_906_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_iI_pn3n3_c20221130_znkFSBJ1qpFj" title="Assumed lease obligation">2,676</span> an assumed lease obligation, as discounted (representing
$<span id="xdx_90B_eus-gaap--DeferredRevenue_iI_pn3n3_c20221130_znWoFZfYJNza" title="Deferred payments">3,189</span> in deferred payments over twenty-seven months (27) for the assumption of a lease obligation); and (ii) $<span id="xdx_907_ecustom--DeferredRevenueObligation_iI_c20221130_znB9NBy8zfNa" title="Deferred revenue obligation">4,078</span> in deferred revenue
obligations to deliver certain publications to the subscribers of Men&#8217;s Journal ($<span id="xdx_905_eus-gaap--UnearnedPremiums_iI_pn3n3_c20221130_zAl6StEbg4U6" title="Unearned revenue">3,941</span> in unearned revenue after consideration
of an estimated subscription refund liability of $<span id="xdx_905_eus-gaap--CustomerRefundLiabilityCurrent_iI_pn3n3_c20221130_zQoCOpzKx0W3" title="Refund liability">137</span>). In accordance with the practical expedients under ASU 2021-08, the Company has
elected to apply (i) the practical expedient to the modification of the subscriber contracts at the acquisition date to determine the
performance obligations and transaction price; and (ii) to use the estimated selling price of a subscriber contract as the standalone
selling price of the replacement magazine based on the number of magazines expected to be delivered to the Men&#8217;s Journal subscribers
to satisfy the performance obligations. The agreement contains customary representations, warranties and covenants. Men&#8217;s Journal
operates in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for the asset acquisition as a business combination in accordance with ASC 805 since the acquisition met the definition
of a business under the applicable guidance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred $<span id="xdx_902_eus-gaap--AssetAcquisitionConsiderationTransferredTransactionCost_pn3n3_c20221215__20221215_zwHGEE9bmldh" title="Transaction cost">283</span> in transaction costs related to the acquisition, which primarily consisted of legal and accounting expenses. The
acquisition-related expenses were recorded within general and administrative expense on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the acquisition of Men&#8217;s Journal, the Company received a final valuation report during the quarterly period
ended September 30, 2023 from a third party valuation firm after the preliminary purchase price was determined. After considering
the results of the final valuation report, the Company estimated that the purchase consideration increased by $<span id="xdx_900_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--MensJournalMember_zkiEGp6ZOQac" title="Goodwill, acquired during period">1,246</span>
as a result of an increase in the fair value of the assumed lease obligation with an offset recorded to goodwill (see Note
11).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_ecustom--PreliminaryPriceAllocationTableTextBlock_z0FbDxu0hiZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the closing
date of the acquisition based upon their respective fair values as summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zchIUZR7TZh6" style="display: none">Schedule
of Preliminary Price Allocation</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20231231_zW26LEiBXS28" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zFW5k6qyBLhb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Lease deposit receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">420</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zRgr58wPNMi3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Advertiser relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,860</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_znh0LJ8NCxah" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Brand names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,090</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zQLSP7Se0Wjl" style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,384</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zrbigUcHcuLf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,941</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zA3ssgNovCO1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Subscription refund liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(137</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_ztHG9TXJ02Gk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Assumed lease obligation</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,676</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_mtBCRIAzrWD_zihQ2yobSH02" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net assets acquired</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">25,000</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A6_zemWWPYCIq4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilized an independent appraisal firm to assist in the determination of the fair values of the assets acquired and liabilities
assumed, which required certain significant management assumptions and estimates. The fair value of the advertiser relationships were
determined by applying the multi-period earnings method of the income approach and the fair values of the brand names were determined
by applying the relief-from-royalty method. The estimated weighted average useful life is twelve and one-half years (<span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--A360MediaLLCMember__srt--TitleOfIndividualAxis__custom--AdvertiserRelationshipMember_zGUyHjiSdQrb" title="Weighted average useful lives">12.5 </span>years) for
the advertiser relationships and eleven years (<span id="xdx_901_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--A360MediaLLCMember__srt--TitleOfIndividualAxis__custom--BrandNameMember_zRzlOfNNqAz3" title="Weighted average useful lives">11.0</span> years) for the brand names.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
excess-of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents goodwill from
the acquisition. Goodwill is recorded as a non-current asset that is not amortized but is subject to an annual review for impairment.
The Company expects $<span id="xdx_906_eus-gaap--BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_iI_pn3n3_c20231231_z44haoaboe22" title="Goodwill for tax">12,299</span> of goodwill to be deductible for tax purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Supplemental
Pro Forma Information</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma disclosures have been deemed impracticable for this acquisition since after making reasonable efforts the Company is unable
to accept assumptions made by Men&#8217;s Journal. The Company has determined, based on the information provided by Men&#8217;s Journal
and made available to the Company, that the earnings from the prior periods could not be verified since the acquisition only included
certain activities of Men&#8217;s Journal and financial statements were not available. In this regard, the Company: (1) made reasonable
effort to obtain certain financial results of the certain activities but Men&#8217;s Journal was unable to apply the requirement; and
(2) the presentation of the pro forma results and the assumptions made by management were unable be independently substantiated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735286064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepayments and Other Current Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract', window );"><strong>Prepayments And Other Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PrepaymentsAndOtherCurrentAssetsTextBlock', window );">Prepayments and Other Current Assets</a></td>
<td class="text"><p id="xdx_80F_ecustom--PrepaymentsAndOtherCurrentAssetsTextBlock_zPuocP0aOew4" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>5</b>.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_825_z1TzmsbZPEZf">Prepayments and Other Current Assets</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_ecustom--ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock_zK21i0AyAXs3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments
and other current assets are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z52qj90FVIZ1" style="display: none">Schedule
of Prepayments and Other Current Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20231231_zxRSM98gSmEd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20221231_z2aVu4WSZfWc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--PrepaidExpenseCurrent_iI_pn3n3_maPEAOAz2Qi_zJXP5KDmgx51" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Prepaid expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,946</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,321</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--PrepaidSuppliesCurrent_iI_pn3n3_maPEAOAz2Qi_zmQmNq1cyVU8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepaid supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">773</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">927</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--RefundableIncomeAndFranchiseTaxes_iI_pn3n3_maPEAOAz2Qi_zccHzQlbKAsf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Refundable income and franchise taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">157</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">957</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--UnamortizedDebtIssuanceExpense_iI_pn3n3_maPEAOAz2Qi_za6mXI3yoJq2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Unamortized debt costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">209</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">216</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--EmployeeRetentionCredits_iI_pn3n3_maPEAOAz2Qi_zcFBlFeyijPi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Employee retention credits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,468</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1358">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OtherReceivablesNetCurrent_iI_pn3n3_maPEAOAz2Qi_zrOUrSKRot2j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Other receivables</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pn3n3_mtPEAOAz2Qi_zPhGd2b5E9Ek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Total prepayments and other current assets</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,441</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AE_zX2WTuWHqDVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the provisions of the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) and the subsequent extensions
of the CARES Act, the Company was eligible for a refundable employee retention credit subject to certain criteria. The Company determined
that it qualifies for the tax credit under the CARES Act. In connection with the CARES Act, the Company adopted a policy to recognize
the employee retention credit when earned and to offset the credit against the related expenditure. During the year ended December 31,
2023, the Company recorded the employee retention credits as a reduction to payroll and related expenses of $<span id="xdx_906_eus-gaap--OtherLaborRelatedExpenses_pn3n3_c20230101__20231231_zO4xbNltNFK5" title="Employee retention credits">6,868</span> in operating expenses
on the consolidated statements of operations with a corresponding receivable included in prepaid expenses and other current assets on
the consolidated balance sheets for the respective periods. During the year ended December 31, 2023, the Company received $<span id="xdx_90D_ecustom--EmployeeRetentionPayable_pn3n3_c20230101__20231231_zG672UcrBTha" title="Retention Payable">4,400 </span>in employee
retention credits and has a receivable balance remaining of $<span id="xdx_909_ecustom--EmployeeRetentionCredits_iI_pn3n3_c20231231_zduN6gOwQ9Ga" title="Employee retention credits">2,468</span> as of December 31, 2023.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_PrepaymentsAndOtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepayments And Other Current Assets [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_PrepaymentsAndOtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735873936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_805_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z3Hg37ldTFh" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>6.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_822_zdVfLk3g2l52">Property and Equipment</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_894_eus-gaap--PropertyPlantAndEquipmentTextBlock_zrVBM4nfXDV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z00fXVxvVns5" style="display: none">Schedule
of Property and Equipment</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20231231_ztUb904c6zD9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20221231_zxMkf96zdw12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember_zG7nYHo7rrqg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Office equipment and computers</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,744</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,744</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zw5uzQL0rvOe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Furniture and fixtures</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">166</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">240</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzTTM_zxgEiOJC5C5b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross property and equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,910</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,984</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzTTM_zPkDfoa6qxae" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,582</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,249</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzTTM_zwnAoQd435qf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net property and equipment</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">328</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">735</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8AF_zuYWTEt2IYlh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
and amortization expense for the years ended December 31, 2023 and 2022 was $<span id="xdx_90D_eus-gaap--Depreciation_pn3n3_c20230101__20231231_zdaL43uw8j8c" title="Depreciation expense">352</span> and $<span id="xdx_909_eus-gaap--Depreciation_pn3n3_c20220101__20221231_zoH8zUsisaW4" title="Depreciation expense">539</span>, respectively. Impairment charges for property
and equipment for the years ended December 31, 2023 and 2022 of $<span id="xdx_908_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_pn3n3_c20230101__20231231__us-gaap--FairValueByAssetClassAxis__us-gaap--PropertyPlantAndEquipmentMember_z0nDHDAYQZjl" title="Impairment charges for property and equipment">55</span> and $<span id="xdx_90E_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_pn3n3_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--PropertyPlantAndEquipmentMember_z5xbJahBsWO2" title="Impairment charges for property and equipment">0</span>, respectively, have been recorded on the consolidated statements
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656734909008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_808_eus-gaap--LesseeOperatingLeasesTextBlock_zp7r0tGPOlvc" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>7.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82A_zURCtNm2fX9f">Leases</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s real estate lease for the use of office space was subleased during the year ended December 31, 2023. The Company determines
whether an arrangement contains a lease at inception. Lease assets and liabilities are recognized upon commencement of the lease based
on the present value of the future minimum lease payments over the lease term. The lease term includes options to extend the lease when
it is reasonably certain that the Company will exercise that option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company&#8217;s current operating lease
has a remaining fixed payment term of <span id="xdx_902_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20231231_z5DwXVVTobC2" title="Operating lease, remaining fixed payment term">0.75</span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_ecustom--SupplementalInformationRelatedToOperatingLeasesTableTextBlock_z52YZlcmodh3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below presents supplemental information related to the operating lease:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zbc8Sd4pa3G1" style="display: none">Schedule
of Supplemental Information Related to Operating Leases</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Operating lease costs during the year (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--LeaseCost_pn3n3_c20230101__20231231_fKDEp_zwycTJTBHuPg" style="width: 16%; text-align: right" title="Operating lease costs during the year">1,052</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--LeaseCost_pn3n3_c20220101__20221231_fKDEp_z73jF7LNQxa5" style="width: 16%; text-align: right" title="Operating lease costs during the year">969</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash payments included in the measurement of operating lease liability during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--OperatingLeasePayments_pn3n3_c20230101__20231231_z2yyjd2lZEh9" style="text-align: right" title="Cash payments included in the measurement of operating lease liabilities during the year">486</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--OperatingLeasePayments_pn3n3_c20220101__20221231_zV3eA2wVOeb8" style="text-align: right" title="Cash payments included in the measurement of operating lease liabilities during the year">469</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted-average remaining lease term (in years) as of year-end</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_zvVHFKuBJfxf" title="Weighted-average remaining lease term (in years) as of year-end">0.75</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zV1asf4n4CX6" title="Weighted-average remaining lease term (in years) as of year-end">1.75</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted-average discount rate during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20231231_z3naXHOK2tSf" title="Weighted-average discount rate during the year">9.90</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231_z3QuF40HSk5c" title="Weighted-average discount rate during the year">9.90</span></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F08_zb7OynYi8UTh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F18_zEBwpg9r4gh8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease
costs is presented net of sublease income that is not material.</span></td>
</tr></table>

<p id="xdx_8A6_zPM9gRvgFt43" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generally utilizes its incremental borrowing rate based on information available at the commencement of the lease in determining
the present value of future payments since the implicit rate for the Company&#8217;s lease is not readily determinable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Variable
lease expense includes rental increases that are not fixed, such as those based on amounts paid to the lessor based on cost or consumption,
such as maintenance and utilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zJfBLkQAHXFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of operating lease costs were follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zO2LqGqlKC0c" style="display: none">Schedule
of Operating Lease Costs</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230101__20231231_zinowhJF3MF8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220101__20221231_zG8RsxWcdt29" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating lease costs:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingLeaseCost_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zV0B4SpXnKy7" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">General and administrative</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">1,344</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">1,187</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseCost_pn3n3_maLCzoNR_zpSk8bcA8Md1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Total operating costs (<span id="xdx_F4B_zLdAqtn6mQj3">1</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,344</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,187</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--SubleaseIncome_iN_pn3n3_di_msLCzoNR_zkt2DSPB3R76" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Less sublease income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(292</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(218</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--LeaseCost_iT_pn3n3_mtLCzoNR_zBWuVL4CSMb2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total operating lease costs</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,052</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">969</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F02_zTMXHN40VhG6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1D_zEregB25HjTh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes certain
costs associated with a business membership agreement (see below) that permits access to certain office space for the years ended December
31, 2023 and 2022 of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_904_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessMembershipAgreementMember_zU6h5otEQ9t7" title="Operating lease cost">620</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--OperatingLeaseCost_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--BusinessMembershipAgreementMember_z6Ipd2wuVVn6" title="Operating lease cost">668</span>, respectively, and month-to-month lease arrangements for the years ended December 31, 2023 and 2022
of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--MonthToMonthLeaseArrangementMember_zKURtxpM8Jmd" title="Operating lease cost">396</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--OperatingLeaseCost_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--MonthToMonthLeaseArrangementMember_zmCHQMmJCq5d" title="Operating lease cost">320</span>, respectively.</span></td>
</tr></table>


<p id="xdx_8A3_zj6IvB2CrPGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zmOuJ48hGynk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturities
of the operating lease liability as of December 31, 2023 are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zVtIOD6SsG02" style="display: none">Summary
of Maturity of Lease Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20231231_zQ9FCrzvbBFa" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtLOLLPzG3L_zYptFfV4rQMa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Minimum lease payments - 2024</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">373</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_zKMGTQFvJeW6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(15</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zdX0MRz6KWX3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Present value of operating lease liability</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">358</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_z45RPMTavPHc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Current portion of operating lease liability</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">358</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zyDmUs7j4Ru9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Long-term portion of operating lease liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1455">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zrTlsJVExJT6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total operating lease liability</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">358</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A2_z5VISfiKK3T2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sublease
Agreement </i>&#8211; The Company has entered into agreements to sublease certain space that it does not occupy, through the duration
of the lease terms, with one sublease through September 2024 and two other subleases through March 2024. As of December 31, 2023, the
Company is entitled to receive total sublease income of $<span id="xdx_90A_eus-gaap--SubleaseIncome_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SubleaseAgreementMember_z7BmfQ5fLWy1" title="Sublease income">537</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Business
Membership</i> &#8211; Effective October 1, 2021, the Company entered into a business membership agreement with York Factory LLC, doing
business as SaksWorks, that permits access to certain office space with furnishings, referred to as SaksWorks Memberships. This membership
provides a certain number of accounts that equate to the use of the space granted. Effective June 1, 2022, the SaksWorks membership agreement
was amended and assigned to Convene SW MSA Holdings, LLC (&#8220;Convene&#8221;). The initial term of the agreement with Convene was
through December 31, 2023, with provisions for renewals. The Company terminated the arrangement effective December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lease
Termination </i>&#8211; Effective September 30, 2021, the Company terminated a certain lease arrangement for office space. In connection
with the termination, the Company agreed to pay the landlord cash of $<span id="xdx_90B_eus-gaap--ProceedsFromLeasePayments_pn3n3_c20210901__20210930__us-gaap--TypeOfArrangementAxis__custom--LeaseArrangementMember_zVQwRn51UMvi" title="Proceeds from lease payments">10,000</span> (the &#8220;Cash Payments&#8221;) and $<span id="xdx_909_eus-gaap--AdvertisingExpense_pn3n3_c20210901__20210930__us-gaap--TypeOfArrangementAxis__custom--LeaseArrangementMember_zI2X2wgvnx7b" title="Advertising expense">1,475</span> in market rate
advertising. The Cash Payments were paid or remain due as follows: $<span id="xdx_90D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_c20211231_zbZxuqy619hd" title="Cash payments">1,000</span> paid in December 2021; $<span id="xdx_909_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_c20221031_zMMB9veji3Wl" title="Cash payments">1,000</span> paid in October 2022; $<span id="xdx_906_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_c20231031_zic96oG2Ioe1" title="Cash payments">4,000</span>
paid in October 2023; and $<span id="xdx_907_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_c20231231__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandAndTwentyFourMember_zT6tXoNfElPj" title="Cash payments">4,000</span> due on October 1, 2024, with imputed interest recognized at <span id="xdx_90B_ecustom--ImputedInterestRate_pid_dp_uPure_c20230101__20231231__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandAndTwentyFourMember_zhGVlKA0zrI9" title="Imputed interest recognized">10.0</span>% per annum, and the market advertising
of $<span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_pn3n3_c20230101__20231231_zWw3wEyELd4f" title="Market advertising">615</span> has been delivered during the year ended December 31, 2023, leaving $<span id="xdx_90C_ecustom--MarketingAndAdvertisingExpenseRemaining_pn3n3_c20230101__20231231_z6Y52a9imf4e" title="Market advertising leaving">860</span> to be delivered as of December 31, 2023, with the current amount due, net of imputed interest, reflected in accrued expenses and other on the consolidated
balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731113872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Platform Development<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosurePlatformDevelopmentAbstract', window );"><strong>Platform Development</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PlatformDevelopmentDisclosureTextBlock', window );">Platform Development</a></td>
<td class="text"><p id="xdx_807_ecustom--PlatformDevelopmentDisclosureTextBlock_z8pHwPLaU6Wd" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>8.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82C_zDP3yfcPuCMf">Platform Development</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_ecustom--SummaryOfPlatformDevelopmentCostsTableTextBlock_zIxqj5lvxKH1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Platform
development costs are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zCGkr6fcwnh" style="display: none">Summary
of Platform Development Costs</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20231231_zScIWEATpF9e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20221231_zoi0Y6qHmrOh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_maPPAENzOa4_zpkMwALs7ny4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Platform development</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">26,054</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">21,493</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pn3n3_di_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_msPPAENzOa4_zb7BOt9cBcWi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less accumulated amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(17,331</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,163</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_mtPPAENzOa4_zg9J7Ivq3mdj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net platform development</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,723</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,330</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A3_zxpBfsFw1Khe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_ecustom--SummaryOfPlatformDevelopmentCostActivityTableTextBlock_zA9So66Ye86b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of platform development activity is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zvFdcOV5qJ31" style="display: none">Summary
of Platform Development Cost Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Platform development beginning of year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentOther_iS_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zEedoL1Wx1Jf" style="width: 16%; text-align: right" title="Platform development beginning of year">21,493</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentOther_iS_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zSMpkLYBnVe7" style="width: 16%; text-align: right" title="Platform development beginning of year">21,997</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payroll-based costs capitalized</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FinitelivedIntangibleAssetsAcquired1_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zi8ilA0LQW37" style="text-align: right" title="Payroll-based costs capitalized">3,773</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FinitelivedIntangibleAssetsAcquired1_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_z4lU2ZiU6H7k" style="text-align: right" title="Payroll-based costs capitalized">5,179</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less dispositions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--GainLossOnDispositionOfAssets1_iN_pn3n3_di_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zBDuanU1FMJf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less dispositions">(164</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--GainLossOnDispositionOfAssets1_iN_pn3n3_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zntQAbyAsiml" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less dispositions">(7,357</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total capitalized payroll-based costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zbgJijmJSww3" style="text-align: right" title="Total capitalized payroll-based costs">25,102</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zm28SsBRk7Ui" style="text-align: right" title="Total capitalized payroll-based costs">19,819</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zRXwggsvC8a8" style="text-align: right" title="Stock-based compensation">1,016</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zGBZkksY9Unk" style="text-align: right" title="Stock-based compensation">1,884</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Impairments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pn3n3_di_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zD3wrHAZConj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairments">(64</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pn3n3_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zQDa9e618Mf3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairments">(210</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Platform development end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentOther_iE_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zifcqCCr2A97" style="border-bottom: Black 2.5pt double; text-align: right" title="Platform development end of year">26,054</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentOther_iE_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zwvUFv2XESl9" style="border-bottom: Black 2.5pt double; text-align: right" title="Platform development end of year">21,493</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A1_zzTfVgXOcT3l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for platform development for the year ended December 31, 2023 and 2022 was $<span id="xdx_908_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_ziaWLfP2j086" title="Amortization expense of intangible asset">6,332</span> and $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_z0QRcEi260Oe" title="Amortization expense of intangible asset">5,822</span>, respectively. Amortization expense
for platform development is included in cost of revenue on the consolidated statements of operations. Impairment charges for platform
development for the years ended December 31, 2023 and 2022 of $<span id="xdx_903_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zDfRxxhbd1L1" title="Impairment charges">64 </span>and $<span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zDcG0HxUfJM5" title="Impairment charges">210</span>, <span id="xdx_90E_eus-gaap--ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_dxL_c20230101__20231231_zUYFQGCbiRFg" title="::XDX::http%3A%2F%2Ffasb.org%2Fus-gaap%2F2023%23AssetImpairmentCharges"><span style="-sec-ix-hidden: xdx2ixbrl1529">respectively</span></span>, have been recorded on the consolidated statements
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosurePlatformDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosurePlatformDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_PlatformDevelopmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Platform Development Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_PlatformDevelopmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735294384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text"><p id="xdx_806_eus-gaap--IntangibleAssetsDisclosureTextBlock_z64g7eKbPyo" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>9.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_827_zSv6iL6pkzo">Intangible Assets</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_891_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zGqPiHulnNc8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets subject to amortization consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zUxXsWZaoRVi" style="display: none">Schedule
of Intangible Assets Subject to Amortization</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 7pt"></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/>
 Average<br/>
 Useful<br/>
 Life (in<br/>
 years)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Carrying<br/>
 Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Accumulated<br/>
 Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Net<br/>
 Carrying<br/>
 Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Carrying<br/>
 Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Accumulated<br/>
 Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Net<br/>
 Carrying<br/>
 Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left">Developed technology</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zUlmoVeH7gKg" style="width: 6%; text-align: center" title="Intangible assets, weighted average useful life">4.70</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zPLtTlPFqcP2" style="width: 6%; text-align: right" title="Intangible assets, gross">17,333</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zMgGGax6T5D4" style="width: 6%; text-align: right" title="Intangible assets, accumulated amortization">(17,333</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zjAkav9a8Sx7" style="width: 6%; text-align: right" title="Intangible assets, net"><span style="-sec-ix-hidden: xdx2ixbrl1541">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_z7Wjm0Ok4Wt3" style="width: 6%; text-align: right" title="Intangible assets, gross">17,333</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zLxS893m0ogd" style="width: 6%; text-align: right" title="Intangible assets, accumulated amortization">(14,883</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zBCHpRcyDwM" style="width: 6%; text-align: right" title="Intangible assets, net">2,450</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade name</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zzVktJNWpdne" style="text-align: center" title="Intangible assets, weighted average useful life">16.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zDUrUFaiScql" style="text-align: right" title="Intangible assets, gross">5,181</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zlgZtjptU8Qb" style="text-align: right" title="Intangible assets, accumulated amortization">(1,547</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zPuAiq2cDMO9" style="text-align: right" title="Intangible assets, net">3,634</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zll02mCKq6qj" style="text-align: right" title="Intangible assets, gross">5,380</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zeJxzjxEVDK7" style="text-align: right" title="Intangible assets, accumulated amortization">(1,180</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zY63KfZKeS52" style="text-align: right" title="Intangible assets, net">4,200</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Brand name</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z5YUIFZbkNLj" style="text-align: center" title="Intangible assets, weighted average useful life">9.70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zBFW48O2JV3e" style="text-align: right" title="Intangible assets, gross">12,774</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zugLjIgyb9g5" style="text-align: right" title="Intangible assets, accumulated amortization">(2,374</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zkmEvK9I8C44" style="text-align: right" title="Intangible assets, net">10,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z2PJ48WtLwAc" style="text-align: right" title="Intangible assets, gross">12,115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zPp8GVRc0Fyd" style="text-align: right" title="Intangible assets, accumulated amortization">(908</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zkqmfZtDPs1b" style="text-align: right" title="Intangible assets, net">11,207</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Subscriber relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zuJYxejpJFEh" style="text-align: center" title="Intangible assets, weighted average useful life">5.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_z1En2GiaAO69" style="text-align: right" title="Intangible assets, gross">73,459</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_z9zrN0oCQVFd" style="text-align: right" title="Intangible assets, accumulated amortization">(61,654</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zU7gGu6Memo1" style="text-align: right" title="Intangible assets, net">11,805</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zPjVJZuHqYA1" style="text-align: right" title="Intangible assets, gross">73,459</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zDRJ180J2Upb" style="text-align: right" title="Intangible assets, accumulated amortization">(47,146</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zGE6F5MhgFyk" style="text-align: right" title="Intangible assets, net">26,313</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Advertiser relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zgkNT25EFh74" style="text-align: center" title="Intangible assets, weighted average useful life">10.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zEWRXOtzKjb1" style="text-align: right" title="Intangible assets, gross">15,182</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_z95TgOZE8c4a" style="text-align: right" title="Intangible assets, accumulated amortization">(2,832</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zAqCXJVxhvSb" style="text-align: right" title="Intangible assets, net">12,350</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zbBtoclSBlFl" style="text-align: right" title="Intangible assets, gross">15,302</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zsk0z7qULDdb" style="text-align: right" title="Intangible assets, accumulated amortization">(1,368</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zryIDTvmRqsc" style="text-align: right" title="Intangible assets, net">13,934</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Database</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zT3XTIqhh8Ki" style="text-align: center" title="Intangible assets, weighted average useful life">3.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zQgKWkLR70Zf" style="text-align: right" title="Intangible assets, gross">2,397</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zVrkRWfZWgY1" style="text-align: right" title="Intangible assets, accumulated amortization">(2,171</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_z9vGaJNNZMVi" style="text-align: right" title="Intangible assets, net">226</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zmXwPweU27Yb" style="text-align: right" title="Intangible assets, gross">2,397</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zqzxbu8f1RAl" style="text-align: right" title="Intangible assets, accumulated amortization">(1,753</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zbcCyeO2Oluf" style="text-align: right" title="Intangible assets, net">644</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Digital content</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zoenZA2G2Wu3" style="padding-bottom: 1.5pt; text-align: center" title="Intangible assets, weighted average useful life">2.00</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_z27QSShJFPH" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, gross">355</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zv39eNcxRjX" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, accumulated amortization">(311</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zMJTMqwTBTWa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, net">44</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zrN1I2QkoX6l" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, gross">355</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zxf7JUM4GUma" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, accumulated amortization">(133</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zWUfzZ9F9TQ" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, net">222</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Total intangible assets</td><td style="padding-bottom: 2.5pt; font-size: 10pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 7pt; text-align: center"></td><td style="padding-bottom: 2.5pt; font-size: 7pt; text-align: left"></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231_zRnBAslxkjLj" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, gross">126,681</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231_zGiKhMSlei9f" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, accumulated amortization">(88,222</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231_zI4CGWw40rwe" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net">38,459</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231_zYd3UO3kWlVc" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, gross">126,341</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231_z9iw7ItRHiK4" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, accumulated amortization">(67,371</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231_zhQzPuBKRfg8" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net">58,970</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_8AA_zTaibOTCoOHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets subject to amortization were recorded as part of the Company&#8217;s business acquisitions. Amortization expense for the years
ended December 31, 2023 and 2022 was $<span id="xdx_90E_eus-gaap--AmortizationOfAcquisitionCosts_pn3n3_c20230101__20231231_zs4lzgZp8O2g" title="Amortization expense of intangible asset acquisition">21,022</span> and $<span id="xdx_90C_eus-gaap--AmortizationOfAcquisitionCosts_pn3n3_c20220101__20221231_zrCmGdf9pGg4" title="Amortization expense of intangible asset acquisition">20,748</span>, respectively, of which amortization expense for developed technology of $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_z1HR0AfETNy3" title="Amortization expense of intangible asset">2,130</span>
and $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zUhwB378ynN7" title="Amortization expense of intangible asset">2,831</span>, respectively, is included in cost of revenue on the consolidated statements of operations. <span id="xdx_906_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pn3n3_do_c20230101__20231231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zzA0oEBDS5F1" title="Impairment charges">No</span> impairment charges
for the year ended December 31, 2023 was recorded for the intangible assets. Impairment charges for the year ended December 31, 2022
of $<span id="xdx_90C_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pn3n3_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zzFxP0iBySGh" title="Impairment charges">47</span> were recorded for the intangible assets on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zuyRfzrqd0T8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
total amortization expense for the next five years and thereafter related to the Company&#8217;s intangible assets subject to amortization
as of December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zqqKW07qTw9h" style="display: none">Schedule
of Future Estimated Amortization expense For Intangible Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: left; font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_497_20231231_zYAjGNyCvCJ4">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-weight: bold">Years Ending December 31,</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_iI_pn3n3_maFLIANzfm1_z9gvHtQccBsg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 79%; text-align: left">2024</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">14,544</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo_iI_pn3n3_maFLIANzfm1_z1H3hJWm4jr1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,427</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree_iI_pn3n3_maFLIANzfm1_zyzr9y1cm7nd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,214</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour_iI_pn3n3_maFLIANzfm1_zIeuwnD8FEI6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2027</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,214</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive_iI_pn3n3_maFLIANzfm1_zvTboWyk7Kwa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,964</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive_iI_pn3n3_maFLIANzfm1_zfDcpcwcmJFh" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,096</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzfm1_zWG5Dwvonkjb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
    assets ,net</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">38,459</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AD_zf2eXqoM1kx5" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735288416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Long-Term Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsDisclosureTextBlock', window );">Other Long-Term Assets</a></td>
<td class="text"><p id="xdx_809_eus-gaap--OtherAssetsDisclosureTextBlock_ztJKIVhtI4Xe" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>10.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span><span id="xdx_82B_zXOQ596nflp2">Other
Long-Term Assets</span></span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_eus-gaap--ScheduleOfOtherAssetsNoncurrentTextBlock_zbLVWHPCANGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
assets are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zm2wbNP0GrZc" style="display: none">Summary
of Other Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20231231_zWHtJmgelNKj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20221231_z8aJMAK8Mkoh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--SecurityDeposit_iI_pn3n3_maOANzDET_zpVxvTTopPo8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Security deposit</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">420</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">420</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OtherReceivables_iI_pn3n3_maOANzDET_zqWGhbImfvfk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1681">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PrepaidInsurance_iI_pn3n3_maOANzDET_zNU3A6qIzWaf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Prepaid insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">284</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">504</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--UnamortizedDebtCost_iI_pn3n3_maOANzDET_zYhHCihRnmad" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Unamortized debt cost</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">209</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">216</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherAssetsNoncurrent_iTI_pn3n3_mtOANzDET_zc71b3mHVZM5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total other assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,003</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,140</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p id="xdx_8A8_z2wbWsdTyIij" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736032032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text"><p id="xdx_803_eus-gaap--GoodwillDisclosureTextBlock_zLo7pNSDpYqh" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>11.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_822_zA8SAqcy52jf">Goodwill</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_89A_eus-gaap--ScheduleOfGoodwillTextBlock_zgqiNgwIwcP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
changes in carrying value of goodwill are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BD_z6oMhibAbeTg" style="display: none">Schedule
of Changes in Carrying Value of Goodwill</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_z54GMFz6llBd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20220101__20221231_zpKLTNlPeqpc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Goodwill_iS_pn3n3_zY5bhtZukAuj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Carrying value at beginning of year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">39,344</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">19,619</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_z7sIbTW6gjMb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Goodwill acquired in acquisition of Parade</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1699">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,587</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--MensJournalMember_zhQrkm1SyGji" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Goodwill acquired in acquisition of Men&#8217;s Journal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,246</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,138</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zi5zzU65rDze" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Goodwill acquired in acquisition of Fexy Studios</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,985</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1706">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--GoodwillImpairmentLoss_pn3n3_zPl4H5Aggyg8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss on impairment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1708">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1709">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--Goodwill_iE_pn3n3_z1MlBj06RKPd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Carrying value at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">42,575</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">39,344</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AE_zn1uAjHx8ish" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company performs its annual impairment test at the reporting unit level, which is the operating segment or one level below the operating
segment. Management determined that the Company would be aggregated into a single reporting unit for purposes of performing the impairment
test for goodwill.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, as part of its annual impairment evaluation of goodwill of its one reporting unit, performs the goodwill impairment test in
accordance with applicable guidance. The guidance provides an entity the option to first perform a qualitative assessment to determine
whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines
that this is the case, it is required to perform the goodwill impairment test to identify potential goodwill impairment and measure the
amount of goodwill impairment loss to be recognized for that reporting unit, if any. If an entity determines that the fair value of a
reporting unit is greater than its carrying amount, the goodwill impairment test is not required. The annual impairment test was performed
on December 31, 2023. <span id="xdx_90F_eus-gaap--GoodwillImpairmentLoss_doxL_c20230101__20231231_zZjLeV4bDb93" title="Impairment of goodwill::XDX::-"><span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_doxL_c20220101__20221231_zd6stMLXluWg" title="Impairment of goodwill::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1714"><span style="-sec-ix-hidden: xdx2ixbrl1716">No</span></span></span></span> goodwill impairment was identified during the years ended December 31, 2023 and 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-20/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731092656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restricted Stock Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosureRestrictedStockLiabilitiesAbstract', window );"><strong>Restricted Stock Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_RestrictedStockLiabilitiesTextBlock', window );">Restricted Stock Liabilities</a></td>
<td class="text"><p id="xdx_801_ecustom--RestrictedStockLiabilitiesTextBlock_zxC9Yj5Go6V1" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>12.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82B_zbCIX0GXUBy7">Restricted Stock Liabilities</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded the repurchase of <span id="xdx_90A_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zVXRrfTOivV" title="Stock repurchased during period, shares">26,214</span> shares of the Company&#8217;s restricted common stock during the year ended December 31, 2022
on the consolidated statement of stockholders&#8217; deficiency. Effective April 4, 2022, there are no longer any shares of
the Company&#8217;s common stock subject to repurchase. During the year ended December 31, 2022, the Company paid $<span id="xdx_904_eus-gaap--PaymentsForRepurchaseOfEquity_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z3kzbOibPQni" title="Payments for repurchase Of equity">2,307</span> in cash for
the repurchase ($<span id="xdx_903_ecustom--RestrictedStockPrincipalAmount_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQmyduDaybp9" title="Restricted stock principal amount">2,152</span> in principal and $<span id="xdx_909_ecustom--RestrictedStockInterestPayment_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zr92X15tTDFb" title="Restricted stock interest payment">155</span> in interest).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosureRestrictedStockLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosureRestrictedStockLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_RestrictedStockLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restricted stock liabilities [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_RestrictedStockLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736032032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses and Other</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zFMTPtkEIuTh" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>13.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82A_z3pgpIuYtbk4">Accrued Expenses and Other</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zoKITz2tC5r3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
expenses and other are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_zXRiw98G4eza" style="display: none">Schedule
of Accrued Expenses</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20231231_z2IvZHnY1aE8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20221231_zaDWqhP6fpY8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_401_ecustom--GeneralAccruedExpenses_iI_pn3n3_maALCzErP_zvEVHQmS9p6i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">General accrued expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,486</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,339</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccruedPayrollTaxesCurrent_iI_pn3n3_maALCzErP_zgADpXqNjNK4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Accrued payroll and related taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,448</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,221</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccruedAdvertisingCurrent_iI_pn3n3_maALCzErP_zWhsjuBqslfc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Accrued publisher expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,596</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,911</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InterestPayableCurrent_iI_pn3n3_maALCzErP_z2DpbicCVEEc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,824</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1742">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--LiabilitiesInConnectionWithAcquisitionsAndDispositions_iI_pn3n3_maALCzErP_za2u7I06ihW1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Liabilities in connection with acquisitions and dispositions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,119</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,123</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LeaseDepositLiability_iI_pn3n3_maALCzErP_znl7JMQaCdDh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Assumed lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,328</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1748">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--LeaseTerminationLiability_iI_pn3n3_maALCzErP_zBb3Qlhezbwe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Lease termination liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,481</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,753</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maALCzErP_z4rq3OtxmYk3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">489</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">755</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedLiabilitiesCurrent_iTI_pn3n3_mtALCzErP_zUGWjDkRuT75" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total accrued expenses and other</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">30,771</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">23,102</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p id="xdx_8A7_zcEexnx63Vq7" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>



<p style="margin-top: 0; margin-bottom: 0"></p>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731867648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Line of Credit<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Line of Credit</a></td>
<td class="text"><p id="xdx_804_eus-gaap--DebtDisclosureTextBlock_zrnxQidmTccf" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>14.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_820_z4tzOq8IFphl">Line of Credit</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Arena
Credit Agreement</i> &#8211; On December 15, 2022, the Company entered into an amendment to its financing and security agreement for
its line of credit with SLR Digital Finance LLC (&#8220;SLR&#8221; or the &#8220;amended line of credit&#8221;), as further amended
on August 31, 2023 in connection with the Business Combination (see Note 28) (the &#8220;SLR Amendment&#8221;) pursuant to which the
SLR Amendment provided for an extension of the maturity date, additional event of default provisions in connection with the Business
Combination, payment of certain fees in connection with the Business Combination, additional borrowings under the 2023 Notes (see
Note 18) pursuant to the First Amendment (see Note 18 and Note 27), and issuance of Series A preferred stock in connection with the
Business Combination, all of which are more fully described herein. Collectively the amended line of credit and SLR Amendment are
referred to as the &#8220;line of credit&#8221; (or the &#8220;Arena Credit Agreement&#8221;). In connection with the Arena Notes
Default (as further described under the heading <i>Arena Loan Agreement </i> in Note 28) there was a cross-default of the line of
credit, or the SLR Default (as further described under the heading <i>Arena Credit Agreement Default</i> in Note 28). The line of
credit provided for (i) $<span id="xdx_901_eus-gaap--LineOfCredit_iI_pn3n3_c20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember__srt--RangeAxis__srt--MaximumMember_zJMANQ2LEqMb" title="Line of credit">40,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">maximum
amount of advances available (subject to certain limits and eighty-five (<span id="xdx_90B_ecustom--AccountsReceivablePercentage_pid_dp_uPure_c20221215__20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember__srt--RangeAxis__srt--MaximumMember_zX0c7yycZAOd" title="Accounts receivable percentage">85</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%)
of eligible accounts receivable) pursuant to the amended line of credit, (ii) <span id="xdx_905_eus-gaap--LineOfCreditFacilityInterestRateDescription_c20221215__20221215__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember_zie0R2Wjyvka" title="Line of credit facility, interest rate description">an
interest rate at the prime rate plus 4.0% per annum of the amount advanced (subject to minimum utilization of at least 10% of the
maximum amount of advances available) (as of December 31, 2023 the stated interest rate was 12.5%), (iii) payment of a fee equal to
2.25% of the maximum line amount with respect to any termination of the agreement prior to December 31, 2025 at the option of the
Company at any time with 60 day notice pursuant to the SLR Amendment, (iv) a payment of a performance fee in the amount equal to
2.25% of the maximum line amount, under certain circumstances pursuant to the Business Combination in connection with a deal
deadline or in the event of a deal failure, as defined in the SLR Amendment, further the performance fee will survive the
termination of the agreement, pursuant to the SLR Amendment, (v) a payment of a success fee if the Business Combination is
consummated, of 0.3% or 0.6% of the maximum line amount if the transaction closes on or before December 31, 2023 or after December
31, 2023, respectively, or $0 if the transaction closes after the deal deadline, pursuant to the SLR Amendment, and (vi) a maturity
date of </span></span><span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_dd_c20221215__20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember_zhS9HlaoRw8i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Maturity date">December
31, 2025</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The SLR Amendment also permitted the
Company to enter into the 2023 Notes in an aggregate of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember__us-gaap--LongtermDebtTypeAxis__custom--TwoThousandTwentyThreeNotesMember_zs21Rbo6NxW5" title="Debt instrument, face amount">8,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(as
further described under the heading <i>2023 Bridge Notes</i> in Note 18) and permitted the issuance of the Series A preferred stock
for $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember__us-gaap--StatementEquityComponentsAxis__custom--SeriesLPreferredStockMember_zsRlgIbqohBa" title="Debt instrument, face amount">25,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
connection with the Business Combination. The line of credit was for working capital purposes and was secured by a first lien on all
the Company&#8217;s cash and accounts receivable and a second lien on all other assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the SLR Amendment and amended line of credit, the Company incurred debt costs of $<span id="xdx_902_eus-gaap--DebtDefaultLongtermDebtAmount_iI_pn3n3_c20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zDVkDo1n3TXj" title="Debt costs">200
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90A_eus-gaap--UnamortizedDebtIssuanceExpense_iI_pn3n3_c20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zEGAqll9zEc7" title="Debt costs">441</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, with the SLR Amendment debt cost plus the unamortized debt cost at the time of the SLR Amendment being amortized over the
life of the extended maturity date of the line of credit. The unamortized balance, as of December 31, 2023 and 2022, was reflected in
prepayment and other current assets of $<span id="xdx_907_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zQxBwKN4cXne" title="Prepayment and other current assets">209
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_903_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zOyUXz8lMqNe" title="Prepayment and other current assets">216</span><span style="line-height: 115%">, respectively,
and </span>other long-term assets of $<span id="xdx_905_eus-gaap--OtherAssetsNoncurrent_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zEhEOTKWbum" title="Other long-term assets">209
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_900_eus-gaap--OtherAssetsNoncurrent_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zG2A5BKdb7aj" title="Other long-term assets">216</span>,
respectively</span>. As of December 31, 2023, the effective interest rate on the line of credit was <span id="xdx_905_eus-gaap--LineOfCreditFacilityInterestRateAtPeriodEnd_iI_pid_dp_uPure_c20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zzpTpnqbnAji" title="Effective interest rate, line of credit">13.7</span>%.
As of December 31, 2023 and 2022, the balance outstanding under the line of credit was $<span id="xdx_907_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zlvzovJVkXU3" title="Line of credit">19,609
</span>and $<span id="xdx_906_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zWdoiiaI8br6" title="Line of credit">14,092</span>,
respectively, as reflected on the consolidated balance sheets. As of December 31, 2023, in connection with the SLR Default, the Company
recorded a $<span id="xdx_908_eus-gaap--DebtInstrumentFeeAmount_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zfskYoJYzka7" title="Termination fee">900
</span>termination fee representing <span id="xdx_903_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zLNTD6t2LLp8" title="Interest rate, line of credit">2.25</span>%
of the maximum line amount, as reflected in accrued expenses and other on the consolidated balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735240528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liquidated Damages Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosureLiquidatedDamagesPayableAbstract', window );"><strong>Liquidated Damages Payable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesPayableTextBlock', window );">Liquidated Damages Payable</a></td>
<td class="text"><p id="xdx_809_ecustom--LiquidatedDamagesPayableTextBlock_zpxEob7RK7ni" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>15.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_824_zRrpr5VZnOEd">Liquidated Damages Payable</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidated
damages were recorded as a result of the following: (i) certain registration rights agreements provide for damages if the Company does
not register certain shares of the Company&#8217;s common stock within the requisite time frame (the &#8220;Registration Rights Damages&#8221;);
and (ii) certain securities purchase agreements provide for damages if the Company does not maintain its periodic filings with the SEC
within the requisite time frame (the &#8220;Public Information Failure Damages&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_ecustom--SummaryOfLiquidatedDamagesTableTextBlock_gL3SOLDTTB-KNKL_zDGTwIincM2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations
with respect to the liquidated damages payable are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B5_zMegz0GqMS1a" style="display: none">Summary
of Liquidated Damages</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Registration<br/>
 Rights Damages</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Public<br/>
 Information<br/>
 Failure Damages</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accrued<br/>
 Interest</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">MDB common stock to be issued (<span id="xdx_F42_zZAapBO2gps9">1</span>)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zDqlJnuraLZh" style="width: 12%; text-align: right" title="Registration Rights Damages">15</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zirnilVnafnd" style="width: 12%; text-align: right" title="Public Information Failure Damages"><span style="-sec-ix-hidden: xdx2ixbrl1803">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_z4G7I3rqJu3l" style="width: 12%; text-align: right" title="Accrued Interest"><span style="-sec-ix-hidden: xdx2ixbrl1805">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_z35RJgXoCam" style="width: 12%; text-align: right" title="Balance">15</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series H convertible preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zZMZaArqvnu3" style="text-align: right" title="Registration Rights Damages">565</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zPBLMRLCtnKk" style="text-align: right" title="Public Information Failure Damages">574</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zmj1VuA20GT2" style="text-align: right" title="Accrued Interest">659</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zrdXkHLPLGEd" style="text-align: right" title="Balance">1,798</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_F4E_zs8iFrZCBsvi" style="text-align: left">Convertible debentures (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zHjuFFJuUt69" style="text-align: right" title="Registration Rights Damages"><span style="-sec-ix-hidden: xdx2ixbrl1817">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zkACreHtTaZ6" style="text-align: right" title="Public Information Failure Damages">144</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zyVXLmuIRu22" style="text-align: right" title="Accrued Interest">72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zNi1hi2GuUxe" style="text-align: right" title="Balance">216</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series J convertible preferred stock (<span id="xdx_F42_zB3Dv8wiU987">2</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zDDZEmJvDOP7" style="text-align: right" title="Registration Rights Damages">152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zuDyvhBzhao" style="text-align: right" title="Public Information Failure Damages">152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zMMbTt20YTBd" style="text-align: right" title="Accrued Interest">129</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zOcPtTGLre05" style="text-align: right" title="Balance">433</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series K convertible preferred stock (<span id="xdx_F4C_zQ7O58bIoMu3">2</span>)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zjdbdtNBHFgi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Registration Rights Damages">166</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zdTZF3ORJqHj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Public Information Failure Damages">70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zs968JTFeeP4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accrued Interest">226</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zDnuJNHOtOw" style="border-bottom: Black 1.5pt solid; text-align: right" title="Balance">462</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231_zZTVJj6CNDbi" style="border-bottom: Black 2.5pt double; text-align: right" title="Registration Rights Damages">898</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231_zfymHuAEnpak" style="border-bottom: Black 2.5pt double; text-align: right" title="Public Information Failure Damages">940</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231_zq2lIzgEeo12" style="border-bottom: Black 2.5pt double; text-align: right" title="Accrued Interest">1,086</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231_zRxTxJkYT124" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance">2,924</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F04_z3VFS35LQHIc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F16_zwNEu3NvNq85" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
                                            of common stock issuable to MDB Capital Group, LLC (&#8220;MDB&#8221;) (see <i>Common Stock
                                            to be Issued</i> in Note 21).</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F09_zPiUdwXpxay2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F13_zjoO0f4ruTR7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            previously issued and converted debt or equity securities.</span></td></tr></table>

<p id="xdx_8A9_zZej9dRcH5z7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2023, the Company entered into a stock purchase agreement with an investor, where the Company was liable for liquidated damages,
pursuant to which the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230208__20230208__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zia0jNW8KAwh" title="Shares issued">47,252</span>
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock, in satisfaction of
the liquidated damages, at a price equal to $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230208__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z9kj8PGe283d">10.56
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (determined based on the volume-weighted
average price of the Company&#8217;s common stock at the close of trading on the sixty (60) previous trading days), to the investor in
lieu of an aggregate of $<span id="xdx_900_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20230208__20230208__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zOPFfCfo6Dag">499
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">owed in liquidated damages as of the conversion
date. The Company prepared and filed a registration statement covering the resale of these shares of the Company&#8217;s common stock
issued in lieu of payment of these liquidated damages in cash. During the year ended December 31, 2023, the Company recorded $<span id="xdx_90E_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zswDtd90Csnh">499
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in connection with the issuance of shares of
the Company&#8217;s common stock on the consolidated statements of stockholders&#8217; deficiency (further details are provided under
the heading <i>Common Stock for Liquidated Damages </i>in Note 21).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 1, 2023, the Company entered into a waiver of liquidated damages and release of claims, where B. Riley, a principal stockholder
at the time, relinquished any claims to liquidated damages and accrued interest thereon amounting to $<span id="xdx_90C_eus-gaap--DebtInstrumentDecreaseForgiveness_pn3n3_c20231201__20231201__srt--TitleOfIndividualAxis__custom--BRileyMember_zIYo9Q7aV9N7" title="Gain on forgiveness of debt">3,497</span>, which resulted in a gain
on forgiveness of debt. Given this transaction was with a related party and in connection with other contemporaneous transactions with
another principal stockholder, Simplify (further described in Note 26), the gain of $<span id="xdx_902_ecustom--AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zk5ceR3Z9qKh" title="Gain on forgiveness of debt">3,497</span> was recorded within additional paid-in capital
on the consolidated statement of stockholders&#8217; deficiency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the short-term liquidated damages payable was $<span id="xdx_90C_ecustom--LiquidatedDamagesPayableCurrent_iI_pn3n3_c20231231_zf5LCJ8OR7qh" title="Short-term liquidated damages">2,924</span>. The Company will continue to accrue interest on the liquidated
damages balance at <span id="xdx_90B_ecustom--LiquidatedDamagesPayableAccruedInterestPercentage_pid_dp_uPure_c20230101__20231231_zQDnSBsX4mpe" title="Liquidated damages payable accrued interest percentage">1</span>% per month based on the balance outstanding as of December 31, 2023, or $<span id="xdx_906_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231_zn0R0h5fDQXe" title="Liquidated damages outstanding amount">2,924</span>, until paid. There is no scheduled
date when the unpaid liquidated damages become due. The previously issued and converted Series K convertible preferred stock remains
subject to Registration Rights Damages and Public Information Failure Damages, which will accrue in certain circumstances, limited to
<span id="xdx_907_ecustom--PercentageOfAggregateAmountInvested_pid_dp_uPure_c20230101__20231231_zjUxwAOvDBic" title="Percentage of aggregate amount invested">6</span>% of the aggregate amount invested.</span></p>

<div id="xdx_C05_gL3SOLDTTB-KNKL_zg0S3T9Doi9j"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_306_134_zLWqsaxl7i5c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Liquidated Damages (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap">&#160;</td><td style="white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Registration<br/>
 Rights Damages</td><td style="white-space: nowrap; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Public<br/>
 Information<br/>
 Failure
    Damages</td><td style="white-space: nowrap; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Accrued<br/>
 Interest</td><td style="white-space: nowrap; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Balance</td><td style="white-space: nowrap; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">MDB common stock to be issued (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zhbG7wqvMsp4" style="width: 12%; text-align: right" title="Registration Rights Damages">15</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zOkqE9IM4m54" style="width: 12%; text-align: right" title="Public Information Failure Damages"><span style="-sec-ix-hidden: xdx2ixbrl1870">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_znOKNlmxcGVg" style="width: 12%; text-align: right" title="Accrued Interest"><span style="-sec-ix-hidden: xdx2ixbrl1872">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zh4pS70UZ014" style="width: 12%; text-align: right" title="Balance">15</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series H Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zcnVr4RdmnCl" style="text-align: right" title="Registration Rights Damages">618</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zvsojiPfENoc" style="text-align: right" title="Public Information Failure Damages">626</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zMJ2eqMVY7s2" style="text-align: right" title="Accrued Interest">570</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zzjK3JA7zvd3" style="text-align: right" title="Balance">1,814</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible debentures (<span id="xdx_F49_zphT2fK5b3u">2</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zY0wmjJ2jXTj" style="text-align: right" title="Registration Rights Damages"><span style="-sec-ix-hidden: xdx2ixbrl1884">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zz3S6lbFCXcg" style="text-align: right" title="Public Information Failure Damages">704</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zGUIY42ddsl4" style="text-align: right" title="Accrued Interest">280</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zebUolESDQMj" style="text-align: right" title="Balance">984</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series J convertible preferred stock (<span id="xdx_F42_zQxUbIHB1zl9">2</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_z1KydlfNJPpi" style="text-align: right" title="Registration Rights Damages">932</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zwPaFfQdUg08" style="text-align: right" title="Public Information Failure Damages">932</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_z7WnqsPmvlP" style="text-align: right" title="Accrued Interest">525</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zQ8chrfdJ2k" style="text-align: right" title="Balance">2,389</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series K convertible preferred stock (<span id="xdx_F4C_zUqtmOqrq3F5">2</span>)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_z11OeUxmZJqa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Registration Rights Damages">437</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zYBRUpEoQfY1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Public Information Failure Damages">478</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zVkGyt4b2GZc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accrued Interest">220</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zqvyX3zC2VUh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Balance">1,135</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231_zl7QFhHFxK3g" style="border-bottom: Black 2.5pt double; text-align: right" title="Registration Rights Damages">2,002</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231_zHm8sHhnuF51" style="border-bottom: Black 2.5pt double; text-align: right" title="Public Information Failure Damages">2,740</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231_zrgH99cf9FDj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accrued Interest">1,595</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231_zdSVTzUMvWv6" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance">6,337</td><td style="text-align: left">&#160;</td></tr>
  </table>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_zVQwPxgU9mH3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_zE3iDtl8Jxl1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
                                            of common stock issuable to MDB.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F02_zTnG0ctsL4vj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F16_zV2VYzn6F8v5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            previously issued and converted debt or equity securities.</span></td></tr></table>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C0E_gL3SOLDTTB-KNKL_zvYv4swqcvYg">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the short-term and long-term liquidated damages payable were $<span id="xdx_905_ecustom--LiquidatedDamagesPayableCurrent_iI_pn3n3_c20221231_zm6OdE0Kk7ob" title="Short-term liquidated damages">5,843</span> and $<span id="xdx_90A_ecustom--LiquidatedDamagesPayableNonCurrent_iI_pn3n3_c20221231_z96EcSHe8Yrd" title="Long-term liquidated damages">494</span>, respectively, totaling $<span id="xdx_90C_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231_zn9OueICee1d" title="Liquidated damages outstanding amount">6,337</span>. The
long-term portion was converted into shares of the Company&#8217;s common stock on January 24, 2022 (further details are provided under
heading <i>Common Stock for Liquidated Damages </i>in Note 21).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to the liquidated damages recognized on the consolidated statements of operations is provided in Note 23.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosureLiquidatedDamagesPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosureLiquidatedDamagesPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LiquidatedDamagesPayableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidated Damages Payable [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LiquidatedDamagesPayableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656729994128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Long-term Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosureOtherLongtermLiabilitiesAbstract', window );"><strong>Other Long-term Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_OtherLongtermLiabilitiesTextBlock', window );">Other Long-term Liabilities</a></td>
<td class="text"><p id="xdx_80D_ecustom--OtherLongtermLiabilitiesTextBlock_zYlNZNPv9GB2" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>16.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_820_z89ie0sHKZSc">Other Long-term Liabilities</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_89A_ecustom--OtherLongtermLiabilitiesTableTextBlock_znxixkzx3hJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
long-term liabilities consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BC_zmw0NNfxV0j6" style="display: none">Schedule
of Other long- term liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20231231_zGeXXw97s7B3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20221231_znXhoVIujHrf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--LeaseTerminationLiabilityNonCurrent_iI_pn3n3_maOLNz6kY_zReJPruxu3sa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Lease termination liability</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1928">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,621</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_maOLNz6kY_zc2YXmiWK5Ud" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Assumed lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">350</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,486</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--OtherLongTermLiabilitiesNoncurrent_iI_pn3n3_maOLNz6kY_zH2eDVGxNCYj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Other</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">56</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">200</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OtherLiabilitiesNoncurrent_iTI_pn3n3_mtOLNz6kY_zAWc9uR9NT55" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total other long-term liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">406</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,307</td><td style="text-align: left">&#160;</td></tr>
  </table>
<p id="xdx_8AF_zIR6v2kKDJRd" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosureOtherLongtermLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosureOtherLongtermLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_OtherLongtermLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other long term liabilities [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_OtherLongtermLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656729987040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurement</a></td>
<td class="text"><p id="xdx_802_eus-gaap--FairValueDisclosuresTextBlock_zumazjFcEkde" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>17.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_828_zqFuGY3YLiOl">Fair Value Measurement</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of level 1, Level 2 and level 3 assets as of December 31, 2023 and 2022. As of December
31, 2023 and 2022, the Company&#8217;s cash and cash equivalents of $<span id="xdx_904_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20231231_zahS6RvGe688" title="Cash and cash equivalents">9,284</span> and $<span id="xdx_90B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20221231_zdUWJGS2R9t5" title="Cash and cash equivalents">13,871</span>, respectively, were Level 1 assets and included
savings deposits, overnight investments, and other liquid funds with financial institutions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for certain common stock issued in connection with the acquisition of Fexy Studios that is subject to a put option
(which provides for a cash payment to the sellers on the first anniversary date of the closing (or January 11, 2024) in the event the
common stock trading price on such date is less than the common stock trading price on the day immediately preceding the acquisition
date, or $<span id="xdx_904_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_c20231231__us-gaap--BusinessAcquisitionAxis__custom--FlexyStudiosMember_zNLVWV04Ez48" title="Preceding acquistion price per share">8.10</span> per share), as a derivative liability, which requires the Company to carry such amounts on its consolidated
balance sheets as a liability at fair value, as adjusted at each reporting period-end (further details are provided under the heading
<i>Fexy Put Option</i> in Note 28).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments measured at fair value during
the year ended December 31, 2023, related to the Company&#8217;s current debt, with a carrying value of $<span id="xdx_906_eus-gaap--FinancialInstrumentsOwnedAtFairValue_iI_pn3n3_c20231231_zyTLzCow57y3" title="Financial instruments measured fair value debt bridge notes">7,887</span> and $<span id="xdx_902_eus-gaap--FinancialInstrumentsOwnedOtherAtFairValue_iI_pn3n3_c20231231_zGBXXbZNEkI7" title="Debt fair value">102,309</span> for the Bridge Notes
and Debt as of December 31, 2023, respectively, approximates fair value due to their short nature and based on current market interest
rates for debt instruments of similar credit standing.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zfaz0sRL9HOl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments measured at fair value during the year consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BD_zDRBiyiFr0F5" style="display: none">Schedule
of Fair Value of Financial Instruments</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted
Prices <br/>
in Active <br/>
Markets for<br/>
Identical <br/>
Assets (Level 1)</b></span></p></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant<br/>
Other <br/>
Observable<br/>
Inputs (Level 2)</b></span></p></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant
<br/>
Unobservable<br/>
Inputs (Level 3)</b></span></p></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left; width: 36%">Contingent consideration</td><td style="padding-bottom: 2.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td id="xdx_985_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember_zBqy5pqnWLte" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%" title="Long term debt fair value">1,571</td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 2.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td id="xdx_986_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zAnw5mckc7L6" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%" title="Long term debt fair value">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1956">-</span></td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 2.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td id="xdx_982_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z3BUQe1t0cZj" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%" title="Long term debt fair value">1,571</td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 2.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td id="xdx_98E_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember_zYFQ4GVPfRS5" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%" title="Long term debt fair value">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1960">-</span></td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted
Prices <br/>
in Active <br/>
Markets for<br/>
Identical <br/>
Assets (Level 1)</b></span></p></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant<br/>
Other <br/>
Observable<br/>
Inputs (Level 2)</b></span></p></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant
<br/>
Unobservable<br/>
Inputs (Level 3)</b></span></p></td><td>&#160;</td></tr>
  <tr id="xdx_433_c20231231_zLh1urT9FVq4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Senior Secured Notes</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember_z3l5qJvtiOAj" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Long term debt fair value">61,787</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zzH51p02O4m2" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Long term debt fair value">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1965">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zTWvTclZT9Ij" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Long term debt fair value">61,787</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zhxdxdUbSY4g" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Long term debt fair value">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1969">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A7_zBTOL38MkJtk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contingent
Consideration &#8211;</i> The fair value of the contingent consideration is primarily dependent on the common stock trading price on
the first anniversary of the closing of the Fexy Studios acquisition, or January 11, 2024. The estimated fair value was calculated based
on the $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20231231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zExRuvR838D7" title="Exercise price">8.10</span> put option amount based on the exercise price of the Company&#8217;s common stock at the acquisition date, less the $<span id="xdx_90C_eus-gaap--SharePrice_iI_pid_c20231231_zdoZdr6vE384" title="Common stock trading price">2.38</span>
the Company&#8217;s common stock trading price as of the reporting date, or $<span id="xdx_903_eus-gaap--SharePrice_iI_pid_c20231231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zyRVw0UK22U9" title="Trading price, per share">5.72</span> per share, multiplied by the number of shares subject
to the put option of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230101__20231231__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosAcquistionMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zdu0NU0Z7pbc" title="Issuance of common stock in connection with acquisitions, shares">274,692</span>, which approximated the value if the Black-Scholes option-pricing model was used given the proximity date
of the put option. For the year ended December 31, 2023, the change in valuation of the contingent consideration of $<span id="xdx_902_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_pn3n3_di_c20230101__20231231_z1BxlaWtbgEa" title="Change in valuation of contingent consideration">1,010</span> was recognized
in other expenses on the consolidated statement of operations. Further details are provided under the heading <i>Fexy Put Option
</i>in Note 28.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Senior
Secured Notes</i> &#8211; The carrying value of the Senior Secured Notes (as defined below) approximates fair value based on current
market interest rates for debt instruments of similar credit standing and, consequently, their fair values are based on Level 2 inputs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
quantitative information utilized in the fair value calculation of the Level 3 liabilities are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unearned
Revenue</i> &#8211; The fair value of unearned revenue remaining in connection with the 2019 acquisitions of Sports Illustrated licensed
brands, was determined with the following inputs: (1) projection of when unearned revenue will be earned; (2) expense necessary to fulfill
the subscriptions; (3) gross up of the fulfillment costs to include a market participant level of profitability; (4) slight premium to
the fulfillment-costs plus a reasonable profit metric; and (5) reduce projected future cash flows to present value using an appropriate
discount rate. The unearned revenue remaining from the acquisitions as of December 31, 2023 and 2022 was $<span id="xdx_90C_ecustom--UnearnedRevenue_iI_pn3n3_c20231231_zhL6nZnj0Hnb" title="Unearned revenue">523</span> and $<span id="xdx_904_ecustom--UnearnedRevenue_iI_pn3n3_c20221231_zhGuGn2hJAw8" title="Unearned revenue">1,154</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
changes in unearned revenue with inputs classified as Level 3 of the fair value hierarchy are reflected within revenue on the consolidated
statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656730948880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Bridge Notes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTextBlock', window );">Bridge Notes</a></td>
<td class="text"><p id="xdx_803_eus-gaap--ShortTermDebtTextBlock_z9lEydQ2F7X1" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>18.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82B_zpgVzjwg75f5">Bridge Notes</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2023
Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Note Purchase Agreement, First Amendment and Second Amendment (as further described under the heading <i>Principal
Stockholders</i> in Note 26), on August 31, 2023, the Company issued $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20230831__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zv65i3wDg7Uj" title="Aggregate principal amount">5,000</span> aggregate principal amount of senior secured notes (the &#8220;2023
Notes&#8221;). The provisions of the First Amendment also permit certain incremental borrowings in the amount up to $<span id="xdx_904_eus-gaap--OtherBorrowings_iI_pn3n3_c20230831__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zoXVmz2bb103" title="Incremental borrowings">3,000</span> at the sole
discretion of the purchaser (the &#8220;Incremental 2023 Notes&#8221;), subject to a minimum amount of $<span id="xdx_90C_ecustom--AggregatePrincipalMinimumAmount_pn3n3_c20230831__20230831__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zgdEQ2qI3ZBc" title="Incremental borrowings">1,000</span> and other conditions. On
September 29, 2023, the Company issued $<span id="xdx_90C_ecustom--AggregatePrincipalMinimumAmount_pn3n3_c20230929__20230929__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zcfaZftKQxjc" title="Incremental borrowings">1,000</span> aggregate principal amount of senior secured notes pursuant to the incremental borrowings.
On November 27, 2023, the Company issued $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231127__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zKapEXhgsnh4" title="Aggregate principal amount">2,000</span> aggregate principal amount of senior secured notes pursuant to the incremental borrowings.
In connection with the issuance of the 2023 Notes, the Company received net proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfDebt_pn3n3_c20230929__20230929__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zyevAeVBXR2i" title="Net proceeds">7,643</span> from the issuance of the notes and incurred
debt costs of $<span id="xdx_904_eus-gaap--DebtSecuritiesAvailableForSaleAmortizedCostCurrent_iI_pn3n3_c20230929__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zm0eUc6Hf2ag" title="Amortized debt cost">357</span> that is being amortized over the expected life of the debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The terms of 2023 Notes provide for:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    interest rate fixed at <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_c20230831__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zeFXSz2zznB1" title="Debt instrument interest rate effective percentage">10.0</span>% per annum;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    maturity date of <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--BridgeNotesMember_zAjgeSddw7Dj" title="Debt maturity term">April
    30, 2024</span>, as amended pursuant to the Second Amendment from December 31, 2023, subject to consummation of the Business
    Combination (see Note 28) on or prior to April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, which
    may result in an event of default if not consummated, and a prepayment requirement to apply a portion of the net proceeds from the
    Business Combination to repay $<span id="xdx_907_eus-gaap--ProceedsFromDebtNetOfIssuanceCosts_pn3n3_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zRbUM4KJsrB" title="Net proceeds from business combination">8,000</span>
    (and any additional amounts borrowed pursuant to the incremental borrowing arrangement described above) under the notes;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    provision for the failure to repay the $<span id="xdx_904_eus-gaap--PrepaymentFeesOnAdvancesNet_pn3n3_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zMWY2jyyosR3" title="Prepayment fees on advances, net">8,000</span> prepayment requirement in full with the proceeds of the Business Combination or failure
    to consummate the Business Combination by April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, will
    result in an event of default under the notes; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    election to prepay the notes, at any time, at <span id="xdx_906_ecustom--PrincipalAmountPrepayDue_iI_pid_dp_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_z6BcoGL0gzjj" title="Principal amount prepay due percentage">100</span>% of the principal amount due with no premium or penalty.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
debt issuance cost incurred under the debt modifications pursuant to the First Amendment are being amortized over the term of the
2023 Notes. The debt modification pursuant to the Second Amendment resulted in the unamortized debt issuance cost being amortized
over the extended term of the 2023 Notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, the Company failed to make the interest payment due on the 2023  Notes resulting in an event of default with
subsequent agreement to a forbearance period through the earlier of the following: (a) April 30, 2024; <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%">(b)
the occurrence of the closing of the Business Combination and (c) the termination of the Business Combination prior</span> to closing (collectively the &#8220;forbearance&#8221;) <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">(</span>further details are provided for under the heading <i>Arena Loan
Agreement </i> in Note 28).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the effective interest rate on the 2023 Notes was <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20231231__us-gaap--DebtInstrumentAxis__custom--BridgeNotesMember_zp0h855GaQ6e">14.2</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%. As of <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">December 31, 2023,
the current balance outstanding under the 2023 Notes was $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--BridgeNotesMember_znbSSFnkRLd1" title="Balance outstanding">7,887</span>, net of unamortized cost of $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--BridgeNotesMember_zKigqmHGNRK2" title="Debt instrument, unamortized discount, current">113</span>, with the principal balance due of $<span id="xdx_909_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--BridgeNotesMember_zP67bvywf1X4" title="Debt payment principal amount">8,000</span>,
subject to the forbearance.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
for the years ended December 31, 2023 and 2022, with respect to interest expense related to the 2023 Notes is provided under the heading
<i>Interest Expense</i> in Note 19.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2022
Bridge Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 15, 2022, the Company issued $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20221215__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zR0yh62J8pEe" title="Principal amount">36,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">aggregate principal amount of senior secured
notes (the &#8220;2022 Bridge Notes&#8221;) pursuant to the Note Purchase Agreement. In connection with the issuance of the notes, the
Company received net proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfDebt_pn3n3_c20221215__20221215__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zb1z9Gy3G76i" title="Proceeds from issuance of debt">34,728
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and incurred debt costs of $<span id="xdx_90E_eus-gaap--DeferredFinanceCostsNet_iI_pn3n3_c20221215__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zSZysIUc0Vak" title="Incurred debt costs">1,272
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that were being amortized over the expected life
of the debt. As of December 31, 2022, the balance outstanding under the 2022 Bridge Notes was $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zuP3Ch37Qpt" title="Principal balance">34,805
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($<span id="xdx_909_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zUPAGcu3Wf35" title="Principal balance">36,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">principal balance less unamortized debt costs
of $<span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zyYh1XdIBlo7" title="Unamortized debt costs">1,195</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">),
that was modified during the year ended December 31, 2023 (further details are provided under the heading <i>2022 Bridge Notes</i> in
Note 19).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656730020192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-term Debt</a></td>
<td class="text"><p id="xdx_802_eus-gaap--LongTermDebtTextBlock_zFjkIytLbso2" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>19.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_822_zX99Dffbm6J">Long-term Debt</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Senior
Secured Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Pursuant
to the Note Purchase Agreement, as amended by the First Amendment and Second Amendment (<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">as further described
under the heading <i>Principal Stockholders</i> in Note 26),</span> as of December 31, 2023 and 2022, the
Company has notes outstanding referred to as the senior secured notes (the &#8220;Senior Secured Notes&#8221;), the delayed draw term notes (the &#8220;Delayed Draw Term Notes&#8221;) and the 2022 Bridge Notes, as further
described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The terms of the Senior Secured Notes
provide for:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
provision for the Company to enter into Delayed Draw Term Notes (as described below);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    provision where the Company added $<span id="xdx_902_eus-gaap--InterestPayableCurrent_iI_pn3n3_c20220101_z702hnpMYyzk" title="Interest payable">13,852</span> to the principal balance of the notes for interest payable prior to January 1, 2022 as
    payable in-kind;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    provision where the paid in-kind interest can be paid in shares of the Company&#8217;s common stock based upon the conversion rate
    specified in the Certificate of Designation for the Series K convertible preferred stock, subject to certain adjustments;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    interest rate of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateIncreaseDecrease_pid_dp_uPure_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zgy9GRsORt06" title="Debt instrument interest rate">10.0</span>% per annum, subject to adjustment in the event of default, with a provision that within one (1) business day
    after receipt of cash proceeds from any issuance of equity interests, unless waived, the Company will prepay certain obligations
    in an amount equal to such cash proceeds, net of underwriting discounts and commissions; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest
    on the notes payable after February 15, 2022, at the agent&#8217;s sole discretion, either (a) in cash quarterly in arrears on the
    last day of each fiscal quarter or (b) by continuing to add such interest due on such payment dates to the principal amount of the
    notes;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    maturity date of <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zCwbqEp4aKvh" title="Debt instrument maturity date">December
    31, 2026</span> (as amended from December 31, 2023 pursuant to the First Amendment), subject to consummation of the Business
    Combination (see Note 28) on or prior to April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, which
    may result in an event of default if not consummated, and subject to certain acceleration conditions; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company to enter into the 2022 Bridge Notes for $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231231__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember_zflF9Vb2tgF8" title="Principal amount of debt">36,000</span> and to increase the line of credit with SLR in an aggregate principal amount
    not to exceed $<span id="xdx_901_eus-gaap--LineOfCredit_iI_pn3n3_c20231231__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember_z2iced0m17jf" title="Line of credit">40,000</span>. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="margin: 0"></p>

<p style="margin: 0"></p>



<p style="margin: 0"></p>

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Delayed
Draw Term Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Delayed Draw Term Notes provide for:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    interest rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--LongtermDebtTypeAxis__custom--DelayedDrawTermNotesMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zqpTRfThzMBe" title="Debt instrument interest rate percentage">10.0</span>% per annum, subject to adjustment in the event of default; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest
    on the notes payable after February 15, 2022, at the agent&#8217;s sole discretion, either (a) in cash quarterly in arrears on the
    last day of each fiscal quarter or (b) by continuing to add such interest due on such payment dates to the principal amount of the
    notes; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    maturity date on <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--DelayedDrawTermNotesMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zPJ250sUHu5e" title="Debt instrument maturity date">December 31, 2026</span> (as amended from December 31, 2023 pursuant to the First Amendment), subject to consummation of
    the Business Combination on or prior to April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, which
    may result in an event of default if not consummated, and subject to certain acceleration terms.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2022
Bridge Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the First Amendment, the 2022 Bridge Notes outstanding as of December 31, 2022 were amended and reclassified from a current liability
to a noncurrent liability. In connection with the debt modification, the Company incurred debt issuance costs of $<span id="xdx_903_eus-gaap--DeferredFinanceCostsNet_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zfpiTnMvEr9" title="Incurred debt costs">100 </span>that are being amortized
over the life of the 2022 Bridge Notes and a portion of the note maturity was extended as further described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The terms of the 2022 Bridge Notes provide
for:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    interest rate fixed at <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20221215__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zInSABbLegIl" title="Debt fixed rate">10.0</span>% per annum (as amended from interest that was payable in cash at an interest rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_z9gnhLJEHLPi" title="Debt due rate">12</span>% per annum quarterly;
    with interest rate increases of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230301__20230301__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zYJEziTRMZle" title="Debt interest rate"><span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230501__20230501__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zF40MQFoXpd7" title="Debt interest rate"><span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230701__20230701__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zo4mBMc1QcOc" title="Debt interest rate">1.5</span></span></span>% per annum on March 1, 2023, May 1, 2023, and July 1, 2023, pursuant to the First Amendment);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    maturity date of <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20221231__20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zu54uwhUn8ia" title="Debt maturity date">December 31, 2026</span> (as amended from December 31, 2023 pursuant to the First Amendment), subject to consummation of
    the Business Combination on or prior to April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, which
    may result in an event of default if not consummated, and subject to certain mandatory prepayment requirements, including, but not
    limited to, a requirement that the Company apply the net proceeds from certain debt incurrences or equity offerings to repay the
    notes;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    prepayment requirement to apply a portion of the net proceeds from the Business Combination to repay $<span id="xdx_90B_ecustom--DebtInstrumentPeriodicPaymentPrincipalBalance_pn3n3_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zPgKN6jglPff" title="Principal amount of debt">20,000</span> of the principal balance
    under the notes upon the earlier of April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023 or the closing
    of the Business Combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    provision for the failure to repay the $<span id="xdx_90C_eus-gaap--RepaymentsOfDebt_pn3n3_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zsgYS7fPpoU4" title="Repayment of debt">20,000</span> prepayment requirement in full with the proceeds of the Business Combination or failure
    to consummate the Business Combination by April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, will
    result in an event of default under the notes; and</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    election to prepay the notes, at any time, in whole or in part with no premium or penalty.</span></td></tr>
  </table>
<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>



<p style="margin: 0"></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_893_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zpNVfkEbXUk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the  debt:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B7_zPf0exAAQenh" style="display: none">Schedule of long term debt</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal<br/>
 Balance</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unamortized<br/>
 Discount<br/>
 and Debt<br/>
 Issuance<br/>
 Costs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carrying<br/>
 Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal<br/>
 Balance</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unamortized<br/>
 Discount<br/>
 and Debt<br/>
 Issuance<br/>
 Costs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carrying<br/>
 Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Senior Secured Notes, effective interest rate of 10.1% as of December 31, 2023, as amended, matures December 31, 2026, subject to acceleration</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zcYjvd5gaSGj" style="text-align: right" title="Principal balance (including accrued interest), total">62,691</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zIoRVimMAX1" style="text-align: right" title="Unamortized discount and debt issuance cost, total">&#160;&#160;&#160;&#160;(272</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zpgzjUR1Fm4i" style="text-align: right" title="Carrying value, total">62,419</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zt0PoFfmwV63" style="text-align: right" title="Principal balance (including accrued interest), total">62,691</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zIbv1nQL0m4d" style="text-align: right" title="Unamortized discount and debt issuance cost, total">(904</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zEBYgjSV3fn9" style="text-align: right" title="Carrying value">61,787</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left">Senior Secured Notes, effective interest rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zJw5w7uSa7dl" title="Debt instrument interest rate, percentage"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zGWrxq55TJqk" title="Debt instrument interest rate, percentage">10.1</span></span>% as of December 31, 2023, as amended</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zOtoQbAeGPW7" style="width: 7%; text-align: right" title="Principal balance (including accrued interest), total">62,691</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zOv0sS3e9dff" style="width: 7%; text-align: right" title="Unamortized discount and debt issuance cost, total">&#160;&#160;&#160;&#160;(272</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zSHfX28sCHvh" style="width: 7%; text-align: right" title="Carrying value, total">62,419</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zrD5MKTDiFtk" style="width: 7%; text-align: right" title="Principal balance (including accrued interest), total">62,691</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zpZVojmgZyH7" style="width: 7%; text-align: right" title="Unamortized discount and debt issuance cost, total">(904</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zn5vQAeU1A5j" style="width: 7%; text-align: right" title="Carrying value">61,787</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Delayed Draw Term Notes, effective interest rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--LongtermDebtTypeAxis__custom--DelayedDrawTermNoteMember_z9eaQhOl32Ti" title="Debt instrument interest rate, percentage"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--DelayedDrawTermNoteMember_z3BQWOUedm7e" title="Debt instrument interest rate, percentage">10.2</span></span>% as of December 31, 2023, as amended</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_znsgAfdfFlJ8" style="text-align: right" title="Principal balance (including accrued interest), total">4,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zQ2sW6iDmSt" style="text-align: right" title="Unamortized discount and debt issuance cost, total">(31</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_z0KbI0jXYPSf" style="text-align: right" title="Carrying value, total">3,969</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_z8SDiNHSNT3a" style="text-align: right" title="Principal balance (including accrued interest), total">4,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zrvkIJYG2xN5" style="text-align: right" title="Unamortized discount and debt issuance cost, total">(103</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zHTNTPXwimZ4" style="text-align: right" title="Carrying value, total">3,897</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">2022 Bridge Notes, effective interest rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--LongtermDebtTypeAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zF1L3SxJJaJ2" title="Debt instrument interest rate, percentage"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zTJxSXHR4Vvj" title="Debt instrument interest rate, percentage">10.2</span></span>% as of December 31, 2023, as amended</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zdUBkwGStIof" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal balance (including accrued interest), total">36,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zw0Zy88ndiek" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unamortized discount and debt issuance cost, total">(79</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zyt6vREqIKX1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Carrying value, total">35,921</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zGhack6rDr58" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal balance (including accrued interest), total"><span style="-sec-ix-hidden: xdx2ixbrl2120">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zVncpNjyPBEb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unamortized discount and debt issuance cost, total"><span style="-sec-ix-hidden: xdx2ixbrl2122">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zQEqEstGdft7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Carrying value, total"><span style="-sec-ix-hidden: xdx2ixbrl2124">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231_zVNZ4l9s8c1h" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal balance">102,691</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231_z1J5bKDJw1U1" style="border-bottom: Black 2.5pt double; text-align: right" title="Unamortized discount and debt issuance costs">(382</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--LongTermDebt_iI_pn3n3_c20231231_zBSXt3ukQq22" style="border-bottom: Black 2.5pt double; text-align: right" title="Carrying value">102,309</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231_zf5GkLDyXwuk" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal balance">66,691</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231_z4NOVAQZhEvf" style="border-bottom: Black 2.5pt double; text-align: right" title="Unamortized discount and debt issuance costs">(1,007</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20221231_zfrOgT9VrQx6" style="border-bottom: Black 2.5pt double; text-align: right" title="Carrying value">65,684</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A0_zdmS0w4zSoFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
debt issuance costs incurred under the debt modification pursuant to the First Amendment are being amortized over the term of the
long-term debt. The debt modification pursuant to the Second Amendment resulted in the unamortized debt issuance cost being
amortized over the extended term of the long-term debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, the Company failed to make the interest payment due on the Secured Senior Notes, Delayed Draw Term Notes and 2022
Bridge Notes (collectively the &#8220;debt&#8221;) resulting in an event of default with subsequent agreement to a forbearance
period through the earlier of the following: (a) April 30, 2024; <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%">(b)
the occurrence of the closing of the Business Combination and (c) the termination of the Business Combination prior</span> to closing (or the forbearance) (further details are provided for under the <i>heading Arena Loan Agreement </i> in Note
28).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">As of December 31, 2023,
the current maturities of the debt were $<span id="xdx_906_eus-gaap--ShortTermBorrowings_iI_pn3n3_c20231231_zLFHH9qcNzje" title="current maturities of debt">102,309</span>, with the principal balance due of $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20230101__20231231_z4bjzhK0PrZk" title="Principal balance">102,691</span>, subject to the forbearance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
for the years ended December 31, 2023 and 2022 with respect to interest expense related to long-term debt is provided below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interest
Expense</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_89B_ecustom--SummaryOfInterestExpenseTableTextBlock_zDVNRtWPBTKg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table represents interest expense:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zky9uH4bGeCi" style="display: none">Summary
of Interest Expense</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_zeCyTRvlvGO4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20220101__20221231_zAVowYRW2j12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Amortization of debt costs:</td><td>&#160;</td>
    <td style="text-align: right"></td>
    <td style="text-align: right"></td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: right"></td>
    <td style="text-align: right"></td><td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember_z3uCtcZZPluj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: justify">Line of credit</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">214</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">9</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zHBh3OAeO4f4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">2023 Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">244</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2148">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredNotesMember_ztQMvMlKGe5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Senior Secured Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">632</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,031</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zsTNebWWvqNd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Delayed Draw Term Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">464</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zfqQMFiR5dBe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">2022 Bridge Notes</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,216</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">77</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_zV2buGQgkoq5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total amortization of debt costs</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,378</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,581</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Noncash and accrued interest:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zYag8MI0MKOb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">2023 Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">173</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2163">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredNotesMember_zLmj52I0E0ic" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Senior Secured Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,602</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2166">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zKKNOX7J7Src" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Delayed Draw Term Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">102</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2169">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zA0NRFaiAE9h" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">2022 Bridge Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">920</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2172">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--LineOfCreditTerminationFeeMember_zlUzagbdPRMg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Line of credit termination fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2175">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--ParadeMember_zncKzyrvJ63a" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Parade</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2177">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">116</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--OtherAccruedInterestMember_zLp5ARGseRnl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Other accrued interest</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">127</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">204</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_z71CZWLWfwP8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total noncash and accrued interest</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,824</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">320</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--CashPaidInterestAbstract_iB_z9kBsiDehMz2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash paid interest:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember_zpx9gtOYVFSc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Line of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,328</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zUQMLl338i0f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">2023 Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2193">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredNotesMember_zr5e4IRGTU9l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Senior Secured Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,754</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,356</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zGOTGbNiJAoj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Delayed Draw Term Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">303</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">980</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zH2xXv4O9SRl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">2022 Bridge Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,763</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2202">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--OtherMember_zfd4GF6yJhOj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Other</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,214</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">863</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--InterestPaid_pn3n3_zEFpui48U3t8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total cash paid interest</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,527</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--InterestExpenseDebt_iN_pn3n3_di_zI2XsWYeUMK6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less interest income <sup id="xdx_F4F_zmG8jzJPWYke">(1)</sup></span></td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(338</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2211">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--InterestExpense_pn3n3_z9NYNIQG58B8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total interest expense</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">17,965</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,428</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0C_znEq8p3u86Ed" style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"></td><td id="xdx_F1B_zvNUkNYeBRtb" style="text-align: justify">During the year ended December 31, 2023, the Company recorded interest income of $<span id="xdx_904_eus-gaap--InterestExpenseDebt_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zb04DjNbtnCa">338</span> related
to the refunds received from the employee retention credits.</td>
</tr></table>



<p id="xdx_8AE_zDoQxTVhUU5l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncash
and accrued interest of $<span id="xdx_90E_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20221231__20221231__srt--TitleOfIndividualAxis__custom--BRileyMember_zlaNPA6JAR87" title="Paid in cash">204</span> as of December 31, 2022 related to the 2022 Bridge Notes, was paid in cash during the year ended December
31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656730055952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Preferred Stock</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--PreferredStockTextBlock_z3mUDii3kv3h" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>20.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82C_zPHkqxw12jxg">Preferred Stock</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has the authority to issue <span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zGhtKgwDGmyl" title="Preferred stock, shares authorized">1,000,000</span> shares of Preferred Stock, $<span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zRg31xm4A8p4" title="Preferred stock, par value">0.01</span> par value per share, consisting of authorized and/or outstanding
shares as of December 31, 2023 as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zosvyr74CWXj" title="Preferred stock, shares authorized">1,800</span>
    authorized shares designated as &#8220;Series G Convertible Preferred Stock&#8221; (as further described below), of which <span id="xdx_900_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zIEkzNELXHpk" title="Temporary equity, shares outstanding"><span id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zp9OsraaPQP6" title="Temporary equity, shares outstanding">168</span></span> shares
    are outstanding as of December 31, 2023 and 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zmQ44GoHucpl" title="Preferred stock, designated shares">23,000</span>
    authorized shares designated as &#8220;Series H Convertible Preferred Stock&#8221; (as further described below), of which <span id="xdx_908_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_dn_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zSwI4TfYaNSc" title="Shares outstanding">none</span> and
    <span id="xdx_907_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_ztHiKRyZuSFb" title="Shares outstanding">14,356</span> shares were outstanding as of December 31, 2023 and 2022, respectively.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
G Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 30, 2000, the Company sold <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20000530__20000530__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zY0xgPAO6DD7" title="Shares sold">1,800</span> shares of its Series G convertible Preferred Stock (the &#8220;Series G Preferred Stock&#8221;),
of which <span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_pid_c20000530__20000530__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zMtySjRsJxM" title="Conversion Of stock shares converted">1,631.504</span> were converted prior to November 2001 and <span id="xdx_90C_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20000530__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zybYhOgaG4Pl" title="Temporary equity shares outstanding">168.496</span> shares continue to be outstanding, at a stated value of $<span id="xdx_900_eus-gaap--PreferredStockLiquidationPreference_iI_pid_c20000530__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zyozSB9nBaJ3" title="Preferred stock liquidation preference">1,000</span> per
share, convertible into shares of the Company&#8217;s common stock, as adjusted for the stock split on February 8, 2022, and will be
further adjusted in the event of another stock splits, stock dividends, combinations of shares and similar transactions subject to stock
splits. The Series G Preferred Stock is convertible into shares of common stock, at the option of the holder, subject to certain limitations.
The Company may require holders to convert all (but not less than all) of the Series G Preferred Stock or buy out all outstanding shares
of Series G Preferred Stock at the liquidation value of $<span id="xdx_90A_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_pn3n3_c20231231__srt--TitleOfIndividualAxis__custom--OriginalInvestorMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zig4c3HzJV4" title="Preferred stock liquidation preference value">168</span>. Holders of Series G Preferred Stock are not entitled to dividends and have
no voting rights, unless required by law or with respect to certain matters relating to the Series G Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
a change in control, sale of or similar transaction, as defined in the Certificate of Designation for the Series G Preferred Stock, the
holder of the Series G Preferred Stock has the option to deem such transaction as a liquidation and may redeem their <span id="xdx_909_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__srt--TitleOfIndividualAxis__custom--OriginalInvestorMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zAAZpynwqfyi" title="Shares outstanding">168.496</span> shares at
the liquidation value of $<span id="xdx_906_eus-gaap--TemporaryEquityLiquidationPreferencePerShare_iI_pid_c20231231__srt--TitleOfIndividualAxis__custom--OriginalInvestorMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zIKMupV8n4Vf" title="Temporary equity, liquidation preference per share value">1,000</span> per share, or an aggregate amount of $<span id="xdx_900_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_pn3n3_c20231231__srt--TitleOfIndividualAxis__custom--OriginalInvestorMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zlg8nmYRcT2f" title="Preferred stock, liquidation aggregate amount">168</span>. The sale of all the assets of the Company on June 28, 2007
triggered the redemption option. As such redemption was not in the control of the Company, the Series G Preferred Stock has been accounted
for as if it is redeemable preferred stock and is classified on the consolidated balance sheets as a mezzanine obligation between liabilities
and stockholders&#8217; deficiency. The holder of the Series G Preferred Stock still has the ability to exercise the redemption option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
H Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the then outstanding shares of Series H convertible Preferred Stock (the &#8220;Series H Preferred Stock&#8221;) automatically converted
into shares of the Company&#8217;s common stock on the fifth anniversary date of the initial first closing of the Series H Preferred
Stock, or on August 10, 2023, at the conversion price of $<span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230810__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zvuXSbn0iDQ2" title="Conversion price">7.26</span> per share (the &#8220;automatic mandatory conversion&#8221;). Further
details are provided under the heading <i>Common Stock</i> in Note 21.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656850392784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Deficiency<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders&#8217; Deficiency</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z35WgF19zLz3" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>21.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span><span id="xdx_829_zX1ofr9feBa4">Stockholders&#8217; Deficiency</span></span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has the authority to issue <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zln4hIMbuXXe" title="Common stock authorized">1,000,000,000</span> shares of common stock, as the result of filing on December 18, 2020, a Certificate
of Amendment with the Secretary of the State of Delaware to increase the number of authorized shares of its common stock from <span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20201218_z1wOL00qXDp2" title="Common stock authorized">100,000,000</span>
shares to <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zOvaTyIrbM1b" title="Common stock, shares authorized">1,000,000,000</span> shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock Registered Direct Offering</i> &#8211; On March 31, 2023, the Company entered into common stock purchase agreements with certain
purchasers, pursuant to which the Company issued and sold in a registered direct offering an aggregate of <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20230330__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_zpsQQs9hZLM3" title="Sale of stock number of shares issued in transaction">2,963,918</span> shares of the Company&#8217;s
common stock, at a purchase price of $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_z2uLwox69Qp6" title="Sale of stock price per share">3.88</span> per share. The gross proceeds received were $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20230330__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_znd67qF6gIrc" title="Proceeds from issuance of offering">11,500</span> and after deducting offering expenses
of $<span id="xdx_904_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_c20230330__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_zKl2L8CaC2Oe" title="Payments of stock issuance costs">356</span>, the Company received net proceeds of $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn3n3_c20230330__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_zyWyE7iVLn2k" title="Net proceeds from common stock">11,144</span>, as reflected on the consolidated statements of stockholder&#8217;s deficiency.
No underwriter or placement agent participated in the registered direct offering. The net proceeds were intended for working capital
and other general corporate purposes. Further information is provided in Note 26.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock for Series H Preferred Stock</i> &#8211; During the years ended December 31, 2023 and 2022, the Company recorded the issuance of
<span id="xdx_907_eus-gaap--ConversionOfStockSharesIssued1_pid_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zYOi6gClbF23" title="Conversion of shares issued">1,981,128</span> (of which <span id="xdx_90E_eus-gaap--ConversionOfStockSharesIssued1_pid_c20230101__20231231_zl3qLq6ItiQ3" title="Conversion of shares issued">1,759,224</span> were issued in accordance with the automatic mandatory conversion) and <span id="xdx_90C_eus-gaap--ConversionOfStockSharesIssued1_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq8JyTuCpIok" title="Conversion of shares issued">97,980</span> shares of common stock, respectively,
upon conversion of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zZzdd0KAVeia" title="Conversion of shares">14,356</span> (of which <span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_pid_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zf23UXfQZZ97" title="Conversion of shares converted">12,748</span> were issued were issued in accordance with the automatic mandatory conversion) and <span id="xdx_90A_eus-gaap--ConversionOfStockSharesConverted1_pid_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_znbsy6v4U2D5" title="Conversion of shares converted">710</span> shares
of Series H Preferred Stock, respectively, with a corresponding amount of $<span id="xdx_906_eus-gaap--ConversionOfStockAmountConverted1_pn3n3_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z11jM5ipSV2g" title="Conversion of stock amount">13,008</span> (representing <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z8pNLJqWmjqd" title="Conversion of shares">14,356</span> shares of Series H Preferred Stock
at $<span id="xdx_90F_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z41Wk5RczIxc" title="Preferred stock stated par value">1,000</span> stated par value per share, less issuance cost of $<span id="xdx_90F_eus-gaap--ConversionOfStockAmountConverted1_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqMtH0EwwMUk" title="Conversion of stock amount">1,348</span>) and $<span id="xdx_90A_eus-gaap--ConversionOfStockAmountConverted1_pn3n3_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zb6ffPYdgMZ1" title="Conversion of stock amount">710</span> (representing <span id="xdx_900_eus-gaap--ConversionOfStockSharesConverted1_pid_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zPBPNpARpTAi" title="Conversion of shares converted">710</span> shares of Series H Preferred Stock at
$<span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z5oHjoV8SS38" title="Preferred stock stated par value">1,000</span> stated par value per share), respectively, as reflected on the consolidated statements of stockholders&#8217; deficiency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock for Acquisitions</i> &#8211; During the years ended December 31, 2023 and 2022, the Company recorded the issuance of <span id="xdx_90E_ecustom--StockIssuedDuringPeriodSharesAcquisition_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgnakdszlnXc" title="Common stock shares issuance fo acquisitions">274,692</span> and
<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDVV76cCHWCd" title="Common stock shares issuance fo acquisitions">330,863</span> shares of the Company&#8217;s common stock, respectively, as reflected on the consolidated statements of stockholders&#8217;
deficiency as follows: (i) <span id="xdx_90F_ecustom--BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares_pid_c20230110__20230111__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosAcquisitionMember_zuo4bhTp7Dw3" title="Issuance of common stock">274,692</span> shares issued pursuant to the Fexy Studios asset acquisition on January 11, 2023, with a fair value
of $<span id="xdx_902_eus-gaap--BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_pn3n3_c20230110__20230111__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosAcquisitionMember_zEhrULxF2B79" title="Fair value of acquisition">2,000</span> on the transaction closing date, as further described in Note 4; and (ii) <span id="xdx_90D_eus-gaap--SharesIssued_iI_pid_c20231101__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zvtFKryjx3A4" title="Shares issued">330,863</span> shares issued consisted of (a) <span id="xdx_906_ecustom--BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares_pid_c20220328__20220402__us-gaap--BusinessAcquisitionAxis__custom--ParadeStockMember_zLd796zCQ6N6" title="Issuance of common stock">314,103</span> shares
issued pursuant to the Parade stock acquisition on April 1, 2022, with a fair market value of $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_pn3n3_c20220328__20220402__us-gaap--BusinessAcquisitionAxis__custom--ParadeStockMember_zfgI8N1Kw3ml" title="Fair value of acquisition">3,141</span>, as further described in Note 4;
and (b) <span id="xdx_901_eus-gaap--SharesIssued_iI_pid_c20220309__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zVBeHIkxrnA9" title="Shares issued">16,760</span> shares issued on March 9, 2022, pursuant to an asset acquisition entered into March 9, 2020 with no fair value recognized
at the time of issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock for Liquidated Damages</i> &#8211; During the years ended December 31, 2023 and 2022, the Company entered into several stock purchase
agreements with an investor where it was liable for liquidated damages, pursuant to which the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zdUdQ1rKCgNl" title="Stock issued during period shares new issues">47,252</span> and <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_z0GPIG3rik1h" title="Number of shares issued">505,655</span>, respectively,
shares of its common stock, as follows: <span id="xdx_90F_eus-gaap--LossContingencyDamagesSought_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_ziHB0OAqsXld" title="Loss contingency damages sought">(i) <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zGSuS9BiyTIg" title="Stock issued during period shares new issues">47,252</span> shares of common stock were issued to the investor in lieu of an aggregate of $<span id="xdx_90C_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zQyoedeEJMW8" title="Loss contingency damages sought value">499</span>
owed in liquidated damages as of the conversion date ($494 as of December 31, 2022 plus $5 in additional interest through the conversion
date), where the Company recorded $369 in connection with the issuance of shares of the Company&#8217;s common stock and a gain of $130
on the settlement of the liquidated damages, both as reflected in additional paid-in capital, totaling $499;</span> and (ii) <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zMuGabh2hlWl" title="Stock issued during period shares new issues">505,655</span> shares
of common stock were issued at a price equal to $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zyRQh8fFmoA8" title="Shares issued price per share">13.86</span> per share (determined based on the volume-weighted average price of the Company&#8217;s
common stock at the close of trading on the sixty (60) previous trading days), to the investors in lieu of an aggregate of $<span id="xdx_904_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zfy7gH7QE3h6" title="Loss contingency damages sought value">7,008</span> owed
in liquidated damages, where the Company recorded $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zsx5joUi6ek1" title="Number of share issued value">6,685</span> in connection with the issuance of shares of the Company&#8217;s common stock
and recognized a gain of $<span id="xdx_909_ecustom--AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zrYy7GE4iU1d" title="Liquidated damages">323</span> on the settlement of the liquidated damages, both of which were recorded as additional paid-in capital
on the consolidated statements of stockholders&#8217; deficiency. In connection with the <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zULnLdSG3r0h" title="Stock issued during period shares new issues">505,655</span> shares of common stock issued, the Company
filed a registration statement covering the resale of those shares of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
Stock Units</i> &#8211; The Company issued, in connection with the vesting of restricted stock units, <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zE6WuCMlLyL" title="Vesting of restricted stock units">429,528</span> shares of the Company&#8217;s
common stock and <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zoymioKrOZlh" title="Vesting of restricted stock units">832,233</span> shares of the Company&#8217;s common stock (as described in Note 22) during the years ended December 31, 2023
and 2022, respectively, as reflected on the consolidated statements of stockholders&#8217; equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock Withheld</i> &#8211; The Company recorded the repurchase of vested restricted common stock of <span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--RestrictedCommonStockMember_z3ggkQQuYtg" title="Repurchase of restricted common stock">202,382</span> shares for the payment for
taxes of $<span id="xdx_900_eus-gaap--PaymentsRelatedToTaxWithholdingForShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--RestrictedCommonStockMember_zZ0jpYiH6EH8" title="Payment of taxes">1,423</span>, and <span id="xdx_901_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--RestrictedCommonStockMember_zCmGCbrE4ork" title="Repurchase of restricted common stock">373,394</span> shares for the payment for taxes of $<span id="xdx_907_eus-gaap--PaymentsRelatedToTaxWithholdingForShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--RestrictedCommonStockMember_znLyfhUuMdhi" title="Payment of taxes">4,468</span>, during the years ended December 31, 2023 and 2022, respectively,
as reflected on the consolidated statements of stockholders&#8217; deficiency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise
of Stock Options</i> &#8211; The Company recorded the exercise of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--ExerciseOfStockOptionMember_znK3TD0xTVj8" title="Exercise of stock options, shares">795</span> and <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--ExerciseOfStockOptionMember_z2eTo8oRBQeb" title="Exercise of stock options, shares">96,408</span> common stock options for shares of the Company&#8217;s
common stock for cash of $<span id="xdx_902_ecustom--StockIssuedDuringPeriodValueForCash_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--ExerciseOfStockOptionMember_zMwmUQWepjHi" title="Exercise of stock options">0</span> and $<span id="xdx_90D_ecustom--StockIssuedDuringPeriodValueForCash_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--ExerciseOfStockOptionMember_zsaRLsxQLKKc" title="Exercise of stock options">95</span>, during the years ended December 31, 2023 and 2022, respectively, as reflected on the consolidated
statements of stockholders&#8217; deficiency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock to be Issued <b>&#8211; </b></i>In connection with the Say Media merger on December 12, 2018, the Company issued <span id="xdx_90C_ecustom--StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRUHxDyEEtz7" title="Common stock to be issued">38,582</span> and <span id="xdx_905_ecustom--StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKanTW5gPZe2" title="Common stock to be issued">7,851</span>
shares of the Company&#8217;s common stock during the year ended December 31, 2023 and 2022, respectively, which were required to be issued
as of January 1, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
Services</i> &#8211; During the year ended December 31, 2022, the Company issued, in connection with entering into several professional
services agreements, <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220120__20220121__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zbcis00NAI4f" title="Stock issued for professional services">14,617</span> shares of the Company&#8217;s common stock (<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220111__20220112__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zydJiS3DrYya" title="Stock issued for professional services">14,617</span> shares consisted of <span id="xdx_90A_eus-gaap--SharesIssued_iI_pid_c20220112__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zNAcVYlBe3Nb" title="Stock issued for professional services">1,134</span> shares issued on January 12,
2022 at $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20220112__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zyoFLCMqRCa6" title="Trading price, per share">13.20</span> and <span id="xdx_90F_eus-gaap--SharesIssued_iI_pid_c20220126__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zDJ0OkLznDBl" title="Stock issued for professional services">13,483</span> shares issued on January 26, 2022 at $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20220126__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zkoDoMaXPcE9" title="Trading price, per share">12.54</span>) that were recorded at the trading price on the issuance date of
$<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zd2X0hoRFxx4" title="Trading price, per share">184</span>, as reflected on the consolidated statements of stockholders&#8217; deficiency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock Public Offering</i> &#8211; On February 15, 2022 and March 11, 2022, the Company raised gross proceeds of $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20220311__20220311__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zDVf3WMCYJh3" title="Gross proceed from offerings"><span id="xdx_906_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20220215__20220215__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zVvCYFYmPEKf" title="Gross proceed from offerings">34,498</span></span> pursuant to a
firm commitment underwritten public offering of <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20220311__20220311__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zCoCinSO9LV1" title="Number of common shares sold"><span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20220215__20220215__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zg079kzNRsbk" title="Number of common shares sold">4,181,603</span></span> shares of the Company&#8217;s common stock (on February 15, 2022 the Company
issued <span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20220215__20220215__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingOverallotmentMember_zcoL6IMu7JB" title="Number of common shares sold">3,636,364</span> shares and on March 11, 2022 the Company issued <span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20220311__20220311__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingOverallotmentMember_zlej33QPmm7d" title="Number of common shares sold">545,239</span> shares pursuant to the underwriter&#8217;s overallotment that
was exercised on March 10, 2022), at a public offering price of $<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20220310_zQHAqKej2gBb" title="Stock price">8.25</span> per share. The Company received net proceeds of $<span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20230101__20231231_zZuUPenhoMq3" title="Net proceed from offerings">32,058</span>, after
deducting underwriting discounts and commissions and other offering costs payable by the Company of $<span id="xdx_907_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--BRileyMember_zdMnLGMFtd7c" title="Offering costs">2,440</span> to B. Riley (see Note 26).
In addition, the Company directly incurred offering costs of $<span id="xdx_900_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zrMhq89D7obk" title="Offering costs">1,568</span> and recorded $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn3n3_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zH4i03weUSS9" title="Proceeds from issuance of common stock">30,490</span> upon the issuance of its common stock, as reflected
on the consolidated statements of stockholders&#8217; deficiency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted
Stock Awards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise stated, the fair value of a restricted stock award is determined based on the number of shares granted and the quoted price
of the Company&#8217;s common stock on the date issued. The estimated fair value of these shares is being recognized as compensation
expense over the vesting period of the award (see Note 22).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zCiZ4l6nK3Q8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the restricted stock award activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zVV9BCcrulei" style="display: none">Summary of Restricted Stock Award Activity</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of <br/>
Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
                                            Average <br/>
                                            Grant-Date</b></span></p>
                                                                  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    stock awards outstanding at January 1, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zNmNgl4Ptij7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of Shares, Restricted Stock Awards Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,403</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zpakTQuXhBg1" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted Average Grant-Fair Value Date, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.94</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQoE7Sbc3j99" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares,  Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(97,403</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zkrHmNS326Ie" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Fair Value Date, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16.94</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    stock awards outstanding at December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zCipvKPr5vTj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Restricted stock awards outstanding, Unvested at Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2408">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_8A4_zbKyH6P0Vxj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to stock-based compensation cost and unrecognized stock-based compensation cost related to the restricted stock awards is
provided under the heading <i>Stock-Based Compensation</i> in Note 22.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock to be Issued</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with a closing of a private placement on January 4, 2018, MDB, as the placement agent, was entitled to receive <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20180103__20180104__dei--LegalEntityAxis__custom--MDBCapitalGroupLLCMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zkWcbDGPFQN2" title="Number of common shares sold">2,701</span> shares
of the Company&#8217;s common stock (<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">subject to liquidated
damages, see Note 15), which</span> have not been issued as of December 31, 2023, as reflected on the consolidated statements of
stockholders&#8217; deficiency as common stock to be issued (see Note 15).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Warrants
were issued to purchase shares of the Company&#8217;s common stock in connection with various financings (the &#8220;Financing Warrants&#8221;), all of which have expired.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z0ULsOccHYhj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the Financing Warrants activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BF_zUdfua79NEC7" style="display: none">Summary of Warrant Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Life</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in Years)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify">Financing Warrants outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zaOyrerdlMWi" style="width: 12%; text-align: right" title="Number of Shares, outstanding, at beginning of year">107,956</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zJjhjE20OUG5" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, outstanding, at beginning of year">10.61</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zGcSY18wELGc" title="Weighted Average Remaining Contractual Life, Outstanding at beginning of year">0.58</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zbYMGmEGCjql" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Expired">(107,956</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zZIKYHxtdEjj" style="text-align: right" title="Weighted Average Exercise Price, Expired">10.61</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Financing Warrants outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zZs6o4s8Szg9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, outstanding at end of year"><span style="-sec-ix-hidden: xdx2ixbrl2424">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zU2fcnw5J3E4" style="text-align: right" title="Weighted Average Exercise Price, outstanding, at end of year"><span style="-sec-ix-hidden: xdx2ixbrl2426">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A1_zAVzRdzdPUS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>AllHipHop
Warrants</i> &#8211; On October 26, 2020, the Company granted AllHipHop, LLC an aggregate of <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20201026__us-gaap--StatementEquityComponentsAxis__custom--AllHipHopWarrantsMember_zJR8rRUHfsij" title="Exeercise price">5,682</span> warrants for shares of the Company&#8217;s
common stock with an exercise price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201026__us-gaap--StatementEquityComponentsAxis__custom--AllHipHopWarrantsMember_zWL6VHm6rIVg" title="Exercise price">14.30</span> (the &#8220;AllHipHop Warrants&#8221;). The AllHipHop Warrants are exercisable for a period
of five years, subject to customary anti-dilution adjustments, and may be exercised on a cashless basis. The AllHipHop Warrants were
in exchange for the surrender and termination of <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20201026__us-gaap--StatementEquityComponentsAxis__custom--PublisherPartnerWarrantsMember_zoy0etW5Z4Ag" title="Exeercise price">6,819</span> previously issued Publisher Partner Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ABG
Warrants</i> &#8211; On June 14, 2019, the Company issued <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20190614__us-gaap--StatementEquityComponentsAxis__custom--ABGWarrantsMember_zfQjNQ9hgAG4" title="Warrants issued">999,540</span> warrants to acquire the Company&#8217;s common stock to ABG (the &#8220;ABG
Warrants&#8221;) in connection with the Licensing Agreement, expiring in <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dt_c20190614__us-gaap--StatementEquityComponentsAxis__custom--ABGWarrantsMember_zsl6OLvWHBMl" title="Expiration date">ten years</span>. The warrants provided time-based vesting in equal
monthly increments over a period of two years beginning on the one year anniversary of the date of issuance of the warrants (the &#8220;Time-Based
Warrants&#8221;) and performance based vesting based on the achievement of certain performance goals for the licensed brands in calendar
years 2020, 2021, 2022, or 2023 (the &#8220;Performance-Based Warrants&#8221;). The warrants also provide that <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20190613__20190614__us-gaap--StatementEquityComponentsAxis__custom--ABGWarransMember_zrJ50wbDFPlj" title="Warrant or right, reason for issuance, description">(1) under certain circumstances
the Company may require ABG to exercise all (and not less than all) of the warrants, in which case all of the warrants will be vested;
(2) all of the warrants automatically vest upon certain terminations of the Licensing Agreement by ABG or upon a change of control of
the Company; and (3) ABG has the right to participate, on a pro-rata basis (including vested and unvested warrants, exercised or unexercised),
in any future equity issuance of the Company (subject to customary exceptions).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As
of December 31, 2023, <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--ABGTimeBasedWarrantsMember_zRBrE5cRHKL8" title="Number of warrant shares">399,816</span> Time-Based Warrants vested and <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--ABGPerformanceBasedWarrantsMember_z3LZRRyUkxX" title="Exercise price">599,724</span> Performance-Based Warrants vested as of the issuance date
of these consolidated financial statements were issued (further details are provided under the heading <i>ABG Warrants</i> in Note 28 as to the full vesting of the ABG Warrants in January 2024).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to stock-based compensation cost and unrecognized stock-based compensation cost related to the ABG Warrants is provided
in Note 22.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Publisher
Partner Warrants</i> &#8211; On May 20, 2020, the Board approved a third publisher partner warrant program, which superseded the second
publisher partner warrant program and authorized the Company to grant publisher partner warrants to purchase up to <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20200520__us-gaap--StatementEquityComponentsAxis__custom--PublisherPartnerWarrantsMember_zqHJZHmBLYsj" title="Number of warrant shares">90,910</span> shares of the
Company&#8217;s common stock (the &#8220;Publisher Partner Warrants&#8221;). The issuance of the Publisher Partner Warrants is administered
by management and approved by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>New
Publisher Partner Warrants</i> &#8211; On November 2, 2022, the Board approved a warrant incentive program to grant warrants to certain
publishers (the &#8220;New Publisher Partner Warrants&#8221;), that authorized the Company to grant New Publisher Partner Warrants to
purchase up to <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20221102__us-gaap--StatementEquityComponentsAxis__custom--NewPublisherPartnerWarrantsMember_zSuIlsiLiOdd" title="Number of warrant shares">33,000</span> shares of the Company&#8217;s common stock. The New Publisher Partner Warrants will have the following terms: (i)
one-third will become exercisable and vest on the one-year anniversary of the issuance; (ii) the remaining warrants will become exercisable
and vest in a series of twenty-four (24) successive equal monthly installments following the first anniversary of the issuance; and (iii)
a five-year term. The issuance of the New Publisher Partner Warrants is administered by management and approved by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to stock-based compensation cost and unrecognized stock-based compensation cost related to the New Publisher Partner Warrants
is provided in Note 22.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656729973680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock&#8211;Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock&#8211;Based Compensation</a></td>
<td class="text"><p id="xdx_804_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zhw8Z4lehdud" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>22.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span><span id="xdx_82D_zCXtdm1zesO9">Stock&#8211;Based Compensation</span></span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued stock-based compensation awards under several plans as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2016
                                            Plan</i> &#8211; On December 19, 2016, the Board adopted the 2016 Stock Incentive Plan (the
                                            &#8220;2016 Plan&#8221;) that allowed the Company to grant restricted stock awards and statutory
                                            and non-statutory common stock options to acquire shares of the Company&#8217;s common stock
                                            to employees, directors and consultants, with vesting variable vesting provisions consisting
                                            of time-based and performance-based. The Company is no longer issuing awards under the 2016
                                            Plan.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2019
                                            Plan</i> &#8211; On April 4, 2019, the Board adopted the 2019 Equity Incentive Plan (the
                                            &#8220;2019 Plan&#8221;) that allowed awards of stock options, restricted stock awards, restricted
                                            stock units, unrestricted stock awards, and stock appreciation rights, with variable vesting
                                            provisions consisting of time-based, performance-based, or market-based. The Company is no
                                            longer issuing option awards under the 2019 Plan.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Outside
                                            Options</i> &#8211; The Company granted stock options outside the 2016 Plan and 2019 Plan
                                            (the &#8220;Outside Options&#8221;) that allowed the Company to grant statutory and non-statutory
                                            common stock options, with variable vesting provisions consisting time-based, performance-based
                                            targets and certain performance achievements. The Company is no longer issuing Outside Options.</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>



<p style="margin: 0"></p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2022
                                            Plan</i> &#8211; On April 18, 2022, the Board adopted the 2022 Stock and Equity Compensation
                                            Plan (the &#8220;2022 Plan&#8221;) that was approved by the Company&#8217;s stockholders
                                            on June 2, 2022 with a maximum number of shares authorized to be issued under the plan of
                                            <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20220602__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zR6Y0nnNjH35" title="Number of shares authorized to issue">1,800,000</span>. The purpose of the 2022 Plan is to foster the growth and success of the Company
                                            by providing a means to attract, motivate and retain officers, directors, key employees,
                                            and consultants through awards of stock options, stock appreciation rights, restricted stock
                                            awards, unrestricted stock awards and restricted stock units. Shares subject to an award
                                            that have been canceled, expired, settled in cash, or not issued or forfeited for any reason
                                            will not reduce the aggregate number of shares that may be subject to or delivered under
                                            the 2022 Plan and will be available for future awards granted under the 2022 Plan. Common
                                            stock options issued under the 2022 Plan may have a term of up to ten years and may have
                                            variable vesting provisions based on time and performance. The issuance of awards under the
                                            2022 Plan is administered by the Board or any committee of directors designated by the Board.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted
Stock Units</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2023 and 2022, the Company issued restricted stock units to various employees and members of the board subject
to continued service. Upon vesting of the award, subject to certain conditions for release of the award, the Company issues the underlying
common stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of a restricted stock unit was determined based on the number of shares granted and the quoted price of the Company&#8217;s
common stock on the date issued during the years ended December 31, 2023, and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89F_ecustom--ScheduleOfRestrictedStockUnitsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zGuBZFrp1rZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the restricted stock unit activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span id="xdx_8BB_zIHR8WiR6UKk" style="display: none">Schedule of Restricted Stock Units Activity</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of Shares</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Weighted<br/>
 Average<br/>
 Grant-Date</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Unvested</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Vested</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"> Fair Value</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Restricted stock units outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zrFTbYnzKOga" style="width: 12%; text-align: right" title="Number of Shares, Unvested, outstanding, at beginning of year">994,766</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_z22DVdAYusBb" style="width: 12%; text-align: right" title="Number of Shares, Vested, outstanding, at beginning of year">397,376</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zQg3Vc1Fe4bc" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, outstanding, at beginning of year">15.44</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zaj3ujE8Nqw8" style="text-align: right" title="Number of Shares, Unvested granted">148,970</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zGY5Y5ndefia" style="text-align: right" title="Weighted Average Exercise Price,Granted">5.77</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zqJM1VHKCyx2" style="text-align: right" title="Number of Shares, Unvested, Vested">(645,023</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zuOov30y7j7e" style="text-align: right" title="Number of Shares, Vested">645,023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Released</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased_iNS_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zzaTB17oOD1f" style="text-align: right" title="Number of Shares, Vested, Released">(429,528</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Cancelled</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zFDvmEEZBKe7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Unvested, Cancelled">(299,446</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Restricted stock units outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_ziKU1b60cNCi" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Unvested, outstanding at end of year">199,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zHFYcTzEM0n" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Vested, outstanding, at end of year">612,871</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20231231_zJ8I064rZMEl" style="text-align: right" title="Weighted Average Exercise Price, outstanding, at end of year">13.55</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_8A5_zRnKkIYL4Tmj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 28, 2023 and June 30, 2023, the Company modified certain restricted stock units as a result of the resignation of two senior
executives, where <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230227__20230228_zpyxXalA0mCb" title="Number of Shares, Granted">38,026</span> and <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230629__20230630_zDJkmmLH3mKe" title="Number of Shares, Granted">42,635</span> restricted stock units with time-based vesting that were unvested were vested, respectively, subject
to certain provisions, resulting in no incremental cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 22, 2022, the Company modified <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20221120__20221122_zZawFToWBvT8" title="Number of Shares, Granted">232,816</span> restricted stock units that were issued to one former employee (Ross Levinsohn) to remove
the market trading volume condition, resulting in incremental cost of $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_pn3n3_c20221120__20221122_zrcp0Z2Dmkbe" title="Incremental cost">321</span> at the modification date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s policy is to repurchase the number of shares of its common stock at the fair market value at the time of issuance of
new shares of its common stock upon conversion of a restricted stock unit to cover the tax obligations. During the year ending December
31, 2024, the Company expects to repurchase approximately <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zz2qlVCwELda" title="Conversion of restricted stock units">295,000</span> shares of its common stock upon conversion of restricted stock units
that are expected to vest and be released during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total intrinsic value of shares of the Company&#8217;s common stock issued for restricted stock units that were released during the years
ended December 31, 2023 and 2022 were $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zVAGeNe2iFJi" title="Common stock issued for restricted stock units">2,955</span> and $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z2CgUYCaAy9c" title="Common stock issued for restricted stock units">8,707</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to stock-based compensation cost related to the restricted stock units is included within the Restricted Stock caption under
the heading <i>Stock-Based Compensation</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock Options</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2023 and 2022, the Company issued common stock options under the 2022 Plan, consisting of primarily of incentive
stock options with a term of up to ten years with time-based vesting provisions over three years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of common stock option awards granted during the years ended December 31, 2023 and 2022 was calculated using a Black-Scholes
options-pricing model for the time-based awards under the Up-list Scenario, after the Company&#8217;s common stock was listed on the
NYSE American. The fair value of common stock option awards granted during the year ended December 31, 2022 was calculated using the
Black-Scholes option-pricing model for the time-based under the Probability Weighted Scenarios, prior to the Company&#8217;s common stock
being listed on the NYSE American. The assumptions utilized are as follows:</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--AwardTypeAxis__custom--CommonEquityAwardsMember_zruV6hVDiU3a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_zat2CAmRKCAe" style="display: none">Schedule of Fair Value of Stock Options Assumptions</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Up-list</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Up-list</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">No Up-list</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zCj3B41l2gfl" title="Risk-free interest rate, minimum">3.46</span>% - <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zrMKGLP8Xsd5" title="Risk-free interest rate, maximum">4.82</span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zRiwnCvK9OZ8" title="Risk-free interest rate, minimum">0.97</span>% - <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zTqp9zaL2xW" title="Risk-free interest rate, maximum">4.36</span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_ziL8E5Pl3Wxd" title="Risk-free interest rate, minimum">0.97</span>% - <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_z0ASPaVHQ5G3" title="Risk-free interest rate, maximum">1.44</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left">Expected dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z9ylUE08FYIa" style="width: 14%; text-align: right" title="Expected dividend yield">0.00</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z8CJWlg43aUc" style="width: 14%; text-align: right" title="Expected dividend yield">0.00</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_zcG9GjR1dJ1g" style="width: 14%; text-align: right" title="Expected dividend yield">0.00</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zCCvMSb8Rqmj" title="Expected volatility, minimum">46.43</span>% - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zEDWfeYi1oRg" title="Expected volatility, maximum">47.27</span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zmNf6DQKDVA7" title="Expected volatility, minimum">42.00</span>% - <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z7FebLjn403h" title="Expected volatility, maximum">82.00</span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_zVBOkOksxVDb" title="Expected volatility, minimum">82.00</span>% - <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_z8i5zmjNevi7" title="Expected volatility, maximum">137.00</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z5vbyqVED6q" title="Expected life">6</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember__srt--RangeAxis__srt--MinimumMember_z1xhfG7PfEfd" title="Expected life">3.0</span> &#8211; <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember__srt--RangeAxis__srt--MaximumMember_zjcp9qiN2bz9" title="Expected life">6.0</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember__srt--RangeAxis__srt--MinimumMember_zA6mEhz5mcki" title="Expected life">3.0</span> &#8211; <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember__srt--RangeAxis__srt--MaximumMember_zYyKMk3xpJ85" title="Expected life">6.0</span> years</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_z7GBRL7pFh3f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--CommonEquityAwardsMember_zb4madCHi1g8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the common stock option activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zQFCpcZeQdZ" style="display: none">Summary of Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Life</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in Years)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify">Common stock options outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zRzWUNDrYcgj" style="width: 12%; text-align: right" title="Number of Shares Common stock options, outstanding at Beginning balance">6,199,521</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zgkUt0bimyBg" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, outstanding at Beginning balance">15.26</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zq4o4r2EGbCb" title="Weighted Average Remaining Contractual Life (in Years), outstanding at Beginning balance">8.20</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zx1VcSd4ruT5" style="text-align: right" title="Number of Shares, Granted">287,993</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zKL9zbaQ7nuj" style="text-align: right" title="Weighted Average Exercise Price, Granted">4.22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zcRP5JHduar1" style="text-align: right" title="Number of Shares, Exercised">(6,927</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zDKEqdFQ8Pm6" style="text-align: right" title="Weighted Average Exercise Price, Exercised">8.82</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zdTsjUIDAtq" style="text-align: right" title="Number of Shares, Forfeited">(449,333</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zxXJj1flaRj7" style="text-align: right" title="Weighted Average Exercise Price, Forfeited">9.70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pid_di_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zr2BNgAs937f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Expired">(579,286</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zU8ZFRa4Ryie" style="text-align: right" title="Weighted Average Exercise Price, Expired">9.38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Common stock options outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zgYeuo0oOi5c" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares Common stock options, outstanding at Ending balance">5,451,968</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zzUZXLPvCyyg" style="text-align: right" title="Weighted Average Exercise Price, outstanding at Ending balance">9.56</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zwHIAIuMyNh7" title="Weighted Average Remaining Contractual Life (in Years), outstanding at Beginning balance">4.43</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Common stock options exercisable at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zdi9CFLomXwh" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares Common stock options, exercisable at Ending balance">4,049,393</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z3Y4yhhdaT64" style="text-align: right" title="Weighted Average Exercise Price, exercisable at Ending balance">9.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z9TfaB3o0pkk" title="Weighted Average Remaining Contractual Life (in Years), exercisable at Ending balance">5.06</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Common stock options not vested at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zEYc8CtZ4ave" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares Common stock options, not vested at Ending balance">1,402,575</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Common stock options available for future grants at December 31, 2023 (1)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_fKDEp_zEG4P5zCTLNf" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares Common stock options, available for future grants at Ending balance">542,847</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F04_zrM5Mcwlca8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span id="xdx_F1A_z6kmn735Og68" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock available
for future issuance under the 2022 Plan represent <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zz0cVnn4Bci8" title="Number of shares authorized to issue">1,800,000</span> of authorized shares; less <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zbkmhNt13S1c" title="Number of shares common stock options, outstanding">1,066,597</span> common stock options outstanding and
<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzOJA6aChy6g" title="Number of shares common stock options, outstanding">190,556</span> restricted stock units outstanding.</span></td>
</tr></table>

<p id="xdx_8AF_zqAfSb9Yy35g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate grant date fair value of common stock options granted during the years ended December 31, 2023 and 2022 was $<span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_pn3n3_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zstBiXwIEsa7" title="Aggregate grant date fair value">610</span> and $<span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_pn3n3_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zsTZLPyU2sp6" title="Aggregate grant date fair value">7,194</span>,
respectively. The weighted-average grant-date fair value of common stock options granted during the years ended December 31, 2023 and
2022 were $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zXfmHqpL6byi" title="Weighted-average grant-date fair value">2.12</span> and $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_znNNc3xZGPda" title="Weighted-average grant-date fair value">5.25</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total intrinsic value of common stock options exercised during the years ended December 31, 2023 and 2022 were $<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pn3n3_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zYiTLMVP0Ujh" title="Common stock options vested">10</span> and $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pn3n3_c20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zSdUx6TDNbJb" title="Common stock options vested">1,507</span>, respectively.
The total fair value of common stock options vested during the years ended December 31, 2023 and 2022 were $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_pn3n3_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zYEOLj5qqCj" title="Common stock options vested">10,155</span> and $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_pn3n3_c20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z7tRRnmSZKDl" title="Common stock options vested">12,694</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unvested common stock options for which the vesting is expected based on achievement of a performance condition as of December 31, 2023
were <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20230101__20231231_z6lOn1KHdx92">583,143</span> with a weighted average remaining contractual term of <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zb0eoVKFX778" title="Weighted average remaining contractual term">5.28</span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s policy is to repurchase the number of shares of its common stock at the fair market value at the time of issuance of
its common stock upon exercise of common stock options to cover the tax obligations and any cashless exercise. In addition, the Company&#8217;s
policy is to issue new shares of its common stock upon exercise of common stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pn3n3_do_c20231231_zgpKiCetfCm4" title="Intrinsic value of stock option">no</span> intrinsic value of exercisable but unexercised in-the-money common stock option awards as of December 31, 2023 based on a fair
market value of the Company&#8217;s common stock of $<span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20231231_zV9lv5OuiQ3l" title="Share price">2.38</span> per share on December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_hus-gaap--AwardTypeAxis__custom--CommonStockAwardsMember_zJz3KNt0Xhbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise prices under the common stock options outstanding and exercisable are as follows as of December 31, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zcMgSiYQCtbc" style="display: none">Schedule of Exercise Prices of Common Stock Options</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Outstanding</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Vested</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">$</td><td style="width: 30%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z50C95osBHK3" title="Exercise price">2.48</span> to $<span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_ztJWvaRdXPv9" title="Exercise price upper range">10.50</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z5b9S5kSuBhe" style="width: 30%; text-align: right" title="Number of Shares, Outstanding">4,318,901</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zHdvtffEfP85" style="width: 30%; text-align: right" title="Number of Shares, Vested">3,308,790</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zpYczAq7Kiy7" title="Exercise price">10.51</span> to $<span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zbHV55BXbYFl" title="Exercise price">15.52</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zQZiDOZv3Mz" style="text-align: right" title="Number of Shares, Outstanding">1,062,379</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zfyfeAz1xzfl" style="text-align: right" title="Number of Shares, Vested">670,956</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zsNlWqFs4FUa">15.53</span> to $<span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zVUNs0wKDLqh" title="Exercise price">20.54</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zhYcjlp21bDd" style="text-align: right" title="Number of Shares, Outstanding">9,091</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zJSsI8WWigoi" style="text-align: right" title="Number of Shares, Vested">9,091</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zLdUQpQ3VgH2" title="Exercise price">20.55</span> to $<span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zSGZ3rihBIha" title="Exercise price">25.56</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zVftdPZkIC0g" style="text-align: right" title="Number of Shares, Outstanding">25,683</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zbwDFxcG4ZE5" style="text-align: right" title="Number of Shares, Vested">24,642</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zb6SBS9cAY9l" title="Exercise price">25.57</span> to $<span id="xdx_904_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_ziWt5byD4axk" title="Exercise price">30.58</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zXqFcRVHLpEd" style="text-align: right" title="Number of Shares, Outstanding">910</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_z6nzf57X6me9" style="text-align: right" title="Number of Shares, Vested">910</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z1Hko8NG4tAk" title="Exercise price">30.59</span> to $<span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z9NRzZF1ocEc" title="Exercise price">35.60</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zbdhVFh44NUe" style="text-align: right" title="Number of Shares, Outstanding">4,320</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zOQC17slKSlf" style="text-align: right" title="Number of Shares, Vested">4,320</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_ziFaBhOV5pI9" title="Exercise price">35.61</span> to $<span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zk7x5rdyPcrg" title="Exercise price">40.62</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_z6QC6tOpZkx9" style="text-align: right" title="Number of Shares, Outstanding">2,728</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_z9UpFiDuxfde" style="text-align: right" title="Number of Shares, Vested">2,728</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zeoRnjPZFH89" title="Exercise price">40.63</span> to $<span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zfCESoZlc248" title="Exercise price">48.40</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zsYPY0Ab4wPe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Outstanding">27,956</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zkNlqkOYJl1f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Vested">27,956</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_ztdxMZPyshXj" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Outstanding">5,451,968</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z0JBAg8wcuCb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Vested">4,049,393</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A5_zCHH1ENW3W82" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Modification
of Awards </i>&#8211; On February 28, 2023, the Company modified certain equity awards as a result of the resignation of a senior executive
employee where <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20230228__20230228__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7jQDWrloFHc" title="Share based compensation, vesting, number">38,026</span> restricted stock units with time-based vesting that were unvested were vested and <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20230228__20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zVW07Kv2xs59" title="Share based compensation, vesting, number">21,117</span> options to purchase shares
of the Company&#8217;s common stock with time-based vesting that were unvested were vested, each subject to compliance with applicable
securities laws and certain other provisions. In connection with the modification of these equity awards, the Company agreed to purchase
a total of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20230228__20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_z4MWBU2bxrUe" title="Number of shares, agreed to purchase">45,632</span> options to purchase shares of the Company&#8217;s common stock (including previously vested options to purchase shares
of the Company&#8217;s common stock of <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20230228__20230228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVxBLegbVplb" title="Sharebased compensation arrangement by sharebased payment award options vested number of shares">24,515</span>) as of the resignation date of the employee at a price of $<span id="xdx_905_eus-gaap--SharePrice_iI_pid_c20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zQYMCCCZmuja" title="Share price per share">10.29</span> per share, reduced by
the exercise price and required tax withholdings, subject to certain conditions. The modification of the equity awards resulted in the
unamortized costs being recognized at the modification date. The cash price of $<span id="xdx_90C_eus-gaap--SharePrice_iI_pid_c20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_z7DE7rQeiIN5" title="Share price per share">10.29</span> per option less the strike price of $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zMfwp12qxcfe" title="Strike price per share">8.82</span> per option
resulted in incremental cost of $<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_pn3n3_c20230228__20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zGhkRHhIXlA1" title="Incremental cost">68</span> being recognized at the modification date. The modification resulted in liability classification
of the equity awards, with $<span id="xdx_909_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_z4DCGMw2DeAb" title="Accrued expenses and other">68</span> paid during the year ended December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 30, 2023, the Company modified certain equity awards upon the resignation of a senior executive employee pursuant to which unvested
restricted stock units for <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zCXncc0kVgS4" title="Unvested restricted stock units">42,635</span> shares of the Company&#8217;s common stock vested, and unvested options for <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_z3kHG8wPiKob" title="Common stock vested">29,701</span> shares of the Company&#8217;s
common stock vested with the exercise period extended for the <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zn7JvjGrRSjf" title="Vested contractual term">10</span>-year contractual term of the options from the grant date of the award.
In connection with the termination, the unamortized costs of the awards of $<span id="xdx_904_eus-gaap--UnamortizedDebtIssuanceExpense_iI_pn3n3_c20230630__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zoYdDF500SX3" title="Unamortized costs">773</span> was recognized at the termination date and $<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_pn3n3_c20230629__20230630__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zvdeDCjbMYUl" title="Incremental cost">284</span> of incremental
cost was recognized as a result of the option award modification upon termination of the senior executive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 2, 2023, the Company modified options of former a senior executive officer for <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20231101__20231102_zL0cWRhIu2g2" title="Unvested restricted stock units">450,560</span>
shares of the Company&#8217;s common stock, pursuant to which the exercise period would be extended for the <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20231101__20231102_zczDkQp8qeA7" title="Vested contractual term">10</span>-year
contractual term from the grant date of the award subject to continued employment through the closing date of the Business
Combination (see Note 28) (the &#8220;conditions&#8221;). Incremental costs in connection with the modification was $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_pn3n3_c20231101__20231102_ztTmD6xKqNze" title="Incremental cost">380</span>,
of which no cost was recognized at the modification date since the conditions were not satisfied and the employment of the officer
was terminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2022
Stock Option Repricing</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 18, 2022, the Company approved a repricing of certain outstanding stock options (the &#8220;Stock Option Repricing&#8221;) granted
under the Company&#8217;s 2016 Plan and 2019 Plan that had an exercise price above $ <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220315__20220318_zuASn8tuxWVg" title="Weighted Average Exercise Price, Granted">8.82</span> per share, as well as certain outstanding stock
options held by senior management of the Company under the Outside Options. The Stock Options Repricing was approved by the Board and
stockholders. As a result of the Stock Option Repricing, the exercise prices were set to $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220315__20220318_z3ksuL735Nwc" title="Weighted Average Exercise Price, Granted">8.82</span> per share, which was the closing sale
price of the Company&#8217;s common stock as listed on the NYSE American exchange on March 18, 2022. Except for the repricing of the
stock options under the 2019 Plan, all terms and conditions of each stock option remain in full force and effect. For the repricing of
the stock options under the 2019 Plan, the Company (i) modified the exercise price; (ii) will allow cashless exercise as a method of
paying the exercise price, and (iii) will waive a lock-up provision in the stock option agreements. All other term and conditions of
each of the stock options under the 2019 Plan remain in full force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Stock Option Repricing of approximately <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220315__20220318_zAfYh6i525d6" title="Share based compensation arrangement options grants">4,343,017 </span>stock option grants (for 340 employees) that were issued to employees of the Company,
including senior management, resulted in incremental cost of $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_pn3n3_c20220315__20220318_zN8JJMv7xsn7" title="Share based compensation incremental cost">6,061</span>, of which $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_pn3n3_c20220318_zRoUabhVXRf5" title="Share based compensation aggregate intrinsic value">143</span> was recognized at the time of the Stock Option Repricing
for the fully vested awards and included on the consolidated statements of operations, and $<span id="xdx_909_ecustom--OriginalAwardAtTheRepricingDate_pn3n3_c20220315__20220318_z3WFenVEnsf1" title="Original award repricing date">5,918</span> will recognized over the remaining
vesting term of the original award at the repricing date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to stock-based compensation cost and unrecognized stock-based compensation cost related to the common stock options is provided
under the heading <i>Stock-Based Compensation</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>ABG
Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Licensing Agreement and issuance of the ABG Warrants to purchase up to <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231231__us-gaap--TypeOfArrangementAxis__custom--SportsIllustratedLicensingAgreementMember__us-gaap--RelatedPartyTransactionAxis__custom--ABGWarrantsMember_znWHc0pp6vWj" title="Exeercise price">999,540</span> shares of the Company&#8217;s common
stock, the Company recorded the issuance of the warrants as stock-based compensation with the fair value of the warrants measured at
the time of issuance and expensed over the requisite service period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_894_ecustom--ScheduleOfWarrantsActivityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--ABGWarrantsMember_zNoWOLPinfg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the ABG Warrant activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zsfds2bgUzxf" style="display: none">Schedule of Warrants Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Weighted<br/>
 Average</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Weighted<br/>
 Average<br/>
 Remaining <br/>
Contractual<br/>
 Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unvested</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Vested</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">ABG Warrants outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zpYtxuK091Oi" style="width: 11%; text-align: right" title="Number of Shares, unvested outstanding, at beginning of year">599,724</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zI955IU90hX8" style="width: 11%; text-align: right" title="Number of Shares, vested outstanding, at beginning of year">399,816</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_z5xwTK6i8sXk" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, outstanding, at beginning of year">11.55</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span id="xdx_909_ecustom--WeightedAverageRemainingContractualLifeOutstanding_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zWh6N91O9Ndb" title="Weighted Average Remaining Contractual Life, Outstanding at beginning of year">6.46</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zxEdsvqKDzha" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, unvested issued"><span style="-sec-ix-hidden: xdx2ixbrl2731">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zkUIJoVr7rLb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, vested"><span style="-sec-ix-hidden: xdx2ixbrl2733">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">ABG Warrants outstanding at December 31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zLK1LvPlKc24" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, unvested outstanding, at end of year">599,724</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zsRYxtLY03M9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, vested outstanding, at end of year">399,816</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_z1qAdjUfb1U6" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, outstanding, at end of year">11.55</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_905_ecustom--WeightedAverageRemainingContractualLifeOutstanding_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zbHIJqMqOmG2" title="Weighted Average Remaining Contractual Life, Outstanding at ending of year">5.46</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A9_zaK24Z9Zj0W2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pn3n3_do_c20231231__us-gaap--TypeOfArrangementAxis__custom--SportsIllustratedLicensingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ABGWarrantsMember_zCpw5eySBgGe" title="Intrinsic value of stock option">no</span> intrinsic value of exercisable but unexercised in-the-money ABG Warrants as of December 31, 2023 based on a fair market value
of the Company&#8217;s common stock of $<span id="xdx_900_ecustom--FairMarketValueOfStockOption_iI_pid_c20231231__us-gaap--TypeOfArrangementAxis__custom--SportsIllustratedLicensingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ABGWarrantsMember_zqJdcgu2VEV7" title="Fair market value of stock option">2.38</span> per share on December 31, 2023. Information on the acceleration of the vesting of the ABG
Warrants is provided in Note 28.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--ABGWarrantsMember_z4J5vzOaTKMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise prices of the ABG Warrants outstanding and exercisable are as follows as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zrRikuEiWc3k" style="display: none">Schedule of Exercise Prices of Common Stock Options</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Outstanding</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercisable</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">$</td><td style="width: 30%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zKgPGThkQJp" title="Exercise price lower range">9.24</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zU50JB6QzUpa" style="width: 30%; text-align: right" title="Number of shares, outstanding">749,655</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zmLSzRp7LgZ6" style="width: 30%; text-align: right" title="Number of shares, exercisable">299,862</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z4BtTlp0SgTg" title="Exercise price lower range">18.48</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z0Ui8koEijLc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, outstanding">249,885</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zmz0wrBVcrR2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, exercisable">99,954</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zHK5IRpMCj1g" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares, outstanding">999,540</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_z7pIqsolUyp7" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares, exercisable">399,816</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zVoemDEMnQk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to compensation cost and unrecognized compensation cost related to the ABG Warrants is provided under the heading <i>Stock-Based
Compensation</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Publisher
Partner Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Publisher
Partner Warrants</i> &#8211; Publisher Partner Warrants outstanding as of January 1, 2023, totaling <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--PublisherPartnerWarrantProgramMember_zJSpsWIjsGfl" title="Warrant to purchase common stock">4,154</span>, expired during the year ended
December 31, 2023. As of December 31, 2023, there are no Publisher Partner Warrants outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>New
Publisher Partner Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_ecustom--ScheduleOfWarrantsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zWf6xvowhFOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the New Publisher Partner Warrants activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zMUmq9oxdM1i" style="display: none">Schedule of Warrants Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Life</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in Years)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">New Publisher Partner Warrants outstanding at January 1, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z2gAsbkB70j6" style="text-align: right" title="Number of Shares, outstanding, at beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl2769">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zB6OeYbpL0I2" style="text-align: right" title="Weighted Average Exercise Price, outstanding, at beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl2771">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: justify">Granted</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z9IT6Os7LKw9" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Number of Shares, Forfeited">9,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zxaq3necnJlb" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Ending Balance">6.91</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">New Publisher Partner Warrants outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zKibk2Uz7Mzl" style="border-bottom: Black 2.5pt double; text-align: right">9,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z0KXTc7fuHq5" style="text-align: right" title="Weighted Average Exercise Price, Ending Balance">6.91</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--WeightedAverageRemainingContractualLifeOutstanding1_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zZFv88FPShT7" title="Weighted Average Remaining Contractual Life, Outstanding at ending of year">4.15</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">New Publisher Partner Warrants exercisable at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zImrjS8X6red" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Exercisable at end of year">1,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zkDCeOQoEOUh" style="text-align: right" title="Weighted Average Exercise Price, Exercisable at end of year">10.56</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--WeightedAverageRemainingContractualLifeExercisable_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_ztp3qO5ifYu5" title="Weighted Average Remaining Contractual Life, Exercisable">3.92</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">New Publisher Partner Warrants not vested at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zBtAAmFtMima" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, not vested at end of year">8,716</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">New Publisher Partner Warrants available for future grants at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zT2cm3ei9vM2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Available for future grants at end of year">23,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AF_zUyjfep3fcDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_do_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zB98MN8IsIQ3" title="Intrinsic value of stock option">no</span> intrinsic value of exercisable but unexercised in-the-money New Publisher Partner Warrants since the fair market value of $<span id="xdx_907_ecustom--FairMarketValueOfStockOption_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zN4HxOPx2by1" title="Fair market value of stock option">2.38</span>
per share of the Company&#8217;s common stock was lower than the exercise prices on December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_hus-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z8BjKnMgfMCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise prices of the New Publisher Partner Warrants outstanding and exercisable are as follows as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_z8TEOqBkMmBg" style="display: none">Schedule of Exercise Prices of Common Stock Options</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Outstanding</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercisable</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">$</td><td style="width: 30%; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z6kXo03sJvla" title="Exercise price lower range">5.30</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zkf8QRw8NRR9" style="width: 30%; text-align: right" title="Number of Shares, Outstanding">6,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z3GJQ8PdBt8h" style="width: 30%; text-align: right" title="Number of Shares, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2802">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zSD2JPrm9F2b" title="Exercise price lower range">10.56</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zOCapmwRMr9h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Outstanding">3,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z0Tlm5Wc0sX6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Exercisable">1,084</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zK0kEaqALdS2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Outstanding">9,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zpWefQy49wkd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Exercisable">1,084</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AE_z3kyW9jPavQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock-Based
Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--ABGWarrantsMember_zkMesvIjkW3i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock&#8211;based
compensation and equity-based expense charged to operations or capitalized during the years ended December 31, 2023 and 2022 are summarized
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zqWOdX3kw9E" style="display: none">Summary of Stock-based Compensation</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Restricted<br/>
 Stock</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/>
Stock Options</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">ABG Warrants</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Totals</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Cost of revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zS4aB10vPkx7" style="width: 12%; text-align: right" title="Cost of revenue">2,092</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zjfeLSqdTWH1" style="width: 12%; text-align: right" title="Cost of revenue">4,460</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z4SWUTwrHBPk" style="width: 12%; text-align: right" title="Cost of revenue">10</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zuh3OCpomXM" style="width: 12%; text-align: right" title="Cost of revenue">6,562</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Selling and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zv3oA1jKt3V1" style="text-align: right" title="Selling and marketing">257</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z9sW55HnO8o5" style="text-align: right" title="Selling and marketing">1,402</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_ziehUIhFx4L9" style="text-align: right" title="Selling and marketing"><span style="-sec-ix-hidden: xdx2ixbrl2828">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zQIXd86TXcBg" style="text-align: right" title="Selling and marketing">1,659</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zj34EBLFgL9b" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative">6,372</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zJIAxKFs8dm6" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative">3,457</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zVOIDSewmT25" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative">1,010</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zyxbAKu6wZi" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative">10,839</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total costs charged to operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z1qDiccyYDI6" style="text-align: right" title="Total costs charged to operations">8,721</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zDvdTPfm9Q0c" style="text-align: right" title="Total costs charged to operations">9,319</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zohVYeJuar94" style="text-align: right" title="Total costs charged to operations">1,020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zSBKQGqlB3V4" style="text-align: right" title="Total costs charged to operations">19,060</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Capitalized platform development</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z8avxe0oOTc2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"><span style="-sec-ix-hidden: xdx2ixbrl2848">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zirhH6aEfK6f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development">1,016</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z0jtwB0FCUHb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"><span style="-sec-ix-hidden: xdx2ixbrl2852">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zprrWOJiUQQc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development">1,016</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total stock-based compensation</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zdfE9zZ40QZ3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation">8,721</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zm6IXAv1zbCe" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation">10,335</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zpksmIkYPFR9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation">1,020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z1UlLBoEHiR9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation">20,076</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Restricted<br/>
 Stock</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/>
Stock Options</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">ABG Warrants</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Totals</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Cost of revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zbc4io1WKOTl" style="width: 12%; text-align: right" title="Cost of revenue">3,730</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zmYy9EsXMQpf" style="width: 12%; text-align: right" title="Cost of revenue">6,505</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zXQelMvmOKii" style="width: 12%; text-align: right" title="Cost of revenue"><span style="-sec-ix-hidden: xdx2ixbrl2868">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zHgmqrdHBuIk" style="width: 12%; text-align: right" title="Cost of revenue">10,235</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Selling and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zzI21pyXIxUl" style="text-align: right" title="Selling and marketing">270</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zqHeRFs34xsf" style="text-align: right" title="Selling and marketing">2,502</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zp6hLT9CnNcl" style="text-align: right" title="Selling and marketing"><span style="-sec-ix-hidden: xdx2ixbrl2876">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zUD4N25qWy57" style="text-align: right" title="Selling and marketing">2,772</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zY3IthpAUkla" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative">9,067</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zGOlOGCYdgG9" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative">7,776</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zjITvekToWN9" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative">1,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zBl31ToAqh1c" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative">18,338</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total costs charged to operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zBl2pwO6bKue" style="text-align: right" title="Total costs charged to operations">13,067</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zSnjNhzBUna4" style="text-align: right" title="Total costs charged to operations">16,783</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zq4l8XzjoUo5" style="text-align: right" title="Total costs charged to operations">1,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zyxMhPgM26Fa" style="text-align: right" title="Total costs charged to operations">31,345</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Capitalized platform development</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zDUTrOX49saj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"><span style="-sec-ix-hidden: xdx2ixbrl2896">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zLU4MABAJzF4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development">1,884</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zKZN0rxKseac" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"><span style="-sec-ix-hidden: xdx2ixbrl2900">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zbx2FBLwBMlc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development">1,884</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total stock-based compensation</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zWiko2EKKVy7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation">13,067</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zo7kdn5kDXp" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation">18,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zTn3jXVl4HJ1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation">1,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_ztpqGxcsOFk8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation">33,229</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_zG2z1g1GxoW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_ecustom--ScheduleOfUnrecognizedCompensationExpense_z5zoP8UKu54f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrecognized
compensation expense related to the stock-based compensation awards and equity-based awards as of December 31, 2023 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zSpQfxxmfmD5" style="display: none">Schedule of Unrecognized Compensation Expense</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Restricted<br/>
 Stock</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/>
Stock Options</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">ABG Warrants</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Totals</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Unrecognized compensation expense</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zK2fgOgUbWok" style="width: 12%; text-align: right" title="Unrecognized compensation expense">1,191</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zIfBhtP9vhp" style="width: 12%; text-align: right" title="Unrecognized compensation expense">4,192</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zTvMG4y7ZrHf" style="width: 12%; text-align: right" title="Unrecognized compensation expense">26</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zxz6nz9YmTF6" style="width: 12%; text-align: right" title="Unrecognized compensation expense">5,409</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted average period expected to be recognized (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zmt8Fp8nBx29" title="Weighted average period expected to be recognized (in years)">1.84</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zEXcy2KCOGzd" title="Weighted average period expected to be recognized (in years)">1.33</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zbEEcYF3gId7" title="Weighted average period expected to be recognized (in years)">2.01</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zPB1D1Ix63w8" title="Weighted average period expected to be recognized (in years)">1.45</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AC_zwb7DtE161Qk" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735287328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liquidated Damages<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosureLiquidatedDamagesAbstract', window );"><strong>Liquidated Damages</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatingDamagesPayableDisclosureTextBlock', window );">Liquidated Damages</a></td>
<td class="text"><p id="xdx_80C_ecustom--LiquidatingDamagesPayableDisclosureTextBlock_zjzExnaKew2c" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>23.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82C_z8ixUqsRSkgd">Liquidated Damages</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years December 31, 2023 and 2022, the Company recorded liquidated damages of $<span id="xdx_907_ecustom--LiquidatedDamagesPayable_iI_pn3n3_c20231231_zDZp8iqLS5Wd" title="Liquidated damages payable">583</span> and $<span id="xdx_90C_ecustom--LiquidatedDamagesPayable_iI_pn3n3_c20221231_z7Uq5ALjKB1h" title="Liquidated damages payable">1,140</span> (including accrued interest of $<span id="xdx_90D_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20230101__20231231_zdBOTwREbmb1" title="Liquidated damages payable accrued interest percentage">583</span>
and $<span id="xdx_90E_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20220101__20221231_zOdKMetvwysf" title="Liquidated damages payable accrued interest percentage">652</span>), respectively. During the year December 31, 2022, liquidated damages of $<span id="xdx_905_ecustom--LiquidatedDamagesPayable_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_zKySdlFvUyY3" title="Liquidating damages payable">488</span> were recorded as a result of Registration Rights
Damages resulting from not registering the Series K convertible preferred stock timely.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosureLiquidatedDamagesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosureLiquidatedDamagesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LiquidatingDamagesPayableDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidating Damages Payable Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LiquidatingDamagesPayableDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656730958688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_808_eus-gaap--IncomeTaxDisclosureTextBlock_zmjbbzkwqF15" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>24.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_82E_z0qHBN64Qysc">Income Taxes</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_894_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zh5bOd87Uomb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of the (provision) benefit for income taxes consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_zJxUib8MGzf" style="display: none">Schedule of Income Taxes</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230101__20231231_zo2q3k3R6nF1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220101__20221231_zDAfweOglcij" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current tax (provision) benefit:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_maCFSALzf1Y_zzi04Day80Ke" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Federal</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2946">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2947">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pn3n3_maCFSALzf1Y_zQzMzV1Bz3w1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 60%; text-align: left; padding-bottom: 1.5pt">State and local</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">(88</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">(77</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_iT_pn3n3_mtCFSALzf1Y_maITEBzavD_maOTEBzTPw_zKfHARmqo5cb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total current tax (provision) benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(88</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(77</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax (provision) benefit:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_iN_pn3n3_di_maDITEBzGRA_zPXuvLKDRKsa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(57</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">985</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_pn3n3_di_maDITEBzGRA_zxHSDpKfudGg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">State and local</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(77</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">155</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredIncomeTaxExpenseBenefit_iNT_pn3n3_di_maITEBzavD_mtDITEBzGRA_maOTEBzTPw_zyIkaH8oJeDc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total deferred tax (provision) benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(134</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,140</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iNT_pn3n3_di_mtOTEBzTPw_zp500xwh83S" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total income tax (provision) benefit</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(222</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,063</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p id="xdx_8A9_zLUTegjAUkt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ztTl5HtUJgW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of deferred tax assets and liabilities were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BD_zT2pwna5LL4g" style="display: none">Schedule of Components of Deferred Tax Assets and Liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20231231_znBJW5Og44Z1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20221231_zlVTQSX3TqH" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzAs8_z7fuwzQTwAah" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left">Net operating loss carryforwards</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">52,353</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">51,023</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pn3n3_maDTAGzAs8_zA0j0FMZH0A4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Interest limitation carryforward</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,444</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_iI_pn3n3_maDTAGzAs8_zlpBsrKm3E99" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Tax credit carryforwards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">264</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">264</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_iI_pn3n3_maDTAGzAs8_zTGa0ENod1Vk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Allowance for doubtful accounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">388</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">757</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_iI_pn3n3_maDTAGzAs8_zT1mRYg7xvL9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accrued expenses and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">891</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,340</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--LeaseTermination_iI_pn3n3_maDTAGzAs8_zVEZ4UGK5Tzc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Lease termination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,017</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,869</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsLiquidatingDamagesPayable_iI_pn3n3_maDTAGzAs8_zssmQy207hS5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Liquidated damages</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">794</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,717</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_pn3n3_maDTAGzAs8_ztMZUlzFsGql" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,148</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,744</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pn3n3_maDTAGzAs8_zdesa3BX48A5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,229</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,931</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DeferredTaxAssetsOperatingLeaseLiability_iI_pn3n3_maDTAGzAs8_zLH6m1yltgx1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Operating lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsDepreciationAndAmortization_iI_pn3n3_maDTAGzAs8_znyngA1yTyN7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,146</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,706</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzAs8_maDTANzxgS_zYQ2APvNmCDb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82,316</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">76,913</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzxgS_za38z5xoLyl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Valuation allowance</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(76,367</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(65,406</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzxgS_maDTALNz54l_zwo4JkolOVDc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Total deferred tax assets</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,949</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,507</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred tax liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pn3n3_di_maDTLzOWA_zHE4CMkLB3T2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Acquisition-related intangibles</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,548</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,972</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxLiabilities_iNTI_pn3n3_di_mtDTLzOWA_msDTALNz54l_zgYFLmlwBfld" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Total deferred tax liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,548</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,972</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNTI_pn3n3_di_mtDTALNz54l_zKIpt2xb1Wne" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net deferred tax liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(599</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(465</td><td style="text-align: left">)</td></tr>
  </table>

<p id="xdx_8AE_z6OXf6EZELB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company must make judgements as to the realization of deferred tax assets that are dependent upon a variety of factors, including the
generation of future taxable income, the reversal of deferred tax liabilities, and tax planning strategies. To the extent that the Company
believes that recovery is not likely, it must establish a valuation allowance. A valuation allowance has been established for deferred
tax assets which the Company does not believe meet the &#8220;more likely than not&#8221; criteria. The Company&#8217;s judgments regarding
future taxable income may change due to changes in market conditions, changes in tax laws, tax planning strategies or other factors.
If the Company&#8217;s assumptions and consequently its estimates change in the future, the valuation allowances it has established may
be increased or decreased, resulting in a respective increase or decrease in income tax expense. Based upon the Company&#8217;s historical
operating losses and the uncertainty of future taxable income, the Company has provided a valuation allowance primarily against its deferred
tax assets up to the deferred tax liabilities, except for deferred tax liabilities on indefinite lived intangible assets, as of December
31, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the Company had federal, state, and local net operating loss carryforwards available of $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zypOj2es3t21" title="Net operating loss carryforwards">193,801</span>, $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20231231__us-gaap--IncomeTaxAuthorityAxis__custom--StateMember_zeRdK5W1GFZ7" title="Net operating loss carryforwards">145,968</span> and
$<span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20231231__us-gaap--IncomeTaxAuthorityAxis__custom--LocalJurisdictionMember_ziiZMZ2vWA7h" title="Net operating loss carryforwards">53,002</span> respectively, to offset future taxable income. Net operating losses for U.S. federal tax purposes of $<span id="xdx_908_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20231231__us-gaap--IncomeTaxAuthorityAxis__custom--USFederalTaxMember_zpG51Ef0QGL2" title="Net operating loss">138,243</span> do not expire (limited
to 80% of taxable income in a given year) and $<span id="xdx_90C_ecustom--NetOperatingLossExpirationAmount_pn3n3_c20230101__20231231_zXfGBtQD5Ymd" title="Net operating losses expiration amount">55,558</span> will expire, if not utilized, through 2037 in various amounts. As of December 31,
2022, the Company had federal, state, and local net operating loss carryforwards available of $<span id="xdx_903_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z1Z0L0AKrnGf" title="Net operating loss carryforwards">190,070</span>, $<span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20221231__us-gaap--IncomeTaxAuthorityAxis__custom--StateMember_zRv5TY6Wp9m3" title="Net operating loss carryforwards">133,419</span> and $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20221231__us-gaap--IncomeTaxAuthorityAxis__custom--LocalJurisdictionMember_zxqZKsr9tXwk" title="Net operating loss carryforwards">51,503</span>, respectively,
to offset future taxable income</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sections
382 and 383 of the Internal Revenue Code imposes restrictions on the use of a corporation&#8217;s net operating losses, as well as certain
recognized built-in losses and other carryforwards, after an ownership change occurs. A section 382 ownership change occurs if one or
more stockholders or groups of stockholders who own at least 5% of the Company&#8217;s common stock increase their ownership by more
than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Future issuances or sales of the
Company&#8217;s common stock (including certain transactions involving the Company&#8217;s common stock that are outside of the Company&#8217;s
control) could also result in an ownership change under section 382. If an ownership change occurs, Section 382 would impose an annual
limit on the amount of pre-change net operating losses and other losses the Company can use to reduce its taxable income generally equal
to the product of the total value of the Company&#8217;s outstanding equity immediately prior to the ownership change (subject to certain
adjustments) and the long-term tax exempt interest rate for the month of the ownership change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes that it did have a change in control under these sections in connection with its recapitalization on November 4, 2016
and utilization of the carryforwards would be limited such that the majority of the carryforwards will never be available. Accordingly,
the Company has not recorded those net operating loss carryforwards and credit carryforwards in its deferred tax assets. The Company
completed a preliminary section 382 analysis as of December 31, 2023 and 2022 and concluded it may have experienced an ownership change
as a result of certain equity transactions during the rolling three-year period of 2021 to 2023. The Company concluded that its federal
net operating loss carryforwards, including any net operating loss carryforwards as a result of the mergers during 2018 and 2019, resulted
in annual limitations on the overall net operating loss carryforward and that an ownership change, if any, would impose an annual limit
on the net operating loss carryforwards and could cause federal income taxes (similar provisions apply for state and local income taxes)
to be paid earlier than otherwise would be paid if such limitations were not in effect. The federal, state, and local net operating loss
carryforwards are stated net of any such anticipated limitations as of December 31, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z3R2TC0j2jk5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provision (benefit) for income taxes on the statements of operations differs from the amount computed by applying the statutory federal
income tax rate to loss before the benefit for income taxes, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_zrMosgqbD2J7" style="display: none">Schedule of Tax Benefit and Effective Income Tax</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percent</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percent</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Federal benefit expected at statutory rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_maABC_c20230101__20231231_zYcKZ9wqwXid" style="width: 12%; text-align: right" title="Federal benefit expected at statutory rate">(11,626</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maDEF_c20230101__20231231_zdcDf2HfnJmb" title="Federal benefit expected at statutory rate, percentage">21.0</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_maABC_c20220101__20221231_zq0T4YPWtUZk" style="width: 12%; text-align: right" title="Federal benefit expected at statutory rate">(14,375</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maDEF_c20220101__20221231_zxfBfTilVLz8" title="Federal benefit expected at statutory rate, percentage">21.0</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State and local taxes, net of federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_maABC_c20230101__20231231_zF4sqVqLVLJb" style="text-align: right" title="State and local taxes, net of federal benefit">(2,526</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maDEF_c20230101__20231231_z4We90obneJe" title="State and local taxes, net of federal benefit, percentage">4.6</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_maABC_c20220101__20221231_zcd5PBPGBppc" style="text-align: right" title="State and local taxes, net of federal benefit">(3,429</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maDEF_c20220101__20221231_zPfrVpImLqbi" title="State and local taxes, net of federal benefit, percentage">5.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_maABC_c20230101__20231231_zCeZznCT0nxf" style="text-align: right" title="Stock-based compensation">3,472</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_maDEF_c20230101__20231231_zul7BhTmovs3" title="Stock-based compensation, percentage">-6.3</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_maABC_c20220101__20221231_zRHueoy8qPrj" style="text-align: right" title="Stock-based compensation">3,894</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_maDEF_c20220101__20221231_z4sjAtoOMpm6" title="Stock-based compensation, percentage">-5.7</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenue_pn3n3_maABC_c20230101__20231231_zLcAf9CooIAc" style="text-align: right" title="Unearned revenue">(562</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage_pid_dp_uPure_maDEF_c20230101__20231231_z9XTWk39r5Be" title="Unearned revenue percentage">1.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenue_pn3n3_maABC_c20220101__20221231_zoT5YCVvUiyi" style="text-align: right" title="Unearned revenue">(696</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage_pid_dp_uPure_maDEF_c20220101__20221231_zV8CHYMEE9Q2" title="Unearned revenue percentage">1.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpense_pn3n3_maABC_c20230101__20231231_zaEQ1aIqW4ma" style="text-align: right" title="Interest expense">62</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpensePercentage_pid_dp_uPure_maDEF_c20230101__20231231_zieWVxDyIBUa" title="Interest expense percentage">-0.1</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpense_pn3n3_maABC_c20220101__20221231_zahXcV4gLeA4" style="text-align: right" title="Interest expense">56</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpensePercentage_pid_dp_uPure_maDEF_c20220101__20221231_zVt6UnuYyYCl" title="Interest expense percentage">-0.1</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Gain upon debt extinguishment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment_pn3n3_maABC_c20230101__20231231_ztrbDGN5pZ3k" style="text-align: right" title="Gain upon debt extinguishment"><span style="-sec-ix-hidden: xdx2ixbrl3078">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage_pid_dp_uPure_maDEF_c20230101__20231231_zOW4KfX73CMk" title="Gain upon debt extinguishment percentage">0.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment_pn3n3_maABC_c20220101__20221231_zuCUM6gET4Sf" style="text-align: right" title="Gain upon debt extinguishment">(760</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage_pid_dp_uPure_maDEF_c20220101__20221231_z8T4PXGTY8i2" title="Gain upon debt extinguishment percentage">0.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other differences, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pn3n3_maABC_c20230101__20231231_z91PVqepRv34" style="text-align: right" title="Other differences, net">678</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maDEF_c20230101__20231231_zOe6P2h0ysWj" title="Other differences, net percentage">-1.2</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pn3n3_maABC_c20220101__20221231_zxvqTufnLFo4" style="text-align: right" title="Other differences, net">(997</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maDEF_c20220101__20221231_zm3mp98Oi9B4" title="Other differences, net percentage">1.6</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_maABC_c20230101__20231231_zw3bz20nJuNi" style="text-align: right" title="Valuation allowance">10,961</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maDEF_c20230101__20231231_zSHiRkDePcgk" title="Valuation allowance percentage">-19.8</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_maABC_c20220101__20221231_zFjqdX2nH2Xk" style="text-align: right" title="Valuation allowance">14,959</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maDEF_c20220101__20221231_zccpwDF5W146" title="Valuation allowance percentage">-21.9</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other permanent differences</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_pn3n3_maABC_c20230101__20231231_zgzNRO5F0zwh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other permanent differences">(237</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_maDEF_c20230101__20231231_zF2El0cOWnY2" title="Other permanent differences percentage">0.4</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_pn3n3_maABC_c20220101__20221231_zS6k4kCrh7i4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other permanent differences">285</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_maDEF_c20220101__20221231_zx8ZIXsOxCYc" title="Other permanent differences percentage">-0.4</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income tax provision (benefit) and effective income tax rate</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_mtABC_c20230101__20231231_zElUn0Rgf3hd" style="border-bottom: Black 2.5pt double; text-align: right" title="Income tax benefit and effective income tax rate">222</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_mtDEF_c20230101__20231231_zEoPqHXa8xq4" title="Income tax benefit and effective income tax rate, percentage">-0.4</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_mtABC_c20220101__20221231_zgKibdO2kzq2" style="border-bottom: Black 2.5pt double; text-align: right" title="Income tax benefit and effective income tax rate">(1,063</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_mtDEF_c20220101__20221231_zsxInu9KDHv7" title="Income tax benefit and effective income tax rate, percentage">1.6</span></td><td style="text-align: left">%</td></tr>
  </table>

<p id="xdx_8A0_zoxiihU6jSjf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes the tax benefit from uncertain tax positions only if it is &#8220;more likely than not&#8221; that the tax positions
will be sustained on examination by the tax authorities, based on the technical merits of the position. The tax benefit is measured based
on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The Company recognizes interest
and penalties related to income tax matters in income tax expense. The Company is also required to assess at each reporting date whether
it is reasonably possible that any significant increases or decreases to its unrecognized tax benefits will occur during the next 12
months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not recognize any uncertain tax position, or any accrued interest and penalties associated with uncertain tax positions for
the years ended December 31, 2023 and 2022. The Company files tax returns in the U.S. federal jurisdiction and New York, California,
and other states. The Company is generally subject to examination by income tax authorities for three years from the filing of a tax
return, therefore, the federal and certain state returns from 2020 forward and the California returns from 2019 forward are subject to
examination. The Company currently is under examination by a state tax authority.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735287328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Pension Plans</a></td>
<td class="text"><p id="xdx_802_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zMDJZ7PE2awe" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>25.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_826_zvBSHxR64tJ5">Pension Plans</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a qualified 401(k) defined contribution plan that allows eligible employees of the Company to participate in the plan, subject
to limitations. <span id="xdx_901_eus-gaap--DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_c20230101__20231231_zROCOlyM4ys6" title="Pension plan, description">The plan allows for discretionary matching contributions by the Company, up to 4% of eligible annual compensation made
by participants of the plan</span>. The Company contributions to the plan were $<span id="xdx_903_eus-gaap--MultiemployerPlanPensionSignificantPlanContribution_pn3n3_c20230101__20231231_zLwy8xk529Cg" title="Contribution to plan">2,125</span> and $<span id="xdx_906_eus-gaap--MultiemployerPlanPensionSignificantPlanContribution_pn3n3_c20220101__20221231_zSIlOFDreld" title="Contribution to plan">1,808</span> for the years ended December 31, 2023 and 2022,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//710/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 712<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//712/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//715/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656730958688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zdTu4q7zShOj" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>26.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_827_zBqRMTcZo3R5">Related Party Transactions</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Principal
Stockholders</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has an outstanding obligation with Renew, an affiliated entity of Simplify, where Renew purchased the all the outstanding
debt held by BRF Finance Co., LLC (&#8220;BRF&#8221;) an affiliated entity of B. Riley Financial, Inc. (&#8220;B. Riley&#8221;) (as
further described below), who now holds the debt in its capacity as agent for the purchasers and as purchaser, pursuant to the third
amended and restated note purchase agreement entered into on December 15, 2022 (the &#8220;Note Purchase Agreement&#8221;), as
amended by the first amendment to the Note Purchase Agreement on August 14, 2023 (the &#8220;First Amendment&#8221;) with an
effective date of August 31, 2023, as further amended by the second amendment to the Note Purchase Agreement on December 1, 2023
(the &#8220;Second Amendment&#8221;). The Note Purchase Agreement contains provisions related to the 2023 Notes, Senior Secured
Notes, Delayed Draw Term Notes and 2022 Bridge Notes, all as further described above and referred to as the &#8220;Notes&#8221;. Under the terms of the
Note Purchase Agreement, First Amendment and Second Amendment, in the event there is a mandatory prepayment requirement, the
principal payment of the Notes will be applied to: <span id="xdx_907_eus-gaap--DebtInstrumentDescription_c20230101__20231231_zy1ifPNug1G7" title="Note purchase agreement description">(1)
the 2023 Notes until paid in full; (2) then to the 2022 Bridge Notes until paid in full; (3) then to the Delayed Draw Terms Notes
until paid in full; and (4) then to the Senior Secured Notes. All borrowings under the Notes are collateralized by substantially all
assets of the Company secured by liens and guaranteed by the Company&#8217;s subsidiaries. The Notes provide for a default interest
rate equal to the rate of interest in effect at the time of default plus 4.0%, along with other provision for acceleration of the
Notes under certain conditions. The Notes provide for certain affirmative covenants, including certain financial reporting
obligations.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 30, 2023, Simplify entered into a stock purchase and assignment agreement (the &#8220;Stock Purchase Agreement&#8221;),
pursuant to which it purchased an aggregate of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20231201__20231201__us-gaap--DebtInstrumentAxis__custom--BRileyFBRIncMember_z7sYFkHR9iY3" title="Debt instrument face amount">10,512,236</span>
shares of the Company&#8217;s common stock for aggregate consideration of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_c20231201__20231201__us-gaap--DebtInstrumentAxis__custom--BRileyFBRIncMember_zANbzlCwBWB1" title="Debt instrument face amount">30,485</span>
on December 1, 2023 from B. Riley and other affiliated entities of B. Riley and certain other sellers (collectively the &#8220;Sellers&#8221;),
resulting in Simplify becoming a principal stockholder and the Sellers no longer owning any of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 30, 2023, Renew, an affiliated entity of Simplify and a principal stockholder, and BRF, an affiliate of the Sellers, entered into a securities purchase
and assignment agreement (the &#8220;Debt Purchase Agreement&#8221;), pursuant to which BRF sold and assigned to Renew all of BRF&#8217;s
rights, duties, liabilities and obligations pursuant to the Note Purchase Agreement, as amended, and the Notes purchased thereunder and
the collateral securing such Notes on December 1, 2023 (further details are provided under the heading <i>Arena Loan Agreement
</i>in Note 28), resulting in BRF no longer holding any debt securities of the Company. The aggregate principal balance under the Notes was $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231231_z5WXmH88GNH8" title="Aggregate principal amount">110,691</span> at the time of purchase by Renew.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of November 30, 2023, Daniel Shribman, Chief Investment Officer of BRF, and Todd Sims, President of B. Riley Venture Capital, a subsidiary
of BRF, resigned as members of the Board of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2023 and 2022, the Company paid in cash interest of $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zSJbgXl5E6Y" title="Paid in cash">9,068</span> and $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BRileyMember_zeHi1PBZOkIe" title="Paid in cash">7,132</span>, respectively, on the Notes due to
BRF, an affiliated of B. Riley, a former principal stockholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2023, the Company incurred interest of $<span id="xdx_90E_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zFblG6JHQUY5" title="Interest on notes">2,797</span> for the period from October 1, 2023 to December 31, 2023 on
the Notes held by Renew, an affiliated entity of Simplify, a principal stockholder, where the Company defaulted on the payment of $<span id="xdx_906_ecustom--DebtInstrumentIncreaseAccruedInterestAmountDue_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zYxCbzh4RSMc" title="Interest on notes">2,797</span>
interest due on December 29, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 31, 2023, in connection with the registered direct offering, the Company entered into common stock purchase agreements for <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__srt--TitleOfIndividualAxis__custom--BRileyMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__custom--DirectOfferingMember_zG4ZGy5plwta">1,009,021</span>
shares of the Company&#8217;s common stock for a total of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__srt--TitleOfIndividualAxis__custom--BRileyMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__custom--DirectOfferingMember_z2UWVIOzITj">3,915</span> in gross proceeds with B. Riley, a former principal stockholder, at
a price per share of $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230331__us-gaap--SubsidiarySaleOfStockAxis__custom--DirectOfferingMember__srt--TitleOfIndividualAxis__custom--BRileyMember_z2A3nKywT5kg" title="Sale of stock, price per share">3.88</span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 10, 2023, the Series H Preferred Stock automatically converted into shares of the Company&#8217;s common stock at the conversion
price of $<span id="xdx_902_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_c20230810__srt--TitleOfIndividualAxis__custom--BRileyMember__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zhr9WZ3BO6Cl" title="Preferred Stock issued onversion price">7.26</span> per share, of which <span id="xdx_906_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_pid_c20230810__srt--TitleOfIndividualAxis__custom--BRileyMember__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zzh8bJxsd3s6" title="Preferred Stock issued upon conversion">134,550</span> shares were issued to B. Riley, a former principal stockholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 31, 2023, September 29, 2023 and November 27, 2023, in connection with the 2023 Notes, BRF, an affiliated entity of B. Riley,
a former principal stockholder, issued $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20230831__srt--TitleOfIndividualAxis__custom--BRileyMember_zarAdcUjAFKg" title="Aggregate principal amount">5,000</span>, $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20230929__srt--TitleOfIndividualAxis__custom--BRileyMember_zE2KUQFSh21b" title="Aggregate principal amount">1,000</span> and $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231127__srt--TitleOfIndividualAxis__custom--BRileyMember_zJnXdt5OeP17" title="Aggregate principal amount">2,000</span>, respectively, in aggregate principal amount under the 2023 Note, where
the Company incurred fees of $<span id="xdx_901_eus-gaap--DebtInstrumentFeeAmount_iI_pn3n3_c20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_z3EgDpVko6F4" title="Fee incurred">357</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into transactions with B. Riley, a former principal stockholder, where it borrowed funds under the 2022 Bridge Notes
of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231231__dei--LegalEntityAxis__custom--BRileyFinancialIncMember_zCccLpvi4P9j" title="Face amount">36,000</span> during the year ended December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2022, the Company had certain transactions with B. Riley, a former principal stockholder, where it paid fees
associated with the common stock public offering totaling $<span id="xdx_900_eus-gaap--DebtInstrumentFeeAmount_iI_pn3n3_c20221231__srt--TitleOfIndividualAxis__custom--BRileyMember_z7xbHxEj0Pi7" title="Fee incurred">2,440</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registered
Direct Offering</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 31, 2023, in connection with the registered direct offering, the Company entered into common stock purchase agreements for <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_zqJAabGivp98" title="Sale of stock, number of shares issued in transaction">317,518</span>
shares of the Company&#8217;s common stock for a total of $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember_zi5GzaUcOLYh" title="Proceeds from issuance of private placement">1,232</span> in gross proceeds with certain directors and affiliates, at a price
of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_zTDiC9ENBgVc" title="Per share">3.88</span> per share, as follows: (i) <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HHuntAllredMember_zgdwa3orbRUi" title="Shares Issues">64,000</span> shares for $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HHuntAllredMember_zVwRd0Vrgei7" title="Value">248</span> to H. Hunt Allred, a director, through certain trusts (<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__dei--LegalEntityAxis__custom--AllredTrustHHAMember_z6zM40T6LXTg" title="Shares issues">32,000</span> shares are directly
beneficially owned by the Allred 2002 Trust - HHA and <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__dei--LegalEntityAxis__custom--AllredTrustNLAMember_zwuFiIfOmULf" title="Shares issues">32,000</span> shares are directly beneficially owned by the by Allred 2002Trust - NLA);
(ii) <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneEightyDegreeCapitalCorpMember_zXIuYgqywgp5" title="Shares isssue">195,529</span> shares for $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneEightyDegreeCapitalCorpMember_znHR2ih8ybra" title="Value">759</span> to 180 Degree Capital Corp, a beneficial holder of more than 5% of the Company&#8217;s common stock; (iii)
<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DanielShribmanMember_z5ZXcQp0KL1l" title="Shares isssue">25,773</span> shares for $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DanielShribmanMember_zBc8xfHlk13f" title="Value">100</span> to Daniel Shribman, a former director; (iv) <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RossLevinsohnMember_zK5tR119aRr6" title="Shares isssue">25,773</span> shares for $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RossLevinsohnMember_zY3UGNgNyTn8" title="Value">100</span> to Ross Levinsohn, a former director and the
Company&#8217;s former Chief Executive Officer; and (v) <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PaulEdmonsonMember_zEcbXl0nuWld" title="Shares isssue">6,443</span> shares for $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PaulEdmonsonMember_zPcdEOpu6ol3" title="Value">25</span> to Paul Edmonson, an executive officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Repurchases
of Restricted Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 15, 2020, the Company entered into an amendment for certain restricted stock awards and units that were previously issued to
certain employees in connection with the HubPages merger, pursuant to which the Company agreed to repurchase from certain key personnel
of HubPages, Inc., including Paul Edmondson, one of the Company&#8217;s officers, and his spouse, an aggregate of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20201214__20201215__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zis7RhGTkB1g" title="Stock issued during period, shares, issued for services">764</span> shares of the Company&#8217;s
common stock at a price of $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20201215__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_znhiR54eH0W7" title="Stock price">88.00</span> per share each month for a period of 24 months, for aggregate proceeds to Mr. Edmondson and his spouse
of $<span id="xdx_90C_ecustom--StockRepurchasedDuringPeriodValue1_iN_pn3n3_di_c20201214__20201215__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zaIRF2Tgy0n3" title="Proceeds from repurchase of restricted stock">67</span> per month. For year ended December 31, 2022, the Company paid Mr. Edmonson and his spouse $<span id="xdx_90F_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrEdmonsonMember_zn4PpH4Ck8Fg" title="Stock repurchase value">269</span> for <span id="xdx_90D_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrEdmonsonMember_zR2Z4vqHk3Y1" title="Number of shares repurchased">3,056</span> shares of the Company&#8217;s
common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735287328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p id="xdx_801_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zki80sJsEYb7" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>27.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_822_zp5LkMTFOgNl">Commitments and Contingencies</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Claims
and Litigation</i> &#8211; From time to time, the Company may be subject to claims and litigation arising in the ordinary course of
business. The Company is not currently a party to any pending or threatened legal proceedings that it believes would reasonably be
expected to have a material adverse effect on the Company&#8217;s business, financial condition, results of operations or cash
flows. Further information is provided under the heading <i>Legal Contingencies</i> in Note 28.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Athlon working capital adjustment (as previously disclosed in Note 4), the Company prepared the working capital adjustment.
The sellers are challenging the Company&#8217;s adjustments and both parties have agreed to a standstill and tolling agreement while
the adjustments are being reviewed and discussed. The amount due from this challenge, if any, is not estimatable as of the issuance date
of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Royalty
Fees</i> &#8211; The Company guaranteed minimum annual royalties of $<span id="xdx_900_eus-gaap--RoyaltyExpense_pn3n3_c20230101__20231231__dei--LegalEntityAxis__custom--ABGSILLCMember__srt--RangeAxis__srt--MinimumMember_zh5Vw0XVo3G9" title="Royalty expense">15,000</span> to ABG. The initial term of the minimum guarantee will expire
December 31, 2029. Further details are provided under the heading <i>Sports Illustrated Licensing Termination Rights</i> in Note 28.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656730048384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zCp6Ol96Daj3" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b>28.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><b><span id="xdx_821_zxE2lYifSQ1i">Subsequent Events</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company performed an evaluation of subsequent events through the date of filing of these consolidated financial statements with the SEC.
Other than the below described subsequent events, there were no material subsequent events which affected, or could affect, the amounts
or disclosures on the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Arena Loan Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 5, 2024, as part of negotiations with Renew, in connection with the Company&#8217;s failure on December 29, 2023 to make the
interest payment due on the Arena Loan Agreement, dated December 15, 2022 held by Renew (the &#8220;Arena Notes&#8221;) in the
amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240105__us-gaap--TypeOfArrangementAxis__custom--ArenaLoanAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8YACdNPQPwd" title="Renew note">2,797</span>,
that resulted in an event of default under the Arena Notes (the &#8220;Arena Notes Default&#8221;), Renew agreed in writing to a
forbearance period through March 29, 2024, subject to the Company retaining a chief restructuring officer acceptable to
Renew, while reserving its rights and remedies. The outstanding principal on the Arena Notes was $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--ArenaLoanAgreementMember_zhycx2GbxmCi" title="Outstanding principal">110,691</span>
as of December 31, 2023. In addition, while the Company continues discussions with Renew to restructure and/or amend the Arena
Notes, the Board engaged, and Renew accepted, FTI Consulting Inc., (&#8220;FTI&#8221;), a global business advisory firm, to assist
the Company with its turnaround plans and forge an expedited path to sustainable positive cash flow and earnings to create
shareholder value (the &#8220;FTI Engagement&#8221;). In connection with the FTI Engagement, Jason Frankl, a senior managing
director of FTI, was appointed as the Company&#8217;s Chief Business Transformation Officer. He was later appointed as interim
President in addition to his role as the Company&#8217;s Chief Business Transformation Officer, as referenced below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="color: #181717">On March 27, 2024, the
forbearance period was extended through the earlier of the following: (a) April 30, 2024</span><span style="color: #393A39">; </span><span style="color: #181717">(b)
the occurrence of the closing of the Business Combination (as further described below) and (c) the termination of the Business Combination
prior to closing.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sports
Illustrated License Termination Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 2, 2024, the Company failed to make a quarterly payment due to ABG, pursuant to the Licensing Agreement, of $<span id="xdx_902_ecustom--ExerciseRightTerminationAmount_iI_pn3n3_c20240102__us-gaap--TypeOfArrangementAxis__custom--LicensingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zd8t0QYGd1sc" title="Exercise right termination amount">3,750</span> (the &#8220;ABG
Default&#8221;). On January 3, 2024, ABG issued a notice of breach with the intent to exercise its right of termination. On January 18,
2024, ABG notified the Company of its intention to terminate the Licensing Agreement, effective immediately, in accordance with its rights
under the Licensing Agreement. Upon such termination, a fee of $<span id="xdx_90B_ecustom--TerminationFeeDue_iI_pn3n3_c20240102__us-gaap--TypeOfArrangementAxis__custom--LicensingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyyqFH232IT4" title="Termination fee">45,000</span> became immediately due and payable by the Company to ABG pursuant
to the terms and conditions of the Licensing Agreement. On March 18, 2024, ABG announced it had reached an agreement in principle with
a third party that will become the new operator of the Sports Illustrated media business. The Company is engaging in continuing discussions
with ABG regarding the timing and terms of the transition of the Sports Illustrated media business to this third party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>ABG
Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 2, 2024, in connection with the ABG Default, the Performance-Based Warrants totaling <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20240102__20240102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--ABGWarrantsMember_z244ZrEg9ee3" title="Performance based warrant vested">599,724</span> vested as a result of the default
pursuant to certain provisions where all of the warrants automatically vest upon certain terminations of the Licensing Agreement by ABG.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Resignation
and Appointments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify">On January 3, 2024, the Board appointed
Jason Frankl as Chief Business Transformation Officer of the Company, effective immediately, reporting directly to the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2024, the Board accepted the resignation of Manoj Bhargava from his position as interim Chief Executive Officer effective
immediately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 19, 2024, the Company accepted the resignation of Ross Levinsohn, the Company&#8217;s former Chief Executive Officer and Chairman
of the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 23, 2024, the Board appointed Jason Frankl as interim President of the Company, effective immediately, reporting directly to
the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 23, 2024, the Board appointed Cavitt Randall as Chairman of the Board, effective immediately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 9, 2024, the Board appointed Cavitt Randall as the Company&#8217;s Chief Executive Officer, effective February 13, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 16, 2024, the Board appointed Manoj Bhargava as the Company&#8217;s Co-President, effective immediately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combination</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 9, 2024, New Arena Holdco, Inc. (&#8220;New Arena&#8221;), a wholly owned subsidiary of the Company, filed a Registration Statement
on Form S-4 (File No. 333-276999) with the SEC in connection with the Business Combination Agreement by and among the Company, Simplify,
Bridge Media Networks, LLC (&#8220;Bridge Media&#8221;), New Arena and the other parties dated November 5, 2023, as amended on December
1, 2023 (the &#8220;Transaction Agreement&#8221;), that provides for the Company to combine its operations with those of Bridge Media,
a wholly owned subsidiary of Simplify by way of a series of mergers with and among New Arena (the &#8220;Mergers&#8221;), subject to
customary conditions, including the approval by the Company&#8217;s shareholders and certain regulatory approvals. Immediately following
the Mergers, the Transaction Agreement provides for: (i) the purchase by The Hans Foundation USA, a nonprofit nonstock corporation (the
&#8220;Hans Foundation&#8221;) of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TransactionAgreementMember_z5IESXxle1Na" title="Shares issue">25,000</span> shares of New Arena Series A Preferred Stock, par value $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TransactionAgreementMember_zcg0cc7Vktg1" title="Preffered stock, par value">0.0001</span> per share, at a purchase price
of $<span id="xdx_905_eus-gaap--SharePrice_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TransactionAgreementMember_zFCMLhLLcusj" title="Purchase price">1,000.00</span> per share, for an aggregate purchase price of $<span id="xdx_90A_eus-gaap--BusinessCombinationPriceOfAcquisitionExpected_pn3n3_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TransactionAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zw9K8jlgjmmi" title="Aggregate purchase price">25,000</span> (such amount, the &#8220;Preferred Stock Financing Amount,&#8221;
and such financing, the &#8220;Preferred Stock Financing&#8221;) pursuant to the subscription agreement, dated as of November 5, 2023
(the &#8220;Preferred Stock Subscription Agreement&#8221;), by and between New Arena and the Hans Foundation; and (ii) the purchase by
5-Hour International Corporation Pte. Ltd. (&#8220;5-Hour&#8221;) of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1Zo1uOqRAL6" title="Shares issue">5,000,000</span> shares of New Arena common stock, par value $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zaY5Dc9i8Crc" title="Preffered stock, par value">0.0001</span> per
share at a purchase price of $<span id="xdx_903_eus-gaap--SharePrice_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zaXzcPfYg9L5" title="Purchase price">5.00</span> per share, for an aggregate purchase price of $<span id="xdx_908_eus-gaap--BusinessCombinationPriceOfAcquisitionExpected_pn3n3_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOOWzwDLpFI1" title="Aggregate purchase price">25,000</span> (such amount, the &#8220;Common Stock Financing
Amount,&#8221; such financing, the &#8220;Common Stock Financing&#8221;) pursuant to the subscription agreement, dated as of November
5, 2023 (the &#8220;Common Stock Subscription Agreement&#8221;), by and between New Arena and 5-Hour. Further, concurrently with the
closing of the Mergers, pursuant to that certain Committed Equity Facility Term Sheet, dated November 5, 2023, by and between Arena and
Simplify (the &#8220;Committed Equity Facility Term Sheet&#8221;), New Arena will enter into a Stock Purchase Agreement (the &#8220;Stock
Purchase Agreement&#8221;) with Simplify, pursuant to which Simplify will agree to purchase, at New Arena&#8217;s request, up to $<span id="xdx_90B_eus-gaap--BusinessCombinationConsiderationTransferredOther1_pn3n3_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zvnd3cUhNVA9" title="Business combination, consideration amount">20,000</span>
in aggregate purchase price of shares of New Arena common stock from time to time during the 12 months following the closing date at
a price per share equal to the lesser of (i) the volume-weighted average price of the New Arena common stock for the last sixty trading
days prior to the purchase date and (ii) $<span id="xdx_905_eus-gaap--SharePrice_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zy52Sy7a5Po4" title="Purchase price">3.86</span> per share (the &#8220;Equity Line of Credit&#8221;), along with New Arena <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zzkfCgDAZfd7" title="Shares issue">60,000</span> shares
of New Arena&#8217;s common stock as payment of a <span id="xdx_904_eus-gaap--LineOfCreditFacilityCommitmentFeePercentage_pid_dp_uPure_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zfnQKM2Oioe3" title="Commitment fee percentage">1.5</span>% commitment fee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
following the closing, (i) Simplify will own approximately <span id="xdx_90C_ecustom--SharesOutstandingPercentage_iI_pid_dp_uPure_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_z7yzS6Narce5" title="Shares outstanding percentage">79</span>% of the outstanding shares of New Arena common stock, par value $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zEtyhgkaYSqg" title="Common stock, par value">0.0001</span>
per share, on a fully diluted basis, (ii) 5-Hour will own approximately <span id="xdx_909_ecustom--OutstandingPercentage_iI_pid_dp_uPure_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zh1rWJvNHiRi" title="Shares outstanding percentage">6</span>% of the outstanding New Arena common stock and (iii) former
Arena stockholders will own the remaining outstanding New Arena common stock. Such amounts exclude the ownership of shares of New Arena
common stock that may be issued from time to time pursuant to the Equity Line of Credit. Following the closing, Arena common stock will
be delisted from the NYSE American and deregistered under the Securities Exchange Act of 1934, as amended, and cease to be publicly traded.
New Arena and its subsidiaries will operate under Arena&#8217;s current name &#8220;The Arena Group Holdings, Inc.&#8221; The Company anticipates that New Arena
common stock will be traded on the NYSE American under Arena&#8217;s current stock ticker symbol &#8220;AREN.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock Private Placement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 14, 2024, the Company entered into a subscription agreement (the &#8220;Subscription Agreement&#8221;) with Simplify, pursuant
to which the Company agreed to sell and issue to Simplify in a private placement (the &#8220;Private Placement&#8221;) an aggregate of
<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240214__20240214__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_ziMLSO5Ld51e" title="Aggregate shares">5,555,555</span> shares (the &#8220;Private Placement Shares&#8221;) of the Company&#8217;s common stock, par value $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240214__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zd8ZU3NAdUth" title="Common stock, par value">0.01</span> per share, at a purchase
price of $<span id="xdx_90B_eus-gaap--SharePrice_iI_pid_c20240214__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zBIBDEknsrv6" title="Purchase price">2.16</span> per share, a price equal to the 60-day volume weighted average price of the Company&#8217;s common stock. The Private
Placement closed on February 14, 2024 and the Company received net proceeds from the Private Placement of approximately $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn3n3_c20240214__20240214__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zHCvsDNbv2g" title="Net proceeds from the Private Placement">12,000</span>. The
Company intends to use the net proceeds from the Private Placement for working capital and general corporate purposes. Prior to the consummation
of the Private Placement, the Company&#8217;s public stockholders held a majority of the outstanding shares of the Company&#8217;s common
stock. Following the issuance of the Private Placement Shares to Simplify, Simplify owns approximately <span id="xdx_907_ecustom--SharesOutstandingPercentage_iI_pid_dp_uPure_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zXIgK8DzCVb2" title="Shares outstanding percentage">54.5</span>% of the outstanding shares
of the Company&#8217;s common stock, resulting in a change in control. As a result, Simplify has the ability to determine the outcome of any issue submitted to the Company&#8217;s
stockholders for approval, including the election of directors. The funds used by Simplify to purchase the Private Placement Shares came
from the working capital of Simplify.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Arena
Credit Agreement Default</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Arena Notes Default created an event of cross-default under the Arena Credit Agreement with SLR (the &#8220;SLR Default&#8221;), resulting
in SLR no longer providing for any additional funding under the debt, while paying down the debt with payments received from the
Company&#8217;s customers in accordance with the terms of the agreement. The Company has refinanced the line of credit with a new
credit facility with Simplify (as described below under the heading <i>Simplify Loan</i>). As of the issuance date of the
consolidated financial statements, there was no principal amount due under the Arena Credit Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fexy
Put Option</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 15, 2024, in connection with the contingent consideration related to the acquisition of Fexy Studios, the Company agreed to
pay the amount due of $<span id="xdx_909_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_c20240215__20240215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zxZYW45Ejrfa" title="Total installment amount">2,478</span> in four (4) equal installments of approximately $<span id="xdx_908_ecustom--BusinessCombinationConsiderationTransferredInstallmentDue_pn3n3_c20240215__20240215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zV2Avm38N1Zh" title="Total installment amount">620</span> starting February 16, 2024 and then on the 15th day
of each March, April and May of 2024 comprised of the following: <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20240215__20240215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zWy7inYuaea2" title="Flexy put option description">(i) $2,225 pursuant to the put option where the Company gave the recipients
of the contingent consideration a right to put their 274,692 shares of the Company&#8217;s common stock; (ii) $200 deferred payment due
under the purchase agreement; and (iii) $53 in other costs and reimbursable transition expenses payable.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Simplify
Loan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 13, 2024, the Company entered into a working capital loan with Simplify (the &#8220;Simplify Loan&#8221;), pursuant to which the Company has available up to
$<span id="xdx_90E_ecustom--WorkingCapital_pn3n3_c20240313__20240314__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQYPZZVrE1B2" title="Working capital">25,000</span> at <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240313__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SimplyfyLoanMember_zTgc3hEo0eP4" title="Interest rate">10</span>%
interest rate per annum. The loan is secured by certain assets of the Company. On closing, the Company borrowed
$<span id="xdx_904_eus-gaap--ShortTermBorrowings_iI_pn3n3_c20240313__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zF1RzXfaknqe" title="Company borrowed">7,748</span>,
of which $<span id="xdx_900_eus-gaap--DebtInstrumentFeeAmount_iI_pn3n3_c20240313__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z6t0Du8zRQg" title="Outstanding loan balance">3,448</span>
was used to repay the outstanding loan balance, accrued interest, certain fees and contingency reserves under the Arena Credit
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Legal Contingencies</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 30, 2024, the former President&#160;of
Media filed an action against the Company and Manoj Bhargava, alleging claims for breach of contract, failure to pay wages and defamation, among
other things, in the United States District Court of the Southern District of New York, and seeking&#160;damages in an unspecified amount.
The Company believes that it has strong defenses to these claims and intends to vigorously defend itself and the allegations
made in this lawsuit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 21, 2024, the former CEO and Chairman of
the Board filed an action against the Company, members of the Board of directors and Simplify, alleging claims for retaliation, breach
of contract, wrongful termination and age discrimination, among other things, in the Superior Court of the State of California seeking
damages in an amount of $<span id="xdx_902_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20240321__20240321__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMiPbXOw0ZT" title="Damage, value">20,000</span>. The Company believes that it has strong defenses to these claims and intends to vigorously
defend itself and the allegations made in this lawsuit.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Common Stock</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">From January 1, 2024 through the date these consolidated
financial statements were issued, the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSzBp8bbCk7c" title="Shares issued">378,292</span> shares of its common stock as follows: (i) <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MembersOfBoardMember_zElhpoIO2Rqf" title="Shares issued">36,608</span> shares to members of the
Board; (ii) <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20240101__20240101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zMrsLvR24Jji" title="Vested restricted stock units">256,853</span> shares pursuant to vested restricted stock units that were released; and (iii) <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--FormerEmployeesMember_zjhftOUyHp4l" title="Shares issued">84,831</span> shares to certain former employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Plans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
January 1, 2024 through the date these consolidated financial statements were issued, the Company granted common stock options and restricted
stock units totaling <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240101__20240314__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJJtSrikw8je" title="Granted common stock options">22,843</span> and <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20240101__20240314__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zE7fHtSJhsJe" title="Working capital">222,396</span>, respectively, to acquire shares of the Company&#8217;s common stock to officers, directors,
employees and consultants.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656823525728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zzFtoQvQnNx7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zy3G9ui5Z5Z5">Principles
of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#8220;GAAP&#8221;) and include the financial statements of The Arena Group and its wholly owned subsidiaries,
Arena Media, Arena Platform, TheStreet, The Spun and Parade. Intercompany balances and transactions have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--UseOfEstimates_z8NcpjojKmQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_z4pyTs3jB2Ci">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make certain estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of
the date of the consolidated financial statements and the reported results of operations during the reporting period. Significant estimates
include: reserves for bad debt; capitalization of platform development and associated useful lives; goodwill and other acquired intangible
assets and associated useful lives; assumptions used in accruals for potential liabilities; revenue recognition and estimates of standalone
selling price of performance obligations for revenue contracts with multiple performance obligations; stock-based compensation and the
determination of the fair value; valuation allowances for deferred tax assets and uncertain tax positions; accounting for business combinations;
and assumptions used to calculate contingent liabilities. These estimates are based on information available as of the date of the consolidated
financial statements; therefore, actual results could differ from management&#8217;s estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_RisksAndUncertaintiesPolicy', window );">Risks and Uncertainties</a></td>
<td class="text"><p id="xdx_849_ecustom--RisksAndUncertaintiesPolicy_zeQRbLriArwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zsjI6LF7LMy2">Risks
and Uncertainties</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s business and operations are sensitive to general business and economic conditions in the United States and worldwide.
These conditions include short-term and long-term interest rates, inflation, fluctuations in debt and equity capital markets and the
general condition of the United States and world economy. A host of factors beyond the Company&#8217;s control could cause fluctuations
in these conditions. Adverse developments in these general business and economic conditions could have a material adverse effect on the
Company&#8217;s financial condition and the results of its operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company will compete with many companies that currently have extensive and well-funded projects, marketing and sales operations
as well as extensive human capital. The Company may be unable to compete successfully against these companies. The Company&#8217;s industry
is characterized by rapid changes in technology and market demands. As a result, the Company&#8217;s products, services, or expertise
may become obsolete or unmarketable. The Company&#8217;s future success will depend on its ability to adapt to technological advances,
anticipate customer and market demands, and enhance its current technology under development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Uncertainty
in the global economy presents significant risks to the Company&#8217;s business. Increases in inflation, rising interest rates,
instability in the global banking system, geopolitical factors, including the ongoing conflicts in Ukraine and Israel and the
responses thereto, and the remaining effects of the COVID-19 pandemic may have an adverse effect on the Company&#8217;s business.
While the Company is closely monitoring the impact of the current macroeconomic conditions on all aspects of its business, the
ultimate extent of the impact on its business remains highly uncertain and will depend on future developments and factors that
continue to evolve. Most of these developments and factors are outside of the Company&#8217;s control and could exist for an
extended period of time. As a result, the Company is subject to continuing risks and uncertainties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
December 1, 2023, B. Riley FBR, Inc. (&#8220;B. Riley FBR&#8221;), a registered broker-dealer owned by B. Riley Financial, Inc., a diversified
publicly traded financial services company (&#8220;B. Riley&#8221;) that was instrumental in providing investment banking services to
the Company and in raising debt and equity capital for the Company, and Renew Group Private Limited (&#8220;Renew&#8221;) entered into
agreement where Renew purchased $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20231201__us-gaap--DebtInstrumentAxis__custom--BRileyFBRIncMember_zTC4YweVY0wd">110,691
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in aggregate principal amount of the notes outstanding
with B. Riley, including the 2023 Notes (as described in Note 18), Senior Secured Notes, Delayed Draw Term Notes and 2022 Bridge Notes
(as described in Note 19), which constitute all of the notes outstanding with B. Riley and also assumed the role of agent under the Note
Purchase Agreement, as further described in Note 26. The indirect owner of Renew also has an indirect non-controlling interest in Simplify
Inventions, LLC (&#8220;Simplify&#8221;), a principal stockholder (as further described in Note 26).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p id="xdx_840_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zHxbngcdmK8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zNDHompCPvHb">Segment
Reporting</span> </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates in one reportable segment which focuses on a publishing platform. The Company&#8217;s business offerings have similar
operating characteristics and similar long-term operating performance, including the types of customers, nature of product or services,
distribution methods and regulatory environment. The chief operating decision maker (the &#8220;CODM&#8221;) of the Company reviews specific
financial and operational data and other key metrics to make resource allocation decisions and assesses performance by review of profit
and loss information on a consolidated basis. The CODM does not review specific financial or operational data on a disaggregated basis
or by aggregating operating segments into one reportable segment. The consolidated financial statements reflect the financial results
of the Company&#8217;s one reportable segment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_846_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zGkVoSwSsy6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zbJUQHQnkXde">Revenue
Recognition</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606, <i>Revenue from Contracts with Customers</i>, revenues are
recognized when control of the promised goods or services are transferred to the Company&#8217;s customers, in an amount that reflects
the consideration that the Company expects to receive in exchange for those goods or services. The Company generates all of its revenue
from contracts with customers. The Company accounts for revenue on a gross basis, as compared to a net basis, on its statements of operations.
The Company has made this determination based on its control of the advertising inventory and the ability to monetize the advertising
inventory or publications before transfer to the customer and because it is also the primary obligor responsible for providing the services
to the customer. Cost of revenue is presented as a separate line item on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a description of the principal activities from which the Company generates revenue:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advertising
Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Digital
Advertising &#8211; </i>The Company recognizes revenue from digital advertisements at the point when each ad is viewed. The quantity
of advertisements, the impression bid prices and revenue are reported on a real-time basis. The Company enters into contracts with advertising
networks to serve display or video advertisements on the digital media pages associated with its various channels. Although reported
advertising transactions are subject to adjustment by the advertising network partners, any such adjustments are known within a few days
of month end. The Company owes its independent Publisher Partners a revenue share of the advertising revenue earned, which is recorded
as service costs in the same period in which the associated advertising revenue is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising
revenue that is comprised of fees charged for the placement of advertising, on the Company&#8217;s flagship website, <i>TheStreet.com,
</i>is recognized as the advertising or sponsorship is displayed, if collection of the resulting receivable is reasonably assured.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Print
Advertising &#8211; </i>Advertising related revenues for print advertisements are recognized when advertisements are published (defined
as an issue&#8217;s on-sale date), net of provisions for estimated rebates, rate adjustments, and discounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Subscription
Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Digital
Subscriptions</i> &#8211; The Company enters into contracts with internet users that subscribe to premium content on the owned and operated
media channels and facilitate such contracts between internet users and its Publisher Partners. These contracts provide internet users
with a membership subscription to access the premium content. The Company owes its independent Publisher Partners a revenue share of
the membership subscription revenue earned, which is initially deferred and recorded as deferred contract costs. The Company recognizes
deferred contract costs over the membership subscription term in the same pattern that the associated membership subscription revenue
is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
revenue generated from the Company&#8217;s flagship website <i>TheStreet.com</i> from institutional and retail customers is comprised
of subscriptions and license fees for access to securities investment information, stock market commentary, director and officer profiles,
relationship capital management services, and transactional information pertaining to mergers and acquisitions and other changes in the
corporate control environment. Subscriptions are charged to customers&#8217; credit cards or are directly billed to corporate subscribers,
and are generally billed in advance on a monthly, quarterly or annual basis. The Company calculates net subscription revenue by deducting
from gross revenue an estimate of potential refunds from cancelled subscriptions as well as chargebacks of disputed credit card charges.
Net subscription revenue is recognized ratably over the subscription periods. Unearned revenue relates to payments for subscription fees
for which revenue has not been recognized because services have not yet been provided.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Print
Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print
revenue includes magazine subscriptions and single copy sales at newsstands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Print
Subscriptions &#8211;</i> Revenue from magazine subscriptions is deferred and recognized proportionately as products are distributed
to subscribers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Newsstand
</i>&#8211; Single copy revenue is recognized on the publication&#8217;s on-sale date, net of provisions for estimated returns. The Company
bases its estimates for returns on historical experience and current marketplace conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Licensing
and Syndication Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Content
licensing-based revenues and syndication revenues are accrued generally monthly or quarterly based on the specific mechanisms of each
contract. Generally, revenues are accrued based on estimated sales and adjusted as actual sales are reported by partners. These adjustments
are typically recorded within three months of the initial estimates and have not been material. Any minimum guarantees are typically
earned evenly over the fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nature
of Performance Obligations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
contract inception, the Company assesses the obligations promised in its contracts with customers and identifies a performance obligation
for each promise to transfer a good or service or bundle that is distinct. To identify the performance obligations, the Company considers
all the promises in the contract, whether explicitly stated or implied based on customary business practices. For a contract that has
more than one performance obligation, the Company allocates the total contract consideration to each distinct performance obligation
on a relative standalone selling price basis. Revenue is recognized when, or as, the performance obligations are satisfied, and control
is transferred to the customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Digital
Advertising</i> &#8211; The Company sells digital advertising inventory on its websites directly to advertisers or through advertising
agencies. The Company&#8217;s performance obligations related to digital advertising are generally satisfied when the advertisement is
run on the Company&#8217;s platform. The price for direct digital advertising is determined in contracts with the advertisers. Revenue
from the sale of direct digital advertising is recognized when the advertisements are delivered based on the contract. The customer is
invoiced the agreed-upon price in the month following the month that the advertisements are delivered with normal trade terms. The agreed
upon price is adjusted for estimated provisions for rebates, rate adjustments, and discounts. As part of the Company&#8217;s customary
business practices, digital advertising contracts may include a guaranteed number of impressions and sales incentives to its customers
including volume discounts, rebates, value added impressions, etc. For all such contracts that include these types of variable consideration,
the Company estimates the variable consideration and factors in such an estimate when determining the transaction price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Print
Advertising</i> <b>&#8211; </b>The Company provides advertisement placements in print media directly to advertisers or through advertising
agencies. The Company&#8217;s performance obligations related to print advertising are satisfied when the magazine in which an advertisement
appears is published, which is defined as an issue&#8217;s on-sale date. The customer is invoiced the agreed-upon price when the advertisements
are published under normal industry trade terms. The agreed upon price is adjusted for estimated provisions for rebates, rate adjustments,
and discounts. As part of the Company&#8217;s customary business practices, print advertising contracts include guaranteed circulation
levels of magazines, referred to as rate base, and a number of sales incentives to its customers including volume discounts, rebates,
bonus pages, etc. For all such contracts that include these types of variable consideration, the Company estimates such when determining
the transaction price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Digital
Subscriptions</i> &#8211; The Company recognizes revenue from each membership subscription to access the premium content over time based
on a daily calculation of revenue during the reporting period, which is generally one year. Subscriber payments are initially recorded
as unearned revenue on the balance sheets. As the Company provides access to the premium content over the membership subscription term,
the Company recognizes revenue and proportionately reduces the unearned revenue balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Print
Subscriptions</i> &#8211; The Company sells magazines to consumers through subscriptions. Each copy of a magazine is determined to be
a distinct performance obligation that is satisfied when the publication is sent to the customer. The majority of the Company&#8217;s
subscription sales are prepaid at the time of order. Subscriptions may be canceled at any time for a refund of the price paid for remaining
issues. As the contract may be canceled at any time for a full refund of the unserved copies, the contract term is determined to be on
an issue-to-issue basis as these contracts do not have substantive termination penalties. Revenues from subscriptions are deferred and
recognized proportionately as subscribers are served. Some magazine subscription offers contain more than one magazine title in a bundle.
The Company allocates the total contract consideration to each distinct performance obligation, or magazine title, based on a standalone-selling
price basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Newsstand
</i>&#8211; The Company sells single copy magazines, or bundles of single copy magazines, to wholesalers for ultimate resale on newsstands
primarily at major retailers and grocery/drug stores, and in digital form on tablets and other electronic devices. Publications sold
to magazine wholesalers are sold with the right to receive credit from the Company for magazines returned to the wholesaler by retailers.
Revenue is recognized on the issue&#8217;s on-sale date as the date aligns most closely with the date that control is transferred to
the customer. The Company bases its estimates for returns on historical experience and current marketplace conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Licensing
and Syndication &#8211; </i>The Company has entered into various licensing and syndication agreements that provide third party
partners with the right to utilize the Company&#8217;s content. Functional licenses in national media consist of content
licensing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Timing
of Satisfaction of Performance Obligations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Point-in-Time
Performance Obligations &#8211; </i>For performance obligations related to certain digital advertising space and sales of print advertisements,
the Company determines that the customer can direct the use of and obtain substantially all the benefits from the advertising products
as the digital impressions are served or on the issue&#8217;s on-sale date. For performance obligations related to sales of magazines
through subscriptions, the customer obtains control when each magazine issue is mailed to the customer on or before the issue&#8217;s
on-sale date. For sales of single copy magazines on newsstands, revenue is recognized on the issue&#8217;s on-sale date as the date aligns
most closely with the date that control is transferred to the customer. Revenues from functional licenses and syndication arrangements
are recognized at a point-in-time when access to the completed content is granted to the partner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Over-Time
Performance Obligations</i> <b>&#8211; </b>For performance obligations related to sales of certain digital advertising space, the Company
transfers control and recognizes revenue over time by measuring progress towards complete satisfaction using the most appropriate method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
performance obligations related to digital advertising, the Company satisfies its performance obligations on some flat-fee digital advertising
placements over time using a time-elapsed output method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determining
a measure of progress requires management to make judgments that affect the timing of revenue recognized. The Company has determined
that the above method provides a faithful depiction of the transfer of goods or services to the customer. For performance obligations
recognized using a time-elapsed output method, the Company&#8217;s efforts are expended evenly throughout the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
obligations related to subscriptions to premium content on the digital media channels provides access for a given period of time, which
is generally one year. The Company recognizes revenue from each membership subscription over time based on a daily calculation of revenue
during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transaction
Price and Amounts Allocated to Performance Obligations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Determining
the Transaction Price &#8211; </i>Certain advertising contracts contain variable components of the transaction price, such as volume
discounts and rebates. The Company has sufficient historical data and has established processes to reliably estimate these variable components
of the transaction price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
revenue generated from the flagship website <i>TheStreet.com</i> is subject to estimation and variability due to the fact that, in the
normal course of business, subscribers may for various reasons contact the Company or their credit card companies to request a refund
or other adjustment for a previously purchased subscription. With respect to many of the Company&#8217;s annual newsletter subscription
products, the Company offers the ability to receive a refund during the first 30 days but none thereafter. Accordingly, the Company maintains
a provision for estimated future revenue reductions resulting from expected refunds and chargebacks related to subscriptions for which
revenue was recognized in a prior period. The calculation of this provision is based upon historical trends and is reevaluated each quarter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company typically does not offer any type of variable consideration in standard magazine subscription contracts. For these contracts,
the transaction price is fixed upon establishment of the contract that contains the final terms of the sale including description, quantity
and price of each subscription purchased. Therefore, the Company does not estimate variable consideration or perform a constraint analysis
for these contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
right of return exists for newsstand contracts. The Company has sufficient historical data to estimate the final amount of returns and
reduces the transaction price at contract inception for the expected return reserve.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no variable consideration related to functional licenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Estimating
Standalone-Selling Prices</i> <b>&#8211; </b>For contracts that contain multiple performance obligations, the Company allocates the transaction
price to each performance obligation on a relative standalone-selling price basis. The standalone-selling price is the price at which
the Company would sell a promised good or service separately to the customer. In situations in which an obligation is bundled with other
obligations and the total amount of consideration does not reflect the sum of individual observable prices, the Company allocates the
discount to (1) a single obligation if the discount is attributable to that obligation or (2) prorates across all obligations if the
discount relates to the bundle. When standalone-selling price is not directly observable, the Company estimates and considers all the
information that is reasonably available to the Company, including market conditions, entity specific factors, customer information,
etc. The Company maximizes the use of observable inputs and applies estimation methods consistently in similar circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Measuring
Obligations for Returns and Refunds</i> &#8211; The Company accepts product returns in some cases. The Company establishes provisions
for estimated returns concurrently with the recognition of revenue. The provisions are established based upon consideration of a variety
of factors, including, among other things, recent and historical return rates for both specific products and distributors and the impact
of any new product releases and projected economic conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023 and 2022, a subscription refund liability of $<span id="xdx_903_eus-gaap--ContractWithCustomerRefundLiabilityCurrent_iI_pn3n3_c20231231_zPBgu0X43SHc" title="Subscription refund liability">449</span> and $<span id="xdx_907_eus-gaap--ContractWithCustomerRefundLiabilityCurrent_iI_pn3n3_c20221231_zn36hWjiWCki" title="Subscription refund liability">845</span>, respectively, was recorded for the provision for the
estimated returns and refunds on the consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Contract
Modifications</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company occasionally enters into amendments to previously executed contracts that constitute contract modifications. The Company assesses
each of these contract modifications to determine:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the additional services and goods are distinct from the services and goods in the original arrangement; and</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the amount of consideration expected for the added services or goods reflects the stand-alone selling price of those services and
    goods.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
contract modification meeting both criteria is accounted for as a separate contract. A contract modification not meeting both criteria
is considered a change to the original contract and is accounted for on either a prospective basis as a termination of the existing contract
and the creation of a new contract, or a cumulative catch-up basis (further details are provided under the headings <i>Contract Balances
</i>and <i>Subscription Acquisition Costs</i>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Disaggregation
of Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_eus-gaap--DisaggregationOfRevenueTableTextBlock_zqIHuXdmsySi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information about disaggregated revenue by category, geographical market and timing of revenue recognition:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_z6Kcyvj050lh" style="display: none">Schedule
of Disaggregation of Revenue</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230101__20231231_zkXxx6cmdky8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20221231_ztGAhuYNbwml" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Revenue by category:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><b>Digital revenue</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalAdvertisingMember_zo01p5dvBfP" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 60%; text-align: justify">Digital advertising</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">135,376</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">109,317</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalSubscriptionsMember_zD0kRLElyCW" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Digital subscriptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,764</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,156</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--LicensingAndSyndicationRevenueMember_zfNDuHqh6Ld8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Licensing and syndication revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,173</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__us-gaap--ProductAndServiceOtherMember_zx2y2DOEFCp1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Other digital revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,384</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,166</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zgsNr7azyhMl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify; padding-bottom: 1.5pt">Total digital revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">172,006</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">149,812</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><b>Print revenue</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintAdvertisingMember_zbRG7M168fX4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Print advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,881</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,214</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintSubscriptionsMember_zv5dvOGnfQz2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Print subscriptions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">62,316</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">60,909</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_zzQN9CQzquF8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify; padding-bottom: 1.5pt">Total print revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">72,197</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">71,123</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zUzRiEu6CZTh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">244,203</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">220,935</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Revenue by geographical market:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__country--US_zKX1xgZJTcp9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">234,012</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">218,110</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__custom--OtherMember_zS4cb0vzdZL4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,191</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,825</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zgadvHNx3Wz9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">244,203</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">220,935</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Revenue by timing of recognition:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_zumKpCgm0fo5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">At point in time</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">231,439</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">199,779</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zpFUGfTLJXS6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Over time</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,764</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,156</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zmjvuJAzMUPa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0pt; text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">244,203</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">220,935</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A1_zErk4ulyJWh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_CostOfRevenuePolicyTextBlock', window );">Cost of Revenue</a></td>
<td class="text"><p id="xdx_849_ecustom--CostOfRevenuePolicyTextBlock_zBsWZ7XiYoJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zMoE01NyV7Ge">Cost
of Revenue</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenue represents the cost of providing the Company&#8217;s digital media channels and advertising and membership services. The cost
of revenue that the Company has incurred in the periods presented primarily include: Publisher Partner guarantees and revenue share payments;
amortization of developed technology and platform development; royalty fees; hosting and bandwidth and software license fees; printing
and distribution costs; payroll and related expenses for customer support, technology maintenance; fees paid for data analytics and to
other outside service providers; and stock-based compensation of related personnel (as described in Note 22).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ContractBalancesPolicyTextBlock', window );">Contract Balances</a></td>
<td class="text"><p id="xdx_844_ecustom--ContractBalancesPolicyTextBlock_zyCXvDn3m8ee" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zZnVYYxSPCql">Contract
Balances</span> </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
timing of the Company&#8217;s performance under its various contracts often differs from the timing of the customer&#8217;s payment,
which results in the recognition of a contract asset or a contract liability. A contract asset is recognized when a good or service is
transferred to a customer and the Company does not have the contractual right to bill for the related performance obligations. An asset
is recognized when certain costs incurred to obtain a contract meet the capitalization criteria (further details are provided under the
heading <i>Subscription Acquisition Costs</i>). A contract liability is recognized when consideration is received from the customer prior
to the transfer of goods or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_898_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_zaHl7ipmaYU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information about contract balances:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zB03ZNauj0wc" style="display: none">Schedule
of Contract with Customer, Asset and Liability</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20231231_zaeO3S0cr5pd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20221231_z3Gw4AyXnoya" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unearned revenue (short-term contract liabilities):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zNXnIczbDXRb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Digital revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">14,397</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">18,571</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_z7Oqs9MAbBK9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Print revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,389</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">40,132</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_z1TaModhTRyk" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total short-term contract
    liabilities</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">59,786</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">58,703</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unearned revenue (long-term contract liabilities):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zce7hTDFpFCe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Digital revenue</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">542</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,118</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_zUy5wqyC5QDa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Print revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,137</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,583</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_zxVz3y32mAu9" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total long-term contract
    liabilities</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,679</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,701</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_zGBCCJVDLCcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unearned
Revenue</i> &#8211; Unearned revenue, also referred to as contract liabilities, include payments received in advance of performance under
the contracts and are recognized as revenue over time. The Company records contract liabilities as unearned revenue on the consolidated
balance sheets. Digital subscription and print subscription revenue of $<span id="xdx_901_ecustom--UnearnedRevenue_iI_pn3n3_c20231231__srt--ProductOrServiceAxis__custom--DigitalAndPrintSubscriptionsMember_zavJ3vDtUiH8" title="Contract with customer liability noncurrent">68,985</span> was recognized during the year ended December 31, 2023
from unearned revenue at the beginning of the year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
January 2020, February 2020 and December 2021, the Company modified certain digital and print subscription contracts that prospectively
changed the frequency of the related issues (or magazines) required to be delivered on a yearly basis (the &#8220;Contract Modifications&#8221;).
The Company determined that the remaining digital content and magazines to be delivered are distinct from the digital content or magazines
already provided under the original contract. As a result, the Company in effect established a new contract that included only the remaining
digital content or magazines. Accordingly, the Company allocated the remaining performance obligations in the contracts as consideration
from the original contract that has not yet been recognized as revenue. For the years ended December 31, 2023 and 2022, the Company recognized
revenue of $<span id="xdx_90E_eus-gaap--ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_pn3n3_c20230101__20231231_zJWXinQwW492" title="Contract modification - revenue">554</span> and $<span id="xdx_907_eus-gaap--ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_pn3n3_c20220101__20221231_zDp3CYXxDNIk" title="Contract modification - revenue">2,986</span>, respectively, resulting from the Contract Modifications.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents, and Restricted Cash</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_z9UwVGtuxJeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zAzFgaT3AaBg">Cash,
Cash Equivalents, and Restricted Cash</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains cash, cash equivalents, and restricted cash at banks where amounts on deposit may exceed the Federal Deposit Insurance
Corporation limit during the year. Cash and cash equivalents represent cash and highly liquid investments with an original contractual
maturity at the date of purchase of three months. As of December 31, 2023 and 2022, cash and cash equivalents consist primarily of checking,
savings deposits and money market accounts. These deposits exceeded federally insured limits. The Company has not experienced any losses
in such accounts and believes it is not exposed to significant credit risk regarding its cash and cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_zWFdppVl58t5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reconciles total cash, cash equivalents, and restricted cash:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zTCWT3MYdZO7" style="display: none">Schedule
of Cash and Restricted Cash</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20231231_zUskfSfE2iV1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20221231_znUZ7fvHtDW2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_zno6kDP5lx" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">9,284</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">13,871</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RestrictedCashCurrent_iI_pn3n3_zdHIlDDBpFjf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0929">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">502</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_zznDqR4ifFL" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total cash, cash equivalents, and restricted cash</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,284</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,373</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_z4OLwY6zlTZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023 and 2022, the Company had restricted cash of $<span id="xdx_900_eus-gaap--RestrictedCashCurrent_iI_pn3n3_dxL_c20231231_zOooSWMkC0Wa" title="Restricted cash::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0935">0</span></span> and $<span id="xdx_901_eus-gaap--RestrictedCashCurrent_iI_pn3n3_c20221231_zl4OXUGn5BEj" title="Restricted cash">502</span>, which served as collateral for certain credit card merchant
accounts with a bank.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable and Allowance for Doubtful Accounts</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zS2uwglgvJDc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_z8Sbs2Iwcjt7">Accounts
Receivable and Allowance for Doubtful Accounts</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company receives payments from advertising customers based upon contractual payment terms; accounts receivable is recorded when the right
to consideration becomes unconditional and are generally collected within 90 days. The Company generally receives payments from digital
and print subscription customers at the time of sign up for each subscription; accounts receivable from merchant credit card processors
are recorded when the right to consideration becomes unconditional and are generally collected weekly. Accounts receivable have been
reduced by an allowance for doubtful accounts. The Company maintains the allowance for estimated losses resulting from the inability
of the Company&#8217;s customers to make required payments. The allowance represents the current estimate of lifetime expected credit
losses over the remaining duration of existing accounts receivable considering current market conditions and supportable forecasts when
appropriate. The estimate is a result of the Company&#8217;s ongoing evaluation of collectability, customer creditworthiness, historical
levels of credit losses, and future expectations. Accounts receivable are written off when deemed uncollectible and collection of the
receivable is no longer being actively pursued. Accounts receivable as of December 31, 2023 and 2022 of $<span id="xdx_90F_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20231231_zl4wAyzTyJxj" title="Accounts receivable">44,811</span> and $<span id="xdx_903_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20221231_zk8tBgn9UdK9" title="Accounts receivable">33,950</span>, respectively,
are presented net of allowance for doubtful accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_eus-gaap--AccountsReceivableAllowanceForCreditLossTableTextBlock_zE6UsT17gkr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the allowance for doubtful accounts activity:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_8BF_zEgFA9pr0K7c" style="display: none">Schedule
of Allowance For Doubtful Accounts</span></i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230101__20231231_z2oNAD11QwDd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220101__20221231_zEvHgtnlkRJb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pn3n3_z52Kpe9D4YZ1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Allowance for doubtful accounts beginning of year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,236</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,578</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_pn3n3_zbWpUqbjztzi" style="vertical-align: bottom; background-color: White">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">315</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">658</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_pn3n3_di_zVYZVuWNQZE7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Deductions - write-offs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,570</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0954">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pn3n3_zAW7wIVI4Tvi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Allowance for doubtful accounts end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">981</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,236</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_z90ATvKk8wH" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_SubscriptionAcquisitionCostsPoliceTextBlock', window );">Subscription Acquisition Costs</a></td>
<td class="text"><p id="xdx_844_ecustom--SubscriptionAcquisitionCostsPoliceTextBlock_z22oJSGvtoSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zKboqtjKDKK1">Subscription
Acquisition Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
acquisition costs include the incremental costs of obtaining a contract with a customer, paid to external parties, if the Company
expects to recover those costs. The Company has determined that sales commissions paid on all third party agent sales of
subscriptions are direct and incremental costs of obtaining a contract with a customer and, therefore, meet the capitalization
criteria. The Company has elected to apply the practical expedient to amortize these costs at the portfolio level. The sales
commissions paid to third party agents are amortized as the magazines are sent to the subscriber on an issue-by-issue basis. The
Company determined that commissions paid for subscriber renewal contracts to all third party agents are not from a specifically
anticipated future contract, therefore, the commissions paid on renewals are amortized as the magazines are sent to the subscriber
over the renewal term on an issue-by-issue basis. Direct mail costs for renewal subscriptions are expensed as incurred since they do
not meet the capitalization criteria.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
of subscription acquisition costs of $<span id="xdx_900_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20230101__20231231_z3yqarK4qbT2" title="Amortization subscription costs">38,112</span> and $<span id="xdx_909_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20220101__20221231_zetPKUQdqnV" title="Amortization subscription costs">37,190</span> for the years ended December 31, 2023 and 2022, respectively, are included within
selling and marketing expenses on the consolidated statements of operations. No impairment losses have been recognized for subscription
acquisition costs for the years ended December 31, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Contract Modifications resulted in subscription acquisition costs to be recognized on a prospective basis in the same proportion as the
revenue that has not yet been recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current portion of the subscription acquisition costs as of December 31, 2023 and 2022 was $<span id="xdx_90D_eus-gaap--CapitalizedContractCostNet_iI_pn3n3_c20231231_zuQHX4IgjvLj" title="Subscription acquisition cost">29,706</span> and $<span id="xdx_908_eus-gaap--CapitalizedContractCostNet_iI_pn3n3_c20221231_zHgzmcuDTO2c" title="Subscription acquisition cost">25,931</span>, respectively. The noncurrent
portion of the subscription acquisition costs as of December 31, 2023 and 2022 was $<span id="xdx_90F_eus-gaap--CapitalizedContractCostNetNoncurrent_iI_pn3n3_c20231231_zuQZ8za8uVQ1" title="Acquisition cost long term">7,215</span> and $<span id="xdx_90A_eus-gaap--CapitalizedContractCostNetNoncurrent_iI_pn3n3_c20221231_zT9PoCGd3K8" title="Subscription acquisition cost noncurrent">14,133</span>, respectively. Subscription acquisition
costs as of December 31, 2023 presented as current assets of $<span id="xdx_90F_eus-gaap--CapitalizedContractCostNetCurrent_iI_pn3n3_c20231231_zo1MLlajxgTa" title="Subscription acquisition cost current">29,706</span> are expected to be amortized over a one-year period, or through
December 31, 2024, and presented as long-term assets of $<span id="xdx_903_eus-gaap--CapitalizedContractCostNetNoncurrent_iI_pn3n3_c20231231_zxsAKyrm7EHd" title="Acquisition cost long term">7,215</span> are expected to be amortized after the one-year period ending December
31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations</a></td>
<td class="text"><p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zuFwj24pNbIb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zdfqSnGTBc5i">Concentrations</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Significant
Customers</i> &#8211; Concentration of credit risk with respect to accounts receivable is limited to customers to whom the Company makes
significant sales. While a reserve for the potential write-off of accounts receivable is maintained, the Company has not written off
any material accounts to date. To control credit risk, the Company performs regular credit evaluations of its customers&#8217; financial
condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Revenue from significant customers
as a percentage of the Company&#8217;s total revenue represent approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zThted2Odbo8" title="Percentage of revenue">10.0%</span> from a customer for the year ended December 31,
2023. Revenue from significant customers as a percentage of the Company&#8217;s total revenue represent <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_ziHFVgMQvzek" title="Percentage of revenue">13.9</span>%
from a customer for the year ended December 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Significant
Vendors</i> &#8211; Concentrations of risk with respect to third party vendors who provide products and services to the Company are limited.
If not limited, such concentrations could impact profitability if a vendor failed to fulfill their obligations or if a significant vendor
was unable to renew an existing contract and the Company was not able to replace the related product or service at the same cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
accounts payable balances as a percentage of the Company&#8217;s total accounts payable represent <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zLCCYvLPg5sa" title="Percentage of revenue">12.2</span>%, and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zt1aDfZZD7h8" title="Percentage of revenue">14.1</span>% from a vendor for
the years ended December 31, 2023, and 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--LesseeLeasesPolicyTextBlock_zgFMOy83caE9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zaJmjfnbPHh1">Leases</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has lease arrangements for its offices. Leases are recorded as an operating lease right-of-use assets and
operating lease liabilities on the consolidated balance sheets. Leases with an initial term of 12 months or less are not recorded on
the consolidated balance sheets. At inception, the Company determines whether an arrangement that provides control over the use of an
asset is a lease. When it is reasonably certain that the Company will exercise the renewal period, the Company includes the impact of
the renewal in the lease term for purposes of determining total future lease payments. Rent expense is recognized on a straight-line
basis over the lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zDl5ILyJlW6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zfB4YD9VIXwd">Property
and Equipment</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment is stated at cost less accumulated depreciation. Maintenance and repairs are charged to expense as incurred. Gains and
losses from disposition of property and equipment are included on the consolidated statements of operations when realized.
Depreciation and amortization are provided using the straight-line method over the following estimated useful lives:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_ecustom--ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock_zW0c7n0xBdG" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zTBFGihIfjp5" style="display: none">Schedule
of Depreciation and Amortization, Useful Lives of Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; background-color: white; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Office equipment and computers</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember__srt--RangeAxis__srt--MinimumMember_zcxEM3qmqqvh" title="Property plant and equipment useful life">1</span>
    &#8211; <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember__srt--RangeAxis__srt--MaximumMember_zJxfuGiMd98k" title="Property plant and equipment useful life">3</span> years </span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Furniture and fixtures</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zswoOMa1XqJ5" title="Property plant and equipment useful life">1</span>
    &#8211; <span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_ziKDN4X4JdCf" title="Property plant and equipment useful life">5</span> years </span></td>
    </tr>
  </table>
<p id="xdx_8A9_zMfJETCLDmIl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PlatformDevelopmentPolicyTextBlock', window );">Platform Development</a></td>
<td class="text"><p id="xdx_846_ecustom--PlatformDevelopmentPolicyTextBlock_zy56NXyb0kWf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zyaIkOWXtRzd">Platform
Development</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes platform development costs for internal use when planning and design efforts are successfully completed, and development
is ready to commence. The Company places capitalized platform development assets into service and commences amortization when the applicable
project or asset is substantially complete and ready for its intended use. Once placed into service, the Company capitalizes qualifying
costs of specified upgrades or enhancements to capitalized platform development assets when the upgrade or enhancement will result in
new or additional functionality.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes internal labor costs, including payroll-based and stock-based compensation, benefits and payroll taxes, that are
incurred for certain capitalized platform development projects related to the Platform. The Company&#8217;s policy with respect to capitalized
internal labor stipulates that labor costs for employees working on eligible internal use capital projects are capitalized as part of
the historical cost of the project when the impact, as compared to expensing such labor costs, is material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Platform
development costs are amortized on a straight-line basis over three years, which is the estimated useful life of the related asset and
is recorded in cost of revenue on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><p id="xdx_845_eus-gaap--BusinessCombinationsPolicy_zT2MpaT5HXH9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zJI7DmkaUBF4">Business
Combinations</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for business combinations using the acquisition method of accounting. The acquisition method of accounting requires
that the purchase price, including the fair value of contingent consideration, of the acquisition be allocated to the assets acquired
and liabilities assumed using the estimated fair values determined by management as of the acquisition date. Goodwill is measured as
the excess of consideration transferred and the net fair values of the assets acquired, and the liabilities assumed at the date of acquisition.
While the Company uses its best estimates and assumptions as part of the purchase price allocation process to accurately value assets
acquired and liabilities assumed at the acquisition date, the Company&#8217;s estimates are inherently uncertain and subject to refinement.
As a result, during the measurement period, the Company records adjustments to the assets acquired and liabilities assumed, with the
corresponding offset to goodwill to the extent the Company identifies adjustments to the preliminary purchase price allocation. Upon
the conclusion of the measurement period, which may be up to one year from the acquisition date, or final determination of the values
of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements
of operations. Additionally, the Company identifies acquisition-related contingent payments and determines their respective fair values
as of the acquisition date, which are recorded as accrued liabilities on the consolidated balance sheets. Subsequent changes in fair
value of contingent payments are recorded on the consolidated statements of operations. The Company expenses transaction costs related
to the acquisition as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text"><p id="xdx_849_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zRmHtX5pTvZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zer3MX8n32Zc">Intangible
Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets with finite lives, consisting of developed technology and trade names, are amortized using the straight-line method over the estimated
economic lives of the assets. A finite lived intangible asset is tested for recoverability whenever events or changes in circumstances
indicate that its carrying amount may not be recoverable. Determination of recoverability is based on an estimate of undiscounted future
cash flows resulting from the use of the asset and its eventual disposition. Intangible assets with an indefinite useful life are not
amortized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zKkJeRxhDs7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zvWY7l29zly8">Long-Lived
Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company periodically evaluates the carrying value of long-lived assets to be held and used when events or circumstances warrant such
a review. The carrying value of a long-lived asset to be held and used is considered impaired when the anticipated separately identifiable
undiscounted cash flows from such an asset are less than the carrying value of the asset. In that event, a loss is recognized based on
the amount by which the carrying value exceeds the fair value of the long-lived asset. Fair value is determined primarily by reference
to the anticipated cash flows discounted at a rate commensurate with the risk involved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><p id="xdx_844_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zqeKGDJnsdl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_z2AQsN3mg3vf">Goodwill</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
represents the excess of the purchase price over the fair value of the net tangible and intangible assets of businesses acquired in a
business combination. Goodwill is not amortized but rather is tested for impairment at least annually on December 31, or more frequently
if events or changes in circumstances indicate that the carrying amount of goodwill may not be recoverable. The Company operates as one
reporting unit, therefore, the impairment test is performed at the consolidated entity level. Recoverability of goodwill is determined
by comparing the fair value of Company&#8217;s reporting unit to the carrying value of the underlying net assets in the reporting unit.
If the fair value of the reporting unit is determined to be less than the carrying value of its net assets, goodwill is deemed impaired,
and an impairment loss is recognized to the extent that the carrying value of goodwill exceeds the difference between the fair value
of the reporting unit and the fair value of its other assets and liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Debt Costs</a></td>
<td class="text"><p id="xdx_849_eus-gaap--DebtPolicyTextBlock_zSYHH4D9R5m2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zsLTIsIEsTe5">Debt
Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt
costs consist of cash and noncash consideration paid to lenders and third parties with respect to debt and other financing transactions,
including legal fees and placement fees. Such costs are deferred and amortized over the term of the related debt. Upon the settlement
of debt the pro rata portion of any related unamortized debt costs are charged to operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
consideration in the form of warrants and other derivative financial instruments issued to lenders are accounted for at fair value utilizing
information determined by consultants with the Company&#8217;s independent valuation firm. The fair value of warrants and derivatives
are recorded as a reduction to the carrying amount of the related debt and amortized to interest expense over the term of such debt,
with the initial offsetting entries recorded as a liability on the balance sheet. Upon the settlement of the debt the pro rata portion
of any related unamortized debt cost is charged to operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesPolicyTextBlock', window );">Liquidated Damages</a></td>
<td class="text"><p id="xdx_844_ecustom--LiquidatedDamagesPolicyTextBlock_zO8iSJcjfLf1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z8RIaUQLlYs4">Liquidated
Damages</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--LiquidatedDamagesDescription_c20230101__20231231_zonRRIz47iA3" title="Liquidated damages description">The
Company incurred liquidated damages when: (i) a registration rights agreement provides for damages if the Company does not register the
shares of the Company&#8217;s common stock within the requisite time frame (the &#8220;Registration Rights Damages&#8221;), which, in
general, provides for a cash payment equal to 1.0% per month of the amount invested, on a daily pro rata basis for any portion of a month,
as partial liquidated damages per month, upon the occurrence of certain events, up to a maximum amount of 6.0% of the aggregate amount
invested, subject to interest at the rate of 1.0% per month until paid in full; and (ii) a securities purchase agreement provides for
damages if the Company fails for any reason to satisfy a public information requirement within the requisite time frame with the Securities
and Exchange Commission (&#8220;SEC&#8221;) (the &#8220;Public Information Failure Damages&#8221;), which, in general, provides for a
cash payment equal to 1.0% of the aggregate amount invested for each 30-day period, or pro rata portion thereof, as partial liquidated
damages per month, up to a maximum of 6 months, subject to interest at the rate of 1.0% per month until paid in full. </span>Collectively, the
Registration Rights Damages and the Public Information Failure Damages are referred to as the &#8220;Liquidated Damages&#8221; on the
consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_SellingAndMarketingPolicyTextBlock', window );">Selling and Marketing</a></td>
<td class="text"><p id="xdx_844_ecustom--SellingAndMarketingPolicyTextBlock_z0QK2t5Wt1Td" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_z3MWHRefDrKh">Selling
and Marketing</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
and marketing expenses consist of compensation, employee benefits and stock-based compensation of selling and marketing, account management
support teams, as well as commissions, travel, trade show sponsorships and events, conferences and advertising costs. The Company&#8217;s
advertising expenses relate to direct-mail costs for magazine subscription acquisition efforts, and print and digital advertising that
are expensed when an advertisement takes place. During the years ended December 31, 2023 and 2022, the Company incurred advertising expenses
of $<span id="xdx_90B_eus-gaap--AdvertisingExpense_pn3n3_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zPoX2qm3OAc8" title="Advertising expense">4,372</span> and $<span id="xdx_90B_eus-gaap--AdvertisingExpense_pn3n3_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zxjpFaaFJ06g" title="Advertising expense">5,987</span>, respectively, which are included within selling and marketing on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_GeneralandAdministrativePolicyTextBlock', window );">General and Administrative</a></td>
<td class="text"><p id="xdx_84A_ecustom--GeneralandAdministrativePolicyTextBlock_zCq43ynBTIca" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zHESIMYAoQnd">General
and Administrative</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses consist primarily of payroll for executive personnel, technology personnel incurred in developing conceptual
formulation and determination of existence of needed technology, and administrative personnel along with any related payroll costs; professional
services, including accounting, legal and insurance; facilities costs; conferences; other general corporate expenses; and stock-based
compensation of related personnel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--DerivativesPolicyTextBlock_z3pQuzSXL8qj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zfzZMmqi8hhf">Derivative
Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for freestanding contracts that are settleable in the Company&#8217;s equity securities, including the put option
on the Company&#8217;s common stock, to be designated as an equity instrument, generally as a liability. A contract so
designated is carried at fair value on the consolidated balance sheets, with any changes in fair value recorded as a gain or loss
on the consolidated statements of operations, with no impact on cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the date of settlement of a freestanding equity contract, the pro rata fair value of the related liability is transferred to additional
paid-in capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zmMSvz7HBx56" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zzFyoRQo3clh">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
authoritative guidance with respect to fair value established a fair value hierarchy that prioritizes the inputs to valuation techniques
used to measure fair value into three levels and requires that assets and liabilities carried at fair value be classified and disclosed
in one of three categories, as presented below. Disclosure as to transfers in and out of Levels 1 and 2, and activity in Level 3 fair
value measurements, is also required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
1</i>. Observable inputs such as quoted prices in active markets for an identical asset or liability that the Company has the ability
to access as of the measurement date. Financial assets and liabilities utilizing Level 1 inputs include active-exchange traded securities
and exchange-based derivatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
2</i>. Inputs, other than quoted prices included within Level 1, which are directly observable for the asset or liability or indirectly
observable through corroboration with observable market data. Financial assets and liabilities utilizing Level 2 inputs include fixed
income securities, non-exchange-based derivatives, mutual funds, and fair-value hedges.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
3</i>. Unobservable inputs in which there is little or no market data for the asset or liability which requires the reporting entity
to develop its own assumptions. Financial assets and liabilities utilizing Level 3 inputs include infrequently traded non-exchange-based
derivatives and commingled investment funds and are measured using present value pricing models.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines the level in the fair value hierarchy within which each fair value measurement falls in its entirety, based on the
lowest level input that is significant to the fair value measurement in its entirety. In determining the appropriate levels, the Company
performs an analysis of the assets and liabilities at each reporting period end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of the Company&#8217;s financial instruments comprising of cash, restricted cash, accounts receivable, accounts payable
and accrued expenses and other approximate fair value because of the short-term maturity of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PreferredStockPolicyTextBlock', window );">Preferred Stock</a></td>
<td class="text"><p id="xdx_84E_ecustom--PreferredStockPolicyTextBlock_zDlpskR8gWFg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zMpV7zgSR8na">Preferred
Stock</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
stock (the &#8220;Preferred Stock&#8221;) (as described in Note 20) is reported as a mezzanine obligation between liabilities and stockholders&#8217;
deficiency. If it becomes probable that the Preferred Stock will become redeemable, the Company will re-measure the Preferred Stock by
adjusting the carrying value to the redemption value of the Preferred Stock assuming each balance sheet date is a redemption date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zIuIuxLGOIB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zpSOz2pWbCmh">Stock-Based
Compensation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides stock-based compensation in the form of (a) stock awards to employees and directors, comprised of restricted stock awards
and restricted stock units, (b) stock option grants to employees, directors and consultants, (c) common stock warrants to Publisher Partners
(no warrants were issued during the year ended December 31, 2022) (further details are provided under the headings <i>Publisher Partner
Warrants</i> and <i>New Publisher Partner Warrants</i> in Note 22), and (d) common stock warrants to ABG (further details are provided
under the heading <i>ABG Warrants</i> in Note 22).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for stock awards and stock option grants to employees, directors and consultants, and non-employee awards to certain
directors and consultants by measuring the cost of services received in exchange for the stock-based payments as compensation expense
in the Company&#8217;s consolidated financial statements. Stock awards and stock option grants to employees and non-employees which are
time-vested, are measured at fair value on the grant date, and charged to operations ratably over the vesting period. Stock awards and
stock option grants to employees and non-employees which are performance-vested, are measured at fair value on the grant date and charged
to operations when the performance condition is satisfied or over the service period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value measurement of stock awards and grants used for stock-based compensation is as follows: (1) restricted stock awards and restricted
stock units which are time-vested, are determined using the quoted market price of the Company&#8217;s common stock at the grant date;
(2) stock option grants which are time-vested and performance-vested, are determined utilizing the Black-Scholes option-pricing model
at the grant date; (3) restricted stock units and stock option grants which provide for market-based vesting with a time-vesting overlay,
are determined through consultants with the Company&#8217;s independent valuation firm using the Monte Carlo model at the grant date;
(4) Publisher Partner Warrants were determined utilizing the Black-Scholes option-pricing model; and (5) ABG warrants are determined
utilizing the Monte Carlo model (further details are provided in Note 22). Estimated volatility was determined under the (1) &#8220;Probability
Weighted Scenarios&#8221; (prior to the reverse stock split on February 8, 2022) where one scenario assumes that the Company&#8217;s
common stock will be up-listed on a national stock exchange (the &#8220;Exchange&#8221;) on a certain listing date (the &#8220;Up-list&#8221;)
where the estimated volatility was based on evaluating the average historical volatility of a group of peer companies that are publicly
traded and the second scenario assumes that the Company&#8217;s common stock is not up-listed on the Exchange prior to the final vesting
date of the grants (the &#8220;No Up-list&#8221;) where the historical volatility of the Company&#8217;s common stock was evaluated based
upon market comparisons; and the (2) &#8220;Up-list Scenario&#8221; (after the reverse stock split on February 8, 2022) where the Company
estimated volatility based on evaluating the average historical volatility of a group of peer companies that are publicly traded after
the Company up-listed to the NYSE American. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time
of grant. The fair market value of common stock is determined by reference to the quoted market price of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has elected to recognize forfeitures as they occur and to recognize stock-based compensation cost on a straight-line basis over
the total requisite service period for awards with graded vesting. The Company classifies stock-based compensation cost on its consolidated
statements of operations in the same manner in which the award recipient&#8217;s cash compensation cost is classified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--IncomeTaxPolicyTextBlock_zDKKsMkd28U" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zMvqGY6kRZR3">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the future
tax consequences attributable to operating loss carryforwards and temporary differences between financial statement bases of existing
assets and liabilities and their respective income tax bases. Deferred tax assets and liabilities are measured using enacted income tax
rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
The effect of a change in the income tax rates on deferred tax asset and liability balances is recognized in income in the period that
includes the enactment date of such rate change. A valuation allowance is recorded for loss carryforwards and other deferred tax assets
when it is determined that it is more likely than not that such loss carryforwards and deferred tax assets will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows accounting guidance that sets forth a threshold for financial statement recognition, measurement, and disclosure of a
tax position taken or expected to be taken on a tax return. Such guidance requires the Company to determine whether a tax position of
the Company is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any
related appeals or litigation processes, based on technical merits of the position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss per Common Share</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zW0EOEfnZsc4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zP4yJZ86ccOj">Loss
per Common Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
loss per share is computed using the weighted average number of common shares outstanding during the period and excludes any dilutive
effects of common stock equivalent shares, such as stock options, restricted stock, and warrants. All restricted stock awards are considered
outstanding but are included in the computation of basic loss per common share only when the restrictions expire, the shares are no longer
forfeitable, and are thus vested. Restricted stock units are included in the computation of basic loss per common share only when the
restrictions expire, the shares are no longer forfeitable, and are thus vested. Contingently issuable shares are included in basic loss
per common share only when there are no circumstances under which those shares would not be issued. Diluted loss per common share is
computed using the weighted average number of common shares outstanding and common stock equivalent shares outstanding during the period
using the treasury stock method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company excluded the outstanding securities summarized below (capitalized terms are described herein), which entitle the holders thereof
to acquire shares of the Company&#8217;s common stock, from its calculation of net loss per common share, as their effect would have
been anti-dilutive. Common stock equivalent shares are excluded from the diluted calculations when a net loss is incurred as they would
be anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zcNoxzT4AHKc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zUHosAth0BJk" style="display: none">Schedule of Net Income (Loss) Per Common Share</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Series G Preferred Stock</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesGConvertiblePreferredStockMember_zxS1HyVzT6Hg" style="width: 16%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">8,582</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesGConvertiblePreferredStockMember_zy05uUvS9Bi8" style="width: 16%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">8,582</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series H Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_zs3G5RlmtVc5" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"><span style="-sec-ix-hidden: xdx2ixbrl1043">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_zPxiV0ZDttT2" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">1,981,128</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Financing Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--FinancingWarrantsMember_zWBVv26ftGIb" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"><span style="-sec-ix-hidden: xdx2ixbrl1047">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--FinancingWarrantsMember_zZoIMd1yBJEk" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">107,956</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">ABG Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ABGWarrantsMember_znZyyHEUN9n8" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">999,540</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ABGWarrantsMember_zZnThCEIVN0l" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">999,540</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">AllHipHop Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--AllHipHopWarrantsMember_zHrXsJSzGy91" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">5,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--AllHipHopWarrantsMember_zPa0CoHEe7p4" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">5,682</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Publisher Partner Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublisherPartnerWarrantsMember_z12mD82wm2fk" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">9,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublisherPartnerWarrantsMember_zzrC8Hp0G7fc" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">4,154</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Restricted stock awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockAwardsMember_zzBBvqBjcCLa" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"><span style="-sec-ix-hidden: xdx2ixbrl1063">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockAwardsMember_zQPv2XEZ5SN1" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">97,403</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Restricted stock units</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_z7eIQKbpKSIg" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">199,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zFC86bgITA7d" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">994,766</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Common stock options</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockOptionsMember_z0wnOpFkLHua" style="border-bottom: Black 1.5pt solid; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">5,451,968</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockOptionsMember_zh8GnBEkgfRl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">6,199,521</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231_zip2RniEz9B6" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">6,674,839</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zLIoGGwnyhJ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">10,398,732</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AF_zyEVyspNnUD7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z6eBmGl1Tudc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zX0scoSqXuz6">Recent
Accounting Pronouncements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recently
Adopted Accounting Standards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2022, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued ASU 2022-02, <i>Financial Instruments-Credit Losses(Topic
326): Troubled Debt Restructurings and Vintage Disclosures, </i>addressing areas identified by the FASB as part of its post-implementation
review of its previously issued credit losses standard (ASU 2016-13) that introduced the current expected credit losses (CECL) model.
ASU 2022-02 eliminates the accounting guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhances
disclosure requirements for certain loan refinancings and restructurings made with borrowers experiencing financial difficulty. This
update requires an entity to disclose current-period gross write-offs for financing receivables and net investment in leases by year
of origination in the vintage disclosures. As the Company has already adopted ASU 2016-13, the new guidance was adopted on January 1,
2023. The adoption of ASU 2022-02 did not have a material impact on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recently
Issued Accounting Standards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the FASB issued ASU 2022-03, <i>Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to
Contractual Sale Restrictions</i>, which clarifies that a contractual restriction on the sale of an equity security is not considered
part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. This update also clarifies
that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction and requires certain disclosures
for equity securities subject to contractual sale restrictions. ASU 2022-03 is effective for the Company in the fiscal year beginning
after December 15, 2023, and interim periods within the fiscal year. Early adoption is permitted for both interim and annual financial
statements that have not yet been issued or made available for issuance. The Company is currently evaluating the impact that the adoption
of this new accounting standard will have on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2023, the FASB issued ASU 2023-06, <i>Disclosure Improvements: Codification Amendments in Response to the SEC&#8217;s Disclosure
Update and Simplification Initiative</i>, which incorporates certain SEC disclosure requirements into the FASB Accounting Standards Codification
(&#8220;Codification&#8221;). The amendments are expected to clarify or improve disclosure and presentation requirements of a variety
of Codification Topics, allow users to more easily compare entities subject to the SEC&#8217;s existing disclosures with those entities
that were not previously subject to the requirements, and align the requirements in the Codification with the SEC&#8217;s regulations.
ASU 2023-06 will become effective for each amendment on the effective date of the SEC&#8217;s corresponding disclosure rule changes.
The Company is currently evaluating the impact that the adoption of this new standard will have on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes</i> (Topic 740): Improvements to Income Tax Disclosures, which will require
the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for
reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid
disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. The provisions
of ASU 2023-09 are effective for annual periods beginning after December 15, 2024; early adoption is permitted using either a prospective
or retrospective transition method. The Company expects ASU 2023-09 to require additional disclosures in the notes to its consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material
impact on the Company&#8217;s financial statement presentation or disclosures.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ContractBalancesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract Balances [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ContractBalancesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_CostOfRevenuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost Of Revenue [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_CostOfRevenuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_GeneralandAdministrativePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generaland Administrative [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_GeneralandAdministrativePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LiquidatedDamagesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidated Damages [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LiquidatedDamagesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_PlatformDevelopmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Platform Development [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_PlatformDevelopmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_PreferredStockPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_PreferredStockPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_RisksAndUncertaintiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Risks And Uncertainties [Policy]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_RisksAndUncertaintiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_SellingAndMarketingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Selling And Marketing [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_SellingAndMarketingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_SubscriptionAcquisitionCostsPoliceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subscription Acquisition Costs [Police Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_SubscriptionAcquisitionCostsPoliceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483256/920-350-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483256/920-350-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483256/920-350-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-11B<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735595440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><p id="xdx_895_eus-gaap--DisaggregationOfRevenueTableTextBlock_zqIHuXdmsySi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information about disaggregated revenue by category, geographical market and timing of revenue recognition:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_z6Kcyvj050lh" style="display: none">Schedule
of Disaggregation of Revenue</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230101__20231231_zkXxx6cmdky8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20221231_ztGAhuYNbwml" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Revenue by category:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><b>Digital revenue</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalAdvertisingMember_zo01p5dvBfP" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 60%; text-align: justify">Digital advertising</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">135,376</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">109,317</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalSubscriptionsMember_zD0kRLElyCW" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Digital subscriptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,764</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,156</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--LicensingAndSyndicationRevenueMember_zfNDuHqh6Ld8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Licensing and syndication revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,173</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__us-gaap--ProductAndServiceOtherMember_zx2y2DOEFCp1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Other digital revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,384</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,166</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zgsNr7azyhMl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify; padding-bottom: 1.5pt">Total digital revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">172,006</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">149,812</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><b>Print revenue</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintAdvertisingMember_zbRG7M168fX4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Print advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,881</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,214</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintSubscriptionsMember_zv5dvOGnfQz2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Print subscriptions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">62,316</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">60,909</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_zzQN9CQzquF8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: justify; padding-bottom: 1.5pt">Total print revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">72,197</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">71,123</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zUzRiEu6CZTh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">244,203</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">220,935</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Revenue by geographical market:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__country--US_zKX1xgZJTcp9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">United States</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">234,012</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">218,110</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__custom--OtherMember_zS4cb0vzdZL4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,191</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,825</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zgadvHNx3Wz9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">244,203</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">220,935</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Revenue by timing of recognition:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_zumKpCgm0fo5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">At point in time</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">231,439</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">199,779</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zpFUGfTLJXS6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Over time</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,764</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,156</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zmjvuJAzMUPa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0pt; text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">244,203</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">220,935</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Contract with Customer, Asset and Liability</a></td>
<td class="text"><p id="xdx_898_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_zaHl7ipmaYU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information about contract balances:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zB03ZNauj0wc" style="display: none">Schedule
of Contract with Customer, Asset and Liability</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20231231_zaeO3S0cr5pd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20221231_z3Gw4AyXnoya" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unearned revenue (short-term contract liabilities):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zNXnIczbDXRb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Digital revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">14,397</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">18,571</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_z7Oqs9MAbBK9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Print revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,389</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">40,132</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_z1TaModhTRyk" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total short-term contract
    liabilities</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">59,786</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">58,703</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unearned revenue (long-term contract liabilities):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zce7hTDFpFCe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Digital revenue</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">542</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,118</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_zUy5wqyC5QDa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Print revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,137</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,583</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_zxVz3y32mAu9" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total long-term contract
    liabilities</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,679</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,701</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of Cash and Restricted Cash</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_zWFdppVl58t5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reconciles total cash, cash equivalents, and restricted cash:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zTCWT3MYdZO7" style="display: none">Schedule
of Cash and Restricted Cash</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20231231_zUskfSfE2iV1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20221231_znUZ7fvHtDW2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_zno6kDP5lx" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">9,284</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">13,871</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RestrictedCashCurrent_iI_pn3n3_zdHIlDDBpFjf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0929">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">502</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_zznDqR4ifFL" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total cash, cash equivalents, and restricted cash</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,284</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,373</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Schedule of Allowance For Doubtful Accounts</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--AccountsReceivableAllowanceForCreditLossTableTextBlock_zE6UsT17gkr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the allowance for doubtful accounts activity:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_8BF_zEgFA9pr0K7c" style="display: none">Schedule
of Allowance For Doubtful Accounts</span></i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230101__20231231_z2oNAD11QwDd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220101__20221231_zEvHgtnlkRJb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pn3n3_z52Kpe9D4YZ1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Allowance for doubtful accounts beginning of year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,236</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,578</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_pn3n3_zbWpUqbjztzi" style="vertical-align: bottom; background-color: White">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">315</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">658</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_pn3n3_di_zVYZVuWNQZE7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Deductions - write-offs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,570</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0954">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pn3n3_zAW7wIVI4Tvi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Allowance for doubtful accounts end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">981</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,236</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock', window );">Schedule of Depreciation and Amortization, Useful Lives of Assets</a></td>
<td class="text"><p id="xdx_89B_ecustom--ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock_zW0c7n0xBdG" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zTBFGihIfjp5" style="display: none">Schedule
of Depreciation and Amortization, Useful Lives of Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; background-color: white; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Office equipment and computers</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember__srt--RangeAxis__srt--MinimumMember_zcxEM3qmqqvh" title="Property plant and equipment useful life">1</span>
    &#8211; <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember__srt--RangeAxis__srt--MaximumMember_zJxfuGiMd98k" title="Property plant and equipment useful life">3</span> years </span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Furniture and fixtures</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zswoOMa1XqJ5" title="Property plant and equipment useful life">1</span>
    &#8211; <span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_ziKDN4X4JdCf" title="Property plant and equipment useful life">5</span> years </span></td>
    </tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Net Income (Loss) Per Common Share</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zcNoxzT4AHKc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zUHosAth0BJk" style="display: none">Schedule of Net Income (Loss) Per Common Share</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Series G Preferred Stock</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesGConvertiblePreferredStockMember_zxS1HyVzT6Hg" style="width: 16%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">8,582</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesGConvertiblePreferredStockMember_zy05uUvS9Bi8" style="width: 16%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">8,582</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series H Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_zs3G5RlmtVc5" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"><span style="-sec-ix-hidden: xdx2ixbrl1043">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_zPxiV0ZDttT2" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">1,981,128</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Financing Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--FinancingWarrantsMember_zWBVv26ftGIb" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"><span style="-sec-ix-hidden: xdx2ixbrl1047">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--FinancingWarrantsMember_zZoIMd1yBJEk" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">107,956</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">ABG Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ABGWarrantsMember_znZyyHEUN9n8" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">999,540</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ABGWarrantsMember_zZnThCEIVN0l" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">999,540</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">AllHipHop Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--AllHipHopWarrantsMember_zHrXsJSzGy91" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">5,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--AllHipHopWarrantsMember_zPa0CoHEe7p4" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">5,682</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Publisher Partner Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublisherPartnerWarrantsMember_z12mD82wm2fk" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">9,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublisherPartnerWarrantsMember_zzrC8Hp0G7fc" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">4,154</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Restricted stock awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockAwardsMember_zzBBvqBjcCLa" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"><span style="-sec-ix-hidden: xdx2ixbrl1063">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockAwardsMember_zQPv2XEZ5SN1" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">97,403</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Restricted stock units</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_z7eIQKbpKSIg" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">199,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zFC86bgITA7d" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">994,766</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Common stock options</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockOptionsMember_z0wnOpFkLHua" style="border-bottom: Black 1.5pt solid; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">5,451,968</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockOptionsMember_zh8GnBEkgfRl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">6,199,521</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231_zip2RniEz9B6" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">6,674,839</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zLIoGGwnyhJ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount">10,398,732</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Depreciation And Amortization Useful Lives Of Assets [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656730080352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosureDiscontinuedOperationsAbstract', window );"><strong>Discontinued Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Discontinued Operations</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zDQuJsdj6e0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets forth the loss from discontinued operations for the period from April 1, 2022 to December 31, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zn22JF4NU2u1" style="display: none">Schedule
of Discontinued Operations</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20230101__20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ParadePrintMember_zpAqssYGLUo4" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_pn3n3_maDGIDOzNh5_z1Oaknj4Fcv3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-weight: bold; text-align: justify">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">26,817</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_pn3n3_msDGIDOzNh5_z01J6AkuB3R3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Cost of revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23,015</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_pn3n3_mtDGIDOzNh5_maDOILFz1bv_zyA3TSwAKUr4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Gross profit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,802</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingExpensesAbstract_iB_zPiAToi6biSf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Operating expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense_i01_pn3n3_maDGIDOz1uJ_zYCavD1n3Xsh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Selling and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,396</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_i01_pn3n3_maDGIDOz1uJ_znzXXSt0ioXc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,722</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges_i01_pn3n3_maDGIDOz1uJ_zp1wni88eKt4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Loss on impairment of assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">209</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_i01T_pn3n3_mtDGIDOz1uJ_msDOILFz1bv_zyiQLv9Zvla9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,327</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_iT_pn3n3_mtDOILFz1bv_maILFDOzJiH_zEUMX57Z38xe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Loss from discontinued operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,525</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--DiscontinuedOperationTaxEffectOfDiscontinuedOperation_pn3n3_msILFDOzJiH_zNYoXAHTZAH" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Income tax benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">55</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_iT_pn3n3_mtILFDOzJiH_zySvqJIUxHYk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net loss from discontinued operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,470</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosureDiscontinuedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosureDiscontinuedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-4A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-4B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5D<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3A<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656737760464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Dispositions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Schedule of Supplemental Proforma Information</a></td>
<td class="text"><p id="xdx_899_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zG6IKhpF3Y11" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the results of continuing operations of the Parade acquisition from the acquisition date included in the consolidated
results of continuing operations and the unaudited pro forma results of continuing operations of the combined entity had the date of
the acquisition been January 1, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zcU5rNh4TdRb" style="display: none">Schedule
of Supplemental Proforma Information</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_495_20220101__20221231_z7remYnAFZUe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended<br/>
 December 31, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Parade continuing operations from acquisition date of April 1, 2022 (unaudited):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_z0IgHpsFega5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 80%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">40,071</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_zmLU31f2hiYe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,494</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Combined entity continuing operations supplemental pro forma information had the acquisition date been January 1, 2022 (unaudited):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Revenue:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_z56KFyPQBJTd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Parade</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">55,981</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ArenaMember_zXoW2umzo1Mh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt">Arena</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">207,681</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_zKkEAGwHIyVd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Total continuing operations supplemental pro forma revenue</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">263,662</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Net loss:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_zXre08hcmKIg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Parade</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(3,070</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ArenaMember_zkGp4Jcz3AUl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt">Arena</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(67,788</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AdjustmentsMember_z8RHDUqrILie" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Adjustments</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,940</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_zFokrXxMi8Ii" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Total continuing operations supplemental pro forma net loss</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(72,798</td><td style="text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PreliminaryPriceAllocationTableTextBlock', window );">Schedule of Preliminary Price Allocation</a></td>
<td class="text"><p id="xdx_895_ecustom--PreliminaryPriceAllocationTableTextBlock_z0FbDxu0hiZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the closing
date of the acquisition based upon their respective fair values as summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zchIUZR7TZh6" style="display: none">Schedule
of Preliminary Price Allocation</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20231231_zW26LEiBXS28" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zFW5k6qyBLhb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Lease deposit receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">420</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zRgr58wPNMi3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Advertiser relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,860</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_znh0LJ8NCxah" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Brand names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,090</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zQLSP7Se0Wjl" style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,384</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zrbigUcHcuLf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,941</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zA3ssgNovCO1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Subscription refund liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(137</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_ztHG9TXJ02Gk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Assumed lease obligation</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,676</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_mtBCRIAzrWD_zihQ2yobSH02" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net assets acquired</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">25,000</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_AthlonHoldingsIncMember', window );">Athlon Holdings Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Composition of Purchase Price</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zVU71i5ront5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of the purchase price is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zwoDcSHUgxF3" style="display: none">Schedule
of Composition of Purchase Price</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20220401__20220401_zwWFAR22WvQk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PaymentsToAcquireBusinessesGross_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z06h1E9eddT8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">12,085</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zKefsckbnuA3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,141</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--BusinessCombinationConsiderationTransferredOther1_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zWMQEOG6nLX5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred cash payments, as discounted</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">628</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zfMsmFECWBY2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total purchase consideration</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,854</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Summary of Purchase Price Allocation</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zkjC4t2Uej3a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the closing
date of the acquisition based upon their respective fair values as summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span id="xdx_8B3_zz11kMAZmCik" style="display: none">Summary
of Purchase Price Allocation</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20220401_zwJKPlcE4Bz5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zJSpTofVvLOf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,604</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zH4qtZRDuZga" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,855</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zBgAJM5kdXSd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,337</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z3GlLmnxNIYf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Equity investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,450</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zqRHG02u1aaa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fixed assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">108</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z7lf3nyVTBD9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Digital content</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">355</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zBZ8aVJw4Pk3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Advertiser relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,202</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zUzZt8DEbBq2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,261</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Goodwill_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zYFqYAyq6HIk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,587</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zQYCeWwBC2db" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,416</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z1rSZYK6FWCj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued expenses and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,440</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zDwmMH6zpqRc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,203</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zt1sMzBsO7wl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other long-term liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(543</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zFmtJ1scgfze" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred tax liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,303</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pn3n3_zEMBrdmRhRqc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net assets acquired</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,854</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=AREN_FexyStudiosMember', window );">Fexy Studios [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionTableTextBlock', window );">Schedule of Composition Preliminary Assets Purchase Price</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--AssetAcquisitionTableTextBlock_hus-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zZ04CRkYXmLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of the purchase price is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zmnG52KIiqZf" style="display: none">Schedule
of Composition Preliminary Assets Purchase Price</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_494_20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zgZD4Tm5K2T" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_zVVk8z3HmHfe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_pn3n3_zpj6GXTndzJ3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AssetAcquisitionConsiderationTransferredContingentConsideration_pn3n3_z6AIBH3OCEt3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Contingent consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">561</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted_pn3n3_zwucxxjQkZTf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Deferred cash payments, as discounted</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">246</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetAcquisitionConsiderationTransferred_pn3n3_znH0qohjrN09" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total purchase consideration</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,307</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ScheduleOfAssetsAcquiredTableTextBlock', window );">Summary of Preliminary Assets Purchase Price Allocation</a></td>
<td class="text"><p id="xdx_89A_ecustom--ScheduleOfAssetsAcquiredTableTextBlock_hus-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zkjMMaoHiFE3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the closing
date of the acquisition based upon their respective fair values as summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zVECqHb6rdrc" style="display: none">Summary
of Preliminary Assets Purchase Price Allocation</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_z43ZG3xIYba9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zEJ8X7Od0Yb1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Advertiser relationships</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">663</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zsr2ZG29ddp5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Brand names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">659</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_z3qPiUF5h4cf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,985</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zikUkgFTNWY1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net assets acquired</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,307</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_PreliminaryPriceAllocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Preliminary Price Allocation [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_PreliminaryPriceAllocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ScheduleOfAssetsAcquiredTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Assets Acquired [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ScheduleOfAssetsAcquiredTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_AthlonHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_AthlonHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=AREN_FexyStudiosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=AREN_FexyStudiosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735809184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepayments and Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract', window );"><strong>Prepayments And Other Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock', window );">Schedule of Prepayments and Other Current Assets</a></td>
<td class="text"><p id="xdx_89B_ecustom--ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock_zK21i0AyAXs3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments
and other current assets are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z52qj90FVIZ1" style="display: none">Schedule
of Prepayments and Other Current Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20231231_zxRSM98gSmEd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20221231_z2aVu4WSZfWc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--PrepaidExpenseCurrent_iI_pn3n3_maPEAOAz2Qi_zJXP5KDmgx51" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Prepaid expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,946</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,321</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--PrepaidSuppliesCurrent_iI_pn3n3_maPEAOAz2Qi_zmQmNq1cyVU8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepaid supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">773</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">927</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--RefundableIncomeAndFranchiseTaxes_iI_pn3n3_maPEAOAz2Qi_zccHzQlbKAsf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Refundable income and franchise taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">157</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">957</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--UnamortizedDebtIssuanceExpense_iI_pn3n3_maPEAOAz2Qi_za6mXI3yoJq2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Unamortized debt costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">209</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">216</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--EmployeeRetentionCredits_iI_pn3n3_maPEAOAz2Qi_zcFBlFeyijPi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Employee retention credits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,468</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1358">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OtherReceivablesNetCurrent_iI_pn3n3_maPEAOAz2Qi_zrOUrSKRot2j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Other receivables</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pn3n3_mtPEAOAz2Qi_zPhGd2b5E9Ek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Total prepayments and other current assets</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,441</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Prepayments And Other Current Assets [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656730047264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><p id="xdx_894_eus-gaap--PropertyPlantAndEquipmentTextBlock_zrVBM4nfXDV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z00fXVxvVns5" style="display: none">Schedule
of Property and Equipment</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20231231_ztUb904c6zD9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20221231_zxMkf96zdw12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember_zG7nYHo7rrqg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Office equipment and computers</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,744</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,744</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zw5uzQL0rvOe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Furniture and fixtures</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">166</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">240</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzTTM_zxgEiOJC5C5b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross property and equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,910</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,984</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzTTM_zPkDfoa6qxae" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,582</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,249</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzTTM_zwnAoQd435qf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net property and equipment</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">328</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">735</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736379648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_SupplementalInformationRelatedToOperatingLeasesTableTextBlock', window );">Schedule of Supplemental Information Related to Operating Leases</a></td>
<td class="text"><p id="xdx_890_ecustom--SupplementalInformationRelatedToOperatingLeasesTableTextBlock_z52YZlcmodh3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below presents supplemental information related to the operating lease:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zbc8Sd4pa3G1" style="display: none">Schedule
of Supplemental Information Related to Operating Leases</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Operating lease costs during the year (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--LeaseCost_pn3n3_c20230101__20231231_fKDEp_zwycTJTBHuPg" style="width: 16%; text-align: right" title="Operating lease costs during the year">1,052</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--LeaseCost_pn3n3_c20220101__20221231_fKDEp_z73jF7LNQxa5" style="width: 16%; text-align: right" title="Operating lease costs during the year">969</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash payments included in the measurement of operating lease liability during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--OperatingLeasePayments_pn3n3_c20230101__20231231_z2yyjd2lZEh9" style="text-align: right" title="Cash payments included in the measurement of operating lease liabilities during the year">486</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--OperatingLeasePayments_pn3n3_c20220101__20221231_zV3eA2wVOeb8" style="text-align: right" title="Cash payments included in the measurement of operating lease liabilities during the year">469</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted-average remaining lease term (in years) as of year-end</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_zvVHFKuBJfxf" title="Weighted-average remaining lease term (in years) as of year-end">0.75</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zV1asf4n4CX6" title="Weighted-average remaining lease term (in years) as of year-end">1.75</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted-average discount rate during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20231231_z3naXHOK2tSf" title="Weighted-average discount rate during the year">9.90</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231_z3QuF40HSk5c" title="Weighted-average discount rate during the year">9.90</span></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F08_zb7OynYi8UTh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F18_zEBwpg9r4gh8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease
costs is presented net of sublease income that is not material.</span></td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Operating Lease Costs</a></td>
<td class="text"><p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zJfBLkQAHXFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of operating lease costs were follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zO2LqGqlKC0c" style="display: none">Schedule
of Operating Lease Costs</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230101__20231231_zinowhJF3MF8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220101__20221231_zG8RsxWcdt29" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating lease costs:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingLeaseCost_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zV0B4SpXnKy7" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">General and administrative</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">1,344</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">1,187</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseCost_pn3n3_maLCzoNR_zpSk8bcA8Md1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Total operating costs (<span id="xdx_F4B_zLdAqtn6mQj3">1</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,344</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,187</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--SubleaseIncome_iN_pn3n3_di_msLCzoNR_zkt2DSPB3R76" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Less sublease income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(292</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(218</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--LeaseCost_iT_pn3n3_mtLCzoNR_zBWuVL4CSMb2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total operating lease costs</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,052</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">969</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F02_zTMXHN40VhG6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1D_zEregB25HjTh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes certain
costs associated with a business membership agreement (see below) that permits access to certain office space for the years ended December
31, 2023 and 2022 of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_904_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessMembershipAgreementMember_zU6h5otEQ9t7" title="Operating lease cost">620</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--OperatingLeaseCost_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--BusinessMembershipAgreementMember_z6Ipd2wuVVn6" title="Operating lease cost">668</span>, respectively, and month-to-month lease arrangements for the years ended December 31, 2023 and 2022
of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--MonthToMonthLeaseArrangementMember_zKURtxpM8Jmd" title="Operating lease cost">396</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--OperatingLeaseCost_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--MonthToMonthLeaseArrangementMember_zmCHQMmJCq5d" title="Operating lease cost">320</span>, respectively.</span></td>
</tr></table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Summary of Maturity of Lease Liabilities</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zmOuJ48hGynk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturities
of the operating lease liability as of December 31, 2023 are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zVtIOD6SsG02" style="display: none">Summary
of Maturity of Lease Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20231231_zQ9FCrzvbBFa" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtLOLLPzG3L_zYptFfV4rQMa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Minimum lease payments - 2024</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">373</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_zKMGTQFvJeW6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(15</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zdX0MRz6KWX3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Present value of operating lease liability</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">358</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_z45RPMTavPHc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Current portion of operating lease liability</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">358</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zyDmUs7j4Ru9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Long-term portion of operating lease liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1455">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zrTlsJVExJT6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total operating lease liability</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">358</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_SupplementalInformationRelatedToOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Information Related to Operating Leases [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_SupplementalInformationRelatedToOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656729894368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Platform Development (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosurePlatformDevelopmentAbstract', window );"><strong>Platform Development</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_SummaryOfPlatformDevelopmentCostsTableTextBlock', window );">Summary of Platform Development Costs</a></td>
<td class="text"><p id="xdx_895_ecustom--SummaryOfPlatformDevelopmentCostsTableTextBlock_zIxqj5lvxKH1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Platform
development costs are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zCGkr6fcwnh" style="display: none">Summary
of Platform Development Costs</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20231231_zScIWEATpF9e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20221231_zoi0Y6qHmrOh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_maPPAENzOa4_zpkMwALs7ny4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Platform development</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">26,054</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">21,493</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pn3n3_di_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_msPPAENzOa4_zb7BOt9cBcWi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less accumulated amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(17,331</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,163</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_mtPPAENzOa4_zg9J7Ivq3mdj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net platform development</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,723</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,330</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_SummaryOfPlatformDevelopmentCostActivityTableTextBlock', window );">Summary of Platform Development Cost Activity</a></td>
<td class="text"><p id="xdx_89A_ecustom--SummaryOfPlatformDevelopmentCostActivityTableTextBlock_zA9So66Ye86b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of platform development activity is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zvFdcOV5qJ31" style="display: none">Summary
of Platform Development Cost Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Platform development beginning of year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentOther_iS_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zEedoL1Wx1Jf" style="width: 16%; text-align: right" title="Platform development beginning of year">21,493</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentOther_iS_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zSMpkLYBnVe7" style="width: 16%; text-align: right" title="Platform development beginning of year">21,997</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payroll-based costs capitalized</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FinitelivedIntangibleAssetsAcquired1_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zi8ilA0LQW37" style="text-align: right" title="Payroll-based costs capitalized">3,773</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FinitelivedIntangibleAssetsAcquired1_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_z4lU2ZiU6H7k" style="text-align: right" title="Payroll-based costs capitalized">5,179</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less dispositions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--GainLossOnDispositionOfAssets1_iN_pn3n3_di_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zBDuanU1FMJf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less dispositions">(164</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--GainLossOnDispositionOfAssets1_iN_pn3n3_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zntQAbyAsiml" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less dispositions">(7,357</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total capitalized payroll-based costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zbgJijmJSww3" style="text-align: right" title="Total capitalized payroll-based costs">25,102</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zm28SsBRk7Ui" style="text-align: right" title="Total capitalized payroll-based costs">19,819</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zRXwggsvC8a8" style="text-align: right" title="Stock-based compensation">1,016</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zGBZkksY9Unk" style="text-align: right" title="Stock-based compensation">1,884</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Impairments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pn3n3_di_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zD3wrHAZConj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairments">(64</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pn3n3_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zQDa9e618Mf3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairments">(210</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Platform development end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentOther_iE_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zifcqCCr2A97" style="border-bottom: Black 2.5pt double; text-align: right" title="Platform development end of year">26,054</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentOther_iE_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zwvUFv2XESl9" style="border-bottom: Black 2.5pt double; text-align: right" title="Platform development end of year">21,493</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosurePlatformDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosurePlatformDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_SummaryOfPlatformDevelopmentCostActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of Platform Development Cost Activity [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_SummaryOfPlatformDevelopmentCostActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_SummaryOfPlatformDevelopmentCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of Platform Development Costs [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_SummaryOfPlatformDevelopmentCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731045504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets Subject to Amortization</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zGqPiHulnNc8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets subject to amortization consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zUxXsWZaoRVi" style="display: none">Schedule
of Intangible Assets Subject to Amortization</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 7pt"></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/>
 Average<br/>
 Useful<br/>
 Life (in<br/>
 years)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Carrying<br/>
 Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Accumulated<br/>
 Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Net<br/>
 Carrying<br/>
 Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Carrying<br/>
 Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Accumulated<br/>
 Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Net<br/>
 Carrying<br/>
 Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left">Developed technology</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zUlmoVeH7gKg" style="width: 6%; text-align: center" title="Intangible assets, weighted average useful life">4.70</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zPLtTlPFqcP2" style="width: 6%; text-align: right" title="Intangible assets, gross">17,333</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zMgGGax6T5D4" style="width: 6%; text-align: right" title="Intangible assets, accumulated amortization">(17,333</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zjAkav9a8Sx7" style="width: 6%; text-align: right" title="Intangible assets, net"><span style="-sec-ix-hidden: xdx2ixbrl1541">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_z7Wjm0Ok4Wt3" style="width: 6%; text-align: right" title="Intangible assets, gross">17,333</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zLxS893m0ogd" style="width: 6%; text-align: right" title="Intangible assets, accumulated amortization">(14,883</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zBCHpRcyDwM" style="width: 6%; text-align: right" title="Intangible assets, net">2,450</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade name</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zzVktJNWpdne" style="text-align: center" title="Intangible assets, weighted average useful life">16.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zDUrUFaiScql" style="text-align: right" title="Intangible assets, gross">5,181</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zlgZtjptU8Qb" style="text-align: right" title="Intangible assets, accumulated amortization">(1,547</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zPuAiq2cDMO9" style="text-align: right" title="Intangible assets, net">3,634</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zll02mCKq6qj" style="text-align: right" title="Intangible assets, gross">5,380</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zeJxzjxEVDK7" style="text-align: right" title="Intangible assets, accumulated amortization">(1,180</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zY63KfZKeS52" style="text-align: right" title="Intangible assets, net">4,200</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Brand name</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z5YUIFZbkNLj" style="text-align: center" title="Intangible assets, weighted average useful life">9.70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zBFW48O2JV3e" style="text-align: right" title="Intangible assets, gross">12,774</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zugLjIgyb9g5" style="text-align: right" title="Intangible assets, accumulated amortization">(2,374</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zkmEvK9I8C44" style="text-align: right" title="Intangible assets, net">10,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z2PJ48WtLwAc" style="text-align: right" title="Intangible assets, gross">12,115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zPp8GVRc0Fyd" style="text-align: right" title="Intangible assets, accumulated amortization">(908</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zkqmfZtDPs1b" style="text-align: right" title="Intangible assets, net">11,207</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Subscriber relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zuJYxejpJFEh" style="text-align: center" title="Intangible assets, weighted average useful life">5.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_z1En2GiaAO69" style="text-align: right" title="Intangible assets, gross">73,459</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_z9zrN0oCQVFd" style="text-align: right" title="Intangible assets, accumulated amortization">(61,654</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zU7gGu6Memo1" style="text-align: right" title="Intangible assets, net">11,805</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zPjVJZuHqYA1" style="text-align: right" title="Intangible assets, gross">73,459</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zDRJ180J2Upb" style="text-align: right" title="Intangible assets, accumulated amortization">(47,146</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zGE6F5MhgFyk" style="text-align: right" title="Intangible assets, net">26,313</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Advertiser relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zgkNT25EFh74" style="text-align: center" title="Intangible assets, weighted average useful life">10.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zEWRXOtzKjb1" style="text-align: right" title="Intangible assets, gross">15,182</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_z95TgOZE8c4a" style="text-align: right" title="Intangible assets, accumulated amortization">(2,832</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zAqCXJVxhvSb" style="text-align: right" title="Intangible assets, net">12,350</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zbBtoclSBlFl" style="text-align: right" title="Intangible assets, gross">15,302</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zsk0z7qULDdb" style="text-align: right" title="Intangible assets, accumulated amortization">(1,368</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zryIDTvmRqsc" style="text-align: right" title="Intangible assets, net">13,934</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Database</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zT3XTIqhh8Ki" style="text-align: center" title="Intangible assets, weighted average useful life">3.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zQgKWkLR70Zf" style="text-align: right" title="Intangible assets, gross">2,397</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zVrkRWfZWgY1" style="text-align: right" title="Intangible assets, accumulated amortization">(2,171</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_z9vGaJNNZMVi" style="text-align: right" title="Intangible assets, net">226</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zmXwPweU27Yb" style="text-align: right" title="Intangible assets, gross">2,397</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zqzxbu8f1RAl" style="text-align: right" title="Intangible assets, accumulated amortization">(1,753</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zbcCyeO2Oluf" style="text-align: right" title="Intangible assets, net">644</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Digital content</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zoenZA2G2Wu3" style="padding-bottom: 1.5pt; text-align: center" title="Intangible assets, weighted average useful life">2.00</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_z27QSShJFPH" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, gross">355</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zv39eNcxRjX" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, accumulated amortization">(311</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zMJTMqwTBTWa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, net">44</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zrN1I2QkoX6l" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, gross">355</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zxf7JUM4GUma" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, accumulated amortization">(133</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zWUfzZ9F9TQ" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, net">222</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Total intangible assets</td><td style="padding-bottom: 2.5pt; font-size: 10pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 7pt; text-align: center"></td><td style="padding-bottom: 2.5pt; font-size: 7pt; text-align: left"></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231_zRnBAslxkjLj" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, gross">126,681</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231_zGiKhMSlei9f" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, accumulated amortization">(88,222</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231_zI4CGWw40rwe" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net">38,459</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231_zYd3UO3kWlVc" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, gross">126,341</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231_z9iw7ItRHiK4" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, accumulated amortization">(67,371</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231_zhQzPuBKRfg8" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net">58,970</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Future Estimated Amortization expense For Intangible Assets</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zuyRfzrqd0T8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
total amortization expense for the next five years and thereafter related to the Company&#8217;s intangible assets subject to amortization
as of December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zqqKW07qTw9h" style="display: none">Schedule
of Future Estimated Amortization expense For Intangible Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%; margin-left: 0.75in">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: left; font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_497_20231231_zYAjGNyCvCJ4">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-weight: bold">Years Ending December 31,</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_iI_pn3n3_maFLIANzfm1_z9gvHtQccBsg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 79%; text-align: left">2024</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">14,544</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo_iI_pn3n3_maFLIANzfm1_z1H3hJWm4jr1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,427</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree_iI_pn3n3_maFLIANzfm1_zyzr9y1cm7nd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,214</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour_iI_pn3n3_maFLIANzfm1_zIeuwnD8FEI6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2027</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,214</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive_iI_pn3n3_maFLIANzfm1_zvTboWyk7Kwa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,964</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive_iI_pn3n3_maFLIANzfm1_zfDcpcwcmJFh" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,096</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzfm1_zWG5Dwvonkjb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
    assets ,net</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">38,459</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735642464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Long-Term Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Summary of Other Assets</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfOtherAssetsNoncurrentTextBlock_zbLVWHPCANGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
assets are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zm2wbNP0GrZc" style="display: none">Summary
of Other Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20231231_zWHtJmgelNKj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20221231_z8aJMAK8Mkoh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--SecurityDeposit_iI_pn3n3_maOANzDET_zpVxvTTopPo8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Security deposit</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">420</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">420</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OtherReceivables_iI_pn3n3_maOANzDET_zqWGhbImfvfk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1681">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PrepaidInsurance_iI_pn3n3_maOANzDET_zNU3A6qIzWaf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Prepaid insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">284</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">504</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--UnamortizedDebtCost_iI_pn3n3_maOANzDET_zYhHCihRnmad" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Unamortized debt cost</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">209</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">216</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherAssetsNoncurrent_iTI_pn3n3_mtOANzDET_zc71b3mHVZM5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total other assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,003</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,140</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656730056704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Changes in Carrying Value of Goodwill</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfGoodwillTextBlock_zgqiNgwIwcP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
changes in carrying value of goodwill are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BD_z6oMhibAbeTg" style="display: none">Schedule
of Changes in Carrying Value of Goodwill</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_z54GMFz6llBd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20220101__20221231_zpKLTNlPeqpc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Goodwill_iS_pn3n3_zY5bhtZukAuj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Carrying value at beginning of year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">39,344</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">19,619</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_z7sIbTW6gjMb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Goodwill acquired in acquisition of Parade</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1699">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,587</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--MensJournalMember_zhQrkm1SyGji" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Goodwill acquired in acquisition of Men&#8217;s Journal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,246</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,138</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zi5zzU65rDze" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Goodwill acquired in acquisition of Fexy Studios</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,985</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1706">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--GoodwillImpairmentLoss_pn3n3_zPl4H5Aggyg8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss on impairment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1708">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1709">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--Goodwill_iE_pn3n3_z1MlBj06RKPd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Carrying value at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">42,575</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">39,344</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656730982432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zoKITz2tC5r3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
expenses and other are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_zXRiw98G4eza" style="display: none">Schedule
of Accrued Expenses</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20231231_z2IvZHnY1aE8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20221231_zaDWqhP6fpY8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_401_ecustom--GeneralAccruedExpenses_iI_pn3n3_maALCzErP_zvEVHQmS9p6i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">General accrued expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,486</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,339</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccruedPayrollTaxesCurrent_iI_pn3n3_maALCzErP_zgADpXqNjNK4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Accrued payroll and related taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,448</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,221</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccruedAdvertisingCurrent_iI_pn3n3_maALCzErP_zWhsjuBqslfc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Accrued publisher expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,596</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,911</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InterestPayableCurrent_iI_pn3n3_maALCzErP_z2DpbicCVEEc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,824</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1742">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--LiabilitiesInConnectionWithAcquisitionsAndDispositions_iI_pn3n3_maALCzErP_za2u7I06ihW1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Liabilities in connection with acquisitions and dispositions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,119</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,123</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LeaseDepositLiability_iI_pn3n3_maALCzErP_znl7JMQaCdDh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Assumed lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,328</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1748">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--LeaseTerminationLiability_iI_pn3n3_maALCzErP_zBb3Qlhezbwe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Lease termination liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,481</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,753</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maALCzErP_z4rq3OtxmYk3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">489</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">755</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedLiabilitiesCurrent_iTI_pn3n3_mtALCzErP_zUGWjDkRuT75" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total accrued expenses and other</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">30,771</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">23,102</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735821040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liquidated Damages Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosureLiquidatedDamagesPayableAbstract', window );"><strong>Liquidated Damages Payable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_SummaryOfLiquidatedDamagesTableTextBlock', window );">Summary of Liquidated Damages</a></td>
<td class="text"><p id="xdx_895_ecustom--SummaryOfLiquidatedDamagesTableTextBlock_gL3SOLDTTB-KNKL_zDGTwIincM2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations
with respect to the liquidated damages payable are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B5_zMegz0GqMS1a" style="display: none">Summary
of Liquidated Damages</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Registration<br/>
 Rights Damages</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Public<br/>
 Information<br/>
 Failure Damages</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accrued<br/>
 Interest</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">MDB common stock to be issued (<span id="xdx_F42_zZAapBO2gps9">1</span>)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zDqlJnuraLZh" style="width: 12%; text-align: right" title="Registration Rights Damages">15</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zirnilVnafnd" style="width: 12%; text-align: right" title="Public Information Failure Damages"><span style="-sec-ix-hidden: xdx2ixbrl1803">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_z4G7I3rqJu3l" style="width: 12%; text-align: right" title="Accrued Interest"><span style="-sec-ix-hidden: xdx2ixbrl1805">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_z35RJgXoCam" style="width: 12%; text-align: right" title="Balance">15</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series H convertible preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zZMZaArqvnu3" style="text-align: right" title="Registration Rights Damages">565</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zPBLMRLCtnKk" style="text-align: right" title="Public Information Failure Damages">574</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zmj1VuA20GT2" style="text-align: right" title="Accrued Interest">659</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zrdXkHLPLGEd" style="text-align: right" title="Balance">1,798</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_F4E_zs8iFrZCBsvi" style="text-align: left">Convertible debentures (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zHjuFFJuUt69" style="text-align: right" title="Registration Rights Damages"><span style="-sec-ix-hidden: xdx2ixbrl1817">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zkACreHtTaZ6" style="text-align: right" title="Public Information Failure Damages">144</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zyVXLmuIRu22" style="text-align: right" title="Accrued Interest">72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zNi1hi2GuUxe" style="text-align: right" title="Balance">216</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series J convertible preferred stock (<span id="xdx_F42_zB3Dv8wiU987">2</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zDDZEmJvDOP7" style="text-align: right" title="Registration Rights Damages">152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zuDyvhBzhao" style="text-align: right" title="Public Information Failure Damages">152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zMMbTt20YTBd" style="text-align: right" title="Accrued Interest">129</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zOcPtTGLre05" style="text-align: right" title="Balance">433</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series K convertible preferred stock (<span id="xdx_F4C_zQ7O58bIoMu3">2</span>)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zjdbdtNBHFgi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Registration Rights Damages">166</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zdTZF3ORJqHj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Public Information Failure Damages">70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zs968JTFeeP4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accrued Interest">226</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zDnuJNHOtOw" style="border-bottom: Black 1.5pt solid; text-align: right" title="Balance">462</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231_zZTVJj6CNDbi" style="border-bottom: Black 2.5pt double; text-align: right" title="Registration Rights Damages">898</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231_zfymHuAEnpak" style="border-bottom: Black 2.5pt double; text-align: right" title="Public Information Failure Damages">940</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231_zq2lIzgEeo12" style="border-bottom: Black 2.5pt double; text-align: right" title="Accrued Interest">1,086</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231_zRxTxJkYT124" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance">2,924</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F04_z3VFS35LQHIc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F16_zwNEu3NvNq85" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
                                            of common stock issuable to MDB Capital Group, LLC (&#8220;MDB&#8221;) (see <i>Common Stock
                                            to be Issued</i> in Note 21).</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F09_zPiUdwXpxay2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F13_zjoO0f4ruTR7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            previously issued and converted debt or equity securities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_306_134_zLWqsaxl7i5c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Liquidated Damages (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap">&#160;</td><td style="white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Registration<br/>
 Rights Damages</td><td style="white-space: nowrap; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Public<br/>
 Information<br/>
 Failure
    Damages</td><td style="white-space: nowrap; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Accrued<br/>
 Interest</td><td style="white-space: nowrap; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Balance</td><td style="white-space: nowrap; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">MDB common stock to be issued (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zhbG7wqvMsp4" style="width: 12%; text-align: right" title="Registration Rights Damages">15</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zOkqE9IM4m54" style="width: 12%; text-align: right" title="Public Information Failure Damages"><span style="-sec-ix-hidden: xdx2ixbrl1870">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_znOKNlmxcGVg" style="width: 12%; text-align: right" title="Accrued Interest"><span style="-sec-ix-hidden: xdx2ixbrl1872">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zh4pS70UZ014" style="width: 12%; text-align: right" title="Balance">15</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series H Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zcnVr4RdmnCl" style="text-align: right" title="Registration Rights Damages">618</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zvsojiPfENoc" style="text-align: right" title="Public Information Failure Damages">626</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zMJ2eqMVY7s2" style="text-align: right" title="Accrued Interest">570</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zzjK3JA7zvd3" style="text-align: right" title="Balance">1,814</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible debentures (<span id="xdx_F49_zphT2fK5b3u">2</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zY0wmjJ2jXTj" style="text-align: right" title="Registration Rights Damages"><span style="-sec-ix-hidden: xdx2ixbrl1884">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zz3S6lbFCXcg" style="text-align: right" title="Public Information Failure Damages">704</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zGUIY42ddsl4" style="text-align: right" title="Accrued Interest">280</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zebUolESDQMj" style="text-align: right" title="Balance">984</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series J convertible preferred stock (<span id="xdx_F42_zQxUbIHB1zl9">2</span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_z1KydlfNJPpi" style="text-align: right" title="Registration Rights Damages">932</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zwPaFfQdUg08" style="text-align: right" title="Public Information Failure Damages">932</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_z7WnqsPmvlP" style="text-align: right" title="Accrued Interest">525</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zQ8chrfdJ2k" style="text-align: right" title="Balance">2,389</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series K convertible preferred stock (<span id="xdx_F4C_zUqtmOqrq3F5">2</span>)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_z11OeUxmZJqa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Registration Rights Damages">437</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zYBRUpEoQfY1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Public Information Failure Damages">478</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zVkGyt4b2GZc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accrued Interest">220</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zqvyX3zC2VUh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Balance">1,135</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231_zl7QFhHFxK3g" style="border-bottom: Black 2.5pt double; text-align: right" title="Registration Rights Damages">2,002</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231_zHm8sHhnuF51" style="border-bottom: Black 2.5pt double; text-align: right" title="Public Information Failure Damages">2,740</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231_zrgH99cf9FDj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accrued Interest">1,595</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231_zdSVTzUMvWv6" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance">6,337</td><td style="text-align: left">&#160;</td></tr>
  </table>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_zVQwPxgU9mH3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_zE3iDtl8Jxl1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
                                            of common stock issuable to MDB.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F02_zTnG0ctsL4vj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F16_zV2VYzn6F8v5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            previously issued and converted debt or equity securities.</span></td></tr></table>

&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosureLiquidatedDamagesPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosureLiquidatedDamagesPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_SummaryOfLiquidatedDamagesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liquidation damages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_SummaryOfLiquidatedDamagesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656730020192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Long-term Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosureOtherLongtermLiabilitiesAbstract', window );"><strong>Other Long-term Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_OtherLongtermLiabilitiesTableTextBlock', window );">Schedule of Other long- term liabilities</a></td>
<td class="text"><p id="xdx_89A_ecustom--OtherLongtermLiabilitiesTableTextBlock_znxixkzx3hJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
long-term liabilities consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BC_zmw0NNfxV0j6" style="display: none">Schedule
of Other long- term liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20231231_zGeXXw97s7B3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20221231_znXhoVIujHrf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--LeaseTerminationLiabilityNonCurrent_iI_pn3n3_maOLNz6kY_zReJPruxu3sa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Lease termination liability</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1928">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,621</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_maOLNz6kY_zc2YXmiWK5Ud" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Assumed lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">350</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,486</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--OtherLongTermLiabilitiesNoncurrent_iI_pn3n3_maOLNz6kY_zH2eDVGxNCYj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Other</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">56</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">200</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OtherLiabilitiesNoncurrent_iTI_pn3n3_mtOLNz6kY_zAWc9uR9NT55" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total other long-term liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">406</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,307</td><td style="text-align: left">&#160;</td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosureOtherLongtermLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosureOtherLongtermLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_OtherLongtermLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other long term liabilities [TableText Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_OtherLongtermLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656734832416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zfaz0sRL9HOl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments measured at fair value during the year consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BD_zDRBiyiFr0F5" style="display: none">Schedule
of Fair Value of Financial Instruments</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted
Prices <br/>
in Active <br/>
Markets for<br/>
Identical <br/>
Assets (Level 1)</b></span></p></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant<br/>
Other <br/>
Observable<br/>
Inputs (Level 2)</b></span></p></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant
<br/>
Unobservable<br/>
Inputs (Level 3)</b></span></p></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left; width: 36%">Contingent consideration</td><td style="padding-bottom: 2.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td id="xdx_985_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember_zBqy5pqnWLte" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%" title="Long term debt fair value">1,571</td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 2.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td id="xdx_986_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zAnw5mckc7L6" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%" title="Long term debt fair value">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1956">-</span></td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 2.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td id="xdx_982_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z3BUQe1t0cZj" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%" title="Long term debt fair value">1,571</td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 2.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td id="xdx_98E_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember_zYFQ4GVPfRS5" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%" title="Long term debt fair value">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1960">-</span></td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted
Prices <br/>
in Active <br/>
Markets for<br/>
Identical <br/>
Assets (Level 1)</b></span></p></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant<br/>
Other <br/>
Observable<br/>
Inputs (Level 2)</b></span></p></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant
<br/>
Unobservable<br/>
Inputs (Level 3)</b></span></p></td><td>&#160;</td></tr>
  <tr id="xdx_433_c20231231_zLh1urT9FVq4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Senior Secured Notes</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember_z3l5qJvtiOAj" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Long term debt fair value">61,787</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zzH51p02O4m2" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Long term debt fair value">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1965">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zTWvTclZT9Ij" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Long term debt fair value">61,787</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zhxdxdUbSY4g" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Long term debt fair value">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1969">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656730978016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of long term debt</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zpNVfkEbXUk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the  debt:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B7_zPf0exAAQenh" style="display: none">Schedule of long term debt</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal<br/>
 Balance</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unamortized<br/>
 Discount<br/>
 and Debt<br/>
 Issuance<br/>
 Costs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carrying<br/>
 Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal<br/>
 Balance</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unamortized<br/>
 Discount<br/>
 and Debt<br/>
 Issuance<br/>
 Costs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carrying<br/>
 Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Senior Secured Notes, effective interest rate of 10.1% as of December 31, 2023, as amended, matures December 31, 2026, subject to acceleration</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zcYjvd5gaSGj" style="text-align: right" title="Principal balance (including accrued interest), total">62,691</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zIoRVimMAX1" style="text-align: right" title="Unamortized discount and debt issuance cost, total">&#160;&#160;&#160;&#160;(272</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zpgzjUR1Fm4i" style="text-align: right" title="Carrying value, total">62,419</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zt0PoFfmwV63" style="text-align: right" title="Principal balance (including accrued interest), total">62,691</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zIbv1nQL0m4d" style="text-align: right" title="Unamortized discount and debt issuance cost, total">(904</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zEBYgjSV3fn9" style="text-align: right" title="Carrying value">61,787</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left">Senior Secured Notes, effective interest rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zJw5w7uSa7dl" title="Debt instrument interest rate, percentage"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zGWrxq55TJqk" title="Debt instrument interest rate, percentage">10.1</span></span>% as of December 31, 2023, as amended</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zOtoQbAeGPW7" style="width: 7%; text-align: right" title="Principal balance (including accrued interest), total">62,691</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zOv0sS3e9dff" style="width: 7%; text-align: right" title="Unamortized discount and debt issuance cost, total">&#160;&#160;&#160;&#160;(272</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zSHfX28sCHvh" style="width: 7%; text-align: right" title="Carrying value, total">62,419</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zrD5MKTDiFtk" style="width: 7%; text-align: right" title="Principal balance (including accrued interest), total">62,691</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zpZVojmgZyH7" style="width: 7%; text-align: right" title="Unamortized discount and debt issuance cost, total">(904</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zn5vQAeU1A5j" style="width: 7%; text-align: right" title="Carrying value">61,787</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Delayed Draw Term Notes, effective interest rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--LongtermDebtTypeAxis__custom--DelayedDrawTermNoteMember_z9eaQhOl32Ti" title="Debt instrument interest rate, percentage"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--DelayedDrawTermNoteMember_z3BQWOUedm7e" title="Debt instrument interest rate, percentage">10.2</span></span>% as of December 31, 2023, as amended</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_znsgAfdfFlJ8" style="text-align: right" title="Principal balance (including accrued interest), total">4,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zQ2sW6iDmSt" style="text-align: right" title="Unamortized discount and debt issuance cost, total">(31</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_z0KbI0jXYPSf" style="text-align: right" title="Carrying value, total">3,969</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_z8SDiNHSNT3a" style="text-align: right" title="Principal balance (including accrued interest), total">4,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zrvkIJYG2xN5" style="text-align: right" title="Unamortized discount and debt issuance cost, total">(103</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zHTNTPXwimZ4" style="text-align: right" title="Carrying value, total">3,897</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">2022 Bridge Notes, effective interest rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--LongtermDebtTypeAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zF1L3SxJJaJ2" title="Debt instrument interest rate, percentage"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zTJxSXHR4Vvj" title="Debt instrument interest rate, percentage">10.2</span></span>% as of December 31, 2023, as amended</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zdUBkwGStIof" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal balance (including accrued interest), total">36,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zw0Zy88ndiek" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unamortized discount and debt issuance cost, total">(79</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zyt6vREqIKX1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Carrying value, total">35,921</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zGhack6rDr58" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal balance (including accrued interest), total"><span style="-sec-ix-hidden: xdx2ixbrl2120">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zVncpNjyPBEb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unamortized discount and debt issuance cost, total"><span style="-sec-ix-hidden: xdx2ixbrl2122">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zQEqEstGdft7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Carrying value, total"><span style="-sec-ix-hidden: xdx2ixbrl2124">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231_zVNZ4l9s8c1h" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal balance">102,691</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231_z1J5bKDJw1U1" style="border-bottom: Black 2.5pt double; text-align: right" title="Unamortized discount and debt issuance costs">(382</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--LongTermDebt_iI_pn3n3_c20231231_zBSXt3ukQq22" style="border-bottom: Black 2.5pt double; text-align: right" title="Carrying value">102,309</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231_zf5GkLDyXwuk" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal balance">66,691</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231_z4NOVAQZhEvf" style="border-bottom: Black 2.5pt double; text-align: right" title="Unamortized discount and debt issuance costs">(1,007</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20221231_zfrOgT9VrQx6" style="border-bottom: Black 2.5pt double; text-align: right" title="Carrying value">65,684</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_SummaryOfInterestExpenseTableTextBlock', window );">Summary of Interest Expense</a></td>
<td class="text"><p id="xdx_89B_ecustom--SummaryOfInterestExpenseTableTextBlock_zDVNRtWPBTKg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table represents interest expense:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zky9uH4bGeCi" style="display: none">Summary
of Interest Expense</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_zeCyTRvlvGO4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20220101__20221231_zAVowYRW2j12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Amortization of debt costs:</td><td>&#160;</td>
    <td style="text-align: right"></td>
    <td style="text-align: right"></td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: right"></td>
    <td style="text-align: right"></td><td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember_z3uCtcZZPluj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: justify">Line of credit</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">214</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">9</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zHBh3OAeO4f4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">2023 Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">244</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2148">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredNotesMember_ztQMvMlKGe5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Senior Secured Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">632</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,031</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zsTNebWWvqNd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Delayed Draw Term Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">464</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zfqQMFiR5dBe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">2022 Bridge Notes</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,216</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">77</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_zV2buGQgkoq5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total amortization of debt costs</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,378</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,581</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Noncash and accrued interest:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zYag8MI0MKOb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">2023 Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">173</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2163">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredNotesMember_zLmj52I0E0ic" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Senior Secured Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,602</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2166">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zKKNOX7J7Src" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Delayed Draw Term Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">102</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2169">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zA0NRFaiAE9h" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">2022 Bridge Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">920</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2172">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--LineOfCreditTerminationFeeMember_zlUzagbdPRMg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Line of credit termination fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2175">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--ParadeMember_zncKzyrvJ63a" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Parade</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2177">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">116</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--OtherAccruedInterestMember_zLp5ARGseRnl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Other accrued interest</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">127</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">204</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_z71CZWLWfwP8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total noncash and accrued interest</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,824</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">320</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--CashPaidInterestAbstract_iB_z9kBsiDehMz2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash paid interest:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember_zpx9gtOYVFSc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Line of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,328</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zUQMLl338i0f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">2023 Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2193">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredNotesMember_zr5e4IRGTU9l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Senior Secured Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,754</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,356</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zGOTGbNiJAoj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Delayed Draw Term Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">303</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">980</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zH2xXv4O9SRl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">2022 Bridge Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,763</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2202">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--OtherMember_zfd4GF6yJhOj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Other</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,214</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">863</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--InterestPaid_pn3n3_zEFpui48U3t8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total cash paid interest</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,527</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--InterestExpenseDebt_iN_pn3n3_di_zI2XsWYeUMK6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less interest income <sup id="xdx_F4F_zmG8jzJPWYke">(1)</sup></span></td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(338</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2211">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--InterestExpense_pn3n3_z9NYNIQG58B8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total interest expense</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">17,965</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,428</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0C_znEq8p3u86Ed" style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"></td><td id="xdx_F1B_zvNUkNYeBRtb" style="text-align: justify">During the year ended December 31, 2023, the Company recorded interest income of $<span id="xdx_904_eus-gaap--InterestExpenseDebt_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zb04DjNbtnCa">338</span> related
to the refunds received from the employee retention credits.</td>
</tr></table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_SummaryOfInterestExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary Of Interest Expense [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_SummaryOfInterestExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-8<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656730955312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Deficiency (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of Restricted Stock Award Activity</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zCiZ4l6nK3Q8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the restricted stock award activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zVV9BCcrulei" style="display: none">Summary of Restricted Stock Award Activity</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of <br/>
Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
                                            Average <br/>
                                            Grant-Date</b></span></p>
                                                                  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    stock awards outstanding at January 1, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zNmNgl4Ptij7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of Shares, Restricted Stock Awards Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,403</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zpakTQuXhBg1" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted Average Grant-Fair Value Date, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.94</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQoE7Sbc3j99" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares,  Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(97,403</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zkrHmNS326Ie" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Fair Value Date, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16.94</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    stock awards outstanding at December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zCipvKPr5vTj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Restricted stock awards outstanding, Unvested at Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2408">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Summary of Warrant Activity</a></td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z0ULsOccHYhj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the Financing Warrants activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BF_zUdfua79NEC7" style="display: none">Summary of Warrant Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Life</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in Years)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify">Financing Warrants outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zaOyrerdlMWi" style="width: 12%; text-align: right" title="Number of Shares, outstanding, at beginning of year">107,956</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zJjhjE20OUG5" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, outstanding, at beginning of year">10.61</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zGcSY18wELGc" title="Weighted Average Remaining Contractual Life, Outstanding at beginning of year">0.58</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zbYMGmEGCjql" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Expired">(107,956</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zZIKYHxtdEjj" style="text-align: right" title="Weighted Average Exercise Price, Expired">10.61</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Financing Warrants outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zZs6o4s8Szg9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, outstanding at end of year"><span style="-sec-ix-hidden: xdx2ixbrl2424">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zU2fcnw5J3E4" style="text-align: right" title="Weighted Average Exercise Price, outstanding, at end of year"><span style="-sec-ix-hidden: xdx2ixbrl2426">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656732253456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock&#8211;Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ScheduleOfUnrecognizedCompensationExpense', window );">Schedule of Unrecognized Compensation Expense</a></td>
<td class="text"><p id="xdx_89A_ecustom--ScheduleOfUnrecognizedCompensationExpense_z5zoP8UKu54f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrecognized
compensation expense related to the stock-based compensation awards and equity-based awards as of December 31, 2023 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zSpQfxxmfmD5" style="display: none">Schedule of Unrecognized Compensation Expense</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Restricted<br/>
 Stock</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/>
Stock Options</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">ABG Warrants</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Totals</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Unrecognized compensation expense</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zK2fgOgUbWok" style="width: 12%; text-align: right" title="Unrecognized compensation expense">1,191</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zIfBhtP9vhp" style="width: 12%; text-align: right" title="Unrecognized compensation expense">4,192</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zTvMG4y7ZrHf" style="width: 12%; text-align: right" title="Unrecognized compensation expense">26</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zxz6nz9YmTF6" style="width: 12%; text-align: right" title="Unrecognized compensation expense">5,409</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Weighted average period expected to be recognized (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zmt8Fp8nBx29" title="Weighted average period expected to be recognized (in years)">1.84</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zEXcy2KCOGzd" title="Weighted average period expected to be recognized (in years)">1.33</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zbEEcYF3gId7" title="Weighted average period expected to be recognized (in years)">2.01</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zPB1D1Ix63w8" title="Weighted average period expected to be recognized (in years)">1.45</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_NewPublisherPartnerWarrantMember', window );">New Publisher Partner Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of Exercise Prices of Common Stock Options</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_hus-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z8BjKnMgfMCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise prices of the New Publisher Partner Warrants outstanding and exercisable are as follows as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_z8TEOqBkMmBg" style="display: none">Schedule of Exercise Prices of Common Stock Options</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Outstanding</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercisable</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">$</td><td style="width: 30%; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z6kXo03sJvla" title="Exercise price lower range">5.30</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zkf8QRw8NRR9" style="width: 30%; text-align: right" title="Number of Shares, Outstanding">6,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z3GJQ8PdBt8h" style="width: 30%; text-align: right" title="Number of Shares, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2802">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zSD2JPrm9F2b" title="Exercise price lower range">10.56</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zOCapmwRMr9h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Outstanding">3,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z0Tlm5Wc0sX6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Exercisable">1,084</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zK0kEaqALdS2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Outstanding">9,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zpWefQy49wkd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Exercisable">1,084</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ScheduleOfWarrantsActivityTableTextBlock', window );">Schedule of Warrants Activity</a></td>
<td class="text"><p id="xdx_89B_ecustom--ScheduleOfWarrantsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zWf6xvowhFOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the New Publisher Partner Warrants activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zMUmq9oxdM1i" style="display: none">Schedule of Warrants Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Life</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in Years)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">New Publisher Partner Warrants outstanding at January 1, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z2gAsbkB70j6" style="text-align: right" title="Number of Shares, outstanding, at beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl2769">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zB6OeYbpL0I2" style="text-align: right" title="Weighted Average Exercise Price, outstanding, at beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl2771">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: justify">Granted</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z9IT6Os7LKw9" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Number of Shares, Forfeited">9,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zxaq3necnJlb" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Ending Balance">6.91</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">New Publisher Partner Warrants outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zKibk2Uz7Mzl" style="border-bottom: Black 2.5pt double; text-align: right">9,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z0KXTc7fuHq5" style="text-align: right" title="Weighted Average Exercise Price, Ending Balance">6.91</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--WeightedAverageRemainingContractualLifeOutstanding1_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zZFv88FPShT7" title="Weighted Average Remaining Contractual Life, Outstanding at ending of year">4.15</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">New Publisher Partner Warrants exercisable at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zImrjS8X6red" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Exercisable at end of year">1,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zkDCeOQoEOUh" style="text-align: right" title="Weighted Average Exercise Price, Exercisable at end of year">10.56</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--WeightedAverageRemainingContractualLifeExercisable_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_ztp3qO5ifYu5" title="Weighted Average Remaining Contractual Life, Exercisable">3.92</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">New Publisher Partner Warrants not vested at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zBtAAmFtMima" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, not vested at end of year">8,716</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">New Publisher Partner Warrants available for future grants at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zT2cm3ei9vM2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Available for future grants at end of year">23,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=AREN_ABGWarrantsMember', window );">ABG Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of Exercise Prices of Common Stock Options</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--ABGWarrantsMember_z4J5vzOaTKMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise prices of the ABG Warrants outstanding and exercisable are as follows as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zrRikuEiWc3k" style="display: none">Schedule of Exercise Prices of Common Stock Options</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Outstanding</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercisable</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">$</td><td style="width: 30%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zKgPGThkQJp" title="Exercise price lower range">9.24</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zU50JB6QzUpa" style="width: 30%; text-align: right" title="Number of shares, outstanding">749,655</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zmLSzRp7LgZ6" style="width: 30%; text-align: right" title="Number of shares, exercisable">299,862</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z4BtTlp0SgTg" title="Exercise price lower range">18.48</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z0Ui8koEijLc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, outstanding">249,885</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zmz0wrBVcrR2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, exercisable">99,954</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zHK5IRpMCj1g" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares, outstanding">999,540</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_z7pIqsolUyp7" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares, exercisable">399,816</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ScheduleOfWarrantsActivityTableTextBlock', window );">Schedule of Warrants Activity</a></td>
<td class="text"><p id="xdx_894_ecustom--ScheduleOfWarrantsActivityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--ABGWarrantsMember_zNoWOLPinfg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the ABG Warrant activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zsfds2bgUzxf" style="display: none">Schedule of Warrants Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Weighted<br/>
 Average</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Weighted<br/>
 Average<br/>
 Remaining <br/>
Contractual<br/>
 Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unvested</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Vested</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">ABG Warrants outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zpYtxuK091Oi" style="width: 11%; text-align: right" title="Number of Shares, unvested outstanding, at beginning of year">599,724</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zI955IU90hX8" style="width: 11%; text-align: right" title="Number of Shares, vested outstanding, at beginning of year">399,816</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_z5xwTK6i8sXk" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, outstanding, at beginning of year">11.55</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span id="xdx_909_ecustom--WeightedAverageRemainingContractualLifeOutstanding_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zWh6N91O9Ndb" title="Weighted Average Remaining Contractual Life, Outstanding at beginning of year">6.46</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zxEdsvqKDzha" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, unvested issued"><span style="-sec-ix-hidden: xdx2ixbrl2731">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zkUIJoVr7rLb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, vested"><span style="-sec-ix-hidden: xdx2ixbrl2733">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">ABG Warrants outstanding at December 31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zLK1LvPlKc24" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, unvested outstanding, at end of year">599,724</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zsRYxtLY03M9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, vested outstanding, at end of year">399,816</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_z1qAdjUfb1U6" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, outstanding, at end of year">11.55</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_905_ecustom--WeightedAverageRemainingContractualLifeOutstanding_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zbHIJqMqOmG2" title="Weighted Average Remaining Contractual Life, Outstanding at ending of year">5.46</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Summary of Stock-based Compensation</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--ABGWarrantsMember_zkMesvIjkW3i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock&#8211;based
compensation and equity-based expense charged to operations or capitalized during the years ended December 31, 2023 and 2022 are summarized
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zqWOdX3kw9E" style="display: none">Summary of Stock-based Compensation</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Restricted<br/>
 Stock</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/>
Stock Options</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">ABG Warrants</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Totals</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Cost of revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zS4aB10vPkx7" style="width: 12%; text-align: right" title="Cost of revenue">2,092</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zjfeLSqdTWH1" style="width: 12%; text-align: right" title="Cost of revenue">4,460</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z4SWUTwrHBPk" style="width: 12%; text-align: right" title="Cost of revenue">10</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zuh3OCpomXM" style="width: 12%; text-align: right" title="Cost of revenue">6,562</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Selling and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zv3oA1jKt3V1" style="text-align: right" title="Selling and marketing">257</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z9sW55HnO8o5" style="text-align: right" title="Selling and marketing">1,402</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_ziehUIhFx4L9" style="text-align: right" title="Selling and marketing"><span style="-sec-ix-hidden: xdx2ixbrl2828">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zQIXd86TXcBg" style="text-align: right" title="Selling and marketing">1,659</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zj34EBLFgL9b" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative">6,372</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zJIAxKFs8dm6" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative">3,457</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zVOIDSewmT25" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative">1,010</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zyxbAKu6wZi" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative">10,839</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total costs charged to operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z1qDiccyYDI6" style="text-align: right" title="Total costs charged to operations">8,721</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zDvdTPfm9Q0c" style="text-align: right" title="Total costs charged to operations">9,319</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zohVYeJuar94" style="text-align: right" title="Total costs charged to operations">1,020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zSBKQGqlB3V4" style="text-align: right" title="Total costs charged to operations">19,060</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Capitalized platform development</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z8avxe0oOTc2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"><span style="-sec-ix-hidden: xdx2ixbrl2848">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zirhH6aEfK6f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development">1,016</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z0jtwB0FCUHb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"><span style="-sec-ix-hidden: xdx2ixbrl2852">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zprrWOJiUQQc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development">1,016</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total stock-based compensation</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zdfE9zZ40QZ3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation">8,721</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zm6IXAv1zbCe" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation">10,335</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zpksmIkYPFR9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation">1,020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z1UlLBoEHiR9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation">20,076</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Restricted<br/>
 Stock</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common <br/>
Stock Options</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">ABG Warrants</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Totals</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Cost of revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zbc4io1WKOTl" style="width: 12%; text-align: right" title="Cost of revenue">3,730</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zmYy9EsXMQpf" style="width: 12%; text-align: right" title="Cost of revenue">6,505</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zXQelMvmOKii" style="width: 12%; text-align: right" title="Cost of revenue"><span style="-sec-ix-hidden: xdx2ixbrl2868">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zHgmqrdHBuIk" style="width: 12%; text-align: right" title="Cost of revenue">10,235</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Selling and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zzI21pyXIxUl" style="text-align: right" title="Selling and marketing">270</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zqHeRFs34xsf" style="text-align: right" title="Selling and marketing">2,502</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zp6hLT9CnNcl" style="text-align: right" title="Selling and marketing"><span style="-sec-ix-hidden: xdx2ixbrl2876">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zUD4N25qWy57" style="text-align: right" title="Selling and marketing">2,772</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zY3IthpAUkla" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative">9,067</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zGOlOGCYdgG9" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative">7,776</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zjITvekToWN9" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative">1,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zBl31ToAqh1c" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative">18,338</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total costs charged to operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zBl2pwO6bKue" style="text-align: right" title="Total costs charged to operations">13,067</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zSnjNhzBUna4" style="text-align: right" title="Total costs charged to operations">16,783</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zq4l8XzjoUo5" style="text-align: right" title="Total costs charged to operations">1,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zyxMhPgM26Fa" style="text-align: right" title="Total costs charged to operations">31,345</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Capitalized platform development</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zDUTrOX49saj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"><span style="-sec-ix-hidden: xdx2ixbrl2896">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zLU4MABAJzF4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development">1,884</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zKZN0rxKseac" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"><span style="-sec-ix-hidden: xdx2ixbrl2900">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zbx2FBLwBMlc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development">1,884</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total stock-based compensation</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zWiko2EKKVy7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation">13,067</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zo7kdn5kDXp" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation">18,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zTn3jXVl4HJ1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation">1,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_ztpqGxcsOFk8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation">33,229</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=AREN_RestrictedStockUnitsMember', window );">Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ScheduleOfRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text"><p id="xdx_89F_ecustom--ScheduleOfRestrictedStockUnitsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zGuBZFrp1rZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the restricted stock unit activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span id="xdx_8BB_zIHR8WiR6UKk" style="display: none">Schedule of Restricted Stock Units Activity</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of Shares</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Weighted<br/>
 Average<br/>
 Grant-Date</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Unvested</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Vested</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"> Fair Value</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Restricted stock units outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zrFTbYnzKOga" style="width: 12%; text-align: right" title="Number of Shares, Unvested, outstanding, at beginning of year">994,766</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_z22DVdAYusBb" style="width: 12%; text-align: right" title="Number of Shares, Vested, outstanding, at beginning of year">397,376</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zQg3Vc1Fe4bc" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, outstanding, at beginning of year">15.44</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zaj3ujE8Nqw8" style="text-align: right" title="Number of Shares, Unvested granted">148,970</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zGY5Y5ndefia" style="text-align: right" title="Weighted Average Exercise Price,Granted">5.77</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zqJM1VHKCyx2" style="text-align: right" title="Number of Shares, Unvested, Vested">(645,023</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zuOov30y7j7e" style="text-align: right" title="Number of Shares, Vested">645,023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Released</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased_iNS_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zzaTB17oOD1f" style="text-align: right" title="Number of Shares, Vested, Released">(429,528</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Cancelled</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zFDvmEEZBKe7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Unvested, Cancelled">(299,446</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Restricted stock units outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_ziKU1b60cNCi" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Unvested, outstanding at end of year">199,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zHFYcTzEM0n" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Vested, outstanding, at end of year">612,871</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20231231_zJ8I064rZMEl" style="text-align: right" title="Weighted Average Exercise Price, outstanding, at end of year">13.55</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=AREN_CommonEquityAwardsMember', window );">Common Equity Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Fair Value of Stock Options Assumptions</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--AwardTypeAxis__custom--CommonEquityAwardsMember_zruV6hVDiU3a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_zat2CAmRKCAe" style="display: none">Schedule of Fair Value of Stock Options Assumptions</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Up-list</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Up-list</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">No Up-list</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zCj3B41l2gfl" title="Risk-free interest rate, minimum">3.46</span>% - <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zrMKGLP8Xsd5" title="Risk-free interest rate, maximum">4.82</span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zRiwnCvK9OZ8" title="Risk-free interest rate, minimum">0.97</span>% - <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zTqp9zaL2xW" title="Risk-free interest rate, maximum">4.36</span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_ziL8E5Pl3Wxd" title="Risk-free interest rate, minimum">0.97</span>% - <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_z0ASPaVHQ5G3" title="Risk-free interest rate, maximum">1.44</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left">Expected dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z9ylUE08FYIa" style="width: 14%; text-align: right" title="Expected dividend yield">0.00</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z8CJWlg43aUc" style="width: 14%; text-align: right" title="Expected dividend yield">0.00</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_zcG9GjR1dJ1g" style="width: 14%; text-align: right" title="Expected dividend yield">0.00</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zCCvMSb8Rqmj" title="Expected volatility, minimum">46.43</span>% - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zEDWfeYi1oRg" title="Expected volatility, maximum">47.27</span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zmNf6DQKDVA7" title="Expected volatility, minimum">42.00</span>% - <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z7FebLjn403h" title="Expected volatility, maximum">82.00</span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_zVBOkOksxVDb" title="Expected volatility, minimum">82.00</span>% - <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_z8i5zmjNevi7" title="Expected volatility, maximum">137.00</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z5vbyqVED6q" title="Expected life">6</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember__srt--RangeAxis__srt--MinimumMember_z1xhfG7PfEfd" title="Expected life">3.0</span> &#8211; <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember__srt--RangeAxis__srt--MaximumMember_zjcp9qiN2bz9" title="Expected life">6.0</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember__srt--RangeAxis__srt--MinimumMember_zA6mEhz5mcki" title="Expected life">3.0</span> &#8211; <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember__srt--RangeAxis__srt--MaximumMember_zYyKMk3xpJ85" title="Expected life">6.0</span> years</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--CommonEquityAwardsMember_zb4madCHi1g8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the common stock option activity during the year ended December 31, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zQFCpcZeQdZ" style="display: none">Summary of Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Life</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in Years)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify">Common stock options outstanding at January 1, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zRzWUNDrYcgj" style="width: 12%; text-align: right" title="Number of Shares Common stock options, outstanding at Beginning balance">6,199,521</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zgkUt0bimyBg" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, outstanding at Beginning balance">15.26</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zq4o4r2EGbCb" title="Weighted Average Remaining Contractual Life (in Years), outstanding at Beginning balance">8.20</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zx1VcSd4ruT5" style="text-align: right" title="Number of Shares, Granted">287,993</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zKL9zbaQ7nuj" style="text-align: right" title="Weighted Average Exercise Price, Granted">4.22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zcRP5JHduar1" style="text-align: right" title="Number of Shares, Exercised">(6,927</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zDKEqdFQ8Pm6" style="text-align: right" title="Weighted Average Exercise Price, Exercised">8.82</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zdTsjUIDAtq" style="text-align: right" title="Number of Shares, Forfeited">(449,333</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zxXJj1flaRj7" style="text-align: right" title="Weighted Average Exercise Price, Forfeited">9.70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Expired</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pid_di_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zr2BNgAs937f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Expired">(579,286</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zU8ZFRa4Ryie" style="text-align: right" title="Weighted Average Exercise Price, Expired">9.38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Common stock options outstanding at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zgYeuo0oOi5c" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares Common stock options, outstanding at Ending balance">5,451,968</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zzUZXLPvCyyg" style="text-align: right" title="Weighted Average Exercise Price, outstanding at Ending balance">9.56</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zwHIAIuMyNh7" title="Weighted Average Remaining Contractual Life (in Years), outstanding at Beginning balance">4.43</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Common stock options exercisable at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zdi9CFLomXwh" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares Common stock options, exercisable at Ending balance">4,049,393</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z3Y4yhhdaT64" style="text-align: right" title="Weighted Average Exercise Price, exercisable at Ending balance">9.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z9TfaB3o0pkk" title="Weighted Average Remaining Contractual Life (in Years), exercisable at Ending balance">5.06</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Common stock options not vested at December 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zEYc8CtZ4ave" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares Common stock options, not vested at Ending balance">1,402,575</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Common stock options available for future grants at December 31, 2023 (1)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_fKDEp_zEG4P5zCTLNf" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares Common stock options, available for future grants at Ending balance">542,847</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F04_zrM5Mcwlca8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span id="xdx_F1A_z6kmn735Og68" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock available
for future issuance under the 2022 Plan represent <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zz0cVnn4Bci8" title="Number of shares authorized to issue">1,800,000</span> of authorized shares; less <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zbkmhNt13S1c" title="Number of shares common stock options, outstanding">1,066,597</span> common stock options outstanding and
<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzOJA6aChy6g" title="Number of shares common stock options, outstanding">190,556</span> restricted stock units outstanding.</span></td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=AREN_CommonStockAwardsMember', window );">Common Stock Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of Exercise Prices of Common Stock Options</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_hus-gaap--AwardTypeAxis__custom--CommonStockAwardsMember_zJz3KNt0Xhbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise prices under the common stock options outstanding and exercisable are as follows as of December 31, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zcMgSiYQCtbc" style="display: none">Schedule of Exercise Prices of Common Stock Options</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Outstanding</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Vested</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Shares)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">$</td><td style="width: 30%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z50C95osBHK3" title="Exercise price">2.48</span> to $<span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_ztJWvaRdXPv9" title="Exercise price upper range">10.50</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z5b9S5kSuBhe" style="width: 30%; text-align: right" title="Number of Shares, Outstanding">4,318,901</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zHdvtffEfP85" style="width: 30%; text-align: right" title="Number of Shares, Vested">3,308,790</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zpYczAq7Kiy7" title="Exercise price">10.51</span> to $<span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zbHV55BXbYFl" title="Exercise price">15.52</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zQZiDOZv3Mz" style="text-align: right" title="Number of Shares, Outstanding">1,062,379</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zfyfeAz1xzfl" style="text-align: right" title="Number of Shares, Vested">670,956</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zsNlWqFs4FUa">15.53</span> to $<span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zVUNs0wKDLqh" title="Exercise price">20.54</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zhYcjlp21bDd" style="text-align: right" title="Number of Shares, Outstanding">9,091</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zJSsI8WWigoi" style="text-align: right" title="Number of Shares, Vested">9,091</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zLdUQpQ3VgH2" title="Exercise price">20.55</span> to $<span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zSGZ3rihBIha" title="Exercise price">25.56</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zVftdPZkIC0g" style="text-align: right" title="Number of Shares, Outstanding">25,683</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zbwDFxcG4ZE5" style="text-align: right" title="Number of Shares, Vested">24,642</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zb6SBS9cAY9l" title="Exercise price">25.57</span> to $<span id="xdx_904_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_ziWt5byD4axk" title="Exercise price">30.58</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zXqFcRVHLpEd" style="text-align: right" title="Number of Shares, Outstanding">910</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_z6nzf57X6me9" style="text-align: right" title="Number of Shares, Vested">910</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z1Hko8NG4tAk" title="Exercise price">30.59</span> to $<span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z9NRzZF1ocEc" title="Exercise price">35.60</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zbdhVFh44NUe" style="text-align: right" title="Number of Shares, Outstanding">4,320</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zOQC17slKSlf" style="text-align: right" title="Number of Shares, Vested">4,320</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_ziFaBhOV5pI9" title="Exercise price">35.61</span> to $<span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zk7x5rdyPcrg" title="Exercise price">40.62</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_z6QC6tOpZkx9" style="text-align: right" title="Number of Shares, Outstanding">2,728</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_z9UpFiDuxfde" style="text-align: right" title="Number of Shares, Vested">2,728</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zeoRnjPZFH89" title="Exercise price">40.63</span> to $<span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zfCESoZlc248" title="Exercise price">48.40</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zsYPY0Ab4wPe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Outstanding">27,956</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zkNlqkOYJl1f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Vested">27,956</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_ztdxMZPyshXj" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Outstanding">5,451,968</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z0JBAg8wcuCb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Vested">4,049,393</td><td style="text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ScheduleOfRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Restricted Stock Units Activity [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ScheduleOfRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ScheduleOfUnrecognizedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of unrecognized compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ScheduleOfUnrecognizedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ScheduleOfWarrantsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Warrants Activity [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ScheduleOfWarrantsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=AREN_NewPublisherPartnerWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=AREN_NewPublisherPartnerWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=AREN_ABGWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=AREN_ABGWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=AREN_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=AREN_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=AREN_CommonEquityAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=AREN_CommonEquityAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=AREN_CommonStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=AREN_CommonStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735286064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Income Taxes</a></td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zh5bOd87Uomb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of the (provision) benefit for income taxes consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_zJxUib8MGzf" style="display: none">Schedule of Income Taxes</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230101__20231231_zo2q3k3R6nF1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220101__20221231_zDAfweOglcij" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current tax (provision) benefit:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_maCFSALzf1Y_zzi04Day80Ke" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Federal</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2946">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2947">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pn3n3_maCFSALzf1Y_zQzMzV1Bz3w1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 60%; text-align: left; padding-bottom: 1.5pt">State and local</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">(88</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">(77</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_iT_pn3n3_mtCFSALzf1Y_maITEBzavD_maOTEBzTPw_zKfHARmqo5cb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total current tax (provision) benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(88</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(77</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax (provision) benefit:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_iN_pn3n3_di_maDITEBzGRA_zPXuvLKDRKsa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(57</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">985</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_pn3n3_di_maDITEBzGRA_zxHSDpKfudGg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">State and local</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(77</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">155</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredIncomeTaxExpenseBenefit_iNT_pn3n3_di_maITEBzavD_mtDITEBzGRA_maOTEBzTPw_zyIkaH8oJeDc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total deferred tax (provision) benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(134</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,140</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iNT_pn3n3_di_mtOTEBzTPw_zp500xwh83S" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total income tax (provision) benefit</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(222</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,063</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Components of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ztTl5HtUJgW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of deferred tax assets and liabilities were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BD_zT2pwna5LL4g" style="display: none">Schedule of Components of Deferred Tax Assets and Liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20231231_znBJW5Og44Z1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20221231_zlVTQSX3TqH" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzAs8_z7fuwzQTwAah" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left">Net operating loss carryforwards</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">52,353</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">51,023</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pn3n3_maDTAGzAs8_zA0j0FMZH0A4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Interest limitation carryforward</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,444</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_iI_pn3n3_maDTAGzAs8_zlpBsrKm3E99" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Tax credit carryforwards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">264</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">264</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_iI_pn3n3_maDTAGzAs8_zTGa0ENod1Vk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Allowance for doubtful accounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">388</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">757</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_iI_pn3n3_maDTAGzAs8_zT1mRYg7xvL9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accrued expenses and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">891</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,340</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--LeaseTermination_iI_pn3n3_maDTAGzAs8_zVEZ4UGK5Tzc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Lease termination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,017</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,869</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsLiquidatingDamagesPayable_iI_pn3n3_maDTAGzAs8_zssmQy207hS5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Liquidated damages</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">794</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,717</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_pn3n3_maDTAGzAs8_ztMZUlzFsGql" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,148</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,744</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pn3n3_maDTAGzAs8_zdesa3BX48A5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,229</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,931</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DeferredTaxAssetsOperatingLeaseLiability_iI_pn3n3_maDTAGzAs8_zLH6m1yltgx1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Operating lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsDepreciationAndAmortization_iI_pn3n3_maDTAGzAs8_znyngA1yTyN7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,146</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,706</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzAs8_maDTANzxgS_zYQ2APvNmCDb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82,316</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">76,913</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzxgS_za38z5xoLyl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Valuation allowance</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(76,367</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(65,406</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzxgS_maDTALNz54l_zwo4JkolOVDc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Total deferred tax assets</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,949</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,507</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred tax liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pn3n3_di_maDTLzOWA_zHE4CMkLB3T2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Acquisition-related intangibles</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,548</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,972</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxLiabilities_iNTI_pn3n3_di_mtDTLzOWA_msDTALNz54l_zgYFLmlwBfld" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Total deferred tax liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,548</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,972</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNTI_pn3n3_di_mtDTALNz54l_zKIpt2xb1Wne" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net deferred tax liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(599</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(465</td><td style="text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Tax Benefit and Effective Income Tax</a></td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z3R2TC0j2jk5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provision (benefit) for income taxes on the statements of operations differs from the amount computed by applying the statutory federal
income tax rate to loss before the benefit for income taxes, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_zrMosgqbD2J7" style="display: none">Schedule of Tax Benefit and Effective Income Tax</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percent</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percent</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Federal benefit expected at statutory rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_maABC_c20230101__20231231_zYcKZ9wqwXid" style="width: 12%; text-align: right" title="Federal benefit expected at statutory rate">(11,626</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maDEF_c20230101__20231231_zdcDf2HfnJmb" title="Federal benefit expected at statutory rate, percentage">21.0</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_maABC_c20220101__20221231_zq0T4YPWtUZk" style="width: 12%; text-align: right" title="Federal benefit expected at statutory rate">(14,375</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maDEF_c20220101__20221231_zxfBfTilVLz8" title="Federal benefit expected at statutory rate, percentage">21.0</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State and local taxes, net of federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_maABC_c20230101__20231231_zF4sqVqLVLJb" style="text-align: right" title="State and local taxes, net of federal benefit">(2,526</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maDEF_c20230101__20231231_z4We90obneJe" title="State and local taxes, net of federal benefit, percentage">4.6</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_maABC_c20220101__20221231_zcd5PBPGBppc" style="text-align: right" title="State and local taxes, net of federal benefit">(3,429</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maDEF_c20220101__20221231_zPfrVpImLqbi" title="State and local taxes, net of federal benefit, percentage">5.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_maABC_c20230101__20231231_zCeZznCT0nxf" style="text-align: right" title="Stock-based compensation">3,472</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_maDEF_c20230101__20231231_zul7BhTmovs3" title="Stock-based compensation, percentage">-6.3</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_maABC_c20220101__20221231_zRHueoy8qPrj" style="text-align: right" title="Stock-based compensation">3,894</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_maDEF_c20220101__20221231_z4sjAtoOMpm6" title="Stock-based compensation, percentage">-5.7</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenue_pn3n3_maABC_c20230101__20231231_zLcAf9CooIAc" style="text-align: right" title="Unearned revenue">(562</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage_pid_dp_uPure_maDEF_c20230101__20231231_z9XTWk39r5Be" title="Unearned revenue percentage">1.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenue_pn3n3_maABC_c20220101__20221231_zoT5YCVvUiyi" style="text-align: right" title="Unearned revenue">(696</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage_pid_dp_uPure_maDEF_c20220101__20221231_zV8CHYMEE9Q2" title="Unearned revenue percentage">1.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpense_pn3n3_maABC_c20230101__20231231_zaEQ1aIqW4ma" style="text-align: right" title="Interest expense">62</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpensePercentage_pid_dp_uPure_maDEF_c20230101__20231231_zieWVxDyIBUa" title="Interest expense percentage">-0.1</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpense_pn3n3_maABC_c20220101__20221231_zahXcV4gLeA4" style="text-align: right" title="Interest expense">56</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpensePercentage_pid_dp_uPure_maDEF_c20220101__20221231_zVt6UnuYyYCl" title="Interest expense percentage">-0.1</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Gain upon debt extinguishment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment_pn3n3_maABC_c20230101__20231231_ztrbDGN5pZ3k" style="text-align: right" title="Gain upon debt extinguishment"><span style="-sec-ix-hidden: xdx2ixbrl3078">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage_pid_dp_uPure_maDEF_c20230101__20231231_zOW4KfX73CMk" title="Gain upon debt extinguishment percentage">0.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment_pn3n3_maABC_c20220101__20221231_zuCUM6gET4Sf" style="text-align: right" title="Gain upon debt extinguishment">(760</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage_pid_dp_uPure_maDEF_c20220101__20221231_z8T4PXGTY8i2" title="Gain upon debt extinguishment percentage">0.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other differences, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pn3n3_maABC_c20230101__20231231_z91PVqepRv34" style="text-align: right" title="Other differences, net">678</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maDEF_c20230101__20231231_zOe6P2h0ysWj" title="Other differences, net percentage">-1.2</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pn3n3_maABC_c20220101__20221231_zxvqTufnLFo4" style="text-align: right" title="Other differences, net">(997</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maDEF_c20220101__20221231_zm3mp98Oi9B4" title="Other differences, net percentage">1.6</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_maABC_c20230101__20231231_zw3bz20nJuNi" style="text-align: right" title="Valuation allowance">10,961</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maDEF_c20230101__20231231_zSHiRkDePcgk" title="Valuation allowance percentage">-19.8</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_maABC_c20220101__20221231_zFjqdX2nH2Xk" style="text-align: right" title="Valuation allowance">14,959</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maDEF_c20220101__20221231_zccpwDF5W146" title="Valuation allowance percentage">-21.9</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other permanent differences</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_pn3n3_maABC_c20230101__20231231_zgzNRO5F0zwh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other permanent differences">(237</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_maDEF_c20230101__20231231_zF2El0cOWnY2" title="Other permanent differences percentage">0.4</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_pn3n3_maABC_c20220101__20221231_zS6k4kCrh7i4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other permanent differences">285</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_maDEF_c20220101__20221231_zx8ZIXsOxCYc" title="Other permanent differences percentage">-0.4</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income tax provision (benefit) and effective income tax rate</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_mtABC_c20230101__20231231_zElUn0Rgf3hd" style="border-bottom: Black 2.5pt double; text-align: right" title="Income tax benefit and effective income tax rate">222</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_mtDEF_c20230101__20231231_zEoPqHXa8xq4" title="Income tax benefit and effective income tax rate, percentage">-0.4</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_mtABC_c20220101__20221231_zgKibdO2kzq2" style="border-bottom: Black 2.5pt double; text-align: right" title="Income tax benefit and effective income tax rate">(1,063</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_mtDEF_c20220101__20221231_zsxInu9KDHv7" title="Income tax benefit and effective income tax rate, percentage">1.6</span></td><td style="text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735915616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 08, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Stockholders' Equity, Reverse Stock Split</a></td>
<td class="text">one-for-twenty-two (1-for-22) reverse stock split<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents, at Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,284<span></span>
</td>
<td class="nump">$ 13,871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_WorkingCapitalDeficit', window );">[custom:WorkingCapitalDeficit-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Working capital deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731427680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Over time</a></td>
<td class="nump">$ 244,203<span></span>
</td>
<td class="nump">$ 220,935<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">244,203<span></span>
</td>
<td class="nump">220,935<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember', window );">Transferred at Point in Time [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Over time</a></td>
<td class="nump">231,439<span></span>
</td>
<td class="nump">199,779<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">231,439<span></span>
</td>
<td class="nump">199,779<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Transferred over Time [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Over time</a></td>
<td class="nump">12,764<span></span>
</td>
<td class="nump">21,156<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">12,764<span></span>
</td>
<td class="nump">21,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Over time</a></td>
<td class="nump">234,012<span></span>
</td>
<td class="nump">218,110<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">234,012<span></span>
</td>
<td class="nump">218,110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=AREN_OtherMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Over time</a></td>
<td class="nump">10,191<span></span>
</td>
<td class="nump">2,825<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">10,191<span></span>
</td>
<td class="nump">2,825<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AREN_DigitalAdvertisingMember', window );">Digital Advertising [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Over time</a></td>
<td class="nump">135,376<span></span>
</td>
<td class="nump">109,317<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">135,376<span></span>
</td>
<td class="nump">109,317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AREN_DigitalSubscriptionsMember', window );">Digital Subscriptions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Over time</a></td>
<td class="nump">12,764<span></span>
</td>
<td class="nump">21,156<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">12,764<span></span>
</td>
<td class="nump">21,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AREN_LicensingAndSyndicationRevenueMember', window );">Licensing And Syndication Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Over time</a></td>
<td class="nump">18,482<span></span>
</td>
<td class="nump">18,173<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">18,482<span></span>
</td>
<td class="nump">18,173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Product and Service, Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Over time</a></td>
<td class="nump">5,384<span></span>
</td>
<td class="nump">1,166<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">5,384<span></span>
</td>
<td class="nump">1,166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AREN_DigitalRevenueMember', window );">Digital Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Over time</a></td>
<td class="nump">172,006<span></span>
</td>
<td class="nump">149,812<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">172,006<span></span>
</td>
<td class="nump">149,812<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AREN_PrintAdvertisingMember', window );">Print Advertising [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Over time</a></td>
<td class="nump">9,881<span></span>
</td>
<td class="nump">10,214<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">9,881<span></span>
</td>
<td class="nump">10,214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AREN_PrintSubscriptionsMember', window );">Print Subscriptions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Over time</a></td>
<td class="nump">62,316<span></span>
</td>
<td class="nump">60,909<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">62,316<span></span>
</td>
<td class="nump">60,909<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AREN_PrintRevenueMember', window );">Print Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Over time</a></td>
<td class="nump">72,197<span></span>
</td>
<td class="nump">71,123<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 72,197<span></span>
</td>
<td class="nump">$ 71,123<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=AREN_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=AREN_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AREN_DigitalAdvertisingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AREN_DigitalAdvertisingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AREN_DigitalSubscriptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AREN_DigitalSubscriptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AREN_LicensingAndSyndicationRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AREN_LicensingAndSyndicationRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AREN_DigitalRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AREN_DigitalRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AREN_PrintAdvertisingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AREN_PrintAdvertisingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AREN_PrintSubscriptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AREN_PrintSubscriptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AREN_PrintRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AREN_PrintRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656847667872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Contract with Customer, Asset and Liability (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Total short-term contract liabilities</a></td>
<td class="nump">$ 59,786<span></span>
</td>
<td class="nump">$ 58,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Total long-term contract liabilities</a></td>
<td class="nump">10,679<span></span>
</td>
<td class="nump">19,701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AREN_DigitalRevenueMember', window );">Digital Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Total short-term contract liabilities</a></td>
<td class="nump">14,397<span></span>
</td>
<td class="nump">18,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Total long-term contract liabilities</a></td>
<td class="nump">542<span></span>
</td>
<td class="nump">1,118<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AREN_PrintRevenueMember', window );">Print Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Total short-term contract liabilities</a></td>
<td class="nump">45,389<span></span>
</td>
<td class="nump">40,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Total long-term contract liabilities</a></td>
<td class="nump">$ 10,137<span></span>
</td>
<td class="nump">$ 18,583<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AREN_DigitalRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AREN_DigitalRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AREN_PrintRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AREN_PrintRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735778592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Cash and Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 9,284<span></span>
</td>
<td class="nump">$ 13,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">502<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, and restricted cash</a></td>
<td class="nump">$ 9,284<span></span>
</td>
<td class="nump">$ 14,373<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735072256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Allowance For Doubtful Accounts (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for doubtful accounts beginning of year</a></td>
<td class="nump">$ 2,236<span></span>
</td>
<td class="nump">$ 1,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries', window );">Additions</a></td>
<td class="nump">315<span></span>
</td>
<td class="nump">658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Deductions - write-offs</a></td>
<td class="num">(1,570)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for doubtful accounts end of year</a></td>
<td class="nump">$ 981<span></span>
</td>
<td class="nump">$ 2,236<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in allowance for credit loss on accounts receivable, from recovery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656825971632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Depreciation and Amortization, Useful Lives of Assets (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AREN_OfficeEquipmentAndComputersMember', window );">Office Equipment And Computers [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property plant and equipment useful life</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AREN_OfficeEquipmentAndComputersMember', window );">Office Equipment And Computers [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property plant and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property plant and equipment useful life</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property plant and equipment useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AREN_OfficeEquipmentAndComputersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=AREN_OfficeEquipmentAndComputersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656825920944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Net Income (Loss) Per Common Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount</a></td>
<td class="nump">6,674,839<span></span>
</td>
<td class="nump">10,398,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_SeriesGConvertiblePreferredStockMember', window );">Series G Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount</a></td>
<td class="nump">8,582<span></span>
</td>
<td class="nump">8,582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesHPreferredStockMember', window );">Series H Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,981,128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_FinancingWarrantsMember', window );">Financing Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">107,956<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_ABGWarrantsMember', window );">ABG Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount</a></td>
<td class="nump">999,540<span></span>
</td>
<td class="nump">999,540<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_AllHipHopWarrantsMember', window );">All Hip Hop Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount</a></td>
<td class="nump">5,682<span></span>
</td>
<td class="nump">5,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_PublisherPartnerWarrantsMember', window );">Publisher Partner Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount</a></td>
<td class="nump">9,800<span></span>
</td>
<td class="nump">4,154<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_RestrictedStockAwardsMember', window );">Restricted Stock Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">97,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount</a></td>
<td class="nump">199,267<span></span>
</td>
<td class="nump">994,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_CommonStockOptionsMember', window );">Common Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount</a></td>
<td class="nump">5,451,968<span></span>
</td>
<td class="nump">6,199,521<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_SeriesGConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_SeriesGConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesHPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesHPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_FinancingWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_FinancingWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_ABGWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_ABGWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_AllHipHopWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_AllHipHopWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_PublisherPartnerWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_PublisherPartnerWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_RestrictedStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_RestrictedStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_CommonStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=AREN_CommonStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731216128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 110,691,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent', window );">Subscription refund liability</a></td>
<td class="nump">449,000<span></span>
</td>
<td class="nump">$ 845,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_UnearnedRevenue', window );">Contract with customer liability noncurrent</a></td>
<td class="nump">523,000<span></span>
</td>
<td class="nump">1,154,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract', window );">Contract modification - revenue</a></td>
<td class="nump">554,000<span></span>
</td>
<td class="nump">2,986,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">502,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">44,811,000<span></span>
</td>
<td class="nump">33,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization subscription costs</a></td>
<td class="nump">38,112,000<span></span>
</td>
<td class="nump">37,190,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Subscription acquisition cost</a></td>
<td class="nump">29,706,000<span></span>
</td>
<td class="nump">25,931,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNetNoncurrent', window );">Acquisition cost long term</a></td>
<td class="nump">7,215,000<span></span>
</td>
<td class="nump">14,133,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNetCurrent', window );">Subscription acquisition cost current</a></td>
<td class="nump">$ 29,706,000<span></span>
</td>
<td class="nump">25,931,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesDescription', window );">Liquidated damages description</a></td>
<td class="text">The
Company incurred liquidated damages when: (i) a registration rights agreement provides for damages if the Company does not register the
shares of the Company&#8217;s common stock within the requisite time frame (the &#8220;Registration Rights Damages&#8221;), which, in
general, provides for a cash payment equal to 1.0% per month of the amount invested, on a daily pro rata basis for any portion of a month,
as partial liquidated damages per month, upon the occurrence of certain events, up to a maximum amount of 6.0% of the aggregate amount
invested, subject to interest at the rate of 1.0% per month until paid in full; and (ii) a securities purchase agreement provides for
damages if the Company fails for any reason to satisfy a public information requirement within the requisite time frame with the Securities
and Exchange Commission (&#8220;SEC&#8221;) (the &#8220;Public Information Failure Damages&#8221;), which, in general, provides for a
cash payment equal to 1.0% of the aggregate amount invested for each 30-day period, or pro rata portion thereof, as partial liquidated
damages per month, up to a maximum of 6 months, subject to interest at the rate of 1.0% per month until paid in full.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and Marketing Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense</a></td>
<td class="nump">$ 4,372,000<span></span>
</td>
<td class="nump">$ 5,987,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">13.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember', window );">Accounts Payable [Member] | Customer Concentration Risk [Member] | Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue</a></td>
<td class="nump">12.20%<span></span>
</td>
<td class="nump">14.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=AREN_DigitalAndPrintSubscriptionsMember', window );">Digital And Print Subscriptions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_UnearnedRevenue', window );">Contract with customer liability noncurrent</a></td>
<td class="nump">$ 68,985,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_BRileyFBRIncMember', window );">B Riley FBR Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,691<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LiquidatedDamagesDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidated damages description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LiquidatedDamagesDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_UnearnedRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unearned Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_UnearnedRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from contract modification which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRefundLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=AREN_CustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=AREN_CustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=AREN_DigitalAndPrintSubscriptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=AREN_DigitalAndPrintSubscriptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_BRileyFBRIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_BRileyFBRIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736343392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Discontinued Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net loss from discontinued operations</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (3,470)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=AREN_ParadePrintMember', window );">Parade Print [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MultiemployerPlansLineItems', window );"><strong>Multiemployer Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Revenue</a></td>
<td class="nump">26,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold', window );">Cost of revenue</a></td>
<td class="nump">23,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss', window );">Gross profit</a></td>
<td class="nump">3,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">5,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">1,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges', window );">Loss on impairment of assets</a></td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Total operating expenses</a></td>
<td class="nump">7,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Loss from discontinued operations</a></td>
<td class="num">(3,525)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax benefit</a></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net loss from discontinued operations</a></td>
<td class="num">$ (3,470)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal group including discontinued operation asset impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal group including discontinued operation selling and marketing expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-4<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MultiemployerPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480547/715-80-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480606/715-80-35-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-9<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MultiemployerPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=AREN_ParadePrintMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=AREN_ParadePrintMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736179488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosureDiscontinuedOperationsAbstract', window );"><strong>Discontinued Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationDiscontinuedOperations', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on impairment of assets</a></td>
<td class="nump">$ 209<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosureDiscontinuedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosureDiscontinuedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortizationDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deprecation and amortization expense attributable to property, plant and equipment and intangible assets of discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortizationDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656826074432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Composition Preliminary Assets Purchase Price (Details) - Teneology Inc [Member] - Fexy Studios [Member]<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jan. 11, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Cash</a></td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable', window );">Common stock</a></td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration', window );">Contingent consideration</a></td>
<td class="nump">561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted', window );">Deferred cash payments, as discounted</a></td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Total purchase consideration</a></td>
<td class="nump">$ 3,307<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset acquisition consideration transferred deferred cash payments as discounted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contingent consideration recognized as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_TeneologyIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_TeneologyIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=AREN_FexyStudiosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=AREN_FexyStudiosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735842272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Preliminary Assets Purchase Price Allocation (Details) - Teneology Inc [Member] - Fexy Studios [Member]<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jan. 11, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AssetAcquisitionAssetsAcquired', window );">Net assets acquired</a></td>
<td class="nump">$ 3,307<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_TeneologyIncMember', window );">Advertiser Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AssetAcquisitionAssetsAcquired', window );">Net assets acquired</a></td>
<td class="nump">663<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_TeneologyIncMember', window );">Brand Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AssetAcquisitionAssetsAcquired', window );">Net assets acquired</a></td>
<td class="nump">659<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_TeneologyIncMember', window );">Goodwill [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AssetAcquisitionAssetsAcquired', window );">Net assets acquired</a></td>
<td class="nump">$ 1,985<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_AssetAcquisitionAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset acquisition assets acquired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_AssetAcquisitionAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_TeneologyIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_TeneologyIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=AREN_FexyStudiosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=AREN_FexyStudiosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=AREN_AdvertiserRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=AREN_AdvertiserRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=AREN_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=AREN_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656730111776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Composition of Purchase Price (Details) - Athlon Holdings Inc [Member]<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Apr. 01, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash</a></td>
<td class="nump">$ 12,085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock</a></td>
<td class="nump">3,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredOther1', window );">Deferred cash payments, as discounted</a></td>
<td class="nump">628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase consideration</a></td>
<td class="nump">$ 15,854<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredOther1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredOther1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_AthlonHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_AthlonHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656737290976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Purchase Price Allocation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 42,575<span></span>
</td>
<td class="nump">$ 39,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_AthlonHoldingsIncMember', window );">Athlon Holdings Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement', window );">Equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent', window );">Digital content</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement', window );">Advertiser relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,416)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses', window );">Accrued expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,203)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(543)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,303)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed advertisement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed digital content.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed equity investement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed trade name.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_AthlonHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_AthlonHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656826101104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Supplemental Proforma Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (55,582)<span></span>
</td>
<td class="num">$ (70,858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Total continuing operations supplemental pro forma revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Total continuing operations supplemental pro forma net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72,798)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_ParadeMember', window );">Parade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,071<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,494)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Total continuing operations supplemental pro forma revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Total continuing operations supplemental pro forma net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,070)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_ArenaMember', window );">Arena [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Total continuing operations supplemental pro forma revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Total continuing operations supplemental pro forma net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67,788)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_AdjustmentsMember', window );">Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Total continuing operations supplemental pro forma net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,940)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_ParadeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_ParadeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_ArenaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_ArenaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_AdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_AdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735931440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Preliminary Price Allocation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation', window );">Assumed lease obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,676)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_AthlonHoldingsIncMember', window );">Athlon Holdings Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable', window );">Lease deposit receivable</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship', window );">Advertiser relationships</a></td>
<td class="nump">6,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName', window );">Brand names</a></td>
<td class="nump">6,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill', window );">Goodwill</a></td>
<td class="nump">18,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue', window );">Unearned revenue</a></td>
<td class="num">(3,941)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability', window );">Subscription refund liability</a></td>
<td class="num">(137)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation', window );">Assumed lease obligation</a></td>
<td class="num">(2,676)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed advertisement relationship.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed assumed lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed brand name.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed lease deposit receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed subscription refund liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed unearned revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_AthlonHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_AthlonHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656723357728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Dispositions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 17, 2023</div></th>
<th class="th"><div>May 01, 2023</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 01, 2023</div></th>
<th class="th"><div>Jan. 11, 2023</div></th>
<th class="th"><div>Dec. 15, 2022</div></th>
<th class="th"><div>Dec. 07, 2022</div></th>
<th class="th"><div>Sep. 27, 2022</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Share value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,490,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost', window );">Transaction cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 283,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,575,000<span></span>
</td>
<td class="nump">39,344,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,619,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable net current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,811,000<span></span>
</td>
<td class="nump">33,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,357,000<span></span>
</td>
<td class="nump">$ 12,863,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">$ 23,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments', window );">Adjustment description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
adjustments for the year ended December 31, 2022 of ($1,940), represents adjustments: (1) to record depreciation and amortization expense
related to the fixed and intangible assets acquired from the acquisition of ($864); (2) to reverse the nonrecurring transaction cost
related to the acquisition of $200; and (3) to reverse the deferred tax benefit related to the acquisition of ($1,276).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Escrow deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation', window );">Assumed lease obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,676,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,189,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DeferredRevenueObligation', window );">Deferred revenue obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnearnedPremiums', window );">Unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,941,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CustomerRefundLiabilityCurrent', window );">Refund liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill for tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,299,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Share value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=AREN_Disposition2023Member', window );">Disposition 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities', window );">Cash proceeds</a></td>
<td class="nump">$ 1,061,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_SalePrice', window );">Sale price</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_WorkingCapital', window );">Working capital</a></td>
<td class="nump">272,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PreliminaryWorkingCapital', window );">Preliminary working capital</a></td>
<td class="nump">61,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_WorkingCapitalAdjustments', window );">Adjustment for working capital</a></td>
<td class="nump">153,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_FinalSalePrice', window );">Sale price</a></td>
<td class="nump">908,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Business component carrying value</a></td>
<td class="nump">$ 172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">639,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable net current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">453,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_FexyStudiosMember', window );">Fexy Studios [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, acquired during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,985,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_AthlonHoldingsIncMember', window );">Athlon Holdings Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,587,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Acquired percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination consideration transferred1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,854,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,840,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates', window );">Cash portion in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,827,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PaymentsToAcquireBusinessesAtClosing', window );">Cash payments paid at closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,840,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Payments for acquire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 987,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Number of shares issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">314,103,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Fair value of shares issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,141,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity', window );">Acquisition description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
amount estimated to be paid post-closing of $987 will be or was paid as follows: (i) $742 is expected to be paid upon receipts of certain
tax refunds due to the sellers (consisting of $3,000 for the deferred cash payments, as discounted, less a $2,258 cash adjustment); and
(ii) $245 was paid within two business days from the date the Company received proceeds from the sale of the equity interest in Just
Like Falling Off a Bike, LLC that was held by Parade as of the closing date (paid on April 7, 2022).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription', window );">Acquisition description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
Company received a final valuation report from a third party valuation firm after the preliminary purchase price was adjusted during
the quarterly period ended September 30, 2022. After considering the results of the final valuation report, the Company estimated
that the purchase consideration decreased by $321. The decrease in the purchase price was related to an increase in identifiable
assets of $54, an increase in deferred tax liabilities of $27, with a decrease in the working capital adjustment of $321, resulting
in a decrease in goodwill of $348.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Transaction cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation', window );">Assumed lease obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,676,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_AthlonHoldingsIncMember', window );">Athlon Holdings Inc [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Stock value assigned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_MensJournalMember', window );">Mens Journal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, acquired during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,246,000<span></span>
</td>
<td class="nump">$ 17,138,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_A360MediaLLCMember', window );">A360 Media LLC [Member] | Advertiser Relationship [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_A360MediaLLCMember', window );">A360 Media LLC [Member] | Brand Name [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=AREN_AdvertiserRelationshipsMember', window );">Advertiser Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=AREN_AdvertiserRelationshipsMember', window );">Advertiser Relationships [Member] | Athlon Holdings Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=AREN_BrandNamesMember', window );">Brand Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=AREN_DigitalContentMember', window );">Digital Content [Member] | Athlon Holdings Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member] | Athlon Holdings Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">14 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_TeneologyIncMember', window );">Teneology Inc [Member] | Fexy Studios [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,678,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_TeneologyIncMember', window );">Teneology Inc [Member] | Fexy Studios [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,307,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Cash paid for consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForAdvanceToAffiliate', window );">Advance payments of cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DeferredCashPayments', window );">Deferred cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DeferredCashPaymentsDue', window );">Deferred cash payment due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Number of shares issued for asset acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets', window );">Fair value of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Share value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Common stock trading price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToEmployees', window );">Cash retention pool for employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost', window );">Transaction cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_BuffaloGroupeLLCMember', window );">Buffalo Groupe LLC [Member] | Intellectual Properties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Cash paid for consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed assumed lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DeferredCashPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred cash payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DeferredCashPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DeferredCashPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred cash payments due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DeferredCashPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DeferredRevenueObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Revenue Obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DeferredRevenueObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_FinalSalePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Final sale price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_FinalSalePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_PaymentsToAcquireBusinessesAtClosing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to acquire businesses at closing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_PaymentsToAcquireBusinessesAtClosing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_PreliminaryWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Preliminary working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_PreliminaryWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_SalePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_SalePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_WorkingCapitalAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Working capital adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_WorkingCapitalAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction cost incurred as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents a description of such arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents a description of the nature of any measurement period adjustments (as defined) realized during the reporting period to the assets, liabilities, equity interests, or items of consideration for which the initial accounting was incomplete in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerRefundLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CustomerRefundLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPaymentsToAcquireBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPaymentsToAcquireBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForAdvanceToAffiliate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from advancing money to an affiliate (an entity that is related but not strictly controlled by the entity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForAdvanceToAffiliate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments of cash to employees, including wages and salaries, during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale of other assets recognized in investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnearnedPremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(13)(a)(2))<br> -SubTopic 210<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnearnedPremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=AREN_Disposition2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=AREN_Disposition2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_FexyStudiosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_FexyStudiosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_AthlonHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_AthlonHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_MensJournalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_MensJournalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_A360MediaLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_A360MediaLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AREN_AdvertiserRelationshipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AREN_AdvertiserRelationshipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AREN_BrandNameMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AREN_BrandNameMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=AREN_AdvertiserRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=AREN_AdvertiserRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=AREN_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=AREN_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=AREN_DigitalContentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=AREN_DigitalContentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_TeneologyIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_TeneologyIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=AREN_FexyStudiosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=AREN_FexyStudiosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_BuffaloGroupeLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_BuffaloGroupeLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=AREN_IntellectualPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=AREN_IntellectualPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656737295504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Prepayments and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract', window );"><strong>Prepayments And Other Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">$ 2,946<span></span>
</td>
<td class="nump">$ 2,321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PrepaidSuppliesCurrent', window );">Prepaid supplies</a></td>
<td class="nump">773<span></span>
</td>
<td class="nump">927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_RefundableIncomeAndFranchiseTaxes', window );">Refundable income and franchise taxes</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt costs</a></td>
<td class="nump">209<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_EmployeeRetentionCredits', window );">Employee retention credits</a></td>
<td class="nump">2,468<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepayments and other current assets</a></td>
<td class="nump">$ 6,598<span></span>
</td>
<td class="nump">$ 4,441<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_EmployeeRetentionCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee retention credits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_EmployeeRetentionCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_PrepaidSuppliesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid supplies current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_PrepaidSuppliesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_RefundableIncomeAndFranchiseTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Refundable income and franchise taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_RefundableIncomeAndFranchiseTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735650656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepayments and Other Current Assets (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract', window );"><strong>Prepayments And Other Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLaborRelatedExpenses', window );">Employee retention credits</a></td>
<td class="nump">$ 6,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_EmployeeRetentionPayable', window );">Retention Payable</a></td>
<td class="nump">4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_EmployeeRetentionCredits', window );">Employee retention credits</a></td>
<td class="nump">$ 2,468<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_EmployeeRetentionCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee retention credits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_EmployeeRetentionCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_EmployeeRetentionPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee retention payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_EmployeeRetentionPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLaborRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of labor-related expenses classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLaborRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656826058528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property and equipment</a></td>
<td class="nump">$ 1,910<span></span>
</td>
<td class="nump">$ 1,984<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(1,582)<span></span>
</td>
<td class="num">(1,249)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net property and equipment</a></td>
<td class="nump">328<span></span>
</td>
<td class="nump">735<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AREN_OfficeEquipmentAndComputersMember', window );">Office Equipment And Computers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property and equipment</a></td>
<td class="nump">1,744<span></span>
</td>
<td class="nump">1,744<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property and equipment</a></td>
<td class="nump">$ 166<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AREN_OfficeEquipmentAndComputersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=AREN_OfficeEquipmentAndComputersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735103296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems', window );"><strong>Impairment Effects on Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 352<span></span>
</td>
<td class="nump">$ 539<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems', window );"><strong>Impairment Effects on Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment charges for property and equipment</a></td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731641200">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of Supplemental Information Related to Operating Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Operating lease costs during the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,052<span></span>
</td>
<td class="nump">$ 969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash payments included in the measurement of operating lease liabilities during the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 486<span></span>
</td>
<td class="nump">$ 469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years) as of year-end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">9 months<span></span>
</td>
<td class="text">1 year 9 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate during the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9.90%<span></span>
</td>
<td class="nump">9.90%<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Operating lease
costs is presented net of sublease income that is not material.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735072256">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of Operating Lease Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Total operating costs ()</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,344<span></span>
</td>
<td class="nump">$ 1,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Less sublease income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(292)<span></span>
</td>
<td class="num">(218)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total operating lease costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">1,052<span></span>
</td>
<td class="nump">969<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Total operating costs ()</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,344<span></span>
</td>
<td class="nump">$ 1,187<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes certain
costs associated with a business membership agreement (see below) that permits access to certain office space for the years ended December
31, 2023 and 2022 of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_904_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessMembershipAgreementMember_zU6h5otEQ9t7" title="Operating lease cost">620</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--OperatingLeaseCost_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--BusinessMembershipAgreementMember_z6Ipd2wuVVn6" title="Operating lease cost">668</span>, respectively, and month-to-month lease arrangements for the years ended December 31, 2023 and 2022
of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--MonthToMonthLeaseArrangementMember_zKURtxpM8Jmd" title="Operating lease cost">396</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--OperatingLeaseCost_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--MonthToMonthLeaseArrangementMember_zmCHQMmJCq5d" title="Operating lease cost">320</span>, respectively.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Operating lease
costs is presented net of sublease income that is not material.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656733256256">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of Operating Lease Costs (Details) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,344<span></span>
</td>
<td class="nump">$ 1,187<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_BusinessMembershipAgreementMember', window );">Business Membership Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">620<span></span>
</td>
<td class="nump">668<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_MonthToMonthLeaseArrangementMember', window );">Month To Month Lease Arrangement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 396<span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes certain
costs associated with a business membership agreement (see below) that permits access to certain office space for the years ended December
31, 2023 and 2022 of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_904_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessMembershipAgreementMember_zU6h5otEQ9t7" title="Operating lease cost">620</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--OperatingLeaseCost_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--BusinessMembershipAgreementMember_z6Ipd2wuVVn6" title="Operating lease cost">668</span>, respectively, and month-to-month lease arrangements for the years ended December 31, 2023 and 2022
of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--MonthToMonthLeaseArrangementMember_zKURtxpM8Jmd" title="Operating lease cost">396</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--OperatingLeaseCost_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--MonthToMonthLeaseArrangementMember_zmCHQMmJCq5d" title="Operating lease cost">320</span>, respectively.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_BusinessMembershipAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_BusinessMembershipAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_MonthToMonthLeaseArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_MonthToMonthLeaseArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735776608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Maturity of Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Minimum lease payments - 2024</a></td>
<td class="nump">$ 373<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liability</a></td>
<td class="nump">358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion of operating lease liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735652960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, remaining fixed payment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Market advertising</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_MarketingAndAdvertisingExpenseRemaining', window );">Market advertising leaving</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=AREN_OctoberOneTwoThousandAndTwentyFourMember', window );">October One Two Thousand And Twenty Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ImputedInterestRate', window );">Imputed interest recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_SubleaseAgreementMember', window );">Sublease Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_LeaseArrangementMember', window );">Lease Arrangement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLeasePayments', window );">Proceeds from lease payments</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense</a></td>
<td class="nump">$ 1,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ImputedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Imputed interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ImputedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_MarketingAndAdvertisingExpenseRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketing and advertising expense remaining carrying on.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_MarketingAndAdvertisingExpenseRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from lease payment, classified as operating activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479016/842-30-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479016/842-30-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=AREN_OctoberOneTwoThousandAndTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=AREN_OctoberOneTwoThousandAndTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_SubleaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_SubleaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_LeaseArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_LeaseArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736301088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Platform Development Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Platform development</a></td>
<td class="nump">$ 126,681<span></span>
</td>
<td class="nump">$ 126,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less accumulated amortization</a></td>
<td class="nump">88,222<span></span>
</td>
<td class="nump">67,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net platform development</a></td>
<td class="nump">38,459<span></span>
</td>
<td class="nump">58,970<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AREN_PlatformDevelopmentMember', window );">Platform Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Platform development</a></td>
<td class="nump">26,054<span></span>
</td>
<td class="nump">21,493<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less accumulated amortization</a></td>
<td class="num">(17,331)<span></span>
</td>
<td class="num">(11,163)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net platform development</a></td>
<td class="nump">$ 8,723<span></span>
</td>
<td class="nump">$ 10,330<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AREN_PlatformDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=AREN_PlatformDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736341040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Platform Development Cost Activity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Total capitalized payroll-based costs</a></td>
<td class="nump">$ 38,112<span></span>
</td>
<td class="nump">$ 37,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">19,060<span></span>
</td>
<td class="nump">31,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AREN_PlatformDevelopmentMember', window );">Platform Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOther', window );">Platform development beginning of year</a></td>
<td class="nump">21,493<span></span>
</td>
<td class="nump">21,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Payroll-based costs capitalized</a></td>
<td class="nump">3,773<span></span>
</td>
<td class="nump">5,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Less dispositions</a></td>
<td class="num">(164)<span></span>
</td>
<td class="num">(7,357)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Total capitalized payroll-based costs</a></td>
<td class="nump">25,102<span></span>
</td>
<td class="nump">19,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,016<span></span>
</td>
<td class="nump">1,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairments</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOther', window );">Platform development end of year</a></td>
<td class="nump">$ 26,054<span></span>
</td>
<td class="nump">$ 21,493<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AREN_PlatformDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=AREN_PlatformDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736392800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Platform Development (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense of intangible asset</a></td>
<td class="nump">$ 27,354<span></span>
</td>
<td class="nump">$ 26,570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Loss on impairment of assets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AREN_PlatformDevelopmentMember', window );">Platform Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense of intangible asset</a></td>
<td class="nump">$ 6,332<span></span>
</td>
<td class="nump">5,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment charges</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes impairment of finite-lived intangible asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=AREN_PlatformDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=AREN_PlatformDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656832448352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Intangible Assets Subject to Amortization (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 27, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 126,681<span></span>
</td>
<td class="nump">$ 126,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, accumulated amortization</a></td>
<td class="num">(88,222)<span></span>
</td>
<td class="num">(67,371)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 38,459<span></span>
</td>
<td class="nump">58,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_DevelopedTechnologyMember', window );">Developed Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, weighted average useful life</a></td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 17,333<span></span>
</td>
<td class="nump">17,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, accumulated amortization</a></td>
<td class="num">(17,333)<span></span>
</td>
<td class="num">(14,883)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, weighted average useful life</a></td>
<td class="text">16 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 5,181<span></span>
</td>
<td class="nump">5,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, accumulated amortization</a></td>
<td class="num">(1,547)<span></span>
</td>
<td class="num">(1,180)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 3,634<span></span>
</td>
<td class="nump">4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_BrandNamesMember', window );">Brand Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, weighted average useful life</a></td>
<td class="text">9 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 12,774<span></span>
</td>
<td class="nump">12,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, accumulated amortization</a></td>
<td class="num">(2,374)<span></span>
</td>
<td class="num">(908)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 10,400<span></span>
</td>
<td class="nump">11,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_SubscriberRelationshipsMember', window );">Subscriber Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, weighted average useful life</a></td>
<td class="text">5 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 73,459<span></span>
</td>
<td class="nump">73,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, accumulated amortization</a></td>
<td class="num">(61,654)<span></span>
</td>
<td class="num">(47,146)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 11,805<span></span>
</td>
<td class="nump">26,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_AdvertiserRelationshipsMember', window );">Advertiser Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, weighted average useful life</a></td>
<td class="text">10 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 15,182<span></span>
</td>
<td class="nump">15,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, accumulated amortization</a></td>
<td class="num">(2,832)<span></span>
</td>
<td class="num">(1,368)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 12,350<span></span>
</td>
<td class="nump">13,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember', window );">Database Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, weighted average useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 2,397<span></span>
</td>
<td class="nump">2,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, accumulated amortization</a></td>
<td class="num">(2,171)<span></span>
</td>
<td class="num">(1,753)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 226<span></span>
</td>
<td class="nump">644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_DigitalContentMember', window );">Digital Content [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, weighted average useful life</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, accumulated amortization</a></td>
<td class="num">(311)<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_SubscriberRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_SubscriberRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_AdvertiserRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_AdvertiserRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_DigitalContentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_DigitalContentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656826076224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Future Estimated Amortization expense For Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths', window );">2024</a></td>
<td class="nump">$ 14,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo', window );">2025</a></td>
<td class="nump">3,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree', window );">2026</a></td>
<td class="nump">3,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour', window );">2027</a></td>
<td class="nump">3,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive', window );">2028</a></td>
<td class="nump">2,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive', window );">Thereafter</a></td>
<td class="nump">11,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets ,net</a></td>
<td class="nump">$ 38,459<span></span>
</td>
<td class="nump">$ 58,970<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fourth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656737786640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfAcquisitionCosts', window );">Amortization expense of intangible asset acquisition</a></td>
<td class="nump">$ 21,022<span></span>
</td>
<td class="nump">$ 20,748<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense of intangible asset</a></td>
<td class="nump">27,354<span></span>
</td>
<td class="nump">26,570<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember', window );">Finite-Lived Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_DevelopedTechnologyMember', window );">Developed Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense of intangible asset</a></td>
<td class="nump">$ 2,130<span></span>
</td>
<td class="nump">$ 2,831<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=AREN_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735168160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Other Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Other receivables</a></td>
<td class="nump">90<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_UnamortizedDebtCost', window );">Unamortized debt cost</a></td>
<td class="nump">209<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total other assets</a></td>
<td class="nump">$ 1,003<span></span>
</td>
<td class="nump">$ 1,140<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_UnamortizedDebtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unamortized debt cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_UnamortizedDebtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736059872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Changes in Carrying Value of Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Carrying value at beginning of year</a></td>
<td class="nump">$ 39,344<span></span>
</td>
<td class="nump">$ 19,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Loss on impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Carrying value at end of year</a></td>
<td class="nump">42,575<span></span>
</td>
<td class="nump">39,344<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_ParadeMember', window );">Parade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired in acquisition of Fexy Studios</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,587<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_MensJournalMember', window );">Mens Journal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired in acquisition of Fexy Studios</a></td>
<td class="nump">1,246<span></span>
</td>
<td class="nump">17,138<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_FexyStudiosMember', window );">Fexy Studios [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired in acquisition of Fexy Studios</a></td>
<td class="nump">$ 1,985<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_ParadeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_ParadeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_MensJournalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_MensJournalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_FexyStudiosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_FexyStudiosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731754512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735820640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restricted Stock Liabilities (Details Narrative) - Restricted Stock [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased during period, shares</a></td>
<td class="nump">26,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfEquity', window );">Payments for repurchase Of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_RestrictedStockPrincipalAmount', window );">Restricted stock principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_RestrictedStockInterestPayment', window );">Restricted stock interest payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_RestrictedStockInterestPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restricted stock interest payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_RestrictedStockInterestPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_RestrictedStockPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restricted stock principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_RestrictedStockPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736579664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_GeneralAccruedExpenses', window );">General accrued expenses</a></td>
<td class="nump">$ 6,486<span></span>
</td>
<td class="nump">$ 6,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrent', window );">Accrued payroll and related taxes</a></td>
<td class="nump">5,448<span></span>
</td>
<td class="nump">5,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedAdvertisingCurrent', window );">Accrued publisher expenses</a></td>
<td class="nump">7,596<span></span>
</td>
<td class="nump">4,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">3,824<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 13,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiabilitiesInConnectionWithAcquisitionsAndDispositions', window );">Liabilities in connection with acquisitions and dispositions</a></td>
<td class="nump">1,119<span></span>
</td>
<td class="nump">1,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseDepositLiability', window );">Assumed lease liability</a></td>
<td class="nump">1,328<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LeaseTerminationLiability', window );">Lease termination liability</a></td>
<td class="nump">4,481<span></span>
</td>
<td class="nump">4,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">489<span></span>
</td>
<td class="nump">755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses and other</a></td>
<td class="nump">$ 30,771<span></span>
</td>
<td class="nump">$ 23,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_GeneralAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>General accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_GeneralAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LeaseTerminationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease termination liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LeaseTerminationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LiabilitiesInConnectionWithAcquisitionsAndDispositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liabilities in connection with acquisitions and dispositions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LiabilitiesInConnectionWithAcquisitionsAndDispositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedAdvertisingCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for advertising of the entity's goods and services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedAdvertisingCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseDepositLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for lease payments received, including variable lease payments, when collectability is not probable at commencement date for sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479341/842-30-25-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseDepositLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731872000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Line of Credit (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 15, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Debt costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="nump">$ 216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayment and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,598<span></span>
</td>
<td class="nump">4,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">1,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,609<span></span>
</td>
<td class="nump">14,092<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=AREN_SLRDigitalFinanceLLCMember', window );">SLR Digital Finance LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_FinancingAndSecurityAgreementMember', window );">Financing And Security Agreement [Member] | SLR Digital Finance LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDefaultLongtermDebtAmount', window );">Debt costs</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Debt costs</a></td>
<td class="nump">$ 441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayment and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 209<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Effective interest rate, line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,609<span></span>
</td>
<td class="nump">$ 14,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Termination fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate, line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_FinancingAndSecurityAgreementMember', window );">Financing And Security Agreement [Member] | SLR Digital Finance LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDescription', window );">Line of credit facility, interest rate description</a></td>
<td class="text">an
interest rate at the prime rate plus 4.0% per annum of the amount advanced (subject to minimum utilization of at least 10% of the
maximum amount of advances available) (as of December 31, 2023 the stated interest rate was 12.5%), (iii) payment of a fee equal to
2.25% of the maximum line amount with respect to any termination of the agreement prior to December 31, 2025 at the option of the
Company at any time with 60 day notice pursuant to the SLR Amendment, (iv) a payment of a performance fee in the amount equal to
2.25% of the maximum line amount, under certain circumstances pursuant to the Business Combination in connection with a deal
deadline or in the event of a deal failure, as defined in the SLR Amendment, further the performance fee will survive the
termination of the agreement, pursuant to the SLR Amendment, (v) a payment of a success fee if the Business Combination is
consummated, of 0.3% or 0.6% of the maximum line amount if the transaction closes on or before December 31, 2023 or after December
31, 2023, respectively, or $0 if the transaction closes after the deal deadline, pursuant to the SLR Amendment, and (vi) a maturity
date of<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">Dec. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_FinancingAndSecurityAgreementMember', window );">Financing And Security Agreement [Member] | SLR Digital Finance LLC [Member] | Series L Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_FinancingAndSecurityAgreementMember', window );">Financing And Security Agreement [Member] | SLR Digital Finance LLC [Member] | 2023 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_FinancingAndSecurityAgreementMember', window );">Financing And Security Agreement [Member] | SLR Digital Finance LLC [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AccountsReceivablePercentage', window );">Accounts receivable percentage</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_AccountsReceivablePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_AccountsReceivablePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDefaultLongtermDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of outstanding long-term debt or borrowing associated with any securities or credit agreement for which there has been a default in principal, interest, sinking fund, or redemption provisions, or any breach of covenant that existed at the end of the period and subsequently has not been cured.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDefaultLongtermDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of interest rate for borrowing under credit facility. Includes, but is not limited to, terms and method for determining interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AREN_SLRDigitalFinanceLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AREN_SLRDigitalFinanceLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_FinancingAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_FinancingAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=AREN_SLRDigitalFinanceLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=AREN_SLRDigitalFinanceLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=AREN_SeriesLPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=AREN_SeriesLPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=AREN_TwoThousandTwentyThreeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=AREN_TwoThousandTwentyThreeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656737109168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Liquidated Damages (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_RegistrationRightsDamages', window );">Registration Rights Damages</a></td>
<td class="nump">$ 898<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2,002<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PublicInformationFailureDamages', window );">Public Information Failure Damages</a></td>
<td class="nump">940<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,740<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued Interest</a></td>
<td class="nump">1,086<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,595<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesPayableCurrentAndNonCurrent', window );">Balance</a></td>
<td class="nump">2,924<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,337<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=AREN_MDBCommonStockToBeIssuedMember', window );">MDB Common Stock To Be Issued [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_RegistrationRightsDamages', window );">Registration Rights Damages</a></td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PublicInformationFailureDamages', window );">Public Information Failure Damages</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued Interest</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesPayableCurrentAndNonCurrent', window );">Balance</a></td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesHConvertiblePreferredStockMember', window );">Series H Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_RegistrationRightsDamages', window );">Registration Rights Damages</a></td>
<td class="nump">565<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">618<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PublicInformationFailureDamages', window );">Public Information Failure Damages</a></td>
<td class="nump">574<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">626<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued Interest</a></td>
<td class="nump">659<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">570<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesPayableCurrentAndNonCurrent', window );">Balance</a></td>
<td class="nump">1,798<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,814<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=AREN_ConvertibleDebenturesMember', window );">Convertible Debentures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_RegistrationRightsDamages', window );">Registration Rights Damages</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PublicInformationFailureDamages', window );">Public Information Failure Damages</a></td>
<td class="nump">144<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">704<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued Interest</a></td>
<td class="nump">72<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">280<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesPayableCurrentAndNonCurrent', window );">Balance</a></td>
<td class="nump">216<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">984<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesJPreferredStockMember', window );">Series J Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_RegistrationRightsDamages', window );">Registration Rights Damages</a></td>
<td class="nump">152<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">932<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PublicInformationFailureDamages', window );">Public Information Failure Damages</a></td>
<td class="nump">152<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">932<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued Interest</a></td>
<td class="nump">129<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">525<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesPayableCurrentAndNonCurrent', window );">Balance</a></td>
<td class="nump">433<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">2,389<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesKPreferredStockMember', window );">Series K Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_RegistrationRightsDamages', window );">Registration Rights Damages</a></td>
<td class="nump">166<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">437<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PublicInformationFailureDamages', window );">Public Information Failure Damages</a></td>
<td class="nump">70<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">478<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued Interest</a></td>
<td class="nump">226<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">220<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesPayableCurrentAndNonCurrent', window );">Balance</a></td>
<td class="nump">$ 462<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 1,135<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Shares
                                            of common stock issuable to MDB Capital Group, LLC (&#8220;MDB&#8221;) (see <i>Common Stock
                                            to be Issued</i> in Note 21).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Shares
                                            of common stock issuable to MDB.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Represents
                                            previously issued and converted debt or equity securities.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Represents
                                            previously issued and converted debt or equity securities.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LiquidatedDamagesPayableCurrentAndNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidated damages payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LiquidatedDamagesPayableCurrentAndNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_PublicInformationFailureDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Public information failure damages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_PublicInformationFailureDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_RegistrationRightsDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Registration Rights Damages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_RegistrationRightsDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=AREN_MDBCommonStockToBeIssuedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=AREN_MDBCommonStockToBeIssuedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesHConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=AREN_SeriesHConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=AREN_ConvertibleDebenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=AREN_ConvertibleDebenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesJPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=AREN_SeriesJPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesKPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=AREN_SeriesKPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736634400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liquidated Damages Payable (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 01, 2023</div></th>
<th class="th"><div>Feb. 08, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages', window );">Gain on forgiveness of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesPayableCurrent', window );">Short-term liquidated damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,924<span></span>
</td>
<td class="nump">$ 5,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesPayableAccruedInterestPercentage', window );">Liquidated damages payable accrued interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesPayableCurrentAndNonCurrent', window );">Liquidated damages outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,924<span></span>
</td>
<td class="nump">6,337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PercentageOfAggregateAmountInvested', window );">Percentage of aggregate amount invested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesPayableNonCurrent', window );">Long-term liquidated damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=AREN_BRileyMember', window );">B Riley [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDecreaseForgiveness', window );">Gain on forgiveness of debt</a></td>
<td class="nump">$ 3,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages', window );">Gain on forgiveness of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementMember', window );">Stock Purchase Agreement [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss Contingency, Damages Sought, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 499<span></span>
</td>
<td class="nump">$ 499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital gain upon issuance of common stock in connection with forgiveness of liquidated damages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LiquidatedDamagesPayableAccruedInterestPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidated damages payable accrued interest percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LiquidatedDamagesPayableAccruedInterestPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LiquidatedDamagesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidated damages payable current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LiquidatedDamagesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LiquidatedDamagesPayableCurrentAndNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidated damages payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LiquidatedDamagesPayableCurrentAndNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LiquidatedDamagesPayableNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidated damages payable non current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LiquidatedDamagesPayableNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_PercentageOfAggregateAmountInvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of aggregate amount invested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_PercentageOfAggregateAmountInvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDecreaseForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDecreaseForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AREN_BRileyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AREN_BRileyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731909344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Other long- term liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DisclosureOtherLongtermLiabilitiesAbstract', window );"><strong>Other Long-term Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LeaseTerminationLiabilityNonCurrent', window );">Lease termination liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Assumed lease liability</a></td>
<td class="nump">350<span></span>
</td>
<td class="nump">1,486<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_OtherLongTermLiabilitiesNoncurrent', window );">Other</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total other long-term liabilities</a></td>
<td class="nump">$ 406<span></span>
</td>
<td class="nump">$ 5,307<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DisclosureOtherLongtermLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DisclosureOtherLongtermLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LeaseTerminationLiabilityNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease termination liability non current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LeaseTerminationLiabilityNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_OtherLongTermLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other long term liabilities non current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_OtherLongTermLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736289456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Fair Value of Financial Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=AREN_ContingentConsiderationMember', window );">Contingent Consideration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long term debt fair value</a></td>
<td class="nump">$ 1,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=AREN_ContingentConsiderationMember', window );">Contingent Consideration [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long term debt fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=AREN_ContingentConsiderationMember', window );">Contingent Consideration [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long term debt fair value</a></td>
<td class="nump">1,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=AREN_ContingentConsiderationMember', window );">Contingent Consideration [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long term debt fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=AREN_SeniorSecuredNoteMember', window );">Senior Secured Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long term debt fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,787<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=AREN_SeniorSecuredNoteMember', window );">Senior Secured Note [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long term debt fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=AREN_SeniorSecuredNoteMember', window );">Senior Secured Note [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long term debt fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,787<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=AREN_SeniorSecuredNoteMember', window );">Senior Secured Note [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long term debt fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=AREN_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=AREN_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=AREN_SeniorSecuredNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=AREN_SeniorSecuredNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656826089184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 9,284<span></span>
</td>
<td class="nump">$ 13,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedAtFairValue', window );">Financial instruments measured fair value debt bridge notes</a></td>
<td class="nump">7,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedOtherAtFairValue', window );">Debt fair value</a></td>
<td class="nump">$ 102,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Trading price, per share</a></td>
<td class="nump">$ 2.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in valuation of contingent consideration</a></td>
<td class="nump">$ 1,010<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_UnearnedRevenue', window );">Unearned revenue</a></td>
<td class="nump">$ 523<span></span>
</td>
<td class="nump">$ 1,154<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_PutOptionMember', window );">Put Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 8.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Trading price, per share</a></td>
<td class="nump">$ 5.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_PutOptionMember', window );">Put Option [Member] | Fexy Studios Acquistion [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock in connection with acquisitions, shares</a></td>
<td class="nump">274,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_FlexyStudiosMember', window );">Flexy Studios [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Preceding acquistion price per share</a></td>
<td class="nump">$ 8.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_UnearnedRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unearned Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_UnearnedRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481961/940-320-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsOwnedOtherAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of firm holdings in securities classified as other. Includes pledged and unpledged holdings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481961/940-320-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsOwnedOtherAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_PutOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_PutOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=AREN_FexyStudiosAcquistionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=AREN_FexyStudiosAcquistionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_FlexyStudiosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_FlexyStudiosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736688752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Bridge Notes (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 29, 2023</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 15, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 27, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Principal balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyThreeNotesMember', window );">2023 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherBorrowings', window );">Incremental borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AggregatePrincipalMinimumAmount', window );">Incremental borrowings</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of debt</a></td>
<td class="nump">7,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent', window );">Amortized debt cost</a></td>
<td class="nump">$ 357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument interest rate effective percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Net proceeds from business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaymentFeesOnAdvancesNet', window );">Prepayment fees on advances, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_PrincipalAmountPrepayDue', window );">Principal amount prepay due percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_BridgeNotesMember', window );">Bridge Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Debt instrument, unamortized discount, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Principal balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyTwoBridgeNotesMember', window );">2022 Bridge Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,805<span></span>
</td>
<td class="nump">$ 36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument interest rate effective percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Principal balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Incurred debt costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 1,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Unamortized debt costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_AggregatePrincipalMinimumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate principal minimum amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_AggregatePrincipalMinimumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_PrincipalAmountPrepayDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount prepay due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_PrincipalAmountPrepayDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaymentFeesOnAdvancesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income earned, after hedging basis adjustments, from fees charged for prepayment of certain Federal Home Loan Bank (FHLBank) advances before original maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaymentFeesOnAdvancesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyThreeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyThreeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_BridgeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_BridgeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyTwoBridgeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyTwoBridgeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656823515872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of long term debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal balance</a></td>
<td class="nump">$ 102,691<span></span>
</td>
<td class="nump">$ 66,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount and debt issuance costs</a></td>
<td class="num">(382)<span></span>
</td>
<td class="num">(1,007)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="nump">102,309<span></span>
</td>
<td class="nump">65,684<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_SeniorSecuredNoteMember', window );">Senior Secured Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal balance</a></td>
<td class="nump">62,691<span></span>
</td>
<td class="nump">62,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount and debt issuance costs</a></td>
<td class="num">(272)<span></span>
</td>
<td class="num">(904)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="nump">62,419<span></span>
</td>
<td class="nump">61,787<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_DelayedDrawTermNoteMember', window );">Delayed Draw Term Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal balance</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount and debt issuance costs</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="nump">3,969<span></span>
</td>
<td class="nump">3,897<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyTwoBridgeNotesMember', window );">2022 Bridge Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal balance</a></td>
<td class="nump">36,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount and debt issuance costs</a></td>
<td class="num">(79)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="nump">$ 35,921<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_SeniorSecuredNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_SeniorSecuredNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_DelayedDrawTermNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_DelayedDrawTermNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyTwoBridgeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyTwoBridgeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656728896736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Long Term Debt (Details) (Parenthetical)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=AREN_DelayedDrawTermNoteMember', window );">Delayed Draw Term Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate, percentage</a></td>
<td class="nump">10.20%<span></span>
</td>
<td class="nump">10.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=AREN_TwoThousandTwentyTwoBridgeNotesMember', window );">2022 Bridge Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate, percentage</a></td>
<td class="nump">10.20%<span></span>
</td>
<td class="nump">10.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_SeniorSecuredNoteMember', window );">Senior Secured Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate, percentage</a></td>
<td class="nump">10.10%<span></span>
</td>
<td class="nump">10.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=AREN_DelayedDrawTermNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=AREN_DelayedDrawTermNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=AREN_TwoThousandTwentyTwoBridgeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=AREN_TwoThousandTwentyTwoBridgeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_SeniorSecuredNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_SeniorSecuredNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731599216">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Summary of Interest Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Total amortization of debt costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,378<span></span>
</td>
<td class="nump">$ 1,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_NoncashAndAccruedInterest', window );">Total noncash and accrued interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,824<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_CashPaidInterestAbstract', window );"><strong>Cash paid interest:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Total cash paid interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,101<span></span>
</td>
<td class="nump">9,527<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Less interest income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(338)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,965<span></span>
</td>
<td class="nump">11,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">338<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=AREN_BRileyMember', window );">B Riley [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_CashPaidInterestAbstract', window );"><strong>Cash paid interest:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Less interest income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(338)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Total amortization of debt costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">214<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_CashPaidInterestAbstract', window );"><strong>Cash paid interest:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Total cash paid interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,023<span></span>
</td>
<td class="nump">1,328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyTwoBridgeNotesMember', window );">2022 Bridge Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Total amortization of debt costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">244<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_NoncashAndAccruedInterest', window );">Total noncash and accrued interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">920<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_CashPaidInterestAbstract', window );"><strong>Cash paid interest:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Total cash paid interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,763<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_SeniorSecuredNotesMember', window );">Senior Secured Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Total amortization of debt costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">632<span></span>
</td>
<td class="nump">1,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_NoncashAndAccruedInterest', window );">Total noncash and accrued interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,602<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_CashPaidInterestAbstract', window );"><strong>Cash paid interest:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Total cash paid interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,754<span></span>
</td>
<td class="nump">6,356<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_DelayedDrawTermNoteMember', window );">Delayed Draw Term Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Total amortization of debt costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72<span></span>
</td>
<td class="nump">464<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_NoncashAndAccruedInterest', window );">Total noncash and accrued interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">102<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_CashPaidInterestAbstract', window );"><strong>Cash paid interest:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Total cash paid interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">303<span></span>
</td>
<td class="nump">980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyThreeNotesMember', window );">2023 Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Total amortization of debt costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,216<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_NoncashAndAccruedInterest', window );">Total noncash and accrued interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">173<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_CashPaidInterestAbstract', window );"><strong>Cash paid interest:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Total cash paid interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">44<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_LineOfCreditTerminationFeeMember', window );">Line Of Credit Termination Fee [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_NoncashAndAccruedInterest', window );">Total noncash and accrued interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">900<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_ParadeMember', window );">Parade [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_NoncashAndAccruedInterest', window );">Total noncash and accrued interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_OtherAccruedInterestMember', window );">Other Accrued Interest [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_NoncashAndAccruedInterest', window );">Total noncash and accrued interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">127<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_OtherMember', window );">Other [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_CashPaidInterestAbstract', window );"><strong>Cash paid interest:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Total cash paid interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,214<span></span>
</td>
<td class="nump">$ 863<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">During the year ended December 31, 2023, the Company recorded interest income of $<span id="xdx_904_eus-gaap--InterestExpenseDebt_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zb04DjNbtnCa">338</span> related
to the refunds received from the employee retention credits.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_CashPaidInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Paid Interest Abstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_CashPaidInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_NoncashAndAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash and accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_NoncashAndAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AREN_BRileyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AREN_BRileyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyTwoBridgeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyTwoBridgeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_SeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_SeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_DelayedDrawTermNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_DelayedDrawTermNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyThreeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyThreeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_LineOfCreditTerminationFeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_LineOfCreditTerminationFeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_ParadeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_ParadeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_OtherAccruedInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_OtherAccruedInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656733183440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2023</div></th>
<th class="th"><div>May 01, 2023</div></th>
<th class="th"><div>Mar. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 27, 2023</div></th>
<th class="th"><div>Sep. 29, 2023</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Dec. 15, 2022</div></th>
<th class="th"><div>Jan. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Interest payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3,824<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">current maturities of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Paid in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=AREN_BRileyMember', window );">B Riley [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Paid in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 204<span></span>
</td>
<td class="nump">$ 9,068<span></span>
</td>
<td class="nump">$ 7,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=AREN_DelayedDrawTermNotesMember', window );">Delayed Draw Term Notes [Member] | Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt due rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=AREN_SLRDigitalFinanceLLCMember', window );">SLR Digital Finance LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_SeniorSecuredNoteMember', window );">Senior Secured Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease', window );">Debt instrument interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt due rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.10%<span></span>
</td>
<td class="nump">10.10%<span></span>
</td>
<td class="nump">10.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyTwoBridgeNotesMember', window );">2022 Bridge Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt due rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Incurred debt costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt fixed rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DebtInstrumentPeriodicPaymentPrincipalBalance', window );">Principal amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Paid in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DebtInstrumentPeriodicPaymentPrincipalBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument periodic payment principal balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DebtInstrumentPeriodicPaymentPrincipalBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incremental percentage increase (decrease) in the stated rate on a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AREN_BRileyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AREN_BRileyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=AREN_DelayedDrawTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=AREN_DelayedDrawTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_PurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_PurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AREN_SLRDigitalFinanceLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AREN_SLRDigitalFinanceLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_SeniorSecuredNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_SeniorSecuredNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyTwoBridgeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_TwoThousandTwentyTwoBridgeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656740725008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 30, 2000</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Aug. 10, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesGConvertiblePreferredStockMember', window );">Series G Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Preferred stock, designated shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesHConvertiblePreferredStockMember', window );">Series H Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion Of stock shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">710<span></span>
</td>
<td class="nump">12,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember', window );">Series H Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Preferred stock, designated shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesGPreferredStockMember', window );">Series G Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding</a></td>
<td class="nump">168.496<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold</a></td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion Of stock shares converted</a></td>
<td class="nump">1,631.504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred stock liquidation preference</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesGPreferredStockMember', window );">Series G Preferred Stock [Member] | Original Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168.496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Preferred stock, liquidation aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Temporary equity, liquidation preference per share value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreferencePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesGConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=AREN_SeriesGConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesHConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=AREN_SeriesHConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesGPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesGPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AREN_OriginalInvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AREN_OriginalInvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656729815088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Restricted Stock Award Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of Shares, Vested</a></td>
<td class="num">(583,143)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Shares, Restricted Stock Awards Outstanding, Beginning balance</a></td>
<td class="nump">97,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Fair Value Date, Beginning balance | $ / shares</a></td>
<td class="nump">$ 16.94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of Shares, Vested</a></td>
<td class="num">(97,403)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Fair Value Date, Vested | $ / shares</a></td>
<td class="num">$ (16.94)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Shares, Restricted stock awards outstanding, Unvested at Beginning balance</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736414032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Warrant Activity (Details) - Common Stock Financing Warrant [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Shares, outstanding, at beginning of year | shares</a></td>
<td class="nump">107,956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber', window );">Weighted Average Exercise Price, outstanding, at beginning of year | $ / shares</a></td>
<td class="nump">$ 10.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life, Outstanding at beginning of year</a></td>
<td class="text">6 months 29 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations', window );">Number of Shares, Expired | shares</a></td>
<td class="num">(107,956)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice', window );">Weighted Average Exercise Price, Expired | $ / shares</a></td>
<td class="nump">$ 10.61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Shares, outstanding at end of year | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber', window );">Weighted Average Exercise Price, outstanding, at end of year | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Award non option equity instruments expired price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for warrants awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=AREN_CommonStockFinancingWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=AREN_CommonStockFinancingWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656717894016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Deficiency (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jan. 11, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Mar. 11, 2022</div></th>
<th class="th"><div>Feb. 15, 2022</div></th>
<th class="th"><div>Jan. 21, 2022</div></th>
<th class="th"><div>Jan. 12, 2022</div></th>
<th class="th"><div>Jun. 14, 2019</div></th>
<th class="th"><div>Jan. 04, 2018</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 01, 2023</div></th>
<th class="th"><div>Nov. 02, 2022</div></th>
<th class="th"><div>Mar. 10, 2022</div></th>
<th class="th"><div>Mar. 09, 2022</div></th>
<th class="th"><div>Jan. 26, 2022</div></th>
<th class="th"><div>Dec. 18, 2020</div></th>
<th class="th"><div>Oct. 26, 2020</div></th>
<th class="th"><div>May 20, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceed from offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,500<span></span>
</td>
<td class="nump">$ 32,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">1,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,759,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock stated par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of share issued value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages', window );">Liquidated damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
<td class="nump">323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,423<span></span>
</td>
<td class="nump">4,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceed from offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=AREN_UnderwritingPublicOfferingMember', window );">Underwriting Public Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of common shares sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,181,603<span></span>
</td>
<td class="nump">4,181,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceed from offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,498<span></span>
</td>
<td class="nump">$ 34,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=AREN_UnderwritingOverallotmentMember', window );">Underwriting Overallotment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of common shares sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">545,239<span></span>
</td>
<td class="nump">3,636,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=AREN_BRileyMember', window );">B Riley [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | MDB Capital Group LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of common shares sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of share issued value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,955<span></span>
</td>
<td class="nump">$ 8,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_FexyStudiosAcquisitionMember', window );">Fexy Studios Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares', window );">Issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Fair value of acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=AREN_ParadeStockMember', window );">Parade Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares', window );">Issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">314,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Fair value of acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,981,128<span></span>
</td>
<td class="nump">97,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of stock amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodSharesAcquisition', window );">Common stock shares issuance fo acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Common stock shares issuance fo acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,582<span></span>
</td>
<td class="nump">330,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period shares new issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,181,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of share issued value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages', window );">Liquidated damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Vesting of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">429,528<span></span>
</td>
<td class="nump">832,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of restricted common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">795<span></span>
</td>
<td class="nump">96,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger', window );">Common stock to be issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,582<span></span>
</td>
<td class="nump">7,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued for professional services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Restricted Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of restricted common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202,382<span></span>
</td>
<td class="nump">373,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,423<span></span>
</td>
<td class="nump">$ 4,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=AREN_AllHipHopWarrantsMember', window );">All Hip Hop Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrant shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=AREN_PublisherPartnerWarrantsMember', window );">Publisher Partner Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrant shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,819<span></span>
</td>
<td class="nump">90,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=AREN_ABGWarrantsMember', window );">ABG Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrant shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">999,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=AREN_ABGWarransMember', window );">ABG Warrans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees', window );">Warrant or right, reason for issuance, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(1) under certain circumstances
the Company may require ABG to exercise all (and not less than all) of the warrants, in which case all of the warrants will be vested;
(2) all of the warrants automatically vest upon certain terminations of the Licensing Agreement by ABG or upon a change of control of
the Company; and (3) ABG has the right to participate, on a pro-rata basis (including vested and unvested warrants, exercised or unexercised),
in any future equity issuance of the Company (subject to customary exceptions).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=AREN_ABGTimeBasedWarrantsMember', window );">ABG Time Based Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrant shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">399,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=AREN_ABGPerformanceBasedWarrantsMember', window );">ABG Performance Based Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 599,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=AREN_NewPublisherPartnerWarrantsMember', window );">New Publisher Partner Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrant shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesHConvertiblePreferredStockMember', window );">Series H Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,981,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,356<span></span>
</td>
<td class="nump">14,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">710<span></span>
</td>
<td class="nump">12,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of stock amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,008<span></span>
</td>
<td class="nump">$ 710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock stated par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=AREN_EmployeesMember', window );">Employees [Member] | Common Stock [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Vesting of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">429,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">832,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementsMember', window );">Stock Purchase Agreements [Member] | Purchasers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of common shares sold</a></td>
<td class="nump">2,963,918<span></span>
</td>
<td class="nump">317,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock price</a></td>
<td class="nump">$ 3.88<span></span>
</td>
<td class="nump">$ 3.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceed from offerings</a></td>
<td class="nump">$ 11,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs</a></td>
<td class="nump">356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">$ 11,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Trading price, per share</a></td>
<td class="nump">$ 3.88<span></span>
</td>
<td class="nump">$ 3.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_AssetPurchaseAgreementMember', window );">Asset Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Stock issued for professional services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">330,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_SeveralStockPurchaseAgreementsMember', window );">Several Stock Purchase Agreements [Member] | Several Investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period shares new issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,252<span></span>
</td>
<td class="nump">505,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSought', window );">Loss contingency damages sought</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(i) 47,252 shares of common stock were issued to the investor in lieu of an aggregate of $499
owed in liquidated damages as of the conversion date ($494 as of December 31, 2022 plus $5 in additional interest through the conversion
date), where the Company recorded $369 in connection with the issuance of shares of the Company&#8217;s common stock and a gain of $130
on the settlement of the liquidated damages, both as reflected in additional paid-in capital, totaling $499;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency damages sought value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 499<span></span>
</td>
<td class="nump">$ 7,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Trading price, per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of share issued value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages', window );">Liquidated damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_ExerciseOfStockOptionMember', window );">Exercise Of Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">795<span></span>
</td>
<td class="nump">96,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockIssuedDuringPeriodValueForCash', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_ServicesAgreementMember', window );">Services Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Stock issued for professional services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Trading price, per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 184,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued for professional services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,617<span></span>
</td>
<td class="nump">14,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital gain upon issuance of common stock in connection with settlement of liquidated damages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination step acquisition equity interest in acquiree fair value shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_StockIssuedDuringPeriodSharesAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_StockIssuedDuringPeriodSharesAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares issuance of stock in connection with merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_StockIssuedDuringPeriodValueForCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value for cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_StockIssuedDuringPeriodValueForCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reason for issuing warrant or right.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSought">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the form and magnitude of the award the plaintiff seeks in the legal matter, which may include an unspecified amount of money.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSought</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=AREN_UnderwritingPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=AREN_UnderwritingPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=AREN_UnderwritingOverallotmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=AREN_UnderwritingOverallotmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=AREN_BRileyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=AREN_BRileyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AREN_MDBCapitalGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AREN_MDBCapitalGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_FexyStudiosAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_FexyStudiosAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_ParadeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_ParadeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=AREN_RestrictedCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=AREN_RestrictedCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=AREN_AllHipHopWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=AREN_AllHipHopWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=AREN_PublisherPartnerWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=AREN_PublisherPartnerWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=AREN_ABGWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=AREN_ABGWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=AREN_ABGWarransMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=AREN_ABGWarransMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=AREN_ABGTimeBasedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=AREN_ABGTimeBasedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=AREN_ABGPerformanceBasedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=AREN_ABGPerformanceBasedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=AREN_NewPublisherPartnerWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=AREN_NewPublisherPartnerWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesHConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=AREN_SeriesHConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AREN_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AREN_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AREN_PurchasersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AREN_PurchasersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_AssetPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_AssetPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_SeveralStockPurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_SeveralStockPurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AREN_SeveralInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AREN_SeveralInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_ExerciseOfStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_ExerciseOfStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_ServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_ServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736429552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Restricted Stock Units Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price, outstanding, at beginning of year | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price, outstanding, at end of year | $ / shares</a></td>
<td class="nump">$ 13.55<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=AREN_RestrictedStockUnitsMember', window );">Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Shares, Unvested, outstanding, at beginning of year</a></td>
<td class="nump">994,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber', window );">Number of Shares, Vested, outstanding, at beginning of year</a></td>
<td class="nump">397,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price, outstanding, at beginning of year | $ / shares</a></td>
<td class="nump">$ 15.44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of Shares, Unvested granted</a></td>
<td class="nump">148,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted', window );">Weighted Average Exercise Price,Granted | $ / shares</a></td>
<td class="nump">$ 5.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of Shares, Unvested, Vested</a></td>
<td class="num">(645,023)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested', window );">Number of Shares, Vested</a></td>
<td class="nump">645,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased', window );">Number of Shares, Vested, Released</a></td>
<td class="num">(429,528)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of Shares, Unvested, Cancelled</a></td>
<td class="num">(299,446)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Shares, Unvested, outstanding at end of year</a></td>
<td class="nump">199,267<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber', window );">Number of Shares, Vested, outstanding, at end of year</a></td>
<td class="nump">612,871<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Instruments other than option nonvested weighted average grant date fair value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation arrangement by sharebased payment award equity instrument sotherthanoptionnonvestedweightedaveragegrantdatefairvaluegranted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Award equity instruments other than options vested number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments other than options vested number released.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments other than options vested number vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=AREN_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=AREN_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656823686592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Fair Value of Stock Options Assumptions (Details) - 2022 Plan [Member] - Black-Scholes Option Pricing Model [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">Up-List [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">3.46%<span></span>
</td>
<td class="nump">0.97%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">4.82%<span></span>
</td>
<td class="nump">4.36%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">46.43%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">47.27%<span></span>
</td>
<td class="nump">82.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">Up-List [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">Up-List [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">No Up-List [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.97%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.44%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">No Up-List [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">No Up-List [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=AREN_BlackScholesOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=AREN_BlackScholesOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=AREN_UpListMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=AREN_UpListMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=AREN_NoUpListMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=AREN_NoUpListMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656733983952">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Summary of Stock Option Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Nov. 22, 2022</div></th>
<th class="th"><div>Mar. 18, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Shares, Granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42,635<span></span>
</td>
<td class="nump">38,026<span></span>
</td>
<td class="nump">232,816<span></span>
</td>
<td class="nump">4,343,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life (in Years), exercisable at Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 3 months 10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares Common stock options, outstanding at Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,199,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, outstanding at Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life (in Years), outstanding at Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 5 months 4 days<span></span>
</td>
<td class="text">8 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Shares, Granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Shares, Exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,927)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Shares, Forfeited</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(449,333)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Shares, Expired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(579,286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares Common stock options, outstanding at Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,451,968<span></span>
</td>
<td class="nump">6,199,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, outstanding at Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.56<span></span>
</td>
<td class="nump">$ 15.26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Shares Common stock options, exercisable at Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,049,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, exercisable at Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life (in Years), exercisable at Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Shares Common stock options, not vested at Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,402,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber', window );">Number of Shares Common stock options, available for future grants at Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">542,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Common stock available
for future issuance under the 2022 Plan represent <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zz0cVnn4Bci8" title="Number of shares authorized to issue">1,800,000</span> of authorized shares; less <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zbkmhNt13S1c" title="Number of shares common stock options, outstanding">1,066,597</span> common stock options outstanding and
<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzOJA6aChy6g" title="Number of shares common stock options, outstanding">190,556</span> restricted stock units outstanding.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares common stock options, available for future grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656833294624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Stock Option Activity (Details) (Parenthetical) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Nov. 22, 2022</div></th>
<th class="th"><div>Mar. 18, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares common stock options, outstanding</a></td>
<td class="nump">42,635<span></span>
</td>
<td class="nump">38,026<span></span>
</td>
<td class="nump">232,816<span></span>
</td>
<td class="nump">4,343,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized to issue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Number of shares common stock options, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,066,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares common stock options, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares common stock options, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656717821696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Exercise Prices of Common Stock Options (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding</a></td>
<td class="nump">5,451,968<span></span>
</td>
<td class="nump">6,199,521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Shares, Vested</a></td>
<td class="nump">4,049,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Shares, Exercisable</a></td>
<td class="nump">4,049,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Exercise Price Range One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price lower range</a></td>
<td class="nump">$ 2.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price</a></td>
<td class="nump">$ 10.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding</a></td>
<td class="nump">4,318,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Shares, Vested</a></td>
<td class="nump">3,308,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Exercise Price Range Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price lower range</a></td>
<td class="nump">$ 10.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price</a></td>
<td class="nump">$ 15.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding</a></td>
<td class="nump">1,062,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Shares, Vested</a></td>
<td class="nump">670,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Exercise Price Range Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price lower range</a></td>
<td class="nump">$ 15.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price</a></td>
<td class="nump">$ 20.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding</a></td>
<td class="nump">9,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Shares, Vested</a></td>
<td class="nump">9,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Exercise Price Range Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price lower range</a></td>
<td class="nump">$ 20.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price</a></td>
<td class="nump">$ 25.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding</a></td>
<td class="nump">25,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Shares, Vested</a></td>
<td class="nump">24,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Exercise Price Range Five [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price lower range</a></td>
<td class="nump">$ 25.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price</a></td>
<td class="nump">$ 30.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding</a></td>
<td class="nump">910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Shares, Vested</a></td>
<td class="nump">910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Exercise Price Range Six [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price lower range</a></td>
<td class="nump">$ 30.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price</a></td>
<td class="nump">$ 35.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding</a></td>
<td class="nump">4,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Shares, Vested</a></td>
<td class="nump">4,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Exercise Price Range Seven [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price lower range</a></td>
<td class="nump">$ 35.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price</a></td>
<td class="nump">$ 40.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding</a></td>
<td class="nump">2,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Shares, Vested</a></td>
<td class="nump">2,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Exercise Price Range Eight [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price lower range</a></td>
<td class="nump">$ 40.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price</a></td>
<td class="nump">$ 48.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding</a></td>
<td class="nump">27,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Shares, Vested</a></td>
<td class="nump">27,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_ABGWarrantsMember', window );">ABG Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding</a></td>
<td class="nump">999,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Shares, Exercisable</a></td>
<td class="nump">399,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_ABGWarrantsMember', window );">ABG Warrants [Member] | Exercise Price Range One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price lower range</a></td>
<td class="nump">$ 9.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding</a></td>
<td class="nump">749,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Shares, Exercisable</a></td>
<td class="nump">299,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_ABGWarrantsMember', window );">ABG Warrants [Member] | Exercise Price Range Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price lower range</a></td>
<td class="nump">$ 18.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding</a></td>
<td class="nump">249,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Shares, Exercisable</a></td>
<td class="nump">99,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_NewPublisherPartnerWarrantMember', window );">New Publisher Partner Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding</a></td>
<td class="nump">9,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Shares, Exercisable</a></td>
<td class="nump">1,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_NewPublisherPartnerWarrantMember', window );">New Publisher Partner Warrant [Member] | Exercise Price Range One [Member] | Black-Scholes Option Pricing Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price lower range</a></td>
<td class="nump">$ 5.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding</a></td>
<td class="nump">6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Shares, Exercisable</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_NewPublisherPartnerWarrantMember', window );">New Publisher Partner Warrant [Member] | Exercise Price Range Two [Member] | Black-Scholes Option Pricing Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price lower range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne', window );">Number of Shares, Outstanding</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne', window );">Number of Shares, Exercisable</a></td>
<td class="nump">1,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options exercisable number one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options outstanding number one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=AREN_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=AREN_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=AREN_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=AREN_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=AREN_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=AREN_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=AREN_ExercisePriceRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=AREN_ExercisePriceRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=AREN_ExercisePriceRangeFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=AREN_ExercisePriceRangeFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=AREN_ExercisePriceRangeSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=AREN_ExercisePriceRangeSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=AREN_ExercisePriceRangeSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=AREN_ExercisePriceRangeSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=AREN_ExercisePriceRangeEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=AREN_ExercisePriceRangeEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=AREN_ABGWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=AREN_ABGWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=AREN_NewPublisherPartnerWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=AREN_NewPublisherPartnerWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=AREN_BlackScholesOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=AREN_BlackScholesOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736209696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Warrants Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_ABGWarrantsMember', window );">ABG Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber', window );">Number of Shares, unvested outstanding, at beginning of year</a></td>
<td class="nump">599,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber', window );">Number of Shares, vested outstanding, at beginning of year</a></td>
<td class="nump">399,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding', window );">Weighted Average Exercise Price, outstanding, at beginning of year</a></td>
<td class="nump">$ 11.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_WeightedAverageRemainingContractualLifeOutstanding', window );">Weighted Average Remaining Contractual Life, Outstanding at ending of year</a></td>
<td class="text">5 years 5 months 15 days<span></span>
</td>
<td class="text">6 years 5 months 15 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber', window );">Number of Shares, unvested issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber', window );">Number of Shares, vested</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber', window );">Number of Shares, unvested outstanding, at end of year</a></td>
<td class="nump">599,724<span></span>
</td>
<td class="nump">599,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber', window );">Number of Shares, vested outstanding, at end of year</a></td>
<td class="nump">399,816<span></span>
</td>
<td class="nump">399,816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding', window );">Weighted Average Exercise Price, Ending Balance</a></td>
<td class="nump">$ 11.55<span></span>
</td>
<td class="nump">$ 11.55<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_NewPublisherPartnerWarrantMember', window );">New Publisher Partner Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding', window );">Weighted Average Exercise Price, outstanding, at beginning of year</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding', window );">Weighted Average Exercise Price, Ending Balance</a></td>
<td class="nump">$ 6.91<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Shares, outstanding, at beginning of year</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Number of Shares, Forfeited</a></td>
<td class="nump">9,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Shares, outstanding at end of year</a></td>
<td class="nump">9,800<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_WeightedAverageRemainingContractualLifeOutstanding1', window );">Weighted Average Remaining Contractual Life, Outstanding at ending of year</a></td>
<td class="text">4 years 1 month 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable', window );">Number of Shares, Exercisable at end of year</a></td>
<td class="nump">1,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable', window );">Weighted Average Exercise Price, Exercisable at end of year</a></td>
<td class="nump">$ 10.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_WeightedAverageRemainingContractualLifeExercisable', window );">Weighted Average Remaining Contractual Life, Exercisable</a></td>
<td class="text">3 years 11 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested', window );">Number of Shares, not vested at end of year</a></td>
<td class="nump">8,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber', window );">Number of Shares, Available for future grants at end of year</a></td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing warrant, exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instrument non vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award nonoption equity instruments available for future grants number.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option equity instruments unvested issued number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity instruments unvested outstanding number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option equity instruments vested outstanding number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity instruments vested outstanding vested in period number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price outstanding exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_WeightedAverageRemainingContractualLifeExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual life exercisable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_WeightedAverageRemainingContractualLifeExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_WeightedAverageRemainingContractualLifeOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual life outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_WeightedAverageRemainingContractualLifeOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_WeightedAverageRemainingContractualLifeOutstanding1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual life outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_WeightedAverageRemainingContractualLifeOutstanding1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=AREN_ABGWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=AREN_ABGWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=AREN_NewPublisherPartnerWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=AREN_NewPublisherPartnerWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731421616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Stock-based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">$ 142,240<span></span>
</td>
<td class="nump">$ 132,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">74,245<span></span>
</td>
<td class="nump">72,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">44,152<span></span>
</td>
<td class="nump">53,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total stock-based compensation</a></td>
<td class="nump">19,060<span></span>
</td>
<td class="nump">31,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=AREN_StockBasedCompensationMember', window );">Stock Based Compensation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">6,562<span></span>
</td>
<td class="nump">10,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">1,659<span></span>
</td>
<td class="nump">2,772<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">10,839<span></span>
</td>
<td class="nump">18,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_CostsChargedToOperations', window );">Total costs charged to operations</a></td>
<td class="nump">19,060<span></span>
</td>
<td class="nump">31,345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DevelopmentCosts', window );">Capitalized platform development</a></td>
<td class="nump">1,016<span></span>
</td>
<td class="nump">1,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total stock-based compensation</a></td>
<td class="nump">20,076<span></span>
</td>
<td class="nump">33,229<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member] | Stock Based Compensation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">2,092<span></span>
</td>
<td class="nump">3,730<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">257<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">6,372<span></span>
</td>
<td class="nump">9,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_CostsChargedToOperations', window );">Total costs charged to operations</a></td>
<td class="nump">8,721<span></span>
</td>
<td class="nump">13,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DevelopmentCosts', window );">Capitalized platform development</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total stock-based compensation</a></td>
<td class="nump">8,721<span></span>
</td>
<td class="nump">13,067<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=AREN_CommonStockAwardsMember', window );">Common Stock Awards [Member] | Stock Based Compensation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">4,460<span></span>
</td>
<td class="nump">6,505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">1,402<span></span>
</td>
<td class="nump">2,502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">3,457<span></span>
</td>
<td class="nump">7,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_CostsChargedToOperations', window );">Total costs charged to operations</a></td>
<td class="nump">9,319<span></span>
</td>
<td class="nump">16,783<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DevelopmentCosts', window );">Capitalized platform development</a></td>
<td class="nump">1,016<span></span>
</td>
<td class="nump">1,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total stock-based compensation</a></td>
<td class="nump">10,335<span></span>
</td>
<td class="nump">18,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=AREN_ABGWarrantsMember', window );">ABG Warrants [Member] | Stock Based Compensation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">10<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">1,010<span></span>
</td>
<td class="nump">1,495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_CostsChargedToOperations', window );">Total costs charged to operations</a></td>
<td class="nump">1,020<span></span>
</td>
<td class="nump">1,495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DevelopmentCosts', window );">Capitalized platform development</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total stock-based compensation</a></td>
<td class="nump">$ 1,020<span></span>
</td>
<td class="nump">$ 1,495<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_CostsChargedToOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs charged to operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_CostsChargedToOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The capitalized costs incurred during the period (excluded from amortization) to obtain access to proved reserves and to provide facilities for extracting, treating, gathering and storing the oil and gas.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 932<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(7)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479664/932-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=AREN_StockBasedCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=AREN_StockBasedCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=AREN_CommonStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=AREN_CommonStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=AREN_ABGWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=AREN_ABGWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656735491792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Unrecognized Compensation Expense (Details) - Stock Based Compensation [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 5,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period expected to be recognized (in years)</a></td>
<td class="text">1 year 5 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 1,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period expected to be recognized (in years)</a></td>
<td class="text">1 year 10 months 2 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=AREN_CommonStockAwardsMember', window );">Common Stock Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 4,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period expected to be recognized (in years)</a></td>
<td class="text">1 year 3 months 29 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=AREN_ABGWarrantsMember', window );">ABG Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period expected to be recognized (in years)</a></td>
<td class="text">2 years 3 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=AREN_StockBasedCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=AREN_StockBasedCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=AREN_CommonStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=AREN_CommonStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=AREN_ABGWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=AREN_ABGWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656728199376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock&#8211;Based Compensation (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 02, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Nov. 22, 2022</div></th>
<th class="th"><div>Mar. 18, 2022</div></th>
<th class="th"><div>Mar. 14, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 09, 2024</div></th>
<th class="th"><div>Jun. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share based compensation arrangement options grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,026<span></span>
</td>
<td class="nump">232,816<span></span>
</td>
<td class="nump">4,343,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Share based compensation incremental cost</a></td>
<td class="nump">$ 380,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 321,000<span></span>
</td>
<td class="nump">$ 6,061,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,490,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Share based compensation aggregate intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Sharebased compensation arrangement by sharebased payment award options vested number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">583,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 3 months 10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Intrinsic value of stock option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Unvested restricted stock units</a></td>
<td class="nump">450,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 489,000<span></span>
</td>
<td class="nump">755,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vested contractual term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,000<span></span>
</td>
<td class="nump">$ 216,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_OriginalAwardAtTheRepricingDate', window );">Original award repricing date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,918,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_SportsIllustratedLicensingAgreementMember', window );">Sports Illustrated Licensing Agreement [Member] | ABG Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Intrinsic value of stock option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_FairMarketValueOfStockOption', window );">Fair market value of stock option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_SportsIllustratedLicensingAgreementMember', window );">Sports Illustrated Licensing Agreement [Member] | ABG Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">999,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Conversion of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">429,528<span></span>
</td>
<td class="nump">832,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Sharebased compensation arrangement by sharebased payment award options vested number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share based compensation arrangement options grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Conversion of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,955,000<span></span>
</td>
<td class="nump">8,707,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Unvested restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vested contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Conversion of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=AREN_CommonStockOptionsMember', window );">Common Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Share based compensation incremental cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 284,000<span></span>
</td>
<td class="nump">$ 68,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.29<span></span>
</td>
<td class="nump">$ 10.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Unvested restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Number of shares, agreed to purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Common stock trading price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.82<span></span>
</td>
<td class="nump">$ 8.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 773,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 773,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized to issue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share based compensation arrangement options grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted', window );">Aggregate grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 610,000<span></span>
</td>
<td class="nump">$ 7,194,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.12<span></span>
</td>
<td class="nump">$ 5.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Common stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">$ 1,507,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Share based compensation aggregate intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,155,000<span></span>
</td>
<td class="nump">$ 12,694,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember', window );">2022 Plan [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share based compensation arrangement options grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_PublisherPartnerWarrantProgramMember', window );">Publisher Partner Warrant Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=AREN_NewPublisherPartnerWarrantMember', window );">New Publisher Partner Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Intrinsic value of stock option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_FairMarketValueOfStockOption', window );">Fair market value of stock option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_FairMarketValueOfStockOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair market value of stock option.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_FairMarketValueOfStockOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_OriginalAwardAtTheRepricingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Original award repricing date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_OriginalAwardAtTheRepricingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate grant date fair value for the common equity awards granted during the period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares purchased for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_SportsIllustratedLicensingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_SportsIllustratedLicensingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_ABGWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_ABGWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=AREN_ABGWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=AREN_ABGWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=AREN_CommonStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=AREN_CommonStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=AREN_TwoThousandTwentyTwoPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=AREN_PublisherPartnerWarrantProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=AREN_PublisherPartnerWarrantProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=AREN_NewPublisherPartnerWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=AREN_NewPublisherPartnerWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736124064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liquidated Damages (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesPayable', window );">Liquidating damages payable</a></td>
<td class="nump">$ 583<span></span>
</td>
<td class="nump">$ 1,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Liquidated damages payable accrued interest percentage</a></td>
<td class="nump">$ 583<span></span>
</td>
<td class="nump">652<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesKPreferredStockMember', window );">Series K Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LiquidatedDamagesPayable', window );">Liquidating damages payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 488<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LiquidatedDamagesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidated damages payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LiquidatedDamagesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesKPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=AREN_SeriesKPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656734881936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="num">(88)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit', window );">Total current tax (provision) benefit</a></td>
<td class="num">(88)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(57)<span></span>
</td>
<td class="nump">985<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State and local</a></td>
<td class="num">(77)<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred tax (provision) benefit</a></td>
<td class="num">(134)<span></span>
</td>
<td class="nump">1,140<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax (provision) benefit</a></td>
<td class="num">$ (222)<span></span>
</td>
<td class="nump">$ 1,063<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656736649840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Components of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 52,353<span></span>
</td>
<td class="nump">$ 51,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetInterestCarryforward', window );">Interest limitation carryforward</a></td>
<td class="nump">10,028<span></span>
</td>
<td class="nump">5,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carryforwards</a></td>
<td class="nump">264<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="nump">388<span></span>
</td>
<td class="nump">757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accrued expenses and other</a></td>
<td class="nump">891<span></span>
</td>
<td class="nump">1,340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_LeaseTermination', window );">Lease termination</a></td>
<td class="nump">1,017<span></span>
</td>
<td class="nump">1,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DeferredTaxAssetsLiquidatingDamagesPayable', window );">Liquidated damages</a></td>
<td class="nump">794<span></span>
</td>
<td class="nump">1,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Unearned revenue</a></td>
<td class="nump">5,148<span></span>
</td>
<td class="nump">3,744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">7,229<span></span>
</td>
<td class="nump">6,931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DeferredTaxAssetsOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DeferredTaxAssetsDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,146<span></span>
</td>
<td class="nump">3,706<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="nump">82,316<span></span>
</td>
<td class="nump">76,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(76,367)<span></span>
</td>
<td class="num">(65,406)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">5,949<span></span>
</td>
<td class="nump">11,507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Acquisition-related intangibles</a></td>
<td class="num">(6,548)<span></span>
</td>
<td class="num">(11,972)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(6,548)<span></span>
</td>
<td class="num">(11,972)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax liabilities</a></td>
<td class="num">$ (599)<span></span>
</td>
<td class="num">$ (465)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DeferredTaxAssetsDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets depreciation and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DeferredTaxAssetsDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DeferredTaxAssetsLiquidatingDamagesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets liquidating damages payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DeferredTaxAssetsLiquidatingDamagesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DeferredTaxAssetsOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets Operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DeferredTaxAssetsOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_LeaseTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease termination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_LeaseTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetInterestCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetInterestCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656866427744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Tax Benefit and Effective Income Tax (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Federal benefit expected at statutory rate</a></td>
<td class="num">$ (11,626)<span></span>
</td>
<td class="num">$ (14,375)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal benefit expected at statutory rate, percentage</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State and local taxes, net of federal benefit</a></td>
<td class="num">$ (2,526)<span></span>
</td>
<td class="num">$ (3,429)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local taxes, net of federal benefit, percentage</a></td>
<td class="nump">4.60%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Stock-based compensation</a></td>
<td class="nump">$ 3,472<span></span>
</td>
<td class="nump">$ 3,894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Stock-based compensation, percentage</a></td>
<td class="num">(6.30%)<span></span>
</td>
<td class="num">(5.70%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue', window );">Unearned revenue</a></td>
<td class="num">$ (562)<span></span>
</td>
<td class="num">$ (696)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage', window );">Unearned revenue percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_EffectiveIncomeTaxRateReconciliationInterestExpense', window );">Interest expense</a></td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_EffectiveIncomeTaxRateReconciliationInterestExpensePercentage', window );">Interest expense percentage</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment', window );">Gain upon debt extinguishment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (760)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage', window );">Gain upon debt extinguishment percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other differences, net</a></td>
<td class="nump">$ 678<span></span>
</td>
<td class="num">$ (997)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other differences, net percentage</a></td>
<td class="num">(1.20%)<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">$ 10,961<span></span>
</td>
<td class="nump">$ 14,959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance percentage</a></td>
<td class="num">(19.80%)<span></span>
</td>
<td class="num">(21.90%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Other permanent differences</a></td>
<td class="num">$ (237)<span></span>
</td>
<td class="nump">$ 285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Other permanent differences percentage</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit and effective income tax rate</a></td>
<td class="nump">$ 222<span></span>
</td>
<td class="num">$ (1,063)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax benefit and effective income tax rate, percentage</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain upon debt extinguishment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain upon debt extinguishment, percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_EffectiveIncomeTaxRateReconciliationInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation, interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_EffectiveIncomeTaxRateReconciliationInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_EffectiveIncomeTaxRateReconciliationInterestExpensePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation, interest expense, percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_EffectiveIncomeTaxRateReconciliationInterestExpensePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation, unearned revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation, unearned revenue, percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -SubTopic 740<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480887/718-740-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -SubTopic 740<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480887/718-740-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656729021296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_NetOperatingLossExpirationAmount', window );">Net operating losses expiration amount</a></td>
<td class="nump">$ 55,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">193,801<span></span>
</td>
<td class="nump">$ 190,070<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=AREN_StateMember', window );">State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">145,968<span></span>
</td>
<td class="nump">133,419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=AREN_LocalJurisdictionMember', window );">Local [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">53,002<span></span>
</td>
<td class="nump">$ 51,503<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=AREN_USFederalTaxMember', window );">U.S Federal Tax [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 138,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_NetOperatingLossExpirationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net operating losses expiration amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_NetOperatingLossExpirationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=AREN_StateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=AREN_StateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=AREN_LocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=AREN_LocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=AREN_USFederalTaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=AREN_USFederalTaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656731867648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans', window );">Pension plan, description</a></td>
<td class="text">The plan allows for discretionary matching contributions by the Company, up to 4% of eligible annual compensation made
by participants of the plan<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MultiemployerPlanPensionSignificantPlanContribution', window );">Contribution to plan</a></td>
<td class="nump">$ 2,125<span></span>
</td>
<td class="nump">$ 1,808<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of defined contribution pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MultiemployerPlanPensionSignificantPlanContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by multiemployer pension plan from all employers participating in multiemployer pension plan determined to be individually significant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480547/715-80-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MultiemployerPlanPensionSignificantPlanContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656728212608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 01, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 15, 2020</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 27, 2023</div></th>
<th class="th"><div>Sep. 29, 2023</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Aug. 10, 2023</div></th>
<th class="th"><div>Mar. 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Note purchase agreement description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(1)
the 2023 Notes until paid in full; (2) then to the 2022 Bridge Notes until paid in full; (3) then to the Delayed Draw Terms Notes
until paid in full; and (4) then to the Senior Secured Notes. All borrowings under the Notes are collateralized by substantially all
assets of the Company secured by liens and guaranteed by the Company&#8217;s subsidiaries. The Notes provide for a default interest
rate equal to the rate of interest in effect at the time of default plus 4.0%, along with other provision for acceleration of the
Notes under certain conditions. The Notes provide for certain affirmative covenants, including certain financial reporting
obligations.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 184,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,691,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Paid in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,691,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Interest on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 583,000<span></span>
</td>
<td class="nump">652,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,490,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchase value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued during period, shares, issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 88.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_StockRepurchasedDuringPeriodValue1', window );">Proceeds from repurchase of restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase restricted stock awards in connection with HubPages merger, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_MrEdmonsonMember', window );">Mr. Edmonson [Member] | Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchase value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase restricted stock awards in connection with HubPages merger, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementsMember', window );">Stock Purchase Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,232,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementsMember', window );">Stock Purchase Agreements [Member] | H Hunt Allred [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with public offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementsMember', window );">Stock Purchase Agreements [Member] | One Eighty Degree Capital Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with public offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 759,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementsMember', window );">Stock Purchase Agreements [Member] | Daniel Shribman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with public offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementsMember', window );">Stock Purchase Agreements [Member] | Ross Levinsohn [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with public offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementsMember', window );">Stock Purchase Agreements [Member] | Paul Edmonson [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with public offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=AREN_BRileyFinancialIncMember', window );">BRiley Financial Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=AREN_AllredTrustHHAMember', window );">Allred Trust HHA [Member] | Stock Purchase Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with public offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=AREN_AllredTrustNLAMember', window );">Allred Trust NLA [Member] | Stock Purchase Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with public offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued during period, shares, issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with public offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,181,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchase value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase restricted stock awards in connection with HubPages merger, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=AREN_BRileyMember', window );">B Riley [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Paid in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 204,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,068,000<span></span>
</td>
<td class="nump">$ 7,132,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Interest on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,797,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_DebtInstrumentIncreaseAccruedInterestAmountDue', window );">Interest on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,797,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Fee incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,440,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 357,000<span></span>
</td>
<td class="nump">$ 2,440,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=AREN_BRileyMember', window );">B Riley [Member] | Series H Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Preferred Stock issued onversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Preferred Stock issued upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=AREN_BRileyMember', window );">B Riley [Member] | Direct Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.88<span></span>
</td>
<td class="nump">$ 3.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=AREN_BRileyMember', window );">B Riley [Member] | Common Stock [Member] | Direct Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with public offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,009,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,915,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=AREN_PurchasersMember', window );">Purchasers [Member] | Stock Purchase Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.88<span></span>
</td>
<td class="nump">$ 3.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,963,918<span></span>
</td>
<td class="nump">317,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Common stock trading price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.88<span></span>
</td>
<td class="nump">$ 3.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=AREN_BRileyFBRIncMember', window );">B Riley FBR Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued during period, shares, issued for services</a></td>
<td class="nump">10,512,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Debt instrument face amount</a></td>
<td class="nump">$ 30,485,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 110,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_DebtInstrumentIncreaseAccruedInterestAmountDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument increase accrued interest amount due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_DebtInstrumentIncreaseAccruedInterestAmountDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_StockRepurchasedDuringPeriodValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock repurchased during period value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_StockRepurchasedDuringPeriodValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share conversion price of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_MrEdmonsonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_MrEdmonsonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_HHuntAllredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_HHuntAllredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_OneEightyDegreeCapitalCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_OneEightyDegreeCapitalCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_DanielShribmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_DanielShribmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_RossLevinsohnMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_RossLevinsohnMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_PaulEdmonsonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=AREN_PaulEdmonsonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AREN_BRileyFinancialIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AREN_BRileyFinancialIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AREN_AllredTrustHHAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AREN_AllredTrustHHAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AREN_AllredTrustNLAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AREN_AllredTrustNLAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AREN_BRileyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AREN_BRileyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=AREN_SeriesHConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=AREN_SeriesHConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=AREN_DirectOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=AREN_DirectOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AREN_PurchasersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AREN_PurchasersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=AREN_BRileyFBRIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=AREN_BRileyFBRIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656729846272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=AREN_ABGSILLCMember', window );">ABG-SI, LLC [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=AREN_ABGSILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=AREN_ABGSILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139656723968960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 21, 2024</div></th>
<th class="th"><div>Mar. 14, 2024</div></th>
<th class="th"><div>Feb. 15, 2024</div></th>
<th class="th"><div>Feb. 14, 2024</div></th>
<th class="th"><div>Feb. 09, 2024</div></th>
<th class="th"><div>Jan. 02, 2024</div></th>
<th class="th"><div>Jan. 01, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Nov. 22, 2022</div></th>
<th class="th"><div>Mar. 18, 2022</div></th>
<th class="th"><div>Mar. 14, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 13, 2024</div></th>
<th class="th"><div>Jan. 05, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Performance based warrant vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">583,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preffered stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Company borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Shares, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,026<span></span>
</td>
<td class="nump">232,816<span></span>
</td>
<td class="nump">4,343,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Performance based warrant vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,181,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of common stock for restricted stock units, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">429,528<span></span>
</td>
<td class="nump">832,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">378,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preffered stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_WorkingCapital', window );">Working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Company borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Outstanding loan balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damage, value</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Shares, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of common stock for restricted stock units, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Members Of Board [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Former Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Simplyfy Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Fexy Studios [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total installment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_BusinessCombinationConsiderationTransferredInstallmentDue', window );">Total installment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription', window );">Flexy put option description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(i) $2,225 pursuant to the put option where the Company gave the recipients
of the contingent consideration a right to put their 274,692 shares of the Company&#8217;s common stock; (ii) $200 deferred payment due
under the purchase agreement; and (iii) $53 in other costs and reimbursable transition expenses payable.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | ABG Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Performance based warrant vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">599,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationPriceOfAcquisitionExpected', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of common stock for restricted stock units, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_ArenaLoanAgreementMember', window );">Arena Loan Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_ArenaLoanAgreementMember', window );">Arena Loan Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,797<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_LicensingAgreementMember', window );">Licensing Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_ExerciseRightTerminationAmount', window );">Exercise right termination amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_TerminationFeeDue', window );">Termination fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_TransactionAgreementMember', window );">Transaction Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preffered stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_TransactionAgreementMember', window );">Transaction Agreement [Member] | Subsequent Event [Member] | Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationPriceOfAcquisitionExpected', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementMember', window );">Stock Purchase Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredOther1', window );">Business combination, consideration amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_SharesOutstandingPercentage', window );">Shares outstanding percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_OutstandingPercentage', window );">Shares outstanding percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=AREN_SubscriptionAgreementMember', window );">Subscription Agreement [Member] | Subsequent Event [Member] | Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,555,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_AREN_SharesOutstandingPercentage', window );">Shares outstanding percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Net proceeds from the Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_BusinessCombinationConsiderationTransferredInstallmentDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination consideration transferred installment due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_BusinessCombinationConsiderationTransferredInstallmentDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_ExerciseRightTerminationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise right termination amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_ExerciseRightTerminationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_OutstandingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Outstanding percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_OutstandingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_SharesOutstandingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares outstanding percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_SharesOutstandingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_TerminationFeeDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Termination fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_TerminationFeeDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_AREN_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">AREN_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>AREN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredOther1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredOther1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationPriceOfAcquisitionExpected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of expected business acquisition prior to consideration being transferred. Excludes asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479455/805-10-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationPriceOfAcquisitionExpected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AREN_MembersOfBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AREN_MembersOfBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=AREN_FormerEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=AREN_FormerEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=AREN_SimplyfyLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=AREN_SimplyfyLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=AREN_FexyStudiosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=AREN_FexyStudiosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=AREN_ABGWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=AREN_ABGWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_ArenaLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_ArenaLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_LicensingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_LicensingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_TransactionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_TransactionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_StockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=AREN_SubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=AREN_SubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>144
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M-3RJ\J:%8Q@ +S< WD$&(.N.Q ?/]"RD,>/8HS,0R2D+ @XR(!*N!8WTK-H
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MY/>_L<8@7^E;\4SH7W3?R#H3M*J$Y'DS&!#D:5%?Z4/CB*,!.!@90)H!I#_
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M$6>2CD.)G4-UR[ECL-15^:TW-I(^F,&2(2]".W&#?A*;Y(+(\_$(V(Y B9U
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MP0& IGM(&]@7%%5^![#UCJ!##OOG2@H)O5PU!$NIN$,N)\0E;CCX!F>0Q&$
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M]<;QT(\.=K$GZ=#M],,QT!WOY%ZOD><KY-TD6;);49EGC@<&S8'UV?;U^B+
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MUP<BM?D(DV%24=8L1IYBS0DYW87VZ$[O,0=8L<;PF0@:G:$A1[S0$/'.? (
M5JOCG_,%]5W#T2^TEU\T>>''5HS-1-#X#.( &,( .'<.&E:OXR?+"!AR! RG
M/JL^=P87[HB.LRR'Z$+.B:'U'*C4$[:B>18$]3W1>>'P.\N>POW1\=GY@OH^
MX] 9VGM+43M)">O6\<_Y@OK^X40:6HAQCB7Z8!TZ?K#,KB%GU]!>3'-B.C 4
M(?9"%LF$>V;Z%B]GXFCL)8*YLH:P8HUI82)HW$.<B2.8B>?+&L**=3QD*7C:
M]Q!'XPA&8YVL(2Q*Q^;S!?7-Y8@;P8@+90WA0W7,LXRG$<?3:-)+"U+K;/&D
M!4%]ZSA/1C!/3HA21)(7)",7#=9M2:M^+*/?08YYT?0PH8VT(ZQ.-X)F(@T<
MN$Z]";LHIY=VA)5K>TGR#)\Z/1EQ7(OL/7,W.3T)Z]0VW3+#19SA(ICA9DL]
MP7JU'62YX@7AJ$<L)K?'4RZP-EVWF$@#W<+YCL!\]]-ZW< \.TT^)NGZ@GGC
M-MFG%?L,929@J=KFST%PA!,<@0D.N.:W1P;]JV'D#X/V1,PI8]?U5766",<M
M8B^BJ!>U)V)A"U07SAI:-L<S>83S&(%Y;*Z8/!%3NPC'9/@V@*19Y"JJ0!".
M8<1>^M<@FDXD=<%BH6@'W$?3@>6D1^PEA(T*3(FY7+&&EJ11&*K>3"2<U@A,
M:R]81DOR!*!81TM23DQ52(MT2H49XIA>G)6(;X=>"&N0I(WB,7_"B8G Q/3B
M$64BB8DA'P]OK63-?#]4Y']C#D"QW;=%M:+!L&Z=BFCBRZ:JY[)B#CGQ],2N
M<: 7UJ%CHN0=".0IYG/,*29^K3<@8LD#<T()++AWAI>3F'-2_%IO-\0B)TE*
M8,'=,S6?8U(,8Y).$#(6F496 DO2#"B!%7/XB<U?.X /U3G'+"<J8\XUL?%K
M![$$25 L7@$D[08W'?V^<2Z)IT>1;$378'6Z=X$FTL QXR@3OT)D"=:I[1Q)
MM0U5$:VX4PWUE:)&L%YMXZW72>T62GW1N-&(.NW::J[(2Y[K^ZI:@&ZG8JH+
M0],G6K%K*IL./R?%CEE3@@&A$6GZ=LT1$D(N[IAO'!1Z/K2?W<:>&PU7<FE+
M'&",%&LY<CLE3]W7"@V-:-8I]VHB:<(X=DJCNJ\30!K1J^4CR_E Y'9*I[JO
M&HH:4:_EI3GB5<CME&YU7S=B-:)?RU>6$Y7([121=;^7X-=(3[0<9ID]D=NI
M;.N^2"!M1(V6-VR7LW4[]6S=[RPL-](A+;_9YM1N0?^1BOXS5[BW%=^S(6G@
MH^XF "\0!QQ1HN4+R^]SH.ZN "/; LQ8,=_>9@$FDL:O^=UM!4;V%9BQLK[)
MG@$*+\W"V-WM!T;V'] JP&^R68#";MO<W-UR8&3/ ;"0OV3W 'DE?UE#J)1_
M=Z.!D9T&H/M7)*GZYD4D#(3M6&1[#0SN= <][(#BR'8#UDOZP_JT0Q FXN#I
MU6%"C>T.[)7UM[SI@?5=#[K;'HSL>S!;Y')$L;Z3;#-A9XL$-+)'@NW8I=VM
M$8S$25VS[.Q&V8QLO4EGR4P\[*KC1HZG;T\[@?[4;'\Y^/ZFWB&TV>62BSEN
M+_HA89?_7>ED])Z)=-_4#T 7QPT[CQ^J?-_L>7F75U6^;?[<T(1=_.L&[/?[
M/*^>/]0*3ONF7O\?4$L#!!0    ( ,N!@5A2;VK- PL   TX   8    >&PO
M=V]R:W-H965T<R]S:&5E=#<N>&ULK5M=<]NV$OTK'+73:6>BF  (BDIMSR3*
M[;0S_?#$S;W/- E9N*5(E:3LN+^^"Y(B2&(!28Y>8DE9@+N+Q9ZS"_#ZN2C_
MJC9"U-Z7;997-[--7>_>75U5R49LX^IML1,Y_,^Z*+=Q#5_+QZMJ5XHX;09M
MLROJ^^'5-I;Y[/:Z^>VNO+TN]G4F<W%7>M5^NXW+EP\B*YYO9F1V^.&3?-S4
MZH>KV^M=_"CN1?UY=U?"MZM^EE1N15[)(O=*L;Z9O2?O5F&D!C02_Y7BN1I\
M]I0I#T7QE_KR2WHS\Y5&(A-)K::(X<^36(DL4S.!'G]WD\[Z9ZJ!P\^'V7]J
MC =C'N)*K(KL?S*M-S>S:.:E8AWOL_I3\?RSZ SB:KZDR*KF7^^YD_5G7K*O
MZF+;#08-MC)O_\9?.D<,!I#0,H!V ^AT0& 9P+H!K#&TU:PQZV-<Q[?79?'L
ME4H:9E,?&M\TH\$:F:MEO*]+^%\)X^K;59%712;3N!:I=U_#'UBCNO**M;>*
MJXWW$ZQSY<V]S_<?O>^__<'[UI.Y]^>FV%=QGE;75S7HH&:Z2KKG?6B?1RW/
M(]3[K<CK3>7])T]%.I[@"I3O+: '"SY0YXP?1?+68^2-1WW*$(56IP^G#G58
M[U#6S,=L#E5>6S=>6Y?%UH,-5\:US!_;B)6U%*C;VED#?%:UF=]5NS@1-S/8
MK94HG\3L]KMO2.C_B)E\H<E&#@AZ!P2NV6]_A]R3%15J9#N2-R-5@GFZG7/.
M(_#[TU!]1&SA1SSJQ4:*\5XQ[ER9]^G_83^UX5T7D(.2(D]D)KR\TUC]JCXG
M:@GW%6P(B'5L_=YAMO%++N"%)AOY*>S]%#H7\*. 21,9-VD6\L"N5#ZH7SS8
M\9[X>R]WRH>8"]IYP\&Z,3Y=6U.&LR6^L(M>X853X??;HJSE/UKA+*X5P$$Z
M?P*<:M1ME)=Y'>>/\@'6/*XJ4:,QNC 4I O&@XD9B%3(%SYN2-0;$IUE2"H>
M(!J+"E<T,E5@BVBBIRE$>$1P-9>]FDOW#H=]H[:(<FF<).6^V2FU@%!$PV)I
MAD5$IPY%A*C%G<37X.8[-?U5[6KPI=SN8EDV<0!NM:]]-]W(760YT101"L+0
MHNH A\E)JE8Q1*=;28*XBD^5=#X-SR">(WD0J@VA3D-6&]AC0J7.ISC;][$,
MR59E4;4$\+&2:9-6BQRUD)K+X!-_:J)3CU>8J"&>. 'T]E<)6;"E3&F\!;:+
MKQ,S4UW$ID:80H0$ML#7&$S<('Q?%\E?<\5O4W#W%DA_9?=V8*JP]$/#W:88
M(RS@%E4U*A,GF '<K$59-BD$-!5>'7^Q^).;>K)I&D&$Y@1J&HN6&A.)&Q0_
MQ&F;CL47Y4R!*HC@'S$VIBD4VI@-T0A(W!#X1[T1):J3<]Q)FZ33VT0\$@46
MO37@D<C-EOMD,>!93>9KT"63\8/,&L[5,#/((V*]A@JPR9 )[,)*JK#&&1EQ
MHNVYE.Q2LXT]I3&7N$'W?9(4>T5=@9L)^10#B4%M-G%T3@A?&B"&R%&?60*1
M:L2E;L2]WS]422EW78W>KY"=QE 33AD)IGD2D9J3,%Q8]-6P2]VP^ZEXB3/@
MMFN!)QWW\#/V#S51FQ#*+8F):KBE;KB]*\4N?FFK&K5E"I4)O&0/*56Q7BN+
MH";&SBGABZG?33%*(YO6&D&I&T&;? 5%5_XX!]ZX=>EI N1\86B)"-'( DU4
MHRAUHVB_Y\##M@U'35B<TS TXA<1"SFSJ:C1D[K1\WW'OSM8&L0 JJR)CH#@
MAJX(AM+ETD)QJ<90ZL;0S[F(RQR4+:$NR_>X.TUXG"^6BRD90<18M+1E+PVC
MU VCH^Q5BO5^@$$OJ+HF*L[9P%.=MH@4U&J6LI=J]*3N>O&/'C,S 53OB*IF
M*0A*D*FJF!2Q.5:C%W6CUW2_#X =U15!IY $QK9'Q!CC%K\R#6+,#6*_G]($
M0IMX"$K18+&8-D$P.4*8;^%33,,9(V=U'V7^!$7Y"8J_ N8<[<<+S39V@H9$
M=@02]V6RB54R/*M[Y9[U#*AG"+1R9L%,-F@LNS%S%>]D'6?R'XA)K,6%VH0
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ML7R@-"W47S+CCN;%(<VG8M_OO,Y&/^;C5]7TDT6J/&!8\7=]_=7^5Y%7\<>
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M>#S@;'*J^.S@%\?';9]7#/FNZ0 >1%^$]QO8W;VI>T1+T0 :6*O#0AX1N#-
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M+.LEN#;M7I5P))L<Y2V<Q)^PB\4>*'I7+O%K$$!\QJ;8U$W5K/>T(=X>4 )
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MJXGQ,.E<&CL ,FI\P*>8.$BC9.;@GB0U]36DIDL[16@?J-J=/(;W^39?#U+
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M1%AW+=T]5&;+5\$7IJK,AC^N%42RM #?+XVIF@<ZH/V_ 4_^#5!+ P04
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M;CAR+QGWX0NA:Z6Z*;*5KCCED\AT[;C*H=:E3'=,DK*K-XJ*Q"?E;;^V!2I
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M*K*8V.&5,FR\68>7P=QX>&>$Y0H>=LHB YPOC/&[#2K8/Q6G_P-02P,$%
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MCT:5D#J>G8>U>SL[-XU74N.]!==4E;"K*U1F>1$G\7KABRQ*SPNCV7DM"GQ
M_U=];VDVZE%R6:%VTFBPN+B(+Y.SJRG;!X.O$I=N:PP<R=R81Y[<YA?QF FA
MPLPS@J"_9[Q&I1B(:#QUF'%_)#MNC]?HGT/L%,M<.+PVZF^9^_(B/HDAQX5H
ME/]BEK]B%\\AXV5&N? +R];V<!)#UCAOJLZ9&%12M__BI=-AR^%D_(Y#VCFD
M@7=[4&!Y([R8G5NS!,O6A,:#$&KP)G)2<U(>O*5=27Y^]HLQ^5(J=3[RA,9K
MHZSSO&H]TW<\DQ3NC/:E@Y]UCOEK@!'1Z+FD:RY7Z5[$&\R&,$D&D([3R1Z\
M21_;).!-OA,;")W#K?9"%W*N$"Z=0^_@1KI,&==8A'\NY\Y;JI!_=^G0GC+=
M?0K?FC-7BPPO8KH6#NTSQK./'Y*C\:<],4S[&*;[T/?F9Z_G;EY),H1>EC]+
MC+*25$$'4D,FK%U)7<"S4 V"64#1"T@:"0<+H^@2NS-XH-Z0-PHC,KK>(%RO
M$;ZN$=9G19Q2SFL:73K>H%QC-4?+^=[:O'[-07B88R&UYB7R6J&P\!-,3@>3
MZ90&R>G@*#F--HG.GAII,6<R8>QDN/OD>B^LR!$.(!T<GAS_D,L=ZH\?3M+D
M^).#WTQCM5"0#-+I$23'@V1R\D,@G_%E!0^^R:5QY'UZ<@@'T>_&D0H:9%4+
M::G'>2)VL"-ZI,K=Q#TE[L>'&P$X@=>&,/0*:K3<HBD/5-I"ZX;(;L%[=)X!
M?8G42VMC/9_3:.E!X3.J 2Q+F94@73"AIF]%,'%8! !CB3"VQI04JH/7AE%G
M.(0[H:F=!Z<</5KJ6J2,+[O3UX27IE$Y(8$H"HN%\$$^;T" (SSU#4\*#^K&
MUL9A**$N8MYGW$VP40B6S=<%/-R6:L"E7 OK&62W6L@)$.L4]M>@LV<=7G,;
M;.1G*KW#VP1('8DL,S87.D/J]+X$4==*9H+[4M'(L!'8]C.HK7F6.3)/J@<O
M_:I3/O CP1;2$G;'@.1[HFBD%_RYHU!)+=<R,)M\1,L2"<12/)SRRM %5_(1
M%6/3.=KX3<86%,.F*8BW>2%_16>TCJQ/WTA$91JNB-O%%O>>@XNZ$PB@*[N,
MOJ^#CI/%[DX1[W5L>\4E.Y*)#EG0;3">1Y357>;\/:A0A-9/D%'+\U6JMZP5
M7U8"GW/6,U-H^1^QXO(*_-]6@N1@5^\&_:ZLT;>RTKV@:V'?57;PG6IS(8]K
M(=NR>J<U+/E.M"IC'E%=;3?H\$$>PA\&=GW11ENOCPIM$=Y8Q)49M@^1?K5_
MQEVVKY>->?L&O!.6NCW7TX)<Q\/CPQAL^ZYJ)][4X2TS-YY>1F%8TE,4+1O0
M_L)0XKL)'] _;F?_ U!+ P04    " #+@8%80&]+D2@"   7!0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970Q.2YX;6RME-]OVC 0Q]_W5YP\:4^() ;:CD&D
M0C=MTBHAV(]GDUR(16)G]E':_WZV$S(F4:1)>XE]]MWGON?X/#MJL[<E(L%S
M72D[9R51,XTBFY58"SO4#2JW4VA3"W*FV46V,2CR$%17$8_CFZ@64K%T%M96
M)IWI U52X<J /=2U,"\+K/1QSA)V6EC+74E^(4IGC=CA!NE[LS+.BGI*+FM4
M5FH%!HLYNT^FB['W#PX_)![MV1Q\)5NM]][XDL]9[ 5AA1EY@G##$RZQJCS(
MR?C5,5F?T@>>ST_T3Z%V5\M66%SJZJ?,J9RS.P8Y%N)0T5H?/V-7S\3S,EW9
M\(5CZ\O?,\@.EG3=!3L%M53M*)Z[<S@+N(M?">!=  ^ZVT1!Y8,@D<Z,/H+Q
MWH[F)Z'4$.W$2>5_RH:,VY4NCM(U6C(R(\QA0SK;PU<IMK*2)-'.(G(9O%^4
M=;1%2^.OT!(.CUI1:>&CRC'_&Q Y:;T^?M*WX%>)#Y@-890,@,=\=(4WZNL=
M!=[H/]7;TL:7:;YCIK81&<Z9:PF+Y@E9^NYM<A-_N*)UW&L=7Z/_L]:KM,M:
M$SZ$:VG@6XEOEKINA'IQ/9AIXWXK4(G.: XF*UU#@"Z WPQX,@8^&,6W[IM,
M."23"5PZA.CLLM9H=J$E+63ZH*B]M_UJW_7W[67_X]X^&8_"[*2R4&'A0N/A
M[82!:=NP-4@WX>IO-;E&"M/2O5QHO(/;+[2FD^$3]&]A^AM02P,$%     @
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M/G.VXH);C@Y<DEQ)V8V7+;<ELOW=<,.=H*U5P4VM=H(D3)*I6VF*R6/Q,((
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M0UO"Q5@C28Q+M>TT1<9W X._,=+\XJ?8]YY[7T=#SZ3+>V6A8/LT=#;W[2R
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MIN,!T^Y#M'LQJK8??Q?*&%7:1X)?H8D ^TN%@/D7.J#_WX#+_P%02P,$%
M  @ RX&!6&C=-C*/ P  ]@<  !D   !X;"]W;W)K<VAE971S+W-H965T,C<N
M>&ULC57;;MLX$'WW5PR4(N@"AG6QXSCQ!7"2[F8?@@V:;?NPV =:&DE$*%(E
MJ;C^^QU2LNHFCK$/LGF9<^;,##E<;)5^-B6BA1^5D&89E-;6UV%HTA(K9D:J
M1DD[N=(5LS3516AJC2SSH$J$211-PXIQ&:P6?NU1KQ:JL8)+?-1@FJIB>G>#
M0FV701SL%S[SHK1N(5PM:E;@$]HO]:.F6=BS9+Q":;B2H#%?!NOX^F;B[+W!
M5XY;<S &%\E&J6<W^3-;!I$3A )3ZQ@8_;W@+0KAB$C&]XXSZ%TZX.%XS_Z[
MCYUBV3"#MTI\XYDME\$L@ QSU@C[66WOL8OGPO&E2AC_"]O6-B;CM#%651V8
M%%1<MO_L1Y>' \ L>@>0=(#$ZVX=>95WS++50JLM:&=-;&[@0_5H$L>E*\J3
MU;3+"6=7CY0$U!HS>+(J?5Z$EDC=5IAV!#<M0?(.09S @Y*V-/!)9IC]2A"2
MFEY2LI=TDYQDO,-T!.-X"$F4C$_PC?L0QYYO_ [?I^\-MSOX9[TQ5M,I^/=8
MD"W%Y#B%NQG7IF8I+@,Z^@;U"P:K\[-X&LU/")ST B>GV/]/#4X2')>71"-X
MQ0Q_ESBX557-Y Y*9L"6"*RQI=(N0U8!-Z9!B(=1%+D/HE$4#\[/KJ:75W-:
MGM%2/)WU*\G86TDE"309CB^F\(2:HQG\\<;W7W+PP'8PCEQAB=X[WXLQ2F1[
M_N%T'(\NHHGS-)I<35LY;@9?:B4'#-*2R0*!2TCIZ&DEAF"80% Y*&HXO.*"
M::!B2\/\Y1\"!4MWE?*6.9AWC=KRG*?,>N =&EY(YEL%]3IOTL8";V+QV@<E
M:4;ML*=L^SRKVG-3DC/$BKI@6AY*= H9"$Z'-6M5,)G13=]1Z_, XN#Z2$ZZ
MA-^_<;P68M")HT\"M61CB93+ DS)Z* X[9WN>Y?*%Y>2#27R-=5'1W)^-DN2
M:-X#7AGY[7C^FSM0BMHE95:(W9X6LP&7%/M/QP?E=]#X<F[(N*HH<N.=JK9.
M.<]M2<F0U+VUH8<#LJYD;I=+;CD39*6-A50HX\+[M28'4@==_:C 1+]N"NJP
M$$=MKZ%38CVNU>S?G5KSU#O[ )>C9.H4.X5M6H[=_?"@%U>H"__BN,@::=NV
MW*_VC]JZ[>4_S=L7\8'I@DL# G."1J/+BP!T^\JT$ZMJW]DWRE+*_;"DAQFU
M,Z#]7"F[GS@'_5._^@]02P,$%     @ RX&!6&&PD#6R!P  P1(  !D   !X
M;"]W;W)K<VAE971S+W-H965T,C@N>&ULQ5A;;]LX%G[7KSCP+ 8QH-BZ6VXN
M@).TTRZFG:"9:;%8[ ,MT;:VLN225)SLKY_O4++L7+=8+# /B2F2YSOWBW2Z
MK=4WO9+2T-VZK/398&7,YLUXK+.57 L]JC>RPLFB5FMA\*B68[U14N26:%V.
M \]+QFM15(/S4[MWK<Y/Z\:4126O%>EFO1;J_D*6]?9LX ]V&Y^+Y<KPQOC\
M=".6\D::/S;7"D_C'B4OUK+215V1DHNSP<Q_<Q'Q?7OA2R&W^F!-K,F\KK_Q
MPX?\;."Q0+*4F6$$@9];>2G+DH$@QO<.<]"S9,+#]0[]G=4=NLR%EI=U^;7(
MS>ILD XHEPO1E.9SO7TO.WUBQLOJ4MO_M&WO!O& LD:;>MT10X)U4;6_XJZS
MPP%!ZKU $'0$@96[962EO!)&G)^J>DN*;P.-%U952PWABHJ=<F,43@O0F?,;
M4V??5G692Z5__BD-_,D)7<E%D16RRNY/QP8\^.8XZ_ N6KS@!3P_H(]U95::
MWE:YS!\"C"%<+V&PD_ B>!7Q2F8C"GV7 B\(7\$+>XU#BQ>^@/?V>U.8>_KG
M;*Z-0E#\ZSDE6XCH>0A.E#=Z(S)Y-D F:*ENY>#\YY_\Q#MY1<"H%S!Z#?U_
M<,FK>,]+&_@C>IT17=;K=5TY]A;]OI(.-C:BNJ>5T&16DD1C5K5B8YJ:"JT;
M2;[K>=[NC_S#]8.3!]B?Y;+01BJ9TU6AD*[TVV(A55$M*7"G2>A._93"49J2
M[[LQJ,,XX:4?10^!4*/H!H12TWNZ1GI+Q:#MH>].4] $0'$G\=0-@HBF$VQ"
MMLBUD($[B5*:^-@)(6;:'W0:A-VIO?%4#V8_RQ!>NN"*HRF81&XR#2@,/3=-
MPOXYL+2[W1!<? ^_4,@G/W$GR3/ OQ8 SH5A(XDUZJ6F:.(&<4"Q%[M)'--1
M,=QM1=-IO^W#<@E-K#Z)FZ0QA4'8GWZ6R((B VS'ZX^J,( .IFX,4Z5AX 9A
M^%"<KX59K629<T:Z81K %A$@PTGHAM.((C=*4GI[)U56:.G4B\X!OVU:JTRF
M,4T3-X(\'F'] !N1-)?T@8,I)QN4_@F%J1N#S<1-8Q]^K1=2<U,0I0-OWQ89
M; $;)OZD_W'],&+- ^O** WAW%&,K?11R%PW\[+(]@$70OII"AU\!$MBO9*$
MB1LF$<51#%M,*1T%;$/7BU-X,HHX%F)H#'=&4^^I16=;H7(-PY80VZF1.6H+
MPY V[$W7IM)"%(IN18D4@KT$VMT.!-<81# (D@P=!YF"1H 3[D8YH;4Q0M6L
MYU(QM5X)D--2B8KI197;"]^;FA\W@+5.X;TNH[ODUY19TW0L.V".N3:[\Q&7
M 8)HQ=H&XD.I<9FU:KE#TKED@R*?ZV55_(<EL0PP3FC!D>#(.UZ#]A:",ZM;
MA@;-!KZH\PZS4_U(2TF?H (%P7!$,Z<;(W:W7K"8[?I<HO+&^I>OWDNA2')[
M0KG+I+7;KL&PX)!S49<85_0;NMESV3N6#AR+C&\Y.)^L!]BT7^TL@ "803.D
M*KV#H9PO;"CG(#P.Y-2$@0D!4>4LI##T=U$US'<G%BI5A&C\&^K#:!HY7X "
M.8ZZ[2$=V7T:_BC^4\6/Z4/5#GGLFRURG&VZX7*,I+18QVW$'3H1#]K8&&NJ
M U>_?EW)TL8/<%]V'<>0LU'U;<&.:N"N-DA6&#U9">N#XPO+XO*0Q<OUY$/E
M9'55=0.A55%05M::\6S>(3MN.=XW)?HE9D_#6;#S1<26\E.7/EY=N-0UP?U-
M.+HR+FUQ@$5ARE9#6$5B\$2IF'@^AM_YOSN3EGU%=_*VHKO4![D?#P&U*K+5
MH]HK%.>U[A?.%HVSRT]&W30J0X/N$_%',KU@OSRTRZU "C9(A*(250;[:#IB
M' 8(O)-WN^U>#GO@GT!J49;,M15^): Z$AU]/7\F:Y_B_#\SML/<I^CCQ.PW
MD-S\!@-^?<Y>8HSE^;!!F_G4%]==6T,_7DCGIK7Q-==4]-^*_@%!]=!Y1JW_
MDM^^AU$$HP82W!LE/GFC.'7>MG9#<G>GP_;T!_"?R^]CFI7E^V+SOMXX/1W&
M .[@T2CT,!ZD_I1F%[_LCZ=3# )H<496U@L( W_896,FE1$<.X7*FC5S1R=V
M#J(-+RKWB'^$.4(4L!R?<F= #I,C+AQ5;8A;(SPM*MX>[J)CVTGA<H2V\92)
MCO31%40M-N=M#Y'YB7,4#)^]AZ&UYAJ7X?#>WJ9FPX6I4Z;MKJ(=53KB7^'>
MRA:)V5+)-MOG]U8C3&:6''4$TB]M(\PX<FIF?6B,$ULEC\*AI=O-T(KCS^:M
M4!"JV* >N&0!4?N.%=[IN,\CQA%>6=E8_[8Z=E6W>]C;:F?AW I7]8]#UX%^
M[)9%8QIX1+9O0EP[V'6/2@4Z[KY6M6^B'+#R+I/M(,==6'.[>Q)K+H4(F]1/
M*,;O!(,VJ]S'U%_59QX( 8ONF@N;I9LL1NU B/=IY5S#(Q6TVN>"AS<1CS[)
MK=/?HB>WPM!.]W^5DI".7I;..5";#M5^[KUU?/!982W5TGX\X=;15*;]PM#O
M]M]G9NUGB?WU]N/.1Z&6!1*JE N0>J-)/&A#?_=@ZHW]2#&O#0+-+KG12\47
M<+ZH(6GWP SZKU;G?P)02P,$%     @ RX&!6(FI)_]\#0  P"H  !D   !X
M;"]W;W)K<VAE971S+W-H965T,CDN>&ULU5IKC]O&%?W.7S'8.($-<+GD\!T_
M@+5CIPD:9V''"8JB'T;42&)-D0H?N][^^IX[,Z3(74I:QVG1 K9$D3-W[ON>
M>Y?/;JKZ8[.1LF6?MD79/#_;M.WNVXN+)MO(K6B<:B=+/%E5]5:T^%FO+YI=
M+<52;=H6%]QUHXNMR,NS%\_4O:OZQ;.J:XN\E%<U:[KM5M2W+V51W3P_\\[Z
M&^_R]::E&Q<OGNW$6KZ7[8?=58U?%P.59;Z599-7):OEZOG9I??MRX#6JP6_
MYO*F&5TSDF1151_IQP_+YV<N,20+F;5$0>#K6KZ214&$P,;OAN;9<"1M'%_W
MU-\HV2'+0C3R557\EB_;S?.SY(PMY4IT1?NNNOF+-/*$1"^KBD9]LAN]-O#/
M6-8U;;4UF\'!-B_UM_AD]##:D+@'-G"S@2N^]4&*R^]$*UX\JZL;5M-J4*,+
M):K:#>;RDHSROJWQ-,>^]L7[MLH^?O-5PCWOZ4M(MV2OJBTLW@A2VK.+%F?0
MRHO,T'NIZ?$#]#S.?JK*=M.PU^52+J<$+L#<P"'O.7S)CU+\3F8.\SV;<9?[
M1^CY@\2^HN<?DG@C:GFN9;T2MW"PEEW6M2C74EW__7+1M#6\Y1]STFO:P3QM
MBJ!OFYW(Y/,SA$@CZVMY]N*;K[S(?7J$\V#@/#A&_0_8ZBB]>6XY=]CQ@]@O
M&VG1#5'>LKQI.CQO:,?Y0JW-QFO%C:B7#>O@#$@%\EK6HF"[0I0-$PU;506R
M0O.M]<U7:12G3V%C+[*N\'A\)YW>^;EKFWPIK9]W=$(S6LFY6LD\.W%=VW5=
M]D["EGG6RJ6EA&(?RKQMV'==G9=KJ]U(=BM%S23Y*H.GR>T"?/;>QD2Y5&1M
M1DOOR%P/M+7X$))HMQ6[%G5>=0V3VUU1W4K9*$);1;QAU4I16U30#)+AXI](
M4!9V98B;O%3:A"GR3#KLPPXJO,8YX+;?IS1J]QOIN$S6+=(O$5CF2B=0; W^
M"@F#W-EW3Y!&W5(&*FY)*[#?%L=JF<QFL\-1ME^)O(:,1:=HBWE%L!O8=RE;
M62-KX8GV#= E<F6G](S=#45CP]:(/]I/>J(%OW<5_=R!K+S#@_++^&ESAT]-
M>"E:V=MGJ8S,>B,WAZQL#V9VV*5EJE-_Z+QLJI;D[>W=,PXZ4CYQ=_8>M779
M%4JTO8NRL8M>FB.LMX.NWFM=_:8J#3SZ0TFN@7V_ZJ\W9)=?R2[6NWG?1%5N
M6DA+/(N6_2C*CF3MN4S3P(ZCB/EI;/MQQ!XQ+W2"P/K>6,<+$CN-77;.0B>.
M+7/LXR@(;=K^A)DK'*]<;XF5CP.>VB%/V!/KE2@SE%_:PM/4#H((6\X?R.M]
MG7J@P:.811ZWD]ACGN^$(?NYM-[(1:WDXLDHCG_L2LE\M[?Y. ZVU3)?Y92Z
M3"0="&V84'D[*O[(/_)UJ7,=W;JI$+UE7M66_"2SCB!'8[.;C:QQ> +E1"S@
M=N0K1M]6UUHFRC#W\\S %O<AH0>[<&^<?/M(8+NJR#,*9\H&M=QU=;:AR)\-
M-5R1+)/H@7YIK0IL>/]'@$$=W^9!"QRF-B*RR(BXMDH@KB,D.TI=R$C(^(U1
MSJ%,H7(?UNFCQ"=6+8I\K73:."973T*,?O?^8!E_"*:ZDY]VR(YW%2)VN[KZ
ME /,R0+ND8:J2)!*VZI%8<I+L ? F>W3VU[$F1PT%=GD'9U[YVO#!@J](5^H
M^PBYFZ6L4[5([W_$N)W"W1,[=F/V0ZGA.31FW>3MAL[?F>IPL#1G5=,2'X*X
MQ,*#Z:XAS\K+K.B(,Z*?ZVQ[+W5E0M5D74U4>=V@42#YU//S&3#Q2FG05&=3
MTN_6YX.I^WB!GA8(0UHC$5JME$EXP28_;?*ARJ+J( CR0A4!R U4B#"VIG24
MF@6C^D;+NIU2H2P-P^HQA8W1?%_$X7_7>:,H&)>OI1%RKKC.B-!#JKYD/K3,
MC1P(>2P31=9ITW>-2K'L92%@(I2FJI"-9>0\IQ),SY&,9*%\NT\(1K()PJ-G
M'W;G!92)(B=+ D*HKZO6/#L:/\07[1QP@O7V;^]?L\NM! ^B5/IA7ZJ? ^HY
MH!5B8J(7<\AIM>SU<557"['("\(+?>T>E(/B %*TO3JI(&LAZ<B)BMB,B@3<
M?]N[>XN#_T5FJN5!"+('#@IF3$+Q<D_,^IORK]?W%&@I_U+XNS=^__VVZB^M
M=WGS\7Q%[HXT*RG3L)K@FN\ " 1.PMG7S'72&-=^U%][P!_L:^NU2N=D38"B
M)4S(;G-9++$&^?OKZ==^\74%6VK%!Y$3^"R('1YC8<!I9<+U-OWM^?&=[46^
MD@Q5UW%9A/_]]SV,..N$7XH0]T>,[;&'A0,*O*2>:BV'&\C*-(RA_&D>P:E*
MU=%VHAC!R=>?9)WEJ(I_A9R6 9=7"G$_1H)7QGYBO9I+HB=P9&03-@N!5A2"
M!.9)'.X.,)(GL9VFL(8#A^FY(!QII[#.$RQ.N/6FJE<R5_@R"%+;]PE?ID[L
MDGWRFNZ',0!@$JG[?O(@3N_K/;2#T+/3* &1D/PP\.<I2<VH6!1RGE)@N\0H
M!$N=* !$=J-Y2F75,H/<YX&M';C<#N-P?KNX%GFAV*"TL^K:#J&MLETS3^^Q
M]X2%0)U)$%MT/:$Z4+-&U :<-U,M"4_1M*!L1WVV9[M19(<4L*EKAU DU3*Q
M7M=R33&NV-/=V<D$_J6E[1$Z I?%\,& <<?CL 0/CX.\62[DX)E_@ ^-T3S2
M3 B YKFV![2&3B4"5\1+US=OLV>3+6XV>;91A_;@(6\,KAWWTR+;Y/):SZX4
MR-[)6J%!LM\P$J#D@J?W6+84IV'BVQ[R(S25_.]T&/,]16^6@W8[UDXH"Q%$
MS$2S03G?6]D!B&9BJ;5ES]5B:Z($A3'90YJ@4PRKHEU+BWRWK."ROK;!L$]-
M0<8(:U;L2::#E)-\-2G^AWQA"@J&\G"EC\<MDS@F &%(X&HNUS.@1P.6J2:Z
MMCP9+BQT+TZ0("J<T$7>]+W$3EV/^;;OHJ%)7>N1>N91]0BYRB[<]N.41;&+
MMB>R5%T)"7,X8<!2VTT]_4FD79H#\)#2.0_M*,&RP(X"3L]P-V8^5B#?(SKQ
M'W?I=\K\T(D4-]Q\TA/<\UC@.A%'PQ4C.M0GGM ]Y/S$"5S&8V+*?%G[BK*O
M"#^I5C[3'1HT>:DQJID(<,_V/. >,.MS8C;T0E( 3\TG540&@OCW<VE]SB1#
M_MX1"NE!^LZ@QCMC"V&&%FP86@RS2X98IY!4O:1.27WJL@YTBY2\S)"#I^A/
M/<J#<0PS),%T['%4A,&Q5T01"'>.S6H%M>*1.C-$Z8$)<9J?N!J/3L#3.]G#
M=G#QDT .8UXR-WE1<X)KJL^JVND]%+Y&J^-8FT;A8R)#&8.[3^?/5@^]IT_Z
M*F?MX_INUJ5IN*ZYNK!XJ?ZEQ@@;09F,3;,$$POPC<JC/$9]4"HYH 6R_&0B
M K</?-N%+T8(.=B-:H*=>LD73!B(]:ZL95:M2]6)?-9 8C;5(0.K/GHYT=[)
M4</ER^^MWT2MD=(/I87B6)H_#NIV?4-8.*._.(+,);"+KJHDP:@NJ76@Q09:
MX'6HB'H0D!+^#69ZA=&^/W6*//!R>FY\>( \3?FJ"[C57<!$W!/H/X3L,0^8
MCV^:6B)7>Y21T8%%_<SXG)T?I3F#T^]0U31#ZAT?5C[G#/?E-=/Y\VKFZ_WA
M1PIGZD ),<I*1$6.E!%18?,2*J@<]Y,DA/NA$@56[X6]SHX%\0,"]V2P3G0[
M"E)V-$BM29!>=4!K#2QJ78FZ+;%MH'CD40!X';"W\L8:%K%[B^X%(]:S(^O_
ML_'YWVK@3PAY(IC/$;X4K'WOGE++AU &WCK_3-+W]34B%CA>>(K>R0X<.!$(
M@Y C36U2?HK@J48<6-2+3A'Y['8<@,?\U>'A6>MS-/W_D<="QX?IE0.<&[@/
MH_7#A 3)2SW3)CV8+<9O*BA$84W?/B!=* 1L\ :USR7X1:VNUSIQ5>B737,(
M^V5BE[="CTP_O^TG7>L<0P2L8P,]P]!8&C5?G1FOZD9]],<68XM)NOV%9AL-
MM-.H,4 MKV79Z;\3N2E'@@PT,GX$I8<H&>]E4?3NHAMR^L71':GQ$X+>0XE)
MK>]EJ=[94(WS<HN\1&_'*.P=H27CL%F@-KDT['#MQ$\MQ8NJ$,T!32.R.'5L
M/B MMJ+C\M"^1:[U:J3_'8H+%2RVA#!%M5-@[%P=%?7?YJR#F/*1.0J<^>A'
M]%G4(]IN'!U3./_#"O?MV#=Z=D.5/LF];>Z'AY0>HUG!8E(ZVLN8'U,ZJ2EF
M,99%9*DTI!;&]Y,'*-WSU5XOLN/$-YLAK1^$#U-[@D@TWZ?5;@XC9&)'^D(=
M"/WX-D=/^V$$+:91VP?I'71QZAVC>\'>WY_/>&I6>*A<CYF;-A&O-7/6Y8%Y
MVL.\YL-!7-4+3_KR4IJ@ ]L@@.&S!*5#!&>ZAPK"  08.:^6^^D@5+8@!0YG
M[+$\\QPJDHZ/2N10;^X$(9M[.^UB]%8ANN^U>G>2!EQ=V>H7#(>[P^N9E_JM
MQ/UR_6XG>NUU#@\LY I;72<.SUBMWY?4/]IJI]Y17%1M6VW5)2%%6=,"/%]5
M5=O_H .&EU9?_!M02P,$%     @ RX&!6*/XZ4(S @  (04  !D   !X;"]W
M;W)K<VAE971S+W-H965T,S N>&ULI93?;],P$,??^2M.!O%4-3];2FDCK2T(
M)"95FX!G-[DVUF([LYUE_>^QG30KHJN0>$GN[+N/OV?[O&BE>M EHH%G7@F]
M)*4Q]3P(=%XBIWHL:Q1V9B\5I\:ZZA#H6B$M?!*O@C@,IP&G3)!LX<>V*EO(
MQE1,X%:!;CBGZKC"2K9+$I'3P!T[E,8-!-FBI@>\1_.CWBKK!0.E8!R%9E*
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M!WUHR"">JLB217D#,"3H.^J'CL,4P$?T'RCB(1"HBAW=E=,RJ2-\/>=(]C-
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MCD'S] X+]EAPI_F./0I=>G&7$RZJ-UIF&]&"4#WU_')(7[Y2\*7/I+70VNO
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MT;C0%4)VFTNQQLSV!')P<?N";$"9-=[U5C^J+*/$@E?OP2+0R#>';OS['0_
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MTP'3_B.KO[%JZSYLKI0%J[M+FB:$)@&\7RLP1G-#&W1?NJ_^"U!+ P04
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MUOR@H1< SV\<'ZY]1Q(,3^3R.U!+ P04    " #+@8%8.? 7,2(+  "K'
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MGQ7Z:/PW#07&R#)D4.K9D<-\UM$BMQ[B\3=/?M32(V7(16>BEB,9*Q/N#Y$
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M(9E(Y'KC0"-2$!D(1Q! (T^VWN6BCZXCG29LA2OH$LG.W<NETJHVJ.IV2TK
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M:C.8'QAH 2('']9-"9^^&+TP50-"3!L+CD*,IS6(JQTCO-FDC4Y7*Y G!!=
M6E8(0[I%*B5:@>=-PYN59^D\R[,FD\U;9O4B+^NV(F0"?$C7",'0.SB@PHEP
MI189CR^>""4$#Q8,(HK  V'.N*WULJWP7/DGZ93!<2F7QY$H\ B1P_)*RQ;6
M&E ,% IK,_/F6B_27=:D>?:GV[Z=$#T\< \*P(XP+G@M 7 $KZW-JLUAZ3#@
MM5Z7Y?(ARW-ZJ@3H*CCEM&M(W$U:K+-Y#MS'XVQPJ'#OX!?+8:HVS1GR7=D
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M%7TVT>@0_3:1C*O<N*$U)-HB"W,P]<530OI?+0 QY:Q*T%0,"QU-S*7>D$]
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M&I@Y4WB6V#V _$S<D*_8G]"0SJ$L6+?9&G4-%?Q&)W4RN8Z>M[Y,4H0RUIB
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MP!A>*8:=QF@@G%V?L%L[UU./$4;'OPZ;JJHAT)G5QK5Y'DT\T-.QX P:5N>
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M+=\7\9Y:8S[_H]R!6C*;GK]XI?^H2B 4BJG.&Q9U[:(A3LCJ^-\S[A#LLYA
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M+$F67Q;TCT#M'.A\KI3=&2[!_J^3_@%02P,$%     @ RX&!6!C<<]U(!@
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M]*C^>Y<>B^> &QI5!@V<0-*;I"._#I*X4S!-70M."N/Q ";).+C#HI&Y>]S
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M70[P3,FJ+U4#+8JR%ZR$QLY2FEMLY2"- ZZOA=#'@4G0_#F(_@)02P,$%
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M4AK:!NY:TOI%90U(7TAIMH(-T"_T]"]02P,$%     @ RX&!6-]$2>?G @
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M;N >-Q[$=F?LAC>;[/D65VC^W"\5K;P>)1<E5EK("A1NINY-<#6/K'PC\)?
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M2[IJH[(&M#^75(GVQ3K87=XG_P-02P,$%     @ RX&!6)L#F-<R P  /P@
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M8?>(6D35XZK>&+ET(V(N#0T<M\QIPJ.R#G2>26G6&YN@_<\P^0%02P,$%
M  @ RX&!6(Z@D*-]"0  @28  !D   !X;"]W;W)K<VAE971S+W-H965T-3,N
M>&ULU1K;;MLX]EU?07@N2 !9)BF)DCI)@"23=F<Q[01)+U@,]D&QZ42H+'DD
M.FGVZ_<<ZNI:IA-O.L4^Q*0H\MQX[M'10UY\+N^D5.3+(LW*X]&=4LM7DTDY
MO9.+N'3RI<S@S3PO%K&"Q^)V4BX+&<_TH44ZX92*R2).LM')D5Z[+$Z.\I5*
MDTQ>%J1<+19Q\7@FT_SA>,1&S<)5<GNG<&%R<K2,;^6U5!^6EP4\35HHLV0A
MLS+),U+(^?'HE+TZXRX>T#L^)O*A[,T)LG*3YY_QX;?9\8@B13*54X4@8ACN
MY;E,4X0$=/Q5 QVU./%@?]Y ?ZV9!V9NXE*>Y^FG9*;NCD?AB,SD/%ZEZBI_
M^(>L&?(1WC1/2_U+'JJ]030BTU6I\D5]&"A8)%DUQE]J0?0.A'3+ 5X?X)KN
M"I&F\M=8Q2='1?Y "MP-T'"B6=6G@;@DPUNY5@6\3>"<.KE6^?3SSS^$G+%?
MSH"[&3G/%W#E9:R%=O ^ODEE>7@T48 ,CTRF->"S"C#? IAQ\C;/U%U)+K*9
MG*T#F "5+:F\(?6,&R'^*J<.<9E-..6N 9[;LNYJ>.XVUN_B0HX'F#XMBCB[
ME:![BMP\DOZ^R_A1+Y\^Q,6,_/D[@"2_*;DH_STDH0J_-XP?[>U5N8RG\G@$
M!E7*XEZ.3G[^@0GZBX$[K^7.,T$_N0;[G:U22?(Y^9 5<IK?9LE_OF;UX@O.
MY1#Q1O##Q/?Q6-,^'EGA 3M.8P5$J)RH.TE*U+[QC1;MVOX8Y5N2.)L1^=<J
M48_UIF:]1+9 (>3B1A:M4I"'6+^;YREXF_(5>980K--AJ-:5+%613%5U;H$:
M<O:&?(I1351)WN<J3DMK#?X@\S\29K.(P>C!R&'D GY\VZ.1]4G[#V3Q7A;@
M#\E2%DD^TX>GM<AN4( MCH,D(X\R+LI#PIS0@Q_7)=RA#&:>3PPZY+<ZY!MU
MZ!TXU<O539J ?RE ]PN5P5@S3OY\J^4TJ/E&N'MJOFBI%M_9KL4WX"YHN0N>
M;-<77V0Q34"S+D$]I=;>6D&U6R=_+)'O<H@%(Y)A%M[?24LV&)<M1K1CHZ+
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MJCZ-['UZ5SWS[5.QX,FFS*#"7C].50!7:+K[:A! [H4 Y%0)<(6F!T#-&6B
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MU2LZ'8 BE,EOZ!P]C@;H].0;.D$T10\Q7TH=*[NVTOK,4^Q)H>4ZU^+NT3*
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MBT 3B'PFSA>*+[*Q<LR5GA.STUA_1X P ?K^C'.U69A)M?PRB?X!4$L#!!0
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MM\M<CV,0QD!_SSA7NXT)T SX^ ]02P,$%     @ RX&!6#0?;";1 @  HPL
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MYE 1CM/P[%1XSAZ\JXS'49P4Y: %$QP6-.:QH.WN+4P*D3&849*67.<%1]4
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M!]GR<@W:4@OS@GZ^Y%R]-DR"YK\7\3]02P,$%     @ RX&!6%_%B.MV @
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M2XO-%:B5'L]/4)\O&).O._G;RNK]]_0_4$L#!!0    ( ,N!@5C-'H7EU0,
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M@,H:T/>IE&8]L0ZJGY#H-U!+ P04    " #+@8%8,2<XD5X#  "D"0  &0
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M:Q,J:T#O5U*:_<(&:"]BLR]02P,$%     @ RX&!6"B 9(VU P  30T  !D
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M'F0X8\O"?)#KO[!.Z,KRI;+0[A?6]=S @W2IC2QK,$50<E']L^^U$#N ,#X
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ME:>ALB)HKG?O"RKD64 7-_( B9AJ(-^O*!5O%74@J(^DT3]02P,$%     @
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MI>'Q5H:C&P$I_]UEM>*VN[E5*U[QG(0PT&2O<6!+T(*/'TS7^-1E_$AD:VG
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M]#\N#R:V43=[PO"<;%=H@,/(S!4[AS[I]++]#$*@E(J2":I+@+G3.9UOW^#
M/R-HD@J]P05WXJ-6CO],A6UP3\YW@)WS$FL0P]$07W*M>^#M7JW*-E G'!P<
MG#,U2 V'_@6BAT:.>QMD_)B7A'*=7&8W>MUS[1Z^0<C%%_H4/C17W-]=C14
M5#7LR7W<[9ENX PZC UB)S6BIFP?#:$Y\%4UFZN,9IM"UK-;N]O.__?5U'NV
M_Z#_"ZKA]@!3_U0\$:Y*FD 9+!6D<QLJ3KR>T^N%9&4UZBZ85(-S];A6_S;
MM8!ZOV1,OBST!]J_I?@_4$L#!!0    ( ,N!@5C I-BD1 ,  '$*   9
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MWV&J9NR.-'!IH, E0;8O!L1(5PU.-;"J]#W"0EGJ./QC3CTA:A= [Y=*V?W
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M/3[WY-HYO17C#R(!D.@I2ZGH6XF4^;EMBRB!#(M3E@-53V:,9UBJ*9_;(N>
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M971S+W-H965T.3 N>&ULK59=3]LP%/TK5QF:0 +2I&TZL382+9N&!!NB8WM
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M:@UHZA<MIHX&^BQ1\_XH.5QE$"?G=_ 9I2NTX#1D$IW[5!(6"?0SX9RH*;E
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M+"LO8X)#PHL&\'[#F'R]*1PT!YZ+_P!02P,$%     @ RX&!6*8A# 6' @
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MV?9O1+K-]_AZ3(5(X_SEFH4+QM4!\OMEFHJ7-RK!86^\V?]02P,$%     @
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MEGGK0;HF=8)B,9*28@6Y-H(GLB1":KK/(6F0E#1H2-9D6/!$FCQ(X'>#IWG
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MW=W5O]!)?%VT$0+5)%2344U!-175-%334<U -1/5+%2S4<U!-1?5/%3S42U
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MO)J@_/G]:E4<OJAF\'V5_W/[=+[\+U!+ P04    " #+@8%8>*GR=;X#  !
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M1@V0GR^21+R\41/LGGF=_ M02P,$%     @ RX&!6+'(KA!#!   3QL  !H
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MDUHGDIH6>J"2Q)&?QR1N G39@[H;UFLW[JQ6XN_KO(-LXP.R#,L^TJ#[=GE
M9AUD]4_*O7;Y5[J1<JN06T?D?KO\ ;,.,OLGY4&[W".1[+MYLO'A&:_..-KX
M1BGLVE%VP;-/.4J9XN.='!YB=$\S.69R7%J*,9POB!S'!)J]H-VX"7XI'M]N
M,8O1MR\2B3X+DO&_C_3GKLS?/9Y?C=TW?(4C,M+DX,P)VQ!M_.LOIFO\=LP8
MD# /$N9#P@)(6 @$:]BK6]NKVT8??UUG,\+4>%6./BBB62;=Q8O1BQ:C%_^
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M3L_1$"M/;\H;05?%X<&,"D&SXG))<$R8"I#?SRD5KS<J07V&-OX/4$L#!!0
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M*3#+!<YR<= RM^- LR[7$93YH2IL"EAR@99<E##,[#C4;S5\)_2$*FD*J*$
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M5K1^N8"K/,M<Y>E<%8:AQ]5[0CSO6%U 5IXI69WXDH"GXQ4+P\#5!O44@"4
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MM))YO4'U]\<L*[^]J1,<5Q2\^C]02P,$%     @ RX&!6+WE^WWU!   3AL
M !H   !X;"]W;W)K<VAE971S+W-H965T,3$R+GAM;,596X_B-A3^*Q:MJE::
M);$A7*8,$C"[VY5VMFA&[3RL^F#( :)-8FH[,/S[VDE(N 1#,J"^D OV=\YW
M?'S\.>ZM&?\A%@ 2O05^*!YJ"RF7]Y8EI@L(J*BS)83JGQGC 97JD<\ML>1
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MCVS_.STXY$F\)4N*\B_85[9!- '+;<%9>F@L&*1Q5OTGWPZ!:#2 ?D\#=&B
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MU$,TJ(D&5J*?&!<TBT:N6396AXELH-& D>-WAUZWPA W8M\B&]9D0_O(2YK
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M?>=H,@O]/E7!2ORQ7?PO+M^!+T0F2/Y\.;'W-?B-]DAH[<@T7O^_^/O_<0\
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ME";&AU;'A[SZ>MH)5N5/I=,;@.23=DX:M F+:B:J6:AFHYJ#:BZJ>:CFHUJ
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M6.&X+_@*"1.MU<R#G1N;K=T09I9QHH1^2W2>BB=Z7Z0+"HC/T!U+> [H";^
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MI4NX?<ST+0N$"=#O9YRK=<,,4-_;XK]02P,$%     @ RX&!6!9^O*1N!
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M3XO+'5"]M\D#]/L-Y^KU)O] ?<2W^A]02P,$%     @ RX&!6,9LP)N- P
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M/B-[*K7^YS\^3FT,3 QR_:+<SG^0VVWD=B]V>2'WA)D]X+-=-!I?DE<#=#V
MVS+;M-6-HB@)MZ>\X<D4<%0;/^L:,ED)4P]$XVW6R:">HC_A]2Z:$;6A0@/#
MM4V-[MY:;E7/=VT86?J96DEC)]1?"[L24;D ^[Z6TAP-1] LV?0W4$L#!!0
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M]MK34U[[\,4GGYWRE_;H+ZP0/\.G5![NO.&)J:S\VV\>H3AUL:S^]\C3^_S
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M%-4R2A,SNNM6:O)NY;_6Y1_SU:URE=_/ZWQQ-*315F6K[4>7-G[V3WX=G=1
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M/YRI9\KENJ[7R]W-NR*_+LKM YKOWZS7]>,7VPF^K<L_=B_GX_\!4$L#!!0
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M5KTS0.^L>F> WEGUS@"]L^J= 7H7U;L ]"ZJ=P'H753O M"[J-X%H'=1O0M
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M,D<*F2.#S)%#YC"0.0K('"5DC@HRARC*(!11A4*J4$P5"JI"454HK K%5:'
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MBB)K19%5%(56411;15%P%471512%5U$47T51@!5%$584A5A1&&-!<2R,L9Q
M%B>1Q8ED<3)9G% 6)Y7%B65A<EF""68))IDEF&B68+)9\E_#6=_'\?"/VY^N
M<5^WPTO_9"GJ;GX"4$L! A0#%     @ RX&!6 =!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #+@8%8
M'L9(K^\    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " #+@8%8F5R<(Q &  "<)P  $P              @ '-
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ,N!@5@0RQ$IQP@
M $LV   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX
M;6Q02P$"% ,4    " #+@8%8=!@T@SX(  "N*   &               @($+
M$0  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ RX&!6.4Q
MT@4#!   ?Q(  !@              ("!?QD  'AL+W=O<FMS:&5E=',O<VAE
M970S+GAM;%!+ 0(4 Q0    ( ,N!@5@3=4N_808  +L;   8
M  " @;@=  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " #+
M@8%8GR931H,"  #G!0  &               @(%/)   >&PO=V]R:W-H965T
M<R]S:&5E=#4N>&UL4$L! A0#%     @ RX&!6-S?RB P#0  0W4  !@
M         ("!""<  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0
M   ( ,N!@5A2;VK- PL   TX   8              " @6XT  !X;"]W;W)K
M<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " #+@8%8M67<+?L/   W*@
M&               @(&G/P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L!
M A0#%     @ RX&!6(^=>/W:*@  ?X8  !@              ("!V$\  'AL
M+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( ,N!@5COVX\@)@0
M ',)   9              " @>AZ  !X;"]W;W)K<VAE971S+W-H965T,3 N
M>&UL4$L! A0#%     @ RX&!6-_WR8F$#@  )S   !D              ("!
M17\  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " #+@8%8
M-5NKY_H#   N"0  &0              @($ C@  >&PO=V]R:W-H965T<R]S
M:&5E=#$R+GAM;%!+ 0(4 Q0    ( ,N!@5@[17>!X@(  )4&   9
M      " @3&2  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%
M  @ RX&!6,DS%,KL!0  @PX  !D              ("!2I4  'AL+W=O<FMS
M:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " #+@8%8\A5[PS\#  #Q!P
M&0              @(%MFP  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+
M 0(4 Q0    ( ,N!@5CEBX42A@0  #8*   9              " @>.>  !X
M;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ RX&!6(&L9%RR
M @  [04  !D              ("!H*,  'AL+W=O<FMS:&5E=',O<VAE970Q
M-RYX;6Q02P$"% ,4    " #+@8%8_T_EP8,$  #H"@  &0
M@(&)I@  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( ,N!
M@5A ;TN1* (  !<%   9              " @4.K  !X;"]W;W)K<VAE971S
M+W-H965T,3DN>&UL4$L! A0#%     @ RX&!6!RV@77_ @  RP8  !D
M         ("!HJT  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
M    " #+@8%8S6/;%X@%  #%#0  &0              @('8L   >&PO=V]R
M:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( ,N!@5CNQ]ZSL08  +01
M   9              " @9>V  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL
M4$L! A0#%     @ RX&!6#B_!2IW @  Y 4  !D              ("!?[T
M 'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " #+@8%8<\U^
MD-<$   :"P  &0              @($MP   >&PO=V]R:W-H965T<R]S:&5E
M=#(T+GAM;%!+ 0(4 Q0    ( ,N!@5BZ&$7&6P4   8-   9
M  " @3O%  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @
MRX&!6.$LSY[&"   &1@  !D              ("!S<H  'AL+W=O<FMS:&5E
M=',O<VAE970R-BYX;6Q02P$"% ,4    " #+@8%8:-TV,H\#  #V!P  &0
M            @('*TP  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4
M Q0    ( ,N!@5AAL) UL@<  ,$2   9              " @9#7  !X;"]W
M;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ RX&!6(FI)_]\#0
MP"H  !D              ("!>=\  'AL+W=O<FMS:&5E=',O<VAE970R.2YX
M;6Q02P$"% ,4    " #+@8%8H_CI0C,"   A!0  &0              @($L
M[0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( ,N!@5AD
M0#9 ) T  !HB   9              " @9;O  !X;"]W;W)K<VAE971S+W-H
M965T,S$N>&UL4$L! A0#%     @ RX&!6-Z)V1NM @  [ 4  !D
M     ("!\?P  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,N!@5A#U>O)<P8  $@2   9              "
M@0U, 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ RX&!
M6$IS@&CA @  @08  !D              ("!MU(! 'AL+W=O<FMS:&5E=',O
M<VAE970S."YX;6Q02P$"% ,4    " #+@8%8&-QSW4@&   @%@  &0
M        @('/50$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0
M   ( ,N!@5A2.K*JV0(  'H&   9              " @4Y< 0!X;"]W;W)K
M<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ RX&!6-$O"+Z[ @  * 8
M !D              ("!7E\! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q0
M2P$"% ,4    " #+@8%8ZDA.HU\$  "&"P  &0              @(%08@$
M>&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( ,N!@5A#B7D2
M)0,  "@(   9              " @>9F 0!X;"]W;W)K<VAE971S+W-H965T
M-#,N>&UL4$L! A0#%     @ RX&!6$OSL/Q=!   1PH  !D
M ("!0FH! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " #+
M@8%82O;[@+4"  #<!0  &0              @('6;@$ >&PO=V]R:W-H965T
M<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( ,N!@5C?1$GGYP(  )L&   9
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M970U,"YX;6Q02P$"% ,4    " #+@8%8GD#Y5Y4$  #("P  &0
M    @(&Q@0$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    (
M ,N!@5B; YC7,@,  #\(   9              " @7V& 0!X;"]W;W)K<VAE
M971S+W-H965T-3(N>&UL4$L! A0#%     @ RX&!6(Z@D*-]"0  @28  !D
M             ("!YHD! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"
M% ,4    " #+@8%8*U';DM\%  #7#@  &0              @(&:DP$ >&PO
M=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( ,N!@5AXL0NVP0,
M  $,   9              " @;"9 0!X;"]W;W)K<VAE971S+W-H965T-34N
M>&UL4$L! A0#%     @ RX&!6";.MN]@!@  ^2P  !D              ("!
MJ)T! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " #+@8%8
MW^\>N"8#  "E#   &0              @($_I $ >&PO=V]R:W-H965T<R]S
M:&5E=#4W+GAM;%!+ 0(4 Q0    ( ,N!@5@T'U>"= (  ),&   9
M      " @9RG 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%
M  @ RX&!6.K+](78 @  [ <  !D              ("!1ZH! 'AL+W=O<FMS
M:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " #+@8%8-!]L)M$"  "C"P
M&0              @(%6K0$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+
M 0(4 Q0    ( ,N!@5BQVJ)&' 4  &(B   9              " @5ZP 0!X
M;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ RX&!6$WV19K=
M!P  WR@  !D              ("!L;4! 'AL+W=O<FMS:&5E=',O<VAE970V
M,BYX;6Q02P$"% ,4    " #+@8%8%6-PF.X#  #)$   &0
M@('%O0$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( ,N!
M@5A?Q8CK=@(  'X&   9              " @>K! 0!X;"]W;W)K<VAE971S
M+W-H965T-C0N>&UL4$L! A0#%     @ RX&!6-D#1[BM @  9 8  !D
M         ("!E\0! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4
M    " #+@8%8S6@28-H"  #H"0  &0              @(%[QP$ >&PO=V]R
M:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( ,N!@5AN]Y;(B0(  ,D%
M   9              " @8S* 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL
M4$L! A0#%     @ RX&!6.-#=8CN!   "Q\  !D              ("!3,T!
M 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " #+@8%8S1Z%
MY=4#  "W$P  &0              @(%QT@$ >&PO=V]R:W-H965T<R]S:&5E
M=#8Y+GAM;%!+ 0(4 Q0    ( ,N!@5BA(RN-?@,  )(-   9
M  " @7W6 0!X;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @
MRX&!6 KOQDL#'   ^+T! !D              ("!,MH! 'AL+W=O<FMS:&5E
M=',O<VAE970W,2YX;6Q02P$"% ,4    " #+@8%8:6)LY@,#   E"0  &0
M            @(%L]@$ >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4
M Q0    ( ,N!@5CYHP,<B@(  &L'   9              " @:;Y 0!X;"]W
M;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @ RX&!6*W=GI\9 P
MZPL  !D              ("!9_P! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX
M;6Q02P$"% ,4    " #+@8%8!"T/PM("  "0"   &0              @(&W
M_P$ >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( ,N!@5@Q
M)SB17@,  *0)   9              " @< " @!X;"]W;W)K<VAE971S+W-H
M965T-S8N>&UL4$L! A0#%     @ RX&!6,C+OV)J P  E D  !D
M     ("!508" 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,N!@5@%"N4BK ,  #D-   9              "
M@>X9 @!X;"]W;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#%     @ RX&!
M6,"DV*1$ P  <0H  !D              ("!T1T" 'AL+W=O<FMS:&5E=',O
M<VAE970X,RYX;6Q02P$"% ,4    " #+@8%8$>0P_2L'   U.@  &0
M        @(%,(0( >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0
M   ( ,N!@5@X%<7TV@(  *L)   9              " @:XH @!X;"]W;W)K
M<VAE971S+W-H965T.#4N>&UL4$L! A0#%     @ RX&!6-<&XUTJ P  ^ L
M !D              ("!ORL" 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6Q0
M2P$"% ,4    " #+@8%8=/;;ZL0"  #%!P  &0              @($@+P(
M>&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+ 0(4 Q0    ( ,N!@5CPBN34
MI@,  / /   9              " @1LR @!X;"]W;W)K<VAE971S+W-H965T
M.#@N>&UL4$L! A0#%     @ RX&!6"%,N^-0 @  \@4  !D
M ("!^#4" 'AL+W=O<FMS:&5E=',O<VAE970X.2YX;6Q02P$"% ,4    " #+
M@8%8[A6!X 0#  # "   &0              @(%_. ( >&PO=V]R:W-H965T
M<R]S:&5E=#DP+GAM;%!+ 0(4 Q0    ( ,N!@5C-S$JOG0,   $.   9
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M970Y-2YX;6Q02P$"% ,4    " #+@8%80>;*<Q8$  "L'   &0
M    @(& 50( >&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4 Q0    (
M ,N!@5@+K.07>P0  &P3   9              " @<U9 @!X;"]W;W)K<VAE
M971S+W-H965T.3<N>&UL4$L! A0#%     @ RX&!6-/4#.W(!P  )T\  !D
M             ("!?UX" 'AL+W=O<FMS:&5E=',O<VAE970Y."YX;6Q02P$"
M% ,4    " #+@8%86. MJ- #  "D$@  &0              @(%^9@( >&PO
M=V]R:W-H965T<R]S:&5E=#DY+GAM;%!+ 0(4 Q0    ( ,N!@5CD:B8 R@(
M &P+   :              " @85J @!X;"]W;W)K<VAE971S+W-H965T,3 P
M+GAM;%!+ 0(4 Q0    ( ,N!@5C%UB14+P<   XS   :              "
M@8=M @!X;"]W;W)K<VAE971S+W-H965T,3 Q+GAM;%!+ 0(4 Q0    ( ,N!
M@5A75?8Z? D  /I\   :              " @>YT @!X;"]W;W)K<VAE971S
M+W-H965T,3 R+GAM;%!+ 0(4 Q0    ( ,N!@5A#-,U(N 4  -DK   :
M          " @:)^ @!X;"]W;W)K<VAE971S+W-H965T,3 S+GAM;%!+ 0(4
M Q0    ( ,N!@5C%?K3%(0,  .4)   :              " @9*$ @!X;"]W
M;W)K<VAE971S+W-H965T,3 T+GAM;%!+ 0(4 Q0    ( ,N!@5CY),KJ) ,
M &@)   :              " @>N' @!X;"]W;W)K<VAE971S+W-H965T,3 U
M+GAM;%!+ 0(4 Q0    ( ,N!@5B2CQG)_B@  +\; P :              "
M@4>+ @!X;"]W;W)K<VAE971S+W-H965T,3 V+GAM;%!+ 0(4 Q0    ( ,N!
M@5AXJ?)UO@,  $ .   :              " @7VT @!X;"]W;W)K<VAE971S
M+W-H965T,3 W+GAM;%!+ 0(4 Q0    ( ,N!@5CU.1H3OP0  "T=   :
M          " @7.X @!X;"]W;W)K<VAE971S+W-H965T,3 X+GAM;%!+ 0(4
M Q0    ( ,N!@5AB)#H++P<  /\Z   :              " @6J] @!X;"]W
M;W)K<VAE971S+W-H965T,3 Y+GAM;%!+ 0(4 Q0    ( ,N!@5BQR*X00P0
M $\;   :              " @='$ @!X;"]W;W)K<VAE971S+W-H965T,3$P
M+GAM;%!+ 0(4 Q0    ( ,N!@5@WW). V0@  %U0   :              "
M@4S) @!X;"]W;W)K<VAE971S+W-H965T,3$Q+GAM;%!+ 0(4 Q0    ( ,N!
M@5B]Y?M]]00  $X;   :              " @5W2 @!X;"]W;W)K<VAE971S
M+W-H965T,3$R+GAM;%!+ 0(4 Q0    ( ,N!@5AV;SWFXP4  /8A   :
M          " @8K7 @!X;"]W;W)K<VAE971S+W-H965T,3$S+GAM;%!+ 0(4
M Q0    ( ,N!@5CE@/JI>0,  ( .   :              " @:7= @!X;"]W
M;W)K<VAE971S+W-H965T,3$T+GAM;%!+ 0(4 Q0    ( ,N!@5B&QX3CJ!,
M ,HX 0 :              " @5;A @!X;"]W;W)K<VAE971S+W-H965T,3$U
M+GAM;%!+ 0(4 Q0    ( ,N!@5BUF2A=JP(  %('   :              "
M@3;U @!X;"]W;W)K<VAE971S+W-H965T,3$V+GAM;%!+ 0(4 Q0    ( ,N!
M@5BSL\ &! ,  ,,)   :              " @1GX @!X;"]W;W)K<VAE971S
M+W-H965T,3$W+GAM;%!+ 0(4 Q0    ( ,N!@5@6?KRD;@0  ,$/   :
M          " @57[ @!X;"]W;W)K<VAE971S+W-H965T,3$X+GAM;%!+ 0(4
M Q0    ( ,N!@5C/H5SIS00  .X3   :              " @?O_ @!X;"]W
M;W)K<VAE971S+W-H965T,3$Y+GAM;%!+ 0(4 Q0    ( ,N!@5C&;,";C0,
M +D0   :              " @0 % P!X;"]W;W)K<VAE971S+W-H965T,3(P
M+GAM;%!+ 0(4 Q0    ( ,N!@5BX;[M[U (  !4'   :              "
M@<4( P!X;"]W;W)K<VAE971S+W-H965T,3(Q+GAM;%!+ 0(4 Q0    ( ,N!
M@5@16YN^;A8  #)F 0 :              " @=$+ P!X;"]W;W)K<VAE971S
M+W-H965T,3(R+GAM;%!+ 0(4 Q0    ( ,N!@5@U,ID07P(  ' %   :
M          " @7<B P!X;"]W;W)K<VAE971S+W-H965T,3(S+GAM;%!+ 0(4
M Q0    ( ,N!@5B_&M 3GQD  +CE 0 :              " @0XE P!X;"]W
M;W)K<VAE971S+W-H965T,3(T+GAM;%!+ 0(4 Q0    ( ,N!@5CJ,S$J/ ,
M -(3   -              "  >4^ P!X;"]S='EL97,N>&UL4$L! A0#%
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K P!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    "$ (0 ;"0  *=2 P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>450</ContextCount>
  <ElementCount>660</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>189</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/StatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Operations (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/StatementsOfOperationsParenthetical</Role>
      <ShortName>Consolidated Statements of Operations (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Stockholders' Deficiency</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/StatementsOfStockholdersDeficiency</Role>
      <ShortName>Consolidated Statements of Stockholders' Deficiency</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Organization and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/OrganizationAndBasisOfPresentation</Role>
      <ShortName>Organization and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Discontinued Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/DiscontinuedOperations</Role>
      <ShortName>Discontinued Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Acquisitions and Dispositions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/AcquisitionsAndDispositions</Role>
      <ShortName>Acquisitions and Dispositions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Prepayments and Other Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssets</Role>
      <ShortName>Prepayments and Other Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/PropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Platform Development</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/PlatformDevelopment</Role>
      <ShortName>Platform Development</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Other Long-Term Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/OtherLong-termAssets</Role>
      <ShortName>Other Long-Term Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Restricted Stock Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/RestrictedStockLiabilities</Role>
      <ShortName>Restricted Stock Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Accrued Expenses and Other</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/AccruedExpensesAndOther</Role>
      <ShortName>Accrued Expenses and Other</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Line of Credit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/LineOfCredit</Role>
      <ShortName>Line of Credit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Liquidated Damages Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/LiquidatedDamagesPayable</Role>
      <ShortName>Liquidated Damages Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Other Long-term Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/OtherLong-termLiabilities</Role>
      <ShortName>Other Long-term Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Fair Value Measurement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/FairValueMeasurement</Role>
      <ShortName>Fair Value Measurement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Bridge Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://thearenagroup.net/role/BridgeNotes</Role>
      <ShortName>Bridge Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Long-term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/Long-termDebt</Role>
      <ShortName>Long-term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/PreferredStock</Role>
      <ShortName>Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Stockholders??? Deficiency</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/StockholdersDeficiency</Role>
      <ShortName>Stockholders??? Deficiency</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Stock???Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/StockbasedCompensation</Role>
      <ShortName>Stock???Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Liquidated Damages</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/LiquidatedDamages</Role>
      <ShortName>Liquidated Damages</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Pension Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/PensionPlans</Role>
      <ShortName>Pension Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Discontinued Operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/DiscontinuedOperationsTables</Role>
      <ShortName>Discontinued Operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/DiscontinuedOperations</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Acquisitions and Dispositions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/AcquisitionsAndDispositionsTables</Role>
      <ShortName>Acquisitions and Dispositions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/AcquisitionsAndDispositions</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Prepayments and Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsTables</Role>
      <ShortName>Prepayments and Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssets</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/PropertyAndEquipment</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/Leases</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Platform Development (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/PlatformDevelopmentTables</Role>
      <ShortName>Platform Development (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/PlatformDevelopment</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/IntangibleAssets</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Other Long-Term Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/OtherLong-termAssetsTables</Role>
      <ShortName>Other Long-Term Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/OtherLong-termAssets</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/Goodwill</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Accrued Expenses and Other (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/AccruedExpensesAndOtherTables</Role>
      <ShortName>Accrued Expenses and Other (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/AccruedExpensesAndOther</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Liquidated Damages Payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/LiquidatedDamagesPayableTables</Role>
      <ShortName>Liquidated Damages Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/LiquidatedDamagesPayable</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Other Long-term Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/OtherLong-termLiabilitiesTables</Role>
      <ShortName>Other Long-term Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/OtherLong-termLiabilities</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Fair Value Measurement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/FairValueMeasurementTables</Role>
      <ShortName>Fair Value Measurement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/FairValueMeasurement</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - Long-term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/Long-termDebtTables</Role>
      <ShortName>Long-term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/Long-termDebt</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - Stockholders??? Deficiency (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/StockholdersDeficiencyTables</Role>
      <ShortName>Stockholders??? Deficiency (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/StockholdersDeficiency</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Stock???Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/StockbasedCompensationTables</Role>
      <ShortName>Stock???Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/StockbasedCompensation</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/IncomeTaxes</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - Organization and Basis of Presentation (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/OrganizationAndBasisOfPresentationDetailsNarrative</Role>
      <ShortName>Organization and Basis of Presentation (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/OrganizationAndBasisOfPresentation</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - Schedule of Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails</Role>
      <ShortName>Schedule of Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - Schedule of Contract with Customer, Asset and Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails</Role>
      <ShortName>Schedule of Contract with Customer, Asset and Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - Schedule of Cash and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfCashAndRestrictedCashDetails</Role>
      <ShortName>Schedule of Cash and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - Schedule of Allowance For Doubtful Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfAllowanceForDoubtfulAccountsDetails</Role>
      <ShortName>Schedule of Allowance For Doubtful Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - Schedule of Depreciation and Amortization, Useful Lives of Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails</Role>
      <ShortName>Schedule of Depreciation and Amortization, Useful Lives of Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - Schedule of Net Income (Loss) Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails</Role>
      <ShortName>Schedule of Net Income (Loss) Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - Schedule of Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails</Role>
      <ShortName>Schedule of Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - Discontinued Operations (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/DiscontinuedOperationsDetailsNarrative</Role>
      <ShortName>Discontinued Operations (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/DiscontinuedOperationsTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - Schedule of Composition Preliminary Assets Purchase Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails</Role>
      <ShortName>Schedule of Composition Preliminary Assets Purchase Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - Summary of Preliminary Assets Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails</Role>
      <ShortName>Summary of Preliminary Assets Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - Schedule of Composition of Purchase Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails</Role>
      <ShortName>Schedule of Composition of Purchase Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - Summary of Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails</Role>
      <ShortName>Summary of Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - Schedule of Supplemental Proforma Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails</Role>
      <ShortName>Schedule of Supplemental Proforma Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - Schedule of Preliminary Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails</Role>
      <ShortName>Schedule of Preliminary Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - Acquisitions and Dispositions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative</Role>
      <ShortName>Acquisitions and Dispositions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/AcquisitionsAndDispositionsTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - Schedule of Prepayments and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails</Role>
      <ShortName>Schedule of Prepayments and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - Prepayments and Other Current Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsDetailsNarrative</Role>
      <ShortName>Prepayments and Other Current Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - Property and Equipment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>Property and Equipment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/PropertyAndEquipmentTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - Schedule of Supplemental Information Related to Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails</Role>
      <ShortName>Schedule of Supplemental Information Related to Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - Schedule of Operating Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails</Role>
      <ShortName>Schedule of Operating Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>00000078 - Disclosure - Schedule of Operating Lease Costs (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetailsParenthetical</Role>
      <ShortName>Schedule of Operating Lease Costs (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>00000079 - Disclosure - Summary of Maturity of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfMaturityOfLeaseLiabilitiesDetails</Role>
      <ShortName>Summary of Maturity of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>00000080 - Disclosure - Leases (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/LeasesDetailsNarrative</Role>
      <ShortName>Leases (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/LeasesTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>00000081 - Disclosure - Summary of Platform Development Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails</Role>
      <ShortName>Summary of Platform Development Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>00000082 - Disclosure - Summary of Platform Development Cost Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails</Role>
      <ShortName>Summary of Platform Development Cost Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>00000083 - Disclosure - Platform Development (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative</Role>
      <ShortName>Platform Development (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/PlatformDevelopmentTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>00000084 - Disclosure - Schedule of Intangible Assets Subject to Amortization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails</Role>
      <ShortName>Schedule of Intangible Assets Subject to Amortization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>00000085 - Disclosure - Schedule of Future Estimated Amortization expense For Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails</Role>
      <ShortName>Schedule of Future Estimated Amortization expense For Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>00000086 - Disclosure - Intangible Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative</Role>
      <ShortName>Intangible Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/IntangibleAssetsTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>00000087 - Disclosure - Summary of Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfOtherAssetsDetails</Role>
      <ShortName>Summary of Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>00000088 - Disclosure - Schedule of Changes in Carrying Value of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails</Role>
      <ShortName>Schedule of Changes in Carrying Value of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>00000089 - Disclosure - Goodwill (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/GoodwillDetailsNarrative</Role>
      <ShortName>Goodwill (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/GoodwillTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>00000090 - Disclosure - Restricted Stock Liabilities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative</Role>
      <ShortName>Restricted Stock Liabilities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/RestrictedStockLiabilities</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>00000091 - Disclosure - Schedule of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails</Role>
      <ShortName>Schedule of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>00000092 - Disclosure - Line of Credit (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/LineOfCreditDetailsNarrative</Role>
      <ShortName>Line of Credit (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/LineOfCredit</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>00000093 - Disclosure - Summary of Liquidated Damages (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails</Role>
      <ShortName>Summary of Liquidated Damages (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>00000094 - Disclosure - Liquidated Damages Payable (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative</Role>
      <ShortName>Liquidated Damages Payable (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/LiquidatedDamagesPayableTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>00000095 - Disclosure - Schedule of Other long- term liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails</Role>
      <ShortName>Schedule of Other long- term liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>00000096 - Disclosure - Schedule of Fair Value of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails</Role>
      <ShortName>Schedule of Fair Value of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>00000097 - Disclosure - Fair Value Measurement (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative</Role>
      <ShortName>Fair Value Measurement (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/FairValueMeasurementTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>00000098 - Disclosure - Bridge Notes (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://thearenagroup.net/role/BridgeNotesDetailsNarrative</Role>
      <ShortName>Bridge Notes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/BridgeNotes</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>00000099 - Disclosure - Schedule of long term debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails</Role>
      <ShortName>Schedule of long term debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>00000100 - Disclosure - Schedule of Long Term Debt (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical</Role>
      <ShortName>Schedule of Long Term Debt (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>00000101 - Disclosure - Summary of Interest Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfInterestExpenseDetails</Role>
      <ShortName>Summary of Interest Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>00000102 - Disclosure - Long-term Debt (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/Long-termDebtDetailsNarrative</Role>
      <ShortName>Long-term Debt (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/Long-termDebtTables</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>00000103 - Disclosure - Preferred Stock (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/PreferredStockDetailsNarrative</Role>
      <ShortName>Preferred Stock (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/PreferredStock</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>00000104 - Disclosure - Summary of Restricted Stock Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails</Role>
      <ShortName>Summary of Restricted Stock Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>00000105 - Disclosure - Summary of Warrant Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfWarrantActivityDetails</Role>
      <ShortName>Summary of Warrant Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>00000106 - Disclosure - Stockholders??? Deficiency (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative</Role>
      <ShortName>Stockholders??? Deficiency (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/StockholdersDeficiencyTables</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>00000107 - Disclosure - Schedule of Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Schedule of Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>00000108 - Disclosure - Schedule of Fair Value of Stock Options Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails</Role>
      <ShortName>Schedule of Fair Value of Stock Options Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>00000109 - Disclosure - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails</Role>
      <ShortName>Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>00000110 - Disclosure - Summary of Stock Option Activity (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical</Role>
      <ShortName>Summary of Stock Option Activity (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>00000111 - Disclosure - Schedule of Exercise Prices of Common Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails</Role>
      <ShortName>Schedule of Exercise Prices of Common Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>00000112 - Disclosure - Schedule of Warrants Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails</Role>
      <ShortName>Schedule of Warrants Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>00000113 - Disclosure - Summary of Stock-based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails</Role>
      <ShortName>Summary of Stock-based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>00000114 - Disclosure - Schedule of Unrecognized Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails</Role>
      <ShortName>Schedule of Unrecognized Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>00000115 - Disclosure - Stock???Based Compensation (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative</Role>
      <ShortName>Stock???Based Compensation (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/StockbasedCompensationTables</ParentRole>
      <Position>115</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>00000116 - Disclosure - Liquidated Damages (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/LiquidatedDamagesDetailsNarrative</Role>
      <ShortName>Liquidated Damages (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/LiquidatedDamagesPayableTables</ParentRole>
      <Position>116</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>00000117 - Disclosure - Schedule of Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails</Role>
      <ShortName>Schedule of Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>00000118 - Disclosure - Schedule of Components of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Schedule of Components of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>00000119 - Disclosure - Schedule of Tax Benefit and Effective Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails</Role>
      <ShortName>Schedule of Tax Benefit and Effective Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>119</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>00000120 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/IncomeTaxesTables</ParentRole>
      <Position>120</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>00000121 - Disclosure - Pension Plans (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/PensionPlansDetailsNarrative</Role>
      <ShortName>Pension Plans (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/PensionPlans</ParentRole>
      <Position>121</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>00000122 - Disclosure - Related Party Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>Related Party Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/RelatedPartyTransactions</ParentRole>
      <Position>122</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>00000123 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/CommitmentsAndContingencies</ParentRole>
      <Position>123</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>00000124 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thearenagroup.net/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thearenagroup.net/role/SubsequentEvents</ParentRole>
      <Position>124</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>aren-20231231.xsd</File>
    <File>aren-20231231_cal.xml</File>
    <File>aren-20231231_def.xml</File>
    <File>aren-20231231_lab.xml</File>
    <File>aren-20231231_pre.xml</File>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="form10-k.htm">form10-k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1432">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>150
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form10-k.htm": {
   "nsprefix": "AREN",
   "nsuri": "http://thearenagroup.net/20231231",
   "dts": {
    "schema": {
     "local": [
      "aren-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "aren-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "aren-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "aren-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aren-20231231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form10-k.htm"
     ]
    }
   },
   "keyStandard": 498,
   "keyCustom": 162,
   "axisStandard": 40,
   "axisCustom": 0,
   "memberStandard": 34,
   "memberCustom": 130,
   "hidden": {
    "total": 174,
    "http://fasb.org/us-gaap/2023": 120,
    "http://thearenagroup.net/20231231": 51,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 450,
   "entityCount": 1,
   "segmentCount": 189,
   "elementCount": 1016,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 1432,
    "http://xbrl.sec.gov/dei/2023": 39
   },
   "report": {
    "R1": {
     "role": "http://thearenagroup.net/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://thearenagroup.net/role/BalanceSheets",
     "longName": "00000002 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://thearenagroup.net/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://thearenagroup.net/role/StatementsOfOperations",
     "longName": "00000004 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:GrossProfit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://thearenagroup.net/role/StatementsOfOperationsParenthetical",
     "longName": "00000005 - Statement - Consolidated Statements of Operations (Parenthetical)",
     "shortName": "Consolidated Statements of Operations (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:CostOfGoodsAndServicesSoldAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:CostOfGoodsAndServicesSoldAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency",
     "longName": "00000006 - Statement - Consolidated Statements of Stockholders' Deficiency",
     "shortName": "Consolidated Statements of Stockholders' Deficiency",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-12-31",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://thearenagroup.net/role/StatementsOfCashFlows",
     "longName": "00000007 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:AmortizationOfFinancingCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://thearenagroup.net/role/OrganizationAndBasisOfPresentation",
     "longName": "00000008 - Disclosure - Organization and Basis of Presentation",
     "shortName": "Organization and Basis of Presentation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://thearenagroup.net/role/SummaryOfSignificantAccountingPolicies",
     "longName": "00000009 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://thearenagroup.net/role/DiscontinuedOperations",
     "longName": "00000010 - Disclosure - Discontinued Operations",
     "shortName": "Discontinued Operations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:DiscontinuedOperationsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:DiscontinuedOperationsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://thearenagroup.net/role/AcquisitionsAndDispositions",
     "longName": "00000011 - Disclosure - Acquisitions and Dispositions",
     "shortName": "Acquisitions and Dispositions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssets",
     "longName": "00000012 - Disclosure - Prepayments and Other Current Assets",
     "shortName": "Prepayments and Other Current Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:PrepaymentsAndOtherCurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:PrepaymentsAndOtherCurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://thearenagroup.net/role/PropertyAndEquipment",
     "longName": "00000013 - Disclosure - Property and Equipment",
     "shortName": "Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://thearenagroup.net/role/Leases",
     "longName": "00000014 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://thearenagroup.net/role/PlatformDevelopment",
     "longName": "00000015 - Disclosure - Platform Development",
     "shortName": "Platform Development",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:PlatformDevelopmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:PlatformDevelopmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://thearenagroup.net/role/IntangibleAssets",
     "longName": "00000016 - Disclosure - Intangible Assets",
     "shortName": "Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://thearenagroup.net/role/OtherLong-termAssets",
     "longName": "00000017 - Disclosure - Other Long-Term Assets",
     "shortName": "Other Long-Term Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://thearenagroup.net/role/Goodwill",
     "longName": "00000018 - Disclosure - Goodwill",
     "shortName": "Goodwill",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://thearenagroup.net/role/RestrictedStockLiabilities",
     "longName": "00000019 - Disclosure - Restricted Stock Liabilities",
     "shortName": "Restricted Stock Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:RestrictedStockLiabilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:RestrictedStockLiabilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://thearenagroup.net/role/AccruedExpensesAndOther",
     "longName": "00000020 - Disclosure - Accrued Expenses and Other",
     "shortName": "Accrued Expenses and Other",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://thearenagroup.net/role/LineOfCredit",
     "longName": "00000021 - Disclosure - Line of Credit",
     "shortName": "Line of Credit",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://thearenagroup.net/role/LiquidatedDamagesPayable",
     "longName": "00000022 - Disclosure - Liquidated Damages Payable",
     "shortName": "Liquidated Damages Payable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:LiquidatedDamagesPayableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:LiquidatedDamagesPayableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://thearenagroup.net/role/OtherLong-termLiabilities",
     "longName": "00000023 - Disclosure - Other Long-term Liabilities",
     "shortName": "Other Long-term Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:OtherLongtermLiabilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:OtherLongtermLiabilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://thearenagroup.net/role/FairValueMeasurement",
     "longName": "00000024 - Disclosure - Fair Value Measurement",
     "shortName": "Fair Value Measurement",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://thearenagroup.net/role/BridgeNotes",
     "longName": "00000025 - Disclosure - Bridge Notes",
     "shortName": "Bridge Notes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://thearenagroup.net/role/Long-termDebt",
     "longName": "00000026 - Disclosure - Long-term Debt",
     "shortName": "Long-term Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://thearenagroup.net/role/PreferredStock",
     "longName": "00000027 - Disclosure - Preferred Stock",
     "shortName": "Preferred Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:PreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:PreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://thearenagroup.net/role/StockholdersDeficiency",
     "longName": "00000028 - Disclosure - Stockholders\u2019 Deficiency",
     "shortName": "Stockholders\u2019 Deficiency",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://thearenagroup.net/role/StockbasedCompensation",
     "longName": "00000029 - Disclosure - Stock\u2013Based Compensation",
     "shortName": "Stock\u2013Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://thearenagroup.net/role/LiquidatedDamages",
     "longName": "00000030 - Disclosure - Liquidated Damages",
     "shortName": "Liquidated Damages",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:LiquidatingDamagesPayableDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:LiquidatingDamagesPayableDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://thearenagroup.net/role/IncomeTaxes",
     "longName": "00000031 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://thearenagroup.net/role/PensionPlans",
     "longName": "00000032 - Disclosure - Pension Plans",
     "shortName": "Pension Plans",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://thearenagroup.net/role/RelatedPartyTransactions",
     "longName": "00000033 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://thearenagroup.net/role/CommitmentsAndContingencies",
     "longName": "00000034 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://thearenagroup.net/role/SubsequentEvents",
     "longName": "00000035 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "00000036 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "00000037 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://thearenagroup.net/role/DiscontinuedOperationsTables",
     "longName": "00000038 - Disclosure - Discontinued Operations (Tables)",
     "shortName": "Discontinued Operations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "AREN:DiscontinuedOperationsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "AREN:DiscontinuedOperationsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://thearenagroup.net/role/AcquisitionsAndDispositionsTables",
     "longName": "00000039 - Disclosure - Acquisitions and Dispositions (Tables)",
     "shortName": "Acquisitions and Dispositions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsTables",
     "longName": "00000040 - Disclosure - Prepayments and Other Current Assets (Tables)",
     "shortName": "Prepayments and Other Current Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "AREN:PrepaymentsAndOtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "AREN:PrepaymentsAndOtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://thearenagroup.net/role/PropertyAndEquipmentTables",
     "longName": "00000041 - Disclosure - Property and Equipment (Tables)",
     "shortName": "Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://thearenagroup.net/role/LeasesTables",
     "longName": "00000042 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:SupplementalInformationRelatedToOperatingLeasesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:SupplementalInformationRelatedToOperatingLeasesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://thearenagroup.net/role/PlatformDevelopmentTables",
     "longName": "00000043 - Disclosure - Platform Development (Tables)",
     "shortName": "Platform Development (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:SummaryOfPlatformDevelopmentCostsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "AREN:PlatformDevelopmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:SummaryOfPlatformDevelopmentCostsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "AREN:PlatformDevelopmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://thearenagroup.net/role/IntangibleAssetsTables",
     "longName": "00000044 - Disclosure - Intangible Assets (Tables)",
     "shortName": "Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://thearenagroup.net/role/OtherLong-termAssetsTables",
     "longName": "00000045 - Disclosure - Other Long-Term Assets (Tables)",
     "shortName": "Other Long-Term Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://thearenagroup.net/role/GoodwillTables",
     "longName": "00000046 - Disclosure - Goodwill (Tables)",
     "shortName": "Goodwill (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://thearenagroup.net/role/AccruedExpensesAndOtherTables",
     "longName": "00000047 - Disclosure - Accrued Expenses and Other (Tables)",
     "shortName": "Accrued Expenses and Other (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://thearenagroup.net/role/LiquidatedDamagesPayableTables",
     "longName": "00000048 - Disclosure - Liquidated Damages Payable (Tables)",
     "shortName": "Liquidated Damages Payable (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:SummaryOfLiquidatedDamagesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "AREN:LiquidatedDamagesPayableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:SummaryOfLiquidatedDamagesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "AREN:LiquidatedDamagesPayableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://thearenagroup.net/role/OtherLong-termLiabilitiesTables",
     "longName": "00000049 - Disclosure - Other Long-term Liabilities (Tables)",
     "shortName": "Other Long-term Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:OtherLongtermLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "AREN:OtherLongtermLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:OtherLongtermLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "AREN:OtherLongtermLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://thearenagroup.net/role/FairValueMeasurementTables",
     "longName": "00000050 - Disclosure - Fair Value Measurement (Tables)",
     "shortName": "Fair Value Measurement (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://thearenagroup.net/role/Long-termDebtTables",
     "longName": "00000051 - Disclosure - Long-term Debt (Tables)",
     "shortName": "Long-term Debt (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "51",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://thearenagroup.net/role/StockholdersDeficiencyTables",
     "longName": "00000052 - Disclosure - Stockholders\u2019 Deficiency (Tables)",
     "shortName": "Stockholders\u2019 Deficiency (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "52",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://thearenagroup.net/role/StockbasedCompensationTables",
     "longName": "00000053 - Disclosure - Stock\u2013Based Compensation (Tables)",
     "shortName": "Stock\u2013Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "53",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:ScheduleOfUnrecognizedCompensationExpense",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:ScheduleOfUnrecognizedCompensationExpense",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://thearenagroup.net/role/IncomeTaxesTables",
     "longName": "00000054 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "54",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://thearenagroup.net/role/OrganizationAndBasisOfPresentationDetailsNarrative",
     "longName": "00000055 - Disclosure - Organization and Basis of Presentation (Details Narrative)",
     "shortName": "Organization and Basis of Presentation (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "From2022-02-082022-02-08",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-02-082022-02-08",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails",
     "longName": "00000056 - Disclosure - Schedule of Disaggregation of Revenue (Details)",
     "shortName": "Schedule of Disaggregation of Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R57": {
     "role": "http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails",
     "longName": "00000057 - Disclosure - Schedule of Contract with Customer, Asset and Liability (Details)",
     "shortName": "Schedule of Contract with Customer, Asset and Liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_DigitalRevenueMember",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "AREN:ContractBalancesPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://thearenagroup.net/role/ScheduleOfCashAndRestrictedCashDetails",
     "longName": "00000058 - Disclosure - Schedule of Cash and Restricted Cash (Details)",
     "shortName": "Schedule of Cash and Restricted Cash (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R59": {
     "role": "http://thearenagroup.net/role/ScheduleOfAllowanceForDoubtfulAccountsDetails",
     "longName": "00000059 - Disclosure - Schedule of Allowance For Doubtful Accounts (Details)",
     "shortName": "Schedule of Allowance For Doubtful Accounts (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-12-31",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails",
     "longName": "00000060 - Disclosure - Schedule of Depreciation and Amortization, Useful Lives of Assets (Details)",
     "shortName": "Schedule of Depreciation and Amortization, Useful Lives of Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31_custom_OfficeEquipmentAndComputersMember_srt_MinimumMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "AREN:ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_OfficeEquipmentAndComputersMember_srt_MinimumMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "AREN:ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails",
     "longName": "00000061 - Disclosure - Schedule of Net Income (Loss) Per Common Share (Details)",
     "shortName": "Schedule of Net Income (Loss) Per Common Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "00000062 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)",
     "shortName": "Summary of Significant Accounting Policies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "AREN:ContractBalancesPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails",
     "longName": "00000063 - Disclosure - Schedule of Discontinued Operations (Details)",
     "shortName": "Schedule of Discontinued Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_ParadePrintMember",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "AREN:DiscontinuedOperationsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://thearenagroup.net/role/DiscontinuedOperationsDetailsNarrative",
     "longName": "00000064 - Disclosure - Discontinued Operations (Details Narrative)",
     "shortName": "Discontinued Operations (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:DepreciationAndAmortizationDiscontinuedOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "AREN:DiscontinuedOperationsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:DepreciationAndAmortizationDiscontinuedOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "AREN:DiscontinuedOperationsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails",
     "longName": "00000065 - Disclosure - Schedule of Composition Preliminary Assets Purchase Price (Details)",
     "shortName": "Schedule of Composition Preliminary Assets Purchase Price (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember",
      "name": "us-gaap:PaymentsToAcquireProductiveAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember",
      "name": "us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:AssetAcquisitionTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails",
     "longName": "00000066 - Disclosure - Summary of Preliminary Assets Purchase Price Allocation (Details)",
     "shortName": "Summary of Preliminary Assets Purchase Price Allocation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember",
      "name": "AREN:AssetAcquisitionAssetsAcquired",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:ScheduleOfAssetsAcquiredTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember",
      "name": "AREN:AssetAcquisitionAssetsAcquired",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:ScheduleOfAssetsAcquiredTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails",
     "longName": "00000067 - Disclosure - Schedule of Composition of Purchase Price (Details)",
     "shortName": "Schedule of Composition of Purchase Price (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "From2022-04-012022-04-01_custom_AthlonHoldingsIncMember",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-04-012022-04-01_custom_AthlonHoldingsIncMember",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails",
     "longName": "00000068 - Disclosure - Summary of Purchase Price Allocation (Details)",
     "shortName": "Summary of Purchase Price Allocation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:Goodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-04-01",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails",
     "longName": "00000069 - Disclosure - Schedule of Supplemental Proforma Information (Details)",
     "shortName": "Schedule of Supplemental Proforma Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails",
     "longName": "00000070 - Disclosure - Schedule of Preliminary Price Allocation (Details)",
     "shortName": "Schedule of Preliminary Price Allocation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "AsOf2022-11-30",
      "name": "AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_AthlonHoldingsIncMember",
      "name": "AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:PreliminaryPriceAllocationTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
     "longName": "00000071 - Disclosure - Acquisitions and Dispositions (Details Narrative)",
     "shortName": "Acquisitions and Dispositions (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-12-152022-12-15",
      "name": "us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails",
     "longName": "00000072 - Disclosure - Schedule of Prepayments and Other Current Assets (Details)",
     "shortName": "Schedule of Prepayments and Other Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock",
       "AREN:PrepaymentsAndOtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock",
       "AREN:PrepaymentsAndOtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsDetailsNarrative",
     "longName": "00000073 - Disclosure - Prepayments and Other Current Assets (Details Narrative)",
     "shortName": "Prepayments and Other Current Assets (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:OtherLaborRelatedExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "AREN:PrepaymentsAndOtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:OtherLaborRelatedExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "AREN:PrepaymentsAndOtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails",
     "longName": "00000074 - Disclosure - Schedule of Property and Equipment (Details)",
     "shortName": "Schedule of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://thearenagroup.net/role/PropertyAndEquipmentDetailsNarrative",
     "longName": "00000075 - Disclosure - Property and Equipment (Details Narrative)",
     "shortName": "Property and Equipment (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_us-gaap_PropertyPlantAndEquipmentMember",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://thearenagroup.net/role/ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails",
     "longName": "00000076 - Disclosure - Schedule of Supplemental Information Related to Operating Leases (Details)",
     "shortName": "Schedule of Supplemental Information Related to Operating Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:LeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:SupplementalInformationRelatedToOperatingLeasesTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:SupplementalInformationRelatedToOperatingLeasesTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails",
     "longName": "00000077 - Disclosure - Schedule of Operating Lease Costs (Details)",
     "shortName": "Schedule of Operating Lease Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetailsParenthetical",
     "longName": "00000078 - Disclosure - Schedule of Operating Lease Costs (Details) (Parenthetical)",
     "shortName": "Schedule of Operating Lease Costs (Details) (Parenthetical)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_BusinessMembershipAgreementMember",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://thearenagroup.net/role/SummaryOfMaturityOfLeaseLiabilitiesDetails",
     "longName": "00000079 - Disclosure - Summary of Maturity of Lease Liabilities (Details)",
     "shortName": "Summary of Maturity of Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R80": {
     "role": "http://thearenagroup.net/role/LeasesDetailsNarrative",
     "longName": "00000080 - Disclosure - Leases (Details Narrative)",
     "shortName": "Leases (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails",
     "longName": "00000081 - Disclosure - Summary of Platform Development Costs (Details)",
     "shortName": "Summary of Platform Development Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_PlatformDevelopmentMember",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:SummaryOfPlatformDevelopmentCostsTableTextBlock",
       "AREN:PlatformDevelopmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R82": {
     "role": "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails",
     "longName": "00000082 - Disclosure - Summary of Platform Development Cost Activity (Details)",
     "shortName": "Summary of Platform Development Cost Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:CapitalizedContractCostAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "AREN:SubscriptionAcquisitionCostsPoliceTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-12-31_custom_PlatformDevelopmentMember",
      "name": "us-gaap:PropertyPlantAndEquipmentOther",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:SummaryOfPlatformDevelopmentCostActivityTableTextBlock",
       "AREN:PlatformDevelopmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R83": {
     "role": "http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative",
     "longName": "00000083 - Disclosure - Platform Development (Details Narrative)",
     "shortName": "Platform Development (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_PlatformDevelopmentMember",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "AREN:PlatformDevelopmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R84": {
     "role": "http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails",
     "longName": "00000084 - Disclosure - Schedule of Intangible Assets Subject to Amortization (Details)",
     "shortName": "Schedule of Intangible Assets Subject to Amortization (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "AsOf2022-09-27",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_DevelopedTechnologyMember",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails",
     "longName": "00000085 - Disclosure - Schedule of Future Estimated Amortization expense For Intangible Assets (Details)",
     "shortName": "Schedule of Future Estimated Amortization expense For Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative",
     "longName": "00000086 - Disclosure - Intangible Assets (Details Narrative)",
     "shortName": "Intangible Assets (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:AmortizationOfAcquisitionCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:AmortizationOfAcquisitionCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://thearenagroup.net/role/SummaryOfOtherAssetsDetails",
     "longName": "00000087 - Disclosure - Summary of Other Assets (Details)",
     "shortName": "Summary of Other Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:SecurityDeposit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:SecurityDeposit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R88": {
     "role": "http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails",
     "longName": "00000088 - Disclosure - Schedule of Changes in Carrying Value of Goodwill (Details)",
     "shortName": "Schedule of Changes in Carrying Value of Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:Goodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31_custom_ParadeMember",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R89": {
     "role": "http://thearenagroup.net/role/GoodwillDetailsNarrative",
     "longName": "00000089 - Disclosure - Goodwill (Details Narrative)",
     "shortName": "Goodwill (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R90": {
     "role": "http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative",
     "longName": "00000090 - Disclosure - Restricted Stock Liabilities (Details Narrative)",
     "shortName": "Restricted Stock Liabilities (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_us-gaap_RestrictedStockMember",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "AREN:RestrictedStockLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31_us-gaap_RestrictedStockMember",
      "name": "us-gaap:PaymentsForRepurchaseOfEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "AREN:RestrictedStockLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R91": {
     "role": "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails",
     "longName": "00000091 - Disclosure - Schedule of Accrued Expenses (Details)",
     "shortName": "Schedule of Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "AREN:GeneralAccruedExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "AREN:GeneralAccruedExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R92": {
     "role": "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
     "longName": "00000092 - Disclosure - Line of Credit (Details Narrative)",
     "shortName": "Line of Credit (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember",
      "name": "us-gaap:DebtDefaultLongtermDebtAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R93": {
     "role": "http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails",
     "longName": "00000093 - Disclosure - Summary of Liquidated Damages (Details)",
     "shortName": "Summary of Liquidated Damages (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "AREN:RegistrationRightsDamages",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:SummaryOfLiquidatedDamagesTableTextBlock",
       "AREN:LiquidatedDamagesPayableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "AREN:RegistrationRightsDamages",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:SummaryOfLiquidatedDamagesTableTextBlock",
       "AREN:LiquidatedDamagesPayableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R94": {
     "role": "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative",
     "longName": "00000094 - Disclosure - Liquidated Damages Payable (Details Narrative)",
     "shortName": "Liquidated Damages Payable (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:LiquidatedDamagesPayableAccruedInterestPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "AREN:LiquidatedDamagesPayableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R95": {
     "role": "http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails",
     "longName": "00000095 - Disclosure - Schedule of Other long- term liabilities (Details)",
     "shortName": "Schedule of Other long- term liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "AREN:LeaseTerminationLiabilityNonCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:OtherLongtermLiabilitiesTableTextBlock",
       "AREN:OtherLongtermLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "AREN:LeaseTerminationLiabilityNonCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:OtherLongtermLiabilitiesTableTextBlock",
       "AREN:OtherLongtermLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R96": {
     "role": "http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails",
     "longName": "00000096 - Disclosure - Schedule of Fair Value of Financial Instruments (Details)",
     "shortName": "Schedule of Fair Value of Financial Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31_custom_ContingentConsiderationMember",
      "name": "us-gaap:LongTermDebtFairValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_ContingentConsiderationMember",
      "name": "us-gaap:LongTermDebtFairValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R97": {
     "role": "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative",
     "longName": "00000097 - Disclosure - Fair Value Measurement (Details Narrative)",
     "shortName": "Fair Value Measurement (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:FinancialInstrumentsOwnedAtFairValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R98": {
     "role": "http://thearenagroup.net/role/BridgeNotesDetailsNarrative",
     "longName": "00000098 - Disclosure - Bridge Notes (Details Narrative)",
     "shortName": "Bridge Notes (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-08-31_custom_TwoThousandTwentyThreeNotesMember",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R99": {
     "role": "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails",
     "longName": "00000099 - Disclosure - Schedule of long term debt (Details)",
     "shortName": "Schedule of long term debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R100": {
     "role": "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical",
     "longName": "00000100 - Disclosure - Schedule of Long Term Debt (Details) (Parenthetical)",
     "shortName": "Schedule of Long Term Debt (Details) (Parenthetical)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31_custom_DelayedDrawTermNoteMember66267140",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_DelayedDrawTermNoteMember66267140",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R101": {
     "role": "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails",
     "longName": "00000101 - Disclosure - Summary of Interest Expense (Details)",
     "shortName": "Summary of Interest Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:AmortizationOfDebtDiscountPremium",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:SummaryOfInterestExpenseTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:AmortizationOfDebtDiscountPremium",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:SummaryOfInterestExpenseTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R102": {
     "role": "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
     "longName": "00000102 - Disclosure - Long-term Debt (Details Narrative)",
     "shortName": "Long-term Debt (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:InterestPayableCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_DelayedDrawTermNotesMember_custom_PurchaseAgreementMember",
      "name": "us-gaap:DebtInstrumentMaturityDate",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R103": {
     "role": "http://thearenagroup.net/role/PreferredStockDetailsNarrative",
     "longName": "00000103 - Disclosure - Preferred Stock (Details Narrative)",
     "shortName": "Preferred Stock (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R104": {
     "role": "http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails",
     "longName": "00000104 - Disclosure - Summary of Restricted Stock Award Activity (Details)",
     "shortName": "Summary of Restricted Stock Award Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_us-gaap_RestrictedStockMember",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R105": {
     "role": "http://thearenagroup.net/role/SummaryOfWarrantActivityDetails",
     "longName": "00000105 - Disclosure - Summary of Warrant Activity (Details)",
     "shortName": "Summary of Warrant Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31_custom_CommonStockFinancingWarrantMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_custom_CommonStockFinancingWarrantMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R106": {
     "role": "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
     "longName": "00000106 - Disclosure - Stockholders\u2019 Deficiency (Details Narrative)",
     "shortName": "Stockholders\u2019 Deficiency (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2020-12-18",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R107": {
     "role": "http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails",
     "longName": "00000107 - Disclosure - Schedule of Restricted Stock Units Activity (Details)",
     "shortName": "Schedule of Restricted Stock Units Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:ScheduleOfRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:ScheduleOfRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R108": {
     "role": "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails",
     "longName": "00000108 - Disclosure - Schedule of Fair Value of Stock Options Assumptions (Details)",
     "shortName": "Schedule of Fair Value of Stock Options Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R109": {
     "role": "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails",
     "longName": "00000109 - Disclosure - Summary of Stock Option Activity (Details)",
     "shortName": "Summary of Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "From2023-06-292023-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R110": {
     "role": "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical",
     "longName": "00000110 - Disclosure - Summary of Stock Option Activity (Details) (Parenthetical)",
     "shortName": "Summary of Stock Option Activity (Details) (Parenthetical)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "110",
     "firstAnchor": {
      "contextRef": "From2023-06-292023-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R111": {
     "role": "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails",
     "longName": "00000111 - Disclosure - Schedule of Exercise Prices of Common Stock Options (Details)",
     "shortName": "Schedule of Exercise Prices of Common Stock Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "111",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R112": {
     "role": "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails",
     "longName": "00000112 - Disclosure - Schedule of Warrants Activity (Details)",
     "shortName": "Schedule of Warrants Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "112",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31_custom_ABGWarrantsMember",
      "name": "AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:ScheduleOfWarrantsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_ABGWarrantsMember66276312",
      "name": "AREN:WeightedAverageRemainingContractualLifeOutstanding",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "AREN:ScheduleOfWarrantsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R113": {
     "role": "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails",
     "longName": "00000113 - Disclosure - Summary of Stock-based Compensation (Details)",
     "shortName": "Summary of Stock-based Compensation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "113",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:CostOfRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_StockBasedCompensationMember",
      "name": "us-gaap:CostOfRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R114": {
     "role": "http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails",
     "longName": "00000114 - Disclosure - Schedule of Unrecognized Compensation Expense (Details)",
     "shortName": "Schedule of Unrecognized Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "114",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31_custom_StockBasedCompensationMember",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:ScheduleOfUnrecognizedCompensationExpense",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_StockBasedCompensationMember",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "AREN:ScheduleOfUnrecognizedCompensationExpense",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R115": {
     "role": "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
     "longName": "00000115 - Disclosure - Stock\u2013Based Compensation (Details Narrative)",
     "shortName": "Stock\u2013Based Compensation (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "115",
     "firstAnchor": {
      "contextRef": "From2023-06-292023-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-11-012023-11-02",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R116": {
     "role": "http://thearenagroup.net/role/LiquidatedDamagesDetailsNarrative",
     "longName": "00000116 - Disclosure - Liquidated Damages (Details Narrative)",
     "shortName": "Liquidated Damages (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "116",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "AREN:LiquidatedDamagesPayable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "AREN:LiquidatingDamagesPayableDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "AREN:LiquidatedDamagesPayable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "AREN:LiquidatingDamagesPayableDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R117": {
     "role": "http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails",
     "longName": "00000117 - Disclosure - Schedule of Income Taxes (Details)",
     "shortName": "Schedule of Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "117",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R118": {
     "role": "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails",
     "longName": "00000118 - Disclosure - Schedule of Components of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Schedule of Components of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "118",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R119": {
     "role": "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails",
     "longName": "00000119 - Disclosure - Schedule of Tax Benefit and Effective Income Tax (Details)",
     "shortName": "Schedule of Tax Benefit and Effective Income Tax (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "119",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R120": {
     "role": "http://thearenagroup.net/role/IncomeTaxesDetailsNarrative",
     "longName": "00000120 - Disclosure - Income Taxes (Details Narrative)",
     "shortName": "Income Taxes (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "120",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:NetOperatingLossExpirationAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "AREN:NetOperatingLossExpirationAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R121": {
     "role": "http://thearenagroup.net/role/PensionPlansDetailsNarrative",
     "longName": "00000121 - Disclosure - Pension Plans (Details Narrative)",
     "shortName": "Pension Plans (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "121",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R122": {
     "role": "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
     "longName": "00000122 - Disclosure - Related Party Transactions (Details Narrative)",
     "shortName": "Related Party Transactions (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "122",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:DebtInstrumentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "us-gaap:DebtInstrumentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R123": {
     "role": "http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "00000123 - Disclosure - Commitments and Contingencies (Details Narrative)",
     "shortName": "Commitments and Contingencies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "123",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_ABGSILLCMember_srt_MinimumMember",
      "name": "us-gaap:RoyaltyExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_ABGSILLCMember_srt_MinimumMember",
      "name": "us-gaap:RoyaltyExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R124": {
     "role": "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative",
     "longName": "00000124 - Disclosure - Subsequent Events (Details Narrative)",
     "shortName": "Subsequent Events (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "124",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-02-092024-02-09_us-gaap_SubsequentEventMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "AREN_A360MediaLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "A360MediaLLCMember",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "A360 Media LLC [Member]",
        "documentation": "A360 Media LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ABGPerformanceBasedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ABGPerformanceBasedWarrantsMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ABG Performance Based Warrants [Member]",
        "documentation": "ABG Performance Based Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ABGSILLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ABGSILLCMember",
     "presentation": [
      "http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ABG-SI, LLC [Member]",
        "documentation": "ABG-SI, LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ABGTimeBasedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ABGTimeBasedWarrantsMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ABG Time Based Warrants [Member]",
        "documentation": "ABG Time Based Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ABGWarransMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ABGWarransMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ABG Warrans [Member]",
        "documentation": "ABG Warrans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ABGWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ABGWarrantsMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails",
      "http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails",
      "http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails",
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockbasedCompensationTables",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ABG Warrants [Member]",
        "documentation": "ABG Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/AccruedExpensesAndOther"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Expenses and Other",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "verboseLabel": "Accounts payable current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r914"
     ]
    },
    "us-gaap_AccountsPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableMember",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable [Member]",
        "documentation": "Obligations incurred and payable to vendors for goods and services received."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Allowance For Doubtful Accounts",
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable, net",
        "verboseLabel": "Accounts receivable",
        "terseLabel": "Accounts receivable net current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r355"
     ]
    },
    "AREN_AccountsReceivablePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "AccountsReceivablePercentage",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable percentage",
        "documentation": "Accounts receivable percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedAdvertisingCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedAdvertisingCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued publisher expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for advertising of the entity's goods and services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses and other",
        "totalLabel": "Total accrued expenses and other",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_AccruedPayrollTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedPayrollTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued payroll and related taxes",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less accumulated depreciation and amortization",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r266",
      "r729"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r282",
      "r283",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r282",
      "r283",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average useful lives",
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r578",
      "r579",
      "r580",
      "r762",
      "r988",
      "r989",
      "r990",
      "r1072",
      "r1103"
     ]
    },
    "AREN_AdjustmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "AdjustmentsMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments [Member]",
        "documentation": "Adjustments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative",
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain upon forgiveness of liquidated damages with principal stockholder",
        "verboseLabel": "Gain on forgiveness of debt",
        "documentation": "Adjustments to additional paid in capital gain upon issuance of common stock in connection with forgiveness of liquidated damages."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain upon issuance of common stock in connection with settlement of liquidated damages",
        "verboseLabel": "Liquidated damages",
        "documentation": "Adjustments to additional paid in capital gain upon issuance of common stock in connection with settlement of liquidated damages."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassification to liability upon modification of common stock option",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r544"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_AdvertiserRelationshipMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "AdvertiserRelationshipMember",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertiser Relationship [Member]",
        "documentation": "Advertiser Relationship [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_AdvertiserRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "AdvertiserRelationshipsMember",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails",
      "http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertiser Relationships [Member]",
        "documentation": "Advertiser Relationships [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising expense",
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
       }
      }
     },
     "auth_ref": [
      "r582"
     ]
    },
    "AREN_AggregatePrincipalMinimumAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "AggregatePrincipalMinimumAmount",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Incremental borrowings",
        "documentation": "Aggregate principal minimum amount.",
        "label": "AggregatePrincipalMinimumAmount"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_AllHipHopWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "AllHipHopWarrantsMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Hip Hop Warrants [Member]",
        "documentation": "All Hip Hop Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfAllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Allowance for doubtful accounts beginning of year",
        "periodEndLabel": "Allowance for doubtful accounts end of year",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r358",
      "r396",
      "r399",
      "r403",
      "r1096"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfAllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions",
        "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfAllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deductions - write-offs",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "AREN_AllredTrustHHAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "AllredTrustHHAMember",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allred Trust HHA [Member]",
        "documentation": "Allred Trust HHA [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_AllredTrustNLAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "AllredTrustNLAMember",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allred Trust NLA [Member]",
        "documentation": "Allred Trust NLA [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfAcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfAcquisitionCosts",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization expense of intangible asset acquisition",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r71"
     ]
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfDebtDiscountPremium",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total amortization of debt costs",
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r130",
      "r184",
      "r479"
     ]
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of debt costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r479",
      "r640",
      "r980"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative",
      "http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative",
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of platform development and intangible assets",
        "verboseLabel": "Amortization expense of intangible asset",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r71",
      "r75"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive securities excluded from computation of earnings per share amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "AREN_ArenaLoanAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ArenaLoanAgreementMember",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arena Loan Agreement [Member]",
        "documentation": "Arena Loan Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ArenaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ArenaMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arena [Member]",
        "documentation": "Arena [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative",
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetailsParenthetical",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "AREN_AssetAcquisitionAssetsAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "AssetAcquisitionAssetsAcquired",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net assets acquired",
        "documentation": "Asset acquisition assets acquired."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionAxis",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsTables",
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails",
      "http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition [Axis]",
        "documentation": "Information by asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionConsiderationTransferred",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total purchase consideration",
        "verboseLabel": "Purchase price",
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer."
       }
      }
     },
     "auth_ref": [
      "r912",
      "r1068",
      "r1069",
      "r1070"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionConsiderationTransferredContingentConsideration",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Contingent consideration",
        "label": "Asset Acquisition, Consideration Transferred, Contingent Consideration",
        "documentation": "Amount of contingent consideration recognized as part of consideration transferred in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1068",
      "r1069",
      "r1070"
     ]
    },
    "AREN_AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred cash payments, as discounted",
        "documentation": "Asset acquisition consideration transferred deferred cash payments as discounted."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock",
        "documentation": "Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1068",
      "r1069",
      "r1070"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionConsiderationTransferredTransactionCost",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction cost",
        "documentation": "Amount of transaction cost incurred as part of consideration transferred in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r912",
      "r1068",
      "r1069",
      "r1070"
     ]
    },
    "us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionContingentConsiderationLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent consideration",
        "documentation": "Amount of liability recognized from contingent consideration in asset acquisition, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_AssetAcquisitionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionDomain",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsTables",
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails",
      "http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_AssetAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionLineItems",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsTables",
      "http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails",
      "http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_AssetAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionTable",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsTables",
      "http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails",
      "http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition [Table]",
        "documentation": "Disclosure of information about asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_AssetAcquisitionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Composition Preliminary Assets Purchase Price",
        "documentation": "Tabular disclosure of asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on impairment of assets",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r76"
     ]
    },
    "AREN_AssetPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "AssetPurchaseAgreementMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Purchase Agreement [Member]",
        "documentation": "Asset Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets [Default Label]",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r270",
      "r300",
      "r331",
      "r344",
      "r348",
      "r393",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r614",
      "r616",
      "r631",
      "r722",
      "r800",
      "r914",
      "r927",
      "r1023",
      "r1024",
      "r1082"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r278",
      "r300",
      "r393",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r614",
      "r616",
      "r631",
      "r914",
      "r1023",
      "r1024",
      "r1082"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_AthlonHoldingsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "AthlonHoldingsIncMember",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsTables",
      "http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails",
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails",
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Athlon Holdings Inc [Member]",
        "documentation": "Athlon Holdings Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r939",
      "r941",
      "r942"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r939",
      "r941",
      "r942"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r939",
      "r941",
      "r942"
     ]
    },
    "us-gaap_AwardDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardDateAxis",
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Date [Axis]",
        "documentation": "Information by date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058"
     ]
    },
    "us-gaap_AwardDateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardDateDomain",
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockbasedCompensationTables",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails",
      "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572"
     ]
    },
    "AREN_BRileyFBRIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BRileyFBRIncMember",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "B Riley FBR Inc [Member]",
        "documentation": "B Riley FBR Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_BRileyFinancialIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BRileyFinancialIncMember",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BRiley Financial Inc [Member]",
        "documentation": "BRiley Financial Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_BRileyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BRileyMember",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "B Riley [Member]",
        "documentation": "B Riley [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_BlackScholesOptionPricingModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BlackScholesOptionPricingModelMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails",
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Black-Scholes Option Pricing Model [Member]",
        "documentation": "Black-Scholes Option Pricing Model [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_BrandNameMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BrandNameMember",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Brand Name [Member]",
        "documentation": "Brand Name [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_BrandNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BrandNamesMember",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails",
      "http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Brand Names [Member]",
        "documentation": "Brand Names [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_BridgeNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BridgeNotes",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bridge notes",
        "documentation": "Bridge notes."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_BridgeNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BridgeNotesMember",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bridge Notes [Member]",
        "documentation": "Bridge Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_BuffaloGroupeLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BuffaloGroupeLLCMember",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Buffalo Groupe LLC [Member]",
        "documentation": "Buffalo Groupe LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsTables",
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails",
      "http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails",
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails",
      "http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r610",
      "r903",
      "r906"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsTables",
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails",
      "http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails",
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails",
      "http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r109",
      "r610",
      "r903",
      "r906"
     ]
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Transaction cost",
        "label": "Business Acquisition, Transaction Costs",
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionDescriptionOfAcquiredEntity",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition description",
        "documentation": "With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock value assigned",
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares issued in acquisition",
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails",
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails",
      "http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails",
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired percentage",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Supplemental Proforma Information",
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate."
       }
      }
     },
     "auth_ref": [
      "r957",
      "r958"
     ]
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill for tax",
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionSharePrice",
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preceding acquistion price per share",
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total continuing operations supplemental pro forma net loss",
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period."
       }
      }
     },
     "auth_ref": [
      "r608",
      "r609"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total continuing operations supplemental pro forma revenue",
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period."
       }
      }
     },
     "auth_ref": [
      "r608",
      "r609"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total purchase consideration",
        "label": "Business combination consideration transferred1",
        "terseLabel": "Total installment amount",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3",
      "r13"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock",
        "label": "Fair value of shares issued in acquisition",
        "terseLabel": "Fair value of acquisition",
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3"
     ]
    },
    "AREN_BusinessCombinationConsiderationTransferredInstallmentDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BusinessCombinationConsiderationTransferredInstallmentDue",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total installment amount",
        "documentation": "Business combination consideration transferred installment due."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferredOther1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferredOther1",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred cash payments, as discounted",
        "label": "Business combination, consideration amount",
        "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationArrangementsDescription",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Acquisition description",
        "label": "Business Combination, Contingent Consideration Arrangements, Description",
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents a description of such arrangements."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisitions and Dispositions",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r611"
     ]
    },
    "us-gaap_BusinessCombinationPriceOfAcquisitionExpected": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationPriceOfAcquisitionExpected",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate purchase price",
        "documentation": "Purchase price of expected business acquisition prior to consideration being transferred. Excludes asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r952"
     ]
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment description",
        "documentation": "This element represents a description of the nature of any measurement period adjustments (as defined) realized during the reporting period to the assets, liabilities, equity interests, or items of consideration for which the initial accounting was incomplete in connection with a business combination."
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertiser relationships",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed advertisement."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Advertiser relationships",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed advertisement relationship.",
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Assumed lease obligation",
        "label": "Assumed lease obligation",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed assumed lease obligation."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Brand names",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed brand name."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current assets",
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable",
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts payable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued expenses and other",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued expenses.",
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unearned revenue",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other long-term liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt",
        "documentation": "Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred tax liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Digital content",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed digital content."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity investment",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed equity investement."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed goodwill.",
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease deposit receivable",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed lease deposit receivable."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net assets acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r111"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed assets",
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r111"
     ]
    },
    "AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Subscription refund liability",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed subscription refund liability.",
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade names",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed trade name."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unearned revenue",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed unearned revenue.",
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net assets acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "AREN_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock",
        "documentation": "Business combination step acquisition equity interest in acquiree fair value shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationsPolicy",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations",
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "AREN_BusinessMembershipAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "BusinessMembershipAgreementMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Membership Agreement [Member]",
        "documentation": "Business Membership Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalizedContractCostAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalizedContractCostAmortization",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization subscription costs",
        "verboseLabel": "Total capitalized payroll-based costs",
        "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer."
       }
      }
     },
     "auth_ref": [
      "r414"
     ]
    },
    "us-gaap_CapitalizedContractCostNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalizedContractCostNet",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscription acquisition cost",
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "us-gaap_CapitalizedContractCostNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalizedContractCostNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscription acquisition costs, current portion",
        "verboseLabel": "Subscription acquisition cost current",
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "us-gaap_CapitalizedContractCostNetNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalizedContractCostNetNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscription acquisition costs, net of current portion",
        "verboseLabel": "Acquisition cost long term",
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAcquiredFromAcquisition",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash acquired for acquisition",
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative",
      "http://thearenagroup.net/role/OrganizationAndBasisOfPresentationDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfCashAndRestrictedCashDetails",
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodEndLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r264",
      "r876"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, and Restricted Cash",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r229"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfCashAndRestrictedCashDetails",
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Total cash, cash equivalents, and restricted cash",
        "totalLabel": "Total cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r187",
      "r295"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, cash equivalents, and restricted cash"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents, and restricted cash \u2013 beginning of year",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash \u2013 end of year",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r187",
      "r295"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (decrease) increase in cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r187"
     ]
    },
    "AREN_CashPaidInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "CashPaidInterestAbstract",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid interest:",
        "documentation": "Cash Paid Interest Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/BalanceSheetsParenthetical",
      "http://thearenagroup.net/role/LiquidatedDamagesDetailsNarrative",
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r272",
      "r273",
      "r274",
      "r300",
      "r320",
      "r321",
      "r323",
      "r325",
      "r329",
      "r330",
      "r393",
      "r448",
      "r450",
      "r451",
      "r452",
      "r455",
      "r456",
      "r489",
      "r490",
      "r494",
      "r497",
      "r505",
      "r631",
      "r753",
      "r754",
      "r755",
      "r756",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r787",
      "r809",
      "r832",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r949",
      "r983",
      "r992"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r329",
      "r489",
      "r490",
      "r492",
      "r494",
      "r497",
      "r503",
      "r505",
      "r753",
      "r754",
      "r755",
      "r756",
      "r894",
      "r949",
      "r983"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercise price",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r506"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of warrant shares",
        "verboseLabel": "Warrant to purchase common stock",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r506"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightReasonForIssuingToNonemployees",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant or right, reason for issuance, description",
        "documentation": "Description of reason for issuing warrant or right."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative",
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies (Note 27)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r139",
      "r723",
      "r786"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r440",
      "r441",
      "r860",
      "r1017"
     ]
    },
    "AREN_CommonEquityAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "CommonEquityAwardsMember",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Equity Awards [Member]",
        "documentation": "Common Equity Awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_CommonStockAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "CommonStockAwardsMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails",
      "http://thearenagroup.net/role/StockbasedCompensationTables",
      "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock Awards [Member]",
        "documentation": "Common Stock Awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_CommonStockFinancingWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "CommonStockFinancingWarrantMember",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock Financing Warrant [Member]",
        "documentation": "Common Stock Financing Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r917",
      "r918",
      "r919",
      "r921",
      "r922",
      "r923",
      "r924",
      "r988",
      "r989",
      "r1072",
      "r1101",
      "r1103"
     ]
    },
    "AREN_CommonStockOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "CommonStockOptionsMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock Options [Member]",
        "documentation": "Common Stock Options [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheetsParenthetical",
      "http://thearenagroup.net/role/OrganizationAndBasisOfPresentationDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value",
        "verboseLabel": "Common stock par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheetsParenthetical",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r787"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r166",
      "r787",
      "r806",
      "r1103",
      "r1104"
     ]
    },
    "AREN_CommonStockToBeIssuedDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "CommonStockToBeIssuedDuringPeriod",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock to be issued",
        "documentation": "Common stock to be issued during period."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_CommonStockToBeIssuedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "CommonStockToBeIssuedMember",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock To Be Issued [Member]",
        "documentation": "Common Stock To Be Issued [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, $0.01 par value, authorized 1,000,000,000 shares: issued and outstanding; 23,836,706 and 18,303,193 shares December 31, 2023 and 2022, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r724",
      "r914"
     ]
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/PensionPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Plans",
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r212",
      "r213",
      "r214"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-Based Compensation",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r67",
      "r128",
      "r129",
      "r353",
      "r859"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r67",
      "r128",
      "r129",
      "r353",
      "r748",
      "r859"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r67",
      "r128",
      "r129",
      "r353",
      "r859",
      "r956"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentrations",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r247"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of revenue",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r67",
      "r128",
      "r129",
      "r353"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r67",
      "r128",
      "r129",
      "r353",
      "r859"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principles of Consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r879"
     ]
    },
    "AREN_ContingentConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ContingentConsiderationMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Consideration [Member]",
        "documentation": "Contingent Consideration [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ContractBalancesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ContractBalancesPolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract Balances",
        "documentation": "Contract Balances [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Contract with Customer, Asset and Liability",
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability."
       }
      }
     },
     "auth_ref": [
      "r1029"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract modification - revenue",
        "documentation": "Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from contract modification which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r895"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned revenue",
        "verboseLabel": "Total short-term contract liabilities",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r508",
      "r509",
      "r520"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned revenue, net of current portion",
        "verboseLabel": "Total long-term contract liabilities",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r508",
      "r509",
      "r520"
     ]
    },
    "us-gaap_ContractWithCustomerRefundLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerRefundLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscription refund liability",
        "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockAmountConverted1",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of stock amount",
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r62"
     ]
    },
    "us-gaap_ConversionOfStockAmountIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockAmountIssued1",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock upon conversion of Series H convertible preferred stock",
        "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r62"
     ]
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockSharesConverted1",
     "presentation": [
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion Of stock shares converted",
        "verboseLabel": "Conversion of shares converted",
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r62"
     ]
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockSharesIssued1",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of shares issued",
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r62"
     ]
    },
    "AREN_ConvertibleDebenturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ConvertibleDebenturesMember",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Debentures [Member]",
        "documentation": "Convertible Debentures [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock issued upon conversion",
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r87",
      "r165",
      "r207",
      "r500"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization cost of developed technology and platform development",
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service."
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations",
      "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of revenue (includes amortization for developed technology and platform development for 2023 and 2022 of $8,782 and $9,459, respectively)",
        "verboseLabel": "Cost of revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r300",
      "r393",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r631",
      "r1023"
     ]
    },
    "AREN_CostOfRevenuePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "CostOfRevenuePolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue",
        "documentation": "Cost Of Revenue [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_CostsChargedToOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "CostsChargedToOperations",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total costs charged to operations",
        "documentation": "Costs charged to operations"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current tax (provision) benefit",
        "label": "Current Federal, State and Local, Tax Expense (Benefit)",
        "documentation": "Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r961",
      "r986",
      "r1065"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and local",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r961",
      "r986",
      "r1065"
     ]
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r353"
     ]
    },
    "AREN_CustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "CustomerMember",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Member]",
        "documentation": "Customer [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRefundLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerRefundLiabilityCurrent",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Refund liability",
        "documentation": "Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DanielShribmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DanielShribmanMember",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Daniel Shribman [Member]",
        "documentation": "Daniel Shribman [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DatabasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DatabasesMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Database Rights [Member]",
        "documentation": "Exclusive legal rights granted to the owner or licensee of collections of information stored in electronic form (such as on computer disks or files)."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_DebtDefaultLongtermDebtAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDefaultLongtermDebtAmount",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt costs",
        "documentation": "Amount of outstanding long-term debt or borrowing associated with any securities or credit agreement for which there has been a default in principal, interest, sinking fund, or redemption provisions, or any breach of covenant that existed at the end of the period and subsequently has not been cured."
       }
      }
     },
     "auth_ref": [
      "r297"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCredit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r297",
      "r457",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r473",
      "r480",
      "r481",
      "r483"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails",
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical",
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r162",
      "r163",
      "r231",
      "r232",
      "r303",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r641",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r984"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Principal balance",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r232",
      "r484"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion price",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r460"
     ]
    },
    "us-gaap_DebtInstrumentDecreaseForgiveness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentDecreaseForgiveness",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on forgiveness of debt",
        "documentation": "Decrease for amounts of indebtedness forgiven by the holder of the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "us-gaap_DebtInstrumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentDescription",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note purchase agreement description",
        "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r87",
      "r141",
      "r162",
      "r231",
      "r232"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative",
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Debt instrument, face amount",
        "terseLabel": "Principal balance",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r133",
      "r458",
      "r641",
      "r890",
      "r891"
     ]
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFeeAmount",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination fee",
        "verboseLabel": "Fee incurred",
        "terseLabel": "Outstanding loan balance",
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamagesDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liquidated damages payable accrued interest percentage",
        "label": "Interest on notes",
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period."
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "AREN_DebtInstrumentIncreaseAccruedInterestAmountDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DebtInstrumentIncreaseAccruedInterestAmountDue",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest on notes",
        "documentation": "Debt instrument increase accrued interest amount due.",
        "label": "DebtInstrumentIncreaseAccruedInterestAmountDue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt interest rate",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r131",
      "r476"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrument interest rate effective percentage",
        "verboseLabel": "Debt fixed rate",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r131",
      "r486",
      "r641"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateIncreaseDecrease": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateIncreaseDecrease",
     "presentation": [
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrument interest rate",
        "documentation": "Incremental percentage increase (decrease) in the stated rate on a debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "verboseLabel": "Debt instrument interest rate, percentage",
        "terseLabel": "Debt due rate",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r459"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r303",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r482",
      "r641",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r984"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative",
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity date",
        "verboseLabel": "Debt maturity term",
        "terseLabel": "Debt maturity date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r889",
      "r1073"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails",
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical",
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r303",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r641",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r984"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal balance",
        "verboseLabel": "Paid in cash",
        "documentation": "Amount of the required periodic payments applied to principal."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "AREN_DebtInstrumentPeriodicPaymentPrincipalBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DebtInstrumentPeriodicPaymentPrincipalBalance",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal amount of debt",
        "documentation": "Debt instrument periodic payment principal balance."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r87",
      "r90",
      "r130",
      "r131",
      "r133",
      "r140",
      "r206",
      "r208",
      "r303",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r482",
      "r641",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r984"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedDiscount",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unamortized discount and debt issuance costs",
        "label": "Debt Instrument, Unamortized Discount",
        "documentation": "Amount, after accumulated amortization, of debt discount."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r133",
      "r1026"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedDiscountCurrent",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrument, unamortized discount, current",
        "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r133"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedPremium",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unamortized debt costs",
        "label": "Debt Instrument, Unamortized Premium",
        "documentation": "Amount, after accumulated amortization, of debt premium."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r133",
      "r1026"
     ]
    },
    "us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt costs recorded in accrued expenses and other and in other long-term liabilities",
        "documentation": "The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r62"
     ]
    },
    "us-gaap_DebtPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtPolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Costs",
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostCurrent",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortized debt cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r994"
     ]
    },
    "AREN_DeferredCashPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DeferredCashPayments",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred cash payments",
        "documentation": "Deferred cash payments."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DeferredCashPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DeferredCashPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred cash payment due",
        "documentation": "Deferred cash payments due."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DeferredCashPaymentsRecordedInConnectionWithAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DeferredCashPaymentsRecordedInConnectionWithAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred cash payments recorded in connection with acquisitions",
        "documentation": "Deferred cash payments recorded in connection with acquisitions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Federal",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r986",
      "r1064",
      "r1065"
     ]
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFinanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incurred debt costs",
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r1026"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred tax (provision) benefit",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r220",
      "r253",
      "r601",
      "r602",
      "r986"
     ]
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income taxes",
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits."
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "us-gaap_DeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenue",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred payments",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "AREN_DeferredRevenueObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DeferredRevenueObligation",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred revenue obligation",
        "documentation": "Deferred Revenue Obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "State and local",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r986",
      "r1064",
      "r1065"
     ]
    },
    "us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAndOtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetInterestCarryforward": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetInterestCarryforward",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest limitation carryforward",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward."
       }
      }
     },
     "auth_ref": [
      "r1063"
     ]
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsDeferredIncome",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unearned revenue",
        "label": "Deferred Tax Assets, Deferred Income",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r1063"
     ]
    },
    "AREN_DeferredTaxAssetsDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DeferredTaxAssetsDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depreciation and amortization",
        "documentation": "Deferred tax assets depreciation and amortization.",
        "label": "DeferredTaxAssetsDepreciationAndAmortization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r592"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net deferred tax liabilities",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "AREN_DeferredTaxAssetsLiquidatingDamagesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DeferredTaxAssetsLiquidatingDamagesPayable",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liquidated damages",
        "documentation": "Deferred tax assets liquidating damages payable.",
        "label": "DeferredTaxAssetsLiquidatingDamagesPayable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "AREN_DeferredTaxAssetsOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DeferredTaxAssetsOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liability",
        "documentation": "Deferred tax assets Operating lease liability.",
        "label": "DeferredTaxAssetsOperatingLeaseLiability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r1063"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax credit carryforwards",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r104",
      "r1063"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r1063"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued expenses and other",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r1063"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for doubtful accounts",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r1063"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r593"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r1062"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition-related intangibles",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r1063"
     ]
    },
    "AREN_DelayedDrawTermNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DelayedDrawTermNoteMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails",
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical",
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Delayed Draw Term Notes [Member]",
        "documentation": "Delayed Draw Term Notes [Member]",
        "label": "Delayed Draw Term Notes [Member] [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DelayedDrawTermNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DelayedDrawTermNotesMember",
     "presentation": [
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed Draw Term Notes [Member]",
        "documentation": "Delayed Draw Term Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/PropertyAndEquipmentDetailsNarrative",
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation of property and equipment",
        "verboseLabel": "Depreciation expense",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r77"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r77"
     ]
    },
    "us-gaap_DepreciationAndAmortizationDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationAndAmortizationDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depreciation and amortization",
        "label": "Depreciation and Amortization, Discontinued Operations",
        "documentation": "Amount of deprecation and amortization expense attributable to property, plant and equipment and intangible assets of discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r980"
     ]
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeGainLossOnDerivativeNet",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      },
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative",
      "http://thearenagroup.net/role/StatementsOfCashFlows",
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation of contingent consideration",
        "negatedLabel": "Change in valuation of contingent consideration",
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Financial Instruments",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r119",
      "r120",
      "r121",
      "r122",
      "r302"
     ]
    },
    "us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans",
     "presentation": [
      "http://thearenagroup.net/role/PensionPlansDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension plan, description",
        "documentation": "Description of defined contribution pension and other postretirement plans."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DevelopedTechnologyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DevelopedTechnologyMember",
     "presentation": [
      "http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Developed Technology [Member]",
        "documentation": "Developed Technology [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DevelopmentCosts",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized platform development",
        "documentation": "The capitalized costs incurred during the period (excluded from amortization) to obtain access to proved reserves and to provide facilities for extracting, treating, gathering and storing the oil and gas."
       }
      }
     },
     "auth_ref": [
      "r705"
     ]
    },
    "AREN_DigitalAdvertisingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DigitalAdvertisingMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Digital Advertising [Member]",
        "documentation": "Digital Advertising [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DigitalAndPrintSubscriptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DigitalAndPrintSubscriptionsMember",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Digital And Print Subscriptions [Member]",
        "documentation": "Digital And Print Subscriptions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DigitalContentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DigitalContentMember",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Digital Content [Member]",
        "documentation": "Digital Content [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DigitalRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DigitalRevenueMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails",
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Digital Revenue [Member]",
        "documentation": "Digital Revenue [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DigitalSubscriptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DigitalSubscriptionsMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Digital Subscriptions [Member]",
        "documentation": "Digital Subscriptions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DirectOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DirectOfferingMember",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Direct Offering [Member]",
        "documentation": "Direct Offering [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Disaggregation of Revenue",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "AREN_DisclosureDiscontinuedOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DisclosureDiscontinuedOperationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DisclosureLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DisclosureLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "verboseLabel": "Schedule Of Supplemental Information Related To Operating Leases",
        "terseLabel": "Summary Of Maturity Of Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DisclosureLiquidatedDamagesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DisclosureLiquidatedDamagesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidated Damages"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DisclosureLiquidatedDamagesPayableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DisclosureLiquidatedDamagesPayableAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidated Damages Payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock\u2013Based Compensation",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r542",
      "r546",
      "r573",
      "r574",
      "r577",
      "r910"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DisclosureOtherLongtermLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DisclosureOtherLongtermLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Long-term Liabilities",
        "verboseLabel": "Schedule Of Other Long- Term Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DisclosurePlatformDevelopmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DisclosurePlatformDevelopmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Development"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DisclosurePrepaymentsAndOtherCurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DisclosurePrepaymentsAndOtherCurrentAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepayments And Other Current Assets",
        "verboseLabel": "Schedule Of Prepayments And Other Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DisclosureRestrictedStockLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DisclosureRestrictedStockLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from discontinued operations",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax",
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r155",
      "r174",
      "r1097"
     ]
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax benefit",
        "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r149",
      "r155",
      "r158",
      "r587",
      "r600",
      "r605"
     ]
    },
    "AREN_DiscontinuedOperationsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DiscontinuedOperationsTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/DiscontinuedOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Discontinued Operations",
        "documentation": "Discontinued Operations [Text Block]",
        "label": "DiscontinuedOperationsTextBlock"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss on impairment of assets",
        "documentation": "Disposal group including discontinued operation asset impairment charges.",
        "label": "DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of revenue",
        "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r261"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "General and administrative",
        "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense",
        "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Disposal Group, Including Discontinued Operation, Gross Profit (Loss)",
        "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r261"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Disposal Group, Including Discontinued Operation, Operating Expense",
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r261"
     ]
    },
    "AREN_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Selling and marketing",
        "documentation": "Disposal group including discontinued operation selling and marketing expense.",
        "label": "DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss on impairment of assets",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down",
        "documentation": "Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r8",
      "r198"
     ]
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r903",
      "r906"
     ]
    },
    "AREN_Disposition2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "Disposition2023Member",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposition 2023 [Member]",
        "documentation": "Disposition 2023 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r939",
      "r941",
      "r942"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r939",
      "r941",
      "r942",
      "r944"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r943"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://thearenagroup.net/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Authority [Member]",
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic net loss per common share",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r287",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r318",
      "r320",
      "r323",
      "r324",
      "r325",
      "r327",
      "r627",
      "r628",
      "r719",
      "r734",
      "r881"
     ]
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasicAbstract",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted net loss per common share:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted net loss per common share",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r287",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r320",
      "r323",
      "r324",
      "r325",
      "r327",
      "r627",
      "r628",
      "r719",
      "r734",
      "r881"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per Common Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax benefit and effective income tax rate, percentage",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal benefit expected at statutory rate, percentage",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r588",
      "r603"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation allowance percentage",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1061",
      "r1066"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other permanent differences percentage",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates."
       }
      }
     },
     "auth_ref": [
      "r603",
      "r1061"
     ]
    },
    "AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain upon debt extinguishment",
        "documentation": "Gain upon debt extinguishment."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain upon debt extinguishment percentage",
        "documentation": "Gain upon debt extinguishment, percentage."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_EffectiveIncomeTaxRateReconciliationInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationInterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "documentation": "Effective income tax rate reconciliation, interest expense."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_EffectiveIncomeTaxRateReconciliationInterestExpensePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationInterestExpensePercentage",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense percentage",
        "documentation": "Effective income tax rate reconciliation, interest expense, percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other differences, net percentage",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r1061",
      "r1066"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r953",
      "r1061"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation, percentage",
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r953",
      "r1061"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and local taxes, net of federal benefit, percentage",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r1061",
      "r1066"
     ]
    },
    "AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationUnearnedRevenue",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unearned revenue",
        "documentation": "Effective income tax rate reconciliation, unearned revenue.",
        "label": "EffectiveIncomeTaxRateReconciliationUnearnedRevenue"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned revenue percentage",
        "documentation": "Effective income tax rate reconciliation, unearned revenue, percentage."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_EmployeeRetentionCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "EmployeeRetentionCredits",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee retention credits",
        "documentation": "Employee retention credits"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_EmployeeRetentionPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "EmployeeRetentionPayable",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retention Payable",
        "documentation": "Employee retention payable."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average period expected to be recognized (in years)",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized compensation expense",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1059"
     ]
    },
    "AREN_EmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "EmployeesMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employees [Member]",
        "documentation": "Employees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r945"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r259",
      "r282",
      "r283",
      "r284",
      "r304",
      "r305",
      "r306",
      "r308",
      "r314",
      "r316",
      "r328",
      "r394",
      "r395",
      "r507",
      "r578",
      "r579",
      "r580",
      "r597",
      "r598",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r626",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r657",
      "r743",
      "r744",
      "r745",
      "r762",
      "r832"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "auth_ref": [
      "r390",
      "r391",
      "r392"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r390"
     ]
    },
    "us-gaap_EscrowDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EscrowDeposit",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Escrow deposit",
        "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r861"
     ]
    },
    "AREN_ExerciseOfStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ExerciseOfStockOptionMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Of Stock Option [Member]",
        "documentation": "Exercise Of Stock Option [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ExercisePriceRangeEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ExercisePriceRangeEightMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Eight [Member]",
        "documentation": "Exercise Price Range Eight [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ExercisePriceRangeFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ExercisePriceRangeFiveMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Five [Member]",
        "documentation": "Exercise Price Range Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ExercisePriceRangeFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ExercisePriceRangeFourMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Four [Member]",
        "documentation": "Exercise Price Range Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ExercisePriceRangeOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ExercisePriceRangeOneMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range One [Member]",
        "documentation": "Exercise Price Range One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ExercisePriceRangeSevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ExercisePriceRangeSevenMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Seven [Member]",
        "documentation": "Exercise Price Range Seven [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ExercisePriceRangeSixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ExercisePriceRangeSixMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Six [Member]",
        "documentation": "Exercise Price Range Six [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ExercisePriceRangeThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ExercisePriceRangeThreeMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Three [Member]",
        "documentation": "Exercise Price Range Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ExercisePriceRangeTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ExercisePriceRangeTwoMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Two [Member]",
        "documentation": "Exercise Price Range Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ExerciseRightTerminationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ExerciseRightTerminationAmount",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise right termination amount",
        "documentation": "Exercise right termination amount."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_FairMarketValueOfStockOption": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "FairMarketValueOfStockOption",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair market value of stock option",
        "documentation": "Fair market value of stock option."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value of Financial Instruments",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative",
      "http://thearenagroup.net/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative",
      "http://thearenagroup.net/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r126"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r471",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r630",
      "r670",
      "r671",
      "r672",
      "r890",
      "r891",
      "r900",
      "r901",
      "r902"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r471",
      "r522",
      "r527",
      "r630",
      "r670",
      "r900",
      "r901",
      "r902"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r471",
      "r522",
      "r527",
      "r630",
      "r671",
      "r890",
      "r891",
      "r900",
      "r901",
      "r902"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r471",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r630",
      "r672",
      "r890",
      "r891",
      "r900",
      "r901",
      "r902"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r471",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r670",
      "r671",
      "r672",
      "r890",
      "r891",
      "r900",
      "r901",
      "r902"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r29"
     ]
    },
    "us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOffBalanceSheetRisksDisclosureInformationLineItems",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_FexyStudiosAcquisitionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "FexyStudiosAcquisitionMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fexy Studios Acquisition [Member]",
        "documentation": "Fexy Studios Acquisition [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_FexyStudiosAcquistionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "FexyStudiosAcquistionMember",
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fexy Studios Acquistion [Member]",
        "documentation": "Fexy Studios Acquistion [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_FexyStudiosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "FexyStudiosMember",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsTables",
      "http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails",
      "http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fexy Studios [Member]",
        "documentation": "Fexy Studios [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_FinalSalePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "FinalSalePrice",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Sale price",
        "documentation": "Final sale price.",
        "label": "FinalSalePrice"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r397",
      "r398",
      "r404",
      "r405",
      "r406",
      "r408",
      "r409",
      "r410",
      "r482",
      "r503",
      "r624",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r733",
      "r886",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r995",
      "r996",
      "r997",
      "r998"
     ]
    },
    "us-gaap_FinancialInstrumentsOwnedAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentsOwnedAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial instruments measured fair value debt bridge notes",
        "documentation": "The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_FinancialInstrumentsOwnedOtherAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentsOwnedOtherAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt fair value",
        "documentation": "Fair value of firm holdings in securities classified as other. Includes pledged and unpledged holdings."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "AREN_FinancingAndSecurityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "FinancingAndSecurityAgreementMember",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing And Security Agreement [Member]",
        "documentation": "Financing And Security Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_FinancingWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "FinancingWarrantsMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Warrants [Member]",
        "documentation": "Financing Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Useful lives",
        "verboseLabel": "Intangible assets, weighted average useful life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails",
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less accumulated amortization",
        "label": "Intangible assets, accumulated amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r428"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2024",
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Thereafter",
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2028",
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027",
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fourth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025",
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r427",
      "r428",
      "r430",
      "r703",
      "r704"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails",
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform development",
        "verboseLabel": "Intangible assets, gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r704"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r703"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r74"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMember",
     "presentation": [
      "http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Member]",
        "documentation": "Assets, excluding financial assets, that lack physical substance, having a limited useful life."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFutureEstimatedAmortizationExpenseForIntangibleAssetsDetails",
      "http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails",
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net platform development",
        "verboseLabel": "Intangible assets, net",
        "totalLabel": "Intangible assets ,net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r703"
     ]
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payroll-based costs capitalized",
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "AREN_FlexyStudiosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "FlexyStudiosMember",
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Flexy Studios [Member]",
        "documentation": "Flexy Studios [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_FormerEmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "FormerEmployeesMember",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Employees [Member]",
        "documentation": "Former Employees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails",
      "http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnDispositionOfAssets",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss on impairment of assets",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r980",
      "r1014",
      "r1015"
     ]
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnDispositionOfAssets1",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on assets",
        "negatedLabel": "Less dispositions",
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee."
       }
      }
     },
     "auth_ref": [
      "r980"
     ]
    },
    "AREN_GeneralAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "GeneralAccruedExpenses",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General accrued expenses",
        "documentation": "General accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations",
      "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r811"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "AREN_GeneralandAdministrativePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "GeneralandAdministrativePolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative",
        "documentation": "Generaland Administrative [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails",
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "periodStartLabel": "Carrying value at beginning of year",
        "periodEndLabel": "Carrying value at end of year",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r416",
      "r718",
      "r888",
      "r914",
      "r1003",
      "r1010"
     ]
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAcquiredDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill, acquired during period",
        "verboseLabel": "Goodwill acquired in acquisition of Fexy Studios",
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r888"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r422",
      "r888"
     ]
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillDisclosureTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/Goodwill"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "label": "Goodwill Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r418",
      "r421",
      "r888"
     ]
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/GoodwillDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on impairment",
        "verboseLabel": "Impairment of goodwill",
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r417",
      "r420",
      "r422",
      "r888"
     ]
    },
    "us-gaap_GoodwillMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillMember",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Member]",
        "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r300",
      "r331",
      "r343",
      "r347",
      "r349",
      "r393",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r631",
      "r883",
      "r1023"
     ]
    },
    "AREN_HHuntAllredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "HHuntAllredMember",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "H Hunt Allred [Member]",
        "documentation": "H Hunt Allred [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r939",
      "r941",
      "r942"
     ]
    },
    "us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentEffectsOnEarningsPerShareLineItems",
     "presentation": [
      "http://thearenagroup.net/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment Effects on Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentEffectsOnEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentEffectsOnEarningsPerShareTable",
     "presentation": [
      "http://thearenagroup.net/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment Effects on Earnings Per Share [Table]",
        "documentation": "Disclosure of information about the effects of asset impairment charge on per share or per unit basis."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "presentation": [
      "http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes impairment of finite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative",
      "http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Impairments",
        "label": "Impairment charges",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value."
       }
      }
     },
     "auth_ref": [
      "r980",
      "r1013"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment charges for property and equipment",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r76",
      "r197"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r200"
     ]
    },
    "AREN_ImputedInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ImputedInterestRate",
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Imputed interest recognized",
        "documentation": "Imputed interest rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperations",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from continuing operations",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r179",
      "r189",
      "r309",
      "r310",
      "r311",
      "r312",
      "r322",
      "r325"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r173",
      "r236",
      "r331",
      "r343",
      "r347",
      "r349",
      "r720",
      "r731",
      "r883"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/OrganizationAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r300",
      "r307",
      "r331",
      "r343",
      "r347",
      "r349",
      "r393",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r628",
      "r631",
      "r731",
      "r883",
      "r1023"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Continuing operations - Basic",
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r235",
      "r237",
      "r287",
      "r307",
      "r309",
      "r310",
      "r311",
      "r312",
      "r320",
      "r323",
      "r324",
      "r628",
      "r719",
      "r1098"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Continuing operations - Diluted",
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r287",
      "r307",
      "r309",
      "r310",
      "r311",
      "r312",
      "r320",
      "r323",
      "r324",
      "r325",
      "r628",
      "r719",
      "r1098"
     ]
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      },
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails",
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss from discontinued operations, net of tax",
        "totalLabel": "Net loss from discontinued operations",
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r155",
      "r158",
      "r225"
     ]
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued operations - Basic",
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r287",
      "r321",
      "r323",
      "r324",
      "r1091",
      "r1098"
     ]
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued operations - Diluted",
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r321",
      "r323",
      "r324"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group Name [Axis]",
        "documentation": "Information by name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r903",
      "r906"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r435",
      "r816"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r816"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://thearenagroup.net/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority [Axis]",
        "documentation": "Information by tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://thearenagroup.net/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r583",
      "r589",
      "r590",
      "r595",
      "r599",
      "r604",
      "r606",
      "r607",
      "r758"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0,
       "order": 2.0
      },
      "http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfIncomeTaxesDetails",
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails",
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax (provision) benefit",
        "negatedTotalLabel": "Total income tax (provision) benefit",
        "label": "Income tax benefit and effective income tax rate",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r254",
      "r315",
      "r316",
      "r335",
      "r587",
      "r600",
      "r735"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r585",
      "r586",
      "r590",
      "r591",
      "r594",
      "r596",
      "r752"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other permanent differences",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates."
       }
      }
     },
     "auth_ref": [
      "r584",
      "r588"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal benefit expected at statutory rate",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other differences, net",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfTaxBenefitAndEffectiveIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and local taxes, net of federal benefit",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for income taxes",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued expenses and other",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unearned revenue",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r698",
      "r979"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in operating assets and liabilities net of effect of acquisitions:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liability",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r959",
      "r979"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other long-term assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other long-term liabilities",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepayments and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidRoyalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidRoyalties",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Royalty fees",
        "label": "Increase (Decrease) in Prepaid Royalties",
        "documentation": "Amount of increase (decrease) of consideration paid in advance for royalties that provide economic benefits in future periods."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "AREN_IncreaseDecreaseInSubscriptionAcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "IncreaseDecreaseInSubscriptionAcquisitionCosts",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Subscription acquisition costs",
        "documentation": "Increase decrease in subscription acquisition costs.",
        "label": "IncreaseDecreaseInSubscriptionAcquisitionCosts"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_IncreaseDecreaseInSubscriptionRefundLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "IncreaseDecreaseInSubscriptionRefundLiability",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Subscription refund liability",
        "documentation": "Increase decrease in subscription refund liability.",
        "label": "IncreaseDecreaseInSubscriptionRefundLiability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r426",
      "r429"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r194"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/IntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible Assets",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r699",
      "r700",
      "r701",
      "r703",
      "r880"
     ]
    },
    "AREN_IntellectualPropertiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "IntellectualPropertiesMember",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intellectual Properties [Member]",
        "documentation": "Intellectual Properties [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations",
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense, net",
        "label": "Total interest expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r239",
      "r285",
      "r334",
      "r639",
      "r817",
      "r925",
      "r1102"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less interest income",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r477",
      "r487",
      "r892",
      "r893"
     ]
    },
    "us-gaap_InterestPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaid",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total cash paid interest",
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities."
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r293",
      "r294"
     ]
    },
    "us-gaap_InterestPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest",
        "verboseLabel": "Interest payable",
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Interest",
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r1092"
     ]
    },
    "us-gaap_InvestorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestorMember",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investor [Member]",
        "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value."
       }
      }
     },
     "auth_ref": [
      "r1078",
      "r1079"
     ]
    },
    "AREN_IssuanceOfCommonStockInConnectionWithAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "IssuanceOfCommonStockInConnectionWithAcquisition",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock in connection with an acquisition",
        "documentation": "Issuance of common stock in connection with acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LeaseArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LeaseArrangementMember",
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Arrangement [Member]",
        "documentation": "Lease Arrangement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails",
      "http://thearenagroup.net/role/ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease costs during the year",
        "totalLabel": "Total operating lease costs",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r647",
      "r913"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Operating Lease Costs",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1076"
     ]
    },
    "us-gaap_LeaseDepositLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseDepositLiability",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assumed lease liability",
        "documentation": "Amount of liability for lease payments received, including variable lease payments, when collectability is not probable at commencement date for sales-type lease."
       }
      }
     },
     "auth_ref": [
      "r654"
     ]
    },
    "AREN_LeaseTermination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LeaseTermination",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease termination",
        "documentation": "Lease termination."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LeaseTerminationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LeaseTerminationLiability",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease termination liability",
        "documentation": "Lease termination liability."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LeaseTerminationLiabilityNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LeaseTerminationLiabilityNonCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease termination liability",
        "documentation": "Lease termination liability non current.",
        "label": "Lease termination liability non current"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Maturity of Lease Liabilities",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1077"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfMaturityOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Minimum lease payments - 2024",
        "label": "Cash payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r653"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfMaturityOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r653"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease, remaining fixed payment term",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1075"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r642"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r300",
      "r393",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r615",
      "r616",
      "r617",
      "r631",
      "r785",
      "r882",
      "r927",
      "r1023",
      "r1082",
      "r1083"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities, mezzanine equity and stockholders\u2019 deficiency",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r233",
      "r727",
      "r914",
      "r985",
      "r999",
      "r1074"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, mezzanine equity and stockholders\u2019 deficiency"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r263",
      "r300",
      "r393",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r615",
      "r616",
      "r617",
      "r631",
      "r914",
      "r1023",
      "r1082",
      "r1083"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LiabilitiesInConnectionWithAcquisitionsAndDispositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LiabilitiesInConnectionWithAcquisitionsAndDispositions",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities in connection with acquisitions and dispositions",
        "documentation": "Liabilities in connection with acquisitions and dispositions."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LicensingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LicensingAgreementMember",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Licensing Agreement [Member]",
        "documentation": "Licensing Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LicensingAndSyndicationRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LicensingAndSyndicationRevenueMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Licensing And Syndication Revenue [Member]",
        "documentation": "Licensing And Syndication Revenue [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Line of credit",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r232",
      "r1094"
     ]
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityAxis",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lender Name [Axis]",
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r984"
     ]
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitment fee percentage",
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective interest rate, line of credit",
        "documentation": "The effective interest rate at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_LineOfCreditFacilityInterestRateDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityInterestRateDescription",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of credit facility, interest rate description",
        "documentation": "Description of interest rate for borrowing under credit facility. Includes, but is not limited to, terms and method for determining interest rate."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate, line of credit",
        "documentation": "The effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityLenderDomain",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r984"
     ]
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LineOfCreditTerminationFeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LineOfCreditTerminationFeeMember",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line Of Credit Termination Fee [Member]",
        "documentation": "Line Of Credit Termination Fee [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LinesOfCreditCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LinesOfCreditCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of credit",
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r231"
     ]
    },
    "AREN_LiquidatedDamagesDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LiquidatedDamagesDescription",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidated damages description",
        "documentation": "Liquidated damages description."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LiquidatedDamagesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LiquidatedDamagesPayable",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamagesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidating damages payable",
        "documentation": "Liquidated damages payable."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LiquidatedDamagesPayableAccruedInterestPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LiquidatedDamagesPayableAccruedInterestPercentage",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidated damages payable accrued interest percentage",
        "documentation": "Liquidated damages payable accrued interest percentage."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LiquidatedDamagesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LiquidatedDamagesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidated damages payable",
        "verboseLabel": "Short-term liquidated damages",
        "documentation": "Liquidated damages payable current."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LiquidatedDamagesPayableCurrentAndNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LiquidatedDamagesPayableCurrentAndNonCurrent",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance",
        "verboseLabel": "Liquidated damages outstanding amount",
        "documentation": "Liquidated damages payable."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LiquidatedDamagesPayableNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LiquidatedDamagesPayableNonCurrent",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term liquidated damages",
        "documentation": "Liquidated damages payable non current."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LiquidatedDamagesPayableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LiquidatedDamagesPayableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamagesPayable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liquidated Damages Payable",
        "documentation": "Liquidated Damages Payable [Text Block]",
        "label": "Liquidated Damages Payable [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LiquidatedDamagesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LiquidatedDamagesPolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liquidated Damages",
        "documentation": "Liquidated Damages [Policy Text Block]",
        "label": "Liquidated Damages [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LiquidatedDamagesUnderRegistrationRightsAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LiquidatedDamagesUnderRegistrationRightsAgreements",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidated damages",
        "documentation": "Liquidated damages under registration rights agreements."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LiquidatingDamagesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LiquidatingDamagesPayable",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liquidated damages",
        "documentation": "Liquidating damages payable.",
        "label": "LiquidatingDamagesPayable"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LiquidatingDamagesPayableDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LiquidatingDamagesPayableDisclosureTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamages"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liquidated Damages",
        "documentation": "Liquidating Damages Payable Disclosure [Text Block]",
        "label": "LiquidatingDamagesPayableDisclosureTextBlock"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LiquidatingDamagesPayableNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LiquidatingDamagesPayableNonCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidating damages payable, net of current portion",
        "documentation": "Liquidating damages payable non current."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_LocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LocalJurisdictionMember",
     "presentation": [
      "http://thearenagroup.net/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local [Member]",
        "documentation": "Local [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying value",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r232",
      "r470",
      "r485",
      "r890",
      "r891",
      "r1094"
     ]
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "us-gaap_LongTermDebtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long term debt fair value",
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/Long-termDebt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt",
        "documentation": "The entire disclosure for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r81"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r443",
      "r444",
      "r447",
      "r1019",
      "r1020"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingencies [Table]",
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r443",
      "r444",
      "r447",
      "r1019",
      "r1020"
     ]
    },
    "us-gaap_LossContingencyDamagesSought": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingencyDamagesSought",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss contingency damages sought",
        "documentation": "Describes the form and magnitude of the award the plaintiff seeks in the legal matter, which may include an unspecified amount of money."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r80",
      "r202"
     ]
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingencyDamagesSoughtValue",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingency, Damages Sought, Value",
        "verboseLabel": "Loss contingency damages sought value",
        "terseLabel": "Damage, value",
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter."
       }
      }
     },
     "auth_ref": [
      "r1018",
      "r1019",
      "r1020"
     ]
    },
    "AREN_LossOnSaleOfAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "LossOnSaleOfAssets",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      },
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows",
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on sale of assets",
        "documentation": "Loss on sale of assets"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_MDBCapitalGroupLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "MDBCapitalGroupLLCMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MDB Capital Group LLC [Member]",
        "documentation": "MDB Capital Group LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_MDBCommonStockToBeIssuedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "MDBCommonStockToBeIssuedMember",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MDB Common Stock To Be Issued [Member]",
        "documentation": "MDB Common Stock To Be Issued [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r353",
      "r898",
      "r1030",
      "r1099",
      "r1100"
     ]
    },
    "us-gaap_MarketingAndAdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketingAndAdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Market advertising",
        "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising."
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "AREN_MarketingAndAdvertisingExpenseRemaining": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "MarketingAndAdvertisingExpenseRemaining",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Market advertising leaving",
        "documentation": "Marketing and advertising expense remaining carrying on."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails",
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r443",
      "r444",
      "r445",
      "r446",
      "r534",
      "r697",
      "r742",
      "r777",
      "r778",
      "r840",
      "r842",
      "r844",
      "r845",
      "r850",
      "r871",
      "r872",
      "r885",
      "r894",
      "r909",
      "r916",
      "r1025",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089"
     ]
    },
    "AREN_MembersOfBoardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "MembersOfBoardMember",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Members Of Board [Member]",
        "documentation": "Members Of Board [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_MensJournalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "MensJournalMember",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mens Journal [Member]",
        "documentation": "Mens Journal [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails",
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r443",
      "r444",
      "r445",
      "r446",
      "r534",
      "r697",
      "r742",
      "r777",
      "r778",
      "r840",
      "r842",
      "r844",
      "r845",
      "r850",
      "r871",
      "r872",
      "r885",
      "r894",
      "r909",
      "r916",
      "r1025",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089"
     ]
    },
    "AREN_MonthToMonthLeaseArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "MonthToMonthLeaseArrangementMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Month To Month Lease Arrangement [Member]",
        "documentation": "Month To Month Lease Arrangement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_MrEdmonsonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "MrEdmonsonMember",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mr. Edmonson [Member]",
        "documentation": "Mr. Edmonson [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MultiemployerPlanPensionSignificantPlanContribution": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MultiemployerPlanPensionSignificantPlanContribution",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/PensionPlansDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contribution to plan",
        "documentation": "Amount of contribution received by multiemployer pension plan from all employers participating in multiemployer pension plan determined to be individually significant."
       }
      }
     },
     "auth_ref": [
      "r540",
      "r909"
     ]
    },
    "us-gaap_MultiemployerPlansLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MultiemployerPlansLineItems",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Multiemployer Plan [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r541",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "auth_ref": [
      "r353",
      "r898",
      "r1030",
      "r1099",
      "r1100"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r292"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r292"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r188",
      "r189"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails",
      "http://thearenagroup.net/role/StatementsOfCashFlows",
      "http://thearenagroup.net/role/StatementsOfOperations",
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "label": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r189",
      "r238",
      "r261",
      "r279",
      "r280",
      "r284",
      "r300",
      "r307",
      "r309",
      "r310",
      "r311",
      "r312",
      "r315",
      "r316",
      "r322",
      "r331",
      "r343",
      "r347",
      "r349",
      "r393",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r628",
      "r631",
      "r732",
      "r808",
      "r830",
      "r831",
      "r883",
      "r925",
      "r1023"
     ]
    },
    "AREN_NetOperatingLossExpirationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "NetOperatingLossExpirationAmount",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating losses expiration amount",
        "documentation": "Net operating losses expiration amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_NewPublisherPartnerWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "NewPublisherPartnerWarrantMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails",
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Publisher Partner Warrant [Member]",
        "documentation": "New Publisher Partner Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_NewPublisherPartnerWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "NewPublisherPartnerWarrantsMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Publisher Partner Warrants [Member]",
        "documentation": "New Publisher Partner Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_NoUpListMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "NoUpListMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Up-List [Member]",
        "documentation": "No Up-List [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_NoncashAndAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "NoncashAndAccruedInterest",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows",
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Noncash and accrued interest",
        "negatedTerseLabel": "Total noncash and accrued interest",
        "documentation": "Noncash and accrued interest.",
        "label": "Noncash and accrued interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash investing and financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assumption of liabilities in connection with acquisitions",
        "documentation": "The total amount of [all] liabilities that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r62"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other expenses",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r183"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other expenses"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_OctoberOneTwoThousandAndTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "OctoberOneTwoThousandAndTwentyFourMember",
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "October One Two Thousand And Twenty Four [Member]",
        "documentation": "October One Two Thousand And Twenty Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_OfficeEquipmentAndComputersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "OfficeEquipmentAndComputersMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails",
      "http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office Equipment And Computers [Member]",
        "documentation": "Office Equipment And Computers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_OneEightyDegreeCapitalCorpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "OneEightyDegreeCapitalCorpMember",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "One Eighty Degree Capital Corp [Member]",
        "documentation": "One Eighty Degree Capital Corp [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails",
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses",
        "verboseLabel": "Operating expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r343",
      "r347",
      "r349",
      "r883"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails",
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total operating costs ()",
        "verboseLabel": "Operating lease cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r648",
      "r913"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfMaturityOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total operating lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r644"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/SummaryOfMaturityOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability",
        "verboseLabel": "Current portion of operating lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r644"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/SummaryOfMaturityOfLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability, net of current portion",
        "verboseLabel": "Long-term portion of operating lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r644"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash payments included in the measurement of operating lease liabilities during the year",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r645",
      "r650"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease right-of-use assets",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted-average discount rate during the year",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r652",
      "r913"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfSupplementalInformationRelatedToOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted-average remaining lease term (in years) as of year-end",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r651",
      "r913"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net operating loss carryforwards",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://thearenagroup.net/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://thearenagroup.net/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OptionIndexedToIssuersEquityTypeAxis",
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option Indexed to Issuer's Equity, Type [Axis]",
        "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r123",
      "r124",
      "r227"
     ]
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/OrganizationAndBasisOfPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization and Basis of Presentation",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r224",
      "r749",
      "r750"
     ]
    },
    "AREN_OriginalAwardAtTheRepricingDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "OriginalAwardAtTheRepricingDate",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Original award repricing date",
        "documentation": "Original award repricing date."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_OriginalInvestorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "OriginalInvestorMember",
     "presentation": [
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Original Investor [Member]",
        "documentation": "Original Investor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_OtherAccruedInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "OtherAccruedInterestMember",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Accrued Interest [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfAccruedExpensesDetails",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other accrued expenses",
        "verboseLabel": "Accrued expenses and other",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_OtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/OtherLong-termAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Long-Term Assets",
        "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      },
      "http://thearenagroup.net/role/SummaryOfOtherAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other long-term assets",
        "totalLabel": "Total other assets",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "us-gaap_OtherBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental borrowings",
        "documentation": "The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r234"
     ]
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired and other intangible assets, net",
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLaborRelatedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLaborRelatedExpenses",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Employee retention credits",
        "label": "Other Labor-related Expenses",
        "documentation": "Amount of labor-related expenses classified as other."
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Assumed lease liability",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r914"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      },
      "http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other long-term liabilities",
        "totalLabel": "Total other long-term liabilities",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "AREN_OtherLongTermLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "OtherLongTermLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfOtherLong-TermLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "documentation": "Other long term liabilities non current.",
        "label": "Other long term liabilities non current"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_OtherLongtermLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "OtherLongtermLiabilitiesTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/OtherLong-termLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other long- term liabilities",
        "documentation": "Other long term liabilities [TableText Block]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_OtherLongtermLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "OtherLongtermLiabilitiesTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/OtherLong-termLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other Long-term Liabilities",
        "documentation": "Other long term liabilities [Text Block]",
        "label": "OtherLongtermLiabilitiesTextBlock"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_OtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "OtherMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails",
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other [Member]",
        "documentation": "Other [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherPaymentsToAcquireBusinesses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherPaymentsToAcquireBusinesses",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for acquire",
        "documentation": "The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/SummaryOfOtherAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other receivables",
        "label": "Other Receivables",
        "documentation": "Amount due from parties in nontrade transactions, classified as other."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r795"
     ]
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other receivables",
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "AREN_OutstandingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "OutstandingPercentage",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shares outstanding percentage",
        "documentation": "Outstanding percentage.",
        "label": "OutstandingPercentage"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ParadeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ParadeMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails",
      "http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails",
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parade [Member]",
        "documentation": "Parade [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ParadePrintMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ParadePrintMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parade Print [Member]",
        "documentation": "Parade Print [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ParadeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ParadeStockMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parade Stock [Member]",
        "documentation": "Parade Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_PaulEdmonsonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PaulEdmonsonMember",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Paul Edmonson [Member]",
        "documentation": "Paul Edmonson [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_PaymentOfDeferredCashPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PaymentOfDeferredCashPayment",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of deferred cash payment",
        "documentation": "Payment of deferred cash payment.",
        "label": "PaymentOfDeferredCashPayment"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_PaymentOfRestrictedStockLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PaymentOfRestrictedStockLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of restricted stock liabilities",
        "documentation": "Payment of restricted stock liabilities.",
        "label": "PaymentOfRestrictedStockLiabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForAdvanceToAffiliate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForAdvanceToAffiliate",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advance payments of cash",
        "documentation": "The cash outflow from advancing money to an affiliate (an entity that is related but not strictly controlled by the entity)."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "AREN_PaymentsForCapitalizedPlatformDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PaymentsForCapitalizedPlatformDevelopment",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Capitalized platform development",
        "documentation": "Payments for capitalized platform development.",
        "label": "PaymentsForCapitalizedPlatformDevelopment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRepurchaseOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfEquity",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for repurchase Of equity",
        "documentation": "The cash outflow to reacquire common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r756"
     ]
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDebtIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of debt issuance costs",
        "label": "Payments of Debt Issuance Costs",
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of issuance costs from common stock public offering",
        "label": "Offering costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment for taxes related to common stock withheld for taxes",
        "label": "Payment of taxes",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r290"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesAndInterestInAffiliates",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash portion in acquisition",
        "documentation": "The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment)."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "AREN_PaymentsToAcquireBusinessesAtClosing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PaymentsToAcquireBusinessesAtClosing",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash payments paid at closing",
        "documentation": "Payments to acquire businesses at closing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash",
        "label": "Payments to Acquire Businesses, Gross",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r612"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments for acquisitions, net of cash",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireProductiveAssets",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash",
        "verboseLabel": "Cash paid for consideration",
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r1068",
      "r1069",
      "r1070"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "us-gaap_PaymentsToEmployees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToEmployees",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash retention pool for employees",
        "documentation": "Payments of cash to employees, including wages and salaries, during the current period."
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "AREN_PercentageOfAggregateAmountInvested": {
     "xbrltype": "percentItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PercentageOfAggregateAmountInvested",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of aggregate amount invested",
        "documentation": "Percentage of aggregate amount invested."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails",
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails",
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockbasedCompensationTables",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails",
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails",
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockbasedCompensationTables",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058"
     ]
    },
    "AREN_PlatformDevelopmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PlatformDevelopmentDisclosureTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/PlatformDevelopment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Platform Development",
        "documentation": "Platform Development Disclosure [Text Block]",
        "label": "Platform Development Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_PlatformDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PlatformDevelopmentMember",
     "presentation": [
      "http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails",
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Development [Member]",
        "documentation": "Platform Development [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_PlatformDevelopmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PlatformDevelopmentNet",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform development, net",
        "documentation": "Platform development net."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_PlatformDevelopmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PlatformDevelopmentPolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Platform Development",
        "documentation": "Platform Development [Policy Text Block]",
        "label": "Platform Development [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "us-gaap_PreferredStockConvertibleConversionPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockConvertibleConversionPrice",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock issued onversion price",
        "documentation": "Per share conversion price of preferred stock."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock liquidation preference",
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r165",
      "r983",
      "r1027"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockLiquidationPreferenceValue",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, liquidation aggregate amount",
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r494"
     ]
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r917",
      "r918",
      "r921",
      "r922",
      "r923",
      "r924",
      "r1101",
      "r1103"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, par value",
        "verboseLabel": "Preferred stock stated par value",
        "terseLabel": "Preffered stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r489"
     ]
    },
    "AREN_PreferredStockPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PreferredStockPolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred Stock",
        "documentation": "Preferred Stock [Policy Text Block]",
        "label": "Preferred Stock [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r787"
     ]
    },
    "us-gaap_PreferredStockTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/PreferredStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock",
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock."
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "AREN_PreliminaryPriceAllocationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PreliminaryPriceAllocationTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Preliminary Price Allocation",
        "documentation": "Preliminary Price Allocation [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_PreliminaryWorkingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PreliminaryWorkingCapital",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preliminary working capital",
        "documentation": "Preliminary working capital."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      },
      "http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepayments and other current assets",
        "totalLabel": "Total prepayments and other current assets",
        "verboseLabel": "Prepayment and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r411",
      "r412",
      "r877"
     ]
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/SummaryOfOtherAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r878",
      "r887",
      "r1001"
     ]
    },
    "AREN_PrepaidSuppliesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PrepaidSuppliesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid supplies",
        "documentation": "Prepaid supplies current."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaymentFeesOnAdvancesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaymentFeesOnAdvancesNet",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepayment fees on advances, net",
        "documentation": "Amount of income earned, after hedging basis adjustments, from fees charged for prepayment of certain Federal Home Loan Bank (FHLBank) advances before original maturity."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_PrepaymentsAndOtherCurrentAssetsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PrepaymentsAndOtherCurrentAssetsTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepayments and Other Current Assets",
        "documentation": "Prepayments And Other Current Assets [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_PrincipalAmountPrepayDue": {
     "xbrltype": "percentItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PrincipalAmountPrepayDue",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal amount prepay due percentage",
        "documentation": "Principal amount prepay due."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_PrintAdvertisingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PrintAdvertisingMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Print Advertising [Member]",
        "documentation": "Print Advertising [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_PrintRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PrintRevenueMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails",
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Print Revenue [Member]",
        "documentation": "Print Revenue [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_PrintSubscriptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PrintSubscriptionsMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Print Subscriptions [Member]",
        "documentation": "Print Subscriptions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from business combination",
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination."
       }
      }
     },
     "auth_ref": [
      "r289"
     ]
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business component carrying value",
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from common stock public offering, net of offering costs",
        "verboseLabel": "Gross proceed from offerings",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of common stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of debt",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of private placement",
        "verboseLabel": "Net proceeds from the Private Placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ProceedsFromLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromLeasePayments",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from lease payments",
        "documentation": "Amount of cash inflow from lease payment, classified as operating activity."
       }
      }
     },
     "auth_ref": [
      "r655",
      "r656"
     ]
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromLinesOfCredit",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds, net of repayments, under line of credit",
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r984"
     ]
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of equity investment",
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfOtherAssetsInvestingActivities",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash proceeds",
        "documentation": "Amount of cash inflow from the sale of other assets recognized in investing activities."
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of assets",
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r185"
     ]
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromShortTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from bridge notes, net of debt costs",
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of common stock options",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r26"
     ]
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProductAndServiceOtherMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service, Other [Member]",
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails",
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails",
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r350",
      "r702",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r874",
      "r896",
      "r915",
      "r960",
      "r1021",
      "r1022",
      "r1030",
      "r1099"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails",
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "auth_ref": [
      "r350",
      "r702",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r874",
      "r896",
      "r915",
      "r960",
      "r1021",
      "r1022",
      "r1030",
      "r1099"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails",
      "http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails",
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r248",
      "r251",
      "r252"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross property and equipment",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r265",
      "r730"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails",
      "http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails",
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentMember",
     "presentation": [
      "http://thearenagroup.net/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Member]",
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "totalLabel": "Net property and equipment",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r721",
      "r730",
      "r914"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentOther",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Platform development beginning of year",
        "periodEndLabel": "Platform development end of year",
        "label": "Property, Plant and Equipment, Other, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r248",
      "r251",
      "r728"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property and Equipment",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails",
      "http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails",
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property plant and equipment useful life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bad debt expense",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r400"
     ]
    },
    "AREN_PublicInformationFailureDamages": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PublicInformationFailureDamages",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public Information Failure Damages",
        "documentation": "Public information failure damages."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_PublisherPartnerWarrantProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PublisherPartnerWarrantProgramMember",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Publisher Partner Warrant Program [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_PublisherPartnerWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PublisherPartnerWarrantsMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Publisher Partner Warrants [Member]",
        "documentation": "Publisher Partner Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_PurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PurchaseAgreementMember",
     "presentation": [
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Agreement [Member]",
        "documentation": "Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_PurchasersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "PurchasersMember",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchasers [Member]",
        "documentation": "Purchasers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PutOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PutOptionMember",
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Put Option [Member]",
        "documentation": "A financial contract between two parties, the buyer and the seller (writer) of the option, where the buyer has the right but not the obligation to sell a commodity or financial instrument (the underlying instrument) to the seller (writer) at a certain time for a certain price (the strike price). The seller (writer) has the obligation to purchase the underlying asset at that strike price, if the buyer exercises the option."
       }
      }
     },
     "auth_ref": [
      "r847",
      "r848",
      "r849"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails",
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r443",
      "r444",
      "r445",
      "r446",
      "r521",
      "r534",
      "r569",
      "r570",
      "r571",
      "r673",
      "r697",
      "r742",
      "r777",
      "r778",
      "r840",
      "r842",
      "r844",
      "r845",
      "r850",
      "r871",
      "r872",
      "r885",
      "r894",
      "r909",
      "r916",
      "r919",
      "r1016",
      "r1025",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails",
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails"
     ],
     "auth_ref": [
      "r443",
      "r444",
      "r445",
      "r446",
      "r521",
      "r534",
      "r569",
      "r570",
      "r571",
      "r673",
      "r697",
      "r742",
      "r777",
      "r778",
      "r840",
      "r842",
      "r844",
      "r845",
      "r850",
      "r871",
      "r872",
      "r885",
      "r894",
      "r909",
      "r916",
      "r919",
      "r1016",
      "r1025",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089"
     ]
    },
    "AREN_ReclassificationOfStockbasedCompensationToPlatformDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ReclassificationOfStockbasedCompensationToPlatformDevelopment",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassification of stock-based compensation to platform development",
        "documentation": "Reclassification of stockbased compensation to platform development."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ReclassificationToLiabilityUponCommonStockModification": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ReclassificationToLiabilityUponCommonStockModification",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassification to liability upon common stock modification",
        "documentation": "Reclassification to liability upon common stock modification."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_RefundableIncomeAndFranchiseTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "RefundableIncomeAndFranchiseTaxes",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Refundable income and franchise taxes",
        "documentation": "Refundable income and franchise taxes."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_RegistrationRightsDamages": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "RegistrationRightsDamages",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Rights Damages",
        "documentation": "Registration Rights Damages."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r528",
      "r661",
      "r662",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r805",
      "r807",
      "r839"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r661",
      "r662",
      "r1081"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r812",
      "r813",
      "r816"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party, Type [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r528",
      "r661",
      "r662",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r805",
      "r807",
      "r839",
      "r1081"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r659",
      "r660",
      "r662",
      "r663",
      "r759",
      "r760",
      "r761",
      "r814",
      "r815",
      "r816",
      "r836",
      "r838"
     ]
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayment of debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of long-term debt",
        "label": "Repayments of Long-Term Debt",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r756"
     ]
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Restricted cash",
        "label": "Restricted Cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r969",
      "r982",
      "r1090",
      "r1095"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/ScheduleOfCashAndRestrictedCashDetails",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r969",
      "r982"
     ]
    },
    "AREN_RestrictedCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "RestrictedCommonStockMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Common Stock [Member]",
        "documentation": "Restricted Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_RestrictedStockAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "RestrictedStockAwardsMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Awards [Member]",
        "documentation": "Restricted Stock Awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_RestrictedStockInterestPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "RestrictedStockInterestPayment",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock interest payment",
        "documentation": "Restricted stock interest payment."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_RestrictedStockLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "RestrictedStockLiabilitiesTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/RestrictedStockLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restricted Stock Liabilities",
        "documentation": "Restricted stock liabilities [Text Block]",
        "label": "RestrictedStockLiabilitiesTextBlock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails",
      "http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails",
      "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "AREN_RestrictedStockPrincipalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "RestrictedStockPrincipalAmount",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock principal amount",
        "documentation": "Restricted stock principal amount."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_RestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "RestrictedStockUnitsMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://thearenagroup.net/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units [Member]",
        "documentation": "Restricted Stock Units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r209",
      "r726",
      "r746",
      "r747",
      "r757",
      "r788",
      "r914"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r304",
      "r305",
      "r306",
      "r308",
      "r314",
      "r316",
      "r394",
      "r395",
      "r578",
      "r579",
      "r580",
      "r597",
      "r598",
      "r618",
      "r620",
      "r621",
      "r623",
      "r626",
      "r743",
      "r745",
      "r762",
      "r1103"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails",
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue",
        "verboseLabel": "Over time",
        "totalLabel": "Total revenue",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r332",
      "r333",
      "r342",
      "r345",
      "r346",
      "r350",
      "r351",
      "r353",
      "r518",
      "r519",
      "r702"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerMember",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r955"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r257",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r873"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r286",
      "r300",
      "r332",
      "r333",
      "r342",
      "r345",
      "r346",
      "r350",
      "r351",
      "r353",
      "r393",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r631",
      "r720",
      "r1023"
     ]
    },
    "AREN_RisksAndUncertaintiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "RisksAndUncertaintiesPolicy",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties",
        "documentation": "Risks And Uncertainties [Policy]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_RossLevinsohnMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "RossLevinsohnMember",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ross Levinsohn [Member]",
        "documentation": "Ross Levinsohn [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RoyaltyExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RoyaltyExpense",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty expense",
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "AREN_SLRDigitalFinanceLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SLRDigitalFinanceLLCMember",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SLR Digital Finance LLC [Member]",
        "documentation": "SLR Digital Finance LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceed from offerings",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares sold",
        "verboseLabel": "Number of common shares sold",
        "terseLabel": "Sale of stock, number of shares issued in transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock price",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SalePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SalePrice",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale price",
        "documentation": "Sale price."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails",
      "http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails",
      "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails"
     ],
     "auth_ref": [
      "r317",
      "r539",
      "r950",
      "r991"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/AccruedExpensesAndOtherTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accrued Expenses",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Net Income (Loss) Per Common Share",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "AREN_ScheduleOfAssetsAcquiredTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ScheduleOfAssetsAcquiredTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Preliminary Assets Purchase Price Allocation",
        "documentation": "Schedule Of Assets Acquired [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfCompositionOfPurchasePriceDetails",
      "http://thearenagroup.net/role/ScheduleOfPreliminaryPriceAllocationDetails",
      "http://thearenagroup.net/role/ScheduleOfSupplementalProformaInformationDetails",
      "http://thearenagroup.net/role/SummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r109",
      "r610"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Composition of Purchase Price",
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r109"
     ]
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative",
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Income Taxes",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r219"
     ]
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/Long-termDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of long term debt",
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r87",
      "r90",
      "r130",
      "r131",
      "r133",
      "r140",
      "r206",
      "r208",
      "r890",
      "r892",
      "r987"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of Deferred Tax Assets and Liabilities",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "AREN_ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Depreciation and Amortization, Useful Lives of Assets",
        "documentation": "Schedule Of Depreciation And Amortization Useful Lives Of Assets [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/DiscontinuedOperationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Discontinued Operations",
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r27",
      "r34",
      "r144",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r157",
      "r159",
      "r160",
      "r199"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Tax Benefit and Effective Income Tax",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r217"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r390",
      "r391",
      "r392"
     ]
    },
    "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFairValueOffBalanceSheetRisksTable",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value, off-Balance-Sheet Risks [Table]",
        "documentation": "Schedule detailing the information required and determined to be disclosed regarding the fair value of financial assets and financial liabilities, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r228"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://thearenagroup.net/role/IntangibleAssetsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r74",
      "r703"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Intangible Assets Subject to Amortization",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r74"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/GoodwillTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Changes in Carrying Value of Goodwill",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r888",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012"
     ]
    },
    "us-gaap_ScheduleOfMultiemployerPlansTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfMultiemployerPlansTable",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Multiemployer Plan [Table]",
        "documentation": "Disclosure of information about multiemployer plan."
       }
      }
     },
     "auth_ref": [
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r541",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909"
     ]
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/OtherLong-termAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Other Assets",
        "documentation": "Tabular disclosure of noncurrent assets."
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "AREN_ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/PrepaymentsAndOtherCurrentAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Prepayments and Other Current Assets",
        "documentation": "Schedule Of Prepayments And Other Current Assets [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfContractWithCustomerAssetAndLiabilityDetails",
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Product Information [Table]",
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://thearenagroup.net/role/PlatformDevelopmentDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsDetails",
      "http://thearenagroup.net/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails",
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Purchase Price Allocation",
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r222"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r135",
      "r812",
      "r813",
      "r816"
     ]
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Cash and Restricted Cash",
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r229",
      "r1095"
     ]
    },
    "AREN_ScheduleOfRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ScheduleOfRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Restricted Stock Units Activity",
        "documentation": "Schedule Of Restricted Stock Units Activity [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfChangesInCarryingValueOfGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Stock-based Compensation",
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r96"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails",
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails",
      "http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails",
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockbasedCompensationTables",
      "http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails",
      "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r545",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Restricted Stock Award Activity",
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Exercise Prices of Common Stock Options",
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Stock Option Activity",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r95"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value of Stock Options Assumptions",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r216"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails",
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical",
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Short-Term Debt [Table]",
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock by Class [Table]",
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r85",
      "r86",
      "r87",
      "r88",
      "r89",
      "r90",
      "r206",
      "r208",
      "r209",
      "r272",
      "r273",
      "r274",
      "r329",
      "r489",
      "r490",
      "r492",
      "r494",
      "r497",
      "r503",
      "r505",
      "r753",
      "r754",
      "r755",
      "r756",
      "r894",
      "r949",
      "r983"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Warrant Activity",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "AREN_ScheduleOfUnrecognizedCompensationExpense": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ScheduleOfUnrecognizedCompensationExpense",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Unrecognized Compensation Expense",
        "documentation": "Schedule of unrecognized compensation expense."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ScheduleOfWarrantsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ScheduleOfWarrantsActivityTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Warrants Activity",
        "documentation": "Schedule Of Warrants Activity [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Future Estimated Amortization expense For Intangible Assets",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "us-gaap_SecurityDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecurityDeposit",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/SummaryOfOtherAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security deposit",
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease."
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r937"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "auth_ref": [
      "r351",
      "r352",
      "r774",
      "r775",
      "r776",
      "r841",
      "r843",
      "r846",
      "r851",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r875",
      "r897",
      "r919",
      "r1030",
      "r1099"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r351",
      "r884"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations",
      "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling and marketing",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpenseMember",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling and Marketing Expense [Member]",
        "documentation": "Primary financial statement caption encompassing selling and marketing expense."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "AREN_SellingAndMarketingPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SellingAndMarketingPolicyTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling and Marketing",
        "documentation": "Selling And Marketing [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SeniorSecuredNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SeniorSecuredNoteMember",
     "presentation": [
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails",
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails",
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Secured Note [Member]",
        "documentation": "Senior Secured Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SeniorSecuredNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SeniorSecuredNotesMember",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Secured Notes [Member]",
        "documentation": "Senior Secured Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SeriesGConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SeriesGConvertiblePreferredStockMember",
     "presentation": [
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series G Convertible Preferred Stock [Member]",
        "documentation": "Series G Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesGPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesGPreferredStockMember",
     "presentation": [
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series G Preferred Stock [Member]",
        "documentation": "Series G preferred stock."
       }
      }
     },
     "auth_ref": [
      "r972",
      "r973",
      "r1028"
     ]
    },
    "AREN_SeriesGRedeemableAndConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SeriesGRedeemableAndConvertiblePreferredStockMember",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series G Redeemable And Convertible Preferred Stock [Member]",
        "documentation": "Series G Redeemable And Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SeriesHConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SeriesHConvertiblePreferredStockMember",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series H Convertible Preferred Stock [Member]",
        "documentation": "Series H Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesHPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesHPreferredStockMember",
     "presentation": [
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfNetIncomeLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series H Preferred Stock [Member]",
        "documentation": "Series H preferred stock."
       }
      }
     },
     "auth_ref": [
      "r972",
      "r973",
      "r1028"
     ]
    },
    "AREN_SeriesHRedeemableAndConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SeriesHRedeemableAndConvertiblePreferredStockMember",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series H Redeemable And Convertible Preferred Stock [Member]",
        "documentation": "Series H Redeemable And Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SeriesJPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SeriesJPreferredStockMember",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series J Convertible Preferred Stock [Member]",
        "documentation": "Series J Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SeriesKPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SeriesKPreferredStockMember",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamagesDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series K Convertible Preferred Stock [Member]",
        "documentation": "Series K Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SeriesLPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SeriesLPreferredStockMember",
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series L Preferred Stock [Member]",
        "documentation": "Series L Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ServicesAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ServicesAgreementMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Services Agreement [Member]",
        "documentation": "Services Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SeveralInvestorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SeveralInvestorsMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Several Investors [Member]",
        "documentation": "Several Investors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SeveralStockPurchaseAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SeveralStockPurchaseAgreementsMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Several Stock Purchase Agreements [Member]",
        "documentation": "Several Stock Purchase Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows",
      "http://thearenagroup.net/role/SummaryOfPlatformDevelopmentCostActivityDetails",
      "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "label": "Total stock-based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vested contractual term",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r910"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Flexy put option description",
        "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r93"
     ]
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Exercise Price, outstanding, at beginning of year",
        "periodEndLabel": "Weighted Average Exercise Price, outstanding, at end of year",
        "documentation": "Instruments other than option nonvested weighted average grant date fair value",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price,Granted",
        "documentation": "Sharebased compensation arrangement by sharebased payment award equity instrument sotherthanoptionnonvestedweightedaveragegrantdatefairvaluegranted."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of Shares, Unvested, Cancelled",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r563"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Shares, Unvested granted",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of Shares, Unvested, outstanding, at beginning of year",
        "periodEndLabel": "Number of Shares, Unvested, outstanding at end of year",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r558",
      "r559"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Grant-Fair Value Date, Beginning balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r558",
      "r559"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of Shares, Unvested, Vested",
        "label": "Vested restricted stock units",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Weighted Average Grant-Fair Value Date, Vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of Shares, Vested, outstanding, at beginning of year",
        "periodEndLabel": "Number of Shares, Vested, outstanding, at end of year",
        "documentation": "Award equity instruments other than options vested number",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodStartLabel": "Number of Shares, Vested, Released",
        "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options vested number released.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of Shares, Vested",
        "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options vested number vested.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise price",
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility, maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility, minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate, maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate, minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails",
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails",
      "http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails",
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockbasedCompensationTables",
      "http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails",
      "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r545",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572"
     ]
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of Shares, Exercisable at end of year",
        "documentation": "Financing warrant, exercisable.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of Shares, not vested at end of year",
        "documentation": "Share based compensation arrangement by share based payment award non option equity instrument non vested.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of Shares, Available for future grants at end of year",
        "documentation": "Share based compensation arrangement by share based payment award nonoption equity instruments available for future grants number.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of Shares, Expired",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations",
        "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Expired",
        "documentation": "Award non option equity instruments expired price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Shares, Forfeited",
        "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails",
      "http://thearenagroup.net/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of Shares, outstanding, at beginning of year",
        "periodEndLabel": "Number of Shares, outstanding at end of year",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21"
     ]
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Shares, unvested issued",
        "documentation": "Option equity instruments unvested issued number"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of Shares, unvested outstanding, at beginning of year",
        "periodEndLabel": "Number of Shares, unvested outstanding, at end of year",
        "documentation": "Equity instruments unvested outstanding number",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of Shares, vested outstanding, at beginning of year",
        "periodEndLabel": "Number of Shares, vested outstanding, at end of year",
        "documentation": "Option equity instruments vested outstanding number",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Shares, vested",
        "documentation": "Equity instruments vested outstanding vested in period number"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Exercise Price, outstanding, at beginning of year",
        "periodEndLabel": "Weighted Average Exercise Price, Ending Balance",
        "documentation": "Weighted average exercise price outstanding.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted Average Exercise Price, Exercisable at end of year",
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price outstanding exercisable.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares authorized to issue",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r911"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of Shares Common stock options, exercisable at Ending balance",
        "label": "Number of Shares, Exercisable",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r552"
     ]
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of Shares, Exercisable",
        "documentation": "Share based compensation arrangement by share based payment award options exercisable number one.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted Average Exercise Price, exercisable at Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r552"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of Shares, Expired",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r557"
     ]
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of Shares Common stock options, available for future grants at Ending balance",
        "documentation": "Number of shares common stock options, available for future grants.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of Shares, Forfeited",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares common stock options, outstanding",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Shares, Granted",
        "verboseLabel": "Number of shares common stock options, outstanding",
        "terseLabel": "Share based compensation arrangement options grants",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted-average grant-date fair value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of Shares Common stock options, outstanding at Beginning balance",
        "periodEndLabel": "Number of Shares Common stock options, outstanding at Ending balance",
        "label": "Number of Shares, Outstanding",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r550",
      "r551"
     ]
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of Shares, Outstanding",
        "documentation": "Share based compensation arrangement by share based payment award options outstanding number one.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Exercise Price, outstanding at Beginning balance",
        "periodEndLabel": "Weighted Average Exercise Price, outstanding at Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r550",
      "r551"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock options vested",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share based compensation aggregate intrinsic value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Shares, Vested",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share based compensation incremental cost",
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification."
       }
      }
     },
     "auth_ref": [
      "r575"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares, agreed to purchase",
        "documentation": "Number of shares purchased for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "AREN_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Exercise Price, outstanding, at beginning of year",
        "periodEndLabel": "Weighted Average Exercise Price, outstanding, at end of year",
        "documentation": "Number of warrants outstanding, including both vested and non-vested options.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockbasedCompensationTables",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails",
      "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted Average Exercise Price, Expired",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r557"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Forfeited",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise price lower range",
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercise price",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading price, per share",
        "verboseLabel": "Share price per share",
        "terseLabel": "Purchase price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unvested restricted stock units",
        "documentation": "Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate grant date fair value",
        "documentation": "Aggregate grant date fair value for the common equity awards granted during the period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected life",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r568"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intrinsic value of stock option",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life (in Years), exercisable at Ending balance",
        "verboseLabel": "Weighted average remaining contractual term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of Shares, Restricted Stock Awards Outstanding, Beginning balance",
        "periodEndLabel": "Number of Shares, Restricted stock awards outstanding, Unvested at Beginning balance",
        "label": "Number of Shares Common stock options, not vested at Ending balance",
        "documentation": "Number of non-vested options outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life (in Years), outstanding at Beginning balance",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r215"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfRestrictedStockAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of Shares, Vested",
        "label": "Sharebased compensation arrangement by sharebased payment award options vested number of shares",
        "verboseLabel": "Performance based warrant vested",
        "documentation": "Number of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life, Outstanding at beginning of year",
        "documentation": "Weighted average remaining contractual term for warrants awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssued",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued for professional services",
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock trading price",
        "verboseLabel": "Shares Issued, Price Per Share",
        "terseLabel": "Trading price, per share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, shares",
        "periodEndLabel": "Balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SharesOutstandingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SharesOutstandingPercentage",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares outstanding percentage",
        "documentation": "Shares outstanding percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "current maturities of debt",
        "verboseLabel": "Company borrowed",
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r231",
      "r914",
      "r1093"
     ]
    },
    "us-gaap_ShortTermDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtLineItems",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails",
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical",
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bridge Notes",
        "documentation": "The entire disclosure for short-term debt."
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r296"
     ]
    },
    "AREN_SimplyfyLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SimplyfyLoanMember",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Simplyfy Loan [Member]",
        "documentation": "Simplyfy Loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r938"
     ]
    },
    "AREN_SportsIllustratedLicensingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SportsIllustratedLicensingAgreementMember",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sports Illustrated Licensing Agreement [Member]",
        "documentation": "Sports Illustrated Licensing Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_StateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StateMember",
     "presentation": [
      "http://thearenagroup.net/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State [Member]",
        "documentation": "State [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/BalanceSheetsParenthetical",
      "http://thearenagroup.net/role/LiquidatedDamagesDetailsNarrative",
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r272",
      "r273",
      "r274",
      "r300",
      "r320",
      "r321",
      "r323",
      "r325",
      "r329",
      "r330",
      "r393",
      "r448",
      "r450",
      "r451",
      "r452",
      "r455",
      "r456",
      "r489",
      "r490",
      "r494",
      "r497",
      "r505",
      "r631",
      "r753",
      "r754",
      "r755",
      "r756",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r787",
      "r809",
      "r832",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r949",
      "r983",
      "r992"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r48",
      "r259",
      "r282",
      "r283",
      "r284",
      "r304",
      "r305",
      "r306",
      "r308",
      "r314",
      "r316",
      "r328",
      "r394",
      "r395",
      "r507",
      "r578",
      "r579",
      "r580",
      "r597",
      "r598",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r626",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r657",
      "r743",
      "r744",
      "r745",
      "r762",
      "r832"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r351",
      "r352",
      "r774",
      "r775",
      "r776",
      "r841",
      "r843",
      "r846",
      "r851",
      "r858",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r875",
      "r897",
      "r919",
      "r1030",
      "r1099"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/BalanceSheetsParenthetical",
      "http://thearenagroup.net/role/LiquidatedDamagesDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails",
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency",
      "http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r305",
      "r306",
      "r328",
      "r702",
      "r751",
      "r773",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r787",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r796",
      "r797",
      "r798",
      "r799",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r807",
      "r810",
      "r811",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r832",
      "r920"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails",
      "http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails",
      "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r317",
      "r539",
      "r950",
      "r951",
      "r991"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/BalanceSheetsParenthetical",
      "http://thearenagroup.net/role/LiquidatedDamagesDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails",
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency",
      "http://thearenagroup.net/role/SummaryOfLiquidatedDamagesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r305",
      "r306",
      "r328",
      "r702",
      "r751",
      "r773",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r787",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r796",
      "r797",
      "r798",
      "r799",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r807",
      "r810",
      "r811",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r832",
      "r920"
     ]
    },
    "AREN_StockBasedCompensationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockBasedCompensationMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfUnrecognizedCompensationExpenseDetails",
      "http://thearenagroup.net/role/SummaryOfStock-basedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Based Compensation [Member]",
        "documentation": "Stock Based Compensation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock in connection with settlement of liquidated damages",
        "label": "Stock Issued",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r62"
     ]
    },
    "AREN_StockIssuedDuringPeriodSharesAcquisition": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockIssuedDuringPeriodSharesAcquisition",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock shares issuance fo acquisitions",
        "documentation": "Stock issued during period shares acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative",
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock in connection with acquisition, shares",
        "verboseLabel": "Issuance of common stock in connection with acquisitions, shares",
        "terseLabel": "Common stock shares issuance fo acquisitions",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r209"
     ]
    },
    "AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock withheld for taxes upon issuance of underlying shares for restricted stock units, shares",
        "documentation": "Stock issued during period shares common stock with held for taxes."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock withheld for taxes, shares",
        "documentation": "Stock issued during period shares common stock withheld for taxes shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock upon conversion of series H preferred stock, shares",
        "verboseLabel": "Conversion of shares",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r47",
      "r87",
      "r209",
      "r474"
     ]
    },
    "AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock in connection with the acquisition of Fexy Studios, shares",
        "documentation": "Stock issued during period shares issuance of common stock in connection with acquisition one."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock in connection with registered direct offering, shares",
        "documentation": "Stock issued during period shares issuance of common stock in connection with registered direct offering."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock in connection with settlement of liquidated damages, shares",
        "documentation": "Stock issued during period shares issuance of common stock in connection with settlement of liquidated damages shares."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock in connection with the merger of SayMedia, shares",
        "verboseLabel": "Common stock to be issued",
        "documentation": "Stock issued during period shares issuance of stock in connection with merger."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock in connection with professional services, shares",
        "verboseLabel": "Stock issued for professional services",
        "terseLabel": "Stock issued during period, shares, issued for services",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock in connection with public offering, shares",
        "verboseLabel": "Shares issued",
        "terseLabel": "Stock issued during period shares new issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r165",
      "r166",
      "r209",
      "r753",
      "r832",
      "r853"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares issued for asset acquisition",
        "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock for restricted stock units, shares",
        "verboseLabel": "Vesting of restricted stock units",
        "terseLabel": "Conversion of restricted stock units",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r209"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock in connection with the exercise of stock options, shares",
        "verboseLabel": "Exercise of stock options, shares",
        "negatedLabel": "Number of Shares, Exercised",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r165",
      "r166",
      "r209",
      "r555"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of stock in connection with acquisitions",
        "documentation": "Value of stock issued pursuant to acquisitions during the period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r48",
      "r209"
     ]
    },
    "AREN_StockIssuedDuringPeriodValueCommonStockWithheldForTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockIssuedDuringPeriodValueCommonStockWithheldForTaxes",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock withheld for taxes upon issuance of underlying shares for restricted stock units",
        "documentation": "Stock issued during period value common stock withheld for taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock upon conversion of series H preferred stock",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r48",
      "r209"
     ]
    },
    "AREN_StockIssuedDuringPeriodValueForCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockIssuedDuringPeriodValueForCash",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of stock options",
        "documentation": "Stock issued during period value for cash."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock in connection with the acquisition of Fexy Studios",
        "documentation": "Stock issued during period value issuance of common stock in connection with acquisition one."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of stock in connection with the merger of Say Media",
        "documentation": "Stock issued during period value issuance of common stock in connection with merger."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock in connection with registered direct offering",
        "documentation": "Stock issued during period value issuance of common stock in connection with registered direct offering."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock in connection with settlement of liquidated damages",
        "documentation": "Stock issued during period value issuance of common stock in connection with settlement of liquidated damages."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock in connection with professional services",
        "verboseLabel": "Debt instrument face amount",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock in connection with public offering",
        "verboseLabel": "Share value",
        "terseLabel": "Number of share issued value",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r165",
      "r166",
      "r209",
      "r762",
      "r832",
      "r853",
      "r926"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValuePurchaseOfAssets",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of shares issued",
        "documentation": "Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock for restricted stock units",
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r165",
      "r166",
      "r209"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock in connection with the exercise of stock options",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r48",
      "r209"
     ]
    },
    "AREN_StockPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockPurchaseAgreementMember",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Purchase Agreement [Member]",
        "documentation": "Stock Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_StockPurchaseAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockPurchaseAgreementsMember",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Purchase Agreements [Member]",
        "documentation": "Stock Purchase Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/RestrictedStockLiabilitiesDetailsNarrative",
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repurchase restricted stock awards in connection with HubPages merger, shares",
        "verboseLabel": "Stock repurchased during period, shares",
        "terseLabel": "Repurchase of restricted common stock",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r165",
      "r166",
      "r209",
      "r756",
      "r832",
      "r855"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repurchase restricted stock awards in connection with HubPages merger",
        "verboseLabel": "Stock repurchase value",
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r165",
      "r166",
      "r209",
      "r762",
      "r832",
      "r855",
      "r926"
     ]
    },
    "AREN_StockRepurchasedDuringPeriodValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "StockRepurchasedDuringPeriodValue1",
     "crdr": "debit",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Proceeds from repurchase of restricted stock",
        "documentation": "Stock repurchased during period value.",
        "label": "StockRepurchasedDuringPeriodValue1"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets",
      "http://thearenagroup.net/role/StatementsOfStockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 deficiency",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r169",
      "r170",
      "r191",
      "r789",
      "r806",
      "r833",
      "r834",
      "r914",
      "r927",
      "r985",
      "r999",
      "r1074",
      "r1103"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 deficiency:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Deficiency",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r299",
      "r488",
      "r490",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r501",
      "r502",
      "r504",
      "r507",
      "r625",
      "r835",
      "r837",
      "r857"
     ]
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityReverseStockSplit",
     "presentation": [
      "http://thearenagroup.net/role/OrganizationAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Reverse Stock Split",
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r210"
     ]
    },
    "AREN_SubleaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SubleaseAgreementMember",
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sublease Agreement [Member]",
        "documentation": "Sublease Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less sublease income",
        "label": "Sublease income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r649",
      "r913"
     ]
    },
    "AREN_SubscriberRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SubscriberRelationshipsMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscriber Relationships [Member]",
        "documentation": "Subscriber Relationships [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SubscriptionAcquisitionCostsPoliceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SubscriptionAcquisitionCostsPoliceTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscription Acquisition Costs",
        "documentation": "Subscription Acquisition Costs [Police Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SubscriptionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SubscriptionAgreementMember",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscription Agreement [Member]",
        "documentation": "Subscription Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r638",
      "r665"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r638",
      "r665"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r638",
      "r665"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r638",
      "r665"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r638",
      "r665"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r664",
      "r666"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SummaryOfInterestExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SummaryOfInterestExpenseTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/Long-termDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Interest Expense",
        "documentation": "Summary Of Interest Expense [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SummaryOfLiquidatedDamagesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SummaryOfLiquidatedDamagesTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/LiquidatedDamagesPayableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Liquidated Damages",
        "documentation": "Tabular disclosure of liquidation damages."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SummaryOfPlatformDevelopmentCostActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SummaryOfPlatformDevelopmentCostActivityTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/PlatformDevelopmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Platform Development Cost Activity",
        "documentation": "Summary of Platform Development Cost Activity [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SummaryOfPlatformDevelopmentCostsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SummaryOfPlatformDevelopmentCostsTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/PlatformDevelopmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Platform Development Costs",
        "documentation": "Summary of Platform Development Costs [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosure of cash flow information"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_SupplementalInformationRelatedToOperatingLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "SupplementalInformationRelatedToOperatingLeasesTableTextBlock",
     "presentation": [
      "http://thearenagroup.net/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Supplemental Information Related to Operating Leases",
        "documentation": "Supplemental Information Related to Operating Leases [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityAbstract",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mezzanine equity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://thearenagroup.net/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total mezzanine equity",
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r448",
      "r450",
      "r451",
      "r452",
      "r455",
      "r456",
      "r581",
      "r725"
     ]
    },
    "AREN_TemporaryEquityCommonSharesIssuableUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "TemporaryEquityCommonSharesIssuableUponConversion",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, common shares issuable upon conversion",
        "documentation": "Temporary equity common shares issuable upon conversion."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityLiquidationPreference",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, liquidation preference value",
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityLiquidationPreferencePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityLiquidationPreferencePerShare",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheetsParenthetical",
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, liquidation preference per share value",
        "documentation": "The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, par value",
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r83"
     ]
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquitySharesAuthorized",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheetsParenthetical",
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, shares designated",
        "verboseLabel": "Preferred stock, designated shares",
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquitySharesIssued",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, shares issued",
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquitySharesOutstanding",
     "presentation": [
      "http://thearenagroup.net/role/BalanceSheetsParenthetical",
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, shares outstanding",
        "verboseLabel": "Shares outstanding",
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "AREN_TeneologyIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "TeneologyIncMember",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfCompositionPreliminaryAssetsPurchasePriceDetails",
      "http://thearenagroup.net/role/SummaryOfPreliminaryAssetsPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Teneology Inc [Member]",
        "documentation": "Teneology Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_TerminationFeeDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "TerminationFeeDue",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Termination fee",
        "documentation": "Termination fee due.",
        "label": "TerminationFeeDue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Timing of Transfer of Good or Service [Axis]",
        "documentation": "Information by timing of transfer of good or service to customer."
       }
      }
     },
     "auth_ref": [
      "r899",
      "r1030"
     ]
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time."
       }
      }
     },
     "auth_ref": [
      "r899",
      "r1030"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r993",
      "r1080"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/PreferredStockDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "auth_ref": []
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable and Allowance for Doubtful Accounts",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r356",
      "r357",
      "r359"
     ]
    },
    "us-gaap_TradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TradeNamesMember",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfIntangibleAssetsSubjectToAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Names [Member]",
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_TransactionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "TransactionAgreementMember",
     "presentation": [
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Agreement [Member]",
        "documentation": "Transaction Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransferredAtPointInTimeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransferredAtPointInTimeMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transferred at Point in Time [Member]",
        "documentation": "Contract with customer in which good or service is transferred at point in time."
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "us-gaap_TransferredOverTimeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransferredOverTimeMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transferred over Time [Member]",
        "documentation": "Contract with customer in which good or service is transferred over time."
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r482",
      "r503",
      "r624",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r733",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r995",
      "r996",
      "r997",
      "r998"
     ]
    },
    "AREN_TwoThousandTwentyThreeNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "TwoThousandTwentyThreeNotesMember",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative",
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2023 Notes [Member]",
        "documentation": "2023 Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_TwoThousandTwentyTwoBridgeNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "TwoThousandTwentyTwoBridgeNotesMember",
     "presentation": [
      "http://thearenagroup.net/role/BridgeNotesDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetails",
      "http://thearenagroup.net/role/ScheduleOfLongTermDebtDetailsParenthetical",
      "http://thearenagroup.net/role/SummaryOfInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2022 Bridge Notes [Member]",
        "documentation": "2022 Bridge Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_TwoThousandTwentyTwoPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "TwoThousandTwentyTwoPlanMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails",
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetails",
      "http://thearenagroup.net/role/SummaryOfStockOptionActivityDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2022 Plan [Member]",
        "documentation": "2022 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://thearenagroup.net/role/LeasesDetailsNarrative",
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/LiquidatedDamagesPayableDetailsNarrative",
      "http://thearenagroup.net/role/Long-termDebtDetailsNarrative",
      "http://thearenagroup.net/role/RelatedPartyTransactionsDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfOperatingLeaseCostsDetailsParenthetical",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative",
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfDisaggregationOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_USFederalTaxMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "USFederalTaxMember",
     "presentation": [
      "http://thearenagroup.net/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "U.S Federal Tax [Member]",
        "documentation": "U.S Federal Tax [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_UnamortizedDebtCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "UnamortizedDebtCost",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/SummaryOfOtherAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unamortized debt cost",
        "documentation": "Unamortized debt cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnamortizedDebtIssuanceExpense",
     "crdr": "debit",
     "calculation": {
      "http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://thearenagroup.net/role/LineOfCreditDetailsNarrative",
      "http://thearenagroup.net/role/ScheduleOfPrepaymentsAndOtherCurrentAssetsDetails",
      "http://thearenagroup.net/role/StockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unamortized debt costs",
        "verboseLabel": "Debt costs",
        "terseLabel": "Unamortized costs",
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_UnderwritingOverallotmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "UnderwritingOverallotmentMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriting Overallotment [Member]",
        "documentation": "Underwriting Overallotment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_UnderwritingPublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "UnderwritingPublicOfferingMember",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriting Public Offering [Member]",
        "documentation": "Underwriting Public Offering [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnearnedPremiums": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnearnedPremiums",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unearned revenue",
        "label": "Unearned Premiums",
        "documentation": "Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r256"
     ]
    },
    "AREN_UnearnedRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "UnearnedRevenue",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/FairValueMeasurementDetailsNarrative",
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with customer liability noncurrent",
        "verboseLabel": "Unearned revenue",
        "documentation": "Unearned Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_UpListMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "UpListMember",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Up-List [Member]",
        "documentation": "Up-List [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://thearenagroup.net/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69",
      "r70",
      "r245",
      "r246",
      "r249",
      "r250"
     ]
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails",
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfExercisePricesOfCommonStockOptionsDetails",
      "http://thearenagroup.net/role/ScheduleOfFairValueOfStockOptionsAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://thearenagroup.net/role/StockholdersDeficiencyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration date",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1073"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of common shares outstanding - Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r325"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://thearenagroup.net/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of common shares outstanding - Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r325"
     ]
    },
    "AREN_WeightedAverageRemainingContractualLifeExercisable": {
     "xbrltype": "durationItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "WeightedAverageRemainingContractualLifeExercisable",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life, Exercisable",
        "documentation": "Weighted average remaining contractual life exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_WeightedAverageRemainingContractualLifeOutstanding": {
     "xbrltype": "durationItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "WeightedAverageRemainingContractualLifeOutstanding",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life, Outstanding at ending of year",
        "documentation": "Weighted average remaining contractual life outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_WeightedAverageRemainingContractualLifeOutstanding1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "WeightedAverageRemainingContractualLifeOutstanding1",
     "presentation": [
      "http://thearenagroup.net/role/ScheduleOfWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted Average Remaining Contractual Life, Outstanding at ending of year",
        "documentation": "Weighted average remaining contractual life outstanding.",
        "label": "WeightedAverageRemainingContractualLifeOutstanding1"
       }
      }
     },
     "auth_ref": []
    },
    "AREN_WorkingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "WorkingCapital",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative",
      "http://thearenagroup.net/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Working capital",
        "documentation": "Working capital."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_WorkingCapitalAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "WorkingCapitalAdjustments",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/AcquisitionsAndDispositionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment for working capital",
        "documentation": "Working capital adjustments."
       }
      }
     },
     "auth_ref": []
    },
    "AREN_WorkingCapitalDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://thearenagroup.net/20231231",
     "localname": "WorkingCapitalDeficit",
     "crdr": "credit",
     "presentation": [
      "http://thearenagroup.net/role/OrganizationAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:WorkingCapitalDeficit-0]",
        "documentation": "Working capital deficit."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://thearenagroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(3)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(4)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(19)",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(27)",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "63",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481620/480-10-55-63"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(CFRR 211.02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b),(f(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)-(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-4A"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-18"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-4"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "940",
   "SubTopic": "320",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481961/940-320-45-2"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3A"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3B"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-4"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-1"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.13)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r195": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r196": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r197": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r198": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r199": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A"
  },
  "r200": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r201": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r202": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r203": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r204": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5"
  },
  "r205": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r206": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r207": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r208": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r209": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r210": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4"
  },
  "r211": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//710/tableOfContent"
  },
  "r212": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "712",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//712/tableOfContent"
  },
  "r213": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//715/tableOfContent"
  },
  "r214": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r215": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r216": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r217": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r218": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r219": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r220": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r221": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//805/tableOfContent"
  },
  "r222": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r223": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r224": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r225": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r226": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 5.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479836/810-10-S99-5"
  },
  "r227": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-3"
  },
  "r228": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r229": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r230": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r231": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r232": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r233": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r234": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r235": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r236": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r237": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r238": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r239": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r240": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B"
  },
  "r241": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15"
  },
  "r242": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "10",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(13)(a)(2))",
   "SubTopic": "210",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479483/340-40-50-3"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479483/340-40-50-3"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-20/tableOfContent"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-30/tableOfContent"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-7"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.E.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-15"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479341/842-30-25-3"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-5"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-7"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479664/932-10-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column B)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479908/805-50-55-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479455/805-10-15-3"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "SubTopic": "740",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480887/718-740-35-2"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-27"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>151
<FILENAME>0001493152-24-012368-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-012368-xbrl.zip
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M9)F1O%H,?:2(5>TY6^FPA5=YV&.:LT<Q<6D,/RA6HM94+I4KNKU<\I^#LNQ
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MZ/KE<;=#]!!!4*06K^N_JOD.05QEV8D=EJ88W)).A!+KF<UZ:""H49Y?:O;
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M86F@-F)P2FJD7:NB-DA7:G"MT;QB-B/ID@<<H&:A%33=2,%!:?)9M PUO3G
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M]C]]^O26_&OW*?/ERWV1=F.\?]N1L\8,_YI(OJ<H*9,?2T+>11Z%%5&[<IA
M^ 7^VU[WV1[^U=[^P=[[_6]?ROA-)WPBP2)/T0U:!/A/T-YZU.H!A07*PF61
MUX_?9JAZB[]X>YR#50*Y!/:A0(M?WN#/8(B#]_L'S0!_ZGU4O3Z"=98)-JXW
MP=MM!C\*4RRMVP>$JE)%!/=C6\1<XR_@PRJ)PM2(,B[DA&3B:816,$1YM;AZ
MQ%,?;$LI/#F4=?*,Q&F PA+AMU4>_?:0IS'XS1.T2*($G/6K"=UR#);(/@[+
MA[,T?S:R!@9H0N*NBF68)?\B"CS,XJ.P3&#$ZP*5,#;YK8I2?0Q3RK1>K<+B
M%;28++,$E!=FU6$4Y756P7I]G:=8G6HA&V&9D/R3I(QR/$B-8GT/(8>:D+S#
MZ/<Z*1."'E0*XS[F[5]5-&J 3D@H6-EC^$JF"0QV!5\5QW6!O=!A66HL6+KP
MDY*<@^JJ5QCO%$3UB =7DRF&F9"T"P21BU)F_:^FE$P:5HN\6)V@)Y3F>H(1
M@TQ(V#GXL6R9W*=(SZI$WT_IMK&I7N39<J]"Q4J/+!G,A*1]SO/X.4F5,<3P
MNPE)N$%E5211A6*RR%\DX7V2@A-2&[<:<E(W&Q7@RD]?'E$&4ZKS0&H7*P6;
MTB$D&8+PHT!QHIR*O&\G)04<7PPQ47P2KL(E@F#S-;S':%5DR>&LS4D#HU,"
M3DCD69@49'O_!=QX72 =+RN#F7)W5R3Q$EWFE5IBG$^GM+5.%2?H7FWWO(^G
M#7$6"$*2QB%I!#2<KR?=S(S;=\VVUX*!< (FQJDU\(]:6Q@YE$TO9NR^K(0W
M4;Y"=^&+FAS.IU.:.D@>Y Y!G7J?P?MVT@@BQ4*_#B'JOBM@C##2VOZHX"8D
M$4QUE53=WN68; R7,*TT%AP-T$GWZO<E^KV&T4Z?\)#J73G_^]G3!].F$2RF
M$_0(N,-QST3,]'%9SXSHD:X#.T^61(]>;00S9DST*#?#8CE[HDNR"G+R3(H>
M8;QO[695- 6F K288=&C4 YE.=NB1Z(:TD+F18\T_M?VTQNZOE$#>(;\@N8<
MUH*>(]<PQBR%X);S#GJTJB%M;?TU=2\&L;[OU@SI-&"M[\$-2%7 VMGZZBXY
M H!9CV1/4!4F:7D9%CC&?5(F0<=CG-(LH@<4URFZ6D"@&RZ7!5J2H:\6-Q!A
M0,S>TJ T$4,\5EC >^8"]O:_)M7#<5U68!0%6=U!O)T[?35F: Q6.^R%Y0.,
MN3D-P;\P9T<#BQ7R#],T?\;U/F=Y<9+7]]6B3ML];&G,A0$R.[,%/18H2KK)
M>[C*BZJ=RU]+!,1<P'R%Z=P$E^:3:!OT5AB^1%7C9B_RLKR&G66^6N79[0-
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M3^J[P9?],A2?AD4&=E8>1E&]JLFES*:KB_3.CAK6=:2JK3Y]0?BD/FK%AR#
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M'S W\^9P"RIK/F!6+<HW8 1S&O-9F!1_#],:?8%E":@1+A0'S$*&00,"&_2
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M"EF:/(X:K^#T-]L%//_%=$,<D0BZ)O_<,!(X3RA@GYWFC7EM7YNE^K%<B5%
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M6RMK"<FBB(]M5MHM#MWFAMJVM[58U>4!!,^8IX$9)/LU#83;#-3#=I"$=(/
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M4S76(#1U7Q,K#!9"SZ[%0NA1,]D$/7L(4AW.0(S,YD&4N%>.N7/[]! ^-9Y
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M/* DR1SADUFESGU;*X;PH_U4%ZW,0\K3-)&JM?5$R$LV3FN+C,*W^ZE*;<@
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M-.G/ZMMGPZ7!7L)FLS'>YTN#S?V(AO:I1C<%^=1#,FZ\([5Z,?.D5W7!1$R
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ME+,!>;VL2?\30P,F_,&2L#[#;[<LISC\PVMK0?!'('U1"5)+<_AVB;QUEM*
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M-)U^L/B6CY!H"(</NN.>0?"KO_H5KXK\:''(D]]Z^M9F.4L)!W5>M[#OTJ?
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M5>QLMH?TX]NI,^A;2(9]B8@<PSGS[+N3V0Q%Y"?A!BCK-CTU%)VN,7UP77;
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M*C>M,6G<.LRKO:41:K.(.ORQ'T\I&\H(TCQ[2TC*9A^'4T/+:$U*?CR=;4.
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M*AV.9.3H3XL2&H\_5A@UA%<T.)5/"T([F7#N4=4-99OX-D+ <"3=9"1K9L*
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MO7Y28Z# RDP>V)H( T9?==5 4#O52M4]G4]FGUB<J1N/RX:Z;\Q\Q-%A)KR
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M%'DD*IXHI 2O()(@#Y%.*I!&4I6*/KGU@,,#JQ#^_L/38UPDLLVE*.)L3E*
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M:T@_,[A)"PS[K*%*;LS5@M4JSW^PD;ADM5[;^MXLV&T28+ERE?CD>\VWDT!
MFD#![,]6J$%*>6$X*I#JP"*=)5KCH<+;S'(Q\/[<!61->.FJB&^XZ&*5U_VV
M\QVIM3WZ\TPF:;QX*E4PD^TXO *%:^V*KV?MIAD:+YO@EBR](W7=[W'D-#3A
MD:%6QFEHJM6'RE4;T&;")FTK:-\T@_:8E"X:F&SF-N:KQBUE]\9$+8^<59F@
MH>E0!2HS%3C-9*R<@A'.XVW*!F%HO)/VN1.Z*[Q1<^IH"96+.K"31T? 8V+I
M*!W33VL-[V-A'[IQ'"S%H?).@M%Z_ /BL)9:M&Z/=\:\B)Z:=Z9)C##2K:,#
MFW,B4&OB=<[N%CIP&\9*E"[UIJ^P*(G/>WXO_X5N]^FP*SL;FM"(LP.YR08V
M!W2C6_!.QY-@F\D95D=Z[>#(&D.'/2\54#?G?;CL' ^-= )9:7H*>1CC_+%0
M\\[5\5CUL1)P'#X=BRRWQUH-3WRSV19KQ"'RRW([W.=5-=JUD3?P^*7=:BBE
MO?)*O<50B,+EDW9K(>42D&V%8(EY2Z%7\<HHPU9")P^76^8MA)1@,VX?3F;9
M34J7C9C/ZCMSYGFEM$MN&2!W::40!<,H/;XAF4IIU(BCO]4*_^6=1_=EVHMK
M^J5DB32N7L/DP C/,LO1_V7W+95Q/1-:<AM9-=G4?JC5Z&; \'8Z]B&G[\%D
M ,Z+]:9"HQS_>S)NYU,)O/X$VA$ PQ,9*G&*S'G*B"IQ#OI#G#+VL$7]CF6/
M^*T\5MADI*[#R:Y;X_ YS9)L6\:^["65.KE&+U2>/>6?_WSVIS]_X/_TS]^?
M_9___?M^_+S_FY0?29;G=R3;*"-->Q)."Y6)T'JURMJ?805>B<"$LF5, NVY
MB'<&-#E\KJJ2#H9%F4;>2T8F%6QI)J:A,)BARX10G7FIKL3AG4@/.$G8))Q&
M/P7D5]PQ1F&S3L%ID+$1>"_86"D-ADQ&B,*-Q%*!SU.[6L4[H3[BE)(\H6:L
MHEV<QJQ#L'E3SRJCEM,YS,Z$WKRF5P%#,CN<PM17:G&F!3T][W2[Q'N"PYBO
M_YA5G>6@XA5H-=SF4#)"[Z=-4HJ#H9<9HY@<J=4H^=71\<XNGN/^9K</8L*V
M"Q?/ =DJL^*HA)W7)U "%LH/"))@F*2%)V0;9"MSRI^XD6?;N'F*SZJ25])'
MKM.'(,'KC;2.L%+*76I*)<0V$Z4@XIT >ERJ+Y]3T?F^^?S;,]L-A.?MF-4V
M#-;&705/?D4J@[<#:PPH7?>,T293NY)>^")"E3*F%0/*&0&@='QA+Z%F3I;Z
M9\RG+,WZ%E3<-SB!+/1<LLG:C"ZWC$K>)["Q2.6Y;,$,3Y>8Q"]\K_<QB--R
M8F[_[1-6YZTUZKG=;%F:T=]R&93 D,T6J7"P\DS_AE&<\L"[<A?&4G,O5(UK
MAE"$ M-W5^B]28*4V] #*<1^R$%/Q V+OB]9E.(MB\[438]R>&*D02E5#U4\
MK[NK<FV?TXC5[-Q6CJ@LO8^WST6^VA+,PQ[DN[$)K?@KZF9MHKK.F[$)[^/7
M:;C-U>"\#UC*5<#850.0M=FH-1FL5;\)IF+'"&LYUNY8ZL":.#U0@];-]N0<
M;S*"2[G'X!7G5Z^T%V4DBM. '&\*O.,IZUE(3L8/D.J!7#D;+/A$]S&!B[XZ
M,:YPD<?!ZE?+&RK=E3_Q1NG2E0<\%JQ9(+V3FEB-+.<XQ>H@':6T^UZAA"PR
M6A"%MWS5P50$S++:''_8D^PE9A?@_DC9Q96 ,$K7N2;W2FBC[[1!]*V-A49'
M8]@H0?(Y]@V[C/,*)HY:TS[A8KUA17)Z>=KO,2_PE6ZOJ((RT=R,[?MC]0RO
M14W^$QKWOLU;RB)U+XHZ;7?Z45-\CH[WWOL4M=1XYC.0<;H'E,'K[?NZ K#&
M81FT(5FH#$KHS]YY4&>GK2]+GP=Y'!K.<@PZ+GEB!;_+&ZT"F+'*!J50N9[)
M\#"F*$X.S ^55B3C6>"ZV1?\5XPPKU6HZ=PB7<*%T:W 6G1*31RW NTU 8:^
MTW"+%V\DBU'T#G'%M\'@R[(GGLSA?CO@6"PS<S2/NXV\+29+D-MRN5(%QF;]
MXGC\R#RJ/:A;J)&C]8C&@+)]O 5"@+5\(P1T##?:.WHT']DB8.:/&^%'-?=6
MV6\QZJOY#V7<EVXTQFQ* &SWK+=Y8)BF0R??UBFW<N 85#';TO)&VB>+!I!U
M/*I$P3*ICT\<CPR. >]L^AFS:!L<K5[H8+G%GPZLJ.!Z(Z0STHU3(]MPR;Q)
MYG7Y.*H!,"R=@GK(W;H-%)2-H)2W4D:,=A.+=K)7@5EH*EY =PEAD3YM="L
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M7QXH Z4@3?R+\%/!RXXN=5K[B7X;.@.OTF@5AN3 )GM6$BH?KB1-PL[.6XV
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MZ *7%ZNT6Q/:M^)A=3C61,DZT;8)[XP\#;>8=+A11U0?\090U4(YF"Z6'M.
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MC@ 9INM5C3W%M!H^UK*6Y-*(0]E3V4-5+4X7]_:H:^W9.7UL]#WX?NS-DKB
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MBQIE[QR\QW1Y=L#7]$NR721;\_\<%\\7A[S(=IC8D7%L(VX=O5,,[/MZQ[0
MAJ>38(L>7]X()6R8;=-XP;A.%H.ZWE3/T]/.0M[9U&H#NYE;=<+>>6.+4'1&
MY05;>55*B]&CI/!Y0!\>UA.^@2$&%8<DL0+?X8E6'@I5;$"*;"FU4*WF?0:\
M"/)GYHJE_V$WIEZ"A/DKV@3#\M^E2_YYFG3J6)C!^)[CX83VO--Z1B,$VE-9
M5ETD?T8=E;*R2">7-1/PWB$>21#AIIY*E6R6+@ PA?V48"WS+75=4GR4.5TN
M6RF"(>T8M)(<P%P<M?)E[NLDR;ZP41IM,H(NL\-3L3DDJ!9?:*IGON.0Q'L>
MQ172WI+S=2>_I,3-T-_-&*7N; DPP:AF.3!"USL=)P*6G1_4+:!.$V6=)N]#
MY 7[VFPAPR_1Q?FO9=):]B>ULUNMX?@HP01]<)*@$O?.-7N,DE5HJ^&?3F6Q
MYK+ZLIW'1:OAOHZV%KI81%LJ#N5.F3U4H+79[TBVQZ0XLA#F@H5!T]&3E\JU
MHY:]NML\,>.,ZB>.L=.%QL"1N,7#TE*=+^4:77?%N"U<-#9:/HMPFQPU9A4H
MG!H']TT4WCX_Y'%*!^F+;/<4I^54KMV<ZA1<CF5FX-W12RT-9@%FA"CD7:P4
M4%?#.Z&&Q92OXS0N\&W\@B,MKRST?):]5IJA*WHM*$$9R,8"AE_W^F:W#V+"
MAM0UN8SS?98'R7K#<DUR:TJ4=FNW:4TY)><)QO;X.J$=,./E">"E*4FY%A0Z
MUX5EZ8)UV$?KG[2CZ0A]'[6#K<V251(V*D,;9<<"7ZK*\"R5P.S&4*FDZPI@
M%B.@1 S, *?&)BT>-XM3U[H"DWE;:M;Q6'_)L"4U*4 98<: ]98G[ $G5&A+
M1[^? O(K;L/]]"=0%EKN#IZL36C/FXPJW@>:<3C%,$RNR!UCC>I"%/J(4TQ8
MK$NTBG9TCY+S4X<7FQ W:U5G9!II3,,H2ST8M!H'5ECQE-KE^7E/'\ :B,0O
M'(KE=E*GX'9%9 +>7QBII+WSRQJBN$RJ%=!UG 9I&%.*W:246H<=B.MU3>V>
M]:8!V,&GW?%9ZGJIL&1CCK32DDX1# _'H-547LHVR[!2==;4*[1@<\RD5W!W
MPF0#O#U<TDF#6L;;((5>_T*5%MOVJK"EMJ\<<!8FJ=*_:53!#&3C\$H3F;^;
M/X7Y?#E:+=W_2G$ON5EMW/@*62C#FR5.T&E9KP*2TOUM?H<)S_%OQR6CEM-"
M8G8F]"J+Z57 C%QV.,5CGSQ'>TS8<+7+4L15O3/M$_Y2Q88S5PS)4OK'$'>6
MDG;4&]^,2RY.-;)+SK%M@&'K1.#BM=*0U])IFD+]MKPS^3+.@^V6X"U?!S0W
M(A_9U0BCU\1.UW%I''MS!@5PS(I@V#D&K; &#)]Q=$CX9K;?SHR76^>X>"#<
MY.;'L:LTJNNX'ZU8.JDEQQ<5IIHZN, PMADP?)Z.7<?NY@KN%]HLJML]*^-'
MN-^Z:=L[WVO<K"_KKU\:$Z9,:<EI^I3IIO:2J8QO!@S?IV/7\IW=NH5XT5:\
MI=E<N+S.2'F)B2WTK<;SJ8VYI/AI!G=9/JTE,$0_";Z.Z^V-W6N7-W:;?GN)
M]P2'<5V!8;5C:8Y^XW_]G&,*A84JYNM-&4*F)?:L+;L+MYCU5;0A&;,TZYW_
M\]NB7<9WFB_/XSL/.$/E(Q!_!N\[,.)GV]>SHEOC*$X.[-CW 8<'$K.T=5>O
M87*(<%0F=MKM#T6UVQEZDNQ71/,]R,^":>X7)5]/S?44[[UP<=-TG?(3W6-4
M[O$_L"GNC^@.FANS,T!5P?D?27;8YQ0V?1^LS&2<ASSE^@%'ZSVNKI&75CW0
ME\2=6%6"HX=GS/=KJRCB&0R"I,WS/F+3XA")GS[L_%7+.[DS& !' =>V&UQP
MS4-1^U3O8T/I?FD3DO!%B6J5+Y=UNN/2P>UMJ&2"8#BJ0R<D,^)NK&[.F+]Q
M<?^E#(96W,8IOJ'=1Y4L7"/ODT,";!V/&F&P7!HBM. 34T%<!QZI[)Q%!B7O
M0Y3>^:/5 $NT"8[Z'9V/2\[=$9S$NS@-R+':J*(["O8YR#']+0Z7RKO:V2/P
MIW)["([&N&[TFAY<,S:F2%PO.C7OK!N/5<RYMMLQ>E'F&=G&'8TAC""YUN@Z
MK42GT^7GQVX7M-YOC6G*SX9IO+'R'8]].]XY/@-XV_&6=8)9Q]=9CT)Y,O;?
M<'03T:U7O(GKG %U?^^<#\<XI[\==H8A>[&G^#I"G?$5J8Y79W@$P"XUIUVZ
M*0;L?"(94^Y(=IV177"3LBQ8@<U4,KH5'QFH1IHH2TMEV008HD_#K9LV'@[[
M?<*=8$'"XAAY(ZC3V'+7H.I%&N]#;1<R+\[M=5U>CAIE3O>>E)6B=PI.0:LC
M7G>5/O<H:MP.TH?O@V-=R)9G';\X$*I5C#_;']N6ARWC-',EF\AQ#<'@[(GH
M#1RN&^1']+Q)5+4)Y4A>F8C5M BP402115<[U9NUO--T-%0])QTFSNVN'CIK
MANH2XV-6G7VEVS*[M,6P>EJ##BLBS&!XIT;"":UYI^]L)EBO4SL/0-434)&A
MYAD(2#)S#H-=Y;7R7BBEW:;$UT+NI\.7BGKGHQT^'=D&1 )2MZ/,Z=_O2,UE
MAY^"@@4^V5V?F=22^\(,DTP5"S:,:@80>Z=BU_BM:CWVYY+:'5_88FL$_GBZ
M_!83N/..9;,J&-F$PW7 ).,Z,_\H?>_L/ &TSITJR="_:%Y-DP6KL(A?3*/I
M22V!8:C>5&NBRIMY&WS58I]"6U2WZ'W-T#H_.BGFA\F01YZMC6C)S_G9:%/E
M9V36S7AG^>G8=:MAH>@ W8P]_1V'!=MS=6^E@&%[IK/_^D#70+B+^^J5)4VR
MRX\P[R-\](\Y7XZLX\S1/K@>-:-1NJY6MH2N\B+><:]&MU&$RU;Y[4AXE4#:
MP:>LXLI1?:*\+-WA]O.+2=W/I&)GE'PFT>N"([LE8,W*J#P( 4?,NJ"#/1<E
M&G[HIX0N9YP@#I!D*HS:*+=G^@O.49RBBX"0(_/1-6E<P=3KZ$2RAB$YX&[$
MT<C%MKD!3[=6+0U3W$8U: -DJR5D;7Z#L@E4K0X6=VX(!2I&N#.,NNX=&);F
MB"X+@Z)WLDU!JYE\G148X;,\J^%58+*S'>)&:3HCV3A3&HK9J<$@V"BLVM,Q
MOKA+6.TVQ-I"R7QG"/.E\J^B?GO1OC_A@-WEC=;I/<L30,KZ*W2%2^J_G@=Y
MG#/]*I R?$YI;[*<M1T]VTLI 1>O4UJ*8,D'>^^8/JS5^A^6+XLP9X(+_%1T
MD(W(1Z%4])0^PF"((MN#0@L,JZVAZBC)YIERFHEH(TLOF6]2^BB<%S8NX5&:
M[I?+5J:(BV6MFG=JC<>J62C7ZO6&#-#0QG,)\9H._>(0=0Y(7O3A<QK3N>)+
M0"*K\^K%GN)GT)SU%<E'V%D>X;W/+&N7IG]U4I;R%A%O#>+A.(?WG"41)CF+
MF2Z.G[("_QP0$M#I:DWNX^WSF 7&Z/8\=:%I9BLZR[C&(':+219H.D"E"I+Q
MTB%@Q?!NRS(&Y\=6YJZ\Y<+[KRYIU(SM0YI41K^6,=.)=>,0>\PL%FGC_IFV
MI+H5ZCX$/1U[@M6#JOD&2@8MX\M2O:M;0ZJM.1IVVMUF>Q&]?G9RJW ZV%RF
M"#W+HC<9.M/M?.G#C-=TI2M2^]#<2>UXN)X[WDS)U5S[1KS3_%3DNOE"V'/P
MYF"OP+H]F(->[WDNH,:CR[.4E/\V>8=_RD-\K\5.?T&F!=GT)WCO38N:97]8
M4/:VJGW4:1=DE^M.?MT7,ZLCS:9AWUUKVHL8L[\QMPJZ"TTR1>,3Z/83V--2
MSW+VK_GJ4#QGA&77^IQ&F'1>!TM90/=Z5Z^8A'&.>4*7>[:B/+D/S?!@4'UL
MMA<YJ@^>_-2WTT?G,E4W]=7:9>:BO,J_R(M =*?!Q3=(M6]RRJ;(I.MA(V1G
MCF3SHU?TSMTI:'7TJQMX._/'K.NJM["6FF_]!)33L\ WK9/>/0FNJL7'U,\L
MKJI*(MI]<!4DH._:1F4/HZJE09)AU:#IG8.3X.H&UFX+?0<IO! 1GO Y9<<?
M+!"&U;-Y#%XKF.<XQ9O8+NW022WZ&7(GFRX?=T<WYYWX\]F@O_C-*YW1A@ $
M=G>#"3>8\+H K[)PV9&D']F:KP#1"2:KHD9'- 60Z%/P&_/F\XY35MTL6V>D
MK[,==(N*0[CBT+Z+J\T&L^45;GK\?5!@E@,]#2E:<SKE>9KTTR>F&R_O&./;
M ]@[)ANAZR*L+U1S2)E5M'Y(9X;PWRN$X*U[_$+_C/D/#WO:>55OST;3*<?M
M3>E1V:P&A['66 5B=C3_&RIUSU"E7;G?N+Z.D0M^O-(/R''<!61->)')B!^3
MU15G91_/0NV7#TX_'WVA3UF.;S5?<0SHX7>L_*4Y_V#[@* 7IN9]&"E'-%;;
MMRP<S*MXQNFV5SNT+"UZQU*S9.FJ*$C\="CXJ)JQ=!E4B;Y!BFI;WS!0O+^E
M'N9RL%KVA76[R#)/<M.GOB_[5(JWK(?H^M2B5@X[8;^6-?NPJ'UBIW+M&:]\
M72X%SE # %4(4!<"RPK6!]%<M/$U) ?Y,]TEL/^P^8(.-+P$0%%G$.$#EG10
MME'\Y3MPP_(HV,+ 3-7X,H__H=/ &0J*0=:5A9RQ/V?D5_J,BV ?%T%"]V1Q
M**S>=(+.G*Q:H(U#52KE?2EFA#8DQM_" YVM=S](==Y]"R# NE/I(XL.8=&M
MB61U:T&IYV>+:S!#OH]5*'GGVUBDAB(73+-7" !*F+]HU:TA?E^KX;C"B@GZ
MH+2*2AP,V\P8ASR3<NO6+NI]P6_#=KCI =>+0A*$Q<]Q\7S!QV1,KEZK-1ES
M6M+_9?Y1V3>;T R\?><I1@P_]YH^#Q7Q3KN6^7U^5[<+UR*CJX6YOZIJ$?O(
M'H9(V:(W3Y!H1%/!H2H2)G<%F?7@]<E1J.6?*W^FV\EW/-='6+5FFUO*UV=L
MLZ.._I*MZAO[F!+@\N_)4X2!^YQT5SO8&;=WAJJ=<_\?.I(J)\'D!AU_>N,8
M/(\Q<CJ$5/J,_W^$>UZ%-$*DO;;%!+POXEDMTB\!)=-U1BZSPU.Q.22K,,P.
M_(6$F*)7[R=ME5TN[<<9U.6WG:93&N\QB;/HH0A(H2/S*.1#SC;*B&X#4%2I
MHZ#21T]X&Z<I\X31_>@1!^2-<):=!=,9@ [ )[VU;C/P>"P:.9[1;1M@-K,3
M@0O4CJ(8QM4\.X-^)G&!UYO-:8SMM */L(*)X_G:- 'M1&L:_"%I+S'SRO#+
MI>_0%R;\+J/2GE:1BT^G;M>%Y81ZE<[P'96+0-.$BNDR$,I4VO-1*VHRVQXH
M:-6]G2M8&*4\7M#H@IDJ1P*6.(&YTAGB:OUBVI".&N2FW9I/'(R*($J["X98
ME7:_A7@,80=U)!%OY\O&LQP;/^>8CO2W\48U7EII@N"C:(H5(5LU^(P4L*HH
MB?8-(W'#R /71@E5]T[(3O&6M(BC.#FPH.4'EC6=>R#+$P4<E2<.N_VAX*=]
MZ\U50-C./J^#&.WF^GD>XJF<SXPO2%'R9X8G@.D\BYBE+1W4>0QJGX/J!]6Q
M>\VC>):"ZF&(/JU,Z09FY7+B:S.M;^9KWJFK8.:7TMMVSM0VF"XXLT'";G6N
M#@=IA7;B.UOMV$Y]F>]1M_V&^EO_=<S8V<J&?R\]K6>-MIOE;3?#O6X6]KL9
MKKL978:BG'>S@#_$>P?KUSFY#D)]GU&+N^P&)M!=9JMDP9#5 %#T*C\5G>I&
M9XAIH-4L;%($MW].&7]Q5(4[#>R0BS@+:%> :T+9![][_^P:4.*%LRH&Y4M<
M/*.PBFII(E*.*&WB6KR/(X9@JMTA"=B(>1$4X?/G_2KZ.Y7A+LVL>@<_95&\
MB<-J2*Z;FQ:Z-?UI+D>QA5_9B "]J8_RWIG<V*?LE[N.%GKG.7A3/-CZA M-
MT*9.'EY\GQ5:8:U6G]211LO_0%E>0BHS/I4\NLCR@D[@I(A_XU121KI9:#H=
MP.Q-Z8<?&M7@#"S66 7N=410?GC*0Q*7*71#VH#_0!:%9;17C7L57 $ ZSK
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MNZ58\-LM5* 7W->RARQ+N(KV01RQ8V]@*9)KJZXSLHI> OJUJ7V;#1U"Z+K
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M7)+"ZY*F)P"&'3)40QJ4,G6I/\>^W]]QAG;_/F+7EKZ9].QUXD-]:6Q!RN6
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M/F!5$]E]>]"% 6,Z-(3)6=(8&%ED!-Q,:7"^I^*6&4<W^*54E)_3@RV6WL9
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MK3/'EZ:;-1.@)IDD_YP'S*UE@K]P<V;G'&#3(Z1V71/E^+LBP[G!'T^ZE(%
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M^Z[4L%; :.YHTJ78X@J47YS15-D@U+AQ'=NY*>N,N]J7P2/;\)?!PI$]_1;
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MZIJ_8-2R$K0*V >K @;*_5I%)OME,Z:6.%\^C[TN<2IK",E.(PJ:[JIT]N*
MQOO:,WI\:$KBKUD4;^.0H=RE8<X0Y,D[M6@&=;V*T-$1@SG)/![0+Y@U94%F
MG2=XW#3%CGU\+1O4&^;O66^.>9SNN-7B!\6/9(W-8[K@,3 V)/J5851+X(S_
M:5S()[S$4<D+*G!VSEOABT(E1^*&G&S031=L+W:E?^DKO73IL"E?<?[\&HA+
MB>)RM\OQ+BCQ74K828LX_"U(COPFPG#Y[8669:_;/ YW]];- R'>K3T$[OOS
MOT;BSAN*Z)_;(,[1&T5>KR^G]'5[H4+LXPWA^)8PS 9K$8_;@8I5>'BG#?%\
MFS8K"=XM@5^^=8<)GZK#!&8*/IV;*=#4&&@%\FDLZ$S".X&>-9F'DX=]@<(:
M=F+.QF2<.@+R!D*N:^B0363-%J,5#0_"8KC0<P86PWW8ERW%\Y-:#.<1<#]2
MKO<B<=6.W?686X_';-4Z ]>M_JU5T8G[@1:L,A=[2N6R7%>\?/"BO!SLP'M$
M >VRMX*AM%?&=Z6:V%K='5[+/.-\K[SQ]4 &O,A9GX-@O0;.ZQ=+8>O%4DD:
M@>&,33-NW65&%_TQ9X>+NU.S#MQ,<[S7V]DL2%86^]/TKNO.L.6DM5_RN:BP
M)[E:/6!?@9K@+FUJ)Y,7\3Z0%9PMW^NU@9=AB!,::8\CZ@XY572=MI]56#S;
M,$UBZ'2=K-^^63B3HU"%ESS/M;&_XQ^^QW@@,GFEGVZSG/T\]?Y:V\TJ#FLL
M@S3)&8RF#U@S;7K&].\C^2[T @6['/,HSX-HPY,3P2ZAB=W(CSBZCX.7.(G+
M&!?7QSPGO*J4P8P!S]EPI%>Z6.<854!^@0+Z9I6VM5Z[R/Y'K S\RM&X]YJL
MBU780\/@3&(+%>VOWP[JF>K/)WX*..A88T8M^9X&^RPO:63]#7XI:3P>S93[
MF4]VE=S-&-"B#!VIE3W"&HT_%9XI='"3Q[LX#1*N0^7S*W[$=*]'M(@&/*CB
MKJPHBP7B.1)?Q\M9X+T;@0%$]O6EPA*'[WF%PL+0?&5V2(*BV&Q_9S<&Y29_
MI$>L]>T##H\Y7_^#),'1U8> *P2@\H+GQ";A^413,22=9W/ ME]+KW'J (.9
MS D-D/H:Y'_@DAWC$1::)Y@J93?#+V9(7,BNK8@)&(8)<:"PKR\4!>T9SO"C
MU1,4YC[^YS&F-BJZ"?;!CNSD@@]=VD ][&**8B.W5A(=( P%L5#75XX*G*\G
M#(%>]DZ1L6^"7"7$J:I#N=FK'6+KQ)[Q+B7^&=:^,7/$73:KR0!VNJE.'!"A
MK7Y#B-8I)7&0>SJ) G%B$(L6Z+U%2-]?[?SKJSCMN,41SH/D.?@A=@)7.,7;
M6*>I5JPE==21A8[?9D;Q;A6'T2DMGAP<BFX]E6167*;1/>EDJ(;9<#WHF1L[
M"FTS(T+3.2=JI<M9BL0.1*E&@=% ,2%.443')OS9O=%JZ82_["$63:IAW*4.
MIUR3]8XWA,K@!_K3(<_>8OI@]L_HA>-ZU]\;O,6$PDAP2CR2;(]=-=<5>5E_
M<@A#78?2!7,9/?T/KJ<IBVE69F$=1374=;QBHC/1QNFB6Q,^-'((<RJ]=,&'
MJIT#:(>^XE<LC5-/4!HY0@D!Z=VS;1%WHUF];D<"=\S"/:/D!DA,Q_5"-P(#
M966C5BVEF&&!=ZX(6Y=%@<M"I$I.=_=945P'>?ZQS7*6YLVBPDXM^# A UA3
MF1,'=##;UN$T2\%8N*RR7J<[LIP5!0K;:. 4MCJ1;#/G.#IJ5)\J:F+&I)LJ
M/+!*:2!6\;2 'Q8G\3XN^5NWMCJ"T\:"_'%-_AV7HTRG#MNKV32S9#29:E2P
MFFFF5UK?R9(>,FC@)I*R5?TF?)='7.#\#1=DO\-N=H*DN$R2[)V&0=UF^4UV
M?"FWQX1\RXZIH=C ]!WY5O5I!LHV*T[K!?0$FH0U*=ZX0F$5<R*!1"\5&=9*
MI]RDH[J&J3/=](!W:WX"%\M%U^LB?N@5/WV,':>!+BQ,AEDNPD=#7A/9TP/P
M;B!-5$E!$Q2,A7L+N)F$+*EH*X3('N@U!'LQQ1C.4JTR[JA03,TXLNTA.O 6
MS^ZIJ*O%[6-Y70[5+!C7O2X*%*T;1J[\9 ('><H>T4Y28V\)1ZWSR">-Q#%O
MH7X%9,B6/T]7P)R\T8,UT 4<W _X^3,=C_)UY#RET%S]BN;0F7HVU:O2#Z?E
M3(OKSZ>PL*/W*#2(4#1S#-'2$Z?FJH!YL4D%OY2NW>!#CL.XFC.7_(&>=A,S
M#-^?SCFPI=<[ S)LW;,3WM>_-@;;)0<M''C.1J=ZAVV!$,!>%WQMN1$U)*P(
M22.-LB:UHBD"!@Y/?^C3,3X[JO-05]95F%XU2\^*4<UD-*CQ9':2I20 %2 *
M*DAX*O@-.^]W&*A7)6L1:]0J @?<=#44.@2#P3-?K=0R7[(L>H^3A"SP=VE)
M.(EI5G9&L7TP7-OQI'7#V-2HI%LC@,W>( ;DNX]_'N."E0?]E..$'53&-2I4
MI1XT*!#4TUT'0<9B&DEUL)!)@P1)HZHC_9JX :MM'\OKPJMFP;@&=U&@:YV!
M9E5()5CEJX.::5GF-"1D594V5;'.E^WG9D="S4>#+V<FFJF/)15[EN%1AL!/
MT8'W:^\YN=(\#*LBZ9OBX$&)BJHAE%M2+2TRR3YOMX2T^ UW^.J.S;BI-4G+
M2TZH"8>B/8TF:!;,Y)F.E_%3Y@)2>@Z--5$_V-/ZXH-; ;#.V%AT6$ET38!1
M]W%T6YY@4C^+9A).Z7.6+=IV%=^[1KM,\8'J?5J3T): (8I_2GM@9L$$3)PT
M)4 9?*?!4$9%?/X1XH*&5E2NY9[&AY\RYH.Z 3>-1@S2X*DUH \HU\\S\[=4
M0 Z@B?; K<?LXUSWL\ZIUANF>>::Z&1=:]L(SERGV91KFR8NR87%*A;VD8?"
MJB)B1C6S6)32"4S6P4HCVH"R:)Q(_]RAT=-IYD,]6R8:@7:#D+559OP4O6U:
M\VZ))V/!IL0P+&V5-J!7L&+H8$C-@-)=#9.#-+;7QGKT5$VX-GV$>$@)1R5/
M-[&&!B&KZ8DF5MO::E77:F+[2@S#Q'X)XG23TESAGW_0^/]C7+SNY0W@!.V!
MTF8;VX.46=?8>G39PD%?E2DX.AZR%$4$A2AT&P>@,I]NI5U:7H6"GVBW[<VN
M7^FMEMRH_I#.WS57<KQ69/2/8U%2B@=>M,K8 "Y8=2PY7*SV4;TK\#AZI1=]
M% Q%,9D(Q*"&XL;(NTJZ3$Q'_1S7%+3S9A?-'=,.&#4^@7@WG5Z!Q;U^I25&
M[]+Q#\&F:!B G1XQ$ XF?$"K8*;%9*RLX?69BPTX?8Y,W@NTM>+$V3-Q%V"F
MTCQ\.<RK%:T\G]. 1HB."O#7M0%H/5&S-V#IZ#8 1K7'4*WVFHBJ[H.4;E!;
M_I-WK1TR=9U4^)0&H9I[NW*/;PV,II_,P@"U=[3;2YBS\<4U_@I&=#8*Y9N0
ML"JE4;U@H-&MN-* =JT-P.]^KK.TC--CG.Y$]J0L'794H6[ OQ4R,6:W.BIL
M,*HZF.13=1=4/+:^BLBS(EVL,]:2&NO(0EM-+2A@=-.-3GWF-HJ&.GCH;PSS
M_P!6O/LXQ7<EWNLLIQ,F# 646'%3PAIM!8K8IW68,E)LQ- A:^3@08&B?\/4
M#DHTKC.E2U>XTL0AD&X[I!*?-^8N@_*-DB/.8K$#KN3740$V!.]6:PB5=ATB
MFT-<X](LE,?3(UHFR"Q3A'E\8#=EVQOB=*;T>45:YO'+D?[X0'9=,4NUR3:]
M#UE1YKB,<\S"&0C'^KQ&IS>\;'Z:J0:BF\+FU%:]3X+)6>G/%(&(#N37"Q0U
MW7B?'%^/21GC_2')/@A#A#Q!ZE.\2^-M' :<L?8H: 9O5$M+JO\)K+;U?40S
M8!1\/.U]C6Z#H#)CFNU=F9_"5QP=$[S9/O*<>0]!7GX\YV1B!B$[E[CZZ'PQ
M[-M'MK6D0I_$;ENE1S4$1JE/H5YZ/"G:HKD!! YB2*C=W@5Z^>A]AG)6H!D"
MVT&!'6U)Q79EHJW#-APPZNI(:%\SM=H(ZV2 !@3?I<0O.E*?J.50:5TN+?RR
MKK&%[*['JP$&HV,V"J6=7%9B=" 4O-+R%<$NQ\RE=?54YUSCZ&OVNZ(XXNCF
MF)-]Y@/.XRQB#^4+_OMMEC_A_"T.U8EQAK6P\,5@B7/SP<Y(ZI5) 5#,X%'$
M&J)7*Z2E"U2PMBZJK[2T:"':@R5T&D.$3Y&YNH&__P7::=XX\N5:#B\EBFLK
M@+9!B!W.9!:SLG=IF--R.:+.9_7"SVYQ-8@+R]'=_MKHU;YU)(M[2BSS7(>Q
M3E3R$\ ;=::.H2TL6$IH#&NM8D)#T*&8C_&DSZZ!)_N5#[D(/66V\3I+R3B4
M-!<^_Y,>8CSDL3:XV1U]2:]S*%-MD^B*"\8F#B18.D*MT%''EZEQT8$B>]?3
M%E]=AML>V_<#K5Q84:X9KU$M+:F])[#:5N01S8#1Z?&T.ZHW>R<;UL@@_+9;
MC/6Y$C6@\'QL&Z%RUF@6G7:D,O*U+0KH(2?3CV_'_0O.R3]:>G:7MDZ%E+NB
M ?C@]L%C:)=VP0$_V2UH,Q<H90VQ'UA3U:2+4U0VK7E?4A[R+,0X*FZ),E!N
MZ=N9S9:LE6]!B1\2LJM3I!P9BKRLVS.$H:[3XX()9GD81*Z\(G!D1 >/J29[
M-$6T]< ;H'=NO(69]H=LMCWBZEQ0/HOX1;4!<<%:;!_HSD*]][.C0"DZ-HQ<
MLW[E=0M4P^C>C[C3]+Z!V4J?YX FWK1G?R8D>+Z(.\GJ<]V6\-XHN/<EBT4A
MLF<!.YR&,39&R.N EUR2S 2WU4L-"6;),9+7UQX>9MR&!G./+?%Q;[G!-B%X
MU22)<*,VW8.[K[:2Z*)5]X"NJ!^SCR I/]1I475 BX8_* GL!#MT(,"HBI(L
M*9"! TV5C?3TH+'C2X'_>21N].<W\C_&F# EZ*(A7P9B.TZ0 @Z,FAB(D_R;
M&A0Q6##K4X\'V^JD!_>H/<:520<+58MLJY*L21.N2;JLFS]P'L8%?HQWK^4S
MSO=Q:GGK8L-8+DNF$^E-]DLCN'>=<:>QKS85$LHI%BH;M(F>MVA4IT7?+<::
MZW<%T&(*HB6PU@D) LJVVTB=5#:[)?$M]I7Q@IUUO_0+PUSF.4WI08\ KSX:
MD(?@@_YT21_R;5CP7O$;+DH<=4_.E59_AGX6ODIP.6^9DTOY[4^^S6@:E1 C
M7I6'M$1Z*M$;:\:31G7O*Q^"?).S4GG\P(D0S=BR1Q[H,*%=( VD6G4_2Q/@
M1-7ET2'([8=M<UL$;71(\Q6:'!2426-='6;"".FX.A;$4Z2'(/L7L1(P^C?;
MR_"?Q[B(Z2^?11%A#=<#VUAR4S"*O;:N#6K NRMX"M5]1;W<[7)V/=/$SEM5
M=EE)7I/5*HY$5AYV1<Z-('N_^HNC-,V-  J['4][7[)52[2"7M74!0W$:1J#
M\KR=;F,WVVO"4US>!C3;6_E!!F ?ER*P15N_850+BYZE#V>M<[CNC@Y&A8?3
M++_,K:#I?F7^.CG<_=T<RZ(,THC?6QKJA1C!EXL+L!/=! 3H8;VKC2.!TF$8
MCW?*&I3Y]<190WSKAIM6^-<'VPG'(@JQYC Q<'$@ ^E6Y>,Y=*)ZB).#!#IZ
M<(D6@^&=GNJ8_@)MTSN*=NDD,BN#A#WH"Y*$K>^SGD /H/FNH4ES4GU"8XO9
M_9,9KM>&T2W!\"=.)7\IQ3W]$E=9;ET^![[JGP/;\QI,T_2BE\,3#H9T%'EB
MN][GQ0S,2 ],$OSC QV.-*<>.U^ E";L\S^/9"/Z%9>O&9GS].*"<K9Y3\G*
M]QH?K$<, _ 7S> ]E*U. F]79##:.Y1B[;-@6U[Y6<U4EK/;^ZLLS[-WLE/1
M7&1*8/#\?1.1BF.=0Y!^H!<&ZNW:<(*G@,!\<QN94I;FUAXYR8(4O02)K4S8
MG&>DG?#<CYM@3^9O\90==Z^E]HV$%0F:D-P)EK*@,- +_W>U8[P&;K ;[2S8
MM<7S:Y!V(A'N4OY69%+W:V#?@*Z!%F=9*G;&P*175.B8QN72.978CNXA"4H:
MA'*#WW"2'2AOW[ <Q:<&^WN4A8O)E?3%ACY0[*WL-$J1! *8^-(U-"UZ^J\^
MA' ?$_6*:,B),%]$]6@P\S5]4ZZ(J;3 PQ*+&['24Y$:"T4<#1TX'@HYHA=)
M7>5QM,,T*5XA2:7U#98$9,*D2VT&P1/Z>)T!9!7O:LFW++7- @,.+#FX$ZR;
M#=2S[$^'E.8!\3@EZ*UREK+8N>?L"LO)Z23!63%@B<V57-5U.Y$-7^#+#+U@
M99I%+T)[(EWCXLLCCC#>4S6Z3"-MRIJOF(:SRK??P]N )=CQ#$B7I*PE] 4U
M;2'2&&JUAOIY?/[&6S2^,)E7_+].(/Y!;4 4_Q@&-.+_=2WB?\;[0Y8'^0??
MU@@#5R?-H?3KLW.-:P&6Z,>2+S\!$>T@S!JB08',YC=9@Y@R]))UP=AD?$\C
MG#_B74SVHFRDV/.GXK+*\2Q[N,.;@"7VT?0[[$Z.M"FRL6_:X@_#BB9IMA_7
M6NF^:&RZ 1:6).V$:KPQ;GR?,W2%$<?RNQ!;\CGS.)\6MW?4**68Y1_[/2Y?
MO^)\IUJ<IVD7EM"G9<H]$3H_(>XDV@K;OGW,;+OH![V3CM">]>3'M3]UE)YP
M62;,8&VVDL6<7M.,W9V9 KKP.JM>%C4!%#J1EK%U:BQ?P>D;O)LX)S]OZ(,\
MTL[TRJKKZ<STU,+FK"J:UWVCB'5.D'COZU3.UJ.Q3:IX0S!M^V>FB$KF9E6_
MH.D192D&IW.MP:(#](H36O+C.?@Q<&TVM+,>';(S,5A7.OKQ+AIEI6]*VBPD
M?6@=6,R]0D[0U2JT:CH^!RA>^[3HK!;) :,Y;I4<W<&Y*>.IZ^0(%02\4 X8
M....3,Z&LUROYZ:A[BS/J[:V';!H$YXZ&WR=,7IJ;6Y%"NC*RW#-LGB#8)6E
MF9(3G!H/:')%2C.$G]-,$L13XLOH'T?^R*-XSBZCB*WC0?(0Q!$9B> 0ET'R
M)8A3>@WJ9-_)A-O%;YB^#G0Y-EZX?UAZZ8=Y*4=10P4-3PIJ.M"!$,+TE9."
M=H06?H<]9*7=-D0!.FR>?.R'79<LV_V9J_V8ZY2YM?ZD&Y83'N6+.IZ7:?2-
MS("@>!7!1W+YW(Y('+ 6>V;OSD(SG:PHP*: *[V2VG)$%*01C?BEJ"*@J&1U
MR3@RK-AM]XAM6$*RD3D@.MN+0*K2OC>8__<NI2G.JQ?CK:.BZZQ01'D-0X<E
MNE&TRX^9.3**1"O4SA>M=CIG7R%M":"<'_'VF$;W<?#"4L4-%',/>TU25I,^
M7,@Y:X<LX:(A+S(6CQ +XN$+#RG^;QPIGKI)\G7&A"7;H61+#_L$/CND"9L6
M:$U$Z<6?3Y%NMH_U*U#FW58:&RNV#0XX(,7H0+!&@*IB@_5<C#UM'FNN;D0P
M_S7QP\2/>IDI@($*2T^I04I1];"!.:4'_L&+>!YQF 1%$6_CD/$JCO:D?/[/
MF8L!/:DU6 *>@A6I6E>OS?JDDY<R"%O-THTV&/,[]#Y5=IP&-@!+%492+[E/
MXVZ*O4A<8=4*HKU9'M%MMY9S>14>VQ L#3B1"RF-BLK\%V3MYBU:%,+/.MZW
M7<]9O5W@[[[JF?$UBVHHZPKAU@PL;3B)!^N:0 Q_O7^J7L&UC,6^U:071?@]
MR_^(TYW8:1!5CL-8]@244+#$:"*Q+R4!6Q]T1QS:DVU.@@\<W>3!.TUWQI)4
M:!ZGZ4%AB<)*IVQ!&0*B&(BB((;C^85X&F?Y$PZ/Q+2;I*(#A"43"Y7R@VX*
MC@0\ ''HDN@\XQ_E54),J?:L78L!2T"NY!I>X@I$)##1WR@N8LA^IM!QOP_R
M#\75Y+-9=*Z(L"0XD&KI*7WP<DR"'$5Q$2990>9=^_Z4^A(^HP:^ISC(4QP]
MDLUKJLCKW?L.2S)JXOH"J*"0 //B#<0[ZI%<IM%#'J=E^U1?ZQ5846 )PYE>
MR4O@B"RQ"$-%'5RORY.<0D$7_Z*%A"4E&YGRQJ>5]X$C5.N1%WOU]>9J2-X'
M,S@LT3C1VI</04(P,T \'%^2.+Q+6258RO-M$"=D]=--( L\+%FY$2M7^:18
M*&[0T);C>?4!+(DL>4S/R)2='618,AQ!N7LR3X_)[WX=F?!LC3G.3DQK!C6/
M68NN&_Q"QH&8")V?:("%)3([H7)JHT8\#0J !(/_.6!>*6%A2<9.J&8&_2?8
M&<0)_-\#Y*2$A2@G$Z$:.?UON'*B%%35S^OT=#I!&8"!2<I.J?KI55T(OD8"
M>3PKHK:KV&Y#T=#!+< 2Y%CR!Z1]#T0$?!7KWBI#ZB<6K.Y^LZW+O?,*,;R"
M$I8S7SO@P)*K.\'2)J[&I.>X084K"OP1*7)L/RDQCT69[7&N<Q4[GV$)1$F;
MY! *H-HF>AEE5B+E/DMW9+[N6W&?^HL/*P8L6;B2*]6)HG@H(8B(8K:C6KU?
M6FEY,E]9N:&M1'PNUU5F&58M^!3D=AN'F.:W9J&6++?Y_G"D];0T9L^* 4Q\
MCN1*DF-XJ$84F=H%JE\WDKY#H0$@HK9N'8EE.EBTX\"2FSO!DG/(GNF4#6HK
MMLQW%93:F#QWC0E]YJF1G!T%EN"<Z1UB*WW+3=JX:&H66X%AR<J!4H>M5ZO.
ML,\J->,.ZFUHL 0VB&9M^1FHQU>WQ&"G89SN?@]HK<52YX)HX&")RDRD5+R[
M@D85N%=)7%Y]L<A @H U^CKRI(0)5U^ C'B2_!H??LT.MG%7PP$;?2.1D@R2
M!!%P1.!AR()%%A3$&WD(\C+%N44D9G!8DG&B51EI09&0P((AIMZ;85:!5R<C
M RPL =D)E8/*ZN?/? GG.)ZOW.O0JXTQ+E,'"$LH%BJ-180V  (O6Z5=-7*0
M(& )0$>>ID*M_Y<8-W$1LG+S1QQM#IB'?!K.M"WPL*3A1JP<F=Q@H0;-^UGV
M+?[Q\50>HSC3[C?Z$+#$H2-/VF,0."0 _1:6?,^>7[-C$:31\SOA[(/\8#=1
M3EBP)#.$Y+ZT_O)O?_D+@F//%*_!92.F ((E$ .%;@_6H;Q^=7_\"G%>V,B<
M\NGK"<DR;_!+N2%;GQU?J3;'LBC)5&X51.DRI8=>+#FFG>26KNA H2F+A4Y9
M6UY*E#48*&M0_,0 .4;DK2(8;U@<'K (/)7]OU$\U-3 P9*$F4C'!"S1T4]<
MW&51X+*3:3,MXDAL"I[S("TXN2HF+PNVESBFJN"YJ1J&)>N)N9*.8&GSO7RE
MK0Y0V?2@3N16H*!@C[)Y-UY4ZNI8Q#2-_'6V?Q%7_S1AT2ZEB1WO(D)EO(U9
MN"GEMF"CF;,LRZUK:O*-2"*ZC-@-68&5.=]FZPF6TLW-IG1Z(_JCV7^J#EF&
M*-XCBEM=$GVC?7*=S47*ZW;(0,#[14&[X]7K)9GJ$?X6[.4E:Y9>SE<?^RPN
MHHLE[12EI%<_:V[YFF3IKUE"/>'B+@UU=XQJ.%C*8"926N 8-*K $8'W>R(_
MH2I?D<4YFMTFU+W 4H,Y65S$)KSDK%B#-YM0+8_Y(T[X?ODU/FBC#TS0L!3#
MA52YZDN%@SI(GB_OA%;J[^ZZ +#DH*%.OKFCTX#!^7U"6>6GJAZC??Y!$Q1C
MUV1<1C18DAE$LQ1,R)'19HLJ="3PQ<L&Y/E>3Y3.(9:^][Q0$IX6$I:\;&3V
M123@V<K3?Q;I*8HZI0FER6H8EZW0_ENLN\ZP(<"2CR.U<D1UBNDTXHBHA8D(
MJM\P'G:*%->*=OE"LU>%\@S2 <(2D(5**8R'3AX*WUBX"L/+VY$\WA'%2/B+
MVDSW+%4-!DL01AJE=R$"&%709[-QHX_+R@_Q0GKV@T:I-U@ZL02KBVSH,.N\
M>KI^%J>.(JGD=4;LX,Q:VNWJ?%54R><B^AF)#*$A[WKURBE>@[8_<&=7;$?D
M.*5%>S]?%79E?1&M%J]#N]_$I@<+>CP5$=%5-M.?)CC@P%(K=X(-KQ>DXFW>
M0X.[1MJ<6KH#!$LZ!@IUZ:,%+*3W/32;=1@?@H0G%K)-FAXX+(DXT6J=*H<*
M3:1+@F#?ZAQ>FG*'9G#04E+3:I52DXG,8\U#]6W(H%L>B);-@5+'.QZOENX+
M3G%.9K_%;U6#P9*(D<:^+ 0P#$=-FW%&/I;60<(2A8W, 8ES_.3U4*;]U%:8
M,D'#$HP+J:X)37V_E.?T:+.%]0%@"4)#G2Z(W3'OUTDO3N3P79?:H[:P<',;
M"[Y.&<>>,2Y_W255IRNE"K&"ZM5QNPV2[$N>'0_X_OY:%\&B!(,E/".-\A$7
M T8<&A%PKV::[ER2A&C&,4@>\NQ '6!M.)$)&)9('"B5"E*W4%"#<S97BN(_
MS)5K'LW->@*N[A*6IBS&[S)/&L1_$^:P-R\=O99-%_4 #4JGA82E*S8RM<NQ
M0$ ;OP)YR'$2TRU<_O&0QR&^3)@'2M^)F6,871%AB6L@U9)OWZ CAH^:!H $
M,DYIO)C5NL&'C'B%I!$<OU'$6=<'=9>PE&@Q?A=9'_BZ$'$2:&N"AM5?]7<>
M$;9/;^=U<'2]GJ\.VUA>_N4F::VA8O6*_"7+HO<X26;5VZJ3\U73'H>+:.5.
M]+EZ';05*Y^QK_/52+<BZK,HYK&JS)[SOE>OH.W"Y8]X>VQ@Y"NYA?H]7\6U
M,[V($A<M,DACE [/MY"7?_V?__851W&@/[Z606#IB98^*3:" "(&Z?W(NGXV
M:GOT"G' U<3IG[SZO</-<76'1"P#J\)2%>UFD]9X8.2&"4LZ0\E6'!G5EVZT
M*A0O7".:0+P-[Z&K3^$KCHX)WFRM[%I>-H]L");,3^1"BL80S=%WFX[J .$D
MD2_LE)*[E*S:F)![2XQ0^!K35]\_%"%G5@Q88G8E5P[:K/!0S!"9@[*M4%%)
M<;VX'Y_WAR3[P/@1TWALPC9_)BQ+2@<(2T 6*OMRJ<")*RC@4<@10,A"E"^V
MRT(  I=%ETH'68BBRWZB X^'0\*.!ND[XFV6[\4&**'%R9XSD6$^W;'S>.LJ
M=TIKL,0Z!2MRMH^F3=1J%(E649FANEW$&P:RYK6RX_/8*DJW/=%_'Q:6C.V$
M&I/_-SB@"IE*\N@#P!*"ACIK6+77, WB!7&7M"KD2":L*/ZH6\W<46')9S#=
MVL@.XOY5)UA)TT9= -/G,B@QV37O^A-35T3@,C53[2+19MWB]^9^CQLE!F_P
M(<=AS$:$IG[:9WD9_[<YPLH%&;A<[92[R#9JM<+S8+7:\?2H)=!6[VA]@R4=
MF3#Y>0J!\.M,9&&0_.<QCXLH#@T^G@8.UH";B90\# KM=?"_/]UBFBP^(?-7
M,^XR"*PAU]+7'^WO__J$!"@BL%['_1LNFP4P*XK//PXQ3]FO>21O0X E$T=J
MI<2'N$19LZH31.*DX1K7YVOYS]LM?:#S)LXGB?X\$L-);VW3D#@=C#Y;8,:(
M-F")=3P#TIE4U5)U;$O7_IPN17FGM0L8T1$C&'_ 9/3)6.XFT8.FM=5KA,3*
M=+IQ@0YUXV#UI)>T=Y1V]-I8GTZH&1BO"76N#I&)8"W2/]%*:%M;O49,:"7Z
MNK$**_$EB---2BOB??Y!O:%C7+PJ\_*<TMCZM,3"B92GA("CXX&XCA&M+8@[
M.*N3_8G&PM[L^>B#U7P8-<.[A5 $B#Z5^-#*,5!ERN6F[2X5,:+X-HCSWX+D
MB)]>@]PMA>:XEF'IRM1L.<7,%J2'3NV].H.P6'"(BHG 68RVI!_T1CM"!>O)
MSQO3@%:R8CEI=(E?^A"P!*TC3XKU8W"(9]_Q>=+#3L5="\F:@&')P8%2=:U*
M8(5EJXG-2:!OU&PRLF+ $I0KN5J+UR "$=G7+"U?GS/V'W9Y>)GGA'*3S.PH
ML(3F3&]?:@P#/6>(_\%#&%K(7@4G!;_$0T)Z6L"PA.5 J4-03PPCJL<^E]8P
M?P;-&5B3Y F_T1NJ@3D4'9!@26@ Q=*5-4=%,#,K"NJJFC<6B?7 0,I(3:-.
M*C6TW[=125#28-<;0E62'2B;M)9ZDA7'W)1)QPD-EI0&T2QMDP0R:F&C!MW_
M:ZBJU*&"R^NLL#^"&H8/2[+CB-<5?,RV2"EMUA*0F&\;QY?T/# N/TZ4NKJ9
M=0G?R,,8'4!5BT!T0<&W[LA*!PE+HC8RG6RS5]>&.ER/^" \KNCFF,?I[@'G
M<1:Q(]1?Y)EH18$E(V=ZU6F^\P8310R5WB007'[RZ^7(]VO^.=IG::'=:?<!
M8$E$0YUT\)'_*ZH O4Z27W\]IN5EDN0XTHRW! %KP'7D]4?\5T0!$8?T.N3"
M/N+H&8>O:99DNP]=R2<=)"P1V,B4(^@%/&H0/!=C9]E@7KKE7;1[81,T+,FX
MD"H[7Q5.IW"-WPUR]2A8)Y/>=UA24!.G>_?L=Z"Y?7S.CT7YZZ^7NGL_!1"L
M(3=0*-WS\16!P2("#&7XO]T[#'\-!';X^Q0:AY\  RD%>)WM]S0H0Q]Y8("%
M)0P[H8;:<AP%0&#"YQ\X#^,";[:,ELW!<!EG@(4E&CNATBHA,&A&("X4CN1_
MIWU7%$?%#O0VRVD=&O56VXP#2U;N!*LWVS%#5>VST3;+69$=/\%[CW&"/V[C
M-$C#F%Z?A+I($@T@+#%9J)3B1A@XJN$10?!\(9>_Q2$N;'$]&CA8PC 3*=_)
M<6@@@3LW<8[#<K/=8CIC=5MT!1 L&1@HE*LR4U!4P?KUA*^^/-T9<J%V/L,:
M<25MDM][]>73T]V%]P2H7V^NKH,#+<;-BHCI1UP'"&OL+51*Y[ W5TC \R)J
MWN71\M'%HI3N?@]HM(]N);!BP)*0*[E]475V(C4F$JA^UVP:(7]%KU$(D?31
M%G\[WH1H77TT(*(BX^5[D$>"^&)S+(LR2"/"T+>C>KF?O M86C$;?]*C??:1
M7BV_"TR4-:CT^5V8'.F?Z"4K7Q&-#A)YQ-,L_23^F;$]EY\W$6P87NPC]>(P
M4K_C>/=*&+JDP5 [_(CW09R2WZ^SM,P#5KV0)AY37)1Z( *@POH9@;Y*5^@H
MX/@HKQJ@E5JK%EAJ.+;5K!4_H/1(^H_^Y2']K_1K>O.<_DK^\_0OB.=AO&#(
M^$>P/R3X@D#]\E__X^LO?[WY%WJ/3,:8Q3*6K[3[0Y93>K:D9SK3LA2C#QSD
MI 7Z G9/@[V+"S:IRM>8@.(41<&'Q_DTQO)\RU)^]E*]U2K*G.D,SQ]"@&F=
MM^DLN5M_ &?)[,Q*OC5M@=IK8:B;EVYU*SQ/"]'1 VW'3TZ=]X?C2Q(7KSA_
M"/(RQ7EE&C2.GA4#ENQ=R973ZKRC&A$)S,K/\WL[]OR>/;]FQX)8KN=WPOL'
M^>&!$*\1F!D<EK2<:.V+ZB__]I>_T! ]S\?/8XV,9%M83OWGUT#8GN(WYNY-
M[9(/ZA:6EBS*L]JL*VQYQDHAE*2QRC.O_/:4M7=62DE61LY<SVO\0LWC35 V
M3\27TUAWFGX2=1X\('(!>8-Z4]=&*/A[W_??L=.0B&:6:=[P_Z03@/V"(XCS
M0)#V?Z>#<5RD&Z)Z1TTS6]04HJ#U&O+E@V>LX&"B9 [?ZLIK!RK8Y*)SBT^M
M>F95$TO,*S:MZ*RBDXK-J1VGU,^=;1*$?SR%KP2VX"-,MT/T>B>+<**[OW5
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M-=TMQR2MPE*&*5E2)XDBV_<=;9P^BN:MHZC5?'.MB0I1J8XJT[ZN5.?S]F3
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MB"G2,\^(HGX[OX8=(G@E*FA)FREV%"T78],*-(E6#H'"G75& BU%':U#'2:
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M[SAM\[H_"LICE$NGC"@4WM:>ACAG/015_.V.A/(8Y:ZI(@Z%S^>$U0:+KN.
MO/XWV:H8W1L*Y33*'5-)'@JK;].099#<A[Y^T^B/A3(;Y6:I)A"%VP_>ZW5
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MGKT@'@EE,,I-3T4<VMZ[ NV]*\.]%^7&)R,*B;=E;CA=48O'*"R[X:G9+ 0
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M(Q;CYR1.VH35'2&U=R, *'H;+#,1@YF!OG]>D#1\YA;G1R^,RXU^_SME5RP
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M6C%W9_3TAF(_MU<JE;S\R$&J%0L[0BFK$BLAL-_8@UBMI<(1AX.DXY-N!6C
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M Y4.Z.]M/1SH53ULWE(E''MC.\6.7S?LYT%[A!0%>LT/&Z:EFE]O33O:AO1
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M1R[I40RS='# ]<B:U]WV1C*:Y4>N=O?%9A/Q$]F+ZA/Y.F8O,4H9Z[L"0A%
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MY'5[GQ=!F&AZL??'8>\W:@UI]5Z7$8F^Y=QZ6Q8OSAX23DA*JF>+X3/1N1\
MH-C]0G6F>K<5'909Z&+K4G9.S8DPJ*,GS,8HW2&7=$1.3[J<4,[GUUE6D(#>
MQ=@_S"Z8@S_@VB+5Z<#$G#T:33GG/KH5RQUICABO(5+$V'G"MC1#PTD'\[6@
ME%U4TV6%R>J]<IYQ!V]!%X+H60'#/QUZ[.QBL,I,2_:1;27C]PS\]&%;FX-"
MF+CMP=4QAWD4U?675=&''Q4-PO4!A_U'3K&'4^SA%'LXQ1Y.L8=3[,$%<9YB
M#Z?8PRGV<(H]G&(/I]B#&_O-6X@]7-/+ZC*,PYS<A,\DN*;LBU<A7:SE]?!L
M6S8^B[Q,6_S*$)&;ZT)=N<J01/1>XYH9[^<+*3\U")D;4AZHY6;R%S/ SJY9
MEREE'7^B,IOW*=RH=U -#/9N.D)76QY?"&<L534^H\9]P*:G%D1_&'889B+>
MR^A'/^58P:"7,(IT+?FZX[!C'1/(14*9U770,S;Y;*MX/C1"U04ZECP&""V.
MQ1]$[Q\62_B#AY^@#QY8".+TP,&!HM3U?!N3HU80//Y@CLD-0W"2T(0Y\?A1
M"\%,>SN87*U=CET,5>J.4-6DXD<V!/-37\BE &]=;([$+D0S*PT [4T; .J&
M$#5*"9!5ARQ+M^7\*4KBOR<1*[F3Z4(;TM'8-V2P1K5,437MZ%>S7KYO327)
M>)U/^2K10R)?&2!GKB[[6<*-HWYJ+S#"8!F^F4'R]*0?<7#EZS3) I/_*$JW
MH/?D5-$(;@ J; >?705J,^R/HB;3: A<.:QY&>TJARV]0$[5'9"9^[,J,_>4
MAGORD+ETI3MYR$X>LI.'[&V*[>0A.WG(3AZR8_&0"4[D.^(GJYAU:;\.*%?"
M9>CMD@+J*#,]M6_HK\.(LH%D]&_%NGS?2/_ ;OS/7L0\3486VZ3?/3[OW&$D
M\=;NS\-95*1,CN5(BH503E'(0ZFL].L.[G('U5R-6-[6AMDD%D'QWHKK<%H!
MV,K?G'#>M5/]F61EOUM9,JC=;QZ3;_$ ['B#.]1MFFQ(FF]9*?^\LB@V$H6S
ML#X5G\>N'X&\<VD%<P2[V$6X"G,O8N5T#K.%=3^(W5L.<_\2,_\(M&;W!N-
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MBM-L9^%H09'J%/<DV)OB@_H)#!R#&WW3P%+LUC0&T]FL$8M6]T@\PYMND,1
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M]K1Z7D6=/&Y<2SY1Z)92(#<NY8:P,.EBV? "JW-$),./32 2,M"S/YK1;7K
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M,8JC3P7ZJ[+FE'0A?=%8Q\0@4ZV.1$24V(G;?[HX.T_6ZR3FWWI(S@CS=I%
MW4M/ X0=BY0K3:N3'HAT2U5*RIRGOY\G,2\+Q6*@IFE?>F#LB"),#F:LL"2/
MQM>I>4Y)HZ:%.F]8"8$=&81Q'D"T5?7_+V.=ET!@Q_I,%%U)M%5V_[<QNR40
MV)$W$W8KB;96@W<5LML'X\==N'K*L^IN(F&V8CQV@7/II:1=2%=#KR4^WQ:/
M4>A?Q\LD7?./7WEA1/<P-;>U4-CF"XSI0.+177SB&HOE>WQM_ D$C&WFZ.5E
M0HW5%2/SEK2F(@]8E*4835!@&T*PM32$+:[X6&5SA]7R^KY?RZOG7ZT0'JZ]
MWMOUN.YJN)\G$9U]4K*Q7ZC$E_RY6;4$W&-ONF^]"<^O!;[@>X\GH*6W0PH\
M;)-^Q1'?G+4UV77J3<H\?'_Y6RJ_=C E.%5O.U5OF\JIPYL+55V@8&7;U"#8
M]]X)ZK5!>()2E.F!6=V+Y74<A,]A4'B1O$"39*@;Z\3^1BGGP*3UWP8+CO4<
MN",1YWOV%&X>DDMUH3@103HD^/6CE JKDI6.-.P.H]?Q,\DH6MU!UAV'68%J
MH!+VW$\BRBUYFL[NPHALE:=1>PA:#&<\?_O$..)[+?O:\:AVOX/H9_+"_Z1K
MP0J 1XY2V+C\BAJR@CEYU$]$2II*6F_3T&>OL_GO%'HB!\$V*@^A&SJ&';4Z
MW"19=I[0W8]R)O:WE:_M/BE63_D_O*A0J 4 %#MV<P#U #,0_;AH)Z9?$#]E
M'86N*!9*?4PR<+\#(2AV*.@ H@8ST)+1-0_^660Y)^HAF0<!;X/F1;=>&%S'
MY]Z&%:?Y2 V8+YLDKE^ULIO<+@NNVURM,75!$K_$KCOX+-#3?RQJ%@I#\8^M
M8?'K82%K!Q*:+"L0D&U')/"J,=<NHT)7/&D 'NR:!5A*H67M'RPWQ5J% N15
MK\MJ<64+V"O@8CE?K5*R8J^^^3O6TJ.USY?I9OI!(+%K&=C6 @/V'7AA#U[.
M Q:QM6(&6(O8W82T?8B(%]Y@U8Z^9EUI&TTTE:]_?^B]_JT0LN>_'.4L8CAG
MK(;2+-ICM?T0>$=.WJ8&G):F1S#ILI.U ]:O.P@DEL_7E*6")05GS%%[[DK>
MF+99'M&X=WHG[CAAZ\C"E[%DZ>X([>R;RI1Y!@D!1'.YCE^Y<+Z\J84+KM0U
M3N+3>UZM+-\)A>U,$^Z]S73EA2F/"M!_ELTGO6CO4E9;3C^J+">&>,8Q\Y]J
MW+,&\I$&U&B]W]&^)T)E7%5@:BCL1/^&/)=G7L1<L_=/A.1W8?8[/(4?@L6-
M!#&(#*49^1 R\7/ME;/<D]UXFM>[X2FT> A2-T0_1.D[JC"*"_@I\8(=6YT4
M+P5X.Q*548B>\LY=,-18R'AOY_0Y9'V>Q:<NRP[/) >RIBC-M%]Q0RTT:MY]
M\C I!^SDTN_R,W+ZKRRDG^ LU14 4<%@)S[94.].\1 ]RZS5LXC#).4-V4G
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M.#ML#7XGDLLLU].7-2 ED;>E-^;4>V'K4LMJQ7CL6+$)L[5D8P8RG$]3LQ9
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MGOB_PQX1?>@^(MHAF7$L[KPBNOQ7P=("M:^'NN/07PTQ-IYMSR,OR^"/AOI
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MK\R'4LH+.YD=4@9\YG@S'=X6D8$H6L $FV!%TJ<X7ZTU+5+TLZ"4]L),!D$
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MJ)F.!3+<R+LTR2J'A/UT."#LA]]$1S9^OI_F) H2&BM$'!NK&.K'D7 FW=2
M5X)/3TBO<@LO4;HE<[JD9*&49GSKZN'(=%/CM8E_-1!N1-C+]IZFF594'0]!
M$TEZ[#3ED0PR1['!#S$ C?5!: '?MHB40X<BPF=<L*G%=N7/YR^J*\!6PJE/
M3 LEQ^\V".5V]R*XP3MU7.ZVVE'0MD+F=QK13;[1H;,V!"W$OHZN!C*EL*"(
MB^_!NQ&KQT/08KS-6)7!@FXW:&V+W7OL*BZT&4U_OTT(V35-G#&=J60F!W9S
MZQV,Z>;]T/ 3,&UQ5C&9=K<#; O"@+GVF(CGQ;4W[TSOYYV0Z!M=D&C! 3X1
MN\H_?7[)X*?#W3DSZ"]QR)8):?9Q>FW L(<Q8[LW0GX*WCVI4F#8P_DE:",@
MT2?>?36#_&H#,J^*K:D;[_*;YYUG[910WA2USC>;(/DXBL8%E;+^J1&)6ZQ4
M#[T=ZU>/8;=CV.T8=CN&W8YAMV/8[1AV.X;=CF&W PR[;2U3RP2T2ALC9XGX
MZD^-#C%+JF"7"O*)7VO9JD?]V$["Q?H-8(NX(3 WA(3GP?)MC#9&?,T(O[W8
M[Z_B2+SE\B#DUIRO!O8_]6;.VS6'0]K!:Q['M7>_)7'JXI&M^]CH?K,GC?]L
MIWRZ2H%SI$3TN8G/ZVGKGY3X[*MK+%^M/++;OJXD8(NUSM<UUAJQYUV@SW2&
M=NC EHB6^SB_ZL-(B/1%+G946<KRFWE"7/;DT'WL_"H'N\36*'JEB$$2OM8[
M^;P%@AT1=? "^.9]2Q,QYP0"6/JQL7:O/6D^MP"6( 9-^[7<R1D6^$7#94<_
M UOS-4Z)WT?!8S?PF9;L=8FN7CQC':M3^\2S7KN";?A[H"ZPTR!QY/J#>8>'
MX;F6U))/0?GX\_G,E'09^76'%QPI#=X E+?/T-'6+PW/@>,[!'6HL:4*ZG"1
M)M=E,]"3,$ O(1YM_;#P=8"]UNBIS"(P!>VX^""4/P?J_7-'(]\ZFQ]LYK<Y
M-YD7 1T08T2GACC@ST(9;4!.O=,@SI$BX&LJ\J.@Y9ID=!Z$>^BK><E?_M(^
M+_GB7X_6'_.4QSQERT_XD=(VYBF/><I#R&/M U-CGK*_]!WSE,<\Y3%/^;1,
M7AQ*]@&].*H-\X/%7<NC&M#H/8#:0WF )%I Q9J;K_G!.5*N[RW>10>_DQ+T
M%CPT(TQKI[R\F'C<OD0T2V=/+TIA7,XS3/,^8Z_#R:BQ!0B!Z&*]M:I\;)^<
MY-DZ3NC_:+.=^O_46'["DBK#Y3=IQJ [IW/].]AZI'^LIB7(F?&9Q\GMGR_@
M#);<WD<(,(ZW8O]8.8K-2(7)=1-'U51872'5+U\:#HMR9>ZQV*U]42S.?U4L
M?^3+2,?:JJ//8O19C#Z+T6<Q^BQ&G\7HL_"$6*//XC/X+!0XGUQ^^S5(Q"-
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MR4MAN>NTY[(6ED]']"J.V.LR9P_,,KLLCJS5>?D:Z/WG^CJ".A3YTE"H$C$
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M?*TTP%D0]XPD5MJ#SIK2:>_Z+U!+ P04    " #.@8%8*]LL=+H#  !F$0
M"@   &5X,C,M,2YH=&WE6&UO&CD0_H[$?YA#:G656):7T"2P12*!-*B4(-C>
M*1^-UX"O7GMK>YMPO[[C?:'DFNJB4QH)'1*L=STS?IYYQL;>X#K\.!U4*\'U
M>#C"*[A/$$["Z7@0^/D5>_VB.[BX&=W",KR=CM_5UDK:'K2:B860Q\S C-W!
M0L5$UO,'=5@RS=<U=$37>>D7$[WAL@?-VN"U7)FD'_CS?YA8=F\](O@&S33?
M;&T?#KR"B\'X?LM7W$*[TV@%_L7@QQ!/&.6I! X&1]/]MP^',/]*C>7K':*[
MNIF%AT-X:Q)SL>O]VR"9K>%_LQP31O)=J$>X/2MPRJ1E^OEP%]&M)M*LE8Y[
MD"8)TY08AH-\&DQDQ!*&/])6*PNVX0:'9Q',TY7@%(:4JE1:+C=PQ77\6ILO
MJ>H;N%32H$O@?WJAO/P"0<M"/%+X?[)JA>8R@%5@MPRXI$HG2A/+E835#C1;
MHYJ2NJ[,(E>X,%A:8EGL_-4:0NP=HBV!]UJE"5PK$:'L"& B:0.(C&"9K@R/
M.-$<@:+_%=93M;+T6O#[%1<,9JH!G4[':[]M=L]/W]0S UAZG7V_*0W.3LY.
MZT7[O'/>J</S%;S@DGE;YA8J?-3JOJH-LH%.6^V39B'WFVK%,2H GOT(L-L^
M?1%,[>YY^SLFU$&E&F5#$2U$*$\$PT1S :TZM)OMDSK<;3G=.J5%&B$$(H'=
M)X)(8I7>04(TV6B2;(&8LBJHBA,B=_NY2U9<<+MSW5@_.+=3YJP);!0*GA45
M91HYW7&[12PF830K,0>-I!&WQA5,'EH:)7@.=,TED903 :8L+/-?*HN8+!$C
M1EF\8AHZ.?=.9HF-=M; Q0P8P5044.R=@ATCVI2ECJL<5Q&XM2UZ)%B>QR+3
MW)09C7)WCAB&4J9(9I&;%/6.>GH?GL#*P7,H'*2?86@<[=ISY$NG;_QJY2/1
M-(T?F>-?L0R)(V!B(H1'26)J R&2/=TC97WDHN5Z(>+_C6#.\E;ISW68W1XM
MB0=_7[^*Q?'M\U]L?O_F>;AU9R+JP9QL6!_=OZ1N2XAN?;A)W$[0]&!*C 7/
M*PZ=P6CRQ\.CF[=2UBH\/KQUVYF5TA'3^V<7@M#/T&ITD6>V'T!:X?!B.H;+
M\70Z'XY&D]G[=[5F+;M?SH>7Y7TQ1A&/*B%P\B*TLM7'34ADMXYB\]5C8H6+
M,L97IBVG1)09MBIYF'+!UIG'J/0X"/T]>^'(';47[L<QP"OFHDS+03)]E\T\
M8\=?),<-_R<O&O;L?/>>)']QXMZO? -02P,$%     @ SH&!6+X W;86"
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M;I_6_5SJ^A]9?/XY[AH])NZ>&Z?'R_\/4$L#!!0    ( ,Z!@5@<>#]^O@0
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MA2.XL?N[GMCK[>W#__>]U_L'WJO>@4-W\+JXI%H Q0 B4^0@IT>HY+27Y1&
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M4G$G0/<7FGN@S4U0)XVF.DRD3FU;UW+$BR&#7[T+[7; MIV8[#)H?:([+DS
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M2J&"(SRL$Z/F^_!$$1$&#+K(9Q;(!:Z3Y"Y84=) M_7Q<20'2AOQK3C[+@2
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MLJR@VP%>P*E&&T<C-YF^HU$"29QCO+B9Y&:S#?=Z^[6L,= Q"J-IE\EX)3$
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ML9+Q\D?!4,.QQ;9N!$L:!7-DBXV92!G@>@%E= (V\H*>WA8YTXB.SUKJ^EV
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M_7H ]SV$%F-@7V=PQH =M9?],=,W&O<8[IQ/0=%TI7"#1+D_!14_( UH&8Y
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M!]WZ[K9MY]M,_N>,=5U4Q4#5.!K>$-Q-B8ISYFNT,>&=+8 K37( W%0@G7=
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M+_R_/X5.SCGW3%<Y:6_9NGMRR]FZ,Y-.<N+T;&^]U25+M,UI6?)04A+/I[\
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MOI.XINS>7%Z? ETA0)<O2_>@,]TDO%PO_V@;.7;T7+=TVR"M'B&8&=\T38H
MT:U+ZAJ6XV+V^_D0_A@XKFY]9HX_<.$1 $W (%X#?*2V3\Q[X#Q':"+(,LHY
M9>;&$%>M1I\"Q#T1FSB6TQT"JV5!1I":0EZ'+0^X[Q3 \CT2"QAJ8@1NR%M9
MZ 9'T/DP_DL,3^-\F0FHA2RQZX(6&/_XU*716;PBNV64[[M%<G51)"?NV0B2
MZX'MY)\4DA62YT!R?7&;G+AG(TANA$AN*"0K),^'Y,822&YL&LF'(9(/%9(5
MDN=#\N$22#[<#)+#NF7E'2O\SE7%G/!SMUC%')RT1!@7#LJI1P<%0.&-;9(.
MM:E';NDS,6]LX&@7"SHY' ",7_6_'79AZ6XBL6P:.U008"Y(G8/.FW=ZG[Q9
M%(UR0 %G2C\C-2ON9%8\]UUJ$X!MQB?&C;?WJ,+,>QQ]BEIQ8NB8\P5_S#\
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M)\]<FMS&Z7]O?-H=MW<G"7L'NN2P@9R(>6;J!1@VCPTO''."^?O\^<M1M?;
MKBID'>[^ODL,S"GUR( YSZ@9HPOK6FW</DZE&]?8EOZB8P+=;,/HF:N+LO;?
M&]2<=1"X&ZP=);#VI+_>R+1N@\MMFLOV6+FPK@QV?>4=K6>2K8^#: )!>V='
M)_MP0^WP^'!. ,'_L6Q8%V!67B:(G[C>QC*,9__C,,T!1X!I?_N,NB;E!RC
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M3"VB/25>.[!TVP;.G0=T73C]-ES,I? 3L-8D<"]<T":6\_*.#YW)] !O+#V
MO +TL5MF"9\KT(IOT4V@73>&^%;D0@=<8B#Q0!-UPTEV(>2).0^R>>V>#KRS
M'4^#:SV'X>RF=?@(X8>2;KF.-AGJ!]KO1.OIS\ S1HE9UEZ ') #TP:.ZU*8
MV\J("8I&&71[RI.T]A"L 0/&@Z/?'6JN;_00F1*0H(-E"<22_.J%6E;P77"9
MX?B6.?JEVTO[%E@-NN*.?HW-_W"'U"-C/P%20$O<43JXI$:O!6E3X,/8]RXA
M/\:^)&!:^HDWHMP=+EH X$!GW,^)L><@IP8YU[/)B/F+SRJS=:W,CQD@KWI_
M@$H1GY&PC^2'K?(D$ -_5^1$QYWF4:=Z87H2/O5$WWMOR=C *O$A25GEH+9F
M'W&=X98-$GEZ='RZ)BHWK'$PU7':8)EI8<(P3"6ZT4/#RBUD'R8ZGH$'<WD'
MIGAYE?2YA%N0&.@*P:CE 9=-A&63JFU/0 H3FZ,JUV8F-"WP"M+IX*H*C(X[
M=&'61B<<?4%FPU2/_C9S+ WK.&.K!,8] )@\%=;R1)6R/\7!1*[MC^YY#!;A
MF@T/<?VV:S#:#FJAX.<!?/9UD\"" E;M?"4=NP@N8 3O!#>(LN GL>NAL)<G
MJI0]*@XF\F./P&QPVES?,#"D"?Z.C+920P0OPVHG#-YBZ(.9VD!G&&168,H3
M5<K % <3^3$P*0X/(P;SJ2?W1_C2ZQ\\>*=#B<G='<>VB:6 E">JE'$I#B9R
M;5SZO'L$WSD5F\)13,<:EN56-*ZBO!YS_&XOYN[HQC\^=:E:.^6.*F5]BH.)
M7%L?&<LI:R8!>^,,RG$GQ] '?/_UP6];U,4=?RS6Y'UO1/:(B.HD\D<P=8%Y
M(O1,VSZV&E0PS!-5RC1EJY9A[6471;!7//:LFYQ7[M38<_PBN #M$K5]G@T8
M_H3),+@K_V#I'N8!IEHWA=@\4:6L6'$PD6N#A6NZ(.G7[6$^*SA6N-@++93X
MD:<CZ_:06[;@JQ?"$[Q%$8'"6HZH4O:G.)C(M?UAQ!TXPCGJ$EBZZ99&P ER
M^M1 9\A4T:/\4:6,2W$PD1_C$NR\BR*CH,;(=IX)9AHRQ]:?*?/=L$[KXOZW
MF\O]ZFE0HZ4!(28!NZ. E2>JE+$I#B;R8VQ2/)EXZ :/A7 [0^WNS]:5UNP3
M+ VT-4NNJ!AVP5*(RA-5RLJHJ'-&D!*8GK#R-7!U7!_/R:+$CFJ=PR!.5,?M
MPO<&P6)GK+4FIDA#E'7@406O";>X\+WEO/# M"C/$'D SH!@HU2[R^F(EX;S
MZEL%XAQ1I0Q;<3"1(QN&]?F<.FR7X##<SO)T:H'9X:V7A3V3_3BP_X&'/\F%
M6]00K.5_KU3J>V>/U/VA78LG84NP [FF2T7=AKMUJ<K_)/&_DY(AFO]HU'XF
M+I>V:)YA3VUJ,8"Y"G<6YNG&4<;="?Y0N271UW]@[Q'=LH;X$[5++]C'!=[0
M84X?NY1P/QW_6^9=/-JZ"V^2&ZV\ T4')U;L\.+Z?5'_ T\UX<=A>:P3CN$S
M!K3"R_1G@+%H.>&4-=\]T%K8C2,:5RGQMMC3RU''$L/#<08M5+!9!Y"DZ3SO
M#C=\A]H/VWFQ^0V^+3XST %XAL=XGPWXVA -?+"N0#PZ4#7DDZ""##'TBE-Z
M6(K)XDL:$ &>57Z@-2WL,]/M(7ME>P[!;KPWSB&=-Y/17<?610.3'AF&75*Z
MOL[ PR#"91$N1RG6VT:0Z89C!O?D&4O3@:T#YCQSB;5Q@\IP&!X% W3!&]&G
M\2VO+&@1K O;VN OX.L EMM$$VU+" \VFQ2XR00:T*,2O^D)23@ND==A#S:7
M ZN-^/( Z[IUP ^"X VL1"9D@&[1- 6$3[0(^EC\,>2=>.PIJ"^77GH4N[?$
M0((0MJ7$@Q%Q KFH-9"";+Q#(G8C4GG[F,BC&V4*:@Q_@FJ(LL/V6EQMN<A,
MZAJ^Z\[7?0CE+_H+C9JS8/]6M,#I@"[;W;#6B&C?#EI@DJ*V5OB@L+75A=/O
M4]?E[9?B3;.N+H+F.@":('P:7ALVN<JI*'*-HR< 2FDF4"Q>R,J;2<(4":+W
MB)@]<(J<-@EC/A.F2<H9#6Q:D <@ZDK0X JC5N(=QDA/MSH<SF!0P=*X8+RB
M6A31780R[M(Q I,,=J[JA6929T,MM1\7O!,\/@)6GQOO0$&DA\@[:9D.SC$E
M[CYZ./LCD4X;&"^F:+[7:,'41+0!YHL:.%G#)0SF&)?/77 %[P\VF1O\&1T+
MWAKKT6909OA]N(K/$7H')@?>"<U$F\N7YE-5>;-:D^CIN M-FMI0MJYZQZZS
M=VQ=]8Y5O6,_;K>#[&9&(AY&S9_W^!(?CYX48\$$_])-C@>7:V=C7#*U4#+\
M9(CJ0=C,,\<RVGH;YHWXA:34A.6=KGUFCC_0OC@6&FJXX\8V#A+N/9YD#Y[0
M:&?-V-VC/[V0T6_ <2J/KQ'\H)_ONW*)XE*]3TRJB[Z<]E!$$"QL>0KV%KPK
M8O1D!U-<Z/L4UM F(0/N!Z+C&LP"KC9P7@@3D1!PNWKPQC;3^6(8W5UP0UUT
M??8-2W==6%AU^=X'?SDVAY5)]#$6!)GU82X(Z?-7H/\W"*J+8!75<V1Z25F&
M?\H:,7T#/#W9@Q9G<O19#[1['V<OT6=7HV(/Q3'0?X:U/!F6P"'_&QW)/C]Z
M.S8VW@96TWV3BJ@#.M,#G:^TT*/D+2]AC# %8HH</M\!M_DG<M ]*&LN^I>"
M#7+'YIU\X OA89" W2+"B@& KM<KR>TBP\&P@^!DD!O,HRJ2F*#Y,.-N=-^Q
MB4?_%>XU>&"]H&OSZ*-TS!2&-0C\%QMYXL\"""%K>0,,+-PJ_41THP?,#"4S
M6ML5M52^Y\XZLI1RKLJA!=V.PVH))%I2@@L'4$>"0:"(X[S*]97V07W"H9:8
M((38/;[O!7R2AZ@+23L#3]R0X +P,4";'!NO\8!5O2?&+J*+>$J[%^S1^5C[
M(:-783&(9EA4Q(-T&:'K D$>CXR#%!L5S7G!A9$@!;?CL-2?X4>QK(]8'OL6
M,,!\&WDE%VJ\&UMPF+*74DC'EU;PJE+L11K8EA8@AP KGK!)]L '>P1W\)@3
M/W&>\*! ]?BCJ_T"Q&.S-_R>ZQ1PC!$QC'JM,N/]R0)C4NJCW9 @]XC>UUR*
M.Z#<DJ!985@N<ZW;=UP>*B*Q ^*O0&]*8Y+4_G8HKK'C94QM[#?Z+!N7BT!G
M&*=RN'7$QH&(T3[&?P/%'CBBIARU&2QIPG126)=(U<3]:=YE/-8\7>Z4CU%W
MD%9#"LCSA<8:CBL:%0<S$5I 2;2,:& >LR08@VDVL5Q9JFH0^+*DR^H*28%L
MN(ZFP3$HU]Y@Z)0%KP%GBA@ZAI&#'7X,1>P[G7WX8Q_/)8U-F?@R"VV;Y@(O
MHJ'&K&!)I 0,9%49C,<E.C-Z:-S 9PL8I\L^\@[OQL@M-:BUF;1T/%(?:XXF
M:T)X[_<47LKD*-R/*07V+XB] Q.[#E?P8#2\D3H80QE2P3D]F(%D'3 _/R(<
MRH'6-$6F.+Z@G-RE(# QZ.$,$$U1I1 W92%/D(8&5M$)#30:;(R=I8Q'( VG
M",EH8+ I9DUNXN%YL/[DI//PE\=3,@*YYE2S<VV6<.U"N5L<J,2G]_0LQQY^
MKJ7Q.RE)329FPDZAZX<>"Z/$PW PS IHFF+>5.C \TF?3PPF[BBB(1GWB82C
M&9Q\@22-:W/I)W3L=>Z5Q+JQR6,NN >'SDM$0C -A-8?M^9,!QO?NN^"W6&3
M F$8].7&Q9%&D$?3X\^046=.>BE!NG!MHF-%>..""R=J7! =7\)WC>/[MDAX
MT.B;]V\!-N )%7Q#G#O-F.$5D" [MWB.(V:MDBM/LP_8RU=:?NS("K[W%$DP
M+K' B4U8=##*_#/]QR?!Q!COA2<2 BP+%AR^=(9#.94B9S!PAE.8P;UX,4.E
MCU8B:730SSJCCH^K1!>0)>91''*L_EKNV_,J)<DA+>003A(FH]P[T9-3HH/K
MG#ZV%84QRNW<\ R6Z)B*Q+P:/C>^//T:NZ+4<BR^6>+&#KS K5Y8U>#30@\J
MTJB4A2XJ)G]/<CD5_NS@KK<;6X6VL4[K1\@^?O),N C"=;H+ID+H"<*-G_G#
MQ,DP:KK;4?PGE&:P,G+'/<B85>/@+DOP!U;6#1U!4!!IO3#A1?JX9:P'=BW"
M8QAQ;>_C80,V][WX 42E0._ (7;Z>&12D&MA.S!V\,-BJ1="+^+Q(#0/)KAT
MV"E<!)#@G9@BQI?1'2*.@^2)'0Q]<#T9]0G5KB3;DO/]1S .AN7XYKY03=>G
M8L<NT$$9Q'$ZW@O?T>1>L@@*<:#+4Y#B+BFN2=U@_Q,N1>4QM8AXN8YU261B
MX4?NL7/C&B\BD,]-NO$A->VA3.'E<V+,_AJ.28050#:!Y<!]2I$F@.LJ6&OO
MBQQ@_+WOVS!GE$L#R\?M5+ZUR>7#N,PC(J-X0G @$7?U>8LO)C[R6<\C79$;
M+(48S=:A<T_<*"3E$J+Y?%;0+%@&[.,Y/<$"P14;SLI\[-I\!'-%<.[8=@_<
MV:Q$%MK*G'^ B9W-^ 9J96S/NI+8Z5RQ)**TA@-SWI^MX2&;36S.8D[SA?2,
MM 7^$<ZYB"J/SIAB)HMB3F,3I\=T+/C0,$DSFIK+6L]QP^*,>?_A,7+X/R[$
ME+SIW2)T.4B^00S^AK[;0H*/_+\0.&(JQ\40'H\H5QO@%NKH.04S//I+1%99
M!VOF8;!<3.VIIR"4"PA=ZFZO[>C,=!?"4;"QEQ(KC?N.@7\(@.(N*H9FA3^M
M6T.0M!NYG!:%Y>9GQ^E:9"%*FL&C% ;SBL%OKJP.FO<?W3 <W_9B\ZD2_ML3
M/@U,BXRI1A&P:!.9]'4J0WBQV!SX5+I"3%X1\\0CR\#RA6#C^@.>C,W3"+!G
M@_Q[TBR&05\//&[M)]K1],' @C?"VO'=:'=.A:.\XJ@9[5PLAB1T6=!OEBLR
M+!MX3VT7'\:W 4R^>3'$[.+$DB\\Z9"C"_.B14%#&H2"LM58O"6,HHR<2IQV
M@?QI2C)^0R7CKS,9OZ&2\3>7C#\)^9F(YNW8W*MPWGI"*6)?>*&)(+:\Y9L7
MQ!9U<YBZ-;1-N<D5RP0*TG:;X$X0) X(NM8-TG:<']J-C45E'E@8 (8%M"Y$
MBU@Y:\VO#^7@,V[5\9GFL=72.H28[KL)#5N4PY(+C-Z';33F_2?8*<6^!J):
M7!:U@[D4M96)W<:QZN*#,:RD.29YW C*#?'W/AM/KW5YMX&$[,)=NR@AJ"R]
M3Q'J%8O@(&4FD7F*N:$Z;V[ TV;#G!+<GA490E%O7C1G,GU?T[N,R%K9-O%>
M"+'#',DIRRH_F>T29 PWPX>-)*F,)0:-I>IR@F5*+N_-Q_-UQ=Y[-$H05<\7
M&0BRBU6\59;HY\!W]67RTX./IS>(G"U,1A\GE*>>!DE**:-U8=7HA<F_HN$Q
MAM+#[?EQZ?FR(X"!A_@94>24$Y!6',&S[@,YAHU&9#<0X 3EW2L.M OY*=C5
MQ4UYD7<1RT]^T67N@$FQXP:F- &68([K8^<3HQ1/]G)UG*3X+='(@'6IO, G
M^6-7IXQS/*=*CT5NRJ7D SBMX5R+60@LL4$!BW9BNWRQ!K],&C&XR/0Y>!HN
MZ2Q,T8:;[1\J'6$7Q+=$L51)SD^A&=*29HC;FC&ME)DI&I%M+L)"G#%E*T_2
MVR[VK>%XA>M+KL.357 *3;T^U$)9^(/I.FAPHP9#463R)_I.P(]V>YY(>)'F
MN:QA-QGXPX!1$1XL"*RXW+0KE\).!C)[L1QE:1$>CK#=/L6]9<<$B6 6OSX0
M_) 9[QSI.B];>''8C["78& _XOF?J9430'))7H2S"^4=&P3'^[)I3QJG/\+
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M7BRPRZW,9*NBYH&=%7&@!WP>U?M^%L>2MF2Q;<[+.HI0?(X""A/=8>XAEJR
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MW+;=O?Z1%QH%Y'Z;)W<CY[9!LS]4ER:?^.]#)0]!KR?0@R]\3H.5W]27#0?
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MFZ::M,DP%>^VO 3\T00QL&]Q#1B"#(!7K>='9 K(-0 4T@:H/1QME?HY4E%
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MG\VR,K4N2)6H&GDR[6%%"WIZ+]Q:$+Y?BH"VM"-T?0BCW38OPU)1,5_Y#A&
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MBFX#973'[?T*8HM\B/R2;:=2S0J<F)X^1HE9]BE;K!X3U1TIN%*D/Y^]/E-
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M,Z3=E:AZ-KW(D"H! D":'J!,SC_J=2XA#&-IJ:$,BQ957F#ICQ5>?M3V\IW
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M+!<%/INV>4=2'!5WR[30>ND2+8E HS\RH.+KG*+O#C_]Q#F<HN3S@L*G4)2
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M?CS6.N8X(VQ:MIO)K2R.B+&NGAN*_TN0C67]GC:#H"42$KQR"5C#SM':-ZA
MQE6,<? @+T@\+OB3:+0<'IJYI[3!JF)H\-ZQM?QY$$5?N0FL>LN8JDVHG[N
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MBH5']]*V_S,G/ E<6V2<RP88GS]]4!TP**((EK+"9R6B1R]M/U7[Q_QB I"
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M,<O)DPH*<3^K +M0S^4P\YS1^!!,=Q&'@^#W%\^6;\J/4LP]H=L,AJ=@VMQ
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M$>-1S1&S;([P,,\RK(TR',S#&@X/LABD#OQ2/#Q%S@!!C("LB$BNN&00)!]
M'1&-N!G!5&&9XT5*(!0"1-$QMHB90'T]*V^9SP/.0N>4'N.\Q+LI(BQP:%24
MAK@K[K8>89<[<C?2R*"!5:BL/QD5XP5B3O/J+UK$=Q0NB4R!_D&8F3F?D93R
M/?),%&]!LL",\D)F@3T,RR527!-0>YRK2I%%C5>#OTR\M!G./3/@=+.N"AB&
M][N1O]\5R^#- L4Y]3+.>91^?^J[L>\)7*?Z3K7YP#8FG4?9NEZ+DF&^'ADU
MC EXZW#>!(95H.,TU:/E_V'?9>,[U=A1/"?CY$5;0MVINJ*B(2,)G8#)\(B-
MTHC5D5*W*T67J9)"WN):\0-%W;Q0T8__%1:+RNW"*>,'\.2\[%DC9RC!$JH
M0P#SC"(PKVQX;6.PYP_3.I.=;;3&9C]EFYTEULA)K)[R</,9#^;WE,81%Z%Q
MJ\:5$J';VR7IS6(^>/<;; >O-( /:O(HZ]K@)JV9L['1C:A2>\J=D#=:9?2/
M)IR/GQF52K1LF*.D5GX5;:1<+&N%F:O9S.+B%.$$82C#+VEX2N=@;UHLV0)M
MY/EDJ M;.C-_R;*#ZQ 3#N)."5QXP=1=JCX*6HL"3"Q-%8F4&C/<F<7*[/+%
M5FFB;ALUTTS4RC7<HZEJ5IFJWW5X\U9FY6$6IJ^Q#]-W+V-EN[ERK*^-@[UU
MS0J5(X7&D4SS1PD8/J+=OU7 L!JLGK,_C&K[HU)>U]HA?<?JCVS5BT7VXZY6
M+QBXZ ZMP8C8$0PMGN&'YU_]4,OJ4HRC8XTPR"%QG800P .1BM8&H-]DZ"L+
M5E6_6LR[,9A.*1>\M26UPLK>/A#*U'@H<71BR/B ^X:+:J;X5"KE+9L?I<(;
M8YO$XP9;ZWN"C<;*W."J&J%J\V;5MS=;.,8Z"T>& JUU)H[U/3:.46X'!3\2
MVF.C@93_\<,L':/"TEFUG(VQTQ@[C;&S7V/'V,;8^1-5D3^5<1OJ6Z7LD+!D
MSCCKM2(SX2JPEK$*W-;?%.59IRO6&5JYO5UY-;_LYJ-"3\M<>*)&T-;U+:.F
MOF6O]2VCIKZE7O4M3U/+[+GPY2)+;-2XR*7^/#AK#NO'T/BK&RZ01L76$;>D
MV2@/AK8_4^&D57%_<AJ^@'<%C[U9,D*SJD[A7N2Y\*&*[I[I9LY$C0W:4\+8
M_!RYTW<1>!@S;^J[&ME^UH] M97!U!BV):6>2N*9K^DI'Z([C_3=.P^=KUV?
M9>C/>N=]6YZ/8Y<R(K+]4I+"[R/UR->*.>=#%'[UEE>>9_XS6GQ9C#WS\A9\
M52\H#:** @/?95[1LY5[;QE<0*^V@'O@$#S'ZK0'(MV8_^N:XB7SS'X%%FF[
MS6XO&:AN*NWXU^:9 W\>].1?A5L-;B;WL, >PW!+P9I1AXD@F,E4ZTNG5P*Y
MF&?X_%>6\,SRG]*BZ2 8_AB&T($A.#!"<% ](H'1!V-H+B\7K< "^]@= @]S
MP>]A[H *8 %FNV<AQCO(@:"V7+R-9]U7)3R2,^A:_9%C)K=N3.7J!O=+F,VB
MD#D+*U\2P!_.%W/M%99J/:8-4&"*T-^/J=4J;R]#T<^T3^\IHZM8&L88=S'(
M@Z/Y2"Y*=S['JG<W>,4S4DVJ<RPJ<RQ_9Y0!^P5RU%D%/9^MK"VUFCY-X9*]
M(15<X>4P:#ED;JUJQ%0EA--SX,3PQ!:)3!+I:XJ- V4,=:+V'$,I_HS$*479
MF6.&7269A%(SI%+++_19U>IO>"W%F >M49=2:[0$K^H:PZW_E49S^'A]??Z+
MR")<W2+-S$4<8\NLF:33J>G<:FWX_1&%37+C2!+Q072Y1OI)ZE2)-_33J#5_
M"CKK3\^@\)UJ1C[1MDFGQZ)$HQO[&:YX)=.BUK0^LZ,IR3";!]%2X>/P-8E%
M 4N1!E!&/(PXH)YBEJ)\Q%R4.P-G&CY3K#22B;J(LTA:&2A/GX48#]4ARQ$8
MV7"USO S#W\.]D:"78QA"-2I2G8+TYH->_$=7,:))9B#_A7%(I$E^J\B&?<B
M6S383M-VN.\BC/)*4+ 9 XKV_DZ3)MHUC@)C#0)^GBW"K[P(YB?.)>G?Y8BQ
MCI/CO^*8^1LC?IHDY#61"(*_XS,#UXY4H.0!S+C^6H_GKHC66OH*ES?84!L\
MYCGDZ]P5CW!#GG6LP?]*Y/:&JHHAWE>18J7]Y(1J%6"4JBRPV[9G8F"/).+2
MC8-D[$XM^*_ AV^$OBL8M+UO<Y_!O\)QP^IX2Q:5:(?+R%(!LH>?[/+GHZ>-
M[WUI6]W.B%HT,XV@;/4G!DWDU.12\+^SOLSPXVO_&W'=+S.'<C@2.6AT.EF4
M+>/EB$M)TGLON),?<Y4)F.BEOV0%&Z"WN%4?:24R][%1 '4I1,N>OB\=V5QM
M0:C<:&T>1B[A?X^\X&.6M7P,130JR!J2T/>2Q*-BY2# *6/?:(RU9  2].YM
M1_5&4=P3X.2!YY*2'N2L:+9MC:@>Y6;G'N-R]Z<,FB](X!6<$Q>#0_[$U:60
MTY"RT+SMV.*Z+8E7H7^O@2<(A0:EKC/HJ//Z<9)&XEG=,B9%#K)P$->?0T<3
MA]SC:[ICM3YNV<U@5X1K<^E[5^^5)&HO6']E?Q&A1>X,O\1XE;#S:$C_C.*O
MEOJO%4>3PI.<]%58&J7%M7,'OPZB>-H<I5,9/%BHH@.;(3NP_<J\U35VM&J]
M(])+5*P_F]J!"/YN_#\<R)7")6/79$>)FC5A0V#A%4KR'?ABT2(I\IX1\;FQ
MBM!\%3Q$<8!CL!29ORG=D#PEIK2=$NC;3W"[5/L+S'BO2:XSFN*%R(M7@Q;4
M.NFI]>RKM CW F\UCH)I[HOJP3 \7)7_?M$OH@768#Y*S\[O(,,IL/-@\73M
M-D@""IS<0CG[7RB4N1V7YM3&[QQH:ZM2WO'-^,QI=RVG,[2<7N]5>?N%J/41
MU%)Y%"X%43-GAHMC%S]W?JA>R@*^Y8<J',S+%<^T^X6OQ[A"+]Z,VE9G-%KU
MH\I75!^'(XQ],+3ZH]Z#Q_X]1^%/1C]L)?YRS[7V-W+,ZY9JVX6O6)@S!VMJ
M'7O=5_F1KPX^$KMO=?K=K4=R6/FLW)\_JXV40Z^,Z!!S GMD=P96OU]2 AOW
M2$#I#F^1R:G4R_I;V0#YWA,$HULT$"*>5PKRBZ9A+\5NK;"A':N0Q7G)&IY0
M-Q&^9)*[@@2O#NL+L_0E36>MZH_L6)7^A9R+#B$R7K+*+K\G-QA6&>L'\Z@>
MP:.>OXW@Z4Z[ 4_O$SS=:3?@Z7J!I^MZ(V!()&L&+5,Z&-E<4J7?BD9V65CD
M5,CD<\O?1#0.'M'X)QV/MZ7CT<0UFKC&2<0U_O!23MD0,162NG%G2VK@G?IW
M.:_WB"&#,Z=K#0:EQ5W[CE>G,&[;MCKMDAN]S;@?*\Q1.@)^>.<E*X[ H5S9
MCN78I^!2@R3U1NU3CGJH[5*%S^.ECN#::<LV:[YM%W.W)XGE!A]T6 X$;GKE
M"4^HU[6Z=G^W"3VFG)]-/6:M?97CK\7S9/&IPF3AG1LP.%02P,7^)!55. _>
M!(>6#GLO!MY6FG7'IT@)[EGMX?8AL=.=2-?J;1-D?#Q;HCI&OOW)L220#GVF
M4U]]:A=^<,7T2).QNU9G4#*LMSM+CQ8K;C @-/AW46S(P,*JN +#0C>:[5RY
MQH9S+KJ<(?$)W]<968/.@&"QJB(TC0PN(_!PL)_@:/D)LB5]<N,T]&+X[.TW
MQ(R95&_BCQ=IA!\FB_D<^7F$!KB#"43R'X@3BY%[:.%Q%1T2):FB+?H*F#37
M7I)PYQX%^>?&/+9CV6T[/\KK*..)LA!TB;7*8 Z]=)R!U>[WU;<5"2\3/,.V
M13,89<M\)SBNUBPWHW"-+9>;[?UURVVC;G&*RVUNM=S&OI;;DGW <!QQM'2#
ME.CZU^V# %G#O30TMMP&F&NW/=BX#365U>>H:*J<0T$'C2[<FH/? 3W4H;,B
M4DTPF"EW@2 ,*2:C/@5N"O\]XZ.&1>HKN++U2GKMP-D@]3:?K@1,$?JFZ$*X
ME:0;N\R77,5U$^Y9G8Z]S0Q>]BQ[,"JNC4%K8Q;71LAAK\.+H\"[1'R>55#I
M8FAU>^VLT89:F5!" WF2^+M&%$]?%#<Y_N+>)]]ZS?'$FZK3,<^\;Y(-0[2X
M-&1W Q9._G)_@"YC1;<$9HB$"VNBNB)H%3:"&P$.>,\>\ _&Q5YM>+BKNV!:
MQLN!U>OF!LE=&20W0S;";F_5"'4BAWQ+JM=YW=&%SU/W6P9?IS(Z2O4P8S66
M$MU&P53,,:-#R-$'D!@++@7M5B>I'?3T%CJ5_!:BW"_4%8927\9&0V67,\+A
MBG4JK&UU1VWS3)0AR944FHDN?^X$U.L/5ZR^N\7I<(;6L%U^C5EZ#?81(@-%
M+!7:(<RN]XKI]?0W8R$C542<XYG!UX %V16C8NM'U9JM.8/"[.GQ#[UO7CSQ
M$WW;!>,%<VGD[R-8W_Z0;X 5Y\K\[G.%T^HYAE;RJ1?1:4XX/T4#8XBI=7L=
MO6!T^T-94W5;Z[MB:ZJ^CMV@3?:*-K$;M$G=T":-SN"M'K_Y3!S0=%]^Y-@%
MD8*,ZUKG!5.26U+G.1"%5NPG8$3 SKQC8G"R3^$BSO[IU'N6JW:J5@"D)P\R
M.JDYD0P@I]\B,0^(JMG[]C:@J'V HDYJ_"^)PO/&J_,<?GC8'!X%G-;I_R!,
M%$I6\#7Q>, MIQJXY71AZ.V2X)U8@=VJP3MM:]1Y>(7=<0??L9S^\#3&OO;!
MJR9@MUN[+?T/>P<"@6')]&NQ%*J3AT[97<=RNEM [VH#!K,[CC4JW]TUGM'(
MZMB#)S2?06N+\[8'Z=P-7,6O_2V.B.,QNMZNI/78A[UM6Z/^4SKLPZ'5W@:3
M7)L)82_#WA:UY?694*^U!=)S_[?KZG>!&?M108,DNZ!NT1X(M[[YB[MN;3.8
M$QG,X]X[KTT1BCO'?\D8WI47!)(>=N;&7ST\WP=>JP$,N[O7VH#O&8QC=;=!
ME3_*8&QKT-NQQN!@8W%:6Z"D'T\#5Q_?W[P0=#)W>7&G,S_TDQ1U]-U6?M%W
MK$ZWBZGY$]FJ7L?JEAF#CC28,W ENENX$H<N^#JW!V5G_41\@.K#_*N'#4]\
M5[7N=&<1C.$_+G?;.JSF&8)#N]>RB.\9S,#J]_8:+_@NG>P,3F5A!JTM5,ZQ
M=?+OZ-W""?9G<]>/)2 N3Z]VJ+VR3T4+.KV]1E.^1Q_;G5+(]0C:N-=I;;$B
M)Z2-Y3'.H\UKX#MWG*=4=WO^A.;RM';&;K<?*<CZP.N(Q/@+\95%%:&;TU_@
MSL :])_4D>EVGA@MP%G?LCO;LTJ<]%S.NZTMHOPG<45G-S1!]R,-^'A88ZK3
MLX;M4Z SZ<% AEMLUZ$'XK2M]G"OJ8?OL3([)Y8W6'<EI5@&7*/KZ,P>6;W>
MOGR)HT_&P<JF)S*9OC7:@=KHI.?2Z[6VB("?V"7$=1](O!/-/"P(.SRM%NC_
M3G]?>_X] ^D/K>XVN>=##\3N6.W1R5Q$]JBUQ5B.?!&]5^<53G#HU0..<N;L
MC:']V-Z0U7Y2L)HSVW*&6SAW==B;<]MI/Y(IN:>+"$G@ N4187->/UQ0V?&C
M.4=P)_6&I^ <]0=69W@"46_;!F_Q5!+ZCY<0_9X[*7^,IWXB3C(2;*N#K+JG
MPM55!V7RE)1\Q^H.GHBOL>54:K,WYX\7DM]\:6VH7^*12&E_\.(^&O?H/J^V
MH\YDT+:&AXWB/!;W9<]R!GN]7!\TFQWD=^.4SAW[ =&/ING3'CBXJ =\14(!
M82QQA,R&+SG431V?. U0:@3%0?EB%Q%^J5$B=8+O4?MO%YDZL3(NQ]PLZKMD
MEWOS)66:3$GSG.>JE&'DM61X1GZVH;2TF#"*%)P%+U)O(&(F$K+B1-WLQ_@E
M5BF*#F\=D94!3\+OB%4E=!!VE5JU^C@V>&WJNP$15TG^)3?,+9;DJ)0+0</J
M6[W. +\6+*:"W!-C[H9:K)KR+D@QK.7@?QYC>VI5$8SMJ.M+@.&KO:AM6^TO
MM]CG7;0L,IFW@QJ_@32GMYD6FN3+3IE@[$:K9%L3=VB:19\XLTGFB4N#A5R-
MTR4\J1QNQ5NV)FXXF1781(_RL)D?CC7E80OW2&0J)W),'HEZY>G.=A51R].=
M\2I:E\.*__>SO7S.LU(4OM+0O&P[^(;F93]C7_O@$Z9Y62OO+U:1P&SXU>E&
MKE=0Q*S0=ML.I7[+4,TK\]R6H9*,YKDM0@6#S=9+<&14@AR?PVM<Q7>S:DK.
MP[;EL5(.U50XE9-X^-$\[36H)L]Y5DM03;=3CR789[JJBJ5GZU58E<1JLE@/
MSF*9]YYYZQ;"LI3%8;UEE1)6+,Q;96XL/>="W3E8#%JFKM_-N1>C#XM$\%L\
MM4,)GJ[=&OY0&EQG!)^N>XC,9SE-(N<XB8-B%N]FQ4' /9[&/K@JA=2=@:D_
MJH:1_>RX;2'ZCY8).X^>&)R,K'4-/,G%SB>+@/O)B =-S:E_@]VUL/T+VC@)
M-13B_*K*X,+_NXG=V<P%&\C$)CH1]<<*TRA>&K,H]"391LO\<NLG6H9QJR1D
M(45"<R%3EJ8R@'GPP'%HE"RY!34*LC!730'GW!30*'3WHW8WE ;.YIMZD]L0
M3+6;I97OK99$U^D]_BSP8?T3U>RI$9*3[NGB-#U=PGWV='&:GBZEV%73TZ4.
M@]\N([\FW8Y7T\1-O1NXUIK4>Y-Z;U+O3>J]2;TWJ?<F]?[D4N]EL^]7X0<+
M,^&G;7#OWU%4MOF+CUCAU@QFGX,Y0#8[0XJ4/985G*CEL,X)(!QL; !?KCVI
M!SS#;E?F5^LQ>*=OM7NEI$.-L"5.I[4;-.8D*LSSPI@LQLDD]N>/451N.]:@
M?RK\NXYMV2=#T'XVM#JC$ZBV/^^,'HG:]?MHB54XG*+DRW *+R6J[1TZ:7W/
M01Y:W6TJ2!_E[,!@[,%>N4>^8S"=]JFP-MLUX"@NN!]51_TC4<M-\YY [0%1
M8'(-2Q?!<T.%P074+UU SVT10'#LDA'UW!:ATZ_05H^)$-SY-MY"<S$UYE/3
M7/; L=IE'J#G=F+M[L@:;H8./O5E<!S+'C476;?L!Y\VOOG%FT^Q'Z9-9+49
MS.E%5K?S@?D 5\12#[0XH.]/AAO<;H/5>"J!I+-.YP2XV\\[-2#\W\)JY&-=
M&96L[?W8=ZR._>Q-QG[;&I6C0\]M%6RKVW[V]7!.65<]#6]WKEN5M=^F 7HW
MS_ZP#FS+;NIX;:M=;IWY[!:AS"5PVG[NRCK>+]$.0;G3KN!<00Y2CQ+.?:U!
M-<?(\UJ#2JJ2>BS!#CIJB\+VS5IJYTK>>E<;U&;P6_+;YLHLLSI"23V+U<!"
M*W)IR4NA'[8J#L:"2<_@,LTE7(:+>.(E>BWD=K7 'E8[8J$+5K\D/YEG_JO*
MPDZN/B8,G@5?TKZ5"P)PE3(!B.AK\+U@$PJ$/H^J$NBR-G78IY?>O1*6>W%@
M%/2BQYS)[QBY83$YK?#O:WGD:BTO^DFEJN28.DG<>KEB7CC"19E)3-"L/A82
MB]X4Y8,IOWM_ZT]N95,E^0/7[#@_@,;E%WS^]"$Q1(4ROEP4 \_\;S@<61H<
MPWG-BINY9EE_H>!.7BM6HJ0%OP?/ T'$;[?,'$K$R.BF:>A8LCV+DC18FAZ8
MDK,95G-GY*^9_A@OS9>4CV<";,1HD#)(<M7A"<MV91&U3FEM5,HQ"0RAW?02
M:I@Z,F=3-HV+Q;M$(Z#O8EJ53]Y*&1D%-H+\ZF%UNQ]-6^9[& 1<DSA,J6-S
M_GQAI<@C0A575AUR%?B+G4X'58@Q+X<VS9L8SCH_K=L>-'7=1V.Q1A8VO&.>
M!IMUK3=D0]%LD9JA*9YMBF>W"N@TQ;--\6Q3/-L4SS;%LT^O>'9=->*+-Y\4
M*],G9F4R\ZQ,<W=)GDUQIL<HBAM8=CG14I."OK9EMT^$+'K7L0^L=AF,7Z-:
MQ$ZOW*3Z2#S7Y7=]V8'@[-H[>,-U#(:.]MHL\GNP;*#2RA#B(PW&L?JC4ZF)
MM+LG6\'UXLWG:.D&Z?(Q3JO=L]KMDSFMIS28O?;B_8YQ/%:CUJWU[2688LCC
MB2K6F_II%/MNH!H+'G@UNBA%IW)$NEVKWS^5DM2.U3L9"/7P9)H+5YCK&"@'
M6\#"GN%I[(\7E-7#TWR]"*[](""66J)"/;R^ZXQ.9<_LKC4L@SR.-)C>R9 G
M=$Z+LN#%FXM9%$OZ88Q43\'9#*)YCNF73O-<VL+B&WBL#RWWUN!DF M&5K?,
M_W*DL9SU!UN<HH-7<0Q:6VS.D=3R51I-OIZ/*:^)Z50P)NB('WA-^E:O?RHG
M%@N/3D8#GW6L_C;$'X<O/:KH'7%,#;PR@LHPB<D3:[A5MD^>&RZ[T^#SSYS.
MPZOQ7]5^^N<#NVXUZ!NP^3MJJ=/&9F_9$_ TP=E[ZS2U54/ )[T&6W4#/,T5
MV"=$?XM^@">'T)?SKQ=\:CM _3W"82?130B_G%;V_A$*K-QU2TCU)ARJP6VW
M8F\>>XE'T:U<RR'57ZAE7A;Q;=NVWO)A6).40:?RP=CXB*#W*@5NK$^!TT@H
M&2K0^+LT)\)L"$/K,8\D<?J3JFBT(:/1]'V*C%H,M%=H_"TC@/2 7J__>C,D
M&8Y4M0MK\"# G6H@N"?=6JG3M%8*]]E:J=.T5BK!)9K62G48/,/V/S+8.[PQ
MWJKL9JV1^SPMN3/UGHK_Y@KD&S<'+^X/;OS52XFHRJ_KE&HM,1OJ*A+>*S*R
M9G*O%&B@*;,X[3*+U69"_>H/F@J,4ZG .-JI:HHSFN*,ICCC>11GN,L8;D .
M#\WF0;3T/%EN3\&=:L/$G4Q@%"E\$H+K1>&@9#&?@RD#[W!GIU#+88\LNTP5
M7H]Z"+MK=?LU;2S5M?J=.O>5ZC@G7,MQ)!20;?5/!BOF6(/!J2"2SFS+MD\!
M!-1MGS!T[5,<77M) L?4#;0[)/'B.W]R<$1\Q^J6KX%C >*MGE,"2ASQ[):M
MU".<7:>B@<%QM>RE'T\6 2.('P/GW@-1V@+_^CC(\JH&*\=2];U3 ?_W3KA@
MXTKC- +#_-\+/_$?[>C"..UR)YHC[5)G8-DG4UHZVD:Y/HX8E2DICZM?+S2V
MKL<XI%VK<S(F8\\:#4]%UX,)T+>W.!N'-P$J,%DGHE\WP-G7YVVVB@^=,K+7
ML2KZJSPW=+=C]<H1C>>V"" V#V^B\@0@[L-R5*@673-RL/9*;;5I6J<-:AZ
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MF+KB_<G1=^8(XK93"UJ6613Z:<0PQL6<2'PJ+WE"5(8>1LB)]R/. 8HQXHC
M#-6;!IO.P&&F(YO0F5I&"YX4V428V ,!TK ]8UQ0!0S00B(+4:JV-5;&J+T!
M\D2\LGR%5*]0(?5+R_Q(B=_W&2BE8? XG0W\&!K*FW!&&HKMVB6\&SD(7R7S
MAN"[$VT!P#GQ<K%0RL!0GO[BO]S9_/5G\X]/%\4TG_#\*G+&6%RR2!1(_0*$
M?TED93KJ^E(1V>-W/E.;2?K*QXP^3$(N?O?AWID2:S/BM]VYGY)7R%>7!LWP
M0N1FO/(F2+UO( .2PD-)_'+6QHI4XC<B+82;[*73&IJP]@%=MMSVD@/8C,T7
M[-&P "[\1<MC7H"-YE)3$$S!A>9?W9 X$GNT"5WJC4GA/UHVO#E1 8\]EPT"
M5>.;HXI\IWWC0GXC8XU$#?O90]3-;\21^"GV[U"SDPOA"8+6P*,QTDB-RBVU
M<KO.M&S\6!H5W_.YT0HZ.4F<S*A)<=ZZU)0Q()L"@1VB<B9&SCJZ[ T!*>)U
M$K\=R-^*?C;%5U%Z"7M/<7J*WTNFKQL'/O)57N>!@3]1-YP+N.L"L]/FI[^F
MGC7X->&08U)-_!#-*.XRRJ2[\E+4FC(SDFCR2E'(%GIV5OY&,;Z*%S#K9+1(
ML=?:5,O=PATHW#WM*-&\"R?4MMNM@3RCJVHF<BH%F0+/;XF5%K'2O1]>O,EN
MV5KJN5HKZ=(MVR_<LI>YRKS/*HL&ZL!#P_^O"[!;I[ZPA<E ^\3P:KB7N84J
MM1"OLQU2>UL*Y-= [\B?4#?$FL[B:0G:0 F:*"MX7^,#]A2$I+1#P[PJA*L.
M5*'J65<J5>3HP644S\EG-G]#KQ)MR\>F/&ED3@N-5E8U%IC\,) $=H_<N:F)
ML2@_+#%?8UP#S9]E!I:2D0NRZ22LXH/GI<)^H]9>MU& 4&*#BRDKJGTPS(%E
M$!2V"4W;:9M3=YDP>WA%$6I-]^-):HE104O8+4TUY-N.UG;2C19HM$"C!=9H
M ;M=T ).BV,^&"'Z>(\M8V]]:AQQ*8I.?J$\!%?[T]^Y<8Z&E:88%%??:><'
M 0MP'.KL437:I-$FCZ!-UJ- .PT*=*\HT$Z# FU0H$_J2B^T%K [+75YT[V,
M<4VXU)/<3?TE=L'<5[191)K*(0-BS.7NC4U$H+F]F]O[R2J. ANZW46\D"3B
MRPB3S7>R&_T5%YT_MDW?H!<:35&;_7B2FB)C7.<<T#]J/+E:2WMI9PITW'8/
MH[JW_EBV Z_H>F!>36Z]*19F'&X7#[UAF7.E.U-%9VOGN>1\K94^V0OTAC3'
M:_OG5[AH+X1KE7EE.P^WW7(.>R."2WB"@SQS7^UCA/N^C'$8&=7:-)HL1%.9
M6%Z+;D(D/M4M1G[2YT2..!XVX8O72%/56LW:+2/W,'K=%%EAR<CZB8TKA(@A
M;[%H,'.IMWFLZC8C%H.)-[9H"BD*1SXK1@'$_2UFYN^_?[(T+SU%M),HUS<^
M<;F^UM_DG1_/^/3YDJHBZWI3?09E#16&MM!JG#+S]T\UW<TG<X%\SUU1>?6<
MYHU1&<A4UXC]V%==(<(^+D?8'SXU?J@V.[@C\_+ D>\]VY 8N\T9?_I=\Q##
MILRF\Y?+R[=OW[T[X2/[LVO>@NO[WR_^\@X,Z=Z+-YFBK5:N9K5R_?E']\VI
M&2*'%$=Y9@][2M^=.P<\G8+KJ29GL__B3<ZX^,4-".=_=>MYZ<H6 &1 (-EN
M<T /<T [C?I41W10.*):C\5\89(D<_VGY\:)^78%F4-S= ][=,7HNXUN':X]
MN'IH6Q3IP6F530B:PWP2A[G7Z&%YG)WVVN-\Z2:WYKL@NF_T\&D<W4%CXXJ#
M:U/UEY=L&4EKCN,ACN.P"3X??_#.#L'G#>D]$6^6GYCOWZN"_W\H%AC4\?^[
M@/E<+S&D(:(;.]P0!MX0=<W7[TS+VGT-[@SY,C_A:ZZX<EBA=+O=!J:[!YAN
MMX'I;K_"SP&Z^V22.%NB #8KC >DX/><@<<6XPPV*283'F[ZB)U3$Z<I'R[]
M4PW7VIP%^J[].#Q(Z%=BG*5KZN=D,<>9T?_=8\IGKUB6_=I/]E/V#0Y]>*17
M=INF\^2G'W^\O[]O)=ZD=1/=_7@13VZ17_%';WKCQC]BIZH?AZ/N<&#_V&ZW
M;;O;==I=>]BV>_V^\V-ZUQT.AYW^__&^V>USNW6;SI0V/H='GL-,8G<"\_98
MB[QXHPB;R"K]%+A$%/3!BV^PRS [A)SN8 XDNX-FJ#VTN /Z%#FJ!(&B:#I@
MF?_S"6S:?R_\Q!==R5J(GIC __V?Q1BOPD3^F][I+@+S[10>,TV8*HBZ1XL:
M25';&'O8K@N&Z6+UM"7XGY!W2"%\A&*$56W9$E=[2?Q):;$!YQ#[;W*#8LGM
M9(]X7JVBI_M41=9I1/8H(ML==>R>XX"MT^[W.C]ZWYQS9RM!!2&=S@2#Y?92
MR]QB3J]2:K_<>A_<.R]4XGE4P84SN4W?7"FWDKMN2'ZQ_6P$M],([G'OVHXS
ML-MXUXYZ0V>XPUU[Y2$5K_E 2?[K(O1,NP9RO-T%_..%)LHXM>XSNX"[C1R?
MR@7<W49Z!2/IPX3W@[L4$5PT-$]8>.%<-I?P9N'M-<)[3.%MMYW.:.3\N/W=
M^R["9M /%5^5A;&9*;E]TC*\JP><D7%SCJG];,2XWXCQ<6WI;J?3&X MW8-/
MAYU=XE8S9MD6A.PI">M%DGBI^6D!+W<3C8R\X!(O;F UI+VY+I!%,@W_A$7D
MOB:9S%[!A?X!VXC)#_<HCV* SRTB-6B$\<C".&B/1B2,]F@TVE48U:WZW9+I
MG+QH.L]--H>-;!Y7-GM=Q^&+LCL8=0^2X/DX22.R<9W-XG?U896!6Y(^9J],
M4_A+.+GU_B/MVZN\??OY</:MFMC@F4GMJ)':TY/:0V9[BB?]E$78:41X&V1%
MNY'A8\KPJ-UI]WM]E&&GTQD<!EK!J9WJ\'!.9K]<?5DEM/B++[?>50HO30]@
M^?(8V308/1_Q:Y!-1PWT.NU.'_Y!69KMA&Z#HZEBG=S+S2D'<D5G,[H S5]B
M^!M,\???+RWS3\_':XY)"5S!Y I_X<Z!,%!Y:]*WUR99'AB?Y19QSDF+'TS.
M^4YIT>#5^S[<WW\D.^W.:- =;7\D*SONK8B _(&M:W&K>[(M9O%<<A/%_P&+
MRP]O5!KA"CMGPPSAG]AA31U-"TZP/[WQQ''^PTOOH_BK_!NN'3\5GS>)Y-/>
MAG!)+<5595XMQN;[[*!7_/']-J==N\AD]\VM3K]:DH'BJ71/\M1WGO:I[W;Z
MH\$.&;?,A?DC:IET!+:3A"S9)F5 J.@QG%[/"PMNS F??&EC/?3HJY7HG?+1
MWY_!T&F Y,<&Q3B]#IE;G>](PR$9OG]-%';,[21)D+4VM$SR!-95NE:".@^,
M]'6>%1ZETZ"Y3T=NMHKOZ5#0HOC\L@S<^V2#6#PL>O;<Q*+!2A];+)S>8+#]
M=5*X.=X&OMZ^'$<*4WB'=!5TZ+ 8]1.1Z<>R%YJIQ$5QX?_J@3PA'2L(7>RE
M"%<DHB%Z20B?SE/=P;#W=B%E3WYV@M> FT]&\+:ZC[82O/?'%;SMK[RM!4\Q
MK7Q?7?ZAR^[7L6/T&B*,_1)A]!HBC,<EPM#$2#Z.2&%.1R:?#PG&SL/=.\5%
M9S^U%<?D+W^JED1G;Y;$7X]K270:$WZS&#:U$2<C>%O5)VXE>'\[KN!U&\';
M+'A-'<21(2=MI]/N/SAHE>4]=Q8G64TK<1YE:7I(&$H]M5\#],@^!:DI6C@9
M07I($.HRBF/F^I1)PY62)OZ^<S;2*O5-K9!+?K;ZAY)A76#[JP3V@1&L9RNS
M3<G"L66VTV\[#[[\:B"S[[QQ3++5V4IFM[]GU8-'-9#9#E46/&6\FCT:#7M[
ML.($?NL!YW3SN7HH,(S ^,[S (5U&U#8<>Z$]JC7MIW.^:A_WF[W[&Z_E7Y+
M-P);YMX$1H2E*;,91@@HL*#)R5JQZ')HK@(Z*O%B=+5DU/M2.JY^.7=^O##/
M<E_#'W<ZG?/NL-UMO\K'*Q!6"AJB?])*>I]"U"#$CDT;V(&;B6@#^YVVH#K9
M+J*N2Y*J;/G3C1$]:?I)LM NA3[71Z+(_.Z8E^[<3]U@<T6*W=XA*%ZH!GLN
MQ9C=!DYV=!GJV?T.R]"H*VHQMPN.[R)#=B\3HJLTCF981/"?_[BA#W]\MP #
M$/N!KY>F[2/=RIRSGYDT-1BQ8[,3H%%'[ 0]9S38X4:B$TS>_G92I?#'0TE+
ML,>K2#[<>5X$LMV&@_*X\C-H.WV[._KQKMOO#$<.B$]W-^F1<H)MORYOW3#T
M O.3&Z>A%R?FISBZB=W9-M[2)JY6T57LVD_@')M+SXU-KZJWF/U\G*$&VW!4
MT>G;'7LX1-'I.7:G_8";Y\.OOQ3O&3\T)Q$($4>?L^CP+<9]WWZ#NRF\R1$"
M?/<=9&674+Y(^1E)4@-6.#)*R!Z-!LABWCV'4_?=GM"9]\V+)SY\,H_]B6>^
M!$_&,>=PL!.4HU>R1IO]I*YDK!$BB*&[7WX[OWJ_,=[0;=G]S7>7)F"">-'N
M/RLP4+?!,!Q;OF27 )"OP4'D:]@]C'P-&A[_S>+5P V.+5[#SG#(XC7<Q0!$
MN=B'!\51OFW%A+MIC9Z9D#0<A"<D):/=I,1I[T5*1HV4;)22QE0[$:K [K8M
M85A(!$_4'U'J):T-<O!T:?M0R)\V(*QKV]0R:,?C@1@K/AR;E.0J1-?_@FF=
M>G&PK%";_UL10V*[_SD@NYSV_],HS>]7FGBFG38=:KT1.==]$46W#ZKME+7/
M_A8%.?>:,W7<Q'*[/7)&U(W<&?1W:5:1G=8U%+XR5E'L$E-!#TF?3^"HNGYH
M^B$,/8W Z W=V?]E[VV[$U66/]#W^13\Y^QS[NQ[24; QYF]9RV?DCB3:$;-
M9&;>9*&T2H)@ //TZ6]W XJ*"M@(:)^U]]DSB4)U=?VJJJNJJU T901T(&^N
MTPW<)=NF+7=4N6C4S9]B+GF8\W7K:J%DMBT/1Z81.^8"=;<[6LS1<L2XPS)V
M;@"9-W+V[5J$OV&$S+81+D2,&T>S!#Z01DL5$X0T<E9MKTCC*=)\((T6-2:P
MQ)[@V<U=7\^N=1^!")$TL9^B1WE>.\+*>\@C6O^80)3Y*H#T=UI;0MGFL]HN
M8 M^:>SXP$9+)..>:RWDN:(U9#Y?* 8P:4X*R)=I6QAA7=H#]L(,KN8RQX8^
MFI5/(/I\'>$<]/DR>7M'7Z 0I3_TI:0;^8ZT;6]IGJ<MS<FV-,_3EN;[;6F>
M0-32KN4N<HEW+8<&@4@I.6U;'N7E=G)QK-4;[7Y<#2=T'*&??Z2WX1&;:)5Z
MS)#+9[/%#(9<B<L$.6?[@MQ\+"R?,,S-*1..#G2TUBZ!H",72=XKZ (%DX\9
M=+38+E;0E3)<+LL5$.BX?%$02%LZJRS!=BU+B3%S%EF\I0A*1P0W6F>70+B1
MLW'[@UL@ W>T<*/%=G'#+9_/67 K".1+@&RY+B33NA6/#FZTXBZ!<"-MW?8!
MMS#6[?C@1DOOXH9;*2O@>@2N6."))P:LWA=).[I95'''YTO2VKL$HHV<<=L;
MV@+9MJ-%&ZVUBQEM0B:?PTEO7A *MBN9\X.V&RBZ0X!18INYMW5EY9DEM*W<
MEF*A<_>,)P!!;EF3L!IJ_XQE+J<]5"QC.'_OB&_,-9!DT?E!M]-EROVGJ6S@
M[\$GG#F_0F]"[P@'WUS8V2;'A%[:"S%N]'+98M9";Y$O!9H0I YD?6S92CR@
M3K3';:$?K,%Q-H4X#C&CJ'1L..9I'4S<.!8*A1+&<;90X*.];V+=J5KV@+UO
M,&/_UQZ-:@ HPZ(RKWY?N,YL:H1O62KVN-6C B*MC4D@$*.Z>A(7$(.URCE.
M(-)ZF3C;=Z HD)#/Y#\%QQ\TA!K$B^?LY1M=&\N&H>EON#LG(TV!V[/=,M@[
M*'+FDV./#SZT_B5N^.2R'/\I4C_2N3>PG"?<U8!%=+V!XXX.A;0L)CDHC,J)
MC ^%@8SA$:.05LLDI,F_7UO8'<GZ&@\2NXU^+ASE'(=R?:@48W#:,V1)1GW;
MAE,1S=Q 7>(FHFZ^S4]SE?8Y<RZK(KJ C>.B>)03!*,X1+!#CY]A>!XNU=#W
MW> >0.^7,2&_<=-Y]-^E]T1QORD5@PS(XIV6ZR0'[[ZL;D=^-4<6WA&8D9Q;
M<),A9#?G-\,#'GG8MB%V#/0"'*T77[69FCR436BF'0VP;8Y;4,M\S%"EM3ZQ
M0A7^,9<I%$(XR%SNOU!P%?$-85 77Y@N@+] UIEU#9&W*T:MX$Z&*&K<?6#Y
MS!%!AA;LQ P9+I_EBJ$B.]CF7&X+\9#O(,<?'TIH84Q"9ERC:C9_I=K3G@(@
M%);'5W SZ[%4*MH1'PWF?^)X\F7FP$'7#']D31',EH*S0'WUCW.X-:KGH;4J
M"8)6U@^T6H,!&EQ]!3QC)K/V0[DU-=D=$WX#&1I3E!7F#D"Q;[#,U<TLTC$[
M8&T!6)8\P&C_1:O_8H'V7R3;?[% ^R_2_HNT_V*T_1<%(N5VM %C%)Z%KZ'E
M9<. GL&VQ@&E)0_>"LVN<=)OH)LQ!J8N]PW[)Y*&XL"]J2&KP#"04W$E#\S&
M4)5-=[[%KQ<2;"[ZT;KY_/]'_?S$H#$?K 3/U*!SU[(&"I=?1)1,=9#)X!'7
MW!?DZN?M3T*8P=] DI@;1=Q:=I /-!7K> $D4  E"$"^+F4%!5")J3]-45XR
M((($BB _",I2!"4'005?4=R&*H$)JMN!0*G).NBC^X(NMQ ,!O!G""A6]=QR
MC?;V9J5=39*8VAG3D<?&-J 5:$C7%]!R%&C) 5HQX\M4R3J4U86:&824T%Y=
M,4.AX@<J>0J5!$'%;Q.HV8TD,EBA9L475@H4*PG"2L +$ 8*P:$8GGW$L8Y!
M%ZA$&M5YH83B[B>A(HTE^$)2D2(I04@*%$MP(<FR-;<JE'W2.*(1!5\X*E$<
M)0A'OHI7-L7BEMK!<SZ;"M:TZ5"! *J<,9VQ;(ZVHBN"PI4#1%<V0]&5('3Y
M:B*8!'3E*+K\H(NV)HH97)FB4'0*_SE?IZGJ2%15H# WHFZJZ KHG:ACQ^]&
MUX:Z.&9$29N8SH66MUFA_M9+ %RP<Q-N;ELZ.L30$H9$0<9719$?@S2[&I#W
M:9+*JJ3#A?\X8[[KXF#['1LN6(W0D<*+%C@D"5Z\K[21!:^X<,4'2S(=*:YH
MV4/LN.*"-2RQ2EGKKZ _Q2&[BJ9.#5^!NV ]61>OQ!T3)F@/G[@AX38UO@X_
M\WQK4SMCL*#/B^B0]4#X0!'R:Z /42&WT^E<>9NU\M_4S:,[ M;--'>?\@UM
MS+?9)GJD\H%#6OX0.Q"SN4+. J*O^/G<*M7'$T5[P_#SK,B;F1=+JK=Z?S?B
M5&'J$D2F9&A;+5W6AZ5#?P8]'5/!"T<'+EHOD2!P^;=QRSWJHD-<T-"ZGXXZ
M1XXY6ED1.^;<GF4A<(S074FQ.&-N9>P5&4,&B:2>XG9@T5*+) %+"! =) <L
MQU[Y,E:01HJKK;C*T2*+1.$J4 NXA1+TS9FN+<CJ0Q$59949(I "R ,1/0 @
MCJ.G:OBIAFNRZ0RRVT 8K+;]2$'(41#&#<+Y2<U7.:[_0YEU,7%V)N**/@]G
M;=1%RX0.)%,1X6G+W)H.\S,9\;A/9SDZ!2INF+EMG;]Z7: _0X]Q[;R,>;MK
M?DUCQV5@W8UD8P*_4):>94/3#=9/"VY(K0]#=L0FC%9O) I;Q*IUYS?J[7'!
MVZ_4!XQ_"'X*=H\86;1^(W9DS9W#? +#^';9E*^:J3QU$K?AC7:O2!#>_ 7P
M-\P(C1!VSS+S1QZ+CUO;QE#,;<,<K0.)'W,%/A>@1G%-%PQ<NFB52.%KR(4O
MQL9[R):3Z1$=V;W.<0%2FTL<:=MOJ^UWD;;])MOVNTC;?M.VW[3M]R#2MM\Y
M,H5NM.]W%)&HK+^,IF?[N7#.A'V_/._S[FO63X;RB,-/M*(M47#R54<:OO,/
M? &%PR8XT$EP\:"!RV;Y3)8K9/@\1,:GYVQ>*);X>_":]7=O(5QWQNR9KUX]
MFHZC0P/9@&++O %19ZQ0U"P[*5CM3O+'@Y0\'>P6=_>>3*%0LKOW^'/"_ W)
MGD=5?$]A673F6/MCUT"21::BPZ\[67C/6WCG-S=!QF47'<C^@%3"8Z;RYH':
M'TZ3E,*QF; \[?R3'&#Z:F+B<3KRB]7ED=G[!"NBS@=<2Q2N&^%*B]:2 U?.
MU[V'!@IN]G4(F*5Q%<OV<]TLXB6#AW]7:9_/?H:OH?NI6LM0;&W$ED"QE1QL
M^8H4>K2!V *W-2:0.-8XBK6-6,M2K,6,-;Y8R >XC3X;7V9YES*D>'4TYVHK
M%8P@($*HP.^BGQL RJ6H,!/[R[K!&)!1(D3K&_J #DR-T-5SW/4R=W30HNV,
MD@.M@-W\A[(!?XDKL-OR<&0:>X>6SWM#1PJM/(56S- 2"ADA2&$:CO&OGR']
M;:H")KM4X^G1#VQMU*.J*0H8 J8SF3J_;ZA]38>@02] WS3ADUZ8*VW<$W5)
M9IFR\H8N\G5&D$- 45R_@1S4S!'T%$7X2KN0^Q*]0$?\=6910T3JP("+$%':
M@FP30,2.XW-&"Q36<=>;SFJ\ ]>;AJ_QMMO]\WF?=P7;FF$P5^!95@UMM#UY
M3@N]M^&N2'$7+^X$+E,,THNV.Y)U*5SN8>F";GZ=S?5(-JSD)/SG(+::9YRD
M$*$6N($>[6R4@I\(3Q"[.ENVU2KCJ$!.>S7%BW(>_KF8RP1M/+@855TRN/\3
MQY,O_DWNIBOZ?GI?!#&[?F)#JTVO+5CRQP/+ BW(B1N5?*X0Y"@["\"N.=+Z
M[>HDJY X$[>ZB*!]/%\\.B31"IJ8O5B^F.,Y"TF^.EV4#0.8G@A: YWSJ:*8
M<"'04U1-T7B#[B0$@N-TNEO+Y_S=6,SYS@XVM6?;<SRZ:&N!_]]_7G-U(H),
MX17>4 E"B><#&"K'2;R2^T UT,G0MXTJ5RY..PU"QZ]/Y;EYFL&(+Z7 /B'A
M%QSAWTGJ7;<H20OI[J(E9#*EDC,+I^ K5;9X-,%J-%(Q*P2:?6T5EUC5_;Q@
MBU@"92M[\%(E9$)XUE!$QB@QLS9GY$,EN41M=DO1C_^<%M%!_7 .67:X4JD8
M)!/AF8) !L86(_3S^14C)!E065D9?M\CO,+*%,[F\4F7J/QA"U26XTI!O*>*
MK$JX5AZ8\&" U!*J:)Q'T9P9U5;26M@:/>O(XXD"EP,?\XRD4%,-?Q6,ZR1O
M\Y%EU>-R*$VN!!:.1@(#5?K]U,Q96F<ZP5N]$M,-*HU.$ IW$A]IB@1TX\Q/
M1/?P)9'LV9FF5F,]-2^@+N#)!DJ[*\^Z[%LT-1-L*&@* $C6*AJ<]@Q9DE'L
M=@CQ)*HH-,Q,(+)<-8/>)? 0IN+0&;@X*SJ<%RIIZ/ON:L2!KHT9'$A#B$;_
M77J/C]K$"!1!<H, I0/WMET@\75O?_'X+Y#-3,Z;&Q=\6K-@F<ELU';,JW&=
MJ[&5(PN3=1_PT1.N1'O"D>T)5Z(]X?;;$VX=(&ACMM7&;*A]0F8W$[3<1RT]
M!LE7*M'C,KX_D^/X:3F?IN82J-!#"SP&)G<<9R<DJ-SQ^$J^^LYW\&T@9$QV
M/K6'%+[\\0@??SS"Y[,).S'A"SJ7N' \4B<<C=#Y:EF%A$XU1^'JTVVQ=#)P
MFRZ#S8*83N@$78:V[V ZDKL0V+!>?=5F:O)0-D4E</^JXQ#G T]+N\395Z.G
MCBP!)PWD7>?@R&ZK;VIXBWVJ5/_U#Z7CD;[<84N?4"ID2P'RD O%$!VHZ?JZ
M;,\&\PZ?S;9Z?J2QQ0^MMJP#54276:6^9EW.P9*8.[U$Q36X:8N*T^)0.U;M
M^SDX26Z",^;*E,Z82%/E,^(+21?3_'^.1DY]92MOX!L!W& I:E'M0M&Z%%4#
M2L]4E2SIO.V4?=U'.7RQ//0<NI O%4)?H>)WR^G-;P\>8%)O)WS,.)-+.CZ*
M1X,/7]GN.Q$^%5<W7<E/4]F6<W$,1<^PL:$ ! 94EJF(\MC8"@:/@]JZVB>K
MK=L9TX9R],;<Z#(\($Z@X]' 5Z,0]/S52*U-2!^6[)8.67:S\(]YKA0@"0VW
ML@=$*[IE'<]"9WZ#W*RSQ"2;6#$I90Y<3/*%7)!>"9L=T?F0.^M@G/5=R!GI
M.6B%K.2*&_?_)E_>K&"/)2X>>H,A5[-F2\T)?N)7M/UV7=-"O0I0X0,O=&TZ
M05;O&4HBM+]C&0FD^WQD-TDM6 ]C3VQ!L.ND[/\D4"S(L9/GSI!\T1+*74LH
MP2O/V?H2:\3E>+EUV+9$$AVY975H6(?N)-?F$10T@0H:*4$3'$&K0D<?63I;
ME4W'T)F_81D9GKPGZ/@-?Z7C7IL Q8W$?E^;JKC6?2#KXV,1O"P5/"*"]Q_C
MY3Z3X3]\O=%>K"-MV30U784GRX_P8*E,4;A'MOPYJQWK5 >X3,]@K!#)W\<A
M<0*UJ:14G3"SJ56TVP.XW_B8@:(E(QD,7$5HK0'\K16Q,Z:BE1-O3Q7 <()X
MRF4_BG\[IMC5V;O^VA^)ZA":YS[6HEQ)R%JA02M\>20Z$DHL3R66E,3R&R76
MKM,0%2JQNT@L#W4L%5DR(LOOI&0[J,LL_#@GY#(S@17UGJ@"X[3UBB+/MJRB
M7F#'(Y\\E4]B\KF+2J7RZ<'>4N$H?=2Y4)4*CM(C1W]5$5]ZZ![8C:;(_3=\
M1%H7]EEXJR*KX'0$T"0,^"PN]]\/7S>'(><WX-Q7?OQSQWT9+JKMH[>--@GC
M; T\OE)'\$X\=]9H=C"M#14)%O.KTKXB@O7-"RF274A#-4R40L#$UK3^%&65
MSI*IF2.WAFA7.]7+_>TJ2>*[XJNF:N,W3&#]U435O:CBLC\"8Y%N+=S::OGJ
MH+:V*BK]J6)Y:5>R^MA#%2YTH[FS6OW\H#:Z!@:R*M-]7M[GJW+EH/;Y2NP!
MA6ZQ>XMOVO4#V.*;V80M"F'W_F;3L9=5#3+6VDC4 @)?+Q&MH4\UT129CZCR
M4D*)N1?9'-G).9?$,I*]TU;3,OAX$?X*I_'FE5;<WYYBX!Q!=SI_PH_._HWZ
M+)I$.A<IW-"1)I>A'6F(=J3)96A'FOUVI$D0[-*I'F@P;:'/#H][]Y!C=N+B
MX>>H6AD3<@ET@"QX,OTQHIN0#L>K.Y(-3%Q_(24E&XR$ZM\E1M5,N]H<&@>4
MCYIH!K#;[]GYJ&*(]#[S$7T!E;KSF2_.AS$A\ OXQ]R7OUD&OA+?7WN1#7Q)
M[@&^TRF75V1H$!74&P*_7H3N@441"XF&HC02%861T9 89RVR:Y(@JM['-U&Q
ML915W/3A#2T5ZA],R!32J2^O:[X<P;T<3"GZJ'O="3UUD!2?_Z1"R*M6_P],
MG]$? 6FJ .O6FGWYPV!&(CQJ]- U#FTLFT@^W*G7A@G&3#[#?13__IC[VQ[]
M[@0&.Z??SV:CX-$)!%T=,=#7!E-=E8T1%-S)1,&W2:!(6N=5$=JC"99<)'7.
M.QWBD#39I#G2WJE7F>D$ODY'#IYQ#,)%;II0Y!(VWWY,X@A=RW#D2-/Q149'
M23K["C\R ;K](4O7S,2L]_='+K,D9P86M,/?=5+31TFYP9'+3D.5D-D%EAWV
M^S\14JO"PPD.>D!UT7<F56CZ&S-1(&WPAZ*N(V.$/R.K]CTT2=:AG43WR[&6
M<4JB-*OD)" 5.A1HR!D9.?104Z&;Y#*ZFVN",[?/C[<Q-3NR>JI*%_W=$5CU
MZ0S''"V$Q0P&52!B6XA*O1BG_Y4^<YK0W_I]^U*:"=W%39.5\+UN^%WD-5K?
MQX38?A[V(VWGSH<[Z?:E=G<%,2'PPV]A',*-SN!ZOV^2]E C/:DOG-0)']1)
MUHE%%DV SDC2X@F.[CK#Q'0 L#PG+H=*S<6>]@R\_23B\(O!$D5%O!4M)1KS
MZWWM7M9/RNUZL\Q<M%NW-\QEZZK6:%YT6*;1K)XQY6:-Z=Q6.HU:H]QNU#O_
M?.I]3>U:+:MXXF$54[TL1P)3O(2.?:H^:312O8X#V J4^</>Z GTFWY O$!]
MB3MD6E=ZC?0N[C<0X=FICF.;LTY!3G-:[!>C(8/I7-L_\M>/?YW@K+LV->!:
M#.@2R'O9J#W9U$"I3?\+])<$7?9SE[U7*\\]=V 7DIB+?YUY9_!%:'W_?N _
M;/CXDA]W^F*7[O<T1?+NMS)[+K>2ZMV0L%]YN+?$EB'K\5$U&'$^>+ ^/[R1
M/:L!MH![$Y:[/'GF5D0%E:$;C&C^T],_P9=6 $2?"H7;_CM4R4B+!69^@A99
M'4&5@B)1]I*JFF'B2+_]]_HK"I*!X *6H#6V4!0DS0NH06^L;^'<VA74D=+^
M8QL80'].]P8MSRZR:F@R*W5+F450.G%&DO\+0 IT7>8:P E<^=X OYH2VD3(
MUJ&.6O(BNZCIGQE]V/O(9[(L+Q19/I?[VSM4L_3R!7\ [X($^G83ZL]6N Y5
M!W[XBOROA6C KA8SC*W1$>GTN3Z>NXL@W8UD$ZQ*C^UJ";G_>E6/E15%>\$]
MWE!$6M*F/7,P59PF0P:C0V=>?D;^X3(DG(MO__56,8N?XCQ?_M>:9Y:6/FWS
MC8<8R:_YBO<+O)7D_BD7N%PJZ3Y-)=4?.397R 0B_>_XJ2X5N=#<CM;^K+Y[
M%LA@1$=_&)8"<;K;F^(K(QH&,(V-"G/M&[QER8-M^1R;S:QHA6T/C(B8%;S$
M1 >784OY%7$Z<J84\JR0+P0C)@)[O-Y;V^IB6_19D;1(6;7]@WO<-TK,P1*S
M;[L5W-N-2D%##Z68D(W+YY)"25(L15+H\#SPQ&.PDNK^Y3)L-AO0J!^\W'!9
MMI0K)828I# ES$%AN70F17F^O6?,HUF#]3!9^O?#]WOH]\[NTJ&2IQ,N?^;4
MF>"Q$=R7[TQG.H;$OJ5XU?NK>HJ ^*:F+M8^IXAV#\9OOLS-T<O<\\P/B<O<
M'+W,G:K+W >D"R,I^)I;+]QUGYN9KT[CHEGNWK;W5_69ZLV)@/@;^X+CB7V)
M ETLE'5\66CQ0H: [EYPN8]2F#[>UGQ+U_5(=#>N+TX-=$::WR;QJIM%MSMZ
MU@P&:]@5NJ[2 R-1&:#+&NBY.')H?8"U!EA.T<4-::J\,>+4'&DZ7+!T0.:8
MWL@@?LET[1T,CUQV'!2B.GK[0M>FX4LN)>H=!HG[^DR.;%_5""[/"$DG,%N(
MF,+DB W)==;0_;[/%H(FNJS8HVBS2;O75'FSB-Q$U]*!JN==I;9W'25__61\
MPK16RS\;W2[3+C=KY:NKA3KQ@Q4P<E!/+%6I<9JJXK-LFH$J*=NB*HF*$MF%
M;Z++0Y,B,'DKTTS67CNF6#M2JC[.1J5[2XQW0TPJ+I0J*A-Q>'^I=OQJK=N+
MJW*'J9PQG>M&]Y*Z?@="56I<OYHV'2IBL Y&2%K'[HZ4Z7#^5D:%4>>/4K71
M^9M+#+J,7I[/T-[H"]*6*?$FS.;U'GA:]8EK6C7-F\5#_/=FZ^ZD?'7%W-3;
MG583.CR_F>YEO5-G;MKP_YO=#FOU( -B?X1Z/!H::KVG&>YQXN)D@AI&,#V@
M:"]H8 $DTYR:P&I+"G^KR2@-9P4SG  %_IUMY*#A.L&&BV4>T&=1P@O^U@!0
M=\./ON$<',JO:3IJZL:(MM08I[(*EXXZJF'Z4#=FG$J;.-/0C6G/(@;W3T-%
MC2-Y[#Q&5G%7-$PD)*@OHB042@2R*(V(UF?]'B7_K$PBSBYN[!K'XL>A?JDR
MZB*(QJ[#[[,6:;,.K:;3F@[=4T5_F<U\,!!5D(6JE; \P9]\P:R9K>[VK'/F
M3ENBI\Q2EU5M/)8- Z\7?1=U@A--NS6)/5!B(.MC_%>XZOGN(G:)LN3!W1/,
M-V/.3=S4=?XW*&!C\0VN 3=O1/E0.]TI:2I Z<UG63>G -.C#5(*E53C?%M^
M/$0B?'/S1)09QRV([8RWI1NL3/?)0$.%QD@"+8UBH._:R7";&'</8A4W>40_
MG4,4_L3J-"I9(+)^+Z'6H_-?T5QY.G+EY,(!\^SB\KW,:+IQ.39P.66]<W:4
MWW/Z-K5;T)5-987]],!(J=I_^#?Q4<W-Z>QD;EL2J-J0I\3>1W4D0H\:M2FW
MG)>*)NK2X>LC5W9Z.>N<D(U+ICC13":N8DI!$5,RY8>F-BE529")Q/L[V[*X
MR=RX)%#E)SEWL'K'G7I=2:DF9(.2*39$TG2')4O4T4F744O&.BE529*)Q#LZ
MEV?,Y6VSRY2OKMKU&G5S?&MG>WS<X:N82VN^T"4TP$Q9470@)6TODBDAQV*"
MJ)]"A>1@N)],JJB?PE3+[:L6\Z=U5:8^"O515O-)NJ)A0OYHBIBT?4BF=!R+
MZ:'^"162@^%^,JFB_@E3O6PW.MW6S66]S=S4NW_JM$B&^BD>R3%=-B U(Z!C
M<FZ ^0YH[4MBU0[U5ZB0)%)(TL+]9%)%_17FJGS;+C-7]3IU4ZB;LKS2BI7R
MN1*GNLA< 9"TG4BF?!R+[:$."A62@^%^,JFB#LI"0.6\=7=5;U-/A7HJVP(J
MY]J+LEAHG 0JDRDEQV**J+\2C9 <1%.DS8-]>#K8A^Q@'YX.]J&#?9;Z,.QW
M/%TTK21&X&3]5 I\AZ4S[1FR)(NZ#(STKK6A2N 5M0*J:BI6<+B/SORV3L>$
M/\"]@:)9'^V5DR[?:[M38[,F<\;)ZH+*VW)B]3"U@?<C<Y:3U3VHAYOR1?W8
M&\ULVMID4+K3CJQ.4?Y/M5JOGY_O,C+(<YL)2J;[21@$$NAKJ.>?!E^&AXHI
ML@K5TC\B,]+!X-\/_SF_SW"Y#U^=OFT#!AF$">KLIIIVYS6 YC[?3'N*W'=?
MW#R7]?$_GT0' \S'FVJY56$:-:;9^LS,^WV^2J_WI4SQ'DA /CTM3R79U'3T
MY89TWX?G-B'#9;C[>_0G#OYS_W[U^Z*FFLT^UT7R(;]^5C6U.1W#-?=1QT*T
MKC:B_5S7QNA;IQD._F-J^,\<?RIP'_"+S\6^F8'_RQ8^,"KT6__] "GXO$#
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MUWBWH0>!CFV6(%FO@J*I]9!Q/-&!:&@JEBSD<.GXW9;_\#("\"OZ^J,O L-
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MG3</O!;U_G3,K#[[&:)81&0:8RC IWUQ8GSX"O=@MEED6@Q&M<1C:=FVW Z
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M5S*9?.;#U].%7%CL%F*SK'MNLW_9SG,$9#N7X;<*]HX6S:["-]KPH 0!W5-
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MPFNE9@S$^1A7]W>AL%FK#;24[;6B?N@.IX,*)*IPBVS!LYYT0^^[G?9EY>#
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M+FF*9)-Z7%8D*^OZD>?^G$\RWWY/!P>D2+8X)#F_%4A[52/;B";H'F;//'N
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MGQ#!O3V*VF- [3;OH!BY=^!K,F>V^%.N#TW^J52B;H*GO@DZ:;/H]]BXQE^
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MF3^Y:64S&+'UY'9T1X@ _"W^W$9-$,(^4%NFJ8$WSU#T/JO%I%ZLNG*Q#MD
MZ&\9>'7A0I23:J#6<_:J]W_=[B\C/S4@S3M<+??MTSA#71@&!P8>7H!@J(/!
MI..DKP%>H"63?+H\4I>XF!K ?S]^L%AMMNA?T95])/UFB/-*'B#[6B5M)MNC
M>6Q/%=Y]%UAF1/L\[YPX@>%TK9;-FK[/ G^2ZP:??K#1X>AZ_[RT%(D\'P.J
MJR8&M(T J0UTO66V2^Q'S&A%&](-VM%*+]5T8B_(IOE SPJ56G4].74!HL[B
MW<4,X#&2[A9J]>(RV/<PDWV/>4K9Z1ZX?AKSG@T;O]__]:MVTWIJE3G.L29K
M@0V%RWQ&ER=)OP7YL9['Y2E4ZK.M]S5@QSDH.HL9YRTRG5JM!CYH&A[OT;P(
M?I L)CH#1P%\@J9C-MMM+T0')V >\]&7*9_=F-9-WU=X,>Q;@?=Q^&UP6E^A
M(A6+)EUI\&6CSJ1UK^0:87;Z328I%V/):JX=\BN%O?*:J<H%B#J#*ZN+.0>9
M@-FE*,JRZDM:_L#U#?L]L-'@S W@W[AKRP%"B#B$ZV"HXKUA.>?.=P]TW:%[
ME^)W[M<&1U_\7XW;R^I3*U%<GPZG:O4'AN61D0NJ]!D8MHM2=T%^KN2A$DJ/
M]:U> JUGL7D>SD5U-PUF^VCN;L2J%W=[[ES!Z\\[68[KY:?VP8?/W^Z]X7+2
M1P_C8#@_MF+>):4P2;D%67*QZ/6X&J@]6Y:<L_JR6L\>=+K ':\FHJ&>=0O,
M?<N0L?G!Q;\[8QEVYL?SS@?7 WWQ,<=LV7R7_: 'KCC#^/BM88>1Z\>E51>U
M%P*B+5/(K!7'^V90=T&^R'606JE0+#W64EHYB]2*N;+(GJ(&K+\A@O?@<AT:
M?:/+_ MCB+#!26W0J+8/AE>?VE^;Y55J [%@<+I,ON 5:H(LXBUV\6NYQ+]3
M&SX\C]N>%R5G6&"U7&S=0JFZ% ]K?[Q5R[[A,Q/;K3#'S\C;?3SI5PZN@T.W
M:#^U0J+JL^T6KE%O*XM<J>9)I]N"7)='Y+K4*!1WGZ^:R8N8LQ@O%XNV5*A4
M'VO4SL1+';(.\SP,Z"#>XMJX9W[3,>%_#^"75IHS% S/PS8SS,I9=X7J3ZX;
M+$1<N![@RE=L!4ZGY()<F4L(N_)L@XXSH%$+$746=^9L5Y>+BPB\:0@I%<A"
MP"<?GGGL>H=NV HZH=ULMX&G4B,57O>T8=18@-+\:17DOF'RS!R[1^')5LJ,
MTZBV&"/NY@)I*3W?*$6^])S!@[MYF/B[<Z 4%\O+1=QW'O28EX(U1$@B5G1%
MA5Z3K'AJ5YN_SOY\<KX]%=IEZQTM]YGXZKO517WU%=WQN<]ZH0N?BW6]]U@]
M/M,>!$7K,;"!#QG_7P5I*WI8*3#;\CY<\]NKGT&G[(7?%C$'<XH1*AA:"D13
M3MJVC)9ETQ$2ZM;MZ*S386V>^&J#H^U3CZX-VG:A6W,\]=9(Y7#)VLRZ%8&T
MRF2(N6,?!G[Q!_M^W7H"*5G.0AB)U2)F6RQWM7;O/ 1=S(ZI+P9H&$^ %FJ-
M17*@K]>4K#.D>ST/X[!<*%86,6AFU%K("/?DWJ_"EM_VK &^IQG+0PD 3.'6
M'BL/?Y_VG?WVTH1]%HNJBU6E]PJ!@!2Q?1A9%^39Q0*YF2"D4FJGR&>AGC(8
M."]2S^+C/# +I<+N;GV)$8%),EQX;&!8YJ4[-&PT=]*9]^1WJWQP>+GK%1<!
M'^6E:ODBAWJ'+3]>-Z>G4M]=,T]E]@U8Z/(OAC[.BHN5X)HL)7'4G(<79.#P
MB >CFHY)[EV$\$GAC[-O'VH'U:#!G$50M8]2;K3H(:\<1-?%Q;7J[1!V@,4H
M3P'T>;#E- ^A%U1WBP5HQZVI4NT14OBY<?;#R3R#V_=R!3:7"^6]I1>LI,0F
MD 8(3N:<,HV[G3_5+Y>WNS6[N@B6*2_M1PO6;1<^&#"O_TQ9.Y6LB_'R7AZ!
MWOIS9.0E4G46Z^:!ZRCO+9**F+>N/]O1CF%5E62\O-WMG_F?F_5O/Q:!53U*
M_4;AGP%?W'.[.6.T6Y 3<VW-408G9Q$G\MEQY3RTG<6/N;;?V"W4*GFS9F,6
M:V)-SVD<+Y_DSB <7AX/OO[8,U<<IZ4R,Y%B5HSE9V:U39)T0:;- _Y1*51K
MZQ;P>31I9_%LKB"0<J'16*1091K/3L_*'<".\3W?K:!W0!%>YDF2#"?9]YO9
MZ7RY'9F7%XNP[Z.4ZU>'&9X#3.NQ6^:$STZY3J7D8ES;R+7"L5YH+-0,X+EY
ML@\G] P>;N3A6U0*>XVEP$C*\Z9>8"W :U.8]]#:N_AN^?4/GW97J'L3"1B/
MUAREV(?/-BLP1MP%^7FQM$!6_N4QJF)-23R+DW/V32KU1R2G4[EY=SZ,S"G^
M>PHK!_9W\U-S_\.?]TLK ,\,/448&1L7N6K>G1(G22?F@JR;:U*C7%FD$\BS
M\WD?0N%9G+N8@Y)%WU+> (BCA\2/IWK OSZ?OO_;K=8^-1>!5N>CA3/;6X_'
ME17LVSC]'M @6WQC=E/L>2_OPYZ44Z#UL4YXO9AKJF2W4*K.CF=G] J?(EPV
MY[M0)*!>S+<=3:%2FVU[//1T9[9BG+\O.G;'O;[I![%DZQL'!T>7!Z-!__IF
M--COE0]*/[]]MI?6YNUADNULGGZY+YT'YC_>!25<K@"S<K50K\_NW;H1<3D=
M[RP!EZOW6BH5*L7990BY2+CF; EWXMPR?\KDA]WF:6FO=_[M\]XB\NRA5ELQ
M=9['/,,@++F/S3"(_  C%P)3=>T2.-1C%Z+9]H5M.$'3,8]DOVW4B@G,R/D>
M7!Y[_VKH?JLZ7_\N$GA[5&W+1>BU>P:FN%;6(WP^]&2]V'AVZ,D9XG;^:[&(
MN"WE46!1J^1=4UR)P]%R_\>N)VJZK!$S+T0?[,.X#78Z5_PZ[U7"^V]&>__W
M"AL *"M/;>&]PG#IW/1=S%@KY9/VJ-?7"+^1 UUGL6T>H*I:H91[Y+F9; ;0
M9LST<4N\\1[\Q@S18HB[[L<CCXA=?US==>S:]_>=XI,W[I;+Y2;.,^A;J)2S
MSZ#C@JR92Y5OH;C[V(;3*[<*2@O75,RVZB8.#_5U,/S,@IYK<H> Y,0D+WQI
M_*[\[>^?G!BK;-V6SA:,-B$<@6=DWY7VGIU]]U#FSK@?"ZF)?&H3JLLIC:E-
M<W[V0]]R&$@W'WSI\PYZH.(O9KJA5R]>=[R?X7'M>I&VMX_0')G!0+DG/()$
M"7]!5OACJ/"EAXL><K*+Z;%R'O7,M3GZ(FUB@+D=Z@S!5<[%:Z@5*G.DP)\J
MO9$2_$NF-U",)=(;SL X;W1WCSUOD0:2#Q\*.']:8UH \*7>^?F/=4$QEB]N
MJU N;;(:3W:ZL^19KI Q8.A:(W]UE2K8#F8+MFCT4496P[GK!\W=XX/W/W*<
M7[E0WJ(C5[K)6SS.=-_-\G![KA=<,XQOM8*$1WO;N;P9W0ZNF=_[^]W>>QJ%
M-NZ]MCS+[#+=<0,6&^'/9$!;)AD7TR:5/ +[>X7B0NU"GYM?/9.<,\1W/A-B
MJX5Z>2G@_:+"C9=1;X;SSJGK=%5F3#C-Q)"GS?>6<?KEZY?=2GZB.84+I2<,
M[!;#_I#QGDG8J%)Y=F&C&?9*UCDO=+WS:"14*S06NMWS5I6I#'V*OB9XF=16
M>5+-_/KZJ?)^_^KN?; <\&NVFHF42MPBI0!T,A'N"FNFF \M^MG(Q@0I%U0U
M>320KQ5JI44:)SPS53.;G+-X,9^IJJ4Y4$^/U#3JMD]\/P3+FIW ,BS#O@A;
MMM4^[W28!\;V)(-^._1__WC_^[A8:R]5[22,O[;;[^- ,AR-H0]HA<"/?(D1
MW\I?/#.#<"I]%^3:/'(#V%KS)5B(#Z?O##9><!+K^)BX0G$Y7</W4E(OYQV:
M&B-)(1MKIEB-M4\?VE^^]:SS;W^>2K\J!J0E%LA9=#9O/P_X5AIU%V/<:AZQ
M\=)CFCZN#2UG,6D^(Z=JN\NL XLWC>;]'-SYW2T>]K]\*I^U<QP[-9TE*822
MY,OG<E,FB+8@T^6!E:D^SQY_<_K(U7Q!,D=9(41D[7.JU?:/[IG7MGR>\D^:
MD'_=O_:7OU_O=X^>VL?C&H>)I?$YGXKV<?G2G\NAK34>)NTJ+"3H\[!U&TL9
M;U::0#JCS.+M,RG9PG^9+NJ#DZ^CKGG9=S_DV 0V4]1S22\FF5$Z6,0X5H^R
M3:798I*^ED>LM_Z(GFCK0<<9')?+5-3%&H'-#4\6-L(ELW$P[;5[;=QCMY^>
M:V/:]-CU,@=]IK#B^]W+3GUPZ8XN.T_K$Q&ZC 8*ZA[?B1ZX295TA[MBMAE_
M]'E89P^E_((,G4^;_&IYC2H0ED+I62R?BXE<J.;N31535.PE\P//:@--R,A(
M]M)(86^C_=G\[GYQ3__F.*KPH4A2GEB0"Q?,_9*:9\QKU=;JV5;MW*B7]'6O
M'<WFTNK9UWTA3L^CSR>VO,\?H#9S>/?\&*8D.!.E0 *<6;+JUK"]^_U^?Q%4
MTS+ F0.Q)[TUG(IT6MNKOA""+^5D%[,C=O,(Z9?+A;TY',E_FA!;ZLG.D&:Y
MS,JM@>%2FMTI<:%SG=F_'HF#_\7*H5M8'QE\4N 3%-\QD[]0/GG!/ L+C<;[
M%K7M$)=Z=-^FP9678#\>T4#*&PNEHB().S\''>O;Q8?=KSFVZYTD"<JY5Z98
MWVL<I4X_(1P=Q5^!"T$6[ZQ '0@4@TDMMUF-/?ZT)[6@G,NUO4ZM4-Q[CK,7
MG_TYS9):>7BUU4*M/-L&6T ZU?*23A'5#BU_X/J&_1Z$QP"^ ?]&HEE.R$S1
M>LAUP&:[NAG5K]K&WJ_#6O]P.1V(Y[;,#N872_K_^[][Y5()%L2ZEN.@X0;.
MWI 9W@O7[4]Y.Y)\UO3/.YG<E0>DK50M5.9H6[&Q]9[5?2BEWH<\4'F-PEXM
MQW+$F4*XNC(A?'0SNG7N#<,_NOZ\VWC*@%EY<<G+<#K+?#*WO!B/T==TTPU;
M-DL[T7_-Q5_93UD/!DLW.G/)T!;*>P]O]E=^G+S=W(6\E6\^0]\74[YS78:9
MJ<5'T351.]F^'%[\^?;+^#1:!"D]VY:=NXSR>;C7+[.:LC%V=>!VC-^)X,#P
MO"'<U&^&'>(\PA+HV(]7=B_\^>-7^=>3-\NBREH\__%;L1C-)Z3=0J)L)MWF
MUT?U/)*9\^FC?&_O*BF9+LUS<:4JA;WZ8]N,S8Q4)$6R8#+6[#5*0?VH[9=6
MUH4K,\)PF2Y]U]<WG#,!7)\":]SXT\DZ4?5./X!M\S#(:\4<,[Q/Y^\*SO]S
M^_OKW6?SX)N_Q.+H3!?VV@T,>Y',QL91&?OD_%I_+X]4X,8+7?GAIDJT7(:[
M/[E;J99)7(6#@<T0T6/82(9CV[T[<?B>8!4)Q_'#L'%="8]KQXL@PW/R&]7U
MZJ;EMVW7#STF.Q]29Q[=BC?P#/VU9[68F0;L"7 ":H4+PS+/&.^,,/K]=\1^
M'?P^N;Y=VC3=J5[B !9#R&-+K&Y5CLT8=1;+CN_ED0DH88'^4W=-?AH"SDA;
MYS(BO%&H+:>1SF%R_I[;9]>(ED^PD]'Y<W38^O%Y^+Z[TH$"2<["M3X)M'_F
M^+,QHBW&98U<NE<]MF!K>42<T\UME'(MN:RK.%C701T<]S=TS A/=Q*P?C(,
M_<L,^GO#4V<0YEA3/)<-(=:I=AP%UV?3R"\GZ^$PKHVX9&W;\'VK X>*S"*J
M[%OCM2'7;L;PE9O15>>740GM;[>_S17*QO&-H+U)M1+;M!>LC8HV@[52^0UD
M65S%$ES_42>PH*#-)3I;*,Z!?7TNULR22#W#\%EPM/,XH?<>G5"8V>5UHF/"
M"9]=:AZ&V$Y%".1S[\+PL%>.^/>U9P#)VK) \F9T-/CJNS\;5^7AWE.['8=1
M1T_=8VV,6%#3:J/=]D+XD=WC\3*?-(E+LXCQ)YS6.7LP\4K,JD<?R8+"(9<6
M40O!?Y]!)X+E$'VZF-A;<'KS&*RWNI1462)-[8(]YOFQY&SV@7V)7LPL<0GP
M>73=./G8.3GYL4C@(2]K0![A1*..<  _MJ-]X-^OF >LKG\0OPZLELWT@2=[
M'M#W5HM+GTKVA;A\KYA+7+12@$>M)Z,O0-197)S+>+;24KA85?51&ZV(9_N5
M#XUCT_GVS:\^M=;.9%2+V-1A_.RPF8'NLR#@D65J*6S]#2V36A^81M_HKEA;
MJU1=D"5S*:5OK*GBG4F_6=R7AT]3ST&>S?*XY8T_[QS0?><;=PZBRXZM&IKQ
MX"C.HM\^!(/?QMGNV?USU*HIS&HXZO2KE5PM\OD>2NX%>3>?XOBU:[R?'XEG
ML7<>7DFE4%J.D5R.V3NEE9)_*?S1*33ADR!'C3^77P[#_>''6_;T_G-*DZ^D
M+SW!X\KZ5W?]%J7X8IQ>R@,M4JX^=>3LV1%Z!K_G,D&Z47VL,303<I8("(A_
M*'LGV.QY1VF]T@1AV8\L[TJIU#+/#/;^<!&T65YZG=8TD%%S)?[U+)D^:A"Q
M*.D79/Q\.HJM'>LOA]RSV#^7*=7U0JFTE"&VI>P$VK4K23#\.G =Q2+Z[)K1
MISCW__!_]OK#DMO^_ONIM?U$NBQP(\8?RBB98N'WE<6O3@,M1NP%^3V/W,U"
M;>V>$QIA;_'9VI)S_A,8+9N]T[3_#E00 +^;^K75!SUSQN[T2[=O. 7^BP)%
M93MO];[A=2UX/'XT^F_R0O\&3K0ZP[$M$<Z@8_0M>_AFUDOHL[XU8GQ-> 6C
MG5COHLT/UFT/5XQI1ALSWX:#13Q\!A[O%.I0;0&%SP2NPK#AO? +LNMVUGCG
M\NB4Q6O__3_;V_JQQ6SSC7YA=-E;^/;?D('7^D:O-=[JI+[@ ?KVMN RT[J=
MOT*#;S3ZQ"X= -U[O<UL6\CD_VT5M^C?L+*V_'?R'2#;;6/@PU+D3V_![#*#
M'FZN^.^T<P;-E*$[ G>0)OLS.+C-$.F7>-W6N^-ME7*29F_UZ^$ 5M#T0/JV
MW^IG(*(Y7<]<I&!=_=)_Y+?P+[%HD'+AO_\!2J?0W&/&G^T6 Q$,CQ[0D0DJ
MP[8DB:,[J=RT^ (,$@]7EX1+I:->HVO]WU:TL=:3L":_$#EOX?K#D8:ZO*F_
MOSS_>J%_.#\]/#E[?U703\X.=O3FV:%^]77_ZN3PI'EY<G3U5'M]&C&T3@?%
M'T86T4VQ7-J2QW!V?GUTI5V?ZP?G9U?GIR>'S>NC0_WXY*QY=G#2/-6OKN$7
MGX_.KI_L[):R_;5G->O=JW]IX+\'/3?T#<>DF80V\WT.>+G#,1:D[\W7,W4]
MXC07WFJYLE./"V$"A$J@7?T&O(P!\\"-9*FL*'YI.6"1PA*VQ6/RH]'D@L!,
M9^E\RVWX,_!G/:L]MSO!P"T8H);UL'9:=2[*H/B3[O6YUS4<:T0.RT%DG6&!
MCV->>,S'>AJ.63N6YMI59*T=1F4VU["N?1L<(%*.TF/=2R2 \W[5S:C>[/?:
M%[?O#805/)@_IMP+5>/3D8T96G35]67?"! 'I1U%%#S%"V/Q2P=8;MR,PNOO
MI^;=L/.Y6-EZIQXB(=GV#=^BN4SJ$4:W>$R,K9,>16(D_;&U-0GX5M2C>Q$;
M6MG9I(7%[GA8++\]7O>8UO288^@?^  %7Z>F1V"Q.NT=_14R+O/LH?['<>^
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M<D/W-T+HX.&E?JJ+O,6Y3'XN[3Y@AR!@%WU <XE\C/UA5H"9.QI*D P)Y+'
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MW$5 V>AYT<?$R;B$J><ON#,\\' ##.;!$N&TR(BZMS"X;?, D(_.O]'M>J#
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MJ )T%;=1[I7ZT_H^&GD=CNS26LP!3SZ0AQ#Z0(<"I[M)BX)?Z&W;BJ=\X-_
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MZ$??HNCPMMO9AG]LPS)5Q8LOLU$"\AKE:*N*K-20>M@?E201[L=GA@<>-(A
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M#J8^@:QE7;PNES(;S),ITT&!JDB=Z_LWHP_W+:?;-ON?]EIKGINIW(S.#C^
M1CNXN/W0VGHG"*!%%(B@M>N=RWB9:9FX/S]VL78D#(*"1#X_22&Z>4M3[@VE
MM<A-CZU$+@\U\\11]-S#\\'"L0U/$Q$M=#6C"!+LMRT:GO)/*5F9^/,*1F!<
MX07# <<GR  ,-G*D)HP$3!"=$+%'F(PD:8G^D7T6]%Q3MHSM8IH>)VDPY];R
M7(=WL,'-MGL6ZRA+0D/"Y\W+_Z#<5GJ@'IP?QL.YQF"5'KNUV!VX1.!?8I!
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MR"/E4XNQAV@2_!AC!0-__ C5CIX6.:AHX,B0O=KV0G:W'_N6%G\+,:04D1.
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M6 \-&B&(BU+&GZ%N43-LCQGF,*6.!CX'7W3$%W$[.WH39+HH>$H>&!P1ZW2
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M,!!X?)#*9ZYN@3*S/"J)$.#Q"%BO3@%0=%F6]?6PO:ZK9'Y!>#ENS*3U;1<
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ME!+)6G0-:AJ6\INF,5;IPJ?B#QCQ=[LY/5$>M41YC H:2!A'S\Y&B+;BQI,
M<-FA+K:@'L $A3;C^,M ]?Q]X57$/.8#DV,A<KZQBEJ/;B0WG+59E<T?[A)]
M\P:Z0BT*CTILFSHY3<<\,;P[ @[/PK;O_&=;D_S/'\6@<A,4KLPU#YQOMR:E
MDYM#NO2[WH_^EV]\]JCPY/P_1@S]C<W93%FRE%T:B%T*&Q;4*'L$AD)@-$3Q
M*-)@*S":P+ZD1[Z4$Z$8I1U-\T=#N#_HU(V!CU?'(WV68S'P^Q+0+CR#JNH<
M+V/V^^ZC#HU&ONOY?6O(!B3,%SH/GH[D_5\F1D=]QO[F!WXBMH6F_DRN"8L^
M8)Z &@*=8'- ];T"7T%UN#&!8FEHU1'F<J2S@T/QL&:WH6=QZ#33ZB&8A?I5
MR+MB"(A_GI>G05$9_Q7G=P#Z:)9XV-)WPV:OF<0["N].I.U'&/-)TX<8S/_B
MOLZVDA]LA@_ML6=:0Z?DE.:0FQTYT.IT*?IICGD'5PS$+D&E\H\(F+IS]W?Q
M?E Z:W9":J?F]#SF$3M-S^*9K&+S1AJ[=19EPMTL26JFDL+,='VY^^5;.5>J
MI1*$X5XOOW'I=&!9;=S3W^&^8>Q_SU=[K[!QZ3Q<S]NXXJ)$K+,VKI)KU&MI
M&Q?EQ%([XR0Z/_=#$C7L?P)HY,V(3:@ 1".E!\SAHEO0-(&1AKD/#V2VT=@,
MC<8%7]":[-R72V-G^^JH8ZRYY;C3FASN71Z=_&FZ/QWSRS>^!&B31!?A8YB/
M:YVL4S?'B&S.M-485HD#S0C'*L/PP1.5=WR&JA[?=1RTX\+N-/FOH2UB.:*1
MC3/V A'6B X$M"^@B0F*A*D6;*3Y%7$MAQ ST@F7TQ-F$G[?@*)XT6T59I[$
M9-#J^Q>9BPG:I71 @AQ9184(P21RO%B$E9="W3MFT+M&1S0T\W<J)NN_/-O)
MHSGT3QXUD,$(%4O^;]S\UN+FMQRYF-JZZOJW2(<5IWJ*=\,,[5S5KI3.I3U$
M?>?AS]'D\O=Q_?[OFJOS>FO2G=R>#.ZM>K_?A:(M,6MM7^;HC\(<_:=2?_/!
MIP+L=#U"H%[<5&G2?0DTR9/W!L-E3,8PH6YO,%:B]7&PG.$HH!8H2^\GOT)-
MW^1X/30#M>60>]B/R[X3UG[DA+JDUT^T(@':D27EN^]JRKLLUB]LL0)TM4)C
M+LI$+KPE8A@3_!71^H@>9%< _\/U?>TY-CK_CN-*ND1':;+Z2%I];0;?##05
MERA:T6)$#Q&74R%_N6BA2U)O +NWPWH:RX\ +$%"(2R@@DS'9@CV^H'$8?$"
MSM)G 6?&!9R%SP+.-T\IK-S&G4(]@.Y?/$AG76FX*79;8M>H&E!<Z/G69'!R
M^3"I'6X_5:IK;OD66Y/)_MB]^.F6.G:?GC8 F/HEM/FG\?L^!P_&KS$*^BZU
M3YG[WX.$/"BX>&.(<CW#C=ZV+6K[F7KDWNY;U%+S.OVQSCFW+7@QXL"S EIJ
M\"( 0E@3C-$(ZQXPT1"8@/Z1@].I+T:B @9/C1V0/J<Y8-B4W"9/;(]+L6FI
M&=VQZ1.,PX!EH/P.-4@1LAV![] (@2]"HVC/]=!^AUH.UFX+1C"A9N>6OLN>
M1 XNAM''312T@K%@>X3FT#$;>H'EGGCT!8+;S'IG?]=+*CB; M3'<-8-VW?%
MQ#\4.L#:#)XJ/]PH#3BPOFWI9VV(>G$_$ 6<85\ <88;,, (UG/,-IOP!(4H
MO^*@&H#+S\ R%&3$L3[%,=_G)33\!QI#Y$0>95D$J,([,BC34 &G'!-9^L^E
ML" FPS,M?.R;1-1O8>K95)Q;1O;,_\P3X4HQ_Z>LOJ6L%IFL'N&>YGA,%7NJ
MXT(:S:MQ85!3;RSS#X'M4/!!DD- KX@ (TF/>$93GJ'*U1WUH#G0\]RVRTO-
M\-I1?L7."DBQL804%^-2W+6>4,-#WC82F*'VY&:Z\.;TP0BAR;HCQ^3%"Z"E
M-_F]1\S>IX2_K827F(1?.^Z4/K:<$!;(0S@?*BZ!C31#CJN*V"Q!9J]0; ZU
M@9_!,VC80(N9&M:W_^BH<,M+"' I+L"6$X)="!T\+;N:(KN2:XJ^U<9L$A2S
MLA9=D&9FAG@DA+AF"(C<SN$&$^@'^->!:U(;YE/4WSA2'<499D:Q[!E,,LBY
M/F="C"7,RL]4>Z%KV#8>&81DI&+MD6"<"_$?H2R7FKU0?BR^"F%LACE);1\Z
M>VI4=P"PC+?HI7PH]@E$_1+3DB#VPZ'G4M&#Z"(S_"/E6AK'3,$HN.$8]ABY
M;*+PZG&<[H!-/SR[K(@;"L4^Q?J-Q#JEBS.>#4GN<X5TK\<*I3@B M8-!51C
M"12V7)C:H88(L?!Z4/YQ:(P1THYY9 QH6Z;TPY9;%,<GAGT:<28[AH)JZE-W
M.MC$3E+Z2[ PQOQ//E$'OJ[2]@[B=8TH&:KH,+B$--GLG/2>PH,ZZ['69-<>
M^G<7]=[-?F_-8W,[K<G)\%=MTKN\J#O&EV]RXAK._&/$X3X"J%NX,:Q?+]($
M)=MH<-/"1BE#]$*V6:G0*?7G]&+^*\.T@DM.Y%T'9#(Q'"C/=MMT#@9G76$0
M59$[4A34]%T;@ .X M8 ;[EC$:<#MS5 4X'J0Y8&JA?;W*OC\8K8>!F')_LY
M=/$3,F Z6(UM<)[/31$!3'I/>ZPQ\@=A(\10N;C1 9]@9G<TIQA_'9KG:,&#
M41!):[.DIL5A!\3;,)ZRIO+U%O5#I2G,K1VE/.N"I7@19&JVXMY5LBL+OJ$U
M.1H=C9Z.#\Z.MM=<A==:D^'EV:0XO&GO#*##",O=MM'74U?CP^CRC])D% &.
M%HVHJ;U",=27#>,K[]PV'@W@)0(>5LD0R[(6$%AS/>SS03.8F*SD4=J_Z@LT
MEC:)_0TJ\ND+-MKB:ZPF2>\Q5!;UH[GPBSRN(-%@Z LZ7V/]Y@+8A;X"FT5]
ML*+/#2]PZ*VB;3AN^)-'%II!R!HSVL23TL-3I)=?=^1Q,)P .YHACL&7V60(
ME?B6/C&@:L'7J5A-#42[X6, 4<-9T5_!#D_]4H_\4MZUQ:\L(KAASIA_<_M@
M]G"UJ>'".."QM*]^I&MH;0:?6B\8.:C2@EKV+'%,OTW9;!AJ (Y/H*4^C11W
M:$))&XDS\(KZ;.X%,X-1IG1$\%-53R$?E!]55=P]UE)J'R/U?*'?'E;V;0D#
M;/$%FUH4/TQ+: '=MDV!N! )9R96,^+K.>$6+E\2;!(6IK4AU2'PH> #8<QH
M>@[:2^8@((#!!%UJ*NI,M.A,)+*_\@W8)%8]AY$[ Z ?+$;-)B?,)49,>$T/
M[8MJZLJ?-749U]05/VOJ/J_8V5=L2M( [K#XM<&U+)8/R8LXT;K&6ZQ+3X[[
MZ/^C;Q2^IMG)>M1.UA0[65'74U>.@I08LHCQ!#O/,G(@_@7 FG@<)=3N_VH;
MQ60+/7%(K,,^Y4911RI3CO YU%Z;EYV^:P.H%'YF,Y+\TZ8'IF^4$I:2+5?:
MQ<[&S(U?#AX *\0W3ERTK+$@G!=&^:DFLXUQ3HO-)*PH>!%$I;)W)Q#^T'<,
MSW;9Y!-WI?QUAJO ')L7K#='?JI\11<BQ,J,O%6+OG5ZW+,])=6IT/<D@_*#
M"\V%+/MM1)#Y0U\%3I$,44(0D)4EW1# #((P&[TX#&H[2&B?#2P+#.-T=#-]
M;G/J_I ^#';-/FE[(^"WK0M7[Q%S]U"8Y_,W<LY8?ZI&2F)8Q,#/, "ICX:;
MMH4'!.'%6+,DFJ;P*VD,J[%7 5HE@Z[XI, )LSG?(%I@ZF/7[$OB*8U-(5"Y
M ^-++-.LG%=*)D*![:$'"5TZ3 ^+Q90GL=4"X(F&V&U*&'DN70J+* U+#-'+
M'FN\;$# ./G 7V@NOJQ1-<6I/2*K"@])H*_(=C.J8'Z0-=$U(D^4'UD_:BW$
MEE /ES!U)>:CX!F^I.WB/%(:0L%Q%<T),WRJ1?Z5BP2J-[JM4K*E8!M=CLGW
M7*E64]J)HO$:8B&J27 6FAJ6#_>6[^+IG\L]O8D18L-A\#' 6K4)W3XA.IG'
MP^=JZ8!^O75)'_#P2A_K8["W],[(>\ F.M+M0K4Q%SO0^0"Y@I*AX ;S;5+8
MBZ/B&,4KE@Q=8O!+WL<?R/59G\&KP18H?"6 4L?D4-*U@.W0)18PC_H<7V[,
M$!W9X55_FFH:L@ ):/4HZ2M#FP2# T]$X )(40AX&/6.64$O,R#1[NBQ$\75
M790P2):?SP@'BU%9032@HJ4U2(H L@\0C'2!P1!1J]_8Z&!!K*%%'P\EG7%'
MQ+\-/:&R3'Y%)V"K6+&<CPR34BI-LW)#&O3*>'H&;VK*(ZW)[H\?_LF=6:Q?
MKWF.J]Z:G#S<'_RIWEW<7I2 [QFFK-$YOR5(]*<NGA?XYM74 >R3XAB$Y,YA
M#2WCT ;":='!:SRE%NIQ\'_.R26"TYQC&AX$E<AC1U#71[W/]HA%U<+8)S#4
M ,$75@G0=X3N/56@@"1"K9"0L,N7Y1 )(6LT9'P)JX+0@2E#9T:CY2GX5<HR
ML1<MO@JQPEQJ=>(E&+Y08]1S$)(7UZ,Q'())Y\*?>2TT_II?$ P;3[D:7)^D
MK(A X!-O#EGP6*B8M7R;6QK<;MR"0\N3V__\B\KTV6B162*^ #%YX?48<7XV
M*!V-3(??OX@8R"NE.1TBK)7L@Y',#HQ^%<<'B BA_V] ; ACXY;"ZM#E8 4)
M4B2X.*9V4L.(^S2E'>-FAW]%ZD+;N@-B76S% #\*_XYC3/E@PJ>8:RL9"JD*
M^&"LYVLS>%5'\CBC@G\4-E>R7>8]8"S U:>J LJM&/9(@O;A\L\P2)68:$YM
M7X2J*3A\J!^'+@?=!(1,1-R(G6/^[V#VXKDD5+4ZG+-+CC72\2 FAXT.7*C!
MB67EL7KDJVXWXD6F2CP.Q:>;8;#0TA"SBX;$L6J/12TXM7R8>C>>L%B8=ZZ.
M55P5.E+7'BD,8)J D: OH&?#9UT=@:A_&WIN!QE-U1IW;$H%;QILP""D4^53
M^TAG:^76[Q1^U)[A08&_?TZ\2^ N6-P(GO-D:W*3WSO;ZSJW?J>\YL9PH34Y
M+X^_W]:KG<[9WR_?C@$K![#==UA, N?_:16_^>"W#=_J:'A7P^X@&0>ZS53K
MC8)((NA1A,1%U,X983F3$L+B5!ZC0&+F**50W,CA;;;,QL%>(,M&0$&-&5_^
M5$P,%#@U<> 285_(R19E-3/CYZ9R..QN$3D':BIA?6Y*RLPCDGV2F)HZ"6![
MCJ"V6@+T"1;)$,H:@BT=7:ZENBA4*]OCL(A!C %C'O12LP2O,E]!>,)Q=0 P
M))[& T2\YX-WNP7]D:^SE!CP*2?GKC(<L_:L,>OSQ[SCHE'!.@&A< ZO1N5E
MZLC#86JSAPD@!FP@4<9LYM>IW@+_TJ,[LDUA?++Z/8!$L%'XD]?%PLQ,)L=#
M]#:FR_KLTZ2%WP]$4)J]B+NJ:ZJ67E3P4ODL>,FXX*7T6?#R:40LYC;RQ6=9
M1U5W*:1/_F@ X,(3@4&C;W#,.T9P2; C%NL#1%\0*';+$?Q(K%W=YHE4UN/#
ME#_X;"XC;/"DBE\@.Y;3N]0[8(D*P^X(4&)$'0Z2KX$<3]98GH@:L:ND3_6_
MUB;(]!!8F\*ZV1*6;YJ>9W$JOG@X&@0FY#>1,BI>#&F$0[-\A?B!9Y!P,'0<
ML5&LJ80E'8_,/;TI%+7+3I^8(YN<=9MT$<4:AHQ@>WR[X'L[H5UUUHT[>BG.
M8:.@.(?9?ZPUZ9RZ3Y.K<O/P1V=]_,FH)[E=;DVN#UV_&?3SV]_OY#1,RQ_:
M!GT_E0'RY9M8/3BRI_1<L.2+O@%^YU?]/,WQ5.7I6??[XJNXF"7P!2ZU&7<_
M,T6^\*N/WKGB1,#U&QH N)K,$H5G;&K+\,E(8P8-G2_J\^*=,#)8D/_[I1JW
M8V;82@F?G#9#OGQKHAY6>V#B8T\<:,+[(V-'T^,]+5TQ^Z4#]97-8JW);(NO
M*QI)]'A>K[U1S)=SQ5(]5ZQ4OH;B(][%#V\5K/AIHQP./]4*!_&&W?C,^%N*
M_R=YH:._*B1^*K;!DB&H7E<9@EYVIS01UV(.#]0+O[$]3GX!HR,*F?E@80]V
M7 <WDZKL* Z"Y"2Z+!R.?TVNJH<*)Y'R?M4>C9I=L0@)X<-4XF,,Y>-+?'>J
ML>U!DMRYI$=9;,R"!%=L#5N++6',.'HARQ4.UO_RK9ZKU).(KA)/Q4+R_@H'
MJ;"2@Y3.R_6N#M(X7QE=/UPVMJWZ?_0@31..O> @E5_(.K:B@_22N_*&4<G&
MSUKJI7B8=BG..KG/.*[ECW3O*31\L'B'R8?4+QU4+NQ!\*M36?4A33J8JO.W
M23^U:3UM]BW3!/9XNB=%ZZGMV53V2U^^;4JG*RJI\_8W(]DH?215OIALG#]9
MO_*WNT%P57P+V7@W2CMDB4Q=K)BJKF2CJ@LY:D+D"L7Z7'6].AT]WY^9_C9'
M^W1Z"H)#IH=QYR,I:F%7R543BR;.X<WVKX=BM1L<'+7?LXZN?>KH5Q6+6_?H
MQ"R,M[_OW?VGU3.WJ5/6*::9,_)&"_E:KE&IOJ%>7MAVC@+I9'K>MC^B&J;K
M%3]ISNUX?+AW?=IP5N[)OJ.3EAH&FEJAZ!FK9.2H-AJ-7*6<?^$9^[Q<GBGL
MM\Y5?V?OZ-=IWOX/"7OJM3)/V$OO2=A?V]!OVO:A-3QTAZNZ859SZ-[ZAA&K
M%C]ZA]YO__OEY&#<*/R'CE[Z/9.\3K$#F)&O7<E5%PB+OM)=L_\A[YHTL3\W
M\CONX1ZI#<O_(;%/OW$6$OO:^Q'[5W%C9F&2KL'9>^,K1ZX>7[SX$2P4![OU
MXN.@V/TOQ1)2;Y[9RQ4[B1F%%!JY>O[=.#O-CW@!S3L$$V^G?CC,']2ZG?_0
M(4B]AYYS"*H9^?SE7*%27C,G:*J'BO6%K<6)?.-K*5PZS*4U<>'D<=S>?KC?
M_MO9.3;><=JC^O:IZ=I'5-8S1>/G^4/Q]]YMY?+TO^0HIVKJ&6L54],9.<N-
M6JZ<+ZV#VY#<X/J9!UF@-B0F5=>P<!>7U^(,ULC1SQ_MX8_+HY77R;ZC,SCM
M,HCJD)G+%3N&&3GOA48C5ZS6WHO34/U(]]"BQV!_IUYM]XZNFC7S/W0,THND
MGG,,LO*<&^5<K?J6R?CGNPVI73.19D^.3[%05\O,\O7Y33;_=5>$K3O*[!E;
M=7'"\X_.V7#_[OAPM'(_Y'G;].ZN0FZ.IBUE]/37,@H95'+E2B'7J,XODDQI
M!ENT4>2-3]W>1[I=YY^Z?OW V=Z[ZW4O5EZ&L%:G+M4)7/#4952O4,V!\5DI
M%E9SZE;@&\;'463']PJ0K>>-N;C<4<?'=-,=M6WRK+/^.O7-$VM8O'"LO4EC
MN_HF9RQ]?=['U18%@(@<HXP"*=5<M5;.U4N-9Q^CXLLNK]>6Z-6T5L5OK\GQ
MD7MP\.B,^]\;GQ(]\]J(R7-6$8E\KM2HYVJE^34%2PFTN!<X9%0"C*>"DM+<
M;TW&>[_&_O#4N=ZMK0^0R5P6X%5CE]8:<40;.OJFQ/,]]UR'_F>',3$P,-+9
M8*9%Y?@_]U6M295L#P[LPM7(7",TFD1TTT9K\COO=]S+^]^C217"TX!>H87K
MH4<7Y!/H],T'3W>1[9(]UIJF.X14@K)?EP!3QO*]UN?^O,'@CQSMQ/ Z?226
M8L"B^Q)%/&FC]&T7N&!4PJW]YN6VI-KB7-S-RVN=79STK50(PI<>.3Y5F7@^
M-W<\8EJ!#FA1Q-^X<H=61RL5JU_I/#RT H"^NQTPH-51)T <3@9H_\MR D ?
MW)4(YG26($7T8J3_C?B<!F!S4OT!N'5(4<LQP6' @-@V-#PD'0#\N:'K!YO6
M8&BCZD 30?/(@T574OP"_J<[\CEN*J##L>';.'S=YTND;[#)%ZJ;A=)7#MWO
M!)YKCCH<H ]!XYP@!%:/OFEC9V_G^"NCX-O2E*74B6TAP#G'54\"B4?&"[%Z
M)JR>%UT]N@CL<Z['^;P .T\W^.E$S#[Z?<%<"+C!3A_A7#4%+I[CNS,V(?BF
MY+5SJ6AZI"L:RA16S' , \,DC.R(&H*>^PA(@K 8GD58ZVL(90^D$E9G9 =C
M8$*R?&TT1%(&"3!//X? A Q>GHU0+O$FAS^F3J[OZX_4)"2;;K?KJWCY"/\.
MQ-9@%7&J90)[!IBY"*(/TR)(XT$7#T@P@&#,I4:I )OG*+\/7"C#=0+TXR@&
M/A!2&3:53',LUUP1&'8&'2IV<D>!>4[\DG[KN^$@&UPAIX$]POBA\._<^E8%
MQK08RB[;8ATHXCQ852KI1B<0]&K3&(WS:+C75-VMM:Y6[](CKF8_UE4:,]S7
M<@[T1OT^<HAZH<)U,W4OEMB]"-2$")NLGRB$Q>PNU.O%/+T+4WY#3_H>58%4
M[X7.KGXY:O\%4-3 U0#I&]S'$3VYE]3GE'#E+"EF?1.PKAW;\!BE'&-W1!=(
M/*G@CPMMX1L,\!$4+QL CPN,!:VG N@N[EAX$!Q>?)!)K?CG^$NH'.<8KBR@
M%N>F7PKJEE&9X%4A.9_9!:'S"X)ZW&XX-XW-3=X5'<.A+T4T68-^F@X3GHF-
M,*>0 ,*UP/E38DN$ZZ&N$[OP^/4D[D7E3@!H^=BL&3ZOV+N9KX<K)90B6!T&
MA L!&D%W)=E3',Z?"E$'O+GT-J&' @(?&B,>E=B0A0K2BY88<#SR<5H##GC.
MF FGW[:E[QF>/0ZO'PMC/@,K"#@!4MNEE[QX&2+2.P[,2MXJ*BMA:(W AH\)
MH,,#'1([.TCV; )]J6'9B!J*/&* 84^OR2A/(G I, N CBY&?\KO/DE4*P:O
MH3R"M-'#KIA6TK!#PB0<7@*[XN<]^5X&3S7P62=P0::9/*<HX=)FOHI*./0A
M]*,!L%NSS?N'2A.U/JT.L_&:]!]-)J?T(%!E.@0B.<$/>[FW(\VG\'W:-==%
M5/ OP;L(7W<$I$P&G%I5%P-!F0=T:H&B.NB[]333FQXM-YQ@HL>FSD+;X$Z;
M^H_">>.F9#A/(T;BQK3I&$ZBQ19*'1<RQU-%)?RGZ$"1W.V!/D^",9RTR-KB
M=4>W%(G4])&/R.(N8WZB.I>* >=7)DQ_Q]1E? ,$TYZJ= 6G.S@'XAWL4D"J
M=5 XBH<7>[DZ$TZL >([]3>A<".3DV3RZA ]TA/ XM+% X$4A..(HQQ5[,0
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MA?DP#\MP-H5BN[.<V.ZX?N"?=0]<U_0OJ;@(^?45^<T7OE>;=Z/MTL4R\KL
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M>'7;/'P;17X4UM2WJ1W\GXAS/7_GLI7T3'S7UXS]JJ;- FK"/R5T(>F:-H/
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M"I8'P_8<J@7&*[L?J]>=\T;#^MD[:"0&I<UP3(O@"KWLQBJ4XBA"SULE!BO
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MOR@@(A7F]12$_P-0"ZU)S2.#/TYS__8ZS'#.3P1.#20J-@P+[LNW/]02U_>
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M0Q,];8@^]!R I7*4S!9S0<0(2/!9H'?:!"@E.+1(BRR4P7PD<B.O@KKUB1?
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M&7LTE\ &[LRME%4%0M/'8"3@"?[[PO6P+ER9WG),S_O7-^29^LJ%7KBB]5O
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M,_F&4$"ISFLE"29+_0LJ. Y/"P(""EK%R+0K7Z9A\]0M.4MF?PA89_&;J*@
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ML*GIZ@SN_U#N48N8C17WJK0UG>/@O)&D!Q&RT#*0>@L6W /H9N&'R5_,/U
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MG:BXU9=;A9L)3.)T.180UAS<( QX&;FN"-VBZ?18F7D9J]^\-A),#X=UOH,
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M-#@!8ZEUS3#;QD8!CM+PA,R+&N([1)N $>6/P,, G/3\(=9XDEFT[%'ME"W
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MHW!!Z&@?TK:C?@'%W39Z?)5TXUHO=4,]2[^2=;,"K1H7:Y9Q3Y 5V/%@:;Y
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MF]7CIA<"\07'4^OJ#-C+AJI//@58G^LN.X?P?29,E*DPM0Y@&:1\#4+@$!Z
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MKF1WR< Z4SCC51HMZ'QD"[I))C[8?D1M]L O7,9M85<#2TN18?5T+P?S@R'
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M&-9HOHCO@-UJNCD0$ [M(^_9,N<\VF>YS6SU)CKXI0XN8@R(QT!""\V&A (
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MA)+(+8)4+H!=_MHV3K\N+$JQU\5<];!G;YY8UUS;/!*:N[>\Z*:<,71<K):
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M>XZ6R* S=W\JN(?)<ZEVD9AO>%Z:HMA+C52_^JMC[8UB 1VO5W#.F'LSA^*
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M"Q!L3Y)1]P>$=U*GI-TTT4)031-\+GCII(L=+QN%SB<VT;H)^I/C##385Z+
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M5>BLQ,S(G27-)ZVNE#(CTB(?A7;T5'FJJ*+4DX78"NTH+<^MBJ:R-I +2U(
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M74D]Q>&V7 [&%^*1H/>/1G9YCS/_'9D30%E;A^&+6.5==!D/)9KV6QF ;\R
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MAS!7%'O 5NR_S,6_KER[AU6ER[T!6BL8)-1UJEH3,?J+PP$T:B;J0[#I(^$
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MU__"F7MG#Y CS&'8E?#[W_\Y.*":HB#U?E(W_$#X!4;ZF @ "' $,+\'7IK
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M6V"@ULL>T$#=+5I_53Q:;_I>"9&!7$9H)P]U5DF"_P_%;L[$[E" 9OG"=.8
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M*!>,BZG9F=]O*("BALV@GLNS.!1XI+#\*_Y&K.0 L5/*R7*A*_H+/MNX(>C
M2X):_23WB#1Z7<.W IVOFX&M$',N*&;D4NP"0H$D5#/="%C"&L'#)I,&QTB9
MQ^@JU3$9PW^N:BQV!/,96WWCZ99Z"[UM5C$(JP[.$2])0J^^,-]B_%!;5=H0
MWL.V^@ZERAU?>S=65&#.21+X-XI)LU9K+=97+/@6\Z(;7M47;3"NAH6<>V"P
M&^8TK22 Q],N/1Z7IH]OSC+VZ]2Q3[E1<?(BX^^(\8!OI1ZM(EW=C6JUFB^&
M5Z>/E<Z4,V+TG,X[*'G4GN&X\T)Y9L(8:*>A<LDBD#XOJECC]ST_$GAMHB+%
M-N=4;*T7(D\9CKYW:4,?$U$382R.H$Z-;'Q1V=L(FB"VN%:2BPNA/L"52FR9
M*]"E;Y0 U-(Q#-M0H97CA"'+?'.JSW?=H=";2()%2UH-X&HJ HJ&,1=M,)<Z
M]*U^<]6^K!9L2R#N"*_#U6PNDFU<*X^MRQM1[@\*>U-LLY;3)J,1+$#I%PX4
M;^Q3W+QGJ-CQ,.$0.M&UG_M- RXI6*F77I=:OZ>QG<']<MZWSK<G:F.)!V\!
M) *$@HDUN)N6B#7AYNW3@;9EK="J^%L7+PCK6ZPRYZM+F.-@J[#:Y&AW9^A2
M#@XG]7Y1QCJM$#,4?O8ML*8SF#3<J__[5EJCGG[ *X/FZRV [)UYX#0#1L]X
MY7;=WK@3"EZN>3'Z;T?]![S&N!_].Q>-_W5K>C(H_,&1'5!N_.)2[!/:H;@=
M!?RD%O*^C5,@2YX"S<26G0<AL14__&7K=<>$_#WK_B[*2%'2?FR6?21K2&(H
M! 48E.V/L79Y"YR!6;Q.G?,R*EYNZ'_>Q1H#L_\-/@'WKYC MX=V9CAV*/A)
MKV>N%1E?5^#*GF<R,*0GZ+;!9$T!S1GN$K?P"S 9QL_Z?')!5YF6N*(S@UW2
MPYY.'NY_1P#ZL6R$"^ ,+<^F>G=U99L&;'!M<#=#[K=6&Y$><S%=L8QBM9HO
MLT'YQ8%0C@72#:"_E"GZ'S:"_;-JL7AV7Z6'3Y45V-]OY(?L) G<IRNZS@'<
M5YCH1EG;P?U_-@[Y57&CCN,C3 +%^:Q]41(KVM-[_,#:/26%F#M,@C32QZXS
M0"\+JLRU"\2Q<N#0LPZ/E/ <C&46.^QA: @[J<!,36<M$F"3DL#CL'0-U)_J
M=:\33@*VJ>Z8%#+/7>W9@JDA1@H\:WFPHY &/=@EUE/Y.CQ'GJVZG-GK;_6W
MWZ7#0BDD$3XQ'C-H5!]B>:UA\:ZD"*(]4=F-V ZXT')X2;RD%#-O]+3IQ\7Q
M<LC'L1EPM&C*?J1.YSI$^X$X/QB*O9X ?@/VE!7G'55BRQSS[?=!"#AC.+)6
M\;<M0X;;K,*-/S"#E\ECZ/W^[%QY4,OJY:J.@%,2K6SC0H?;(>AD\<+ W4G\
M_-=Z-]NDU^]:9/&NKG*/^2Y(HQ;.)F-JB=N;,MMRHC5(,K/+"^9R>B-==-E"
M$B>: $N9>RPGDLU/=\.K%A6:X=9;N73>A;A>M4#\)^<[GXM\0KUP1(E'NWV>
MZY?/-'=57=\+MZ^DLXY;;DW"2=>[+:Y;;N.$D_2%F[JPB>V_(TH\S$>M]W;?
M[S#WI>3^NR BBK'=>^?$6Y.0TB?>QW/B[0TIK0\-?\5  CX_ F33.3T[_[CZ
M:(U.6"(^/P'_M8;#;[V0U1)8:4R'7X%)[? KQG?X)8+2FEWDJZ]+_H(MO%1?
MWNC'K+O(V^7.]BEB=$\#7=NP_SLJ_1A9?29%PU!#1D"LN9-;&3NCMZ=L.25$
MJR^<WT1RL*/QK"@L[NJ#$V?!4U=2,6K)ZDA[R[HQ:_@^;R:9!#)*MEHI>/@A
MYV><0)3/@)&@"7+<7%59"4TK$?V[+M@[074F.AC+K-$"LXT/]*%P,%)D8>%.
MA,)]8?TQ[3BA!*:/X_P10*OO@H[?%K>KL2]1F;9%<1,,>H7&1*?5ZCMJZN]&
MOM2ZQ/%QWNL.)NQ#X\&NT-#T;EU<\D!B=-4>;17=Z=M=LH?<BJ9S9G4HB#]_
MFSG*D=5KIL_S9M5VT6Y>8&9JVRD>5AJG,Q<7E@,Q*EE_Y2\ESE\JE'UET:T$
MI&"+#$.A-M&'B@HSK.]A2K0#X5"O!C3H,K9N(=6')3^Y2@-E_O+4>5.%\^)T
MV>+;%U>]O<F;@I6;O 7]@M)K73<"*(70EDV0KNUTJ3 !M.>DZ$FC M8$0,7[
MI"$^=KGW.&E4;O<)VB.C\9NKAN,FDZN,XLW0M/I)\1-=B9-O58+AU<:3*@[T
MAH^NG8(5$+>^9C1^9!Q][(#[V)'U,6?HL(-W=Y(.17O-22;( LHR2R$P*6,#
M^TPNS0(++U^2Q5^PAHUDA$0%Y[I_S7GS1T+<D'1D-;%8.HE?([E49H**_Q)'
MHD[0T?]*8L)!2I3[Q?[O6[)@:DD7@YN3]O#]S_G869/"65=;@NNGD#V8K*(9
MF7V/;(FZ6L<VOUBQ&1Z%._U-0?4P\+(Z79#E9C)!Z@1K\P7<-8?['_:)=NZ+
M]'F]]&=Y/PX*F=2,2V[%>8$5D[=E6C>0S 7UV@153%?R%!!DOK0OT?.N"$]B
MA.10$3\7(8TN[Y:WX_+EX*6T@I <1NYN$)+O/#9$2&D;>5?SE5)0[?C="?N/
MH1[&4 E+7RIA;&ILSQ3+<5;7V]*8OANT!W^K3FCMAH?RTCOFF<IA(=0SOPKC
M07)F8WD*QU_J8#3=T/=BY5UIB&^7W375P60I$'NM)(916+I 1Q8HB95*M)*X
M,X35^%(/HPEKM*1G:OVAJ]ZR:ZJ'.TA862N-8825M@QGOEJ,CKS?I=R:,&LO
M=OX0<2:1.",@VK>Y9?&[/+THGMV.KX[>F $)V9<PL'^WA)^; $OIW!_A=7!W
M%;1K]9K;AFA;EL=G'T ,W"_&91)R9<N@)2-8/*!-YVJ(FW>R9F3QRL#BRNOR
M01%&QXTK^<\[LS>1'WM>.3Z\#42,U@^1[1Y<L2_.T+*H-@^YS]+F 7=*<+:$
MWML>"7@IP8N(W9&>^>I(+Y/M2%_]ZDB_1>#OV2(^$2.Z >J:J T%-0?#T&4@
M3KYZT6Q_\I$'@SK-,T ,6#^CO#]S1\FB$$]/9=D\X+<Z6 34&U;D*F78GB;8
M5K'69"S)&/%&508J/S+-E_.[L?9X]J:=]"4[W]'HL>#LO^-,&]F!!C-Q%N>Q
M0M*5C2CDF4#7E=&@4IB/1=BB); ;12X@/:(6'%&-^LNH./Y:5F+B<E_UT?UF
M+HCQ@]_GP@_I$S+_Y!DKX+TA5&N2:WCB2JE,HO%./57CG6 N&[6JU^5COS2?
M*K-AL_6^-XX$7^L=^.@*9O35C<=.(VF\+J_N1Q]59=Z[8L2O;CP1O4#B1K6O
M-U*6 V\LF\-J$9-Y*L?7::4_K9"V19_QL':= C8X0ZMLR@Z=^Z86_\]N'DDR
M0MS@!)W=O/X^U-C=[7;WA'8_'36H_]M>@X=8UF)PR\1]RKO<_^174::> WN,
M;35U-- <C+!LXW456Q40LT:T2X%$M$MXA42B79.B'1_LH*9UWNME^BTH(>?.
M'\X5T3(F107W4C6\@GN:8*=5*2:N^-Q=*"^:Y5G72RWAN3.^I,]6E$U,WBTH
MQ=&75_1]('OTL2-%#S87\1J2&F5X=HKL?T.<9"?P</UV5[PDQV@YDBP-LI8M
M>VPJ:E\0]0E@2QE22O6L76IIY<N+V:JBUL9<UNIP86ZJ]U"S#1R,M9_KY5A%
MWQ0X[P;*Z<(+J_D*'1T1NV,)P97=D"C)"U9'T\F<_^!DH2N?2RN:;WDE2@,K
M:G4>O+3K2_!=CS+VH$[UFH22/O&P=%AE]H-6XIV\3Q)O)%]Y(Y9*:(.7S07O
M5S=NSF3)D"[$SCM[ORQ?+:7=#.%?8Z<R8"ZE#4CA3/7U3?7@VPGI2E\\M;OE
M_N3THYA:NO[%$K6R&8FZ)3O5&\YXE*9) Y.X2T,TFE^:TTJE"?:T7=ZUI@W1
M@(K5NZ%"I^S=P'S[73ADBC&;-VRU5DM<A<=5KW8G%)Y:EH+#D9J7K6PX&ZEO
M=Y6GD@J]#Z$>BH9[]_>TW5;#F9=)6CQ4V%0Z$9.G*VFSY8GI1/0NZ$0;(X'W
MXR.A]4=IM.Z':ZA'T12Q;;@GV.@,R**0O@ 2?5A,FQ&\PVJ3$^?9:4WZF/MH
M%<7^\V2%#;!*:W*B9!=TI%(2'<FU".ZPRFY=14I2I21"59(5W>R3N1N:4C%+
M<0*^P%TTLQ42=;U6&S7U*\"M5NA)[JW?4S7)VM$,I$$R&]J4!)5\.75MB,PD
M ?F20!N>S$:J<D;EEDQY44)*%8 )U9_ "T5J8'RW$\PL6W]AS5Q_4U&;:/7H
M<E[;A,^[S79'G"!6IU=!1=-,%E=;?4)[RO,B-IX\)ZS2Z<H6<GEZVS[TOX 5
MQBL@U'Q=WB_>^L*8ZW>/I8SS_NRR%_N4/;?9I+\]VYSP_J>^I@J9]3\-Z7R:
M6%VN5JZN*V?:V1_N<_0E79.[![1I#NXV2F^HQ6B$WJ6)L'0/S.3U]18-[!M:
M3M\W-"FTK@NG\];-G.TLF!WIZKDF-M)[Q%;UZLPY>G7&: H+N0ZNS:X/>=RY
MT]=.,*CEYWYG<>] E8-J:>OM.<O;:L^9E/0K];<+^6K0OSH:[$UUA14-.M>)
M\?IJV5FG 0#:C=9'_?UJ5!_$J;7PU;+SJV7G3DWRJV7GSF0M?K7LW,.6G=$5
MPK?<GRE2A[$'@+8&FG);Z YE\6/B&0KA D@S11(T8^Y@NH"]72D]0=IVLPU'
M+[;2^Y-"<]KY5.(_5?>GR+,T?A?KH-9MV59-'VU:/.2"/,3[T$R42#(!N?85
M?R-5O_<K?VYGE>O;VU6IBZU/T:ITFY1>H=/=!)7V,:619'<X IT^_D;ZYD[.
M_U1N>G6],HP7^!N;ON/EZE=H-CQ7?_\[B98WK:FREJ;*?F$^I"W<W3%[?J..
MJDVVLX^:*FMIJNPVY%=PG[@*G5V$[VZW."61 !*FM0!&_27&XI!TZX@?CV:W
M5VIUE1@+4E,)=GI,%Y2T @.[H[R&$7^Z3.#LHYAVE>)]6NL7Q<=MFMR61L7'
M+JT]K:HT%J2X[AK%!V%@]RD^70@WB3RWKZZP"6.7FWOF5EM>T.\-_J-VV;M;
M%9(<6[KO8Y/8M8*+*DPZ9U+VE3G( IK;,S_2<OPH]/\L"M79>\QTZYT&=*(&
MLFL">OMIU>L%@S=>E]S[XK'Z=L-/_W3W)DPI*#!N;^*%<'NF55U<OQHSA;5O
M+I78,E> =EQHK&*%*:P;JQBK15-UC?C#R(Y-@7WH(AMZOU\)VO3L[?V1$_>&
M5!'.C6:&*-@]YVJ'C$(%47K3 ?H6MJL#7PI4%VSL +=(5L:"BGZM48I*@6,7
M85/#I;^GG1;:U F^!GHB42@B;B %!\A]UDY/[.ORX['5>^+>9]5&:/"AW4@+
M<R-\ FYN]!G;/?G2D](%2T&&0SI:"M:HAU7-@M"<>3#>[@:1W0J:#H0(K/_<
M4?\![T3 W>>P."/$%R_'$^B[OZMR=K3?YW6T8?_<=5>PD9!%KO1?"!Y-A^Q;
M%::"//&%N!((B@AJ&D [>P>#&;3ZM_C]KV.9D[F(4$1DDL%F[5C=L3ZW21M1
M@>G#U50=Z%LZKR,3[PX<#!#=BEM50@_XE##K'K7 UQEZ>O,^MTOP>38N73EF
MJ[FP<R]B1N\9S[X&K]Y0@U>MSZ/[QKWA..# F@$BP?0Y;U(?FZ?M6C/[$J3#
MD@2E"2S,G-'VHU]HY%#YUA<N[SYZ[<=39O=0:> N;/GKPS*N&WX5+ OY0FGO
M8L>8+&#I-PT) +)P]WC?GJFG]9OWG06D?^%K0Y&-ZW->!45F5W$8)*ZY)!!,
MCZ?)D&L=C971T]7.PFD-U,1U[*Y"32E?+!&4JQN))KP#5KV9THE3UATI:X0*
M>+HN^O#[:G+ORGQ; WN$=E.YG')*C7F[T+D'6XP'[MGZA38M[V7HEFQ'QV3C
MAM"MU#&+Y5VI'UO*#'X;4".KVF.Q>"JW*DIQ9_%'6IMD21@Y3+Y 1S/C#4'P
M*',(9J(RBL+P_FS8G!<NJRG %S,"GZULJ5L>R6-*O^=_SIYZE5+[J0N+"NPV
MP<>G:(Z(4IXO%:M[%JQU(LB"RDOHY/C>2)1%(*+!-DV%.- E&BY:<8#;F!9
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MJA!D[1:LTD2N:;)W"Q+#,)<)AC>@7BKE]YY<?#]^&N\]A@FKF%6:T&U/:5]
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M;L&'96L54 \%<E;I]X$<#!;RAY1_UP0-2=W[P[M#D_EB-6RBCA7X;1 SK6P
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M8 +N1-2&(T>4_W;T&#BUEGP,IM5PS2I:H='5SO')=7'\PME!GBL7NI)W.3,
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M!WUNV'-$R5F+ZCAJDH>N>C53#5_:>ES5O;)D\I<A$9/-LMD&92<"R!HL-/I
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M_0QC-D"TH0:;"]1C2?#U6/+TVW.AOR_"GNA(9 OZ1,7M1N%@]X=WAU;5Q3>
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MRN;6)N"5.5#0'6P.*3 P_ 9S>HOKN80F>F:%CI%S:CVSH=@=PH@N6S^$&MT
M/#4PB&65ZQJ][$S3)D+O&(7QW(!U*SW4S4C#GS<5%6S&5.P:K32[F+';+![^
M%2(::G-1>WTUJ__5D;[8K-\"/?(*;>'KLJP]-]]/;ZOBL]U2[A@KAN8@5)\'
M2BR/^W%%.+W76T_(E0/#8G^W\9<Q_U?_]-VBAELK/]MR@..YH=HB18;-LUQH
M.&=.0S_U,&6+RW:5T4B1#<PACF:A "P3,& '<_/=9]2C08%\LP&8L&^3B*&B
M=MU92D>S^F.=R1 5P0LB# H2]U. T10"DP4Q+ +4<!P*9-EP=@R4U]83,9Y<
MOS3%DA$U)4@2M+Z^0[7!O%:A7%H^^H'-GP!&X=T3$'!@$(LU=H!..X(?\I2M
MCFJV!\,*;#+& Q8;!24V^$:9R>A!>1$'^U]7/CLC%V-Z.K!@#(9%'GU9OVVZ
MAS&!8( E[Y.\4%/%\#8E8RZ6^$5L9I6%[Y>^T->B@<DZY#LV$['G!MJ6D,2P
MTP7"-8?R)\"D>Q,<& V6U 'KP@&6D%9MY<_GXP@U)*'K!-OS>8N6#.74Z3M2
M!:S/@I\@8\>V!HQ- Y2F3<"R\+-!S.6[;2<#1B%AJ\+0@'L.DV,H\$C/_5?\
M75.!^DM=*N ,;4L?WCG\!CP"+8FM@,UUL0ZXKS83@' PN0!R'3F.V,T5L%YN
M2S\;5QU>0AXQKU4T WOG$XF%4(L7,'?!Z'LJGKD%(+1WBX]/H]-*Y>3ZM&))
MKUK ;.()K[!7N^5436OUPVQ@CL@5/=!/2M70S@5>^\O2>8%)B,C@BRMO8?(U
M+0?.(H Q'_.R*$C4W5 5.VB@HZ$H]*DS>2K@^H]4"W#:+I2]?9/Y]JBVTNM!
MI@W>> ,H%5 []B19VL,#^&"BPMCDL:A#CS%OV_Z+G#D4?!2Q2!XF=,"9611<
M5V#4LH><]W3S]QHYS;7"]_,N+Y'INNKRVM!VU019'70HB\4:NMB]P?Y*Z\YK
M1?#:JZ;J!P=MR&];_3.Y)P)Q-.&E(&O#M#/NSCN#)ZG8*#W;<8^.R:_'FL.F
MO"JPS6;9;H,BT)0@472DFJ=+X9%6@:%NJ0[)&]V6X)"$4Y&YJ;^TWL^$39^2
M+_8MQBF1*/E7S@/#,>R4$ .U MSR9CX=UF1Z$P$F>OCTY9Z33T.^#.>(?* !
M.O<7Q]TRQPUCN&X^"TYNHJK.5*T@'ML()=\S(_>OAC.^S*Y99%ELLR.=E,Y/
M_]P_%_W-OQ24;@J]7^N0<,B\2?'9 I'2)/ER8&%S=T3K&#$C[*QI=77%:60!
M<\\O<!4Y9].Z>=<?.YX@U,3&@09.;!GW)W:ZKN/B,"@8VCS\6">%#9ACJS\R
M(:@]SX\ZRV'A]NZJNS[44%^7]69/#'!D8MA7 "YG<0@H'YPF/5O%R/IB^=MQ
MFEWQP$YV\'=\P2@+73M<"%U\"@-1PPZNGJC"^TX%EBX3Y8%;)+B\8*X+ ?]=
M.\Z/6:7MK;Q- <M$7SENA6B.,T@8_[4V";\Z7@VX&)QEXV,"^!A<GP)KMFGX
M:6?R(U@CFJA_#,OTO./A%-"OW&\_1IO9,O;29"0GA9>317$LS70^U863M45A
MG(([X!C[KR!.8:[FU;]0X]=!2_#P%R[=Q52>IH'9P(;Z?M:^EP*R3>>E0%'"
MQKR'<J#/(4(^"?[8^\>'L];RK/V6YF9K5]!'POO(Y:M,>(868)H#5=%0%$97
M$'H:9IQQS1WPO9Y#NA&N"4XA/ ?"T]D7RG&H-_!1L/6(9)!/V,T24T,B@3;$
MUCCY8C%K%]_M5#[X4K@NM/B\=\618 M9<(@GVH6JP%5%:T9KU4AR0N;&Y%[<
M827<WV$M_4O]V8[Z8X:ZTD[[%OX>#'0*G<Q&S"4.BN$G "X\RJV24-HLS+0R
MM9TUA)!Q5X$'@ %@.4P)40+)F@^:SA%^/\P-/K)&0H3AY@ 5AB8CBHXD7M,"
M>0;>L5/'C-Q3-7G"4*T^OG#U5LG1B=N[R2*2)I2U(LPEHGA#W*T)XQ65 [!+
M01+(^"S>"CW<8ZW*N8'<HWS(AH;CV-PC#Y&#[X)7!5N%3MX9GG0/] Q[SW86
M2<MAI7,^UWJ<LV1 ,))042V;UJ*0E&"7-@FJ8LHH+ZZ0+Q9#>Z^:7&R& [S1
M_@'>]N6XW>'))\QV+GUE.Q/.=BY\93M_93M_.O9B:\FVE_!.&.MN_RTN@&<&
M>K#E"'^B,X$JX*[0GP:8ST79T(:T6N/Z.#2,BJXDNP#@U5JO>_]6:UX,-A]X
M!;2-.,[^(@EG?S%/TZ$Z1-Y_!I4$9U!EJTG.H,%>W/]IW@U9IK.%,Z@>@%E'
MGP&9FC4KSF#=2(KPB$*&+2<YAG/YJ:<76\(-4]Y"#")S &8=?0Q$NNBL)@5W
MJ(0H!X:%XDUP1(5:[-&X&LT%7KOWC9)OOG-FPL]96!$XFN"8N<;@>/SPKI2:
M=L<&\ YKCFL>K! CMC3&N9((@>&*H;>97U;.EFL<N&X9=4=!CW7][CCN0-2-
MC%5(4X (-3<ENG-K<^O%$:X.U7[M">+!P27@!U(#J3R!J4EF=J8C0>FHV[T<
M3\7"3?7-IKOX"4E)8KH]&4>^2;EIL$0BB(4KK91QCL+?*X*6V"]RW<UH,D_4
M[I"W,[^(T#0* X8R,N>M&8Z=[Z[@A(XD=JV8!GP_#/]8A]*#16OBL-/RO',Z
M;[S1-V(Y<]$:.[JT1"94J% (I>HO:MU:8:=;*\@GAZ]+*?.^=,^+.^'EF2>T
MUTO9Q9 M-C@HX7H"^0?XA^/>Y$QVU%\+#]RRAH,>UU:_IJJPFZ4_=QO' AC3
MM/+ZM'6"%FZL^DXFX_TXK_&=$W$ZKE;" A=DM#3T ;XO,9Q/;M&U1CQ#Y%ZM
M%T.S>E^,'WE7[N'T:S4H]MTS<4PY7V1"(Q](AFPQKAMR'( #-PCN(LRV;/5O
M5'$*I/^-!!1=N!&K8K;(0&\I%D^6_'VW=?D\=-Q/&M%!*-Y:-*:'LA7Q!&%=
M93S#Z.ON..LD"!H/.$AX3I@\&YYD$A9396J(F*4I9E4VTW4,2VGIE!%+%6BJ
M.5V13FJ+'4*U#9;4/A:/JHWK^N"AZRB0'S=L*FR5<>*F2'"2]&$0\8*H<&DY
M!=7>_TE]%W]D&EQ,"!"1963K"^<W[K%/3X%&7Y,D(+]-J QZ,YY3U,[MO6A+
M+\QLC6C,+404QT*1;S%N&)73!3Z4"BM]"88\@K+&QS*J)&."=Q0V#[/;'OV@
M#@2'M8D6M84(8")H(6*H%L*Y#E"63P\I. D*SP)Z)DRI!#5L59D,A@Z/!IBV
M1GU/$&^^:8ZTVB>)%]N&RSD]K9GP*2VO"G2[=/G4'GBYCKC;7"=H/1XHI=2$
M5]X0F8P'!GQC]$B+'.YRV,75$)69;%<VQ+,%AA_-4FC.U $%IHV4H#T0=K&A
M=7UI06LV:8IG_=;H_K*_O]"RUN.!5K+X\N30HL*A!?[G0)<)+C#Q'[]RW\4
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M/[D>7"_:<F4_^%$T8DB$.T:P(S@)RII% #<R*[[FO&J4\3M<W[$Q%[H3U(_
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M.:,FA&T8=X518'*%9O=%LFH$9@KXJ1CZFY'=P>1+4&'JU@!EJV?Z$PEW++#
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M2P$"% ,4    " #.@8%8\4W9A<$F  #C) ( %0              @ $Z)
M87)E;BTR,#(S,3(S,5]C86PN>&UL4$L! A0#%     @ SH&!6-M'^^W:A
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M,3 M.3$N:'1M4$L! A0#%     @ SH&!6,H;Q\S: @  PAX   H
M     ( !_F<" &5X,C$M,2YH=&U02P$"% ,4    " #.@8%8*]LL=+H#  !F
M$0  "@              @ $ :P( 97@R,RTQ+FAT;5!+ 0(4 Q0    ( ,Z!
M@5B^ -VV%@@  -\]   *              "  >)N @!E>#,Q+3$N:'1M4$L!
M A0#%     @ SH&!6.:A$"$A"   93X   H              ( !('<" &5X
M,S$M,BYH=&U02P$"% ,4    " #.@8%8''@_?KX$  ![(   "@
M    @ %I?P( 97@S,BTQ+FAT;5!+ 0(4 Q0    ( ,Z!@5C1D>;?F@0  (X=
M   *              "  4^$ @!E>#,R+3(N:'1M4$L! A0#%     @ SH&!
M6$>Z.!Q[%0  GY$   H              ( !$8D" &5X-"TR,"YH=&U02P$"
M% ,4    " #.@8%80KIA);8B  !41P$ "@              @ &TG@( 97@Y
M-RTQ+FAT;5!+ 0(4 Q0    ( ,Z!@5CP<^*JY/P# $)W*0 ,
J  "  9+! @!F;W)M,3 M:RYH=&U02P4&      \ #P!^ P  H+X&

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>form10-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:AREN="http://thearenagroup.net/20231231"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="aren-20231231.xsd" xlink:type="simple"/>
    <context id="From2023-01-01to2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-03-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesGRedeemableAndConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesGRedeemableAndConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SeriesHConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesHRedeemableAndConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesHRedeemableAndConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CommonStockToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:CommonStockToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:CommonStockToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CommonStockToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:CommonStockToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CommonStockToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:CommonStockToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:CommonStockToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-02-082022-02-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <startDate>2022-02-08</startDate>
            <endDate>2022-02-08</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-01_custom_BRileyFBRIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:BRileyFBRIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-01</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DigitalAndPrintSubscriptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalAndPrintSubscriptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AREN:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AREN:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AREN:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">AREN:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_SellingAndMarketingExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_SellingAndMarketingExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DigitalAdvertisingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalAdvertisingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_DigitalAdvertisingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalAdvertisingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DigitalSubscriptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalSubscriptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_DigitalSubscriptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalSubscriptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_LicensingAndSyndicationRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:LicensingAndSyndicationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_LicensingAndSyndicationRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:LicensingAndSyndicationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_ProductAndServiceOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_ProductAndServiceOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DigitalRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_DigitalRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PrintAdvertisingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:PrintAdvertisingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_PrintAdvertisingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:PrintAdvertisingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PrintSubscriptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:PrintSubscriptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_PrintSubscriptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:PrintSubscriptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PrintRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:PrintRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_PrintRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:PrintRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">AREN:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">AREN:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_TransferredAtPointInTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_TransferredAtPointInTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_TransferredOverTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_TransferredOverTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DigitalRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_DigitalRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:DigitalRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PrintRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:PrintRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PrintRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">AREN:PrintRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OfficeEquipmentAndComputersMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:OfficeEquipmentAndComputersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OfficeEquipmentAndComputersMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:OfficeEquipmentAndComputersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SeriesGConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SeriesGConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_SeriesHPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_SeriesHPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_FinancingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:FinancingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_FinancingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:FinancingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ABGWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ABGWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AllHipHopWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:AllHipHopWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AllHipHopWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:AllHipHopWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PublisherPartnerWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:PublisherPartnerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_PublisherPartnerWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:PublisherPartnerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RestrictedStockAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:RestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_RestrictedStockAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:RestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CommonStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:CommonStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_CommonStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">AREN:CommonStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ParadePrintMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">AREN:ParadePrintMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-11</startDate>
            <endDate>2023-01-11</endDate>
        </period>
    </context>
    <context id="From2023-03-012023-03-01_custom_TeneologyIncMember_custom_FexyStudiosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-01</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-04-01_custom_TeneologyIncMember_custom_FexyStudiosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-05-01_custom_TeneologyIncMember_custom_FexyStudiosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-01</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-11</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AdvertiserRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">AREN:AdvertiserRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">AREN:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TeneologyIncMember_custom_FexyStudiosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-11-172023-11-17_custom_Disposition2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">AREN:Disposition2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-17</startDate>
            <endDate>2023-11-17</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_Disposition2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">AREN:Disposition2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Disposition2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">AREN:Disposition2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-04-01_custom_AthlonHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-01_custom_AthlonHoldingsIncMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_AthlonHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember_custom_DigitalContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">AREN:DigitalContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember_custom_AdvertiserRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">AREN:AdvertiserRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember_us-gaap_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="From2022-09-272022-09-27_custom_BuffaloGroupeLLCMember_custom_IntellectualPropertiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:IntellectualPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:BuffaloGroupeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-27</startDate>
            <endDate>2022-09-27</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <instant>2022-09-27</instant>
        </period>
    </context>
    <context id="From2022-12-152022-12-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <startDate>2022-12-15</startDate>
            <endDate>2022-12-15</endDate>
        </period>
    </context>
    <context id="From2022-12-072022-12-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <startDate>2022-12-07</startDate>
            <endDate>2022-12-07</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <instant>2022-12-15</instant>
        </period>
    </context>
    <context id="AsOf2022-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_MensJournalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:MensJournalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_A360MediaLLCMember_custom_AdvertiserRelationshipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:AdvertiserRelationshipMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:A360MediaLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_A360MediaLLCMember_custom_BrandNameMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BrandNameMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:A360MediaLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_FexyStudiosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AthlonHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember_custom_AdvertiserRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">AREN:AdvertiserRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-11</instant>
        </period>
    </context>
    <context id="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember_custom_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">AREN:BrandNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-11</instant>
        </period>
    </context>
    <context id="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember_us-gaap_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:TeneologyIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-11</instant>
        </period>
    </context>
    <context id="AsOf2022-04-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ParadeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:ParadeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ArenaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:ArenaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AthlonHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:AthlonHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OfficeEquipmentAndComputersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:OfficeEquipmentAndComputersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_OfficeEquipmentAndComputersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:OfficeEquipmentAndComputersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SubleaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SubleaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2021-09-012021-09-30_custom_LeaseArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:LeaseArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-10-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="AsOf2023-10-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OctoberOneTwoThousandAndTwentyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">AREN:OctoberOneTwoThousandAndTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_OctoberOneTwoThousandAndTwentyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">AREN:OctoberOneTwoThousandAndTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_BusinessMembershipAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:BusinessMembershipAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_BusinessMembershipAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:BusinessMembershipAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_MonthToMonthLeaseArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:MonthToMonthLeaseArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_MonthToMonthLeaseArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:MonthToMonthLeaseArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PlatformDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:PlatformDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PlatformDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:PlatformDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PlatformDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:PlatformDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PlatformDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:PlatformDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_PlatformDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">AREN:PlatformDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DevelopedTechnologyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_DevelopedTechnologyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SubscriberRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:SubscriberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SubscriberRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:SubscriberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AdvertiserRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:AdvertiserRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_AdvertiserRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:AdvertiserRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_DatabasesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_DatabasesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DigitalContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:DigitalContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_DigitalContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:DigitalContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DevelopedTechnologyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_DevelopedTechnologyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">AREN:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_FiniteLivedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_FiniteLivedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ParadeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:ParadeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_MensJournalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:MensJournalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_FexyStudiosMember66260062">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_FexyStudiosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-15</instant>
        </period>
    </context>
    <context id="From2022-12-152022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-15</startDate>
            <endDate>2022-12-15</endDate>
        </period>
    </context>
    <context id="From2022-12-152022-12-15_custom_SLRDigitalFinanceLLCMember_custom_FinancingAndSecurityAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-15</startDate>
            <endDate>2022-12-15</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember_custom_TwoThousandTwentyThreeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-15</instant>
        </period>
    </context>
    <context id="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember_custom_SeriesLPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:SeriesLPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-15</instant>
        </period>
    </context>
    <context id="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-15</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:FinancingAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_MDBCommonStockToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:MDBCommonStockToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ConvertibleDebenturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:ConvertibleDebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SeriesJPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesJPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SeriesKPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesKPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_MDBCommonStockToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:MDBCommonStockToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ConvertibleDebenturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:ConvertibleDebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SeriesJPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesJPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SeriesKPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesKPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-02-082023-02-08_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-08</startDate>
            <endDate>2023-02-08</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-08_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-08</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-12-012023-12-01_custom_BRileyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-01</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_BRileyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_FlexyStudiosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:FlexyStudiosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_PutOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_FexyStudiosAcquistionMember_us-gaap_PutOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">AREN:FexyStudiosAcquistionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ContingentConsiderationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">AREN:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ContingentConsiderationMember_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">AREN:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ContingentConsiderationMember_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">AREN:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_custom_ContingentConsiderationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">AREN:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SeniorSecuredNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">AREN:SeniorSecuredNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SeniorSecuredNoteMember_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">AREN:SeniorSecuredNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SeniorSecuredNoteMember_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">AREN:SeniorSecuredNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SeniorSecuredNoteMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">AREN:SeniorSecuredNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-08-31_custom_TwoThousandTwentyThreeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="From2023-08-312023-08-31_custom_TwoThousandTwentyThreeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-31</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2023-09-292023-09-29_custom_TwoThousandTwentyThreeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-29</startDate>
            <endDate>2023-09-29</endDate>
        </period>
    </context>
    <context id="AsOf2023-11-27_custom_TwoThousandTwentyThreeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-27</instant>
        </period>
    </context>
    <context id="AsOf2023-09-29_custom_TwoThousandTwentyThreeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-29</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_BridgeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:BridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandTwentyThreeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BridgeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:BridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-15_custom_TwoThousandTwentyTwoBridgeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-15</instant>
        </period>
    </context>
    <context id="From2022-12-152022-12-15_custom_TwoThousandTwentyTwoBridgeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-15</startDate>
            <endDate>2022-12-15</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-01-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SeniorSecuredNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:SeniorSecuredNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SLRDigitalFinanceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:SLRDigitalFinanceLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DelayedDrawTermNotesMember_custom_PurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">AREN:DelayedDrawTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DelayedDrawTermNotesMember_custom_PurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">AREN:DelayedDrawTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-03-012023-03-01_custom_TwoThousandTwentyTwoBridgeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-01</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-05-01_custom_TwoThousandTwentyTwoBridgeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-01</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-07-01_custom_TwoThousandTwentyTwoBridgeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-07-01</endDate>
        </period>
    </context>
    <context id="From2022-12-312022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-12-312022-12-31_custom_BRileyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SeniorSecuredNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:SeniorSecuredNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SeniorSecuredNoteMember66266859">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:SeniorSecuredNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DelayedDrawTermNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:DelayedDrawTermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_DelayedDrawTermNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:DelayedDrawTermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DelayedDrawTermNoteMember66267140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">AREN:DelayedDrawTermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_DelayedDrawTermNoteMember66267140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">AREN:DelayedDrawTermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember66267156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember66267156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">AREN:TwoThousandTwentyTwoBridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_LineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_LineOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SeniorSecuredNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:SeniorSecuredNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SeniorSecuredNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:SeniorSecuredNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DelayedDrawTermNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:DelayedDrawTermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_DelayedDrawTermNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:DelayedDrawTermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TwoThousandTwentyThreeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:TwoThousandTwentyThreeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_LineOfCreditTerminationFeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:LineOfCreditTerminationFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_LineOfCreditTerminationFeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:LineOfCreditTerminationFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ParadeMember66267484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:ParadeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ParadeMember66267484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:ParadeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_OtherAccruedInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:OtherAccruedInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_OtherAccruedInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:OtherAccruedInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_OtherMember66267546">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_OtherMember66267562">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SeriesGConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_SeriesHPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_SeriesGPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_SeriesGPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2000-05-302000-05-30_us-gaap_SeriesGPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2000-05-30</startDate>
            <endDate>2000-05-30</endDate>
        </period>
    </context>
    <context id="AsOf2000-05-30_us-gaap_SeriesGPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2000-05-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OriginalInvestorMember_us-gaap_SeriesGPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:OriginalInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-08-10_custom_SeriesHConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-10</instant>
        </period>
    </context>
    <context id="AsOf2020-12-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <instant>2020-12-18</instant>
        </period>
    </context>
    <context id="From2023-03-302023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:PurchasersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-30</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:PurchasersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SeriesHConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SeriesHConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-102023-01-11_custom_FexyStudiosAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:FexyStudiosAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-10</startDate>
            <endDate>2023-01-11</endDate>
        </period>
    </context>
    <context id="AsOf2023-11-01_custom_AssetPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-01</instant>
        </period>
    </context>
    <context id="From2022-03-282022-04-02_custom_ParadeStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:ParadeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-28</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-09_custom_AssetPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-09</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:SeveralInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SeveralStockPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:SeveralInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SeveralStockPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:SeveralInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SeveralStockPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_CommonStockMember_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_CommonStockMember_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_CommonStockMember_custom_RestrictedCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:RestrictedCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CommonStockMember_custom_RestrictedCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:RestrictedCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ExerciseOfStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ExerciseOfStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ExerciseOfStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ExerciseOfStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-202022-01-21_custom_ServicesAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-21</endDate>
        </period>
    </context>
    <context id="From2022-01-112022-01-12_custom_ServicesAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-12</endDate>
        </period>
    </context>
    <context id="AsOf2022-01-12_custom_ServicesAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-12</instant>
        </period>
    </context>
    <context id="AsOf2022-01-26_custom_ServicesAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-26</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ServicesAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-03-112022-03-11_custom_UnderwritingPublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">AREN:UnderwritingPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-11</startDate>
            <endDate>2022-03-11</endDate>
        </period>
    </context>
    <context id="From2022-02-152022-02-15_custom_UnderwritingPublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">AREN:UnderwritingPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-15</startDate>
            <endDate>2022-02-15</endDate>
        </period>
    </context>
    <context id="From2022-02-152022-02-15_custom_UnderwritingOverallotmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">AREN:UnderwritingOverallotmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-15</startDate>
            <endDate>2022-02-15</endDate>
        </period>
    </context>
    <context id="From2022-03-112022-03-11_custom_UnderwritingOverallotmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">AREN:UnderwritingOverallotmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-11</startDate>
            <endDate>2022-03-11</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <instant>2022-03-10</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_BRileyMember66269906">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">AREN:BRileyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_UnderwritingPublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">AREN:UnderwritingPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2018-01-032018-01-04_custom_MDBCapitalGroupLLCMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:MDBCapitalGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-03</startDate>
            <endDate>2018-01-04</endDate>
        </period>
    </context>
    <context id="AsOf2020-10-26_custom_AllHipHopWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:AllHipHopWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-26</instant>
        </period>
    </context>
    <context id="AsOf2020-10-26_custom_PublisherPartnerWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:PublisherPartnerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-26</instant>
        </period>
    </context>
    <context id="AsOf2019-06-14_custom_ABGWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-14</instant>
        </period>
    </context>
    <context id="From2019-06-132019-06-14_custom_ABGWarransMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:ABGWarransMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-13</startDate>
            <endDate>2019-06-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ABGTimeBasedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:ABGTimeBasedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ABGPerformanceBasedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:ABGPerformanceBasedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-05-20_custom_PublisherPartnerWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:PublisherPartnerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-20</instant>
        </period>
    </context>
    <context id="AsOf2022-11-02_custom_NewPublisherPartnerWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:NewPublisherPartnerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-02</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CommonStockFinancingWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:CommonStockFinancingWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CommonStockFinancingWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:CommonStockFinancingWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CommonStockFinancingWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:CommonStockFinancingWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-02_custom_TwoThousandTwentyTwoPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-02</instant>
        </period>
    </context>
    <context id="From2023-02-272023-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <startDate>2023-02-27</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2023-06-292023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <startDate>2023-06-29</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-11-202022-11-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <startDate>2022-11-20</startDate>
            <endDate>2022-11-22</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember66271921">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember66271937">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TwoThousandTwentyTwoPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-02-282023-02-28_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-28</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2023-02-282023-02-28_custom_CommonStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-28</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2023-02-282023-02-28_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-28</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_CommonStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CommonStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_custom_CommonStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_CommonStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-06-292023-06-30_custom_CommonStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-29</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-11-012023-11-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-02</endDate>
        </period>
    </context>
    <context id="From2022-03-152022-03-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <startDate>2022-03-15</startDate>
            <endDate>2022-03-18</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
        </entity>
        <period>
            <instant>2022-03-18</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SportsIllustratedLicensingAgreementMember_custom_ABGWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SportsIllustratedLicensingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SportsIllustratedLicensingAgreementMember_custom_ABGWarrantsMember66272984">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SportsIllustratedLicensingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PublisherPartnerWarrantProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:PublisherPartnerWarrantProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:NewPublisherPartnerWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CommonEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CommonStockAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ABGWarrantsMember66273406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_NewPublisherPartnerWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:NewPublisherPartnerWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:UpListMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:UpListMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:NoUpListMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:UpListMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:UpListMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:NoUpListMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:NoUpListMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:TwoThousandTwentyTwoPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ABGWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:NewPublisherPartnerWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:NewPublisherPartnerWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:NewPublisherPartnerWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:NewPublisherPartnerWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">AREN:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">AREN:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ABGWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ABGWarrantsMember66276281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ABGWarrantsMember66276312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_NewPublisherPartnerWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">AREN:NewPublisherPartnerWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_StockBasedCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_StockBasedCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:CommonStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_StockBasedCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">AREN:StockBasedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_StateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">AREN:StateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">AREN:LocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_USFederalTaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">AREN:USFederalTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_StateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">AREN:StateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_LocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">AREN:LocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-12-012023-12-01_custom_BRileyFBRIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">AREN:BRileyFBRIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-01</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_BRileyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-03-312023-03-31_custom_BRileyMember_us-gaap_CommonStockMember_custom_DirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">AREN:DirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_DirectOfferingMember_custom_BRileyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">AREN:DirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-08-10_custom_BRileyMember_custom_SeriesHConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">AREN:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-10</instant>
        </period>
    </context>
    <context id="AsOf2023-08-31_custom_BRileyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-29_custom_BRileyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-29</instant>
        </period>
    </context>
    <context id="AsOf2023-11-27_custom_BRileyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-27</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BRileyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BRileyFinancialIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:BRileyFinancialIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_BRileyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:BRileyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:PurchasersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_HHuntAllredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:HHuntAllredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_AllredTrustHHAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:AllredTrustHHAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_AllredTrustNLAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:AllredTrustNLAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_OneEightyDegreeCapitalCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:OneEightyDegreeCapitalCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_DanielShribmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:DanielShribmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_RossLevinsohnMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:RossLevinsohnMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_PaulEdmonsonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:PaulEdmonsonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2020-12-142020-12-15_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-14</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-15_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-15</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_MrEdmonsonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">AREN:MrEdmonsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ABGSILLCMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">AREN:ABGSILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-01-05_custom_ArenaLoanAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ArenaLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-05</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ArenaLoanAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:ArenaLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-01-02_custom_LicensingAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:LicensingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-02</instant>
        </period>
    </context>
    <context id="From2024-01-022024-01-02_us-gaap_SubsequentEventMember_custom_ABGWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">AREN:ABGWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-02</startDate>
            <endDate>2024-01-02</endDate>
        </period>
    </context>
    <context id="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_custom_TransactionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:TransactionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-09</startDate>
            <endDate>2024-02-09</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_TransactionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:TransactionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-09</instant>
        </period>
    </context>
    <context id="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_custom_TransactionAgreementMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:TransactionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-09</startDate>
            <endDate>2024-02-09</endDate>
        </period>
    </context>
    <context id="From2024-02-092024-02-09_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-09</startDate>
            <endDate>2024-02-09</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-09_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-09</instant>
        </period>
    </context>
    <context id="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-09</startDate>
            <endDate>2024-02-09</endDate>
        </period>
    </context>
    <context id="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-09</startDate>
            <endDate>2024-02-09</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-09</instant>
        </period>
    </context>
    <context id="From2024-02-142024-02-14_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SubscriptionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-14</startDate>
            <endDate>2024-02-14</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-14_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SubscriptionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-14</instant>
        </period>
    </context>
    <context id="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_SubscriptionAgreementMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">AREN:SubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-09</instant>
        </period>
    </context>
    <context id="From2024-02-152024-02-15_us-gaap_SubsequentEventMember_custom_FexyStudiosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">AREN:FexyStudiosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-15</startDate>
            <endDate>2024-02-15</endDate>
        </period>
    </context>
    <context id="From2024-03-132024-03-14_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-13</startDate>
            <endDate>2024-03-14</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-13_us-gaap_SubsequentEventMember_custom_SimplyfyLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">AREN:SimplyfyLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-13</instant>
        </period>
    </context>
    <context id="AsOf2024-03-13_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-13</instant>
        </period>
    </context>
    <context id="From2024-03-212024-03-21_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-21</startDate>
            <endDate>2024-03-21</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-01-01_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-01</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-01-01_us-gaap_SubsequentEventMember_custom_MembersOfBoardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:MembersOfBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-01</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-01-01_us-gaap_SubsequentEventMember_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-01</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-01-01_us-gaap_SubsequentEventMember_custom_FormerEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">AREN:FormerEmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-01</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-14_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-14</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-14_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894871</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-14</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Segment">
        <measure>AREN:Segment</measure>
    </unit>
    <unit id="Integer">
        <measure>AREN:Integer</measure>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2023-01-01to2023-12-31" id="Fact000004">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2023-01-01to2023-12-31" id="Fact000005">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2023-01-01to2023-12-31" id="Fact000006">0000894871</dei:EntityCentralIndexKey>
    <us-gaap:RestrictedCashCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0060"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0124"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0141"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:LiquidatingDamagesPayableNonCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0144"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0156"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0157"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember"
      id="xdx2ixbrl0195"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:CommonStockToBeIssuedDuringPeriod
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0251"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:CommonStockToBeIssuedDuringPeriod
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0252"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:LossOnSaleOfAssets
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0295"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0307"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl0327"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl0342"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl0344"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0367"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering
      contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0377"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0379"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0385"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0387"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne
      contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0393"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0395"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0400"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0401"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0403"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0409"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0411"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0415"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0417"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl0418"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes
      contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0423"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0425"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0430"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0431"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0432"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0433"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl0434"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0438"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0439"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0440"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0441"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl0442"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0448"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0449"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0451"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0454"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages
      contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0455"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0460"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0461"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0463"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0466"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0467"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0468"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0483"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0493"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0505"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0511"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0513"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0518"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger
      contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0519"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0520"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0521"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithMerger
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0522"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0528"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0529"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0531"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0537"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0539"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0544"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0545"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0547"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0551"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0553"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0559"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0561"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0562"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes
      contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0567"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0569"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0574"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0575"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0576"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0577"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0578"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0583"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0585"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0590"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0591"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0593"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0596"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0597"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0598"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0603"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_CommonStockToBeIssuedMember"
      id="xdx2ixbrl0613"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:LossOnSaleOfAssets
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0647"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0650"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl0664"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInPrepaidRoyalties
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl0676"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl0709"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0716"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl0718"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl0733"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0746"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl0748"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:PaymentOfRestrictedStockLiabilities
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl0757"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RestrictedCash
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0778"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0791"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:ReclassificationToLiabilityUponCommonStockModification
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0818"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RestrictedCashCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0929"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RestrictedCashCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0935"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0954"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_us-gaap_SeriesHPreferredStockMember"
      id="xdx2ixbrl1043"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_custom_FinancingWarrantsMember"
      id="xdx2ixbrl1047"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockAwardsMember"
      id="xdx2ixbrl1063"
      unitRef="Shares"
      xsi:nil="true"/>
    <AREN:EmployeeRetentionCredits
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl1358"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl1529">http://fasb.org/us-gaap/2023#AssetImpairmentCharges</us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-12-31_custom_DevelopedTechnologyMember"
      id="xdx2ixbrl1541"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherReceivables
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl1681"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2023-01-012023-12-31_custom_ParadeMember"
      id="xdx2ixbrl1699"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2022-01-012022-12-31_custom_FexyStudiosMember"
      id="xdx2ixbrl1706"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl1708"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl1709"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl1714"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl1716"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl1742"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LeaseDepositLiability
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl1748"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:PublicInformationFailureDamages
      contextRef="AsOf2023-12-31_custom_MDBCommonStockToBeIssuedMember"
      id="xdx2ixbrl1803"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2023-12-31_custom_MDBCommonStockToBeIssuedMember"
      id="xdx2ixbrl1805"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:RegistrationRightsDamages
      contextRef="AsOf2023-12-31_custom_ConvertibleDebenturesMember"
      id="xdx2ixbrl1817"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:PublicInformationFailureDamages
      contextRef="AsOf2022-12-31_custom_MDBCommonStockToBeIssuedMember"
      id="xdx2ixbrl1870"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2022-12-31_custom_MDBCommonStockToBeIssuedMember"
      id="xdx2ixbrl1872"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:RegistrationRightsDamages
      contextRef="AsOf2022-12-31_custom_ConvertibleDebenturesMember"
      id="xdx2ixbrl1884"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:LeaseTerminationLiabilityNonCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1928"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtFairValue
      contextRef="AsOf2023-12-31_custom_ContingentConsiderationMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1956"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtFairValue
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_custom_ContingentConsiderationMember"
      id="xdx2ixbrl1960"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtFairValue
      contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1965"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtFairValue
      contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1969"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      id="xdx2ixbrl2120"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      id="xdx2ixbrl2122"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      id="xdx2ixbrl2124"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      id="xdx2ixbrl2148"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyThreeNotesMember"
      id="xdx2ixbrl2163"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2022-01-012022-12-31_custom_SeniorSecuredNotesMember"
      id="xdx2ixbrl2166"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2022-01-012022-12-31_custom_DelayedDrawTermNoteMember"
      id="xdx2ixbrl2169"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      id="xdx2ixbrl2172"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2022-01-012022-12-31_custom_LineOfCreditTerminationFeeMember"
      id="xdx2ixbrl2175"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2023-01-012023-12-31_custom_ParadeMember66267484"
      id="xdx2ixbrl2177"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaid
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyThreeNotesMember"
      id="xdx2ixbrl2193"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaid
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      id="xdx2ixbrl2202"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseDebt
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2211"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2023-12-31_us-gaap_RestrictedStockMember"
      id="xdx2ixbrl2408"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_CommonStockFinancingWarrantMember"
      id="xdx2ixbrl2424"
      unitRef="Shares"
      xsi:nil="true"/>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_CommonStockFinancingWarrantMember"
      id="xdx2ixbrl2426"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber
      contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember66276312"
      id="xdx2ixbrl2731"
      unitRef="Shares"
      xsi:nil="true"/>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber
      contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember66276312"
      id="xdx2ixbrl2733"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_NewPublisherPartnerWarrantMember"
      id="xdx2ixbrl2769"
      unitRef="Shares"
      xsi:nil="true"/>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding
      contextRef="AsOf2022-12-31_custom_NewPublisherPartnerWarrantMember"
      id="xdx2ixbrl2771"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeOneMember"
      id="xdx2ixbrl2802"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember"
      id="xdx2ixbrl2828"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DevelopmentCosts
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember"
      id="xdx2ixbrl2848"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DevelopmentCosts
      contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember"
      id="xdx2ixbrl2852"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-012022-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember"
      id="xdx2ixbrl2868"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-01-012022-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember"
      id="xdx2ixbrl2876"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DevelopmentCosts
      contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember"
      id="xdx2ixbrl2896"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DevelopmentCosts
      contextRef="From2022-01-012022-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember"
      id="xdx2ixbrl2900"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl2946"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2947"
      unitRef="USD"
      xsi:nil="true"/>
    <AREN:EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl3078"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2023-01-01to2023-12-31" id="Fact000014">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2023-01-01to2023-12-31" id="Fact000015">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2023-01-01to2023-12-31" id="Fact000016">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-01-01to2023-12-31" id="Fact000017">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2023-01-01to2023-12-31" id="Fact000018">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="From2023-01-01to2023-12-31" id="Fact000019">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2023-01-01to2023-12-31" id="Fact000020">001-12471</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2023-01-01to2023-12-31" id="Fact000021">THE ARENA GROUP HOLDINGS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-01-01to2023-12-31" id="Fact000022">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-01-01to2023-12-31" id="Fact000023">68-0232575</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-01-01to2023-12-31" id="Fact000024">200                                             Vesey Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-01-01to2023-12-31" id="Fact000025">24th     Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-01-01to2023-12-31" id="Fact000026">New     York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-01-01to2023-12-31" id="Fact000027">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-01-01to2023-12-31" id="Fact000028">10281</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-01-01to2023-12-31" id="Fact000029">(212)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-01-01to2023-12-31" id="Fact000030">321-5002</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2023-01-01to2023-12-31" id="Fact000031">Common     Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-01-01to2023-12-31" id="Fact000032">AREN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-01-01to2023-12-31" id="Fact000033">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2023-01-01to2023-12-31" id="Fact000034">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2023-01-01to2023-12-31" id="Fact000035">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2023-01-01to2023-12-31" id="Fact000036">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2023-01-01to2023-12-31" id="Fact000037">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2023-01-01to2023-12-31" id="Fact000038">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2023-01-01to2023-12-31" id="Fact000039">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-01-01to2023-12-31" id="Fact000040">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="From2023-01-01to2023-12-31" id="Fact000041">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2023-01-01to2023-12-31" id="Fact000042">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="From2023-01-01to2023-12-31" id="Fact000043">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact000044"
      unitRef="USD">57218045</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2024-03-28"
      decimals="INF"
      id="Fact000045"
      unitRef="Shares">29770553</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000046">Portions
of the registrant&#x2019;s definitive proxy statement for its 2024 Annual Meeting of Stockholders, or Proxy Statement, to be filed within
120 days after the end of the fiscal year covered by this Annual Report on Form 10-K, are incorporated by reference in Part III. Except
with respect to information specifically incorporated by reference in this Annual Report, the Proxy Statement shall not be deemed to
be filed as part hereof.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId contextRef="From2023-01-01to2023-12-31" id="Fact000047">688</dei:AuditorFirmId>
    <dei:AuditorName contextRef="From2023-01-01to2023-12-31" id="Fact000048">Marcum LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2023-01-01to2023-12-31" id="Fact000049">New York, NY</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000057"
      unitRef="USD">9284000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000058"
      unitRef="USD">13871000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000061"
      unitRef="USD">502000</us-gaap:RestrictedCashCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000063"
      unitRef="USD">44811000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000064"
      unitRef="USD">33950000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000066"
      unitRef="USD">29706000</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000067"
      unitRef="USD">25931000</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000069"
      unitRef="USD">6598000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000070"
      unitRef="USD">4441000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000072"
      unitRef="USD">90399000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000073"
      unitRef="USD">78695000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000075"
      unitRef="USD">328000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000076"
      unitRef="USD">735000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000078"
      unitRef="USD">176000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000079"
      unitRef="USD">372000</us-gaap:OperatingLeaseRightOfUseAsset>
    <AREN:PlatformDevelopmentNet
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000081"
      unitRef="USD">8723000</AREN:PlatformDevelopmentNet>
    <AREN:PlatformDevelopmentNet
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000082"
      unitRef="USD">10330000</AREN:PlatformDevelopmentNet>
    <us-gaap:CapitalizedContractCostNetNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000084"
      unitRef="USD">7215000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:CapitalizedContractCostNetNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000085"
      unitRef="USD">14133000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000087"
      unitRef="USD">38459000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000088"
      unitRef="USD">58970000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000090"
      unitRef="USD">1003000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000091"
      unitRef="USD">1140000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Goodwill
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000093"
      unitRef="USD">42575000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000094"
      unitRef="USD">39344000</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000096"
      unitRef="USD">188878000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000097"
      unitRef="USD">203719000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000105"
      unitRef="USD">10357000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000106"
      unitRef="USD">12863000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000108"
      unitRef="USD">30771000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000109"
      unitRef="USD">23102000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000111"
      unitRef="USD">19609000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000112"
      unitRef="USD">14092000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000114"
      unitRef="USD">59786000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000115"
      unitRef="USD">58703000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000117"
      unitRef="USD">449000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000118"
      unitRef="USD">845000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000120"
      unitRef="USD">358000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000121"
      unitRef="USD">427000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000123"
      unitRef="USD">1571000</us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent>
    <AREN:LiquidatedDamagesPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000126"
      unitRef="USD">2924000</AREN:LiquidatedDamagesPayableCurrent>
    <AREN:LiquidatedDamagesPayableCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000127"
      unitRef="USD">5843000</AREN:LiquidatedDamagesPayableCurrent>
    <AREN:BridgeNotes
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000129"
      unitRef="USD">7887000</AREN:BridgeNotes>
    <AREN:BridgeNotes
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000130"
      unitRef="USD">34805000</AREN:BridgeNotes>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000132"
      unitRef="USD">102309000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000133"
      unitRef="USD">65684000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000135"
      unitRef="USD">236021000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000136"
      unitRef="USD">216364000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000138"
      unitRef="USD">10679000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000139"
      unitRef="USD">19701000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000142"
      unitRef="USD">358000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <AREN:LiquidatingDamagesPayableNonCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000145"
      unitRef="USD">494000</AREN:LiquidatingDamagesPayableNonCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000147"
      unitRef="USD">406000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000148"
      unitRef="USD">5307000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000150"
      unitRef="USD">599000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000151"
      unitRef="USD">465000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000153"
      unitRef="USD">247705000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000154"
      unitRef="USD">242689000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000165"
      unitRef="USDPShares">0.01</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000167"
      unitRef="USDPShares">0.01</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000169"
      unitRef="USDPShares">1000</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000171"
      unitRef="USDPShares">1000</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000173"
      unitRef="Shares">1800</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000175"
      unitRef="Shares">1800</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact000177"
      unitRef="USD">168000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact000179"
      unitRef="USD">168000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000181"
      unitRef="Shares">168</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000183"
      unitRef="Shares">168</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000185"
      unitRef="Shares">168</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000187"
      unitRef="Shares">168</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000189"
      unitRef="Shares">168</us-gaap:TemporaryEquitySharesOutstanding>
    <AREN:TemporaryEquityCommonSharesIssuableUponConversion
      contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000191"
      unitRef="Shares">8582</AREN:TemporaryEquityCommonSharesIssuableUponConversion>
    <AREN:TemporaryEquityCommonSharesIssuableUponConversion
      contextRef="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000193"
      unitRef="Shares">8582</AREN:TemporaryEquityCommonSharesIssuableUponConversion>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact000162"
      unitRef="USD">168000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31_custom_SeriesGRedeemableAndConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact000163"
      unitRef="USD">168000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2023-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000198"
      unitRef="USDPShares">0.01</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000200"
      unitRef="USDPShares">0.01</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="AsOf2023-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000202"
      unitRef="USDPShares">1000</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="AsOf2022-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000204"
      unitRef="USDPShares">1000</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2023-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000206"
      unitRef="Shares">23000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2022-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000208"
      unitRef="Shares">23000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="AsOf2023-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact000210"
      unitRef="USD">0</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="AsOf2022-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact000212"
      unitRef="USD">14356000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2023-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000214"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000216"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2022-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000218"
      unitRef="Shares">14356</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2022-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000220"
      unitRef="Shares">14356</us-gaap:TemporaryEquitySharesOutstanding>
    <AREN:TemporaryEquityCommonSharesIssuableUponConversion
      contextRef="AsOf2023-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000222"
      unitRef="Shares">0</AREN:TemporaryEquityCommonSharesIssuableUponConversion>
    <AREN:TemporaryEquityCommonSharesIssuableUponConversion
      contextRef="AsOf2022-12-31_custom_SeriesHRedeemableAndConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000224"
      unitRef="Shares">1981128</AREN:TemporaryEquityCommonSharesIssuableUponConversion>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact000196"
      unitRef="USD">13008000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000226"
      unitRef="USD">168000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000227"
      unitRef="USD">13176000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000235"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact000237"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000239"
      unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact000241"
      unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000243"
      unitRef="Shares">23836706</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000245"
      unitRef="Shares">23836706</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact000247"
      unitRef="Shares">18303193</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact000249"
      unitRef="Shares">18303193</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000232"
      unitRef="USD">237000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000233"
      unitRef="USD">182000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000254"
      unitRef="USD">319421000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000255"
      unitRef="USD">270743000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000257"
      unitRef="USD">-378653000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000258"
      unitRef="USD">-323071000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000260"
      unitRef="USD">-58995000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000261"
      unitRef="USD">-52146000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000263"
      unitRef="USD">188878000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000264"
      unitRef="USD">203719000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000266"
      unitRef="USD">244203000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000267"
      unitRef="USD">220935000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000272"
      unitRef="USD">8782000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000274"
      unitRef="USD">9459000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfRevenue
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000269"
      unitRef="USD">142240000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000270"
      unitRef="USD">132923000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000276"
      unitRef="USD">101963000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000277"
      unitRef="USD">88012000</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000282"
      unitRef="USD">74245000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000283"
      unitRef="USD">72489000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000285"
      unitRef="USD">44152000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000286"
      unitRef="USD">53499000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000288"
      unitRef="USD">18924000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000289"
      unitRef="USD">17650000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AssetImpairmentCharges
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000291"
      unitRef="USD">119000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000292"
      unitRef="USD">257000</us-gaap:AssetImpairmentCharges>
    <AREN:LossOnSaleOfAssets
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000294"
      unitRef="USD">325000</AREN:LossOnSaleOfAssets>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000297"
      unitRef="USD">137765000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000298"
      unitRef="USD">143895000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000300"
      unitRef="USD">-35802000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000301"
      unitRef="USD">-55883000</us-gaap:OperatingIncomeLoss>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000306"
      unitRef="USD">-1010000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:InterestExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000309"
      unitRef="USD">17965000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000310"
      unitRef="USD">11428000</us-gaap:InterestExpense>
    <AREN:LiquidatedDamagesUnderRegistrationRightsAgreements
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000312"
      unitRef="USD">-583000</AREN:LiquidatedDamagesUnderRegistrationRightsAgreements>
    <AREN:LiquidatedDamagesUnderRegistrationRightsAgreements
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000313"
      unitRef="USD">-1140000</AREN:LiquidatedDamagesUnderRegistrationRightsAgreements>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000315"
      unitRef="USD">-19558000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000316"
      unitRef="USD">-12568000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000318"
      unitRef="USD">-55360000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000319"
      unitRef="USD">-68451000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000321"
      unitRef="USD">222000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000322"
      unitRef="USD">-1063000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000324"
      unitRef="USD">-55582000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000325"
      unitRef="USD">-67388000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000328"
      unitRef="USD">-3470000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000330"
      unitRef="USD">-55582000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000331"
      unitRef="USD">-70858000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact000336"
      unitRef="USDPShares">-2.49</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact000338"
      unitRef="USDPShares">-2.49</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000340"
      unitRef="USDPShares">-3.82</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000346"
      unitRef="USDPShares">-0.20</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000348"
      unitRef="USDPShares">-0.20</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact000350"
      unitRef="USDPShares">-2.49</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact000352"
      unitRef="USDPShares">-2.49</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000354"
      unitRef="USDPShares">-4.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000356"
      unitRef="USDPShares">-4.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact000358"
      unitRef="Shares">22323763</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact000360"
      unitRef="Shares">22323763</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000362"
      unitRef="Shares">17625619</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000364"
      unitRef="Shares">17625619</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000372"
      unitRef="Shares">18303193</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000366"
      unitRef="USD">182000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_CommonStockToBeIssuedMember"
      decimals="INF"
      id="Fact000374"
      unitRef="Shares">41283</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000368"
      unitRef="USD">270743000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000369"
      unitRef="USD">-323071000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000370"
      unitRef="USD">-52146000</us-gaap:StockholdersEquity>
    <AREN:StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000382"
      unitRef="Shares">2963918</AREN:StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000376"
      unitRef="USD">30000</AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000378"
      unitRef="USD">11114000</AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000380"
      unitRef="USD">11144000</AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithRegisteredDirectOffering>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000390"
      unitRef="Shares">1981128</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000384"
      unitRef="USD">20000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000386"
      unitRef="USD">12988000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000388"
      unitRef="USD">13008000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <AREN:StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000398"
      unitRef="Shares">274692</AREN:StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithAcquisitionOne>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000392"
      unitRef="USD">3000</AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000394"
      unitRef="USD">1997000</AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000396"
      unitRef="USD">2000000</AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithAcquisitionOne>
    <AREN:StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000406"
      unitRef="Shares">47252</AREN:StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000402"
      unitRef="USD">369000</AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000404"
      unitRef="USD">369000</AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000410"
      unitRef="USD">130000</AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000412"
      unitRef="USD">130000</AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000420"
      unitRef="Shares">429528</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000414"
      unitRef="USD">4000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000416"
      unitRef="USD">-4000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <AREN:StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000428"
      unitRef="Shares">-202382</AREN:StockIssuedDuringPeriodSharesCommonStockWithheldForTaxesShares>
    <AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000422"
      unitRef="USD">-2000</AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes>
    <AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000424"
      unitRef="USD">-1421000</AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes>
    <AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000426"
      unitRef="USD">-1423000</AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000436"
      unitRef="Shares">795</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000444"
      unitRef="Shares">38582</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-01-012023-12-31_custom_CommonStockToBeIssuedMember"
      decimals="INF"
      id="Fact000446"
      unitRef="Shares">-38582</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000450"
      unitRef="USD">-68000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000452"
      unitRef="USD">-68000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000456"
      unitRef="USD">3497000</AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000458"
      unitRef="USD">3497000</AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000462"
      unitRef="USD">20076000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000464"
      unitRef="USD">20076000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000469"
      unitRef="USD">-55582000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000470"
      unitRef="USD">-55582000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000478"
      unitRef="Shares">23836706</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000472"
      unitRef="USD">237000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_CommonStockToBeIssuedMember"
      decimals="INF"
      id="Fact000480"
      unitRef="Shares">2701</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000474"
      unitRef="USD">319421000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000475"
      unitRef="USD">-378653000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000476"
      unitRef="USD">-58995000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000488"
      unitRef="Shares">12635591</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000482"
      unitRef="USD">126000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_custom_CommonStockToBeIssuedMember"
      decimals="INF"
      id="Fact000490"
      unitRef="Shares">49134</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000484"
      unitRef="USD">200410000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000485"
      unitRef="USD">-252213000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact000486"
      unitRef="USD">-51677000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000498"
      unitRef="Shares">12635591</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000492"
      unitRef="USD">126000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_custom_CommonStockToBeIssuedMember"
      decimals="INF"
      id="Fact000500"
      unitRef="Shares">49134</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000494"
      unitRef="USD">200410000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000495"
      unitRef="USD">-252213000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact000496"
      unitRef="USD">-51677000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000508"
      unitRef="Shares">97980</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000502"
      unitRef="USD">1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000504"
      unitRef="USD">709000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000506"
      unitRef="USD">710000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000516"
      unitRef="Shares">330863</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000510"
      unitRef="USD">3000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000512"
      unitRef="USD">3138000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000514"
      unitRef="USD">3141000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <AREN:StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000524"
      unitRef="Shares">7851</AREN:StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger>
    <AREN:StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger
      contextRef="From2022-01-012022-12-31_custom_CommonStockToBeIssuedMember"
      decimals="INF"
      id="Fact000526"
      unitRef="Shares">-7851</AREN:StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000534"
      unitRef="Shares">14617</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000530"
      unitRef="USD">184000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000532"
      unitRef="USD">184000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <AREN:StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000542"
      unitRef="Shares">505655</AREN:StockIssuedDuringPeriodSharesIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamagesShares>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000536"
      unitRef="USD">5000</AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000538"
      unitRef="USD">6680000</AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages>
    <AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000540"
      unitRef="USD">6685000</AREN:StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000546"
      unitRef="USD">323000</AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000548"
      unitRef="USD">323000</AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000556"
      unitRef="Shares">96408</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000550"
      unitRef="USD">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000552"
      unitRef="USD">94000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000554"
      unitRef="USD">95000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000564"
      unitRef="Shares">832233</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000558"
      unitRef="USD">8000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000560"
      unitRef="USD">-8000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <AREN:StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000572"
      unitRef="Shares">-373394</AREN:StockIssuedDuringPeriodSharesCommonStockWithheldForTaxes>
    <AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000566"
      unitRef="USD">-4000</AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes>
    <AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000568"
      unitRef="USD">-4464000</AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes>
    <AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000570"
      unitRef="USD">-4468000</AREN:StockIssuedDuringPeriodValueCommonStockWithheldForTaxes>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000580"
      unitRef="Shares">-26214</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000588"
      unitRef="Shares">4181603</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000582"
      unitRef="USD">42000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000584"
      unitRef="USD">30448000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000586"
      unitRef="USD">30490000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000592"
      unitRef="USD">33229000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000594"
      unitRef="USD">33229000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000599"
      unitRef="USD">-70858000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000600"
      unitRef="USD">-70858000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000608"
      unitRef="Shares">18303193</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000602"
      unitRef="USD">182000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_CommonStockToBeIssuedMember"
      decimals="INF"
      id="Fact000610"
      unitRef="Shares">41283</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000604"
      unitRef="USD">270743000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000605"
      unitRef="USD">-323071000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000606"
      unitRef="USD">-52146000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000618"
      unitRef="Shares">18303193</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000612"
      unitRef="USD">182000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_CommonStockToBeIssuedMember"
      decimals="INF"
      id="Fact000620"
      unitRef="Shares">41283</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000614"
      unitRef="USD">270743000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000615"
      unitRef="USD">-323071000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000616"
      unitRef="USD">-52146000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000625"
      unitRef="USD">-55582000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000626"
      unitRef="USD">-70858000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000631"
      unitRef="USD">352000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000632"
      unitRef="USD">539000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000634"
      unitRef="USD">27354000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000635"
      unitRef="USD">26570000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000637"
      unitRef="USD">2378000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000638"
      unitRef="USD">1581000</us-gaap:AmortizationOfFinancingCosts>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000640"
      unitRef="USD">-3824000</AREN:NoncashAndAccruedInterest>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000641"
      unitRef="USD">-320000</AREN:NoncashAndAccruedInterest>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000643"
      unitRef="USD">119000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000644"
      unitRef="USD">466000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <AREN:LossOnSaleOfAssets
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000646"
      unitRef="USD">325000</AREN:LossOnSaleOfAssets>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000649"
      unitRef="USD">-1010000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <AREN:LiquidatingDamagesPayable
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000652"
      unitRef="USD">583000</AREN:LiquidatingDamagesPayable>
    <AREN:LiquidatingDamagesPayable
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000653"
      unitRef="USD">1140000</AREN:LiquidatingDamagesPayable>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000655"
      unitRef="USD">19060000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000656"
      unitRef="USD">31345000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000658"
      unitRef="USD">134000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000659"
      unitRef="USD">-1200000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000661"
      unitRef="USD">315000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000662"
      unitRef="USD">658000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000665"
      unitRef="USD">184000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000670"
      unitRef="USD">11599000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000671"
      unitRef="USD">2038000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <AREN:IncreaseDecreaseInSubscriptionAcquisitionCosts
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000673"
      unitRef="USD">-3143000</AREN:IncreaseDecreaseInSubscriptionAcquisitionCosts>
    <AREN:IncreaseDecreaseInSubscriptionAcquisitionCosts
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000674"
      unitRef="USD">1667000</AREN:IncreaseDecreaseInSubscriptionAcquisitionCosts>
    <us-gaap:IncreaseDecreaseInPrepaidRoyalties
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000677"
      unitRef="USD">-11250000</us-gaap:IncreaseDecreaseInPrepaidRoyalties>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000679"
      unitRef="USD">2157000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000680"
      unitRef="USD">-2280000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000682"
      unitRef="USD">77000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000683"
      unitRef="USD">285000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000685"
      unitRef="USD">-2663000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000686"
      unitRef="USD">-6535000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000688"
      unitRef="USD">3453000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000689"
      unitRef="USD">-2996000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000691"
      unitRef="USD">-7970000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000692"
      unitRef="USD">3898000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <AREN:IncreaseDecreaseInSubscriptionRefundLiability
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000694"
      unitRef="USD">-396000</AREN:IncreaseDecreaseInSubscriptionRefundLiability>
    <AREN:IncreaseDecreaseInSubscriptionRefundLiability
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000695"
      unitRef="USD">-2379000</AREN:IncreaseDecreaseInSubscriptionRefundLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000697"
      unitRef="USD">-231000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000698"
      unitRef="USD">-218000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000700"
      unitRef="USD">-6147000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000701"
      unitRef="USD">-3359000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000703"
      unitRef="USD">-24772000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000704"
      unitRef="USD">-11304000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000710"
      unitRef="USD">530000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <AREN:PaymentsForCapitalizedPlatformDevelopment
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000712"
      unitRef="USD">3773000</AREN:PaymentsForCapitalizedPlatformDevelopment>
    <AREN:PaymentsForCapitalizedPlatformDevelopment
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000713"
      unitRef="USD">5179000</AREN:PaymentsForCapitalizedPlatformDevelopment>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000715"
      unitRef="USD">1061000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000719"
      unitRef="USD">2450000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000721"
      unitRef="USD">500000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000722"
      unitRef="USD">35331000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000724"
      unitRef="USD">-3212000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000725"
      unitRef="USD">-38590000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000730"
      unitRef="USD">8000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000731"
      unitRef="USD">34728000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000734"
      unitRef="USD">5928000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000736"
      unitRef="USD">5517000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000737"
      unitRef="USD">2104000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000739"
      unitRef="USD">11500000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000740"
      unitRef="USD">32058000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000742"
      unitRef="USD">167000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000743"
      unitRef="USD">1568000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000745"
      unitRef="USD">457000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000749"
      unitRef="USD">95000</us-gaap:ProceedsFromStockOptionsExercised>
    <AREN:PaymentOfDeferredCashPayment
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000751"
      unitRef="USD">75000</AREN:PaymentOfDeferredCashPayment>
    <AREN:PaymentOfDeferredCashPayment
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000752"
      unitRef="USD">453000</AREN:PaymentOfDeferredCashPayment>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000754"
      unitRef="USD">1423000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000755"
      unitRef="USD">4468000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <AREN:PaymentOfRestrictedStockLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000758"
      unitRef="USD">2152000</AREN:PaymentOfRestrictedStockLiabilities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000760"
      unitRef="USD">22895000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000761"
      unitRef="USD">54416000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000763"
      unitRef="USD">-5089000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000764"
      unitRef="USD">4522000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000766"
      unitRef="USD">14373000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact000767"
      unitRef="USD">9851000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000769"
      unitRef="USD">9284000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000770"
      unitRef="USD">14373000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000775"
      unitRef="USD">9284000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000776"
      unitRef="USD">13871000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000779"
      unitRef="USD">502000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000781"
      unitRef="USD">9284000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000782"
      unitRef="USD">14373000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000787"
      unitRef="USD">12101000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000788"
      unitRef="USD">9528000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000790"
      unitRef="USD">85000</us-gaap:IncomeTaxesPaidNet>
    <AREN:ReclassificationOfStockbasedCompensationToPlatformDevelopment
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000796"
      unitRef="USD">1016000</AREN:ReclassificationOfStockbasedCompensationToPlatformDevelopment>
    <AREN:ReclassificationOfStockbasedCompensationToPlatformDevelopment
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000797"
      unitRef="USD">1884000</AREN:ReclassificationOfStockbasedCompensationToPlatformDevelopment>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000799"
      unitRef="USD">189000</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000800"
      unitRef="USD">441000</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000802"
      unitRef="USD">13008000</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000803"
      unitRef="USD">511000</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:StockIssued1
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000805"
      unitRef="USD">499000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000806"
      unitRef="USD">7008000</us-gaap:StockIssued1>
    <AREN:IssuanceOfCommonStockInConnectionWithAcquisition
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000808"
      unitRef="USD">2000000</AREN:IssuanceOfCommonStockInConnectionWithAcquisition>
    <AREN:IssuanceOfCommonStockInConnectionWithAcquisition
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000809"
      unitRef="USD">3141000</AREN:IssuanceOfCommonStockInConnectionWithAcquisition>
    <AREN:DeferredCashPaymentsRecordedInConnectionWithAcquisitions
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000811"
      unitRef="USD">246000</AREN:DeferredCashPaymentsRecordedInConnectionWithAcquisitions>
    <AREN:DeferredCashPaymentsRecordedInConnectionWithAcquisitions
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000812"
      unitRef="USD">949000</AREN:DeferredCashPaymentsRecordedInConnectionWithAcquisitions>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000814"
      unitRef="USD">1246000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000815"
      unitRef="USD">17110000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1>
    <AREN:ReclassificationToLiabilityUponCommonStockModification
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000817"
      unitRef="USD">68000</AREN:ReclassificationToLiabilityUponCommonStockModification>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000820">&lt;p id="xdx_80C_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z7AmhcPvGa02" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;1.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_829_zuTWLdwyfM03"&gt;Organization and Basis of Presentation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Organization&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Arena Holdings Group, Inc. (formerly known as TheMaven, Inc.) (&#x201c;The Arena Group&#x201d; or the &#x201c;Company&#x201d;), was incorporated
in Delaware on October 1, 1990. On October 11, 2016, the predecessor entity now known as The Arena Group exchanged its shares with another
entity that was incorporated in Delaware on July 22, 2016. On November 4, 2016, these entities consummated a recapitalization. This resulted
in The Arena Group becoming the parent entity, and the other Delaware entity becoming the wholly owned subsidiary. On December 19, 2019,
the Company&#x2019;s wholly owned subsidiaries The Arena Platform, Inc. (formerly known as Maven Coalition, Inc.), and HubPages, Inc.
(&#x201c;HubPages&#x201d;), which was acquired by the Company in a merger during 2018, were merged into another of the Company&#x2019;s
wholly owned subsidiaries, Say Media, Inc. (&#x201c;Say Media&#x201d;), which was acquired by the Company in a merger during 2018, with
Say Media as the surviving corporation. On January 6, 2020, Say Media changed its name to The Arena Platform, Inc. (&#x201c;Arena Platform&#x201d;).
As of December 31, 2023, the Company&#x2019;s wholly owned subsidiaries consist of The Arena Platform, The Arena Media Brands, LLC (&#x201c;Arena
Media&#x201d;) (formerly known as Maven Media Brands, LLC) formed during 2019 as a wholly owned subsidiary of The Arena Group), TheStreet,
Inc. (&#x201c;TheStreet&#x201d; acquired by the Company in a merger during 2019), College Spun Media Incorporated (&#x201c;The Spun&#x201d;
acquired by the Company in a merger during 2021) and Athlon Holdings, Inc. (&#x201c;Parade&#x201d; acquired by the Company in a merger
during 2022 as further described in Note 4).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company changed its legal name to The Arena Group Holdings, Inc. from TheMaven, Inc. on February 8, 2022. The Company&#x2019;s subsidiaries
changed their corporate names to The Arena Platform, Inc. from Maven Coalition, Inc. and to The Arena Media Brands, LLC from Maven Media
Brands, LLC on February 18, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unless
the context indicates otherwise, The Arena Group, The Arena Platform, TheStreet, The Spun and Parade, are together hereinafter referred
to as the &#x201c;Company.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reverse
Stock Split&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 8, 2022, the Board approved a &lt;span id="xdx_902_eus-gaap--StockholdersEquityReverseStockSplit_c20220208__20220208_zH7I3iuuXedl"&gt;one-for-twenty-two (1-for-22) reverse stock split&lt;/span&gt; of its outstanding shares of common stock that
was effective February 8, 2022. The Company&#x2019;s common stock began trading on the NYSE American (the &#x201c;NYSE American&#x201d;)
on February 9, 2022 (as further described below). At the effective time, every twenty-two shares of issued and outstanding common stock
were automatically combined into one issued and outstanding share of common stock, without any change in the number of authorized shares.
No fractional shares were issued as a result of the reverse stock split. Any fractional shares that would otherwise have resulted from
the reverse stock split were rounded up to the next whole number.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements and notes to the financial statements give effect to the reverse stock split for all periods presented.
The shares of common stock retained a par value of $&lt;span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_znh03xD8wsM4" title="Common stock par value"&gt;0.01&lt;/span&gt; per share. Accordingly, stockholders&#x2019; deficiency reflects the reverse
stock split by reclassifying from &#x201c;common stock&#x201d; to &#x201c;additional paid-in capital&#x201d; in an amount equal to the par
value of the decreased shares resulting from the reverse stock split. In connection with the reverse stock split, proportionate adjustments
were made to increase the per share exercise prices and decrease the number of shares of common stock issuable upon exercise of common
stock options and warrants whereby approximately the same aggregate price is required to be paid for such securities upon exercise as
had been payable immediately preceding the reverse stock split. Any fractional shares that would otherwise be issued as a result of the
reverse stock split were rounded up to the nearest whole share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 9, 2022, in connection with the Company&#x2019;s legal name change and reverse stock split, the Company up-listed its common
stock to the NYSE American, which began trading on February 9, 2022 under the symbol &#x201c;AREN.&#x201d; The Company&#x2019;s common stock,
prior to the up-list, was quoted on the OTC Markets Group Inc.&#x2019;s (&#x201c;OTCM&#x201d;) OTCQX&lt;sup&gt;&#xae;&lt;/sup&gt; Best Market (the &#x201c;OTCQX&#x201d;)
under the symbol &#x201c;MVEN.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Business
Operations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company is a media company that leverages technology to build deep content verticals powered by anchor brands and a best-in-class digital
media platform (the &#x201c;Platform&#x201d;) empowering publishers who impact, inform, educate, and entertain. The Company&#x2019;s strategy
is to focus on key subject matter verticals where audiences are passionate about a topic category (e.g., sports and finance) where it
can leverage the strength of its core brands to grow its audience and increase monetization both within its core brands as well as for
its media publisher partners (each, a &#x201c;Publisher Partner&#x201d;). The Company&#x2019;s focus is on leveraging its Platform and brands
in targeted verticals to maximize audience reach, enhance engagement, and optimize monetization of digital publishing assets for the
benefit of its users, its advertiser clients, and its greater than 40 owned and operated properties as well as properties it runs on
behalf of independent Publisher Partners. The Company owns and operates TheStreet, The Spun, Parade, and Men&#x2019;s Journal and powers
more than 320 independent Publisher Partners, including the many sports team sites that comprise FanNation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Each
Publisher Partner joins the Platform by invitation only with the objective of improving our position in key verticals while optimizing
the performance of the Publisher Partner. Publisher Partners incur the costs in content creation on their respective channels and receive
a share of the revenue associated with their content. Because of the state-of-the-art technology and large scale of the Platform and
our expertise in search engine optimization, social media, ad monetization and subscription marketing, Publisher Partners continually
benefit from our ongoing technological advances and audience development expertise. Additionally, we believe the lead brands within our
verticals create a halo benefit for all Publisher Partners while each of them adds to the breadth and quality of content.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Platform&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company developed the Platform, a proprietary online publishing platform that provides its owned and operated media businesses, Publisher
Partners (who are third parties producing and publishing content on their own domains), and individual creators contributing content
to its owned and operated sites (&#x201c;Expert Contributors&#x201d;), the ability to produce and manage editorially focused content through
tools and services provided by it. The Company has also developed proprietary advertising technology, techniques and relationships that
allow it, its Publisher Partners, and its Expert Contributors to monetize editorially focused online content through various display
and video advertisements and tools and services for driving a subscription or membership based business and other monetization services
(the &#x201c;Monetization Solutions&#x201d; and, together with the Platform, the &#x201c;Platform Services&#x201d;). The Company&#x2019;s
Platform offers audiences bespoke content with optimized design and page construction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Platform comprises state-of-the-art publishing tools, video platforms, social distribution channels, newsletter technology, machine learning
content recommendations, notifications, and other technology that deliver a complete set of features to drive a digital media business
in an entirely cloud-based suite of services. The Company&#x2019;s software engineering and product development teams are experienced
at delivering these services at scale. The Company continues to develop the Platform software by combining proprietary code with components
from the open-source community, plus select commercial services as well as identifying, acquiring, and integrating other platform technologies
where it sees unique long-term benefits to it.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Seasonality&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company does experience seasonality during the year, as a result of advertising seasonality and sports seasons and major sporting events.
Advertising typically peaks in the fourth quarter of the Company&#x2019;s fiscal year as advertisers concentrate their budgets during
the holiday season. This trend is magnified as it also includes the professional sports and college football seasons, which account for
a significant portion of the Company&#x2019;s advertising revenue during that period of the year. Other sporting events such as the Super
Bowl, Winter and Summer Olympics, soccer&#x2019;s World Cup, and major golf, tennis and cycling events create increased traffic surrounding
the respective events.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Going
Concern&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company performed an annual reporting period going concern assessment. Management is required to assess the Company&#x2019;s ability to
continue as a going concern. These consolidated financial statements have been prepared assuming that the Company will continue as a
going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. The
Company&#x2019;s consolidated financial statements do not include any adjustments that might be necessary if it is unable to continue
as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Most
recently, for the year ended December 31, 2023, the Company incurred a net loss from continuing operations of $&lt;span id="xdx_903_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_iN_pn3n3_di_c20230101__20231231_zENQiOCp4Ul9"&gt;55,582&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
had cash on hand of $&lt;span id="xdx_90F_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20231231_zg42Hh1wYD1b"&gt;9,284&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and
a working capital deficit of $&lt;span id="xdx_902_ecustom--WorkingCapitalDeficit_iI_pn3n3_c20231231_z7oLjDxbA0T9"&gt;145,622&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
The Company&#x2019;s net loss from continuing operations and working capital deficit have been evaluated by management to determine
if the significance of those conditions or events would limit its ability to meet its obligations when due. Also, since the
Company&#x2019;s 2023 Notes (see Note 18), Senior Secured Notes, Delayed Draw Term Notes and 2022 Bridge Notes (see Note 19)
(collectively &#x201c;its current debt&#x201d;) are subject to a &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%"&gt;forbearance
period through the earlier of the following: (a) April 30, 2024&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #393A39; line-height: 115%"&gt;;
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%"&gt;(b) the occurrence
of the closing of the Business Combination and (c) the termination of the Business Combination prior to closing&lt;/span&gt; (as further described in Note 28) unless the Company is
able to refinance or modify the terms of its current debt it runs the risk that its debt could be called, therefore, it may not be able to meet its
obligations when due.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
its evaluation, management determined there is substantial doubt about the Company&#x2019;s ability to continue as a going concern for
a one-year period following the financial statement issuance date, unless it is able to refinance or modify its current debt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company plans to refinance or modify the maturities of its current debt and complete the Business Combination to alleviate the
conditions that raise substantial doubt about its ability to continue as a going concern, however, there can be no assurance that the Company will be able to refinance or modify its current debt and complete
the Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2022-02-082022-02-08" id="Fact000821">one-for-twenty-two (1-for-22) reverse stock split</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000823"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000824"
      unitRef="USD">-55582000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000825"
      unitRef="USD">9284000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <AREN:WorkingCapitalDeficit
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000826"
      unitRef="USD">145622000</AREN:WorkingCapitalDeficit>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000828">&lt;p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_z0PJwvau6Jt5" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;2.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_82F_zW3uYdnXz5tg"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zzFtoQvQnNx7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_zy3G9ui5Z5Z5"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#x201c;GAAP&#x201d;) and include the financial statements of The Arena Group and its wholly owned subsidiaries,
Arena Media, Arena Platform, TheStreet, The Spun and Parade. Intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--UseOfEstimates_z8NcpjojKmQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_z4pyTs3jB2Ci"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the Company&#x2019;s consolidated financial statements in conformity with GAAP requires management to make certain estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of
the date of the consolidated financial statements and the reported results of operations during the reporting period. Significant estimates
include: reserves for bad debt; capitalization of platform development and associated useful lives; goodwill and other acquired intangible
assets and associated useful lives; assumptions used in accruals for potential liabilities; revenue recognition and estimates of standalone
selling price of performance obligations for revenue contracts with multiple performance obligations; stock-based compensation and the
determination of the fair value; valuation allowances for deferred tax assets and uncertain tax positions; accounting for business combinations;
and assumptions used to calculate contingent liabilities. These estimates are based on information available as of the date of the consolidated
financial statements; therefore, actual results could differ from management&#x2019;s estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_ecustom--RisksAndUncertaintiesPolicy_zeQRbLriArwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_869_zsjI6LF7LMy2"&gt;Risks
and Uncertainties&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s business and operations are sensitive to general business and economic conditions in the United States and worldwide.
These conditions include short-term and long-term interest rates, inflation, fluctuations in debt and equity capital markets and the
general condition of the United States and world economy. A host of factors beyond the Company&#x2019;s control could cause fluctuations
in these conditions. Adverse developments in these general business and economic conditions could have a material adverse effect on the
Company&#x2019;s financial condition and the results of its operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, the Company will compete with many companies that currently have extensive and well-funded projects, marketing and sales operations
as well as extensive human capital. The Company may be unable to compete successfully against these companies. The Company&#x2019;s industry
is characterized by rapid changes in technology and market demands. As a result, the Company&#x2019;s products, services, or expertise
may become obsolete or unmarketable. The Company&#x2019;s future success will depend on its ability to adapt to technological advances,
anticipate customer and market demands, and enhance its current technology under development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Uncertainty
in the global economy presents significant risks to the Company&#x2019;s business. Increases in inflation, rising interest rates,
instability in the global banking system, geopolitical factors, including the ongoing conflicts in Ukraine and Israel and the
responses thereto, and the remaining effects of the COVID-19 pandemic may have an adverse effect on the Company&#x2019;s business.
While the Company is closely monitoring the impact of the current macroeconomic conditions on all aspects of its business, the
ultimate extent of the impact on its business remains highly uncertain and will depend on future developments and factors that
continue to evolve. Most of these developments and factors are outside of the Company&#x2019;s control and could exist for an
extended period of time. As a result, the Company is subject to continuing risks and uncertainties.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
December 1, 2023, B. Riley FBR, Inc. (&#x201c;B. Riley FBR&#x201d;), a registered broker-dealer owned by B. Riley Financial, Inc., a diversified
publicly traded financial services company (&#x201c;B. Riley&#x201d;) that was instrumental in providing investment banking services to
the Company and in raising debt and equity capital for the Company, and Renew Group Private Limited (&#x201c;Renew&#x201d;) entered into
agreement where Renew purchased $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20231201__us-gaap--DebtInstrumentAxis__custom--BRileyFBRIncMember_zTC4YweVY0wd"&gt;110,691
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in aggregate principal amount of the notes outstanding
with B. Riley, including the 2023 Notes (as described in Note 18), Senior Secured Notes, Delayed Draw Term Notes and 2022 Bridge Notes
(as described in Note 19), which constitute all of the notes outstanding with B. Riley and also assumed the role of agent under the Note
Purchase Agreement, as further described in Note 26. The indirect owner of Renew also has an indirect non-controlling interest in Simplify
Inventions, LLC (&#x201c;Simplify&#x201d;), a principal stockholder (as further described in Note 26).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zHxbngcdmK8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zNDHompCPvHb"&gt;Segment
Reporting&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company operates in one reportable segment which focuses on a publishing platform. The Company&#x2019;s business offerings have similar
operating characteristics and similar long-term operating performance, including the types of customers, nature of product or services,
distribution methods and regulatory environment. The chief operating decision maker (the &#x201c;CODM&#x201d;) of the Company reviews specific
financial and operational data and other key metrics to make resource allocation decisions and assesses performance by review of profit
and loss information on a consolidated basis. The CODM does not review specific financial or operational data on a disaggregated basis
or by aggregating operating segments into one reportable segment. The consolidated financial statements reflect the financial results
of the Company&#x2019;s one reportable segment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zGkVoSwSsy6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zbJUQHQnkXde"&gt;Revenue
Recognition&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 606, &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;, revenues are
recognized when control of the promised goods or services are transferred to the Company&#x2019;s customers, in an amount that reflects
the consideration that the Company expects to receive in exchange for those goods or services. The Company generates all of its revenue
from contracts with customers. The Company accounts for revenue on a gross basis, as compared to a net basis, on its statements of operations.
The Company has made this determination based on its control of the advertising inventory and the ability to monetize the advertising
inventory or publications before transfer to the customer and because it is also the primary obligor responsible for providing the services
to the customer. Cost of revenue is presented as a separate line item on the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a description of the principal activities from which the Company generates revenue:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Advertising
Revenue&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Digital
Advertising &#x2013; &lt;/i&gt;The Company recognizes revenue from digital advertisements at the point when each ad is viewed. The quantity
of advertisements, the impression bid prices and revenue are reported on a real-time basis. The Company enters into contracts with advertising
networks to serve display or video advertisements on the digital media pages associated with its various channels. Although reported
advertising transactions are subject to adjustment by the advertising network partners, any such adjustments are known within a few days
of month end. The Company owes its independent Publisher Partners a revenue share of the advertising revenue earned, which is recorded
as service costs in the same period in which the associated advertising revenue is recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advertising
revenue that is comprised of fees charged for the placement of advertising, on the Company&#x2019;s flagship website, &lt;i&gt;TheStreet.com,
&lt;/i&gt;is recognized as the advertising or sponsorship is displayed, if collection of the resulting receivable is reasonably assured.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Print
Advertising &#x2013; &lt;/i&gt;Advertising related revenues for print advertisements are recognized when advertisements are published (defined
as an issue&#x2019;s on-sale date), net of provisions for estimated rebates, rate adjustments, and discounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Subscription
Revenue&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Digital
Subscriptions&lt;/i&gt; &#x2013; The Company enters into contracts with internet users that subscribe to premium content on the owned and operated
media channels and facilitate such contracts between internet users and its Publisher Partners. These contracts provide internet users
with a membership subscription to access the premium content. The Company owes its independent Publisher Partners a revenue share of
the membership subscription revenue earned, which is initially deferred and recorded as deferred contract costs. The Company recognizes
deferred contract costs over the membership subscription term in the same pattern that the associated membership subscription revenue
is recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subscription
revenue generated from the Company&#x2019;s flagship website &lt;i&gt;TheStreet.com&lt;/i&gt; from institutional and retail customers is comprised
of subscriptions and license fees for access to securities investment information, stock market commentary, director and officer profiles,
relationship capital management services, and transactional information pertaining to mergers and acquisitions and other changes in the
corporate control environment. Subscriptions are charged to customers&#x2019; credit cards or are directly billed to corporate subscribers,
and are generally billed in advance on a monthly, quarterly or annual basis. The Company calculates net subscription revenue by deducting
from gross revenue an estimate of potential refunds from cancelled subscriptions as well as chargebacks of disputed credit card charges.
Net subscription revenue is recognized ratably over the subscription periods. Unearned revenue relates to payments for subscription fees
for which revenue has not been recognized because services have not yet been provided.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Print
Revenue&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Print
revenue includes magazine subscriptions and single copy sales at newsstands.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Print
Subscriptions &#x2013;&lt;/i&gt; Revenue from magazine subscriptions is deferred and recognized proportionately as products are distributed
to subscribers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Newsstand
&lt;/i&gt;&#x2013; Single copy revenue is recognized on the publication&#x2019;s on-sale date, net of provisions for estimated returns. The Company
bases its estimates for returns on historical experience and current marketplace conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Licensing
and Syndication Revenue&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Content
licensing-based revenues and syndication revenues are accrued generally monthly or quarterly based on the specific mechanisms of each
contract. Generally, revenues are accrued based on estimated sales and adjusted as actual sales are reported by partners. These adjustments
are typically recorded within three months of the initial estimates and have not been material. Any minimum guarantees are typically
earned evenly over the fiscal year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Nature
of Performance Obligations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
contract inception, the Company assesses the obligations promised in its contracts with customers and identifies a performance obligation
for each promise to transfer a good or service or bundle that is distinct. To identify the performance obligations, the Company considers
all the promises in the contract, whether explicitly stated or implied based on customary business practices. For a contract that has
more than one performance obligation, the Company allocates the total contract consideration to each distinct performance obligation
on a relative standalone selling price basis. Revenue is recognized when, or as, the performance obligations are satisfied, and control
is transferred to the customer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Digital
Advertising&lt;/i&gt; &#x2013; The Company sells digital advertising inventory on its websites directly to advertisers or through advertising
agencies. The Company&#x2019;s performance obligations related to digital advertising are generally satisfied when the advertisement is
run on the Company&#x2019;s platform. The price for direct digital advertising is determined in contracts with the advertisers. Revenue
from the sale of direct digital advertising is recognized when the advertisements are delivered based on the contract. The customer is
invoiced the agreed-upon price in the month following the month that the advertisements are delivered with normal trade terms. The agreed
upon price is adjusted for estimated provisions for rebates, rate adjustments, and discounts. As part of the Company&#x2019;s customary
business practices, digital advertising contracts may include a guaranteed number of impressions and sales incentives to its customers
including volume discounts, rebates, value added impressions, etc. For all such contracts that include these types of variable consideration,
the Company estimates the variable consideration and factors in such an estimate when determining the transaction price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Print
Advertising&lt;/i&gt; &lt;b&gt;&#x2013; &lt;/b&gt;The Company provides advertisement placements in print media directly to advertisers or through advertising
agencies. The Company&#x2019;s performance obligations related to print advertising are satisfied when the magazine in which an advertisement
appears is published, which is defined as an issue&#x2019;s on-sale date. The customer is invoiced the agreed-upon price when the advertisements
are published under normal industry trade terms. The agreed upon price is adjusted for estimated provisions for rebates, rate adjustments,
and discounts. As part of the Company&#x2019;s customary business practices, print advertising contracts include guaranteed circulation
levels of magazines, referred to as rate base, and a number of sales incentives to its customers including volume discounts, rebates,
bonus pages, etc. For all such contracts that include these types of variable consideration, the Company estimates such when determining
the transaction price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Digital
Subscriptions&lt;/i&gt; &#x2013; The Company recognizes revenue from each membership subscription to access the premium content over time based
on a daily calculation of revenue during the reporting period, which is generally one year. Subscriber payments are initially recorded
as unearned revenue on the balance sheets. As the Company provides access to the premium content over the membership subscription term,
the Company recognizes revenue and proportionately reduces the unearned revenue balance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Print
Subscriptions&lt;/i&gt; &#x2013; The Company sells magazines to consumers through subscriptions. Each copy of a magazine is determined to be
a distinct performance obligation that is satisfied when the publication is sent to the customer. The majority of the Company&#x2019;s
subscription sales are prepaid at the time of order. Subscriptions may be canceled at any time for a refund of the price paid for remaining
issues. As the contract may be canceled at any time for a full refund of the unserved copies, the contract term is determined to be on
an issue-to-issue basis as these contracts do not have substantive termination penalties. Revenues from subscriptions are deferred and
recognized proportionately as subscribers are served. Some magazine subscription offers contain more than one magazine title in a bundle.
The Company allocates the total contract consideration to each distinct performance obligation, or magazine title, based on a standalone-selling
price basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Newsstand
&lt;/i&gt;&#x2013; The Company sells single copy magazines, or bundles of single copy magazines, to wholesalers for ultimate resale on newsstands
primarily at major retailers and grocery/drug stores, and in digital form on tablets and other electronic devices. Publications sold
to magazine wholesalers are sold with the right to receive credit from the Company for magazines returned to the wholesaler by retailers.
Revenue is recognized on the issue&#x2019;s on-sale date as the date aligns most closely with the date that control is transferred to
the customer. The Company bases its estimates for returns on historical experience and current marketplace conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Licensing
and Syndication &#x2013; &lt;/i&gt;The Company has entered into various licensing and syndication agreements that provide third party
partners with the right to utilize the Company&#x2019;s content. Functional licenses in national media consist of content
licensing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Timing
of Satisfaction of Performance Obligations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Point-in-Time
Performance Obligations &#x2013; &lt;/i&gt;For performance obligations related to certain digital advertising space and sales of print advertisements,
the Company determines that the customer can direct the use of and obtain substantially all the benefits from the advertising products
as the digital impressions are served or on the issue&#x2019;s on-sale date. For performance obligations related to sales of magazines
through subscriptions, the customer obtains control when each magazine issue is mailed to the customer on or before the issue&#x2019;s
on-sale date. For sales of single copy magazines on newsstands, revenue is recognized on the issue&#x2019;s on-sale date as the date aligns
most closely with the date that control is transferred to the customer. Revenues from functional licenses and syndication arrangements
are recognized at a point-in-time when access to the completed content is granted to the partner.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Over-Time
Performance Obligations&lt;/i&gt; &lt;b&gt;&#x2013; &lt;/b&gt;For performance obligations related to sales of certain digital advertising space, the Company
transfers control and recognizes revenue over time by measuring progress towards complete satisfaction using the most appropriate method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
performance obligations related to digital advertising, the Company satisfies its performance obligations on some flat-fee digital advertising
placements over time using a time-elapsed output method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Determining
a measure of progress requires management to make judgments that affect the timing of revenue recognized. The Company has determined
that the above method provides a faithful depiction of the transfer of goods or services to the customer. For performance obligations
recognized using a time-elapsed output method, the Company&#x2019;s efforts are expended evenly throughout the period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Performance
obligations related to subscriptions to premium content on the digital media channels provides access for a given period of time, which
is generally one year. The Company recognizes revenue from each membership subscription over time based on a daily calculation of revenue
during the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Transaction
Price and Amounts Allocated to Performance Obligations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Determining
the Transaction Price &#x2013; &lt;/i&gt;Certain advertising contracts contain variable components of the transaction price, such as volume
discounts and rebates. The Company has sufficient historical data and has established processes to reliably estimate these variable components
of the transaction price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subscription
revenue generated from the flagship website &lt;i&gt;TheStreet.com&lt;/i&gt; is subject to estimation and variability due to the fact that, in the
normal course of business, subscribers may for various reasons contact the Company or their credit card companies to request a refund
or other adjustment for a previously purchased subscription. With respect to many of the Company&#x2019;s annual newsletter subscription
products, the Company offers the ability to receive a refund during the first 30 days but none thereafter. Accordingly, the Company maintains
a provision for estimated future revenue reductions resulting from expected refunds and chargebacks related to subscriptions for which
revenue was recognized in a prior period. The calculation of this provision is based upon historical trends and is reevaluated each quarter.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company typically does not offer any type of variable consideration in standard magazine subscription contracts. For these contracts,
the transaction price is fixed upon establishment of the contract that contains the final terms of the sale including description, quantity
and price of each subscription purchased. Therefore, the Company does not estimate variable consideration or perform a constraint analysis
for these contracts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
right of return exists for newsstand contracts. The Company has sufficient historical data to estimate the final amount of returns and
reduces the transaction price at contract inception for the expected return reserve.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
is no variable consideration related to functional licenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Estimating
Standalone-Selling Prices&lt;/i&gt; &lt;b&gt;&#x2013; &lt;/b&gt;For contracts that contain multiple performance obligations, the Company allocates the transaction
price to each performance obligation on a relative standalone-selling price basis. The standalone-selling price is the price at which
the Company would sell a promised good or service separately to the customer. In situations in which an obligation is bundled with other
obligations and the total amount of consideration does not reflect the sum of individual observable prices, the Company allocates the
discount to (1) a single obligation if the discount is attributable to that obligation or (2) prorates across all obligations if the
discount relates to the bundle. When standalone-selling price is not directly observable, the Company estimates and considers all the
information that is reasonably available to the Company, including market conditions, entity specific factors, customer information,
etc. The Company maximizes the use of observable inputs and applies estimation methods consistently in similar circumstances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Measuring
Obligations for Returns and Refunds&lt;/i&gt; &#x2013; The Company accepts product returns in some cases. The Company establishes provisions
for estimated returns concurrently with the recognition of revenue. The provisions are established based upon consideration of a variety
of factors, including, among other things, recent and historical return rates for both specific products and distributors and the impact
of any new product releases and projected economic conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023 and 2022, a subscription refund liability of $&lt;span id="xdx_903_eus-gaap--ContractWithCustomerRefundLiabilityCurrent_iI_pn3n3_c20231231_zPBgu0X43SHc" title="Subscription refund liability"&gt;449&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--ContractWithCustomerRefundLiabilityCurrent_iI_pn3n3_c20221231_zn36hWjiWCki" title="Subscription refund liability"&gt;845&lt;/span&gt;, respectively, was recorded for the provision for the
estimated returns and refunds on the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Contract
Modifications&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company occasionally enters into amendments to previously executed contracts that constitute contract modifications. The Company assesses
each of these contract modifications to determine:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if
    the additional services and goods are distinct from the services and goods in the original arrangement; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if
    the amount of consideration expected for the added services or goods reflects the stand-alone selling price of those services and
    goods.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
contract modification meeting both criteria is accounted for as a separate contract. A contract modification not meeting both criteria
is considered a change to the original contract and is accounted for on either a prospective basis as a termination of the existing contract
and the creation of a new contract, or a cumulative catch-up basis (further details are provided under the headings &lt;i&gt;Contract Balances
&lt;/i&gt;and &lt;i&gt;Subscription Acquisition Costs&lt;/i&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Disaggregation
of Revenue&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--DisaggregationOfRevenueTableTextBlock_zqIHuXdmsySi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table provides information about disaggregated revenue by category, geographical market and timing of revenue recognition:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_z6Kcyvj050lh" style="display: none"&gt;Schedule
of Disaggregation of Revenue&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230101__20231231_zkXxx6cmdky8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220101__20221231_ztGAhuYNbwml" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Revenue by category:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Digital revenue&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalAdvertisingMember_zo01p5dvBfP" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: justify"&gt;Digital advertising&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;135,376&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;109,317&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalSubscriptionsMember_zD0kRLElyCW" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Digital subscriptions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,764&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,156&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--LicensingAndSyndicationRevenueMember_zfNDuHqh6Ld8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Licensing and syndication revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__us-gaap--ProductAndServiceOtherMember_zx2y2DOEFCp1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"&gt;Other digital revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,384&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,166&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zgsNr7azyhMl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify; padding-bottom: 1.5pt"&gt;Total digital revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;172,006&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;149,812&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Print revenue&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintAdvertisingMember_zbRG7M168fX4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Print advertising&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,881&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintSubscriptionsMember_zv5dvOGnfQz2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"&gt;Print subscriptions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;62,316&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;60,909&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_zzQN9CQzquF8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify; padding-bottom: 1.5pt"&gt;Total print revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;72,197&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;71,123&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zUzRiEu6CZTh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;244,203&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;220,935&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Revenue by geographical market:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__country--US_zKX1xgZJTcp9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;234,012&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;218,110&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__custom--OtherMember_zS4cb0vzdZL4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,191&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,825&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zgadvHNx3Wz9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;244,203&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;220,935&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Revenue by timing of recognition:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_zumKpCgm0fo5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;At point in time&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;231,439&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;199,779&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zpFUGfTLJXS6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"&gt;Over time&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12,764&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,156&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zmjvuJAzMUPa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0pt; text-align: left; padding-bottom: 2.5pt"&gt;Total revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;244,203&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;220,935&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zErk4ulyJWh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_ecustom--CostOfRevenuePolicyTextBlock_zBsWZ7XiYoJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zMoE01NyV7Ge"&gt;Cost
of Revenue&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost
of revenue represents the cost of providing the Company&#x2019;s digital media channels and advertising and membership services. The cost
of revenue that the Company has incurred in the periods presented primarily include: Publisher Partner guarantees and revenue share payments;
amortization of developed technology and platform development; royalty fees; hosting and bandwidth and software license fees; printing
and distribution costs; payroll and related expenses for customer support, technology maintenance; fees paid for data analytics and to
other outside service providers; and stock-based compensation of related personnel (as described in Note 22).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--ContractBalancesPolicyTextBlock_zyCXvDn3m8ee" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zZnVYYxSPCql"&gt;Contract
Balances&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
timing of the Company&#x2019;s performance under its various contracts often differs from the timing of the customer&#x2019;s payment,
which results in the recognition of a contract asset or a contract liability. A contract asset is recognized when a good or service is
transferred to a customer and the Company does not have the contractual right to bill for the related performance obligations. An asset
is recognized when certain costs incurred to obtain a contract meet the capitalization criteria (further details are provided under the
heading &lt;i&gt;Subscription Acquisition Costs&lt;/i&gt;). A contract liability is recognized when consideration is received from the customer prior
to the transfer of goods or services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_zaHl7ipmaYU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table provides information about contract balances:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BD_zB03ZNauj0wc" style="display: none"&gt;Schedule
of Contract with Customer, Asset and Liability&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20231231_zaeO3S0cr5pd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20221231_z3Gw4AyXnoya" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Unearned revenue (short-term contract liabilities):&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zNXnIczbDXRb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Digital revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;14,397&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;18,571&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_z7Oqs9MAbBK9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Print revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;45,389&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;40,132&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_z1TaModhTRyk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total short-term contract
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;59,786&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;58,703&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Unearned revenue (long-term contract liabilities):&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zce7hTDFpFCe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Digital revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;542&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_zUy5wqyC5QDa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Print revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,137&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,583&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_zxVz3y32mAu9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total long-term contract
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;10,679&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;19,701&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zGBCCJVDLCcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Unearned
Revenue&lt;/i&gt; &#x2013; Unearned revenue, also referred to as contract liabilities, include payments received in advance of performance under
the contracts and are recognized as revenue over time. The Company records contract liabilities as unearned revenue on the consolidated
balance sheets. Digital subscription and print subscription revenue of $&lt;span id="xdx_901_ecustom--UnearnedRevenue_iI_pn3n3_c20231231__srt--ProductOrServiceAxis__custom--DigitalAndPrintSubscriptionsMember_zavJ3vDtUiH8" title="Contract with customer liability noncurrent"&gt;68,985&lt;/span&gt; was recognized during the year ended December 31, 2023
from unearned revenue at the beginning of the year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
January 2020, February 2020 and December 2021, the Company modified certain digital and print subscription contracts that prospectively
changed the frequency of the related issues (or magazines) required to be delivered on a yearly basis (the &#x201c;Contract Modifications&#x201d;).
The Company determined that the remaining digital content and magazines to be delivered are distinct from the digital content or magazines
already provided under the original contract. As a result, the Company in effect established a new contract that included only the remaining
digital content or magazines. Accordingly, the Company allocated the remaining performance obligations in the contracts as consideration
from the original contract that has not yet been recognized as revenue. For the years ended December 31, 2023 and 2022, the Company recognized
revenue of $&lt;span id="xdx_90E_eus-gaap--ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_pn3n3_c20230101__20231231_zJWXinQwW492" title="Contract modification - revenue"&gt;554&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_pn3n3_c20220101__20221231_zDp3CYXxDNIk" title="Contract modification - revenue"&gt;2,986&lt;/span&gt;, respectively, resulting from the Contract Modifications.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_z9UwVGtuxJeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zAzFgaT3AaBg"&gt;Cash,
Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company maintains cash, cash equivalents, and restricted cash at banks where amounts on deposit may exceed the Federal Deposit Insurance
Corporation limit during the year. Cash and cash equivalents represent cash and highly liquid investments with an original contractual
maturity at the date of purchase of three months. As of December 31, 2023 and 2022, cash and cash equivalents consist primarily of checking,
savings deposits and money market accounts. These deposits exceeded federally insured limits. The Company has not experienced any losses
in such accounts and believes it is not exposed to significant credit risk regarding its cash and cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_zWFdppVl58t5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reconciles total cash, cash equivalents, and restricted cash:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_zTCWT3MYdZO7" style="display: none"&gt;Schedule
of Cash and Restricted Cash&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231231_zUskfSfE2iV1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20221231_znUZ7fvHtDW2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_zno6kDP5lx" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;9,284&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;13,871&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RestrictedCashCurrent_iI_pn3n3_zdHIlDDBpFjf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0929"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;502&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_zznDqR4ifFL" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total cash, cash equivalents, and restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,284&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;14,373&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_z4OLwY6zlTZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023 and 2022, the Company had restricted cash of $&lt;span id="xdx_900_eus-gaap--RestrictedCashCurrent_iI_pn3n3_dxL_c20231231_zOooSWMkC0Wa" title="Restricted cash::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0935"&gt;0&lt;/span&gt;&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--RestrictedCashCurrent_iI_pn3n3_c20221231_zl4OXUGn5BEj" title="Restricted cash"&gt;502&lt;/span&gt;, which served as collateral for certain credit card merchant
accounts with a bank.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zS2uwglgvJDc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_z8Sbs2Iwcjt7"&gt;Accounts
Receivable and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company receives payments from advertising customers based upon contractual payment terms; accounts receivable is recorded when the right
to consideration becomes unconditional and are generally collected within 90 days. The Company generally receives payments from digital
and print subscription customers at the time of sign up for each subscription; accounts receivable from merchant credit card processors
are recorded when the right to consideration becomes unconditional and are generally collected weekly. Accounts receivable have been
reduced by an allowance for doubtful accounts. The Company maintains the allowance for estimated losses resulting from the inability
of the Company&#x2019;s customers to make required payments. The allowance represents the current estimate of lifetime expected credit
losses over the remaining duration of existing accounts receivable considering current market conditions and supportable forecasts when
appropriate. The estimate is a result of the Company&#x2019;s ongoing evaluation of collectability, customer creditworthiness, historical
levels of credit losses, and future expectations. Accounts receivable are written off when deemed uncollectible and collection of the
receivable is no longer being actively pursued. Accounts receivable as of December 31, 2023 and 2022 of $&lt;span id="xdx_90F_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20231231_zl4wAyzTyJxj" title="Accounts receivable"&gt;44,811&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20221231_zk8tBgn9UdK9" title="Accounts receivable"&gt;33,950&lt;/span&gt;, respectively,
are presented net of allowance for doubtful accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--AccountsReceivableAllowanceForCreditLossTableTextBlock_zE6UsT17gkr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the allowance for doubtful accounts activity:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_8BF_zEgFA9pr0K7c" style="display: none"&gt;Schedule
of Allowance For Doubtful Accounts&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230101__20231231_z2oNAD11QwDd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220101__20221231_zEvHgtnlkRJb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years Ended of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pn3n3_z52Kpe9D4YZ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Allowance for doubtful accounts beginning of year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,236&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,578&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_pn3n3_zbWpUqbjztzi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;315&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;658&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_pn3n3_di_zVYZVuWNQZE7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Deductions - write-offs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,570&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0954"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pn3n3_zAW7wIVI4Tvi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Allowance for doubtful accounts end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;981&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,236&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_z90ATvKk8wH" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--SubscriptionAcquisitionCostsPoliceTextBlock_z22oJSGvtoSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zKboqtjKDKK1"&gt;Subscription
Acquisition Costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subscription
acquisition costs include the incremental costs of obtaining a contract with a customer, paid to external parties, if the Company
expects to recover those costs. The Company has determined that sales commissions paid on all third party agent sales of
subscriptions are direct and incremental costs of obtaining a contract with a customer and, therefore, meet the capitalization
criteria. The Company has elected to apply the practical expedient to amortize these costs at the portfolio level. The sales
commissions paid to third party agents are amortized as the magazines are sent to the subscriber on an issue-by-issue basis. The
Company determined that commissions paid for subscriber renewal contracts to all third party agents are not from a specifically
anticipated future contract, therefore, the commissions paid on renewals are amortized as the magazines are sent to the subscriber
over the renewal term on an issue-by-issue basis. Direct mail costs for renewal subscriptions are expensed as incurred since they do
not meet the capitalization criteria.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
of subscription acquisition costs of $&lt;span id="xdx_900_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20230101__20231231_z3yqarK4qbT2" title="Amortization subscription costs"&gt;38,112&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20220101__20221231_zetPKUQdqnV" title="Amortization subscription costs"&gt;37,190&lt;/span&gt; for the years ended December 31, 2023 and 2022, respectively, are included within
selling and marketing expenses on the consolidated statements of operations. No impairment losses have been recognized for subscription
acquisition costs for the years ended December 31, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Contract Modifications resulted in subscription acquisition costs to be recognized on a prospective basis in the same proportion as the
revenue that has not yet been recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
current portion of the subscription acquisition costs as of December 31, 2023 and 2022 was $&lt;span id="xdx_90D_eus-gaap--CapitalizedContractCostNet_iI_pn3n3_c20231231_zuQHX4IgjvLj" title="Subscription acquisition cost"&gt;29,706&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--CapitalizedContractCostNet_iI_pn3n3_c20221231_zHgzmcuDTO2c" title="Subscription acquisition cost"&gt;25,931&lt;/span&gt;, respectively. The noncurrent
portion of the subscription acquisition costs as of December 31, 2023 and 2022 was $&lt;span id="xdx_90F_eus-gaap--CapitalizedContractCostNetNoncurrent_iI_pn3n3_c20231231_zuQZ8za8uVQ1" title="Acquisition cost long term"&gt;7,215&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--CapitalizedContractCostNetNoncurrent_iI_pn3n3_c20221231_zT9PoCGd3K8" title="Subscription acquisition cost noncurrent"&gt;14,133&lt;/span&gt;, respectively. Subscription acquisition
costs as of December 31, 2023 presented as current assets of $&lt;span id="xdx_90F_eus-gaap--CapitalizedContractCostNetCurrent_iI_pn3n3_c20231231_zo1MLlajxgTa" title="Subscription acquisition cost current"&gt;29,706&lt;/span&gt; are expected to be amortized over a one-year period, or through
December 31, 2024, and presented as long-term assets of $&lt;span id="xdx_903_eus-gaap--CapitalizedContractCostNetNoncurrent_iI_pn3n3_c20231231_zxsAKyrm7EHd" title="Acquisition cost long term"&gt;7,215&lt;/span&gt; are expected to be amortized after the one-year period ending December
31, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zuFwj24pNbIb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zdfqSnGTBc5i"&gt;Concentrations&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Significant
Customers&lt;/i&gt; &#x2013; Concentration of credit risk with respect to accounts receivable is limited to customers to whom the Company makes
significant sales. While a reserve for the potential write-off of accounts receivable is maintained, the Company has not written off
any material accounts to date. To control credit risk, the Company performs regular credit evaluations of its customers&#x2019; financial
condition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;Revenue from significant customers
as a percentage of the Company&#x2019;s total revenue represent approximately &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zThted2Odbo8" title="Percentage of revenue"&gt;10.0%&lt;/span&gt; from a customer for the year ended December 31,
2023. Revenue from significant customers as a percentage of the Company&#x2019;s total revenue represent &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_ziHFVgMQvzek" title="Percentage of revenue"&gt;13.9&lt;/span&gt;%
from a customer for the year ended December 31, 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Significant
Vendors&lt;/i&gt; &#x2013; Concentrations of risk with respect to third party vendors who provide products and services to the Company are limited.
If not limited, such concentrations could impact profitability if a vendor failed to fulfill their obligations or if a significant vendor
was unable to renew an existing contract and the Company was not able to replace the related product or service at the same cost.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant
accounts payable balances as a percentage of the Company&#x2019;s total accounts payable represent &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zLCCYvLPg5sa" title="Percentage of revenue"&gt;12.2&lt;/span&gt;%, and &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zt1aDfZZD7h8" title="Percentage of revenue"&gt;14.1&lt;/span&gt;% from a vendor for
the years ended December 31, 2023, and 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--LesseeLeasesPolicyTextBlock_zgFMOy83caE9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zaJmjfnbPHh1"&gt;Leases&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has lease arrangements for its offices. Leases are recorded as an operating lease right-of-use assets and
operating lease liabilities on the consolidated balance sheets. Leases with an initial term of 12 months or less are not recorded on
the consolidated balance sheets. At inception, the Company determines whether an arrangement that provides control over the use of an
asset is a lease. When it is reasonably certain that the Company will exercise the renewal period, the Company includes the impact of
the renewal in the lease term for purposes of determining total future lease payments. Rent expense is recognized on a straight-line
basis over the lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zDl5ILyJlW6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zfB4YD9VIXwd"&gt;Property
and Equipment&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment is stated at cost less accumulated depreciation. Maintenance and repairs are charged to expense as incurred. Gains and
losses from disposition of property and equipment are included on the consolidated statements of operations when realized.
Depreciation and amortization are provided using the straight-line method over the following estimated useful lives:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock_zW0c7n0xBdG" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zTBFGihIfjp5" style="display: none"&gt;Schedule
of Depreciation and Amortization, Useful Lives of Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; background-color: white; border-collapse: collapse; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"&gt;Office equipment and computers&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember__srt--RangeAxis__srt--MinimumMember_zcxEM3qmqqvh" title="Property plant and equipment useful life"&gt;1&lt;/span&gt;
    &#x2013; &lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember__srt--RangeAxis__srt--MaximumMember_zJxfuGiMd98k" title="Property plant and equipment useful life"&gt;3&lt;/span&gt; years &lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zswoOMa1XqJ5" title="Property plant and equipment useful life"&gt;1&lt;/span&gt;
    &#x2013; &lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_ziKDN4X4JdCf" title="Property plant and equipment useful life"&gt;5&lt;/span&gt; years &lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A9_zMfJETCLDmIl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--PlatformDevelopmentPolicyTextBlock_zy56NXyb0kWf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zyaIkOWXtRzd"&gt;Platform
Development&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company capitalizes platform development costs for internal use when planning and design efforts are successfully completed, and development
is ready to commence. The Company places capitalized platform development assets into service and commences amortization when the applicable
project or asset is substantially complete and ready for its intended use. Once placed into service, the Company capitalizes qualifying
costs of specified upgrades or enhancements to capitalized platform development assets when the upgrade or enhancement will result in
new or additional functionality.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company capitalizes internal labor costs, including payroll-based and stock-based compensation, benefits and payroll taxes, that are
incurred for certain capitalized platform development projects related to the Platform. The Company&#x2019;s policy with respect to capitalized
internal labor stipulates that labor costs for employees working on eligible internal use capital projects are capitalized as part of
the historical cost of the project when the impact, as compared to expensing such labor costs, is material.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Platform
development costs are amortized on a straight-line basis over three years, which is the estimated useful life of the related asset and
is recorded in cost of revenue on the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--BusinessCombinationsPolicy_zT2MpaT5HXH9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zJI7DmkaUBF4"&gt;Business
Combinations&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for business combinations using the acquisition method of accounting. The acquisition method of accounting requires
that the purchase price, including the fair value of contingent consideration, of the acquisition be allocated to the assets acquired
and liabilities assumed using the estimated fair values determined by management as of the acquisition date. Goodwill is measured as
the excess of consideration transferred and the net fair values of the assets acquired, and the liabilities assumed at the date of acquisition.
While the Company uses its best estimates and assumptions as part of the purchase price allocation process to accurately value assets
acquired and liabilities assumed at the acquisition date, the Company&#x2019;s estimates are inherently uncertain and subject to refinement.
As a result, during the measurement period, the Company records adjustments to the assets acquired and liabilities assumed, with the
corresponding offset to goodwill to the extent the Company identifies adjustments to the preliminary purchase price allocation. Upon
the conclusion of the measurement period, which may be up to one year from the acquisition date, or final determination of the values
of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements
of operations. Additionally, the Company identifies acquisition-related contingent payments and determines their respective fair values
as of the acquisition date, which are recorded as accrued liabilities on the consolidated balance sheets. Subsequent changes in fair
value of contingent payments are recorded on the consolidated statements of operations. The Company expenses transaction costs related
to the acquisition as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zRmHtX5pTvZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zer3MX8n32Zc"&gt;Intangible
Assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets with finite lives, consisting of developed technology and trade names, are amortized using the straight-line method over the estimated
economic lives of the assets. A finite lived intangible asset is tested for recoverability whenever events or changes in circumstances
indicate that its carrying amount may not be recoverable. Determination of recoverability is based on an estimate of undiscounted future
cash flows resulting from the use of the asset and its eventual disposition. Intangible assets with an indefinite useful life are not
amortized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zKkJeRxhDs7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zvWY7l29zly8"&gt;Long-Lived
Assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company periodically evaluates the carrying value of long-lived assets to be held and used when events or circumstances warrant such
a review. The carrying value of a long-lived asset to be held and used is considered impaired when the anticipated separately identifiable
undiscounted cash flows from such an asset are less than the carrying value of the asset. In that event, a loss is recognized based on
the amount by which the carrying value exceeds the fair value of the long-lived asset. Fair value is determined primarily by reference
to the anticipated cash flows discounted at a rate commensurate with the risk involved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zqeKGDJnsdl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_z2AQsN3mg3vf"&gt;Goodwill&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill
represents the excess of the purchase price over the fair value of the net tangible and intangible assets of businesses acquired in a
business combination. Goodwill is not amortized but rather is tested for impairment at least annually on December 31, or more frequently
if events or changes in circumstances indicate that the carrying amount of goodwill may not be recoverable. The Company operates as one
reporting unit, therefore, the impairment test is performed at the consolidated entity level. Recoverability of goodwill is determined
by comparing the fair value of Company&#x2019;s reporting unit to the carrying value of the underlying net assets in the reporting unit.
If the fair value of the reporting unit is determined to be less than the carrying value of its net assets, goodwill is deemed impaired,
and an impairment loss is recognized to the extent that the carrying value of goodwill exceeds the difference between the fair value
of the reporting unit and the fair value of its other assets and liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--DebtPolicyTextBlock_zSYHH4D9R5m2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zsLTIsIEsTe5"&gt;Debt
Costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Debt
costs consist of cash and noncash consideration paid to lenders and third parties with respect to debt and other financing transactions,
including legal fees and placement fees. Such costs are deferred and amortized over the term of the related debt. Upon the settlement
of debt the pro rata portion of any related unamortized debt costs are charged to operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additional
consideration in the form of warrants and other derivative financial instruments issued to lenders are accounted for at fair value utilizing
information determined by consultants with the Company&#x2019;s independent valuation firm. The fair value of warrants and derivatives
are recorded as a reduction to the carrying amount of the related debt and amortized to interest expense over the term of such debt,
with the initial offsetting entries recorded as a liability on the balance sheet. Upon the settlement of the debt the pro rata portion
of any related unamortized debt cost is charged to operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--LiquidatedDamagesPolicyTextBlock_zO8iSJcjfLf1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_z8RIaUQLlYs4"&gt;Liquidated
Damages&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--LiquidatedDamagesDescription_c20230101__20231231_zonRRIz47iA3" title="Liquidated damages description"&gt;The
Company incurred liquidated damages when: (i) a registration rights agreement provides for damages if the Company does not register the
shares of the Company&#x2019;s common stock within the requisite time frame (the &#x201c;Registration Rights Damages&#x201d;), which, in
general, provides for a cash payment equal to 1.0% per month of the amount invested, on a daily pro rata basis for any portion of a month,
as partial liquidated damages per month, upon the occurrence of certain events, up to a maximum amount of 6.0% of the aggregate amount
invested, subject to interest at the rate of 1.0% per month until paid in full; and (ii) a securities purchase agreement provides for
damages if the Company fails for any reason to satisfy a public information requirement within the requisite time frame with the Securities
and Exchange Commission (&#x201c;SEC&#x201d;) (the &#x201c;Public Information Failure Damages&#x201d;), which, in general, provides for a
cash payment equal to 1.0% of the aggregate amount invested for each 30-day period, or pro rata portion thereof, as partial liquidated
damages per month, up to a maximum of 6 months, subject to interest at the rate of 1.0% per month until paid in full. &lt;/span&gt;Collectively, the
Registration Rights Damages and the Public Information Failure Damages are referred to as the &#x201c;Liquidated Damages&#x201d; on the
consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--SellingAndMarketingPolicyTextBlock_z0QK2t5Wt1Td" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_z3MWHRefDrKh"&gt;Selling
and Marketing&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Selling
and marketing expenses consist of compensation, employee benefits and stock-based compensation of selling and marketing, account management
support teams, as well as commissions, travel, trade show sponsorships and events, conferences and advertising costs. The Company&#x2019;s
advertising expenses relate to direct-mail costs for magazine subscription acquisition efforts, and print and digital advertising that
are expensed when an advertisement takes place. During the years ended December 31, 2023 and 2022, the Company incurred advertising expenses
of $&lt;span id="xdx_90B_eus-gaap--AdvertisingExpense_pn3n3_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zPoX2qm3OAc8" title="Advertising expense"&gt;4,372&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--AdvertisingExpense_pn3n3_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zxjpFaaFJ06g" title="Advertising expense"&gt;5,987&lt;/span&gt;, respectively, which are included within selling and marketing on the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--GeneralandAdministrativePolicyTextBlock_zCq43ynBTIca" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zHESIMYAoQnd"&gt;General
and Administrative&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;General
and administrative expenses consist primarily of payroll for executive personnel, technology personnel incurred in developing conceptual
formulation and determination of existence of needed technology, and administrative personnel along with any related payroll costs; professional
services, including accounting, legal and insurance; facilities costs; conferences; other general corporate expenses; and stock-based
compensation of related personnel.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--DerivativesPolicyTextBlock_z3pQuzSXL8qj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zfzZMmqi8hhf"&gt;Derivative
Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for freestanding contracts that are settleable in the Company&#x2019;s equity securities, including the put option
on the Company&#x2019;s common stock, to be designated as an equity instrument, generally as a liability. A contract so
designated is carried at fair value on the consolidated balance sheets, with any changes in fair value recorded as a gain or loss
on the consolidated statements of operations, with no impact on cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
the date of settlement of a freestanding equity contract, the pro rata fair value of the related liability is transferred to additional
paid-in capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zmMSvz7HBx56" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zzFyoRQo3clh"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
authoritative guidance with respect to fair value established a fair value hierarchy that prioritizes the inputs to valuation techniques
used to measure fair value into three levels and requires that assets and liabilities carried at fair value be classified and disclosed
in one of three categories, as presented below. Disclosure as to transfers in and out of Levels 1 and 2, and activity in Level 3 fair
value measurements, is also required.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
1&lt;/i&gt;. Observable inputs such as quoted prices in active markets for an identical asset or liability that the Company has the ability
to access as of the measurement date. Financial assets and liabilities utilizing Level 1 inputs include active-exchange traded securities
and exchange-based derivatives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
2&lt;/i&gt;. Inputs, other than quoted prices included within Level 1, which are directly observable for the asset or liability or indirectly
observable through corroboration with observable market data. Financial assets and liabilities utilizing Level 2 inputs include fixed
income securities, non-exchange-based derivatives, mutual funds, and fair-value hedges.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
3&lt;/i&gt;. Unobservable inputs in which there is little or no market data for the asset or liability which requires the reporting entity
to develop its own assumptions. Financial assets and liabilities utilizing Level 3 inputs include infrequently traded non-exchange-based
derivatives and commingled investment funds and are measured using present value pricing models.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines the level in the fair value hierarchy within which each fair value measurement falls in its entirety, based on the
lowest level input that is significant to the fair value measurement in its entirety. In determining the appropriate levels, the Company
performs an analysis of the assets and liabilities at each reporting period end.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amount of the Company&#x2019;s financial instruments comprising of cash, restricted cash, accounts receivable, accounts payable
and accrued expenses and other approximate fair value because of the short-term maturity of these instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--PreferredStockPolicyTextBlock_zDlpskR8gWFg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zMpV7zgSR8na"&gt;Preferred
Stock&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Preferred
stock (the &#x201c;Preferred Stock&#x201d;) (as described in Note 20) is reported as a mezzanine obligation between liabilities and stockholders&#x2019;
deficiency. If it becomes probable that the Preferred Stock will become redeemable, the Company will re-measure the Preferred Stock by
adjusting the carrying value to the redemption value of the Preferred Stock assuming each balance sheet date is a redemption date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zIuIuxLGOIB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zpSOz2pWbCmh"&gt;Stock-Based
Compensation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company provides stock-based compensation in the form of (a) stock awards to employees and directors, comprised of restricted stock awards
and restricted stock units, (b) stock option grants to employees, directors and consultants, (c) common stock warrants to Publisher Partners
(no warrants were issued during the year ended December 31, 2022) (further details are provided under the headings &lt;i&gt;Publisher Partner
Warrants&lt;/i&gt; and &lt;i&gt;New Publisher Partner Warrants&lt;/i&gt; in Note 22), and (d) common stock warrants to ABG (further details are provided
under the heading &lt;i&gt;ABG Warrants&lt;/i&gt; in Note 22).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for stock awards and stock option grants to employees, directors and consultants, and non-employee awards to certain
directors and consultants by measuring the cost of services received in exchange for the stock-based payments as compensation expense
in the Company&#x2019;s consolidated financial statements. Stock awards and stock option grants to employees and non-employees which are
time-vested, are measured at fair value on the grant date, and charged to operations ratably over the vesting period. Stock awards and
stock option grants to employees and non-employees which are performance-vested, are measured at fair value on the grant date and charged
to operations when the performance condition is satisfied or over the service period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value measurement of stock awards and grants used for stock-based compensation is as follows: (1) restricted stock awards and restricted
stock units which are time-vested, are determined using the quoted market price of the Company&#x2019;s common stock at the grant date;
(2) stock option grants which are time-vested and performance-vested, are determined utilizing the Black-Scholes option-pricing model
at the grant date; (3) restricted stock units and stock option grants which provide for market-based vesting with a time-vesting overlay,
are determined through consultants with the Company&#x2019;s independent valuation firm using the Monte Carlo model at the grant date;
(4) Publisher Partner Warrants were determined utilizing the Black-Scholes option-pricing model; and (5) ABG warrants are determined
utilizing the Monte Carlo model (further details are provided in Note 22). Estimated volatility was determined under the (1) &#x201c;Probability
Weighted Scenarios&#x201d; (prior to the reverse stock split on February 8, 2022) where one scenario assumes that the Company&#x2019;s
common stock will be up-listed on a national stock exchange (the &#x201c;Exchange&#x201d;) on a certain listing date (the &#x201c;Up-list&#x201d;)
where the estimated volatility was based on evaluating the average historical volatility of a group of peer companies that are publicly
traded and the second scenario assumes that the Company&#x2019;s common stock is not up-listed on the Exchange prior to the final vesting
date of the grants (the &#x201c;No Up-list&#x201d;) where the historical volatility of the Company&#x2019;s common stock was evaluated based
upon market comparisons; and the (2) &#x201c;Up-list Scenario&#x201d; (after the reverse stock split on February 8, 2022) where the Company
estimated volatility based on evaluating the average historical volatility of a group of peer companies that are publicly traded after
the Company up-listed to the NYSE American. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time
of grant. The fair market value of common stock is determined by reference to the quoted market price of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has elected to recognize forfeitures as they occur and to recognize stock-based compensation cost on a straight-line basis over
the total requisite service period for awards with graded vesting. The Company classifies stock-based compensation cost on its consolidated
statements of operations in the same manner in which the award recipient&#x2019;s cash compensation cost is classified.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--IncomeTaxPolicyTextBlock_zDKKsMkd28U" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zMvqGY6kRZR3"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the future
tax consequences attributable to operating loss carryforwards and temporary differences between financial statement bases of existing
assets and liabilities and their respective income tax bases. Deferred tax assets and liabilities are measured using enacted income tax
rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
The effect of a change in the income tax rates on deferred tax asset and liability balances is recognized in income in the period that
includes the enactment date of such rate change. A valuation allowance is recorded for loss carryforwards and other deferred tax assets
when it is determined that it is more likely than not that such loss carryforwards and deferred tax assets will not be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows accounting guidance that sets forth a threshold for financial statement recognition, measurement, and disclosure of a
tax position taken or expected to be taken on a tax return. Such guidance requires the Company to determine whether a tax position of
the Company is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any
related appeals or litigation processes, based on technical merits of the position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zW0EOEfnZsc4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zP4yJZ86ccOj"&gt;Loss
per Common Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
loss per share is computed using the weighted average number of common shares outstanding during the period and excludes any dilutive
effects of common stock equivalent shares, such as stock options, restricted stock, and warrants. All restricted stock awards are considered
outstanding but are included in the computation of basic loss per common share only when the restrictions expire, the shares are no longer
forfeitable, and are thus vested. Restricted stock units are included in the computation of basic loss per common share only when the
restrictions expire, the shares are no longer forfeitable, and are thus vested. Contingently issuable shares are included in basic loss
per common share only when there are no circumstances under which those shares would not be issued. Diluted loss per common share is
computed using the weighted average number of common shares outstanding and common stock equivalent shares outstanding during the period
using the treasury stock method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company excluded the outstanding securities summarized below (capitalized terms are described herein), which entitle the holders thereof
to acquire shares of the Company&#x2019;s common stock, from its calculation of net loss per common share, as their effect would have
been anti-dilutive. Common stock equivalent shares are excluded from the diluted calculations when a net loss is incurred as they would
be anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zcNoxzT4AHKc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zUHosAth0BJk" style="display: none"&gt;Schedule of Net Income (Loss) Per Common Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Series G Preferred Stock&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesGConvertiblePreferredStockMember_zxS1HyVzT6Hg" style="width: 16%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;8,582&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesGConvertiblePreferredStockMember_zy05uUvS9Bi8" style="width: 16%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;8,582&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series H Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_zs3G5RlmtVc5" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1043"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_zPxiV0ZDttT2" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;1,981,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Financing Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--FinancingWarrantsMember_zWBVv26ftGIb" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1047"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--FinancingWarrantsMember_zZoIMd1yBJEk" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;107,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;ABG Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ABGWarrantsMember_znZyyHEUN9n8" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;999,540&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ABGWarrantsMember_zZnThCEIVN0l" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;999,540&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;AllHipHop Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--AllHipHopWarrantsMember_zHrXsJSzGy91" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;5,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--AllHipHopWarrantsMember_zPa0CoHEe7p4" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;5,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Publisher Partner Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublisherPartnerWarrantsMember_z12mD82wm2fk" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;9,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublisherPartnerWarrantsMember_zzrC8Hp0G7fc" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;4,154&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Restricted stock awards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockAwardsMember_zzBBvqBjcCLa" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1063"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockAwardsMember_zQPv2XEZ5SN1" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;97,403&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Restricted stock units&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_z7eIQKbpKSIg" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;199,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zFC86bgITA7d" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;994,766&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Common stock options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockOptionsMember_z0wnOpFkLHua" style="border-bottom: Black 1.5pt solid; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;5,451,968&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockOptionsMember_zh8GnBEkgfRl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;6,199,521&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231_zip2RniEz9B6" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;6,674,839&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zLIoGGwnyhJ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;10,398,732&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zyEVyspNnUD7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z6eBmGl1Tudc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_869_zX0scoSqXuz6"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recently
Adopted Accounting Standards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2022, the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued ASU 2022-02, &lt;i&gt;Financial Instruments-Credit Losses(Topic
326): Troubled Debt Restructurings and Vintage Disclosures, &lt;/i&gt;addressing areas identified by the FASB as part of its post-implementation
review of its previously issued credit losses standard (ASU 2016-13) that introduced the current expected credit losses (CECL) model.
ASU 2022-02 eliminates the accounting guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhances
disclosure requirements for certain loan refinancings and restructurings made with borrowers experiencing financial difficulty. This
update requires an entity to disclose current-period gross write-offs for financing receivables and net investment in leases by year
of origination in the vintage disclosures. As the Company has already adopted ASU 2016-13, the new guidance was adopted on January 1,
2023. The adoption of ASU 2022-02 did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recently
Issued Accounting Standards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2022, the FASB issued ASU 2022-03, &lt;i&gt;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to
Contractual Sale Restrictions&lt;/i&gt;, which clarifies that a contractual restriction on the sale of an equity security is not considered
part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. This update also clarifies
that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction and requires certain disclosures
for equity securities subject to contractual sale restrictions. ASU 2022-03 is effective for the Company in the fiscal year beginning
after December 15, 2023, and interim periods within the fiscal year. Early adoption is permitted for both interim and annual financial
statements that have not yet been issued or made available for issuance. The Company is currently evaluating the impact that the adoption
of this new accounting standard will have on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2023, the FASB issued ASU 2023-06, &lt;i&gt;Disclosure Improvements: Codification Amendments in Response to the SEC&#x2019;s Disclosure
Update and Simplification Initiative&lt;/i&gt;, which incorporates certain SEC disclosure requirements into the FASB Accounting Standards Codification
(&#x201c;Codification&#x201d;). The amendments are expected to clarify or improve disclosure and presentation requirements of a variety
of Codification Topics, allow users to more easily compare entities subject to the SEC&#x2019;s existing disclosures with those entities
that were not previously subject to the requirements, and align the requirements in the Codification with the SEC&#x2019;s regulations.
ASU 2023-06 will become effective for each amendment on the effective date of the SEC&#x2019;s corresponding disclosure rule changes.
The Company is currently evaluating the impact that the adoption of this new standard will have on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09, &lt;i&gt;Income Taxes&lt;/i&gt; (Topic 740): Improvements to Income Tax Disclosures, which will require
the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for
reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid
disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. The provisions
of ASU 2023-09 are effective for annual periods beginning after December 15, 2024; early adoption is permitted using either a prospective
or retrospective transition method. The Company expects ASU 2023-09 to require additional disclosures in the notes to its consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material
impact on the Company&#x2019;s financial statement presentation or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_859_z98cXF9iWlm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000830">&lt;p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zzFtoQvQnNx7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_zy3G9ui5Z5Z5"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted
in the United States of America (&#x201c;GAAP&#x201d;) and include the financial statements of The Arena Group and its wholly owned subsidiaries,
Arena Media, Arena Platform, TheStreet, The Spun and Parade. Intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2023-01-01to2023-12-31" id="Fact000832">&lt;p id="xdx_84B_eus-gaap--UseOfEstimates_z8NcpjojKmQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_z4pyTs3jB2Ci"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the Company&#x2019;s consolidated financial statements in conformity with GAAP requires management to make certain estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of
the date of the consolidated financial statements and the reported results of operations during the reporting period. Significant estimates
include: reserves for bad debt; capitalization of platform development and associated useful lives; goodwill and other acquired intangible
assets and associated useful lives; assumptions used in accruals for potential liabilities; revenue recognition and estimates of standalone
selling price of performance obligations for revenue contracts with multiple performance obligations; stock-based compensation and the
determination of the fair value; valuation allowances for deferred tax assets and uncertain tax positions; accounting for business combinations;
and assumptions used to calculate contingent liabilities. These estimates are based on information available as of the date of the consolidated
financial statements; therefore, actual results could differ from management&#x2019;s estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <AREN:RisksAndUncertaintiesPolicy contextRef="From2023-01-01to2023-12-31" id="Fact000834">&lt;p id="xdx_849_ecustom--RisksAndUncertaintiesPolicy_zeQRbLriArwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_869_zsjI6LF7LMy2"&gt;Risks
and Uncertainties&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s business and operations are sensitive to general business and economic conditions in the United States and worldwide.
These conditions include short-term and long-term interest rates, inflation, fluctuations in debt and equity capital markets and the
general condition of the United States and world economy. A host of factors beyond the Company&#x2019;s control could cause fluctuations
in these conditions. Adverse developments in these general business and economic conditions could have a material adverse effect on the
Company&#x2019;s financial condition and the results of its operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, the Company will compete with many companies that currently have extensive and well-funded projects, marketing and sales operations
as well as extensive human capital. The Company may be unable to compete successfully against these companies. The Company&#x2019;s industry
is characterized by rapid changes in technology and market demands. As a result, the Company&#x2019;s products, services, or expertise
may become obsolete or unmarketable. The Company&#x2019;s future success will depend on its ability to adapt to technological advances,
anticipate customer and market demands, and enhance its current technology under development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Uncertainty
in the global economy presents significant risks to the Company&#x2019;s business. Increases in inflation, rising interest rates,
instability in the global banking system, geopolitical factors, including the ongoing conflicts in Ukraine and Israel and the
responses thereto, and the remaining effects of the COVID-19 pandemic may have an adverse effect on the Company&#x2019;s business.
While the Company is closely monitoring the impact of the current macroeconomic conditions on all aspects of its business, the
ultimate extent of the impact on its business remains highly uncertain and will depend on future developments and factors that
continue to evolve. Most of these developments and factors are outside of the Company&#x2019;s control and could exist for an
extended period of time. As a result, the Company is subject to continuing risks and uncertainties.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
December 1, 2023, B. Riley FBR, Inc. (&#x201c;B. Riley FBR&#x201d;), a registered broker-dealer owned by B. Riley Financial, Inc., a diversified
publicly traded financial services company (&#x201c;B. Riley&#x201d;) that was instrumental in providing investment banking services to
the Company and in raising debt and equity capital for the Company, and Renew Group Private Limited (&#x201c;Renew&#x201d;) entered into
agreement where Renew purchased $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20231201__us-gaap--DebtInstrumentAxis__custom--BRileyFBRIncMember_zTC4YweVY0wd"&gt;110,691
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in aggregate principal amount of the notes outstanding
with B. Riley, including the 2023 Notes (as described in Note 18), Senior Secured Notes, Delayed Draw Term Notes and 2022 Bridge Notes
(as described in Note 19), which constitute all of the notes outstanding with B. Riley and also assumed the role of agent under the Note
Purchase Agreement, as further described in Note 26. The indirect owner of Renew also has an indirect non-controlling interest in Simplify
Inventions, LLC (&#x201c;Simplify&#x201d;), a principal stockholder (as further described in Note 26).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</AREN:RisksAndUncertaintiesPolicy>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-01_custom_BRileyFBRIncMember"
      decimals="0"
      id="Fact000835"
      unitRef="USD">110691</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000837">&lt;p id="xdx_840_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zHxbngcdmK8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zNDHompCPvHb"&gt;Segment
Reporting&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company operates in one reportable segment which focuses on a publishing platform. The Company&#x2019;s business offerings have similar
operating characteristics and similar long-term operating performance, including the types of customers, nature of product or services,
distribution methods and regulatory environment. The chief operating decision maker (the &#x201c;CODM&#x201d;) of the Company reviews specific
financial and operational data and other key metrics to make resource allocation decisions and assesses performance by review of profit
and loss information on a consolidated basis. The CODM does not review specific financial or operational data on a disaggregated basis
or by aggregating operating segments into one reportable segment. The consolidated financial statements reflect the financial results
of the Company&#x2019;s one reportable segment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000839">&lt;p id="xdx_846_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zGkVoSwSsy6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zbJUQHQnkXde"&gt;Revenue
Recognition&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 606, &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;, revenues are
recognized when control of the promised goods or services are transferred to the Company&#x2019;s customers, in an amount that reflects
the consideration that the Company expects to receive in exchange for those goods or services. The Company generates all of its revenue
from contracts with customers. The Company accounts for revenue on a gross basis, as compared to a net basis, on its statements of operations.
The Company has made this determination based on its control of the advertising inventory and the ability to monetize the advertising
inventory or publications before transfer to the customer and because it is also the primary obligor responsible for providing the services
to the customer. Cost of revenue is presented as a separate line item on the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a description of the principal activities from which the Company generates revenue:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Advertising
Revenue&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Digital
Advertising &#x2013; &lt;/i&gt;The Company recognizes revenue from digital advertisements at the point when each ad is viewed. The quantity
of advertisements, the impression bid prices and revenue are reported on a real-time basis. The Company enters into contracts with advertising
networks to serve display or video advertisements on the digital media pages associated with its various channels. Although reported
advertising transactions are subject to adjustment by the advertising network partners, any such adjustments are known within a few days
of month end. The Company owes its independent Publisher Partners a revenue share of the advertising revenue earned, which is recorded
as service costs in the same period in which the associated advertising revenue is recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advertising
revenue that is comprised of fees charged for the placement of advertising, on the Company&#x2019;s flagship website, &lt;i&gt;TheStreet.com,
&lt;/i&gt;is recognized as the advertising or sponsorship is displayed, if collection of the resulting receivable is reasonably assured.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Print
Advertising &#x2013; &lt;/i&gt;Advertising related revenues for print advertisements are recognized when advertisements are published (defined
as an issue&#x2019;s on-sale date), net of provisions for estimated rebates, rate adjustments, and discounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Subscription
Revenue&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Digital
Subscriptions&lt;/i&gt; &#x2013; The Company enters into contracts with internet users that subscribe to premium content on the owned and operated
media channels and facilitate such contracts between internet users and its Publisher Partners. These contracts provide internet users
with a membership subscription to access the premium content. The Company owes its independent Publisher Partners a revenue share of
the membership subscription revenue earned, which is initially deferred and recorded as deferred contract costs. The Company recognizes
deferred contract costs over the membership subscription term in the same pattern that the associated membership subscription revenue
is recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subscription
revenue generated from the Company&#x2019;s flagship website &lt;i&gt;TheStreet.com&lt;/i&gt; from institutional and retail customers is comprised
of subscriptions and license fees for access to securities investment information, stock market commentary, director and officer profiles,
relationship capital management services, and transactional information pertaining to mergers and acquisitions and other changes in the
corporate control environment. Subscriptions are charged to customers&#x2019; credit cards or are directly billed to corporate subscribers,
and are generally billed in advance on a monthly, quarterly or annual basis. The Company calculates net subscription revenue by deducting
from gross revenue an estimate of potential refunds from cancelled subscriptions as well as chargebacks of disputed credit card charges.
Net subscription revenue is recognized ratably over the subscription periods. Unearned revenue relates to payments for subscription fees
for which revenue has not been recognized because services have not yet been provided.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Print
Revenue&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Print
revenue includes magazine subscriptions and single copy sales at newsstands.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Print
Subscriptions &#x2013;&lt;/i&gt; Revenue from magazine subscriptions is deferred and recognized proportionately as products are distributed
to subscribers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Newsstand
&lt;/i&gt;&#x2013; Single copy revenue is recognized on the publication&#x2019;s on-sale date, net of provisions for estimated returns. The Company
bases its estimates for returns on historical experience and current marketplace conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Licensing
and Syndication Revenue&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Content
licensing-based revenues and syndication revenues are accrued generally monthly or quarterly based on the specific mechanisms of each
contract. Generally, revenues are accrued based on estimated sales and adjusted as actual sales are reported by partners. These adjustments
are typically recorded within three months of the initial estimates and have not been material. Any minimum guarantees are typically
earned evenly over the fiscal year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Nature
of Performance Obligations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
contract inception, the Company assesses the obligations promised in its contracts with customers and identifies a performance obligation
for each promise to transfer a good or service or bundle that is distinct. To identify the performance obligations, the Company considers
all the promises in the contract, whether explicitly stated or implied based on customary business practices. For a contract that has
more than one performance obligation, the Company allocates the total contract consideration to each distinct performance obligation
on a relative standalone selling price basis. Revenue is recognized when, or as, the performance obligations are satisfied, and control
is transferred to the customer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Digital
Advertising&lt;/i&gt; &#x2013; The Company sells digital advertising inventory on its websites directly to advertisers or through advertising
agencies. The Company&#x2019;s performance obligations related to digital advertising are generally satisfied when the advertisement is
run on the Company&#x2019;s platform. The price for direct digital advertising is determined in contracts with the advertisers. Revenue
from the sale of direct digital advertising is recognized when the advertisements are delivered based on the contract. The customer is
invoiced the agreed-upon price in the month following the month that the advertisements are delivered with normal trade terms. The agreed
upon price is adjusted for estimated provisions for rebates, rate adjustments, and discounts. As part of the Company&#x2019;s customary
business practices, digital advertising contracts may include a guaranteed number of impressions and sales incentives to its customers
including volume discounts, rebates, value added impressions, etc. For all such contracts that include these types of variable consideration,
the Company estimates the variable consideration and factors in such an estimate when determining the transaction price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Print
Advertising&lt;/i&gt; &lt;b&gt;&#x2013; &lt;/b&gt;The Company provides advertisement placements in print media directly to advertisers or through advertising
agencies. The Company&#x2019;s performance obligations related to print advertising are satisfied when the magazine in which an advertisement
appears is published, which is defined as an issue&#x2019;s on-sale date. The customer is invoiced the agreed-upon price when the advertisements
are published under normal industry trade terms. The agreed upon price is adjusted for estimated provisions for rebates, rate adjustments,
and discounts. As part of the Company&#x2019;s customary business practices, print advertising contracts include guaranteed circulation
levels of magazines, referred to as rate base, and a number of sales incentives to its customers including volume discounts, rebates,
bonus pages, etc. For all such contracts that include these types of variable consideration, the Company estimates such when determining
the transaction price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Digital
Subscriptions&lt;/i&gt; &#x2013; The Company recognizes revenue from each membership subscription to access the premium content over time based
on a daily calculation of revenue during the reporting period, which is generally one year. Subscriber payments are initially recorded
as unearned revenue on the balance sheets. As the Company provides access to the premium content over the membership subscription term,
the Company recognizes revenue and proportionately reduces the unearned revenue balance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Print
Subscriptions&lt;/i&gt; &#x2013; The Company sells magazines to consumers through subscriptions. Each copy of a magazine is determined to be
a distinct performance obligation that is satisfied when the publication is sent to the customer. The majority of the Company&#x2019;s
subscription sales are prepaid at the time of order. Subscriptions may be canceled at any time for a refund of the price paid for remaining
issues. As the contract may be canceled at any time for a full refund of the unserved copies, the contract term is determined to be on
an issue-to-issue basis as these contracts do not have substantive termination penalties. Revenues from subscriptions are deferred and
recognized proportionately as subscribers are served. Some magazine subscription offers contain more than one magazine title in a bundle.
The Company allocates the total contract consideration to each distinct performance obligation, or magazine title, based on a standalone-selling
price basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Newsstand
&lt;/i&gt;&#x2013; The Company sells single copy magazines, or bundles of single copy magazines, to wholesalers for ultimate resale on newsstands
primarily at major retailers and grocery/drug stores, and in digital form on tablets and other electronic devices. Publications sold
to magazine wholesalers are sold with the right to receive credit from the Company for magazines returned to the wholesaler by retailers.
Revenue is recognized on the issue&#x2019;s on-sale date as the date aligns most closely with the date that control is transferred to
the customer. The Company bases its estimates for returns on historical experience and current marketplace conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Licensing
and Syndication &#x2013; &lt;/i&gt;The Company has entered into various licensing and syndication agreements that provide third party
partners with the right to utilize the Company&#x2019;s content. Functional licenses in national media consist of content
licensing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Timing
of Satisfaction of Performance Obligations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Point-in-Time
Performance Obligations &#x2013; &lt;/i&gt;For performance obligations related to certain digital advertising space and sales of print advertisements,
the Company determines that the customer can direct the use of and obtain substantially all the benefits from the advertising products
as the digital impressions are served or on the issue&#x2019;s on-sale date. For performance obligations related to sales of magazines
through subscriptions, the customer obtains control when each magazine issue is mailed to the customer on or before the issue&#x2019;s
on-sale date. For sales of single copy magazines on newsstands, revenue is recognized on the issue&#x2019;s on-sale date as the date aligns
most closely with the date that control is transferred to the customer. Revenues from functional licenses and syndication arrangements
are recognized at a point-in-time when access to the completed content is granted to the partner.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Over-Time
Performance Obligations&lt;/i&gt; &lt;b&gt;&#x2013; &lt;/b&gt;For performance obligations related to sales of certain digital advertising space, the Company
transfers control and recognizes revenue over time by measuring progress towards complete satisfaction using the most appropriate method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
performance obligations related to digital advertising, the Company satisfies its performance obligations on some flat-fee digital advertising
placements over time using a time-elapsed output method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Determining
a measure of progress requires management to make judgments that affect the timing of revenue recognized. The Company has determined
that the above method provides a faithful depiction of the transfer of goods or services to the customer. For performance obligations
recognized using a time-elapsed output method, the Company&#x2019;s efforts are expended evenly throughout the period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Performance
obligations related to subscriptions to premium content on the digital media channels provides access for a given period of time, which
is generally one year. The Company recognizes revenue from each membership subscription over time based on a daily calculation of revenue
during the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Transaction
Price and Amounts Allocated to Performance Obligations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Determining
the Transaction Price &#x2013; &lt;/i&gt;Certain advertising contracts contain variable components of the transaction price, such as volume
discounts and rebates. The Company has sufficient historical data and has established processes to reliably estimate these variable components
of the transaction price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subscription
revenue generated from the flagship website &lt;i&gt;TheStreet.com&lt;/i&gt; is subject to estimation and variability due to the fact that, in the
normal course of business, subscribers may for various reasons contact the Company or their credit card companies to request a refund
or other adjustment for a previously purchased subscription. With respect to many of the Company&#x2019;s annual newsletter subscription
products, the Company offers the ability to receive a refund during the first 30 days but none thereafter. Accordingly, the Company maintains
a provision for estimated future revenue reductions resulting from expected refunds and chargebacks related to subscriptions for which
revenue was recognized in a prior period. The calculation of this provision is based upon historical trends and is reevaluated each quarter.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company typically does not offer any type of variable consideration in standard magazine subscription contracts. For these contracts,
the transaction price is fixed upon establishment of the contract that contains the final terms of the sale including description, quantity
and price of each subscription purchased. Therefore, the Company does not estimate variable consideration or perform a constraint analysis
for these contracts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
right of return exists for newsstand contracts. The Company has sufficient historical data to estimate the final amount of returns and
reduces the transaction price at contract inception for the expected return reserve.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
is no variable consideration related to functional licenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Estimating
Standalone-Selling Prices&lt;/i&gt; &lt;b&gt;&#x2013; &lt;/b&gt;For contracts that contain multiple performance obligations, the Company allocates the transaction
price to each performance obligation on a relative standalone-selling price basis. The standalone-selling price is the price at which
the Company would sell a promised good or service separately to the customer. In situations in which an obligation is bundled with other
obligations and the total amount of consideration does not reflect the sum of individual observable prices, the Company allocates the
discount to (1) a single obligation if the discount is attributable to that obligation or (2) prorates across all obligations if the
discount relates to the bundle. When standalone-selling price is not directly observable, the Company estimates and considers all the
information that is reasonably available to the Company, including market conditions, entity specific factors, customer information,
etc. The Company maximizes the use of observable inputs and applies estimation methods consistently in similar circumstances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Measuring
Obligations for Returns and Refunds&lt;/i&gt; &#x2013; The Company accepts product returns in some cases. The Company establishes provisions
for estimated returns concurrently with the recognition of revenue. The provisions are established based upon consideration of a variety
of factors, including, among other things, recent and historical return rates for both specific products and distributors and the impact
of any new product releases and projected economic conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023 and 2022, a subscription refund liability of $&lt;span id="xdx_903_eus-gaap--ContractWithCustomerRefundLiabilityCurrent_iI_pn3n3_c20231231_zPBgu0X43SHc" title="Subscription refund liability"&gt;449&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--ContractWithCustomerRefundLiabilityCurrent_iI_pn3n3_c20221231_zn36hWjiWCki" title="Subscription refund liability"&gt;845&lt;/span&gt;, respectively, was recorded for the provision for the
estimated returns and refunds on the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Contract
Modifications&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company occasionally enters into amendments to previously executed contracts that constitute contract modifications. The Company assesses
each of these contract modifications to determine:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if
    the additional services and goods are distinct from the services and goods in the original arrangement; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if
    the amount of consideration expected for the added services or goods reflects the stand-alone selling price of those services and
    goods.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
contract modification meeting both criteria is accounted for as a separate contract. A contract modification not meeting both criteria
is considered a change to the original contract and is accounted for on either a prospective basis as a termination of the existing contract
and the creation of a new contract, or a cumulative catch-up basis (further details are provided under the headings &lt;i&gt;Contract Balances
&lt;/i&gt;and &lt;i&gt;Subscription Acquisition Costs&lt;/i&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Disaggregation
of Revenue&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--DisaggregationOfRevenueTableTextBlock_zqIHuXdmsySi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table provides information about disaggregated revenue by category, geographical market and timing of revenue recognition:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_z6Kcyvj050lh" style="display: none"&gt;Schedule
of Disaggregation of Revenue&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230101__20231231_zkXxx6cmdky8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220101__20221231_ztGAhuYNbwml" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Revenue by category:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Digital revenue&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalAdvertisingMember_zo01p5dvBfP" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: justify"&gt;Digital advertising&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;135,376&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;109,317&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalSubscriptionsMember_zD0kRLElyCW" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Digital subscriptions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,764&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,156&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--LicensingAndSyndicationRevenueMember_zfNDuHqh6Ld8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Licensing and syndication revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__us-gaap--ProductAndServiceOtherMember_zx2y2DOEFCp1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"&gt;Other digital revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,384&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,166&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zgsNr7azyhMl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify; padding-bottom: 1.5pt"&gt;Total digital revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;172,006&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;149,812&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Print revenue&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintAdvertisingMember_zbRG7M168fX4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Print advertising&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,881&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintSubscriptionsMember_zv5dvOGnfQz2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"&gt;Print subscriptions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;62,316&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;60,909&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_zzQN9CQzquF8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify; padding-bottom: 1.5pt"&gt;Total print revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;72,197&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;71,123&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zUzRiEu6CZTh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;244,203&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;220,935&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Revenue by geographical market:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__country--US_zKX1xgZJTcp9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;234,012&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;218,110&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__custom--OtherMember_zS4cb0vzdZL4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,191&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,825&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zgadvHNx3Wz9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;244,203&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;220,935&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Revenue by timing of recognition:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_zumKpCgm0fo5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;At point in time&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;231,439&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;199,779&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zpFUGfTLJXS6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"&gt;Over time&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12,764&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,156&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zmjvuJAzMUPa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0pt; text-align: left; padding-bottom: 2.5pt"&gt;Total revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;244,203&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;220,935&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zErk4ulyJWh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000841"
      unitRef="USD">449000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000843"
      unitRef="USD">845000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000845">&lt;p id="xdx_895_eus-gaap--DisaggregationOfRevenueTableTextBlock_zqIHuXdmsySi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table provides information about disaggregated revenue by category, geographical market and timing of revenue recognition:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_z6Kcyvj050lh" style="display: none"&gt;Schedule
of Disaggregation of Revenue&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230101__20231231_zkXxx6cmdky8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220101__20221231_ztGAhuYNbwml" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Revenue by category:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Digital revenue&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalAdvertisingMember_zo01p5dvBfP" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: justify"&gt;Digital advertising&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;135,376&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;109,317&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalSubscriptionsMember_zD0kRLElyCW" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Digital subscriptions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,764&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,156&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--LicensingAndSyndicationRevenueMember_zfNDuHqh6Ld8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Licensing and syndication revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__us-gaap--ProductAndServiceOtherMember_zx2y2DOEFCp1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"&gt;Other digital revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,384&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,166&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zgsNr7azyhMl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify; padding-bottom: 1.5pt"&gt;Total digital revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;172,006&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;149,812&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Print revenue&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintAdvertisingMember_zbRG7M168fX4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Print advertising&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,881&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintSubscriptionsMember_zv5dvOGnfQz2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"&gt;Print subscriptions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;62,316&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;60,909&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_zzQN9CQzquF8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: justify; padding-bottom: 1.5pt"&gt;Total print revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;72,197&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;71,123&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zUzRiEu6CZTh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;244,203&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;220,935&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Revenue by geographical market:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__country--US_zKX1xgZJTcp9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;234,012&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;218,110&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hsrt--StatementGeographicalAxis__custom--OtherMember_zS4cb0vzdZL4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,191&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,825&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zgadvHNx3Wz9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;244,203&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;220,935&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Revenue by timing of recognition:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_zumKpCgm0fo5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;At point in time&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;231,439&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;199,779&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zpFUGfTLJXS6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"&gt;Over time&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12,764&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,156&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_iT_pn3n3_zmjvuJAzMUPa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0pt; text-align: left; padding-bottom: 2.5pt"&gt;Total revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;244,203&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;220,935&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_custom_DigitalAdvertisingMember"
      decimals="-3"
      id="Fact000847"
      unitRef="USD">135376000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_DigitalAdvertisingMember"
      decimals="-3"
      id="Fact000848"
      unitRef="USD">109317000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_custom_DigitalSubscriptionsMember"
      decimals="-3"
      id="Fact000850"
      unitRef="USD">12764000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_DigitalSubscriptionsMember"
      decimals="-3"
      id="Fact000851"
      unitRef="USD">21156000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_custom_LicensingAndSyndicationRevenueMember"
      decimals="-3"
      id="Fact000853"
      unitRef="USD">18482000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_LicensingAndSyndicationRevenueMember"
      decimals="-3"
      id="Fact000854"
      unitRef="USD">18173000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_us-gaap_ProductAndServiceOtherMember"
      decimals="-3"
      id="Fact000856"
      unitRef="USD">5384000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_us-gaap_ProductAndServiceOtherMember"
      decimals="-3"
      id="Fact000857"
      unitRef="USD">1166000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_custom_DigitalRevenueMember"
      decimals="-3"
      id="Fact000859"
      unitRef="USD">172006000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_DigitalRevenueMember"
      decimals="-3"
      id="Fact000860"
      unitRef="USD">149812000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_custom_PrintAdvertisingMember"
      decimals="-3"
      id="Fact000862"
      unitRef="USD">9881000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_PrintAdvertisingMember"
      decimals="-3"
      id="Fact000863"
      unitRef="USD">10214000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_custom_PrintSubscriptionsMember"
      decimals="-3"
      id="Fact000865"
      unitRef="USD">62316000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_PrintSubscriptionsMember"
      decimals="-3"
      id="Fact000866"
      unitRef="USD">60909000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_custom_PrintRevenueMember"
      decimals="-3"
      id="Fact000868"
      unitRef="USD">72197000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_PrintRevenueMember"
      decimals="-3"
      id="Fact000869"
      unitRef="USD">71123000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000871"
      unitRef="USD">244203000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000872"
      unitRef="USD">220935000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_country_US"
      decimals="-3"
      id="Fact000874"
      unitRef="USD">234012000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_country_US"
      decimals="-3"
      id="Fact000875"
      unitRef="USD">218110000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_custom_OtherMember"
      decimals="-3"
      id="Fact000877"
      unitRef="USD">10191000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_OtherMember"
      decimals="-3"
      id="Fact000878"
      unitRef="USD">2825000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000880"
      unitRef="USD">244203000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000881"
      unitRef="USD">220935000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_us-gaap_TransferredAtPointInTimeMember"
      decimals="-3"
      id="Fact000883"
      unitRef="USD">231439000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_us-gaap_TransferredAtPointInTimeMember"
      decimals="-3"
      id="Fact000884"
      unitRef="USD">199779000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_us-gaap_TransferredOverTimeMember"
      decimals="-3"
      id="Fact000886"
      unitRef="USD">12764000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_us-gaap_TransferredOverTimeMember"
      decimals="-3"
      id="Fact000887"
      unitRef="USD">21156000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000889"
      unitRef="USD">244203000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000890"
      unitRef="USD">220935000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <AREN:CostOfRevenuePolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000892">&lt;p id="xdx_849_ecustom--CostOfRevenuePolicyTextBlock_zBsWZ7XiYoJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zMoE01NyV7Ge"&gt;Cost
of Revenue&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost
of revenue represents the cost of providing the Company&#x2019;s digital media channels and advertising and membership services. The cost
of revenue that the Company has incurred in the periods presented primarily include: Publisher Partner guarantees and revenue share payments;
amortization of developed technology and platform development; royalty fees; hosting and bandwidth and software license fees; printing
and distribution costs; payroll and related expenses for customer support, technology maintenance; fees paid for data analytics and to
other outside service providers; and stock-based compensation of related personnel (as described in Note 22).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AREN:CostOfRevenuePolicyTextBlock>
    <AREN:ContractBalancesPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000894">&lt;p id="xdx_844_ecustom--ContractBalancesPolicyTextBlock_zyCXvDn3m8ee" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zZnVYYxSPCql"&gt;Contract
Balances&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
timing of the Company&#x2019;s performance under its various contracts often differs from the timing of the customer&#x2019;s payment,
which results in the recognition of a contract asset or a contract liability. A contract asset is recognized when a good or service is
transferred to a customer and the Company does not have the contractual right to bill for the related performance obligations. An asset
is recognized when certain costs incurred to obtain a contract meet the capitalization criteria (further details are provided under the
heading &lt;i&gt;Subscription Acquisition Costs&lt;/i&gt;). A contract liability is recognized when consideration is received from the customer prior
to the transfer of goods or services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_zaHl7ipmaYU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table provides information about contract balances:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BD_zB03ZNauj0wc" style="display: none"&gt;Schedule
of Contract with Customer, Asset and Liability&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20231231_zaeO3S0cr5pd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20221231_z3Gw4AyXnoya" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Unearned revenue (short-term contract liabilities):&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zNXnIczbDXRb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Digital revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;14,397&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;18,571&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_z7Oqs9MAbBK9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Print revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;45,389&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;40,132&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_z1TaModhTRyk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total short-term contract
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;59,786&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;58,703&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Unearned revenue (long-term contract liabilities):&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zce7hTDFpFCe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Digital revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;542&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_zUy5wqyC5QDa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Print revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,137&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,583&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_zxVz3y32mAu9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total long-term contract
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;10,679&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;19,701&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zGBCCJVDLCcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Unearned
Revenue&lt;/i&gt; &#x2013; Unearned revenue, also referred to as contract liabilities, include payments received in advance of performance under
the contracts and are recognized as revenue over time. The Company records contract liabilities as unearned revenue on the consolidated
balance sheets. Digital subscription and print subscription revenue of $&lt;span id="xdx_901_ecustom--UnearnedRevenue_iI_pn3n3_c20231231__srt--ProductOrServiceAxis__custom--DigitalAndPrintSubscriptionsMember_zavJ3vDtUiH8" title="Contract with customer liability noncurrent"&gt;68,985&lt;/span&gt; was recognized during the year ended December 31, 2023
from unearned revenue at the beginning of the year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
January 2020, February 2020 and December 2021, the Company modified certain digital and print subscription contracts that prospectively
changed the frequency of the related issues (or magazines) required to be delivered on a yearly basis (the &#x201c;Contract Modifications&#x201d;).
The Company determined that the remaining digital content and magazines to be delivered are distinct from the digital content or magazines
already provided under the original contract. As a result, the Company in effect established a new contract that included only the remaining
digital content or magazines. Accordingly, the Company allocated the remaining performance obligations in the contracts as consideration
from the original contract that has not yet been recognized as revenue. For the years ended December 31, 2023 and 2022, the Company recognized
revenue of $&lt;span id="xdx_90E_eus-gaap--ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_pn3n3_c20230101__20231231_zJWXinQwW492" title="Contract modification - revenue"&gt;554&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_pn3n3_c20220101__20221231_zDp3CYXxDNIk" title="Contract modification - revenue"&gt;2,986&lt;/span&gt;, respectively, resulting from the Contract Modifications.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AREN:ContractBalancesPolicyTextBlock>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000896">&lt;p id="xdx_898_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_zaHl7ipmaYU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table provides information about contract balances:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BD_zB03ZNauj0wc" style="display: none"&gt;Schedule
of Contract with Customer, Asset and Liability&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20231231_zaeO3S0cr5pd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20221231_z3Gw4AyXnoya" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Unearned revenue (short-term contract liabilities):&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zNXnIczbDXRb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Digital revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;14,397&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;18,571&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_z7Oqs9MAbBK9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Print revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;45,389&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;40,132&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_z1TaModhTRyk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total short-term contract
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;59,786&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;58,703&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Unearned revenue (long-term contract liabilities):&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--DigitalRevenueMember_zce7hTDFpFCe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Digital revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;542&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_hsrt--ProductOrServiceAxis__custom--PrintRevenueMember_zUy5wqyC5QDa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Print revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,137&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,583&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_zxVz3y32mAu9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total long-term contract
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;10,679&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;19,701&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2023-12-31_custom_DigitalRevenueMember"
      decimals="-3"
      id="Fact000898"
      unitRef="USD">14397000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2022-12-31_custom_DigitalRevenueMember"
      decimals="-3"
      id="Fact000899"
      unitRef="USD">18571000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2023-12-31_custom_PrintRevenueMember"
      decimals="-3"
      id="Fact000901"
      unitRef="USD">45389000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2022-12-31_custom_PrintRevenueMember"
      decimals="-3"
      id="Fact000902"
      unitRef="USD">40132000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000904"
      unitRef="USD">59786000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000905"
      unitRef="USD">58703000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="AsOf2023-12-31_custom_DigitalRevenueMember"
      decimals="-3"
      id="Fact000907"
      unitRef="USD">542000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="AsOf2022-12-31_custom_DigitalRevenueMember"
      decimals="-3"
      id="Fact000908"
      unitRef="USD">1118000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="AsOf2023-12-31_custom_PrintRevenueMember"
      decimals="-3"
      id="Fact000910"
      unitRef="USD">10137000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="AsOf2022-12-31_custom_PrintRevenueMember"
      decimals="-3"
      id="Fact000911"
      unitRef="USD">18583000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000913"
      unitRef="USD">10679000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000914"
      unitRef="USD">19701000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <AREN:UnearnedRevenue
      contextRef="AsOf2023-12-31_custom_DigitalAndPrintSubscriptionsMember"
      decimals="-3"
      id="Fact000916"
      unitRef="USD">68985000</AREN:UnearnedRevenue>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000918"
      unitRef="USD">554000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000920"
      unitRef="USD">2986000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="From2023-01-01to2023-12-31" id="Fact000922">&lt;p id="xdx_84B_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_z9UwVGtuxJeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zAzFgaT3AaBg"&gt;Cash,
Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company maintains cash, cash equivalents, and restricted cash at banks where amounts on deposit may exceed the Federal Deposit Insurance
Corporation limit during the year. Cash and cash equivalents represent cash and highly liquid investments with an original contractual
maturity at the date of purchase of three months. As of December 31, 2023 and 2022, cash and cash equivalents consist primarily of checking,
savings deposits and money market accounts. These deposits exceeded federally insured limits. The Company has not experienced any losses
in such accounts and believes it is not exposed to significant credit risk regarding its cash and cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_zWFdppVl58t5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reconciles total cash, cash equivalents, and restricted cash:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_zTCWT3MYdZO7" style="display: none"&gt;Schedule
of Cash and Restricted Cash&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231231_zUskfSfE2iV1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20221231_znUZ7fvHtDW2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_zno6kDP5lx" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;9,284&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;13,871&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RestrictedCashCurrent_iI_pn3n3_zdHIlDDBpFjf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0929"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;502&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_zznDqR4ifFL" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total cash, cash equivalents, and restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,284&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;14,373&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_z4OLwY6zlTZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023 and 2022, the Company had restricted cash of $&lt;span id="xdx_900_eus-gaap--RestrictedCashCurrent_iI_pn3n3_dxL_c20231231_zOooSWMkC0Wa" title="Restricted cash::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0935"&gt;0&lt;/span&gt;&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--RestrictedCashCurrent_iI_pn3n3_c20221231_zl4OXUGn5BEj" title="Restricted cash"&gt;502&lt;/span&gt;, which served as collateral for certain credit card merchant
accounts with a bank.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000924">&lt;p id="xdx_897_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_zWFdppVl58t5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reconciles total cash, cash equivalents, and restricted cash:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_zTCWT3MYdZO7" style="display: none"&gt;Schedule
of Cash and Restricted Cash&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231231_zUskfSfE2iV1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20221231_znUZ7fvHtDW2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_zno6kDP5lx" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;9,284&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;13,871&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RestrictedCashCurrent_iI_pn3n3_zdHIlDDBpFjf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0929"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;502&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_zznDqR4ifFL" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total cash, cash equivalents, and restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,284&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;14,373&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000926"
      unitRef="USD">9284000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000927"
      unitRef="USD">13871000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000930"
      unitRef="USD">502000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000932"
      unitRef="USD">9284000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000933"
      unitRef="USD">14373000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000937"
      unitRef="USD">502000</us-gaap:RestrictedCashCurrent>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2023-01-01to2023-12-31" id="Fact000939">&lt;p id="xdx_84C_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zS2uwglgvJDc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_z8Sbs2Iwcjt7"&gt;Accounts
Receivable and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company receives payments from advertising customers based upon contractual payment terms; accounts receivable is recorded when the right
to consideration becomes unconditional and are generally collected within 90 days. The Company generally receives payments from digital
and print subscription customers at the time of sign up for each subscription; accounts receivable from merchant credit card processors
are recorded when the right to consideration becomes unconditional and are generally collected weekly. Accounts receivable have been
reduced by an allowance for doubtful accounts. The Company maintains the allowance for estimated losses resulting from the inability
of the Company&#x2019;s customers to make required payments. The allowance represents the current estimate of lifetime expected credit
losses over the remaining duration of existing accounts receivable considering current market conditions and supportable forecasts when
appropriate. The estimate is a result of the Company&#x2019;s ongoing evaluation of collectability, customer creditworthiness, historical
levels of credit losses, and future expectations. Accounts receivable are written off when deemed uncollectible and collection of the
receivable is no longer being actively pursued. Accounts receivable as of December 31, 2023 and 2022 of $&lt;span id="xdx_90F_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20231231_zl4wAyzTyJxj" title="Accounts receivable"&gt;44,811&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20221231_zk8tBgn9UdK9" title="Accounts receivable"&gt;33,950&lt;/span&gt;, respectively,
are presented net of allowance for doubtful accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--AccountsReceivableAllowanceForCreditLossTableTextBlock_zE6UsT17gkr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the allowance for doubtful accounts activity:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_8BF_zEgFA9pr0K7c" style="display: none"&gt;Schedule
of Allowance For Doubtful Accounts&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230101__20231231_z2oNAD11QwDd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220101__20221231_zEvHgtnlkRJb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years Ended of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pn3n3_z52Kpe9D4YZ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Allowance for doubtful accounts beginning of year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,236&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,578&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_pn3n3_zbWpUqbjztzi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;315&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;658&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_pn3n3_di_zVYZVuWNQZE7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Deductions - write-offs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,570&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0954"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pn3n3_zAW7wIVI4Tvi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Allowance for doubtful accounts end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;981&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,236&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_z90ATvKk8wH" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000941"
      unitRef="USD">44811000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000943"
      unitRef="USD">33950000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000945">&lt;p id="xdx_89D_eus-gaap--AccountsReceivableAllowanceForCreditLossTableTextBlock_zE6UsT17gkr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the allowance for doubtful accounts activity:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_8BF_zEgFA9pr0K7c" style="display: none"&gt;Schedule
of Allowance For Doubtful Accounts&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230101__20231231_z2oNAD11QwDd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220101__20221231_zEvHgtnlkRJb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years Ended of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pn3n3_z52Kpe9D4YZ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Allowance for doubtful accounts beginning of year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,236&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,578&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_pn3n3_zbWpUqbjztzi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;315&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;658&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_pn3n3_di_zVYZVuWNQZE7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Deductions - write-offs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,570&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0954"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pn3n3_zAW7wIVI4Tvi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Allowance for doubtful accounts end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;981&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,236&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000947"
      unitRef="USD">2236000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact000948"
      unitRef="USD">1578000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000950"
      unitRef="USD">315000</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000951"
      unitRef="USD">658000</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000953"
      unitRef="USD">1570000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000956"
      unitRef="USD">981000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000957"
      unitRef="USD">2236000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <AREN:SubscriptionAcquisitionCostsPoliceTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000959">&lt;p id="xdx_844_ecustom--SubscriptionAcquisitionCostsPoliceTextBlock_z22oJSGvtoSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zKboqtjKDKK1"&gt;Subscription
Acquisition Costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subscription
acquisition costs include the incremental costs of obtaining a contract with a customer, paid to external parties, if the Company
expects to recover those costs. The Company has determined that sales commissions paid on all third party agent sales of
subscriptions are direct and incremental costs of obtaining a contract with a customer and, therefore, meet the capitalization
criteria. The Company has elected to apply the practical expedient to amortize these costs at the portfolio level. The sales
commissions paid to third party agents are amortized as the magazines are sent to the subscriber on an issue-by-issue basis. The
Company determined that commissions paid for subscriber renewal contracts to all third party agents are not from a specifically
anticipated future contract, therefore, the commissions paid on renewals are amortized as the magazines are sent to the subscriber
over the renewal term on an issue-by-issue basis. Direct mail costs for renewal subscriptions are expensed as incurred since they do
not meet the capitalization criteria.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
of subscription acquisition costs of $&lt;span id="xdx_900_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20230101__20231231_z3yqarK4qbT2" title="Amortization subscription costs"&gt;38,112&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20220101__20221231_zetPKUQdqnV" title="Amortization subscription costs"&gt;37,190&lt;/span&gt; for the years ended December 31, 2023 and 2022, respectively, are included within
selling and marketing expenses on the consolidated statements of operations. No impairment losses have been recognized for subscription
acquisition costs for the years ended December 31, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Contract Modifications resulted in subscription acquisition costs to be recognized on a prospective basis in the same proportion as the
revenue that has not yet been recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
current portion of the subscription acquisition costs as of December 31, 2023 and 2022 was $&lt;span id="xdx_90D_eus-gaap--CapitalizedContractCostNet_iI_pn3n3_c20231231_zuQHX4IgjvLj" title="Subscription acquisition cost"&gt;29,706&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--CapitalizedContractCostNet_iI_pn3n3_c20221231_zHgzmcuDTO2c" title="Subscription acquisition cost"&gt;25,931&lt;/span&gt;, respectively. The noncurrent
portion of the subscription acquisition costs as of December 31, 2023 and 2022 was $&lt;span id="xdx_90F_eus-gaap--CapitalizedContractCostNetNoncurrent_iI_pn3n3_c20231231_zuQZ8za8uVQ1" title="Acquisition cost long term"&gt;7,215&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--CapitalizedContractCostNetNoncurrent_iI_pn3n3_c20221231_zT9PoCGd3K8" title="Subscription acquisition cost noncurrent"&gt;14,133&lt;/span&gt;, respectively. Subscription acquisition
costs as of December 31, 2023 presented as current assets of $&lt;span id="xdx_90F_eus-gaap--CapitalizedContractCostNetCurrent_iI_pn3n3_c20231231_zo1MLlajxgTa" title="Subscription acquisition cost current"&gt;29,706&lt;/span&gt; are expected to be amortized over a one-year period, or through
December 31, 2024, and presented as long-term assets of $&lt;span id="xdx_903_eus-gaap--CapitalizedContractCostNetNoncurrent_iI_pn3n3_c20231231_zxsAKyrm7EHd" title="Acquisition cost long term"&gt;7,215&lt;/span&gt; are expected to be amortized after the one-year period ending December
31, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AREN:SubscriptionAcquisitionCostsPoliceTextBlock>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000961"
      unitRef="USD">38112000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000963"
      unitRef="USD">37190000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostNet
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000965"
      unitRef="USD">29706000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostNet
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000967"
      unitRef="USD">25931000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostNetNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000969"
      unitRef="USD">7215000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:CapitalizedContractCostNetNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000971"
      unitRef="USD">14133000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000973"
      unitRef="USD">29706000</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:CapitalizedContractCostNetNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000975"
      unitRef="USD">7215000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2023-01-01to2023-12-31" id="Fact000977">&lt;p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zuFwj24pNbIb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zdfqSnGTBc5i"&gt;Concentrations&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Significant
Customers&lt;/i&gt; &#x2013; Concentration of credit risk with respect to accounts receivable is limited to customers to whom the Company makes
significant sales. While a reserve for the potential write-off of accounts receivable is maintained, the Company has not written off
any material accounts to date. To control credit risk, the Company performs regular credit evaluations of its customers&#x2019; financial
condition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;Revenue from significant customers
as a percentage of the Company&#x2019;s total revenue represent approximately &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zThted2Odbo8" title="Percentage of revenue"&gt;10.0%&lt;/span&gt; from a customer for the year ended December 31,
2023. Revenue from significant customers as a percentage of the Company&#x2019;s total revenue represent &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_ziHFVgMQvzek" title="Percentage of revenue"&gt;13.9&lt;/span&gt;%
from a customer for the year ended December 31, 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Significant
Vendors&lt;/i&gt; &#x2013; Concentrations of risk with respect to third party vendors who provide products and services to the Company are limited.
If not limited, such concentrations could impact profitability if a vendor failed to fulfill their obligations or if a significant vendor
was unable to renew an existing contract and the Company was not able to replace the related product or service at the same cost.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant
accounts payable balances as a percentage of the Company&#x2019;s total accounts payable represent &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zLCCYvLPg5sa" title="Percentage of revenue"&gt;12.2&lt;/span&gt;%, and &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zt1aDfZZD7h8" title="Percentage of revenue"&gt;14.1&lt;/span&gt;% from a vendor for
the years ended December 31, 2023, and 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember"
      decimals="INF"
      id="Fact000979"
      unitRef="Pure">0.100</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember"
      decimals="INF"
      id="Fact000981"
      unitRef="Pure">0.139</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember"
      decimals="INF"
      id="Fact000983"
      unitRef="Pure">0.122</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_AccountsPayableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember"
      decimals="INF"
      id="Fact000985"
      unitRef="Pure">0.141</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000987">&lt;p id="xdx_84D_eus-gaap--LesseeLeasesPolicyTextBlock_zgFMOy83caE9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zaJmjfnbPHh1"&gt;Leases&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has lease arrangements for its offices. Leases are recorded as an operating lease right-of-use assets and
operating lease liabilities on the consolidated balance sheets. Leases with an initial term of 12 months or less are not recorded on
the consolidated balance sheets. At inception, the Company determines whether an arrangement that provides control over the use of an
asset is a lease. When it is reasonably certain that the Company will exercise the renewal period, the Company includes the impact of
the renewal in the lease term for purposes of determining total future lease payments. Rent expense is recognized on a straight-line
basis over the lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000989">&lt;p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zDl5ILyJlW6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zfB4YD9VIXwd"&gt;Property
and Equipment&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment is stated at cost less accumulated depreciation. Maintenance and repairs are charged to expense as incurred. Gains and
losses from disposition of property and equipment are included on the consolidated statements of operations when realized.
Depreciation and amortization are provided using the straight-line method over the following estimated useful lives:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock_zW0c7n0xBdG" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zTBFGihIfjp5" style="display: none"&gt;Schedule
of Depreciation and Amortization, Useful Lives of Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; background-color: white; border-collapse: collapse; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"&gt;Office equipment and computers&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember__srt--RangeAxis__srt--MinimumMember_zcxEM3qmqqvh" title="Property plant and equipment useful life"&gt;1&lt;/span&gt;
    &#x2013; &lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember__srt--RangeAxis__srt--MaximumMember_zJxfuGiMd98k" title="Property plant and equipment useful life"&gt;3&lt;/span&gt; years &lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zswoOMa1XqJ5" title="Property plant and equipment useful life"&gt;1&lt;/span&gt;
    &#x2013; &lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_ziKDN4X4JdCf" title="Property plant and equipment useful life"&gt;5&lt;/span&gt; years &lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A9_zMfJETCLDmIl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <AREN:ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000991">&lt;p id="xdx_89B_ecustom--ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock_zW0c7n0xBdG" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zTBFGihIfjp5" style="display: none"&gt;Schedule
of Depreciation and Amortization, Useful Lives of Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; background-color: white; border-collapse: collapse; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"&gt;Office equipment and computers&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember__srt--RangeAxis__srt--MinimumMember_zcxEM3qmqqvh" title="Property plant and equipment useful life"&gt;1&lt;/span&gt;
    &#x2013; &lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember__srt--RangeAxis__srt--MaximumMember_zJxfuGiMd98k" title="Property plant and equipment useful life"&gt;3&lt;/span&gt; years &lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zswoOMa1XqJ5" title="Property plant and equipment useful life"&gt;1&lt;/span&gt;
    &#x2013; &lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_ziKDN4X4JdCf" title="Property plant and equipment useful life"&gt;5&lt;/span&gt; years &lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;
</AREN:ScheduleOfDepreciationAndAmortizationUsefulLivesOfAssetsTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_custom_OfficeEquipmentAndComputersMember_srt_MinimumMember"
      id="Fact000993">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_custom_OfficeEquipmentAndComputersMember_srt_MaximumMember"
      id="Fact000995">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember_srt_MinimumMember"
      id="Fact000997">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember_srt_MaximumMember"
      id="Fact000999">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <AREN:PlatformDevelopmentPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001001">&lt;p id="xdx_846_ecustom--PlatformDevelopmentPolicyTextBlock_zy56NXyb0kWf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zyaIkOWXtRzd"&gt;Platform
Development&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company capitalizes platform development costs for internal use when planning and design efforts are successfully completed, and development
is ready to commence. The Company places capitalized platform development assets into service and commences amortization when the applicable
project or asset is substantially complete and ready for its intended use. Once placed into service, the Company capitalizes qualifying
costs of specified upgrades or enhancements to capitalized platform development assets when the upgrade or enhancement will result in
new or additional functionality.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company capitalizes internal labor costs, including payroll-based and stock-based compensation, benefits and payroll taxes, that are
incurred for certain capitalized platform development projects related to the Platform. The Company&#x2019;s policy with respect to capitalized
internal labor stipulates that labor costs for employees working on eligible internal use capital projects are capitalized as part of
the historical cost of the project when the impact, as compared to expensing such labor costs, is material.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Platform
development costs are amortized on a straight-line basis over three years, which is the estimated useful life of the related asset and
is recorded in cost of revenue on the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</AREN:PlatformDevelopmentPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy contextRef="From2023-01-01to2023-12-31" id="Fact001003">&lt;p id="xdx_845_eus-gaap--BusinessCombinationsPolicy_zT2MpaT5HXH9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zJI7DmkaUBF4"&gt;Business
Combinations&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for business combinations using the acquisition method of accounting. The acquisition method of accounting requires
that the purchase price, including the fair value of contingent consideration, of the acquisition be allocated to the assets acquired
and liabilities assumed using the estimated fair values determined by management as of the acquisition date. Goodwill is measured as
the excess of consideration transferred and the net fair values of the assets acquired, and the liabilities assumed at the date of acquisition.
While the Company uses its best estimates and assumptions as part of the purchase price allocation process to accurately value assets
acquired and liabilities assumed at the acquisition date, the Company&#x2019;s estimates are inherently uncertain and subject to refinement.
As a result, during the measurement period, the Company records adjustments to the assets acquired and liabilities assumed, with the
corresponding offset to goodwill to the extent the Company identifies adjustments to the preliminary purchase price allocation. Upon
the conclusion of the measurement period, which may be up to one year from the acquisition date, or final determination of the values
of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements
of operations. Additionally, the Company identifies acquisition-related contingent payments and determines their respective fair values
as of the acquisition date, which are recorded as accrued liabilities on the consolidated balance sheets. Subsequent changes in fair
value of contingent payments are recorded on the consolidated statements of operations. The Company expenses transaction costs related
to the acquisition as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2023-01-01to2023-12-31" id="Fact001005">&lt;p id="xdx_849_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zRmHtX5pTvZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zer3MX8n32Zc"&gt;Intangible
Assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets with finite lives, consisting of developed technology and trade names, are amortized using the straight-line method over the estimated
economic lives of the assets. A finite lived intangible asset is tested for recoverability whenever events or changes in circumstances
indicate that its carrying amount may not be recoverable. Determination of recoverability is based on an estimate of undiscounted future
cash flows resulting from the use of the asset and its eventual disposition. Intangible assets with an indefinite useful life are not
amortized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001007">&lt;p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zKkJeRxhDs7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zvWY7l29zly8"&gt;Long-Lived
Assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company periodically evaluates the carrying value of long-lived assets to be held and used when events or circumstances warrant such
a review. The carrying value of a long-lived asset to be held and used is considered impaired when the anticipated separately identifiable
undiscounted cash flows from such an asset are less than the carrying value of the asset. In that event, a loss is recognized based on
the amount by which the carrying value exceeds the fair value of the long-lived asset. Fair value is determined primarily by reference
to the anticipated cash flows discounted at a rate commensurate with the risk involved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="From2023-01-01to2023-12-31" id="Fact001009">&lt;p id="xdx_844_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zqeKGDJnsdl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_z2AQsN3mg3vf"&gt;Goodwill&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill
represents the excess of the purchase price over the fair value of the net tangible and intangible assets of businesses acquired in a
business combination. Goodwill is not amortized but rather is tested for impairment at least annually on December 31, or more frequently
if events or changes in circumstances indicate that the carrying amount of goodwill may not be recoverable. The Company operates as one
reporting unit, therefore, the impairment test is performed at the consolidated entity level. Recoverability of goodwill is determined
by comparing the fair value of Company&#x2019;s reporting unit to the carrying value of the underlying net assets in the reporting unit.
If the fair value of the reporting unit is determined to be less than the carrying value of its net assets, goodwill is deemed impaired,
and an impairment loss is recognized to the extent that the carrying value of goodwill exceeds the difference between the fair value
of the reporting unit and the fair value of its other assets and liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:DebtPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001011">&lt;p id="xdx_849_eus-gaap--DebtPolicyTextBlock_zSYHH4D9R5m2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zsLTIsIEsTe5"&gt;Debt
Costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Debt
costs consist of cash and noncash consideration paid to lenders and third parties with respect to debt and other financing transactions,
including legal fees and placement fees. Such costs are deferred and amortized over the term of the related debt. Upon the settlement
of debt the pro rata portion of any related unamortized debt costs are charged to operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additional
consideration in the form of warrants and other derivative financial instruments issued to lenders are accounted for at fair value utilizing
information determined by consultants with the Company&#x2019;s independent valuation firm. The fair value of warrants and derivatives
are recorded as a reduction to the carrying amount of the related debt and amortized to interest expense over the term of such debt,
with the initial offsetting entries recorded as a liability on the balance sheet. Upon the settlement of the debt the pro rata portion
of any related unamortized debt cost is charged to operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtPolicyTextBlock>
    <AREN:LiquidatedDamagesPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001013">&lt;p id="xdx_844_ecustom--LiquidatedDamagesPolicyTextBlock_zO8iSJcjfLf1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_z8RIaUQLlYs4"&gt;Liquidated
Damages&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--LiquidatedDamagesDescription_c20230101__20231231_zonRRIz47iA3" title="Liquidated damages description"&gt;The
Company incurred liquidated damages when: (i) a registration rights agreement provides for damages if the Company does not register the
shares of the Company&#x2019;s common stock within the requisite time frame (the &#x201c;Registration Rights Damages&#x201d;), which, in
general, provides for a cash payment equal to 1.0% per month of the amount invested, on a daily pro rata basis for any portion of a month,
as partial liquidated damages per month, upon the occurrence of certain events, up to a maximum amount of 6.0% of the aggregate amount
invested, subject to interest at the rate of 1.0% per month until paid in full; and (ii) a securities purchase agreement provides for
damages if the Company fails for any reason to satisfy a public information requirement within the requisite time frame with the Securities
and Exchange Commission (&#x201c;SEC&#x201d;) (the &#x201c;Public Information Failure Damages&#x201d;), which, in general, provides for a
cash payment equal to 1.0% of the aggregate amount invested for each 30-day period, or pro rata portion thereof, as partial liquidated
damages per month, up to a maximum of 6 months, subject to interest at the rate of 1.0% per month until paid in full. &lt;/span&gt;Collectively, the
Registration Rights Damages and the Public Information Failure Damages are referred to as the &#x201c;Liquidated Damages&#x201d; on the
consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</AREN:LiquidatedDamagesPolicyTextBlock>
    <AREN:LiquidatedDamagesDescription contextRef="From2023-01-01to2023-12-31" id="Fact001015">The
Company incurred liquidated damages when: (i) a registration rights agreement provides for damages if the Company does not register the
shares of the Company&#x2019;s common stock within the requisite time frame (the &#x201c;Registration Rights Damages&#x201d;), which, in
general, provides for a cash payment equal to 1.0% per month of the amount invested, on a daily pro rata basis for any portion of a month,
as partial liquidated damages per month, upon the occurrence of certain events, up to a maximum amount of 6.0% of the aggregate amount
invested, subject to interest at the rate of 1.0% per month until paid in full; and (ii) a securities purchase agreement provides for
damages if the Company fails for any reason to satisfy a public information requirement within the requisite time frame with the Securities
and Exchange Commission (&#x201c;SEC&#x201d;) (the &#x201c;Public Information Failure Damages&#x201d;), which, in general, provides for a
cash payment equal to 1.0% of the aggregate amount invested for each 30-day period, or pro rata portion thereof, as partial liquidated
damages per month, up to a maximum of 6 months, subject to interest at the rate of 1.0% per month until paid in full.</AREN:LiquidatedDamagesDescription>
    <AREN:SellingAndMarketingPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001017">&lt;p id="xdx_844_ecustom--SellingAndMarketingPolicyTextBlock_z0QK2t5Wt1Td" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_z3MWHRefDrKh"&gt;Selling
and Marketing&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Selling
and marketing expenses consist of compensation, employee benefits and stock-based compensation of selling and marketing, account management
support teams, as well as commissions, travel, trade show sponsorships and events, conferences and advertising costs. The Company&#x2019;s
advertising expenses relate to direct-mail costs for magazine subscription acquisition efforts, and print and digital advertising that
are expensed when an advertisement takes place. During the years ended December 31, 2023 and 2022, the Company incurred advertising expenses
of $&lt;span id="xdx_90B_eus-gaap--AdvertisingExpense_pn3n3_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zPoX2qm3OAc8" title="Advertising expense"&gt;4,372&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--AdvertisingExpense_pn3n3_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zxjpFaaFJ06g" title="Advertising expense"&gt;5,987&lt;/span&gt;, respectively, which are included within selling and marketing on the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</AREN:SellingAndMarketingPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="From2023-01-012023-12-31_us-gaap_SellingAndMarketingExpenseMember"
      decimals="-3"
      id="Fact001019"
      unitRef="USD">4372000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2022-01-012022-12-31_us-gaap_SellingAndMarketingExpenseMember"
      decimals="-3"
      id="Fact001021"
      unitRef="USD">5987000</us-gaap:AdvertisingExpense>
    <AREN:GeneralandAdministrativePolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001023">&lt;p id="xdx_84A_ecustom--GeneralandAdministrativePolicyTextBlock_zCq43ynBTIca" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zHESIMYAoQnd"&gt;General
and Administrative&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;General
and administrative expenses consist primarily of payroll for executive personnel, technology personnel incurred in developing conceptual
formulation and determination of existence of needed technology, and administrative personnel along with any related payroll costs; professional
services, including accounting, legal and insurance; facilities costs; conferences; other general corporate expenses; and stock-based
compensation of related personnel.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AREN:GeneralandAdministrativePolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001025">&lt;p id="xdx_84A_eus-gaap--DerivativesPolicyTextBlock_z3pQuzSXL8qj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zfzZMmqi8hhf"&gt;Derivative
Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for freestanding contracts that are settleable in the Company&#x2019;s equity securities, including the put option
on the Company&#x2019;s common stock, to be designated as an equity instrument, generally as a liability. A contract so
designated is carried at fair value on the consolidated balance sheets, with any changes in fair value recorded as a gain or loss
on the consolidated statements of operations, with no impact on cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
the date of settlement of a freestanding equity contract, the pro rata fair value of the related liability is transferred to additional
paid-in capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2023-01-01to2023-12-31" id="Fact001027">&lt;p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zmMSvz7HBx56" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zzFyoRQo3clh"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
authoritative guidance with respect to fair value established a fair value hierarchy that prioritizes the inputs to valuation techniques
used to measure fair value into three levels and requires that assets and liabilities carried at fair value be classified and disclosed
in one of three categories, as presented below. Disclosure as to transfers in and out of Levels 1 and 2, and activity in Level 3 fair
value measurements, is also required.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
1&lt;/i&gt;. Observable inputs such as quoted prices in active markets for an identical asset or liability that the Company has the ability
to access as of the measurement date. Financial assets and liabilities utilizing Level 1 inputs include active-exchange traded securities
and exchange-based derivatives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
2&lt;/i&gt;. Inputs, other than quoted prices included within Level 1, which are directly observable for the asset or liability or indirectly
observable through corroboration with observable market data. Financial assets and liabilities utilizing Level 2 inputs include fixed
income securities, non-exchange-based derivatives, mutual funds, and fair-value hedges.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
3&lt;/i&gt;. Unobservable inputs in which there is little or no market data for the asset or liability which requires the reporting entity
to develop its own assumptions. Financial assets and liabilities utilizing Level 3 inputs include infrequently traded non-exchange-based
derivatives and commingled investment funds and are measured using present value pricing models.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines the level in the fair value hierarchy within which each fair value measurement falls in its entirety, based on the
lowest level input that is significant to the fair value measurement in its entirety. In determining the appropriate levels, the Company
performs an analysis of the assets and liabilities at each reporting period end.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amount of the Company&#x2019;s financial instruments comprising of cash, restricted cash, accounts receivable, accounts payable
and accrued expenses and other approximate fair value because of the short-term maturity of these instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <AREN:PreferredStockPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001029">&lt;p id="xdx_84E_ecustom--PreferredStockPolicyTextBlock_zDlpskR8gWFg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zMpV7zgSR8na"&gt;Preferred
Stock&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Preferred
stock (the &#x201c;Preferred Stock&#x201d;) (as described in Note 20) is reported as a mezzanine obligation between liabilities and stockholders&#x2019;
deficiency. If it becomes probable that the Preferred Stock will become redeemable, the Company will re-measure the Preferred Stock by
adjusting the carrying value to the redemption value of the Preferred Stock assuming each balance sheet date is a redemption date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AREN:PreferredStockPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001031">&lt;p id="xdx_84D_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zIuIuxLGOIB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zpSOz2pWbCmh"&gt;Stock-Based
Compensation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company provides stock-based compensation in the form of (a) stock awards to employees and directors, comprised of restricted stock awards
and restricted stock units, (b) stock option grants to employees, directors and consultants, (c) common stock warrants to Publisher Partners
(no warrants were issued during the year ended December 31, 2022) (further details are provided under the headings &lt;i&gt;Publisher Partner
Warrants&lt;/i&gt; and &lt;i&gt;New Publisher Partner Warrants&lt;/i&gt; in Note 22), and (d) common stock warrants to ABG (further details are provided
under the heading &lt;i&gt;ABG Warrants&lt;/i&gt; in Note 22).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for stock awards and stock option grants to employees, directors and consultants, and non-employee awards to certain
directors and consultants by measuring the cost of services received in exchange for the stock-based payments as compensation expense
in the Company&#x2019;s consolidated financial statements. Stock awards and stock option grants to employees and non-employees which are
time-vested, are measured at fair value on the grant date, and charged to operations ratably over the vesting period. Stock awards and
stock option grants to employees and non-employees which are performance-vested, are measured at fair value on the grant date and charged
to operations when the performance condition is satisfied or over the service period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value measurement of stock awards and grants used for stock-based compensation is as follows: (1) restricted stock awards and restricted
stock units which are time-vested, are determined using the quoted market price of the Company&#x2019;s common stock at the grant date;
(2) stock option grants which are time-vested and performance-vested, are determined utilizing the Black-Scholes option-pricing model
at the grant date; (3) restricted stock units and stock option grants which provide for market-based vesting with a time-vesting overlay,
are determined through consultants with the Company&#x2019;s independent valuation firm using the Monte Carlo model at the grant date;
(4) Publisher Partner Warrants were determined utilizing the Black-Scholes option-pricing model; and (5) ABG warrants are determined
utilizing the Monte Carlo model (further details are provided in Note 22). Estimated volatility was determined under the (1) &#x201c;Probability
Weighted Scenarios&#x201d; (prior to the reverse stock split on February 8, 2022) where one scenario assumes that the Company&#x2019;s
common stock will be up-listed on a national stock exchange (the &#x201c;Exchange&#x201d;) on a certain listing date (the &#x201c;Up-list&#x201d;)
where the estimated volatility was based on evaluating the average historical volatility of a group of peer companies that are publicly
traded and the second scenario assumes that the Company&#x2019;s common stock is not up-listed on the Exchange prior to the final vesting
date of the grants (the &#x201c;No Up-list&#x201d;) where the historical volatility of the Company&#x2019;s common stock was evaluated based
upon market comparisons; and the (2) &#x201c;Up-list Scenario&#x201d; (after the reverse stock split on February 8, 2022) where the Company
estimated volatility based on evaluating the average historical volatility of a group of peer companies that are publicly traded after
the Company up-listed to the NYSE American. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time
of grant. The fair market value of common stock is determined by reference to the quoted market price of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has elected to recognize forfeitures as they occur and to recognize stock-based compensation cost on a straight-line basis over
the total requisite service period for awards with graded vesting. The Company classifies stock-based compensation cost on its consolidated
statements of operations in the same manner in which the award recipient&#x2019;s cash compensation cost is classified.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001033">&lt;p id="xdx_84F_eus-gaap--IncomeTaxPolicyTextBlock_zDKKsMkd28U" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zMvqGY6kRZR3"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the future
tax consequences attributable to operating loss carryforwards and temporary differences between financial statement bases of existing
assets and liabilities and their respective income tax bases. Deferred tax assets and liabilities are measured using enacted income tax
rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
The effect of a change in the income tax rates on deferred tax asset and liability balances is recognized in income in the period that
includes the enactment date of such rate change. A valuation allowance is recorded for loss carryforwards and other deferred tax assets
when it is determined that it is more likely than not that such loss carryforwards and deferred tax assets will not be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows accounting guidance that sets forth a threshold for financial statement recognition, measurement, and disclosure of a
tax position taken or expected to be taken on a tax return. Such guidance requires the Company to determine whether a tax position of
the Company is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any
related appeals or litigation processes, based on technical merits of the position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001035">&lt;p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zW0EOEfnZsc4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zP4yJZ86ccOj"&gt;Loss
per Common Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
loss per share is computed using the weighted average number of common shares outstanding during the period and excludes any dilutive
effects of common stock equivalent shares, such as stock options, restricted stock, and warrants. All restricted stock awards are considered
outstanding but are included in the computation of basic loss per common share only when the restrictions expire, the shares are no longer
forfeitable, and are thus vested. Restricted stock units are included in the computation of basic loss per common share only when the
restrictions expire, the shares are no longer forfeitable, and are thus vested. Contingently issuable shares are included in basic loss
per common share only when there are no circumstances under which those shares would not be issued. Diluted loss per common share is
computed using the weighted average number of common shares outstanding and common stock equivalent shares outstanding during the period
using the treasury stock method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company excluded the outstanding securities summarized below (capitalized terms are described herein), which entitle the holders thereof
to acquire shares of the Company&#x2019;s common stock, from its calculation of net loss per common share, as their effect would have
been anti-dilutive. Common stock equivalent shares are excluded from the diluted calculations when a net loss is incurred as they would
be anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zcNoxzT4AHKc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zUHosAth0BJk" style="display: none"&gt;Schedule of Net Income (Loss) Per Common Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Series G Preferred Stock&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesGConvertiblePreferredStockMember_zxS1HyVzT6Hg" style="width: 16%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;8,582&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesGConvertiblePreferredStockMember_zy05uUvS9Bi8" style="width: 16%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;8,582&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series H Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_zs3G5RlmtVc5" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1043"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_zPxiV0ZDttT2" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;1,981,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Financing Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--FinancingWarrantsMember_zWBVv26ftGIb" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1047"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--FinancingWarrantsMember_zZoIMd1yBJEk" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;107,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;ABG Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ABGWarrantsMember_znZyyHEUN9n8" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;999,540&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ABGWarrantsMember_zZnThCEIVN0l" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;999,540&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;AllHipHop Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--AllHipHopWarrantsMember_zHrXsJSzGy91" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;5,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--AllHipHopWarrantsMember_zPa0CoHEe7p4" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;5,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Publisher Partner Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublisherPartnerWarrantsMember_z12mD82wm2fk" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;9,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublisherPartnerWarrantsMember_zzrC8Hp0G7fc" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;4,154&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Restricted stock awards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockAwardsMember_zzBBvqBjcCLa" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1063"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockAwardsMember_zQPv2XEZ5SN1" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;97,403&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Restricted stock units&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_z7eIQKbpKSIg" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;199,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zFC86bgITA7d" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;994,766&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Common stock options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockOptionsMember_z0wnOpFkLHua" style="border-bottom: Black 1.5pt solid; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;5,451,968&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockOptionsMember_zh8GnBEkgfRl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;6,199,521&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231_zip2RniEz9B6" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;6,674,839&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zLIoGGwnyhJ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;10,398,732&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zyEVyspNnUD7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001037">&lt;p id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zcNoxzT4AHKc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zUHosAth0BJk" style="display: none"&gt;Schedule of Net Income (Loss) Per Common Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Series G Preferred Stock&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesGConvertiblePreferredStockMember_zxS1HyVzT6Hg" style="width: 16%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;8,582&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesGConvertiblePreferredStockMember_zy05uUvS9Bi8" style="width: 16%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;8,582&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series H Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_zs3G5RlmtVc5" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1043"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesHPreferredStockMember_zPxiV0ZDttT2" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;1,981,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Financing Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--FinancingWarrantsMember_zWBVv26ftGIb" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1047"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--FinancingWarrantsMember_zZoIMd1yBJEk" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;107,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;ABG Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ABGWarrantsMember_znZyyHEUN9n8" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;999,540&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ABGWarrantsMember_zZnThCEIVN0l" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;999,540&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;AllHipHop Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--AllHipHopWarrantsMember_zHrXsJSzGy91" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;5,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--AllHipHopWarrantsMember_zPa0CoHEe7p4" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;5,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Publisher Partner Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublisherPartnerWarrantsMember_z12mD82wm2fk" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;9,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublisherPartnerWarrantsMember_zzrC8Hp0G7fc" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;4,154&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Restricted stock awards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockAwardsMember_zzBBvqBjcCLa" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1063"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockAwardsMember_zQPv2XEZ5SN1" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;97,403&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Restricted stock units&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_z7eIQKbpKSIg" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;199,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zFC86bgITA7d" style="text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;994,766&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Common stock options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockOptionsMember_z0wnOpFkLHua" style="border-bottom: Black 1.5pt solid; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;5,451,968&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockOptionsMember_zh8GnBEkgfRl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;6,199,521&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231_zip2RniEz9B6" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;6,674,839&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zLIoGGwnyhJ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive securities excluded from computation of earnings per share amount"&gt;10,398,732&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact001039"
      unitRef="Shares">8582000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact001041"
      unitRef="Shares">8582000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_us-gaap_SeriesHPreferredStockMember"
      decimals="-3"
      id="Fact001045"
      unitRef="Shares">1981128000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_custom_FinancingWarrantsMember"
      decimals="-3"
      id="Fact001049"
      unitRef="Shares">107956000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember"
      decimals="-3"
      id="Fact001051"
      unitRef="Shares">999540000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_custom_ABGWarrantsMember"
      decimals="-3"
      id="Fact001053"
      unitRef="Shares">999540000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_custom_AllHipHopWarrantsMember"
      decimals="-3"
      id="Fact001055"
      unitRef="Shares">5682000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_custom_AllHipHopWarrantsMember"
      decimals="-3"
      id="Fact001057"
      unitRef="Shares">5682000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_custom_PublisherPartnerWarrantsMember"
      decimals="-3"
      id="Fact001059"
      unitRef="Shares">9800000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_custom_PublisherPartnerWarrantsMember"
      decimals="-3"
      id="Fact001061"
      unitRef="Shares">4154000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_custom_RestrictedStockAwardsMember"
      decimals="-3"
      id="Fact001065"
      unitRef="Shares">97403000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact001067"
      unitRef="Shares">199267000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact001069"
      unitRef="Shares">994766000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_custom_CommonStockOptionsMember"
      decimals="-3"
      id="Fact001071"
      unitRef="Shares">5451968000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_custom_CommonStockOptionsMember"
      decimals="-3"
      id="Fact001073"
      unitRef="Shares">6199521000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact001075"
      unitRef="Shares">6674839000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001077"
      unitRef="Shares">10398732000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001079">&lt;p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z6eBmGl1Tudc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_869_zX0scoSqXuz6"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recently
Adopted Accounting Standards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2022, the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued ASU 2022-02, &lt;i&gt;Financial Instruments-Credit Losses(Topic
326): Troubled Debt Restructurings and Vintage Disclosures, &lt;/i&gt;addressing areas identified by the FASB as part of its post-implementation
review of its previously issued credit losses standard (ASU 2016-13) that introduced the current expected credit losses (CECL) model.
ASU 2022-02 eliminates the accounting guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhances
disclosure requirements for certain loan refinancings and restructurings made with borrowers experiencing financial difficulty. This
update requires an entity to disclose current-period gross write-offs for financing receivables and net investment in leases by year
of origination in the vintage disclosures. As the Company has already adopted ASU 2016-13, the new guidance was adopted on January 1,
2023. The adoption of ASU 2022-02 did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recently
Issued Accounting Standards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2022, the FASB issued ASU 2022-03, &lt;i&gt;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to
Contractual Sale Restrictions&lt;/i&gt;, which clarifies that a contractual restriction on the sale of an equity security is not considered
part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. This update also clarifies
that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction and requires certain disclosures
for equity securities subject to contractual sale restrictions. ASU 2022-03 is effective for the Company in the fiscal year beginning
after December 15, 2023, and interim periods within the fiscal year. Early adoption is permitted for both interim and annual financial
statements that have not yet been issued or made available for issuance. The Company is currently evaluating the impact that the adoption
of this new accounting standard will have on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2023, the FASB issued ASU 2023-06, &lt;i&gt;Disclosure Improvements: Codification Amendments in Response to the SEC&#x2019;s Disclosure
Update and Simplification Initiative&lt;/i&gt;, which incorporates certain SEC disclosure requirements into the FASB Accounting Standards Codification
(&#x201c;Codification&#x201d;). The amendments are expected to clarify or improve disclosure and presentation requirements of a variety
of Codification Topics, allow users to more easily compare entities subject to the SEC&#x2019;s existing disclosures with those entities
that were not previously subject to the requirements, and align the requirements in the Codification with the SEC&#x2019;s regulations.
ASU 2023-06 will become effective for each amendment on the effective date of the SEC&#x2019;s corresponding disclosure rule changes.
The Company is currently evaluating the impact that the adoption of this new standard will have on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09, &lt;i&gt;Income Taxes&lt;/i&gt; (Topic 740): Improvements to Income Tax Disclosures, which will require
the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for
reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid
disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. The provisions
of ASU 2023-09 are effective for annual periods beginning after December 15, 2024; early adoption is permitted using either a prospective
or retrospective transition method. The Company expects ASU 2023-09 to require additional disclosures in the notes to its consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material
impact on the Company&#x2019;s financial statement presentation or disclosures.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <AREN:DiscontinuedOperationsTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001081">&lt;p id="xdx_80F_ecustom--DiscontinuedOperationsTextBlock_zUwU0ixC1G12" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;3.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_82C_zoLhDU1Nkc43"&gt;Discontinued Operations&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company, upon Board approval on September 15, 2022, discontinued (i.e., the &#x201c;discontinued operations&#x201d;) the Parade print business
(&#x201c;Parade Print&#x201d;) that was acquired on April 1, 2022 (as part of the Parade acquisition, as further described below in Note
4), on November 13, 2022 (the last date of any obligation to deliver issues of Parade Print).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zDQuJsdj6e0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
table below sets forth the loss from discontinued operations for the period from April 1, 2022 to December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zn22JF4NU2u1" style="display: none"&gt;Schedule
of Discontinued Operations&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20230101__20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ParadePrintMember_zpAqssYGLUo4" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_pn3n3_maDGIDOzNh5_z1Oaknj4Fcv3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; font-weight: bold; text-align: justify"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;26,817&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_pn3n3_msDGIDOzNh5_z01J6AkuB3R3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Cost of revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23,015&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_pn3n3_mtDGIDOzNh5_maDOILFz1bv_zyA3TSwAKUr4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Gross profit&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,802&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OperatingExpensesAbstract_iB_zPiAToi6biSf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Operating expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense_i01_pn3n3_maDGIDOz1uJ_zYCavD1n3Xsh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Selling and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,396&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_i01_pn3n3_maDGIDOz1uJ_znzXXSt0ioXc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,722&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges_i01_pn3n3_maDGIDOz1uJ_zp1wni88eKt4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"&gt;Loss on impairment of assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;209&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_i01T_pn3n3_mtDGIDOz1uJ_msDOILFz1bv_zyiQLv9Zvla9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Total operating expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,327&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_iT_pn3n3_mtDOILFz1bv_maILFDOzJiH_zEUMX57Z38xe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Loss from discontinued operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,525&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DiscontinuedOperationTaxEffectOfDiscontinuedOperation_pn3n3_msILFDOzJiH_zNYoXAHTZAH" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Income tax benefit&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;55&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_iT_pn3n3_mtILFDOzJiH_zySvqJIUxHYk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Net loss from discontinued operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(3,470&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_z6m7i83rvf6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
discontinued operations of Parade Print also included Relish and Spry Living print products that were acquired as part of the Parade
acquisition. Further information is provided under the heading Supplemental Pro Forma Information in Note 4.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2022, the Company recorded depreciation and amortization of $&lt;span id="xdx_90F_eus-gaap--DepreciationAndAmortizationDiscontinuedOperations_pn3n3_c20220101__20221231_zg28MDVAUFI9" title="Depreciation and amortization"&gt;0&lt;/span&gt;; and operating and investing noncash items
of $&lt;span id="xdx_90C_eus-gaap--GainLossOnDispositionOfAssets_pn3n3_c20230101__20231231_zD5UBQYu3Fva" title="Loss on impairment of assets"&gt;209&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--GainLossOnDispositionOfAssets_pn3n3_c20220101__20221231_z2iNy06Wludb" title="Loss on impairment of assets"&gt;0&lt;/span&gt;, respectively, as part of the discontinued operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AREN:DiscontinuedOperationsTextBlock>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001083">&lt;p id="xdx_89D_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zDQuJsdj6e0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
table below sets forth the loss from discontinued operations for the period from April 1, 2022 to December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zn22JF4NU2u1" style="display: none"&gt;Schedule
of Discontinued Operations&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20230101__20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--ParadePrintMember_zpAqssYGLUo4" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_pn3n3_maDGIDOzNh5_z1Oaknj4Fcv3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; font-weight: bold; text-align: justify"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;26,817&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_pn3n3_msDGIDOzNh5_z01J6AkuB3R3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Cost of revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23,015&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_pn3n3_mtDGIDOzNh5_maDOILFz1bv_zyA3TSwAKUr4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Gross profit&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,802&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OperatingExpensesAbstract_iB_zPiAToi6biSf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Operating expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense_i01_pn3n3_maDGIDOz1uJ_zYCavD1n3Xsh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Selling and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,396&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_i01_pn3n3_maDGIDOz1uJ_znzXXSt0ioXc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,722&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges_i01_pn3n3_maDGIDOz1uJ_zp1wni88eKt4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt"&gt;Loss on impairment of assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;209&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_i01T_pn3n3_mtDGIDOz1uJ_msDOILFz1bv_zyiQLv9Zvla9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Total operating expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,327&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_iT_pn3n3_mtDOILFz1bv_maILFDOzJiH_zEUMX57Z38xe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Loss from discontinued operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,525&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DiscontinuedOperationTaxEffectOfDiscontinuedOperation_pn3n3_msILFDOzJiH_zNYoXAHTZAH" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Income tax benefit&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;55&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_iT_pn3n3_mtILFDOzJiH_zySvqJIUxHYk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Net loss from discontinued operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(3,470&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="From2023-01-012023-12-31_custom_ParadePrintMember"
      decimals="-3"
      id="Fact001085"
      unitRef="USD">26817000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="From2023-01-012023-12-31_custom_ParadePrintMember"
      decimals="-3"
      id="Fact001087"
      unitRef="USD">23015000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
      contextRef="From2023-01-012023-12-31_custom_ParadePrintMember"
      decimals="-3"
      id="Fact001089"
      unitRef="USD">3802000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
    <AREN:DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense
      contextRef="From2023-01-012023-12-31_custom_ParadePrintMember"
      decimals="-3"
      id="Fact001093"
      unitRef="USD">5396000</AREN:DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31_custom_ParadePrintMember"
      decimals="-3"
      id="Fact001095"
      unitRef="USD">1722000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense>
    <AREN:DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges
      contextRef="From2023-01-012023-12-31_custom_ParadePrintMember"
      decimals="-3"
      id="Fact001097"
      unitRef="USD">209000</AREN:DisposalGroupIncludingDiscontinuedOperationAssetImpairmentCharges>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="From2023-01-012023-12-31_custom_ParadePrintMember"
      decimals="-3"
      id="Fact001099"
      unitRef="USD">7327000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="From2023-01-012023-12-31_custom_ParadePrintMember"
      decimals="-3"
      id="Fact001101"
      unitRef="USD">-3525000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="From2023-01-012023-12-31_custom_ParadePrintMember"
      decimals="-3"
      id="Fact001103"
      unitRef="USD">55000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="From2023-01-012023-12-31_custom_ParadePrintMember"
      decimals="-3"
      id="Fact001105"
      unitRef="USD">-3470000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:DepreciationAndAmortizationDiscontinuedOperations
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001107"
      unitRef="USD">0</us-gaap:DepreciationAndAmortizationDiscontinuedOperations>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact001109"
      unitRef="USD">209000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001111"
      unitRef="USD">0</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001113">&lt;p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_zr9YDOCgzFi6" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;4.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_823_zbxv6U8Ff2U1"&gt;Acquisitions and Dispositions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company uses the acquisition method of accounting, which is based on ASC, &lt;i&gt;Business Combinations (Topic 805)&lt;/i&gt;, and uses the fair
value concepts which requires, among other things, that most assets acquired, and liabilities assumed be recognized at their fair values
as of the acquisition date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2023
Acquisition&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;i&gt;Teneology,
Inc.&lt;/i&gt; &#x2013; On January 11, 2023, the Company entered into an asset purchase agreement with Teneology, Inc., (&#x201c;Teneology&#x201d;)
pursuant to which it acquired certain assets (consisting of the RoadFood media business, including digital and television assets; the
Moveable Feast media business, including digital and television assets; the Fexy-branded content studio business; and the MonkeySee YouTube
Channel media business, collectively &#x201c;Fexy Studios&#x201d;), for a purchase price of $&lt;span id="xdx_906_eus-gaap--AssetAcquisitionConsiderationTransferred_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zkB6Twoqkfla" title="Purchase price"&gt;3,307&lt;/span&gt;. The purchase price consisted of the
following: (1) $&lt;span id="xdx_90C_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zm3r9O5uzLZ2" title="Cash paid for consideration"&gt;500&lt;/span&gt; cash paid at closing (including an advance payment of $&lt;span id="xdx_907_eus-gaap--PaymentsForAdvanceToAffiliate_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_z8eky2HvceZ8" title="Advance payments of cash"&gt;250&lt;/span&gt; prior to closing); (2) $&lt;span id="xdx_90B_ecustom--DeferredCashPayments_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zoRqkNoHFbHe" title="Deferred cash payments"&gt;75&lt;/span&gt; deferred cash payments due
in three equal installments of $&lt;span id="xdx_90D_ecustom--DeferredCashPayments_pn3n3_c20230301__20230301__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zww3AfErgiv2" title="Deferred cash payments"&gt;&lt;span id="xdx_909_ecustom--DeferredCashPayments_pn3n3_c20230401__20230401__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zwANedERU5G2" title="Deferred cash payments"&gt;&lt;span id="xdx_90C_ecustom--DeferredCashPayments_pn3n3_c20230501__20230501__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_z5EhHyhMZAii" title="Deferred cash payments"&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; on March 1, 2023 (paid), April 1, 2023 (paid) and May 1, 2023 (paid); (3) $&lt;span id="xdx_903_ecustom--DeferredCashPaymentsDue_iI_pn3n3_c20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zfbK4Dm4gmG8" title="Deferred cash payment due"&gt;200&lt;/span&gt; deferred cash payment
due on the first anniversary of the closing date, subject to certain indemnity provisions (not paid in January 2024, further details
are provided under the heading &lt;i&gt;Fexy Put Option&lt;/i&gt; in Note 28); and (4) the issuance of &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_pid_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zz6I3R6Sh8ki" title="Number of shares issued for asset acquisition"&gt;274,692&lt;/span&gt; shares of the Company&#x2019;s common
stock, subject to certain lock-up provisions, with a fair value of $&lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_ze7ZQJ0APTyl" title="Fair value of shares issued"&gt;2,000&lt;/span&gt; on the transaction closing date (fair value was determined
based on an independent appraisal); and which is subject to a put option under certain conditions (the &#x201c;contingent consideration&#x201d;)
(as further described below in Note 17). The number of shares of the Company&#x2019;s common stock issued was determined based on a $&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zornQjl2prQ9" title="Share value"&gt;2,225&lt;/span&gt;
value using the common stock trading price on the day immediately preceding the January 11, 2023 closing date (on the closing date the
common stock trading price was $&lt;span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zcv9PW7bd62g" title="Common stock trading price"&gt;7.94&lt;/span&gt; per share). The agreement also provided for a cash retention pool for certain employees of $&lt;span id="xdx_908_eus-gaap--PaymentsToEmployees_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zBlk6jWxkmn1" title="Cash retention pool for employees"&gt;300&lt;/span&gt;,
subject to vesting over three years upon continued employment and other conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--AssetAcquisitionTableTextBlock_hus-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zZ04CRkYXmLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
composition of the purchase price is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_zmnG52KIiqZf" style="display: none"&gt;Schedule
of Composition Preliminary Assets Purchase Price&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zgZD4Tm5K2T" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_zVVk8z3HmHfe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_pn3n3_zpj6GXTndzJ3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AssetAcquisitionConsiderationTransferredContingentConsideration_pn3n3_z6AIBH3OCEt3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Contingent consideration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;561&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted_pn3n3_zwucxxjQkZTf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Deferred cash payments, as discounted&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;246&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AssetAcquisitionConsiderationTransferred_pn3n3_znH0qohjrN09" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total purchase consideration&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,307&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zMZX6QIg5r8e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounted for the asset acquisition as a business combination in accordance with ASC 805 since the acquisition met the definition
of a business under the applicable guidance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company incurred $&lt;span id="xdx_903_eus-gaap--AssetAcquisitionConsiderationTransferredTransactionCost_pn3n3_c20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zZFrRzv1dRyk" title="Asset acquisition transaction cost"&gt;99&lt;/span&gt; in transaction costs related to the acquisition, which primarily consisted of legal and accounting expenses. The
acquisition-related expenses were recorded in general and administrative expenses on the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--ScheduleOfAssetsAcquiredTableTextBlock_hus-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zkjMMaoHiFE3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the closing
date of the acquisition based upon their respective fair values as summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zVECqHb6rdrc" style="display: none"&gt;Summary
of Preliminary Assets Purchase Price Allocation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_z43ZG3xIYba9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zEJ8X7Od0Yb1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Advertiser relationships&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;663&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zsr2ZG29ddp5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Brand names&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_z3qPiUF5h4cf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Goodwill&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,985&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zikUkgFTNWY1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net assets acquired&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,307&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zt48EeFz4Wzg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilized an independent appraisal firm to assist in the determination of the fair values of the assets acquired and
liabilities assumed, which required certain significant management assumptions and estimates. The fair value of the advertiser relationships
were valued using the excess earnings method of the income approach and the brand names were valued using the relief-from-royalty method
of the income approach. The estimated useful life is fifteen years (&lt;span id="xdx_90A_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zKmWkfNaDWT7" title="Weighted average useful lives"&gt;15.0&lt;/span&gt; years) for the advertiser relationships and twelve years (&lt;span id="xdx_901_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zpRG4Lazyb82" title="Estimated useful life"&gt;12.0&lt;/span&gt;
years) for the brand names.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
excess-of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents goodwill from
the acquisition. Goodwill is recorded as a non-current asset that is not amortized but is subject to an annual review for impairment.
The Company expects $&lt;span id="xdx_909_eus-gaap--Goodwill_iI_pn3n3_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zMA2p2fGhgXd" title="Goodwill"&gt;1,678&lt;/span&gt; of goodwill to be deductible for tax purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Supplemental
Pro Forma Information&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
pro forma disclosures have been deemed impracticable for this acquisition since after making reasonable efforts the Company is unable
to accept assumptions made by Teneology. The Company has determined, based on the information provided by Teneology and made available
to the Company, that the earnings from the prior periods could not be verified since the acquisition only included certain activities
of Teneology and financial statements were not available. In this regard, the Company: (1) made reasonable effort to obtain certain financial
results of the certain activities but Teneology was unable to comply with this request; and (2) the presentation of the pro forma results
and the assumptions made by Teneology management were unable to be independently substantiated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2023
Disposition&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 17, 2023, the Company sold certain assets related to one of Parade&#x2019;s business components known as Athlon Outdoors for
cash proceeds of $&lt;span id="xdx_90C_eus-gaap--ProceedsFromSaleOfOtherAssetsInvestingActivities_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zYVtY7panr0g" title="Cash proceeds"&gt;1,061&lt;/span&gt; ($&lt;span id="xdx_907_ecustom--SalePrice_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zAgeQwsg5Wnf" title="Sale price"&gt;1,000&lt;/span&gt; sale price (with a target working capital of $&lt;span id="xdx_90C_ecustom--WorkingCapital_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zTVZKW7x1C12" title="Working capital"&gt;272&lt;/span&gt;) plus a preliminary working capital adjustment of $&lt;span id="xdx_907_ecustom--PreliminaryWorkingCapital_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zPUfa07j0Kcd" title="Preliminary working capital"&gt;61&lt;/span&gt;),
as further reduced by a final working capital adjustment of $&lt;span id="xdx_90F_ecustom--WorkingCapitalAdjustments_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zm3ueyp1hCE1" title="Adjustment for working capital"&gt;153&lt;/span&gt;, as reflected in accrued expenses and other on the consolidated balance
sheets, resulting in a final sale price of $&lt;span id="xdx_90A_ecustom--FinalSalePrice_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zo9Qz0cZi1Sd" title="Sale price"&gt;908&lt;/span&gt;. In connection with the sale, the Company disposed of certain advertiser relationships
and trade name relating to that business component with a carrying value of $&lt;span id="xdx_90A_eus-gaap--ProceedsFromDivestitureOfBusinesses_pn3n3_c20230101__20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zE1hwQ2cQwi9" title="Business component carrying value"&gt;639&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--ProceedsFromDivestitureOfBusinesses_pn3n3_c20231117__20231117__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zfszcMsfqk1i" title="Business component carrying value"&gt;172&lt;/span&gt;, respectively, along with the accounts receivable
and accounts payable of the business component of $&lt;span id="xdx_904_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_z0jzp9bQwLE8" title="Accounts receivable net current"&gt;453&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zrjtY0gR8S0k" title="Accounts payable current"&gt;31&lt;/span&gt;, respectively, resulting in a recognized loss on sale of assets of $&lt;span id="xdx_909_eus-gaap--GainLossOnDispositionOfAssets1_pn3n3_c20230101__20231231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--Disposition2023Member_zs3PQpNKBa22" title="Loss on assets"&gt;325&lt;/span&gt;
as reflected on the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2022
Acquisitions&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Athlon
Holdings, Inc&lt;/i&gt;. - On April 1, 2022, the Company acquired &lt;span id="xdx_90D_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z9HgGxh3cAuj" title="Acquired percentage"&gt;100&lt;/span&gt;% of the issued and outstanding capital stock of Athlon Holdings, Inc.
(or Parade), a Tennessee corporation, for a purchase price of $&lt;span id="xdx_904_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zUAWqPJKXJDd" title="Acquisition purchase price"&gt;15,854&lt;/span&gt;, as adjusted for the working capital adjustment as of the closing
date of the transaction. The working capital adjustment is pending acceptance by the sellers (further details are provided in Note 27).
As a part of the closing consideration, the Company also acquired cash of $&lt;span id="xdx_90C_eus-gaap--CashAcquiredFromAcquisition_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zm43dQOyHe44" title="Acquired cash"&gt;1,840&lt;/span&gt;, that was further adjusted post-closing for the working
capital adjustment. The purchase price of $&lt;span id="xdx_900_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zOtEhTzgp1Ua" title="Business combination consideration transferred1"&gt;15,854&lt;/span&gt;, as discounted, is comprised of (i) a cash portion of $&lt;span id="xdx_902_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zZBeHq6smHrk" title="Cash portion in acquisition"&gt;12,827&lt;/span&gt;, with $&lt;span id="xdx_906_ecustom--PaymentsToAcquireBusinessesAtClosing_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zXH5IKgiGrF" title="Cash payments paid at closing"&gt;11,840&lt;/span&gt; paid at
closing and $&lt;span id="xdx_903_eus-gaap--OtherPaymentsToAcquireBusinesses_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zkdKe6lpRpAd" title="Payments for acquire"&gt;987&lt;/span&gt; estimated to be paid post-closing (as further described below) and (ii) the issuance of &lt;span id="xdx_901_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zNIlktA6ypNg" title="Number of shares issued in acquisition"&gt;314,103&lt;/span&gt; shares of the Company&#x2019;s
common stock with a fair market value of $&lt;span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_pn3n3_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zP8egd6CyLU" title="Fair value of shares issued in acquisition"&gt;3,141&lt;/span&gt;. The number of shares of the Company&#x2019;s common stock issued was determined based
on a $&lt;span id="xdx_908_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_pn3n3_c20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDW7ZUveSKib" title="Stock value assigned"&gt;3,000&lt;/span&gt; value using the common stock trading price for the 10 trading days preceding the April 1, 2022 closing date. Certain of Parade&#x2019;s
key employees entered into either advisory agreements or employment agreements with the Company. Parade operates in the United States.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z6UcP99iQgG9" title="Acquisition description"&gt;The
amount estimated to be paid post-closing of $987 will be or was paid as follows: (i) $742 is expected to be paid upon receipts of certain
tax refunds due to the sellers (consisting of $3,000 for the deferred cash payments, as discounted, less a $2,258 cash adjustment); and
(ii) $245 was paid within two business days from the date the Company received proceeds from the sale of the equity interest in Just
Like Falling Off a Bike, LLC that was held by Parade as of the closing date (paid on April 7, 2022).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--BusinessCombinationContingentConsiderationArrangementsDescription_c20220701__20220930__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zqTF2EckKdNe" title="Acquisition description"&gt;The
Company received a final valuation report from a third party valuation firm after the preliminary purchase price was adjusted during
the quarterly period ended September 30, 2022. After considering the results of the final valuation report, the Company estimated
that the purchase consideration decreased by $321. The decrease in the purchase price was related to an increase in identifiable
assets of $54, an increase in deferred tax liabilities of $27, with a decrease in the working capital adjustment of $321, resulting
in a decrease in goodwill of $348.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zVU71i5ront5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
composition of the purchase price is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_zwoDcSHUgxF3" style="display: none"&gt;Schedule
of Composition of Purchase Price&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20220401__20220401_zwWFAR22WvQk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--PaymentsToAcquireBusinessesGross_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z06h1E9eddT8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;12,085&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zKefsckbnuA3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,141&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--BusinessCombinationConsiderationTransferredOther1_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zWMQEOG6nLX5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred cash payments, as discounted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;628&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zfMsmFECWBY2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total purchase consideration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;15,854&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zm4vRXrEeEP5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company incurred $&lt;span id="xdx_90F_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zHx04YDc0O43" title="Transaction cost"&gt;200&lt;/span&gt; in transaction costs related to the acquisition, which primarily consisted of legal and accounting expenses. The
acquisition-related expenses were recorded within general and administrative expense on the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zkjC4t2Uej3a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the closing
date of the acquisition based upon their respective fair values as summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;span id="xdx_8B3_zz11kMAZmCik" style="display: none"&gt;Summary
of Purchase Price Allocation&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20220401_zwJKPlcE4Bz5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zJSpTofVvLOf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,604&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zH4qtZRDuZga" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,855&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zBgAJM5kdXSd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,337&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z3GlLmnxNIYf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Equity investment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zqRHG02u1aaa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Fixed assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;108&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z7lf3nyVTBD9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Digital content&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;355&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zBZ8aVJw4Pk3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Advertiser relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,202&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zUzZt8DEbBq2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade names&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,261&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Goodwill_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zYFqYAyq6HIk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Goodwill&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,587&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zQYCeWwBC2db" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accounts payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,416&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z1rSZYK6FWCj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued expenses and other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,440&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zDwmMH6zpqRc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Unearned revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,203&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zt1sMzBsO7wl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other long-term liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(543&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zFmtJ1scgfze" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,303&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pn3n3_zEMBrdmRhRqc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net assets acquired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;15,854&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zidnkAUjyobb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilized an independent appraisal firm to assist in the determination of the fair values of the assets acquired and liabilities
assumed, which required certain significant management assumptions and estimates. The fair value of the digital content was determined
using a cost approach. The fair values of the advertiser relationships were determined by projecting the acquired entity&#x2019;s cash
flows, deducting notional contributory asset charges on supporting assets (working capital, tangible assets, trade names, and the assembled
workforce) to compute the excess cash flows associated with the advertiser relationships. The fair values of the trade names were determined
by projecting revenue associated with each trade name and applying a royalty rate to compute the amount of the royalty payments the company
is relieved from paying due to its ownership of the trade names. The estimated weighted average useful life is two years (&lt;span id="xdx_90D_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_z4B0hPvLFXWj" title="Estimated weighted average useful life"&gt;2.00&lt;/span&gt; years)
for digital content, eight point seventy-five years (&lt;span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zBrWFJAucMBe" title="Estimated weighted average useful life"&gt;8.75&lt;/span&gt; years) for advertiser relationships, and fourteen point five years (&lt;span id="xdx_908_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220401__20220401__us-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z0rpFjbmxZ8f" title="Estimated weighted average useful life"&gt;14.50&lt;/span&gt; years)
for trade names.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
excess purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents goodwill from the
acquisition. Goodwill is recorded as a non-current asset that is not amortized but is subject to an annual review for impairment. No
portion of the goodwill related to the acquisition will be deductible for tax purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Supplemental
Pro Forma Information&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zG6IKhpF3Y11" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the results of continuing operations of the Parade acquisition from the acquisition date included in the consolidated
results of continuing operations and the unaudited pro forma results of continuing operations of the combined entity had the date of
the acquisition been January 1, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BD_zcU5rNh4TdRb" style="display: none"&gt;Schedule
of Supplemental Proforma Information&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20220101__20221231_z7remYnAFZUe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;br/&gt;
 December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Parade continuing operations from acquisition date of April 1, 2022 (unaudited):&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--Revenues_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_z0IgHpsFega5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 80%"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;40,071&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_zmLU31f2hiYe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,494&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Combined entity continuing operations supplemental pro forma information had the acquisition date been January 1, 2022 (unaudited):&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Revenue:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_z56KFyPQBJTd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt"&gt;Parade&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;55,981&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ArenaMember_zXoW2umzo1Mh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt"&gt;Arena&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;207,681&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_zKkEAGwHIyVd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Total continuing operations supplemental pro forma revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;263,662&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Net loss:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_zXre08hcmKIg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt"&gt;Parade&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,070&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ArenaMember_zkGp4Jcz3AUl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt"&gt;Arena&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(67,788&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AdjustmentsMember_z8RHDUqrILie" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt"&gt;Adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,940&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_zFokrXxMi8Ii" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Total continuing operations supplemental pro forma net loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(72,798&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zDWUwa8mob3c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
information presented above is for illustrative purposes only and is not necessarily indicative of results that would have been achieved
if the acquisition had occurred at the beginning of the Company&#x2019;s reporting period and does not reflect the discontinued operations
of Parade Print that was acquired on April 1, 2022 (as part of the Parade acquisition).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments_c20220101__20221231_zcNg9RGyUL54" title="Adjustment description"&gt;The
adjustments for the year ended December 31, 2022 of ($1,940), represents adjustments: (1) to record depreciation and amortization expense
related to the fixed and intangible assets acquired from the acquisition of ($864); (2) to reverse the nonrecurring transaction cost
related to the acquisition of $200; and (3) to reverse the deferred tax benefit related to the acquisition of ($1,276).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Buffalo
Groupe, LLC &lt;/i&gt;&#x2013; On September 27, 2022, the Company entered into an asset purchase agreement with Buffalo Groupe, LLC, doing business
as Morning Read, where it purchased certain intellectual properties, certain assumed contracts, and other certain rights related to the
intellectual properties (collectively, the &#x201c;Morning Read Purchased Assets&#x201d;) and assumed certain liabilities related to the
Morning Read Purchased Assets. The purchase consideration consisted of a cash payment of $&lt;span id="xdx_905_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220927__20220927__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BuffaloGroupeLLCMember__us-gaap--AssetAcquisitionAxis__custom--IntellectualPropertiesMember_zUe34YN2It35" title="Cash paid for consideration"&gt;850 &lt;/span&gt;at closing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounted for the acquisition as an asset acquisition in accordance with ASC 805-50, as substantially all of the fair value of
the gross assets acquired by the Company is concentrated in a group of similar identifiable assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purchase consideration totaled $&lt;span id="xdx_902_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220927__20220927__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BuffaloGroupeLLCMember__us-gaap--AssetAcquisitionAxis__custom--IntellectualPropertiesMember_zbKA6r7JVPhk" title="Cash paid for consideration"&gt;850&lt;/span&gt;, which was assigned to the brand name acquired on the closing date of the acquisition. The useful
life for the brand name is ten years (&lt;span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220927_zuhMxXWOiquh" title="Useful lives"&gt;10.0&lt;/span&gt; years).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;A360
Media, &lt;/i&gt;LLC &#x2013; On December 15, 2022 (the closing date), pursuant to an asset purchase agreement entered into December 7, 2022,
the Company acquired certain assets and liabilities from Weider Publications, a subsidiary of A360 Media, LLC (or Men&#x2019;s Journal)
related to the digital media operations of Men&#x2019;s Journal and other men&#x2019;s active lifestyle brands. The Company paid $&lt;span id="xdx_90F_eus-gaap--CashAcquiredFromAcquisition_pn3n3_c20221215__20221215_z8idO6AGKLp4" title="Cash acquired for acquisition"&gt;25,000&lt;/span&gt;
in cash for the acquisition consisting of: (i) $&lt;span id="xdx_90E_eus-gaap--CashAcquiredFromAcquisition_pn3n3_c20221207__20221207_zDcZE9nzLx7k" title="Cash acquired for acquisition"&gt;23,000&lt;/span&gt; paid at closing; (ii) $&lt;span id="xdx_900_eus-gaap--EscrowDeposit_iI_pn3n3_c20221215_zQMkN66ZRDvj" title="Escrow deposit"&gt;1,000&lt;/span&gt; deposited into an escrow account to be released in
accordance with the terms of the agreement, subject to adjustments for any indemnification payments; and (iii) $&lt;span id="xdx_909_eus-gaap--EscrowDeposit_iI_pn3n3_c20221130_z6VrpKYk2xd" title="Escrow deposit"&gt;1,000 &lt;/span&gt;paid in November
2022. The Company also assumed certain liabilities consisting of: (i) $&lt;span id="xdx_906_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_iI_pn3n3_c20221130_znkFSBJ1qpFj" title="Assumed lease obligation"&gt;2,676&lt;/span&gt; an assumed lease obligation, as discounted (representing
$&lt;span id="xdx_90B_eus-gaap--DeferredRevenue_iI_pn3n3_c20221130_znWoFZfYJNza" title="Deferred payments"&gt;3,189&lt;/span&gt; in deferred payments over twenty-seven months (27) for the assumption of a lease obligation); and (ii) $&lt;span id="xdx_907_ecustom--DeferredRevenueObligation_iI_c20221130_znB9NBy8zfNa" title="Deferred revenue obligation"&gt;4,078&lt;/span&gt; in deferred revenue
obligations to deliver certain publications to the subscribers of Men&#x2019;s Journal ($&lt;span id="xdx_905_eus-gaap--UnearnedPremiums_iI_pn3n3_c20221130_zAl6StEbg4U6" title="Unearned revenue"&gt;3,941&lt;/span&gt; in unearned revenue after consideration
of an estimated subscription refund liability of $&lt;span id="xdx_905_eus-gaap--CustomerRefundLiabilityCurrent_iI_pn3n3_c20221130_zQoCOpzKx0W3" title="Refund liability"&gt;137&lt;/span&gt;). In accordance with the practical expedients under ASU 2021-08, the Company has
elected to apply (i) the practical expedient to the modification of the subscriber contracts at the acquisition date to determine the
performance obligations and transaction price; and (ii) to use the estimated selling price of a subscriber contract as the standalone
selling price of the replacement magazine based on the number of magazines expected to be delivered to the Men&#x2019;s Journal subscribers
to satisfy the performance obligations. The agreement contains customary representations, warranties and covenants. Men&#x2019;s Journal
operates in the United States.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounted for the asset acquisition as a business combination in accordance with ASC 805 since the acquisition met the definition
of a business under the applicable guidance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company incurred $&lt;span id="xdx_902_eus-gaap--AssetAcquisitionConsiderationTransferredTransactionCost_pn3n3_c20221215__20221215_zwHGEE9bmldh" title="Transaction cost"&gt;283&lt;/span&gt; in transaction costs related to the acquisition, which primarily consisted of legal and accounting expenses. The
acquisition-related expenses were recorded within general and administrative expense on the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the acquisition of Men&#x2019;s Journal, the Company received a final valuation report during the quarterly period
ended September 30, 2023 from a third party valuation firm after the preliminary purchase price was determined. After considering
the results of the final valuation report, the Company estimated that the purchase consideration increased by $&lt;span id="xdx_900_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--MensJournalMember_zkiEGp6ZOQac" title="Goodwill, acquired during period"&gt;1,246&lt;/span&gt;
as a result of an increase in the fair value of the assumed lease obligation with an offset recorded to goodwill (see Note
11).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--PreliminaryPriceAllocationTableTextBlock_z0FbDxu0hiZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the closing
date of the acquisition based upon their respective fair values as summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zchIUZR7TZh6" style="display: none"&gt;Schedule
of Preliminary Price Allocation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20231231_zW26LEiBXS28" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zFW5k6qyBLhb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Lease deposit receivable&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;420&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zRgr58wPNMi3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Advertiser relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,860&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_znh0LJ8NCxah" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Brand names&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zQLSP7Se0Wjl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Goodwill&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zrbigUcHcuLf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Unearned revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,941&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zA3ssgNovCO1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Subscription refund liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(137&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_ztHG9TXJ02Gk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Assumed lease obligation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,676&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_mtBCRIAzrWD_zihQ2yobSH02" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Net assets acquired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;25,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zemWWPYCIq4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilized an independent appraisal firm to assist in the determination of the fair values of the assets acquired and liabilities
assumed, which required certain significant management assumptions and estimates. The fair value of the advertiser relationships were
determined by applying the multi-period earnings method of the income approach and the fair values of the brand names were determined
by applying the relief-from-royalty method. The estimated weighted average useful life is twelve and one-half years (&lt;span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--A360MediaLLCMember__srt--TitleOfIndividualAxis__custom--AdvertiserRelationshipMember_zGUyHjiSdQrb" title="Weighted average useful lives"&gt;12.5 &lt;/span&gt;years) for
the advertiser relationships and eleven years (&lt;span id="xdx_901_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--A360MediaLLCMember__srt--TitleOfIndividualAxis__custom--BrandNameMember_zRzlOfNNqAz3" title="Weighted average useful lives"&gt;11.0&lt;/span&gt; years) for the brand names.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
excess-of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents goodwill from
the acquisition. Goodwill is recorded as a non-current asset that is not amortized but is subject to an annual review for impairment.
The Company expects $&lt;span id="xdx_906_eus-gaap--BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_iI_pn3n3_c20231231_z44haoaboe22" title="Goodwill for tax"&gt;12,299&lt;/span&gt; of goodwill to be deductible for tax purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Supplemental
Pro Forma Information&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
pro forma disclosures have been deemed impracticable for this acquisition since after making reasonable efforts the Company is unable
to accept assumptions made by Men&#x2019;s Journal. The Company has determined, based on the information provided by Men&#x2019;s Journal
and made available to the Company, that the earnings from the prior periods could not be verified since the acquisition only included
certain activities of Men&#x2019;s Journal and financial statements were not available. In this regard, the Company: (1) made reasonable
effort to obtain certain financial results of the certain activities but Men&#x2019;s Journal was unable to apply the requirement; and
(2) the presentation of the pro forma results and the assumptions made by management were unable be independently substantiated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001115"
      unitRef="USD">3307000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001117"
      unitRef="USD">500000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsForAdvanceToAffiliate
      contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001119"
      unitRef="USD">250000</us-gaap:PaymentsForAdvanceToAffiliate>
    <AREN:DeferredCashPayments
      contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001121"
      unitRef="USD">75000</AREN:DeferredCashPayments>
    <AREN:DeferredCashPayments
      contextRef="From2023-03-012023-03-01_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001123"
      unitRef="USD">25000</AREN:DeferredCashPayments>
    <AREN:DeferredCashPayments
      contextRef="From2023-04-012023-04-01_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001125"
      unitRef="USD">25000</AREN:DeferredCashPayments>
    <AREN:DeferredCashPayments
      contextRef="From2023-05-012023-05-01_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001127"
      unitRef="USD">25000</AREN:DeferredCashPayments>
    <AREN:DeferredCashPaymentsDue
      contextRef="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001129"
      unitRef="USD">200000</AREN:DeferredCashPaymentsDue>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets
      contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="INF"
      id="Fact001131"
      unitRef="Shares">274692</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets
      contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001133"
      unitRef="USD">2000000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001135"
      unitRef="USD">2225000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="INF"
      id="Fact001137"
      unitRef="USDPShares">7.94</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:PaymentsToEmployees
      contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001139"
      unitRef="USD">300000</us-gaap:PaymentsToEmployees>
    <us-gaap:AssetAcquisitionTableTextBlock
      contextRef="From2023-01-012023-12-31_custom_FexyStudiosMember"
      id="Fact001141">&lt;p id="xdx_89D_eus-gaap--AssetAcquisitionTableTextBlock_hus-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zZ04CRkYXmLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
composition of the purchase price is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_zmnG52KIiqZf" style="display: none"&gt;Schedule
of Composition Preliminary Assets Purchase Price&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20230111__20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zgZD4Tm5K2T" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_zVVk8z3HmHfe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_pn3n3_zpj6GXTndzJ3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AssetAcquisitionConsiderationTransferredContingentConsideration_pn3n3_z6AIBH3OCEt3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Contingent consideration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;561&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted_pn3n3_zwucxxjQkZTf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Deferred cash payments, as discounted&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;246&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AssetAcquisitionConsiderationTransferred_pn3n3_znH0qohjrN09" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total purchase consideration&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,307&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:AssetAcquisitionTableTextBlock>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001143"
      unitRef="USD">500000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable
      contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001145"
      unitRef="USD">2000000</us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable>
    <us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration
      contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001147"
      unitRef="USD">561000</us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration>
    <AREN:AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted
      contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001149"
      unitRef="USD">246000</AREN:AssetAcquisitionConsiderationTransferredDeferredCashPaymentsAsDiscounted>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001151"
      unitRef="USD">3307000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost
      contextRef="From2023-01-112023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001153"
      unitRef="USD">99000</us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost>
    <AREN:ScheduleOfAssetsAcquiredTableTextBlock
      contextRef="From2023-01-012023-12-31_custom_FexyStudiosMember"
      id="Fact001155">&lt;p id="xdx_89A_ecustom--ScheduleOfAssetsAcquiredTableTextBlock_hus-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zkjMMaoHiFE3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the closing
date of the acquisition based upon their respective fair values as summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zVECqHb6rdrc" style="display: none"&gt;Summary
of Preliminary Assets Purchase Price Allocation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20230111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_z43ZG3xIYba9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zEJ8X7Od0Yb1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Advertiser relationships&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;663&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zsr2ZG29ddp5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Brand names&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_z3qPiUF5h4cf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Goodwill&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,985&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AssetAcquisitionAssetsAcquired_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TeneologyIncMember__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosMember_zikUkgFTNWY1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net assets acquired&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,307&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</AREN:ScheduleOfAssetsAcquiredTableTextBlock>
    <AREN:AssetAcquisitionAssetsAcquired
      contextRef="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember_custom_AdvertiserRelationshipsMember"
      decimals="-3"
      id="Fact001157"
      unitRef="USD">663000</AREN:AssetAcquisitionAssetsAcquired>
    <AREN:AssetAcquisitionAssetsAcquired
      contextRef="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember_custom_BrandNamesMember"
      decimals="-3"
      id="Fact001159"
      unitRef="USD">659000</AREN:AssetAcquisitionAssetsAcquired>
    <AREN:AssetAcquisitionAssetsAcquired
      contextRef="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember_us-gaap_GoodwillMember"
      decimals="-3"
      id="Fact001161"
      unitRef="USD">1985000</AREN:AssetAcquisitionAssetsAcquired>
    <AREN:AssetAcquisitionAssetsAcquired
      contextRef="AsOf2023-01-11_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001163"
      unitRef="USD">3307000</AREN:AssetAcquisitionAssetsAcquired>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2023-01-012023-12-31_custom_AdvertiserRelationshipsMember"
      id="Fact001165">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2023-01-012023-12-31_custom_BrandNamesMember"
      id="Fact001167">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="AsOf2023-12-31_custom_TeneologyIncMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact001169"
      unitRef="USD">1678000</us-gaap:Goodwill>
    <us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities
      contextRef="From2023-11-172023-11-17_custom_Disposition2023Member"
      decimals="-3"
      id="Fact001171"
      unitRef="USD">1061000</us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities>
    <AREN:SalePrice
      contextRef="From2023-11-172023-11-17_custom_Disposition2023Member"
      decimals="-3"
      id="Fact001173"
      unitRef="USD">1000000</AREN:SalePrice>
    <AREN:WorkingCapital
      contextRef="From2023-11-172023-11-17_custom_Disposition2023Member"
      decimals="-3"
      id="Fact001175"
      unitRef="USD">272000</AREN:WorkingCapital>
    <AREN:PreliminaryWorkingCapital
      contextRef="From2023-11-172023-11-17_custom_Disposition2023Member"
      decimals="-3"
      id="Fact001177"
      unitRef="USD">61000</AREN:PreliminaryWorkingCapital>
    <AREN:WorkingCapitalAdjustments
      contextRef="From2023-11-172023-11-17_custom_Disposition2023Member"
      decimals="-3"
      id="Fact001179"
      unitRef="USD">153000</AREN:WorkingCapitalAdjustments>
    <AREN:FinalSalePrice
      contextRef="From2023-11-172023-11-17_custom_Disposition2023Member"
      decimals="-3"
      id="Fact001181"
      unitRef="USD">908000</AREN:FinalSalePrice>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="From2023-01-012023-12-31_custom_Disposition2023Member"
      decimals="-3"
      id="Fact001183"
      unitRef="USD">639000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="From2023-11-172023-11-17_custom_Disposition2023Member"
      decimals="-3"
      id="Fact001185"
      unitRef="USD">172000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-12-31_custom_Disposition2023Member"
      decimals="-3"
      id="Fact001187"
      unitRef="USD">453000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-12-31_custom_Disposition2023Member"
      decimals="-3"
      id="Fact001189"
      unitRef="USD">31000</us-gaap:AccountsPayableCurrent>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2023-01-012023-12-31_custom_Disposition2023Member"
      decimals="-3"
      id="Fact001191"
      unitRef="USD">325000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember"
      decimals="INF"
      id="Fact001193"
      unitRef="Pure">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001195"
      unitRef="USD">15854000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001197"
      unitRef="USD">1840000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001199"
      unitRef="USD">15854000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates
      contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001201"
      unitRef="USD">12827000</us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates>
    <AREN:PaymentsToAcquireBusinessesAtClosing
      contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001203"
      unitRef="USD">11840000</AREN:PaymentsToAcquireBusinessesAtClosing>
    <us-gaap:OtherPaymentsToAcquireBusinesses
      contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001205"
      unitRef="USD">987000</us-gaap:OtherPaymentsToAcquireBusinesses>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001207"
      unitRef="Shares">314103000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001209"
      unitRef="USD">3141000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact001211"
      unitRef="USD">3000000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity
      contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember"
      id="Fact001213">The
amount estimated to be paid post-closing of $987 will be or was paid as follows: (i) $742 is expected to be paid upon receipts of certain
tax refunds due to the sellers (consisting of $3,000 for the deferred cash payments, as discounted, less a $2,258 cash adjustment); and
(ii) $245 was paid within two business days from the date the Company received proceeds from the sale of the equity interest in Just
Like Falling Off a Bike, LLC that was held by Parade as of the closing date (paid on April 7, 2022).</us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsDescription
      contextRef="From2022-07-012022-09-30_custom_AthlonHoldingsIncMember"
      id="Fact001215">The
Company received a final valuation report from a third party valuation firm after the preliminary purchase price was adjusted during
the quarterly period ended September 30, 2022. After considering the results of the final valuation report, the Company estimated
that the purchase consideration decreased by $321. The decrease in the purchase price was related to an increase in identifiable
assets of $54, an increase in deferred tax liabilities of $27, with a decrease in the working capital adjustment of $321, resulting
in a decrease in goodwill of $348.</us-gaap:BusinessCombinationContingentConsiderationArrangementsDescription>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="From2023-01-012023-12-31_custom_AthlonHoldingsIncMember"
      id="Fact001217">&lt;p id="xdx_89F_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zVU71i5ront5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
composition of the purchase price is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_zwoDcSHUgxF3" style="display: none"&gt;Schedule
of Composition of Purchase Price&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20220401__20220401_zwWFAR22WvQk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--PaymentsToAcquireBusinessesGross_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z06h1E9eddT8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;12,085&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zKefsckbnuA3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,141&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--BusinessCombinationConsiderationTransferredOther1_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zWMQEOG6nLX5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred cash payments, as discounted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;628&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zfMsmFECWBY2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total purchase consideration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;15,854&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001219"
      unitRef="USD">12085000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001221"
      unitRef="USD">3141000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredOther1
      contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001223"
      unitRef="USD">628000</us-gaap:BusinessCombinationConsiderationTransferredOther1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001225"
      unitRef="USD">15854000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001227"
      unitRef="USD">200000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="From2023-01-012023-12-31_custom_AthlonHoldingsIncMember"
      id="Fact001229">&lt;p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zkjC4t2Uej3a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the closing
date of the acquisition based upon their respective fair values as summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;span id="xdx_8B3_zz11kMAZmCik" style="display: none"&gt;Summary
of Purchase Price Allocation&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20220401_zwJKPlcE4Bz5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zJSpTofVvLOf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,604&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zH4qtZRDuZga" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,855&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zBgAJM5kdXSd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,337&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z3GlLmnxNIYf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Equity investment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zqRHG02u1aaa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Fixed assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;108&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z7lf3nyVTBD9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Digital content&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;355&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zBZ8aVJw4Pk3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Advertiser relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,202&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zUzZt8DEbBq2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade names&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,261&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Goodwill_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zYFqYAyq6HIk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Goodwill&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,587&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zQYCeWwBC2db" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accounts payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,416&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_z1rSZYK6FWCj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued expenses and other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,440&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zDwmMH6zpqRc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Unearned revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,203&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zt1sMzBsO7wl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other long-term liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(543&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_zFmtJ1scgfze" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,303&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pn3n3_zEMBrdmRhRqc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net assets acquired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;15,854&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001231"
      unitRef="USD">2604000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001233"
      unitRef="USD">10855000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001235"
      unitRef="USD">1337000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001237"
      unitRef="USD">2450000</AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquityInvestement>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001239"
      unitRef="USD">108000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001241"
      unitRef="USD">355000</AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalContent>
    <AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001243"
      unitRef="USD">6202000</AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisement>
    <AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001245"
      unitRef="USD">2261000</AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName>
    <us-gaap:Goodwill
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001247"
      unitRef="USD">2587000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001249"
      unitRef="USD">7416000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001251"
      unitRef="USD">-2440000</AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001253"
      unitRef="USD">1203000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001255"
      unitRef="USD">543000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="AsOf2022-04-01_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001257"
      unitRef="USD">1303000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="AsOf2022-04-01"
      decimals="-3"
      id="Fact001259"
      unitRef="USD">15854000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember_custom_DigitalContentMember"
      id="Fact001261">P2Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember_custom_AdvertiserRelationshipsMember"
      id="Fact001263">P8Y9M</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2022-04-012022-04-01_custom_AthlonHoldingsIncMember_us-gaap_TradeNamesMember"
      id="Fact001265">P14Y6M</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001267">&lt;p id="xdx_899_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zG6IKhpF3Y11" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the results of continuing operations of the Parade acquisition from the acquisition date included in the consolidated
results of continuing operations and the unaudited pro forma results of continuing operations of the combined entity had the date of
the acquisition been January 1, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BD_zcU5rNh4TdRb" style="display: none"&gt;Schedule
of Supplemental Proforma Information&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20220101__20221231_z7remYnAFZUe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;br/&gt;
 December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Parade continuing operations from acquisition date of April 1, 2022 (unaudited):&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--Revenues_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_z0IgHpsFega5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 80%"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;40,071&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_zmLU31f2hiYe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,494&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Combined entity continuing operations supplemental pro forma information had the acquisition date been January 1, 2022 (unaudited):&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Revenue:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_z56KFyPQBJTd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt"&gt;Parade&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;55,981&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ArenaMember_zXoW2umzo1Mh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt"&gt;Arena&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;207,681&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_zKkEAGwHIyVd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Total continuing operations supplemental pro forma revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;263,662&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Net loss:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_zXre08hcmKIg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt"&gt;Parade&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,070&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ArenaMember_zkGp4Jcz3AUl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt"&gt;Arena&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(67,788&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AdjustmentsMember_z8RHDUqrILie" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt"&gt;Adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,940&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_zFokrXxMi8Ii" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Total continuing operations supplemental pro forma net loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(72,798&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-12-31_custom_ParadeMember"
      decimals="-3"
      id="Fact001269"
      unitRef="USD">40071000</us-gaap:Revenues>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_ParadeMember"
      decimals="-3"
      id="Fact001271"
      unitRef="USD">-2494000</us-gaap:NetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2022-01-012022-12-31_custom_ParadeMember"
      decimals="-3"
      id="Fact001273"
      unitRef="USD">55981000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2022-01-012022-12-31_custom_ArenaMember"
      decimals="-3"
      id="Fact001275"
      unitRef="USD">207681000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001277"
      unitRef="USD">263662000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_ParadeMember"
      decimals="-3"
      id="Fact001279"
      unitRef="USD">-3070000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_ArenaMember"
      decimals="-3"
      id="Fact001281"
      unitRef="USD">-67788000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_AdjustmentsMember"
      decimals="-3"
      id="Fact001283"
      unitRef="USD">-1940000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001285"
      unitRef="USD">-72798000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments contextRef="From2022-01-012022-12-31" id="Fact001287">The
adjustments for the year ended December 31, 2022 of ($1,940), represents adjustments: (1) to record depreciation and amortization expense
related to the fixed and intangible assets acquired from the acquisition of ($864); (2) to reverse the nonrecurring transaction cost
related to the acquisition of $200; and (3) to reverse the deferred tax benefit related to the acquisition of ($1,276).</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteNatureOfAdjustments>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2022-09-272022-09-27_custom_BuffaloGroupeLLCMember_custom_IntellectualPropertiesMember"
      decimals="-3"
      id="Fact001289"
      unitRef="USD">850000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2022-09-272022-09-27_custom_BuffaloGroupeLLCMember_custom_IntellectualPropertiesMember"
      decimals="-3"
      id="Fact001291"
      unitRef="USD">850000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="AsOf2022-09-27" id="Fact001293">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2022-12-152022-12-15"
      decimals="-3"
      id="Fact001295"
      unitRef="USD">25000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2022-12-072022-12-07"
      decimals="-3"
      id="Fact001297"
      unitRef="USD">23000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:EscrowDeposit
      contextRef="AsOf2022-12-15"
      decimals="-3"
      id="Fact001299"
      unitRef="USD">1000000</us-gaap:EscrowDeposit>
    <us-gaap:EscrowDeposit
      contextRef="AsOf2022-11-30"
      decimals="-3"
      id="Fact001301"
      unitRef="USD">1000000</us-gaap:EscrowDeposit>
    <AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation
      contextRef="AsOf2022-11-30"
      decimals="-3"
      id="Fact001303"
      unitRef="USD">2676000</AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation>
    <us-gaap:DeferredRevenue
      contextRef="AsOf2022-11-30"
      decimals="-3"
      id="Fact001305"
      unitRef="USD">3189000</us-gaap:DeferredRevenue>
    <AREN:DeferredRevenueObligation
      contextRef="AsOf2022-11-30"
      decimals="0"
      id="Fact001307"
      unitRef="USD">4078</AREN:DeferredRevenueObligation>
    <us-gaap:UnearnedPremiums
      contextRef="AsOf2022-11-30"
      decimals="-3"
      id="Fact001309"
      unitRef="USD">3941000</us-gaap:UnearnedPremiums>
    <us-gaap:CustomerRefundLiabilityCurrent
      contextRef="AsOf2022-11-30"
      decimals="-3"
      id="Fact001311"
      unitRef="USD">137000</us-gaap:CustomerRefundLiabilityCurrent>
    <us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost
      contextRef="From2022-12-152022-12-15"
      decimals="-3"
      id="Fact001313"
      unitRef="USD">283000</us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2023-01-012023-12-31_custom_MensJournalMember"
      decimals="-3"
      id="Fact001315"
      unitRef="USD">1246000</us-gaap:GoodwillAcquiredDuringPeriod>
    <AREN:PreliminaryPriceAllocationTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001317">&lt;p id="xdx_895_ecustom--PreliminaryPriceAllocationTableTextBlock_z0FbDxu0hiZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the closing
date of the acquisition based upon their respective fair values as summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zchIUZR7TZh6" style="display: none"&gt;Schedule
of Preliminary Price Allocation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20231231_zW26LEiBXS28" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zFW5k6qyBLhb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Lease deposit receivable&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;420&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zRgr58wPNMi3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Advertiser relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,860&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_znh0LJ8NCxah" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Brand names&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zQLSP7Se0Wjl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Goodwill&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zrbigUcHcuLf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Unearned revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,941&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_zA3ssgNovCO1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Subscription refund liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(137&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation_iNI_pn3n3_di_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_maBCRIAzrWD_ztHG9TXJ02Gk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Assumed lease obligation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,676&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--AthlonHoldingsIncMember_mtBCRIAzrWD_zihQ2yobSH02" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Net assets acquired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;25,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</AREN:PreliminaryPriceAllocationTableTextBlock>
    <AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable
      contextRef="AsOf2023-12-31_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001319"
      unitRef="USD">420000</AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseDepositReceivable>
    <AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship
      contextRef="AsOf2023-12-31_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001321"
      unitRef="USD">6860000</AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvertisementRelationship>
    <AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName
      contextRef="AsOf2023-12-31_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001323"
      unitRef="USD">6090000</AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBrandName>
    <AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill
      contextRef="AsOf2023-12-31_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001325"
      unitRef="USD">18384000</AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill>
    <AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue
      contextRef="AsOf2023-12-31_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001327"
      unitRef="USD">3941000</AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnearnedRevenue>
    <AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability
      contextRef="AsOf2023-12-31_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001329"
      unitRef="USD">137000</AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSubscriptionRefundLiability>
    <AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation
      contextRef="AsOf2023-12-31_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001331"
      unitRef="USD">2676000</AREN:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssumedLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2023-12-31_custom_AthlonHoldingsIncMember"
      decimals="-3"
      id="Fact001333"
      unitRef="USD">25000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2022-01-012022-12-31_custom_A360MediaLLCMember_custom_AdvertiserRelationshipMember"
      id="Fact001335">P12Y6M</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2022-01-012022-12-31_custom_A360MediaLLCMember_custom_BrandNameMember"
      id="Fact001337">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001339"
      unitRef="USD">12299000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <AREN:PrepaymentsAndOtherCurrentAssetsTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001341">&lt;p id="xdx_80F_ecustom--PrepaymentsAndOtherCurrentAssetsTextBlock_zPuocP0aOew4" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;5&lt;/b&gt;.&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_825_z1TzmsbZPEZf"&gt;Prepayments and Other Current Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock_zK21i0AyAXs3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepayments
and other current assets are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_z52qj90FVIZ1" style="display: none"&gt;Schedule
of Prepayments and Other Current Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20231231_zxRSM98gSmEd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20221231_z2aVu4WSZfWc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--PrepaidExpenseCurrent_iI_pn3n3_maPEAOAz2Qi_zJXP5KDmgx51" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Prepaid expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,946&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,321&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--PrepaidSuppliesCurrent_iI_pn3n3_maPEAOAz2Qi_zmQmNq1cyVU8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Prepaid supplies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;773&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;927&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--RefundableIncomeAndFranchiseTaxes_iI_pn3n3_maPEAOAz2Qi_zccHzQlbKAsf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Refundable income and franchise taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;157&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--UnamortizedDebtIssuanceExpense_iI_pn3n3_maPEAOAz2Qi_za6mXI3yoJq2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Unamortized debt costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;209&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;216&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--EmployeeRetentionCredits_iI_pn3n3_maPEAOAz2Qi_zcFBlFeyijPi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Employee retention credits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,468&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1358"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OtherReceivablesNetCurrent_iI_pn3n3_maPEAOAz2Qi_zrOUrSKRot2j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;45&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pn3n3_mtPEAOAz2Qi_zPhGd2b5E9Ek" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Total prepayments and other current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,598&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,441&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zX2WTuWHqDVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the provisions of the Coronavirus Aid, Relief, and Economic Security Act (the &#x201c;CARES Act&#x201d;) and the subsequent extensions
of the CARES Act, the Company was eligible for a refundable employee retention credit subject to certain criteria. The Company determined
that it qualifies for the tax credit under the CARES Act. In connection with the CARES Act, the Company adopted a policy to recognize
the employee retention credit when earned and to offset the credit against the related expenditure. During the year ended December 31,
2023, the Company recorded the employee retention credits as a reduction to payroll and related expenses of $&lt;span id="xdx_906_eus-gaap--OtherLaborRelatedExpenses_pn3n3_c20230101__20231231_zO4xbNltNFK5" title="Employee retention credits"&gt;6,868&lt;/span&gt; in operating expenses
on the consolidated statements of operations with a corresponding receivable included in prepaid expenses and other current assets on
the consolidated balance sheets for the respective periods. During the year ended December 31, 2023, the Company received $&lt;span id="xdx_90D_ecustom--EmployeeRetentionPayable_pn3n3_c20230101__20231231_zG672UcrBTha" title="Retention Payable"&gt;4,400 &lt;/span&gt;in employee
retention credits and has a receivable balance remaining of $&lt;span id="xdx_909_ecustom--EmployeeRetentionCredits_iI_pn3n3_c20231231_zduN6gOwQ9Ga" title="Employee retention credits"&gt;2,468&lt;/span&gt; as of December 31, 2023.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AREN:PrepaymentsAndOtherCurrentAssetsTextBlock>
    <AREN:ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001343">&lt;p id="xdx_89B_ecustom--ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock_zK21i0AyAXs3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepayments
and other current assets are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_z52qj90FVIZ1" style="display: none"&gt;Schedule
of Prepayments and Other Current Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20231231_zxRSM98gSmEd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20221231_z2aVu4WSZfWc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--PrepaidExpenseCurrent_iI_pn3n3_maPEAOAz2Qi_zJXP5KDmgx51" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Prepaid expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,946&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,321&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--PrepaidSuppliesCurrent_iI_pn3n3_maPEAOAz2Qi_zmQmNq1cyVU8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Prepaid supplies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;773&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;927&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--RefundableIncomeAndFranchiseTaxes_iI_pn3n3_maPEAOAz2Qi_zccHzQlbKAsf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Refundable income and franchise taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;157&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--UnamortizedDebtIssuanceExpense_iI_pn3n3_maPEAOAz2Qi_za6mXI3yoJq2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Unamortized debt costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;209&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;216&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--EmployeeRetentionCredits_iI_pn3n3_maPEAOAz2Qi_zcFBlFeyijPi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Employee retention credits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,468&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1358"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OtherReceivablesNetCurrent_iI_pn3n3_maPEAOAz2Qi_zrOUrSKRot2j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;45&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pn3n3_mtPEAOAz2Qi_zPhGd2b5E9Ek" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Total prepayments and other current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,598&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,441&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</AREN:ScheduleOfPrepaymentsAndOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001345"
      unitRef="USD">2946000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001346"
      unitRef="USD">2321000</us-gaap:PrepaidExpenseCurrent>
    <AREN:PrepaidSuppliesCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001348"
      unitRef="USD">773000</AREN:PrepaidSuppliesCurrent>
    <AREN:PrepaidSuppliesCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001349"
      unitRef="USD">927000</AREN:PrepaidSuppliesCurrent>
    <AREN:RefundableIncomeAndFranchiseTaxes
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001351"
      unitRef="USD">157000</AREN:RefundableIncomeAndFranchiseTaxes>
    <AREN:RefundableIncomeAndFranchiseTaxes
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001352"
      unitRef="USD">957000</AREN:RefundableIncomeAndFranchiseTaxes>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001354"
      unitRef="USD">209000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001355"
      unitRef="USD">216000</us-gaap:UnamortizedDebtIssuanceExpense>
    <AREN:EmployeeRetentionCredits
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001357"
      unitRef="USD">2468000</AREN:EmployeeRetentionCredits>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001360"
      unitRef="USD">45000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001361"
      unitRef="USD">20000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001363"
      unitRef="USD">6598000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001364"
      unitRef="USD">4441000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:OtherLaborRelatedExpenses
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact001366"
      unitRef="USD">6868000</us-gaap:OtherLaborRelatedExpenses>
    <AREN:EmployeeRetentionPayable
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact001368"
      unitRef="USD">4400000</AREN:EmployeeRetentionPayable>
    <AREN:EmployeeRetentionCredits
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001370"
      unitRef="USD">2468000</AREN:EmployeeRetentionCredits>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001372">&lt;p id="xdx_805_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z3Hg37ldTFh" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;6.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_822_zdVfLk3g2l52"&gt;Property and Equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--PropertyPlantAndEquipmentTextBlock_zrVBM4nfXDV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_z00fXVxvVns5" style="display: none"&gt;Schedule
of Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20231231_ztUb904c6zD9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20221231_zxMkf96zdw12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember_zG7nYHo7rrqg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Office equipment and computers&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,744&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,744&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zw5uzQL0rvOe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Furniture and fixtures&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;166&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;240&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzTTM_zxgEiOJC5C5b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Gross property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,910&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,984&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzTTM_zPkDfoa6qxae" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Less accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,582&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,249&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzTTM_zwnAoQd435qf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Net property and equipment&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;328&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;735&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AF_zuYWTEt2IYlh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
and amortization expense for the years ended December 31, 2023 and 2022 was $&lt;span id="xdx_90D_eus-gaap--Depreciation_pn3n3_c20230101__20231231_zdaL43uw8j8c" title="Depreciation expense"&gt;352&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--Depreciation_pn3n3_c20220101__20221231_zoH8zUsisaW4" title="Depreciation expense"&gt;539&lt;/span&gt;, respectively. Impairment charges for property
and equipment for the years ended December 31, 2023 and 2022 of $&lt;span id="xdx_908_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_pn3n3_c20230101__20231231__us-gaap--FairValueByAssetClassAxis__us-gaap--PropertyPlantAndEquipmentMember_z0nDHDAYQZjl" title="Impairment charges for property and equipment"&gt;55&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_pn3n3_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--PropertyPlantAndEquipmentMember_z5xbJahBsWO2" title="Impairment charges for property and equipment"&gt;0&lt;/span&gt;, respectively, have been recorded on the consolidated statements
of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001374">&lt;p id="xdx_894_eus-gaap--PropertyPlantAndEquipmentTextBlock_zrVBM4nfXDV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_z00fXVxvVns5" style="display: none"&gt;Schedule
of Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20231231_ztUb904c6zD9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20221231_zxMkf96zdw12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentAndComputersMember_zG7nYHo7rrqg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Office equipment and computers&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,744&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,744&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zw5uzQL0rvOe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Furniture and fixtures&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;166&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;240&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzTTM_zxgEiOJC5C5b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Gross property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,910&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,984&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzTTM_zPkDfoa6qxae" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Less accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,582&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,249&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzTTM_zwnAoQd435qf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Net property and equipment&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;328&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;735&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_custom_OfficeEquipmentAndComputersMember"
      decimals="-3"
      id="Fact001376"
      unitRef="USD">1744000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_OfficeEquipmentAndComputersMember"
      decimals="-3"
      id="Fact001377"
      unitRef="USD">1744000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="-3"
      id="Fact001379"
      unitRef="USD">166000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="-3"
      id="Fact001380"
      unitRef="USD">240000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001382"
      unitRef="USD">1910000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001383"
      unitRef="USD">1984000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001385"
      unitRef="USD">1582000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001386"
      unitRef="USD">1249000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001388"
      unitRef="USD">328000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001389"
      unitRef="USD">735000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact001391"
      unitRef="USD">352000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001393"
      unitRef="USD">539000</us-gaap:Depreciation>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2023-01-012023-12-31_us-gaap_PropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fact001395"
      unitRef="USD">55000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2022-01-012022-12-31_us-gaap_PropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fact001397"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001399">&lt;p id="xdx_808_eus-gaap--LesseeOperatingLeasesTextBlock_zp7r0tGPOlvc" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;7.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_82A_zURCtNm2fX9f"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s real estate lease for the use of office space was subleased during the year ended December 31, 2023. The Company determines
whether an arrangement contains a lease at inception. Lease assets and liabilities are recognized upon commencement of the lease based
on the present value of the future minimum lease payments over the lease term. The lease term includes options to extend the lease when
it is reasonably certain that the Company will exercise that option.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company&#x2019;s current operating lease
has a remaining fixed payment term of &lt;span id="xdx_902_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20231231_z5DwXVVTobC2" title="Operating lease, remaining fixed payment term"&gt;0.75&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--SupplementalInformationRelatedToOperatingLeasesTableTextBlock_z52YZlcmodh3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
table below presents supplemental information related to the operating lease:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zbc8Sd4pa3G1" style="display: none"&gt;Schedule
of Supplemental Information Related to Operating Leases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Operating lease costs during the year (1)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LeaseCost_pn3n3_c20230101__20231231_fKDEp_zwycTJTBHuPg" style="width: 16%; text-align: right" title="Operating lease costs during the year"&gt;1,052&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LeaseCost_pn3n3_c20220101__20221231_fKDEp_z73jF7LNQxa5" style="width: 16%; text-align: right" title="Operating lease costs during the year"&gt;969&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cash payments included in the measurement of operating lease liability during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OperatingLeasePayments_pn3n3_c20230101__20231231_z2yyjd2lZEh9" style="text-align: right" title="Cash payments included in the measurement of operating lease liabilities during the year"&gt;486&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OperatingLeasePayments_pn3n3_c20220101__20221231_zV3eA2wVOeb8" style="text-align: right" title="Cash payments included in the measurement of operating lease liabilities during the year"&gt;469&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average remaining lease term (in years) as of year-end&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_zvVHFKuBJfxf" title="Weighted-average remaining lease term (in years) as of year-end"&gt;0.75&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zV1asf4n4CX6" title="Weighted-average remaining lease term (in years) as of year-end"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average discount rate during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20231231_z3naXHOK2tSf" title="Weighted-average discount rate during the year"&gt;9.90&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231_z3QuF40HSk5c" title="Weighted-average discount rate during the year"&gt;9.90&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F08_zb7OynYi8UTh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F18_zEBwpg9r4gh8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating lease
costs is presented net of sublease income that is not material.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A6_zPM9gRvgFt43" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company generally utilizes its incremental borrowing rate based on information available at the commencement of the lease in determining
the present value of future payments since the implicit rate for the Company&#x2019;s lease is not readily determinable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Variable
lease expense includes rental increases that are not fixed, such as those based on amounts paid to the lessor based on cost or consumption,
such as maintenance and utilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zJfBLkQAHXFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of operating lease costs were follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zO2LqGqlKC0c" style="display: none"&gt;Schedule
of Operating Lease Costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230101__20231231_zinowhJF3MF8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220101__20221231_zG8RsxWcdt29" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Operating lease costs:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingLeaseCost_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zV0B4SpXnKy7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt"&gt;General and administrative&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"&gt;1,344&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"&gt;1,187&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OperatingLeaseCost_pn3n3_maLCzoNR_zpSk8bcA8Md1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 20pt"&gt;Total operating costs (&lt;span id="xdx_F4B_zLdAqtn6mQj3"&gt;1&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,187&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--SubleaseIncome_iN_pn3n3_di_msLCzoNR_zkt2DSPB3R76" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"&gt;Less sublease income&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(292&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(218&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LeaseCost_iT_pn3n3_mtLCzoNR_zBWuVL4CSMb2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total operating lease costs&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,052&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;969&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F02_zTMXHN40VhG6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1D_zEregB25HjTh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes certain
costs associated with a business membership agreement (see below) that permits access to certain office space for the years ended December
31, 2023 and 2022 of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_904_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessMembershipAgreementMember_zU6h5otEQ9t7" title="Operating lease cost"&gt;620&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--OperatingLeaseCost_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--BusinessMembershipAgreementMember_z6Ipd2wuVVn6" title="Operating lease cost"&gt;668&lt;/span&gt;, respectively, and month-to-month lease arrangements for the years ended December 31, 2023 and 2022
of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--MonthToMonthLeaseArrangementMember_zKURtxpM8Jmd" title="Operating lease cost"&gt;396&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--OperatingLeaseCost_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--MonthToMonthLeaseArrangementMember_zmCHQMmJCq5d" title="Operating lease cost"&gt;320&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;


&lt;p id="xdx_8A3_zj6IvB2CrPGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zmOuJ48hGynk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Maturities
of the operating lease liability as of December 31, 2023 are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zVtIOD6SsG02" style="display: none"&gt;Summary
of Maturity of Lease Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20231231_zQ9FCrzvbBFa" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtLOLLPzG3L_zYptFfV4rQMa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Minimum lease payments - 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; text-align: right"&gt;373&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_zKMGTQFvJeW6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Less imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(15&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zdX0MRz6KWX3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Present value of operating lease liability&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;358&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_z45RPMTavPHc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Current portion of operating lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;358&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zyDmUs7j4Ru9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Long-term portion of operating lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1455"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zrTlsJVExJT6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total operating lease liability&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;358&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A2_z5VISfiKK3T2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Sublease
Agreement &lt;/i&gt;&#x2013; The Company has entered into agreements to sublease certain space that it does not occupy, through the duration
of the lease terms, with one sublease through September 2024 and two other subleases through March 2024. As of December 31, 2023, the
Company is entitled to receive total sublease income of $&lt;span id="xdx_90A_eus-gaap--SubleaseIncome_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SubleaseAgreementMember_z7BmfQ5fLWy1" title="Sublease income"&gt;537&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Business
Membership&lt;/i&gt; &#x2013; Effective October 1, 2021, the Company entered into a business membership agreement with York Factory LLC, doing
business as SaksWorks, that permits access to certain office space with furnishings, referred to as SaksWorks Memberships. This membership
provides a certain number of accounts that equate to the use of the space granted. Effective June 1, 2022, the SaksWorks membership agreement
was amended and assigned to Convene SW MSA Holdings, LLC (&#x201c;Convene&#x201d;). The initial term of the agreement with Convene was
through December 31, 2023, with provisions for renewals. The Company terminated the arrangement effective December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Lease
Termination &lt;/i&gt;&#x2013; Effective September 30, 2021, the Company terminated a certain lease arrangement for office space. In connection
with the termination, the Company agreed to pay the landlord cash of $&lt;span id="xdx_90B_eus-gaap--ProceedsFromLeasePayments_pn3n3_c20210901__20210930__us-gaap--TypeOfArrangementAxis__custom--LeaseArrangementMember_zVQwRn51UMvi" title="Proceeds from lease payments"&gt;10,000&lt;/span&gt; (the &#x201c;Cash Payments&#x201d;) and $&lt;span id="xdx_909_eus-gaap--AdvertisingExpense_pn3n3_c20210901__20210930__us-gaap--TypeOfArrangementAxis__custom--LeaseArrangementMember_zI2X2wgvnx7b" title="Advertising expense"&gt;1,475&lt;/span&gt; in market rate
advertising. The Cash Payments were paid or remain due as follows: $&lt;span id="xdx_90D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_c20211231_zbZxuqy619hd" title="Cash payments"&gt;1,000&lt;/span&gt; paid in December 2021; $&lt;span id="xdx_909_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_c20221031_zMMB9veji3Wl" title="Cash payments"&gt;1,000&lt;/span&gt; paid in October 2022; $&lt;span id="xdx_906_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_c20231031_zic96oG2Ioe1" title="Cash payments"&gt;4,000&lt;/span&gt;
paid in October 2023; and $&lt;span id="xdx_907_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_c20231231__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandAndTwentyFourMember_zT6tXoNfElPj" title="Cash payments"&gt;4,000&lt;/span&gt; due on October 1, 2024, with imputed interest recognized at &lt;span id="xdx_90B_ecustom--ImputedInterestRate_pid_dp_uPure_c20230101__20231231__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandAndTwentyFourMember_zhGVlKA0zrI9" title="Imputed interest recognized"&gt;10.0&lt;/span&gt;% per annum, and the market advertising
of $&lt;span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_pn3n3_c20230101__20231231_zWw3wEyELd4f" title="Market advertising"&gt;615&lt;/span&gt; has been delivered during the year ended December 31, 2023, leaving $&lt;span id="xdx_90C_ecustom--MarketingAndAdvertisingExpenseRemaining_pn3n3_c20230101__20231231_z6Y52a9imf4e" title="Market advertising leaving"&gt;860&lt;/span&gt; to be delivered as of December 31, 2023, with the current amount due, net of imputed interest, reflected in accrued expenses and other on the consolidated
balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="AsOf2023-12-31" id="Fact001401">P0Y9M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <AREN:SupplementalInformationRelatedToOperatingLeasesTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001403">&lt;p id="xdx_890_ecustom--SupplementalInformationRelatedToOperatingLeasesTableTextBlock_z52YZlcmodh3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
table below presents supplemental information related to the operating lease:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zbc8Sd4pa3G1" style="display: none"&gt;Schedule
of Supplemental Information Related to Operating Leases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Operating lease costs during the year (1)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LeaseCost_pn3n3_c20230101__20231231_fKDEp_zwycTJTBHuPg" style="width: 16%; text-align: right" title="Operating lease costs during the year"&gt;1,052&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LeaseCost_pn3n3_c20220101__20221231_fKDEp_z73jF7LNQxa5" style="width: 16%; text-align: right" title="Operating lease costs during the year"&gt;969&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cash payments included in the measurement of operating lease liability during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OperatingLeasePayments_pn3n3_c20230101__20231231_z2yyjd2lZEh9" style="text-align: right" title="Cash payments included in the measurement of operating lease liabilities during the year"&gt;486&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OperatingLeasePayments_pn3n3_c20220101__20221231_zV3eA2wVOeb8" style="text-align: right" title="Cash payments included in the measurement of operating lease liabilities during the year"&gt;469&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average remaining lease term (in years) as of year-end&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_zvVHFKuBJfxf" title="Weighted-average remaining lease term (in years) as of year-end"&gt;0.75&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zV1asf4n4CX6" title="Weighted-average remaining lease term (in years) as of year-end"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average discount rate during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20231231_z3naXHOK2tSf" title="Weighted-average discount rate during the year"&gt;9.90&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231_z3QuF40HSk5c" title="Weighted-average discount rate during the year"&gt;9.90&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F08_zb7OynYi8UTh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F18_zEBwpg9r4gh8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating lease
costs is presented net of sublease income that is not material.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</AREN:SupplementalInformationRelatedToOperatingLeasesTableTextBlock>
    <us-gaap:LeaseCost
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact001405"
      unitRef="USD">1052000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001407"
      unitRef="USD">969000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact001409"
      unitRef="USD">486000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001411"
      unitRef="USD">469000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2023-12-31" id="Fact001413">P0Y9M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2022-12-31" id="Fact001415">P1Y9M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001417"
      unitRef="Pure">0.0990</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001419"
      unitRef="Pure">0.0990</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001422">&lt;p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zJfBLkQAHXFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of operating lease costs were follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zO2LqGqlKC0c" style="display: none"&gt;Schedule
of Operating Lease Costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230101__20231231_zinowhJF3MF8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220101__20221231_zG8RsxWcdt29" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Operating lease costs:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingLeaseCost_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zV0B4SpXnKy7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt"&gt;General and administrative&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"&gt;1,344&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"&gt;1,187&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OperatingLeaseCost_pn3n3_maLCzoNR_zpSk8bcA8Md1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 20pt"&gt;Total operating costs (&lt;span id="xdx_F4B_zLdAqtn6mQj3"&gt;1&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,187&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--SubleaseIncome_iN_pn3n3_di_msLCzoNR_zkt2DSPB3R76" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"&gt;Less sublease income&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(292&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(218&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LeaseCost_iT_pn3n3_mtLCzoNR_zBWuVL4CSMb2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total operating lease costs&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,052&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;969&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F02_zTMXHN40VhG6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1D_zEregB25HjTh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes certain
costs associated with a business membership agreement (see below) that permits access to certain office space for the years ended December
31, 2023 and 2022 of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_904_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessMembershipAgreementMember_zU6h5otEQ9t7" title="Operating lease cost"&gt;620&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--OperatingLeaseCost_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--BusinessMembershipAgreementMember_z6Ipd2wuVVn6" title="Operating lease cost"&gt;668&lt;/span&gt;, respectively, and month-to-month lease arrangements for the years ended December 31, 2023 and 2022
of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--MonthToMonthLeaseArrangementMember_zKURtxpM8Jmd" title="Operating lease cost"&gt;396&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--OperatingLeaseCost_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--MonthToMonthLeaseArrangementMember_zmCHQMmJCq5d" title="Operating lease cost"&gt;320&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;


</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001424"
      unitRef="USD">1344000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2022-01-012022-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001425"
      unitRef="USD">1187000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact001427"
      unitRef="USD">1344000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001428"
      unitRef="USD">1187000</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact001430"
      unitRef="USD">292000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001431"
      unitRef="USD">218000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact001433"
      unitRef="USD">1052000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001434"
      unitRef="USD">969000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2023-01-012023-12-31_custom_BusinessMembershipAgreementMember"
      decimals="-3"
      id="Fact001437"
      unitRef="USD">620000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2022-01-012022-12-31_custom_BusinessMembershipAgreementMember"
      decimals="-3"
      id="Fact001439"
      unitRef="USD">668000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2023-01-012023-12-31_custom_MonthToMonthLeaseArrangementMember"
      decimals="-3"
      id="Fact001441"
      unitRef="USD">396000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2022-01-012022-12-31_custom_MonthToMonthLeaseArrangementMember"
      decimals="-3"
      id="Fact001443"
      unitRef="USD">320000</us-gaap:OperatingLeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001445">&lt;p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zmOuJ48hGynk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Maturities
of the operating lease liability as of December 31, 2023 are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zVtIOD6SsG02" style="display: none"&gt;Summary
of Maturity of Lease Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20231231_zQ9FCrzvbBFa" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtLOLLPzG3L_zYptFfV4rQMa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Minimum lease payments - 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; text-align: right"&gt;373&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_zKMGTQFvJeW6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Less imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(15&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zdX0MRz6KWX3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Present value of operating lease liability&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;358&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_z45RPMTavPHc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Current portion of operating lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;358&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zyDmUs7j4Ru9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Long-term portion of operating lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1455"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zrTlsJVExJT6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total operating lease liability&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;358&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001447"
      unitRef="USD">373000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001449"
      unitRef="USD">15000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001451"
      unitRef="USD">358000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001453"
      unitRef="USD">358000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001457"
      unitRef="USD">358000</us-gaap:OperatingLeaseLiability>
    <us-gaap:SubleaseIncome
      contextRef="From2023-01-012023-12-31_custom_SubleaseAgreementMember"
      decimals="-3"
      id="Fact001459"
      unitRef="USD">537000</us-gaap:SubleaseIncome>
    <us-gaap:ProceedsFromLeasePayments
      contextRef="From2021-09-012021-09-30_custom_LeaseArrangementMember"
      decimals="-3"
      id="Fact001461"
      unitRef="USD">10000000</us-gaap:ProceedsFromLeasePayments>
    <us-gaap:AdvertisingExpense
      contextRef="From2021-09-012021-09-30_custom_LeaseArrangementMember"
      decimals="-3"
      id="Fact001463"
      unitRef="USD">1475000</us-gaap:AdvertisingExpense>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact001465"
      unitRef="USD">1000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2022-10-31"
      decimals="-3"
      id="Fact001467"
      unitRef="USD">1000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2023-10-31"
      decimals="-3"
      id="Fact001469"
      unitRef="USD">4000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2023-12-31_custom_OctoberOneTwoThousandAndTwentyFourMember"
      decimals="-3"
      id="Fact001471"
      unitRef="USD">4000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <AREN:ImputedInterestRate
      contextRef="From2023-01-012023-12-31_custom_OctoberOneTwoThousandAndTwentyFourMember"
      decimals="INF"
      id="Fact001473"
      unitRef="Pure">0.100</AREN:ImputedInterestRate>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact001475"
      unitRef="USD">615000</us-gaap:MarketingAndAdvertisingExpense>
    <AREN:MarketingAndAdvertisingExpenseRemaining
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact001477"
      unitRef="USD">860000</AREN:MarketingAndAdvertisingExpenseRemaining>
    <AREN:PlatformDevelopmentDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001479">&lt;p id="xdx_807_ecustom--PlatformDevelopmentDisclosureTextBlock_z8pHwPLaU6Wd" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;8.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_82C_zDP3yfcPuCMf"&gt;Platform Development&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--SummaryOfPlatformDevelopmentCostsTableTextBlock_zIxqj5lvxKH1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Platform
development costs are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zCGkr6fcwnh" style="display: none"&gt;Summary
of Platform Development Costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20231231_zScIWEATpF9e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20221231_zoi0Y6qHmrOh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_maPPAENzOa4_zpkMwALs7ny4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Platform development&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;26,054&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;21,493&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pn3n3_di_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_msPPAENzOa4_zb7BOt9cBcWi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Less accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(17,331&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11,163&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_mtPPAENzOa4_zg9J7Ivq3mdj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Net platform development&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;8,723&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;10,330&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A3_zxpBfsFw1Khe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--SummaryOfPlatformDevelopmentCostActivityTableTextBlock_zA9So66Ye86b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of platform development activity is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zvFdcOV5qJ31" style="display: none"&gt;Summary
of Platform Development Cost Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Platform development beginning of year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentOther_iS_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zEedoL1Wx1Jf" style="width: 16%; text-align: right" title="Platform development beginning of year"&gt;21,493&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentOther_iS_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zSMpkLYBnVe7" style="width: 16%; text-align: right" title="Platform development beginning of year"&gt;21,997&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Payroll-based costs capitalized&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FinitelivedIntangibleAssetsAcquired1_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zi8ilA0LQW37" style="text-align: right" title="Payroll-based costs capitalized"&gt;3,773&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FinitelivedIntangibleAssetsAcquired1_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_z4lU2ZiU6H7k" style="text-align: right" title="Payroll-based costs capitalized"&gt;5,179&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less dispositions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--GainLossOnDispositionOfAssets1_iN_pn3n3_di_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zBDuanU1FMJf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less dispositions"&gt;(164&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--GainLossOnDispositionOfAssets1_iN_pn3n3_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zntQAbyAsiml" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less dispositions"&gt;(7,357&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total capitalized payroll-based costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zbgJijmJSww3" style="text-align: right" title="Total capitalized payroll-based costs"&gt;25,102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zm28SsBRk7Ui" style="text-align: right" title="Total capitalized payroll-based costs"&gt;19,819&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zRXwggsvC8a8" style="text-align: right" title="Stock-based compensation"&gt;1,016&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zGBZkksY9Unk" style="text-align: right" title="Stock-based compensation"&gt;1,884&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Impairments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pn3n3_di_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zD3wrHAZConj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairments"&gt;(64&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pn3n3_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zQDa9e618Mf3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairments"&gt;(210&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Platform development end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentOther_iE_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zifcqCCr2A97" style="border-bottom: Black 2.5pt double; text-align: right" title="Platform development end of year"&gt;26,054&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentOther_iE_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zwvUFv2XESl9" style="border-bottom: Black 2.5pt double; text-align: right" title="Platform development end of year"&gt;21,493&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A1_zzTfVgXOcT3l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
expense for platform development for the year ended December 31, 2023 and 2022 was $&lt;span id="xdx_908_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_ziaWLfP2j086" title="Amortization expense of intangible asset"&gt;6,332&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_z0QRcEi260Oe" title="Amortization expense of intangible asset"&gt;5,822&lt;/span&gt;, respectively. Amortization expense
for platform development is included in cost of revenue on the consolidated statements of operations. Impairment charges for platform
development for the years ended December 31, 2023 and 2022 of $&lt;span id="xdx_903_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zDfRxxhbd1L1" title="Impairment charges"&gt;64 &lt;/span&gt;and $&lt;span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zDcG0HxUfJM5" title="Impairment charges"&gt;210&lt;/span&gt;, &lt;span id="xdx_90E_eus-gaap--ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_dxL_c20230101__20231231_zUYFQGCbiRFg" title="::XDX::http%3A%2F%2Ffasb.org%2Fus-gaap%2F2023%23AssetImpairmentCharges"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1529"&gt;respectively&lt;/span&gt;&lt;/span&gt;, have been recorded on the consolidated statements
of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AREN:PlatformDevelopmentDisclosureTextBlock>
    <AREN:SummaryOfPlatformDevelopmentCostsTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001481">&lt;p id="xdx_895_ecustom--SummaryOfPlatformDevelopmentCostsTableTextBlock_zIxqj5lvxKH1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Platform
development costs are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zCGkr6fcwnh" style="display: none"&gt;Summary
of Platform Development Costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20231231_zScIWEATpF9e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20221231_zoi0Y6qHmrOh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_maPPAENzOa4_zpkMwALs7ny4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Platform development&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;26,054&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;21,493&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pn3n3_di_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_msPPAENzOa4_zb7BOt9cBcWi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Less accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(17,331&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11,163&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_mtPPAENzOa4_zg9J7Ivq3mdj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Net platform development&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;8,723&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;10,330&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</AREN:SummaryOfPlatformDevelopmentCostsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001483"
      unitRef="USD">26054000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001484"
      unitRef="USD">21493000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001486"
      unitRef="USD">17331000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001487"
      unitRef="USD">11163000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001489"
      unitRef="USD">8723000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001490"
      unitRef="USD">10330000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <AREN:SummaryOfPlatformDevelopmentCostActivityTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001492">&lt;p id="xdx_89A_ecustom--SummaryOfPlatformDevelopmentCostActivityTableTextBlock_zA9So66Ye86b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of platform development activity is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zvFdcOV5qJ31" style="display: none"&gt;Summary
of Platform Development Cost Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Platform development beginning of year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentOther_iS_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zEedoL1Wx1Jf" style="width: 16%; text-align: right" title="Platform development beginning of year"&gt;21,493&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentOther_iS_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zSMpkLYBnVe7" style="width: 16%; text-align: right" title="Platform development beginning of year"&gt;21,997&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Payroll-based costs capitalized&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FinitelivedIntangibleAssetsAcquired1_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zi8ilA0LQW37" style="text-align: right" title="Payroll-based costs capitalized"&gt;3,773&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FinitelivedIntangibleAssetsAcquired1_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_z4lU2ZiU6H7k" style="text-align: right" title="Payroll-based costs capitalized"&gt;5,179&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less dispositions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--GainLossOnDispositionOfAssets1_iN_pn3n3_di_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zBDuanU1FMJf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less dispositions"&gt;(164&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--GainLossOnDispositionOfAssets1_iN_pn3n3_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zntQAbyAsiml" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less dispositions"&gt;(7,357&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total capitalized payroll-based costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zbgJijmJSww3" style="text-align: right" title="Total capitalized payroll-based costs"&gt;25,102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--CapitalizedContractCostAmortization_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zm28SsBRk7Ui" style="text-align: right" title="Total capitalized payroll-based costs"&gt;19,819&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zRXwggsvC8a8" style="text-align: right" title="Stock-based compensation"&gt;1,016&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zGBZkksY9Unk" style="text-align: right" title="Stock-based compensation"&gt;1,884&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Impairments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pn3n3_di_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zD3wrHAZConj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairments"&gt;(64&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pn3n3_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zQDa9e618Mf3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Impairments"&gt;(210&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Platform development end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentOther_iE_pn3n3_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zifcqCCr2A97" style="border-bottom: Black 2.5pt double; text-align: right" title="Platform development end of year"&gt;26,054&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentOther_iE_pn3n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PlatformDevelopmentMember_zwvUFv2XESl9" style="border-bottom: Black 2.5pt double; text-align: right" title="Platform development end of year"&gt;21,493&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</AREN:SummaryOfPlatformDevelopmentCostActivityTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2022-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001494"
      unitRef="USD">21493000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2021-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001496"
      unitRef="USD">21997000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="From2023-01-012023-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001498"
      unitRef="USD">3773000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="From2022-01-012022-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001500"
      unitRef="USD">5179000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2023-01-012023-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001502"
      unitRef="USD">164000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2022-01-012022-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001504"
      unitRef="USD">7357000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="From2023-01-012023-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001506"
      unitRef="USD">25102000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="From2022-01-012022-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001508"
      unitRef="USD">19819000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001510"
      unitRef="USD">1016000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001512"
      unitRef="USD">1884000</us-gaap:ShareBasedCompensation>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2023-01-012023-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001514"
      unitRef="USD">64000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2022-01-012022-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001516"
      unitRef="USD">210000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2023-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001518"
      unitRef="USD">26054000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2022-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001520"
      unitRef="USD">21493000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-01-012023-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001522"
      unitRef="USD">6332000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-01-012022-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001524"
      unitRef="USD">5822000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2023-01-012023-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001526"
      unitRef="USD">64000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2022-01-012022-12-31_custom_PlatformDevelopmentMember"
      decimals="-3"
      id="Fact001528"
      unitRef="USD">210000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001531">&lt;p id="xdx_806_eus-gaap--IntangibleAssetsDisclosureTextBlock_z64g7eKbPyo" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;9.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_827_zSv6iL6pkzo"&gt;Intangible Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zGqPiHulnNc8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets subject to amortization consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zUxXsWZaoRVi" style="display: none"&gt;Schedule
of Intangible Assets Subject to Amortization&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 7pt"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt;
 Average&lt;br/&gt;
 Useful&lt;br/&gt;
 Life (in&lt;br/&gt;
 years)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Carrying&lt;br/&gt;
 Amount&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Accumulated&lt;br/&gt;
 Amortization&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Net&lt;br/&gt;
 Carrying&lt;br/&gt;
 Amount&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Carrying&lt;br/&gt;
 Amount&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Accumulated&lt;br/&gt;
 Amortization&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Net&lt;br/&gt;
 Carrying&lt;br/&gt;
 Amount&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 30%; text-align: left"&gt;Developed technology&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zUlmoVeH7gKg" style="width: 6%; text-align: center" title="Intangible assets, weighted average useful life"&gt;4.70&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zPLtTlPFqcP2" style="width: 6%; text-align: right" title="Intangible assets, gross"&gt;17,333&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zMgGGax6T5D4" style="width: 6%; text-align: right" title="Intangible assets, accumulated amortization"&gt;(17,333&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zjAkav9a8Sx7" style="width: 6%; text-align: right" title="Intangible assets, net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1541"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_z7Wjm0Ok4Wt3" style="width: 6%; text-align: right" title="Intangible assets, gross"&gt;17,333&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zLxS893m0ogd" style="width: 6%; text-align: right" title="Intangible assets, accumulated amortization"&gt;(14,883&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zBCHpRcyDwM" style="width: 6%; text-align: right" title="Intangible assets, net"&gt;2,450&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade name&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zzVktJNWpdne" style="text-align: center" title="Intangible assets, weighted average useful life"&gt;16.10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zDUrUFaiScql" style="text-align: right" title="Intangible assets, gross"&gt;5,181&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zlgZtjptU8Qb" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(1,547&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zPuAiq2cDMO9" style="text-align: right" title="Intangible assets, net"&gt;3,634&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zll02mCKq6qj" style="text-align: right" title="Intangible assets, gross"&gt;5,380&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zeJxzjxEVDK7" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(1,180&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zY63KfZKeS52" style="text-align: right" title="Intangible assets, net"&gt;4,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Brand name&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z5YUIFZbkNLj" style="text-align: center" title="Intangible assets, weighted average useful life"&gt;9.70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zBFW48O2JV3e" style="text-align: right" title="Intangible assets, gross"&gt;12,774&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zugLjIgyb9g5" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(2,374&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zkmEvK9I8C44" style="text-align: right" title="Intangible assets, net"&gt;10,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z2PJ48WtLwAc" style="text-align: right" title="Intangible assets, gross"&gt;12,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zPp8GVRc0Fyd" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(908&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zkqmfZtDPs1b" style="text-align: right" title="Intangible assets, net"&gt;11,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Subscriber relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zuJYxejpJFEh" style="text-align: center" title="Intangible assets, weighted average useful life"&gt;5.10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_z1En2GiaAO69" style="text-align: right" title="Intangible assets, gross"&gt;73,459&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_z9zrN0oCQVFd" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(61,654&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zU7gGu6Memo1" style="text-align: right" title="Intangible assets, net"&gt;11,805&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zPjVJZuHqYA1" style="text-align: right" title="Intangible assets, gross"&gt;73,459&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zDRJ180J2Upb" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(47,146&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zGE6F5MhgFyk" style="text-align: right" title="Intangible assets, net"&gt;26,313&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Advertiser relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zgkNT25EFh74" style="text-align: center" title="Intangible assets, weighted average useful life"&gt;10.20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zEWRXOtzKjb1" style="text-align: right" title="Intangible assets, gross"&gt;15,182&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_z95TgOZE8c4a" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(2,832&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zAqCXJVxhvSb" style="text-align: right" title="Intangible assets, net"&gt;12,350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zbBtoclSBlFl" style="text-align: right" title="Intangible assets, gross"&gt;15,302&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zsk0z7qULDdb" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(1,368&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zryIDTvmRqsc" style="text-align: right" title="Intangible assets, net"&gt;13,934&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Database&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zT3XTIqhh8Ki" style="text-align: center" title="Intangible assets, weighted average useful life"&gt;3.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zQgKWkLR70Zf" style="text-align: right" title="Intangible assets, gross"&gt;2,397&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zVrkRWfZWgY1" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(2,171&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_z9vGaJNNZMVi" style="text-align: right" title="Intangible assets, net"&gt;226&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zmXwPweU27Yb" style="text-align: right" title="Intangible assets, gross"&gt;2,397&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zqzxbu8f1RAl" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(1,753&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zbcCyeO2Oluf" style="text-align: right" title="Intangible assets, net"&gt;644&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Digital content&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zoenZA2G2Wu3" style="padding-bottom: 1.5pt; text-align: center" title="Intangible assets, weighted average useful life"&gt;2.00&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_z27QSShJFPH" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, gross"&gt;355&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zv39eNcxRjX" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, accumulated amortization"&gt;(311&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zMJTMqwTBTWa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, net"&gt;44&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zrN1I2QkoX6l" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, gross"&gt;355&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zxf7JUM4GUma" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, accumulated amortization"&gt;(133&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zWUfzZ9F9TQ" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, net"&gt;222&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Total intangible assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 7pt; text-align: center"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 7pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231_zRnBAslxkjLj" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, gross"&gt;126,681&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231_zGiKhMSlei9f" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, accumulated amortization"&gt;(88,222&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231_zI4CGWw40rwe" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net"&gt;38,459&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231_zYd3UO3kWlVc" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, gross"&gt;126,341&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231_z9iw7ItRHiK4" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, accumulated amortization"&gt;(67,371&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231_zhQzPuBKRfg8" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net"&gt;58,970&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8AA_zTaibOTCoOHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets subject to amortization were recorded as part of the Company&#x2019;s business acquisitions. Amortization expense for the years
ended December 31, 2023 and 2022 was $&lt;span id="xdx_90E_eus-gaap--AmortizationOfAcquisitionCosts_pn3n3_c20230101__20231231_zs4lzgZp8O2g" title="Amortization expense of intangible asset acquisition"&gt;21,022&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--AmortizationOfAcquisitionCosts_pn3n3_c20220101__20221231_zrCmGdf9pGg4" title="Amortization expense of intangible asset acquisition"&gt;20,748&lt;/span&gt;, respectively, of which amortization expense for developed technology of $&lt;span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_z1HR0AfETNy3" title="Amortization expense of intangible asset"&gt;2,130&lt;/span&gt;
and $&lt;span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zUhwB378ynN7" title="Amortization expense of intangible asset"&gt;2,831&lt;/span&gt;, respectively, is included in cost of revenue on the consolidated statements of operations. &lt;span id="xdx_906_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pn3n3_do_c20230101__20231231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zzA0oEBDS5F1" title="Impairment charges"&gt;No&lt;/span&gt; impairment charges
for the year ended December 31, 2023 was recorded for the intangible assets. Impairment charges for the year ended December 31, 2022
of $&lt;span id="xdx_90C_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_pn3n3_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zzFxP0iBySGh" title="Impairment charges"&gt;47&lt;/span&gt; were recorded for the intangible assets on the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zuyRfzrqd0T8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimated
total amortization expense for the next five years and thereafter related to the Company&#x2019;s intangible assets subject to amortization
as of December 31, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_zqqKW07qTw9h" style="display: none"&gt;Schedule
of Future Estimated Amortization expense For Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%; margin-left: 0.75in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20231231_zYAjGNyCvCJ4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; font-weight: bold"&gt;Years Ending December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_iI_pn3n3_maFLIANzfm1_z9gvHtQccBsg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 79%; text-align: left"&gt;2024&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;14,544&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo_iI_pn3n3_maFLIANzfm1_z1H3hJWm4jr1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,427&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree_iI_pn3n3_maFLIANzfm1_zyzr9y1cm7nd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour_iI_pn3n3_maFLIANzfm1_zIeuwnD8FEI6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive_iI_pn3n3_maFLIANzfm1_zvTboWyk7Kwa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,964&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive_iI_pn3n3_maFLIANzfm1_zfDcpcwcmJFh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,096&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzfm1_zWG5Dwvonkjb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
    assets ,net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;38,459&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zf2eXqoM1kx5" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001533">&lt;p id="xdx_891_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zGqPiHulnNc8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets subject to amortization consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zUxXsWZaoRVi" style="display: none"&gt;Schedule
of Intangible Assets Subject to Amortization&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 7pt"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt;
 Average&lt;br/&gt;
 Useful&lt;br/&gt;
 Life (in&lt;br/&gt;
 years)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Carrying&lt;br/&gt;
 Amount&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Accumulated&lt;br/&gt;
 Amortization&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Net&lt;br/&gt;
 Carrying&lt;br/&gt;
 Amount&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Carrying&lt;br/&gt;
 Amount&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Accumulated&lt;br/&gt;
 Amortization&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Net&lt;br/&gt;
 Carrying&lt;br/&gt;
 Amount&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 30%; text-align: left"&gt;Developed technology&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zUlmoVeH7gKg" style="width: 6%; text-align: center" title="Intangible assets, weighted average useful life"&gt;4.70&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zPLtTlPFqcP2" style="width: 6%; text-align: right" title="Intangible assets, gross"&gt;17,333&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zMgGGax6T5D4" style="width: 6%; text-align: right" title="Intangible assets, accumulated amortization"&gt;(17,333&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zjAkav9a8Sx7" style="width: 6%; text-align: right" title="Intangible assets, net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1541"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_z7Wjm0Ok4Wt3" style="width: 6%; text-align: right" title="Intangible assets, gross"&gt;17,333&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zLxS893m0ogd" style="width: 6%; text-align: right" title="Intangible assets, accumulated amortization"&gt;(14,883&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zBCHpRcyDwM" style="width: 6%; text-align: right" title="Intangible assets, net"&gt;2,450&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade name&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zzVktJNWpdne" style="text-align: center" title="Intangible assets, weighted average useful life"&gt;16.10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zDUrUFaiScql" style="text-align: right" title="Intangible assets, gross"&gt;5,181&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zlgZtjptU8Qb" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(1,547&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zPuAiq2cDMO9" style="text-align: right" title="Intangible assets, net"&gt;3,634&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zll02mCKq6qj" style="text-align: right" title="Intangible assets, gross"&gt;5,380&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zeJxzjxEVDK7" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(1,180&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zY63KfZKeS52" style="text-align: right" title="Intangible assets, net"&gt;4,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Brand name&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z5YUIFZbkNLj" style="text-align: center" title="Intangible assets, weighted average useful life"&gt;9.70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zBFW48O2JV3e" style="text-align: right" title="Intangible assets, gross"&gt;12,774&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zugLjIgyb9g5" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(2,374&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zkmEvK9I8C44" style="text-align: right" title="Intangible assets, net"&gt;10,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z2PJ48WtLwAc" style="text-align: right" title="Intangible assets, gross"&gt;12,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zPp8GVRc0Fyd" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(908&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zkqmfZtDPs1b" style="text-align: right" title="Intangible assets, net"&gt;11,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Subscriber relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zuJYxejpJFEh" style="text-align: center" title="Intangible assets, weighted average useful life"&gt;5.10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_z1En2GiaAO69" style="text-align: right" title="Intangible assets, gross"&gt;73,459&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_z9zrN0oCQVFd" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(61,654&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zU7gGu6Memo1" style="text-align: right" title="Intangible assets, net"&gt;11,805&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zPjVJZuHqYA1" style="text-align: right" title="Intangible assets, gross"&gt;73,459&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zDRJ180J2Upb" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(47,146&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SubscriberRelationshipsMember_zGE6F5MhgFyk" style="text-align: right" title="Intangible assets, net"&gt;26,313&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Advertiser relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zgkNT25EFh74" style="text-align: center" title="Intangible assets, weighted average useful life"&gt;10.20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zEWRXOtzKjb1" style="text-align: right" title="Intangible assets, gross"&gt;15,182&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_z95TgOZE8c4a" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(2,832&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zAqCXJVxhvSb" style="text-align: right" title="Intangible assets, net"&gt;12,350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zbBtoclSBlFl" style="text-align: right" title="Intangible assets, gross"&gt;15,302&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zsk0z7qULDdb" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(1,368&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AdvertiserRelationshipsMember_zryIDTvmRqsc" style="text-align: right" title="Intangible assets, net"&gt;13,934&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Database&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zT3XTIqhh8Ki" style="text-align: center" title="Intangible assets, weighted average useful life"&gt;3.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zQgKWkLR70Zf" style="text-align: right" title="Intangible assets, gross"&gt;2,397&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zVrkRWfZWgY1" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(2,171&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_z9vGaJNNZMVi" style="text-align: right" title="Intangible assets, net"&gt;226&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zmXwPweU27Yb" style="text-align: right" title="Intangible assets, gross"&gt;2,397&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zqzxbu8f1RAl" style="text-align: right" title="Intangible assets, accumulated amortization"&gt;(1,753&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DatabasesMember_zbcCyeO2Oluf" style="text-align: right" title="Intangible assets, net"&gt;644&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Digital content&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zoenZA2G2Wu3" style="padding-bottom: 1.5pt; text-align: center" title="Intangible assets, weighted average useful life"&gt;2.00&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_z27QSShJFPH" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, gross"&gt;355&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zv39eNcxRjX" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, accumulated amortization"&gt;(311&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zMJTMqwTBTWa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, net"&gt;44&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zrN1I2QkoX6l" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, gross"&gt;355&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zxf7JUM4GUma" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, accumulated amortization"&gt;(133&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalContentMember_zWUfzZ9F9TQ" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, net"&gt;222&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Total intangible assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 7pt; text-align: center"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 7pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20231231_zRnBAslxkjLj" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, gross"&gt;126,681&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20231231_zGiKhMSlei9f" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, accumulated amortization"&gt;(88,222&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20231231_zI4CGWw40rwe" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net"&gt;38,459&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231_zYd3UO3kWlVc" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, gross"&gt;126,341&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231_z9iw7ItRHiK4" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, accumulated amortization"&gt;(67,371&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231_zhQzPuBKRfg8" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net"&gt;58,970&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2023-12-31_custom_DevelopedTechnologyMember"
      id="Fact001535">P4Y8M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-12-31_custom_DevelopedTechnologyMember"
      decimals="-3"
      id="Fact001537"
      unitRef="USD">17333000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-12-31_custom_DevelopedTechnologyMember"
      decimals="-3"
      id="Fact001539"
      unitRef="USD">-17333000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_custom_DevelopedTechnologyMember"
      decimals="-3"
      id="Fact001543"
      unitRef="USD">17333000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_custom_DevelopedTechnologyMember"
      decimals="-3"
      id="Fact001545"
      unitRef="USD">-14883000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-12-31_custom_DevelopedTechnologyMember"
      decimals="-3"
      id="Fact001547"
      unitRef="USD">2450000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2023-12-31_us-gaap_TradeNamesMember"
      id="Fact001549">P16Y1M6D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-12-31_us-gaap_TradeNamesMember"
      decimals="-3"
      id="Fact001551"
      unitRef="USD">5181000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-12-31_us-gaap_TradeNamesMember"
      decimals="-3"
      id="Fact001553"
      unitRef="USD">-1547000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-12-31_us-gaap_TradeNamesMember"
      decimals="-3"
      id="Fact001555"
      unitRef="USD">3634000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_us-gaap_TradeNamesMember"
      decimals="-3"
      id="Fact001557"
      unitRef="USD">5380000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_us-gaap_TradeNamesMember"
      decimals="-3"
      id="Fact001559"
      unitRef="USD">-1180000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-12-31_us-gaap_TradeNamesMember"
      decimals="-3"
      id="Fact001561"
      unitRef="USD">4200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2023-12-31_custom_BrandNamesMember"
      id="Fact001563">P9Y8M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-12-31_custom_BrandNamesMember"
      decimals="-3"
      id="Fact001565"
      unitRef="USD">12774000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-12-31_custom_BrandNamesMember"
      decimals="-3"
      id="Fact001567"
      unitRef="USD">-2374000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-12-31_custom_BrandNamesMember"
      decimals="-3"
      id="Fact001569"
      unitRef="USD">10400000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_custom_BrandNamesMember"
      decimals="-3"
      id="Fact001571"
      unitRef="USD">12115000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_custom_BrandNamesMember"
      decimals="-3"
      id="Fact001573"
      unitRef="USD">-908000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-12-31_custom_BrandNamesMember"
      decimals="-3"
      id="Fact001575"
      unitRef="USD">11207000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2023-12-31_custom_SubscriberRelationshipsMember"
      id="Fact001577">P5Y1M6D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-12-31_custom_SubscriberRelationshipsMember"
      decimals="-3"
      id="Fact001579"
      unitRef="USD">73459000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-12-31_custom_SubscriberRelationshipsMember"
      decimals="-3"
      id="Fact001581"
      unitRef="USD">-61654000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-12-31_custom_SubscriberRelationshipsMember"
      decimals="-3"
      id="Fact001583"
      unitRef="USD">11805000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_custom_SubscriberRelationshipsMember"
      decimals="-3"
      id="Fact001585"
      unitRef="USD">73459000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_custom_SubscriberRelationshipsMember"
      decimals="-3"
      id="Fact001587"
      unitRef="USD">-47146000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-12-31_custom_SubscriberRelationshipsMember"
      decimals="-3"
      id="Fact001589"
      unitRef="USD">26313000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2023-12-31_custom_AdvertiserRelationshipsMember"
      id="Fact001591">P10Y2M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-12-31_custom_AdvertiserRelationshipsMember"
      decimals="-3"
      id="Fact001593"
      unitRef="USD">15182000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-12-31_custom_AdvertiserRelationshipsMember"
      decimals="-3"
      id="Fact001595"
      unitRef="USD">-2832000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-12-31_custom_AdvertiserRelationshipsMember"
      decimals="-3"
      id="Fact001597"
      unitRef="USD">12350000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_custom_AdvertiserRelationshipsMember"
      decimals="-3"
      id="Fact001599"
      unitRef="USD">15302000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_custom_AdvertiserRelationshipsMember"
      decimals="-3"
      id="Fact001601"
      unitRef="USD">-1368000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-12-31_custom_AdvertiserRelationshipsMember"
      decimals="-3"
      id="Fact001603"
      unitRef="USD">13934000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2023-12-31_us-gaap_DatabasesMember"
      id="Fact001605">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-12-31_us-gaap_DatabasesMember"
      decimals="-3"
      id="Fact001607"
      unitRef="USD">2397000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-12-31_us-gaap_DatabasesMember"
      decimals="-3"
      id="Fact001609"
      unitRef="USD">-2171000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-12-31_us-gaap_DatabasesMember"
      decimals="-3"
      id="Fact001611"
      unitRef="USD">226000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_us-gaap_DatabasesMember"
      decimals="-3"
      id="Fact001613"
      unitRef="USD">2397000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_us-gaap_DatabasesMember"
      decimals="-3"
      id="Fact001615"
      unitRef="USD">-1753000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-12-31_us-gaap_DatabasesMember"
      decimals="-3"
      id="Fact001617"
      unitRef="USD">644000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2023-12-31_custom_DigitalContentMember"
      id="Fact001619">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-12-31_custom_DigitalContentMember"
      decimals="-3"
      id="Fact001621"
      unitRef="USD">355000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-12-31_custom_DigitalContentMember"
      decimals="-3"
      id="Fact001623"
      unitRef="USD">-311000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-12-31_custom_DigitalContentMember"
      decimals="-3"
      id="Fact001625"
      unitRef="USD">44000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_custom_DigitalContentMember"
      decimals="-3"
      id="Fact001627"
      unitRef="USD">355000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_custom_DigitalContentMember"
      decimals="-3"
      id="Fact001629"
      unitRef="USD">-133000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-12-31_custom_DigitalContentMember"
      decimals="-3"
      id="Fact001631"
      unitRef="USD">222000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001633"
      unitRef="USD">126681000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001635"
      unitRef="USD">-88222000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001637"
      unitRef="USD">38459000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001639"
      unitRef="USD">126341000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001641"
      unitRef="USD">-67371000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001643"
      unitRef="USD">58970000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfAcquisitionCosts
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact001645"
      unitRef="USD">21022000</us-gaap:AmortizationOfAcquisitionCosts>
    <us-gaap:AmortizationOfAcquisitionCosts
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001647"
      unitRef="USD">20748000</us-gaap:AmortizationOfAcquisitionCosts>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-01-012023-12-31_custom_DevelopedTechnologyMember"
      decimals="-3"
      id="Fact001649"
      unitRef="USD">2130000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-01-012022-12-31_custom_DevelopedTechnologyMember"
      decimals="-3"
      id="Fact001651"
      unitRef="USD">2831000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2023-01-012023-12-31_us-gaap_FiniteLivedIntangibleAssetsMember"
      decimals="-3"
      id="Fact001653"
      unitRef="USD">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2022-01-012022-12-31_us-gaap_FiniteLivedIntangibleAssetsMember"
      decimals="-3"
      id="Fact001655"
      unitRef="USD">47000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001657">&lt;p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zuyRfzrqd0T8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimated
total amortization expense for the next five years and thereafter related to the Company&#x2019;s intangible assets subject to amortization
as of December 31, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_zqqKW07qTw9h" style="display: none"&gt;Schedule
of Future Estimated Amortization expense For Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%; margin-left: 0.75in"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: left; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20231231_zYAjGNyCvCJ4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; font-weight: bold"&gt;Years Ending December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_iI_pn3n3_maFLIANzfm1_z9gvHtQccBsg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 79%; text-align: left"&gt;2024&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;14,544&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo_iI_pn3n3_maFLIANzfm1_z1H3hJWm4jr1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,427&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree_iI_pn3n3_maFLIANzfm1_zyzr9y1cm7nd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour_iI_pn3n3_maFLIANzfm1_zIeuwnD8FEI6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive_iI_pn3n3_maFLIANzfm1_zvTboWyk7Kwa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,964&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive_iI_pn3n3_maFLIANzfm1_zfDcpcwcmJFh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,096&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzfm1_zWG5Dwvonkjb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
    assets ,net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;38,459&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001659"
      unitRef="USD">14544000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001661"
      unitRef="USD">3427000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001663"
      unitRef="USD">3214000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001665"
      unitRef="USD">3214000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001667"
      unitRef="USD">2964000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001669"
      unitRef="USD">11096000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001671"
      unitRef="USD">38459000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherAssetsDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001673">&lt;p id="xdx_809_eus-gaap--OtherAssetsDisclosureTextBlock_ztJKIVhtI4Xe" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;10.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span&gt;&lt;span id="xdx_82B_zXOQ596nflp2"&gt;Other
Long-Term Assets&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfOtherAssetsNoncurrentTextBlock_zbLVWHPCANGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
assets are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zm2wbNP0GrZc" style="display: none"&gt;Summary
of Other Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20231231_zWHtJmgelNKj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20221231_z8aJMAK8Mkoh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--SecurityDeposit_iI_pn3n3_maOANzDET_zpVxvTTopPo8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Security deposit&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;420&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;420&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherReceivables_iI_pn3n3_maOANzDET_zqWGhbImfvfk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;90&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1681"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--PrepaidInsurance_iI_pn3n3_maOANzDET_zNU3A6qIzWaf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Prepaid insurance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;284&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;504&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--UnamortizedDebtCost_iI_pn3n3_maOANzDET_zYhHCihRnmad" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Unamortized debt cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;209&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;216&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherAssetsNoncurrent_iTI_pn3n3_mtOANzDET_zc71b3mHVZM5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total other assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,003&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,140&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A8_z2wbWsdTyIij" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:OtherAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001675">&lt;p id="xdx_890_eus-gaap--ScheduleOfOtherAssetsNoncurrentTextBlock_zbLVWHPCANGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
assets are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zm2wbNP0GrZc" style="display: none"&gt;Summary
of Other Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20231231_zWHtJmgelNKj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20221231_z8aJMAK8Mkoh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--SecurityDeposit_iI_pn3n3_maOANzDET_zpVxvTTopPo8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Security deposit&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;420&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;420&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherReceivables_iI_pn3n3_maOANzDET_zqWGhbImfvfk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;90&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1681"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--PrepaidInsurance_iI_pn3n3_maOANzDET_zNU3A6qIzWaf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Prepaid insurance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;284&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;504&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--UnamortizedDebtCost_iI_pn3n3_maOANzDET_zYhHCihRnmad" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Unamortized debt cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;209&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;216&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherAssetsNoncurrent_iTI_pn3n3_mtOANzDET_zc71b3mHVZM5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total other assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,003&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,140&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001677"
      unitRef="USD">420000</us-gaap:SecurityDeposit>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001678"
      unitRef="USD">420000</us-gaap:SecurityDeposit>
    <us-gaap:OtherReceivables
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001680"
      unitRef="USD">90000</us-gaap:OtherReceivables>
    <us-gaap:PrepaidInsurance
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001683"
      unitRef="USD">284000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001684"
      unitRef="USD">504000</us-gaap:PrepaidInsurance>
    <AREN:UnamortizedDebtCost
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001686"
      unitRef="USD">209000</AREN:UnamortizedDebtCost>
    <AREN:UnamortizedDebtCost
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001687"
      unitRef="USD">216000</AREN:UnamortizedDebtCost>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001689"
      unitRef="USD">1003000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001690"
      unitRef="USD">1140000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:GoodwillDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001692">&lt;p id="xdx_803_eus-gaap--GoodwillDisclosureTextBlock_zLo7pNSDpYqh" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;11.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_822_zA8SAqcy52jf"&gt;Goodwill&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfGoodwillTextBlock_zgqiNgwIwcP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
changes in carrying value of goodwill are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BD_z6oMhibAbeTg" style="display: none"&gt;Schedule
of Changes in Carrying Value of Goodwill&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231_z54GMFz6llBd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220101__20221231_zpKLTNlPeqpc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Goodwill_iS_pn3n3_zY5bhtZukAuj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Carrying value at beginning of year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;39,344&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;19,619&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_z7sIbTW6gjMb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Goodwill acquired in acquisition of Parade&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1699"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,587&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--MensJournalMember_zhQrkm1SyGji" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Goodwill acquired in acquisition of Men&#x2019;s Journal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,246&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,138&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zi5zzU65rDze" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Goodwill acquired in acquisition of Fexy Studios&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1706"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--GoodwillImpairmentLoss_pn3n3_zPl4H5Aggyg8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss on impairment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1708"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1709"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--Goodwill_iE_pn3n3_z1MlBj06RKPd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Carrying value at end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;42,575&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;39,344&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zn1uAjHx8ish" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company performs its annual impairment test at the reporting unit level, which is the operating segment or one level below the operating
segment. Management determined that the Company would be aggregated into a single reporting unit for purposes of performing the impairment
test for goodwill.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company, as part of its annual impairment evaluation of goodwill of its one reporting unit, performs the goodwill impairment test in
accordance with applicable guidance. The guidance provides an entity the option to first perform a qualitative assessment to determine
whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines
that this is the case, it is required to perform the goodwill impairment test to identify potential goodwill impairment and measure the
amount of goodwill impairment loss to be recognized for that reporting unit, if any. If an entity determines that the fair value of a
reporting unit is greater than its carrying amount, the goodwill impairment test is not required. The annual impairment test was performed
on December 31, 2023. &lt;span id="xdx_90F_eus-gaap--GoodwillImpairmentLoss_doxL_c20230101__20231231_zZjLeV4bDb93" title="Impairment of goodwill::XDX::-"&gt;&lt;span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_doxL_c20220101__20221231_zd6stMLXluWg" title="Impairment of goodwill::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1714"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1716"&gt;No&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; goodwill impairment was identified during the years ended December 31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001694">&lt;p id="xdx_89A_eus-gaap--ScheduleOfGoodwillTextBlock_zgqiNgwIwcP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
changes in carrying value of goodwill are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BD_z6oMhibAbeTg" style="display: none"&gt;Schedule
of Changes in Carrying Value of Goodwill&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231_z54GMFz6llBd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220101__20221231_zpKLTNlPeqpc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Goodwill_iS_pn3n3_zY5bhtZukAuj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Carrying value at beginning of year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;39,344&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;19,619&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--ParadeMember_z7sIbTW6gjMb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Goodwill acquired in acquisition of Parade&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1699"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,587&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--MensJournalMember_zhQrkm1SyGji" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Goodwill acquired in acquisition of Men&#x2019;s Journal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,246&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,138&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--GoodwillAcquiredDuringPeriod_pn3n3_hus-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zi5zzU65rDze" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Goodwill acquired in acquisition of Fexy Studios&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1706"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--GoodwillImpairmentLoss_pn3n3_zPl4H5Aggyg8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss on impairment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1708"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1709"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--Goodwill_iE_pn3n3_z1MlBj06RKPd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Carrying value at end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;42,575&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;39,344&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001696"
      unitRef="USD">39344000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact001697"
      unitRef="USD">19619000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2022-01-012022-12-31_custom_ParadeMember"
      decimals="-3"
      id="Fact001700"
      unitRef="USD">2587000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2023-01-012023-12-31_custom_MensJournalMember"
      decimals="-3"
      id="Fact001702"
      unitRef="USD">1246000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2022-01-012022-12-31_custom_MensJournalMember"
      decimals="-3"
      id="Fact001703"
      unitRef="USD">17138000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2023-01-012023-12-31_custom_FexyStudiosMember66260062"
      decimals="-3"
      id="Fact001705"
      unitRef="USD">1985000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001711"
      unitRef="USD">42575000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001712"
      unitRef="USD">39344000</us-gaap:Goodwill>
    <AREN:RestrictedStockLiabilitiesTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001718">&lt;p id="xdx_801_ecustom--RestrictedStockLiabilitiesTextBlock_zxC9Yj5Go6V1" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;12.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_82B_zbCIX0GXUBy7"&gt;Restricted Stock Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recorded the repurchase of &lt;span id="xdx_90A_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zVXRrfTOivV" title="Stock repurchased during period, shares"&gt;26,214&lt;/span&gt; shares of the Company&#x2019;s restricted common stock during the year ended December 31, 2022
on the consolidated statement of stockholders&#x2019; deficiency. Effective April 4, 2022, there are no longer any shares of
the Company&#x2019;s common stock subject to repurchase. During the year ended December 31, 2022, the Company paid $&lt;span id="xdx_904_eus-gaap--PaymentsForRepurchaseOfEquity_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z3kzbOibPQni" title="Payments for repurchase Of equity"&gt;2,307&lt;/span&gt; in cash for
the repurchase ($&lt;span id="xdx_903_ecustom--RestrictedStockPrincipalAmount_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQmyduDaybp9" title="Restricted stock principal amount"&gt;2,152&lt;/span&gt; in principal and $&lt;span id="xdx_909_ecustom--RestrictedStockInterestPayment_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zr92X15tTDFb" title="Restricted stock interest payment"&gt;155&lt;/span&gt; in interest).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AREN:RestrictedStockLiabilitiesTextBlock>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="Fact001720"
      unitRef="Shares">26214</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember"
      decimals="-3"
      id="Fact001722"
      unitRef="USD">2307000</us-gaap:PaymentsForRepurchaseOfEquity>
    <AREN:RestrictedStockPrincipalAmount
      contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember"
      decimals="-3"
      id="Fact001724"
      unitRef="USD">2152000</AREN:RestrictedStockPrincipalAmount>
    <AREN:RestrictedStockInterestPayment
      contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember"
      decimals="-3"
      id="Fact001726"
      unitRef="USD">155000</AREN:RestrictedStockInterestPayment>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001728">&lt;p id="xdx_80E_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zFMTPtkEIuTh" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;13.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_82A_z3pgpIuYtbk4"&gt;Accrued Expenses and Other&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zoKITz2tC5r3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
expenses and other are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BE_zXRiw98G4eza" style="display: none"&gt;Schedule
of Accrued Expenses&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20231231_z2IvZHnY1aE8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20221231_zaDWqhP6fpY8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--GeneralAccruedExpenses_iI_pn3n3_maALCzErP_zvEVHQmS9p6i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;General accrued expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,486&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,339&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AccruedPayrollTaxesCurrent_iI_pn3n3_maALCzErP_zgADpXqNjNK4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Accrued payroll and related taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,448&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,221&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AccruedAdvertisingCurrent_iI_pn3n3_maALCzErP_zWhsjuBqslfc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Accrued publisher expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,596&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,911&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InterestPayableCurrent_iI_pn3n3_maALCzErP_z2DpbicCVEEc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1742"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--LiabilitiesInConnectionWithAcquisitionsAndDispositions_iI_pn3n3_maALCzErP_za2u7I06ihW1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Liabilities in connection with acquisitions and dispositions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,119&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,123&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LeaseDepositLiability_iI_pn3n3_maALCzErP_znl7JMQaCdDh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Assumed lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,328&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1748"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--LeaseTerminationLiability_iI_pn3n3_maALCzErP_zBb3Qlhezbwe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Lease termination liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,481&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,753&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maALCzErP_z4rq3OtxmYk3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Other accrued expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;489&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;755&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccruedLiabilitiesCurrent_iTI_pn3n3_mtALCzErP_zUGWjDkRuT75" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total accrued expenses and other&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;30,771&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;23,102&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A7_zcEexnx63Vq7" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001730">&lt;p id="xdx_89B_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zoKITz2tC5r3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
expenses and other are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BE_zXRiw98G4eza" style="display: none"&gt;Schedule
of Accrued Expenses&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20231231_z2IvZHnY1aE8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20221231_zaDWqhP6fpY8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--GeneralAccruedExpenses_iI_pn3n3_maALCzErP_zvEVHQmS9p6i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;General accrued expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,486&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,339&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AccruedPayrollTaxesCurrent_iI_pn3n3_maALCzErP_zgADpXqNjNK4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Accrued payroll and related taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,448&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,221&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AccruedAdvertisingCurrent_iI_pn3n3_maALCzErP_zWhsjuBqslfc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Accrued publisher expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,596&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,911&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InterestPayableCurrent_iI_pn3n3_maALCzErP_z2DpbicCVEEc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1742"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--LiabilitiesInConnectionWithAcquisitionsAndDispositions_iI_pn3n3_maALCzErP_za2u7I06ihW1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Liabilities in connection with acquisitions and dispositions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,119&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,123&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LeaseDepositLiability_iI_pn3n3_maALCzErP_znl7JMQaCdDh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Assumed lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,328&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1748"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--LeaseTerminationLiability_iI_pn3n3_maALCzErP_zBb3Qlhezbwe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Lease termination liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,481&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,753&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maALCzErP_z4rq3OtxmYk3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Other accrued expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;489&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;755&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccruedLiabilitiesCurrent_iTI_pn3n3_mtALCzErP_zUGWjDkRuT75" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total accrued expenses and other&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;30,771&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;23,102&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <AREN:GeneralAccruedExpenses
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001732"
      unitRef="USD">6486000</AREN:GeneralAccruedExpenses>
    <AREN:GeneralAccruedExpenses
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001733"
      unitRef="USD">6339000</AREN:GeneralAccruedExpenses>
    <us-gaap:AccruedPayrollTaxesCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001735"
      unitRef="USD">5448000</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001736"
      unitRef="USD">5221000</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedAdvertisingCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001738"
      unitRef="USD">7596000</us-gaap:AccruedAdvertisingCurrent>
    <us-gaap:AccruedAdvertisingCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001739"
      unitRef="USD">4911000</us-gaap:AccruedAdvertisingCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001741"
      unitRef="USD">3824000</us-gaap:InterestPayableCurrent>
    <AREN:LiabilitiesInConnectionWithAcquisitionsAndDispositions
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001744"
      unitRef="USD">1119000</AREN:LiabilitiesInConnectionWithAcquisitionsAndDispositions>
    <AREN:LiabilitiesInConnectionWithAcquisitionsAndDispositions
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001745"
      unitRef="USD">1123000</AREN:LiabilitiesInConnectionWithAcquisitionsAndDispositions>
    <us-gaap:LeaseDepositLiability
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001747"
      unitRef="USD">1328000</us-gaap:LeaseDepositLiability>
    <AREN:LeaseTerminationLiability
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001750"
      unitRef="USD">4481000</AREN:LeaseTerminationLiability>
    <AREN:LeaseTerminationLiability
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001751"
      unitRef="USD">4753000</AREN:LeaseTerminationLiability>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001753"
      unitRef="USD">489000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001754"
      unitRef="USD">755000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001756"
      unitRef="USD">30771000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001757"
      unitRef="USD">23102000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001759">&lt;p id="xdx_804_eus-gaap--DebtDisclosureTextBlock_zrnxQidmTccf" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;14.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_820_z4tzOq8IFphl"&gt;Line of Credit&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Arena
Credit Agreement&lt;/i&gt; &#x2013; On December 15, 2022, the Company entered into an amendment to its financing and security agreement for
its line of credit with SLR Digital Finance LLC (&#x201c;SLR&#x201d; or the &#x201c;amended line of credit&#x201d;), as further amended
on August 31, 2023 in connection with the Business Combination (see Note 28) (the &#x201c;SLR Amendment&#x201d;) pursuant to which the
SLR Amendment provided for an extension of the maturity date, additional event of default provisions in connection with the Business
Combination, payment of certain fees in connection with the Business Combination, additional borrowings under the 2023 Notes (see
Note 18) pursuant to the First Amendment (see Note 18 and Note 27), and issuance of Series A preferred stock in connection with the
Business Combination, all of which are more fully described herein. Collectively the amended line of credit and SLR Amendment are
referred to as the &#x201c;line of credit&#x201d; (or the &#x201c;Arena Credit Agreement&#x201d;). In connection with the Arena Notes
Default (as further described under the heading &lt;i&gt;Arena Loan Agreement &lt;/i&gt; in Note 28) there was a cross-default of the line of
credit, or the SLR Default (as further described under the heading &lt;i&gt;Arena Credit Agreement Default&lt;/i&gt; in Note 28). The line of
credit provided for (i) $&lt;span id="xdx_901_eus-gaap--LineOfCredit_iI_pn3n3_c20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember__srt--RangeAxis__srt--MaximumMember_zJMANQ2LEqMb" title="Line of credit"&gt;40,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;maximum
amount of advances available (subject to certain limits and eighty-five (&lt;span id="xdx_90B_ecustom--AccountsReceivablePercentage_pid_dp_uPure_c20221215__20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember__srt--RangeAxis__srt--MaximumMember_zX0c7yycZAOd" title="Accounts receivable percentage"&gt;85&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%)
of eligible accounts receivable) pursuant to the amended line of credit, (ii) &lt;span id="xdx_905_eus-gaap--LineOfCreditFacilityInterestRateDescription_c20221215__20221215__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember_zie0R2Wjyvka" title="Line of credit facility, interest rate description"&gt;an
interest rate at the prime rate plus 4.0% per annum of the amount advanced (subject to minimum utilization of at least 10% of the
maximum amount of advances available) (as of December 31, 2023 the stated interest rate was 12.5%), (iii) payment of a fee equal to
2.25% of the maximum line amount with respect to any termination of the agreement prior to December 31, 2025 at the option of the
Company at any time with 60 day notice pursuant to the SLR Amendment, (iv) a payment of a performance fee in the amount equal to
2.25% of the maximum line amount, under certain circumstances pursuant to the Business Combination in connection with a deal
deadline or in the event of a deal failure, as defined in the SLR Amendment, further the performance fee will survive the
termination of the agreement, pursuant to the SLR Amendment, (v) a payment of a success fee if the Business Combination is
consummated, of 0.3% or 0.6% of the maximum line amount if the transaction closes on or before December 31, 2023 or after December
31, 2023, respectively, or $0 if the transaction closes after the deal deadline, pursuant to the SLR Amendment, and (vi) a maturity
date of &lt;/span&gt;&lt;/span&gt;&lt;span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_dd_c20221215__20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember_zhS9HlaoRw8i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Maturity date"&gt;December
31, 2025&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;. The SLR Amendment also permitted the
Company to enter into the 2023 Notes in an aggregate of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember__us-gaap--LongtermDebtTypeAxis__custom--TwoThousandTwentyThreeNotesMember_zs21Rbo6NxW5" title="Debt instrument, face amount"&gt;8,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(as
further described under the heading &lt;i&gt;2023 Bridge Notes&lt;/i&gt; in Note 18) and permitted the issuance of the Series A preferred stock
for $&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember__us-gaap--StatementEquityComponentsAxis__custom--SeriesLPreferredStockMember_zsRlgIbqohBa" title="Debt instrument, face amount"&gt;25,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
connection with the Business Combination. The line of credit was for working capital purposes and was secured by a first lien on all
the Company&#x2019;s cash and accounts receivable and a second lien on all other assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the SLR Amendment and amended line of credit, the Company incurred debt costs of $&lt;span id="xdx_902_eus-gaap--DebtDefaultLongtermDebtAmount_iI_pn3n3_c20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zDVkDo1n3TXj" title="Debt costs"&gt;200
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and $&lt;span id="xdx_90A_eus-gaap--UnamortizedDebtIssuanceExpense_iI_pn3n3_c20221215__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zEGAqll9zEc7" title="Debt costs"&gt;441&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
respectively, with the SLR Amendment debt cost plus the unamortized debt cost at the time of the SLR Amendment being amortized over the
life of the extended maturity date of the line of credit. The unamortized balance, as of December 31, 2023 and 2022, was reflected in
prepayment and other current assets of $&lt;span id="xdx_907_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zQxBwKN4cXne" title="Prepayment and other current assets"&gt;209
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and $&lt;span id="xdx_903_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zOyUXz8lMqNe" title="Prepayment and other current assets"&gt;216&lt;/span&gt;&lt;span style="line-height: 115%"&gt;, respectively,
and &lt;/span&gt;other long-term assets of $&lt;span id="xdx_905_eus-gaap--OtherAssetsNoncurrent_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zEhEOTKWbum" title="Other long-term assets"&gt;209
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and $&lt;span id="xdx_900_eus-gaap--OtherAssetsNoncurrent_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zG2A5BKdb7aj" title="Other long-term assets"&gt;216&lt;/span&gt;,
respectively&lt;/span&gt;. As of December 31, 2023, the effective interest rate on the line of credit was &lt;span id="xdx_905_eus-gaap--LineOfCreditFacilityInterestRateAtPeriodEnd_iI_pid_dp_uPure_c20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zzpTpnqbnAji" title="Effective interest rate, line of credit"&gt;13.7&lt;/span&gt;%.
As of December 31, 2023 and 2022, the balance outstanding under the line of credit was $&lt;span id="xdx_907_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zlvzovJVkXU3" title="Line of credit"&gt;19,609
&lt;/span&gt;and $&lt;span id="xdx_906_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zWdoiiaI8br6" title="Line of credit"&gt;14,092&lt;/span&gt;,
respectively, as reflected on the consolidated balance sheets. As of December 31, 2023, in connection with the SLR Default, the Company
recorded a $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFeeAmount_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zfskYoJYzka7" title="Termination fee"&gt;900
&lt;/span&gt;termination fee representing &lt;span id="xdx_903_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--FinancingAndSecurityAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--SLRDigitalFinanceLLCMember_zLNTD6t2LLp8" title="Interest rate, line of credit"&gt;2.25&lt;/span&gt;%
of the maximum line amount, as reflected in accrued expenses and other on the consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCredit
      contextRef="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember_srt_MaximumMember"
      decimals="-3"
      id="Fact001761"
      unitRef="USD">40000000</us-gaap:LineOfCredit>
    <AREN:AccountsReceivablePercentage
      contextRef="From2022-12-152022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001763"
      unitRef="Pure">0.85</AREN:AccountsReceivablePercentage>
    <us-gaap:LineOfCreditFacilityInterestRateDescription
      contextRef="From2022-12-152022-12-15_custom_SLRDigitalFinanceLLCMember_custom_FinancingAndSecurityAgreementMember"
      id="Fact001765">an
interest rate at the prime rate plus 4.0% per annum of the amount advanced (subject to minimum utilization of at least 10% of the
maximum amount of advances available) (as of December 31, 2023 the stated interest rate was 12.5%), (iii) payment of a fee equal to
2.25% of the maximum line amount with respect to any termination of the agreement prior to December 31, 2025 at the option of the
Company at any time with 60 day notice pursuant to the SLR Amendment, (iv) a payment of a performance fee in the amount equal to
2.25% of the maximum line amount, under certain circumstances pursuant to the Business Combination in connection with a deal
deadline or in the event of a deal failure, as defined in the SLR Amendment, further the performance fee will survive the
termination of the agreement, pursuant to the SLR Amendment, (v) a payment of a success fee if the Business Combination is
consummated, of 0.3% or 0.6% of the maximum line amount if the transaction closes on or before December 31, 2023 or after December
31, 2023, respectively, or $0 if the transaction closes after the deal deadline, pursuant to the SLR Amendment, and (vi) a maturity
date of</us-gaap:LineOfCreditFacilityInterestRateDescription>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2022-12-152022-12-15_custom_SLRDigitalFinanceLLCMember_custom_FinancingAndSecurityAgreementMember"
      id="Fact001767">2025-12-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember_custom_TwoThousandTwentyThreeNotesMember"
      decimals="-3"
      id="Fact001769"
      unitRef="USD">8000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember_custom_SeriesLPreferredStockMember"
      decimals="-3"
      id="Fact001771"
      unitRef="USD">25000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtDefaultLongtermDebtAmount
      contextRef="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember"
      decimals="-3"
      id="Fact001773"
      unitRef="USD">200000</us-gaap:DebtDefaultLongtermDebtAmount>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="AsOf2022-12-15_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember"
      decimals="-3"
      id="Fact001775"
      unitRef="USD">441000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember"
      decimals="-3"
      id="Fact001777"
      unitRef="USD">209000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2022-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember"
      decimals="-3"
      id="Fact001779"
      unitRef="USD">216000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2023-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember"
      decimals="-3"
      id="Fact001781"
      unitRef="USD">209000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2022-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember"
      decimals="-3"
      id="Fact001783"
      unitRef="USD">216000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="AsOf2023-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember"
      decimals="INF"
      id="Fact001785"
      unitRef="Pure">0.137</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LinesOfCreditCurrent
      contextRef="AsOf2023-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember"
      decimals="-3"
      id="Fact001787"
      unitRef="USD">19609000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="AsOf2022-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember"
      decimals="-3"
      id="Fact001789"
      unitRef="USD">14092000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="AsOf2023-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember"
      decimals="-3"
      id="Fact001791"
      unitRef="USD">900000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2023-01-012023-12-31_custom_FinancingAndSecurityAgreementMember_custom_SLRDigitalFinanceLLCMember"
      decimals="INF"
      id="Fact001793"
      unitRef="Pure">0.0225</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <AREN:LiquidatedDamagesPayableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001795">&lt;p id="xdx_809_ecustom--LiquidatedDamagesPayableTextBlock_zpxEob7RK7ni" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;15.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_824_zRrpr5VZnOEd"&gt;Liquidated Damages Payable&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Liquidated
damages were recorded as a result of the following: (i) certain registration rights agreements provide for damages if the Company does
not register certain shares of the Company&#x2019;s common stock within the requisite time frame (the &#x201c;Registration Rights Damages&#x201d;);
and (ii) certain securities purchase agreements provide for damages if the Company does not maintain its periodic filings with the SEC
within the requisite time frame (the &#x201c;Public Information Failure Damages&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--SummaryOfLiquidatedDamagesTableTextBlock_gL3SOLDTTB-KNKL_zDGTwIincM2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Obligations
with respect to the liquidated damages payable are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B5_zMegz0GqMS1a" style="display: none"&gt;Summary
of Liquidated Damages&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Registration&lt;br/&gt;
 Rights Damages&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Public&lt;br/&gt;
 Information&lt;br/&gt;
 Failure Damages&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Accrued&lt;br/&gt;
 Interest&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Balance&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;MDB common stock to be issued (&lt;span id="xdx_F42_zZAapBO2gps9"&gt;1&lt;/span&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zDqlJnuraLZh" style="width: 12%; text-align: right" title="Registration Rights Damages"&gt;15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zirnilVnafnd" style="width: 12%; text-align: right" title="Public Information Failure Damages"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1803"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_z4G7I3rqJu3l" style="width: 12%; text-align: right" title="Accrued Interest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1805"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_z35RJgXoCam" style="width: 12%; text-align: right" title="Balance"&gt;15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series H convertible preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zZMZaArqvnu3" style="text-align: right" title="Registration Rights Damages"&gt;565&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zPBLMRLCtnKk" style="text-align: right" title="Public Information Failure Damages"&gt;574&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zmj1VuA20GT2" style="text-align: right" title="Accrued Interest"&gt;659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zrdXkHLPLGEd" style="text-align: right" title="Balance"&gt;1,798&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_F4E_zs8iFrZCBsvi" style="text-align: left"&gt;Convertible debentures (2)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zHjuFFJuUt69" style="text-align: right" title="Registration Rights Damages"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1817"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zkACreHtTaZ6" style="text-align: right" title="Public Information Failure Damages"&gt;144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zyVXLmuIRu22" style="text-align: right" title="Accrued Interest"&gt;72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zNi1hi2GuUxe" style="text-align: right" title="Balance"&gt;216&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series J convertible preferred stock (&lt;span id="xdx_F42_zB3Dv8wiU987"&gt;2&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zDDZEmJvDOP7" style="text-align: right" title="Registration Rights Damages"&gt;152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zuDyvhBzhao" style="text-align: right" title="Public Information Failure Damages"&gt;152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zMMbTt20YTBd" style="text-align: right" title="Accrued Interest"&gt;129&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zOcPtTGLre05" style="text-align: right" title="Balance"&gt;433&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Series K convertible preferred stock (&lt;span id="xdx_F4C_zQ7O58bIoMu3"&gt;2&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zjdbdtNBHFgi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Registration Rights Damages"&gt;166&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zdTZF3ORJqHj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Public Information Failure Damages"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zs968JTFeeP4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accrued Interest"&gt;226&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zDnuJNHOtOw" style="border-bottom: Black 1.5pt solid; text-align: right" title="Balance"&gt;462&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231_zZTVJj6CNDbi" style="border-bottom: Black 2.5pt double; text-align: right" title="Registration Rights Damages"&gt;898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231_zfymHuAEnpak" style="border-bottom: Black 2.5pt double; text-align: right" title="Public Information Failure Damages"&gt;940&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231_zq2lIzgEeo12" style="border-bottom: Black 2.5pt double; text-align: right" title="Accrued Interest"&gt;1,086&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231_zRxTxJkYT124" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance"&gt;2,924&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F04_z3VFS35LQHIc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F16_zwNEu3NvNq85" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares
                                            of common stock issuable to MDB Capital Group, LLC (&#x201c;MDB&#x201d;) (see &lt;i&gt;Common Stock
                                            to be Issued&lt;/i&gt; in Note 21).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F09_zPiUdwXpxay2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F13_zjoO0f4ruTR7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
                                            previously issued and converted debt or equity securities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A9_zZej9dRcH5z7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 8, 2023, the Company entered into a stock purchase agreement with an investor, where the Company was liable for liquidated damages,
pursuant to which the Company issued &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230208__20230208__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zia0jNW8KAwh" title="Shares issued"&gt;47,252&lt;/span&gt;
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of its common stock, in satisfaction of
the liquidated damages, at a price equal to $&lt;span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230208__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z9kj8PGe283d"&gt;10.56
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share (determined based on the volume-weighted
average price of the Company&#x2019;s common stock at the close of trading on the sixty (60) previous trading days), to the investor in
lieu of an aggregate of $&lt;span id="xdx_900_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20230208__20230208__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zOPFfCfo6Dag"&gt;499
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;owed in liquidated damages as of the conversion
date. The Company prepared and filed a registration statement covering the resale of these shares of the Company&#x2019;s common stock
issued in lieu of payment of these liquidated damages in cash. During the year ended December 31, 2023, the Company recorded $&lt;span id="xdx_90E_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zswDtd90Csnh"&gt;499
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in connection with the issuance of shares of
the Company&#x2019;s common stock on the consolidated statements of stockholders&#x2019; deficiency (further details are provided under
the heading &lt;i&gt;Common Stock for Liquidated Damages &lt;/i&gt;in Note 21).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 1, 2023, the Company entered into a waiver of liquidated damages and release of claims, where B. Riley, a principal stockholder
at the time, relinquished any claims to liquidated damages and accrued interest thereon amounting to $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentDecreaseForgiveness_pn3n3_c20231201__20231201__srt--TitleOfIndividualAxis__custom--BRileyMember_zIYo9Q7aV9N7" title="Gain on forgiveness of debt"&gt;3,497&lt;/span&gt;, which resulted in a gain
on forgiveness of debt. Given this transaction was with a related party and in connection with other contemporaneous transactions with
another principal stockholder, Simplify (further described in Note 26), the gain of $&lt;span id="xdx_902_ecustom--AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zk5ceR3Z9qKh" title="Gain on forgiveness of debt"&gt;3,497&lt;/span&gt; was recorded within additional paid-in capital
on the consolidated statement of stockholders&#x2019; deficiency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, the short-term liquidated damages payable was $&lt;span id="xdx_90C_ecustom--LiquidatedDamagesPayableCurrent_iI_pn3n3_c20231231_zf5LCJ8OR7qh" title="Short-term liquidated damages"&gt;2,924&lt;/span&gt;. The Company will continue to accrue interest on the liquidated
damages balance at &lt;span id="xdx_90B_ecustom--LiquidatedDamagesPayableAccruedInterestPercentage_pid_dp_uPure_c20230101__20231231_zQDnSBsX4mpe" title="Liquidated damages payable accrued interest percentage"&gt;1&lt;/span&gt;% per month based on the balance outstanding as of December 31, 2023, or $&lt;span id="xdx_906_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231_zn0R0h5fDQXe" title="Liquidated damages outstanding amount"&gt;2,924&lt;/span&gt;, until paid. There is no scheduled
date when the unpaid liquidated damages become due. The previously issued and converted Series K convertible preferred stock remains
subject to Registration Rights Damages and Public Information Failure Damages, which will accrue in certain circumstances, limited to
&lt;span id="xdx_907_ecustom--PercentageOfAggregateAmountInvested_pid_dp_uPure_c20230101__20231231_zjUxwAOvDBic" title="Percentage of aggregate amount invested"&gt;6&lt;/span&gt;% of the aggregate amount invested.&lt;/span&gt;&lt;/p&gt;

&lt;div id="xdx_C05_gL3SOLDTTB-KNKL_zg0S3T9Doi9j"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_306_134_zLWqsaxl7i5c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Liquidated Damages (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Registration&lt;br/&gt;
 Rights Damages&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Public&lt;br/&gt;
 Information&lt;br/&gt;
 Failure
    Damages&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Accrued&lt;br/&gt;
 Interest&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Balance&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;MDB common stock to be issued (1)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zhbG7wqvMsp4" style="width: 12%; text-align: right" title="Registration Rights Damages"&gt;15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zOkqE9IM4m54" style="width: 12%; text-align: right" title="Public Information Failure Damages"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1870"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_znOKNlmxcGVg" style="width: 12%; text-align: right" title="Accrued Interest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1872"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zh4pS70UZ014" style="width: 12%; text-align: right" title="Balance"&gt;15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series H Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zcnVr4RdmnCl" style="text-align: right" title="Registration Rights Damages"&gt;618&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zvsojiPfENoc" style="text-align: right" title="Public Information Failure Damages"&gt;626&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zMJ2eqMVY7s2" style="text-align: right" title="Accrued Interest"&gt;570&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zzjK3JA7zvd3" style="text-align: right" title="Balance"&gt;1,814&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Convertible debentures (&lt;span id="xdx_F49_zphT2fK5b3u"&gt;2&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zY0wmjJ2jXTj" style="text-align: right" title="Registration Rights Damages"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1884"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zz3S6lbFCXcg" style="text-align: right" title="Public Information Failure Damages"&gt;704&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zGUIY42ddsl4" style="text-align: right" title="Accrued Interest"&gt;280&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zebUolESDQMj" style="text-align: right" title="Balance"&gt;984&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series J convertible preferred stock (&lt;span id="xdx_F42_zQxUbIHB1zl9"&gt;2&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_z1KydlfNJPpi" style="text-align: right" title="Registration Rights Damages"&gt;932&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zwPaFfQdUg08" style="text-align: right" title="Public Information Failure Damages"&gt;932&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_z7WnqsPmvlP" style="text-align: right" title="Accrued Interest"&gt;525&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zQ8chrfdJ2k" style="text-align: right" title="Balance"&gt;2,389&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Series K convertible preferred stock (&lt;span id="xdx_F4C_zUqtmOqrq3F5"&gt;2&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_z11OeUxmZJqa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Registration Rights Damages"&gt;437&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zYBRUpEoQfY1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Public Information Failure Damages"&gt;478&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zVkGyt4b2GZc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accrued Interest"&gt;220&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zqvyX3zC2VUh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Balance"&gt;1,135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231_zl7QFhHFxK3g" style="border-bottom: Black 2.5pt double; text-align: right" title="Registration Rights Damages"&gt;2,002&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231_zHm8sHhnuF51" style="border-bottom: Black 2.5pt double; text-align: right" title="Public Information Failure Damages"&gt;2,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231_zrgH99cf9FDj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accrued Interest"&gt;1,595&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231_zdSVTzUMvWv6" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance"&gt;6,337&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F00_zVQwPxgU9mH3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1B_zE3iDtl8Jxl1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares
                                            of common stock issuable to MDB.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F02_zTnG0ctsL4vj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F16_zV2VYzn6F8v5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
                                            previously issued and converted debt or equity securities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;/div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_C0E_gL3SOLDTTB-KNKL_zvYv4swqcvYg"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022, the short-term and long-term liquidated damages payable were $&lt;span id="xdx_905_ecustom--LiquidatedDamagesPayableCurrent_iI_pn3n3_c20221231_zm6OdE0Kk7ob" title="Short-term liquidated damages"&gt;5,843&lt;/span&gt; and $&lt;span id="xdx_90A_ecustom--LiquidatedDamagesPayableNonCurrent_iI_pn3n3_c20221231_z96EcSHe8Yrd" title="Long-term liquidated damages"&gt;494&lt;/span&gt;, respectively, totaling $&lt;span id="xdx_90C_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231_zn9OueICee1d" title="Liquidated damages outstanding amount"&gt;6,337&lt;/span&gt;. The
long-term portion was converted into shares of the Company&#x2019;s common stock on January 24, 2022 (further details are provided under
heading &lt;i&gt;Common Stock for Liquidated Damages &lt;/i&gt;in Note 21).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
with respect to the liquidated damages recognized on the consolidated statements of operations is provided in Note 23.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AREN:LiquidatedDamagesPayableTextBlock>
    <AREN:SummaryOfLiquidatedDamagesTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001799">&lt;p id="xdx_895_ecustom--SummaryOfLiquidatedDamagesTableTextBlock_gL3SOLDTTB-KNKL_zDGTwIincM2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Obligations
with respect to the liquidated damages payable are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B5_zMegz0GqMS1a" style="display: none"&gt;Summary
of Liquidated Damages&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Registration&lt;br/&gt;
 Rights Damages&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Public&lt;br/&gt;
 Information&lt;br/&gt;
 Failure Damages&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Accrued&lt;br/&gt;
 Interest&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Balance&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;MDB common stock to be issued (&lt;span id="xdx_F42_zZAapBO2gps9"&gt;1&lt;/span&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zDqlJnuraLZh" style="width: 12%; text-align: right" title="Registration Rights Damages"&gt;15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zirnilVnafnd" style="width: 12%; text-align: right" title="Public Information Failure Damages"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1803"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_z4G7I3rqJu3l" style="width: 12%; text-align: right" title="Accrued Interest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1805"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_z35RJgXoCam" style="width: 12%; text-align: right" title="Balance"&gt;15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series H convertible preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zZMZaArqvnu3" style="text-align: right" title="Registration Rights Damages"&gt;565&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zPBLMRLCtnKk" style="text-align: right" title="Public Information Failure Damages"&gt;574&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zmj1VuA20GT2" style="text-align: right" title="Accrued Interest"&gt;659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zrdXkHLPLGEd" style="text-align: right" title="Balance"&gt;1,798&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_F4E_zs8iFrZCBsvi" style="text-align: left"&gt;Convertible debentures (2)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zHjuFFJuUt69" style="text-align: right" title="Registration Rights Damages"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1817"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zkACreHtTaZ6" style="text-align: right" title="Public Information Failure Damages"&gt;144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zyVXLmuIRu22" style="text-align: right" title="Accrued Interest"&gt;72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zNi1hi2GuUxe" style="text-align: right" title="Balance"&gt;216&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series J convertible preferred stock (&lt;span id="xdx_F42_zB3Dv8wiU987"&gt;2&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zDDZEmJvDOP7" style="text-align: right" title="Registration Rights Damages"&gt;152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zuDyvhBzhao" style="text-align: right" title="Public Information Failure Damages"&gt;152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zMMbTt20YTBd" style="text-align: right" title="Accrued Interest"&gt;129&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zOcPtTGLre05" style="text-align: right" title="Balance"&gt;433&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Series K convertible preferred stock (&lt;span id="xdx_F4C_zQ7O58bIoMu3"&gt;2&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zjdbdtNBHFgi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Registration Rights Damages"&gt;166&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zdTZF3ORJqHj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Public Information Failure Damages"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zs968JTFeeP4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accrued Interest"&gt;226&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zDnuJNHOtOw" style="border-bottom: Black 1.5pt solid; text-align: right" title="Balance"&gt;462&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--RegistrationRightsDamages_iI_pn3n3_c20231231_zZTVJj6CNDbi" style="border-bottom: Black 2.5pt double; text-align: right" title="Registration Rights Damages"&gt;898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20231231_zfymHuAEnpak" style="border-bottom: Black 2.5pt double; text-align: right" title="Public Information Failure Damages"&gt;940&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231_zq2lIzgEeo12" style="border-bottom: Black 2.5pt double; text-align: right" title="Accrued Interest"&gt;1,086&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20231231_zRxTxJkYT124" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance"&gt;2,924&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F04_z3VFS35LQHIc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F16_zwNEu3NvNq85" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares
                                            of common stock issuable to MDB Capital Group, LLC (&#x201c;MDB&#x201d;) (see &lt;i&gt;Common Stock
                                            to be Issued&lt;/i&gt; in Note 21).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F09_zPiUdwXpxay2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F13_zjoO0f4ruTR7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
                                            previously issued and converted debt or equity securities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_306_134_zLWqsaxl7i5c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Liquidated Damages (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Registration&lt;br/&gt;
 Rights Damages&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Public&lt;br/&gt;
 Information&lt;br/&gt;
 Failure
    Damages&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Accrued&lt;br/&gt;
 Interest&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Balance&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;MDB common stock to be issued (1)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zhbG7wqvMsp4" style="width: 12%; text-align: right" title="Registration Rights Damages"&gt;15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zOkqE9IM4m54" style="width: 12%; text-align: right" title="Public Information Failure Damages"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1870"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_znOKNlmxcGVg" style="width: 12%; text-align: right" title="Accrued Interest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1872"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--MDBCommonStockToBeIssuedMember_fKDEp_zh4pS70UZ014" style="width: 12%; text-align: right" title="Balance"&gt;15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series H Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zcnVr4RdmnCl" style="text-align: right" title="Registration Rights Damages"&gt;618&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zvsojiPfENoc" style="text-align: right" title="Public Information Failure Damages"&gt;626&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zMJ2eqMVY7s2" style="text-align: right" title="Accrued Interest"&gt;570&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zzjK3JA7zvd3" style="text-align: right" title="Balance"&gt;1,814&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Convertible debentures (&lt;span id="xdx_F49_zphT2fK5b3u"&gt;2&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zY0wmjJ2jXTj" style="text-align: right" title="Registration Rights Damages"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1884"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zz3S6lbFCXcg" style="text-align: right" title="Public Information Failure Damages"&gt;704&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zGUIY42ddsl4" style="text-align: right" title="Accrued Interest"&gt;280&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertibleDebenturesMember_fKDIp_zebUolESDQMj" style="text-align: right" title="Balance"&gt;984&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series J convertible preferred stock (&lt;span id="xdx_F42_zQxUbIHB1zl9"&gt;2&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_z1KydlfNJPpi" style="text-align: right" title="Registration Rights Damages"&gt;932&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zwPaFfQdUg08" style="text-align: right" title="Public Information Failure Damages"&gt;932&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_z7WnqsPmvlP" style="text-align: right" title="Accrued Interest"&gt;525&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_fKDIp_zQ8chrfdJ2k" style="text-align: right" title="Balance"&gt;2,389&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Series K convertible preferred stock (&lt;span id="xdx_F4C_zUqtmOqrq3F5"&gt;2&lt;/span&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_z11OeUxmZJqa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Registration Rights Damages"&gt;437&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zYBRUpEoQfY1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Public Information Failure Damages"&gt;478&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zVkGyt4b2GZc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accrued Interest"&gt;220&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_fKDIp_zqvyX3zC2VUh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Balance"&gt;1,135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--RegistrationRightsDamages_iI_pn3n3_c20221231_zl7QFhHFxK3g" style="border-bottom: Black 2.5pt double; text-align: right" title="Registration Rights Damages"&gt;2,002&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PublicInformationFailureDamages_iI_pn3n3_c20221231_zHm8sHhnuF51" style="border-bottom: Black 2.5pt double; text-align: right" title="Public Information Failure Damages"&gt;2,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231_zrgH99cf9FDj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accrued Interest"&gt;1,595&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--LiquidatedDamagesPayableCurrentAndNonCurrent_iI_pn3n3_c20221231_zdSVTzUMvWv6" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance"&gt;6,337&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F00_zVQwPxgU9mH3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1B_zE3iDtl8Jxl1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares
                                            of common stock issuable to MDB.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F02_zTnG0ctsL4vj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F16_zV2VYzn6F8v5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
                                            previously issued and converted debt or equity securities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&#160;</AREN:SummaryOfLiquidatedDamagesTableTextBlock>
    <AREN:RegistrationRightsDamages
      contextRef="AsOf2023-12-31_custom_MDBCommonStockToBeIssuedMember"
      decimals="-3"
      id="Fact001801"
      unitRef="USD">15000</AREN:RegistrationRightsDamages>
    <AREN:LiquidatedDamagesPayableCurrentAndNonCurrent
      contextRef="AsOf2023-12-31_custom_MDBCommonStockToBeIssuedMember"
      decimals="-3"
      id="Fact001807"
      unitRef="USD">15000</AREN:LiquidatedDamagesPayableCurrentAndNonCurrent>
    <AREN:RegistrationRightsDamages
      contextRef="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact001809"
      unitRef="USD">565000</AREN:RegistrationRightsDamages>
    <AREN:PublicInformationFailureDamages
      contextRef="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact001811"
      unitRef="USD">574000</AREN:PublicInformationFailureDamages>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact001813"
      unitRef="USD">659000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <AREN:LiquidatedDamagesPayableCurrentAndNonCurrent
      contextRef="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact001815"
      unitRef="USD">1798000</AREN:LiquidatedDamagesPayableCurrentAndNonCurrent>
    <AREN:PublicInformationFailureDamages
      contextRef="AsOf2023-12-31_custom_ConvertibleDebenturesMember"
      decimals="-3"
      id="Fact001819"
      unitRef="USD">144000</AREN:PublicInformationFailureDamages>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2023-12-31_custom_ConvertibleDebenturesMember"
      decimals="-3"
      id="Fact001821"
      unitRef="USD">72000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <AREN:LiquidatedDamagesPayableCurrentAndNonCurrent
      contextRef="AsOf2023-12-31_custom_ConvertibleDebenturesMember"
      decimals="-3"
      id="Fact001823"
      unitRef="USD">216000</AREN:LiquidatedDamagesPayableCurrentAndNonCurrent>
    <AREN:RegistrationRightsDamages
      contextRef="AsOf2023-12-31_custom_SeriesJPreferredStockMember"
      decimals="-3"
      id="Fact001825"
      unitRef="USD">152000</AREN:RegistrationRightsDamages>
    <AREN:PublicInformationFailureDamages
      contextRef="AsOf2023-12-31_custom_SeriesJPreferredStockMember"
      decimals="-3"
      id="Fact001827"
      unitRef="USD">152000</AREN:PublicInformationFailureDamages>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2023-12-31_custom_SeriesJPreferredStockMember"
      decimals="-3"
      id="Fact001829"
      unitRef="USD">129000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <AREN:LiquidatedDamagesPayableCurrentAndNonCurrent
      contextRef="AsOf2023-12-31_custom_SeriesJPreferredStockMember"
      decimals="-3"
      id="Fact001831"
      unitRef="USD">433000</AREN:LiquidatedDamagesPayableCurrentAndNonCurrent>
    <AREN:RegistrationRightsDamages
      contextRef="AsOf2023-12-31_custom_SeriesKPreferredStockMember"
      decimals="-3"
      id="Fact001833"
      unitRef="USD">166000</AREN:RegistrationRightsDamages>
    <AREN:PublicInformationFailureDamages
      contextRef="AsOf2023-12-31_custom_SeriesKPreferredStockMember"
      decimals="-3"
      id="Fact001835"
      unitRef="USD">70000</AREN:PublicInformationFailureDamages>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2023-12-31_custom_SeriesKPreferredStockMember"
      decimals="-3"
      id="Fact001837"
      unitRef="USD">226000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <AREN:LiquidatedDamagesPayableCurrentAndNonCurrent
      contextRef="AsOf2023-12-31_custom_SeriesKPreferredStockMember"
      decimals="-3"
      id="Fact001839"
      unitRef="USD">462000</AREN:LiquidatedDamagesPayableCurrentAndNonCurrent>
    <AREN:RegistrationRightsDamages
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001841"
      unitRef="USD">898000</AREN:RegistrationRightsDamages>
    <AREN:PublicInformationFailureDamages
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001843"
      unitRef="USD">940000</AREN:PublicInformationFailureDamages>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001845"
      unitRef="USD">1086000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <AREN:LiquidatedDamagesPayableCurrentAndNonCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001847"
      unitRef="USD">2924000</AREN:LiquidatedDamagesPayableCurrentAndNonCurrent>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-082023-02-08_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      id="Fact001851"
      unitRef="Shares">47252</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-02-08_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      id="Fact001852"
      unitRef="USDPShares">10.56</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="From2023-02-082023-02-08_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="-3"
      id="Fact001853"
      unitRef="USD">499000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="From2023-01-012023-12-31_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="-3"
      id="Fact001854"
      unitRef="USD">499000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:DebtInstrumentDecreaseForgiveness
      contextRef="From2023-12-012023-12-01_custom_BRileyMember"
      decimals="-3"
      id="Fact001856"
      unitRef="USD">3497000</us-gaap:DebtInstrumentDecreaseForgiveness>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages
      contextRef="From2023-01-012023-12-31_custom_BRileyMember"
      decimals="-3"
      id="Fact001858"
      unitRef="USD">3497000</AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithForgivenessOfLiquidatedDamages>
    <AREN:LiquidatedDamagesPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001860"
      unitRef="USD">2924000</AREN:LiquidatedDamagesPayableCurrent>
    <AREN:LiquidatedDamagesPayableAccruedInterestPercentage
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact001862"
      unitRef="Pure">0.01</AREN:LiquidatedDamagesPayableAccruedInterestPercentage>
    <AREN:LiquidatedDamagesPayableCurrentAndNonCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001864"
      unitRef="USD">2924000</AREN:LiquidatedDamagesPayableCurrentAndNonCurrent>
    <AREN:PercentageOfAggregateAmountInvested
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact001866"
      unitRef="Pure">0.06</AREN:PercentageOfAggregateAmountInvested>
    <AREN:RegistrationRightsDamages
      contextRef="AsOf2022-12-31_custom_MDBCommonStockToBeIssuedMember"
      decimals="-3"
      id="Fact001868"
      unitRef="USD">15000</AREN:RegistrationRightsDamages>
    <AREN:LiquidatedDamagesPayableCurrentAndNonCurrent
      contextRef="AsOf2022-12-31_custom_MDBCommonStockToBeIssuedMember"
      decimals="-3"
      id="Fact001874"
      unitRef="USD">15000</AREN:LiquidatedDamagesPayableCurrentAndNonCurrent>
    <AREN:RegistrationRightsDamages
      contextRef="AsOf2022-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact001876"
      unitRef="USD">618000</AREN:RegistrationRightsDamages>
    <AREN:PublicInformationFailureDamages
      contextRef="AsOf2022-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact001878"
      unitRef="USD">626000</AREN:PublicInformationFailureDamages>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2022-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact001880"
      unitRef="USD">570000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <AREN:LiquidatedDamagesPayableCurrentAndNonCurrent
      contextRef="AsOf2022-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact001882"
      unitRef="USD">1814000</AREN:LiquidatedDamagesPayableCurrentAndNonCurrent>
    <AREN:PublicInformationFailureDamages
      contextRef="AsOf2022-12-31_custom_ConvertibleDebenturesMember"
      decimals="-3"
      id="Fact001886"
      unitRef="USD">704000</AREN:PublicInformationFailureDamages>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2022-12-31_custom_ConvertibleDebenturesMember"
      decimals="-3"
      id="Fact001888"
      unitRef="USD">280000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <AREN:LiquidatedDamagesPayableCurrentAndNonCurrent
      contextRef="AsOf2022-12-31_custom_ConvertibleDebenturesMember"
      decimals="-3"
      id="Fact001890"
      unitRef="USD">984000</AREN:LiquidatedDamagesPayableCurrentAndNonCurrent>
    <AREN:RegistrationRightsDamages
      contextRef="AsOf2022-12-31_custom_SeriesJPreferredStockMember"
      decimals="-3"
      id="Fact001892"
      unitRef="USD">932000</AREN:RegistrationRightsDamages>
    <AREN:PublicInformationFailureDamages
      contextRef="AsOf2022-12-31_custom_SeriesJPreferredStockMember"
      decimals="-3"
      id="Fact001894"
      unitRef="USD">932000</AREN:PublicInformationFailureDamages>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2022-12-31_custom_SeriesJPreferredStockMember"
      decimals="-3"
      id="Fact001896"
      unitRef="USD">525000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <AREN:LiquidatedDamagesPayableCurrentAndNonCurrent
      contextRef="AsOf2022-12-31_custom_SeriesJPreferredStockMember"
      decimals="-3"
      id="Fact001898"
      unitRef="USD">2389000</AREN:LiquidatedDamagesPayableCurrentAndNonCurrent>
    <AREN:RegistrationRightsDamages
      contextRef="AsOf2022-12-31_custom_SeriesKPreferredStockMember"
      decimals="-3"
      id="Fact001900"
      unitRef="USD">437000</AREN:RegistrationRightsDamages>
    <AREN:PublicInformationFailureDamages
      contextRef="AsOf2022-12-31_custom_SeriesKPreferredStockMember"
      decimals="-3"
      id="Fact001902"
      unitRef="USD">478000</AREN:PublicInformationFailureDamages>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2022-12-31_custom_SeriesKPreferredStockMember"
      decimals="-3"
      id="Fact001904"
      unitRef="USD">220000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <AREN:LiquidatedDamagesPayableCurrentAndNonCurrent
      contextRef="AsOf2022-12-31_custom_SeriesKPreferredStockMember"
      decimals="-3"
      id="Fact001906"
      unitRef="USD">1135000</AREN:LiquidatedDamagesPayableCurrentAndNonCurrent>
    <AREN:RegistrationRightsDamages
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001908"
      unitRef="USD">2002000</AREN:RegistrationRightsDamages>
    <AREN:PublicInformationFailureDamages
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001910"
      unitRef="USD">2740000</AREN:PublicInformationFailureDamages>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001912"
      unitRef="USD">1595000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <AREN:LiquidatedDamagesPayableCurrentAndNonCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001914"
      unitRef="USD">6337000</AREN:LiquidatedDamagesPayableCurrentAndNonCurrent>
    <AREN:LiquidatedDamagesPayableCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001918"
      unitRef="USD">5843000</AREN:LiquidatedDamagesPayableCurrent>
    <AREN:LiquidatedDamagesPayableNonCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001920"
      unitRef="USD">494000</AREN:LiquidatedDamagesPayableNonCurrent>
    <AREN:LiquidatedDamagesPayableCurrentAndNonCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001922"
      unitRef="USD">6337000</AREN:LiquidatedDamagesPayableCurrentAndNonCurrent>
    <AREN:OtherLongtermLiabilitiesTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001924">&lt;p id="xdx_80D_ecustom--OtherLongtermLiabilitiesTextBlock_zYlNZNPv9GB2" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;16.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_820_z89ie0sHKZSc"&gt;Other Long-term Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--OtherLongtermLiabilitiesTableTextBlock_znxixkzx3hJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
long-term liabilities consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BC_zmw0NNfxV0j6" style="display: none"&gt;Schedule
of Other long- term liabilities&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20231231_zGeXXw97s7B3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20221231_znXhoVIujHrf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--LeaseTerminationLiabilityNonCurrent_iI_pn3n3_maOLNz6kY_zReJPruxu3sa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Lease termination liability&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1928"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;3,621&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_maOLNz6kY_zc2YXmiWK5Ud" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Assumed lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,486&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--OtherLongTermLiabilitiesNoncurrent_iI_pn3n3_maOLNz6kY_zH2eDVGxNCYj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;56&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OtherLiabilitiesNoncurrent_iTI_pn3n3_mtOLNz6kY_zAWc9uR9NT55" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total other long-term liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;406&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,307&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AF_zIR6v2kKDJRd" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</AREN:OtherLongtermLiabilitiesTextBlock>
    <AREN:OtherLongtermLiabilitiesTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001926">&lt;p id="xdx_89A_ecustom--OtherLongtermLiabilitiesTableTextBlock_znxixkzx3hJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
long-term liabilities consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BC_zmw0NNfxV0j6" style="display: none"&gt;Schedule
of Other long- term liabilities&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20231231_zGeXXw97s7B3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20221231_znXhoVIujHrf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--LeaseTerminationLiabilityNonCurrent_iI_pn3n3_maOLNz6kY_zReJPruxu3sa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Lease termination liability&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1928"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;3,621&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_maOLNz6kY_zc2YXmiWK5Ud" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Assumed lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,486&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--OtherLongTermLiabilitiesNoncurrent_iI_pn3n3_maOLNz6kY_zH2eDVGxNCYj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;56&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OtherLiabilitiesNoncurrent_iTI_pn3n3_mtOLNz6kY_zAWc9uR9NT55" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total other long-term liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;406&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,307&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</AREN:OtherLongtermLiabilitiesTableTextBlock>
    <AREN:LeaseTerminationLiabilityNonCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001929"
      unitRef="USD">3621000</AREN:LeaseTerminationLiabilityNonCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001931"
      unitRef="USD">350000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001932"
      unitRef="USD">1486000</us-gaap:OtherLiabilitiesCurrent>
    <AREN:OtherLongTermLiabilitiesNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001934"
      unitRef="USD">56000</AREN:OtherLongTermLiabilitiesNoncurrent>
    <AREN:OtherLongTermLiabilitiesNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001935"
      unitRef="USD">200000</AREN:OtherLongTermLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001937"
      unitRef="USD">406000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001938"
      unitRef="USD">5307000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001940">&lt;p id="xdx_802_eus-gaap--FairValueDisclosuresTextBlock_zumazjFcEkde" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;17.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_828_zqFuGY3YLiOl"&gt;Fair Value Measurement&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist of level 1, Level 2 and level 3 assets as of December 31, 2023 and 2022. As of December
31, 2023 and 2022, the Company&#x2019;s cash and cash equivalents of $&lt;span id="xdx_904_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20231231_zahS6RvGe688" title="Cash and cash equivalents"&gt;9,284&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20221231_zdUWJGS2R9t5" title="Cash and cash equivalents"&gt;13,871&lt;/span&gt;, respectively, were Level 1 assets and included
savings deposits, overnight investments, and other liquid funds with financial institutions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounted for certain common stock issued in connection with the acquisition of Fexy Studios that is subject to a put option
(which provides for a cash payment to the sellers on the first anniversary date of the closing (or January 11, 2024) in the event the
common stock trading price on such date is less than the common stock trading price on the day immediately preceding the acquisition
date, or $&lt;span id="xdx_904_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_c20231231__us-gaap--BusinessAcquisitionAxis__custom--FlexyStudiosMember_zNLVWV04Ez48" title="Preceding acquistion price per share"&gt;8.10&lt;/span&gt; per share), as a derivative liability, which requires the Company to carry such amounts on its consolidated
balance sheets as a liability at fair value, as adjusted at each reporting period-end (further details are provided under the heading
&lt;i&gt;Fexy Put Option&lt;/i&gt; in Note 28).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Financial instruments measured at fair value during
the year ended December 31, 2023, related to the Company&#x2019;s current debt, with a carrying value of $&lt;span id="xdx_906_eus-gaap--FinancialInstrumentsOwnedAtFairValue_iI_pn3n3_c20231231_zyTLzCow57y3" title="Financial instruments measured fair value debt bridge notes"&gt;7,887&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--FinancialInstrumentsOwnedOtherAtFairValue_iI_pn3n3_c20231231_zGBXXbZNEkI7" title="Debt fair value"&gt;102,309&lt;/span&gt; for the Bridge Notes
and Debt as of December 31, 2023, respectively, approximates fair value due to their short nature and based on current market interest
rates for debt instruments of similar credit standing.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zfaz0sRL9HOl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments measured at fair value during the year consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BD_zDRBiyiFr0F5" style="display: none"&gt;Schedule
of Fair Value of Financial Instruments&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Quoted
Prices &lt;br/&gt;
in Active &lt;br/&gt;
Markets for&lt;br/&gt;
Identical &lt;br/&gt;
Assets (Level 1)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant&lt;br/&gt;
Other &lt;br/&gt;
Observable&lt;br/&gt;
Inputs (Level 2)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant
&lt;br/&gt;
Unobservable&lt;br/&gt;
Inputs (Level 3)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; width: 36%"&gt;Contingent consideration&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember_zBqy5pqnWLte" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%" title="Long term debt fair value"&gt;1,571&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zAnw5mckc7L6" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%" title="Long term debt fair value"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1956"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z3BUQe1t0cZj" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%" title="Long term debt fair value"&gt;1,571&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember_zYFQ4GVPfRS5" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%" title="Long term debt fair value"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1960"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Quoted
Prices &lt;br/&gt;
in Active &lt;br/&gt;
Markets for&lt;br/&gt;
Identical &lt;br/&gt;
Assets (Level 1)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant&lt;br/&gt;
Other &lt;br/&gt;
Observable&lt;br/&gt;
Inputs (Level 2)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant
&lt;br/&gt;
Unobservable&lt;br/&gt;
Inputs (Level 3)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20231231_zLh1urT9FVq4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Senior Secured Notes&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember_z3l5qJvtiOAj" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Long term debt fair value"&gt;61,787&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zzH51p02O4m2" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Long term debt fair value"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1965"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zTWvTclZT9Ij" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Long term debt fair value"&gt;61,787&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zhxdxdUbSY4g" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Long term debt fair value"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1969"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zBTOL38MkJtk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Contingent
Consideration &#x2013;&lt;/i&gt; The fair value of the contingent consideration is primarily dependent on the common stock trading price on
the first anniversary of the closing of the Fexy Studios acquisition, or January 11, 2024. The estimated fair value was calculated based
on the $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20231231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zExRuvR838D7" title="Exercise price"&gt;8.10&lt;/span&gt; put option amount based on the exercise price of the Company&#x2019;s common stock at the acquisition date, less the $&lt;span id="xdx_90C_eus-gaap--SharePrice_iI_pid_c20231231_zdoZdr6vE384" title="Common stock trading price"&gt;2.38&lt;/span&gt;
the Company&#x2019;s common stock trading price as of the reporting date, or $&lt;span id="xdx_903_eus-gaap--SharePrice_iI_pid_c20231231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zyRVw0UK22U9" title="Trading price, per share"&gt;5.72&lt;/span&gt; per share, multiplied by the number of shares subject
to the put option of &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230101__20231231__us-gaap--AssetAcquisitionAxis__custom--FexyStudiosAcquistionMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zdu0NU0Z7pbc" title="Issuance of common stock in connection with acquisitions, shares"&gt;274,692&lt;/span&gt;, which approximated the value if the Black-Scholes option-pricing model was used given the proximity date
of the put option. For the year ended December 31, 2023, the change in valuation of the contingent consideration of $&lt;span id="xdx_902_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_pn3n3_di_c20230101__20231231_z1BxlaWtbgEa" title="Change in valuation of contingent consideration"&gt;1,010&lt;/span&gt; was recognized
in other expenses on the consolidated statement of operations. Further details are provided under the heading &lt;i&gt;Fexy Put Option
&lt;/i&gt;in Note 28.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Senior
Secured Notes&lt;/i&gt; &#x2013; The carrying value of the Senior Secured Notes (as defined below) approximates fair value based on current
market interest rates for debt instruments of similar credit standing and, consequently, their fair values are based on Level 2 inputs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
quantitative information utilized in the fair value calculation of the Level 3 liabilities are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Unearned
Revenue&lt;/i&gt; &#x2013; The fair value of unearned revenue remaining in connection with the 2019 acquisitions of Sports Illustrated licensed
brands, was determined with the following inputs: (1) projection of when unearned revenue will be earned; (2) expense necessary to fulfill
the subscriptions; (3) gross up of the fulfillment costs to include a market participant level of profitability; (4) slight premium to
the fulfillment-costs plus a reasonable profit metric; and (5) reduce projected future cash flows to present value using an appropriate
discount rate. The unearned revenue remaining from the acquisitions as of December 31, 2023 and 2022 was $&lt;span id="xdx_90C_ecustom--UnearnedRevenue_iI_pn3n3_c20231231_zhL6nZnj0Hnb" title="Unearned revenue"&gt;523&lt;/span&gt; and $&lt;span id="xdx_904_ecustom--UnearnedRevenue_iI_pn3n3_c20221231_zhGuGn2hJAw8" title="Unearned revenue"&gt;1,154&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
changes in unearned revenue with inputs classified as Level 3 of the fair value hierarchy are reflected within revenue on the consolidated
statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001942"
      unitRef="USD">9284000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001944"
      unitRef="USD">13871000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="AsOf2023-12-31_custom_FlexyStudiosMember"
      decimals="INF"
      id="Fact001946"
      unitRef="USDPShares">8.10</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001948"
      unitRef="USD">7887000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <us-gaap:FinancialInstrumentsOwnedOtherAtFairValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001950"
      unitRef="USD">102309000</us-gaap:FinancialInstrumentsOwnedOtherAtFairValue>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001952">&lt;p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zfaz0sRL9HOl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments measured at fair value during the year consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BD_zDRBiyiFr0F5" style="display: none"&gt;Schedule
of Fair Value of Financial Instruments&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Quoted
Prices &lt;br/&gt;
in Active &lt;br/&gt;
Markets for&lt;br/&gt;
Identical &lt;br/&gt;
Assets (Level 1)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant&lt;br/&gt;
Other &lt;br/&gt;
Observable&lt;br/&gt;
Inputs (Level 2)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant
&lt;br/&gt;
Unobservable&lt;br/&gt;
Inputs (Level 3)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; width: 36%"&gt;Contingent consideration&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember_zBqy5pqnWLte" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%" title="Long term debt fair value"&gt;1,571&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zAnw5mckc7L6" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%" title="Long term debt fair value"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1956"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z3BUQe1t0cZj" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%" title="Long term debt fair value"&gt;1,571&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--ContingentConsiderationMember_zYFQ4GVPfRS5" style="border-bottom: Black 2.5pt double; text-align: right; width: 12%" title="Long term debt fair value"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1960"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Quoted
Prices &lt;br/&gt;
in Active &lt;br/&gt;
Markets for&lt;br/&gt;
Identical &lt;br/&gt;
Assets (Level 1)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant&lt;br/&gt;
Other &lt;br/&gt;
Observable&lt;br/&gt;
Inputs (Level 2)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant
&lt;br/&gt;
Unobservable&lt;br/&gt;
Inputs (Level 3)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20231231_zLh1urT9FVq4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Senior Secured Notes&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember_z3l5qJvtiOAj" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Long term debt fair value"&gt;61,787&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zzH51p02O4m2" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Long term debt fair value"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1965"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zTWvTclZT9Ij" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Long term debt fair value"&gt;61,787&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LongTermDebtFairValue_iI_pn3n3_c20221231__us-gaap--FinancialInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zhxdxdUbSY4g" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Long term debt fair value"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1969"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:LongTermDebtFairValue
      contextRef="AsOf2023-12-31_custom_ContingentConsiderationMember"
      decimals="-3"
      id="Fact001954"
      unitRef="USD">1571000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="AsOf2023-12-31_custom_ContingentConsiderationMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact001958"
      unitRef="USD">1571000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember"
      decimals="-3"
      id="Fact001963"
      unitRef="USD">61787000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact001967"
      unitRef="USD">61787000</us-gaap:LongTermDebtFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2023-12-31_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001971"
      unitRef="USDPShares">8.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001973"
      unitRef="USDPShares">2.38</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-12-31_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001975"
      unitRef="USDPShares">5.72</us-gaap:SharePrice>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-01-012023-12-31_custom_FexyStudiosAcquistionMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001977"
      unitRef="Shares">274692</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact001979"
      unitRef="USD">-1010000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <AREN:UnearnedRevenue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001981"
      unitRef="USD">523000</AREN:UnearnedRevenue>
    <AREN:UnearnedRevenue
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001983"
      unitRef="USD">1154000</AREN:UnearnedRevenue>
    <us-gaap:ShortTermDebtTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001985">&lt;p id="xdx_803_eus-gaap--ShortTermDebtTextBlock_z9lEydQ2F7X1" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;18.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_82B_zpgVzjwg75f5"&gt;Bridge Notes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2023
Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Note Purchase Agreement, First Amendment and Second Amendment (as further described under the heading &lt;i&gt;Principal
Stockholders&lt;/i&gt; in Note 26), on August 31, 2023, the Company issued $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20230831__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zv65i3wDg7Uj" title="Aggregate principal amount"&gt;5,000&lt;/span&gt; aggregate principal amount of senior secured notes (the &#x201c;2023
Notes&#x201d;). The provisions of the First Amendment also permit certain incremental borrowings in the amount up to $&lt;span id="xdx_904_eus-gaap--OtherBorrowings_iI_pn3n3_c20230831__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zoXVmz2bb103" title="Incremental borrowings"&gt;3,000&lt;/span&gt; at the sole
discretion of the purchaser (the &#x201c;Incremental 2023 Notes&#x201d;), subject to a minimum amount of $&lt;span id="xdx_90C_ecustom--AggregatePrincipalMinimumAmount_pn3n3_c20230831__20230831__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zgdEQ2qI3ZBc" title="Incremental borrowings"&gt;1,000&lt;/span&gt; and other conditions. On
September 29, 2023, the Company issued $&lt;span id="xdx_90C_ecustom--AggregatePrincipalMinimumAmount_pn3n3_c20230929__20230929__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zcfaZftKQxjc" title="Incremental borrowings"&gt;1,000&lt;/span&gt; aggregate principal amount of senior secured notes pursuant to the incremental borrowings.
On November 27, 2023, the Company issued $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231127__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zKapEXhgsnh4" title="Aggregate principal amount"&gt;2,000&lt;/span&gt; aggregate principal amount of senior secured notes pursuant to the incremental borrowings.
In connection with the issuance of the 2023 Notes, the Company received net proceeds of $&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfDebt_pn3n3_c20230929__20230929__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zyevAeVBXR2i" title="Net proceeds"&gt;7,643&lt;/span&gt; from the issuance of the notes and incurred
debt costs of $&lt;span id="xdx_904_eus-gaap--DebtSecuritiesAvailableForSaleAmortizedCostCurrent_iI_pn3n3_c20230929__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zm0eUc6Hf2ag" title="Amortized debt cost"&gt;357&lt;/span&gt; that is being amortized over the expected life of the debt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The terms of 2023 Notes provide for:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;an
    interest rate fixed at &lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_c20230831__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zeFXSz2zznB1" title="Debt instrument interest rate effective percentage"&gt;10.0&lt;/span&gt;% per annum;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a
    maturity date of &lt;span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--BridgeNotesMember_zAjgeSddw7Dj" title="Debt maturity term"&gt;April
    30, 2024&lt;/span&gt;, as amended pursuant to the Second Amendment from December 31, 2023, subject to consummation of the Business
    Combination (see Note 28) on or prior to April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, which
    may result in an event of default if not consummated, and a prepayment requirement to apply a portion of the net proceeds from the
    Business Combination to repay $&lt;span id="xdx_907_eus-gaap--ProceedsFromDebtNetOfIssuanceCosts_pn3n3_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zRbUM4KJsrB" title="Net proceeds from business combination"&gt;8,000&lt;/span&gt;
    (and any additional amounts borrowed pursuant to the incremental borrowing arrangement described above) under the notes;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a
    provision for the failure to repay the $&lt;span id="xdx_904_eus-gaap--PrepaymentFeesOnAdvancesNet_pn3n3_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zMWY2jyyosR3" title="Prepayment fees on advances, net"&gt;8,000&lt;/span&gt; prepayment requirement in full with the proceeds of the Business Combination or failure
    to consummate the Business Combination by April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, will
    result in an event of default under the notes; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;an
    election to prepay the notes, at any time, at &lt;span id="xdx_906_ecustom--PrincipalAmountPrepayDue_iI_pid_dp_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_z6BcoGL0gzjj" title="Principal amount prepay due percentage"&gt;100&lt;/span&gt;% of the principal amount due with no premium or penalty.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
debt issuance cost incurred under the debt modifications pursuant to the First Amendment are being amortized over the term of the
2023 Notes. The debt modification pursuant to the Second Amendment resulted in the unamortized debt issuance cost being amortized
over the extended term of the 2023 Notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 29, 2023, the Company failed to make the interest payment due on the 2023  Notes resulting in an event of default with
subsequent agreement to a forbearance period through the earlier of the following: (a) April 30, 2024; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%"&gt;(b)
the occurrence of the closing of the Business Combination and (c) the termination of the Business Combination prior&lt;/span&gt; to closing (collectively the &#x201c;forbearance&#x201d;) &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%"&gt;(&lt;/span&gt;further details are provided for under the heading &lt;i&gt;Arena Loan
Agreement &lt;/i&gt; in Note 28).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, the effective interest rate on the 2023 Notes was &lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20231231__us-gaap--DebtInstrumentAxis__custom--BridgeNotesMember_zp0h855GaQ6e"&gt;14.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%. As of &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%"&gt;December 31, 2023,
the current balance outstanding under the 2023 Notes was $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--BridgeNotesMember_znbSSFnkRLd1" title="Balance outstanding"&gt;7,887&lt;/span&gt;, net of unamortized cost of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--BridgeNotesMember_zKigqmHGNRK2" title="Debt instrument, unamortized discount, current"&gt;113&lt;/span&gt;, with the principal balance due of $&lt;span id="xdx_909_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--BridgeNotesMember_zP67bvywf1X4" title="Debt payment principal amount"&gt;8,000&lt;/span&gt;,
subject to the forbearance.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
for the years ended December 31, 2023 and 2022, with respect to interest expense related to the 2023 Notes is provided under the heading
&lt;i&gt;Interest Expense&lt;/i&gt; in Note 19.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2022
Bridge Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 15, 2022, the Company issued $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20221215__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zR0yh62J8pEe" title="Principal amount"&gt;36,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;aggregate principal amount of senior secured
notes (the &#x201c;2022 Bridge Notes&#x201d;) pursuant to the Note Purchase Agreement. In connection with the issuance of the notes, the
Company received net proceeds of $&lt;span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfDebt_pn3n3_c20221215__20221215__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zb1z9Gy3G76i" title="Proceeds from issuance of debt"&gt;34,728
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and incurred debt costs of $&lt;span id="xdx_90E_eus-gaap--DeferredFinanceCostsNet_iI_pn3n3_c20221215__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zSZysIUc0Vak" title="Incurred debt costs"&gt;1,272
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;that were being amortized over the expected life
of the debt. As of December 31, 2022, the balance outstanding under the 2022 Bridge Notes was $&lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zuP3Ch37Qpt" title="Principal balance"&gt;34,805
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;($&lt;span id="xdx_909_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zUPAGcu3Wf35" title="Principal balance"&gt;36,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;principal balance less unamortized debt costs
of $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zyYh1XdIBlo7" title="Unamortized debt costs"&gt;1,195&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;),
that was modified during the year ended December 31, 2023 (further details are provided under the heading &lt;i&gt;2022 Bridge Notes&lt;/i&gt; in
Note 19).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShortTermDebtTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-08-31_custom_TwoThousandTwentyThreeNotesMember"
      decimals="-3"
      id="Fact001987"
      unitRef="USD">5000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:OtherBorrowings
      contextRef="AsOf2023-08-31_custom_TwoThousandTwentyThreeNotesMember"
      decimals="-3"
      id="Fact001989"
      unitRef="USD">3000000</us-gaap:OtherBorrowings>
    <AREN:AggregatePrincipalMinimumAmount
      contextRef="From2023-08-312023-08-31_custom_TwoThousandTwentyThreeNotesMember"
      decimals="-3"
      id="Fact001991"
      unitRef="USD">1000000</AREN:AggregatePrincipalMinimumAmount>
    <AREN:AggregatePrincipalMinimumAmount
      contextRef="From2023-09-292023-09-29_custom_TwoThousandTwentyThreeNotesMember"
      decimals="-3"
      id="Fact001993"
      unitRef="USD">1000000</AREN:AggregatePrincipalMinimumAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-11-27_custom_TwoThousandTwentyThreeNotesMember"
      decimals="-3"
      id="Fact001995"
      unitRef="USD">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2023-09-292023-09-29_custom_TwoThousandTwentyThreeNotesMember"
      decimals="-3"
      id="Fact001997"
      unitRef="USD">7643000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="AsOf2023-09-29_custom_TwoThousandTwentyThreeNotesMember"
      decimals="-3"
      id="Fact001999"
      unitRef="USD">357000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2023-08-31_custom_TwoThousandTwentyThreeNotesMember"
      decimals="INF"
      id="Fact002001"
      unitRef="Pure">0.100</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-01-012023-12-31_custom_BridgeNotesMember"
      id="Fact002003">2024-04-30</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeNotesMember"
      decimals="-3"
      id="Fact002005"
      unitRef="USD">8000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:PrepaymentFeesOnAdvancesNet
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeNotesMember"
      decimals="-3"
      id="Fact002007"
      unitRef="USD">8000000</us-gaap:PrepaymentFeesOnAdvancesNet>
    <AREN:PrincipalAmountPrepayDue
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyThreeNotesMember"
      decimals="INF"
      id="Fact002009"
      unitRef="Pure">1</AREN:PrincipalAmountPrepayDue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-12-31_custom_BridgeNotesMember"
      decimals="INF"
      id="Fact002010"
      unitRef="Pure">0.142</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-31_custom_BridgeNotesMember"
      decimals="-3"
      id="Fact002012"
      unitRef="USD">7887000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="AsOf2023-12-31_custom_BridgeNotesMember"
      decimals="-3"
      id="Fact002014"
      unitRef="USD">113000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2023-01-012023-12-31_custom_BridgeNotesMember"
      decimals="-3"
      id="Fact002016"
      unitRef="USD">8000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-12-15_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="-3"
      id="Fact002018"
      unitRef="USD">36000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2022-12-152022-12-15_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="-3"
      id="Fact002020"
      unitRef="USD">34728000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="AsOf2022-12-15_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="-3"
      id="Fact002022"
      unitRef="USD">1272000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="-3"
      id="Fact002024"
      unitRef="USD">34805000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="-3"
      id="Fact002026"
      unitRef="USD">36000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="-3"
      id="Fact002028"
      unitRef="USD">1195000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:LongTermDebtTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002030">&lt;p id="xdx_802_eus-gaap--LongTermDebtTextBlock_zFjkIytLbso2" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;19.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_822_zX99Dffbm6J"&gt;Long-term Debt&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Senior
Secured Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;Pursuant
to the Note Purchase Agreement, as amended by the First Amendment and Second Amendment (&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%"&gt;as further described
under the heading &lt;i&gt;Principal Stockholders&lt;/i&gt; in Note 26),&lt;/span&gt; as of December 31, 2023 and 2022, the
Company has notes outstanding referred to as the senior secured notes (the &#x201c;Senior Secured Notes&#x201d;), the delayed draw term notes (the &#x201c;Delayed Draw Term Notes&#x201d;) and the 2022 Bridge Notes, as further
described below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;The terms of the Senior Secured Notes
provide for:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a
provision for the Company to enter into Delayed Draw Term Notes (as described below);&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a
    provision where the Company added $&lt;span id="xdx_902_eus-gaap--InterestPayableCurrent_iI_pn3n3_c20220101_z702hnpMYyzk" title="Interest payable"&gt;13,852&lt;/span&gt; to the principal balance of the notes for interest payable prior to January 1, 2022 as
    payable in-kind;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a
    provision where the paid in-kind interest can be paid in shares of the Company&#x2019;s common stock based upon the conversion rate
    specified in the Certificate of Designation for the Series K convertible preferred stock, subject to certain adjustments;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;an
    interest rate of &lt;span id="xdx_905_eus-gaap--DebtInstrumentInterestRateIncreaseDecrease_pid_dp_uPure_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zgy9GRsORt06" title="Debt instrument interest rate"&gt;10.0&lt;/span&gt;% per annum, subject to adjustment in the event of default, with a provision that within one (1) business day
    after receipt of cash proceeds from any issuance of equity interests, unless waived, the Company will prepay certain obligations
    in an amount equal to such cash proceeds, net of underwriting discounts and commissions; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;interest
    on the notes payable after February 15, 2022, at the agent&#x2019;s sole discretion, either (a) in cash quarterly in arrears on the
    last day of each fiscal quarter or (b) by continuing to add such interest due on such payment dates to the principal amount of the
    notes;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a
    maturity date of &lt;span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zCwbqEp4aKvh" title="Debt instrument maturity date"&gt;December
    31, 2026&lt;/span&gt; (as amended from December 31, 2023 pursuant to the First Amendment), subject to consummation of the Business
    Combination (see Note 28) on or prior to April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, which
    may result in an event of default if not consummated, and subject to certain acceleration conditions; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    Company to enter into the 2022 Bridge Notes for $&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231231__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember_zflF9Vb2tgF8" title="Principal amount of debt"&gt;36,000&lt;/span&gt; and to increase the line of credit with SLR in an aggregate principal amount
    not to exceed $&lt;span id="xdx_901_eus-gaap--LineOfCredit_iI_pn3n3_c20231231__dei--LegalEntityAxis__custom--SLRDigitalFinanceLLCMember_z2iced0m17jf" title="Line of credit"&gt;40,000&lt;/span&gt;. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Delayed
Draw Term Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms of the Delayed Draw Term Notes provide for:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;an
    interest rate of &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--LongtermDebtTypeAxis__custom--DelayedDrawTermNotesMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zqpTRfThzMBe" title="Debt instrument interest rate percentage"&gt;10.0&lt;/span&gt;% per annum, subject to adjustment in the event of default; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;interest
    on the notes payable after February 15, 2022, at the agent&#x2019;s sole discretion, either (a) in cash quarterly in arrears on the
    last day of each fiscal quarter or (b) by continuing to add such interest due on such payment dates to the principal amount of the
    notes; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a
    maturity date on &lt;span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--DelayedDrawTermNotesMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zPJ250sUHu5e" title="Debt instrument maturity date"&gt;December 31, 2026&lt;/span&gt; (as amended from December 31, 2023 pursuant to the First Amendment), subject to consummation of
    the Business Combination on or prior to April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, which
    may result in an event of default if not consummated, and subject to certain acceleration terms.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2022
Bridge Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the First Amendment, the 2022 Bridge Notes outstanding as of December 31, 2022 were amended and reclassified from a current liability
to a noncurrent liability. In connection with the debt modification, the Company incurred debt issuance costs of $&lt;span id="xdx_903_eus-gaap--DeferredFinanceCostsNet_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zfpiTnMvEr9" title="Incurred debt costs"&gt;100 &lt;/span&gt;that are being amortized
over the life of the 2022 Bridge Notes and a portion of the note maturity was extended as further described below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The terms of the 2022 Bridge Notes provide
for:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;an
    interest rate fixed at &lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20221215__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zInSABbLegIl" title="Debt fixed rate"&gt;10.0&lt;/span&gt;% per annum (as amended from interest that was payable in cash at an interest rate of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_z9gnhLJEHLPi" title="Debt due rate"&gt;12&lt;/span&gt;% per annum quarterly;
    with interest rate increases of &lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230301__20230301__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zYJEziTRMZle" title="Debt interest rate"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230501__20230501__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zF40MQFoXpd7" title="Debt interest rate"&gt;&lt;span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230701__20230701__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zo4mBMc1QcOc" title="Debt interest rate"&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;% per annum on March 1, 2023, May 1, 2023, and July 1, 2023, pursuant to the First Amendment);&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a
    maturity date of &lt;span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20221231__20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zu54uwhUn8ia" title="Debt maturity date"&gt;December 31, 2026&lt;/span&gt; (as amended from December 31, 2023 pursuant to the First Amendment), subject to consummation of
    the Business Combination on or prior to April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, which
    may result in an event of default if not consummated, and subject to certain mandatory prepayment requirements, including, but not
    limited to, a requirement that the Company apply the net proceeds from certain debt incurrences or equity offerings to repay the
    notes;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a
    prepayment requirement to apply a portion of the net proceeds from the Business Combination to repay $&lt;span id="xdx_90B_ecustom--DebtInstrumentPeriodicPaymentPrincipalBalance_pn3n3_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zPgKN6jglPff" title="Principal amount of debt"&gt;20,000&lt;/span&gt; of the principal balance
    under the notes upon the earlier of April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023 or the closing
    of the Business Combination;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a
    provision for the failure to repay the $&lt;span id="xdx_90C_eus-gaap--RepaymentsOfDebt_pn3n3_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zsgYS7fPpoU4" title="Repayment of debt"&gt;20,000&lt;/span&gt; prepayment requirement in full with the proceeds of the Business Combination or failure
    to consummate the Business Combination by April 30, 2024, as amended pursuant to the Second Amendment from December 31, 2023, will
    result in an event of default under the notes; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;an
    election to prepay the notes, at any time, in whole or in part with no premium or penalty.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zpNVfkEbXUk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the  debt:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B7_zPf0exAAQenh" style="display: none"&gt;Schedule of long term debt&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Principal&lt;br/&gt;
 Balance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Unamortized&lt;br/&gt;
 Discount&lt;br/&gt;
 and Debt&lt;br/&gt;
 Issuance&lt;br/&gt;
 Costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Carrying&lt;br/&gt;
 Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Principal&lt;br/&gt;
 Balance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Unamortized&lt;br/&gt;
 Discount&lt;br/&gt;
 and Debt&lt;br/&gt;
 Issuance&lt;br/&gt;
 Costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Carrying&lt;br/&gt;
 Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Senior Secured Notes, effective interest rate of 10.1% as of December 31, 2023, as amended, matures December 31, 2026, subject to acceleration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zcYjvd5gaSGj" style="text-align: right" title="Principal balance (including accrued interest), total"&gt;62,691&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zIoRVimMAX1" style="text-align: right" title="Unamortized discount and debt issuance cost, total"&gt;&#160;&#160;&#160;&#160;(272&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zpgzjUR1Fm4i" style="text-align: right" title="Carrying value, total"&gt;62,419&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zt0PoFfmwV63" style="text-align: right" title="Principal balance (including accrued interest), total"&gt;62,691&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zIbv1nQL0m4d" style="text-align: right" title="Unamortized discount and debt issuance cost, total"&gt;(904&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zEBYgjSV3fn9" style="text-align: right" title="Carrying value"&gt;61,787&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-align: left"&gt;Senior Secured Notes, effective interest rate of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zJw5w7uSa7dl" title="Debt instrument interest rate, percentage"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zGWrxq55TJqk" title="Debt instrument interest rate, percentage"&gt;10.1&lt;/span&gt;&lt;/span&gt;% as of December 31, 2023, as amended&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zOtoQbAeGPW7" style="width: 7%; text-align: right" title="Principal balance (including accrued interest), total"&gt;62,691&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zOv0sS3e9dff" style="width: 7%; text-align: right" title="Unamortized discount and debt issuance cost, total"&gt;&#160;&#160;&#160;&#160;(272&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zSHfX28sCHvh" style="width: 7%; text-align: right" title="Carrying value, total"&gt;62,419&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zrD5MKTDiFtk" style="width: 7%; text-align: right" title="Principal balance (including accrued interest), total"&gt;62,691&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zpZVojmgZyH7" style="width: 7%; text-align: right" title="Unamortized discount and debt issuance cost, total"&gt;(904&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zn5vQAeU1A5j" style="width: 7%; text-align: right" title="Carrying value"&gt;61,787&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Delayed Draw Term Notes, effective interest rate of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--LongtermDebtTypeAxis__custom--DelayedDrawTermNoteMember_z9eaQhOl32Ti" title="Debt instrument interest rate, percentage"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--DelayedDrawTermNoteMember_z3BQWOUedm7e" title="Debt instrument interest rate, percentage"&gt;10.2&lt;/span&gt;&lt;/span&gt;% as of December 31, 2023, as amended&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_znsgAfdfFlJ8" style="text-align: right" title="Principal balance (including accrued interest), total"&gt;4,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zQ2sW6iDmSt" style="text-align: right" title="Unamortized discount and debt issuance cost, total"&gt;(31&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_z0KbI0jXYPSf" style="text-align: right" title="Carrying value, total"&gt;3,969&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_z8SDiNHSNT3a" style="text-align: right" title="Principal balance (including accrued interest), total"&gt;4,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zrvkIJYG2xN5" style="text-align: right" title="Unamortized discount and debt issuance cost, total"&gt;(103&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zHTNTPXwimZ4" style="text-align: right" title="Carrying value, total"&gt;3,897&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2022 Bridge Notes, effective interest rate of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--LongtermDebtTypeAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zF1L3SxJJaJ2" title="Debt instrument interest rate, percentage"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zTJxSXHR4Vvj" title="Debt instrument interest rate, percentage"&gt;10.2&lt;/span&gt;&lt;/span&gt;% as of December 31, 2023, as amended&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zdUBkwGStIof" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal balance (including accrued interest), total"&gt;36,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zw0Zy88ndiek" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unamortized discount and debt issuance cost, total"&gt;(79&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zyt6vREqIKX1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Carrying value, total"&gt;35,921&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zGhack6rDr58" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal balance (including accrued interest), total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2120"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zVncpNjyPBEb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unamortized discount and debt issuance cost, total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2122"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zQEqEstGdft7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Carrying value, total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2124"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231_zVNZ4l9s8c1h" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal balance"&gt;102,691&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231_z1J5bKDJw1U1" style="border-bottom: Black 2.5pt double; text-align: right" title="Unamortized discount and debt issuance costs"&gt;(382&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_pn3n3_c20231231_zBSXt3ukQq22" style="border-bottom: Black 2.5pt double; text-align: right" title="Carrying value"&gt;102,309&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231_zf5GkLDyXwuk" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal balance"&gt;66,691&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231_z4NOVAQZhEvf" style="border-bottom: Black 2.5pt double; text-align: right" title="Unamortized discount and debt issuance costs"&gt;(1,007&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20221231_zfrOgT9VrQx6" style="border-bottom: Black 2.5pt double; text-align: right" title="Carrying value"&gt;65,684&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A0_zdmS0w4zSoFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
debt issuance costs incurred under the debt modification pursuant to the First Amendment are being amortized over the term of the
long-term debt. The debt modification pursuant to the Second Amendment resulted in the unamortized debt issuance cost being
amortized over the extended term of the long-term debt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 29, 2023, the Company failed to make the interest payment due on the Secured Senior Notes, Delayed Draw Term Notes and 2022
Bridge Notes (collectively the &#x201c;debt&#x201d;) resulting in an event of default with subsequent agreement to a forbearance
period through the earlier of the following: (a) April 30, 2024; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #181717; line-height: 115%"&gt;(b)
the occurrence of the closing of the Business Combination and (c) the termination of the Business Combination prior&lt;/span&gt; to closing (or the forbearance) (further details are provided for under the &lt;i&gt;heading Arena Loan Agreement &lt;/i&gt; in Note
28).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;As of December 31, 2023,
the current maturities of the debt were $&lt;span id="xdx_906_eus-gaap--ShortTermBorrowings_iI_pn3n3_c20231231_zLFHH9qcNzje" title="current maturities of debt"&gt;102,309&lt;/span&gt;, with the principal balance due of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20230101__20231231_z4bjzhK0PrZk" title="Principal balance"&gt;102,691&lt;/span&gt;, subject to the forbearance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
for the years ended December 31, 2023 and 2022 with respect to interest expense related to long-term debt is provided below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Interest
Expense&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--SummaryOfInterestExpenseTableTextBlock_zDVNRtWPBTKg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table represents interest expense:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_zky9uH4bGeCi" style="display: none"&gt;Summary
of Interest Expense&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231_zeCyTRvlvGO4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20220101__20221231_zAVowYRW2j12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Amortization of debt costs:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember_z3uCtcZZPluj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: justify"&gt;Line of credit&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;214&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zHBh3OAeO4f4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;2023 Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;244&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2148"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredNotesMember_ztQMvMlKGe5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Senior Secured Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;632&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,031&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zsTNebWWvqNd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Delayed Draw Term Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;464&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zfqQMFiR5dBe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;2022 Bridge Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,216&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;77&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_zV2buGQgkoq5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total amortization of debt costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,378&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,581&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Noncash and accrued interest:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zYag8MI0MKOb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;2023 Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2163"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredNotesMember_zLmj52I0E0ic" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Senior Secured Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,602&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2166"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zKKNOX7J7Src" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Delayed Draw Term Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2169"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zA0NRFaiAE9h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;2022 Bridge Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;920&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2172"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--LineOfCreditTerminationFeeMember_zlUzagbdPRMg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Line of credit termination fee&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2175"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--ParadeMember_zncKzyrvJ63a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Parade&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2177"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--OtherAccruedInterestMember_zLp5ARGseRnl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Other accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;127&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;204&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_z71CZWLWfwP8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total noncash and accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--CashPaidInterestAbstract_iB_z9kBsiDehMz2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Cash paid interest:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember_zpx9gtOYVFSc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Line of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,328&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zUQMLl338i0f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;2023 Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2193"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredNotesMember_zr5e4IRGTU9l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Senior Secured Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,754&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,356&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zGOTGbNiJAoj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Delayed Draw Term Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;303&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;980&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zH2xXv4O9SRl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;2022 Bridge Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,763&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2202"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--OtherMember_zfd4GF6yJhOj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;863&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--InterestPaid_pn3n3_zEFpui48U3t8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total cash paid interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12,101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,527&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--InterestExpenseDebt_iN_pn3n3_di_zI2XsWYeUMK6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less interest income &lt;sup id="xdx_F4F_zmG8jzJPWYke"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(338&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2211"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--InterestExpense_pn3n3_z9NYNIQG58B8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;17,965&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;11,428&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F0C_znEq8p3u86Ed" style="width: 15pt; text-align: right"&gt;(1)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td id="xdx_F1B_zvNUkNYeBRtb" style="text-align: justify"&gt;During the year ended December 31, 2023, the Company recorded interest income of $&lt;span id="xdx_904_eus-gaap--InterestExpenseDebt_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zb04DjNbtnCa"&gt;338&lt;/span&gt; related
to the refunds received from the employee retention credits.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;



&lt;p id="xdx_8AE_zDoQxTVhUU5l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Noncash
and accrued interest of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20221231__20221231__srt--TitleOfIndividualAxis__custom--BRileyMember_zlaNPA6JAR87" title="Paid in cash"&gt;204&lt;/span&gt; as of December 31, 2022 related to the 2022 Bridge Notes, was paid in cash during the year ended December
31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LongTermDebtTextBlock>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2022-01-01"
      decimals="-3"
      id="Fact002032"
      unitRef="USD">13852000</us-gaap:InterestPayableCurrent>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease
      contextRef="From2023-01-012023-12-31_custom_SeniorSecuredNoteMember"
      decimals="INF"
      id="Fact002034"
      unitRef="Pure">0.100</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-01-012023-12-31_custom_SeniorSecuredNoteMember"
      id="Fact002036">2026-12-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-31_custom_SLRDigitalFinanceLLCMember"
      decimals="-3"
      id="Fact002038"
      unitRef="USD">36000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCredit
      contextRef="AsOf2023-12-31_custom_SLRDigitalFinanceLLCMember"
      decimals="-3"
      id="Fact002040"
      unitRef="USD">40000000</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-12-31_custom_DelayedDrawTermNotesMember_custom_PurchaseAgreementMember"
      decimals="INF"
      id="Fact002042"
      unitRef="Pure">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-01-012023-12-31_custom_DelayedDrawTermNotesMember_custom_PurchaseAgreementMember"
      id="Fact002044">2026-12-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="-3"
      id="Fact002046"
      unitRef="USD">100000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2022-12-15_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="INF"
      id="Fact002048"
      unitRef="Pure">0.100</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="INF"
      id="Fact002050"
      unitRef="Pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2023-03-012023-03-01_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="INF"
      id="Fact002052"
      unitRef="Pure">0.015</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2023-05-012023-05-01_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="INF"
      id="Fact002054"
      unitRef="Pure">0.015</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2023-07-012023-07-01_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="INF"
      id="Fact002056"
      unitRef="Pure">0.015</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2022-12-312022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      id="Fact002058">2026-12-31</us-gaap:DebtInstrumentMaturityDate>
    <AREN:DebtInstrumentPeriodicPaymentPrincipalBalance
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="-3"
      id="Fact002060"
      unitRef="USD">20000000</AREN:DebtInstrumentPeriodicPaymentPrincipalBalance>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="-3"
      id="Fact002062"
      unitRef="USD">20000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002064">&lt;p id="xdx_893_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zpNVfkEbXUk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the  debt:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B7_zPf0exAAQenh" style="display: none"&gt;Schedule of long term debt&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Principal&lt;br/&gt;
 Balance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Unamortized&lt;br/&gt;
 Discount&lt;br/&gt;
 and Debt&lt;br/&gt;
 Issuance&lt;br/&gt;
 Costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Carrying&lt;br/&gt;
 Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Principal&lt;br/&gt;
 Balance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Unamortized&lt;br/&gt;
 Discount&lt;br/&gt;
 and Debt&lt;br/&gt;
 Issuance&lt;br/&gt;
 Costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Carrying&lt;br/&gt;
 Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Senior Secured Notes, effective interest rate of 10.1% as of December 31, 2023, as amended, matures December 31, 2026, subject to acceleration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zcYjvd5gaSGj" style="text-align: right" title="Principal balance (including accrued interest), total"&gt;62,691&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zIoRVimMAX1" style="text-align: right" title="Unamortized discount and debt issuance cost, total"&gt;&#160;&#160;&#160;&#160;(272&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zpgzjUR1Fm4i" style="text-align: right" title="Carrying value, total"&gt;62,419&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zt0PoFfmwV63" style="text-align: right" title="Principal balance (including accrued interest), total"&gt;62,691&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zIbv1nQL0m4d" style="text-align: right" title="Unamortized discount and debt issuance cost, total"&gt;(904&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zEBYgjSV3fn9" style="text-align: right" title="Carrying value"&gt;61,787&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-align: left"&gt;Senior Secured Notes, effective interest rate of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zJw5w7uSa7dl" title="Debt instrument interest rate, percentage"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zGWrxq55TJqk" title="Debt instrument interest rate, percentage"&gt;10.1&lt;/span&gt;&lt;/span&gt;% as of December 31, 2023, as amended&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zOtoQbAeGPW7" style="width: 7%; text-align: right" title="Principal balance (including accrued interest), total"&gt;62,691&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zOv0sS3e9dff" style="width: 7%; text-align: right" title="Unamortized discount and debt issuance cost, total"&gt;&#160;&#160;&#160;&#160;(272&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zSHfX28sCHvh" style="width: 7%; text-align: right" title="Carrying value, total"&gt;62,419&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zrD5MKTDiFtk" style="width: 7%; text-align: right" title="Principal balance (including accrued interest), total"&gt;62,691&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zpZVojmgZyH7" style="width: 7%; text-align: right" title="Unamortized discount and debt issuance cost, total"&gt;(904&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zn5vQAeU1A5j" style="width: 7%; text-align: right" title="Carrying value"&gt;61,787&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Delayed Draw Term Notes, effective interest rate of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--LongtermDebtTypeAxis__custom--DelayedDrawTermNoteMember_z9eaQhOl32Ti" title="Debt instrument interest rate, percentage"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--DelayedDrawTermNoteMember_z3BQWOUedm7e" title="Debt instrument interest rate, percentage"&gt;10.2&lt;/span&gt;&lt;/span&gt;% as of December 31, 2023, as amended&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_znsgAfdfFlJ8" style="text-align: right" title="Principal balance (including accrued interest), total"&gt;4,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zQ2sW6iDmSt" style="text-align: right" title="Unamortized discount and debt issuance cost, total"&gt;(31&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_z0KbI0jXYPSf" style="text-align: right" title="Carrying value, total"&gt;3,969&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_z8SDiNHSNT3a" style="text-align: right" title="Principal balance (including accrued interest), total"&gt;4,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zrvkIJYG2xN5" style="text-align: right" title="Unamortized discount and debt issuance cost, total"&gt;(103&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zHTNTPXwimZ4" style="text-align: right" title="Carrying value, total"&gt;3,897&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2022 Bridge Notes, effective interest rate of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--LongtermDebtTypeAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zF1L3SxJJaJ2" title="Debt instrument interest rate, percentage"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIExvbmcgVGVybSBEZWJ0IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zTJxSXHR4Vvj" title="Debt instrument interest rate, percentage"&gt;10.2&lt;/span&gt;&lt;/span&gt;% as of December 31, 2023, as amended&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zdUBkwGStIof" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal balance (including accrued interest), total"&gt;36,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zw0Zy88ndiek" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unamortized discount and debt issuance cost, total"&gt;(79&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermDebt_iI_pn3n3_c20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zyt6vREqIKX1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Carrying value, total"&gt;35,921&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zGhack6rDr58" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal balance (including accrued interest), total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2120"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zVncpNjyPBEb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unamortized discount and debt issuance cost, total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2122"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebt_iI_pn3n3_c20221231__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zQEqEstGdft7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Carrying value, total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2124"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20231231_zVNZ4l9s8c1h" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal balance"&gt;102,691&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20231231_z1J5bKDJw1U1" style="border-bottom: Black 2.5pt double; text-align: right" title="Unamortized discount and debt issuance costs"&gt;(382&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_pn3n3_c20231231_zBSXt3ukQq22" style="border-bottom: Black 2.5pt double; text-align: right" title="Carrying value"&gt;102,309&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DebtInstrumentCarryingAmount_iI_pn3n3_c20221231_zf5GkLDyXwuk" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal balance"&gt;66,691&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pn3n3_di_c20221231_z4NOVAQZhEvf" style="border-bottom: Black 2.5pt double; text-align: right" title="Unamortized discount and debt issuance costs"&gt;(1,007&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermDebt_iI_pn3n3_c20221231_zfrOgT9VrQx6" style="border-bottom: Black 2.5pt double; text-align: right" title="Carrying value"&gt;65,684&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-12-31_custom_SeniorSecuredNoteMember"
      decimals="-3"
      id="Fact002066"
      unitRef="USD">62691000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2023-12-31_custom_SeniorSecuredNoteMember"
      decimals="-3"
      id="Fact002068"
      unitRef="USD">272000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-12-31_custom_SeniorSecuredNoteMember"
      decimals="-3"
      id="Fact002070"
      unitRef="USD">62419000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember66266859"
      decimals="-3"
      id="Fact002072"
      unitRef="USD">62691000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember66266859"
      decimals="-3"
      id="Fact002074"
      unitRef="USD">904000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember66266859"
      decimals="-3"
      id="Fact002076"
      unitRef="USD">61787000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-12-31_custom_SeniorSecuredNoteMember"
      decimals="INF"
      id="Fact002078"
      unitRef="Pure">0.101</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember66266859"
      decimals="INF"
      id="Fact002080"
      unitRef="Pure">0.101</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-12-31_custom_SeniorSecuredNoteMember"
      decimals="-3"
      id="Fact002082"
      unitRef="USD">62691000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2023-12-31_custom_SeniorSecuredNoteMember"
      decimals="-3"
      id="Fact002084"
      unitRef="USD">272000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-12-31_custom_SeniorSecuredNoteMember"
      decimals="-3"
      id="Fact002086"
      unitRef="USD">62419000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember66266859"
      decimals="-3"
      id="Fact002088"
      unitRef="USD">62691000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember66266859"
      decimals="-3"
      id="Fact002090"
      unitRef="USD">904000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_SeniorSecuredNoteMember66266859"
      decimals="-3"
      id="Fact002092"
      unitRef="USD">61787000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-12-31_custom_DelayedDrawTermNoteMember66267140"
      decimals="INF"
      id="Fact002094"
      unitRef="Pure">0.102</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-12-31_custom_DelayedDrawTermNoteMember66267140"
      decimals="INF"
      id="Fact002096"
      unitRef="Pure">0.102</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-12-31_custom_DelayedDrawTermNoteMember"
      decimals="-3"
      id="Fact002098"
      unitRef="USD">4000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2023-12-31_custom_DelayedDrawTermNoteMember"
      decimals="-3"
      id="Fact002100"
      unitRef="USD">31000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-12-31_custom_DelayedDrawTermNoteMember"
      decimals="-3"
      id="Fact002102"
      unitRef="USD">3969000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2022-12-31_custom_DelayedDrawTermNoteMember"
      decimals="-3"
      id="Fact002104"
      unitRef="USD">4000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2022-12-31_custom_DelayedDrawTermNoteMember"
      decimals="-3"
      id="Fact002106"
      unitRef="USD">103000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_DelayedDrawTermNoteMember"
      decimals="-3"
      id="Fact002108"
      unitRef="USD">3897000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember66267156"
      decimals="INF"
      id="Fact002110"
      unitRef="Pure">0.102</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember66267156"
      decimals="INF"
      id="Fact002112"
      unitRef="Pure">0.102</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="-3"
      id="Fact002114"
      unitRef="USD">36000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="-3"
      id="Fact002116"
      unitRef="USD">79000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="-3"
      id="Fact002118"
      unitRef="USD">35921000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002126"
      unitRef="USD">102691000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002128"
      unitRef="USD">382000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002130"
      unitRef="USD">102309000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002132"
      unitRef="USD">66691000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002134"
      unitRef="USD">1007000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002136"
      unitRef="USD">65684000</us-gaap:LongTermDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002138"
      unitRef="USD">102309000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002140"
      unitRef="USD">102691000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <AREN:SummaryOfInterestExpenseTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002142">&lt;p id="xdx_89B_ecustom--SummaryOfInterestExpenseTableTextBlock_zDVNRtWPBTKg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table represents interest expense:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_zky9uH4bGeCi" style="display: none"&gt;Summary
of Interest Expense&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231_zeCyTRvlvGO4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20220101__20221231_zAVowYRW2j12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Amortization of debt costs:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember_z3uCtcZZPluj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: justify"&gt;Line of credit&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;214&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zHBh3OAeO4f4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;2023 Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;244&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2148"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredNotesMember_ztQMvMlKGe5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Senior Secured Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;632&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,031&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zsTNebWWvqNd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Delayed Draw Term Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;464&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zfqQMFiR5dBe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;2022 Bridge Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,216&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;77&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_zV2buGQgkoq5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total amortization of debt costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,378&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,581&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Noncash and accrued interest:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zYag8MI0MKOb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;2023 Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2163"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredNotesMember_zLmj52I0E0ic" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Senior Secured Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,602&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2166"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zKKNOX7J7Src" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Delayed Draw Term Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2169"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zA0NRFaiAE9h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;2022 Bridge Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;920&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2172"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--LineOfCreditTerminationFeeMember_zlUzagbdPRMg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Line of credit termination fee&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2175"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--ParadeMember_zncKzyrvJ63a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Parade&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2177"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_hus-gaap--DebtInstrumentAxis__custom--OtherAccruedInterestMember_zLp5ARGseRnl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Other accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;127&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;204&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NoncashAndAccruedInterest_iN_pn3n3_di_z71CZWLWfwP8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total noncash and accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--CashPaidInterestAbstract_iB_z9kBsiDehMz2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Cash paid interest:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__us-gaap--LineOfCreditMember_zpx9gtOYVFSc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Line of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,328&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zUQMLl338i0f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;2023 Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2193"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredNotesMember_zr5e4IRGTU9l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Senior Secured Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,754&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,356&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--DelayedDrawTermNoteMember_zGOTGbNiJAoj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Delayed Draw Term Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;303&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;980&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyTwoBridgeNotesMember_zH2xXv4O9SRl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;2022 Bridge Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,763&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2202"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--InterestPaid_pn3n3_hus-gaap--DebtInstrumentAxis__custom--OtherMember_zfd4GF6yJhOj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;863&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--InterestPaid_pn3n3_zEFpui48U3t8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total cash paid interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12,101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,527&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--InterestExpenseDebt_iN_pn3n3_di_zI2XsWYeUMK6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less interest income &lt;sup id="xdx_F4F_zmG8jzJPWYke"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(338&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2211"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--InterestExpense_pn3n3_z9NYNIQG58B8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;17,965&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;11,428&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F0C_znEq8p3u86Ed" style="width: 15pt; text-align: right"&gt;(1)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td id="xdx_F1B_zvNUkNYeBRtb" style="text-align: justify"&gt;During the year ended December 31, 2023, the Company recorded interest income of $&lt;span id="xdx_904_eus-gaap--InterestExpenseDebt_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zb04DjNbtnCa"&gt;338&lt;/span&gt; related
to the refunds received from the employee retention credits.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;



</AREN:SummaryOfInterestExpenseTableTextBlock>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-01-012023-12-31_us-gaap_LineOfCreditMember"
      decimals="-3"
      id="Fact002144"
      unitRef="USD">214000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-01-012022-12-31_us-gaap_LineOfCreditMember"
      decimals="-3"
      id="Fact002145"
      unitRef="USD">9000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="-3"
      id="Fact002147"
      unitRef="USD">244000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-01-012023-12-31_custom_SeniorSecuredNotesMember"
      decimals="-3"
      id="Fact002150"
      unitRef="USD">632000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-01-012022-12-31_custom_SeniorSecuredNotesMember"
      decimals="-3"
      id="Fact002151"
      unitRef="USD">1031000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-01-012023-12-31_custom_DelayedDrawTermNoteMember"
      decimals="-3"
      id="Fact002153"
      unitRef="USD">72000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-01-012022-12-31_custom_DelayedDrawTermNoteMember"
      decimals="-3"
      id="Fact002154"
      unitRef="USD">464000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeNotesMember"
      decimals="-3"
      id="Fact002156"
      unitRef="USD">1216000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyThreeNotesMember"
      decimals="-3"
      id="Fact002157"
      unitRef="USD">77000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002159"
      unitRef="USD">2378000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002160"
      unitRef="USD">1581000</us-gaap:AmortizationOfDebtDiscountPremium>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeNotesMember"
      decimals="-3"
      id="Fact002162"
      unitRef="USD">-173000</AREN:NoncashAndAccruedInterest>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2023-01-012023-12-31_custom_SeniorSecuredNotesMember"
      decimals="-3"
      id="Fact002165"
      unitRef="USD">-1602000</AREN:NoncashAndAccruedInterest>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2023-01-012023-12-31_custom_DelayedDrawTermNoteMember"
      decimals="-3"
      id="Fact002168"
      unitRef="USD">-102000</AREN:NoncashAndAccruedInterest>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="-3"
      id="Fact002171"
      unitRef="USD">-920000</AREN:NoncashAndAccruedInterest>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2023-01-012023-12-31_custom_LineOfCreditTerminationFeeMember"
      decimals="-3"
      id="Fact002174"
      unitRef="USD">-900000</AREN:NoncashAndAccruedInterest>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2022-01-012022-12-31_custom_ParadeMember66267484"
      decimals="-3"
      id="Fact002178"
      unitRef="USD">-116000</AREN:NoncashAndAccruedInterest>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2023-01-012023-12-31_custom_OtherAccruedInterestMember"
      decimals="-3"
      id="Fact002180"
      unitRef="USD">-127000</AREN:NoncashAndAccruedInterest>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2022-01-012022-12-31_custom_OtherAccruedInterestMember"
      decimals="-3"
      id="Fact002181"
      unitRef="USD">-204000</AREN:NoncashAndAccruedInterest>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002183"
      unitRef="USD">-3824000</AREN:NoncashAndAccruedInterest>
    <AREN:NoncashAndAccruedInterest
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002184"
      unitRef="USD">-320000</AREN:NoncashAndAccruedInterest>
    <us-gaap:InterestPaid
      contextRef="From2023-01-012023-12-31_us-gaap_LineOfCreditMember"
      decimals="-3"
      id="Fact002189"
      unitRef="USD">2023000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2022-01-012022-12-31_us-gaap_LineOfCreditMember"
      decimals="-3"
      id="Fact002190"
      unitRef="USD">1328000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeNotesMember"
      decimals="-3"
      id="Fact002192"
      unitRef="USD">44000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2023-01-012023-12-31_custom_SeniorSecuredNotesMember"
      decimals="-3"
      id="Fact002195"
      unitRef="USD">4754000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2022-01-012022-12-31_custom_SeniorSecuredNotesMember"
      decimals="-3"
      id="Fact002196"
      unitRef="USD">6356000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2023-01-012023-12-31_custom_DelayedDrawTermNoteMember"
      decimals="-3"
      id="Fact002198"
      unitRef="USD">303000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2022-01-012022-12-31_custom_DelayedDrawTermNoteMember"
      decimals="-3"
      id="Fact002199"
      unitRef="USD">980000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoBridgeNotesMember"
      decimals="-3"
      id="Fact002201"
      unitRef="USD">3763000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2023-01-012023-12-31_custom_OtherMember66267546"
      decimals="-3"
      id="Fact002204"
      unitRef="USD">1214000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2022-01-012022-12-31_custom_OtherMember66267562"
      decimals="-3"
      id="Fact002205"
      unitRef="USD">863000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002207"
      unitRef="USD">12101000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002208"
      unitRef="USD">9527000</us-gaap:InterestPaid>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002210"
      unitRef="USD">338000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002213"
      unitRef="USD">17965000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002214"
      unitRef="USD">11428000</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-01-012023-12-31_custom_BRileyMember"
      decimals="-3"
      id="Fact002216"
      unitRef="USD">338000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2022-12-312022-12-31_custom_BRileyMember"
      decimals="-3"
      id="Fact002218"
      unitRef="USD">204000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:PreferredStockTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002220">&lt;p id="xdx_80C_eus-gaap--PreferredStockTextBlock_z3mUDii3kv3h" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;20.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_82C_zPHkqxw12jxg"&gt;Preferred Stock&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has the authority to issue &lt;span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zGhtKgwDGmyl" title="Preferred stock, shares authorized"&gt;1,000,000&lt;/span&gt; shares of Preferred Stock, $&lt;span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zRg31xm4A8p4" title="Preferred stock, par value"&gt;0.01&lt;/span&gt; par value per share, consisting of authorized and/or outstanding
shares as of December 31, 2023 as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zosvyr74CWXj" title="Preferred stock, shares authorized"&gt;1,800&lt;/span&gt;
    authorized shares designated as &#x201c;Series G Convertible Preferred Stock&#x201d; (as further described below), of which &lt;span id="xdx_900_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zIEkzNELXHpk" title="Temporary equity, shares outstanding"&gt;&lt;span id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zp9OsraaPQP6" title="Temporary equity, shares outstanding"&gt;168&lt;/span&gt;&lt;/span&gt; shares
    are outstanding as of December 31, 2023 and 2022.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zmQ44GoHucpl" title="Preferred stock, designated shares"&gt;23,000&lt;/span&gt;
    authorized shares designated as &#x201c;Series H Convertible Preferred Stock&#x201d; (as further described below), of which &lt;span id="xdx_908_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_dn_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zSwI4TfYaNSc" title="Shares outstanding"&gt;none&lt;/span&gt; and
    &lt;span id="xdx_907_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_ztHiKRyZuSFb" title="Shares outstanding"&gt;14,356&lt;/span&gt; shares were outstanding as of December 31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
G Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 30, 2000, the Company sold &lt;span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20000530__20000530__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zY0xgPAO6DD7" title="Shares sold"&gt;1,800&lt;/span&gt; shares of its Series G convertible Preferred Stock (the &#x201c;Series G Preferred Stock&#x201d;),
of which &lt;span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_pid_c20000530__20000530__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zMtySjRsJxM" title="Conversion Of stock shares converted"&gt;1,631.504&lt;/span&gt; were converted prior to November 2001 and &lt;span id="xdx_90C_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20000530__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zybYhOgaG4Pl" title="Temporary equity shares outstanding"&gt;168.496&lt;/span&gt; shares continue to be outstanding, at a stated value of $&lt;span id="xdx_900_eus-gaap--PreferredStockLiquidationPreference_iI_pid_c20000530__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zyozSB9nBaJ3" title="Preferred stock liquidation preference"&gt;1,000&lt;/span&gt; per
share, convertible into shares of the Company&#x2019;s common stock, as adjusted for the stock split on February 8, 2022, and will be
further adjusted in the event of another stock splits, stock dividends, combinations of shares and similar transactions subject to stock
splits. The Series G Preferred Stock is convertible into shares of common stock, at the option of the holder, subject to certain limitations.
The Company may require holders to convert all (but not less than all) of the Series G Preferred Stock or buy out all outstanding shares
of Series G Preferred Stock at the liquidation value of $&lt;span id="xdx_90A_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_pn3n3_c20231231__srt--TitleOfIndividualAxis__custom--OriginalInvestorMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zig4c3HzJV4" title="Preferred stock liquidation preference value"&gt;168&lt;/span&gt;. Holders of Series G Preferred Stock are not entitled to dividends and have
no voting rights, unless required by law or with respect to certain matters relating to the Series G Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
a change in control, sale of or similar transaction, as defined in the Certificate of Designation for the Series G Preferred Stock, the
holder of the Series G Preferred Stock has the option to deem such transaction as a liquidation and may redeem their &lt;span id="xdx_909_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__srt--TitleOfIndividualAxis__custom--OriginalInvestorMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zAAZpynwqfyi" title="Shares outstanding"&gt;168.496&lt;/span&gt; shares at
the liquidation value of $&lt;span id="xdx_906_eus-gaap--TemporaryEquityLiquidationPreferencePerShare_iI_pid_c20231231__srt--TitleOfIndividualAxis__custom--OriginalInvestorMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zIKMupV8n4Vf" title="Temporary equity, liquidation preference per share value"&gt;1,000&lt;/span&gt; per share, or an aggregate amount of $&lt;span id="xdx_900_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_pn3n3_c20231231__srt--TitleOfIndividualAxis__custom--OriginalInvestorMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zlg8nmYRcT2f" title="Preferred stock, liquidation aggregate amount"&gt;168&lt;/span&gt;. The sale of all the assets of the Company on June 28, 2007
triggered the redemption option. As such redemption was not in the control of the Company, the Series G Preferred Stock has been accounted
for as if it is redeemable preferred stock and is classified on the consolidated balance sheets as a mezzanine obligation between liabilities
and stockholders&#x2019; deficiency. The holder of the Series G Preferred Stock still has the ability to exercise the redemption option.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
H Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
of the then outstanding shares of Series H convertible Preferred Stock (the &#x201c;Series H Preferred Stock&#x201d;) automatically converted
into shares of the Company&#x2019;s common stock on the fifth anniversary date of the initial first closing of the Series H Preferred
Stock, or on August 10, 2023, at the conversion price of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230810__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zvuXSbn0iDQ2" title="Conversion price"&gt;7.26&lt;/span&gt; per share (the &#x201c;automatic mandatory conversion&#x201d;). Further
details are provided under the heading &lt;i&gt;Common Stock&lt;/i&gt; in Note 21.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PreferredStockTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002222"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002224"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2023-12-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002226"
      unitRef="Shares">1800</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002228"
      unitRef="Shares">168</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2022-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002230"
      unitRef="Shares">168</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2023-12-31_us-gaap_SeriesHPreferredStockMember"
      decimals="INF"
      id="Fact002232"
      unitRef="Shares">23000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_SeriesGPreferredStockMember"
      decimals="INF"
      id="Fact002234"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_SeriesGPreferredStockMember"
      decimals="INF"
      id="Fact002236"
      unitRef="Shares">14356</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2000-05-302000-05-30_us-gaap_SeriesGPreferredStockMember"
      decimals="INF"
      id="Fact002238"
      unitRef="Shares">1800</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2000-05-302000-05-30_us-gaap_SeriesGPreferredStockMember"
      decimals="INF"
      id="Fact002240"
      unitRef="Shares">1631.504</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2000-05-30_us-gaap_SeriesGPreferredStockMember"
      decimals="INF"
      id="Fact002242"
      unitRef="Shares">168.496</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="AsOf2000-05-30_us-gaap_SeriesGPreferredStockMember"
      decimals="INF"
      id="Fact002244"
      unitRef="USDPShares">1000</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="AsOf2023-12-31_custom_OriginalInvestorMember_us-gaap_SeriesGPreferredStockMember"
      decimals="-3"
      id="Fact002246"
      unitRef="USD">168000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-12-31_custom_OriginalInvestorMember_us-gaap_SeriesGPreferredStockMember"
      decimals="INF"
      id="Fact002248"
      unitRef="Shares">168.496</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="AsOf2023-12-31_custom_OriginalInvestorMember_us-gaap_SeriesGPreferredStockMember"
      decimals="INF"
      id="Fact002250"
      unitRef="USDPShares">1000</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="AsOf2023-12-31_custom_OriginalInvestorMember_us-gaap_SeriesGPreferredStockMember"
      decimals="-3"
      id="Fact002252"
      unitRef="USD">168000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-08-10_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002254"
      unitRef="USDPShares">7.26</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002256">&lt;p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z35WgF19zLz3" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;21.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span&gt;&lt;span id="xdx_829_zX1ofr9feBa4"&gt;Stockholders&#x2019; Deficiency&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has the authority to issue &lt;span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zln4hIMbuXXe" title="Common stock authorized"&gt;1,000,000,000&lt;/span&gt; shares of common stock, as the result of filing on December 18, 2020, a Certificate
of Amendment with the Secretary of the State of Delaware to increase the number of authorized shares of its common stock from &lt;span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20201218_z1wOL00qXDp2" title="Common stock authorized"&gt;100,000,000&lt;/span&gt;
shares to &lt;span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zOvaTyIrbM1b" title="Common stock, shares authorized"&gt;1,000,000,000&lt;/span&gt; shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Common
Stock Registered Direct Offering&lt;/i&gt; &#x2013; On March 31, 2023, the Company entered into common stock purchase agreements with certain
purchasers, pursuant to which the Company issued and sold in a registered direct offering an aggregate of &lt;span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20230330__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_zpsQQs9hZLM3" title="Sale of stock number of shares issued in transaction"&gt;2,963,918&lt;/span&gt; shares of the Company&#x2019;s
common stock, at a purchase price of $&lt;span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_z2uLwox69Qp6" title="Sale of stock price per share"&gt;3.88&lt;/span&gt; per share. The gross proceeds received were $&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20230330__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_znd67qF6gIrc" title="Proceeds from issuance of offering"&gt;11,500&lt;/span&gt; and after deducting offering expenses
of $&lt;span id="xdx_904_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_c20230330__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_zKl2L8CaC2Oe" title="Payments of stock issuance costs"&gt;356&lt;/span&gt;, the Company received net proceeds of $&lt;span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn3n3_c20230330__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_zyWyE7iVLn2k" title="Net proceeds from common stock"&gt;11,144&lt;/span&gt;, as reflected on the consolidated statements of stockholder&#x2019;s deficiency.
No underwriter or placement agent participated in the registered direct offering. The net proceeds were intended for working capital
and other general corporate purposes. Further information is provided in Note 26.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Common
Stock for Series H Preferred Stock&lt;/i&gt; &#x2013; During the years ended December 31, 2023 and 2022, the Company recorded the issuance of
&lt;span id="xdx_907_eus-gaap--ConversionOfStockSharesIssued1_pid_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zYOi6gClbF23" title="Conversion of shares issued"&gt;1,981,128&lt;/span&gt; (of which &lt;span id="xdx_90E_eus-gaap--ConversionOfStockSharesIssued1_pid_c20230101__20231231_zl3qLq6ItiQ3" title="Conversion of shares issued"&gt;1,759,224&lt;/span&gt; were issued in accordance with the automatic mandatory conversion) and &lt;span id="xdx_90C_eus-gaap--ConversionOfStockSharesIssued1_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq8JyTuCpIok" title="Conversion of shares issued"&gt;97,980&lt;/span&gt; shares of common stock, respectively,
upon conversion of &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zZzdd0KAVeia" title="Conversion of shares"&gt;14,356&lt;/span&gt; (of which &lt;span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_pid_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zf23UXfQZZ97" title="Conversion of shares converted"&gt;12,748&lt;/span&gt; were issued were issued in accordance with the automatic mandatory conversion) and &lt;span id="xdx_90A_eus-gaap--ConversionOfStockSharesConverted1_pid_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_znbsy6v4U2D5" title="Conversion of shares converted"&gt;710&lt;/span&gt; shares
of Series H Preferred Stock, respectively, with a corresponding amount of $&lt;span id="xdx_906_eus-gaap--ConversionOfStockAmountConverted1_pn3n3_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z11jM5ipSV2g" title="Conversion of stock amount"&gt;13,008&lt;/span&gt; (representing &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z8pNLJqWmjqd" title="Conversion of shares"&gt;14,356&lt;/span&gt; shares of Series H Preferred Stock
at $&lt;span id="xdx_90F_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z41Wk5RczIxc" title="Preferred stock stated par value"&gt;1,000&lt;/span&gt; stated par value per share, less issuance cost of $&lt;span id="xdx_90F_eus-gaap--ConversionOfStockAmountConverted1_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqMtH0EwwMUk" title="Conversion of stock amount"&gt;1,348&lt;/span&gt;) and $&lt;span id="xdx_90A_eus-gaap--ConversionOfStockAmountConverted1_pn3n3_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zb6ffPYdgMZ1" title="Conversion of stock amount"&gt;710&lt;/span&gt; (representing &lt;span id="xdx_900_eus-gaap--ConversionOfStockSharesConverted1_pid_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zPBPNpARpTAi" title="Conversion of shares converted"&gt;710&lt;/span&gt; shares of Series H Preferred Stock at
$&lt;span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z5oHjoV8SS38" title="Preferred stock stated par value"&gt;1,000&lt;/span&gt; stated par value per share), respectively, as reflected on the consolidated statements of stockholders&#x2019; deficiency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Common
Stock for Acquisitions&lt;/i&gt; &#x2013; During the years ended December 31, 2023 and 2022, the Company recorded the issuance of &lt;span id="xdx_90E_ecustom--StockIssuedDuringPeriodSharesAcquisition_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgnakdszlnXc" title="Common stock shares issuance fo acquisitions"&gt;274,692&lt;/span&gt; and
&lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDVV76cCHWCd" title="Common stock shares issuance fo acquisitions"&gt;330,863&lt;/span&gt; shares of the Company&#x2019;s common stock, respectively, as reflected on the consolidated statements of stockholders&#x2019;
deficiency as follows: (i) &lt;span id="xdx_90F_ecustom--BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares_pid_c20230110__20230111__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosAcquisitionMember_zuo4bhTp7Dw3" title="Issuance of common stock"&gt;274,692&lt;/span&gt; shares issued pursuant to the Fexy Studios asset acquisition on January 11, 2023, with a fair value
of $&lt;span id="xdx_902_eus-gaap--BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_pn3n3_c20230110__20230111__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosAcquisitionMember_zEhrULxF2B79" title="Fair value of acquisition"&gt;2,000&lt;/span&gt; on the transaction closing date, as further described in Note 4; and (ii) &lt;span id="xdx_90D_eus-gaap--SharesIssued_iI_pid_c20231101__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zvtFKryjx3A4" title="Shares issued"&gt;330,863&lt;/span&gt; shares issued consisted of (a) &lt;span id="xdx_906_ecustom--BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares_pid_c20220328__20220402__us-gaap--BusinessAcquisitionAxis__custom--ParadeStockMember_zLd796zCQ6N6" title="Issuance of common stock"&gt;314,103&lt;/span&gt; shares
issued pursuant to the Parade stock acquisition on April 1, 2022, with a fair market value of $&lt;span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_pn3n3_c20220328__20220402__us-gaap--BusinessAcquisitionAxis__custom--ParadeStockMember_zfgI8N1Kw3ml" title="Fair value of acquisition"&gt;3,141&lt;/span&gt;, as further described in Note 4;
and (b) &lt;span id="xdx_901_eus-gaap--SharesIssued_iI_pid_c20220309__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zVBeHIkxrnA9" title="Shares issued"&gt;16,760&lt;/span&gt; shares issued on March 9, 2022, pursuant to an asset acquisition entered into March 9, 2020 with no fair value recognized
at the time of issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Common
Stock for Liquidated Damages&lt;/i&gt; &#x2013; During the years ended December 31, 2023 and 2022, the Company entered into several stock purchase
agreements with an investor where it was liable for liquidated damages, pursuant to which the Company issued &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zdUdQ1rKCgNl" title="Stock issued during period shares new issues"&gt;47,252&lt;/span&gt; and &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_z0GPIG3rik1h" title="Number of shares issued"&gt;505,655&lt;/span&gt;, respectively,
shares of its common stock, as follows: &lt;span id="xdx_90F_eus-gaap--LossContingencyDamagesSought_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_ziHB0OAqsXld" title="Loss contingency damages sought"&gt;(i) &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zGSuS9BiyTIg" title="Stock issued during period shares new issues"&gt;47,252&lt;/span&gt; shares of common stock were issued to the investor in lieu of an aggregate of $&lt;span id="xdx_90C_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zQyoedeEJMW8" title="Loss contingency damages sought value"&gt;499&lt;/span&gt;
owed in liquidated damages as of the conversion date ($494 as of December 31, 2022 plus $5 in additional interest through the conversion
date), where the Company recorded $369 in connection with the issuance of shares of the Company&#x2019;s common stock and a gain of $130
on the settlement of the liquidated damages, both as reflected in additional paid-in capital, totaling $499;&lt;/span&gt; and (ii) &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zMuGabh2hlWl" title="Stock issued during period shares new issues"&gt;505,655&lt;/span&gt; shares
of common stock were issued at a price equal to $&lt;span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zyRQh8fFmoA8" title="Shares issued price per share"&gt;13.86&lt;/span&gt; per share (determined based on the volume-weighted average price of the Company&#x2019;s
common stock at the close of trading on the sixty (60) previous trading days), to the investors in lieu of an aggregate of $&lt;span id="xdx_904_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zfy7gH7QE3h6" title="Loss contingency damages sought value"&gt;7,008&lt;/span&gt; owed
in liquidated damages, where the Company recorded $&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zsx5joUi6ek1" title="Number of share issued value"&gt;6,685&lt;/span&gt; in connection with the issuance of shares of the Company&#x2019;s common stock
and recognized a gain of $&lt;span id="xdx_909_ecustom--AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zrYy7GE4iU1d" title="Liquidated damages"&gt;323&lt;/span&gt; on the settlement of the liquidated damages, both of which were recorded as additional paid-in capital
on the consolidated statements of stockholders&#x2019; deficiency. In connection with the &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SeveralStockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zULnLdSG3r0h" title="Stock issued during period shares new issues"&gt;505,655&lt;/span&gt; shares of common stock issued, the Company
filed a registration statement covering the resale of those shares of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Restricted
Stock Units&lt;/i&gt; &#x2013; The Company issued, in connection with the vesting of restricted stock units, &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zE6WuCMlLyL" title="Vesting of restricted stock units"&gt;429,528&lt;/span&gt; shares of the Company&#x2019;s
common stock and &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zoymioKrOZlh" title="Vesting of restricted stock units"&gt;832,233&lt;/span&gt; shares of the Company&#x2019;s common stock (as described in Note 22) during the years ended December 31, 2023
and 2022, respectively, as reflected on the consolidated statements of stockholders&#x2019; equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Common
Stock Withheld&lt;/i&gt; &#x2013; The Company recorded the repurchase of vested restricted common stock of &lt;span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--RestrictedCommonStockMember_z3ggkQQuYtg" title="Repurchase of restricted common stock"&gt;202,382&lt;/span&gt; shares for the payment for
taxes of $&lt;span id="xdx_900_eus-gaap--PaymentsRelatedToTaxWithholdingForShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--RestrictedCommonStockMember_zZ0jpYiH6EH8" title="Payment of taxes"&gt;1,423&lt;/span&gt;, and &lt;span id="xdx_901_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--RestrictedCommonStockMember_zCmGCbrE4ork" title="Repurchase of restricted common stock"&gt;373,394&lt;/span&gt; shares for the payment for taxes of $&lt;span id="xdx_907_eus-gaap--PaymentsRelatedToTaxWithholdingForShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--RestrictedCommonStockMember_znLyfhUuMdhi" title="Payment of taxes"&gt;4,468&lt;/span&gt;, during the years ended December 31, 2023 and 2022, respectively,
as reflected on the consolidated statements of stockholders&#x2019; deficiency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Exercise
of Stock Options&lt;/i&gt; &#x2013; The Company recorded the exercise of &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--ExerciseOfStockOptionMember_znK3TD0xTVj8" title="Exercise of stock options, shares"&gt;795&lt;/span&gt; and &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--ExerciseOfStockOptionMember_z2eTo8oRBQeb" title="Exercise of stock options, shares"&gt;96,408&lt;/span&gt; common stock options for shares of the Company&#x2019;s
common stock for cash of $&lt;span id="xdx_902_ecustom--StockIssuedDuringPeriodValueForCash_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--ExerciseOfStockOptionMember_zMwmUQWepjHi" title="Exercise of stock options"&gt;0&lt;/span&gt; and $&lt;span id="xdx_90D_ecustom--StockIssuedDuringPeriodValueForCash_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--ExerciseOfStockOptionMember_zsaRLsxQLKKc" title="Exercise of stock options"&gt;95&lt;/span&gt;, during the years ended December 31, 2023 and 2022, respectively, as reflected on the consolidated
statements of stockholders&#x2019; deficiency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Common
Stock to be Issued &lt;b&gt;&#x2013; &lt;/b&gt;&lt;/i&gt;In connection with the Say Media merger on December 12, 2018, the Company issued &lt;span id="xdx_90C_ecustom--StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRUHxDyEEtz7" title="Common stock to be issued"&gt;38,582&lt;/span&gt; and &lt;span id="xdx_905_ecustom--StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKanTW5gPZe2" title="Common stock to be issued"&gt;7,851&lt;/span&gt;
shares of the Company&#x2019;s common stock during the year ended December 31, 2023 and 2022, respectively, which were required to be issued
as of January 1, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Professional
Services&lt;/i&gt; &#x2013; During the year ended December 31, 2022, the Company issued, in connection with entering into several professional
services agreements, &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220120__20220121__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zbcis00NAI4f" title="Stock issued for professional services"&gt;14,617&lt;/span&gt; shares of the Company&#x2019;s common stock (&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220111__20220112__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zydJiS3DrYya" title="Stock issued for professional services"&gt;14,617&lt;/span&gt; shares consisted of &lt;span id="xdx_90A_eus-gaap--SharesIssued_iI_pid_c20220112__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zNAcVYlBe3Nb" title="Stock issued for professional services"&gt;1,134&lt;/span&gt; shares issued on January 12,
2022 at $&lt;span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20220112__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zyoFLCMqRCa6" title="Trading price, per share"&gt;13.20&lt;/span&gt; and &lt;span id="xdx_90F_eus-gaap--SharesIssued_iI_pid_c20220126__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zDJ0OkLznDBl" title="Stock issued for professional services"&gt;13,483&lt;/span&gt; shares issued on January 26, 2022 at $&lt;span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20220126__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zkoDoMaXPcE9" title="Trading price, per share"&gt;12.54&lt;/span&gt;) that were recorded at the trading price on the issuance date of
$&lt;span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zd2X0hoRFxx4" title="Trading price, per share"&gt;184&lt;/span&gt;, as reflected on the consolidated statements of stockholders&#x2019; deficiency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Common
Stock Public Offering&lt;/i&gt; &#x2013; On February 15, 2022 and March 11, 2022, the Company raised gross proceeds of $&lt;span id="xdx_90D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20220311__20220311__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zDVf3WMCYJh3" title="Gross proceed from offerings"&gt;&lt;span id="xdx_906_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_c20220215__20220215__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zVvCYFYmPEKf" title="Gross proceed from offerings"&gt;34,498&lt;/span&gt;&lt;/span&gt; pursuant to a
firm commitment underwritten public offering of &lt;span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20220311__20220311__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zCoCinSO9LV1" title="Number of common shares sold"&gt;&lt;span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20220215__20220215__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zg079kzNRsbk" title="Number of common shares sold"&gt;4,181,603&lt;/span&gt;&lt;/span&gt; shares of the Company&#x2019;s common stock (on February 15, 2022 the Company
issued &lt;span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20220215__20220215__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingOverallotmentMember_zcoL6IMu7JB" title="Number of common shares sold"&gt;3,636,364&lt;/span&gt; shares and on March 11, 2022 the Company issued &lt;span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20220311__20220311__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingOverallotmentMember_zlej33QPmm7d" title="Number of common shares sold"&gt;545,239&lt;/span&gt; shares pursuant to the underwriter&#x2019;s overallotment that
was exercised on March 10, 2022), at a public offering price of $&lt;span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20220310_zQHAqKej2gBb" title="Stock price"&gt;8.25&lt;/span&gt; per share. The Company received net proceeds of $&lt;span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20230101__20231231_zZuUPenhoMq3" title="Net proceed from offerings"&gt;32,058&lt;/span&gt;, after
deducting underwriting discounts and commissions and other offering costs payable by the Company of $&lt;span id="xdx_907_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--BRileyMember_zdMnLGMFtd7c" title="Offering costs"&gt;2,440&lt;/span&gt; to B. Riley (see Note 26).
In addition, the Company directly incurred offering costs of $&lt;span id="xdx_900_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zrMhq89D7obk" title="Offering costs"&gt;1,568&lt;/span&gt; and recorded $&lt;span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn3n3_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritingPublicOfferingMember_zH4i03weUSS9" title="Proceeds from issuance of common stock"&gt;30,490&lt;/span&gt; upon the issuance of its common stock, as reflected
on the consolidated statements of stockholders&#x2019; deficiency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Restricted
Stock Awards&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unless
otherwise stated, the fair value of a restricted stock award is determined based on the number of shares granted and the quoted price
of the Company&#x2019;s common stock on the date issued. The estimated fair value of these shares is being recognized as compensation
expense over the vesting period of the award (see Note 22).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zCiZ4l6nK3Q8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the restricted stock award activity during the year ended December 31, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zVV9BCcrulei" style="display: none"&gt;Summary of Restricted Stock Award Activity&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of &lt;br/&gt;
Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
                                            Average &lt;br/&gt;
                                            Grant-Date&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair
                                            Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Restricted
    stock awards outstanding at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zNmNgl4Ptij7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of Shares, Restricted Stock Awards Outstanding, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;97,403&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zpakTQuXhBg1" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted Average Grant-Fair Value Date, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16.94&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQoE7Sbc3j99" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares,  Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(97,403&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zkrHmNS326Ie" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Fair Value Date, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(16.94&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Restricted
    stock awards outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zCipvKPr5vTj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Restricted stock awards outstanding, Unvested at Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2408"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8A4_zbKyH6P0Vxj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
with respect to stock-based compensation cost and unrecognized stock-based compensation cost related to the restricted stock awards is
provided under the heading &lt;i&gt;Stock-Based Compensation&lt;/i&gt; in Note 22.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock to be Issued&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with a closing of a private placement on January 4, 2018, MDB, as the placement agent, was entitled to receive &lt;span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20180103__20180104__dei--LegalEntityAxis__custom--MDBCapitalGroupLLCMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zkWcbDGPFQN2" title="Number of common shares sold"&gt;2,701&lt;/span&gt; shares
of the Company&#x2019;s common stock (&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%"&gt;subject to liquidated
damages, see Note 15), which&lt;/span&gt; have not been issued as of December 31, 2023, as reflected on the consolidated statements of
stockholders&#x2019; deficiency as common stock to be issued (see Note 15).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;Warrants
were issued to purchase shares of the Company&#x2019;s common stock in connection with various financings (the &#x201c;Financing Warrants&#x201d;), all of which have expired.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z0ULsOccHYhj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the Financing Warrants activity during the year ended December 31, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BF_zUdfua79NEC7" style="display: none"&gt;Summary of Warrant Activity&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Life&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(in Years)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: justify"&gt;Financing Warrants outstanding at January 1, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zaOyrerdlMWi" style="width: 12%; text-align: right" title="Number of Shares, outstanding, at beginning of year"&gt;107,956&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zJjhjE20OUG5" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, outstanding, at beginning of year"&gt;10.61&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zGcSY18wELGc" title="Weighted Average Remaining Contractual Life, Outstanding at beginning of year"&gt;0.58&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zbYMGmEGCjql" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Expired"&gt;(107,956&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zZIKYHxtdEjj" style="text-align: right" title="Weighted Average Exercise Price, Expired"&gt;10.61&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Financing Warrants outstanding at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zZs6o4s8Szg9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, outstanding at end of year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2424"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zU2fcnw5J3E4" style="text-align: right" title="Weighted Average Exercise Price, outstanding, at end of year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2426"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zAVzRdzdPUS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;AllHipHop
Warrants&lt;/i&gt; &#x2013; On October 26, 2020, the Company granted AllHipHop, LLC an aggregate of &lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20201026__us-gaap--StatementEquityComponentsAxis__custom--AllHipHopWarrantsMember_zJR8rRUHfsij" title="Exeercise price"&gt;5,682&lt;/span&gt; warrants for shares of the Company&#x2019;s
common stock with an exercise price of $&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201026__us-gaap--StatementEquityComponentsAxis__custom--AllHipHopWarrantsMember_zWL6VHm6rIVg" title="Exercise price"&gt;14.30&lt;/span&gt; (the &#x201c;AllHipHop Warrants&#x201d;). The AllHipHop Warrants are exercisable for a period
of five years, subject to customary anti-dilution adjustments, and may be exercised on a cashless basis. The AllHipHop Warrants were
in exchange for the surrender and termination of &lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20201026__us-gaap--StatementEquityComponentsAxis__custom--PublisherPartnerWarrantsMember_zoy0etW5Z4Ag" title="Exeercise price"&gt;6,819&lt;/span&gt; previously issued Publisher Partner Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;ABG
Warrants&lt;/i&gt; &#x2013; On June 14, 2019, the Company issued &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20190614__us-gaap--StatementEquityComponentsAxis__custom--ABGWarrantsMember_zfQjNQ9hgAG4" title="Warrants issued"&gt;999,540&lt;/span&gt; warrants to acquire the Company&#x2019;s common stock to ABG (the &#x201c;ABG
Warrants&#x201d;) in connection with the Licensing Agreement, expiring in &lt;span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dt_c20190614__us-gaap--StatementEquityComponentsAxis__custom--ABGWarrantsMember_zsl6OLvWHBMl" title="Expiration date"&gt;ten years&lt;/span&gt;. The warrants provided time-based vesting in equal
monthly increments over a period of two years beginning on the one year anniversary of the date of issuance of the warrants (the &#x201c;Time-Based
Warrants&#x201d;) and performance based vesting based on the achievement of certain performance goals for the licensed brands in calendar
years 2020, 2021, 2022, or 2023 (the &#x201c;Performance-Based Warrants&#x201d;). The warrants also provide that &lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20190613__20190614__us-gaap--StatementEquityComponentsAxis__custom--ABGWarransMember_zrJ50wbDFPlj" title="Warrant or right, reason for issuance, description"&gt;(1) under certain circumstances
the Company may require ABG to exercise all (and not less than all) of the warrants, in which case all of the warrants will be vested;
(2) all of the warrants automatically vest upon certain terminations of the Licensing Agreement by ABG or upon a change of control of
the Company; and (3) ABG has the right to participate, on a pro-rata basis (including vested and unvested warrants, exercised or unexercised),
in any future equity issuance of the Company (subject to customary exceptions).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;As
of December 31, 2023, &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--ABGTimeBasedWarrantsMember_zRBrE5cRHKL8" title="Number of warrant shares"&gt;399,816&lt;/span&gt; Time-Based Warrants vested and &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--ABGPerformanceBasedWarrantsMember_z3LZRRyUkxX" title="Exercise price"&gt;599,724&lt;/span&gt; Performance-Based Warrants vested as of the issuance date
of these consolidated financial statements were issued (further details are provided under the heading &lt;i&gt;ABG Warrants&lt;/i&gt; in Note 28 as to the full vesting of the ABG Warrants in January 2024).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
with respect to stock-based compensation cost and unrecognized stock-based compensation cost related to the ABG Warrants is provided
in Note 22.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Publisher
Partner Warrants&lt;/i&gt; &#x2013; On May 20, 2020, the Board approved a third publisher partner warrant program, which superseded the second
publisher partner warrant program and authorized the Company to grant publisher partner warrants to purchase up to &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20200520__us-gaap--StatementEquityComponentsAxis__custom--PublisherPartnerWarrantsMember_zqHJZHmBLYsj" title="Number of warrant shares"&gt;90,910&lt;/span&gt; shares of the
Company&#x2019;s common stock (the &#x201c;Publisher Partner Warrants&#x201d;). The issuance of the Publisher Partner Warrants is administered
by management and approved by the Board.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;New
Publisher Partner Warrants&lt;/i&gt; &#x2013; On November 2, 2022, the Board approved a warrant incentive program to grant warrants to certain
publishers (the &#x201c;New Publisher Partner Warrants&#x201d;), that authorized the Company to grant New Publisher Partner Warrants to
purchase up to &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20221102__us-gaap--StatementEquityComponentsAxis__custom--NewPublisherPartnerWarrantsMember_zSuIlsiLiOdd" title="Number of warrant shares"&gt;33,000&lt;/span&gt; shares of the Company&#x2019;s common stock. The New Publisher Partner Warrants will have the following terms: (i)
one-third will become exercisable and vest on the one-year anniversary of the issuance; (ii) the remaining warrants will become exercisable
and vest in a series of twenty-four (24) successive equal monthly installments following the first anniversary of the issuance; and (iii)
a five-year term. The issuance of the New Publisher Partner Warrants is administered by management and approved by the Board.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
with respect to stock-based compensation cost and unrecognized stock-based compensation cost related to the New Publisher Partner Warrants
is provided in Note 22.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002258"
      unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2020-12-18"
      decimals="INF"
      id="Fact002260"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002262"
      unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-03-302023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember"
      decimals="INF"
      id="Fact002264"
      unitRef="Shares">2963918</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember"
      decimals="INF"
      id="Fact002266"
      unitRef="USDPShares">3.88</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-03-302023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember"
      decimals="-3"
      id="Fact002268"
      unitRef="USD">11500000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2023-03-302023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember"
      decimals="-3"
      id="Fact002270"
      unitRef="USD">356000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-03-302023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember"
      decimals="-3"
      id="Fact002272"
      unitRef="USD">11144000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2023-01-012023-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002274"
      unitRef="Shares">1981128</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact002276"
      unitRef="Shares">1759224</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002278"
      unitRef="Shares">97980</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2022-01-012022-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002280"
      unitRef="Shares">14356</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2022-01-012022-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002282"
      unitRef="Shares">12748</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2023-01-012023-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002284"
      unitRef="Shares">710</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2023-01-012023-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact002286"
      unitRef="USD">13008000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002288"
      unitRef="Shares">14356</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002290"
      unitRef="USDPShares">1000</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact002292"
      unitRef="USD">1348000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2022-01-012022-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact002294"
      unitRef="USD">710000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2023-01-012023-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002296"
      unitRef="Shares">710</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002298"
      unitRef="USDPShares">1000</us-gaap:PreferredStockParOrStatedValuePerShare>
    <AREN:StockIssuedDuringPeriodSharesAcquisition
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002300"
      unitRef="Shares">274692</AREN:StockIssuedDuringPeriodSharesAcquisition>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002302"
      unitRef="Shares">330863</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <AREN:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares
      contextRef="From2023-01-102023-01-11_custom_FexyStudiosAcquisitionMember"
      decimals="INF"
      id="Fact002304"
      unitRef="Shares">274692</AREN:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="From2023-01-102023-01-11_custom_FexyStudiosAcquisitionMember"
      decimals="-3"
      id="Fact002306"
      unitRef="USD">2000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:SharesIssued
      contextRef="AsOf2023-11-01_custom_AssetPurchaseAgreementMember"
      decimals="INF"
      id="Fact002308"
      unitRef="Shares">330863</us-gaap:SharesIssued>
    <AREN:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares
      contextRef="From2022-03-282022-04-02_custom_ParadeStockMember"
      decimals="INF"
      id="Fact002310"
      unitRef="Shares">314103</AREN:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValueShares>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="From2022-03-282022-04-02_custom_ParadeStockMember"
      decimals="-3"
      id="Fact002312"
      unitRef="USD">3141000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:SharesIssued
      contextRef="AsOf2022-03-09_custom_AssetPurchaseAgreementMember"
      decimals="INF"
      id="Fact002314"
      unitRef="Shares">16760</us-gaap:SharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-012023-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember"
      decimals="INF"
      id="Fact002316"
      unitRef="Shares">47252</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-012022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember"
      decimals="INF"
      id="Fact002318"
      unitRef="Shares">505655</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:LossContingencyDamagesSought
      contextRef="From2023-01-012023-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember"
      id="Fact002320">(i) 47,252 shares of common stock were issued to the investor in lieu of an aggregate of $499
owed in liquidated damages as of the conversion date ($494 as of December 31, 2022 plus $5 in additional interest through the conversion
date), where the Company recorded $369 in connection with the issuance of shares of the Company&#x2019;s common stock and a gain of $130
on the settlement of the liquidated damages, both as reflected in additional paid-in capital, totaling $499;</us-gaap:LossContingencyDamagesSought>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-012023-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember"
      decimals="INF"
      id="Fact002322"
      unitRef="Shares">47252</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="From2023-01-012023-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember"
      decimals="-3"
      id="Fact002324"
      unitRef="USD">499000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-012022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember"
      decimals="INF"
      id="Fact002326"
      unitRef="Shares">505655</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember"
      decimals="INF"
      id="Fact002328"
      unitRef="USDPShares">13.86</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="From2022-01-012022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember"
      decimals="-3"
      id="Fact002330"
      unitRef="USD">7008000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember"
      decimals="-3"
      id="Fact002332"
      unitRef="USD">6685000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages
      contextRef="From2022-01-012022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember"
      decimals="-3"
      id="Fact002334"
      unitRef="USD">323000</AREN:AdjustmentsToAdditionalPaidInCapitalGainUponIssuanceOfCommonStockInConnectionWithSettlementOfLiquidatedDamages>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-012022-12-31_custom_SeveralStockPurchaseAgreementsMember_custom_SeveralInvestorsMember"
      decimals="INF"
      id="Fact002336"
      unitRef="Shares">505655</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_CommonStockMember_custom_EmployeesMember"
      decimals="INF"
      id="Fact002338"
      unitRef="Shares">429528</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2021-01-012021-12-31_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_CommonStockMember_custom_EmployeesMember"
      decimals="INF"
      id="Fact002340"
      unitRef="Shares">832233</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember_custom_RestrictedCommonStockMember"
      decimals="INF"
      id="Fact002342"
      unitRef="Shares">202382</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember_custom_RestrictedCommonStockMember"
      decimals="-3"
      id="Fact002344"
      unitRef="USD">1423000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_custom_RestrictedCommonStockMember"
      decimals="INF"
      id="Fact002346"
      unitRef="Shares">373394</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember_custom_RestrictedCommonStockMember"
      decimals="-3"
      id="Fact002348"
      unitRef="USD">4468000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-01-012023-12-31_custom_ExerciseOfStockOptionMember"
      decimals="INF"
      id="Fact002350"
      unitRef="Shares">795</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-01-012022-12-31_custom_ExerciseOfStockOptionMember"
      decimals="INF"
      id="Fact002352"
      unitRef="Shares">96408</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <AREN:StockIssuedDuringPeriodValueForCash
      contextRef="From2023-01-012023-12-31_custom_ExerciseOfStockOptionMember"
      decimals="-3"
      id="Fact002354"
      unitRef="USD">0</AREN:StockIssuedDuringPeriodValueForCash>
    <AREN:StockIssuedDuringPeriodValueForCash
      contextRef="From2022-01-012022-12-31_custom_ExerciseOfStockOptionMember"
      decimals="-3"
      id="Fact002356"
      unitRef="USD">95000</AREN:StockIssuedDuringPeriodValueForCash>
    <AREN:StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002358"
      unitRef="Shares">38582</AREN:StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger>
    <AREN:StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002360"
      unitRef="Shares">7851</AREN:StockIssuedDuringPeriodSharesIssuanceOfStockInConnectionWithMerger>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-01-202022-01-21_custom_ServicesAgreementMember"
      decimals="INF"
      id="Fact002362"
      unitRef="Shares">14617</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-01-112022-01-12_custom_ServicesAgreementMember"
      decimals="INF"
      id="Fact002364"
      unitRef="Shares">14617</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:SharesIssued
      contextRef="AsOf2022-01-12_custom_ServicesAgreementMember"
      decimals="INF"
      id="Fact002366"
      unitRef="Shares">1134</us-gaap:SharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2022-01-12_custom_ServicesAgreementMember"
      decimals="INF"
      id="Fact002368"
      unitRef="USDPShares">13.20</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssued
      contextRef="AsOf2022-01-26_custom_ServicesAgreementMember"
      decimals="INF"
      id="Fact002370"
      unitRef="Shares">13483</us-gaap:SharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2022-01-26_custom_ServicesAgreementMember"
      decimals="INF"
      id="Fact002372"
      unitRef="USDPShares">12.54</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2022-12-31_custom_ServicesAgreementMember"
      decimals="-3"
      id="Fact002374"
      unitRef="USDPShares">184000</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2022-03-112022-03-11_custom_UnderwritingPublicOfferingMember"
      decimals="-3"
      id="Fact002376"
      unitRef="USD">34498000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2022-02-152022-02-15_custom_UnderwritingPublicOfferingMember"
      decimals="-3"
      id="Fact002378"
      unitRef="USD">34498000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2022-03-112022-03-11_custom_UnderwritingPublicOfferingMember"
      decimals="INF"
      id="Fact002380"
      unitRef="Shares">4181603</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2022-02-152022-02-15_custom_UnderwritingPublicOfferingMember"
      decimals="INF"
      id="Fact002382"
      unitRef="Shares">4181603</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2022-02-152022-02-15_custom_UnderwritingOverallotmentMember"
      decimals="INF"
      id="Fact002384"
      unitRef="Shares">3636364</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2022-03-112022-03-11_custom_UnderwritingOverallotmentMember"
      decimals="INF"
      id="Fact002386"
      unitRef="Shares">545239</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2022-03-10"
      decimals="INF"
      id="Fact002388"
      unitRef="USDPShares">8.25</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002390"
      unitRef="USD">32058000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2023-01-012023-12-31_custom_BRileyMember66269906"
      decimals="-3"
      id="Fact002392"
      unitRef="USD">2440000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2023-01-012023-12-31_custom_UnderwritingPublicOfferingMember"
      decimals="-3"
      id="Fact002394"
      unitRef="USD">1568000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-01-012023-12-31_custom_UnderwritingPublicOfferingMember"
      decimals="-3"
      id="Fact002396"
      unitRef="USD">30490000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002398">&lt;p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zCiZ4l6nK3Q8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the restricted stock award activity during the year ended December 31, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zVV9BCcrulei" style="display: none"&gt;Summary of Restricted Stock Award Activity&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of &lt;br/&gt;
Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
                                            Average &lt;br/&gt;
                                            Grant-Date&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair
                                            Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Restricted
    stock awards outstanding at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zNmNgl4Ptij7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of Shares, Restricted Stock Awards Outstanding, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;97,403&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zpakTQuXhBg1" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted Average Grant-Fair Value Date, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16.94&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQoE7Sbc3j99" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares,  Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(97,403&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zkrHmNS326Ie" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Fair Value Date, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(16.94&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Restricted
    stock awards outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zCipvKPr5vTj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Restricted stock awards outstanding, Unvested at Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2408"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2022-12-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="Fact002400"
      unitRef="Shares">97403</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2022-12-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="Fact002402"
      unitRef="USDPShares">16.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="Fact002404"
      unitRef="Shares">97403</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="Fact002406"
      unitRef="USDPShares">16.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2018-01-032018-01-04_custom_MDBCapitalGroupLLCMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact002410"
      unitRef="Shares">2701</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002412">&lt;p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z0ULsOccHYhj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the Financing Warrants activity during the year ended December 31, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BF_zUdfua79NEC7" style="display: none"&gt;Summary of Warrant Activity&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Life&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(in Years)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: justify"&gt;Financing Warrants outstanding at January 1, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zaOyrerdlMWi" style="width: 12%; text-align: right" title="Number of Shares, outstanding, at beginning of year"&gt;107,956&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zJjhjE20OUG5" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, outstanding, at beginning of year"&gt;10.61&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zGcSY18wELGc" title="Weighted Average Remaining Contractual Life, Outstanding at beginning of year"&gt;0.58&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zbYMGmEGCjql" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Expired"&gt;(107,956&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zZIKYHxtdEjj" style="text-align: right" title="Weighted Average Exercise Price, Expired"&gt;10.61&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Financing Warrants outstanding at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zZs6o4s8Szg9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, outstanding at end of year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2424"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockFinancingWarrantMember_zU2fcnw5J3E4" style="text-align: right" title="Weighted Average Exercise Price, outstanding, at end of year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2426"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_CommonStockFinancingWarrantMember"
      decimals="INF"
      id="Fact002414"
      unitRef="Shares">107956</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_CommonStockFinancingWarrantMember"
      decimals="INF"
      id="Fact002416"
      unitRef="USDPShares">10.61</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingNumber>
    <AREN:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="From2023-01-012023-12-31_custom_CommonStockFinancingWarrantMember"
      id="Fact002418">P0Y6M29D</AREN:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2023-01-012023-12-31_custom_CommonStockFinancingWarrantMember"
      decimals="INF"
      id="Fact002420"
      unitRef="Shares">107956</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice
      contextRef="From2023-01-012023-12-31_custom_CommonStockFinancingWarrantMember"
      decimals="INF"
      id="Fact002422"
      unitRef="USDPShares">10.61</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredPrice>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2020-10-26_custom_AllHipHopWarrantsMember"
      decimals="INF"
      id="Fact002428"
      unitRef="Shares">5682</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-10-26_custom_AllHipHopWarrantsMember"
      decimals="INF"
      id="Fact002430"
      unitRef="USDPShares">14.30</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2020-10-26_custom_PublisherPartnerWarrantsMember"
      decimals="INF"
      id="Fact002432"
      unitRef="Shares">6819</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2019-06-14_custom_ABGWarrantsMember"
      decimals="INF"
      id="Fact002434"
      unitRef="Shares">999540</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2019-06-14_custom_ABGWarrantsMember"
      id="Fact002436">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees
      contextRef="From2019-06-132019-06-14_custom_ABGWarransMember"
      id="Fact002438">(1) under certain circumstances
the Company may require ABG to exercise all (and not less than all) of the warrants, in which case all of the warrants will be vested;
(2) all of the warrants automatically vest upon certain terminations of the Licensing Agreement by ABG or upon a change of control of
the Company; and (3) ABG has the right to participate, on a pro-rata basis (including vested and unvested warrants, exercised or unexercised),
in any future equity issuance of the Company (subject to customary exceptions).</us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2023-12-31_custom_ABGTimeBasedWarrantsMember"
      decimals="INF"
      id="Fact002440"
      unitRef="Shares">399816</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-12-31_custom_ABGPerformanceBasedWarrantsMember"
      decimals="INF"
      id="Fact002442"
      unitRef="USDPShares">599724</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2020-05-20_custom_PublisherPartnerWarrantsMember"
      decimals="INF"
      id="Fact002444"
      unitRef="Shares">90910</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-11-02_custom_NewPublisherPartnerWarrantsMember"
      decimals="INF"
      id="Fact002446"
      unitRef="Shares">33000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002448">&lt;p id="xdx_804_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zhw8Z4lehdud" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;22.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span&gt;&lt;span id="xdx_82D_zCXtdm1zesO9"&gt;Stock&#x2013;Based Compensation&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company issued stock-based compensation awards under several plans as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;2016
                                            Plan&lt;/i&gt; &#x2013; On December 19, 2016, the Board adopted the 2016 Stock Incentive Plan (the
                                            &#x201c;2016 Plan&#x201d;) that allowed the Company to grant restricted stock awards and statutory
                                            and non-statutory common stock options to acquire shares of the Company&#x2019;s common stock
                                            to employees, directors and consultants, with vesting variable vesting provisions consisting
                                            of time-based and performance-based. The Company is no longer issuing awards under the 2016
                                            Plan.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;2019
                                            Plan&lt;/i&gt; &#x2013; On April 4, 2019, the Board adopted the 2019 Equity Incentive Plan (the
                                            &#x201c;2019 Plan&#x201d;) that allowed awards of stock options, restricted stock awards, restricted
                                            stock units, unrestricted stock awards, and stock appreciation rights, with variable vesting
                                            provisions consisting of time-based, performance-based, or market-based. The Company is no
                                            longer issuing option awards under the 2019 Plan.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Outside
                                            Options&lt;/i&gt; &#x2013; The Company granted stock options outside the 2016 Plan and 2019 Plan
                                            (the &#x201c;Outside Options&#x201d;) that allowed the Company to grant statutory and non-statutory
                                            common stock options, with variable vesting provisions consisting time-based, performance-based
                                            targets and certain performance achievements. The Company is no longer issuing Outside Options.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;2022
                                            Plan&lt;/i&gt; &#x2013; On April 18, 2022, the Board adopted the 2022 Stock and Equity Compensation
                                            Plan (the &#x201c;2022 Plan&#x201d;) that was approved by the Company&#x2019;s stockholders
                                            on June 2, 2022 with a maximum number of shares authorized to be issued under the plan of
                                            &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20220602__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zR6Y0nnNjH35" title="Number of shares authorized to issue"&gt;1,800,000&lt;/span&gt;. The purpose of the 2022 Plan is to foster the growth and success of the Company
                                            by providing a means to attract, motivate and retain officers, directors, key employees,
                                            and consultants through awards of stock options, stock appreciation rights, restricted stock
                                            awards, unrestricted stock awards and restricted stock units. Shares subject to an award
                                            that have been canceled, expired, settled in cash, or not issued or forfeited for any reason
                                            will not reduce the aggregate number of shares that may be subject to or delivered under
                                            the 2022 Plan and will be available for future awards granted under the 2022 Plan. Common
                                            stock options issued under the 2022 Plan may have a term of up to ten years and may have
                                            variable vesting provisions based on time and performance. The issuance of awards under the
                                            2022 Plan is administered by the Board or any committee of directors designated by the Board.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Restricted
Stock Units&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2023 and 2022, the Company issued restricted stock units to various employees and members of the board subject
to continued service. Upon vesting of the award, subject to certain conditions for release of the award, the Company issues the underlying
common stock of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of a restricted stock unit was determined based on the number of shares granted and the quoted price of the Company&#x2019;s
common stock on the date issued during the years ended December 31, 2023, and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_ecustom--ScheduleOfRestrictedStockUnitsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zGuBZFrp1rZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the restricted stock unit activity during the year ended December 31, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;span id="xdx_8BB_zIHR8WiR6UKk" style="display: none"&gt;Schedule of Restricted Stock Units Activity&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Number of Shares&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold"&gt;Weighted&lt;br/&gt;
 Average&lt;br/&gt;
 Grant-Date&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Unvested&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Vested&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt; Fair Value&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Restricted stock units outstanding at January 1, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zrFTbYnzKOga" style="width: 12%; text-align: right" title="Number of Shares, Unvested, outstanding, at beginning of year"&gt;994,766&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_z22DVdAYusBb" style="width: 12%; text-align: right" title="Number of Shares, Vested, outstanding, at beginning of year"&gt;397,376&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zQg3Vc1Fe4bc" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, outstanding, at beginning of year"&gt;15.44&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zaj3ujE8Nqw8" style="text-align: right" title="Number of Shares, Unvested granted"&gt;148,970&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zGY5Y5ndefia" style="text-align: right" title="Weighted Average Exercise Price,Granted"&gt;5.77&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zqJM1VHKCyx2" style="text-align: right" title="Number of Shares, Unvested, Vested"&gt;(645,023&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zuOov30y7j7e" style="text-align: right" title="Number of Shares, Vested"&gt;645,023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Released&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased_iNS_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zzaTB17oOD1f" style="text-align: right" title="Number of Shares, Vested, Released"&gt;(429,528&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Cancelled&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zFDvmEEZBKe7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Unvested, Cancelled"&gt;(299,446&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Restricted stock units outstanding at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_ziKU1b60cNCi" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Unvested, outstanding at end of year"&gt;199,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zHFYcTzEM0n" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Vested, outstanding, at end of year"&gt;612,871&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20231231_zJ8I064rZMEl" style="text-align: right" title="Weighted Average Exercise Price, outstanding, at end of year"&gt;13.55&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8A5_zRnKkIYL4Tmj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 28, 2023 and June 30, 2023, the Company modified certain restricted stock units as a result of the resignation of two senior
executives, where &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230227__20230228_zpyxXalA0mCb" title="Number of Shares, Granted"&gt;38,026&lt;/span&gt; and &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230629__20230630_zDJkmmLH3mKe" title="Number of Shares, Granted"&gt;42,635&lt;/span&gt; restricted stock units with time-based vesting that were unvested were vested, respectively, subject
to certain provisions, resulting in no incremental cost.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 22, 2022, the Company modified &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20221120__20221122_zZawFToWBvT8" title="Number of Shares, Granted"&gt;232,816&lt;/span&gt; restricted stock units that were issued to one former employee (Ross Levinsohn) to remove
the market trading volume condition, resulting in incremental cost of $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_pn3n3_c20221120__20221122_zrcp0Z2Dmkbe" title="Incremental cost"&gt;321&lt;/span&gt; at the modification date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s policy is to repurchase the number of shares of its common stock at the fair market value at the time of issuance of
new shares of its common stock upon conversion of a restricted stock unit to cover the tax obligations. During the year ending December
31, 2024, the Company expects to repurchase approximately &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zz2qlVCwELda" title="Conversion of restricted stock units"&gt;295,000&lt;/span&gt; shares of its common stock upon conversion of restricted stock units
that are expected to vest and be released during the period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
total intrinsic value of shares of the Company&#x2019;s common stock issued for restricted stock units that were released during the years
ended December 31, 2023 and 2022 were $&lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zVAGeNe2iFJi" title="Common stock issued for restricted stock units"&gt;2,955&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z2CgUYCaAy9c" title="Common stock issued for restricted stock units"&gt;8,707&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
with respect to stock-based compensation cost related to the restricted stock units is included within the Restricted Stock caption under
the heading &lt;i&gt;Stock-Based Compensation&lt;/i&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock Options&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended December 31, 2023 and 2022, the Company issued common stock options under the 2022 Plan, consisting of primarily of incentive
stock options with a term of up to ten years with time-based vesting provisions over three years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of common stock option awards granted during the years ended December 31, 2023 and 2022 was calculated using a Black-Scholes
options-pricing model for the time-based awards under the Up-list Scenario, after the Company&#x2019;s common stock was listed on the
NYSE American. The fair value of common stock option awards granted during the year ended December 31, 2022 was calculated using the
Black-Scholes option-pricing model for the time-based under the Probability Weighted Scenarios, prior to the Company&#x2019;s common stock
being listed on the NYSE American. The assumptions utilized are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--AwardTypeAxis__custom--CommonEquityAwardsMember_zruV6hVDiU3a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zat2CAmRKCAe" style="display: none"&gt;Schedule of Fair Value of Stock Options Assumptions&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Up-list&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Up-list&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;No Up-list&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zCj3B41l2gfl" title="Risk-free interest rate, minimum"&gt;3.46&lt;/span&gt;% - &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zrMKGLP8Xsd5" title="Risk-free interest rate, maximum"&gt;4.82&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zRiwnCvK9OZ8" title="Risk-free interest rate, minimum"&gt;0.97&lt;/span&gt;% - &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zTqp9zaL2xW" title="Risk-free interest rate, maximum"&gt;4.36&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_ziL8E5Pl3Wxd" title="Risk-free interest rate, minimum"&gt;0.97&lt;/span&gt;% - &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_z0ASPaVHQ5G3" title="Risk-free interest rate, maximum"&gt;1.44&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z9ylUE08FYIa" style="width: 14%; text-align: right" title="Expected dividend yield"&gt;0.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z8CJWlg43aUc" style="width: 14%; text-align: right" title="Expected dividend yield"&gt;0.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_zcG9GjR1dJ1g" style="width: 14%; text-align: right" title="Expected dividend yield"&gt;0.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zCCvMSb8Rqmj" title="Expected volatility, minimum"&gt;46.43&lt;/span&gt;% - &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zEDWfeYi1oRg" title="Expected volatility, maximum"&gt;47.27&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zmNf6DQKDVA7" title="Expected volatility, minimum"&gt;42.00&lt;/span&gt;% - &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z7FebLjn403h" title="Expected volatility, maximum"&gt;82.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_zVBOkOksxVDb" title="Expected volatility, minimum"&gt;82.00&lt;/span&gt;% - &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_z8i5zmjNevi7" title="Expected volatility, maximum"&gt;137.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z5vbyqVED6q" title="Expected life"&gt;6&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember__srt--RangeAxis__srt--MinimumMember_z1xhfG7PfEfd" title="Expected life"&gt;3.0&lt;/span&gt; &#x2013; &lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember__srt--RangeAxis__srt--MaximumMember_zjcp9qiN2bz9" title="Expected life"&gt;6.0&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember__srt--RangeAxis__srt--MinimumMember_zA6mEhz5mcki" title="Expected life"&gt;3.0&lt;/span&gt; &#x2013; &lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember__srt--RangeAxis__srt--MaximumMember_zYyKMk3xpJ85" title="Expected life"&gt;6.0&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_z7GBRL7pFh3f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--CommonEquityAwardsMember_zb4madCHi1g8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the common stock option activity during the year ended December 31, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zQFCpcZeQdZ" style="display: none"&gt;Summary of Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Life&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(in Years)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: justify"&gt;Common stock options outstanding at January 1, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zRzWUNDrYcgj" style="width: 12%; text-align: right" title="Number of Shares Common stock options, outstanding at Beginning balance"&gt;6,199,521&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zgkUt0bimyBg" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, outstanding at Beginning balance"&gt;15.26&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zq4o4r2EGbCb" title="Weighted Average Remaining Contractual Life (in Years), outstanding at Beginning balance"&gt;8.20&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zx1VcSd4ruT5" style="text-align: right" title="Number of Shares, Granted"&gt;287,993&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zKL9zbaQ7nuj" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;4.22&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zcRP5JHduar1" style="text-align: right" title="Number of Shares, Exercised"&gt;(6,927&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zDKEqdFQ8Pm6" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;8.82&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zdTsjUIDAtq" style="text-align: right" title="Number of Shares, Forfeited"&gt;(449,333&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zxXJj1flaRj7" style="text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;9.70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pid_di_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zr2BNgAs937f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Expired"&gt;(579,286&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zU8ZFRa4Ryie" style="text-align: right" title="Weighted Average Exercise Price, Expired"&gt;9.38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Common stock options outstanding at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zgYeuo0oOi5c" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares Common stock options, outstanding at Ending balance"&gt;5,451,968&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zzUZXLPvCyyg" style="text-align: right" title="Weighted Average Exercise Price, outstanding at Ending balance"&gt;9.56&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zwHIAIuMyNh7" title="Weighted Average Remaining Contractual Life (in Years), outstanding at Beginning balance"&gt;4.43&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Common stock options exercisable at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zdi9CFLomXwh" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares Common stock options, exercisable at Ending balance"&gt;4,049,393&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z3Y4yhhdaT64" style="text-align: right" title="Weighted Average Exercise Price, exercisable at Ending balance"&gt;9.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z9TfaB3o0pkk" title="Weighted Average Remaining Contractual Life (in Years), exercisable at Ending balance"&gt;5.06&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Common stock options not vested at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zEYc8CtZ4ave" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares Common stock options, not vested at Ending balance"&gt;1,402,575&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Common stock options available for future grants at December 31, 2023 (1)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_fKDEp_zEG4P5zCTLNf" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares Common stock options, available for future grants at Ending balance"&gt;542,847&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F04_zrM5Mcwlca8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_z6kmn735Og68" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common stock available
for future issuance under the 2022 Plan represent &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zz0cVnn4Bci8" title="Number of shares authorized to issue"&gt;1,800,000&lt;/span&gt; of authorized shares; less &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zbkmhNt13S1c" title="Number of shares common stock options, outstanding"&gt;1,066,597&lt;/span&gt; common stock options outstanding and
&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzOJA6aChy6g" title="Number of shares common stock options, outstanding"&gt;190,556&lt;/span&gt; restricted stock units outstanding.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AF_zqAfSb9Yy35g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aggregate grant date fair value of common stock options granted during the years ended December 31, 2023 and 2022 was $&lt;span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_pn3n3_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zstBiXwIEsa7" title="Aggregate grant date fair value"&gt;610&lt;/span&gt; and $&lt;span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_pn3n3_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zsTZLPyU2sp6" title="Aggregate grant date fair value"&gt;7,194&lt;/span&gt;,
respectively. The weighted-average grant-date fair value of common stock options granted during the years ended December 31, 2023 and
2022 were $&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zXfmHqpL6byi" title="Weighted-average grant-date fair value"&gt;2.12&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_znNNc3xZGPda" title="Weighted-average grant-date fair value"&gt;5.25&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
total intrinsic value of common stock options exercised during the years ended December 31, 2023 and 2022 were $&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pn3n3_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zYiTLMVP0Ujh" title="Common stock options vested"&gt;10&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pn3n3_c20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zSdUx6TDNbJb" title="Common stock options vested"&gt;1,507&lt;/span&gt;, respectively.
The total fair value of common stock options vested during the years ended December 31, 2023 and 2022 were $&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_pn3n3_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zYEOLj5qqCj" title="Common stock options vested"&gt;10,155&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_pn3n3_c20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z7tRRnmSZKDl" title="Common stock options vested"&gt;12,694&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
unvested common stock options for which the vesting is expected based on achievement of a performance condition as of December 31, 2023
were &lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20230101__20231231_z6lOn1KHdx92"&gt;583,143&lt;/span&gt; with a weighted average remaining contractual term of &lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zb0eoVKFX778" title="Weighted average remaining contractual term"&gt;5.28&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s policy is to repurchase the number of shares of its common stock at the fair market value at the time of issuance of
its common stock upon exercise of common stock options to cover the tax obligations and any cashless exercise. In addition, the Company&#x2019;s
policy is to issue new shares of its common stock upon exercise of common stock options.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
was &lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pn3n3_do_c20231231_zgpKiCetfCm4" title="Intrinsic value of stock option"&gt;no&lt;/span&gt; intrinsic value of exercisable but unexercised in-the-money common stock option awards as of December 31, 2023 based on a fair
market value of the Company&#x2019;s common stock of $&lt;span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20231231_zV9lv5OuiQ3l" title="Share price"&gt;2.38&lt;/span&gt; per share on December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_hus-gaap--AwardTypeAxis__custom--CommonStockAwardsMember_zJz3KNt0Xhbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise prices under the common stock options outstanding and exercisable are as follows as of December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zcMgSiYQCtbc" style="display: none"&gt;Schedule of Exercise Prices of Common Stock Options&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Outstanding&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Vested&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Shares)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Shares)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 30%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z50C95osBHK3" title="Exercise price"&gt;2.48&lt;/span&gt; to $&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_ztJWvaRdXPv9" title="Exercise price upper range"&gt;10.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z5b9S5kSuBhe" style="width: 30%; text-align: right" title="Number of Shares, Outstanding"&gt;4,318,901&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zHdvtffEfP85" style="width: 30%; text-align: right" title="Number of Shares, Vested"&gt;3,308,790&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zpYczAq7Kiy7" title="Exercise price"&gt;10.51&lt;/span&gt; to $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zbHV55BXbYFl" title="Exercise price"&gt;15.52&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zQZiDOZv3Mz" style="text-align: right" title="Number of Shares, Outstanding"&gt;1,062,379&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zfyfeAz1xzfl" style="text-align: right" title="Number of Shares, Vested"&gt;670,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zsNlWqFs4FUa"&gt;15.53&lt;/span&gt; to $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zVUNs0wKDLqh" title="Exercise price"&gt;20.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zhYcjlp21bDd" style="text-align: right" title="Number of Shares, Outstanding"&gt;9,091&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zJSsI8WWigoi" style="text-align: right" title="Number of Shares, Vested"&gt;9,091&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zLdUQpQ3VgH2" title="Exercise price"&gt;20.55&lt;/span&gt; to $&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zSGZ3rihBIha" title="Exercise price"&gt;25.56&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zVftdPZkIC0g" style="text-align: right" title="Number of Shares, Outstanding"&gt;25,683&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zbwDFxcG4ZE5" style="text-align: right" title="Number of Shares, Vested"&gt;24,642&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zb6SBS9cAY9l" title="Exercise price"&gt;25.57&lt;/span&gt; to $&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_ziWt5byD4axk" title="Exercise price"&gt;30.58&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zXqFcRVHLpEd" style="text-align: right" title="Number of Shares, Outstanding"&gt;910&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_z6nzf57X6me9" style="text-align: right" title="Number of Shares, Vested"&gt;910&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z1Hko8NG4tAk" title="Exercise price"&gt;30.59&lt;/span&gt; to $&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z9NRzZF1ocEc" title="Exercise price"&gt;35.60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zbdhVFh44NUe" style="text-align: right" title="Number of Shares, Outstanding"&gt;4,320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zOQC17slKSlf" style="text-align: right" title="Number of Shares, Vested"&gt;4,320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_ziFaBhOV5pI9" title="Exercise price"&gt;35.61&lt;/span&gt; to $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zk7x5rdyPcrg" title="Exercise price"&gt;40.62&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_z6QC6tOpZkx9" style="text-align: right" title="Number of Shares, Outstanding"&gt;2,728&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_z9UpFiDuxfde" style="text-align: right" title="Number of Shares, Vested"&gt;2,728&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zeoRnjPZFH89" title="Exercise price"&gt;40.63&lt;/span&gt; to $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zfCESoZlc248" title="Exercise price"&gt;48.40&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zsYPY0Ab4wPe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Outstanding"&gt;27,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zkNlqkOYJl1f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Vested"&gt;27,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_ztdxMZPyshXj" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Outstanding"&gt;5,451,968&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z0JBAg8wcuCb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Vested"&gt;4,049,393&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A5_zCHH1ENW3W82" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Modification
of Awards &lt;/i&gt;&#x2013; On February 28, 2023, the Company modified certain equity awards as a result of the resignation of a senior executive
employee where &lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20230228__20230228__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7jQDWrloFHc" title="Share based compensation, vesting, number"&gt;38,026&lt;/span&gt; restricted stock units with time-based vesting that were unvested were vested and &lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20230228__20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zVW07Kv2xs59" title="Share based compensation, vesting, number"&gt;21,117&lt;/span&gt; options to purchase shares
of the Company&#x2019;s common stock with time-based vesting that were unvested were vested, each subject to compliance with applicable
securities laws and certain other provisions. In connection with the modification of these equity awards, the Company agreed to purchase
a total of &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20230228__20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_z4MWBU2bxrUe" title="Number of shares, agreed to purchase"&gt;45,632&lt;/span&gt; options to purchase shares of the Company&#x2019;s common stock (including previously vested options to purchase shares
of the Company&#x2019;s common stock of &lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20230228__20230228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVxBLegbVplb" title="Sharebased compensation arrangement by sharebased payment award options vested number of shares"&gt;24,515&lt;/span&gt;) as of the resignation date of the employee at a price of $&lt;span id="xdx_905_eus-gaap--SharePrice_iI_pid_c20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zQYMCCCZmuja" title="Share price per share"&gt;10.29&lt;/span&gt; per share, reduced by
the exercise price and required tax withholdings, subject to certain conditions. The modification of the equity awards resulted in the
unamortized costs being recognized at the modification date. The cash price of $&lt;span id="xdx_90C_eus-gaap--SharePrice_iI_pid_c20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_z7DE7rQeiIN5" title="Share price per share"&gt;10.29&lt;/span&gt; per option less the strike price of $&lt;span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zMfwp12qxcfe" title="Strike price per share"&gt;8.82&lt;/span&gt; per option
resulted in incremental cost of $&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_pn3n3_c20230228__20230228__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zGhkRHhIXlA1" title="Incremental cost"&gt;68&lt;/span&gt; being recognized at the modification date. The modification resulted in liability classification
of the equity awards, with $&lt;span id="xdx_909_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_z4DCGMw2DeAb" title="Accrued expenses and other"&gt;68&lt;/span&gt; paid during the year ended December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 30, 2023, the Company modified certain equity awards upon the resignation of a senior executive employee pursuant to which unvested
restricted stock units for &lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zCXncc0kVgS4" title="Unvested restricted stock units"&gt;42,635&lt;/span&gt; shares of the Company&#x2019;s common stock vested, and unvested options for &lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_z3kHG8wPiKob" title="Common stock vested"&gt;29,701&lt;/span&gt; shares of the Company&#x2019;s
common stock vested with the exercise period extended for the &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zn7JvjGrRSjf" title="Vested contractual term"&gt;10&lt;/span&gt;-year contractual term of the options from the grant date of the award.
In connection with the termination, the unamortized costs of the awards of $&lt;span id="xdx_904_eus-gaap--UnamortizedDebtIssuanceExpense_iI_pn3n3_c20230630__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zoYdDF500SX3" title="Unamortized costs"&gt;773&lt;/span&gt; was recognized at the termination date and $&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_pn3n3_c20230629__20230630__us-gaap--AwardTypeAxis__custom--CommonStockOptionsMember_zvdeDCjbMYUl" title="Incremental cost"&gt;284&lt;/span&gt; of incremental
cost was recognized as a result of the option award modification upon termination of the senior executive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 2, 2023, the Company modified options of former a senior executive officer for &lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20231101__20231102_zL0cWRhIu2g2" title="Unvested restricted stock units"&gt;450,560&lt;/span&gt;
shares of the Company&#x2019;s common stock, pursuant to which the exercise period would be extended for the &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20231101__20231102_zczDkQp8qeA7" title="Vested contractual term"&gt;10&lt;/span&gt;-year
contractual term from the grant date of the award subject to continued employment through the closing date of the Business
Combination (see Note 28) (the &#x201c;conditions&#x201d;). Incremental costs in connection with the modification was $&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_pn3n3_c20231101__20231102_ztTmD6xKqNze" title="Incremental cost"&gt;380&lt;/span&gt;,
of which no cost was recognized at the modification date since the conditions were not satisfied and the employment of the officer
was terminated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;2022
Stock Option Repricing&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 18, 2022, the Company approved a repricing of certain outstanding stock options (the &#x201c;Stock Option Repricing&#x201d;) granted
under the Company&#x2019;s 2016 Plan and 2019 Plan that had an exercise price above $ &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220315__20220318_zuASn8tuxWVg" title="Weighted Average Exercise Price, Granted"&gt;8.82&lt;/span&gt; per share, as well as certain outstanding stock
options held by senior management of the Company under the Outside Options. The Stock Options Repricing was approved by the Board and
stockholders. As a result of the Stock Option Repricing, the exercise prices were set to $&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220315__20220318_z3ksuL735Nwc" title="Weighted Average Exercise Price, Granted"&gt;8.82&lt;/span&gt; per share, which was the closing sale
price of the Company&#x2019;s common stock as listed on the NYSE American exchange on March 18, 2022. Except for the repricing of the
stock options under the 2019 Plan, all terms and conditions of each stock option remain in full force and effect. For the repricing of
the stock options under the 2019 Plan, the Company (i) modified the exercise price; (ii) will allow cashless exercise as a method of
paying the exercise price, and (iii) will waive a lock-up provision in the stock option agreements. All other term and conditions of
each of the stock options under the 2019 Plan remain in full force and effect.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Stock Option Repricing of approximately &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220315__20220318_zAfYh6i525d6" title="Share based compensation arrangement options grants"&gt;4,343,017 &lt;/span&gt;stock option grants (for 340 employees) that were issued to employees of the Company,
including senior management, resulted in incremental cost of $&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_pn3n3_c20220315__20220318_zN8JJMv7xsn7" title="Share based compensation incremental cost"&gt;6,061&lt;/span&gt;, of which $&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_pn3n3_c20220318_zRoUabhVXRf5" title="Share based compensation aggregate intrinsic value"&gt;143&lt;/span&gt; was recognized at the time of the Stock Option Repricing
for the fully vested awards and included on the consolidated statements of operations, and $&lt;span id="xdx_909_ecustom--OriginalAwardAtTheRepricingDate_pn3n3_c20220315__20220318_z3WFenVEnsf1" title="Original award repricing date"&gt;5,918&lt;/span&gt; will recognized over the remaining
vesting term of the original award at the repricing date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
with respect to stock-based compensation cost and unrecognized stock-based compensation cost related to the common stock options is provided
under the heading &lt;i&gt;Stock-Based Compensation&lt;/i&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;ABG
Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Licensing Agreement and issuance of the ABG Warrants to purchase up to &lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231231__us-gaap--TypeOfArrangementAxis__custom--SportsIllustratedLicensingAgreementMember__us-gaap--RelatedPartyTransactionAxis__custom--ABGWarrantsMember_znWHc0pp6vWj" title="Exeercise price"&gt;999,540&lt;/span&gt; shares of the Company&#x2019;s common
stock, the Company recorded the issuance of the warrants as stock-based compensation with the fair value of the warrants measured at
the time of issuance and expensed over the requisite service period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_ecustom--ScheduleOfWarrantsActivityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--ABGWarrantsMember_zNoWOLPinfg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the ABG Warrant activity during the year ended December 31, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zsfds2bgUzxf" style="display: none"&gt;Schedule of Warrants Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Number of Shares&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt;
 Average&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt;
 Average&lt;br/&gt;
 Remaining &lt;br/&gt;
Contractual&lt;br/&gt;
 Life&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Unvested&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Vested&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(in years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;ABG Warrants outstanding at January 1, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zpYtxuK091Oi" style="width: 11%; text-align: right" title="Number of Shares, unvested outstanding, at beginning of year"&gt;599,724&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zI955IU90hX8" style="width: 11%; text-align: right" title="Number of Shares, vested outstanding, at beginning of year"&gt;399,816&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_z5xwTK6i8sXk" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, outstanding, at beginning of year"&gt;11.55&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--WeightedAverageRemainingContractualLifeOutstanding_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zWh6N91O9Ndb" title="Weighted Average Remaining Contractual Life, Outstanding at beginning of year"&gt;6.46&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Vested&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zxEdsvqKDzha" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, unvested issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2731"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zkUIJoVr7rLb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, vested"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2733"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;ABG Warrants outstanding at December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zLK1LvPlKc24" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, unvested outstanding, at end of year"&gt;599,724&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zsRYxtLY03M9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, vested outstanding, at end of year"&gt;399,816&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_z1qAdjUfb1U6" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, outstanding, at end of year"&gt;11.55&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_905_ecustom--WeightedAverageRemainingContractualLifeOutstanding_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zbHIJqMqOmG2" title="Weighted Average Remaining Contractual Life, Outstanding at ending of year"&gt;5.46&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A9_zaK24Z9Zj0W2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
was &lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pn3n3_do_c20231231__us-gaap--TypeOfArrangementAxis__custom--SportsIllustratedLicensingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ABGWarrantsMember_zCpw5eySBgGe" title="Intrinsic value of stock option"&gt;no&lt;/span&gt; intrinsic value of exercisable but unexercised in-the-money ABG Warrants as of December 31, 2023 based on a fair market value
of the Company&#x2019;s common stock of $&lt;span id="xdx_900_ecustom--FairMarketValueOfStockOption_iI_pid_c20231231__us-gaap--TypeOfArrangementAxis__custom--SportsIllustratedLicensingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ABGWarrantsMember_zqJdcgu2VEV7" title="Fair market value of stock option"&gt;2.38&lt;/span&gt; per share on December 31, 2023. Information on the acceleration of the vesting of the ABG
Warrants is provided in Note 28.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--ABGWarrantsMember_z4J5vzOaTKMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise prices of the ABG Warrants outstanding and exercisable are as follows as of December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zrRikuEiWc3k" style="display: none"&gt;Schedule of Exercise Prices of Common Stock Options&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Outstanding&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercisable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Shares)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Shares)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 30%; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zKgPGThkQJp" title="Exercise price lower range"&gt;9.24&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zU50JB6QzUpa" style="width: 30%; text-align: right" title="Number of shares, outstanding"&gt;749,655&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zmLSzRp7LgZ6" style="width: 30%; text-align: right" title="Number of shares, exercisable"&gt;299,862&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z4BtTlp0SgTg" title="Exercise price lower range"&gt;18.48&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z0Ui8koEijLc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, outstanding"&gt;249,885&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zmz0wrBVcrR2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, exercisable"&gt;99,954&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zHK5IRpMCj1g" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares, outstanding"&gt;999,540&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_z7pIqsolUyp7" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares, exercisable"&gt;399,816&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zVoemDEMnQk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
with respect to compensation cost and unrecognized compensation cost related to the ABG Warrants is provided under the heading &lt;i&gt;Stock-Based
Compensation&lt;/i&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Publisher
Partner Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Publisher
Partner Warrants&lt;/i&gt; &#x2013; Publisher Partner Warrants outstanding as of January 1, 2023, totaling &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--PublisherPartnerWarrantProgramMember_zJSpsWIjsGfl" title="Warrant to purchase common stock"&gt;4,154&lt;/span&gt;, expired during the year ended
December 31, 2023. As of December 31, 2023, there are no Publisher Partner Warrants outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;New
Publisher Partner Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--ScheduleOfWarrantsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zWf6xvowhFOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the New Publisher Partner Warrants activity during the year ended December 31, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zMUmq9oxdM1i" style="display: none"&gt;Schedule of Warrants Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Life&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(in Years)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;New Publisher Partner Warrants outstanding at January 1, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z2gAsbkB70j6" style="text-align: right" title="Number of Shares, outstanding, at beginning of year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2769"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zB6OeYbpL0I2" style="text-align: right" title="Weighted Average Exercise Price, outstanding, at beginning of year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2771"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: justify"&gt;Granted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z9IT6Os7LKw9" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Number of Shares, Forfeited"&gt;9,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zxaq3necnJlb" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Ending Balance"&gt;6.91&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;New Publisher Partner Warrants outstanding at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zKibk2Uz7Mzl" style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z0KXTc7fuHq5" style="text-align: right" title="Weighted Average Exercise Price, Ending Balance"&gt;6.91&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageRemainingContractualLifeOutstanding1_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zZFv88FPShT7" title="Weighted Average Remaining Contractual Life, Outstanding at ending of year"&gt;4.15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;New Publisher Partner Warrants exercisable at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zImrjS8X6red" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Exercisable at end of year"&gt;1,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zkDCeOQoEOUh" style="text-align: right" title="Weighted Average Exercise Price, Exercisable at end of year"&gt;10.56&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageRemainingContractualLifeExercisable_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_ztp3qO5ifYu5" title="Weighted Average Remaining Contractual Life, Exercisable"&gt;3.92&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;New Publisher Partner Warrants not vested at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zBtAAmFtMima" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, not vested at end of year"&gt;8,716&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;New Publisher Partner Warrants available for future grants at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zT2cm3ei9vM2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Available for future grants at end of year"&gt;23,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zUyjfep3fcDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
was &lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_do_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zB98MN8IsIQ3" title="Intrinsic value of stock option"&gt;no&lt;/span&gt; intrinsic value of exercisable but unexercised in-the-money New Publisher Partner Warrants since the fair market value of $&lt;span id="xdx_907_ecustom--FairMarketValueOfStockOption_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zN4HxOPx2by1" title="Fair market value of stock option"&gt;2.38&lt;/span&gt;
per share of the Company&#x2019;s common stock was lower than the exercise prices on December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_hus-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z8BjKnMgfMCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise prices of the New Publisher Partner Warrants outstanding and exercisable are as follows as of December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_z8TEOqBkMmBg" style="display: none"&gt;Schedule of Exercise Prices of Common Stock Options&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Outstanding&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercisable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Shares)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Shares)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 30%; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z6kXo03sJvla" title="Exercise price lower range"&gt;5.30&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zkf8QRw8NRR9" style="width: 30%; text-align: right" title="Number of Shares, Outstanding"&gt;6,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z3GJQ8PdBt8h" style="width: 30%; text-align: right" title="Number of Shares, Exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2802"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zSD2JPrm9F2b" title="Exercise price lower range"&gt;10.56&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zOCapmwRMr9h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Outstanding"&gt;3,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z0Tlm5Wc0sX6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Exercisable"&gt;1,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zK0kEaqALdS2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Outstanding"&gt;9,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zpWefQy49wkd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Exercisable"&gt;1,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_z3kyW9jPavQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Stock-Based
Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--ABGWarrantsMember_zkMesvIjkW3i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock&#x2013;based
compensation and equity-based expense charged to operations or capitalized during the years ended December 31, 2023 and 2022 are summarized
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zqWOdX3kw9E" style="display: none"&gt;Summary of Stock-based Compensation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Restricted&lt;br/&gt;
 Stock&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt;
Stock Options&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;ABG Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Totals&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%"&gt;Cost of revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zS4aB10vPkx7" style="width: 12%; text-align: right" title="Cost of revenue"&gt;2,092&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zjfeLSqdTWH1" style="width: 12%; text-align: right" title="Cost of revenue"&gt;4,460&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z4SWUTwrHBPk" style="width: 12%; text-align: right" title="Cost of revenue"&gt;10&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zuh3OCpomXM" style="width: 12%; text-align: right" title="Cost of revenue"&gt;6,562&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Selling and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zv3oA1jKt3V1" style="text-align: right" title="Selling and marketing"&gt;257&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z9sW55HnO8o5" style="text-align: right" title="Selling and marketing"&gt;1,402&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_ziehUIhFx4L9" style="text-align: right" title="Selling and marketing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2828"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zQIXd86TXcBg" style="text-align: right" title="Selling and marketing"&gt;1,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zj34EBLFgL9b" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative"&gt;6,372&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zJIAxKFs8dm6" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative"&gt;3,457&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zVOIDSewmT25" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative"&gt;1,010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zyxbAKu6wZi" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative"&gt;10,839&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total costs charged to operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z1qDiccyYDI6" style="text-align: right" title="Total costs charged to operations"&gt;8,721&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zDvdTPfm9Q0c" style="text-align: right" title="Total costs charged to operations"&gt;9,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zohVYeJuar94" style="text-align: right" title="Total costs charged to operations"&gt;1,020&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zSBKQGqlB3V4" style="text-align: right" title="Total costs charged to operations"&gt;19,060&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Capitalized platform development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z8avxe0oOTc2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2848"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zirhH6aEfK6f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"&gt;1,016&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z0jtwB0FCUHb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2852"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zprrWOJiUQQc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"&gt;1,016&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zdfE9zZ40QZ3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation"&gt;8,721&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zm6IXAv1zbCe" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation"&gt;10,335&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zpksmIkYPFR9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation"&gt;1,020&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z1UlLBoEHiR9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation"&gt;20,076&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Restricted&lt;br/&gt;
 Stock&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt;
Stock Options&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;ABG Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Totals&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%"&gt;Cost of revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zbc4io1WKOTl" style="width: 12%; text-align: right" title="Cost of revenue"&gt;3,730&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zmYy9EsXMQpf" style="width: 12%; text-align: right" title="Cost of revenue"&gt;6,505&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zXQelMvmOKii" style="width: 12%; text-align: right" title="Cost of revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2868"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zHgmqrdHBuIk" style="width: 12%; text-align: right" title="Cost of revenue"&gt;10,235&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Selling and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zzI21pyXIxUl" style="text-align: right" title="Selling and marketing"&gt;270&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zqHeRFs34xsf" style="text-align: right" title="Selling and marketing"&gt;2,502&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zp6hLT9CnNcl" style="text-align: right" title="Selling and marketing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2876"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zUD4N25qWy57" style="text-align: right" title="Selling and marketing"&gt;2,772&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zY3IthpAUkla" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative"&gt;9,067&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zGOlOGCYdgG9" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative"&gt;7,776&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zjITvekToWN9" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative"&gt;1,495&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zBl31ToAqh1c" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative"&gt;18,338&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total costs charged to operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zBl2pwO6bKue" style="text-align: right" title="Total costs charged to operations"&gt;13,067&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zSnjNhzBUna4" style="text-align: right" title="Total costs charged to operations"&gt;16,783&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zq4l8XzjoUo5" style="text-align: right" title="Total costs charged to operations"&gt;1,495&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zyxMhPgM26Fa" style="text-align: right" title="Total costs charged to operations"&gt;31,345&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Capitalized platform development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zDUTrOX49saj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2896"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zLU4MABAJzF4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"&gt;1,884&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zKZN0rxKseac" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2900"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zbx2FBLwBMlc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"&gt;1,884&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zWiko2EKKVy7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation"&gt;13,067&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zo7kdn5kDXp" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation"&gt;18,667&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zTn3jXVl4HJ1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation"&gt;1,495&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_ztpqGxcsOFk8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation"&gt;33,229&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zG2z1g1GxoW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--ScheduleOfUnrecognizedCompensationExpense_z5zoP8UKu54f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unrecognized
compensation expense related to the stock-based compensation awards and equity-based awards as of December 31, 2023 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zSpQfxxmfmD5" style="display: none"&gt;Schedule of Unrecognized Compensation Expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Restricted&lt;br/&gt;
 Stock&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt;
Stock Options&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;ABG Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Totals&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Unrecognized compensation expense&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zK2fgOgUbWok" style="width: 12%; text-align: right" title="Unrecognized compensation expense"&gt;1,191&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zIfBhtP9vhp" style="width: 12%; text-align: right" title="Unrecognized compensation expense"&gt;4,192&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zTvMG4y7ZrHf" style="width: 12%; text-align: right" title="Unrecognized compensation expense"&gt;26&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zxz6nz9YmTF6" style="width: 12%; text-align: right" title="Unrecognized compensation expense"&gt;5,409&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Weighted average period expected to be recognized (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zmt8Fp8nBx29" title="Weighted average period expected to be recognized (in years)"&gt;1.84&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zEXcy2KCOGzd" title="Weighted average period expected to be recognized (in years)"&gt;1.33&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zbEEcYF3gId7" title="Weighted average period expected to be recognized (in years)"&gt;2.01&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zPB1D1Ix63w8" title="Weighted average period expected to be recognized (in years)"&gt;1.45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zwb7DtE161Qk" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="AsOf2022-06-02_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002450"
      unitRef="Shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <AREN:ScheduleOfRestrictedStockUnitsActivityTableTextBlock
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember"
      id="Fact002452">&lt;p id="xdx_89F_ecustom--ScheduleOfRestrictedStockUnitsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zGuBZFrp1rZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the restricted stock unit activity during the year ended December 31, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;span id="xdx_8BB_zIHR8WiR6UKk" style="display: none"&gt;Schedule of Restricted Stock Units Activity&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Number of Shares&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold"&gt;Weighted&lt;br/&gt;
 Average&lt;br/&gt;
 Grant-Date&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Unvested&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Vested&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt; Fair Value&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Restricted stock units outstanding at January 1, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zrFTbYnzKOga" style="width: 12%; text-align: right" title="Number of Shares, Unvested, outstanding, at beginning of year"&gt;994,766&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_z22DVdAYusBb" style="width: 12%; text-align: right" title="Number of Shares, Vested, outstanding, at beginning of year"&gt;397,376&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zQg3Vc1Fe4bc" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, outstanding, at beginning of year"&gt;15.44&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zaj3ujE8Nqw8" style="text-align: right" title="Number of Shares, Unvested granted"&gt;148,970&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zGY5Y5ndefia" style="text-align: right" title="Weighted Average Exercise Price,Granted"&gt;5.77&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zqJM1VHKCyx2" style="text-align: right" title="Number of Shares, Unvested, Vested"&gt;(645,023&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zuOov30y7j7e" style="text-align: right" title="Number of Shares, Vested"&gt;645,023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Released&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased_iNS_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zzaTB17oOD1f" style="text-align: right" title="Number of Shares, Vested, Released"&gt;(429,528&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Cancelled&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zFDvmEEZBKe7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Unvested, Cancelled"&gt;(299,446&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Restricted stock units outstanding at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_ziKU1b60cNCi" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Unvested, outstanding at end of year"&gt;199,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zHFYcTzEM0n" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Vested, outstanding, at end of year"&gt;612,871&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20231231_zJ8I064rZMEl" style="text-align: right" title="Weighted Average Exercise Price, outstanding, at end of year"&gt;13.55&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</AREN:ScheduleOfRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2022-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact002454"
      unitRef="Shares">994766</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber
      contextRef="AsOf2022-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact002456"
      unitRef="Shares">397376</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2022-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact002458"
      unitRef="USDPShares">15.44</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact002460"
      unitRef="Shares">148970</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact002462"
      unitRef="USDPShares">5.77</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValueGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact002464"
      unitRef="Shares">645023</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested
      contextRef="AsOf2022-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact002466"
      unitRef="Shares">645023</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberVested>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased
      contextRef="AsOf2022-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact002468"
      unitRef="Shares">429528</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberReleased>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact002470"
      unitRef="Shares">299446</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2023-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact002472"
      unitRef="Shares">199267</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber
      contextRef="AsOf2023-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact002474"
      unitRef="Shares">612871</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002476"
      unitRef="USDPShares">13.55</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-02-272023-02-28"
      decimals="INF"
      id="Fact002478"
      unitRef="Shares">38026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-06-292023-06-30"
      decimals="INF"
      id="Fact002480"
      unitRef="Shares">42635</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-11-202022-11-22"
      decimals="INF"
      id="Fact002482"
      unitRef="Shares">232816</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="From2022-11-202022-11-22"
      decimals="-3"
      id="Fact002484"
      unitRef="USD">321000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2024-01-012024-12-31_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002486"
      unitRef="Shares">295000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember66271921"
      decimals="-3"
      id="Fact002488"
      unitRef="USD">2955000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember66271937"
      decimals="-3"
      id="Fact002490"
      unitRef="USD">8707000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="From2023-01-012023-12-31_custom_CommonEquityAwardsMember"
      id="Fact002492">&lt;p id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--AwardTypeAxis__custom--CommonEquityAwardsMember_zruV6hVDiU3a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zat2CAmRKCAe" style="display: none"&gt;Schedule of Fair Value of Stock Options Assumptions&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Up-list&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Up-list&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;No Up-list&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zCj3B41l2gfl" title="Risk-free interest rate, minimum"&gt;3.46&lt;/span&gt;% - &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zrMKGLP8Xsd5" title="Risk-free interest rate, maximum"&gt;4.82&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zRiwnCvK9OZ8" title="Risk-free interest rate, minimum"&gt;0.97&lt;/span&gt;% - &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zTqp9zaL2xW" title="Risk-free interest rate, maximum"&gt;4.36&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_ziL8E5Pl3Wxd" title="Risk-free interest rate, minimum"&gt;0.97&lt;/span&gt;% - &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_z0ASPaVHQ5G3" title="Risk-free interest rate, maximum"&gt;1.44&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z9ylUE08FYIa" style="width: 14%; text-align: right" title="Expected dividend yield"&gt;0.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z8CJWlg43aUc" style="width: 14%; text-align: right" title="Expected dividend yield"&gt;0.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_zcG9GjR1dJ1g" style="width: 14%; text-align: right" title="Expected dividend yield"&gt;0.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zCCvMSb8Rqmj" title="Expected volatility, minimum"&gt;46.43&lt;/span&gt;% - &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zEDWfeYi1oRg" title="Expected volatility, maximum"&gt;47.27&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_zmNf6DQKDVA7" title="Expected volatility, minimum"&gt;42.00&lt;/span&gt;% - &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z7FebLjn403h" title="Expected volatility, maximum"&gt;82.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_zVBOkOksxVDb" title="Expected volatility, minimum"&gt;82.00&lt;/span&gt;% - &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember_z8i5zmjNevi7" title="Expected volatility, maximum"&gt;137.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember_z5vbyqVED6q" title="Expected life"&gt;6&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember__srt--RangeAxis__srt--MinimumMember_z1xhfG7PfEfd" title="Expected life"&gt;3.0&lt;/span&gt; &#x2013; &lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--UpListMember__srt--RangeAxis__srt--MaximumMember_zjcp9qiN2bz9" title="Expected life"&gt;6.0&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember__srt--RangeAxis__srt--MinimumMember_zA6mEhz5mcki" title="Expected life"&gt;3.0&lt;/span&gt; &#x2013; &lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__srt--StatementScenarioAxis__custom--NoUpListMember__srt--RangeAxis__srt--MaximumMember_zYyKMk3xpJ85" title="Expected life"&gt;6.0&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember"
      decimals="INF"
      id="Fact002494"
      unitRef="Pure">0.0346</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember"
      decimals="INF"
      id="Fact002496"
      unitRef="Pure">0.0482</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember"
      decimals="INF"
      id="Fact002498"
      unitRef="Pure">0.0097</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember"
      decimals="INF"
      id="Fact002500"
      unitRef="Pure">0.0436</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember"
      decimals="INF"
      id="Fact002502"
      unitRef="Pure">0.0097</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember"
      decimals="INF"
      id="Fact002504"
      unitRef="Pure">0.0144</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember"
      decimals="INF"
      id="Fact002506"
      unitRef="Pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember"
      decimals="INF"
      id="Fact002508"
      unitRef="Pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember"
      decimals="INF"
      id="Fact002510"
      unitRef="Pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember"
      decimals="INF"
      id="Fact002512"
      unitRef="Pure">0.4643</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember"
      decimals="INF"
      id="Fact002514"
      unitRef="Pure">0.4727</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember"
      decimals="INF"
      id="Fact002516"
      unitRef="Pure">0.4200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember"
      decimals="INF"
      id="Fact002518"
      unitRef="Pure">0.8200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember"
      decimals="INF"
      id="Fact002520"
      unitRef="Pure">0.8200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember"
      decimals="INF"
      id="Fact002522"
      unitRef="Pure">1.3700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember"
      id="Fact002524">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember_srt_MinimumMember"
      id="Fact002526">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_UpListMember_srt_MaximumMember"
      id="Fact002528">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember_srt_MinimumMember"
      id="Fact002530">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_BlackScholesOptionPricingModelMember_custom_NoUpListMember_srt_MaximumMember"
      id="Fact002532">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="From2023-01-012023-12-31_custom_CommonEquityAwardsMember"
      id="Fact002534">&lt;p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--CommonEquityAwardsMember_zb4madCHi1g8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the common stock option activity during the year ended December 31, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zQFCpcZeQdZ" style="display: none"&gt;Summary of Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Life&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(in Years)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: justify"&gt;Common stock options outstanding at January 1, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zRzWUNDrYcgj" style="width: 12%; text-align: right" title="Number of Shares Common stock options, outstanding at Beginning balance"&gt;6,199,521&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zgkUt0bimyBg" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, outstanding at Beginning balance"&gt;15.26&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zq4o4r2EGbCb" title="Weighted Average Remaining Contractual Life (in Years), outstanding at Beginning balance"&gt;8.20&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zx1VcSd4ruT5" style="text-align: right" title="Number of Shares, Granted"&gt;287,993&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zKL9zbaQ7nuj" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;4.22&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zcRP5JHduar1" style="text-align: right" title="Number of Shares, Exercised"&gt;(6,927&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zDKEqdFQ8Pm6" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;8.82&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zdTsjUIDAtq" style="text-align: right" title="Number of Shares, Forfeited"&gt;(449,333&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zxXJj1flaRj7" style="text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;9.70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pid_di_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zr2BNgAs937f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Expired"&gt;(579,286&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zU8ZFRa4Ryie" style="text-align: right" title="Weighted Average Exercise Price, Expired"&gt;9.38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Common stock options outstanding at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zgYeuo0oOi5c" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares Common stock options, outstanding at Ending balance"&gt;5,451,968&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zzUZXLPvCyyg" style="text-align: right" title="Weighted Average Exercise Price, outstanding at Ending balance"&gt;9.56&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zwHIAIuMyNh7" title="Weighted Average Remaining Contractual Life (in Years), outstanding at Beginning balance"&gt;4.43&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Common stock options exercisable at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zdi9CFLomXwh" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares Common stock options, exercisable at Ending balance"&gt;4,049,393&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z3Y4yhhdaT64" style="text-align: right" title="Weighted Average Exercise Price, exercisable at Ending balance"&gt;9.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z9TfaB3o0pkk" title="Weighted Average Remaining Contractual Life (in Years), exercisable at Ending balance"&gt;5.06&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Common stock options not vested at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zEYc8CtZ4ave" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares Common stock options, not vested at Ending balance"&gt;1,402,575&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Common stock options available for future grants at December 31, 2023 (1)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_fKDEp_zEG4P5zCTLNf" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares Common stock options, available for future grants at Ending balance"&gt;542,847&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F04_zrM5Mcwlca8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_z6kmn735Og68" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common stock available
for future issuance under the 2022 Plan represent &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zz0cVnn4Bci8" title="Number of shares authorized to issue"&gt;1,800,000&lt;/span&gt; of authorized shares; less &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zbkmhNt13S1c" title="Number of shares common stock options, outstanding"&gt;1,066,597&lt;/span&gt; common stock options outstanding and
&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzOJA6aChy6g" title="Number of shares common stock options, outstanding"&gt;190,556&lt;/span&gt; restricted stock units outstanding.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002536"
      unitRef="Shares">6199521</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002538"
      unitRef="USDPShares">15.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember"
      id="Fact002540">P8Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002542"
      unitRef="Shares">287993</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002544"
      unitRef="USDPShares">4.22</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002546"
      unitRef="Shares">6927</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002548"
      unitRef="USDPShares">8.82</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002550"
      unitRef="Shares">449333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002552"
      unitRef="USDPShares">9.70</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002554"
      unitRef="Shares">579286</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002556"
      unitRef="USDPShares">9.38</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002558"
      unitRef="Shares">5451968</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002560"
      unitRef="USDPShares">9.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      id="Fact002562">P4Y5M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002564"
      unitRef="Shares">4049393</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002566"
      unitRef="USDPShares">9.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      id="Fact002568">P5Y21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002570"
      unitRef="Shares">1402575</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002572"
      unitRef="Shares">542847</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForFutureGrantsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002575"
      unitRef="Shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002577"
      unitRef="Shares">1066597</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact002579"
      unitRef="Shares">190556</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <AREN:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="-3"
      id="Fact002581"
      unitRef="USD">610000</AREN:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted>
    <AREN:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="-3"
      id="Fact002583"
      unitRef="USD">7194000</AREN:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002585"
      unitRef="USDPShares">2.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2022-01-012022-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002587"
      unitRef="USDPShares">5.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="-3"
      id="Fact002589"
      unitRef="USD">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="-3"
      id="Fact002591"
      unitRef="USD">1507000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="-3"
      id="Fact002593"
      unitRef="USD">10155000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2022-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="-3"
      id="Fact002595"
      unitRef="USD">12694000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact002596"
      unitRef="Shares">583143</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2023-01-01to2023-12-31" id="Fact002598">P5Y3M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002600"
      unitRef="USD">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharePrice
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002602"
      unitRef="USDPShares">2.38</us-gaap:SharePrice>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="From2023-01-012023-12-31_custom_CommonStockAwardsMember"
      id="Fact002604">&lt;p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_hus-gaap--AwardTypeAxis__custom--CommonStockAwardsMember_zJz3KNt0Xhbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise prices under the common stock options outstanding and exercisable are as follows as of December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zcMgSiYQCtbc" style="display: none"&gt;Schedule of Exercise Prices of Common Stock Options&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Outstanding&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Vested&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Shares)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Shares)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 30%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z50C95osBHK3" title="Exercise price"&gt;2.48&lt;/span&gt; to $&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_ztJWvaRdXPv9" title="Exercise price upper range"&gt;10.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z5b9S5kSuBhe" style="width: 30%; text-align: right" title="Number of Shares, Outstanding"&gt;4,318,901&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zHdvtffEfP85" style="width: 30%; text-align: right" title="Number of Shares, Vested"&gt;3,308,790&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zpYczAq7Kiy7" title="Exercise price"&gt;10.51&lt;/span&gt; to $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zbHV55BXbYFl" title="Exercise price"&gt;15.52&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zQZiDOZv3Mz" style="text-align: right" title="Number of Shares, Outstanding"&gt;1,062,379&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zfyfeAz1xzfl" style="text-align: right" title="Number of Shares, Vested"&gt;670,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zsNlWqFs4FUa"&gt;15.53&lt;/span&gt; to $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zVUNs0wKDLqh" title="Exercise price"&gt;20.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zhYcjlp21bDd" style="text-align: right" title="Number of Shares, Outstanding"&gt;9,091&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zJSsI8WWigoi" style="text-align: right" title="Number of Shares, Vested"&gt;9,091&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zLdUQpQ3VgH2" title="Exercise price"&gt;20.55&lt;/span&gt; to $&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zSGZ3rihBIha" title="Exercise price"&gt;25.56&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zVftdPZkIC0g" style="text-align: right" title="Number of Shares, Outstanding"&gt;25,683&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zbwDFxcG4ZE5" style="text-align: right" title="Number of Shares, Vested"&gt;24,642&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zb6SBS9cAY9l" title="Exercise price"&gt;25.57&lt;/span&gt; to $&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_ziWt5byD4axk" title="Exercise price"&gt;30.58&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zXqFcRVHLpEd" style="text-align: right" title="Number of Shares, Outstanding"&gt;910&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_z6nzf57X6me9" style="text-align: right" title="Number of Shares, Vested"&gt;910&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z1Hko8NG4tAk" title="Exercise price"&gt;30.59&lt;/span&gt; to $&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z9NRzZF1ocEc" title="Exercise price"&gt;35.60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zbdhVFh44NUe" style="text-align: right" title="Number of Shares, Outstanding"&gt;4,320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zOQC17slKSlf" style="text-align: right" title="Number of Shares, Vested"&gt;4,320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_ziFaBhOV5pI9" title="Exercise price"&gt;35.61&lt;/span&gt; to $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zk7x5rdyPcrg" title="Exercise price"&gt;40.62&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_z6QC6tOpZkx9" style="text-align: right" title="Number of Shares, Outstanding"&gt;2,728&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_z9UpFiDuxfde" style="text-align: right" title="Number of Shares, Vested"&gt;2,728&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zeoRnjPZFH89" title="Exercise price"&gt;40.63&lt;/span&gt; to $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zfCESoZlc248" title="Exercise price"&gt;48.40&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zsYPY0Ab4wPe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Outstanding"&gt;27,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zkNlqkOYJl1f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Vested"&gt;27,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_ztdxMZPyshXj" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Outstanding"&gt;5,451,968&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_z0JBAg8wcuCb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Vested"&gt;4,049,393&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      id="Fact002606"
      unitRef="USDPShares">2.48</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      id="Fact002608"
      unitRef="USDPShares">10.50</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      id="Fact002610"
      unitRef="Shares">4318901</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      id="Fact002612"
      unitRef="Shares">3308790</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact002614"
      unitRef="USDPShares">10.51</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact002616"
      unitRef="USDPShares">15.52</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact002618"
      unitRef="Shares">1062379</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact002620"
      unitRef="Shares">670956</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeThreeMember"
      decimals="INF"
      id="Fact002621"
      unitRef="USDPShares">15.53</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeThreeMember"
      decimals="INF"
      id="Fact002623"
      unitRef="USDPShares">20.54</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeThreeMember"
      decimals="INF"
      id="Fact002625"
      unitRef="Shares">9091</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeThreeMember"
      decimals="INF"
      id="Fact002627"
      unitRef="Shares">9091</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFourMember"
      decimals="INF"
      id="Fact002629"
      unitRef="USDPShares">20.55</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFourMember"
      decimals="INF"
      id="Fact002631"
      unitRef="USDPShares">25.56</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFourMember"
      decimals="INF"
      id="Fact002633"
      unitRef="Shares">25683</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFourMember"
      decimals="INF"
      id="Fact002635"
      unitRef="Shares">24642</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFiveMember"
      decimals="INF"
      id="Fact002637"
      unitRef="USDPShares">25.57</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFiveMember"
      decimals="INF"
      id="Fact002639"
      unitRef="USDPShares">30.58</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFiveMember"
      decimals="INF"
      id="Fact002641"
      unitRef="Shares">910</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeFiveMember"
      decimals="INF"
      id="Fact002643"
      unitRef="Shares">910</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSixMember"
      decimals="INF"
      id="Fact002645"
      unitRef="USDPShares">30.59</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSixMember"
      decimals="INF"
      id="Fact002647"
      unitRef="USDPShares">35.60</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSixMember"
      decimals="INF"
      id="Fact002649"
      unitRef="Shares">4320</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSixMember"
      decimals="INF"
      id="Fact002651"
      unitRef="Shares">4320</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSevenMember"
      decimals="INF"
      id="Fact002653"
      unitRef="USDPShares">35.61</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSevenMember"
      decimals="INF"
      id="Fact002655"
      unitRef="USDPShares">40.62</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSevenMember"
      decimals="INF"
      id="Fact002657"
      unitRef="Shares">2728</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeSevenMember"
      decimals="INF"
      id="Fact002659"
      unitRef="Shares">2728</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeEightMember"
      decimals="INF"
      id="Fact002661"
      unitRef="USDPShares">40.63</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeEightMember"
      decimals="INF"
      id="Fact002663"
      unitRef="USDPShares">48.40</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeEightMember"
      decimals="INF"
      id="Fact002665"
      unitRef="Shares">27956</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember_custom_ExercisePriceRangeEightMember"
      decimals="INF"
      id="Fact002667"
      unitRef="Shares">27956</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002669"
      unitRef="Shares">5451968</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoPlanMember"
      decimals="INF"
      id="Fact002671"
      unitRef="Shares">4049393</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="From2023-02-282023-02-28_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact002673"
      unitRef="Shares">38026</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="From2023-02-282023-02-28_custom_CommonStockOptionsMember"
      decimals="INF"
      id="Fact002675"
      unitRef="Shares">21117</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2023-02-282023-02-28_custom_CommonStockOptionsMember"
      decimals="INF"
      id="Fact002677"
      unitRef="Shares">45632</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2023-02-282023-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002679"
      unitRef="Shares">24515</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharePrice
      contextRef="AsOf2023-02-28_custom_CommonStockOptionsMember"
      decimals="INF"
      id="Fact002681"
      unitRef="USDPShares">10.29</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-02-28_custom_CommonStockOptionsMember"
      decimals="INF"
      id="Fact002683"
      unitRef="USDPShares">10.29</us-gaap:SharePrice>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-02-28_custom_CommonStockOptionsMember"
      decimals="INF"
      id="Fact002685"
      unitRef="USDPShares">8.82</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="From2023-02-282023-02-28_custom_CommonStockOptionsMember"
      decimals="-3"
      id="Fact002687"
      unitRef="USD">68000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_CommonStockOptionsMember"
      decimals="-3"
      id="Fact002689"
      unitRef="USD">68000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="From2023-01-012023-06-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact002691"
      unitRef="Shares">42635</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="From2023-01-012023-06-30_custom_CommonStockOptionsMember"
      decimals="INF"
      id="Fact002693"
      unitRef="Shares">29701</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="From2023-01-012023-06-30_us-gaap_RestrictedStockUnitsRSUMember"
      id="Fact002695">P10Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="AsOf2023-06-30_custom_CommonStockOptionsMember"
      decimals="-3"
      id="Fact002697"
      unitRef="USD">773000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="From2023-06-292023-06-30_custom_CommonStockOptionsMember"
      decimals="-3"
      id="Fact002699"
      unitRef="USD">284000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="From2023-11-012023-11-02"
      decimals="INF"
      id="Fact002701"
      unitRef="Shares">450560</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2023-11-012023-11-02" id="Fact002703">P10Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="From2023-11-012023-11-02"
      decimals="-3"
      id="Fact002705"
      unitRef="USD">380000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-03-152022-03-18"
      decimals="INF"
      id="Fact002707"
      unitRef="USDPShares">8.82</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-03-152022-03-18"
      decimals="INF"
      id="Fact002709"
      unitRef="USDPShares">8.82</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-03-152022-03-18"
      decimals="INF"
      id="Fact002711"
      unitRef="Shares">4343017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="From2022-03-152022-03-18"
      decimals="-3"
      id="Fact002713"
      unitRef="USD">6061000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2022-03-18"
      decimals="-3"
      id="Fact002715"
      unitRef="USD">143000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <AREN:OriginalAwardAtTheRepricingDate
      contextRef="From2022-03-152022-03-18"
      decimals="-3"
      id="Fact002717"
      unitRef="USD">5918000</AREN:OriginalAwardAtTheRepricingDate>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2023-12-31_custom_SportsIllustratedLicensingAgreementMember_custom_ABGWarrantsMember"
      decimals="INF"
      id="Fact002719"
      unitRef="Shares">999540</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <AREN:ScheduleOfWarrantsActivityTableTextBlock
      contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember66273406"
      id="Fact002721">&lt;p id="xdx_894_ecustom--ScheduleOfWarrantsActivityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--ABGWarrantsMember_zNoWOLPinfg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the ABG Warrant activity during the year ended December 31, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zsfds2bgUzxf" style="display: none"&gt;Schedule of Warrants Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Number of Shares&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt;
 Average&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt;
 Average&lt;br/&gt;
 Remaining &lt;br/&gt;
Contractual&lt;br/&gt;
 Life&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Unvested&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Vested&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(in years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;ABG Warrants outstanding at January 1, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zpYtxuK091Oi" style="width: 11%; text-align: right" title="Number of Shares, unvested outstanding, at beginning of year"&gt;599,724&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zI955IU90hX8" style="width: 11%; text-align: right" title="Number of Shares, vested outstanding, at beginning of year"&gt;399,816&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_z5xwTK6i8sXk" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, outstanding, at beginning of year"&gt;11.55&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--WeightedAverageRemainingContractualLifeOutstanding_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zWh6N91O9Ndb" title="Weighted Average Remaining Contractual Life, Outstanding at beginning of year"&gt;6.46&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Vested&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedIssuedNumber_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zxEdsvqKDzha" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, unvested issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2731"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingVestedInPeriodNumber_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zkUIJoVr7rLb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, vested"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2733"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;ABG Warrants outstanding at December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zLK1LvPlKc24" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, unvested outstanding, at end of year"&gt;599,724&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zsRYxtLY03M9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, vested outstanding, at end of year"&gt;399,816&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_z1qAdjUfb1U6" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, outstanding, at end of year"&gt;11.55&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_905_ecustom--WeightedAverageRemainingContractualLifeOutstanding_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zbHIJqMqOmG2" title="Weighted Average Remaining Contractual Life, Outstanding at ending of year"&gt;5.46&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</AREN:ScheduleOfWarrantsActivityTableTextBlock>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber
      contextRef="AsOf2022-12-31_custom_ABGWarrantsMember"
      decimals="INF"
      id="Fact002723"
      unitRef="Shares">599724</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber
      contextRef="AsOf2022-12-31_custom_ABGWarrantsMember"
      decimals="INF"
      id="Fact002725"
      unitRef="Shares">399816</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding
      contextRef="AsOf2022-12-31_custom_ABGWarrantsMember"
      decimals="INF"
      id="Fact002727"
      unitRef="USDPShares">11.55</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding>
    <AREN:WeightedAverageRemainingContractualLifeOutstanding
      contextRef="From2022-01-012022-12-31_custom_ABGWarrantsMember66276281"
      id="Fact002729">P6Y5M15D</AREN:WeightedAverageRemainingContractualLifeOutstanding>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber
      contextRef="AsOf2023-12-31_custom_ABGWarrantsMember"
      decimals="INF"
      id="Fact002735"
      unitRef="Shares">599724</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsUnvestedOutstandingNumber>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber
      contextRef="AsOf2023-12-31_custom_ABGWarrantsMember"
      decimals="INF"
      id="Fact002737"
      unitRef="Shares">399816</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding
      contextRef="AsOf2023-12-31_custom_ABGWarrantsMember"
      decimals="INF"
      id="Fact002739"
      unitRef="USDPShares">11.55</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding>
    <AREN:WeightedAverageRemainingContractualLifeOutstanding
      contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember66276312"
      id="Fact002741">P5Y5M15D</AREN:WeightedAverageRemainingContractualLifeOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2023-12-31_custom_SportsIllustratedLicensingAgreementMember_custom_ABGWarrantsMember66272984"
      decimals="-3"
      id="Fact002743"
      unitRef="USD">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <AREN:FairMarketValueOfStockOption
      contextRef="AsOf2023-12-31_custom_SportsIllustratedLicensingAgreementMember_custom_ABGWarrantsMember66272984"
      decimals="INF"
      id="Fact002745"
      unitRef="USDPShares">2.38</AREN:FairMarketValueOfStockOption>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember66273406"
      id="Fact002747">&lt;p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--ABGWarrantsMember_z4J5vzOaTKMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise prices of the ABG Warrants outstanding and exercisable are as follows as of December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zrRikuEiWc3k" style="display: none"&gt;Schedule of Exercise Prices of Common Stock Options&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Outstanding&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercisable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Shares)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Shares)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 30%; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zKgPGThkQJp" title="Exercise price lower range"&gt;9.24&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zU50JB6QzUpa" style="width: 30%; text-align: right" title="Number of shares, outstanding"&gt;749,655&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zmLSzRp7LgZ6" style="width: 30%; text-align: right" title="Number of shares, exercisable"&gt;299,862&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z4BtTlp0SgTg" title="Exercise price lower range"&gt;18.48&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z0Ui8koEijLc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, outstanding"&gt;249,885&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zmz0wrBVcrR2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, exercisable"&gt;99,954&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_zHK5IRpMCj1g" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares, outstanding"&gt;999,540&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--ABGWarrantsMember_z7pIqsolUyp7" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares, exercisable"&gt;399,816&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      id="Fact002749"
      unitRef="USDPShares">9.24</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      id="Fact002751"
      unitRef="Shares">749655</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      id="Fact002753"
      unitRef="Shares">299862</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact002755"
      unitRef="USDPShares">18.48</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact002757"
      unitRef="Shares">249885</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2023-12-31_custom_ABGWarrantsMember_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact002759"
      unitRef="Shares">99954</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_ABGWarrantsMember"
      decimals="INF"
      id="Fact002761"
      unitRef="Shares">999540</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2023-12-31_custom_ABGWarrantsMember"
      decimals="INF"
      id="Fact002763"
      unitRef="Shares">399816</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2023-12-31_custom_PublisherPartnerWarrantProgramMember"
      decimals="INF"
      id="Fact002765"
      unitRef="Shares">4154</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <AREN:ScheduleOfWarrantsActivityTableTextBlock
      contextRef="From2023-01-012023-12-31_custom_NewPublisherPartnerWarrantMember"
      id="Fact002767">&lt;p id="xdx_89B_ecustom--ScheduleOfWarrantsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zWf6xvowhFOk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the New Publisher Partner Warrants activity during the year ended December 31, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zMUmq9oxdM1i" style="display: none"&gt;Schedule of Warrants Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Life&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(in Years)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;New Publisher Partner Warrants outstanding at January 1, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z2gAsbkB70j6" style="text-align: right" title="Number of Shares, outstanding, at beginning of year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2769"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zB6OeYbpL0I2" style="text-align: right" title="Weighted Average Exercise Price, outstanding, at beginning of year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2771"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: justify"&gt;Granted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z9IT6Os7LKw9" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Number of Shares, Forfeited"&gt;9,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zxaq3necnJlb" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Ending Balance"&gt;6.91&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;New Publisher Partner Warrants outstanding at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zKibk2Uz7Mzl" style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z0KXTc7fuHq5" style="text-align: right" title="Weighted Average Exercise Price, Ending Balance"&gt;6.91&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageRemainingContractualLifeOutstanding1_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zZFv88FPShT7" title="Weighted Average Remaining Contractual Life, Outstanding at ending of year"&gt;4.15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;New Publisher Partner Warrants exercisable at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zImrjS8X6red" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Exercisable at end of year"&gt;1,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zkDCeOQoEOUh" style="text-align: right" title="Weighted Average Exercise Price, Exercisable at end of year"&gt;10.56&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageRemainingContractualLifeExercisable_dtY_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_ztp3qO5ifYu5" title="Weighted Average Remaining Contractual Life, Exercisable"&gt;3.92&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;New Publisher Partner Warrants not vested at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zBtAAmFtMima" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, not vested at end of year"&gt;8,716&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;New Publisher Partner Warrants available for future grants at December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber_iE_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zT2cm3ei9vM2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Available for future grants at end of year"&gt;23,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</AREN:ScheduleOfWarrantsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="From2023-01-012023-12-31_custom_NewPublisherPartnerWarrantMember"
      decimals="INF"
      id="Fact002773"
      unitRef="Shares">9800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding
      contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember"
      decimals="INF"
      id="Fact002775"
      unitRef="USDPShares">6.91</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember"
      decimals="INF"
      id="Fact002776"
      unitRef="Shares">9800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding
      contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember"
      decimals="INF"
      id="Fact002778"
      unitRef="USDPShares">6.91</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding>
    <AREN:WeightedAverageRemainingContractualLifeOutstanding1
      contextRef="From2023-01-012023-12-31_custom_NewPublisherPartnerWarrantMember"
      id="Fact002780">P4Y1M24D</AREN:WeightedAverageRemainingContractualLifeOutstanding1>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable
      contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember"
      decimals="INF"
      id="Fact002782"
      unitRef="Shares">1084</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable
      contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember"
      decimals="INF"
      id="Fact002784"
      unitRef="USDPShares">10.56</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstandingExercisable>
    <AREN:WeightedAverageRemainingContractualLifeExercisable
      contextRef="From2023-01-012023-12-31_custom_NewPublisherPartnerWarrantMember"
      id="Fact002786">P3Y11M1D</AREN:WeightedAverageRemainingContractualLifeExercisable>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested
      contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember"
      decimals="INF"
      id="Fact002788"
      unitRef="Shares">8716</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentNonVested>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber
      contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember"
      decimals="INF"
      id="Fact002790"
      unitRef="Shares">23000</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAvailableForFutureGrantsNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember"
      decimals="0"
      id="Fact002792"
      unitRef="USD">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <AREN:FairMarketValueOfStockOption
      contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember"
      decimals="INF"
      id="Fact002794"
      unitRef="USDPShares">2.38</AREN:FairMarketValueOfStockOption>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="From2023-01-012023-12-31_custom_NewPublisherPartnerWarrantMember"
      id="Fact002796">&lt;p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_hus-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_z8BjKnMgfMCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise prices of the New Publisher Partner Warrants outstanding and exercisable are as follows as of December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_z8TEOqBkMmBg" style="display: none"&gt;Schedule of Exercise Prices of Common Stock Options&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Outstanding&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercisable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Shares)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(Shares)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 30%; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z6kXo03sJvla" title="Exercise price lower range"&gt;5.30&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zkf8QRw8NRR9" style="width: 30%; text-align: right" title="Number of Shares, Outstanding"&gt;6,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z3GJQ8PdBt8h" style="width: 30%; text-align: right" title="Number of Shares, Exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2802"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zSD2JPrm9F2b" title="Exercise price lower range"&gt;10.56&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zOCapmwRMr9h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Outstanding"&gt;3,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesOptionPricingModelMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z0Tlm5Wc0sX6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Exercisable"&gt;1,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zK0kEaqALdS2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Outstanding"&gt;9,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--NewPublisherPartnerWarrantMember_zpWefQy49wkd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Shares, Exercisable"&gt;1,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2023-01-012023-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      id="Fact002798"
      unitRef="USDPShares">5.30</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      id="Fact002800"
      unitRef="Shares">6800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2022-01-012022-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact002804"
      unitRef="USDPShares">10.56</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne
      contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact002806"
      unitRef="Shares">3000</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne>
    <AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne
      contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember_custom_BlackScholesOptionPricingModelMember_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact002808"
      unitRef="Shares">1084</AREN:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember"
      decimals="INF"
      id="Fact002810"
      unitRef="Shares">9800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2023-12-31_custom_NewPublisherPartnerWarrantMember"
      decimals="INF"
      id="Fact002812"
      unitRef="Shares">1084</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember66273406"
      id="Fact002814">&lt;p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--ABGWarrantsMember_zkMesvIjkW3i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock&#x2013;based
compensation and equity-based expense charged to operations or capitalized during the years ended December 31, 2023 and 2022 are summarized
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zqWOdX3kw9E" style="display: none"&gt;Summary of Stock-based Compensation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Restricted&lt;br/&gt;
 Stock&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt;
Stock Options&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;ABG Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Totals&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%"&gt;Cost of revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zS4aB10vPkx7" style="width: 12%; text-align: right" title="Cost of revenue"&gt;2,092&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zjfeLSqdTWH1" style="width: 12%; text-align: right" title="Cost of revenue"&gt;4,460&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z4SWUTwrHBPk" style="width: 12%; text-align: right" title="Cost of revenue"&gt;10&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--CostOfRevenue_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zuh3OCpomXM" style="width: 12%; text-align: right" title="Cost of revenue"&gt;6,562&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Selling and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zv3oA1jKt3V1" style="text-align: right" title="Selling and marketing"&gt;257&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z9sW55HnO8o5" style="text-align: right" title="Selling and marketing"&gt;1,402&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_ziehUIhFx4L9" style="text-align: right" title="Selling and marketing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2828"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SellingAndMarketingExpense_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zQIXd86TXcBg" style="text-align: right" title="Selling and marketing"&gt;1,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zj34EBLFgL9b" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative"&gt;6,372&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zJIAxKFs8dm6" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative"&gt;3,457&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zVOIDSewmT25" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative"&gt;1,010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zyxbAKu6wZi" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative"&gt;10,839&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total costs charged to operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z1qDiccyYDI6" style="text-align: right" title="Total costs charged to operations"&gt;8,721&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zDvdTPfm9Q0c" style="text-align: right" title="Total costs charged to operations"&gt;9,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zohVYeJuar94" style="text-align: right" title="Total costs charged to operations"&gt;1,020&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--CostsChargedToOperations_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zSBKQGqlB3V4" style="text-align: right" title="Total costs charged to operations"&gt;19,060&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Capitalized platform development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z8avxe0oOTc2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2848"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zirhH6aEfK6f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"&gt;1,016&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z0jtwB0FCUHb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2852"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DevelopmentCosts_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zprrWOJiUQQc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"&gt;1,016&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zdfE9zZ40QZ3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation"&gt;8,721&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zm6IXAv1zbCe" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation"&gt;10,335&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zpksmIkYPFR9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation"&gt;1,020&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_z1UlLBoEHiR9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation"&gt;20,076&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Restricted&lt;br/&gt;
 Stock&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt;
Stock Options&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;ABG Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Totals&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%"&gt;Cost of revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zbc4io1WKOTl" style="width: 12%; text-align: right" title="Cost of revenue"&gt;3,730&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zmYy9EsXMQpf" style="width: 12%; text-align: right" title="Cost of revenue"&gt;6,505&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zXQelMvmOKii" style="width: 12%; text-align: right" title="Cost of revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2868"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CostOfRevenue_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zHgmqrdHBuIk" style="width: 12%; text-align: right" title="Cost of revenue"&gt;10,235&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Selling and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zzI21pyXIxUl" style="text-align: right" title="Selling and marketing"&gt;270&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zqHeRFs34xsf" style="text-align: right" title="Selling and marketing"&gt;2,502&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zp6hLT9CnNcl" style="text-align: right" title="Selling and marketing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2876"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zUD4N25qWy57" style="text-align: right" title="Selling and marketing"&gt;2,772&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zY3IthpAUkla" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative"&gt;9,067&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zGOlOGCYdgG9" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative"&gt;7,776&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zjITvekToWN9" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative"&gt;1,495&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zBl31ToAqh1c" style="border-bottom: Black 1.5pt solid; text-align: right" title="General and administrative"&gt;18,338&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total costs charged to operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zBl2pwO6bKue" style="text-align: right" title="Total costs charged to operations"&gt;13,067&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zSnjNhzBUna4" style="text-align: right" title="Total costs charged to operations"&gt;16,783&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zq4l8XzjoUo5" style="text-align: right" title="Total costs charged to operations"&gt;1,495&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--CostsChargedToOperations_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zyxMhPgM26Fa" style="text-align: right" title="Total costs charged to operations"&gt;31,345&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Capitalized platform development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zDUTrOX49saj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2896"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zLU4MABAJzF4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"&gt;1,884&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zKZN0rxKseac" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2900"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DevelopmentCosts_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zbx2FBLwBMlc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized platform development"&gt;1,884&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zWiko2EKKVy7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation"&gt;13,067&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zo7kdn5kDXp" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation"&gt;18,667&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zTn3jXVl4HJ1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation"&gt;1,495&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20221231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_ztpqGxcsOFk8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stock-based compensation"&gt;33,229&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:CostOfRevenue
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002816"
      unitRef="USD">2092000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2023-01-012023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002818"
      unitRef="USD">4460000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002820"
      unitRef="USD">10000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2023-01-012023-12-31_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002822"
      unitRef="USD">6562000</us-gaap:CostOfRevenue>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002824"
      unitRef="USD">257000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-01-012023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002826"
      unitRef="USD">1402000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-01-012023-12-31_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002830"
      unitRef="USD">1659000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002832"
      unitRef="USD">6372000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002834"
      unitRef="USD">3457000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002836"
      unitRef="USD">1010000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002838"
      unitRef="USD">10839000</us-gaap:GeneralAndAdministrativeExpense>
    <AREN:CostsChargedToOperations
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002840"
      unitRef="USD">8721000</AREN:CostsChargedToOperations>
    <AREN:CostsChargedToOperations
      contextRef="From2023-01-012023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002842"
      unitRef="USD">9319000</AREN:CostsChargedToOperations>
    <AREN:CostsChargedToOperations
      contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002844"
      unitRef="USD">1020000</AREN:CostsChargedToOperations>
    <AREN:CostsChargedToOperations
      contextRef="From2023-01-012023-12-31_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002846"
      unitRef="USD">19060000</AREN:CostsChargedToOperations>
    <us-gaap:DevelopmentCosts
      contextRef="From2023-01-012023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002850"
      unitRef="USD">1016000</us-gaap:DevelopmentCosts>
    <us-gaap:DevelopmentCosts
      contextRef="From2023-01-012023-12-31_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002854"
      unitRef="USD">1016000</us-gaap:DevelopmentCosts>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002856"
      unitRef="USD">8721000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002858"
      unitRef="USD">10335000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002860"
      unitRef="USD">1020000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-12-31_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002862"
      unitRef="USD">20076000</us-gaap:ShareBasedCompensation>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002864"
      unitRef="USD">3730000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-012022-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002866"
      unitRef="USD">6505000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-012022-12-31_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002870"
      unitRef="USD">10235000</us-gaap:CostOfRevenue>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002872"
      unitRef="USD">270000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-01-012022-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002874"
      unitRef="USD">2502000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-01-012022-12-31_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002878"
      unitRef="USD">2772000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002880"
      unitRef="USD">9067000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002882"
      unitRef="USD">7776000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002884"
      unitRef="USD">1495000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002886"
      unitRef="USD">18338000</us-gaap:GeneralAndAdministrativeExpense>
    <AREN:CostsChargedToOperations
      contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002888"
      unitRef="USD">13067000</AREN:CostsChargedToOperations>
    <AREN:CostsChargedToOperations
      contextRef="From2022-01-012022-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002890"
      unitRef="USD">16783000</AREN:CostsChargedToOperations>
    <AREN:CostsChargedToOperations
      contextRef="From2022-01-012022-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002892"
      unitRef="USD">1495000</AREN:CostsChargedToOperations>
    <AREN:CostsChargedToOperations
      contextRef="From2022-01-012022-12-31_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002894"
      unitRef="USD">31345000</AREN:CostsChargedToOperations>
    <us-gaap:DevelopmentCosts
      contextRef="From2022-01-012022-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002898"
      unitRef="USD">1884000</us-gaap:DevelopmentCosts>
    <us-gaap:DevelopmentCosts
      contextRef="From2022-01-012022-12-31_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002902"
      unitRef="USD">1884000</us-gaap:DevelopmentCosts>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002904"
      unitRef="USD">13067000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002906"
      unitRef="USD">18667000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002908"
      unitRef="USD">1495000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-12-31_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002910"
      unitRef="USD">33229000</us-gaap:ShareBasedCompensation>
    <AREN:ScheduleOfUnrecognizedCompensationExpense contextRef="From2023-01-01to2023-12-31" id="Fact002912">&lt;p id="xdx_89A_ecustom--ScheduleOfUnrecognizedCompensationExpense_z5zoP8UKu54f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unrecognized
compensation expense related to the stock-based compensation awards and equity-based awards as of December 31, 2023 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zSpQfxxmfmD5" style="display: none"&gt;Schedule of Unrecognized Compensation Expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Restricted&lt;br/&gt;
 Stock&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Common &lt;br/&gt;
Stock Options&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;ABG Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Totals&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Unrecognized compensation expense&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zK2fgOgUbWok" style="width: 12%; text-align: right" title="Unrecognized compensation expense"&gt;1,191&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zIfBhtP9vhp" style="width: 12%; text-align: right" title="Unrecognized compensation expense"&gt;4,192&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zTvMG4y7ZrHf" style="width: 12%; text-align: right" title="Unrecognized compensation expense"&gt;26&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zxz6nz9YmTF6" style="width: 12%; text-align: right" title="Unrecognized compensation expense"&gt;5,409&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Weighted average period expected to be recognized (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zmt8Fp8nBx29" title="Weighted average period expected to be recognized (in years)"&gt;1.84&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--CommonStockAwardsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zEXcy2KCOGzd" title="Weighted average period expected to be recognized (in years)"&gt;1.33&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ABGWarrantsMember__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zbEEcYF3gId7" title="Weighted average period expected to be recognized (in years)"&gt;2.01&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231__srt--StatementScenarioAxis__custom--StockBasedCompensationMember_zPB1D1Ix63w8" title="Weighted average period expected to be recognized (in years)"&gt;1.45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</AREN:ScheduleOfUnrecognizedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002914"
      unitRef="USD">1191000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002916"
      unitRef="USD">4192000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002918"
      unitRef="USD">26000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2023-12-31_custom_StockBasedCompensationMember"
      decimals="-3"
      id="Fact002920"
      unitRef="USD">5409000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_StockBasedCompensationMember"
      id="Fact002922">P1Y10M2D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="From2023-01-012023-12-31_custom_CommonStockAwardsMember_custom_StockBasedCompensationMember"
      id="Fact002924">P1Y3M29D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="From2023-01-012023-12-31_custom_ABGWarrantsMember_custom_StockBasedCompensationMember"
      id="Fact002926">P2Y3D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="From2023-01-012023-12-31_custom_StockBasedCompensationMember"
      id="Fact002928">P1Y5M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <AREN:LiquidatingDamagesPayableDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002930">&lt;p id="xdx_80C_ecustom--LiquidatingDamagesPayableDisclosureTextBlock_zjzExnaKew2c" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;23.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_82C_z8ixUqsRSkgd"&gt;Liquidated Damages&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years December 31, 2023 and 2022, the Company recorded liquidated damages of $&lt;span id="xdx_907_ecustom--LiquidatedDamagesPayable_iI_pn3n3_c20231231_zDZp8iqLS5Wd" title="Liquidated damages payable"&gt;583&lt;/span&gt; and $&lt;span id="xdx_90C_ecustom--LiquidatedDamagesPayable_iI_pn3n3_c20221231_z7Uq5ALjKB1h" title="Liquidated damages payable"&gt;1,140&lt;/span&gt; (including accrued interest of $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20230101__20231231_zdBOTwREbmb1" title="Liquidated damages payable accrued interest percentage"&gt;583&lt;/span&gt;
and $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20220101__20221231_zOdKMetvwysf" title="Liquidated damages payable accrued interest percentage"&gt;652&lt;/span&gt;), respectively. During the year December 31, 2022, liquidated damages of $&lt;span id="xdx_905_ecustom--LiquidatedDamagesPayable_iI_pn3n3_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_zKySdlFvUyY3" title="Liquidating damages payable"&gt;488&lt;/span&gt; were recorded as a result of Registration Rights
Damages resulting from not registering the Series K convertible preferred stock timely.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</AREN:LiquidatingDamagesPayableDisclosureTextBlock>
    <AREN:LiquidatedDamagesPayable
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002932"
      unitRef="USD">583000</AREN:LiquidatedDamagesPayable>
    <AREN:LiquidatedDamagesPayable
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002934"
      unitRef="USD">1140000</AREN:LiquidatedDamagesPayable>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002936"
      unitRef="USD">583000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002938"
      unitRef="USD">652000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <AREN:LiquidatedDamagesPayable
      contextRef="AsOf2022-12-31_custom_SeriesKPreferredStockMember"
      decimals="-3"
      id="Fact002940"
      unitRef="USD">488000</AREN:LiquidatedDamagesPayable>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002942">&lt;p id="xdx_808_eus-gaap--IncomeTaxDisclosureTextBlock_zmjbbzkwqF15" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;24.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_82E_z0qHBN64Qysc"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zh5bOd87Uomb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of the (provision) benefit for income taxes consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B4_zJxUib8MGzf" style="display: none"&gt;Schedule of Income Taxes&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230101__20231231_zo2q3k3R6nF1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220101__20221231_zDAfweOglcij" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Current tax (provision) benefit:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_maCFSALzf1Y_zzi04Day80Ke" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2946"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2947"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pn3n3_maCFSALzf1Y_zQzMzV1Bz3w1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left; padding-bottom: 1.5pt"&gt;State and local&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"&gt;(88&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"&gt;(77&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_iT_pn3n3_mtCFSALzf1Y_maITEBzavD_maOTEBzTPw_zKfHARmqo5cb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;Total current tax (provision) benefit&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(88&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(77&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax (provision) benefit:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_iN_pn3n3_di_maDITEBzGRA_zPXuvLKDRKsa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(57&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_pn3n3_di_maDITEBzGRA_zxHSDpKfudGg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;State and local&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(77&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;155&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredIncomeTaxExpenseBenefit_iNT_pn3n3_di_maITEBzavD_mtDITEBzGRA_maOTEBzTPw_zyIkaH8oJeDc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;Total deferred tax (provision) benefit&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(134&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,140&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iNT_pn3n3_di_mtOTEBzTPw_zp500xwh83S" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total income tax (provision) benefit&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(222&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,063&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_8A9_zLUTegjAUkt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ztTl5HtUJgW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of deferred tax assets and liabilities were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BD_zT2pwna5LL4g" style="display: none"&gt;Schedule of Components of Deferred Tax Assets and Liabilities&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20231231_znBJW5Og44Z1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20221231_zlVTQSX3TqH" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzAs8_z7fuwzQTwAah" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 64%; text-align: left"&gt;Net operating loss carryforwards&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;52,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;51,023&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pn3n3_maDTAGzAs8_zA0j0FMZH0A4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Interest limitation carryforward&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,444&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_iI_pn3n3_maDTAGzAs8_zlpBsrKm3E99" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Tax credit carryforwards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;264&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;264&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_iI_pn3n3_maDTAGzAs8_zTGa0ENod1Vk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Allowance for doubtful accounts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;388&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;757&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_iI_pn3n3_maDTAGzAs8_zT1mRYg7xvL9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Accrued expenses and other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;891&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,340&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--LeaseTermination_iI_pn3n3_maDTAGzAs8_zVEZ4UGK5Tzc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Lease termination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,017&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredTaxAssetsLiquidatingDamagesPayable_iI_pn3n3_maDTAGzAs8_zssmQy207hS5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Liquidated damages&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;794&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_pn3n3_maDTAGzAs8_ztMZUlzFsGql" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Unearned revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,148&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,744&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pn3n3_maDTAGzAs8_zdesa3BX48A5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,229&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,931&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DeferredTaxAssetsOperatingLeaseLiability_iI_pn3n3_maDTAGzAs8_zLH6m1yltgx1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Operating lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;58&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredTaxAssetsDepreciationAndAmortization_iI_pn3n3_maDTAGzAs8_znyngA1yTyN7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,146&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,706&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzAs8_maDTANzxgS_zYQ2APvNmCDb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;82,316&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;76,913&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzxgS_za38z5xoLyl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(76,367&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(65,406&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzxgS_maDTALNz54l_zwo4JkolOVDc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Total deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,949&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,507&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pn3n3_di_maDTLzOWA_zHE4CMkLB3T2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Acquisition-related intangibles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,548&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11,972&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxLiabilities_iNTI_pn3n3_di_mtDTLzOWA_msDTALNz54l_zgYFLmlwBfld" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,548&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11,972&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNTI_pn3n3_di_mtDTALNz54l_zKIpt2xb1Wne" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(599&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(465&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_z6OXf6EZELB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company must make judgements as to the realization of deferred tax assets that are dependent upon a variety of factors, including the
generation of future taxable income, the reversal of deferred tax liabilities, and tax planning strategies. To the extent that the Company
believes that recovery is not likely, it must establish a valuation allowance. A valuation allowance has been established for deferred
tax assets which the Company does not believe meet the &#x201c;more likely than not&#x201d; criteria. The Company&#x2019;s judgments regarding
future taxable income may change due to changes in market conditions, changes in tax laws, tax planning strategies or other factors.
If the Company&#x2019;s assumptions and consequently its estimates change in the future, the valuation allowances it has established may
be increased or decreased, resulting in a respective increase or decrease in income tax expense. Based upon the Company&#x2019;s historical
operating losses and the uncertainty of future taxable income, the Company has provided a valuation allowance primarily against its deferred
tax assets up to the deferred tax liabilities, except for deferred tax liabilities on indefinite lived intangible assets, as of December
31, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, the Company had federal, state, and local net operating loss carryforwards available of $&lt;span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zypOj2es3t21" title="Net operating loss carryforwards"&gt;193,801&lt;/span&gt;, $&lt;span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20231231__us-gaap--IncomeTaxAuthorityAxis__custom--StateMember_zeRdK5W1GFZ7" title="Net operating loss carryforwards"&gt;145,968&lt;/span&gt; and
$&lt;span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20231231__us-gaap--IncomeTaxAuthorityAxis__custom--LocalJurisdictionMember_ziiZMZ2vWA7h" title="Net operating loss carryforwards"&gt;53,002&lt;/span&gt; respectively, to offset future taxable income. Net operating losses for U.S. federal tax purposes of $&lt;span id="xdx_908_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20231231__us-gaap--IncomeTaxAuthorityAxis__custom--USFederalTaxMember_zpG51Ef0QGL2" title="Net operating loss"&gt;138,243&lt;/span&gt; do not expire (limited
to 80% of taxable income in a given year) and $&lt;span id="xdx_90C_ecustom--NetOperatingLossExpirationAmount_pn3n3_c20230101__20231231_zXfGBtQD5Ymd" title="Net operating losses expiration amount"&gt;55,558&lt;/span&gt; will expire, if not utilized, through 2037 in various amounts. As of December 31,
2022, the Company had federal, state, and local net operating loss carryforwards available of $&lt;span id="xdx_903_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z1Z0L0AKrnGf" title="Net operating loss carryforwards"&gt;190,070&lt;/span&gt;, $&lt;span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20221231__us-gaap--IncomeTaxAuthorityAxis__custom--StateMember_zRv5TY6Wp9m3" title="Net operating loss carryforwards"&gt;133,419&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20221231__us-gaap--IncomeTaxAuthorityAxis__custom--LocalJurisdictionMember_zxqZKsr9tXwk" title="Net operating loss carryforwards"&gt;51,503&lt;/span&gt;, respectively,
to offset future taxable income&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sections
382 and 383 of the Internal Revenue Code imposes restrictions on the use of a corporation&#x2019;s net operating losses, as well as certain
recognized built-in losses and other carryforwards, after an ownership change occurs. A section 382 ownership change occurs if one or
more stockholders or groups of stockholders who own at least 5% of the Company&#x2019;s common stock increase their ownership by more
than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Future issuances or sales of the
Company&#x2019;s common stock (including certain transactions involving the Company&#x2019;s common stock that are outside of the Company&#x2019;s
control) could also result in an ownership change under section 382. If an ownership change occurs, Section 382 would impose an annual
limit on the amount of pre-change net operating losses and other losses the Company can use to reduce its taxable income generally equal
to the product of the total value of the Company&#x2019;s outstanding equity immediately prior to the ownership change (subject to certain
adjustments) and the long-term tax exempt interest rate for the month of the ownership change.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company believes that it did have a change in control under these sections in connection with its recapitalization on November 4, 2016
and utilization of the carryforwards would be limited such that the majority of the carryforwards will never be available. Accordingly,
the Company has not recorded those net operating loss carryforwards and credit carryforwards in its deferred tax assets. The Company
completed a preliminary section 382 analysis as of December 31, 2023 and 2022 and concluded it may have experienced an ownership change
as a result of certain equity transactions during the rolling three-year period of 2021 to 2023. The Company concluded that its federal
net operating loss carryforwards, including any net operating loss carryforwards as a result of the mergers during 2018 and 2019, resulted
in annual limitations on the overall net operating loss carryforward and that an ownership change, if any, would impose an annual limit
on the net operating loss carryforwards and could cause federal income taxes (similar provisions apply for state and local income taxes)
to be paid earlier than otherwise would be paid if such limitations were not in effect. The federal, state, and local net operating loss
carryforwards are stated net of any such anticipated limitations as of December 31, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z3R2TC0j2jk5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
provision (benefit) for income taxes on the statements of operations differs from the amount computed by applying the statutory federal
income tax rate to loss before the benefit for income taxes, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B4_zrMosgqbD2J7" style="display: none"&gt;Schedule of Tax Benefit and Effective Income Tax&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Percent&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Percent&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Federal benefit expected at statutory rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_maABC_c20230101__20231231_zYcKZ9wqwXid" style="width: 12%; text-align: right" title="Federal benefit expected at statutory rate"&gt;(11,626&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maDEF_c20230101__20231231_zdcDf2HfnJmb" title="Federal benefit expected at statutory rate, percentage"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_maABC_c20220101__20221231_zq0T4YPWtUZk" style="width: 12%; text-align: right" title="Federal benefit expected at statutory rate"&gt;(14,375&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maDEF_c20220101__20221231_zxfBfTilVLz8" title="Federal benefit expected at statutory rate, percentage"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;State and local taxes, net of federal benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_maABC_c20230101__20231231_zF4sqVqLVLJb" style="text-align: right" title="State and local taxes, net of federal benefit"&gt;(2,526&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maDEF_c20230101__20231231_z4We90obneJe" title="State and local taxes, net of federal benefit, percentage"&gt;4.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_maABC_c20220101__20221231_zcd5PBPGBppc" style="text-align: right" title="State and local taxes, net of federal benefit"&gt;(3,429&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maDEF_c20220101__20221231_zPfrVpImLqbi" title="State and local taxes, net of federal benefit, percentage"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_maABC_c20230101__20231231_zCeZznCT0nxf" style="text-align: right" title="Stock-based compensation"&gt;3,472&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_maDEF_c20230101__20231231_zul7BhTmovs3" title="Stock-based compensation, percentage"&gt;-6.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_maABC_c20220101__20221231_zRHueoy8qPrj" style="text-align: right" title="Stock-based compensation"&gt;3,894&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_maDEF_c20220101__20221231_z4sjAtoOMpm6" title="Stock-based compensation, percentage"&gt;-5.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Unearned revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenue_pn3n3_maABC_c20230101__20231231_zLcAf9CooIAc" style="text-align: right" title="Unearned revenue"&gt;(562&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage_pid_dp_uPure_maDEF_c20230101__20231231_z9XTWk39r5Be" title="Unearned revenue percentage"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenue_pn3n3_maABC_c20220101__20221231_zoT5YCVvUiyi" style="text-align: right" title="Unearned revenue"&gt;(696&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage_pid_dp_uPure_maDEF_c20220101__20221231_zV8CHYMEE9Q2" title="Unearned revenue percentage"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpense_pn3n3_maABC_c20230101__20231231_zaEQ1aIqW4ma" style="text-align: right" title="Interest expense"&gt;62&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpensePercentage_pid_dp_uPure_maDEF_c20230101__20231231_zieWVxDyIBUa" title="Interest expense percentage"&gt;-0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpense_pn3n3_maABC_c20220101__20221231_zahXcV4gLeA4" style="text-align: right" title="Interest expense"&gt;56&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpensePercentage_pid_dp_uPure_maDEF_c20220101__20221231_zVt6UnuYyYCl" title="Interest expense percentage"&gt;-0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Gain upon debt extinguishment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment_pn3n3_maABC_c20230101__20231231_ztrbDGN5pZ3k" style="text-align: right" title="Gain upon debt extinguishment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3078"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage_pid_dp_uPure_maDEF_c20230101__20231231_zOW4KfX73CMk" title="Gain upon debt extinguishment percentage"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment_pn3n3_maABC_c20220101__20221231_zuCUM6gET4Sf" style="text-align: right" title="Gain upon debt extinguishment"&gt;(760&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage_pid_dp_uPure_maDEF_c20220101__20221231_z8T4PXGTY8i2" title="Gain upon debt extinguishment percentage"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other differences, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pn3n3_maABC_c20230101__20231231_z91PVqepRv34" style="text-align: right" title="Other differences, net"&gt;678&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maDEF_c20230101__20231231_zOe6P2h0ysWj" title="Other differences, net percentage"&gt;-1.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pn3n3_maABC_c20220101__20221231_zxvqTufnLFo4" style="text-align: right" title="Other differences, net"&gt;(997&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maDEF_c20220101__20221231_zm3mp98Oi9B4" title="Other differences, net percentage"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_maABC_c20230101__20231231_zw3bz20nJuNi" style="text-align: right" title="Valuation allowance"&gt;10,961&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maDEF_c20230101__20231231_zSHiRkDePcgk" title="Valuation allowance percentage"&gt;-19.8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_maABC_c20220101__20221231_zFjqdX2nH2Xk" style="text-align: right" title="Valuation allowance"&gt;14,959&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maDEF_c20220101__20221231_zccpwDF5W146" title="Valuation allowance percentage"&gt;-21.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other permanent differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_pn3n3_maABC_c20230101__20231231_zgzNRO5F0zwh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other permanent differences"&gt;(237&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_maDEF_c20230101__20231231_zF2El0cOWnY2" title="Other permanent differences percentage"&gt;0.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_pn3n3_maABC_c20220101__20221231_zS6k4kCrh7i4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other permanent differences"&gt;285&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_maDEF_c20220101__20221231_zx8ZIXsOxCYc" title="Other permanent differences percentage"&gt;-0.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Income tax provision (benefit) and effective income tax rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_mtABC_c20230101__20231231_zElUn0Rgf3hd" style="border-bottom: Black 2.5pt double; text-align: right" title="Income tax benefit and effective income tax rate"&gt;222&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_mtDEF_c20230101__20231231_zEoPqHXa8xq4" title="Income tax benefit and effective income tax rate, percentage"&gt;-0.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_mtABC_c20220101__20221231_zgKibdO2kzq2" style="border-bottom: Black 2.5pt double; text-align: right" title="Income tax benefit and effective income tax rate"&gt;(1,063&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_mtDEF_c20220101__20221231_zsxInu9KDHv7" title="Income tax benefit and effective income tax rate, percentage"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zoxiihU6jSjf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes the tax benefit from uncertain tax positions only if it is &#x201c;more likely than not&#x201d; that the tax positions
will be sustained on examination by the tax authorities, based on the technical merits of the position. The tax benefit is measured based
on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The Company recognizes interest
and penalties related to income tax matters in income tax expense. The Company is also required to assess at each reporting date whether
it is reasonably possible that any significant increases or decreases to its unrecognized tax benefits will occur during the next 12
months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company did not recognize any uncertain tax position, or any accrued interest and penalties associated with uncertain tax positions for
the years ended December 31, 2023 and 2022. The Company files tax returns in the U.S. federal jurisdiction and New York, California,
and other states. The Company is generally subject to examination by income tax authorities for three years from the filing of a tax
return, therefore, the federal and certain state returns from 2020 forward and the California returns from 2019 forward are subject to
examination. The Company currently is under examination by a state tax authority.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002944">&lt;p id="xdx_894_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zh5bOd87Uomb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of the (provision) benefit for income taxes consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B4_zJxUib8MGzf" style="display: none"&gt;Schedule of Income Taxes&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230101__20231231_zo2q3k3R6nF1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220101__20221231_zDAfweOglcij" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Current tax (provision) benefit:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_maCFSALzf1Y_zzi04Day80Ke" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2946"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2947"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pn3n3_maCFSALzf1Y_zQzMzV1Bz3w1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left; padding-bottom: 1.5pt"&gt;State and local&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"&gt;(88&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"&gt;(77&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_iT_pn3n3_mtCFSALzf1Y_maITEBzavD_maOTEBzTPw_zKfHARmqo5cb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;Total current tax (provision) benefit&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(88&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(77&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax (provision) benefit:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_iN_pn3n3_di_maDITEBzGRA_zPXuvLKDRKsa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(57&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_pn3n3_di_maDITEBzGRA_zxHSDpKfudGg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;State and local&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(77&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;155&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredIncomeTaxExpenseBenefit_iNT_pn3n3_di_maITEBzavD_mtDITEBzGRA_maOTEBzTPw_zyIkaH8oJeDc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;Total deferred tax (provision) benefit&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(134&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,140&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iNT_pn3n3_di_mtOTEBzTPw_zp500xwh83S" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total income tax (provision) benefit&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(222&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,063&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002949"
      unitRef="USD">-88000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002950"
      unitRef="USD">-77000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002952"
      unitRef="USD">-88000</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002953"
      unitRef="USD">-77000</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002955"
      unitRef="USD">57000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002956"
      unitRef="USD">-985000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002958"
      unitRef="USD">77000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002959"
      unitRef="USD">-155000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002961"
      unitRef="USD">134000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002962"
      unitRef="USD">-1140000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002964"
      unitRef="USD">222000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002965"
      unitRef="USD">-1063000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002967">&lt;p id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ztTl5HtUJgW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of deferred tax assets and liabilities were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BD_zT2pwna5LL4g" style="display: none"&gt;Schedule of Components of Deferred Tax Assets and Liabilities&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20231231_znBJW5Og44Z1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20221231_zlVTQSX3TqH" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzAs8_z7fuwzQTwAah" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 64%; text-align: left"&gt;Net operating loss carryforwards&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;52,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;51,023&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pn3n3_maDTAGzAs8_zA0j0FMZH0A4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Interest limitation carryforward&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,444&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_iI_pn3n3_maDTAGzAs8_zlpBsrKm3E99" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Tax credit carryforwards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;264&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;264&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_iI_pn3n3_maDTAGzAs8_zTGa0ENod1Vk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Allowance for doubtful accounts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;388&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;757&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_iI_pn3n3_maDTAGzAs8_zT1mRYg7xvL9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Accrued expenses and other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;891&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,340&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--LeaseTermination_iI_pn3n3_maDTAGzAs8_zVEZ4UGK5Tzc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Lease termination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,017&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredTaxAssetsLiquidatingDamagesPayable_iI_pn3n3_maDTAGzAs8_zssmQy207hS5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Liquidated damages&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;794&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsDeferredIncome_iI_pn3n3_maDTAGzAs8_ztMZUlzFsGql" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Unearned revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,148&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,744&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pn3n3_maDTAGzAs8_zdesa3BX48A5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,229&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,931&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DeferredTaxAssetsOperatingLeaseLiability_iI_pn3n3_maDTAGzAs8_zLH6m1yltgx1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Operating lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;58&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredTaxAssetsDepreciationAndAmortization_iI_pn3n3_maDTAGzAs8_znyngA1yTyN7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,146&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,706&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzAs8_maDTANzxgS_zYQ2APvNmCDb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;82,316&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;76,913&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzxgS_za38z5xoLyl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(76,367&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(65,406&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzxgS_maDTALNz54l_zwo4JkolOVDc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Total deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,949&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,507&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pn3n3_di_maDTLzOWA_zHE4CMkLB3T2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Acquisition-related intangibles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,548&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11,972&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxLiabilities_iNTI_pn3n3_di_mtDTLzOWA_msDTALNz54l_zgYFLmlwBfld" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,548&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11,972&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNTI_pn3n3_di_mtDTALNz54l_zKIpt2xb1Wne" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(599&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(465&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002969"
      unitRef="USD">52353000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002970"
      unitRef="USD">51023000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetInterestCarryforward
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002972"
      unitRef="USD">10028000</us-gaap:DeferredTaxAssetInterestCarryforward>
    <us-gaap:DeferredTaxAssetInterestCarryforward
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002973"
      unitRef="USD">5444000</us-gaap:DeferredTaxAssetInterestCarryforward>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002975"
      unitRef="USD">264000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002976"
      unitRef="USD">264000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002978"
      unitRef="USD">388000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002979"
      unitRef="USD">757000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002981"
      unitRef="USD">891000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002982"
      unitRef="USD">1340000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <AREN:LeaseTermination
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002984"
      unitRef="USD">1017000</AREN:LeaseTermination>
    <AREN:LeaseTermination
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002985"
      unitRef="USD">1869000</AREN:LeaseTermination>
    <AREN:DeferredTaxAssetsLiquidatingDamagesPayable
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002987"
      unitRef="USD">794000</AREN:DeferredTaxAssetsLiquidatingDamagesPayable>
    <AREN:DeferredTaxAssetsLiquidatingDamagesPayable
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002988"
      unitRef="USD">1717000</AREN:DeferredTaxAssetsLiquidatingDamagesPayable>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002990"
      unitRef="USD">5148000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002991"
      unitRef="USD">3744000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002993"
      unitRef="USD">7229000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002994"
      unitRef="USD">6931000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <AREN:DeferredTaxAssetsOperatingLeaseLiability
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002996"
      unitRef="USD">58000</AREN:DeferredTaxAssetsOperatingLeaseLiability>
    <AREN:DeferredTaxAssetsOperatingLeaseLiability
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002997"
      unitRef="USD">118000</AREN:DeferredTaxAssetsOperatingLeaseLiability>
    <AREN:DeferredTaxAssetsDepreciationAndAmortization
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002999"
      unitRef="USD">4146000</AREN:DeferredTaxAssetsDepreciationAndAmortization>
    <AREN:DeferredTaxAssetsDepreciationAndAmortization
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003000"
      unitRef="USD">3706000</AREN:DeferredTaxAssetsDepreciationAndAmortization>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003002"
      unitRef="USD">82316000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003003"
      unitRef="USD">76913000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003005"
      unitRef="USD">76367000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003006"
      unitRef="USD">65406000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003008"
      unitRef="USD">5949000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003009"
      unitRef="USD">11507000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003011"
      unitRef="USD">6548000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003012"
      unitRef="USD">11972000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003014"
      unitRef="USD">6548000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003015"
      unitRef="USD">11972000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003017"
      unitRef="USD">599000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003018"
      unitRef="USD">465000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-12-31_us-gaap_DomesticCountryMember"
      decimals="-3"
      id="Fact003020"
      unitRef="USD">193801000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-12-31_custom_StateMember"
      decimals="-3"
      id="Fact003022"
      unitRef="USD">145968000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-12-31_custom_LocalJurisdictionMember"
      decimals="-3"
      id="Fact003024"
      unitRef="USD">53002000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-12-31_custom_USFederalTaxMember"
      decimals="-3"
      id="Fact003026"
      unitRef="USD">138243000</us-gaap:OperatingLossCarryforwards>
    <AREN:NetOperatingLossExpirationAmount
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003028"
      unitRef="USD">55558000</AREN:NetOperatingLossExpirationAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2022-12-31_us-gaap_DomesticCountryMember"
      decimals="-3"
      id="Fact003030"
      unitRef="USD">190070000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2022-12-31_custom_StateMember"
      decimals="-3"
      id="Fact003032"
      unitRef="USD">133419000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2022-12-31_custom_LocalJurisdictionMember"
      decimals="-3"
      id="Fact003034"
      unitRef="USD">51503000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact003036">&lt;p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z3R2TC0j2jk5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
provision (benefit) for income taxes on the statements of operations differs from the amount computed by applying the statutory federal
income tax rate to loss before the benefit for income taxes, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B4_zrMosgqbD2J7" style="display: none"&gt;Schedule of Tax Benefit and Effective Income Tax&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Percent&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Percent&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Federal benefit expected at statutory rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_maABC_c20230101__20231231_zYcKZ9wqwXid" style="width: 12%; text-align: right" title="Federal benefit expected at statutory rate"&gt;(11,626&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maDEF_c20230101__20231231_zdcDf2HfnJmb" title="Federal benefit expected at statutory rate, percentage"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pn3n3_maABC_c20220101__20221231_zq0T4YPWtUZk" style="width: 12%; text-align: right" title="Federal benefit expected at statutory rate"&gt;(14,375&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maDEF_c20220101__20221231_zxfBfTilVLz8" title="Federal benefit expected at statutory rate, percentage"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;State and local taxes, net of federal benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_maABC_c20230101__20231231_zF4sqVqLVLJb" style="text-align: right" title="State and local taxes, net of federal benefit"&gt;(2,526&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maDEF_c20230101__20231231_z4We90obneJe" title="State and local taxes, net of federal benefit, percentage"&gt;4.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_maABC_c20220101__20221231_zcd5PBPGBppc" style="text-align: right" title="State and local taxes, net of federal benefit"&gt;(3,429&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maDEF_c20220101__20221231_zPfrVpImLqbi" title="State and local taxes, net of federal benefit, percentage"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_maABC_c20230101__20231231_zCeZznCT0nxf" style="text-align: right" title="Stock-based compensation"&gt;3,472&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_maDEF_c20230101__20231231_zul7BhTmovs3" title="Stock-based compensation, percentage"&gt;-6.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_maABC_c20220101__20221231_zRHueoy8qPrj" style="text-align: right" title="Stock-based compensation"&gt;3,894&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_maDEF_c20220101__20221231_z4sjAtoOMpm6" title="Stock-based compensation, percentage"&gt;-5.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Unearned revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenue_pn3n3_maABC_c20230101__20231231_zLcAf9CooIAc" style="text-align: right" title="Unearned revenue"&gt;(562&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage_pid_dp_uPure_maDEF_c20230101__20231231_z9XTWk39r5Be" title="Unearned revenue percentage"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenue_pn3n3_maABC_c20220101__20221231_zoT5YCVvUiyi" style="text-align: right" title="Unearned revenue"&gt;(696&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage_pid_dp_uPure_maDEF_c20220101__20221231_zV8CHYMEE9Q2" title="Unearned revenue percentage"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpense_pn3n3_maABC_c20230101__20231231_zaEQ1aIqW4ma" style="text-align: right" title="Interest expense"&gt;62&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpensePercentage_pid_dp_uPure_maDEF_c20230101__20231231_zieWVxDyIBUa" title="Interest expense percentage"&gt;-0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpense_pn3n3_maABC_c20220101__20221231_zahXcV4gLeA4" style="text-align: right" title="Interest expense"&gt;56&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--EffectiveIncomeTaxRateReconciliationInterestExpensePercentage_pid_dp_uPure_maDEF_c20220101__20221231_zVt6UnuYyYCl" title="Interest expense percentage"&gt;-0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Gain upon debt extinguishment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment_pn3n3_maABC_c20230101__20231231_ztrbDGN5pZ3k" style="text-align: right" title="Gain upon debt extinguishment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3078"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage_pid_dp_uPure_maDEF_c20230101__20231231_zOW4KfX73CMk" title="Gain upon debt extinguishment percentage"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment_pn3n3_maABC_c20220101__20221231_zuCUM6gET4Sf" style="text-align: right" title="Gain upon debt extinguishment"&gt;(760&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage_pid_dp_uPure_maDEF_c20220101__20221231_z8T4PXGTY8i2" title="Gain upon debt extinguishment percentage"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other differences, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pn3n3_maABC_c20230101__20231231_z91PVqepRv34" style="text-align: right" title="Other differences, net"&gt;678&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maDEF_c20230101__20231231_zOe6P2h0ysWj" title="Other differences, net percentage"&gt;-1.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pn3n3_maABC_c20220101__20221231_zxvqTufnLFo4" style="text-align: right" title="Other differences, net"&gt;(997&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maDEF_c20220101__20221231_zm3mp98Oi9B4" title="Other differences, net percentage"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_maABC_c20230101__20231231_zw3bz20nJuNi" style="text-align: right" title="Valuation allowance"&gt;10,961&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maDEF_c20230101__20231231_zSHiRkDePcgk" title="Valuation allowance percentage"&gt;-19.8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_maABC_c20220101__20221231_zFjqdX2nH2Xk" style="text-align: right" title="Valuation allowance"&gt;14,959&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maDEF_c20220101__20221231_zccpwDF5W146" title="Valuation allowance percentage"&gt;-21.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other permanent differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_pn3n3_maABC_c20230101__20231231_zgzNRO5F0zwh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other permanent differences"&gt;(237&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_maDEF_c20230101__20231231_zF2El0cOWnY2" title="Other permanent differences percentage"&gt;0.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_pn3n3_maABC_c20220101__20221231_zS6k4kCrh7i4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other permanent differences"&gt;285&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_maDEF_c20220101__20221231_zx8ZIXsOxCYc" title="Other permanent differences percentage"&gt;-0.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Income tax provision (benefit) and effective income tax rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_mtABC_c20230101__20231231_zElUn0Rgf3hd" style="border-bottom: Black 2.5pt double; text-align: right" title="Income tax benefit and effective income tax rate"&gt;222&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_mtDEF_c20230101__20231231_zEoPqHXa8xq4" title="Income tax benefit and effective income tax rate, percentage"&gt;-0.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_mtABC_c20220101__20221231_zgKibdO2kzq2" style="border-bottom: Black 2.5pt double; text-align: right" title="Income tax benefit and effective income tax rate"&gt;(1,063&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_mtDEF_c20220101__20221231_zsxInu9KDHv7" title="Income tax benefit and effective income tax rate, percentage"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003038"
      unitRef="USD">-11626000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact003040"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003042"
      unitRef="USD">-14375000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact003044"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003046"
      unitRef="USD">-2526000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact003048"
      unitRef="Pure">0.046</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003050"
      unitRef="USD">-3429000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact003052"
      unitRef="Pure">0.050</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003054"
      unitRef="USD">3472000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact003056"
      unitRef="Pure">-0.063</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003058"
      unitRef="USD">3894000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact003060"
      unitRef="Pure">-0.057</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <AREN:EffectiveIncomeTaxRateReconciliationUnearnedRevenue
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003062"
      unitRef="USD">-562000</AREN:EffectiveIncomeTaxRateReconciliationUnearnedRevenue>
    <AREN:EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact003064"
      unitRef="Pure">0.010</AREN:EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage>
    <AREN:EffectiveIncomeTaxRateReconciliationUnearnedRevenue
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003066"
      unitRef="USD">-696000</AREN:EffectiveIncomeTaxRateReconciliationUnearnedRevenue>
    <AREN:EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact003068"
      unitRef="Pure">0.010</AREN:EffectiveIncomeTaxRateReconciliationUnearnedRevenuePercentage>
    <AREN:EffectiveIncomeTaxRateReconciliationInterestExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003070"
      unitRef="USD">62000</AREN:EffectiveIncomeTaxRateReconciliationInterestExpense>
    <AREN:EffectiveIncomeTaxRateReconciliationInterestExpensePercentage
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact003072"
      unitRef="Pure">-0.001</AREN:EffectiveIncomeTaxRateReconciliationInterestExpensePercentage>
    <AREN:EffectiveIncomeTaxRateReconciliationInterestExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003074"
      unitRef="USD">56000</AREN:EffectiveIncomeTaxRateReconciliationInterestExpense>
    <AREN:EffectiveIncomeTaxRateReconciliationInterestExpensePercentage
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact003076"
      unitRef="Pure">-0.001</AREN:EffectiveIncomeTaxRateReconciliationInterestExpensePercentage>
    <AREN:EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact003080"
      unitRef="Pure">0.000</AREN:EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage>
    <AREN:EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003082"
      unitRef="USD">-760000</AREN:EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishment>
    <AREN:EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact003084"
      unitRef="Pure">0.000</AREN:EffectiveIncomeTaxRateReconciliationGainOnDebtExtinguishmentPercentage>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003086"
      unitRef="USD">678000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact003088"
      unitRef="Pure">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003090"
      unitRef="USD">-997000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact003092"
      unitRef="Pure">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003094"
      unitRef="USD">10961000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact003096"
      unitRef="Pure">-0.198</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003098"
      unitRef="USD">14959000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact003100"
      unitRef="Pure">-0.219</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003102"
      unitRef="USD">-237000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact003104"
      unitRef="Pure">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003106"
      unitRef="USD">285000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact003108"
      unitRef="Pure">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003110"
      unitRef="USD">222000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact003112"
      unitRef="Pure">-0.004</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003114"
      unitRef="USD">-1063000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact003116"
      unitRef="Pure">0.016</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact003118">&lt;p id="xdx_802_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zMDJZ7PE2awe" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;25.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_826_zvBSHxR64tJ5"&gt;Pension Plans&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has a qualified 401(k) defined contribution plan that allows eligible employees of the Company to participate in the plan, subject
to limitations. &lt;span id="xdx_901_eus-gaap--DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_c20230101__20231231_zROCOlyM4ys6" title="Pension plan, description"&gt;The plan allows for discretionary matching contributions by the Company, up to 4% of eligible annual compensation made
by participants of the plan&lt;/span&gt;. The Company contributions to the plan were $&lt;span id="xdx_903_eus-gaap--MultiemployerPlanPensionSignificantPlanContribution_pn3n3_c20230101__20231231_zLwy8xk529Cg" title="Contribution to plan"&gt;2,125&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--MultiemployerPlanPensionSignificantPlanContribution_pn3n3_c20220101__20221231_zSIlOFDreld" title="Contribution to plan"&gt;1,808&lt;/span&gt; for the years ended December 31, 2023 and 2022,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans contextRef="From2023-01-01to2023-12-31" id="Fact003120">The plan allows for discretionary matching contributions by the Company, up to 4% of eligible annual compensation made
by participants of the plan</us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans>
    <us-gaap:MultiemployerPlanPensionSignificantPlanContribution
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003122"
      unitRef="USD">2125000</us-gaap:MultiemployerPlanPensionSignificantPlanContribution>
    <us-gaap:MultiemployerPlanPensionSignificantPlanContribution
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003124"
      unitRef="USD">1808000</us-gaap:MultiemployerPlanPensionSignificantPlanContribution>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact003126">&lt;p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zdTu4q7zShOj" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;26.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_827_zBqRMTcZo3R5"&gt;Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Principal
Stockholders&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has an outstanding obligation with Renew, an affiliated entity of Simplify, where Renew purchased the all the outstanding
debt held by BRF Finance Co., LLC (&#x201c;BRF&#x201d;) an affiliated entity of B. Riley Financial, Inc. (&#x201c;B. Riley&#x201d;) (as
further described below), who now holds the debt in its capacity as agent for the purchasers and as purchaser, pursuant to the third
amended and restated note purchase agreement entered into on December 15, 2022 (the &#x201c;Note Purchase Agreement&#x201d;), as
amended by the first amendment to the Note Purchase Agreement on August 14, 2023 (the &#x201c;First Amendment&#x201d;) with an
effective date of August 31, 2023, as further amended by the second amendment to the Note Purchase Agreement on December 1, 2023
(the &#x201c;Second Amendment&#x201d;). The Note Purchase Agreement contains provisions related to the 2023 Notes, Senior Secured
Notes, Delayed Draw Term Notes and 2022 Bridge Notes, all as further described above and referred to as the &#x201c;Notes&#x201d;. Under the terms of the
Note Purchase Agreement, First Amendment and Second Amendment, in the event there is a mandatory prepayment requirement, the
principal payment of the Notes will be applied to: &lt;span id="xdx_907_eus-gaap--DebtInstrumentDescription_c20230101__20231231_zy1ifPNug1G7" title="Note purchase agreement description"&gt;(1)
the 2023 Notes until paid in full; (2) then to the 2022 Bridge Notes until paid in full; (3) then to the Delayed Draw Terms Notes
until paid in full; and (4) then to the Senior Secured Notes. All borrowings under the Notes are collateralized by substantially all
assets of the Company secured by liens and guaranteed by the Company&#x2019;s subsidiaries. The Notes provide for a default interest
rate equal to the rate of interest in effect at the time of default plus 4.0%, along with other provision for acceleration of the
Notes under certain conditions. The Notes provide for certain affirmative covenants, including certain financial reporting
obligations.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 30, 2023, Simplify entered into a stock purchase and assignment agreement (the &#x201c;Stock Purchase Agreement&#x201d;),
pursuant to which it purchased an aggregate of &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20231201__20231201__us-gaap--DebtInstrumentAxis__custom--BRileyFBRIncMember_z7sYFkHR9iY3" title="Debt instrument face amount"&gt;10,512,236&lt;/span&gt;
shares of the Company&#x2019;s common stock for aggregate consideration of $&lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_c20231201__20231201__us-gaap--DebtInstrumentAxis__custom--BRileyFBRIncMember_zANbzlCwBWB1" title="Debt instrument face amount"&gt;30,485&lt;/span&gt;
on December 1, 2023 from B. Riley and other affiliated entities of B. Riley and certain other sellers (collectively the &#x201c;Sellers&#x201d;),
resulting in Simplify becoming a principal stockholder and the Sellers no longer owning any of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 30, 2023, Renew, an affiliated entity of Simplify and a principal stockholder, and BRF, an affiliate of the Sellers, entered into a securities purchase
and assignment agreement (the &#x201c;Debt Purchase Agreement&#x201d;), pursuant to which BRF sold and assigned to Renew all of BRF&#x2019;s
rights, duties, liabilities and obligations pursuant to the Note Purchase Agreement, as amended, and the Notes purchased thereunder and
the collateral securing such Notes on December 1, 2023 (further details are provided under the heading &lt;i&gt;Arena Loan Agreement
&lt;/i&gt;in Note 28), resulting in BRF no longer holding any debt securities of the Company. The aggregate principal balance under the Notes was $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231231_z5WXmH88GNH8" title="Aggregate principal amount"&gt;110,691&lt;/span&gt; at the time of purchase by Renew.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of November 30, 2023, Daniel Shribman, Chief Investment Officer of BRF, and Todd Sims, President of B. Riley Venture Capital, a subsidiary
of BRF, resigned as members of the Board of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the years ended December 31, 2023 and 2022, the Company paid in cash interest of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zSJbgXl5E6Y" title="Paid in cash"&gt;9,068&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BRileyMember_zeHi1PBZOkIe" title="Paid in cash"&gt;7,132&lt;/span&gt;, respectively, on the Notes due to
BRF, an affiliated of B. Riley, a former principal stockholder.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the year ended December 31, 2023, the Company incurred interest of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zFblG6JHQUY5" title="Interest on notes"&gt;2,797&lt;/span&gt; for the period from October 1, 2023 to December 31, 2023 on
the Notes held by Renew, an affiliated entity of Simplify, a principal stockholder, where the Company defaulted on the payment of $&lt;span id="xdx_906_ecustom--DebtInstrumentIncreaseAccruedInterestAmountDue_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zYxCbzh4RSMc" title="Interest on notes"&gt;2,797&lt;/span&gt;
interest due on December 29, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 31, 2023, in connection with the registered direct offering, the Company entered into common stock purchase agreements for &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__srt--TitleOfIndividualAxis__custom--BRileyMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__custom--DirectOfferingMember_zG4ZGy5plwta"&gt;1,009,021&lt;/span&gt;
shares of the Company&#x2019;s common stock for a total of $&lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__srt--TitleOfIndividualAxis__custom--BRileyMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__custom--DirectOfferingMember_z2UWVIOzITj"&gt;3,915&lt;/span&gt; in gross proceeds with B. Riley, a former principal stockholder, at
a price per share of $&lt;span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230331__us-gaap--SubsidiarySaleOfStockAxis__custom--DirectOfferingMember__srt--TitleOfIndividualAxis__custom--BRileyMember_z2A3nKywT5kg" title="Sale of stock, price per share"&gt;3.88&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 10, 2023, the Series H Preferred Stock automatically converted into shares of the Company&#x2019;s common stock at the conversion
price of $&lt;span id="xdx_902_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_c20230810__srt--TitleOfIndividualAxis__custom--BRileyMember__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zhr9WZ3BO6Cl" title="Preferred Stock issued onversion price"&gt;7.26&lt;/span&gt; per share, of which &lt;span id="xdx_906_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_pid_c20230810__srt--TitleOfIndividualAxis__custom--BRileyMember__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zzh8bJxsd3s6" title="Preferred Stock issued upon conversion"&gt;134,550&lt;/span&gt; shares were issued to B. Riley, a former principal stockholder.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 31, 2023, September 29, 2023 and November 27, 2023, in connection with the 2023 Notes, BRF, an affiliated entity of B. Riley,
a former principal stockholder, issued $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20230831__srt--TitleOfIndividualAxis__custom--BRileyMember_zarAdcUjAFKg" title="Aggregate principal amount"&gt;5,000&lt;/span&gt;, $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20230929__srt--TitleOfIndividualAxis__custom--BRileyMember_zE2KUQFSh21b" title="Aggregate principal amount"&gt;1,000&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231127__srt--TitleOfIndividualAxis__custom--BRileyMember_zJnXdt5OeP17" title="Aggregate principal amount"&gt;2,000&lt;/span&gt;, respectively, in aggregate principal amount under the 2023 Note, where
the Company incurred fees of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentFeeAmount_iI_pn3n3_c20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_z3EgDpVko6F4" title="Fee incurred"&gt;357&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into transactions with B. Riley, a former principal stockholder, where it borrowed funds under the 2022 Bridge Notes
of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231231__dei--LegalEntityAxis__custom--BRileyFinancialIncMember_zCccLpvi4P9j" title="Face amount"&gt;36,000&lt;/span&gt; during the year ended December 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the year ended December 31, 2022, the Company had certain transactions with B. Riley, a former principal stockholder, where it paid fees
associated with the common stock public offering totaling $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFeeAmount_iI_pn3n3_c20221231__srt--TitleOfIndividualAxis__custom--BRileyMember_z7xbHxEj0Pi7" title="Fee incurred"&gt;2,440&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Registered
Direct Offering&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 31, 2023, in connection with the registered direct offering, the Company entered into common stock purchase agreements for &lt;span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_zqJAabGivp98" title="Sale of stock, number of shares issued in transaction"&gt;317,518&lt;/span&gt;
shares of the Company&#x2019;s common stock for a total of $&lt;span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember_zi5GzaUcOLYh" title="Proceeds from issuance of private placement"&gt;1,232&lt;/span&gt; in gross proceeds with certain directors and affiliates, at a price
of $&lt;span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--PurchasersMember_zTDiC9ENBgVc" title="Per share"&gt;3.88&lt;/span&gt; per share, as follows: (i) &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HHuntAllredMember_zgdwa3orbRUi" title="Shares Issues"&gt;64,000&lt;/span&gt; shares for $&lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HHuntAllredMember_zVwRd0Vrgei7" title="Value"&gt;248&lt;/span&gt; to H. Hunt Allred, a director, through certain trusts (&lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__dei--LegalEntityAxis__custom--AllredTrustHHAMember_z6zM40T6LXTg" title="Shares issues"&gt;32,000&lt;/span&gt; shares are directly
beneficially owned by the Allred 2002 Trust - HHA and &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__dei--LegalEntityAxis__custom--AllredTrustNLAMember_zwuFiIfOmULf" title="Shares issues"&gt;32,000&lt;/span&gt; shares are directly beneficially owned by the by Allred 2002Trust - NLA);
(ii) &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneEightyDegreeCapitalCorpMember_zXIuYgqywgp5" title="Shares isssue"&gt;195,529&lt;/span&gt; shares for $&lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneEightyDegreeCapitalCorpMember_znHR2ih8ybra" title="Value"&gt;759&lt;/span&gt; to 180 Degree Capital Corp, a beneficial holder of more than 5% of the Company&#x2019;s common stock; (iii)
&lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DanielShribmanMember_z5ZXcQp0KL1l" title="Shares isssue"&gt;25,773&lt;/span&gt; shares for $&lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DanielShribmanMember_zBc8xfHlk13f" title="Value"&gt;100&lt;/span&gt; to Daniel Shribman, a former director; (iv) &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RossLevinsohnMember_zK5tR119aRr6" title="Shares isssue"&gt;25,773&lt;/span&gt; shares for $&lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RossLevinsohnMember_zY3UGNgNyTn8" title="Value"&gt;100&lt;/span&gt; to Ross Levinsohn, a former director and the
Company&#x2019;s former Chief Executive Officer; and (v) &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PaulEdmonsonMember_zEcbXl0nuWld" title="Shares isssue"&gt;6,443&lt;/span&gt; shares for $&lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230331__20230331__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PaulEdmonsonMember_zPcdEOpu6ol3" title="Value"&gt;25&lt;/span&gt; to Paul Edmonson, an executive officer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Repurchases
of Restricted Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 15, 2020, the Company entered into an amendment for certain restricted stock awards and units that were previously issued to
certain employees in connection with the HubPages merger, pursuant to which the Company agreed to repurchase from certain key personnel
of HubPages, Inc., including Paul Edmondson, one of the Company&#x2019;s officers, and his spouse, an aggregate of &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20201214__20201215__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zis7RhGTkB1g" title="Stock issued during period, shares, issued for services"&gt;764&lt;/span&gt; shares of the Company&#x2019;s
common stock at a price of $&lt;span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20201215__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_znhiR54eH0W7" title="Stock price"&gt;88.00&lt;/span&gt; per share each month for a period of 24 months, for aggregate proceeds to Mr. Edmondson and his spouse
of $&lt;span id="xdx_90C_ecustom--StockRepurchasedDuringPeriodValue1_iN_pn3n3_di_c20201214__20201215__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zaIRF2Tgy0n3" title="Proceeds from repurchase of restricted stock"&gt;67&lt;/span&gt; per month. For year ended December 31, 2022, the Company paid Mr. Edmonson and his spouse $&lt;span id="xdx_90F_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrEdmonsonMember_zn4PpH4Ck8Fg" title="Stock repurchase value"&gt;269&lt;/span&gt; for &lt;span id="xdx_90D_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrEdmonsonMember_zR2Z4vqHk3Y1" title="Number of shares repurchased"&gt;3,056&lt;/span&gt; shares of the Company&#x2019;s
common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:DebtInstrumentDescription contextRef="From2023-01-01to2023-12-31" id="Fact003128">(1)
the 2023 Notes until paid in full; (2) then to the 2022 Bridge Notes until paid in full; (3) then to the Delayed Draw Terms Notes
until paid in full; and (4) then to the Senior Secured Notes. All borrowings under the Notes are collateralized by substantially all
assets of the Company secured by liens and guaranteed by the Company&#x2019;s subsidiaries. The Notes provide for a default interest
rate equal to the rate of interest in effect at the time of default plus 4.0%, along with other provision for acceleration of the
Notes under certain conditions. The Notes provide for certain affirmative covenants, including certain financial reporting
obligations.</us-gaap:DebtInstrumentDescription>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-12-012023-12-01_custom_BRileyFBRIncMember"
      decimals="INF"
      id="Fact003130"
      unitRef="Shares">10512236</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-12-012023-12-01_custom_BRileyFBRIncMember"
      decimals="-3"
      id="Fact003132"
      unitRef="USD">30485000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003134"
      unitRef="USD">110691000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2023-01-012023-12-31_custom_BRileyMember"
      decimals="-3"
      id="Fact003136"
      unitRef="USD">9068000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2022-01-012022-12-31_custom_BRileyMember"
      decimals="-3"
      id="Fact003138"
      unitRef="USD">7132000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2023-01-012023-12-31_custom_BRileyMember"
      decimals="-3"
      id="Fact003140"
      unitRef="USD">2797000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <AREN:DebtInstrumentIncreaseAccruedInterestAmountDue
      contextRef="From2023-01-012023-12-31_custom_BRileyMember"
      decimals="-3"
      id="Fact003142"
      unitRef="USD">2797000</AREN:DebtInstrumentIncreaseAccruedInterestAmountDue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-03-312023-03-31_custom_BRileyMember_us-gaap_CommonStockMember_custom_DirectOfferingMember"
      decimals="INF"
      id="Fact003143"
      unitRef="Shares">1009021</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-03-312023-03-31_custom_BRileyMember_us-gaap_CommonStockMember_custom_DirectOfferingMember"
      decimals="-3"
      id="Fact003144"
      unitRef="USD">3915000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-03-31_custom_DirectOfferingMember_custom_BRileyMember"
      decimals="INF"
      id="Fact003146"
      unitRef="USDPShares">3.88</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="AsOf2023-08-10_custom_BRileyMember_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003148"
      unitRef="USDPShares">7.26</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="AsOf2023-08-10_custom_BRileyMember_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact003150"
      unitRef="Shares">134550</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-08-31_custom_BRileyMember"
      decimals="-3"
      id="Fact003152"
      unitRef="USD">5000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-09-29_custom_BRileyMember"
      decimals="-3"
      id="Fact003154"
      unitRef="USD">1000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-11-27_custom_BRileyMember"
      decimals="-3"
      id="Fact003156"
      unitRef="USD">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="AsOf2023-12-31_custom_BRileyMember"
      decimals="-3"
      id="Fact003158"
      unitRef="USD">357000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-31_custom_BRileyFinancialIncMember"
      decimals="-3"
      id="Fact003160"
      unitRef="USD">36000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="AsOf2022-12-31_custom_BRileyMember"
      decimals="-3"
      id="Fact003162"
      unitRef="USD">2440000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember"
      decimals="INF"
      id="Fact003164"
      unitRef="Shares">317518</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember"
      decimals="-3"
      id="Fact003166"
      unitRef="USD">1232000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-03-31_custom_StockPurchaseAgreementsMember_custom_PurchasersMember"
      decimals="INF"
      id="Fact003168"
      unitRef="USDPShares">3.88</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_HHuntAllredMember"
      decimals="INF"
      id="Fact003170"
      unitRef="Shares">64000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_HHuntAllredMember"
      decimals="-3"
      id="Fact003172"
      unitRef="USD">248000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_AllredTrustHHAMember"
      decimals="INF"
      id="Fact003174"
      unitRef="Shares">32000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_AllredTrustNLAMember"
      decimals="INF"
      id="Fact003176"
      unitRef="Shares">32000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_OneEightyDegreeCapitalCorpMember"
      decimals="INF"
      id="Fact003178"
      unitRef="Shares">195529</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_OneEightyDegreeCapitalCorpMember"
      decimals="-3"
      id="Fact003180"
      unitRef="USD">759000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_DanielShribmanMember"
      decimals="INF"
      id="Fact003182"
      unitRef="Shares">25773</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_DanielShribmanMember"
      decimals="-3"
      id="Fact003184"
      unitRef="USD">100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_RossLevinsohnMember"
      decimals="INF"
      id="Fact003186"
      unitRef="Shares">25773</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_RossLevinsohnMember"
      decimals="-3"
      id="Fact003188"
      unitRef="USD">100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_PaulEdmonsonMember"
      decimals="INF"
      id="Fact003190"
      unitRef="Shares">6443</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-03-312023-03-31_custom_StockPurchaseAgreementsMember_custom_PaulEdmonsonMember"
      decimals="-3"
      id="Fact003192"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2020-12-142020-12-15_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="Fact003194"
      unitRef="Shares">764</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2020-12-15_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="Fact003196"
      unitRef="USDPShares">88.00</us-gaap:SaleOfStockPricePerShare>
    <AREN:StockRepurchasedDuringPeriodValue1
      contextRef="From2020-12-142020-12-15_us-gaap_RestrictedStockMember"
      decimals="-3"
      id="Fact003198"
      unitRef="USD">-67000</AREN:StockRepurchasedDuringPeriodValue1>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_MrEdmonsonMember"
      decimals="-3"
      id="Fact003200"
      unitRef="USD">269000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember_custom_MrEdmonsonMember"
      decimals="INF"
      id="Fact003202"
      unitRef="Shares">3056</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact003204">&lt;p id="xdx_801_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zki80sJsEYb7" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;27.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_822_zp5LkMTFOgNl"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Claims
and Litigation&lt;/i&gt; &#x2013; From time to time, the Company may be subject to claims and litigation arising in the ordinary course of
business. The Company is not currently a party to any pending or threatened legal proceedings that it believes would reasonably be
expected to have a material adverse effect on the Company&#x2019;s business, financial condition, results of operations or cash
flows. Further information is provided under the heading &lt;i&gt;Legal Contingencies&lt;/i&gt; in Note 28.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Athlon working capital adjustment (as previously disclosed in Note 4), the Company prepared the working capital adjustment.
The sellers are challenging the Company&#x2019;s adjustments and both parties have agreed to a standstill and tolling agreement while
the adjustments are being reviewed and discussed. The amount due from this challenge, if any, is not estimatable as of the issuance date
of these consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Royalty
Fees&lt;/i&gt; &#x2013; The Company guaranteed minimum annual royalties of $&lt;span id="xdx_900_eus-gaap--RoyaltyExpense_pn3n3_c20230101__20231231__dei--LegalEntityAxis__custom--ABGSILLCMember__srt--RangeAxis__srt--MinimumMember_zh5Vw0XVo3G9" title="Royalty expense"&gt;15,000&lt;/span&gt; to ABG. The initial term of the minimum guarantee will expire
December 31, 2029. Further details are provided under the heading &lt;i&gt;Sports Illustrated Licensing Termination Rights&lt;/i&gt; in Note 28.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:RoyaltyExpense
      contextRef="From2023-01-012023-12-31_custom_ABGSILLCMember_srt_MinimumMember"
      decimals="-3"
      id="Fact003206"
      unitRef="USD">15000000</us-gaap:RoyaltyExpense>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact003208">&lt;p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zCp6Ol96Daj3" style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;28.&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"&gt;&lt;b&gt;&lt;span id="xdx_821_zxE2lYifSQ1i"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company performed an evaluation of subsequent events through the date of filing of these consolidated financial statements with the SEC.
Other than the below described subsequent events, there were no material subsequent events which affected, or could affect, the amounts
or disclosures on the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Arena Loan Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 5, 2024, as part of negotiations with Renew, in connection with the Company&#x2019;s failure on December 29, 2023 to make the
interest payment due on the Arena Loan Agreement, dated December 15, 2022 held by Renew (the &#x201c;Arena Notes&#x201d;) in the
amount of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20240105__us-gaap--TypeOfArrangementAxis__custom--ArenaLoanAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8YACdNPQPwd" title="Renew note"&gt;2,797&lt;/span&gt;,
that resulted in an event of default under the Arena Notes (the &#x201c;Arena Notes Default&#x201d;), Renew agreed in writing to a
forbearance period through March 29, 2024, subject to the Company retaining a chief restructuring officer acceptable to
Renew, while reserving its rights and remedies. The outstanding principal on the Arena Notes was $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20231231__us-gaap--TypeOfArrangementAxis__custom--ArenaLoanAgreementMember_zhycx2GbxmCi" title="Outstanding principal"&gt;110,691&lt;/span&gt;
as of December 31, 2023. In addition, while the Company continues discussions with Renew to restructure and/or amend the Arena
Notes, the Board engaged, and Renew accepted, FTI Consulting Inc., (&#x201c;FTI&#x201d;), a global business advisory firm, to assist
the Company with its turnaround plans and forge an expedited path to sustainable positive cash flow and earnings to create
shareholder value (the &#x201c;FTI Engagement&#x201d;). In connection with the FTI Engagement, Jason Frankl, a senior managing
director of FTI, was appointed as the Company&#x2019;s Chief Business Transformation Officer. He was later appointed as interim
President in addition to his role as the Company&#x2019;s Chief Business Transformation Officer, as referenced below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="color: #181717"&gt;On March 27, 2024, the
forbearance period was extended through the earlier of the following: (a) April 30, 2024&lt;/span&gt;&lt;span style="color: #393A39"&gt;; &lt;/span&gt;&lt;span style="color: #181717"&gt;(b)
the occurrence of the closing of the Business Combination (as further described below) and (c) the termination of the Business Combination
prior to closing.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Sports
Illustrated License Termination Rights&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 2, 2024, the Company failed to make a quarterly payment due to ABG, pursuant to the Licensing Agreement, of $&lt;span id="xdx_902_ecustom--ExerciseRightTerminationAmount_iI_pn3n3_c20240102__us-gaap--TypeOfArrangementAxis__custom--LicensingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zd8t0QYGd1sc" title="Exercise right termination amount"&gt;3,750&lt;/span&gt; (the &#x201c;ABG
Default&#x201d;). On January 3, 2024, ABG issued a notice of breach with the intent to exercise its right of termination. On January 18,
2024, ABG notified the Company of its intention to terminate the Licensing Agreement, effective immediately, in accordance with its rights
under the Licensing Agreement. Upon such termination, a fee of $&lt;span id="xdx_90B_ecustom--TerminationFeeDue_iI_pn3n3_c20240102__us-gaap--TypeOfArrangementAxis__custom--LicensingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyyqFH232IT4" title="Termination fee"&gt;45,000&lt;/span&gt; became immediately due and payable by the Company to ABG pursuant
to the terms and conditions of the Licensing Agreement. On March 18, 2024, ABG announced it had reached an agreement in principle with
a third party that will become the new operator of the Sports Illustrated media business. The Company is engaging in continuing discussions
with ABG regarding the timing and terms of the transition of the Sports Illustrated media business to this third party.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;ABG
Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 2, 2024, in connection with the ABG Default, the Performance-Based Warrants totaling &lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20240102__20240102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--ABGWarrantsMember_z244ZrEg9ee3" title="Performance based warrant vested"&gt;599,724&lt;/span&gt; vested as a result of the default
pursuant to certain provisions where all of the warrants automatically vest upon certain terminations of the Licensing Agreement by ABG.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Resignation
and Appointments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"&gt;On January 3, 2024, the Board appointed
Jason Frankl as Chief Business Transformation Officer of the Company, effective immediately, reporting directly to the Board.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 4, 2024, the Board accepted the resignation of Manoj Bhargava from his position as interim Chief Executive Officer effective
immediately.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 19, 2024, the Company accepted the resignation of Ross Levinsohn, the Company&#x2019;s former Chief Executive Officer and Chairman
of the Board.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 23, 2024, the Board appointed Jason Frankl as interim President of the Company, effective immediately, reporting directly to
the Board.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 23, 2024, the Board appointed Cavitt Randall as Chairman of the Board, effective immediately.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 9, 2024, the Board appointed Cavitt Randall as the Company&#x2019;s Chief Executive Officer, effective February 13, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 16, 2024, the Board appointed Manoj Bhargava as the Company&#x2019;s Co-President, effective immediately.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Business
Combination&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 9, 2024, New Arena Holdco, Inc. (&#x201c;New Arena&#x201d;), a wholly owned subsidiary of the Company, filed a Registration Statement
on Form S-4 (File No. 333-276999) with the SEC in connection with the Business Combination Agreement by and among the Company, Simplify,
Bridge Media Networks, LLC (&#x201c;Bridge Media&#x201d;), New Arena and the other parties dated November 5, 2023, as amended on December
1, 2023 (the &#x201c;Transaction Agreement&#x201d;), that provides for the Company to combine its operations with those of Bridge Media,
a wholly owned subsidiary of Simplify by way of a series of mergers with and among New Arena (the &#x201c;Mergers&#x201d;), subject to
customary conditions, including the approval by the Company&#x2019;s shareholders and certain regulatory approvals. Immediately following
the Mergers, the Transaction Agreement provides for: (i) the purchase by The Hans Foundation USA, a nonprofit nonstock corporation (the
&#x201c;Hans Foundation&#x201d;) of &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TransactionAgreementMember_z5IESXxle1Na" title="Shares issue"&gt;25,000&lt;/span&gt; shares of New Arena Series A Preferred Stock, par value $&lt;span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TransactionAgreementMember_zcg0cc7Vktg1" title="Preffered stock, par value"&gt;0.0001&lt;/span&gt; per share, at a purchase price
of $&lt;span id="xdx_905_eus-gaap--SharePrice_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TransactionAgreementMember_zFCMLhLLcusj" title="Purchase price"&gt;1,000.00&lt;/span&gt; per share, for an aggregate purchase price of $&lt;span id="xdx_90A_eus-gaap--BusinessCombinationPriceOfAcquisitionExpected_pn3n3_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TransactionAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zw9K8jlgjmmi" title="Aggregate purchase price"&gt;25,000&lt;/span&gt; (such amount, the &#x201c;Preferred Stock Financing Amount,&#x201d;
and such financing, the &#x201c;Preferred Stock Financing&#x201d;) pursuant to the subscription agreement, dated as of November 5, 2023
(the &#x201c;Preferred Stock Subscription Agreement&#x201d;), by and between New Arena and the Hans Foundation; and (ii) the purchase by
5-Hour International Corporation Pte. Ltd. (&#x201c;5-Hour&#x201d;) of &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1Zo1uOqRAL6" title="Shares issue"&gt;5,000,000&lt;/span&gt; shares of New Arena common stock, par value $&lt;span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zaY5Dc9i8Crc" title="Preffered stock, par value"&gt;0.0001&lt;/span&gt; per
share at a purchase price of $&lt;span id="xdx_903_eus-gaap--SharePrice_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zaXzcPfYg9L5" title="Purchase price"&gt;5.00&lt;/span&gt; per share, for an aggregate purchase price of $&lt;span id="xdx_908_eus-gaap--BusinessCombinationPriceOfAcquisitionExpected_pn3n3_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOOWzwDLpFI1" title="Aggregate purchase price"&gt;25,000&lt;/span&gt; (such amount, the &#x201c;Common Stock Financing
Amount,&#x201d; such financing, the &#x201c;Common Stock Financing&#x201d;) pursuant to the subscription agreement, dated as of November
5, 2023 (the &#x201c;Common Stock Subscription Agreement&#x201d;), by and between New Arena and 5-Hour. Further, concurrently with the
closing of the Mergers, pursuant to that certain Committed Equity Facility Term Sheet, dated November 5, 2023, by and between Arena and
Simplify (the &#x201c;Committed Equity Facility Term Sheet&#x201d;), New Arena will enter into a Stock Purchase Agreement (the &#x201c;Stock
Purchase Agreement&#x201d;) with Simplify, pursuant to which Simplify will agree to purchase, at New Arena&#x2019;s request, up to $&lt;span id="xdx_90B_eus-gaap--BusinessCombinationConsiderationTransferredOther1_pn3n3_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zvnd3cUhNVA9" title="Business combination, consideration amount"&gt;20,000&lt;/span&gt;
in aggregate purchase price of shares of New Arena common stock from time to time during the 12 months following the closing date at
a price per share equal to the lesser of (i) the volume-weighted average price of the New Arena common stock for the last sixty trading
days prior to the purchase date and (ii) $&lt;span id="xdx_905_eus-gaap--SharePrice_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zy52Sy7a5Po4" title="Purchase price"&gt;3.86&lt;/span&gt; per share (the &#x201c;Equity Line of Credit&#x201d;), along with New Arena &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zzkfCgDAZfd7" title="Shares issue"&gt;60,000&lt;/span&gt; shares
of New Arena&#x2019;s common stock as payment of a &lt;span id="xdx_904_eus-gaap--LineOfCreditFacilityCommitmentFeePercentage_pid_dp_uPure_c20240209__20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zfnQKM2Oioe3" title="Commitment fee percentage"&gt;1.5&lt;/span&gt;% commitment fee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Immediately
following the closing, (i) Simplify will own approximately &lt;span id="xdx_90C_ecustom--SharesOutstandingPercentage_iI_pid_dp_uPure_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_z7yzS6Narce5" title="Shares outstanding percentage"&gt;79&lt;/span&gt;% of the outstanding shares of New Arena common stock, par value $&lt;span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zEtyhgkaYSqg" title="Common stock, par value"&gt;0.0001&lt;/span&gt;
per share, on a fully diluted basis, (ii) 5-Hour will own approximately &lt;span id="xdx_909_ecustom--OutstandingPercentage_iI_pid_dp_uPure_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zh1rWJvNHiRi" title="Shares outstanding percentage"&gt;6&lt;/span&gt;% of the outstanding New Arena common stock and (iii) former
Arena stockholders will own the remaining outstanding New Arena common stock. Such amounts exclude the ownership of shares of New Arena
common stock that may be issued from time to time pursuant to the Equity Line of Credit. Following the closing, Arena common stock will
be delisted from the NYSE American and deregistered under the Securities Exchange Act of 1934, as amended, and cease to be publicly traded.
New Arena and its subsidiaries will operate under Arena&#x2019;s current name &#x201c;The Arena Group Holdings, Inc.&#x201d; The Company anticipates that New Arena
common stock will be traded on the NYSE American under Arena&#x2019;s current stock ticker symbol &#x201c;AREN.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock Private Placement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 14, 2024, the Company entered into a subscription agreement (the &#x201c;Subscription Agreement&#x201d;) with Simplify, pursuant
to which the Company agreed to sell and issue to Simplify in a private placement (the &#x201c;Private Placement&#x201d;) an aggregate of
&lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240214__20240214__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_ziMLSO5Ld51e" title="Aggregate shares"&gt;5,555,555&lt;/span&gt; shares (the &#x201c;Private Placement Shares&#x201d;) of the Company&#x2019;s common stock, par value $&lt;span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240214__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zd8ZU3NAdUth" title="Common stock, par value"&gt;0.01&lt;/span&gt; per share, at a purchase
price of $&lt;span id="xdx_90B_eus-gaap--SharePrice_iI_pid_c20240214__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zBIBDEknsrv6" title="Purchase price"&gt;2.16&lt;/span&gt; per share, a price equal to the 60-day volume weighted average price of the Company&#x2019;s common stock. The Private
Placement closed on February 14, 2024 and the Company received net proceeds from the Private Placement of approximately $&lt;span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn3n3_c20240214__20240214__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zHCvsDNbv2g" title="Net proceeds from the Private Placement"&gt;12,000&lt;/span&gt;. The
Company intends to use the net proceeds from the Private Placement for working capital and general corporate purposes. Prior to the consummation
of the Private Placement, the Company&#x2019;s public stockholders held a majority of the outstanding shares of the Company&#x2019;s common
stock. Following the issuance of the Private Placement Shares to Simplify, Simplify owns approximately &lt;span id="xdx_907_ecustom--SharesOutstandingPercentage_iI_pid_dp_uPure_c20240209__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zXIgK8DzCVb2" title="Shares outstanding percentage"&gt;54.5&lt;/span&gt;% of the outstanding shares
of the Company&#x2019;s common stock, resulting in a change in control. As a result, Simplify has the ability to determine the outcome of any issue submitted to the Company&#x2019;s
stockholders for approval, including the election of directors. The funds used by Simplify to purchase the Private Placement Shares came
from the working capital of Simplify.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Arena
Credit Agreement Default&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Arena Notes Default created an event of cross-default under the Arena Credit Agreement with SLR (the &#x201c;SLR Default&#x201d;), resulting
in SLR no longer providing for any additional funding under the debt, while paying down the debt with payments received from the
Company&#x2019;s customers in accordance with the terms of the agreement. The Company has refinanced the line of credit with a new
credit facility with Simplify (as described below under the heading &lt;i&gt;Simplify Loan&lt;/i&gt;). As of the issuance date of the
consolidated financial statements, there was no principal amount due under the Arena Credit Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fexy
Put Option&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 15, 2024, in connection with the contingent consideration related to the acquisition of Fexy Studios, the Company agreed to
pay the amount due of $&lt;span id="xdx_909_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_c20240215__20240215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zxZYW45Ejrfa" title="Total installment amount"&gt;2,478&lt;/span&gt; in four (4) equal installments of approximately $&lt;span id="xdx_908_ecustom--BusinessCombinationConsiderationTransferredInstallmentDue_pn3n3_c20240215__20240215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zV2Avm38N1Zh" title="Total installment amount"&gt;620&lt;/span&gt; starting February 16, 2024 and then on the 15th day
of each March, April and May of 2024 comprised of the following: &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20240215__20240215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--BusinessAcquisitionAxis__custom--FexyStudiosMember_zWy7inYuaea2" title="Flexy put option description"&gt;(i) $2,225 pursuant to the put option where the Company gave the recipients
of the contingent consideration a right to put their 274,692 shares of the Company&#x2019;s common stock; (ii) $200 deferred payment due
under the purchase agreement; and (iii) $53 in other costs and reimbursable transition expenses payable.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Simplify
Loan&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 13, 2024, the Company entered into a working capital loan with Simplify (the &#x201c;Simplify Loan&#x201d;), pursuant to which the Company has available up to
$&lt;span id="xdx_90E_ecustom--WorkingCapital_pn3n3_c20240313__20240314__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQYPZZVrE1B2" title="Working capital"&gt;25,000&lt;/span&gt; at &lt;span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240313__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SimplyfyLoanMember_zTgc3hEo0eP4" title="Interest rate"&gt;10&lt;/span&gt;%
interest rate per annum. The loan is secured by certain assets of the Company. On closing, the Company borrowed
$&lt;span id="xdx_904_eus-gaap--ShortTermBorrowings_iI_pn3n3_c20240313__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zF1RzXfaknqe" title="Company borrowed"&gt;7,748&lt;/span&gt;,
of which $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFeeAmount_iI_pn3n3_c20240313__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z6t0Du8zRQg" title="Outstanding loan balance"&gt;3,448&lt;/span&gt;
was used to repay the outstanding loan balance, accrued interest, certain fees and contingency reserves under the Arena Credit
Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Legal Contingencies&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 30, 2024, the former President&#160;of
Media filed an action against the Company and Manoj Bhargava, alleging claims for breach of contract, failure to pay wages and defamation, among
other things, in the United States District Court of the Southern District of New York, and seeking&#160;damages in an unspecified amount.
The Company believes that it has strong defenses to these claims and intends to vigorously defend itself and the allegations
made in this lawsuit.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 21, 2024, the former CEO and Chairman of
the Board filed an action against the Company, members of the Board of directors and Simplify, alleging claims for retaliation, breach
of contract, wrongful termination and age discrimination, among other things, in the Superior Court of the State of California seeking
damages in an amount of $&lt;span id="xdx_902_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_c20240321__20240321__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMiPbXOw0ZT" title="Damage, value"&gt;20,000&lt;/span&gt;. The Company believes that it has strong defenses to these claims and intends to vigorously
defend itself and the allegations made in this lawsuit.&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Common Stock&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;From January 1, 2024 through the date these consolidated
financial statements were issued, the Company issued &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSzBp8bbCk7c" title="Shares issued"&gt;378,292&lt;/span&gt; shares of its common stock as follows: (i) &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MembersOfBoardMember_zElhpoIO2Rqf" title="Shares issued"&gt;36,608&lt;/span&gt; shares to members of the
Board; (ii) &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20240101__20240101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zMrsLvR24Jji" title="Vested restricted stock units"&gt;256,853&lt;/span&gt; shares pursuant to vested restricted stock units that were released; and (iii) &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240101__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--FormerEmployeesMember_zjhftOUyHp4l" title="Shares issued"&gt;84,831&lt;/span&gt; shares to certain former employees.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Compensation
Plans&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
January 1, 2024 through the date these consolidated financial statements were issued, the Company granted common stock options and restricted
stock units totaling &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240101__20240314__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJJtSrikw8je" title="Granted common stock options"&gt;22,843&lt;/span&gt; and &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20240101__20240314__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zE7fHtSJhsJe" title="Working capital"&gt;222,396&lt;/span&gt;, respectively, to acquire shares of the Company&#x2019;s common stock to officers, directors,
employees and consultants.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-01-05_custom_ArenaLoanAgreementMember_us-gaap_SubsequentEventMember"
      decimals="-3"
      id="Fact003210"
      unitRef="USD">2797000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-31_custom_ArenaLoanAgreementMember"
      decimals="-3"
      id="Fact003212"
      unitRef="USD">110691000</us-gaap:DebtInstrumentFaceAmount>
    <AREN:ExerciseRightTerminationAmount
      contextRef="AsOf2024-01-02_custom_LicensingAgreementMember_us-gaap_SubsequentEventMember"
      decimals="-3"
      id="Fact003214"
      unitRef="USD">3750000</AREN:ExerciseRightTerminationAmount>
    <AREN:TerminationFeeDue
      contextRef="AsOf2024-01-02_custom_LicensingAgreementMember_us-gaap_SubsequentEventMember"
      decimals="-3"
      id="Fact003216"
      unitRef="USD">45000000</AREN:TerminationFeeDue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2024-01-022024-01-02_us-gaap_SubsequentEventMember_custom_ABGWarrantsMember"
      decimals="INF"
      id="Fact003218"
      unitRef="Shares">599724</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_custom_TransactionAgreementMember"
      decimals="INF"
      id="Fact003220"
      unitRef="Shares">25000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_TransactionAgreementMember"
      decimals="INF"
      id="Fact003222"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:SharePrice
      contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_TransactionAgreementMember"
      decimals="INF"
      id="Fact003224"
      unitRef="USDPShares">1000.00</us-gaap:SharePrice>
    <us-gaap:BusinessCombinationPriceOfAcquisitionExpected
      contextRef="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_custom_TransactionAgreementMember_us-gaap_PreferredStockMember"
      decimals="-3"
      id="Fact003226"
      unitRef="USD">25000000</us-gaap:BusinessCombinationPriceOfAcquisitionExpected>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-02-092024-02-09_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact003228"
      unitRef="Shares">5000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact003230"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:SharePrice
      contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact003232"
      unitRef="USDPShares">5.00</us-gaap:SharePrice>
    <us-gaap:BusinessCombinationPriceOfAcquisitionExpected
      contextRef="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact003234"
      unitRef="USD">25000000</us-gaap:BusinessCombinationPriceOfAcquisitionExpected>
    <us-gaap:BusinessCombinationConsiderationTransferredOther1
      contextRef="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember"
      decimals="-3"
      id="Fact003236"
      unitRef="USD">20000000</us-gaap:BusinessCombinationConsiderationTransferredOther1>
    <us-gaap:SharePrice
      contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember"
      decimals="INF"
      id="Fact003238"
      unitRef="USDPShares">3.86</us-gaap:SharePrice>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember"
      decimals="INF"
      id="Fact003240"
      unitRef="Shares">60000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="From2024-02-092024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember"
      decimals="INF"
      id="Fact003242"
      unitRef="Pure">0.015</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <AREN:SharesOutstandingPercentage
      contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember"
      decimals="INF"
      id="Fact003244"
      unitRef="Pure">0.79</AREN:SharesOutstandingPercentage>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember"
      decimals="INF"
      id="Fact003246"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <AREN:OutstandingPercentage
      contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_StockPurchaseAgreementMember"
      decimals="INF"
      id="Fact003248"
      unitRef="Pure">0.06</AREN:OutstandingPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-02-142024-02-14_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SubscriptionAgreementMember"
      decimals="INF"
      id="Fact003250"
      unitRef="Shares">5555555</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-14_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SubscriptionAgreementMember"
      decimals="INF"
      id="Fact003252"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SharePrice
      contextRef="AsOf2024-02-14_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SubscriptionAgreementMember"
      decimals="INF"
      id="Fact003254"
      unitRef="USDPShares">2.16</us-gaap:SharePrice>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2024-02-142024-02-14_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SubscriptionAgreementMember"
      decimals="-3"
      id="Fact003256"
      unitRef="USD">12000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <AREN:SharesOutstandingPercentage
      contextRef="AsOf2024-02-09_us-gaap_SubsequentEventMember_custom_SubscriptionAgreementMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact003258"
      unitRef="Pure">0.545</AREN:SharesOutstandingPercentage>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2024-02-152024-02-15_us-gaap_SubsequentEventMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact003260"
      unitRef="USD">2478000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <AREN:BusinessCombinationConsiderationTransferredInstallmentDue
      contextRef="From2024-02-152024-02-15_us-gaap_SubsequentEventMember_custom_FexyStudiosMember"
      decimals="-3"
      id="Fact003262"
      unitRef="USD">620000</AREN:BusinessCombinationConsiderationTransferredInstallmentDue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
      contextRef="From2024-02-152024-02-15_us-gaap_SubsequentEventMember_custom_FexyStudiosMember"
      id="Fact003264">(i) $2,225 pursuant to the put option where the Company gave the recipients
of the contingent consideration a right to put their 274,692 shares of the Company&#x2019;s common stock; (ii) $200 deferred payment due
under the purchase agreement; and (iii) $53 in other costs and reimbursable transition expenses payable.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <AREN:WorkingCapital
      contextRef="From2024-03-132024-03-14_us-gaap_SubsequentEventMember"
      decimals="-3"
      id="Fact003266"
      unitRef="USD">25000000</AREN:WorkingCapital>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2024-03-13_us-gaap_SubsequentEventMember_custom_SimplyfyLoanMember"
      decimals="INF"
      id="Fact003268"
      unitRef="Pure">0.10</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ShortTermBorrowings
      contextRef="AsOf2024-03-13_us-gaap_SubsequentEventMember"
      decimals="-3"
      id="Fact003270"
      unitRef="USD">7748000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="AsOf2024-03-13_us-gaap_SubsequentEventMember"
      decimals="-3"
      id="Fact003272"
      unitRef="USD">3448000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="From2024-03-212024-03-21_us-gaap_SubsequentEventMember"
      decimals="-3"
      id="Fact003274"
      unitRef="USD">20000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-01-01_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact003276"
      unitRef="Shares">378292</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-01-01_us-gaap_SubsequentEventMember_custom_MembersOfBoardMember"
      decimals="INF"
      id="Fact003278"
      unitRef="Shares">36608</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2024-01-012024-01-01_us-gaap_SubsequentEventMember_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact003280"
      unitRef="Shares">256853</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-01-01_us-gaap_SubsequentEventMember_custom_FormerEmployeesMember"
      decimals="INF"
      id="Fact003282"
      unitRef="Shares">84831</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2024-01-012024-03-14_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact003284"
      unitRef="Shares">22843</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2024-01-012024-03-14_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003286"
      unitRef="Shares">222396</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact001405"
          xlink:label="Fact001405"
          xlink:type="locator"/>
        <link:footnote id="Footnote001420" xlink:label="Footnote001420" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Operating lease
costs is presented net of sublease income that is not material.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001405"
          xlink:to="Footnote001420"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001407"
          xlink:label="Fact001407"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001407"
          xlink:to="Footnote001420"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001427"
          xlink:label="Fact001427"
          xlink:type="locator"/>
        <link:footnote id="Footnote001435" xlink:label="Footnote001435" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes certain
costs associated with a business membership agreement (see below) that permits access to certain office space for the years ended December
31, 2023 and 2022 of $<xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__"
  id="xdx_904_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--BusinessMembershipAgreementMember_zU6h5otEQ9t7"
  title="Operating lease cost">620</xhtml:span> and $<xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__"
  id="xdx_90A_eus-gaap--OperatingLeaseCost_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--BusinessMembershipAgreementMember_z6Ipd2wuVVn6"
  title="Operating lease cost">668</xhtml:span>, respectively, and month-to-month lease arrangements for the years ended December 31, 2023 and 2022
of $<xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__"
  id="xdx_90F_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--MonthToMonthLeaseArrangementMember_zKURtxpM8Jmd"
  title="Operating lease cost">396</xhtml:span> and $<xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE9wZXJhdGluZyBMZWFzZSBDb3N0cyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__"
  id="xdx_90C_eus-gaap--OperatingLeaseCost_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--MonthToMonthLeaseArrangementMember_zmCHQMmJCq5d"
  title="Operating lease cost">320</xhtml:span>, respectively.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001427"
          xlink:to="Footnote001435"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001428"
          xlink:label="Fact001428"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001428"
          xlink:to="Footnote001435"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001801"
          xlink:label="Fact001801"
          xlink:type="locator"/>
        <link:footnote id="Footnote001848" xlink:label="Footnote001848" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Shares
                                            of common stock issuable to MDB Capital Group, LLC (&#x201c;MDB&#x201d;) (see <xhtml:i>Common Stock
                                            to be Issued</xhtml:i> in Note 21).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001801"
          xlink:to="Footnote001848"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1803"
          xlink:label="xdx2ixbrl1803"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1803"
          xlink:to="Footnote001848"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1805"
          xlink:label="xdx2ixbrl1805"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1805"
          xlink:to="Footnote001848"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001807"
          xlink:label="Fact001807"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001807"
          xlink:to="Footnote001848"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1817"
          xlink:label="xdx2ixbrl1817"
          xlink:type="locator"/>
        <link:footnote id="Footnote001849" xlink:label="Footnote001849" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
                                            previously issued and converted debt or equity securities.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1817"
          xlink:to="Footnote001849"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001819"
          xlink:label="Fact001819"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001819"
          xlink:to="Footnote001849"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001821"
          xlink:label="Fact001821"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001821"
          xlink:to="Footnote001849"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001823"
          xlink:label="Fact001823"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001823"
          xlink:to="Footnote001849"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001825"
          xlink:label="Fact001825"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001825"
          xlink:to="Footnote001849"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001827"
          xlink:label="Fact001827"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001827"
          xlink:to="Footnote001849"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001829"
          xlink:label="Fact001829"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001829"
          xlink:to="Footnote001849"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001831"
          xlink:label="Fact001831"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001831"
          xlink:to="Footnote001849"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001833"
          xlink:label="Fact001833"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001833"
          xlink:to="Footnote001849"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001835"
          xlink:label="Fact001835"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001835"
          xlink:to="Footnote001849"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001837"
          xlink:label="Fact001837"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001837"
          xlink:to="Footnote001849"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001839"
          xlink:label="Fact001839"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001839"
          xlink:to="Footnote001849"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001868"
          xlink:label="Fact001868"
          xlink:type="locator"/>
        <link:footnote id="Footnote001915" xlink:label="Footnote001915" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Shares
                                            of common stock issuable to MDB.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001868"
          xlink:to="Footnote001915"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1870"
          xlink:label="xdx2ixbrl1870"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1870"
          xlink:to="Footnote001915"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1872"
          xlink:label="xdx2ixbrl1872"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1872"
          xlink:to="Footnote001915"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001874"
          xlink:label="Fact001874"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001874"
          xlink:to="Footnote001915"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1884"
          xlink:label="xdx2ixbrl1884"
          xlink:type="locator"/>
        <link:footnote id="Footnote001916" xlink:label="Footnote001916" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
                                            previously issued and converted debt or equity securities.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1884"
          xlink:to="Footnote001916"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001886"
          xlink:label="Fact001886"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001886"
          xlink:to="Footnote001916"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001888"
          xlink:label="Fact001888"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001888"
          xlink:to="Footnote001916"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001890"
          xlink:label="Fact001890"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001890"
          xlink:to="Footnote001916"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001892"
          xlink:label="Fact001892"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001892"
          xlink:to="Footnote001916"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001894"
          xlink:label="Fact001894"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001894"
          xlink:to="Footnote001916"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001896"
          xlink:label="Fact001896"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001896"
          xlink:to="Footnote001916"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001898"
          xlink:label="Fact001898"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001898"
          xlink:to="Footnote001916"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001900"
          xlink:label="Fact001900"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001900"
          xlink:to="Footnote001916"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001902"
          xlink:label="Fact001902"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001902"
          xlink:to="Footnote001916"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001904"
          xlink:label="Fact001904"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001904"
          xlink:to="Footnote001916"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001906"
          xlink:label="Fact001906"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001906"
          xlink:to="Footnote001916"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002210"
          xlink:label="Fact002210"
          xlink:type="locator"/>
        <link:footnote id="Footnote002215" xlink:label="Footnote002215" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">During the year ended December 31, 2023, the Company recorded interest income of $<xhtml:span id="xdx_904_eus-gaap--InterestExpenseDebt_pn3n3_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BRileyMember_zb04DjNbtnCa">338</xhtml:span> related
to the refunds received from the employee retention credits.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002210"
          xlink:to="Footnote002215"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2211"
          xlink:label="xdx2ixbrl2211"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2211"
          xlink:to="Footnote002215"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002572"
          xlink:label="Fact002572"
          xlink:type="locator"/>
        <link:footnote id="Footnote002573" xlink:label="Footnote002573" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common stock available
for future issuance under the 2022 Plan represent <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zz0cVnn4Bci8"
  title="Number of shares authorized to issue">1,800,000</xhtml:span> of authorized shares; less <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember_zbkmhNt13S1c"
  title="Number of shares common stock options, outstanding">1,066,597</xhtml:span> common stock options outstanding and
<xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU3RvY2sgT3B0aW9uIEFjdGl2aXR5IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzOJA6aChy6g"
  title="Number of shares common stock options, outstanding">190,556</xhtml:span> restricted stock units outstanding.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002572"
          xlink:to="Footnote002573"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
